PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Heatley, SL; Pietra, G; Lin, J; Widjaja, JML; Harpur, CM; Lester, S; Rossjohn, J; Szer, J; Schwarer, A; Bradstock, K; Bardy, PG; Mingari, MC; Moretta, L; Sullivan, LC; Brooks, AG				Heatley, Susan L.; Pietra, Gabriella; Lin, Jie; Widjaja, Jacqueline M. L.; Harpur, Christopher M.; Lester, Sue; Rossjohn, Jamie; Szer, Jeff; Schwarer, Anthony; Bradstock, Kenneth; Bardy, Peter G.; Mingari, Maria Cristina; Moretta, Lorenzo; Sullivan, Lucy C.; Brooks, Andrew G.			Polymorphism in Human Cytomegalovirus UL40 Impacts on Recognition of Human Leukocyte Antigen-E (HLA-E) by Natural Killer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE-BINDING-SPECIFICITY; SURFACE EXPRESSION; DIFFERENTIAL EXPRESSION; CD94/NKG2 RECEPTORS; NK RECEPTORS; LIGANDS; VARIABILITY; AFFINITIES; PROTECTION; EXPANSION	Natural killer (NK) cell recognition of the nonclassical human leukocyte antigen (HLA) molecule HLA-E is dependent on the presentation of a nonamer peptide derived from the leader sequence of other HLA molecules to CD94-NKG2 receptors. However, human cytomegalovirus can manipulate this central innate interaction through the provision of a "mimic" of the HLA-encoded peptide derived from the immunomodulatory glycoprotein UL40. Here, we analyzed UL40 sequences isolated from 32 hematopoietic stem cell transplantation recipients experiencing cytomegalovirus reactivation. The UL40 protein showed a "polymorphic hot spot" within the region that encodes the HLA leader sequence mimic. Although all sequences that were identical to those encoded within HLA-I genes permitted the interaction between HLA-E and CD94-NKG2 receptors, other UL40 polymorphisms reduced the affinity of the interaction between HLA-E and CD94-NKG2 receptors. Furthermore, functional studies using NK cell clones expressing either the inhibitory receptor CD94-NKG2A or the activating receptor CD94-NKG2C identified UL40-encoded peptides that were capable of inhibiting target cell lysis via interaction with CD94-NKG2A, yet had little capacity to activate NK cells through CD94-NKG2C. The data suggest that UL40 polymorphisms may aid evasion of NK cell immunosurveillance by modulating the affinity of the interaction with CD94-NKG2 receptors.	[Heatley, Susan L.; Lin, Jie; Widjaja, Jacqueline M. L.; Harpur, Christopher M.; Sullivan, Lucy C.; Brooks, Andrew G.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Pietra, Gabriella; Mingari, Maria Cristina] Univ Genoa, Dept Expt Med, I-16132 Genoa, Italy; [Lester, Sue] Queen Elizabeth Hosp, Dept Rheumatol, Woodville, SA 5011, Australia; [Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Szer, Jeff] Royal Melbourne Hosp, Dept Clin Haematol, Melbourne, Vic 3050, Australia; [Szer, Jeff] Royal Melbourne Hosp, Bone Marrow Transplant Serv, Melbourne, Vic 3050, Australia; [Schwarer, Anthony] Alfred Hosp, Malignant Haematol & Stem Cell Transplantat Serv, Melbourne, Vic 3004, Australia; [Bradstock, Kenneth] Westmead Hosp, Dept Haematol, Westmead, NSW 2145, Australia; [Bardy, Peter G.] Royal Adelaide Hosp, Canc Serv, Adelaide, SA 5000, Australia; [Mingari, Maria Cristina] IRCCS AOU San Martino IST, I-16132 Genoa, Italy; [Moretta, Lorenzo] Ist Giannina Gaslini, I-16147 Genoa, Italy	University of Melbourne; University of Genoa; Monash University; Royal Melbourne Hospital; Royal Melbourne Hospital; Florey Institute of Neuroscience & Mental Health; University of Sydney; Royal Adelaide Hospital; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS Istituto Giannina Gaslini	Brooks, AG (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	agbrooks@unimelb.edu.au	Moretta, Lorenzo/AAA-7239-2020; pietra, gabriella/J-7204-2016; Mingari, Maria Cristina/AAB-1315-2019; Rossjohn, Jamie/F-9032-2013; Heatley, Susan/AGP-2179-2022	Moretta, Lorenzo/0000-0003-4658-1747; pietra, gabriella/0000-0002-7080-531X; Rossjohn, Jamie/0000-0002-2020-7522; Widjaja, Jacqueline/0000-0002-4946-5584; Sullivan, Lucy/0000-0003-2907-4989; Brooks, Andrew/0000-0002-4085-9683; Heatley, Susan/0000-0001-7497-6477; Szer, Jeff/0000-0001-6783-2301; Harpur, Chris/0000-0002-3238-9861	National Health and Medical Research Council; Australia fellowship from the National Health and Medical Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australia fellowship from the National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council, a career development award from the National Health and Medical Research Council (to L. C. S.), and an Australia fellowship from the National Health and Medical Research Council (to J. R.).	Bland FA, 2003, J BIOL CHEM, V278, P33747, DOI 10.1074/jbc.M305593200; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Braud VM, 1998, CURR BIOL, V8, P1, DOI 10.1016/S0960-9822(98)70014-4; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brooks AG, 1999, J IMMUNOL, V162, P305; Brostjan C, 2002, J IMMUNOL METHODS, V264, P109, DOI 10.1016/S0022-1759(02)00084-4; Carretero M, 1997, EUR J IMMUNOL, V27, P563, DOI 10.1002/eji.1830270230; Cerboni C, 2001, EUR J IMMUNOL, V31, P2926, DOI 10.1002/1521-4141(2001010)31:10<2926::AID-IMMU2926>3.0.CO;2-2; Corte MFD, 2010, J CLIN VIROL, V47, P161, DOI 10.1016/j.jcv.2009.11.023; Garrigue I, 2008, TRANSPLANTATION, V86, P826, DOI 10.1097/TP.0b013e3181859edd; Garrigue I, 2007, J CLIN VIROL, V40, P120, DOI 10.1016/j.jcv.2007.06.015; Guma M, 2006, BLOOD, V107, P3624, DOI 10.1182/blood-2005-09-3682; Hoare HL, 2008, J MOL BIOL, V377, P1297, DOI 10.1016/j.jmb.2008.01.098; Kaiser BK, 2005, J IMMUNOL, V174, P2878, DOI 10.4049/jimmunol.174.5.2878; Llano M, 1998, EUR J IMMUNOL, V28, P2854, DOI 10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W; Magri G, 2011, BLOOD, V117, P848, DOI 10.1182/blood-2010-08-301374; Miller JD, 2003, J IMMUNOL, V171, P1369, DOI 10.4049/jimmunol.171.3.1369; Miyasaka T, 2013, TISSUE ANTIGENS, V81, P72, DOI 10.1111/tan.12041; Miyasaka T, 2011, GENE, V472, P42, DOI 10.1016/j.gene.2010.10.007; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; O'Callaghan CA, 1998, MOL CELL, V1, P531, DOI 10.1016/S1097-2765(00)80053-2; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Petrie EJ, 2008, J EXP MED, V205, P725, DOI 10.1084/jem.20072525; POGGI A, 1990, J EXP MED, V172, P1409, DOI 10.1084/jem.172.5.1409; Prod'homme V, 2012, J IMMUNOL, V188, P2794, DOI 10.4049/jimmunol.1102068; SoderbergNaucler C, 1997, CELL, V91, P119, DOI 10.1016/S0092-8674(01)80014-3; Strong RK, 2003, J BIOL CHEM, V278, P5082, DOI 10.1074/jbc.M208268200; Sullivan LC, 2007, IMMUNITY, V27, P900, DOI 10.1016/j.immuni.2007.10.013; Tomasec P, 2000, SCIENCE, V287, P1031, DOI 10.1126/science.287.5455.1031; Ulbrecht M, 2000, J IMMUNOL, V164, P5019, DOI 10.4049/jimmunol.164.10.5019; Vales-Gomez M, 2000, HUM IMMUNOL, V61, P28, DOI 10.1016/S0198-8859(99)00159-7; Vales-Gomez M, 1999, EMBO J, V18, P4250, DOI 10.1093/emboj/18.15.4250; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; Wang ECY, 2002, P NATL ACAD SCI USA, V99, P7570, DOI 10.1073/pnas.112680099; Wilkinson GWG, 2008, J CLIN VIROL, V41, P206, DOI 10.1016/j.jcv.2007.10.027; Yewdell JW, 2002, NAT IMMUNOL, V3, P1019, DOI 10.1038/ni1102-1019	36	74	75	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8679	8690		10.1074/jbc.M112.409672	http://dx.doi.org/10.1074/jbc.M112.409672			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23335510	Green Published, hybrid			2022-12-25	WOS:000316564500068
J	Chae, M; Carman, GM				Chae, Minjung; Carman, George M.			Characterization of the Yeast Actin Patch Protein App1p Phosphatidate Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIACYLGLYCEROL PYROPHOSPHATE PHOSPHATASE; CYTIDINE DIPHOSPHATE CHOLINE; PHOSPHOLIPASE-D ACTIVITY; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; TRITON X-100; KINETIC-ANALYSIS; ENZYMATIC-SYNTHESIS; MIXED MICELLES; KINASE-C	Yeast App1p is a phosphatidate phosphatase (PAP) that associates with endocytic proteins at cortical actin patches. App1p, which catalyzes the conversion of phosphatidate (PA) to diacylglycerol, is unique among Mg2+-dependent PAP enzymes in that its reaction is not involved with de novo lipid synthesis. Instead, App1p PAP is thought to play a role in endocytosis because its substrate and product facilitate membrane fission/fusion events and regulate enzymes that govern vesicular movement. App1p PAP was purified from yeast and characterized with respect to its enzymological, kinetic, and regulatory properties. Maximum PAP activity was dependent on Triton X-100 (20mM), PA (2mM), Mg2+ (0.5mM), and 2-mercaptoethanol (10 mM) at pH 7.5 and 30 degrees C. Analysis of surface dilution kinetics with Triton X-100/PA-mixed micelles yielded constants for surface binding (K-s(A) = 11mM), interfacialPAbinding (K-m(B) = 4.2 mol %), and catalytic efficiency (V-max = 557 mu mol/min/mg). The activation energy, turnover number, and equilibrium constant were 16.5 kcal/mol, 406 s(-1), and 16.2, respectively. PAP activity was stimulated by anionic lipids (cardiolipin, phosphatidylglycerol, phosphatidylserine, and CDP-diacylglycerol) and inhibited by zwitterionic (phosphatidylcholine and phosphatidyl-ethanolamine) and cationic (sphinganine) lipids, nucleotides (ATP and CTP), N-ethylmaleimide, propranolol, phenylglyoxal, and divalent cations (Ca2+, Mn2+, and Zn2+). App1p also utilized diacylglycerol pyrophosphate and lyso-PA as substrates with specificity constants 4- and 7-fold lower, respectively, when compared with PA.	Rutgers State Univ, Dept Food Sci, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu			National Institutes of Health [GM-28140, NS046593]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028140, R37GM028140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS046593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-28140.; We thank Gil-Soo Han for helpful comments during the course of this work and in the preparation of the manuscript. The mass spectrometry data were obtained from an Orbitrap instrument funded in part by National Institutes of Health Grant NS046593, for the support of the University of Medicine and Dentistry of New Jersey Neuroproteomics Core Facility.	Asp L, 2009, MOL BIOL CELL, V20, P780, DOI 10.1091/mbc.E08-03-0256; BAELEE M, 1990, J BIOL CHEM, V265, P7221; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BHAT BG, 1994, J BIOL CHEM, V269, P13172; BISHOP WR, 1986, J BIOL CHEM, V261, P6993; Blackwood RA, 1997, AM J PHYSIOL-CELL PH, V272, pC1279, DOI 10.1152/ajpcell.1997.272.4.C1279; Bon E, 2000, YEAST, V16, P1229, DOI 10.1002/1097-0061(20000930)16:13<1229::AID-YEA618>3.0.CO;2-Q; BORKENHAGEN LF, 1957, J BIOL CHEM, V227, P951; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; BUXEDA RJ, 1991, J BIOL CHEM, V266, P13859; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2007, BBA-MOL CELL BIOL L, V1771, P322, DOI 10.1016/j.bbalip.2006.05.006; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; CARMAN GM, 1979, J BIOL CHEM, V254, P8391; Carman GM, 1997, BBA-LIPID LIPID MET, V1348, P45, DOI 10.1016/S0005-2760(97)00095-7; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chae M, 2012, J BIOL CHEM, V287, P40186, DOI 10.1074/jbc.M112.421776; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; Das A, 2006, MOL BIOCHEM PARASIT, V150, P201, DOI 10.1016/j.molbiopara.2006.08.002; DAVIDSON JB, 1971, BIOCHEM BIOPH RES CO, V42, P1191, DOI 10.1016/0006-291X(71)90032-5; Dawson Rex M.C., 1986, DATA BIOCH RES; DEEMS RA, 1975, J BIOL CHEM, V250, P9013; Dillon DA, 1997, J BIOL CHEM, V272, P10361; Dillon DA, 1996, J BIOL CHEM, V271, P30548, DOI 10.1074/jbc.271.48.30548; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; EXTON JH, 1990, J BIOL CHEM, V265, P1; Fazi B, 2002, J BIOL CHEM, V277, P5290, DOI 10.1074/jbc.M109848200; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Furneisen JM, 2000, BBA-MOL CELL BIOL L, V1484, P71, DOI 10.1016/S1388-1981(99)00202-4; Goni FM, 1999, PROG LIPID RES, V38, P1, DOI 10.1016/S0163-7827(98)00021-6; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2004, J BIOL CHEM, V279, P5338, DOI 10.1074/jbc.M311779200; Han GS, 2001, J BIOL CHEM, V276, P10126, DOI 10.1074/jbc.M011421200; HANNUN YA, 1985, J BIOL CHEM, V260, P39; Havriluk T, 2008, ANAL BIOCHEM, V373, P392, DOI 10.1016/j.ab.2007.08.037; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HJELMSTAD RH, 1991, BIOCHEMISTRY-US, V30, P1731, DOI 10.1021/bi00221a001; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Howe AG, 2006, CAN J PHYSIOL PHARM, V84, P29, DOI 10.1139/Y05-138; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jain MR, 2012, J PROTEOME RES, V11, P1791, DOI 10.1021/pr201043u; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; JONES GA, 1993, J BIOL CHEM, V268, P20845; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; KENNEDY EP, 1956, J BIOL CHEM, V222, P185; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kent C, 1999, TRENDS BIOCHEM SCI, V24, P146, DOI 10.1016/S0968-0004(99)01365-1; KIYASU JY, 1963, J BIOL CHEM, V238, P2293; Kocsis MG, 1996, LIPIDS, V31, P785, DOI 10.1007/BF02522974; KOTER M, 1978, BIOCHIM BIOPHYS ACTA, V514, P255, DOI 10.1016/0005-2736(78)90296-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; LEHEL C, 1995, J BIOL CHEM, V270, P19651, DOI 10.1074/jbc.270.33.19651; LIAO MJ, 1979, BIOCHIM BIOPHYS ACTA, V550, P157, DOI 10.1016/0005-2736(79)90204-9; LICHTENBERG D, 1983, BIOCHIM BIOPHYS ACTA, V737, P285, DOI 10.1016/0304-4157(83)90004-7; LIN YP, 1989, J BIOL CHEM, V264, P8641; LIN YP, 1990, J BIOL CHEM, V265, P166; Madera M, 2004, NUCLEIC ACIDS RES, V32, pD235, DOI 10.1093/nar/gkh117; Mahuren JD, 2001, ANAL BIOCHEM, V298, P241, DOI 10.1006/abio.2001.5402; Maissel A, 2006, CELL SIGNAL, V18, P1127, DOI 10.1016/j.cellsig.2005.09.003; Michelot A, 2010, CURR BIOL, V20, P1890, DOI 10.1016/j.cub.2010.10.016; MORITZ A, 1992, J BIOL CHEM, V267, P7207; MORLOCK KR, 1991, J BIOL CHEM, V266, P3586; Morris AJ, 2007, BIOCHEM SOC SYMP, V74, P247, DOI 10.1042/BSS2007c20; MULLMANN TJ, 1991, J BIOL CHEM, V266, P2013; NICKELS JT, 1994, J BIOL CHEM, V269, P11018; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; OZIERKALOGEROPOULOS O, 1991, MOL GEN GENET, V231, P7, DOI 10.1007/BF00293815; PAULUS H, 1960, J BIOL CHEM, V235, P1303; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; ROBSON RJ, 1977, J PHYS CHEM-US, V81, P1075, DOI 10.1021/j100526a010; Rose MD., 1990, METHODS YEAST GENETI; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Sambrook J., 1989, MOL CLONING LAB MANU; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; Singer-Kruger B, 1998, J CELL SCI, V111, P3347; SMITH SW, 1957, J BIOL CHEM, V228, P915; Stukey J, 1997, PROTEIN SCI, V6, P469; Sun Y., 2012, J CELL SCI IN PRESS; Sun YD, 2007, J CELL BIOL, V177, P355, DOI 10.1083/jcb.200611011; TALWALKAR RT, 1973, BIOCHIM BIOPHYS ACTA, V306, P412, DOI 10.1016/0005-2760(73)90180-X; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Toke DA, 1999, BIOCHEMISTRY-US, V38, P14606, DOI 10.1021/bi991472x; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Tonikian R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000218; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; WALSH JP, 1986, J BIOL CHEM, V261, P5062; WALSH JP, 1986, J BIOL CHEM, V261, P6239; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; WARNER TG, 1975, J BIOL CHEM, V250, P8004; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; WEISS SB, 1958, J BIOL CHEM, V231, P53; WEISS SB, 1960, J BIOL CHEM, V235, P40; Wu WI, 1996, J BIOL CHEM, V271, P1868, DOI 10.1074/jbc.271.4.1868; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824	121	15	18	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6427	6437		10.1074/jbc.M112.449629	http://dx.doi.org/10.1074/jbc.M112.449629			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23335564	Green Published, hybrid			2022-12-25	WOS:000315820700037
J	Kelly, PJ; Xu, CL; Lucas, H; Loftis, A; Abete, J; Zeoli, F; Stevens, A; Jaegersen, K; Ackerson, K; Gessner, A; Kaltenboeck, B; Wang, CM				Kelly, Patrick J.; Xu, Chuanling; Lucas, Helene; Loftis, Amanda; Abete, Jamie; Zeoli, Frank; Stevens, Audrey; Jaegersen, Kirsten; Ackerson, Kate; Gessner, April; Kaltenboeck, Bernhard; Wang, Chengming			Ehrlichiosis, Babesiosis, Anaplasmosis and Hepatozoonosis in Dogs from St. Kitts, West Indies	PLOS ONE			English	Article							TROPICAL CANINE PANCYTOPENIA; SEROLOGICAL DETECTION; RICKETTSIA-AFRICAE; SPP. INFECTION; DOXYCYCLINE; DIAGNOSIS; BLOOD; PCR; THERAPY; GIBSONI	Background: Although tick-borne diseases are important causes of morbidity and mortality in dogs in tropical areas, there is little information on the agents causing these infections in the Caribbean. Methodology: We used PCRs to test blood from a cross-section of dogs on St Kitts for Ehrlichia (E.) canis, Babesia (B.) spp., Anaplasma (A.) spp. and Hepatozoon (H.) spp. Antibodies against E. canis and A. phagocytophilum/platys were detected using commercial immunochromatography tests. Records of the dogs were examined retrospectively to obtain clinical and laboratory data. Principal findings: There was serological and/or PCR evidence of infections of dogs with E. canis (27%; 46/170), Babesia spp. (24%; 90/372) including B. canis vogeli (12%; 43/372) and B. gibsoni (10%; 36/372), A. platys (11%; 17/157) and H. canis (6%; 15/266). We could not identify the Babesia sp. detected in nine dogs. There was evidence of multiple infections with dual infections with E. canis and B. canis vogeli (8%; 14/179) or B. gibsoni (7%; 11/170) being the most common. There was agreement between immunochromatography and PCR test results for E. canis for 87% of dogs. Only 13% of exposed dogs had signs of a tick-borne disease and 38% had laboratory abnormalities. All 10 dogs presenting for a recheck after treatment of E. canis with doxycycline were apparently healthy although all remained seropositive and six still had laboratory abnormalities despite an average of two treatments with the most recent being around 12 months previously. Infections with Babesia spp. were also mainly subclinical with only 6% (4/67) showing clinical signs and 13% (9/67) having laboratory abnormalities. Similarly, animals with evidence of infections with A. platys and H. canis were largely apparently healthy with only occasional laboratory abnormalities. Conclusions: Dogs are commonly infected with tick-borne pathogens in the Caribbean with most having no clinical signs or laboratory abnormalities.	[Xu, Chuanling; Wang, Chengming] Yangzhou Univ, Yangzhou, Jiangsu, Peoples R China; [Kaltenboeck, Bernhard] Auburn Univ, Coll Vet Med, Auburn, AL 36849 USA	Yangzhou University; Auburn University System; Auburn University	Wang, CM (corresponding author), Yangzhou Univ, Yangzhou, Jiangsu, Peoples R China.	wangcm@yzu.edu.cn	Wang, Chengming/G-2673-2010		Ross University School of Veterinary Medicine	Ross University School of Veterinary Medicine	This study was funded by the Ross University School of Veterinary Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apanaskevich DA, 2007, ONDERSTEPOORT J VET, V74, P181; Ayoob AL, 2010, J VET EMERG CRIT CAR, V20, P77, DOI 10.1111/j.1476-4431.2009.00489.x; Baneth G, 2009, VET MICROBIOL, V136, P321, DOI 10.1016/j.vetmic.2008.11.022; Bartsch RC, 1996, J VET INTERN MED, V10, P271, DOI 10.1111/j.1939-1676.1996.tb02061.x; Beck R, 2009, INT J PARASITOL, V39, P843, DOI 10.1016/j.ijpara.2008.12.005; Belanger M, 2002, J CLIN MICROBIOL, V40, P3506, DOI 10.1128/JCM.40.9.3506-3508.2002; Birkenheuer AJ, 1999, J AM ANIM HOSP ASSOC, V35, P125, DOI 10.5326/15473317-35-2-125; BOOL P. H., 1957, JOUR AMER VET MED ASSOC, V130, P418; Breitschwerdt EB, 1998, J CLIN MICROBIOL, V36, P2645, DOI 10.1128/JCM.36.9.2645-2651.1998; Breitschwerdt EB, 1998, ANTIMICROB AGENTS CH, V42, P362; Brown GK, 2006, AUST VET J, V84, P321, DOI 10.1111/j.1751-0813.2006.00029.x; BUHLES WC, 1975, J COMP PATHOL, V85, P511, DOI 10.1016/0021-9975(75)90118-8; BUHLES WC, 1974, J INFECT DIS, V130, P357, DOI 10.1093/infdis/130.4.357; Criado-Fornelio A, 2003, VET PARASITOL, V113, P189, DOI 10.1016/S0304-4017(03)00078-5; Eddlestone SM, 2007, J VET INTERN MED, V21, P1237, DOI 10.1892/07-061.1; Georges K, 2008, ANN NY ACAD SCI, V1149, P196, DOI 10.1196/annals.1428.082; GROVES MG, 1975, AM J VET RES, V36, P937; Harrus S, 2004, ANTIMICROB AGENTS CH, V48, P4488, DOI 10.1128/AAC.48.11.4488-4490.2004; Harrus S, 1998, J CLIN MICROBIOL, V36, P2140, DOI 10.1128/JCM.36.7.2140-2142.1998; Harrus S, 2002, VET MICROBIOL, V86, P361, DOI 10.1016/S0378-1135(02)00022-6; Harrus S, 1998, J CLIN MICROBIOL, V36, P73, DOI 10.1128/JCM.36.1.73-76.1998; Harrus S, 1997, VET REC, V141, P247, DOI 10.1136/vr.141.10.247; Harrus S, 2011, VET J, V187, P292, DOI 10.1016/j.tvjl.2010.02.001; Hoff B, 2008, CAN VET J, V49, P593; HUXSOLL D L, 1970, Journal of Wildlife Diseases, V6, P220; HUXSOLL DL, 1972, EXP PARASITOL, V31, P53, DOI 10.1016/0014-4894(72)90046-X; IQBAL Z, 1994, J CLIN MICROBIOL, V32, P1644, DOI 10.1128/JCM.32.7.1644-1649.1994; IQBAL Z, 1994, J CLIN MICROBIOL, V32, P1658, DOI 10.1128/JCM.32.7.1658-1662.1994; Jefferies R, 2007, AUST VET J, V85, P459, DOI 10.1111/j.1751-0813.2007.00220.x; Kelly PJ, 2009, J INFECT DEV COUNTR, V3, P561, DOI 10.3855/jidc.475; Kelly PJ, 2006, EMERG INFECT DIS, V12, P224, DOI 10.3201/eid1202.050903; Kelly PJ, 1998, J S AFR VET ASSOC, V69, P55; Kelly PJ, 2000, J S AFR VET ASSOC, V71, P77; Kelly PJ, 2009, P 23 M AM SOC RICK; Kjemtrup AM, 2006, VET PARASITOL, V138, P103, DOI 10.1016/j.vetpar.2006.01.044; Kordick SK, 1999, J CLIN MICROBIOL, V37, P2631, DOI 10.1128/JCM.37.8.2631-2638.1999; Lehtinen LE, 2008, VET PARASITOL, V151, P150, DOI 10.1016/j.vetpar.2007.10.022; Li YH, 2008, VET PARASITOL, V157, P50, DOI 10.1016/j.vetpar.2008.06.027; MATTHEWMAN LA, 1993, J S AFR VET ASSOC, V64, P111; McBride JW, 2003, INFECT IMMUN, V71, P2516, DOI 10.1128/IAI.71.5.2516-2524.2003; McClure JC, 2010, ANTIMICROB AGENTS CH, V54, P5012, DOI 10.1128/AAC.01622-09; Mylonakis ME, 2004, J AM ANIM HOSP ASSOC, V40, P174, DOI 10.5326/0400174; Neer T. M., 2006, INFECT DIS DOG CAT, P203; Neer TM, 2002, J VET INTERN MED, V16, P309, DOI 10.1892/0891-6640(2002)016<0309:CSOEDO>2.3.CO;2; O'Dwyer LH, 2011, REV BRAS PARASITOL V, V20, P181, DOI 10.1590/S1984-29612011000300002; Parola P, 2003, ANN TROP MED PARASIT, V97, P535, DOI 10.1179/000349803225001382; PERILLE AL, 1991, J VET INTERN MED, V5, P195, DOI 10.1111/j.1939-1676.1991.tb00947.x; Schaefer JJ, 2008, ANN NY ACAD SCI, V1149, P263, DOI 10.1196/annals.1428.087; Solano-Gallego L, 2011, VET PARASITOL, V181, P48, DOI 10.1016/j.vetpar.2011.04.023; Taboada J, 2006, INFECT DIS DOG CAT, P722; UILENBERG G, 1989, VET QUART, V11, P33, DOI 10.1080/01652176.1989.9694194; Vargas-Hernandez G, 2012, VET PARASITOL, V186, P254, DOI 10.1016/j.vetpar.2011.11.011; Wang CM, 2010, VET PARASITOL, V168, P11, DOI 10.1016/j.vetpar.2009.10.015; Wen BH, 1997, J CLIN MICROBIOL, V35, P1852, DOI 10.1128/JCM.35.7.1852-1855.1997; Wong SSY, 2011, VECTOR-BORNE ZOONOT, V11, P1269, DOI 10.1089/vbz.2010.0265; WOODY BJ, 1991, VET CLIN N AM-SMALL, V21, P75, DOI 10.1016/S0195-5616(91)50009-7; Yabsley MJ, 2008, VET PARASITOL, V151, P279, DOI 10.1016/j.vetpar.2007.11.008; Yeagley TJ, 2009, JAVMA-J AM VET MED A, V235, P535, DOI 10.2460/javma.235.5.535; Zandvliet MMJM, 2004, TIJDSCHR DIERGENEESK, V129, P740	59	44	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53450	10.1371/journal.pone.0053450	http://dx.doi.org/10.1371/journal.pone.0053450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335965	gold, Green Submitted, Green Published			2022-12-25	WOS:000314707700019
J	Jiao, K; Zhang, J; Zhang, M; Wei, YY; Wu, YP; Qiu, ZY; He, JJ; Cao, YX; Hu, JT; Zhu, H; Niu, LN; Cao, X; Yang, K; Wang, MQ				Jiao, Kai; Zhang, Jing; Zhang, Mian; Wei, Yuying; Wu, Yaoping; Qiu, Zhong Ying; He, Jianjun; Cao, Yunxin; Hu, Jintao; Zhu, Han; Niu, Li-Na; Cao, Xu; Yang, Kun; Wang, Mei-Qing			The Identification of CD163 Expressing Phagocytic Chondrocytes in Joint Cartilage and Its Novel Scavenger Role in Cartilage Degradation	PLOS ONE			English	Article							DIFFERENTIATION ANTIGEN; CONDYLAR CARTILAGE; RECEPTOR CD163; CELLS; MACROPHAGES; ACTIVATION; INHIBITORS; PROTEIN; MEMBER	Background: Cartilage degradation is a typical characteristic of arthritis. This study examined whether there was a subset of phagocytic chondrocytes that expressed the specific macrophage marker, CD163, and investigated their role in cartilage degradation. Methods: Cartilage from the knee and temporomandibular joints of Sprague-Dawley rats was harvested. Cartilage degradation was experimentally-induced in rat temporomandibular joints, using published biomechanical dental methods. The expression levels of CD163 and inflammatory factors within cartilage, and the ability of CD163(+) chondrocytes to conduct phagocytosis were investigated. Cartilage from the knees of patients with osteoarthritis and normal cartilage from knee amputations was also investigated. Results: In the experimentally-induced degrading cartilage from temporomandibular joints, phagocytes were capable of engulfing neighboring apoptotic and necrotic cells, and the levels of CD163, TNF-alpha and MMPs were all increased (P < 0.05). However, the levels of ACP-1, NO and ROS, which relate to cellular digestion capability were unchanged (P > 0.05). CD163(+) chondrocytes were found in the cartilage mid-zone of temporomandibular joints and knee from healthy, three-week old rats. Furthermore, an increased number of CD163(+) chondrocytes with enhanced phagocytic activity were present in Col-II+ chondrocytes isolated from the degraded cartilage of temporomandibular joints in the eight-week experimental group compared with their age-matched controls. Increased number with enhanced phagocytic activity of CD163(+) chondrocytes were also found in isolated Col-II+ chondrocytes stimulated with TNF-alpha (P < 0.05). Mid-zone distribution of CD163(+) cells accompanied with increased expression of CD163 and TNF-alpha were further confirmed in the isolated Col-II+ chondrocytes from the knee cartilage of human patients with osteoarthritis, in contrast to the controls (both P < 0.05). Conclusions: An increased number of CD163(+) chondrocytes with enhanced phagocytic activity were discovered within degraded joint cartilage, indicating a role in eliminating degraded tissues. Targeting these cells provides a new strategy for the treatment of arthritis.	[Jiao, Kai; Zhang, Jing; Zhang, Mian; Qiu, Zhong Ying; He, Jianjun; Wang, Mei-Qing] Fourth Mil Med Univ, Dept Oral Anat & Physiol, Xian 710032, Peoples R China; [Jiao, Kai; Zhang, Jing; Zhang, Mian; Qiu, Zhong Ying; He, Jianjun; Wang, Mei-Qing] Fourth Mil Med Univ, TMD, Sch Stomatol, Xian 710032, Peoples R China; [Wei, Yuying; Cao, Yunxin; Hu, Jintao; Yang, Kun] Fourth Mil Med Univ, Dept Immunol, Xian 710032, Peoples R China; [Wu, Yaoping; Zhu, Han] Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian 710032, Peoples R China; [Niu, Li-Na] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, Xian 710032, Peoples R China; [Cao, Xu] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD USA	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Johns Hopkins University	Yang, K (corresponding author), Fourth Mil Med Univ, Dept Immunol, Xian 710032, Peoples R China.	yangkunkun@fmmu.edu.cn; mqwang@fmmu.edu.cn	Wang, Meiqing/K-3584-2019; niu, lina/GWR-3585-2022	jiao, kai/0000-0002-1901-8329	National Natural Science Foundation of China [81271169, 30801315, 30872870]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (numbers 81271169, 30801315, 30872870). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson SB, 2006, ADV DRUG DELIVER REV, V58, P212, DOI 10.1016/j.addr.2006.01.008; AREND WP, 1990, ARTHRITIS RHEUM-US, V33, P305, DOI 10.1002/art.1780330302; Bigg Heather F., 2001, Current Opinion in Pharmacology, V1, P314, DOI 10.1016/S1471-4892(01)00055-8; Chang C, 2003, OSTEOARTHR CARTILAGE, V11, P603, DOI 10.1016/S1063-4584(03)00087-6; Cho TJ, 2003, ARTHRITIS RHEUM-US, V48, P2845, DOI 10.1002/art.11390; Cristina E, 2004, MICROSC RES TECHNIQ, V64, P269, DOI 10.1002/jemt.20080; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Fabriek BO, 2009, BLOOD, V113, P887, DOI 10.1182/blood-2008-07-167064; GOERDT S, 1993, AM J PATHOL, V142, P1409; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Heinegard D, 2011, NAT REV RHEUMATOL, V7, P50, DOI 10.1038/nrrheum.2010.198; Hogger P, 1998, J IMMUNOL, V161, P1883; Hunter DJ, 2011, NAT REV RHEUMATOL, V7, P13, DOI 10.1038/nrrheum.2010.178; Jiao K, 2011, BONE, V48, P362, DOI 10.1016/j.bone.2010.09.010; Jiao K, 2009, APOPTOSIS, V14, P22, DOI 10.1007/s10495-008-0279-5; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6; LAW SKA, 1993, EUR J IMMUNOL, V23, P2320, DOI 10.1002/eji.1830230940; Ling Y, 2010, BIOORGAN MED CHEM, V18, P3448, DOI 10.1016/j.bmc.2010.03.077; Lotz MK, 2010, ARTHRITIS RHEUM-US, V62, P2206, DOI 10.1002/art.27528; Maniecki MB, 2011, IMMUNOBIOLOGY, V216, P882, DOI 10.1016/j.imbio.2011.02.001; Martel-Pelletier J, 2001, BEST PRACT RES CL RH, V15, P805, DOI 10.1053/berh.2001.0195; Polfliet MMJ, 2006, IMMUNOBIOLOGY, V211, P419, DOI 10.1016/j.imbio.2006.05.015; Sampson ER, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002214; Sanchez C, 1999, J IMMUNOL, V162, P5230; Umlauf D, 2010, CELL MOL LIFE SCI, V67, P4197, DOI 10.1007/s00018-010-0498-0; Wang GW, 2010, ARCH ORAL BIOL, V55, P887, DOI 10.1016/j.archoralbio.2010.07.013; Yatsugi N, 2000, J Orthop Sci, V5, P150, DOI 10.1007/s007760050142; Ye JS, 2010, REGUL PEPTIDES, V161, P58, DOI 10.1016/j.regpep.2009.12.024; ZWADLO G, 1987, EXP CELL BIOL, V55, P295	31	35	37	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53312	10.1371/journal.pone.0053312	http://dx.doi.org/10.1371/journal.pone.0053312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326413	Green Published, Green Submitted, gold			2022-12-25	WOS:000314705800040
J	Lee, S; Paik, SH; Kim, HJ; Ryu, HH; Cha, S; Jo, SJ; Eun, HC; Seo, JS; Kim, JI; Kwon, OS				Lee, Seungbok; Paik, Seung Hwan; Kim, Hyun-Jin; Ryu, Hyeong Ho; Cha, Soeun; Jo, Seong Jin; Eun, Hee Chul; Seo, Jeong-Sun; Kim, Jong-Il; Kwon, Oh Sang			Exomic Sequencing of Immune-Related Genes Reveals Novel Candidate Variants Associated with Alopecia Universalis	PLOS ONE			English	Article							RECEPTOR ANTAGONIST; AREATA; SUSCEPTIBILITY; MUTATIONS; SCLEROSIS; SEVERITY; ALLELES; DISEASE; CANCER; LOCUS	Alopecia areata (AA) is a common autoimmune disorder mostly presented as round patches of hair loss and subclassified into alopecia totalis/alopecia universalis (AT/AU) based on the area of alopecia. Although AA is relatively common, only 5% of AA patients progress to AT/AU, which affect the whole scalp and whole body respectively. To determine genetic determinants of this orphan disease, we undertook whole-exome sequencing of 6 samples from AU patients, and 26 variants in immune-related genes were selected as candidates. When an additional 14 AU samples were genotyped for these candidates, 6 of them remained at the level of significance in comparison with 155 Asian controls (p<1.92610(-3)). Linkage disequilibrium was observed between some of the most significant SNPs, including rs41559420 of HLA-DRB5 (p<0.001, OR 44.57) and rs28362679 of BTNL2 (p<0.001, OR 30.21). While BTNL2 was reported as a general susceptibility gene of AA previously, HLA-DRB5 has not been implicated in AA. In addition, we found several genetic variants in novel genes (HLA-DMB, TLR1, and PMS2) and discovered an additional locus on HLA-A, a known susceptibility gene of AA. This study provides further evidence for the association of previously reported genes with AA and novel findings such as HLA-DRB5, which might represent a hidden culprit gene for AU.	[Lee, Seungbok; Kim, Hyun-Jin; Cha, Soeun; Seo, Jeong-Sun; Kim, Jong-Il] Seoul Natl Univ, Med Res Ctr, GMI, Seoul, South Korea; [Lee, Seungbok; Kim, Hyun-Jin; Seo, Jeong-Sun; Kim, Jong-Il] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Paik, Seung Hwan; Ryu, Hyeong Ho; Jo, Seong Jin; Eun, Hee Chul; Kwon, Oh Sang] Seoul Natl Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Eun, Hee Chul; Kwon, Oh Sang] Seoul Natl Univ Hosp, Clin Res Inst, Lab Cutaneous Aging & Hair Res, Seoul 110744, South Korea; [Eun, Hee Chul; Kwon, Oh Sang] Seoul Natl Univ, Coll Med, Inst Dermatol Sci, Seoul, South Korea; [Seo, Jeong-Sun; Kim, Jong-Il] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Seo, Jeong-Sun; Kim, Jong-Il] Psoma Therapeut Inc, Seoul, South Korea; [Seo, Jeong-Sun] Macrogen Inc, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Macrogen, Inc.	Kim, JI (corresponding author), Seoul Natl Univ, Med Res Ctr, GMI, Seoul, South Korea.	jongil@snu.ac.kr; oskwon@snu.ac.kr	Seo, Jeong-Sun/J-2763-2012; KIM, JONG-IL/D-1019-2011; Kwon, Ohsang/J-2733-2012	KIM, JONG-IL/0000-0002-7240-3744; Kwon, Ohsang/0000-0003-0464-5124; Seungbok, Lee/0000-0002-3145-8714; Jo, Seong Jin/0000-0002-2501-7672	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (Green Cosmetic Research Center) [A092055]; National Research Foundation of Korea [NRF]; Korea government [MESF] [2011-0030738]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (Green Cosmetic Research Center); National Research Foundation of Korea [NRF](National Research Foundation of Korea); Korea government [MESF]	This study was partly supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (Green Cosmetic Research Center, A092055) and conducted under a research agreement with AmorePacific Corporation, Republic of Korea. This work was partly supported by the National Research Foundation of Korea [NRF] grant funded by the Korea government [MESF] [No. 2011-0030738]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903; Amigo J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-105; Barahamani N, 2002, J INVEST DERMATOL, V118, P335, DOI 10.1046/j.0022-202x.2001.01676.x; Barahmani N, 2006, J INVEST DERMATOL, V126, P74, DOI 10.1038/sj.jid.5700009; Betterle C, 1998, J CLIN ENDOCR METAB, V83, P1049, DOI 10.1210/jc.83.4.1049; Botchkarev VA, 2001, FASEB J, V15, P2205, DOI 10.1096/fj.01-0207com; Caillier SJ, 2008, J IMMUNOL, V181, P5473, DOI 10.4049/jimmunol.181.8.5473; Forstbauer LM, 2011, EUR J HUM GENET; Gilhar A, 2007, J CLIN INVEST, V117, P2019, DOI 10.1172/JCI31942; HORDINSKY MK, 1984, ARCH DERMATOL, V120, P464, DOI 10.1001/archderm.120.4.464; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Kahvejian A, 2008, NAT BIOTECHNOL, V26, P1125, DOI 10.1038/nbt1494; Kang SH, 2001, J RHEUMATOL, V28, P1577; KELLY AP, 1991, NATURE, V353, P571, DOI 10.1038/353571a0; Kemp EH, 2006, HUM IMMUNOL, V67, P535, DOI 10.1016/j.humimm.2006.04.006; Kim JJ, 2012, HUM GENET, V131, P471, DOI 10.1007/s00439-011-1096-4; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Kudat H, 2006, INT J IMMUNOGENET, V33, P41, DOI 10.1111/j.1744-313X.2006.00562.x; Lien E, 2002, CRIT CARE MED, V30, pS1, DOI 10.1097/00003246-200201001-00001; Martinez-Mir A, 2007, AM J HUM GENET, V80, P316, DOI 10.1086/511442; Mollenhauer J, 1997, NAT GENET, V17, P32, DOI 10.1038/ng0997-32; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; Park H, 2012, J MED GENET, V49, P747, DOI 10.1136/jmedgenet-2012-101209; Peron S, 2008, J EXP MED, V205, P2465, DOI 10.1084/jem.20080789; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Price VH, 2003, J INVEST DERM SYMP P, V8, P207, DOI 10.1046/j.1087-0024.2003.00811.x; Redler S, 2010, BRIT J DERMATOL, V162, P866, DOI 10.1111/j.1365-2133.2009.09598.x; SAFAVI KH, 1995, MAYO CLIN PROC, V70, P628, DOI 10.4065/70.7.628; SANCHEZ L, 1992, ARCH DIS CHILD, V67, P657, DOI 10.1136/adc.67.5.657; Shapiro J, 1999, INT J DERMATOL, V38, P19, DOI 10.1046/j.1365-4362.1999.00004.x; Sundberg JP, 2004, J INVEST DERMATOL, V123, P294, DOI 10.1111/j.0022-202X.2004.23222.x; TARLOW JK, 1994, J INVEST DERMATOL, V103, P387, DOI 10.1111/1523-1747.ep12395398; Tazi-Ahnini R, 2002, EUR J IMMUNOGENET, V29, P25, DOI 10.1046/j.1365-2370.2002.00271.x; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tornqvist G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000904; Tosti A, 2006, J AM ACAD DERMATOL, V55, P438, DOI 10.1016/j.jaad.2006.05.008; WALKER SA, 1950, J INVEST DERMATOL, V14, P403, DOI 10.1038/jid.1950.52; WELSH EA, 1994, J INVEST DERMATOL, V103, P758, DOI 10.1111/1523-1747.ep12412584; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	45	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53613	10.1371/journal.pone.0053613	http://dx.doi.org/10.1371/journal.pone.0053613			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326468	Green Published, gold			2022-12-25	WOS:000314705800062
J	Liu, ZP; Wan, PX; Duan, HC; Zhou, J; Tan, BW; Liu, Y; Zhou, Q; Zhou, CJ; Huang, ZQ; Tian, BS; Li, CY; Wang, ZC				Liu, Zhiping; Wan, Pengxia; Duan, Hucheng; Zhou, Jin; Tan, Bowei; Liu, Ying; Zhou, Qiang; Zhou, Chenjing; Huang, Zheqian; Tian, Bishan; Li, Chaoyang; Wang, Zhichong			ES Micro-Environment Enhances Stemness and Inhibits Apoptosis in Human Limbal Stem Cells via the Maintenance of Telomerase Activity	PLOS ONE			English	Article							CORNEAL EPITHELIAL-CELLS; MITOCHONDRIAL-DNA; ENDOTHELIAL-CELLS; H9C2 CELLS; PROTECTS; DAMAGE; EXPRESSION; CAPACITY; TISSUES; PATHWAY	Our previous work had found that telomerase rejuvenated in the cytoplasm of corneal epithelial cells cultured in embryonic stem cell-conditioned medium, the functional properties of stem-like corneal epithelial cells can be enhanced by co-culturing with embryonic stem cells (ESCs) via activation of the integrin beta 1-FAK-PI3K/Akt signaling pathway. The goal of this study was to explore the potential molecular mechanisms of the ES micro-environment that enhance the stem cell-like phenotype and inhibit apoptosis in human limbal stem cells (LSC). The LSC were cultured in different media, either CnT-20 medium or CnT-20 +20% ES culture supernatant (ESC-CM). We observed that LSC cultured in ESC-CM had an increased proliferative capacity, greater serial passage capacity, higher colony-forming efficiency (CFE) and higher levels of stem cell-associated marker than those cultured in CnT-20. Compared with CnT-20, ESC-CM enhanced the undifferentiated status and inhibited apoptosis in the LSC by promoting the maintenance of telomerase activity, which could reduce the generation of reactive oxygen species (ROS), maintain the membrane potential (Delta psi m) at higher levels and reduce the expression of the p21 protein. Our findings indicated that ESC-CM system induced LSC to maintain a stem cell phenotype and inhibit the process of apoptosis. These effects might partially be achieved via the telomerase-p21-mitochondrial axis and the activation of the FAK/Wnt signaling pathways. This study may have high impact and clinic implication on the expansion of LSC in regenerative medicine, especially for ocular surface reconstruction.	[Liu, Zhiping; Wan, Pengxia; Zhou, Jin; Tan, Bowei; Liu, Ying; Zhou, Qiang; Zhou, Chenjing; Huang, Zheqian; Tian, Bishan; Li, Chaoyang; Wang, Zhichong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Duan, Hucheng] Second Peoples Hosp Foshan, Ophthalm Ctr, Foshan, Guangdong, Peoples R China	Sun Yat Sen University	Li, CY (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	clioffice@yahoo.cn; wzc001@hotmail.com	zhou, qiang/AAJ-7571-2020; Li, Chao/GSM-8117-2022	Li, Chao/0000-0001-6110-6210	National High Technology Research and Development Program (863 program) of China [2012AA020507]; Guangdong Province e Ministry of Education Industry-University-Research Institute Collaboration Project of China [2011B090400353]; Sun Yat-Sen University 985 Project of China [90035-3283310]; Fundamental Research Funds of State Key Laboratory of Ophthalmology of China	National High Technology Research and Development Program (863 program) of China(National High Technology Research and Development Program of China); Guangdong Province e Ministry of Education Industry-University-Research Institute Collaboration Project of China; Sun Yat-Sen University 985 Project of China; Fundamental Research Funds of State Key Laboratory of Ophthalmology of China	This study was supported by Grant No. 2012AA020507 from the National High Technology Research and Development Program (863 program) of China, Grant No. 2011B090400353 from Guangdong Province e Ministry of Education Industry-University-Research Institute Collaboration Project of China, Grant No. 90035-3283310 from Sun Yat-Sen University 985 Project of China and the Fundamental Research Funds of State Key Laboratory of Ophthalmology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; De Paiva CS, 2006, STEM CELLS, V24, P368, DOI 10.1634/stemcells.2005-0148; Dua HS, 2000, SURV OPHTHALMOL, V44, P415, DOI 10.1016/S0039-6257(00)00109-0; Ferraris C, 2000, DEVELOPMENT, V127, P5487; Gorbunova V, 2002, J BIOL CHEM, V277, P38540, DOI 10.1074/jbc.M202671200; Guo Y, 2006, STEM CELLS, V24, P850, DOI 10.1634/stemcells.2005-0457; Haendeler J, 2009, ARTERIOSCL THROM VAS, V29, P929, DOI 10.1161/ATVBAHA.109.185546; He Y, 2008, INVEST OPHTH VIS SCI, V49, P1447, DOI 10.1167/iovs.07-1361; Santos JH, 2006, HUM MOL GENET, V15, P1757, DOI 10.1093/hmg/ddl098; Kang SS, 1999, J BIOL CHEM, V274, P13085, DOI 10.1074/jbc.274.19.13085; Kawakita T, 2005, AM J PATHOL, V167, P381, DOI 10.1016/S0002-9440(10)62983-5; Kim HS, 2004, EXP EYE RES, V79, P41, DOI 10.1016/j.exer.2004.02.015; Krishan A, 2004, CELL CYCLE, V3, P380; Liu JB, 2007, EXP EYE RES, V84, P599, DOI 10.1016/j.exer.2006.11.014; Liu Y, 2010, TISSUE ENG PART C-ME, V16, P793, DOI [10.1089/ten.tec.2009.0380, 10.1089/ten.TEC.2009.0380]; Liu ZP, 2012, EXP EYE RES, V100, P40, DOI 10.1016/j.exer.2012.04.013; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Lu R, 2011, INT J BIOCHEM CELL B, V43, P751, DOI 10.1016/j.biocel.2011.01.018; Lu XY, 2010, MOL VIS, V16, P611; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McGowan SL, 2007, MOL VIS, V13, P1984; Moore JE, 2002, DNA CELL BIOL, V21, P443, DOI 10.1089/10445490260099737; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Pearton DJ, 2005, P NATL ACAD SCI USA, V102, P3714, DOI 10.1073/pnas.0500344102; Qin M, 2005, STEM CELLS, V23, P712, DOI 10.1634/stemcells.2004-0195; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Santos JH, 2004, AGING CELL, V3, P399, DOI 10.1111/j.1474-9728.2004.00124.x; Saretzki G, 2009, EXP GERONTOL, V44, P485, DOI 10.1016/j.exger.2009.05.004; Singla DK, 2008, AM J PHYSIOL-HEART C, V295, pH907, DOI 10.1152/ajpheart.00279.2008; Singla DK, 2007, AM J PHYSIOL-HEART C, V293, pH1590, DOI 10.1152/ajpheart.00431.2007; Stepp MA, 2005, OCUL SURF, V3, P15, DOI 10.1016/S1542-0124(12)70119-2; TSENG SCG, 1989, EYE, V3, P141, DOI 10.1038/eye.1989.22; Tsuji T, 1998, BLOOD, V91, P1263, DOI 10.1182/blood.V91.4.1263; Ulaner GA, 1997, MOL HUM REPROD, V3, P769, DOI 10.1093/molehr/3.9.769; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Wang H, 2009, STEM CELLS, V27, P2516, DOI 10.1002/stem.174; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Xiao JH, 2011, BIOMATERIALS, V32, P6962, DOI 10.1016/j.biomaterials.2011.05.084; Yew TL, 2011, AGING CELL, V10, P349, DOI 10.1111/j.1474-9726.2011.00676.x; [张嘉晴 ZHANG Jiaqing], 2006, [中国病理生理杂志, Chinese Journal of Pathophysiology], V22, P7; Zhou J, 2011, INT J BIOCHEM CELL B, V43, P1168, DOI 10.1016/j.biocel.2011.04.010	48	8	9	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53576	10.1371/journal.pone.0053576	http://dx.doi.org/10.1371/journal.pone.0053576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326460	gold, Green Published, Green Submitted			2022-12-25	WOS:000314705800056
J	Luo, F; Hou, TY; Zhang, ZH; Xie, Z; Wu, XH; Xu, JZ				Luo, Fei; Hou, Tian-Yong; Zhang, Ze-Hua; Xie, Zhao; Wu, Xue-Hui; Xu, Jian-Zhong			Effects of Initial Cell Density and Hydrodynamic Culture on Osteogenic Activity of Tissue-Engineered Bone Grafts	PLOS ONE			English	Article							POLYMER SCAFFOLDS; STEM-CELLS; IN-VIVO; BIOREACTOR; VASCULARIZATION; STIMULATION; PERFUSION; WALL	This study aimed to study the effects of initial cell density and in vitro culture method on the construction of tissue-engineered bone grafts and osteogenic activities. Human mesenchymal stem cells (hMSCs) were seeded onto cubic scaffolds prepared from demineralized bone matrix (DBM) by three methods - static, hydrodynamic, or fibrin hydrogel-assisted seeding. The resulting cell-scaffold constructs were cultured in vitro by static flask culture or hydrodynamic culture. The initial cell density and the subsequent in vitro proliferation and alkaline phosphate activities of the constructs were analyzed. The constructs were also subcutaneously implanted in nude mice to examine their in vivo osteogenic activities. Hydrogel-assisted seeding gave the highest seeding efficiency, followed by hydrodynamic and conventional static seeding. During in vitro culture, hydrodynamic culture produced higher plateau cell densities, alkaline phosphatase (ALP) activities, and extracellular matrix production than static culture. After subcutaneous implantation in nude mice, the implants prepared by the combination of hydrogel-assisted seeding and hydrodynamic culture produced higher wet weight and bone mineral density than implants prepared by other methods. The results suggest that the hydrogel-assisted seeding can substantially increase the initial seed cell density in scaffolds. Subsequent hydrodynamic culture can promote the proliferation and osteoblastic differentiation of the seeded cells. Correspondingly, bone grafts produced by the combination of these two methods achieved the highest osteogenic activity among the three methods employed.	[Luo, Fei; Hou, Tian-Yong; Zhang, Ze-Hua; Xie, Zhao; Wu, Xue-Hui; Xu, Jian-Zhong] Third Mil Med Univ, Southwest Hosp, Dept Orthoped, Chongqing, Peoples R China	Army Medical University	Xu, JZ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Orthoped, Chongqing, Peoples R China.	xujianzhong1962@163.com		Hou, Tianyong/0000-0002-7685-2088; Xu, Jianzhong/0000-0003-0434-5148	National Natural Science Foundation of China [31100694]; Natural Science Foundation of Chongqing, China [2010BB5163]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing, China(Natural Science Foundation of Chongqing)	The Project was supported by National Natural Science Foundation of China (Grant No. 31100694) and by the Natural Science Foundation of Chongqing, China (Grant No. 2010BB5163). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akakura N, 2006, CANCER RES, V66, P9691, DOI 10.1158/0008-5472.CAN-06-1686; ATRAH HI, 1994, BRIT MED J, V308, P933, DOI 10.1136/bmj.308.6934.933; Aubin H, 2010, BIOMATERIALS, V31, P6941, DOI 10.1016/j.biomaterials.2010.05.056; Bittner S, 2010, ANN NEUROL, V68, P58, DOI 10.1002/ana.22010; Borriello A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028555; Canziani M, 2009, HERNIA, V13, P625, DOI 10.1007/s10029-009-0555-5; Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3; Duty AO, 2007, J BIOMECH ENG-T ASME, V129, P531, DOI 10.1115/1.2746375; Erickson IE, 2009, TISSUE ENG PT A, V15, P1041, DOI 10.1089/ten.tea.2008.0099; Fuchs JR, 2003, J PEDIATR SURG, V38, P1348, DOI 10.1016/S0022-3468(03)00394-4; Hou TY, 2010, TISSUE ENG PT A, V16, P201, DOI [10.1089/ten.tea.2009.0291, 10.1089/ten.TEA.2009.0291]; Jaasma MJ, 2008, J BIOTECHNOL, V133, P490, DOI 10.1016/j.jbiotec.2007.11.010; Jiang T, 2010, ACTA BIOMATER, V6, P3457, DOI 10.1016/j.actbio.2010.03.023; Kilic E, 2004, ACTA ORTHOP TRAUMATO, V41, P295; Kneser U, 2006, TISSUE ENG, V12, P1721, DOI 10.1089/ten.2006.12.1721; Liu Y, 2006, J BIOTECHNOL, V124, P592, DOI 10.1016/j.jbiotec.2006.01.020; Liu YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033225; Lopez-Perez PM, 2010, ACTA BIOMATER, V6, P3704, DOI 10.1016/j.actbio.2010.03.008; Milan JL, 2009, BIOMATERIALS, V30, P4219, DOI 10.1016/j.biomaterials.2009.04.026; Nicolaidou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039871; Ouyang A, 2007, BIOTECHNOL BIOENG, V96, P371, DOI 10.1002/bit.21091; Schulz RM, 2007, EUR BIOPHYS J BIOPHY, V36, P539, DOI 10.1007/s00249-007-0139-1; Seebach C, 2010, INJURY, V41, P731, DOI 10.1016/j.injury.2010.02.017; Shimizu K, 2007, J BIOSCI BIOENG, V104, P171, DOI 10.1263/jbb.104.171; Skardal A, 2010, BIOMATERIALS; Spotnitz WD, 2010, WORLD J SURG, V34, P632, DOI 10.1007/s00268-009-0252-7; Tan HB, 2009, BIOMATERIALS, V30, P3560, DOI 10.1016/j.biomaterials.2009.03.029; Vunjak-Novakovic G, 2002, BIORHEOLOGY, V39, P259; Wang B, 2008, BIOMATERIALS, V29, P2954, DOI 10.1016/j.biomaterials.2008.03.038; Wang JY, 2006, BIOMATERIALS, V27, P2738, DOI 10.1016/j.biomaterials.2005.12.005; Wysocka Aleksandra, 2010, Cell Tissue Bank, V11, P209, DOI 10.1007/s10561-009-9163-y; Xu ZC, 2008, BIOMATERIALS, V29, P1464, DOI 10.1016/j.biomaterials.2007.11.037; Zhang ZY, 2009, BIOMATERIALS, V30, P2694, DOI 10.1016/j.biomaterials.2009.01.028; Zhao LA, 2010, BIOMATERIALS, V31, P6502, DOI 10.1016/j.biomaterials.2010.05.017	34	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53697	10.1371/journal.pone.0053697	http://dx.doi.org/10.1371/journal.pone.0053697			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326488	Green Submitted, Green Published, gold			2022-12-25	WOS:000314705800070
J	So, JY; Smolarek, AK; Salerno, DM; Maehr, H; Uskokovic, M; Liu, F; Suh, N				So, Jae Young; Smolarek, Amanda K.; Salerno, David M.; Maehr, Hubert; Uskokovic, Milan; Liu, Fang; Suh, Nanjoo			Targeting CD44-STAT3 Signaling by Gemini Vitamin D Analog Leads to Inhibition of Invasion in Basal-Like Breast Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; MAMMARY TUMORIGENESIS; STAT3; CD44; ACTIVATION; GROWTH; CELLS; PATHWAY; CARCINOGENESIS	Background: CD44, a transmembrane glycoprotein, is a major receptor for extracellular proteins involved in invasion and metastasis of human cancers. We have previously demonstrated that the novel Gemini vitamin D analog BXL0124 [1 alpha,25-dihydroxy-20R-21(3-hydroxy-3-deuteromethyl-4,4,4-trideuterobutyl)-23-yne-26,27-hexafluro-cholecalciferol] repressed CD44 expression in MCF10DCIS.com basal-like human breast cancer cells and inhibited MCF10DCIS xenograft tumor growth. In the present study, we investigated potential factors downstream of CD44 and the biological role of CD44 repression by BXL0124 in MCF10DCIS cells. Methods and Findings: The treatment with Gemini vitamin D BXL0124 decreased CD44 protein level, suppressed STAT3 signaling, and inhibited invasion and proliferation of MCF10DCIS cells. The interaction between CD44 and STAT3 was determined by co-immunoprecipitation. CD44 forms a complex with STAT3 and Janus kinase 2 (JAK2) to activate STAT3 signaling, which was inhibited by BXL0124 in MCF10DCIS cells. The role of CD44 in STAT3 signaling and invasion of MCF10DCIS cells was further determined by the knockdown of CD44 using small hairpin RNA in vitro and in vivo. MCF10DCIS cell invasion was markedly decreased by the knockdown of CD44 in vitro. The knockdown of CD44 also significantly decreased mRNA expression levels of invasion markers, matrix metalloproteinases (MMPs) and urokinase plasminogen activator (uPA), in MCF10DCIS cells. In MCF10DCIS xenograft tumors, CD44 knockdown decreased tumor size and weight as well as invasion markers. Conclusions: The present study identifies STAT3 as an important signaling molecule interacting with CD44 and demonstrates the essential role of CD44-STAT3 signaling in breast cancer invasion. It also suggests that repression of CD44-STAT3 signaling is a key molecular mechanism in the inhibition of breast cancer invasion by the Gemini vitamin D analog BXL0124.	[So, Jae Young; Smolarek, Amanda K.; Salerno, David M.; Maehr, Hubert; Uskokovic, Milan; Liu, Fang; Suh, Nanjoo] Rutgers State Univ, Dept Biol Chem, Ernest Mario Sch Pharm, Piscataway, NJ 08855 USA; [So, Jae Young] Rutgers State Univ, Grad Program Cellular & Mol Pharmacol, Piscataway, NJ USA; [Liu, Fang] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Liu, Fang; Suh, Nanjoo] Canc Inst New Jersey, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Suh, N (corresponding author), Rutgers State Univ, Dept Biol Chem, Ernest Mario Sch Pharm, Piscataway, NJ 08855 USA.	nsuh@pharmacy.rutgers.edu	Salerno, David/L-7826-2019		National Institutes of Health [R01 CA127645]; Rutgers, The State University of New Jersey; Charles and Johanna Busch Memorial Fund; NATIONAL CANCER INSTITUTE [P30CA072720, R01CA127645] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers, The State University of New Jersey; Charles and Johanna Busch Memorial Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health [R01 CA127645 to NS]; the Trustees Research Fellowship Program at Rutgers, The State University of New Jersey, to NS; and the Charles and Johanna Busch Memorial Fund to FL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriance MC, 2005, BREAST CANCER RES, V7, P190, DOI 10.1186/bcr1286; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Dechow TN, 2004, P NATL ACAD SCI USA, V101, P10602, DOI 10.1073/pnas.0404100101; Duffy MJ, 2000, BREAST CANCER RES, V2, P252, DOI 10.1186/bcr65; Espina V, 2011, NAT REV CANCER, V11, P618, DOI 10.1038/nrc2950-c2; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Hsieh FC, 2005, BIOCHEM BIOPH RES CO, V335, P292, DOI 10.1016/j.bbrc.2005.07.075; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Huang SY, 2007, CLIN CANCER RES, V13, P1362, DOI 10.1158/1078-0432.CCR-06-2313; Jedeszko C, 2009, CANCER RES, V69, P9148, DOI 10.1158/0008-5472.CAN-09-1043; KAUFMANN M, 1995, LANCET, V345, P615, DOI 10.1016/S0140-6736(95)90521-9; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee HJ, 2006, BIOCHEM PHARMACOL, V72, P332, DOI 10.1016/j.bcp.2006.04.030; Lee HJ, 2009, CLIN CANCER RES, V15, P4242, DOI 10.1158/1078-0432.CCR-08-3028; Lee HJ, 2008, CANCER PREV RES, V1, P476, DOI 10.1158/1940-6207.CAPR-08-0084; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; Lin L, 2010, CANCER RES, V70, P2445, DOI 10.1158/0008-5472.CAN-09-2468; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Louderbough JMV, 2011, MOL CANCER RES, V9, P1573, DOI 10.1158/1541-7786.MCR-11-0156; Maehr H, 2009, J MED CHEM, V52, P5505, DOI 10.1021/jm900780q; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Montgomery N, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3199; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; So JY, 2011, MOL PHARMACOL, V79, P360, DOI 10.1124/mol.110.068403; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Wolff C, 2011, J PATHOL, V223, P54, DOI 10.1002/path.2791; Wu ZS, 2008, INT J CANCER, V122, P2050, DOI 10.1002/ijc.23337; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	45	45	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54020	10.1371/journal.pone.0054020	http://dx.doi.org/10.1371/journal.pone.0054020			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326564	Green Published, gold, Green Submitted			2022-12-25	WOS:000314705800103
J	Niemi, NM; Lanning, NJ; Westrate, LM; MacKeigan, JP				Niemi, Natalie M.; Lanning, Nathan J.; Westrate, Laura M.; MacKeigan, Jeffrey P.			Downregulation of the Mitochondrial Phosphatase PTPMT1 Is Sufficient to Promote Cancer Cell Death	PLOS ONE			English	Article							CYTOCHROME-C; SIGNALING CASCADES; CARDIOLIPIN; APOPTOSIS; SPECIFICITY; RELEASE	Protein Tyrosine Phosphatase localized to the Mitochondrion 1 (PTPMT1) is a dual specificity phosphatase exclusively localized to the mitochondria, and has recently been shown to be a critical component in the cardiolipin biosynthetic pathway. The downregulation of PTPMT1 in pancreatic beta cells has been shown to increase cellular ATP levels and insulin production, however, the generalized role of PTPMT1 in cancer cells has not been characterized. Here we report that downregulation of PTPMT1 activity is sufficient to induce apoptosis of cancer cells. Additionally, the silencing of PTPMT1 decreases cardiolipin levels in cancer cells, while selectively increasing ATP levels in glycolytic media. Additionally, sublethal downregulation of PTPMT1 synergizes with low doses of paclitaxel to promote cancer cell death. Our data suggest that inhibition of PTPMT1 causes a metabolic crisis in cancer cells that induces cell death, and may be a mechanism by which cancer cells can be sensitized to currently available therapies.	[Niemi, Natalie M.; Lanning, Nathan J.; Westrate, Laura M.; MacKeigan, Jeffrey P.] Van Andel Res Inst, Dept Syst Biol, Grand Rapids, MI USA; [Niemi, Natalie M.] Van Andel Inst, Grad Sch, Grand Rapids, MI USA	Van Andel Institute; Van Andel Institute	MacKeigan, JP (corresponding author), Van Andel Res Inst, Dept Syst Biol, Grand Rapids, MI USA.	jeff.mackeigan@vai.org	Lanning, Nathan/AAI-2532-2019; Niemi, Natalie/AAH-6963-2021	Lanning, Nathan/0000-0002-0983-7451; Niemi, Natalie/0000-0002-5174-4005; MacKeigan, Jeffrey/0000-0002-0198-5679	National Cancer Institute [R01CA138651]; NATIONAL CANCER INSTITUTE [F32CA159709, R01CA138651] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by award number R01CA138651 from the National Cancer Institute to J.P. MacKeigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi SY, 2007, CELL DEATH DIFFER, V14, P597, DOI 10.1038/sj.cdd.4402020; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Doughty-Shenton D, 2010, J PHARMACOL EXP THER, V333, P584, DOI 10.1124/jpet.109.163329; Elis W, 2008, MOL CANCER RES, V6, P614, DOI 10.1158/1541-7786.MCR-07-0262; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Horbinski C, 2005, FREE RADICAL BIO MED, V38, P2, DOI 10.1016/j.freeradbiomed.2004.09.030; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; MacKeigan JP, 2000, J BIOL CHEM, V275, P38953, DOI 10.1074/jbc.C000684200; Martin KR, 2011, J CELL SCI, V124, P812, DOI 10.1242/jcs.080341; McMillin JB, 2002, BBA-MOL CELL BIOL L, V1585, P97, DOI 10.1016/S1388-1981(02)00329-3; Niemi NM, 2011, MOL CELL BIOL, V31, P1357, DOI 10.1128/MCB.00788-10; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Ostrander DB, 2001, J BIOL CHEM, V276, P38061; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Pagliarini DJ, 2005, MOL CELL, V19, P197, DOI 10.1016/j.molcel.2005.06.008; Pagliarini DJ, 2004, J BIOL CHEM, V279, P38590, DOI 10.1074/jbc.M404959200; Shen JH, 2011, MOL CELL BIOL, V31, P4902, DOI 10.1128/MCB.05629-11; Shoemaker R H, 1988, Prog Clin Biol Res, V276, P265; Soubannier V, 2009, BBA-MOL CELL RES, V1793, P154, DOI 10.1016/j.bbamcr.2008.07.008; Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willers IM, 2011, BBA-BIOENERGETICS, V1807, P543, DOI 10.1016/j.bbabio.2010.10.016; Yip KW, 2006, MOL CANCER THER, V5, P2234, DOI 10.1158/1535-7163.MCT-06-0134; Zhang J, 2011, CELL METAB, V13, P690, DOI 10.1016/j.cmet.2011.04.007	28	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53803	10.1371/journal.pone.0053803	http://dx.doi.org/10.1371/journal.pone.0053803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326511	gold, Green Submitted, Green Published			2022-12-25	WOS:000313552400049
J	Tang, F; Zhang, W; Lu, CP				Tang, Fang; Zhang, Wei; Lu, Chengping			Lysogenic Streptococcus suis Isolate SS2-4 Containing Prophage SMP Showed Increased Mortality in Zebra Fish Compared to the Wild-Type Isolate	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; REPRODUCTIVE FITNESS; FUNCTIONAL-ANALYSIS; VIRULENCE; STRAIN; PHAGE; BACTERIOPHAGE; ENVIRONMENTS; PNEUMONIAE	Streptococcus suis (S. suis) infection is considered to be a major problem in the swine industry worldwide. Based on the capsular type, 33 serotypes of S. suis have been described, with serotype 2 (SS2) being the most frequently isolated from diseased piglets. Little is known, however, about the pathogenesis and virulence factors of S. suis. Research on bacteriophages highlights a new area in S. suis research. A S. suis serotype 2 bacteriophage, designated SMP, has been previously isolated in our laboratory. Here, we selected a lysogenic isolate in which the SMP phage was integrated into the chromosome of strain SS2-4. Compared to the wild-type isolate, the lysogenic strain showed increased mortality in zebra fish. Moreover the sensitivity of the lysogenic strain to lysozyme was seven times higher than that of the wild-type.	[Tang, Fang; Zhang, Wei; Lu, Chengping] Nanjing Agr Univ, Coll Vet Med, Minist Agr, Key Lab Anim Bacteriol, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Lu, CP (corresponding author), Nanjing Agr Univ, Coll Vet Med, Minist Agr, Key Lab Anim Bacteriol, Nanjing, Jiangsu, Peoples R China.	lucp@njau.edu.cn			Chinese National Programs for Fundamental Research and Development [2012CB518804]	Chinese National Programs for Fundamental Research and Development	This study was supported by grants from Chinese National Programs for Fundamental Research and Development (2012CB518804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Beutin L, 2002, DIAGN MICR INFEC DIS, V44, P337, DOI 10.1016/S0732-8893(02)00474-1; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Buchanan JT, 2005, INFECT IMMUN, V73, P6935, DOI 10.1128/IAI.73.10.6935-6944.2005; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; Carrolo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015678; Dmitriev AV, 2006, J BACTERIOL, V188, P7230, DOI 10.1128/JB.00877-06; EDLIN G, 1977, J VIROL, V21, P560, DOI 10.1128/JVI.21.2.560-564.1977; Figueroa-Bossi N, 1999, MOL MICROBIOL, V33, P167, DOI 10.1046/j.1365-2958.1999.01461.x; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Harel J, 2003, INFECT IMMUN, V71, P6104, DOI 10.1128/IAI.71.10.6104-6108.2003; Hu P, 2011, J BACTERIOL, V193, P3428, DOI 10.1128/JB.05018-11; Hu P, 2011, J BACTERIOL, V193, P2375, DOI 10.1128/JB.00083-11; Hu Xiaoshu, 2000, Zhonghua Yufang Yixue Zazhi, V34, P150; Ju CX, 2012, J BACTERIOL, V194, P1464, DOI 10.1128/JB.06231-11; Lin H, 2012, CLIN RHEUMATOL; LIN L, 1977, J VIROL, V21, P554, DOI 10.1128/JVI.21.2.554-559.1977; Lindsay AM, 2009, MICROBIOL-SGM, V155, P443, DOI 10.1099/mic.0.020826-0; Loeffler JM, 2006, INFECT IMMUN, V74, P4486, DOI 10.1128/IAI.00020-06; Ma YL, 2008, VET MICROBIOL, V132, P340, DOI 10.1016/j.vetmic.2008.05.013; MARSH P, 1994, FEMS MICROBIOL ECOL, V15, P99, DOI 10.1016/0168-6496(94)90030-2; METCALF RH, 1973, J BACTERIOL, V113, P278, DOI 10.1128/JB.113.1.278-286.1973; Nagiec MJ, 2004, J BIOL CHEM, V279, P45909, DOI 10.1074/jbc.M405434200; Pasharawipas T, 2005, VIRUS RES, V114, P63, DOI 10.1016/j.virusres.2005.05.012; Paul JH, 2008, ISME J, V2, P579, DOI 10.1038/ismej.2008.35; Pu JunYi, 2007, Scientia Agricultura Sinica, V40, P2655; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rehm HJ, 2010, BIOTECHNOLOGY SET; Rozanov DV, 1998, J BACTERIOL, V180, P6306; Shimada J, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-134; Shkilnyj P, 2007, J BACTERIOL, V189, P3115, DOI 10.1128/JB.01857-06; Staats JJ, 1997, VET RES COMMUN, V21, P381, DOI 10.1023/A:1005870317757; THIBODEAU EA, 1991, ORAL MICROBIOL IMMUN, V6, P313, DOI 10.1111/j.1399-302X.1991.tb00500.x; Tran VTN, 2011, DIAGN MICR INFEC DIS, V70, P461, DOI 10.1016/j.diagmicrobio.2010.12.015; TROTTIER S, 1991, REV INFECT DIS, V13, P1251; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; Wang Y, 2011, VET MICROBIOL, V152, P151, DOI 10.1016/j.vetmic.2011.04.029; Wu ZF, 2008, MICROB PATHOGENESIS, V45, P159, DOI 10.1016/j.micpath.2008.04.009; Yasmin A, 2010, J BACTERIOL, V192, P1122, DOI 10.1128/JB.01293-09	40	12	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54227	10.1371/journal.pone.0054227	http://dx.doi.org/10.1371/journal.pone.0054227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326601	Green Published, Green Submitted, gold			2022-12-25	WOS:000313552400085
J	Tsolis, AC; Papandreou, NC; Iconomidou, VA; Hamodrakas, SJ				Tsolis, Antonios C.; Papandreou, Nikos C.; Iconomidou, Vassiliki A.; Hamodrakas, Stavros J.			A Consensus Method for the Prediction of 'Aggregation-Prone' Peptides in Globular Proteins	PLOS ONE			English	Article							FIBRIL-FORMING SEGMENTS; AMYLOID FORMATION; INCLUSION-BODIES; SEQUENCE DETERMINANTS; SECONDARY STRUCTURE; PROPENSITY; BETA; IDENTIFICATION; REGIONS; SERVER	The purpose of this work was to construct a consensus prediction algorithm of 'aggregation-prone' peptides in globular proteins, combining existing tools. This allows comparison of the different algorithms and the production of more objective and accurate results. Eleven (11) individual methods are combined and produce AMYLPRED2, a publicly, freely available web tool to academic users (http://biophysics.biol.uoa.gr/AMYLPRED2), for the consensus prediction of amyloidogenic determinants/'aggregation-prone' peptides in proteins, from sequence alone. The performance of AMYLPRED2 indicates that it functions better than individual aggregation-prediction algorithms, as perhaps expected. AMYLPRED2 is a useful tool for identifying amyloid-forming regions in proteins that are associated with several conformational diseases, called amyloidoses, such as Altzheimer's, Parkinson's, prion diseases and type II diabetes. It may also be useful for understanding the properties of protein folding and misfolding and for helping to the control of protein aggregation/solubility in biotechnology (recombinant proteins forming bacterial inclusion bodies) and biotherapeutics (monoclonal antibodies and biopharmaceutical proteins).	[Tsolis, Antonios C.; Papandreou, Nikos C.; Iconomidou, Vassiliki A.; Hamodrakas, Stavros J.] Univ Athens, Fac Biol, Dept Cell Biol & Biophys, Athens, Greece	National & Kapodistrian University of Athens	Hamodrakas, SJ (corresponding author), Univ Athens, Fac Biol, Dept Cell Biol & Biophys, Athens, Greece.	shamodr@biol.uoa.gr	Iconomidou, Vassiliki/AAM-2003-2020; Papandreou, Nikos/AAM-9403-2021	Papandreou, Nikos/0000-0002-3533-2182; Tsolis, Antonios/0000-0001-7446-4412	University of Athens; General Secretariat for Research and Technology of the Greek Ministry of Education [11SYN_1_1230]; Religious Affairs, Culture and Sports, under the NSRF	University of Athens; General Secretariat for Research and Technology of the Greek Ministry of Education; Religious Affairs, Culture and Sports, under the NSRF	The authors thank the University of Athens for support. They also thank the Cooperation 2011 program (11SYN_1_1230) of the General Secretariat for Research and Technology of the Greek Ministry of Education and Religious Affairs, Culture and Sports, under the NSRF 2007-2013, for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal NJ, 2011, J PHARM SCI-US, V100, P5081, DOI 10.1002/jps.22705; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bryan AW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000333; Caflisch A, 2006, CURR OPIN CHEM BIOL, V10, P437, DOI 10.1016/j.cbpa.2006.07.009; Carrio M, 2005, J MOL BIOL, V347, P1025, DOI 10.1016/j.jmb.2005.02.030; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Clarke OJ, 2009, J COMPUT CHEM, V30, P621, DOI 10.1002/jcc.21085; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; David MPC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-79; de Groot NS, 2009, TRENDS BIOCHEM SCI, V34, P408, DOI 10.1016/j.tibs.2009.03.009; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; Dubay KF, 2004, J MOL BIOL, V341, P1317, DOI 10.1016/j.jmb.2004.06.043; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fandrich M, 2007, CELL MOL LIFE SCI, V64, P2066, DOI 10.1007/s00018-007-7110-2; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Frousios KK, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-44; Galzitskaya OV, 2006, PLOS COMPUT BIOL, V2, P1639, DOI 10.1371/journal.pcbi.0020177; Garbuzynskiy SO, 2010, BIOINFORMATICS, V26, P326, DOI 10.1093/bioinformatics/btp691; Garcia-Fruitos E, 2011, FEBS J, V278, P2419, DOI 10.1111/j.1742-4658.2011.08165.x; Gonzalez-Montalban N, 2007, BIOCHEM BIOPH RES CO, V355, P637, DOI 10.1016/j.bbrc.2007.01.192; HAMODRAKAS SJ, 1988, COMPUT APPL BIOSCI, V4, P473; Hamodrakas SJ, 2007, INT J BIOL MACROMOL, V41, P295, DOI 10.1016/j.ijbiomac.2007.03.008; Hamodrakas SJ, 2011, FEBS J, V278, P2428, DOI 10.1111/j.1742-4658.2011.08164.x; Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701; Iconomidou VA, 2000, FEBS LETT, V479, P141, DOI 10.1016/S0014-5793(00)01888-3; Iconomidou VA, 2008, CURR PROTEIN PEPT SC, V9, P291, DOI 10.2174/138920308784534041; Idicula-Thomas S, 2005, PROTEIN ENG DES SEL, V18, P175, DOI 10.1093/protein/gzi022; Jefferis R, 2011, MABS-AUSTIN, V3, P503, DOI 10.4161/mabs.3.6.17611; Johnson SM, 2012, J MOL BIOL; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Kim C, 2009, NUCLEIC ACIDS RES, V37, pW469, DOI 10.1093/nar/gkp351; Kumar S, 2011, PHARM RES-DORDR, V28, P949, DOI 10.1007/s11095-011-0414-9; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Mitraki A, 2010, ADV PROTEIN CHEM STR, V79, P89, DOI 10.1016/S1876-1623(10)79003-9; Morell M, 2008, BBA-MOL CELL RES, V1783, P1815, DOI 10.1016/j.bbamcr.2008.06.007; Nair SSK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S13-S21; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; O'Donnell CW, 2011, BIOINFORMATICS, V27, pI34, DOI 10.1093/bioinformatics/btr238; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Saiki M, 2006, BIOCHEM BIOPH RES CO, V343, P1262, DOI 10.1016/j.bbrc.2006.03.089; Tartaglia GG, 2004, PROTEIN SCI, V13, P1939, DOI 10.1110/ps.04663504; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Teng PK, 2009, PROTEIN ENG DES SEL, V22, P531, DOI 10.1093/protein/gzp037; Pastor MT, 2007, PRION, V1, P9, DOI 10.4161/pri.1.1.4100; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Tian J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S45; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; Vajdos FF, 2002, J MOL BIOL, V320, P415, DOI 10.1016/S0022-2836(02)00264-4; Ventura S, 2004, P NATL ACAD SCI USA, V101, P7258, DOI 10.1073/pnas.0308249101; Wang L, 2008, PLOS BIOL, V6, P1791, DOI 10.1371/journal.pbio.0060195; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Yoon S, 2004, PROTEIN SCI, V13, P2149, DOI 10.1110/ps.04790604; Zhang ZQ, 2007, BIOINFORMATICS, V23, P2218, DOI 10.1093/bioinformatics/btm325; Zibaee S, 2007, PROTEIN SCI, V16, P906, DOI 10.1110/ps.062624507	60	196	198	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54175	10.1371/journal.pone.0054175	http://dx.doi.org/10.1371/journal.pone.0054175			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326595	gold, Green Published, Green Submitted			2022-12-25	WOS:000313552400082
J	Naranbhai, V; Altfeld, M; Karim, SSA; Ndung'u, T; Karim, QA; Carr, WH				Naranbhai, Vivek; Altfeld, Marcus; Karim, Salim S. Abdool; Ndung'u, Thumbi; Karim, Quarraisha Abdool; Carr, William H.			Changes in Natural Killer Cell Activation and Function during Primary HIV-1 Infection	PLOS ONE			English	Article							NK CELLS; VIREMIA; REPLICATION; RESPONSES; INNATE; BLOOD	Background: Recent reports suggest that Natural Killer (NK) cells may modulate pathogenesis of primary HIV-1 infection. However, HIV dysregulates NK-cell responses. We dissected this bi-directional relationship to understand how HIV impacts NK-cell responses during primary HIV-1 infection. Methodology/Principal Findings: Paired samples from 41 high-risk, initially HIV-uninfected CAPRISA004 participants were analysed prior to HIV acquisition, and during viraemic primary HIV-1 infection. At the time of sampling post-infection five women were seronegative, 11 women were serodiscordant, and 25 women were seropositive by HIV-1 rapid immunoassay. Flow cytometry was used to measure NK and T-cell activation, NK-cell receptor expression, cytotoxic and cytokine-secretory functions, and trafficking marker expression (CCR7, alpha(4)beta(7)). Non-parametric statistical tests were used. Both NK cells and T-cells were significantly activated following HIV acquisition (p = 0.03 and p<0.0001, respectively), but correlation between NK-cell and T-cell activation was uncoupled following infection (pre-infection r = 0.68;p<0.0001; post-infection, during primary infection r = 0.074;p = 0.09). Nonetheless, during primary infection NK-cell and T-cell activation correlated with HIV viral load (r = 0.32'p = 0.04 and r = 0.35;p = 0.02, respectively). The frequency of Killer Immunoglobulin-like Receptor-expressing (KIRpos) NK cells increased following HIV acquisition (p = 0.006), and KIRpos NK cells were less activated than KIRneg NK cells amongst individuals sampled while seronegative or serodiscordant (p = 0.001;p<0.0001 respectively). During HIV-1 infection, cytotoxic NK cell responses evaluated after IL-2 stimulation alone, or after co-culture with 721 cells, were impaired (p = 0.006 and p = 0.002, respectively). However, NK-cell IFN-y secretory function was not significantly altered. The frequency of CCR7+ NK cells was elevated during primary infection, particularly at early time-points (p<0.0001). Conclusions/Significance: Analyses of immune cells before and after HIV infection revealed an increase in both NK-cell activation and KIR expression, but reduced cytotoxicity during acute infection. The increase in frequency of NK cells able to traffic to lymph nodes following HIV infection suggests that these cells may play a role in events in secondary lymphoid tissue.	[Naranbhai, Vivek; Karim, Salim S. Abdool; Karim, Quarraisha Abdool] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, CAPRISA Ctr AIDS Programme Res S Africa, Durban, South Africa; [Naranbhai, Vivek; Altfeld, Marcus; Ndung'u, Thumbi; Carr, William H.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Altfeld, Marcus; Ndung'u, Thumbi; Carr, William H.] Massachusetts Gen Hosp, Massachusetts Inst Technol & Harvard, Ragon Inst, Boston, MA 02114 USA; [Karim, Salim S. Abdool; Karim, Quarraisha Abdool] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA	University of Kwazulu Natal; University of Kwazulu Natal; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Columbia University	Carr, WH (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa.	wcarr@mec.cuny.edu	Karim, Salim Safurdeen Abdool/N-5947-2013; Abdool Karim, Quarraisha/GVS-1160-2022; Karim, Salim Abdool/AAE-7118-2019; Altfeld, Marcus/AAE-7306-2019; Karim, Salim Abdool/P-3117-2019	Karim, Salim Safurdeen Abdool/0000-0002-4986-2133; Abdool Karim, Quarraisha/0000-0002-0985-477X; Altfeld, Marcus/0000-0001-5972-2997; Karim, Salim Abdool/0000-0002-4986-2133; Naranbhai, Vivek/0000-0003-4281-8882; Ndung'u, Thumbi/0000-0003-2962-3992	South African HIV/AIDS Research Platform (SHARP); US National Institutes for Health [FIC K01-TW007793]; CONRAD, Eastern Virginia Medical School (USAID) [GP00-08-00005-00, PPA-09-046]; US National Institutes for Health's Comprehensive International Program of Research on AIDS (CIPRA) [AI51794]; LIFELab; Columbia University-South Africa Fogarty AIDS International Training and Research Program (AITRP) [D43 TW000231]; Massachusetts General Hospital Physician Scientist Development Award; South African National Research Foundation KISC Award; FOGARTY INTERNATIONAL CENTER [D43TW000231, K01TW007793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051794] Funding Source: NIH RePORTER	South African HIV/AIDS Research Platform (SHARP); US National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CONRAD, Eastern Virginia Medical School (USAID)(United States Agency for International Development (USAID)); US National Institutes for Health's Comprehensive International Program of Research on AIDS (CIPRA); LIFELab; Columbia University-South Africa Fogarty AIDS International Training and Research Program (AITRP); Massachusetts General Hospital Physician Scientist Development Award; South African National Research Foundation KISC Award; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the South African HIV/AIDS Research Platform (SHARP), and US National Institutes for Health FIC K01-TW007793. This study was part of the CAPRISA TRAPS (Tenofovir gel Research for AIDS Prevention Science) Program, which is funded by CONRAD, Eastern Virginia Medical School (USAID co-operative grant #GP00-08-00005-00, subproject agreement # PPA-09-046). The views expressed by the authors do not necessarily reflect the views of USAID, Gilead Sciences, Eastern Virginia Medical School or CONRAD. The authors thank the US National Institutes for Health's Comprehensive International Program of Research on AIDS (CIPRA grant # AI51794) for the research infrastructure. VN was supported by LIFELab and the Columbia University-South Africa Fogarty AIDS International Training and Research Program (AITRP, grant #D43 TW000231). MA is a Distinguished Clinical Scientist of the Doris Duke Charitable Foundation. WHC was supported by a Massachusetts General Hospital Physician Scientist Development Award. TN holds the South African Research Chair in Systems Biology of HIV/AIDS and is a Howard Hughes Medical Institute International Early Career Scientist. Additional training was supported by the South African National Research Foundation KISC Award. Gilead Sciences did not fund this project, however the drug used in the clinical trial from which samples were used for this study belongs to Gilead Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2009, J INTERN MED, V265, P29, DOI 10.1111/j.1365-2796.2008.02045.x; Alter G, 2005, BLOOD, V106, P3366, DOI 10.1182/blood-2005-03-1100; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Alter G, 2007, J INFECT DIS, V195, P1452, DOI 10.1086/513878; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brunetta E, 2010, J LEUKOCYTE BIOL, V88, P1119, DOI 10.1189/jlb.0410225; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Fogli M, 2004, EUR J IMMUNOL, V34, P2313, DOI 10.1002/eji.200425251; GIORGI JV, 1994, J INFECT DIS, V170, P775, DOI 10.1093/infdis/170.4.775; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karre K, 2008, NAT IMMUNOL, V9, P477, DOI 10.1038/ni0508-477; Kottilil S, 2003, J INFECT DIS, V187, P1038, DOI 10.1086/368222; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Luteijn R, 2011, EUR J IMMUNOL, V41, P2729, DOI 10.1002/eji.201040886; Marcenaro E, 2009, BLOOD, V114, P4108, DOI 10.1182/blood-2009-05-222265; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; Milush JM, 2009, BLOOD, V114, P4823, DOI 10.1182/blood-2009-04-216374; Mureithi MW, 2012, JAIDS-J ACQ IMM DEF, V60, P124, DOI 10.1097/QAI.0b013e31824f53a9; Naranbhai V, 2012, J INFECT DIS; Naranbhai V, 2012, AIDS; Naranbhai V, 2011, J IMMUNOL METHODS, V366, P28, DOI 10.1016/j.jim.2011.01.001; Rivera-Nieves J, 2005, J IMMUNOL, V174, P2343, DOI 10.4049/jimmunol.174.4.2343; Robertson MJ, 2002, J LEUKOCYTE BIOL, V71, P173; Soares A, 2010, J IMMUNOL METHODS, V362, P43, DOI 10.1016/j.jim.2010.08.007; Soghoian DZ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003165	28	41	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53251	10.1371/journal.pone.0053251	http://dx.doi.org/10.1371/journal.pone.0053251			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326405	Green Submitted, Green Published, gold			2022-12-25	WOS:000313551500056
J	Shah, A; Xia, L; Goldberg, H; Lee, KW; Quaggin, SE; Fantus, IG				Shah, Anu; Xia, Ling; Goldberg, Howard; Lee, Ken W.; Quaggin, Susan E.; Fantus, I. George			Thioredoxin-interacting Protein Mediates High Glucose-induced Reactive Oxygen Species Generation by Mitochondria and the NADPH Oxidase, Nox4, in Mesangial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED OXIDATIVE STRESS; SMOOTH-MUSCLE-CELLS; DIABETIC-NEPHROPATHY; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; FIBRONECTIN EXPRESSION; FAMILY PROTEINS; UP-REGULATION; P38 MAPK; KAPPA-B	Thioredoxin-interacting protein (TxNIP) is up-regulated by high glucose and is associated with oxidative stress. It has been implicated in hyperglycemia-induced beta-cell dysfunction and apoptosis. As high glucose and oxidative stress mediate diabetic nephropathy (DN), the contribution of TxNIP was investigated in renal mesangial cell reactive oxygen species (ROS) generation and collagen synthesis. To determine the role of TxNIP, mouse mesangial cells (MC) cultured from wild-type C3H and TxNIP-deficient Hcb-19 mice were incubated in HG. Confocal microscopy was used to measure total and mitochondrial ROS production (DCF and MitoSOX) and collagen IV. Trx and NADPH oxidase activities were assayed and NADPH oxidase isoforms, Nox2 and Nox4, and antioxidant enzymes were determined by immunoblotting. C3H MC exposed to HG elicited a significant increase in cellular and mitochondrial ROS as well as Nox4 protein expression and NADPH oxidase activation, whereas Hcb-19MC showed no response. Trx activity was attenuated by HG only in C3H MC. These defects in Hcb-19 MC were not due to increased antioxidant enzymes or scavenging of ROS, but associated with decreased ROS generation. Adenovirus-mediated overexpression of TxNIP in Hcb-19MC and TxNIP knockdown with siRNA in C3H confirmed the specific role of TxNIP. Collagen IV accumulation in HG was markedly reduced in Hcb-19 cells. TxNIP is a critical component of the HG-ROS signaling pathway, required for the induction of mitochondrial and total cell ROS and the NADPH oxidase isoform, Nox4. TxNIP is a potential target to prevent DN.	[Shah, Anu; Lee, Ken W.; Quaggin, Susan E.; Fantus, I. George] Mt Sinai Hosp, Dept Med, Toronto, ON M5T 3L9, Canada; [Shah, Anu; Lee, Ken W.; Quaggin, Susan E.; Fantus, I. George] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5T 3L9, Canada; [Shah, Anu; Xia, Ling; Goldberg, Howard; Lee, Ken W.; Fantus, I. George] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON M5T 3L9, Canada; [Shah, Anu; Lee, Ken W.; Quaggin, Susan E.; Fantus, I. George] Univ Toronto, Dept Physiol, Toronto, ON M5T 3L9, Canada; [Shah, Anu; Xia, Ling; Goldberg, Howard; Lee, Ken W.; Quaggin, Susan E.; Fantus, I. George] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5T 3L9, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto	Fantus, IG (corresponding author), Mt Sinai Hosp, 60 Murray St,Joseph & Wolfe Lebovic Bldg,Suite 5-, Toronto, ON M5T 3L9, Canada.	gfantus@mtsinai.on.ca	Johnson, Michael D. L./B-4352-2012	Shah, Anu/0000-0002-2407-0631	Canadian Institutes of Health Research [MOP 97979, PCN 49409]; Novo Nordisk Studentship from the Banting and Best Diabetes Centre; Canada Graduate Scholarship (NSERC); Ontario Graduate Scholarship; Canadian Diabetes Association [OG-3-10-2997-IF]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Novo Nordisk Studentship from the Banting and Best Diabetes Centre; Canada Graduate Scholarship (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canadian Diabetes Association	This work was supported in part by Canadian Institutes of Health Research Grants MOP 97979 and PCN 49409 (to I. G. F.). Supported in part by a Novo Nordisk Studentship from the Banting and Best Diabetes Centre, a Canada Graduate Scholarship (NSERC), and an Ontario Graduate Scholarship. Supported in part by a Novo Nordisk Studentship from the Banting and Best Diabetes Centre and Canadian Diabetes Association Grant OG-3-10-2997-IF.	Balakumar P, 2009, J CARDIOVASC PHARM, V54, P129, DOI 10.1097/FJC.0b013e3181ad2190; Beard KM, 2006, DIABETES, V55, P2678, DOI 10.2337/db05-1538; BJORNSTEDT M, 1995, METHOD ENZYMOL, V252, P209; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Cha-Molstad H, 2009, J BIOL CHEM, V284, P16898, DOI 10.1074/jbc.M109.010504; Chacko BK, 2010, BIOCHEM J, V432, P9, DOI 10.1042/BJ20100308; Chen CL, 2008, BLOOD, V111, P4365, DOI 10.1182/blood-2007-08-106336; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Chen JQ, 2010, DIABETES, V59, P440, DOI 10.2337/db09-0949; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Cheng Davis W., 2006, Archives of Physiology and Biochemistry, V112, P189, DOI 10.1080/13813450601093518; Diebold I, 2010, MOL BIOL CELL, V21, P2087, DOI 10.1091/mbc.E09-12-1003; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Fujino G, 2007, MOL CELL BIOL, V27, P8152, DOI 10.1128/MCB.00227-07; Fujita H, 2009, J AM SOC NEPHROL, V20, P1303, DOI 10.1681/ASN.2008080844; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Hamada Y, 2007, NEPHROL DIAL TRANSPL, V22, P1547, DOI 10.1093/ndt/gfm099; Hattori K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-9; He XQ, 2009, J MOL CELL CARDIOL, V46, P47, DOI 10.1016/j.yjmcc.2008.10.007; Jeon JH, 2005, CANCER RES, V65, P4485, DOI 10.1158/0008-5472.CAN-04-2271; Kakehi T, 2008, SEMIN IMMUNOPATHOL, V30, P301, DOI 10.1007/s00281-008-0122-7; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; Kitada M, 2003, DIABETES, V52, P2603, DOI 10.2337/diabetes.52.10.2603; Kobayashi T, 2003, KIDNEY INT, V64, P1632, DOI 10.1046/j.1523-1755.2003.00263.x; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Lan T, 2011, MOL ENDOCRINOL, V25, P2094, DOI 10.1210/me.2011-0095; Lee HB, 2003, J AM SOC NEPHROL, V14, pS241, DOI 10.1097/01.ASN.0000077410.66390.0F; Lee S, 2013, ANTIOXID REDOX SIGN, V18, P1165, DOI 10.1089/ars.2011.4322; Li H, 2011, CELL SIGNAL, V23, P1625, DOI 10.1016/j.cellsig.2011.05.016; Li JM, 2010, DIABETES, V59, P2033, DOI 10.2337/db09-1800; Li XN, 2009, BIOCHEM BIOPH RES CO, V381, P660, DOI 10.1016/j.bbrc.2009.02.132; Li YB, 1998, BIOCHEM BIOPH RES CO, V253, P295, DOI 10.1006/bbrc.1998.9729; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022806; Manea A, 2008, ARTERIOSCL THROM VAS, V28, P878, DOI 10.1161/ATVBAHA.108.163592; Manea A, 2010, BIOCHEM BIOPH RES CO, V396, P901, DOI 10.1016/j.bbrc.2010.05.019; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Masson E, 2009, AM J PHYSIOL-ENDOC M, V296, pE1251, DOI 10.1152/ajpendo.90619.2008; Mathur A, 2000, CARDIOVASC RES, V46, P126, DOI 10.1016/S0008-6363(00)00002-X; Mene Paolo, 2009, V466, P3, DOI 10.1007/978-1-59745-352-3_1; Miranda-Vizuete A, 1997, J BIOL CHEM, V272, P30841, DOI 10.1074/jbc.272.49.30841; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Pendyala S, 2011, FREE RADICAL BIO MED, V50, P1749, DOI 10.1016/j.freeradbiomed.2011.03.022; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Saxena G, 2010, J BIOL CHEM, V285, P3997, DOI 10.1074/jbc.M109.034421; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Singh DK, 2011, NAT REV ENDOCRINOL, V7, P176, DOI 10.1038/nrendo.2010.212; Spencer NY, 2011, J BIOL CHEM, V286, P8977, DOI 10.1074/jbc.M110.193821; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Thallas-Bonke V, 2008, DIABETES, V57, P460, DOI 10.2337/db07-1119; Xia L, 2006, AM J PHYSIOL-RENAL, V290, pF345, DOI 10.1152/ajprenal.00119.2005; Yang WS, 2008, AM J PHYSIOL-RENAL, V294, pF1065, DOI 10.1152/ajprenal.00381.2007; Yoshioka J, 2012, J CLIN INVEST, V122, P267, DOI 10.1172/JCI44927; Zhang L, 2008, FREE RADICAL BIO MED, V45, P679, DOI 10.1016/j.freeradbiomed.2008.05.019; Zhang R, 2004, CIRC RES, V94, P1483, DOI 10.1161/01.RES.0000130525.37646.a7; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zitman-Gal T, 2010, NEPHROL DIAL TRANSPL, V25, P2141, DOI 10.1093/ndt/gfp768	73	110	116	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6835	6848		10.1074/jbc.M112.419101	http://dx.doi.org/10.1074/jbc.M112.419101			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23329835	Green Published, hybrid			2022-12-25	WOS:000316002400006
J	Burlet, E; Jain, SK				Burlet, Elodie; Jain, Sushil K.			Manganese Supplementation Reduces High Glucose-induced Monocyte Adhesion to Endothelial Cells and Endothelial Dysfunction in Zucker Diabetic Fatty Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE LIPID-PEROXIDATION; SUPEROXIDE-DISMUTASE; CHEMOATTRACTANT PROTEIN-1; OXIDATIVE STRESS; VASCULAR-DISEASE; EXPRESSION; MAGNESIUM; MELLITUS; COPPER; ZINC	Endothelial dysfunction is a hallmark of increased vascular inflammation, dyslipidemia, and the development of atherosclerosis in diabetes. Previous studies have reported lower levels of Mn2+ in the plasma and lymphocytes of diabetic patients and in the heart and aortic tissue of patients with atherosclerosis. This study examines the hypothesis that Mn2+ supplementation can reduce the markers/risk factors of endothelial dysfunction in type 2 diabetes. Human umbilical vein endothelial cells (HUVECs) were cultured with or without Mn2+ supplementation and then exposed to high glucose (HG, 25 mM) to mimic diabetic conditions. Mn2+ supplementation caused a reduction in monocyte adhesion to HUVECs treated with HG or MCP-1. Mn2+ also inhibited ROS levels, MCP-1 secretion, and ICAM-1 up-regulation in HUVECs treated with HG. Silencing studies using siRNA against MnSOD showed that similar results were observed in MnSOD knockdown HUVECs following Mn2+ supplementation, suggesting that the effect of manganese on monocyte adhesion to endothelial cells is mediated by ROS and ICAM-1, but not MnSOD. To validate the relevance of our findings in vivo, Zucker diabetic fatty rats were gavaged daily with water (placebo) or MnCl2 (16 mg/kg of body weight) for 7 weeks. When compared with placebo, Mn2+-supplemented rats showed lower blood levels of ICAM-1 (17%, p < 0.04), cholesterol (25%, p < 0.05), and MCP-1 (28%, p = 0.25). These in vitro and in vivo studies demonstrate that Mn2+ supplementation can down-regulate ICAM-1 expression and ROS independently of MnSOD, leading to a decrease in monocyte adhesion to endothelial cells, and therefore can lower the risk of endothelial dysfunction in diabetes.	[Jain, Sushil K.] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, Shreveport, LA 71130 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Jain, SK (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, 1501 Kings Highway, Shreveport, LA 71130 USA.	sjain@lsuhsc.edu		Jain, Sushil/0000-0002-9574-0436	National Institutes of Health through the NIDDK [RO1 DK072433]; Office of Dietary Supplements; Malcolm Feist Endowed Chair in Diabetes; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072433] Funding Source: NIH RePORTER	National Institutes of Health through the NIDDK; Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Malcolm Feist Endowed Chair in Diabetes; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK072433 through the NIDDK and the Office of Dietary Supplements. This work was also supported by the Malcolm Feist Endowed Chair in Diabetes.	Anetor JI, 2007, BIOL TRACE ELEM RES, V120, P19, DOI 10.1007/s12011-007-0069-x; Bae YJ, 2011, BIOL TRACE ELEM RES, V141, P224, DOI 10.1007/s12011-010-8714-1; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Bomb B S, 1988, J Assoc Physicians India, V36, P149; Bonazzi M, 2011, J CELL BIOL, V195, P348, DOI 10.1083/jcb.201106011; DAVIS CD, 1990, J NUTR, V120, P507, DOI 10.1093/jn/120.5.507; Egashira K, 2003, HYPERTENSION, V41, P834, DOI 10.1161/01.HYP.0000051642.65283.36; Ekmekcioglu C, 2001, BIOL TRACE ELEM RES, V79, P205, DOI 10.1385/BTER:79:3:205; Faxon DP, 2004, CIRCULATION, V109, P2595, DOI 10.1161/01.CIR.0000128517.52533.DB; Forcheron F, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-16; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; Golias C, 2011, CELL COMMUN ADHES, V18, P19, DOI 10.3109/15419061.2011.606381; Holm AM, 2004, EUR J ENDOCRINOL, V150, P893, DOI 10.1530/eje.0.1500893; Hussain S, 1999, NEUROSCI LETT, V261, P21, DOI 10.1016/S0304-3940(98)01005-2; Isaac AO, 2006, NEUROCHEM RES, V31, P1305, DOI 10.1007/s11064-006-9173-0; JAIN SK, 1989, J BIOL CHEM, V264, P21340; Jain SK, 1997, FREE RADICAL BIO MED, V22, P593, DOI 10.1016/S0891-5849(96)00377-2; JAIN SK, 1989, DIABETES, V38, P1539, DOI 10.2337/diabetes.38.12.1539; Kazi TG, 2008, BIOL TRACE ELEM RES, V122, P1, DOI 10.1007/s12011-007-8062-y; Khan AG, 2010, J VIROL, V84, P3984, DOI 10.1128/JVI.01693-09; Lefer DJ, 1999, CIRC RES, V84, P1353, DOI 10.1161/01.RES.84.11.1353; Malthankar GV, 2004, NEUROCHEM RES, V29, P709, DOI 10.1023/B:NERE.0000018841.98399.ce; Manna P, 2011, J BIOL CHEM, V286, P39848, DOI 10.1074/jbc.M111.270884; Metais C, 2008, METABOLISM, V57, P946, DOI 10.1016/j.metabol.2008.02.010; Mukhopadhyay S, 2012, SCIENCE, V335, P332, DOI 10.1126/science.1215930; Nahar Z, 2010, BIOL TRACE ELEM RES, V133, P284, DOI 10.1007/s12011-009-8441-7; Panee J, 2012, CYTOKINE, V60, P1, DOI 10.1016/j.cyto.2012.06.018; PAYNTER DI, 1980, J NUTR, V110, P437, DOI 10.1093/jn/110.3.437; Peluso Ilaria, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P351; Rains JL, 2012, CAN J PHYSIOL PHARM, V90, P1642, DOI 10.1139/y2012-131; Rains JL, 2011, AM J PHYSIOL-ENDOC M, V301, pE298, DOI 10.1152/ajpendo.00038.2011; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Son EW, 2007, ARCH PHARM RES, V30, P743, DOI 10.1007/BF02977637; SUN Y, 1988, CLIN CHEM, V34, P497; VOLKOV NF, 1963, FED PROC, V22, pT897; WALTER RM, 1991, DIABETES CARE, V14, P1050, DOI 10.2337/diacare.14.11.1050; Xing L, 2007, ANTIOXID REDOX SIGN, V9, P1979, DOI 10.1089/ars.2007.1921; ZIDENBERGCHERR S, 1983, J NUTR, V113, P2498, DOI 10.1093/jn/113.12.2498	38	32	34	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6409	6416		10.1074/jbc.M112.447805	http://dx.doi.org/10.1074/jbc.M112.447805			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23329836	Green Published, hybrid			2022-12-25	WOS:000315820700035
J	Matsuura, S; Shimizu, K; Shinoda, M; Ohara, K; Ogiso, B; Honda, K; Katagiri, A; Sessle, BJ; Urata, K; Iwata, K				Matsuura, Shingo; Shimizu, Kohei; Shinoda, Masamichi; Ohara, Kinuyo; Ogiso, Bunnai; Honda, Kuniya; Katagiri, Ayano; Sessle, Barry J.; Urata, Kentaro; Iwata, Koichi			Mechanisms Underlying Ectopic Persistent Tooth-Pulp Pain following Pulpal Inflammation	PLOS ONE			English	Article							SATELLITE GLIAL-CELLS; TEMPOROMANDIBULAR-JOINT INFLAMMATION; TRIGEMINAL ROOT GANGLION; PRIMARY AFFERENT NEURONS; GENE-RELATED PEPTIDE; SPINAL-CORD NEURONS; PERIPHERAL SENSITIZATION; NEUROPATHIC PAIN; OROFACIAL DEEP; RATS	In order to clarify the peripheral mechanisms of ectopic persistent pain in a tooth pulp following pulpal inflammation of an adjacent tooth, masseter muscle activity, phosphorylated extracellular signal-regulated protein kinase (pERK) and TRPV1 immunohistochemistries and satellite cell activation using glial fibrillary acidic protein (GFAP) immunohistochemistry in the trigeminal ganglion (TG) were studied in the rats with molar tooth-pulp inflammation. And, Fluorogold (FG) and DiI were also used in a neuronal tracing study to analyze if some TG neurons innervate more than one tooth pulp. Complete Freund's adjuvant (CFA) or saline was applied into the upper first molar tooth pulp (M1) in pentobarbital-anesthetized rats, and capsaicin was applied into the upper second molar tooth pulp (M2) on day 3 after the CFA or saline application. Mean EMG activity elicited in the masseter muscle by capsaicin application to M2 was significantly larger in M1 CFA-applied rats compared with M1 vehicle-applied rats. The mean number of pERK-immunoreactive (IR) TG cells was significantly larger in M1 CFA-applied rats compared with M1 vehicle-applied rats. Application of the satellite cell inhibitor fluorocitrate (FC) into TG caused a significant depression of capsaicin-induced masseter muscle activity and a significant reduction of satellite cell activation. The number of TRPV1-IR TG cells innervating M2 was significantly larger in M1 CFA-applied rats compared with M1 vehicle-applied rats, and that was decreased following FC injection into TG. Furthermore, 6% of TG neurons innervating M1 and/or M2 innervated both M1 and M2. These findings suggest that satellite cell activation following tooth pulp inflammation and innervation of multiple tooth pulps by single TG neurons may be involved in the enhancement of the activity of TG neurons innervating adjacent non-inflamed teeth that also show enhancement of TRPV1 expression in TG neurons, resulting in the ectopic persistent tooth-pulp pain following pulpal inflammation of adjacent teeth.	[Matsuura, Shingo; Shimizu, Kohei; Ohara, Kinuyo; Ogiso, Bunnai] Nihon Univ, Sch Dent, Dept Endodont, Tokyo 101, Japan; [Shinoda, Masamichi; Honda, Kuniya; Katagiri, Ayano; Iwata, Koichi] Nihon Univ, Sch Dent, Dept Physiol, Tokyo 101, Japan; [Sessle, Barry J.] Univ Toronto, Fac Dent, Dept Oral Physiol, Toronto, ON, Canada; [Shinoda, Masamichi; Urata, Kentaro] Nihon Univ, Sch Dent, Dept Complete Denture Prosthodont, Tokyo 101, Japan; [Iwata, Koichi] Nihon Univ, Grad Sch Med Sci, Div Appl Syst Neurosci, Adv Med Res Ctr, Tokyo, Japan	Nihon University; Nihon University; University of Toronto; Nihon University; Nihon University	Iwata, K (corresponding author), Nihon Univ, Sch Dent, Dept Physiol, Tokyo 101, Japan.	iwata.kouichi@nihon-u.ac.jp	Sessle, Barry/AAD-7771-2022		Nihon University School of Dentistry; Dental Research Center, Nihon University School of Dentistry; Nihon University; Ministry of Education, Culture, Sports, Science and Technology [22792021, 24659832]; Japan-Canada (CIHR) Joint Health Research Program; NIH [DE04786]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE004786] Funding Source: NIH RePORTER	Nihon University School of Dentistry; Dental Research Center, Nihon University School of Dentistry; Nihon University; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan-Canada (CIHR) Joint Health Research Program(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported in part by Research grants from Sato and Uemura Funds from Nihon University School of Dentistry, and a Grant from the Dental Research Center, Nihon University School of Dentistry; Nihon University multidisciplinary research grant and Individual Research Grant; a Grant from the Ministry of Education, Culture, Sports, Science and Technology to promote multi-disciplinary research Projects (KAKENHI (Grant-in-Aid for Young Scientist (B)) #22792021 to MS, #24659832 to KI); grants from the Ministry of Education, Culture, Sports, Science, Technology to promote multidisciplinary research projects "Brain Mechanisms for Cognition, Memory and Behavior" and "Translational Research Network on Orofacial Neurological Disorders" at Nihon University, and Japan-Canada (CIHR) Joint Health Research Program, and NIH grant DE04786. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-59; Cady RJ, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-94; Cherkas PS, 2004, PAIN, V110, P290, DOI 10.1016/j.pain.2004.04.007; Chiang CY, 2011, NEUROSCIENTIST, V17, P303, DOI 10.1177/1073858410386801; Dai Y, 2002, J NEUROSCI, V22, P7737; GLICK D H, 1962, Oral Surg Oral Med Oral Pathol, V15, P613, DOI 10.1016/0030-4220(62)90181-0; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; HOLLAND GR, 1987, EXP NEUROL, V98, P489, DOI 10.1016/0014-4886(87)90258-5; Imbe H, 2001, CELLS TISSUES ORGANS, V169, P238, DOI 10.1159/000047887; Iwata K, 1999, J NEUROPHYSIOL, V82, P1244, DOI 10.1152/jn.1999.82.3.1244; Iwata K, 2001, J NEUROPHYSIOL, V86, P2868, DOI 10.1152/jn.2001.86.6.2868; Jasmin L, 2010, NEURON GLIA BIOL, V6, P63, DOI 10.1017/S1740925X10000098; Katagiri A, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-23; Lam DK, 2009, BRAIN RES, V1253, P48, DOI 10.1016/j.brainres.2008.11.056; Lam DK, 2009, BRAIN RES, V1251, P130, DOI 10.1016/j.brainres.2008.11.029; LISNEY SJW, 1978, J PHYSIOL-LONDON, V279, P509, DOI 10.1113/jphysiol.1978.sp012359; Nebe J, 1997, EUR J NEUROSCI, V9, P2193, DOI 10.1111/j.1460-9568.1997.tb01386.x; SCHAIBLE HG, 1991, J NEUROPHYSIOL, V66, P1021, DOI 10.1152/jn.1991.66.3.1021; Schaible HG, 1996, PROG BRAIN RES, V113, P423, DOI 10.1016/S0079-6123(08)61102-4; SCHEPELMANN K, 1992, NEUROSCIENCE, V50, P237, DOI 10.1016/0306-4522(92)90395-I; SHIGENAGA Y, 1989, BRAIN RES, V477, P66, DOI 10.1016/0006-8993(89)91395-4; Shimizu K, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-75; Shinoda M, 2011, J NEUROSCI, V31, P7145, DOI 10.1523/JNEUROSCI.0481-11.2011; Sunakawa M, 1999, PAIN, V80, P493, DOI 10.1016/S0304-3959(98)00241-3; Takeda M, 2005, PAIN, V116, P375, DOI 10.1016/j.pain.2005.05.007; Takeda M, 2005, J NEUROPHYSIOL, V93, P2723, DOI 10.1152/jn.00631.2004; Tarsa L, 2010, NEUROSCIENCE, V167, P1205, DOI 10.1016/j.neuroscience.2010.03.002; Vasquez E, 2001, J NEUROSCI, V21, P9001, DOI 10.1523/JNEUROSCI.21-22-09001.2001; Vit JP, 2006, NEURON GLIA BIOL, V2, P247, DOI 10.1017/S1740925X07000427; Zhang S, 2006, NEUROSCIENCE, V142, P833, DOI 10.1016/j.neuroscience.2006.06.063; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	31	31	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e52840	10.1371/journal.pone.0052840	http://dx.doi.org/10.1371/journal.pone.0052840			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341909	Green Submitted, Green Published, gold			2022-12-25	WOS:000313682700016
J	Reboredo, M; Chang, HCY; Barbero, R; Rodriguez-Ortigosa, CM; Perez-Vizcaino, F; Moran, A; Garcia, M; Banales, JM; Carreno, N; Alegre, F; Herrero, I; Quiroga, J; Prieto, J; Sangro, B				Reboredo, Mercedes; Chang, Haisul C. Y.; Barbero, Roberto; Rodriguez-Ortigosa, Carlos M.; Perez-Vizcaino, Francisco; Moran, Asuncion; Garcia, Monica; Banales, Jesus M.; Carreno, Norberto; Alegre, Felix; Herrero, Ignacio; Quiroga, Jorge; Prieto, Jesus; Sangro, Bruno			Zolmitriptan: A Novel Portal Hypotensive Agent Which Synergizes with Propranolol in Lowering Portal Pressure	PLOS ONE			English	Article							SYSTEMIC HEMODYNAMICS; MESENTERIC-ARTERY; RAT MESENTERY; HEALTHY-VOLUNTEERS; RECEPTOR SUBTYPES; CIRRHOTIC RATS; PHARMACOKINETICS; HYPERTENSION; 311C90; MODEL	Objective: Only a limited proportion of patients needing pharmacological control of portal hypertension are hemodynamic responders to propranolol. Here we analyzed the effects of zolmitriptan on portal pressure and its potential interaction with propranolol. Methods: Zolmitriptan, propranolol or both were tested in two rat models of portal hypertension: common bile duct ligation (CBDL) and CCl4-induced cirrhosis. In these animals we measured different hemodynamic parameters including portal venous pressure, arterial renal flow, portal blood flow and cardiac output. We also studied the changes in superior mesenteric artery perfusion pressure and in arterial wall cAMP levels induced by zolmitriptan, propranolol or both. Moreover, we determined the effect of splanchnic sympathectomy on the response of PVP to zolmitriptan. Results: In both models of portal hypertension zolmitriptan induced a dose-dependent transient descent of portal pressure accompanied by reduction of portal flow with only slight decrease in renal flow. In cirrhotic rats, splanchnic sympathectomy intensified and prolonged zolmitriptan-induced portal pressure descent. Also, propranolol caused more intense and durable portal pressure fall when combined with zolmitriptan. Mesenteric artery perfusion pressure peaked for about 1 min upon zolmitriptan administration but showed no change with propranolol. However propranolol enhanced and prolonged the elevation in mesenteric artery perfusion pressure induced by zolmitriptan. In vitro studies showed that propranolol prevented the inhibitory effects of beta 2-agonists on zolmitriptan-induced vasoconstriction and the combination of propranolol and zolmitriptan significantly reduced the elevation of cAMP caused by beta 2-agonists. Conclusion: Zolmitriptan reduces portal hypertension and non-selective beta-blockers can improve this effect. Combination therapy deserves consideration for patients with portal hypertension failing to respond to non-selective beta-blockers.	[Reboredo, Mercedes; Barbero, Roberto; Rodriguez-Ortigosa, Carlos M.; Herrero, Ignacio; Quiroga, Jorge; Prieto, Jesus; Sangro, Bruno] CIBERehd, Pamplona, Spain; [Chang, Haisul C. Y.; Rodriguez-Ortigosa, Carlos M.; Prieto, Jesus] Univ Navarra, Ctr Appl Med Res CIMA, Div Hepatol & Gene Therapy, E-31080 Pamplona, Spain; [Perez-Vizcaino, Francisco] Univ Complutense, Dept Pharmacol, E-28040 Madrid, Spain; [Perez-Vizcaino, Francisco] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain; [Moran, Asuncion; Garcia, Monica] Univ Salamanca, Dept Fisiol & Farmacol, E-37008 Salamanca, Spain; [Banales, Jesus M.] Univ Basque Country UPV EHU, Donostia Univ Hosp, Biodonostia Res Inst, IKERBASQUE,Div Hepatol & Gastroenterol, San Sebastian, Spain; [Carreno, Norberto; Alegre, Felix; Herrero, Ignacio; Quiroga, Jorge; Prieto, Jesus; Sangro, Bruno] Univ Navarra Clin, Liver Unit, Pamplona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Navarra; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Salamanca; Basque Foundation for Science; University Hospital Donostia; University of Basque Country; University of Navarra	Reboredo, M (corresponding author), CIBERehd, Pamplona, Spain.	mmreboredo@unav.es	Morán, Asunción/B-1817-2017; Sangro, Bruno/AFW-4106-2022; Perez-Vizcaino, Francisco/A-9735-2011; Rodriguez-Ortigosa, Carlos/K-9895-2014; Banales, Jesus M/R-9739-2019; Garcia Domingo, Monica/B-1794-2017	Morán, Asunción/0000-0001-7509-1232; Perez-Vizcaino, Francisco/0000-0001-6309-7418; Rodriguez-Ortigosa, Carlos/0000-0002-4931-4719; Sangro, Bruno/0000-0002-4177-6417; Banales, Jesus/0000-0002-5224-2373; Garcia Domingo, Monica/0000-0001-6140-4322; Prieto, Jesus/0000-0002-1091-9593	Instituto de Salud Carlos III; Ministerio de Ciencia e Innovacion; FIMA project UTE; Condesa de FENOSA; Pedro Barrie de la Maza; Fundacion Mario Losantos and Ministerio de Economia y Competitividad [SAF 2011-28150]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FIMA project UTE; Condesa de FENOSA; Pedro Barrie de la Maza; Fundacion Mario Losantos and Ministerio de Economia y Competitividad	CIBEREHD is funded by the Instituto de Salud Carlos III (http://www.ciberehd.org), Ministerio de Ciencia e Innovacion; grants by FIMA project UTE, Condesa de FENOSA, Pedro Barrie de la Maza, Fundacion Mario Losantos and Ministerio de Economia y Competitividad (SAF 2011-28150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli P, 2011, J HEPATOL, V55, P743, DOI 10.1016/j.jhep.2011.02.026; Bosch J, 2000, J HEPATOL, V32, P141, DOI 10.1016/S0168-8278(00)80422-5; DEBAENE B, 1990, ANESTHESIOLOGY, V73, P118, DOI 10.1097/00000542-199007000-00017; Dixon R, 1997, BRIT J CLIN PHARMACO, V43, P273, DOI 10.1046/j.1365-2125.1997.00547.x; Dixon RM, 1997, CEPHALALGIA, V17, P639, DOI 10.1046/j.1468-2982.1997.1706639.x; Dowson AJ, 2002, INFORM HEALTHCARE, V3, P993; Fernandez MD, 2000, EUR J PHARMACOL, V401, P221, DOI 10.1016/S0014-2999(00)00444-1; Fizanne L, 2008, HEPATOL INT, V2, P457, DOI 10.1007/s12072-008-9070-5; Goldberg MR, 2001, BRIT J CLIN PHARMACO, V52, P69, DOI 10.1046/j.0306-5251.2001.01417.x; Gul H, 2003, J CARDIOVASC PHARM, V41, P307, DOI 10.1097/00005344-200302000-00021; Gul H, 2002, N-S ARCH PHARMACOL, V366, P254, DOI 10.1007/s00210-002-0587-1; Hansen MB, 2006, SCAND J CLIN LAB INV, V66, P395, DOI 10.1080/00365510600763301; Hernandez FT, 2006, VASC PHARMACOL, V44, P464, DOI 10.1016/j.vph.2006.03.001; JACKSON EK, 1980, EUR J PHARMACOL, V66, P217, DOI 10.1016/0014-2999(80)90145-4; Janssen BJA, 2004, AM J PHYSIOL-HEART C, V287, pH1618, DOI 10.1152/ajpheart.01192.2003; Knapton AD, 2010, METHOD FIND EXP CLIN, V32, P489, DOI 10.1358/mf.2010.32.7.1507854; KROEGER RJ, 1985, GASTROENTEROLOGY, V88, P896, DOI 10.1016/S0016-5085(85)80005-6; Loder E, 2010, NEW ENGL J MED, V363, P63, DOI 10.1056/NEJMct0910887; Martin GR, 1997, BRIT J PHARMACOL, V121, P157, DOI 10.1038/sj.bjp.0701041; Mejias M, 2009, HEPATOLOGY, V49, P1245, DOI 10.1002/hep.22758; Menendez C, 2011, MOL NUTR FOOD RES, V55, P1780, DOI 10.1002/mnfr.201100378; Minano C, 2010, GASTROENTEROL CLIN N, V39, P681, DOI 10.1016/j.gtc.2010.08.015; Peck RW, 1997, BRIT J CLIN PHARMACO, V44, P595, DOI 10.1046/j.1365-2125.1997.t01-1-00632.x; PROCTOR E, 1982, GASTROENTEROLOGY, V83, P1183; Reuter U, 2004, CEPHALALGIA, V24, P398, DOI 10.1111/j.1468-2982.2004.00683.x; RINGLARSEN H, 1982, HEPATOLOGY, V2, P304; Spencer CM, 1999, DRUGS, V58, P347, DOI 10.2165/00003495-199958020-00016; Tanaka Y, 2005, CLIN EXP PHARMACOL P, V32, P503, DOI 10.1111/j.1440-1681.2005.04222.x; Veal N, 2001, J APPL PHYSIOL, V91, P1274, DOI 10.1152/jappl.2001.91.3.1274; Worlicek M, 2010, GUT, V59, P1127, DOI 10.1136/gut.2009.185413; Wurch T, 2000, J NEUROCHEM, V75, P1180, DOI 10.1046/j.1471-4159.2000.0751180.x	31	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e52683	10.1371/journal.pone.0052683	http://dx.doi.org/10.1371/journal.pone.0052683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341903	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000313682700013
J	Samuel, P; Khan, MA; Nag, S; Inagami, T; Hussain, T				Samuel, Preethi; Khan, Mohammad Azhar; Nag, Sourashish; Inagami, Tadashi; Hussain, Tahir			Angiotensin AT(2) Receptor Contributes towards Gender Bias in Weight Gain	PLOS ONE			English	Article							II TYPE-2 RECEPTOR; FREE FATTY-ACIDS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; PPAR-GAMMA; ENERGY-EXPENDITURE; BODY-WEIGHT; ESTROGEN; MICE; OBESITY	Obesity is a major disease condition, in turn leading to pathological changes collectively recognized as metabolic syndrome. Recently angiotensin receptor AT(2)R has been associated negatively with body weight (BW) gain in male mice. However, the gender differences in AT(2)R and BW changes have not been studied. To understand the gender based role of AT(2)R involving BW changes, we fed male and female wild type (WT) and AT(2)R knock out (AT(2)KO) mice with C57BL6 background with high fat diet (HFD) for 16 weeks. The male AT(2)KO had higher HFD calorie intake (WT: 1280 +/- 80; AT(2)KO: 1680 +/- 80 kcal) but gained less BW compared with the WT (WT: 13; AT(2)KO: 6 g). Contrary to the male animals, the female AT(2)KO mice with equivalent caloric intake (WT: 1424 +/- 48; AT(2)KO: 1456 +/- 80 kcal) gained significantly more BW than the WT mice (WT: 9 g; AT(2)KO: 15 g). The male AT(2)KO on HFD displayed lower plasma insulin level, less impaired glucose tolerance (GT), and higher plasma T3 compared with WT males on HFD; whereas the female AT(2)KO mice on HFD showed elevated levels of plasma insulin, more impaired GT, lower plasma T3 and higher free fatty acid and hepatic triglycerides compared with WT females on HFD. Interestingly, compared with WT, AT(2)KO female mice had significantly lower estrogen, which was further reduced by HFD. These results suggest that AT(2)R in female mice via potentially regulating estrogen may have protective role against BW gain and impaired glucose tolerance and lipid metabolism.	[Samuel, Preethi; Khan, Mohammad Azhar; Nag, Sourashish; Hussain, Tahir] Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77030 USA; [Inagami, Tadashi] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA	University of Houston System; University of Houston; Vanderbilt University	Hussain, T (corresponding author), Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77030 USA.	thussain@central.uh.edu	Khan, Mohammed/AAV-9189-2021		Norman Hackerman Advance Research Program, State of Texas [ROI DK-61578, ROI HL-58205]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061578] Funding Source: NIH RePORTER	Norman Hackerman Advance Research Program, State of Texas; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is supported by the Norman Hackerman Advance Research Program, State of Texas and ROI DK-61578 awarded to TH, and ROI HL-58205 awarded to TI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie DA, 2001, INT J OBESITY, V25, P1680, DOI 10.1038/sj.ijo.0801806; Armando I, 2002, AM J PHYSIOL-RENAL, V283, pF934, DOI 10.1152/ajprenal.00145.2002; Bachmanov AA, 2001, PHYSIOL BEHAV, V72, P603, DOI 10.1016/S0031-9384(01)00412-7; Baiardi G, 2005, REGUL PEPTIDES, V124, P7, DOI 10.1016/j.regpep.2004.06.021; BLACK AE, 1991, EUR J CLIN NUTR, V45, P583; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; BRUCH HR, 1992, J CLIN ENDOCR METAB, V75, P101, DOI 10.1210/jc.75.1.101; Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010; Clasen R, 2005, HYPERTENSION, V46, P137, DOI 10.1161/01.HYP.0000168046.19884.6a; Delarue J, 2007, CURR OPIN CLIN NUTR, V10, P142, DOI 10.1097/MCO.0b013e328042ba90; DOLE VP, 1956, J CLIN INVEST, V35, P150, DOI 10.1172/JCI103259; Engeli S, 1999, J HYPERTENS, V17, P555, DOI 10.1097/00004872-199917040-00014; Erbe DV, 2006, VASC PHARMACOL, V45, P154, DOI 10.1016/j.vph.2006.05.002; Gao Q, 2008, AM J PHYSIOL-ENDOC M, V294, pE817, DOI 10.1152/ajpendo.00733.2007; Grumbach MM, 1999, J CLIN ENDOCR METAB, V84, P4677, DOI 10.1210/jc.84.12.4677; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; HEMSELL DL, 1974, J CLIN ENDOCR METAB, V38, P476, DOI 10.1210/jcem-38-3-476; Henriksen EJ, 2007, AM J PHYSIOL-REG I, V293, pR974, DOI 10.1152/ajpregu.00147.2007; ICHIKI T, 1995, NATURE, V377, P748, DOI 10.1038/377748a0; Jones BH, 1997, ENDOCRINOLOGY, V138, P1512, DOI 10.1210/en.138.4.1512; Kim S, 2001, BIOCHEM J, V357, P899, DOI 10.1042/0264-6021:3570899; KISSEBAH AH, 1994, PHYSIOL REV, V74, P761, DOI 10.1152/physrev.1994.74.4.761; Kotani K, 2007, ANN CLIN BIOCHEM, V44, P83, DOI 10.1258/000456307779595959; Kouyama R, 2005, ENDOCRINOLOGY, V146, P3481, DOI 10.1210/en.2005-0003; Louet Jean-Francois, 2004, Curr Atheroscler Rep, V6, P180, DOI 10.1007/s11883-004-0030-9; Lu H, 2007, AM J PHYSIOL-ENDOC M, V292, pE1280, DOI 10.1152/ajpendo.00277.2006; Lusis AJ, 2008, NAT REV GENET, V9, P819, DOI 10.1038/nrg2468; Miller JA, 1999, KIDNEY INT, V55, P278, DOI 10.1046/j.1523-1755.1999.00260.x; Naftolin F, 1975, Recent Prog Horm Res, V31, P295; NITTA H, 1993, ENDOCRINOLOGY, V132, P1396, DOI 10.1210/en.132.3.1396; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Pelleymounter MA, 1999, AM J PHYSIOL-ENDOC M, V276, pE955, DOI 10.1152/ajpendo.1999.276.5.E955; Poehlman ET, 1998, CORONARY ARTERY DIS, V9, P799, DOI 10.1097/00019501-199809120-00004; RANDLE PJ, 1963, LANCET, V1, P785; Riant E, 2009, ENDOCRINOLOGY, V150, P2109, DOI 10.1210/en.2008-0971; Rosenbaum M, 2000, AM J CLIN NUTR, V71, P1421; Sampson AK, 2008, HYPERTENSION, V52, P666, DOI 10.1161/HYPERTENSIONAHA.108.114058; Sampson AK, 2008, CLIN EXP PHARMACOL P, V35, P391, DOI 10.1111/j.1440-1681.2008.04884.x; Sandberg K, 2008, HYPERTENSION, V52, P615, DOI 10.1161/HYPERTENSIONAHA.108.115063; Shimizu H, 1997, J ENDOCRINOL, V154, P285, DOI 10.1677/joe.0.1540285; SILBIGER SR, 1995, AM J KIDNEY DIS, V25, P515, DOI 10.1016/0272-6386(95)90119-1; Simpson E, 1999, ENDOCR-RELAT CANCER, V6, P131, DOI 10.1677/erc.0.0060131; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Spiegelman BM, 2000, INT J OBESITY, V24, pS8, DOI 10.1038/sj.ijo.0801492; Thomas HV, 1997, CANCER CAUSE CONTROL, V8, P922, DOI 10.1023/A:1018476631561; Wang Chih-Hong, 2010, Open Hypertens J, V3, P1; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yoshimura Y, 1996, ENDOCRINOLOGY, V137, P1204, DOI 10.1210/en.137.4.1204; Yvan-Charvet L, 2005, DIABETES, V54, P991, DOI 10.2337/diabetes.54.4.991; Yvan-Charvet L, 2006, ENDOCRINOLOGY, V147, P5078, DOI 10.1210/en.2006-0754; Yvan-Charvet L, 2009, ENDOCRINOLOGY, V150, P1421, DOI 10.1210/en.2008-1120	52	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e48425	10.1371/journal.pone.0048425	http://dx.doi.org/10.1371/journal.pone.0048425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23341867	Green Published, Green Submitted, gold			2022-12-25	WOS:000314707700001
J	Shin, J; Kho, SA; Choi, YS; Kim, YC; Rhyu, IC; Choi, Y				Shin, Jieun; Kho, Sang-A; Choi, Yun S.; Kim, Yong C.; Rhyu, In-Chul; Choi, Youngnim			Antibody and T Cell Responses to Fusobacterium nucleatum and Treponema denticola in Health and Chronic Periodontitis	PLOS ONE			English	Article							INFLAMED GINGIVAL TISSUE; CENTRAL MEMORY; PORPHYROMONAS-GINGIVALIS; ANTIGEN-SPECIFICITY; CYTOKINE PROFILES; PERIPHERAL-BLOOD; EPITHELIAL-CELLS; ORAL BACTERIA; INDUCE TH1; LYMPHOCYTES	The characteristics of the T cell response to the members of oral flora are poorly understood. We characterized the antibody and T cell responses to FadA and Td92, adhesins from Fusobacterium nucleatum, an oral commensal, and Treponema denticola, a periodontal pathogen, respectively. Peripheral blood and saliva were obtained from healthy individuals and patients with untreated chronic periodontitis (CP, n = 11 paris) and after successful treatment of the disease (n = 9). The levels of antigen-specific antibody were measured by ELISA. In plasma, IgG1 was the most abundant isotype of Ab for both Ags, followed by IgA and then IgG4. The levels of FadA-specific salivary IgA (sIgA) were higher than Td92-specific sIgA and the FadA-specific IgA levels observed in plasma. However, the periodontal health status of the individuals did not affect the levels of FadA-or Td92-specific antibody. Even healthy individuals contained FadA-and Td92-specific CD4(+) T cells, as determined by the detection of intracytoplasmic CD154 after short-term in vitro stimulation of peripheral blood mononuclear cells (PBMCs) with the antigens. Patients with CP tended to possess increased numbers of FadA-and Td92-specific CD4+ T cells but reduced numbers of Td92-specific Foxp(3+)CD(4+) Tregs than the healthy subjects. Both FadA and Td92 induced the production of IFN gamma and IL-10 but inhibited the secretion of IL-4 by PBMCs. In conclusion, F. nucleatum induced Th3 (sIgA)-and Th1 (IFN gamma and IgG1)-dominant immune responses, whereas T. denticola induced a Th1 (IFN gamma and IgG1)-dominant response. This IFN gamma-dominant cytokine response was impaired in CP patients, and the Td92-induced IFN gamma levels were negatively associated with periodontal destruction in patients. These findings may provide new insights into the homeostatic interaction between the immune system and oral bacteria and the pathogenesis of periodontitis.	[Shin, Jieun; Choi, Yun S.; Kim, Yong C.; Choi, Youngnim] Seoul Natl Univ, Sch Dent, CLS BK21, Dept Immunol & Mol Microbiol, Seoul, South Korea; [Shin, Jieun; Kho, Sang-A; Choi, Yun S.; Kim, Yong C.; Rhyu, In-Chul; Choi, Youngnim] Seoul Natl Univ, Dent Res Inst, Seoul, South Korea; [Kho, Sang-A; Rhyu, In-Chul] Seoul Natl Univ, Sch Dent, CLS BK21, Dept Periodontol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Choi, Y (corresponding author), Seoul Natl Univ, Sch Dent, CLS BK21, Dept Immunol & Mol Microbiol, Seoul, South Korea.	youngnim@snu.ac.kr	Choi, Youngnim/AAL-8140-2020	Choi, Youngnim/0000-0002-6496-5560	National Research Foundation of Korea by the Korean Government through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University [2011-0028235]	National Research Foundation of Korea by the Korean Government through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University(National Research Foundation of Korea)	This study was supported by the National Research Foundation of Korea Grant (2011-0028235) by the Korean Government funded through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Berglundh T, 2005, J CLIN PERIODONTOL, V32, P87, DOI 10.1111/j.1600-051X.2005.00820.x; Berglundh T, 2002, J CLIN PERIODONTOL, V29, P705, DOI 10.1034/j.1600-051X.2002.290807.x; Brage M, 2011, J PERIODONTAL RES, V46, P170, DOI 10.1111/j.1600-0765.2010.01325.x; Cardoso CR, 2009, ORAL MICROBIOL IMMUN, V24, P1, DOI 10.1111/j.1399-302X.2008.00463.x; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Costalonga M, 2009, MUCOSAL IMMUNOL, V2, P85, DOI 10.1038/mi.2008.67; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; GASCAN H, 1991, J IMMUNOL, V147, P8; Geginat J, 2001, J EXP MED, V194, P1711, DOI 10.1084/jem.194.12.1711; Gemmell E, 2002, J DENT RES, V81, P303, DOI 10.1177/154405910208100503; Gorska R, 2003, J CLIN PERIODONTOL, V30, P1046, DOI 10.1046/j.0303-6979.2003.00425.x; Guiducci C, 2005, EUR J IMMUNOL, V35, P557, DOI 10.1002/eji.200425810; Haffajee AD, 2006, ORAL MICROBIOL IMMUN, V21, P269, DOI 10.1111/j.1399-302X.2006.00287.x; Hall LM, 2012, J PERIODONTOL, V83, P228, DOI 10.1902/jop.2011.110116; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Ikegami A, 2009, INFECT IMMUN, V77, P3075, DOI 10.1128/IAI.00209-09; Ji S, 2007, J PERIODONTAL RES, V42, P503, DOI 10.1111/j.1600-0765.2007.00974.x; Ji S, 2010, MOL CELLS, V30, P519, DOI 10.1007/s10059-010-0142-8; Jun HK, 2008, INFECT IMMUN, V76, P2428, DOI 10.1128/IAI.01128-07; KAWANO Y, 1994, J IMMUNOL, V153, P4948; Kopitar AN, 2006, ORAL MICROBIOL IMMUN, V21, P1, DOI 10.1111/j.1399-302X.2005.00237.x; Krisanaprakornkit S, 2000, INFECT IMMUN, V68, P2907, DOI 10.1128/IAI.68.5.2907-2915.2000; Lappin DF, 2001, CLIN EXP IMMUNOL, V123, P294, DOI 10.1046/j.1365-2249.2001.01448.x; Liang SA, 2011, J IMMUNOL, V186, P869, DOI 10.4049/jimmunol.1003252; Lux R, 2001, INFECT IMMUN, V69, P6276, DOI 10.1128/IAI.69.10.6276-6283.2001; MAHANONDA R, 1989, CLIN EXP IMMUNOL, V75, P245; Nakajima T, 1999, ARCH ORAL BIOL, V44, P1045, DOI 10.1016/S0003-9969(99)00094-1; Pussinen PJ, 2011, J CLIN PERIODONTOL, V38, P405, DOI 10.1111/j.1600-051X.2011.01703.x; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Shin J, 2008, ORAL DIS, V14, P327, DOI 10.1111/j.1601-0825.2007.01382.x; Sigusch B, 1998, J PERIODONTOL, V69, P1098, DOI 10.1902/jop.1998.69.10.1098; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; STAVNEZER J, 1995, J IMMUNOL, V155, P1647; Stubbe M, 2008, EUR J IMMUNOL, V38, P273, DOI 10.1002/eji.200737611; Stubbe M, 2006, J IMMUNOL, V177, P8185, DOI 10.4049/jimmunol.177.11.8185; Takeuchi Y, 2006, ORAL MICROBIOL IMMUN, V21, P314, DOI 10.1111/j.1399-302X.2006.00296.x; TEW JG, 1985, J PERIODONTAL RES, V20, P580, DOI 10.1111/j.1600-0765.1985.tb00842.x; Tokoro Y, 1997, CLIN EXP IMMUNOL, V107, P166, DOI 10.1046/j.1365-2249.1997.d01-880.x; Vaughan AT, 2010, J IMMUNOL, V185, P3652, DOI 10.4049/jimmunol.0902468; WASSENAAR A, 1995, INFECT IMMUN, V63, P2147, DOI 10.1128/IAI.63.6.2147-2153.1995; Wassenaar A, 1998, CLIN EXP IMMUNOL, V113, P105, DOI 10.1046/j.1365-2249.1998.00630.x; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Yamamoto M, 1997, J PERIODONTAL RES, V32, P115, DOI 10.1111/j.1600-0765.1997.tb01391.x	50	11	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53703	10.1371/journal.pone.0053703	http://dx.doi.org/10.1371/journal.pone.0053703			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335969	Green Submitted, gold, Green Published			2022-12-25	WOS:000314707700025
J	Siero, JCW; Ramsey, NF; Hoogduin, H; Klomp, DWJ; Luijten, PR; Petridou, N				Siero, Jeroen C. W.; Ramsey, Nick F.; Hoogduin, Hans; Klomp, Dennis W. J.; Luijten, Peter R.; Petridou, Natalia			BOLD Specificity and Dynamics Evaluated in Humans at 7 T: Comparing Gradient-Echo and Spin-Echo Hemodynamic Responses	PLOS ONE			English	Article							OCULAR DOMINANCE COLUMNS; INDUCED SIGNAL CHANGES; HUMAN CEREBRAL-CORTEX; FUNCTIONAL MRI; HUMAN-BRAIN; LAMINAR SPECIFICITY; BLOOD-FLOW; FMRI; TESLA; SUPPRESSION	High-field gradient-echo (GE) BOLD fMRI enables very high resolution imaging, and has great potential for detailed investigations of brain function. However, as spatial resolution increases, confounds due to signal from non-capillary vessels increasingly impact the fidelity of GE BOLD fMRI signals. Here we report on an assessment of the microvascular weighting of the GE BOLD response across the cortical depth in human cortex using spin-echo fMRI which is thought to be dominated by microvasculature (albeit not completely). BOLD responses were measured with a hemodynamic impulse response (HRF) obtained from the spin-echo (SE) and gradient-echo (GE) BOLD contrast using very short stimuli (0.25 s) and a fast event-related functional paradigm. We show that the onset (similar to 1.25 s) and the rising slope of the GE and SE HRFs are strikingly similar for voxels in deep gray matter presumably containing the most metabolically demanding neurons (layers III-IV). This finding provides a strong indication that the onset of the GE HRF in deep gray matter is predominantly associated with microvasculature.	[Siero, Jeroen C. W.; Ramsey, Nick F.; Hoogduin, Hans; Petridou, Natalia] Univ Med Ctr Utrecht, Rudolf Magnus Inst, Dept Neurol & Neurosurg, Utrecht, Netherlands; [Hoogduin, Hans; Klomp, Dennis W. J.; Luijten, Peter R.; Petridou, Natalia] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Ramsey, NF (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst, Dept Neurol & Neurosurg, Utrecht, Netherlands.	n.ramsey@umcutrecht.nl	Siero, Jeroen Cornelis Willem/I-4841-2019	Siero, Jeroen Cornelis Willem/0000-0001-5079-2868; , Natalia/0000-0002-0783-0387; ramsey, nick/0000-0002-7136-259X	BrainGain Smart Mix Programme; Dutch Technology Foundation STW; Applied Science Division of Netherlands Organisation for Scientific Research; Technology Program of the Ministry of Economic Affairs; University of Utrecht [UGT7685]	BrainGain Smart Mix Programme; Dutch Technology Foundation STW(Technologiestichting STW); Applied Science Division of Netherlands Organisation for Scientific Research; Technology Program of the Ministry of Economic Affairs; University of Utrecht	This study was funded by the BrainGain Smart Mix Programme, the Dutch Technology Foundation STW, the Applied Science Division of Netherlands Organisation for Scientific Research, the Technology Program of the Ministry of Economic Affairs, and the University of Utrecht (grant UGT7685). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ari N, 2001, P 23 ANN C IEEE EMBS; Bhagat YA, 2004, J MAGN RESON IMAGING, V20, P216, DOI 10.1002/jmri.20102; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P555, DOI 10.1002/mrm.1910340412; Chen BR, 2011, NEUROIMAGE, V54, P1021, DOI 10.1016/j.neuroimage.2010.09.036; Cheng K, 2001, NEURON, V32, P359, DOI 10.1016/S0896-6273(01)00477-9; Duong TQ, 2003, MAGN RESON MED, V49, P1019, DOI 10.1002/mrm.10472; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Duvernoy HM, 1999, HUMAN BRAIN; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2010, NEUROIMAGE; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Goense JBM, 2006, MAGN RESON IMAGING, V24, P381, DOI 10.1016/j.mri.2005.12.032; Hagberg GE, 2001, NEUROIMAGE, V14, P1193, DOI 10.1006/nimg.2001.0880; Harel N, 2006, NEUROIMAGE, V29, P879, DOI 10.1016/j.neuroimage.2005.08.016; Koopmans PJ, 2011, NEUROIMAGE, V56, P1276, DOI 10.1016/j.neuroimage.2011.02.042; Koopmans PJ, 2010, HUM BRAIN MAPP, V31, P1297, DOI 10.1002/hbm.20936; Lauwers F, 2008, NEUROIMAGE, V39, P936, DOI 10.1016/j.neuroimage.2007.09.024; MENON RS, 1993, MAGNET RESON MED, V30, P380, DOI 10.1002/mrm.1910300317; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Nehlig A, 2007, GLIA, V55, P1238, DOI 10.1002/glia.20376; Norris DG, 2012, NEUROIMAGE, V62, P1109, DOI 10.1016/j.neuroimage.2012.01.003; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Osman L, 2007, CIRCULATION, V116, pI282, DOI 10.1161/CIRCULATIONAHA.106.681072; Petridou N, 2013, NMR BIOMED, V26, P65, DOI 10.1002/nbm.2820; Pfeuffer J, 2003, NEUROIMAGE, V18, P990, DOI 10.1016/S1053-8119(03)00035-1; Rossi DJ, 2006, NAT NEUROSCI, V9, P159, DOI 10.1038/nn0206-159; Siero JCW, 2011, J CEREBR BLOOD F MET, V31, P1999, DOI 10.1038/jcbfm.2011.57; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stefanovic B, 2008, J CEREBR BLOOD F MET, V28, P961, DOI 10.1038/sj.jcbfm.9600590; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Tian PF, 2010, P NATL ACAD SCI USA, V107, P15246, DOI 10.1073/pnas.1006735107; Turner R, 2002, NEUROIMAGE, V16, P1062, DOI 10.1006/nimg.2002.1082; Uludag K, 2009, NEUROIMAGE, V48, P150, DOI 10.1016/j.neuroimage.2009.05.051; Yacoub E, 2001, MAGN RESON MED, V45, P588, DOI 10.1002/mrm.1080; Yacoub E, 2005, NEUROIMAGE, V24, P738, DOI 10.1016/j.neuroimage.2004.09.002; Yacoub E, 2003, MAGNET RESON MED, V49, P655, DOI 10.1002/mrm.10433; Yacoub E, 2007, NEUROIMAGE, V37, P1161, DOI 10.1016/j.neuroimage.2007.05.020; Yu X, 2011, NEUROIMAGE; Zhang NY, 2009, NEUROIMAGE, V48, P313, DOI 10.1016/j.neuroimage.2009.06.071; Zwanenburg JJM, 2011, NEUROIMAGE, V56, P1902, DOI 10.1016/j.neuroimage.2011.03.046	40	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54560	10.1371/journal.pone.0054560	http://dx.doi.org/10.1371/journal.pone.0054560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23336008	Green Submitted, Green Published, gold			2022-12-25	WOS:000314707700066
J	Al-Maskari, F; El-Sadig, M; Al-Kaabi, JM; Afandi, B; Nagelkerke, N; Yeatts, KB				Al-Maskari, Fatma; El-Sadig, Mohamed; Al-Kaabi, Juma M.; Afandi, Bachar; Nagelkerke, Nicolas; Yeatts, Karin B.			Knowledge, Attitude and Practices of Diabetic Patients in the United Arab Emirates	PLOS ONE			English	Article							GLYCEMIC CONTROL; ASSOCIATION; MANAGEMENT; EDUCATION; CARE	Introduction: Diabetes self-management education is a cornerstone of diabetes care. However, many diabetics in the United Arab Emirates (UAE) lack sufficient knowledge about their disease due to illiteracy. Thus, before considering any possible intervention it was imperative to assess present knowledge, attitudes, and practices of patients towards the management of diabetes. Methods: A random sample of 575 DM patients was selected from diabetes outpatient's clinics of Tawam and Al-Ain hospitals in Al-Ain city (UAE) during 2006-2007, and their knowledge attitude and practice assessed using a questionnaire modified from the Michigan Diabetes Research Training Center instrument. Results: Thirty-one percent of patients had poor knowledge of diabetes. Seventy-two had negative attitudes towards having the disease and 57% had HbA(1c) levels reflecting poor glycemic control. Only seventeen percent reported having adequate blood sugar control, while 10% admitted non-compliance with their medications. Knowledge, practice and attitude scores were all statistically significantly positively, but rather weakly, associated, but none of these scores was significantly correlated with HbA1c. Conclusions: The study showed low levels of diabetes awareness but positive attitudes towards the importance of DM care and satisfactory diabetes practices in the UAE. Programs to increase patients' awareness about DM are essential for all diabetics in the UAE in order to improve their understanding, compliance and management and, thereby, their ability to cope with the disease.	[Al-Maskari, Fatma; El-Sadig, Mohamed; Nagelkerke, Nicolas] UAE Univ, Coll Med & Hlth Sci, Inst Publ Hlth, Al Ain, U Arab Emirates; [Al-Kaabi, Juma M.] UAE Univ, Coll Med & Hlth Sci, Dept Internal Med, Al Ain, U Arab Emirates; [Afandi, Bachar] John Hopkins Med, Tawam Hosp, Ctr Diabet, Al Ain, U Arab Emirates; [Yeatts, Karin B.] Univ N Carolina, Gillings Sch Publ Hlth, Chapel Hill, NC USA	United Arab Emirates University; United Arab Emirates University; University of North Carolina; University of North Carolina Chapel Hill	Al-Maskari, F (corresponding author), UAE Univ, Coll Med & Hlth Sci, Inst Publ Hlth, Al Ain, U Arab Emirates.	fatma.am@uaeu.ac.ae	Elsadig, Mohamed/AAX-7935-2020	Elsadig, Mohamed/0000-0001-5795-8189; Al-Maskari, Fatma/0000-0001-6598-4942; Alkaabi, Juma/0000-0003-2477-0408	UAE University	UAE University	UAE University funded this research. However, the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah L, 2001, East Mediterr Health J, V7, P662; Al-Adsani AMS, 2009, DIABETES METAB, V35, P121, DOI 10.1016/j.diabet.2008.09.005; Al-Kaabi Juma, 2009, Rev Diabet Stud, V6, P271, DOI 10.1900/RDS.2009.6.271; Al-Kaabi Juma, 2008, Rev Diabet Stud, V5, P110, DOI 10.1900/RDS.2008.5.110; Al-Qazaz HK, 2011, INT J CLIN PHARM-NET, V33, P1028, DOI 10.1007/s11096-011-9582-2; American Diabetes Association, 2002, DIABETES CARE S1, V25, pS33, DOI [10.2337/diacare.25.2007.S33, DOI 10.2337/DIACARE.25.2007.S33, 10.2337/diacare.25.2007.s33]; Ardena GJRA, 2010, DIABETES RES CLIN PR, V90, P160, DOI 10.1016/j.diabres.2010.08.003; Ben Abdelaziz A., 2007, Eastern Mediterranean Health Journal, V13, P505; Duke SAS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005268.pub2; Ezenwaka CE, 2003, ACTA DIABETOL, V40, P173, DOI 10.1007/s00592-003-0107-x; Harrison TA, 2003, AM J PREV MED, V24, P152, DOI 10.1016/S0749-3797(02)00588-3; Hawthorne K, 1999, DIABETIC MED, V16, P591, DOI 10.1046/j.1464-5491.1999.00102.x; He X, 2007, INT NURS REV, V54, P280, DOI 10.1111/j.1466-7657.2007.00570.x; International Diabetes Federation (IDF), ATLAS; Kamel N M, 1999, East Mediterr Health J, V5, P974; Khan LA, 2000, ANN SAUDI MED, V20, P300, DOI 10.5144/0256-4947.2000.300; McPherson ML, 2008, RES SOC ADMIN PHARM, V4, P37, DOI 10.1016/j.sapharm.2007.01.002; Murata GH, 2003, DIABETOLOGIA, V46, P1170, DOI 10.1007/s00125-003-1161-1; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; Ozcelik F, 2010, POL ARCH MED WEWN, V120, P399, DOI 10.20452/pamw.979; Panja S, 2005, J INVEST MED, V53, P264, DOI 10.2310/6650.2005.53509; Rhee MK, 2005, DIABETES EDUCATOR, V31, P410, DOI 10.1177/0145721705277022; Speight J, 2001, DIABETIC MED, V18, P626, DOI 10.1046/j.1464-5491.2001.00537.x	23	119	124	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52857	10.1371/journal.pone.0052857	http://dx.doi.org/10.1371/journal.pone.0052857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341913	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400024
J	Harjanto, D; Zaman, MH				Harjanto, Dewi; Zaman, Muhammad H.			Modeling Extracellular Matrix Reorganization in 3D Environments	PLOS ONE			English	Article							CELL-MIGRATION; PROSTATE-CANCER; MECHANICAL-PROPERTIES; COLLAGEN GELS; COMPUTATIONAL-MODEL; ELASTIC-MODULI; PROTEOLYSIS; INVASION; BREAST; METALLOPROTEINASES	Extracellular matrix (ECM) remodeling is a key physiological process that occurs in a number of contexts, including cell migration, and is especially important for cellular form and function in three-dimensional (3D) matrices. However, there have been few attempts to computationally model how cells modify their environment in a manner that accounts for both cellular properties and the architecture of the surrounding ECM. To this end, we have developed and validated a novel model to simulate matrix remodeling that explicitly defines cells in a 3D collagenous matrix. In our simulation, cells can degrade, deposit, or pull on local fibers, depending on the fiber density around each cell. The cells can also move within the 3D matrix. Different cell phenotypes can be modeled by varying key cellular parameters. Using the model we have studied how two model cancer cell lines, of differing invasiveness, modify matrices with varying fiber density in their vicinity by tracking the metric of fraction of matrix occupied by fibers. Our results quantitatively demonstrate that in low density environments, cells deposit more collagen to uniformly increase fibril fraction. On the other hand, in higher density environments, the less invasive model cell line reduced the fibril fraction as compared to the highly invasive phenotype. These results show good qualitative and quantitative agreement with existing experimental literature. Our simulation is therefore able to function as a novel platform to provide new insights into the clinically relevant and physiologically critical process of matrix remodeling by helping identify critical parameters that dictate cellular behavior in complex native-like environments.	[Harjanto, Dewi; Zaman, Muhammad H.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University	Zaman, MH (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	zaman@bu.edu			National Institutes of Health [1R01CA132633]; NATIONAL CANCER INSTITUTE [R01CA132633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant 1R01CA132633. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatangelo MD, 2005, AM J PATHOL, V167, P475, DOI 10.1016/S0002-9440(10)62991-4; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Berry H, 1999, BIOPHYS J, V77, P655, DOI 10.1016/S0006-3495(99)76921-3; Bloom RJ, 2008, BIOPHYS J, V95, P4077, DOI 10.1529/biophysj.108.132738; Brightman AO, 2000, BIOPOLYMERS, V54, P222; Burns-Cox N, 2001, J UROLOGY, V166, P1698, DOI 10.1016/S0022-5347(05)65656-X; Chen LM, 2001, PROSTATE, V48, P93, DOI 10.1002/pros.1085; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Driessen NJB, 2004, J THEOR BIOL, V226, P53, DOI 10.1016/j.jtbi.2003.08.004; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Harjanto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024891; HOOSEIN NM, 1991, CANCER COMMUN, V3, P255, DOI 10.3727/095535491820873146; Hoshino D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002479; Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808; Israelowitz M, 2005, PROTEIN ENG DES SEL, V18, P329, DOI 10.1093/protein/gzi037; Karamichos D, 2008, J TISSUE ENG REGEN M, V2, P97, DOI 10.1002/term.69; Kim HD, 2008, MOL BIOL CELL, V19, P4249, DOI 10.1091/mbc.E08-05-0501; Kim T, 2009, EXP MECH, V49, P91, DOI 10.1007/s11340-007-9091-3; Kim T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000439; Kirkpatrick ND, 2007, AM J PHYSIOL-HEART C, V292, pH3198, DOI 10.1152/ajpheart.01234.2006; Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260, DOI 10.1177/016173469802000403; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Maaser K, 1999, MOL BIOL CELL, V10, P3067, DOI 10.1091/mbc.10.10.3067; Maini PK, 2002, MATH MODELS CELL MAT; Makareeva E, 2010, CANCER RES, V70, P4366, DOI 10.1158/0008-5472.CAN-09-4057; Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216; Nagakawa O, 1999, CANCER LETT, V147, P207, DOI 10.1016/S0304-3835(99)00309-2; Nagakawa O, 2000, CANCER LETT, V155, P173, DOI 10.1016/S0304-3835(00)00425-0; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Ramtani S, 2002, COMPUT BIOL MED, V32, P283, DOI 10.1016/S0010-4825(02)00018-5; Ranucci CS, 2001, J BIOMED MATER RES, V54, P149, DOI 10.1002/1097-4636(200102)54:2<149::AID-JBM1>3.0.CO;2-O; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; Roeder BA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005331; Sen S, 2009, CELL MOL BIOENG, V2, P39, DOI 10.1007/s12195-009-0052-z; Song H, 2003, BIOTECHNOL PROGR, V19, P1742, DOI 10.1021/bp034061n; Stuart K, 2008, BIOPOLYMERS, V89, P841, DOI 10.1002/bip.21024; Tosin A, 2010, MATH COMPUT MODEL, V52, P969, DOI 10.1016/j.mcm.2010.01.015; Voytik-Harbin SL, 2001, METHOD CELL BIOL, V63, P583; Werb Z, 1999, APMIS, V107, P11, DOI 10.1111/j.1699-0463.1999.tb01521.x; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wozniak MA, 2005, BIOL PROCED ONLINE, V7, P144, DOI 10.1251/bpo112; Yamada KM, 2003, BRAZ J MED BIOL RES, V36, P959, DOI 10.1590/S0100-879X2003000800001; Yang YL, 2010, BIOMATERIALS, V31, P5678, DOI 10.1016/j.biomaterials.2010.03.039; Yang YL, 2009, BIOPHYS J, V97, P2051, DOI 10.1016/j.bpj.2009.07.035; Yang YL, 2009, BIOPHYS J, V96, P1566, DOI [10.1016/j.bpj.2008.10.063, 10.1016/j.bpj.20()8.10.063]; Zaman MH, 2005, BIOPHYS J, V89, P1389, DOI 10.1529/biophysj.105.060723; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799	56	25	26	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52509	10.1371/journal.pone.0052509	http://dx.doi.org/10.1371/journal.pone.0052509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341900	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400017
J	Mai, V; Torrazza, RM; Ukhanova, M; Wang, XY; Sun, YJ; Li, N; Shuster, J; Sharma, R; Hudak, ML; Neu, J				Mai, Volker; Torrazza, Roberto Murgas; Ukhanova, Maria; Wang, Xiaoyu; Sun, Yijun; Li, Nan; Shuster, Jonathan; Sharma, Renu; Hudak, Mark Lawrence; Neu, Josef			Distortions in Development of Intestinal Microbiota Associated with Late Onset Sepsis in Preterm Infants	PLOS ONE			English	Article							PREVENTION; NEONATE	Late onset sepsis (LOS) is a major contributor to neonatal morbidity and mortality, especially in premature infants. Distortions in the establishment of normal gut microbiota, commensal microbes that colonize the digestive tract, might increase the risk of LOS via disruption of the mucosal barrier with resultant translocation of luminal contents. Correlation of distortions of the intestinal microbiota with LOS is a necessary first step to design novel microbiota-based screening approaches that might lead to early interventions to prevent LOS in high risk infants. Using a case/control design nested in a cohort study of preterm infants, we analyzed stool samples that had been prospectively collected from ten preterm infants with LOS and from 18 matched controls. A 16S rRNA based approach was utilized to compare microbiota diversity and identify specific bacterial signatures that differed in their prevalence between cases and controls. Overall alpha-diversity (Chao1) was lower in cases two weeks before (p<0.05) but not one week before or at the time of diagnosis of LOS. Overall microbiota structure (Unifrac) appeared distinct in cases 2 weeks and 1 week before but not at diagnosis (p<0.05). Although we detected few operational taxonomic units (OTUs) unique or enriched in cases, we found many OTUs common in controls that were lacking in cases (p<0.01). Bifidobacteria counts were lower in cases at all time points. Our results support the hypothesis that a distortion in normal microbiota composition, and not an enrichment of potential pathogens, is associated with LOS in preterm infants.	[Mai, Volker; Ukhanova, Maria; Wang, Xiaoyu] Univ Florida, Dept Epidemiol, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA; [Mai, Volker; Ukhanova, Maria; Wang, Xiaoyu] Univ Florida, Coll Med, Gainesville, FL USA; [Mai, Volker; Ukhanova, Maria; Wang, Xiaoyu] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Torrazza, Roberto Murgas; Li, Nan; Neu, Josef] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL USA; [Sun, Yijun] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; [Sun, Yijun] SUNY Buffalo, Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14260 USA; [Shuster, Jonathan] Univ Florida, Coll Med, Dept Hlth Outcomes & Policy, Gainesville, FL USA; [Sharma, Renu; Hudak, Mark Lawrence] Univ Florida, Coll Med, Dept Pediat, Jacksonville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Mai, V (corresponding author), Univ Florida, Dept Epidemiol, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA.	vmai@ufl.edu	Wang, Xiaoyu/J-4101-2018; Neu, Josef/AAI-2799-2020; Shuster, Jonathan/ABB-5773-2021	Shuster, Jonathan/0000-0001-9499-5616; Wang, Xiaoyu/0000-0002-4504-7799	United States National Institutes of Health [HD059153]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The study was funded by United States National Institutes of Health grant # HD059153 to JN, VM, and RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres JS, 2012, NAT MED, V18, P799, DOI 10.1038/nm.2729; Bancalari E, 2001, AM J PERINAT, V18, P1, DOI 10.1055/s-2001-12940; Bezirtzoglou E, 2011, ANAEROBE, V17, P369, DOI 10.1016/j.anaerobe.2011.03.010; Bordon Y, 2012, NAT REV IMMUNOL, V12, P4, DOI [10.1038/nri3135, 10.1038/nri3235]; Caicedo RA, 2005, PEDIATR RES, V58, P625, DOI 10.1203/01.PDR.0000180533.09295.84; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Deitch EA, 2012, SURG-J R COLL SURG E, V10, P350, DOI 10.1016/j.surge.2012.03.003; Hamrick SEG, 2010, PEDIATRICS, V125, P1020, DOI 10.1542/peds.2009-3506; Hattori M, 2009, DNA RES, V16, P1, DOI 10.1093/dnares/dsn033; Jacquot A, 2011, J PEDIATR-US, V158, P390, DOI 10.1016/j.jpeds.2010.09.007; Kansagra K, 2003, AM J PHYSIOL-GASTR L, V285, pG1162, DOI 10.1152/ajpgi.00243.2003; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Mai V, 2009, WORLD J GASTROENTERO, V15, P81, DOI 10.3748/wjg.15.81; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Mai V, 2006, J CLIN MICROBIOL, V44, P4550, DOI 10.1128/JCM.01542-06; Mshvildadze M, 2008, NUTR REV, V66, P658, DOI 10.1111/j.1753-4887.2008.00119.x; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Neu J, 2007, AM J CLIN NUTR, V85, p629S, DOI 10.1093/ajcn/85.2.629S; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Paviour S, 2002, CLIN INFECT DIS, V35, P1434, DOI 10.1086/344463; Sharma Renu, 2010, J Biomed Biotechnol, V2010, P305879, DOI 10.1155/2010/305879; Sherman MP, 2010, CLIN PERINATOL, V37, P565, DOI 10.1016/j.clp.2010.05.006; Shulman RJ, 1998, PEDIATR RES, V44, P519, DOI 10.1203/00006450-199810000-00009; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Strodtbeck Frances, 2003, Crit Care Nurs Clin North Am, V15, P79, DOI 10.1016/S0899-5885(02)00043-6; Sun YJ, 2012, BRIEF BIOINFORM, V13, P107, DOI 10.1093/bib/bbr009; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285	29	153	161	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52876	10.1371/journal.pone.0052876	http://dx.doi.org/10.1371/journal.pone.0052876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341915	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400027
J	Kotak, VC; Takesian, AE; MacKenzie, PC; Sanes, DH				Kotak, Vibhakar C.; Takesian, Anne E.; MacKenzie, Patricia C.; Sanes, Dan H.			Rescue of Inhibitory Synapse Strength following Developmental Hearing Loss	PLOS ONE			English	Article							MEDIAL SUPERIOR OLIVE; OCULAR DOMINANCE PLASTICITY; EXPERIENCE-DEPENDENT REFINEMENT; POSTSYNAPTIC GABA(A) RECEPTORS; AUDITORY CORTICAL DEVELOPMENT; PRIMARY VISUAL-CORTEX; INTRACORTICAL INHIBITION; GABAERGIC TRANSMISSION; HIPPOCAMPAL-NEURONS; BRAIN-STEM	Inhibitory synapse dysfunction may contribute to many developmental brain disorders, including the secondary consequences of sensory deprivation. In fact, developmental hearing loss leads to a profound reduction in the strength of inhibitory postsynaptic currents (IPSCs) in the auditory cortex, and this deficit persists into adulthood. This finding is consistent with the general theory that the emergence of mature synaptic properties requires activity during development. Therefore, we tested the prediction that inhibitory strength can be restored following developmental hearing loss by boosting GABAergic transmission in vivo. Conductive or sensorineural hearing loss was induced surgically in gerbils prior to hearing onset and GABA agonists were then administered for one week. IPSCs were subsequently recorded from pyramidal neurons in a thalamocortical brain slice preparation. Administration of either a GABA(A) receptor a1 subunit specific agonist (zolpidem), or a selective GABA reuptake inhibitor (SGRI), rescued IPSC amplitude in hearing loss animals. Furthermore, this restoration persisted in adults, long after drug treatment ended. In contrast, a GABA(B) receptor agonist baclofen did not restore inhibitory strength. IPSCs could also be restored when SGRI administration began 3 weeks after sensory deprivation. Together, these results demonstrate long-lasting restoration of cortical inhibitory strength in the absence of normal experience. This suggests that in vivo GABA(A) receptor activation is sufficient to promote maturation, and this principle may extend to other developmental disorders associated with diminished inhibitory function.	[Kotak, Vibhakar C.; Takesian, Anne E.; Sanes, Dan H.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [MacKenzie, Patricia C.; Sanes, Dan H.] NYU, Dept Biol, New York, NY 10003 USA	New York University; New York University	Kotak, VC (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	vck1@nyu.edu			National Institutes of Health [DC011284]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funded by the National Institutes of Health (DC011284 to DHS & VCK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baroncelli L, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/286073; Bartley AF, 2008, J NEUROPHYSIOL, V100, P1983, DOI 10.1152/jn.90635.2008; Benarroch EE, 2007, NEUROLOGY, V68, P612, DOI 10.1212/01.wnl.0000255669.83468.dd; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; Chirila FV, 2007, J PHYSIOL-LONDON, V584, P167, DOI 10.1113/jphysiol.2007.137976; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; Dorrn AL, 2010, NATURE, V465, P932, DOI 10.1038/nature09119; Edden RAE, 2009, J NEUROSCI, V29, P15721, DOI 10.1523/JNEUROSCI.4426-09.2009; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Franklin SR, 2008, NEUROSCIENCE, V154, P346, DOI 10.1016/j.neuroscience.2008.02.011; Gittis AH, 2011, J NEUROSCI, V31, P15727, DOI 10.1523/JNEUROSCI.3875-11.2011; Grantyn R, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00013; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; Harrison RV, 2012, ACTA OTO-LARYNGOL, V132, P409, DOI 10.3109/00016489.2011.648271; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Huang ZJ, 2009, J PHYSIOL-LONDON, V587, P1881, DOI 10.1113/jphysiol.2008.168211; Iwai Y, 2003, J NEUROSCI, V23, P6695; Jiao YY, 2006, J NEUROSCI, V26, P8691, DOI 10.1523/JNEUROSCI.2478-06.2006; Jiao YY, 2011, P NATL ACAD SCI USA, V108, P12131, DOI 10.1073/pnas.1105296108; KANDLER K, 1995, J NEUROSCI, V15, P6890; Kanold PO, 2009, J PHYSIOL-LONDON, V587, P2857, DOI 10.1113/jphysiol.2009.171215; Kapfer C, 2002, NAT NEUROSCI, V5, P247, DOI 10.1038/nn810; Katagiri H, 2007, NEURON, V53, P805, DOI 10.1016/j.neuron.2007.02.026; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Kittler JT, 2000, J NEUROSCI, V20, P7972; Kleppner S R, 2001, Expert Opin Ther Targets, V5, P219, DOI 10.1517/14728222.5.2.219; Kotak VC, 2005, J NEUROSCI, V25, P3908, DOI 10.1523/JNEUROSCI.5169-04.2005; Kotak VC, 2008, CEREB CORTEX, V18, P2098, DOI 10.1093/cercor/bhm233; Leventhal AG, 2003, SCIENCE, V300, P812, DOI 10.1126/science.1082874; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Magnusson AK, 2005, J PHYSIOL-LONDON, V568, P497, DOI 10.1113/jphysiol.2005.094763; Meyer DK, 2000, J NEUROSCI, V20, P6743, DOI 10.1523/JNEUROSCI.20-18-06743.2000; Morales B, 2002, J NEUROSCI, V22, P8084; MOWER GD, 1981, BRAIN RES, V220, P255, DOI 10.1016/0006-8993(81)91216-6; Mukherjee J, 2011, J NEUROSCI, V31, P14677, DOI 10.1523/JNEUROSCI.2001-11.2011; Noh J, 2010, NAT NEUROSCI, V13, P232, DOI 10.1038/nn.2478; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Oswald AMM, 2011, CEREB CORTEX, V21, P1351, DOI 10.1093/cercor/bhq214; Otto G, 2006, HEARING RES, V220, P27, DOI 10.1016/j.heares.2006.06.014; Panzanelli P, 2011, J PHYSIOL-LONDON, V589, P4959, DOI 10.1113/jphysiol.2011.216028; Rosen MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041514; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Sale A, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00010; Sanes DH, 2011, HEARING RES, V279, P140, DOI 10.1016/j.heares.2011.03.015; SANES DH, 1993, EUR J NEUROSCI, V5, P570, DOI 10.1111/j.1460-9568.1993.tb00522.x; SANES DH, 1993, J NEUROSCI, V13, P2627, DOI 10.1523/JNEUROSCI.13-06-02627.1993; Sarro EC, 2008, CEREB CORTEX, V18, P2855, DOI 10.1093/cercor/bhn044; Scott LL, 2005, J NEUROSCI, V25, P7887, DOI 10.1523/JNEUROSCI.1016-05.2005; Southwell DG, 2010, SCIENCE, V327, P1145, DOI 10.1126/science.1183962; Sun YJ, 2010, NATURE, V465, P927, DOI 10.1038/nature09079; Takesian AE, 2012, J NEUROPHYSIOL, V107, P937, DOI 10.1152/jn.00515.2011; Takesian AE, 2010, J NEUROSCI, V30, P2716, DOI 10.1523/JNEUROSCI.3903-09.2010; Tanaka DH, 2011, J NEUROSCI, V31, P14116, DOI 10.1523/JNEUROSCI.2786-11.2011; Tritsch NX, 2010, NAT NEUROSCI, V13, P1050, DOI 10.1038/nn.2604; Tucci DL, 2001, HEARING RES, V155, P124, DOI 10.1016/S0378-5955(01)00256-8; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Vale C, 2003, J NEUROSCI, V23, P7516; Vale C, 2000, J NEUROSCI, V20, P1912; Vithlani M, 2011, PHYSIOL REV, V91, P1009, DOI 10.1152/physrev.00015.2010; Wenner P, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/489470; Werthat F, 2008, DEV NEUROBIOL, V68, P1454, DOI 10.1002/dneu.20660; Xu H, 2007, J NEUROSCI, V27, P9417, DOI 10.1523/JNEUROSCI.1992-07.2007; Zipancic I, 2010, CELL TRANSPLANT, V19, P549, DOI 10.3727/096368910X491383	72	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53438	10.1371/journal.pone.0053438	http://dx.doi.org/10.1371/journal.pone.0053438			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326429	Green Published, Green Submitted, gold			2022-12-25	WOS:000314705800043
J	Lim, O; Lee, Y; Chung, H; Her, JH; Kang, SM; Jung, MY; Min, B; Shin, H; Kim, TM; Heo, DS; Hwang, YK; Shin, EC				Lim, Okjae; Lee, Yuna; Chung, Hyejin; Her, Jung Hyun; Kang, Sang Mi; Jung, Mi-Young; Min, Bokyung; Shin, Hyejin; Kim, Tae Min; Heo, Dae Seog; Hwang, Yu Kyeong; Shin, Eui-Cheol			GMP-Compliant, Large-Scale Expanded Allogeneic Natural Killer Cells Have Potent Cytolytic Activity against Cancer Cells In Vitro and In Vivo	PLOS ONE			English	Article							TUMOR-CELLS; NK CELLS; LIGAND INCOMPATIBILITY; ADOPTIVE IMMUNOTHERAPY; ACTIVATING RECEPTORS; DENDRITIC CELLS; CLINICAL-GRADE; T-CELLS; EXPANSION; MELANOMA	Ex vivo-expanded, allogeneic natural killer (NK) cells can be used for the treatment of various types of cancer. In allogeneic NK cell therapy, NK cells from healthy donors must be expanded in order to obtain a sufficient number of highly purified, activated NK cells. In the present study, we established a simplified and efficient method for the large-scale expansion and activation of NK cells from healthy donors under good manufacturing practice (GMP) conditions. After a single step of magnetic depletion of CD3(+) T cells, the depleted peripheral blood mononuclear cells (PBMCs) were stimulated and expanded with irradiated autologous PBMCs in the presence of OKT3 and IL-2 for 14 days, resulting in a highly pure population of CD3(-)CD16(+)CD56(+) NK cells which is desired for allogeneic purpose. Compared with freshly isolated NK cells, these expanded NK cells showed robust cytokine production and potent cytolytic activity against various cancer cell lines. Of note, expanded NK cells selectively killed cancer cells without demonstrating cytotoxicity against allogeneic non-tumor cells in coculture assays. The anti-tumor activity of expanded human NK cells was examined in SCID mice injected with human lymphoma cells. In this model, expanded NK cells efficiently controlled lymphoma progression. In conclusion, allogeneic NK cells were efficiently expanded in a GMP-compliant facility and demonstrated potent anti-tumor activity both in vitro and in vivo.	[Lim, Okjae; Shin, Eui-Cheol] Korea Adv Inst Sci & Technol, BioMed Sci & Engn Interdisciplinary Program, Taejon 305701, South Korea; [Lim, Okjae; Lee, Yuna; Chung, Hyejin; Her, Jung Hyun; Kang, Sang Mi; Min, Bokyung; Hwang, Yu Kyeong] Mogam Biotechnol Res Inst, Cell Therapy Team, Yongin, Gyeonggi Do, South Korea; [Jung, Mi-Young; Shin, Hyejin] Green Cross LabCell Corp, Cell Therapy Div, Yongin, Gyeonggi Do, South Korea; [Kim, Tae Min; Heo, Dae Seog] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Lim, Okjae; Shin, Eui-Cheol] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Immunol & Infect Dis, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Seoul National University Hospital; Korea Advanced Institute of Science & Technology (KAIST)	Hwang, YK (corresponding author), Mogam Biotechnol Res Inst, Cell Therapy Team, Yongin, Gyeonggi Do, South Korea.	ykhwang@mogam.re.kr; ecshin@kaist.ac.kr	Shin, Eui-Cheol/C-1690-2011	Shin, Eui-Cheol/0000-0002-6308-9503	Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A062260]	Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A062260). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderson KL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/379123; Arai S, 2008, CYTOTHERAPY, V10, P625, DOI 10.1080/14653240802301872; Berg M, 2009, CYTOTHERAPY, V11, P341, DOI 10.1080/14653240902807034; Bhat R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000326; Brand JM, 2004, STEM CELLS DEV, V13, P307, DOI 10.1089/154732804323099235; Carlens S, 2001, HUM IMMUNOL, V62, P1092, DOI 10.1016/S0198-8859(01)00313-5; Deguine J, 2010, IMMUNITY, V33, P632, DOI 10.1016/j.immuni.2010.09.016; Farag SS, 2002, BLOOD, V100, P1935, DOI 10.1182/blood-2002-02-0350; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Giebel S, 2003, BLOOD, V102, P814, DOI 10.1182/blood-2003-01-0091; GRIMM EA, 1982, J EXP MED, V155, P1823, DOI 10.1084/jem.155.6.1823; Igarashi T, 2004, BLOOD, V104, P170, DOI 10.1182/blood-2003-12-4438; Koepsell SA, 2012, TRANSFUSION; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lapteva N, 2012, CYTOTHERAPY, V14, P1131, DOI 10.3109/14653249.2012.700767; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Mailliard RB, 2003, J IMMUNOL, V171, P2366, DOI 10.4049/jimmunol.171.5.2366; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; MILLER JS, 1992, BLOOD, V80, P2221; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta A, 2008, IMMUNOL REV, V224, P58, DOI 10.1111/j.1600-065X.2008.00651.x; ROBERTSON MJ, 1990, BLOOD, V76, P2421; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; SCHMIDTWOLF IGH, 1993, EXP HEMATOL, V21, P1673; Selewski DT, 2010, AM J NEURORADIOL, V31, P1178, DOI 10.3174/ajnr.A2142; Siegler U, 2010, CYTOTHERAPY, V12, P750, DOI 10.3109/14653241003786155; Spanholtz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020740; Sutlu T, 2009, J INTERN MED, V266, P154, DOI 10.1111/j.1365-2796.2009.02121.x; Sutlu T, 2010, CYTOTHERAPY, V12, P1044, DOI 10.3109/14653249.2010.504770; Syme RM, 2001, J HEMATOTH STEM CELL, V10, P601, DOI 10.1089/152581601753193814; Terme M, 2008, NAT IMMUNOL, V9, P486, DOI 10.1038/ni1580; Wargo JA, 2005, CANCER GENE THER, V12, P516, DOI 10.1038/sj.cgt.7700818; Wong JL, 2011, J IMMUNOTHER, V34, P270, DOI 10.1097/CJI.0b013e31820b370b	34	53	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53611	10.1371/journal.pone.0053611	http://dx.doi.org/10.1371/journal.pone.0053611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326467	Green Published, Green Submitted, gold			2022-12-25	WOS:000314705800061
J	Preeti; Tapas, S; Kumar, P; Madhubala, R; Tomar, S				Preeti; Tapas, Satya; Kumar, Pravindra; Madhubala, Rentala; Tomar, Shailly			Structural Insight into DFMO Resistant Ornithine Decarboxylase from Entamoeba histolytica: An Inkling to Adaptive Evolution	PLOS ONE			English	Article							POLYAMINE BIOSYNTHETIC-ENZYMES; TRYPANOSOMA-BRUCEI-RHODESIENSE; ANTIZYME-INHIBITOR; ALPHA-DIFLUOROMETHYLORNITHINE; ANGSTROM RESOLUTION; PROTEIN; EXPRESSION; GROWTH; PURIFICATION; DEGRADATION	Background: Polyamine biosynthetic pathway is a validated therapeutic target for large number of infectious diseases including cancer, giardiasis and African sleeping sickness, etc. alpha-Difluoromethylornithine (DFMO), a potent drug used for the treatment of African sleeping sickness is an irreversible inhibitor of ornithine decarboxylase (ODC), the first rate limiting enzyme of polyamine biosynthesis. The enzyme ODC of E. histolytica (EhODC) has been reported to exhibit resistance towards DFMO. Methodology/Principal Finding: The basis for insensitivity towards DFMO was investigated by structural analysis of EhODC and conformational modifications at the active site. Here, we report cloning, purification and crystal structure determination of C-terminal truncated Entamoeba histolytica ornithine decarboxylase (EhODC Delta 15). Structure was determined by molecular replacement method and refined to 2.8 angstrom resolution. The orthorhombic crystal exhibits P2(1)2(1)2(1) symmetry with unit cell parameters a = 76.66, b = 119.28, c = 179.28 angstrom. Functional as well as evolutionary relations of EhODC with other ODC homologs were predicted on the basis of sequence analysis, phylogeny and structure. Conclusions/Significance: We determined the tetrameric crystal structure of EhODC Delta 15, which exists as a dimer in solution. Insensitivity towards DFMO is due to substitution of key substrate binding residues in active site pocket. Additionally, a few more substitutions similar to antizyme inhibitor (AZI), a non-functional homologue of ODCs, were identified in the active site. Here, we establish the fact that EhODC sequence has conserved PLP binding residues; in contrast few substrate binding residues are mutated similar to AZI. Further sequence analysis and structural studies revealed that EhODC may represent as an evolutionary bridge between active decarboxylase and inactive AZI.	[Preeti; Tapas, Satya; Kumar, Pravindra; Tomar, Shailly] Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee, Uttar Pradesh, India; [Madhubala, Rentala] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Jawaharlal Nehru University, New Delhi	Tomar, S (corresponding author), Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee, Uttar Pradesh, India.	shailfbt@iitr.ernet.in	KUMAR, PRAVINDRA/AAF-2859-2020	KUMAR, PRAVINDRA/0000-0003-2128-7736; madhubala, rentala/0000-0002-0034-399X	CSIR (Council of Scientific & Industrial Research); DRDO (Defence Research and Development Organisation, Government of India); DST (Department of Science and Technology, Government of India); ICMR (Indian Council of Medical Research)	CSIR (Council of Scientific & Industrial Research)(Council of Scientific & Industrial Research (CSIR) - India); DRDO (Defence Research and Development Organisation, Government of India)(Defence Research & Development Organisation (DRDO)); DST (Department of Science and Technology, Government of India)(Department of Science & Technology (India)); ICMR (Indian Council of Medical Research)(Indian Council of Medical Research (ICMR))	Preeti thanks CSIR (Council of Scientific & Industrial Research), S. Tapas thanks DRDO (Defence Research and Development Organisation, Government of India), PK thanks DST (Department of Science and Technology, Government of India), and S. Tomar thanks ICMR (Indian Council of Medical Research) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albeck S, 2008, PROTEIN SCI, V17, P793, DOI 10.1110/ps.073427208; Almrud JJ, 2000, J MOL BIOL, V295, P7, DOI 10.1006/jmbi.1999.3331; Anderson IJ, 2005, EXP PARASITOL, V110, P173, DOI 10.1016/j.exppara.2005.03.010; Arteaga-Nieto P, 2002, EXP PARASITOL, V101, P215, DOI 10.1016/S0014-4894(02)00137-6; ArteagaNieto P, 1996, INT J PARASITOL, V26, P253, DOI 10.1016/0020-7519(95)00134-4; Badolo L, 1999, TALANTA, V48, P127, DOI 10.1016/S0039-9140(98)00228-8; BAKKERGRUNWALD T, 1995, J EUKARYOT MICROBIOL, V42, P346, DOI 10.1111/j.1550-7408.1995.tb01592.x; Bansal Devendra, 2004, Ann Clin Microbiol Antimicrob, V3, P27, DOI 10.1186/1476-0711-3-27; Birkholtz LM, 2011, BIOCHEM J, V438, P229, DOI 10.1042/BJ20110362; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cohavi O, 2009, J MOL BIOL, V390, P503, DOI 10.1016/j.jmb.2009.05.029; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dufe VT, 2007, BIOCHEM J, V405, P261, DOI 10.1042/BJ20070188; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evageliou NF, 2009, CLIN CANCER RES, V15, P5956, DOI 10.1158/1078-0432.CCR-08-3213; Fleidervish IA, 2008, P NATL ACAD SCI USA, V105, P18994, DOI 10.1073/pnas.0803464105; FUJITA K, 1982, BIOCHEM J, V204, P647, DOI 10.1042/bj2040647; GHODA L, 1989, SCIENCE, V243, P1493, DOI 10.1126/science.2928784; GILLIN FD, 1984, J PROTOZOOL, V31, P161, DOI 10.1111/j.1550-7408.1984.tb04308.x; Grishin NV, 1999, BIOCHEMISTRY-US, V38, P15174, DOI 10.1021/bi9915115; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Hascilowicz T, 2002, BBA-GENE STRUCT EXPR, V1578, P21, DOI 10.1016/S0167-4781(02)00476-1; Heby O, 2007, AMINO ACIDS, V33, P359, DOI 10.1007/s00726-007-0537-9; Heby O, 2003, BIOCHEM SOC T, V31, P415, DOI 10.1042/BST0310415; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; ITEN M, 1995, TROP MED PARASITOL, V46, P190; Iten M, 1997, ANTIMICROB AGENTS CH, V41, P1922, DOI 10.1128/AAC.41.9.1922; Ivanov IP, 2008, P NATL ACAD SCI USA, V105, P10079, DOI 10.1073/pnas.0801590105; Ivanov IP, 2010, J MOL EVOL, V70, P289, DOI 10.1007/s00239-010-9331-5; Jackson LK, 2003, BIOCHEMISTRY-US, V42, P2933, DOI 10.1021/bi026795z; Jhingran A, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000115; Kahana C, 2009, ESSAYS BIOCHEM, V46, P47, DOI [10.1042/BSE0460004, 10.1042/bse0460004]; Keren-Paz A, 2006, ONCOGENE, V25, P5163, DOI 10.1038/sj.onc.1209521; Kern A, 1996, PROTEINS, V24, P266, DOI 10.1002/(SICI)1097-0134(199602)24:2<266::AID-PROT15>3.3.CO;2-1; Kern AD, 1999, STRUCTURE, V7, P567, DOI 10.1016/S0969-2126(99)80073-2; KITANI T, 1989, BIOCHIM BIOPHYS ACTA, V991, P44, DOI 10.1016/0304-4165(89)90026-3; Krause T, 2000, BIOCHEM J, V352, P287, DOI 10.1042/0264-6021:3520287; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Liu YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026835; Lopez-Vallejo F, 2011, J BIOMOL SCREEN, V16, P862, DOI 10.1177/1087057111414902; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Murakami Y, 1996, J BIOL CHEM, V271, P3340, DOI 10.1074/jbc.271.7.3340; Murakami Y, 2009, EXP CELL RES, V315, P2301, DOI 10.1016/j.yexcr.2009.04.024; Myers DP, 2001, BIOCHEMISTRY-US, V40, P13230, DOI 10.1021/bi0155908; Nilsson J, 2000, BIOCHEM J, V346, P699, DOI 10.1042/0264-6021:3460699; Oredsson SM, 2003, BIOCHEM SOC T, V31, P366, DOI 10.1042/BST0310366; Osterman AL, 1999, BIOCHEMISTRY-US, V38, P11814, DOI 10.1021/bi9906221; OSTERMAN AL, 1995, J BIOL CHEM, V270, P11797, DOI 10.1074/jbc.270.20.11797; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; PEGG AE, 1988, J BIOL CHEM, V263, P11008; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; POULIN R, 1992, J BIOL CHEM, V267, P150; Preeti, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001559; Rosas-Arreguin P, 2008, EXP PARASITOL, V119, P398, DOI 10.1016/j.exppara.2008.04.003; Sakata K, 2000, BIOCHEM J, V347, P297, DOI 10.1042/0264-6021:3470297; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANDMEIER E, 1994, EUR J BIOCHEM, V221, P997, DOI 10.1111/j.1432-1033.1994.tb18816.x; Tanyuksel M, 2003, CLIN MICROBIOL REV, V16, P713, DOI 10.1128/CMR.16.4.713-729.2003; TSIRKA SE, 1993, BIOCHEM J, V293, P289, DOI 10.1042/bj2930289; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510	67	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53397	10.1371/journal.pone.0053397	http://dx.doi.org/10.1371/journal.pone.0053397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326423	Green Published, gold, Green Submitted			2022-12-25	WOS:000314705800042
J	Lai, CY; Lee, CJ; Lu, CY; Lee, PI; Shao, PL; Wu, ET; Wang, CC; Tan, BF; Chang, HY; Hsia, SH; Lin, JJ; Chang, LY; Huang, YC; Huang, LM				Lai, Chen-Yin; Lee, Chia-Jie; Lu, Chun-Yi; Lee, Ping-Ing; Shao, Pei-Lan; Wu, En-Ting; Wang, Ching-Chia; Tan, Boon-Fatt; Chang, Hsin-Yu; Hsia, Shao-Hsuan; Lin, Jainn-Jim; Chang, Luan-Yin; Huang, Yhu-Chering; Huang, Li-Min		Taiwan Pediat Infect Dis Alliance	Adenovirus Serotype 3 and 7 Infection with Acute Respiratory Failure in Children in Taiwan, 2010-2011	PLOS ONE			English	Article							OUTBREAK; DISEASE	Objective: Increased incidence of adenovirus infection in children was noticed since September 2010 in Taiwan and severe cases requiring intensive care were noted later. We did this study to find the clinical characteristics and risk factors associated with severe adenovirus infection. Patients and Methods: We collected cases of severe adenovirus infection between November 2010 and June 2011 to analyze their clinical characteristics in two medical centers in northern Taiwan. Severe adenovirus infection was defined as laboratory-confirmed adenovirus cases with required intensive care. Hexon gene sequencing was performed for molecular genotyping. Results: 45 patients were included, 22 cases (49%) were infected with serotype 7, 19 (42%) with serotype 3, and 4 with serotype 2. The median age (range) was 2.75 years (0.08-15.43 years); 87% were below 5 years. Male to female ratio was 1.65 (28 to 17). Of these patients, 56% had underlying neurological diseases, 50% experienced fever higher than 40 degrees C and 69% suffered fever longer than one week. The clinical diagnosis included pneumonia in 40 (89%) patients, bronchopneumonia in 5 (11%), and encephalitis in 7 (16%). At least 22 patients had pleural effusion. They had complications of respiratory failure (53%), acute respiratory distress syndrome (24%), hypotension (40%), and 6 (13%) patients needed extracorporeal membranous oxygenation. Ten (22%) patients died, all with underlying major systemic diseases and 7 (70%) infected with serotype 7. Conclusions: Adenovirus serotype 7 and 3 can cause severe disease-even death-in children, especially those with underlying neurological diseases. Patients infected with adenovirus serotype 7 tended to have a higher case-fatality rate.	[Lai, Chen-Yin; Lu, Chun-Yi; Lee, Ping-Ing; Shao, Pei-Lan; Wu, En-Ting; Wang, Ching-Chia; Tan, Boon-Fatt; Chang, Hsin-Yu; Chang, Luan-Yin; Huang, Li-Min] Natl Taiwan Univ, Coll Med, Dept Pediat, Natl Taiwan Univ Hosp, Taipei, Taiwan; [Lee, Chia-Jie; Hsia, Shao-Hsuan; Lin, Jainn-Jim; Huang, Yhu-Chering] Chang Gung Mem Hosp, Dept Pediat, Tao Yuan, Taiwan	National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital	Chang, LY (corresponding author), Natl Taiwan Univ, Coll Med, Dept Pediat, Natl Taiwan Univ Hosp, Taipei, Taiwan.	lychang@ntu.edu.tw; ychuang@cgmh.org.tw; lmhuang@ntu.edu.tw		CHANG, LUAN-YIN/0000-0003-2632-1956; WU, EN-TING/0000-0002-1463-8721; LEE, PING-ING/0000-0002-7299-2825; HUANG, LI-MIN/0000-0002-9291-260X; WANG, CHING-CHIA/0000-0002-5954-5684; Huang, Daniel Tsung-Ning/0000-0001-6940-6701; LU, CHUN-YI/0000-0002-5240-2808	National Taiwan University Hospital (A1 program); National Science Council [NSC 99-2321-B-002-025, NSC 100-2321-B-002-012]; Taiwan National Health Research Institutes	National Taiwan University Hospital (A1 program); National Science Council(Ministry of Science and Technology, Taiwan); Taiwan National Health Research Institutes	This work was supported by National Taiwan University Hospital (A1 program), National Science Council (grant number NSC 99-2321-B-002-025 and NSC 100-2321-B-002-012) and the Taiwan National Health Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENYESHMELNICK M, 1964, J PEDIATR-US, V64, P83, DOI 10.1016/S0022-3476(64)80321-8; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Callaway Z, 2011, CLIN RESPIR J, V5, P92, DOI 10.1111/j.1752-699X.2010.00204.x; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P941; Chang SY, 2008, J MED VIROL, V80, P102, DOI 10.1002/jmv.21045; Chuang Yu-Yu, 2003, Journal of Microbiology Immunology and Infection, V36, P37; Cooper RJ, 2000, EPIDEMIOL INFECT, V125, P333, DOI 10.1017/S0950268899004550; FOX JP, 1977, AM J EPIDEMIOL, V105, P362, DOI 10.1093/oxfordjournals.aje.a112394; Ghanaiem H, 2011, PEDIATR INFECT DIS J, V30, P948, DOI 10.1097/INF.0b013e31822702fe; HERBERT FA, 1977, CAN MED ASSOC J, V116, P274; KUO CY, 1990, ACTA PAED SIN, V31, P40; Laurence AB, 2007, NELSON TXB PEDIAT, P915; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Lin Chien-Hui, 2007, Journal of Microbiology Immunology and Infection, V40, P302; Lin KH, 2004, J MED VIROL, V73, P274, DOI 10.1002/jmv.20087; MORRIS DJ, 1993, J INFECTION, V26, P181, DOI 10.1016/0163-4453(93)92896-5; Spaeder MC, 2011, PEDIATR CRIT CARE ME, V12, pE317, DOI 10.1097/PCC.0b013e3182230f6e; Tang LY, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-23; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Tsou TP, 2012, EMERG INFECT DIS, V18, P1825, DOI 10.3201/eid1811.120629	20	66	78	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53614	10.1371/journal.pone.0053614	http://dx.doi.org/10.1371/journal.pone.0053614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326469	Green Submitted, gold, Green Published			2022-12-25	WOS:000313552400030
J	Mao, LL; Wang, J; DeGrado, WF; Inouye, M				Mao, Lili; Wang, Jun; DeGrado, William F.; Inouye, Masayori			An Assay Suitable for High Throughput Screening of Anti-Influenza Drugs	PLOS ONE			English	Article							INFLUENZA-A VIRUS; ION-CHANNEL; THERAPY; PROTEIN; PORE	We developed a novel drug screening system for anti-influenza A virus by targeting the M2 proton channel. In the SPP (Single Protein Production) system, E. coli cell growth occurs only in the presence of effective M2 channel inhibitors, and thus simple measurement of cell growth was used as readouts for drug screening. Two potential inhibitors for M2 (V27A) mutant were verified using this method, which inhibit both the mutant and wild-type M2 channels.	[Mao, Lili; Inouye, Masayori] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Mao, Lili; Inouye, Masayori] Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ USA; [Wang, Jun; DeGrado, William F.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Wang, Jun; DeGrado, William F.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Inouye, M (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	inouye@cabm.rutgers.edu	Mao, Lili/D-9938-2013; Wang, Jun/G-6504-2010	Wang, Jun/0000-0002-4845-4621	National Institutes of Health [1R01GM085449, AI074571]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085449, R01GM056423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is partially supported by the National Institutes of Health grants 1R01GM085449 (to MI) and AI074571 to (WFD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrahan P, 2011, BBA-BIOMEMBRANES, V1808, P394, DOI 10.1016/j.bbamem.2010.08.021; Balannik V, 2010, BIOCHEMISTRY-US, V49, P696, DOI 10.1021/bi901799k; Balannik V, 2009, BIOCHEMISTRY-US, V48, P11872, DOI 10.1021/bi9014488; Centers for Disease Control, 2010, UPD CDC EST 2009 H1N; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Griffin SDC, 2009, P NATL ACAD SCI USA, V106, P12567, DOI 10.1073/pnas.0906760106; Hout DR, 2004, CURR HIV RES, V2, P255, DOI 10.2174/1570162043351246; Jing XH, 2008, P NATL ACAD SCI USA, V105, P10967, DOI 10.1073/pnas.0804958105; Monto AS, 2006, EMERG INFECT DIS, V12, P55, DOI 10.3201/eid1201.051068; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Mould JA, 2000, J BIOL CHEM, V275, P31038, DOI 10.1074/jbc.M003663200; Ohshima M, 2010, PROTEIN ENG DES SEL, V23, P881, DOI 10.1093/protein/gzq066; Suzuki M, 2005, MOL CELL, V18, P253, DOI 10.1016/j.molcel.2005.03.011; Suzuki M, 2007, NAT PROTOC, V2, P1802, DOI 10.1038/nprot.2007.252; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Wang J, 2011, J AM CHEM SOC, V133, P13844, DOI 10.1021/ja2050666; Wang J, 2011, J AM CHEM SOC, V133, P12834, DOI 10.1021/ja204969m	17	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54070	10.1371/journal.pone.0054070	http://dx.doi.org/10.1371/journal.pone.0054070			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326573	Green Published, Green Submitted, gold			2022-12-25	WOS:000313552400072
J	Saito, M; Kurosawa, Y; Okuyama, T				Saito, Maiko; Kurosawa, Yae; Okuyama, Tsuneo			Scanning Electron Microscopy-Based Approach to Understand the Mechanism Underlying the Adhesion of Dengue Viruses on Ceramic Hydroxyapatite Columns	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; ION-EXCHANGE CHROMATOGRAPHY; PURIFICATION; BINDING; PARTICLES; FUSION; PH	Although ceramic hydroxyapatite (HAp) chromatography has been used as an alternative method ultracentrifugation for the production of vaccines, the mechanism of virus separation is still obscure. In order to begin to understand the mechanisms of virus separation, HAp surfaces were observed by scanning electron microscopy after chromatography with dengue viruses. When these processes were performed without elution and with a 10-207 mM sodium phosphate buffer gradient elution, dengue viruses that were adsorbed to HAp were disproportionately located in the columns. However, when eluted with a 10-600 mM sodium phosphate buffer gradient, few viruses were observed on the HAp surface. After incubating the dengue viruses that were adsorbed on HAp beads at 37 degrees C and 2 degrees C, the sphericity of the dengue viruses were reduced with an increase in incubation temperature. These results suggested that dengue virus was adsorbed to the HAp surface by electronic interactions and could be eluted by high-salt concentration buffers, which are commonly used in protein purification. Furthermore, virus fusion was thought to occur with increasing temperature, which implied that virus-HAp adhesion was similar to virus-cell adhesion.	[Saito, Maiko; Kurosawa, Yae] HOYA Corp, PENTAX New Ceram Div, R&D Dept, Tokyo, Japan; [Okuyama, Tsuneo] Prot Technos Inst, Kanagawa, Japan		Saito, M (corresponding author), HOYA Corp, PENTAX New Ceram Div, R&D Dept, Tokyo, Japan.	maiko.saito@pc.hoya.co.jp						Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; DOWNING LA, 1992, J VIROL METHODS, V38, P215, DOI 10.1016/0166-0934(92)90112-Q; GOLLINS SW, 1986, J GEN VIROL, V67, P157, DOI 10.1099/0022-1317-67-1-157; HAYWOOD AM, 1994, J VIROL, V68, P1; HAYWOOD AM, 1986, J GEN VIROL, V67, P2813, DOI 10.1099/0022-1317-67-12-2813; He CY, 2011, J CHROMATOGR A, V1218, P5279, DOI 10.1016/j.chroma.2011.06.043; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; Iyer G, 2011, J CHROMATOGR A, V1218, P3973, DOI 10.1016/j.chroma.2011.04.086; Jiang ZJ, 2011, PROTEIN EXPRES PURIF, V80, P203, DOI 10.1016/j.pep.2011.07.009; Kalbfuss B, 2007, BIOTECHNOL BIOENG, V96, P932, DOI 10.1002/bit.21109; Kuiper M, 2002, BIOTECHNOL BIOENG, V80, P445, DOI 10.1002/bit.10388; Kurosawa Y, 2009, MED BIOL, V153, P607; LAMBERT DM, 1980, J VIROL, V36, P837, DOI 10.1128/JVI.36.3.837-846.1980; Morenweiser R, 2005, GENE THER, V12, pS103, DOI 10.1038/sj.gt.3302624; Parris NA, 1984, INSTRUMENTAL LIQUID; Raviprakash K, 2009, HUM VACCINES, V5, P520, DOI 10.4161/hv.5.8.9008; Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI [10.1172/JCI200421512, 10.1172/JCI21512]; Sakamoto M, 2007, J BIOMED MATER RES A, V82A, P238, DOI 10.1002/jbm.a.31013; Smith GP, 2005, BIOTECHNIQUES, V39, P879, DOI 10.2144/000112032; Song Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-126; Sugo K., 2007, TISSUE CULT RES COMM, V26, P125; Trilisky EI, 2007, J CHROMATOGR A, V1142, P2, DOI 10.1016/j.chroma.2006.12.094; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244	23	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53893	10.1371/journal.pone.0053893	http://dx.doi.org/10.1371/journal.pone.0053893			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326529	Green Submitted, Green Published, gold			2022-12-25	WOS:000313552400054
J	Balabanov, S; Wilhelm, T; Venz, S; Keller, G; Scharf, C; Pospisil, H; Braig, M; Barett, C; Bokemeyer, C; Walther, R; Brummendorf, TH; Schuppert, A				Balabanov, Stefan; Wilhelm, Thomas; Venz, Simone; Keller, Gunhild; Scharf, Christian; Pospisil, Heike; Braig, Melanie; Barett, Christine; Bokemeyer, Carsten; Walther, Reinhard; Bruemmendorf, Tim H.; Schuppert, Andreas			Combination of a Proteomics Approach and Reengineering of Meso Scale Network Models for Prediction of Mode-of-Action for Tyrosine Kinase Inhibitors	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; BCR-ABL KINASE; CHRONIC-PHASE; GENE-EXPRESSION; AURORA KINASES; IMATINIB; CANCER; DASATINIB; NILOTINIB; THERAPY	In drug discovery, the characterisation of the precise modes of action (MoA) and of unwanted off-target effects of novel molecularly targeted compounds is of highest relevance. Recent approaches for identification of MoA have employed various techniques for modeling of well defined signaling pathways including structural information, changes in phenotypic behavior of cells and gene expression patterns after drug treatment. However, efficient approaches focusing on proteome wide data for the identification of MoA including interference with mutations are underrepresented. As mutations are key drivers of drug resistance in molecularly targeted tumor therapies, efficient analysis and modeling of downstream effects of mutations on drug MoA is a key to efficient development of improved targeted anti-cancer drugs. Here we present a combination of a global proteome analysis, reengineering of network models and integration of apoptosis data used to infer the mode-of-action of various tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML) cell lines expressing wild type as well as TKI resistance conferring mutants of BCR-ABL. The inferred network models provide a tool to predict the main MoA of drugs as well as to grouping of drugs with known similar kinase inhibitory activity patterns in comparison to drugs with an additional MoA. We believe that our direct network reconstruction approach, demonstrated on proteomics data, can provide a complementary method to the established network reconstruction approaches for the preclinical modeling of the MoA of various types of targeted drugs in cancer treatment. Hence it may contribute to the more precise prediction of clinically relevant on- and off-target effects of TKIs.	[Balabanov, Stefan; Wilhelm, Thomas; Keller, Gunhild; Braig, Melanie; Barett, Christine; Bokemeyer, Carsten; Bruemmendorf, Tim H.] Univ Hosp Eppendorf UKE, Hubertus Wald Tumor Zentrum UCCH, Dept Oncol Haematol & Bone Marrow Transplantat, Sect Pneumol, Hamburg, Germany; [Balabanov, Stefan] Univ Zurich Hosp, Div Hematol, CH-8091 Zurich, Switzerland; [Wilhelm, Thomas] Rhein Westfal TH Aachen, Univ Hosp Aachen UKA, Dept Biochem, Aachen, Germany; [Venz, Simone; Walther, Reinhard] Ernst Moritz Arndt Univ Greifswald, Dept Med Biochem & Mol Biol, Greifswald, Germany; [Venz, Simone] Ernst Moritz Arndt Univ Greifswald, Interfacultary Inst Genet & Funct Genom, Greifswald, Germany; [Scharf, Christian] Ernst Moritz Arndt Univ Greifswald, Dept Otorhinolaryngol Head & Neck Surg, Greifswald, Germany; [Pospisil, Heike] Univ Appl Sci Wildau, Wildau, Germany; [Bruemmendorf, Tim H.] Rhein Westfal TH Aachen, UKA, D-52062 Aachen, Germany; [Schuppert, Andreas] Rhein Westfal TH Aachen, Aachen Inst Adv Study Computat Engn Sci AICES, Aachen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Zurich; University Zurich Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; University of Applied Sciences Wildau; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University	Schuppert, A (corresponding author), Rhein Westfal TH Aachen, Aachen Inst Adv Study Computat Engn Sci AICES, Aachen, Germany.	schuppert@aices.rwth-aachen.de	Balabanov, Stefan/E-9765-2014; Scharf, Christian/A-7931-2011; Pospisil, Heike/G-7377-2016	Scharf, Christian/0000-0001-6806-6450; Schuppert, Andreas/0000-0003-3783-6605	German Federal Ministry for Education and Research [0315416A]; Eppendorfer Krebsund Leukamiehilfe e.V	German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Eppendorfer Krebsund Leukamiehilfe e.V	This work was supported by the German Federal Ministry for Education and Research (grant: 0315416A) and by a grant from the Eppendorfer Krebsund Leukamiehilfe e.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Atias N, 2011, J COMPUT BIOL, V18, P207, DOI 10.1089/cmb.2010.0255; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Balabanov S, 2007, BLOOD, V109, P1701, DOI 10.1182/blood-2005-03-037648; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Bhojani N, 2008, EUR UROL, V53, P917, DOI 10.1016/j.eururo.2007.11.037; Brehme M, 2009, P NATL ACAD SCI USA, V106, P7414, DOI 10.1073/pnas.0900653106; Breitkopf SB, 2010, J PROTEOME RES, V9, P6033, DOI 10.1021/pr1008527; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cortes JE, 2011, BLOOD; Cortes JE, 2012, J CLIN ONCOL, V30; Dancey J, 2003, NAT REV DRUG DISCOV, V2, P296, DOI 10.1038/nrd1066; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Dyshlovoy SA, 2012, J PROTEOME RES, V11, P2316, DOI 10.1021/pr300170p; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fiedler B, 2008, IMA J APPL MATH, V73, P449, DOI 10.1093/imamat/hxn011; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Force T, 2011, NAT REV DRUG DISCOV, V10, P111, DOI 10.1038/nrd3252; Fukuzaki M, 2009, IEEE INT C BIOINFORM, P142, DOI 10.1109/BIBM.2009.26; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gontarewicz A, 2008, BLOOD, V111, P4355, DOI 10.1182/blood-2007-09-113175; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Guo F, 2005, BLOOD, V105, P1246, DOI 10.1182/blood-2004-05-2041; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jin GX, 2012, CANCER RES, V72, P33, DOI 10.1158/0008-5472.CAN-11-2333; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Keller G, 2009, EXPERT REV HEMATOL, V2, P489, DOI [10.1586/ehm.09.42, 10.1586/EHM.09.42]; Khoury HJ, 2012, BLOOD, V119, P3403, DOI 10.1182/blood-2011-11-390120; Kutalik Z, 2008, NAT BIOTECHNOL, V26, P531, DOI 10.1038/nbt1397; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Laubenbacher R, 2004, J THEOR BIOL, V229, P523, DOI 10.1016/j.jtbi.2004.04.037; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; McArt DG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016382; Mitsos A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000591; Modugno M, 2007, CANCER RES, V67, P7987, DOI 10.1158/0008-5472.CAN-07-1825; Nilsson T, 2010, NAT METHODS, V7, P681, DOI 10.1038/nmeth0910-681; O'Hare T, 2011, CLIN CANCER RES, V17, P212, DOI 10.1158/1078-0432.CCR-09-3314; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Park D, 2010, AMINO ACIDS, V39, P619, DOI 10.1007/s00726-010-0500-z; Pauwels E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-169; Peifer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008919; Preisinger C, 2010, CELL SIGNAL, V22, P848, DOI 10.1016/j.cellsig.2009.12.012; Preukschas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043468; Quintas-Cardama A, 2008, CLIN LYMPHOMA MYELOM, V8, pS82, DOI 10.3816/CLM.2008.s.003; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Ross-Macdonald P, 2008, MOL CANCER THER, V7, P3490, DOI 10.1158/1535-7163.MCT-08-0826; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Schopfer G, 2005, COMP AID CH, V20a-20b, P595; Schuppert A, 1999, EXTRAPOLABILITY STRU; Schuppert AA, 2011, J MATH IND, V1, DOI 10.1186/2190-5983-1-6; Sebolt-Leopold JS, 2006, NATURE, V441, P457, DOI 10.1038/nature04874; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shiotsu Y, 2000, BLOOD, V96, P2284, DOI 10.1182/blood.V96.6.2284; Sirota M, 2011, SCI TRANSLATIONAL ME, V3; Ummanni R, 2012, J PROTEOME RES, V11, P2452, DOI 10.1021/pr201172n; Ummanni R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016833; Wei GQ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-47; Winkler DA, 2009, ARTIF LIFE, V15, P411, DOI 10.1162/artl.2009.Winkler.011; Xing HM, 2006, NAT PROTOC, V1, P2551, DOI 10.1038/nprot.2006.300; Zhao XM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002323	63	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53668	10.1371/journal.pone.0053668	http://dx.doi.org/10.1371/journal.pone.0053668			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326482	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000313551500091
J	Elul, B; Basinga, P; Nuwagaba-Biribonwoha, H; Saito, S; Horowitz, D; Nash, D; Mugabo, J; Mugisha, V; Rugigana, E; Nkunda, R; Asiimwe, A				Elul, Batya; Basinga, Paulin; Nuwagaba-Biribonwoha, Harriet; Saito, Suzue; Horowitz, Deborah; Nash, Denis; Mugabo, Jules; Mugisha, Veronicah; Rugigana, Etienne; Nkunda, Richard; Asiimwe, Anita			High Levels of Adherence and Viral Suppression in a Nationally Representative Sample of HIV-Infected Adults on Antiretroviral Therapy for 6, 12 and 18 Months in Rwanda	PLOS ONE			English	Article							SELF-REPORTED ADHERENCE; SUB-SAHARAN AFRICA; IMMUNOLOGICAL OUTCOMES; PREDICTORS; PROGRAM; HAART; TRIAL	Background: Generalizable data are needed on the magnitude and determinants of adherence and virological suppression among patients on antiretroviral therapy (ART) in Africa. Methods: We conducted a cross-sectional survey with chart abstraction, patient interviews and site assessments in a nationally representative sample of adults on ART for 6, 12 and 18 months at 20 sites in Rwanda. Adherence was assessed using 3- and 30-day patient recall. A systematically selected sub-sample had viral load (VL) measurements. Multivariable logistic regression examined predictors of non-perfect (<100%) 30-day adherence and detectable VL (>40 copies/ml). Results: Overall, 1,417 adults were interviewed and 837 had VL measures. Ninety-four percent and 78% reported perfect adherence for the last 3 and 30 days, respectively. Eighty-three percent had undetectable VL. In adjusted models, characteristics independently associated with higher odds of non-perfect 30-day adherence were: being on ART for 18 months (vs. 6 months); younger age; reporting severe (vs. no or few) side effects in the prior 30 days; having no documentation of CD4 cell count at ART initiation (vs. having a CD4 cell count of <200 cells/mu L); alcohol use; and attending sites which initiated ART services in 2003-2004 and 2005 (vs. 2006-2007); sites with >= 600 (vs. <600 patients) on ART; or sites with peer educators. Participation in an association for people living with HIV/AIDS; and receiving care at sites which regularly conduct home-visits were independently associated with lower odds of non-adherence. Higher odds of having a detectable VL were observed among patients at sites with peer educators. Being female; participating in an association for PLWHA; and using a reminder tool were independently associated with lower odds of having detectable VL. Conclusions: High levels of adherence and viral suppression were observed in the Rwandan national ART program, and associated with potentially modifiable factors.	[Elul, Batya; Nuwagaba-Biribonwoha, Harriet; Saito, Suzue; Horowitz, Deborah; Mugisha, Veronicah] Columbia Univ, ICAP, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Elul, Batya; Saito, Suzue; Nash, Denis] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Basinga, Paulin; Rugigana, Etienne] Natl Univ Rwanda, Sch Publ Hlth, Dept Community Hlth, Kigali, Rwanda; [Basinga, Paulin] Bill & Melinda Gates Fdn, Seattle, WA USA; [Nash, Denis] CUNY Hunter Coll, Epidemiol & Biostat Program, Sch Publ Hlth, New York, NY 10021 USA; [Mugabo, Jules; Asiimwe, Anita] Minist Hlth, RBC, Kigali, Rwanda; [Nkunda, Richard] NRL, Kigali, Rwanda	Columbia University; Columbia University; University of Rwanda; Bill & Melinda Gates Foundation; City University of New York (CUNY) System; Hunter College (CUNY)	Elul, B (corresponding author), Columbia Univ, ICAP, Mailman Sch Publ Hlth, New York, NY 10027 USA.	be2124@columbia.edu	Nash, Denis/AFI-7485-2022	Nash, Denis/0000-0002-3280-5386	Global Fund to Fight AIDS, TB and Malaria; Centers for Disease Control and Prevention [5U62PS222407]	Global Fund to Fight AIDS, TB and Malaria(United States Agency for International Development (USAID)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This article was supported by the Global Fund to Fight AIDS, TB and Malaria, and cooperative agreement number 5U62PS222407 from the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaasa AM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-241; Amberbir A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-265; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bhat VG, 2010, EUR J CLIN MICROBIOL, V29, P947, DOI 10.1007/s10096-010-0949-4; Brambatti LP, 2007, PSYCHOL PROGRAM PROC; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Chang LW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010923; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Dahab M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-63; Demeester R, 2005, JAIDS-J ACQ IMM DEF, V40, P113, DOI 10.1097/01.qai.0000176590.68430.59; El-Khatib Ziad, 2011, J AIDS Clin Res, V2; Etienne Martine, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P98, DOI 10.1177/1545109710361383; Graham SM, 2010, J INFECT DIS, V202, P1538, DOI 10.1086/656790; Hendershot CS, 2009, JAIDS-J ACQ IMM DEF, V52, P180, DOI 10.1097/QAI.0b013e3181b18b6e; Kalichman Seth C, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P317, DOI 10.1177/1545109708328130; Kashuba AD, 2011, LANCET; Kip E, 2009, J NURS SCHOLARSHIP, V41, P149, DOI 10.1111/j.1547-5069.2009.01266.x; Kipp W, 2010, AIDS CARE, V22, P271, DOI 10.1080/09540120903193625; Lowrance DW, 2009, JAIDS-J ACQ IMM DEF, V52, P49, DOI 10.1097/QAI.0b013e3181b03316; Mascolini Mark, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P160, DOI 10.1177/1545109708322728; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Ministry of Health GoR, 2011, ANN REP JUL 2010 JUN; Musiime S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027832; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; National Institute of Statistics of Rwanda (NISR) MoHMR ICF International, 2012, RWAND DEM HLTH SURV; Osborn CY, 2010, AIDS BEHAV, V14, P181, DOI 10.1007/s10461-008-9484-z; Oyugi JH, 2004, JAIDS-J ACQ IMM DEF, V36, P1100, DOI 10.1097/00126334-200408150-00014; Pearson CR, 2007, JAIDS-J ACQ IMM DEF, V46, P238, DOI 10.1097/QAI.0b013e318153f7ba; Peltzer K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-111; Perrine R, 2011, JAIDS-J ACQ IMM DEF, V57, pS40, DOI 10.1097/QAI.0b013e318222b5c2; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Rwanda Go, 2010, UN GEN ASS SPEC SESS; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; Simoni JM, 2011, AIDS BEHAV, V15, P919, DOI 10.1007/s10461-010-9828-3; Somi G, 2009, Tanzan J Health Res, V11, P136; UNAIDS, 2011, GLOB HIV AIDS RESP E; Unge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013613; Uzochukwu BSC, 2009, HEALTH POLICY PLANN, V24, P189, DOI 10.1093/heapol/czp006; Walsh JC, 2002, AIDS, V16, P269, DOI 10.1097/00002030-200201250-00017; Watt MH, 2010, AIDS CARE, V22, P381, DOI 10.1080/09540120903193708; Wise J, 2008, AIDS PATIENT CARE ST, V22, P495, DOI 10.1089/apc.2007.0180; World Health Organization, 2007, ESSENTIAL PREVENTION	44	54	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53586	10.1371/journal.pone.0053586	http://dx.doi.org/10.1371/journal.pone.0053586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326462	gold, Green Published			2022-12-25	WOS:000313551500086
J	Narayan, KM; Agrawal, N; Du, SX; Muranaka, JE; Bauer, K; Leaman, DP; Phung, P; Limoli, K; Chen, HL; Boenig, RI; Wrin, T; Zwick, MB; Whalen, RG				Narayan, Kristin M.; Agrawal, Nitish; Du, Sean X.; Muranaka, Janelle E.; Bauer, Katherine; Leaman, Daniel P.; Pham Phung; Limoli, Kay; Chen, Helen; Boenig, Rebecca I.; Wrin, Terri; Zwick, Michael B.; Whalen, Robert G.			Prime-Boost Immunization of Rabbits with HIV-1 gp120 Elicits Potent Neutralization Activity against a Primary Viral Isolate	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODY; HIGH-LEVEL EXPRESSION; CD4 BINDING-SITE; ENVELOPE GLYCOPROTEIN; TYPE-1 GP120; V3 LOOP; LINKED GLYCOSYLATION; STRUCTURAL BASIS; N-GLYCOSYLATION	Development of a vaccine for HIV-1 requires a detailed understanding of the neutralizing antibody responses that can be experimentally elicited to difficult-to-neutralize primary isolates. Rabbits were immunized with the gp120 subunit of HIV-1 JR-CSF envelope (Env) using a DNA-prime protein-boost regimen. We analyzed five sera that showed potent autologous neutralizing activity (IC50s at similar to 10(3) to 10(4) serum dilution) against pseudoviruses containing Env from the primary isolate JR-CSF but not from the related isolate JR-FL. Pseudoviruses were created by exchanging each variable and constant domain of JR-CSF gp120 with that of JR-FL or with mutations in putative N-glycosylation sites. The sera contained different neutralizing activities dependent on C3 and V5, C3 and V4, or V4 regions located on the glycan-rich outer domain of gp120. All sera showed enhanced neutralizing activity toward an Env variant that lacked a glycosylation site in V4. The JR-CSF gp120 epitopes recognized by the sera are generally distinct from those of several well characterized mAbs (targeting conserved sites on Env) or other type-specific responses (targeting V1, V2, or V3 variable regions). The activity of one serum requires specific glycans that are also important for 2G12 neutralization and this serum blocked the binding of 2G12 to gp120. Our findings show that different fine specificities can achieve potent neutralization of HIV-1, yet this strong activity does not result in improved breadth.	[Narayan, Kristin M.; Du, Sean X.; Muranaka, Janelle E.; Chen, Helen; Boenig, Rebecca I.; Whalen, Robert G.] Maxygen Inc, Dept Infect Dis, Redwood City, CA USA; [Narayan, Kristin M.; Du, Sean X.; Muranaka, Janelle E.; Boenig, Rebecca I.; Whalen, Robert G.] Altravax Inc, Sunnyvale, CA USA; [Agrawal, Nitish; Bauer, Katherine; Leaman, Daniel P.; Zwick, Michael B.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Pham Phung; Limoli, Kay; Wrin, Terri] Monogram Biosci Inc, San Francisco, CA USA	Scripps Research Institute	Zwick, MB (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	zwick@scripps.edu; robert.whalen@altravax.com	AGRAWAL, NITISH/H-6186-2011; AGRAWAL, NITISH/E-3468-2013	AGRAWAL, NITISH/0000-0003-0823-7355; 	National Institutes of Health [P01 AI056375, R43 AI067058, R43 AI070032, R33 AI077381, T32 AI007606]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI070032, P01AI056375, R43AI067058, R33AI077381, T32AI007606] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the following grants from the National Institutes of Health: P01 AI056375 to RGW and DR Burton; R43 AI067058 and R43 AI070032 to RGW; R33 AI077381 to MBZ; and T32 AI007606 to DPL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal-Gamse C, 2011, J VIROL, V85, P470, DOI 10.1128/JVI.01349-10; ALLAWAY GP, 1995, AIDS RES HUM RETROV, V11, P533, DOI 10.1089/aid.1995.11.533; Astronomo RD, 2008, J VIROL, V82, P6359, DOI 10.1128/JVI.00293-08; Astronomo RD, 2010, CHEM BIOL, V17, P357, DOI 10.1016/j.chembiol.2010.03.012; Balzarini J, 2005, J BIOL CHEM, V280, P41005, DOI 10.1074/jbc.M508801200; BARBOSA JA, 1987, J EXP MED, V166, P1329, DOI 10.1084/jem.166.5.1329; Barnet SW, 2001, J VIROL, V75, P5526, DOI 10.1128/JVI.75.12.5526-5540.2001; Barnetta SW, 2008, AIDS, V22, P339, DOI 10.1097/QAD.0b013e3282f3ca57; Beddows S, 2007, VIROLOGY, V360, P329, DOI 10.1016/j.virol.2006.10.032; BERNSTEIN HB, 1994, J VIROL, V68, P463, DOI 10.1128/JVI.68.1.463-468.1994; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2010, J VIROL, V84, P5637, DOI 10.1128/JVI.00105-10; Bonomelli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023521; Brunel FM, 2006, J VIROL, V80, P1680, DOI 10.1128/JVI.80.4.1680-1687.2006; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Carlos MP, 1999, J ACQ IMMUN DEF SYND, V22, P317; Cavacini L, 2003, AIDS, V17, P685, DOI 10.1097/00002030-200303280-00006; Chackerian B, 1997, J VIROL, V71, P7719, DOI 10.1128/JVI.71.10.7719-7727.1997; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chen H, 2008, J GEN VIROL, V89, P2597, DOI 10.1099/vir.0.2008/003491-0; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Ching L, 2010, J VIROL, V84, P9932, DOI 10.1128/JVI.00868-10; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; DAAR ES, 1990, P NATL ACAD SCI USA, V87, P6574, DOI 10.1073/pnas.87.17.6574; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P17107, DOI 10.1073/pnas.1002717107; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Douagi I, 2010, J VIROL, V84, P1683, DOI 10.1128/JVI.01896-09; Du SX, 2008, PROTEIN EXPRES PURIF, V59, P223, DOI 10.1016/j.pep.2008.02.002; Du SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020927; Du SX, 2009, VIROLOGY, V395, P33, DOI 10.1016/j.virol.2009.07.042; Duenas-Decamp MJ, 2008, J VIROL, V82, P5807, DOI 10.1128/JVI.02585-07; Euler Z, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00215; Feng Y, 2012, J BIOL CHEM, V287, P5673, DOI 10.1074/jbc.M111.317776; FUNG MSC, 1992, J VIROL, V66, P848, DOI 10.1128/JVI.66.2.848-856.1992; GEYER H, 1988, J BIOL CHEM, V263, P11760; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Joyce JG, 2008, P NATL ACAD SCI USA, V105, P15684, DOI 10.1073/pnas.0807837105; Kim M, 2005, AIDS RES HUM RETROV, V21, P58, DOI 10.1089/aid.2005.21.58; Koch M, 2003, VIROLOGY, V313, P387, DOI 10.1016/S0042-6822(03)00294-0; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Law M, 2007, J VIROL, V81, P4272, DOI 10.1128/JVI.02536-06; Leaman DP, 2010, J VIROL, V84, P3382, DOI 10.1128/JVI.02363-09; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Li Y, 2008, J VIROL, V82, P638, DOI 10.1128/JVI.01691-07; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; LoomisPrice LD, 1997, J IND MICROBIOL BIOT, V19, P58, DOI 10.1038/sj.jim.2900410; Malenbaum SE, 2000, J VIROL, V74, P11008, DOI 10.1128/JVI.74.23.11008-11016.2000; McBurney SP, 2007, VIROLOGY, V358, P334, DOI 10.1016/j.virol.2006.08.032; McCaffrey RA, 2004, J VIROL, V78, P3279, DOI 10.1128/JVI.78.7.3279-3295.2004; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; MONTEFIORI DC, 1988, P NATL ACAD SCI USA, V85, P9248, DOI 10.1073/pnas.85.23.9248; Moore PL, 2009, CURR OPIN HIV AIDS, V4, P358, DOI 10.1097/COH.0b013e32832ea7e8; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Moulard M, 2000, BBA-REV BIOMEMBRANES, V1469, P121, DOI 10.1016/S0304-4157(00)00014-9; Moulard M, 2002, P NATL ACAD SCI USA, V99, P6913, DOI 10.1073/pnas.102562599; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Pantophlet R, 2007, VIROLOGY, V364, P441, DOI 10.1016/j.virol.2007.03.007; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Poignard P, 2003, J VIROL, V77, P353, DOI 10.1128/JVI.77.1.353-365.2003; Raedler MD, 2009, CLIN VACCINE IMMUNOL, V16, P739, DOI 10.1128/CVI.00478-08; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Rong R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000594; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2007, J MOL BIOL, V372, P16, DOI 10.1016/j.jmb.2007.06.027; Scanlan CN, 2007, NATURE, V446, P1038, DOI 10.1038/nature05818; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Schweighardt B, 2007, JAIDS-J ACQ IMM DEF, V46, P1, DOI 10.1097/01.qai.0000286594.11191.91; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Utachee P, 2010, J VIROL, V84, P4311, DOI 10.1128/JVI.02619-09; Vaine M, 2008, J VIROL, V82, P7369, DOI 10.1128/JVI.00562-08; Vaine M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013916; Van Regenmortel MHV, 2011, J MOL RECOGNIT, V24, P741, DOI 10.1002/jmr.1116; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang SX, 2005, J VIROL, V79, P7933, DOI 10.1128/JVI.79.12.7933-7937.2005; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Whitcomb JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wu XL, 2009, J VIROL, V83, P10892, DOI 10.1128/JVI.01142-09; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	101	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52732	10.1371/journal.pone.0052732	http://dx.doi.org/10.1371/journal.pone.0052732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326351	Green Published, gold, Green Submitted			2022-12-25	WOS:000313551500028
J	Zhou, W; Cao, H; Yang, XH; Cong, K; Wang, W; Chen, TR; Yin, HB; Wu, ZP; Cai, XP; Liu, TL; Xiao, JR				Zhou, Wang; Cao, Hao; Yang, Xinghai; Cong, Kan; Wang, Wei; Chen, Tianrui; Yin, Huabin; Wu, Zhipeng; Cai, Xiaopan; Liu, Tielong; Xiao, Jianru			Characterization of Nuclear Localization Signal in the N Terminus of Integrin-linked Kinase-associated Phosphatase (ILKAP) and Its Essential Role in the Down-regulation of RSK2 Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPORTIN-ALPHA; CELL-SURVIVAL; STRUCTURAL BASIS; DOCKING; COMPLEX; RECOGNITION; APOPTOSIS; SEQUENCES; DOMAINS; BINDING	Integrin-linked kinase-associated phosphatase (ILKAP) is a serine/threonine (S/T) phosphatase that belongs to the protein phosphatase 2C (PP2C) family. Many previous studies have demonstrated that ILKAP plays key roles in the regulation of cell survival and apoptosis. Researchers have thus far considered ILKAP a cytoplasmic protein that negatively regulates integrin signaling by interacting with and phosphorylating integrin-linked kinase 1 (ILK1). In this study, we found that both endogenous and tagged ILKAP mainly localize to the nucleus and that the nuclear transport of ILKAP is nuclear localization signal (NLS) importin-mediated. The ILKAP protein interacts directly with importin alpha 1, alpha 3, and alpha 5. The NLS in ILKAP is located in the N-terminal region between amino acids 71 and 86, and the NLS-deleted ILKAP protein was distributed in the cytoplasm. In addition, we show that Lys-78 and Arg-79 are critical for the binding of ILKAP to importin alpha. We also found that nuclear ILKAP interacts with ribosomal protein S6 kinase-2 (RSK2) and induces apoptosis by inhibiting RSK2 activity and down-regulating the expression level of the RSK2 downstream substrate cyclin D1. These results indicate that ILKAP is a nuclear protein that regulates cell survival and apoptosis through the regulation of RSK2 signaling.	[Zhou, Wang; Yang, Xinghai; Yin, Huabin; Wu, Zhipeng; Cai, Xiaopan; Liu, Tielong; Xiao, Jianru] Second Mil Med Univ, Changzheng Hosp, Shanghai 200433, Peoples R China; [Cao, Hao] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130012, Peoples R China; [Cong, Kan] Calif State Univ Long Beach, Dept Chem & Biochem, Long Beach, CA 90840 USA; [Wang, Wei] Ctr Dis Control & Prevent CDC ONDIEH NCEH, Off Noncommunicable Dis Injury & Environm Hlth, Natl Ctr Environm Hlth, Doraville, GA 30340 USA; [Chen, Tianrui] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA	Naval Medical University; Jilin University; California State University System; California State University Long Beach; Centers for Disease Control & Prevention - USA; Duke University	Liu, TL (corresponding author), Second Mil Med Univ, Changzheng Hosp, 415 Feng Yang Rd, Shanghai 200433, Peoples R China.	cztielongliu@163.com; jianruxiao83@163.com	Xiao, Jian/GYU-4351-2022		National Natural Science Foundation of China [81201556]; Department of Health of the National Natural Science Foundation of China [2012159]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Health of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant 81201556) and the Department of Health of the National Natural Science Foundation of China (Grant 2012159).	CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Dias SMG, 2009, NAT STRUCT MOL BIOL, V16, P930, DOI 10.1038/nsmb.1649; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Doehn U, 2004, BIOCHEM J, V382, P425, DOI 10.1042/BJ20040948; Eisinger-Mathason TSK, 2008, MOL CELL, V31, P722, DOI 10.1016/j.molcel.2008.06.025; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Grashoff C, 2003, EMBO REP, V4, P432, DOI 10.1038/sj.embor.embor801; Gray JJ, 2006, CURR OPIN STRUC BIOL, V16, P183, DOI 10.1016/j.sbi.2006.03.003; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; Kang SM, 2011, EXPERT OPIN THER TAR, V15, P11, DOI 10.1517/14728222.2010.531013; Kumar AS, 2004, ONCOGENE, V23, P3454, DOI 10.1038/sj.onc.1207473; Lange A, 2009, NATURE, V461, P1002, DOI 10.1038/nature08468; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Leung-Hagesteijn C, 2001, EMBO J, V20, P2160, DOI 10.1093/emboj/20.9.2160; Lorenz K, 2007, J CELL BIOL, V177, P501, DOI 10.1083/jcb.200608125; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Sivasubramanian A, 2006, STRUCTURE, V14, P401, DOI 10.1016/j.str.2005.11.022; Tamura S, 2006, CANCER SCI, V97, P563, DOI 10.1111/j.1349-7006.2006.00219.x; Tong Y, 1998, J BIOL CHEM, V273, P35282, DOI 10.1074/jbc.273.52.35282; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Wiehe K, 2005, PROTEINS, V60, P207, DOI 10.1002/prot.20559; Willard FS, 2001, CELL SIGNAL, V13, P653, DOI 10.1016/S0898-6568(01)00185-1	31	11	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6259	6271		10.1074/jbc.M112.432195	http://dx.doi.org/10.1074/jbc.M112.432195			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23329845	hybrid, Green Published			2022-12-25	WOS:000315820700021
J	Banerjee, K; Jhala, YV; Chauhan, KS; Dave, CV				Banerjee, Kausik; Jhala, Yadvendradev V.; Chauhan, Kartikeya S.; Dave, Chittranjan V.			Living with Lions: The Economics of Coexistence in the Gir Forests, India	PLOS ONE			English	Article							PANTHERA-LEO-PERSICA; NATIONAL-PARK; ASIATIC LIONS; MOVEMENT PATTERNS; LARGE CARNIVORES; FOOD-HABITS; PREY; CONSERVATION; CONFLICT; LIVESTOCK	Rarely human communities coexist in harmony with large predators. Most often communities suffer due to predation on their stock while large carnivores suffer losses and at times extirpation due to retaliation. We examine the mechanisms permitting the coexistence of Asiatic lions (Panthera leo persica) and pastoral communities (Maldharis) in the Gir forests, India. We monitored six Maldhari settlements between 2005 and 2007 to quantify seasonal livestock holding, density and losses due to predation and other causes. Lion density, estimated by mark recapture, was 15 +/- 0.1 SE/100 km(2). Livestock density, estimated by total counts, ranged between 25/km(2)-31/km(2) with buffaloes being most abundant. Average livestock holding of Maldhari families was 33 +/- 3 SE. Lions predated mostly on unproductive cattle (30%). Scat analysis (n = 165), predation events (n = 180) and seven continuous monitoring sessions of 1,798 hours on four radio-collared lions estimated livestock to contribute between 25 to 42% of lions' biomass consumptions, of which only 16% was predated; rest scavenged. With free grazing rights within Gir forests, Maldharis offset 58 +/- 0.2 SE% of annual livestock rearing cost in comparison to non-forest dwelling pastoralists. With government compensation scheme for livestock predation, this profit margin augmented to 76 +/- 0.05 SE%. Lion density was higher in areas with Maldhari livestock in comparison to areas without livestock. Thus, the current lifestyles and livestock holdings of Maldharis seem to be beneficial to both lions and local pastoralists. We conclude that a combination of strict protection regime for lions, Maldharis' traditional reverence towards lions and the livelihood economics permit the delicate balance of lion-Maldhari coexistence. Indefinite increase in human and livestock population within Gir might upset this equilibrium undermining the conservation objectives. We see no end to compensation programs worldwide as they constitute a crucial element needed for human-carnivore coexistence.	[Jhala, Yadvendradev V.] Wildlife Inst India, Dept Anim Ecol & Conservat Biol, Dehra Dun, Uttar Pradesh, India	Wildlife Institute of India	Jhala, YV (corresponding author), Wildlife Inst India, Dept Anim Ecol & Conservat Biol, Dehra Dun, Uttar Pradesh, India.	jhalay@wii.gov.in	Jhala, Yadvendradev/AAL-9711-2020; Dave, Chittaranjan/GPX-0631-2022	Dave, Chittaranjan/0000-0002-2006-383X	Wildlife Institute of India	Wildlife Institute of India	The research was funded by the Wildlife Institute of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN BB, 1984, J WILDLIFE MANAGE, V48, P147, DOI 10.2307/3808462; Adams W.M., 2007, CONSERV SOC, V5, P147, DOI DOI 10.2307/26392879; Agarwala M, 2010, BIOL CONSERV, V143, P2945, DOI 10.1016/j.biocon.2010.05.003; Athreya V, 2011, CONSERV BIOL, V25, P133, DOI 10.1111/j.1523-1739.2010.01599.x; Banerjee K, 2012, RANGING PATTERNS HAB; Banerjee K, 2012, J MAMMAL, V93, P1420, DOI 10.1644/11-MAMM-A-231.1; Banerjee K, 2010, ORYX, V44, P248, DOI 10.1017/S0030605309990949; BASU P., 2011, TR2011001 WILDL I IN, VI; BEIER P, 1995, J MAMMAL, V76, P1056, DOI 10.2307/1382599; Berwick S, 1974, COMMUNITY WILD RUMIN; Buchanan J. M., 2003, ENCY PUBLIC CHOICE, P454; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Casimir MJ, 2001, NOMADIC PEOPLES, V5, P154, DOI DOI 10.3167/082279401782310808; Census of India, 2011, RUR URB DISTR IND SE, V1; Champion H. G., 1968, REVISED SURVEY FORES, P404; Check E, 2006, NATURE, V441, P927, DOI 10.1038/441927a; Chellam R, 1993, ECOLOGY ASIATIC LION; Datta A, 2008, BIOL CONSERV, V141, P1429, DOI 10.1016/j.biocon.2008.02.022; Dave C, 2011, J TROP ECOL, V27, P239, DOI 10.1017/S0266467410000738; Dave CV, 2008, ECOLOGY CHITAL AXIS; FAIR J., 2009, BBC WILDLIFE     MAR, P39; Fenton L L, 1924, RIFLE INDIA BEING SP; FLOYD TJ, 1978, J WILDLIFE MANAGE, V42, P528, DOI 10.2307/3800814; GADGIL M, 1990, INTERDISCIPL SCI REV, V15, P209; Gee EP, 1964, WILDLIFE INDIA; Goldman Mara J., 2010, Human Dimensions of Wildlife, V15, P332, DOI 10.1080/10871209.2010.506671; Gopal R, 2010, ORYX, V44, P383, DOI 10.1017/S0030605310000529; Guha R, 2003, BATTLES NATURE SCI P, P139; GUJARAT FOREST DEPARTMENT, 2010, DISTR AS LIONS GIR N; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; Hayward MW, 2009, BIODIVERS CONSERV, V18, P887, DOI 10.1007/s10531-008-9452-y; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Hazzah L, 2009, BIOL CONSERV, V142, P2428, DOI 10.1016/j.biocon.2009.06.006; HINES JE, 1994, SCATMAN; Homewood K, 2009, STUD HUM ECOL ADAPT, V5, P1, DOI 10.1007/978-0-387-87492-0; Ikanda Dennis, 2008, Endangered Species Research, V6, P67, DOI 10.3354/esr00120; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; Jethva BD, 2003, MAMMALIA, V67, P589, DOI 10.1515/mamm-2003-0415; Jethva BD, 2004, BIOL CONSERV, V116, P351, DOI 10.1016/S0006-3207(03)00218-0; Jhala Yadvendradev V., 1999, Journal of the Bombay Natural History Society, V96, P3; Jhala YV, 2011, 2011003 TR WILDL I I; Jhala YV, 2004, MONITORING GIR, P55; Joslin P., 1973, ASIATIC LION STUDY E; Kaavya Varma, 2009, Journal of Environment & Development, V18, P154, DOI 10.1177/1070496508329352; Karanth K.U., 2003, CONSERV SOC, V1, P65; Karanth KU, 2009, ORYX, V43, P1, DOI 10.1017/S003060530843106X; Karanth KU, 2005, CONSERV BIOL SER, V9, P373; Karanth KU, 1998, ECOLOGY, V79, P2852; Kinnear N. B., 1920, J BOMBAY NATURAL HIS, V27, P34; Kissui BM, 2004, P ROY SOC B-BIOL SCI, V271, P1867, DOI 10.1098/rspb.2004.2797; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; Korschgen LJ., 1980, WILDLIFE MANAGEMENT, P113; Kothari A., 1995, Ecologist, V25, P188; Krebs C. J., 2014, ECOLOGICAL METHODOLO; LINK WA, 1994, ECOLOGY, V75, P2456, DOI 10.2307/1940899; Maclennan SD, 2009, BIOL CONSERV, V142, P2419, DOI 10.1016/j.biocon.2008.12.003; Manfredo Michael J., 2003, Human Dimensions of Wildlife, V8, P287, DOI 10.1080/716100425; Manly BF, 1992, RESOURCE SELECTION A; McCabe JT, 2010, HUM ECOL, V38, P322, DOI 10.1007/s10745-010-9312-8; MECH LD, 1991, GREATER YELLOWSTONE ECOSYSTEM, P309; Meena V, 2011, J ZOOL, V284, P60, DOI 10.1111/j.1469-7998.2010.00780.x; MILLS MGL, 1992, WILDLIFE 2001 : POPULATIONS, P1112; Ministry of Finance-Government of India, 2009, PUBL PRIV PARTN IND; Mukherjee A, 2004, BIODIVERS CONSERV, V13, P2165, DOI 10.1023/B:BIOC.0000040009.75090.8c; MUKHERJEE S, 1994, MAMMALIA, V58, P139, DOI 10.1515/mamm.1994.58.1.139; MUKHERJEE S, 1994, ACTA THERIOL, V39, P425, DOI 10.4098/AT.arch.94-50; Narain S.P., 2005, JOINING DOTS REPORT; Ogada MO, 2003, CONSERV BIOL, V17, P1521, DOI 10.1111/j.1523-1739.2003.00061.x; Owen-Smith RN., 2002, ADAPTIVE HERBIVORE E, VStudent; Packer C, 2005, NATURE, V436, P927, DOI 10.1038/436927a; Pathak B., 2002, BIODIVERSITY CONSERV; Pati B. P., 2000, Indian Forester, V126, P1120; Peladeau N, 1995, SIMSTAT 3 5; PENNYCUICK CJ, 1970, J ZOOL, V160, P497; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; Prater S.H., 1971, BOOK INDIAN ANIMALS, V3rd; Rai N., 2007, MAKING CONSERVATION, P147; Rangarajan Mahesh, 1996, FENCING FOREST CONSE; Raval SR, 1991, RESIDENT PEOPLES NAT, P68; Renugadevi, 2012, AFR J HIST CULT, V4, P1, DOI [10.5897/AJHC11.042, DOI 10.5897/AJHC11.042]; Rexstad E., 1991, USERS GUIDE INTERACT; Roskaft E, 2003, EVOL HUM BEHAV, V24, P184, DOI 10.1016/S1090-5138(03)00011-4; Saberwal V., 2003, BATTLES NATURE SCI P; SABERWAL VK, 1994, CONSERV BIOL, V8, P501, DOI 10.1046/j.1523-1739.1994.08020501.x; SAWARKAR V B, 1986, Indian Forester, V112, P858; Schaller G. B., 1972, SERENGETI LION STUDY; Schaller GB., 1967, DEER TIGER; Singh HS, 2011, BIOL CONSERV, V144, P1753, DOI 10.1016/j.biocon.2011.02.009; SINGH H. S., 2007, GIR LION PANTHERA LE; Singh HS, 1996, BIODIVERSITY CONSERV, VI; Sinha Satya Priya, 2004, Tigerpaper (Bangkok), V31, P27; Sinha SP, 1987, ECOLOGY WILDLIFE SPE; Stanley TR, 1999, ENVIRON ECOL STAT, V6, P197, DOI 10.1023/A:1009674322348; Stephens D.W., 1986, pi; Tambling CJ, 2012, ECOLOGY, V93, P1297; Thapar R, 1994, KING ASOKA BUDDHISM, P15; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; VANORSDOL KG, 1985, J ZOOL, V206, P97; Vitterso J, 1998, ANTHROZOOS, V11, P210, DOI 10.2752/089279398787000490; Whitman KL, 2007, CONSERV BIOL, V21, P591, DOI 10.1111/j.1523-1739.2007.00700.x; WWF-India, 2007, LANDSC HOP CONS TIG; Zar JH., 2010, BIOSTAT ANAL	103	47	49	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e49457	10.1371/journal.pone.0049457	http://dx.doi.org/10.1371/journal.pone.0049457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341871	Green Submitted, Green Published, gold			2022-12-25	WOS:000313682700004
J	De Lima, YV; Evans, D; Page-Shipp, L; Barnard, A; Sanne, I; Menezes, CN; Van Rie, A				De Lima, Yara Voss; Evans, Denise; Page-Shipp, Liesl; Barnard, Antonia; Sanne, Ian; Menezes, Colin N.; Van Rie, Annelies			Linkage to Care and Treatment for TB and HIV among People Newly Diagnosed with TB or HIV-Associated TB at a Large, Inner City South African Hospital	PLOS ONE			English	Article							POTENT ANTIRETROVIRAL THERAPY; TUBERCULOSIS TREATMENT; TREATMENT INITIATION; INFECTED PATIENTS; RISK-FACTORS; DEFAULT; MORTALITY; PREVENTION; REFERRALS; PATIENT	Objective: To assess the outcomes of linkage to TB and HIV care and identify risk factors for poor referral outcomes. Design: Cohort study of TB patients diagnosed at an urban hospital. Methods: Linkage to care was determined by review of clinic files, national death register, and telephone contact, and classified as linked to care, delayed linkage to care (>7 days for TB treatment, >30 days for HIV care), or failed linkage to care. We performed log-binomial regression to identify patient and referral characteristics associated with poor referral outcomes. Results: Among 593 TB patients, 23% failed linkage to TB treatment and 30.3% of the 77.0% who linked to care arrived late. Among 486 (86.9%) HIV-infected TB patients, 38.3% failed linkage to HIV care, and 32% of the 61.7% who linked to care presented late. One in six HIV-infected patients failed linkage to both TB and HIV care. Only 20.2% of HIV-infected patients were referred to a single clinic for integrated care. A referral letter was present in 90.3%, but only 23.7% included HIV status and 18.8% CD4 cell count. Lack of education (RR 1.85) and low CD4 count (CD4 <= 50 vs. >250cells/mm(3); RR 1.66) were associated with failed linkage to TB care. Risk factors for failed linkage to HIV care were antiretroviral-naive status (RR 1.29), and absence of referral letter with HIV or CD4 cell count (RR1.23). Conclusions: Linkage to TB/HIV care should be strengthened by communication of HIV and CD4 results, ART initiation during hospitalization and TB/HIV integration at primary care.	[De Lima, Yara Voss; Sanne, Ian] Univ Witwatersrand, Clin HIV Res Unit, Fac Hlth Sci, Johannesburg, South Africa; [Evans, Denise] Univ Witwatersrand, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa; [Page-Shipp, Liesl] Right To Care, Johannesburg, South Africa; [Barnard, Antonia] Gauteng Dept Hlth & Social Dev, Johannesburg, South Africa; [Menezes, Colin N.] Univ Witwatersrand, Fac Hlth Sci, Dept Med, Infect Dis Unit, Johannesburg, South Africa; [Van Rie, Annelies] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA	University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of North Carolina; University of North Carolina Chapel Hill	Van Rie, A (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA.	vanrie@email.unc.edu	Van Rie, Annelies/C-2082-2017; Sanne, Ian/ABH-2231-2020	Van Rie, Annelies/0000-0001-7666-3263; Menezes, Colin/0000-0003-3838-5359	United States Agency for International Development (PEPFAR) [674-A-00-08-00007-00]; National Institutes of Health [ICOHRTA AIDS/TB U2RTW007370]	United States Agency for International Development (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by United States Agency for International Development (PEPFAR in a grant to Right to Care 674-A-00-08-00007-00) and the National Institutes of Health (ICOHRTA AIDS/TB U2RTW007370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu BS, 2008, INT J TUBERC LUNG D, V12, P1055; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Botha E, 2008, INT J TUBERC LUNG D, V12, P936; Botha E, 2008, INT J TUBERC LUNG D, V12, P820; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Buu TN, 2003, INT J TUBERC LUNG D, V7, P735; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Creek TL, 2000, INT J TUBERC LUNG D, V4, P956; Daniel OJ, 2006, NIGERIAN J MED, V15, P64; Department of Health, 2009, NAT TUB MAN GUID; Edginton ME, 2006, INT J TUBERC LUNG D, V10, P1018; Edginton ME, 2005, INT J TUBERC LUNG D, V9, P398; Elbireer S, 2011, TROP MED INT HEALTH, V16, P981, DOI 10.1111/j.1365-3156.2011.02800.x; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Holtz TH, 2006, INT J TUBERC LUNG D, V10, P649; Kapella BK, 2009, INT J TUBERC LUNG D, V13, P232; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Micek MA, 2009, JAIDS-J ACQ IMM DEF, V52, P397, DOI 10.1097/QAI.0b013e3181ab73e2; Murray C J, 1990, Bull Int Union Tuberc Lung Dis, V65, P6; Nuwaha F, 1999, INT J TUBERC LUNG D, V3, P224; de Albuquerque MDPM, 2007, CAD SAUDE PUBLICA, V23, P1573, DOI 10.1590/S0102-311X2007000700008; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Rao VK, 1998, CHEST, V114, P1244, DOI 10.1378/chest.114.5.1244; SANS 5999, 2004, TIN DET TIMB; Squire SB, 2005, INT J TUBERC LUNG D, V9, P25; Terris-Prestholt Fern, 2008, Cost Eff Resour Alloc, V6, P2, DOI 10.1186/1478-7547-6-2; Tsiouris SJ, 2005, TUBERCULOSIS HIV OPE; Tuboi SH, 2009, JAIDS-J ACQ IMM DEF, V51, P615, DOI 10.1097/QAI.0b013e3181a44f0a; Walensky RP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001101; Wanyenze RK, 2011, AIDS BEHAV, V15, P751, DOI 10.1007/s10461-010-9704-1; World Health Organization, 2010, GLOB TUB CONTR SURV; World Health Organization, 2009, GLOB TUB CONTR EP ST	35	12	13	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e49140	10.1371/journal.pone.0049140	http://dx.doi.org/10.1371/journal.pone.0049140			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341869	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700002
J	Kaur, H; Li, JJ; Bay, BH; Yung, LYL				Kaur, Harleen; Li, Jasmine J.; Bay, Boon-Huat; Yung, Lin-Yue Lanry			Investigating the Antiproliferative Activity of High Affinity DNA Aptamer on Cancer Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VITRO SELECTION; FACTOR VEGF; COMBINATORIAL SELECTION; VASCULAR-PERMEABILITY; SIGNALING PATHWAYS; FACTOR RECEPTOR-1; BREAST-CANCER; EXPRESSION; RNA	Vascular endothelial growth factor (VEGF) is an angiogenic mitogen involved in promoting tumor angiogenesis inside the body. VEGF is a key protein required for progression of tumor from benign to malignant phenotype. In this study, we investigated the binding affinity of a previously selected 26-mer DNA aptamer sequence (SL2-B) against heparin binding domain (HBD) of VEGF(165) protein. The SL2-B was first chemically modified by introduction of phosphorothioate linkages (PS-linkages). Subsequently, surface plasmon resonance (SPR) spectroscopy and circular dichroism (CD) were used to determine the binding affinity, specificity and to deduce the conformation of PS-modified SL2-B sequence. Finally, antiproliferative activity of the modified SL2-B sequence on Hep G2 cancer cells was investigated. Our results demonstrate a marked enhancement in the biostability of the SL2-B sequence after PS modification. The modified SL2-B sequence also exhibits enhanced antiproliferative activity against Hep G2 cancer cells in hypoxia conditions. In addition, modified SL2-B sequence inhibits the expression of Jagged-1 protein, which is one of the ligands to VEGF linked delta/jagged-notch signaling pathway.	[Kaur, Harleen; Li, Jasmine J.; Yung, Lin-Yue Lanry] Natl Univ Singapore, Fac Engn, Dept Chem & Biomol Engn, Singapore 117548, Singapore; [Li, Jasmine J.; Bay, Boon-Huat] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore	National University of Singapore; National University of Singapore	Yung, LYL (corresponding author), Natl Univ Singapore, Fac Engn, Dept Chem & Biomol Engn, Singapore 117548, Singapore.	cheyly@nus.edu.sg	Kaur, Harleen/AAJ-8789-2020; K, Harleen/T-2613-2019; Yung, Lanry/B-6515-2009	Yung, Lanry/0000-0001-7579-6347	Singapore Ministry of Education [MOE2008-T2-1-046, R279000282112]; NUS	Singapore Ministry of Education(Ministry of Education, Singapore); NUS(National University of Singapore)	This work was supported by research funding from the Singapore Ministry of Education Academic Research Fund Tier 2 grant MOE2008-T2-1-046 and Tier 1 grant R279000282112. The authors also appreciated the doctoral scholarship (for H.K.) from NUS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAWAL S, 1995, CLIN PHARMACOKINET, V28, P7, DOI 10.2165/00003088-199528010-00002; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Baselga J, 2010, J CLIN ONCOL, V28, P1138, DOI 10.1200/JCO.2009.24.2024; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Boomer RM, 2005, OLIGONUCLEOTIDES, V15, P183, DOI 10.1089/oli.2005.15.183; BROWN LF, 1992, J EXP MED, V176, P1375, DOI 10.1084/jem.176.5.1375; Burmeister PE, 2005, CHEM BIOL, V12, P25, DOI 10.1016/j.chembiol.2004.10.017; Calvani M, 2008, CANCER RES, V68, P285, DOI 10.1158/0008-5472.CAN-07-5564; Costa RB, 2010, ANN ONCOL, V21, P2153, DOI 10.1093/annonc/mdq096; DESMIDT PC, 1991, NUCLEIC ACIDS RES, V19, P4695, DOI 10.1093/nar/19.17.4695; EATON BE, 1995, CHEM BIOL, V2, P633, DOI 10.1016/1074-5521(95)90023-3; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fan F, 2005, ONCOGENE, V24, P2647, DOI 10.1038/sj.onc.1208246; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Frampton JE, 2010, DRUGS, V70, P1987, DOI 10.2165/11205010-000000000-00000; Gao J, 2007, BIOCHEM BIOPH RES CO, V356, P341, DOI 10.1016/j.bbrc.2007.02.130; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Itakura J, 2000, INT J CANCER, V85, P27; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; [姜昕 JIANG Xin], 2007, [中南大学学报. 医学版, Journal of Central South University. Medical Sciences], V32, P1031; Kang J, 2008, BIOORG MED CHEM LETT, V18, P1835, DOI 10.1016/j.bmcl.2008.02.023; Kaur H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031196; KAWASAKI AM, 1993, J MED CHEM, V36, P831, DOI 10.1021/jm00059a007; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Leighl NB, 2010, J THORAC ONCOL, V5, P1970, DOI 10.1097/JTO.0b013e3181f49c22; Lin Y, 1996, NUCLEIC ACIDS RES, V24, P3407, DOI 10.1093/nar/24.17.3407; Los M, 2007, ONCOLOGIST, V12, P443, DOI 10.1634/theoncologist.12-4-443; Masood R, 2001, BLOOD, V98, P1904, DOI 10.1182/blood.V98.6.1904; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Oswald J, 2007, CANCER LETT, V254, P102, DOI 10.1016/j.canlet.2007.02.016; Price DJ, 2001, CELL GROWTH DIFFER, V12, P129; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Robinson CJ, 2001, J CELL SCI, V114, P853; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Santagata S, 2004, CANCER RES, V64, P6854, DOI 10.1158/0008-5472.CAN-04-2500; Sayyed SG, 2009, DIABETOLOGIA, V52, P2445, DOI 10.1007/s00125-009-1493-6; Strizzi L, 2001, J PATHOL, V193, P468, DOI 10.1002/path.824; Suzuki H, 1999, AM J PHYSIOL-GASTR L, V276, pG92, DOI 10.1152/ajpgi.1999.276.1.G92; Thiviyanathan V, 2007, BIOCHEM SOC T, V35, P50, DOI 10.1042/BST0350050; Thurston G, 2008, BRIT J CANCER, V99, P1204, DOI 10.1038/sj.bjc.6604484; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wang ZW, 2010, J CELL BIOCHEM, V109, P726, DOI 10.1002/jcb.22451; Wang ZW, 2008, ANTICANCER RES, V28, P3621; Wey JS, 2005, CANCER-AM CANCER SOC, V104, P427, DOI 10.1002/cncr.21145; Wong SF, 2005, CLIN THER, V27, P684, DOI 10.1016/j.clinthera.2005.06.003; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491	55	32	33	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e50964	10.1371/journal.pone.0050964	http://dx.doi.org/10.1371/journal.pone.0050964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341879	gold, Green Published, Green Submitted			2022-12-25	WOS:000313682700007
J	Gottlieb, A; Muller, HG; Massa, AN; Wanjugi, H; Deal, KR; You, FM; Xu, XY; Gu, YQ; Luo, MC; Anderson, OD; Chan, AP; Rabinowicz, P; Devos, KM; Dvorak, J				Gottlieb, Andrea; Mueller, Hans-Georg; Massa, Alicia N.; Wanjugi, Humphrey; Deal, Karin R.; You, Frank M.; Xu, Xiangyang; Gu, Yong Q.; Luo, Ming-Cheng; Anderson, Olin D.; Chan, Agnes P.; Rabinowicz, Pablo; Devos, Katrien M.; Dvorak, Jan			Insular Organization of Gene Space in Grass Genomes	PLOS ONE			English	Article							ORYZA-SATIVA; EVOLUTION; SEQUENCE; WHEAT; RECOMBINATION; ISLANDS; REGIONS; EXPANSION; LOCUS; ENDS	Wheat and maize genes were hypothesized to be clustered into islands but the hypothesis was not statistically tested. The hypothesis is statistically tested here in four grass species differing in genome size, Brachypodium distachyon, Oryza sativa, Sorghum bicolor, and Aegilops tauschii. Density functions obtained under a model where gene locations follow a homogeneous Poisson process and thus are not clustered are compared with a model-free situation quantified through a non-parametric density estimate. A simple homogeneous Poisson model for gene locations is not rejected for the small O. sativa and B. distachyon genomes, indicating that genes are distributed largely uniformly in those species, but is rejected for the larger S. bicolor and Ae. tauschii genomes, providing evidence for clustering of genes into islands. It is proposed to call the gene islands "gene insulae" to distinguish them from other types of gene clustering that have been proposed. An average S. bicolor and Ae. tauschii insula is estimated to contain 3.7 and 3.9 genes with an average intergenic distance within an insula of 2.1 and 16.5 kb, respectively. Inter-insular distances are greater than 8 and 81 kb and average 15.1 and 205 kb, in S. bicolor and Ae. tauschii, respectively. A greater gene density observed in the distal regions of the Ae. tauschii chromosomes is shown to be primarily caused by shortening of inter-insular distances. The comparison of the four grass genomes suggests that gene locations are largely a function of a homogeneous Poisson process in small genomes. Nonrandom insertions of LTR retroelements during genome expansion creates gene insulae, which become less dense and further apart with the increase in genome size. High concordance in relative lengths of orthologous intergenic distances among the investigated genomes including the maize genome suggests functional constraints on gene distribution in the grass genomes.	[Gottlieb, Andrea; Mueller, Hans-Georg] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA; [Massa, Alicia N.; Xu, Xiangyang; Devos, Katrien M.] Univ Georgia, Dept Plant Biol, Inst Plant Breeding Genet & Genom, Dept Crop & Soil Sci, Athens, GA 30602 USA; [Wanjugi, Humphrey; Gu, Yong Q.; Anderson, Olin D.] ARS, USDA, Western Res Ctr, Albany, CA USA; [Deal, Karin R.; You, Frank M.; Luo, Ming-Cheng; Dvorak, Jan] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Chan, Agnes P.] J Craig Venter Inst, Rockville, MD USA; [Rabinowicz, Pablo] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Rabinowicz, Pablo] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University of California System; University of California Davis; University System of Georgia; University of Georgia; United States Department of Agriculture (USDA); University of California System; University of California Davis; J. Craig Venter Institute; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Dvorak, J (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	jdvorak@ucdavis.edu	Devos, Katrien M/B-1380-2014; Luo, Ming-Cheng/C-5600-2011	Luo, Ming-Cheng/0000-0002-9744-5887	National Science Foundation [DBI-0077766, DBI-0638558]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation Plant Genome Research Program Cooperative Agreements DBI-0077766 and DBI-0638558. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Bennetzen JL, 2002, GENETICA, V115, P29, DOI 10.1023/A:1016015913350; Bennetzen JL, 1997, PLANT CELL, V9, P1509, DOI 10.1105/tpc.9.9.1509; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Cox D., 1980, POINT PROCESSES; Devos KM, 2002, GENOME RES, V12, P1075, DOI 10.1101/gr.132102; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Dvorak J, 2005, GENETICS, V171, P323, DOI 10.1534/genetics.105.041632; Erayman M, 2004, NUCLEIC ACIDS RES, V32, P3546, DOI 10.1093/nar/gkh639; Fan J., 1996, LOCAL POLYNOMIAL MOD; Feuillet C, 1999, P NATL ACAD SCI USA, V96, P8265, DOI 10.1073/pnas.96.14.8265; GILL KS, 1993, CHROMOSOMA, V102, P374, DOI 10.1007/BF00360401; Kendall MG, 1945, BIOMETRIKA, V33, P239, DOI 10.2307/2332303; KIHARA H, 1944, AGR HORTIC, V19, P889, DOI DOI 10.1016/J.JGG.2011.07.002; Kronmiller BA, 2009, PLANT PHYSIOL, V151, P483, DOI 10.1104/pp.109.143370; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Li WL, 2004, PLANT J, V40, P500, DOI 10.1111/j.1365-313X.2004.02228.x; Lou XL, 2009, GENE, V437, P71, DOI 10.1016/j.gene.2009.02.012; Luo MC, 2012, P NATL ACAD SC UNPUB; Massa AN, 2011, MOL BIOL EVOL, V28, P2537, DOI 10.1093/molbev/msr080; MCFADDEN ES, 1946, J HERED, V37, P81, DOI 10.1093/oxfordjournals.jhered.a105590; Nelson W, 2005, GENOME RES, V15, P1284, DOI 10.1101/gr.3869505; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Rustenholz C, 2011, PLANT PHYSIOL, V157, P1596, DOI 10.1104/pp.111.183921; Sandhu D, 2002, PLANT PHYSIOL, V128, P803, DOI 10.1104/pp.010745; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; See DR, 2006, P NATL ACAD SCI USA, V103, P4162, DOI 10.1073/pnas.0508942102; Silverman B.W., 1986, DENSITY ESTIMATION S; Wei FS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000728; Wicker T, 2005, PLANT J, V41, P184, DOI 10.1111/j.1365-313X.2004.02285.x; Williams EJB, 2004, GENOME RES, V14, P1060, DOI 10.1101/gr.2131104; Xu ZY, 2008, GENOMICS, V92, P173, DOI 10.1016/j.ygeno.2008.05.010; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang Z, 2011, COMPUT STAT DATA AN, V55, P2234, DOI 10.1016/j.csda.2011.01.007	38	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54101	10.1371/journal.pone.0054101	http://dx.doi.org/10.1371/journal.pone.0054101			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326580	Green Published, gold, Green Submitted			2022-12-25	WOS:000314705800107
J	Kregel, S; Kiriluk, KJ; Rosen, AM; Cai, Y; Reyes, EE; Otto, KB; Tom, W; Paner, GP; Szmulewitz, RZ; Vander Griend, DJ				Kregel, Steven; Kiriluk, Kyle J.; Rosen, Alex M.; Cai, Yi; Reyes, Edwin E.; Otto, Kristen B.; Tom, Westin; Paner, Gladell P.; Szmulewitz, Russell Z.; Vander Griend, Donald J.			Sox2 Is an Androgen Receptor-Repressed Gene That Promotes Castration-Resistant Prostate Cancer	PLOS ONE			English	Article							STEM-LIKE CELLS; IN-VITRO; SELF-RENEWAL; NANOG; GROWTH; DIFFERENTIATION; EXPRESSION; IDENTIFICATION; CARCINOMA; MECHANISM	Despite advances in detection and therapy, castration-resistant prostate cancer continues to be a major clinical problem. The aberrant activity of stem cell pathways, and their regulation by the Androgen Receptor (AR), has the potential to provide insight into novel mechanisms and pathways to prevent and treat advanced, castrate-resistant prostate cancers. To this end, we investigated the role of the embryonic stem cell regulator Sox2 [SRY (sex determining region Y)-box 2] in normal and malignant prostate epithelial cells. In the normal prostate, Sox2 is expressed in a portion of basal epithelial cells. Prostate tumors were either Sox2-positive or Sox2-negative, with the percentage of Sox2-positive tumors increasing with Gleason Score and metastases. In the castration-resistant prostate cancer cell line CWR-R1, endogenous expression of Sox2 was repressed by AR signaling, and AR chromatin-IP shows that AR binds the enhancer element within the Sox2 promoter. Likewise, in normal prostate epithelial cells and human embryonic stem cells, increased AR signaling also decreases Sox2 expression. Resistance to the anti-androgen MDV3100 results in a marked increase in Sox2 expression within three prostate cancer cell lines, and in the castration-sensitive LAPC-4 prostate cancer cell line ectopic expression of Sox2 was sufficient to promote castration-resistant tumor formation. Loss of Sox2 expression in the castration-resistant CWR-R1 prostate cancer cell line inhibited cell growth. Up-regulation of Sox2 was not associated with increased CD133 expression but was associated with increased FGF5 (Fibroblast Growth Factor 5) expression. These data propose a model of elevated Sox2 expression due to loss of AR-mediated repression during castration, and consequent castration-resistance via mechanisms not involving induction of canonical embryonic stem cell pathways.	[Kregel, Steven; Vander Griend, Donald J.] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA; [Reyes, Edwin E.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Paner, Gladell P.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Szmulewitz, Russell Z.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Kiriluk, Kyle J.; Rosen, Alex M.; Cai, Yi; Otto, Kristen B.; Tom, Westin; Vander Griend, Donald J.] Univ Chicago, Dept Surg, Urol Sect, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Vander Griend, DJ (corresponding author), Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA.	prostate@uchicago.edu	Tom, Westin/ABC-9183-2020; Griend, Donald J Vander/H-7532-2019	Griend, Donald J Vander/0000-0003-4421-5698; Tom, Westin/0000-0001-7788-2070	University of Chicago Department of Surgery; Section of Urology; University of Chicago Comprehensive Cancer Center (UCCCC); National Cancer Institute (NCI) SPORE in Prostate Cancer at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University [P50 CA090386]; Cancer Research Center of the University of Chicago; American Cancer Society (ACS-IRG) [IRG-58-004]; Cancer Center Support Grant [P30 CA14599]; Brinson Foundation; Alvin Baum Family Fund; University of Chicago Cancer Research Foundation Women's Board; HHMI: Med-into-Grad Fellowship [56006772]; Cancer Biology Training Grant [T32-CA09594]; Immunology Training Grant [AI07090-31]; University Of Chicago Section Of Urology; University of Chicago Comprehensive Cancer Center (wUCCCC); NATIONAL CANCER INSTITUTE [P30CA014599, T32CA009594, P50CA090386] Funding Source: NIH RePORTER	University of Chicago Department of Surgery; Section of Urology; University of Chicago Comprehensive Cancer Center (UCCCC); National Cancer Institute (NCI) SPORE in Prostate Cancer at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Cancer Research Center of the University of Chicago; American Cancer Society (ACS-IRG)(American Cancer Society); Cancer Center Support Grant; Brinson Foundation; Alvin Baum Family Fund; University of Chicago Cancer Research Foundation Women's Board; HHMI: Med-into-Grad Fellowship; Cancer Biology Training Grant; Immunology Training Grant; University Of Chicago Section Of Urology; University of Chicago Comprehensive Cancer Center (wUCCCC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this work was generously provided by: The University of Chicago Department of Surgery, the Section of Urology; the University of Chicago Comprehensive Cancer Center (UCCCC); a Pilot Award from the National Cancer Institute (NCI) P50 CA090386 SPORE in Prostate Cancer at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Cancer Research Center of the University of Chicago; an American Cancer Society Institutional Research Grant (ACS-IRG, #IRG-58-004); a Cancer Center Support Grant (P30 CA14599); The Brinson Foundation; the Alvin Baum Family Fund; and The University of Chicago Cancer Research Foundation Women's Board. S. Kregel is supported by an HHMI: Med-into-Grad Fellowship (56006772) and a Cancer Biology Training Grant (T32-CA09594); E. Reyes is supported by an Immunology Training Grant (AI07090-31). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to acknowledge the support of the University Of Chicago Section Of Urology led by Dr. Arieh Shalhav, and the Director of Urologic Research Dr. Carrie Rinker-Schaeffer. We would also like to acknowledge the support of the University of Chicago Comprehensive Cancer Center (wUCCCC) led by Dr. Michelle Le Beau. We also with to thank expert technical assistance of the Human Tissue Resource Center core facility led by Dr. Mark Lingen, and the assistance of Leslie Martin and Mary Jo Fekete. We also thank the Immunohistochemistry Core Facility run by Terri Li, the Functional Genomics Core facility run by Dr. Pieter W. Faber, and the Clinical Chemistry Lab run by Jerry Yeo and managed by Christine Lee. We also wish to thank Dr. Karen Kaul and Dr. Robin Leikin of the Prostate Cancer SPORE of Northshore University and Northwestern University, respectively. Finally, we wish to thank Dr. John Isaacs at Johns Hopkins for generously providing many of the cancer cell lines used.	Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen JL, 2012, CLIN CANCER RES, V18, P4291, DOI 10.1158/1078-0432.CCR-12-0373; Chen LY, 2008, HUM MOL GENET, V17, pR23, DOI 10.1093/hmg/ddn050; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen Y, 2009, LANCET ONCOL, V10, P981, DOI 10.1016/S1470-2045(09)70229-3; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Christophersen NS, 2010, J EXP MED, V207, P2287, DOI 10.1084/jem.20101438; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; D'Antonio JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011475; Denmeade SR, 2003, PROSTATE, V56, P45, DOI 10.1002/pros.10213; Denmeade SR, 2003, PROSTATE, V54, P249, DOI 10.1002/pros.10199; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Gao J, 2001, CANCER RES, V61, P5038; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Gou DM, 2007, J GENE MED, V9, P751, DOI 10.1002/jgm.1080; Griend DJV, 2008, CANCER RES, V68, P9703, DOI 10.1158/0008-5472.CAN-08-3084; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Guzman-Ramirez N, 2009, PROSTATE, V69, P1683, DOI 10.1002/pros.21018; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang PZ, 2011, CLIN BIOCHEM, V44, P582, DOI 10.1016/j.clinbiochem.2011.02.012; Huggins C, 1941, ARCH SURG-CHICAGO, V43, P209, DOI 10.1001/archsurg.1941.01210140043004; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Isaacs JT, 2008, PROSTATE, V68, P1025, DOI 10.1002/pros.20763; Isaacs JT, 2004, NAT MED, V10, P26, DOI 10.1038/nm0104-26; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Jia XP, 2011, J MOL CELL BIOL, V3, P230, DOI 10.1093/jmcb/mjr002; Karoubi Golnaz, 2009, Interact Cardiovasc Thorac Surg, V8, P393, DOI 10.1510/icvts.2008.193995; Kim JH, 2011, GENOME RES, V21, P1028, DOI 10.1101/gr.119347.110; Lin BY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006589; Ling MT, 2001, J ENDOCRINOL, V170, P287, DOI 10.1677/joe.0.1700287; Litvinov IV, 2006, CANCER RES, V66, P8598, DOI 10.1158/0008-5472.CAN-06-1228; Liu T, 2010, MOL CELL BIOCHEM, V340, P265, DOI 10.1007/s11010-010-0426-5; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maier S, 2011, HUM PATHOL, V42, P1078, DOI 10.1016/j.humpath.2010.11.010; Markert EK, 2011, P NATL ACAD SCI USA, V108, P21276, DOI 10.1073/pnas.1117029108; Rizzino A, 2009, WIRES SYST BIOL MED, V1, P228, DOI 10.1002/wsbm.12; Rodriguez-Pinilla SM, 2007, MODERN PATHOL, V20, P474, DOI 10.1038/modpathol.3800760; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Singh P, 2006, ENDOCR-RELAT CANCER, V13, P653, DOI 10.1677/erc.1.00797; Stolzenburg S, 2012, NUCLEIC ACIDS RES, V40, P6725, DOI 10.1093/nar/gks360; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tepper CG, 2002, CANCER RES, V62, P6606; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Ugolkov AV, 2011, PROSTATE, V71, P18, DOI 10.1002/pros.21217; Urbanucci A, 2012, ONCOGENE, V31, P2153, DOI 10.1038/onc.2011.401; Uzgare AR, 2004, J CELL BIOCHEM, V91, P196, DOI 10.1002/jcb.10764; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; Vander Griend DJ, 2010, PROSTATE, V70, P90, DOI 10.1002/pros.21043; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Whitacre DC, 2002, CELL GROWTH DIFFER, V13, P1; Wilbertz T, 2011, MODERN PATHOL, V24, P944, DOI 10.1038/modpathol.2011.49; Wu TT, 1998, INT J CANCER, V77, P887, DOI 10.1002/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z; Ye F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-108; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Yuan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009112; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	66	105	110	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53701	10.1371/journal.pone.0053701	http://dx.doi.org/10.1371/journal.pone.0053701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326489	gold, Green Published, Green Submitted			2022-12-25	WOS:000314705800071
J	Simoens, VL; Tervaniemi, M				Simoens, Veerle L.; Tervaniemi, Mari			Auditory Short-Term Memory Activation during Score Reading	PLOS ONE			English	Article							EYE-HAND SPAN; WORKING-MEMORY; IMAGERY; REPRESENTATION; INTERFERENCE; EXPECTANCY; POTENTIALS; PERCEPTION; RESPONSES; COMPONENT	Performing music on the basis of reading a score requires reading ahead of what is being played in order to anticipate the necessary actions to produce the notes. Score reading thus not only involves the decoding of a visual score and the comparison to the auditory feedback, but also short-term storage of the musical information due to the delay of the auditory feedback during reading ahead. This study investigates the mechanisms of encoding of musical information in short-term memory during such a complicated procedure. There were three parts in this study. First, professional musicians participated in an electroencephalographic (EEG) experiment to study the slow wave potentials during a time interval of short-term memory storage in a situation that requires cross-modal translation and short-term storage of visual material to be compared with delayed auditory material, as it is the case in music score reading. This delayed visual-to-auditory matching task was compared with delayed visual-visual and auditory-auditory matching tasks in terms of EEG topography and voltage amplitudes. Second, an additional behavioural experiment was performed to determine which type of distractor would be the most interfering with the score reading-like task. Third, the self-reported strategies of the participants were also analyzed. All three parts of this study point towards the same conclusion according to which during music score reading, the musician most likely first translates the visual score into an auditory cue, probably starting around 700 or 1300 ms, ready for storage and delayed comparison with the auditory feedback.	[Simoens, Veerle L.; Tervaniemi, Mari] Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland; [Simoens, Veerle L.; Tervaniemi, Mari] Univ Jyvaskyla, Dept Mus, Finnish Ctr Excellence Interdisciplinary Mus Res, Jyvaskyla, Finland; [Tervaniemi, Mari] Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland	University of Helsinki; University of Jyvaskyla; University of Jyvaskyla	Tervaniemi, M (corresponding author), Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland.	veerle.simoens@helsinki.fi	Campailla, Jasmin/AAK-2420-2021	Tervaniemi, Mari/0000-0002-9651-2929	Academy of Finland; Finnish Work Environment Fund [106055]; Signe & Ane Gyllenberg Foundation	Academy of Finland(Academy of Finland); Finnish Work Environment Fund; Signe & Ane Gyllenberg Foundation	This research was funded by the Academy of Finland, Finnish Work Environment Fund [106055] and the Signe & Ane Gyllenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Birbaumer N, 1999, NEUROSCIENTIST, V5, P74, DOI 10.1177/107385849900500211; Bittrich K, 2012, BRAIN RES, V1432, P84, DOI 10.1016/j.brainres.2011.11.011; Brodsky W, 2003, PERCEPT PSYCHOPHYS, V65, P602, DOI 10.3758/BF03194586; Brodsky W, 2008, J EXP PSYCHOL HUMAN, V34, P427, DOI 10.1037/0096-1523.34.2.427; BROPHY AL, 1986, BEHAV RES METH INSTR, V18, P285, DOI 10.3758/BF03204400; Caspers H, 1980, Prog Brain Res, V54, P3, DOI 10.1016/S0079-6123(08)61603-9; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DEUTSCH D, 1970, SCIENCE, V168, P1604, DOI 10.1126/science.168.3939.1604; Furneaux S, 1999, P ROY SOC B-BIOL SCI, V266, P2435, DOI 10.1098/rspb.1999.0943; Gilman E, 2003, VIS COGN, V10, P201, DOI [10.1080/713756679, 10.1080/13506280244000104]; Gordon E., 1975, LEARNING THEORY PATT; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; HAUTUS MJ, 1995, BEHAV RES METH INS C, V27, P46, DOI 10.3758/BF03203619; Highben Z, 2004, B COUN RES MUSIC ED, P58; Hubbard TL, 2010, PSYCHOL BULL, V136, P302, DOI 10.1037/a0018436; Huijbers W, 2011, NEUROPSYCHOLOGIA, V49, P1730, DOI 10.1016/j.neuropsychologia.2011.02.051; Kalakoski V, 2007, SCAND J PSYCHOL, V48, P87, DOI 10.1111/j.1467-9450.2007.00535.x; Kislyuk DS, 2008, J COGNITIVE NEUROSCI, V20, P2175, DOI 10.1162/jocn.2008.20152; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; LANG W, 1992, ELECTROEN CLIN NEURO, V82, P285, DOI 10.1016/0013-4694(92)90108-T; Larsen A, 2003, PERCEPT PSYCHOPHYS, V65, P568, DOI 10.3758/BF03194583; Lindstrom R, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00159; Lloyd-Jones TJ, 2005, TRENDS EXPT PSYCHOL, P111; Paulesu E, 2000, NAT NEUROSCI, V3, P91, DOI 10.1038/71163; PECHMANN T, 1992, MEM COGNITION, V20, P314, DOI 10.3758/BF03199668; Platel H, 1997, BRAIN, V120, P229, DOI 10.1093/brain/120.2.229; Ponton CW, 1997, EVOKED POTENTIAL, V104, P143, DOI 10.1016/S0168-5597(97)96104-9; Rockstroh B., 1989, SLOW CORTICAL POTENT; RUCHKIN DS, 1995, PSYCHOPHYSIOLOGY, V32, P399, DOI 10.1111/j.1469-8986.1995.tb01223.x; RUCHKIN DS, 1990, ELECTROEN CLIN NEURO, V76, P419, DOI 10.1016/0013-4694(90)90096-3; Schon D, 2005, J COGNITIVE NEUROSCI, V17, P694, DOI 10.1162/0898929053467532; Schon D, 2003, ANN NY ACAD SCI, V999, P193, DOI 10.1196/annals.1284.028; Schulze K, 2011, HUM BRAIN MAPP, V32, P771, DOI 10.1002/hbm.21060; Schurmann M, 2002, NEUROIMAGE, V16, P434, DOI 10.1006/nimg.2002.1098; SLOBODA JA, 1984, MUSIC PERCEPT, V2, P222; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Spironelli C, 2006, BEHAV BRAIN RES, V175, P296, DOI 10.1016/j.bbr.2006.08.038; Tervaniemi M, 2003, MUSIC SCI, V7, P241, DOI 10.1177/102986490300700203; Truitt FE, 1997, VIS COGN, V4, P143, DOI 10.1080/713756756; Verde MF, 2006, PERCEPT PSYCHOPHYS, V68, P643, DOI 10.3758/BF03208765; Widmann A, 2007, CEREB CORTEX, V17, P2696, DOI 10.1093/cercor/bhl178; Widmann A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00233; Wong YK, 2010, J COGNITIVE NEUROSCI, V22, P695, DOI 10.1162/jocn.2009.21229; Worsley KJ, 2004, NEUROIMAGE, V23, pS189, DOI 10.1016/j.neuroimage.2004.07.026; Wurtz P, 2009, EXP BRAIN RES, V194, P445, DOI 10.1007/s00221-009-1719-3; Yoo SS, 2001, NEUROREPORT, V12, P3045, DOI 10.1097/00001756-200110080-00013; Yumoto M, 2005, NEUROREPORT, V16, P1175, DOI 10.1097/00001756-200508010-00008; ZATORRE RJ, 1993, NEUROPSYCHOLOGIA, V31, P221, DOI 10.1016/0028-3932(93)90086-F	52	10	10	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53691	10.1371/journal.pone.0053691	http://dx.doi.org/10.1371/journal.pone.0053691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086RY	23326487	Green Published, gold, Green Submitted			2022-12-25	WOS:000314705800069
J	Davis, MI; Sasaki, AT; Shen, M; Emerling, BM; Thorne, N; Michael, S; Pragani, R; Boxer, M; Sumita, K; Takeuchi, K; Auld, DS; Li, ZY; Cantley, LC; Simeonov, A				Davis, Mindy I.; Sasaki, Atsuo T.; Shen, Min; Emerling, Brooke M.; Thorne, Natasha; Michael, Sam; Pragani, Rajan; Boxer, Matthew; Sumita, Kazutaka; Takeuchi, Koh; Auld, Douglas S.; Li, Zhuyin; Cantley, Lewis C.; Simeonov, Anton			A Homogeneous, High-Throughput Assay for Phosphatidylinositol 5-Phosphate 4-Kinase with a Novel, Rapid Substrate Preparation	PLOS ONE			English	Article							II-BETA; CHEMICAL LIBRARIES; PHOSPHATE KINASE; INHIBITORS; RECEPTOR; PI3K; BIOLUMINESCENT; PHOSPHORYLATION; LUCIFERASE; 3-KINASE	Phosphoinositide kinases regulate diverse cellular functions and are important targets for therapeutic development for diseases, such as diabetes and cancer. Preparation of the lipid substrate is crucial for the development of a robust and miniaturizable lipid kinase assay. Enzymatic assays for phosphoinositide kinases often use lipid substrates prepared from lyophilized lipid preparations by sonication, which result in variability in the liposome size from preparation to preparation. Herein, we report a homogeneous 1536-well luciferase-coupled bioluminescence assay for PI5P4K alpha. The substrate preparation is novel and allows the rapid production of a DMSO-containing substrate solution without the need for lengthy liposome preparation protocols, thus enabling the scale-up of this traditionally difficult type of assay. The Z'-factor value was greater than 0.7 for the PI5P4K alpha assay, indicating its suitability for high-throughput screening applications. Tyrphostin AG-82 had been identified as an inhibitor of PI5P4K alpha by assessing the degree of phospho transfer of gamma-P-32-ATP to PI5P; its inhibitory activity against PI5P4Ka was confirmed in the present miniaturized assay. From a pilot screen of a library of bioactive compounds, another tyrphostin, I-OMe tyrphostin AG-538 (I-OMe-AG-538), was identified as an ATP-competitive inhibitor of PI5P4K alpha with an IC50 of 1 mu M, affirming the suitability of the assay for inhibitor discovery campaigns. This homogeneous assay may apply to other lipid kinases and should help in the identification of leads for this class of enzymes by enabling high-throughput screening efforts.	[Davis, Mindy I.; Shen, Min; Thorne, Natasha; Michael, Sam; Pragani, Rajan; Boxer, Matthew; Auld, Douglas S.; Li, Zhuyin; Simeonov, Anton] NIH, Chem Genom Ctr, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Sasaki, Atsuo T.; Emerling, Brooke M.; Cantley, Lewis C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med,Sch Med, Div Signal Transduct,Dept Syst Biol, Boston, MA 02215 USA; [Sasaki, Atsuo T.; Sumita, Kazutaka] Univ Cincinnati, Coll Med, Dept Internal Med,Neurosci Inst, Div Hematol & Oncol,Brain Tumor Ctr, Cincinnati, OH USA; [Takeuchi, Koh] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo, Japan; [Auld, Douglas S.] Novartis Inst Biomed Res, Ctr Prote Chem, Cambridge, MA USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University System of Ohio; University of Cincinnati; National Institute of Advanced Industrial Science & Technology (AIST); Novartis	Simeonov, A (corresponding author), NIH, Chem Genom Ctr, Natl Ctr Adv Translat Sci, Rockville, MD USA.	asimeono@mail.nih.gov	Takeuchi, Koh/B-4971-2010; Sumita, Kazutaka/AAI-1553-2019; Cantley, Lewis C/D-1800-2014	Takeuchi, Koh/0000-0002-6227-4627; Cantley, Lewis C/0000-0002-1298-7653; Sasaki, Atsuo/0000-0003-2963-4501	Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research; National Institutes of Health [GM41890]; Grants-in-Aid for Scientific Research [23790064] Funding Source: KAKEN; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041890, R01GM041890] Funding Source: NIH RePORTER	Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by the Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research and by National Institutes of Health grant GM41890 (to LCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auld DS, 2008, J MED CHEM, V51, P2372, DOI 10.1021/jm701302v; Auld DS, 2009, J MED CHEM, V52, P1450, DOI 10.1021/jm8014525; Balla T, 2009, PHYSIOLOGY, V24, P231, DOI 10.1152/physiol.00014.2009; Blum G, 2000, BIOCHEMISTRY-US, V39, P15705, DOI 10.1021/bi001516y; Bultsma Y, 2010, BIOCHEM J, V430, P223, DOI 10.1042/BJ20100341; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Burden LM, 1999, BIOCHEMISTRY-US, V38, P15141, DOI 10.1021/bi991571a; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Demian DJ, 2009, J BIOMOL SCREEN, V14, P838, DOI 10.1177/1087057109339205; Eastwood BJ, 2006, J BIOMOL SCREEN, V11, P253, DOI 10.1177/1087057105285611; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Fuchikami K, 2002, J BIOMOL SCREEN, V7, P441, DOI 10.1177/108705702237676; Grainger DL, 2011, PFLUG ARCH EUR J PHY, V462, P723, DOI 10.1007/s00424-011-1008-4; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Knight ZA, 2007, BIOCHEM SOC T, V35, P245, DOI 10.1042/BST0350245; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Kouchi Z, 2011, BIOCHEM BIOPH RES CO, V408, P523, DOI 10.1016/j.bbrc.2011.04.045; Kovalenko M, 1997, BIOCHEMISTRY-US, V36, P6260, DOI 10.1021/bi962553l; Lamia KA, 2004, MOL CELL BIOL, V24, P5080, DOI 10.1128/MCB.24.11.5080-5087.2004; LING LE, 1989, J BIOL CHEM, V264, P5080; Lingaraj T, 2008, J BIOMOL SCREEN, V13, P906, DOI 10.1177/1087057108324498; McCrea HJ, 2009, PHYSIOLOGY, V24, P8, DOI 10.1152/physiol.00035.2008; Michael S, 2008, ASSAY DRUG DEV TECHN, V6, P637, DOI 10.1089/adt.2008.150; Morris JB, 2000, FEBS LETT, V475, P57, DOI 10.1016/S0014-5793(00)01625-2; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; POSNER I, 1994, MOL PHARMACOL, V45, P673; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; Sasaki AT, 2006, EUR J CELL BIOL, V85, P873, DOI 10.1016/j.ejcb.2006.04.007; Sasaki T, 2007, BIOL PHARM BULL, V30, P1599, DOI 10.1248/bpb.30.1599; Schulze H, 2006, BLOOD, V107, P3868, DOI 10.1182/blood-2005-07-2755; SERUNIAN LA, 1991, METHOD ENZYMOL, V198, P78; Strelow J., 2004, ASSAY GUIDANCE MANUA; Tanega C, 2009, ASSAY DRUG DEV TECHN, V7, P606, DOI 10.1089/adt.2009.0230; Thorne N, 2012, CHEM BIOL, V19, P1060, DOI 10.1016/j.chembiol.2012.07.015; Tolias KF, 1999, CHEM PHYS LIPIDS, V98, P69, DOI 10.1016/S0009-3084(99)00019-5; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vidugiriene J, 2009, ASSAY DRUG DEV TECHN, V7, P585, DOI 10.1089/adt.2009.0223; Workman P, 2010, CANCER RES, V70, P2146, DOI 10.1158/0008-5472.CAN-09-4355; Yasgar Adam, 2008, JALA Charlottesv Va, V13, P79, DOI 10.1016/j.jala.2007.12.004; Zegzouti H, 2009, ASSAY DRUG DEV TECHN, V7, P560, DOI 10.1089/adt.2009.0222	41	31	33	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54127	10.1371/journal.pone.0054127	http://dx.doi.org/10.1371/journal.pone.0054127			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326584	Green Submitted, Green Published, gold			2022-12-25	WOS:000313552400078
J	Kempster, RM; Hart, NS; Collin, SP				Kempster, Ryan M.; Hart, Nathan S.; Collin, Shaun P.			Survival of the Stillest: Predator Avoidance in Shark Embryos	PLOS ONE			English	Article							ELECTROSENSORY SYSTEM; RESPONSE PROPERTIES; ELECTRORECEPTION; SENSE	Sharks use highly sensitive electroreceptors to detect the electric fields emitted by potential prey. However, it is not known whether prey animals are able to modulate their own bioelectrical signals to reduce predation risk. Here, we show that some shark (Chiloscyllium punctatum) embryos can detect predator-mimicking electric fields and respond by ceasing their respiratory gill movements. Despite being confined to the small space within the egg case, where they are vulnerable to predators, embryonic sharks are able to recognise dangerous stimuli and react with an innate avoidance response. Knowledge of such behaviours, may inform the development of effective shark repellents.	[Kempster, Ryan M.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia	University of Western Australia; University of Western Australia	Kempster, RM (corresponding author), Univ Western Australia, Oceans Inst, Crawley, WA, Australia.	ryankempster@supportoursharks.com	Collin, Shaun/K-8827-2012; Kempster, Ryan M/A-4910-2011; Hart, Nathan S/B-8564-2011	Collin, Shaun/0000-0001-6236-0771; Hart, Nathan S/0000-0002-7289-9399	WA State Government; University of Western Australia	WA State Government; University of Western Australia	This work was supported by funding from the WA State Government and The University of Western Australia (to SPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLARD WW, 1993, J EXP ZOOL, V267, P318, DOI 10.1002/jez.1402670309; Bowers K, 2012, ZOOBIQUITY WHAT ANIM, P320; COX DL, 1993, ENVIRON BIOL FISH, V38, P117, DOI 10.1007/BF00842908; ESPMARK Y, 1985, J MAMMAL, V66, P702, DOI 10.2307/1380796; Fitzgerald TP, 2002, THESIS U HAWAII; Freitas R, 2006, EVOL DEV, V8, P74, DOI 10.1111/j.1525-142X.2006.05076.x; Harahush BK, 2007, J FISH BIOL, V71, P1007, DOI 10.1111/j.1095-8649.2007.01569.x; Honma A, 2006, P ROY SOC B-BIOL SCI, V273, P1631, DOI 10.1098/rspb.2006.3501; Huveneers C, 2012, SARDI RES REP SER, V632; Kajiura SM, 2002, J EXP BIOL, V205, P3609; Kajiura SM, 2009, ZOOLOGY, V112, P241, DOI 10.1016/j.zool.2008.07.001; Kalmijn A.J., 1988, P151; Kalmijn A.J., 1974, P147; KALMIJN AJ, 1971, J EXP BIOL, V55, P371; KALMIJN AJ, 1982, SCIENCE, V218, P916, DOI 10.1126/science.7134985; Kempster RM, 2012, J FISH BIOL, V80, P2055, DOI 10.1111/j.1095-8649.2011.03214.x; MOEN AN, 1978, CAN J ZOOL, V56, P1207, DOI 10.1139/z78-165; Montgomery JC, 2001, ENVIRON BIOL FISH, V60, P109, DOI 10.1023/A:1007679005704; PAULIN MG, 1995, J THEOR BIOL, V174, P325, DOI 10.1006/jtbi.1995.0102; PETERS RC, 1985, J EXP BIOL, V118, P99; Rivera-Vicente AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016008; Sisneros JA, 2002, J PHYSIOL-PARIS, V96, P379, DOI 10.1016/S0928-4257(03)00016-0; Sisneros JA, 2002, BRAIN BEHAV EVOLUT, V59, P130, DOI 10.1159/000064160; Sisneros JA, 1998, J COMP PHYSIOL A, V183, P87, DOI 10.1007/s003590050237; SMITH EN, 1981, COMP BIOCHEM PHYS A, V70, P529, DOI 10.1016/0300-9629(81)92565-2; Smith EN, 2006, PASSIVE FEAR ALTERNA, P112; TRICAS TC, 1982, COPEIA, P948, DOI 10.2307/1444104; Tricas TC, 1995, NEUROSCI LETT, V202, P129, DOI 10.1016/0304-3940(95)12230-3; Wueringer BE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041605	29	39	39	2	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52551	10.1371/journal.pone.0052551	http://dx.doi.org/10.1371/journal.pone.0052551			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326342	gold, Green Submitted, Green Published			2022-12-25	WOS:000313551500019
J	Tamarit, B; Bugault, F; Pillet, AH; Lavergne, V; Bochet, P; Garin, N; Schwarz, U; Theze, J; Rose, T				Tamarit, Blanche; Bugault, Florence; Pillet, Anne-Helene; Lavergne, Vincent; Bochet, Pascal; Garin, Nathalie; Schwarz, Ulf; Theze, Jacques; Rose, Thierry			Membrane Microdomains and Cytoskeleton Organization Shape and Regulate the IL-7 Receptor Signalosome in Human CD4 T-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; INTERLEUKIN-7; ACTIVATION; CYTOKINES; COMPLEX; CLONING; RAFT; EXPRESSION; MICROSCOPY; TRANSPORT	Interleukin (IL)-7 is the main homeostatic regulator of CD4 T-lymphocytes (helper) at both central and peripheral levels. Upon activation by IL-7, several signaling pathways, mainly JAK/STAT, PI3K/Akt and MAPK, induce the expression of genes involved in T-cell differentiation, activation, and proliferation. We have analyzed the early events of CD4 T-cell activation by IL-7. We have shown that IL-7 in the first few min induces the formation of cholesterol-enriched membrane microdomains that compartmentalize its activated receptor and initiate its anchoring to the cytoskeleton, supporting the formation of the signaling complex, the signalosome, on the IL-7 receptor cytoplasmic domains. Here we describe by stimulated emission depletion microscopy the key roles played by membrane microdomains and cytoskeleton transient organization in the IL-7-regulated JAK/STAT signaling pathway. We image phospho-STAT5 and cytoskeleton components along IL-7 activation kinetics using appropriate inhibitors. We show that lipid raft inhibitors delay and reduce IL-7-induced JAK1 and JAK3 phosphorylation. Drug-induced disassembly of the cytoskeleton inhibits phospho-STAT5 formation, transport, and translocation into the nucleus that controls the transcription of genes involved in T-cell activation and proliferation. We fit together the results of these quantitative analyses and propose the following mechanism. Activated IL-7 receptors embedded in membrane microdomains induce actin-microfilament meshwork formation, anchoring microtubules that grow radially from rafted receptors to the nuclear membrane. STAT5 phosphorylated by signalosomes are loaded on kinesins and glide along the microtubules across the cytoplasm to reach the nucleus 2 min after IL-7 stimulation. Radial microtubules disappear 15 min later, while transversal microtubules, independent of phospho-STAT5 transport, begin to bud from the microtubule organization center.	[Tamarit, Blanche; Bugault, Florence; Pillet, Anne-Helene; Lavergne, Vincent; Bochet, Pascal; Theze, Jacques; Rose, Thierry] Inst Pasteur, Dept Immunol, Dept Infect & Epidemiol, Unite Immunogenet Cellulaire, F-75724 Paris 15, France; [Tamarit, Blanche; Pillet, Anne-Helene] Univ Paris 06, Cellule Pasteur UPMC, F-75015 Paris, France; [Bochet, Pascal] CNRS, UMR3525, F-75015 Paris, France; [Garin, Nathalie] Leica Microsyst AG, CH-9435 Heerbrugg, Switzerland; [Schwarz, Ulf] Leica Microsyst CMS GmbH, D-68165 Mannheim, Germany	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Rose, T (corresponding author), Inst Pasteur, Dept Immunol, Dept Infect & Epidemiol, Unite Immunogenet Cellulaire, 25 Rue Dr Roux, F-75724 Paris 15, France.	rose@pasteur.fr		ROSE, Thierry/0000-0001-8863-0207	Institut Pasteur [PTR 424]; Ministere de l'Education Nationale et de la Recherche	Institut Pasteur(European Commission); Ministere de l'Education Nationale et de la Recherche	This work was supported in part by Institut Pasteur and its Transversal Research Program (PTR 424).; Supported by fellowships from the Ministere de l'Education Nationale et de la Recherche.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Alves NL, 2008, J IMMUNOL, V180, P5201, DOI 10.4049/jimmunol.180.8.5201; Cangiani A, 2010, J THEOR BIOL, V267, P614, DOI 10.1016/j.jtbi.2010.08.017; Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6; Colle JH, 2007, AIDS, V21, P101, DOI 10.1097/QAD.0b013e3280115b6a; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Fagerlund R, 2002, J BIOL CHEM, V277, P30072, DOI 10.1074/jbc.M202943200; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; GOODWIN RG, 1989, P NATL ACAD SCI USA, V86, P302, DOI 10.1073/pnas.86.1.302; Grecco HE, 2011, CELL, V144, P897, DOI 10.1016/j.cell.2011.01.029; He HT, 2011, ANNU REV PHYS CHEM, V62, P417, DOI 10.1146/annurev-physchem-032210-103402; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Jiang K, 2011, CURR OPIN CELL BIOL, V23, P94, DOI 10.1016/j.ceb.2010.08.008; Kitazawa H, 1997, J IMMUNOL, V159, P2259; Lasserre R, 2010, FEBS LETT, V584, P4845, DOI 10.1016/j.febslet.2010.09.001; Lasserre R, 2010, EMBO J, V29, P2301, DOI 10.1038/emboj.2010.127; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Leonard WJ, 1999, COLD SPRING HARB SYM, V64, P417, DOI 10.1101/sqb.1999.64.417; Lopez-Perez M, 2006, INT J BIOCHEM CELL B, V38, P1716, DOI 10.1016/j.biocel.2006.04.001; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; McElroy CA, 2012, P NATL ACAD SCI USA, V109, P2503, DOI 10.1073/pnas.1116582109; Melen K, 2001, J BIOL CHEM, V276, P16447, DOI 10.1074/jbc.M008821200; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659; Pillet AH, 2010, J MOL BIOL, V403, P671, DOI 10.1016/j.jmb.2010.08.056; Pillet AH, 2009, J IMMUNOL, V182, P6267, DOI 10.4049/jimmunol.0801933; Pillet AH, 2008, EUR CYTOKINE NETW, V19, P49, DOI 10.1684/ecn.2008.0120; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rose T, 2010, J BIOL CHEM, V285, P14898, DOI 10.1074/jbc.M110.104232; Rose T, 2009, J IMMUNOL, V182, P7389, DOI 10.4049/jimmunol.0900190; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Viola A, 2007, NAT REV IMMUNOL, V7, P889, DOI 10.1038/nri2193; Walsh STR, 2012, IMMUNOL REV, V250, P303, DOI 10.1111/j.1600-065X.2012.01160.x; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Willig KI, 2007, NAT METHODS, V4, P915, DOI 10.1038/NMETH1108; Zoubiane GS, 2004, J CELL SCI, V117, P271, DOI 10.1242/jcs.00855	37	22	22	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8691	8701		10.1074/jbc.M113.449918	http://dx.doi.org/10.1074/jbc.M113.449918			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23329834	hybrid, Green Published			2022-12-25	WOS:000316564500069
J	Peth, A; Kukushkin, N; Bosse, M; Goldberg, AL				Peth, Andreas; Kukushkin, Nikolay; Bosse, Marc; Goldberg, Alfred L.			Ubiquitinated Proteins Activate the Proteasomal ATPases by Binding to Usp14 or Uch37 Homologs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASE; 26S PROTEASOME; DEUBIQUITINATING ENZYME; DISTINCT ROLES; DEGRADATION; POLYUBIQUITIN; RECOGNITION; SUBUNIT; ARCHITECTURE; ASSOCIATION	Degradation of ubiquitinated proteins by 26 S proteasomes requires ATP hydrolysis, but it is unclear how the proteasomal ATPases are regulated and how proteolysis, substrate deubiquitination, degradation, and ATP hydrolysis are coordinated. Polyubiquitinated proteins were shown to stimulate ATP hydrolysis by purified proteasomes, but only if the proteins contain a loosely folded domain. If they were not ubiquitinated, such proteins did not increase ATPase activity. However, they did so upon addition of ubiquitin aldehyde, which mimics the ubiquitin chain and binds to 26 S-associated deubiquitinating enzymes (DUBs): in yeast to Ubp6, which is essential for the ATPase activation, and in mammalian 26 S to the Ubp6 homolog, Usp14, and Uch37. Occupancy of either DUB by a ubiquitin conjugate leads to ATPase stimulation, thereby coupling deubiquitination and ATP hydrolysis. Thus, ubiquitinated loosely folded proteins, after becoming bound to the 26 S, interact with Ubp6/Usp14 or Uch37 to activate ATP hydrolysis and enhance their own destruction.	[Peth, Andreas; Kukushkin, Nikolay; Goldberg, Alfred L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Bosse, Marc] Inbiomed, Gipuzkoa 20009, Spain	Harvard University; Harvard Medical School	Goldberg, AL (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	Alfred_goldberg@hms.harvard.edu	Bosse, Marc/AAM-8593-2021		National Institutes of Health/NIGMS [R01 GM051923-17]; Amyotropic Lateral Sclerosis Association [K2Y740]; Fidelity Biosciences Research Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER	National Institutes of Health/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Amyotropic Lateral Sclerosis Association; Fidelity Biosciences Research Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health/NIGMS (R01 GM051923-17), the Amyotropic Lateral Sclerosis Association (K2Y740), and the Fidelity Biosciences Research Initiative.	Bech-Otschir D, 2009, NAT STRUCT MOL BIOL, V16, P219, DOI 10.1038/nsmb.1547; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Beskow A, 2009, J MOL BIOL, V394, P732, DOI 10.1016/j.jmb.2009.09.050; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Chen X, 2010, MOL CELL, V38, P404, DOI 10.1016/j.molcel.2010.04.019; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; GOLDBERG AL, 1974, ANNU REV BIOCHEM, V43, P835, DOI 10.1146/annurev.bi.43.070174.004155; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Henderson A, 2011, J BIOL CHEM, V286, P17495, DOI 10.1074/jbc.M110.212027; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; HWANG BJ, 1988, J BIOL CHEM, V263, P8727; JOHNSTON JA, 1995, J BIOL CHEM, V270, P8172, DOI 10.1074/jbc.270.14.8172; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Koodathingal P, 2009, J BIOL CHEM, V284, P18674, DOI 10.1074/jbc.M900783200; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Li XH, 2009, BIOCHEM J, V421, P397, DOI 10.1042/BJ20090528; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Mizuguchi M, 1998, J MOL BIOL, V283, P265, DOI 10.1006/jmbi.1998.2100; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; TANAKA K, 1983, J CELL BIOL, V96, P1580, DOI 10.1083/jcb.96.6.1580; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; WAXMAN L, 1986, SCIENCE, V232, P500, DOI 10.1126/science.2938257; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460	39	79	79	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7781	7790		10.1074/jbc.M112.441907	http://dx.doi.org/10.1074/jbc.M112.441907			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23341450	Green Published, hybrid			2022-12-25	WOS:000316455300033
J	Sarell, CJ; Woods, LA; Su, YC; Debelouchina, GT; Ashcroft, AE; Griffin, RG; Stockley, PG; Radford, SE				Sarell, Claire J.; Woods, Lucy A.; Su, Yongchao; Debelouchina, Galia T.; Ashcroft, Alison E.; Griffin, Robert G.; Stockley, Peter G.; Radford, Sheena E.			Expanding the Repertoire of Amyloid Polymorphs by Co-polymerization of Related Protein Precursors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRIL FORMATION; A-BETA; BETA(2)-MICROGLOBULIN; BETA-2-MICROGLOBULIN; STATE; ALPHA; SPECTROSCOPY; SPECIFICITY; AGGREGATION; MECHANISMS	Amyloid fibrils can be generated from proteins with diverse sequences and folds. Although amyloid fibrils assembled in vitro commonly involve a single protein precursor, fibrils formed in vivo can contain more than one protein sequence. How fibril structure and stability differ in fibrils composed of single proteins (homopolymeric fibrils) from those generated by co-polymerization of more than one protein sequence (heteropolymeric fibrils) is poorly understood. Here we compare the structure and stability of homo and heteropolymeric fibrils formed from human beta(2)-microglobulin and its truncated variant Delta N6. We use an array of approaches (limited proteolysis, magic angle spinning NMR, Fourier transform infrared spectroscopy, and fluorescence) combined with measurements of thermodynamic stability to characterize the different fibril types. The results reveal fibrils with different structural properties, different side-chain packing, and strikingly different stabilities. These findings demonstrate how co-polymerization of related precursor sequences can expand the repertoire of structural and thermodynamic polymorphism in amyloid fibrils to an extent that is greater than that obtained by polymerization of a single precursor alone.	[Sarell, Claire J.; Woods, Lucy A.; Ashcroft, Alison E.; Stockley, Peter G.; Radford, Sheena E.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Sarell, Claire J.; Woods, Lucy A.; Ashcroft, Alison E.; Stockley, Peter G.; Radford, Sheena E.] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Su, Yongchao; Griffin, Robert G.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Su, Yongchao; Griffin, Robert G.] MIT, Francis Bitter Magnet Lab, Cambridge, MA 02139 USA; [Debelouchina, Galia T.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	University of Leeds; University of Leeds; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Princeton University	Radford, SE (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	s.e.radford@leeds.ac.uk	Su, Yongchao/B-6749-2009	Su, Yongchao/0000-0001-5063-3218; Stockley, Peter/0000-0002-1360-2751; Radford, Sheena/0000-0002-3079-8039	National Institutes of Health [EB003151, EB002026]; Medical Research Council [G0900958]; Wellcome Trust [075099/Z/04/Z]; NMR [094232]; Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom [BB/526502/1, BB/E012558/I]; MRC [G0900958] Funding Source: UKRI; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026, R01EB003151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NMR; Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants EB003151 and EB002026. This work was also supported by Medical Research Council Grant G0900958, the Wellcome Trust (grant code 075099/Z/04/Z (LCT Premier, mass spectrometry facility) and NMR (094232)), and the Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom (BB/526502/1) (BB/E012558/I, for the Synapt HDMS).	APPEL W, 1986, CLIN BIOCHEM, V19, P317, DOI 10.1016/S0009-9120(86)80002-9; Bellotti V, 1998, EUR J BIOCHEM, V258, P61, DOI 10.1046/j.1432-1327.1998.2580061.x; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Bennett AE, 1998, J CHEM PHYS, V108, P9463, DOI 10.1063/1.476420; BENNETT AE, 1992, J CHEM PHYS, V96, P8624, DOI 10.1063/1.462267; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; Chatani E, 2010, J MOL BIOL, V400, P1057, DOI 10.1016/j.jmb.2010.05.071; Debelouchina GT, 2010, J AM CHEM SOC, V132, P17077, DOI 10.1021/ja107987f; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Eichner T, 2011, MOL CELL, V41, P161, DOI 10.1016/j.molcel.2010.11.028; Eichner T, 2009, J MOL BIOL, V386, P1312, DOI 10.1016/j.jmb.2009.01.013; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; Fabian H, 2008, BIOCHEMISTRY-US, V47, P6895, DOI 10.1021/bi800279y; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Hodkinson JP, 2012, RAPID COMMUN MASS SP, V26, P1783, DOI 10.1002/rcm.6282; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Ichishima E., 1970, METHOD ENZYMOL, V19, P397; Iwadate M, 1999, J BIOMOL NMR, V13, P199, DOI 10.1023/A:1008376710086; Johan K, 1998, P NATL ACAD SCI USA, V95, P2558, DOI 10.1073/pnas.95.5.2558; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Krebs MRH, 2004, PROTEIN SCI, V13, P1933, DOI 10.1110/ps.04707004; Ladner CL, 2010, J BIOL CHEM, V285, P17137, DOI 10.1074/jbc.M110.117234; Lapko VN, 2000, J MASS SPECTROM, V35, P572, DOI 10.1002/(SICI)1096-9888(200004)35:4<572::AID-JMS971>3.0.CO;2-2; Lewandowski JR, 2011, J AM CHEM SOC, V133, P14686, DOI 10.1021/ja203736z; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; Ma B, 2003, PROTEIN ENG, V16, P561, DOI 10.1093/protein/gzg079; Ma BY, 2012, J MOL BIOL, V421, P172, DOI 10.1016/j.jmb.2011.11.023; MacPhee CE, 2000, J AM CHEM SOC, V122, P12707, DOI 10.1021/ja0029580; Makarava N, 2009, J BIOL CHEM, V284, P14386, DOI 10.1074/jbc.M900533200; Myers SL, 2006, RAPID COMMUN MASS SP, V20, P1628, DOI 10.1002/rcm.2482; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; Nguyen PH, 2007, P NATL ACAD SCI USA, V104, P111, DOI 10.1073/pnas.0607440104; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Plattt GW, 2005, J MOL BIOL, V346, P279, DOI 10.1016/j.jmb.2004.11.035; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rahimi F., 2012, NONFIBRILLAR AMYLOID, P377; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Shammas SL, 2011, BIOPHYS J, V100, P2783, DOI 10.1016/j.bpj.2011.04.039; Surmacz-Chwedoruk W, 2012, BIOCHEMISTRY-US, V51, P9460, DOI 10.1021/bi301144d; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; Wasmer C, 2009, J MOL BIOL, V394, P119, DOI 10.1016/j.jmb.2009.09.015; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; White HE, 2009, J MOL BIOL, V389, P48, DOI 10.1016/j.jmb.2009.03.066; Woods LA, 2011, NAT CHEM BIOL, V7, P730, DOI [10.1038/nchembio.635, 10.1038/NCHEMBIO.635]; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Yamaguchi KI, 2004, J MOL BIOL, V338, P559, DOI 10.1016/j.jmb.2004.02.067; Yan LM, 2007, ANGEW CHEM INT EDIT, V46, P1246, DOI 10.1002/anie.200604056; Yanagi K, 2012, J MOL BIOL, V422, P390, DOI 10.1016/j.jmb.2012.05.034	61	32	32	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7327	7337		10.1074/jbc.M112.447524	http://dx.doi.org/10.1074/jbc.M112.447524			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23329840	Green Published, hybrid			2022-12-25	WOS:000316002400052
J	Maas, AE; Blanco-Bercial, L; Lawson, GL				Maas, Amy E.; Blanco-Bercial, Leocadio; Lawson, Gareth L.			Reexamination of the Species Assignment of Diacavolinia Pteropods Using DNA Barcoding	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; LIMACINA-HELICINA; OCEAN ACIDIFICATION; MAXIMUM-LIKELIHOOD; METABOLIC-RESPONSE; SOUTHERN-OCEAN; GASTROPODA; MOLLUSCA; IMPACT; ZOOPLANKTON	Thecosome pteropods (Mollusca, Gastropoda) are an ecologically important, diverse, and ubiquitous group of holoplanktonic animals that are the focus of intense research interest due to their external aragonite shell and vulnerability to ocean acidification. Characterizing the response of these animals to low pH and other environmental stressors has been hampered by continued uncertainty in their taxonomic identification. An example of this confusion in species assignment is found in the genus Diacavolinia. All members of this genus were originally indentified as a single species, Cavolinia longirostris, but over the past fifty years the taxonomy has been revisited multiple times; currently the genus comprises 22 different species. This study examines five species of Diacavolinia, including four sampled in the Northeast Atlantic (78 individuals) and one from the Eastern tropical North Pacific (15 individuals). Diacavolina were identified to species based on morphological characteristics according to the current taxonomy, photographed, and then used to determine the sequence of the "DNA barcoding'' region of the cytochrome c oxidase subunit I (COI). Specimens from the Atlantic, despite distinct differences in shell morphology, showed polyphyly and a genetic divergence of <3% (K2P distance) whereas the Pacific and Atlantic samples were more distant (similar to 19%). Comparisons of Diacavolinia spp. with other Cavolinia spp. reveal larger distances (similar to 24%). These results indicate that specimens from the Atlantic comprise a single monophyletic species and suggest possible species-level divergence between Atlantic and Pacific populations. The findings support the maintenance of Diacavolinia as a separate genus, yet emphasize the inadequacy of our current taxonomic understanding of pteropods. They highlight the need for accurate species identifications to support estimates of biodiversity, range extent and natural exposure of these planktonic calcifiers to environmental variability; furthermore, the apparent variation of the pteropods shell may have implications for our understanding of the species' sensitivity to ocean acidification.	[Maas, Amy E.; Lawson, Gareth L.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Blanco-Bercial, Leocadio] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	Woods Hole Oceanographic Institution; University of Connecticut	Maas, AE (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	amaas@whoi.edu	Maas, Amy/AAC-1181-2022; Blanco-Bercial, Leocadio/G-5441-2013; Blanco-Bercial, Leocadio/N-4061-2019	Maas, Amy/0000-0002-3730-2876; Blanco-Bercial, Leocadio/0000-0003-0658-7183; Blanco-Bercial, Leocadio/0000-0003-0658-7183	National Science Foundation [OCE-0928801]; WHOI Postdoctoral Scholarship; Census of Marine Life/Alfred P. Sloan Foundation; College of Liberal Arts AMP; Sciences, University of Connecticut; Division Of Ocean Sciences [1041068] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); WHOI Postdoctoral Scholarship; Census of Marine Life/Alfred P. Sloan Foundation; College of Liberal Arts AMP; Sciences, University of Connecticut; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This material is based upon work supported by the National Science Foundation under Grant Number OCE-0928801. AEM was funded through the WHOI Postdoctoral Scholarship. Support to LBB was provided by the College of Liberal Arts & Sciences, University of Connecticut; and by the Census of Marine Life/Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JL, 2005, DEEP-SEA RES PT II, V52, P247, DOI 10.1016/j.dsr2.2004.09.019; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Babior BM, 2002, ANTIOXID REDOX SIGN, V4, P35, DOI 10.1089/152308602753625834; Bandel K, 1995, MAR BIOL, V124, P225, DOI 10.1007/BF00347127; Bauerfeind E, 2009, DEEP-SEA RES PT I, V56, P1471, DOI 10.1016/j.dsr.2009.04.011; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Bernard KS, 2009, DEEP-SEA RES PT I, V56, P582, DOI 10.1016/j.dsr.2008.11.007; Bernard KS, 2012, DEEP-SEA RES PT I, V62, P111, DOI 10.1016/j.dsr.2011.12.015; Blanco-Bercial L, 2011, J EXP MAR BIOL ECOL, V404, P108, DOI 10.1016/j.jembe.2011.05.011; Bonferroni C., 1936, PUBBL R 1 SUPER SCI, V8, P3; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Comeau S, 2010, MAR BIOL, V157, P2341, DOI 10.1007/s00227-010-1493-6; Comeau S, 2009, BIOGEOSCIENCES, V6, P1877, DOI 10.5194/bg-6-1877-2009; Comeau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011362; da Silva JM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028233, 10.1371/journal.pone.0019449]; de Blainville H, 1821, DICT SCI NATURELLES, V22, P1; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Eberl R, 2007, AQUAT BIOL, V1, P33, DOI 10.3354/ab00002; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Falk-Petersen S, 2001, POLAR BIOL, V24, P163, DOI 10.1007/s003000000190; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FOSTER BA, 1987, POLAR BIOL, V8, P49, DOI 10.1007/BF00297164; GILMER RW, 1991, MAR ECOL PROG SER, V77, P125, DOI 10.3354/meps077125; GILMER RW, 1974, J EXP MAR BIOL ECOL, V15, P127, DOI 10.1016/0022-0981(74)90039-2; Goetze E, 2003, P ROY SOC B-BIOL SCI, V270, P2321, DOI 10.1098/rspb.2003.2505; Goetze E, 2010, MOL ECOL, V19, P952, DOI 10.1111/j.1365-294X.2009.04520.x; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; HEBERT PDN, 2003, P R SOC LOND B, V270, P313, DOI DOI 10.1098/rspb.2002.2218; Hedgecock D, 2011, B MAR SCI, V87, P971, DOI 10.5343/bms.2010.1051; Honjo S, 2004, ANTARCT SCI, V16, P501, DOI 10.1017/S0954102004002287; Hunt BPV, 2008, PROG OCEANOGR, V78, P193, DOI 10.1016/j.pocean.2008.06.001; Hunt Brian, 2010, PLoS ONE, V5, P1, DOI 10.1371/journal.pone.0009835; Jennings RM, 2010, DEEP-SEA RES PT II, V57, P2199, DOI 10.1016/j.dsr2.2010.09.022; Karnovsky NJ, 2008, MARINE ECOLOGY PROGR, V357, P99; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klussmann-Kolb A, 2006, J ZOOL SYST EVOL RES, V44, P118, DOI 10.1111/j.1439-0469.2006.00351.x; Koehler Frank, 2007, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Zoologische Reihe, V83, P44, DOI 10.1002/mmnz.200600025; Lalli C.M., 1989, PELAGIC SNAILS BIOL; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lischka S, 2011, BIOGEOSCIENCES, V8, P919, DOI 10.5194/bg-8-919-2011; Lohbeck KT, 2012, NAT GEOSCI, V5, P346, DOI [10.1038/NGEO1441, 10.1038/ngeo1441]; Maas AE, 2012, BIOGEOSCIENCES, V9, P747, DOI 10.5194/bg-9-747-2012; Maas AE, MARINE BIOL IN PRESS; Maas AE, 2011, MAR ECOL PROG SER, V441, P129, DOI 10.3354/meps09358; Manno C, 2010, J PLANKTON RES, V32, P145, DOI 10.1093/plankt/fbp108; McGowan JA, 1960, SYSTEMATICS DISTRIBU; Merritt TJS, 1998, MOL MAR BIOL BIOTECH, V7, P7; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Miyamoto H, 2010, DEEP-SEA RES PT II, V57, P2211, DOI 10.1016/j.dsr2.2010.09.023; Newman LJ, 1990, HOLOPLANKTONIC MOLLU; Noji TT, 1997, J PLANKTON RES, V19, P863, DOI 10.1093/plankt/19.7.863; Ott M, 2007, P 2007 ACM IEEE C SU, DOI DOI 10.1145/1362622.1362628; Pakhomov EA, 2002, MAR ECOL PROG SER, V233, P73, DOI 10.3354/meps233073; Paulmier A, 2011, BIOGEOSCIENCES, V8, P239, DOI 10.5194/bg-8-239-2011; Remigio EA, 2003, MOL PHYLOGENET EVOL, V29, P641, DOI 10.1016/S1055-7903(03)00140-4; Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x; Seibel BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030464; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sunday JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022881; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tesch JJ, 1946, THECOSOMATOUS PTEROP; Tesch JJ, 1948, THECOSOMATOUS PTEROP; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; Umbach AL, 2006, BBA-BIOENERGETICS, V1757, P135, DOI 10.1016/j.bbabio.2005.12.005; van der Spoel S., 1970, Basteria, V34, P103; van der Spoel S., 1987, Bulletin Zoologisch Museum Universiteit van Amsterdam, V11, P77; van der Spoel S., 1973, Bulletin Zool Mus Univ Amsterdam, V3, P99; van der Spoel S, 1968, BEAUFORTIA BULL ZOOL, P16; van der Spoel S, 1971, BEAUFORTIA, V19, P1; van der Spoel Siebrecht, 1999, P649; VANDERSPOEL S, 1993, BIJDR DIERKD, V62, P127, DOI 10.1163/26660644-06203001; WIEBE PH, 1985, MAR BIOL, V87, P313, DOI 10.1007/BF00397811; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Zhang AB, 2010, MOL PHYLOGENET EVOL, V54, P1035, DOI 10.1016/j.ympev.2009.09.014; Zhang H, 2002, APPL ENVIRON MICROB, V68, P989, DOI 10.1128/AEM.68.2.989-994.2002	79	20	24	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53889	10.1371/journal.pone.0053889	http://dx.doi.org/10.1371/journal.pone.0053889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335979	gold, Green Published			2022-12-25	WOS:000314707700037
J	Moayed, F; Mashaghi, A; Tans, SJ				Moayed, Fatemeh; Mashaghi, Alireza; Tans, Sander J.			A Polypeptide-DNA Hybrid with Selective Linking Capability Applied to Single Molecule Nano-Mechanical Measurements Using Optical Tweezers	PLOS ONE			English	Article							STREP-TAG; FORCE SPECTROSCOPY; AFFINITY PEPTIDE; PROTEIN; BIOTIN; STREPTAVIDIN; IMMOBILIZATION; TRANSLOCATION; PURIFICATION; DIGOXIGENIN	Many applications in biosensing, biomaterial engineering and single molecule biophysics require multiple non-covalent linkages between DNA, protein molecules, and surfaces that are specific yet strong. Here, we present a novel method to join proteins and dsDNA molecule at their ends, in an efficient, rapid and specific manner, based on the recently developed linkage between the protein StrepTactin (STN) and the peptide StrepTag II (ST). We introduce a two-step approach, in which we first construct a hybrid between DNA and a tandem of two STs peptides (tST). In a second step, this hybrid is linked to polystyrene bead surfaces and Maltose Binding Protein (MBP) using STN. Furthermore, we show the STN-tST linkage is more stable against forces applied by optical tweezers than the commonly used biotin-Streptavidin (STV) linkage. It can be used in conjunction with Neutravidin (NTV)-biotin linkages to form DNA tethers that can sustain applied forces above 65 pN for tens of minutes in a quarter of the cases. The method is general and can be applied to construct other surface-DNA and protein-DNA hybrids. The reversibility, high mechanical stability and specificity provided by this linking procedure make it highly suitable for single molecule mechanical studies, as well as biosensing and lab on chip applications.	[Moayed, Fatemeh; Mashaghi, Alireza; Tans, Sander J.] AMOLF Inst, Amsterdam, Netherlands; [Moayed, Fatemeh; Mashaghi, Alireza; Tans, Sander J.] Delft Univ Technol, Fac Sci Appl, Kavli Inst Nanosci, Dept Bionanosci, Delft, Netherlands	AMOLF; Delft University of Technology	Mashaghi, A (corresponding author), AMOLF Inst, Amsterdam, Netherlands.	mashaghi@amolf.nl; tans@amolf.nl	Tans, Sander/AAS-2901-2020; Mashaghi, Alireza/Q-8218-2017	Mashaghi, Alireza/0000-0002-2157-1211	Foundation for Fundamental Research on Matter (FOM), part of the Netherlands Organisation for Scientific Research (NWO)	Foundation for Fundamental Research on Matter (FOM), part of the Netherlands Organisation for Scientific Research (NWO)	This work was supported by the research programme of the Foundation for Fundamental Research on Matter (FOM), which is part of the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina I, 1997, NUCLEIC ACIDS RES, V25, P2657, DOI 10.1093/nar/25.13.2657; Barhoumi A, 2009, CHEM PHYS LETT, V482, P171, DOI 10.1016/j.cplett.2009.09.076; Bechtluft P, 2007, SCIENCE, V318, P1458, DOI 10.1126/science.1144972; Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826; Busby M, 2010, BIOPHYS CHEM, V152, P170, DOI 10.1016/j.bpc.2010.09.005; Cecconi C, 2008, EUR BIOPHYS J BIOPHY, V37, P729, DOI 10.1007/s00249-007-0247-y; Cecconi C, 2011, METHODS MOL BIOL, V749, P255, DOI 10.1007/978-1-61779-142-0_18; Chevalier J, 1997, J HISTOCHEM CYTOCHEM, V45, P481, DOI 10.1177/002215549704500401; Chivers CE, 2010, NAT METHODS, V7, P391, DOI [10.1038/nmeth.1450, 10.1038/NMETH.1450]; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Fuller DN, 2006, NUCLEIC ACIDS RES, V34, P1; GRAY JI, 1978, J AM OIL CHEM SOC, V55, P539, DOI 10.1007/BF02668066; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Gunnarsson A, 2009, NUCLEIC ACIDS RES, V37, P1; Holmberg A, 2005, ELECTROPHORESIS, V26, P501, DOI 10.1002/elps.200410070; Hout M, 2008, NUCLEIC ACIDS RES, V36, P1; Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059; Kim M, 2012, ANGEW CHEM-GER EDIT, V124, P1939; Kufer SK, 2005, EUR BIOPHYS J BIOPHY, V35, P72, DOI 10.1007/s00249-005-0010-1; Langereis S, 2004, ORG BIOMOL CHEM, V2, P1271, DOI 10.1039/b402917h; Leunissen ME, 2009, NAT MATER, V8, P590, DOI [10.1038/nmat2471, 10.1038/NMAT2471]; Lin CX, 2007, ANGEW CHEM INT EDIT, V46, P6089, DOI 10.1002/anie.200701767; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; Marie Aubin Tam E, 2011, CELL, V145, P257; Marttila AT, 2000, FEBS LETT, V467, P31, DOI 10.1016/S0014-5793(00)01119-4; Mashaghi A, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3658825; Maye MM, 2010, NAT NANOTECHNOL, V5, P116, DOI [10.1038/NNANO.2009.378, 10.1038/nnano.2009.378]; Medintz IL, 2006, CURR OPIN BIOTECH, V17, P17, DOI 10.1016/j.copbio.2006.01.002; Neuert G, 2006, FEBS LETT, V580, P505, DOI 10.1016/j.febslet.2005.12.052; Patolsky F, 2004, NAT MATER, V3, P692, DOI 10.1038/nmat1205; Schmidt TGM, 1996, J MOL BIOL, V255, P753, DOI 10.1006/jmbi.1996.0061; SCHMIDT TGM, 1993, PROTEIN ENG, V6, P109, DOI 10.1093/protein/6.1.109; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Tang JL, 2008, NANO LETT, V8, P4312, DOI 10.1021/nl802092c; Valignat MP, 2005, P NATL ACAD SCI USA, V102, P4225, DOI 10.1073/pnas.0500507102; van den Broek B, 2005, NUCLEIC ACIDS RES, V33, P2676, DOI 10.1093/nar/gki565; van Mameren J, 2008, NUCLEIC ACIDS RES, V36, P4381, DOI 10.1093/nar/gkn412; Waner MJ, 2004, BIOPHYS J, V87, P2701, DOI 10.1529/biophysj.104.047266; WICKNER W, 1991, ANNU REV BIOCHEM, V60, P101, DOI 10.1146/annurev.bi.60.070191.000533; Wong LS, 2009, CHEM REV, V109, P4025, DOI 10.1021/cr8004668	40	11	11	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54440	10.1371/journal.pone.0054440	http://dx.doi.org/10.1371/journal.pone.0054440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23336001	Green Submitted, Green Published, gold			2022-12-25	WOS:000314707700059
J	Tani, Y; Araki, K; Nagai, T; Koida, K; Nakauchi, S; Kitazaki, M				Tani, Yusuke; Araki, Keisuke; Nagai, Takehiro; Koida, Kowa; Nakauchi, Shigeki; Kitazaki, Michiteru			Enhancement of Glossiness Perception by Retinal-Image Motion: Additional Effect of Head-Yoked Motion Parallax	PLOS ONE			English	Article							SURFACE; COLOR; SHAPE; DISPARITY; ILLUMINATION; REFLECTANCE; INFORMATION; STATISTICS; HIGHLIGHTS; CUE	It has been argued that when an observer moves, a contingent retinal-image motion of a stimulus would strengthen the perceived glossiness. This would be attributed to the veridical perception of three-dimensional structure by motion parallax. However, it has not been investigated whether the effect of motion parallax is more than that of retinal-image motion of the stimulus. Using a magnitude estimation method, we examine in this paper whether cross-modal coordination of the stimulus change and the observer's motion (i.e., motion parallax) is essential or the retinal-image motion alone is sufficient for enhancing the perceived glossiness. Our data show that a retinal-image motion simulating motion parallax without head motion strengthened the perceived glossiness but that its effect was weaker than that of motion parallax with head motion. These results suggest the existence of an additional effect of the cross-modal coordination between vision and proprioception on glossiness perception. That is, motion parallax enhances the perception of glossiness, in addition to retinal-image motions of specular surfaces.	[Tani, Yusuke; Araki, Keisuke; Nagai, Takehiro; Koida, Kowa; Nakauchi, Shigeki; Kitazaki, Michiteru] Toyohashi Univ Technol, Dept Comp Sci & Engn, Toyohashi, Aichi, Japan	Toyohashi University of Technology	Tani, Y (corresponding author), Toyohashi Univ Technol, Dept Comp Sci & Engn, Toyohashi, Aichi, Japan.	tani@vpac.cs.tut.ac.jp	Kitazaki, Mitchiteru/AAI-6554-2020	Kitazaki, Mitchiteru/0000-0003-0966-4842; Nakauchi, Shigeki/0000-0002-4954-6915; Koida, Kowa/0000-0003-0156-3406; Nagai, Takehiro/0000-0002-1619-9654	 [22135005]; Grants-in-Aid for Scientific Research [22135001] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grant-in-Aid for Scientific Research on Innovative Areas (for SN, #22135005; http://www.jsps.go.jp/english/e-grants/grants01.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BL, 2009, J VISION, V9, DOI 10.1167/9.11.10; BECK J, 1981, PERCEPT PSYCHOPHYS, V30, P407, DOI 10.3758/BF03206160; Berzhanskaya J, 2005, PERCEPTION, V34, P565, DOI 10.1068/p5401; BLAKE A, 1990, NATURE, V343, P165, DOI 10.1038/343165a0; BRAJE WL, 1994, INVEST OPHTH VIS SCI, V35, P1628; Debevec P., 1998, Computer Graphics. Proceedings. SIGGRAPH 98 Conference Proceedings, P189, DOI 10.1145/280814.280864; Doerschner K, 2011, CURR BIOL, V21, P2010, DOI 10.1016/j.cub.2011.10.036; Fleming RW, 2004, J VISION, V4, P798, DOI 10.1167/4.9.10; Gerhard HE, 2010, J VISION, V10, DOI 10.1167/10.9.14; GILCHRIST AL, 1977, SCIENCE, V195, P185, DOI 10.1126/science.831266; Hartung B., 2002, JOURNAL, V2, P551, DOI DOI 10.1167/2.7.551; Ho YX, 2008, PSYCHOL SCI, V19, P196, DOI 10.1111/j.1467-9280.2008.02067.x; Homberg U, 2011, PHILOS T R SOC B, V366, P680, DOI 10.1098/rstb.2010.0199; Hurlbert A., 1991, INVEST OPHTHALMOL  S, V32, P105; Khang BG, 2007, PERCEPTION, V36, P1191, DOI 10.1068/p5807; Kim J, 2012, NAT NEUROSC IN PRESS; Kim J, 2011, J VISION, V11, DOI 10.1167/11.9.4; Kitazaki M, 1998, PERCEPTION, V27, P1153, DOI 10.1068/p271153; Kitazaki M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003177; KOENDERINK JJ, 1980, OPT ACTA, V27, P981, DOI 10.1080/713820338; Le Floch A, 2010, VISION RES, V50, P2048, DOI 10.1016/j.visres.2010.07.007; LEE HC, 1990, IEEE T PATTERN ANAL, V12, P402, DOI 10.1109/34.50626; Marlow P, 2011, J VISION, V11, DOI 10.1167/11.9.16; Marlow PJ, 2012, CURR BIOL, V22, P1909, DOI 10.1016/j.cub.2012.08.009; MINGOLLA E, 1986, BIOL CYBERN, V53, P137, DOI 10.1007/BF00342882; Motoyoshi I, 2007, NATURE, V447, P206, DOI 10.1038/nature05724; Motoyoshi I, 2010, J VISION, V10, DOI 10.1167/10.9.6; NAKAYAMA K, 1985, VISION RES, V25, P625, DOI 10.1016/0042-6989(85)90171-3; Nefs HT, 2006, ACTA PSYCHOL, V121, P297, DOI 10.1016/j.actpsy.2005.08.001; Nishida S, 1998, J OPT SOC AM A, V15, P2951, DOI 10.1364/JOSAA.15.002951; Nishio A, 2012, J NEUROSCI, V32, P10780, DOI 10.1523/JNEUROSCI.1095-12.2012; Obein G, 2004, J VISION, V4, P711, DOI 10.1167/4.9.4; Okazawa G, 2012, NEUROIMAGE, V63, P1321, DOI 10.1016/j.neuroimage.2012.07.052; Olkkonen M, 2010, J VISION, V10, DOI 10.1167/10.9.5; Oren M, 1997, INT J COMPUT VISION, V24, P105, DOI 10.1023/A:1007954719939; PHONG BT, 1975, COMMUN ACM, V18, P311, DOI 10.1145/360825.360839; Pont SC, 2006, PERCEPTION, V35, P1331, DOI 10.1068/p5440; Richards W., 1988, NATURAL COMPUTATION; ROGERS B, 1979, PERCEPTION, V8, P125, DOI 10.1068/p080125; Roth S., 2006, J VISION, V1, P1869, DOI [10.1167/3.9.413, DOI 10.1167/3.9.413]; Roth S., 2006, P IEEE COMP SOC C CO, V2, P1869; Sakano Y, 2010, J VISION, V10, DOI 10.1167/10.9.15; SHAFER SA, 1985, COLOR RES APPL, V10, P210, DOI 10.1002/col.5080100409; SHUTE CCD, 1978, VISION RES, V18, P1467, DOI 10.1016/0042-6989(78)90247-X; Vangorp P, 2007, ACM T GRAPHIC, V26, DOI [10.1145/1276377.1276473, 10.1145/1239451.1239528]; Wendt G, 2010, J VISION, V10, DOI 10.1167/10.9.7; Wendt G, 2008, J VISION, V8, DOI 10.1167/8.1.14; Wijntjes MWA, 2010, J VISION, V10, DOI 10.1167/10.9.13; Xiao B, 2008, VISUAL NEUROSCI, V25, P371, DOI 10.1017/S0952523808080267	49	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54549	10.1371/journal.pone.0054549	http://dx.doi.org/10.1371/journal.pone.0054549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086SQ	23336006	Green Published, Green Submitted, gold			2022-12-25	WOS:000314707700064
J	Amieva, H; Meillon, C; Helmer, C; Barberger-Gateau, P; Dartigues, JF				Amieva, Helene; Meillon, Celine; Helmer, Catherine; Barberger-Gateau, Pascale; Dartigues, Jean Francois			Ginkgo Biloba Extract and Long-Term Cognitive Decline: A 20-Year Follow-Up Population-Based Study	PLOS ONE			English	Article							PRECLINICAL ALZHEIMERS-DISEASE; PLACEBO-CONTROLLED TRIAL; EGB 761(R); BENZODIAZEPINE USE; RANDOMIZED-TRIAL; VITAMIN-E; DEMENTIA; PREVENTION; SUPPLEMENTATION; IMPAIRMENT	Background: Numerous studies have looked at the potential benefits of various nootropic drugs such as Ginkgo biloba extract (EGb761 (R); Tanakan (R)) and piracetam (Nootropyl (R)) on age-related cognitive decline often leading to inconclusive results due to small sample sizes or insufficient follow-up duration. The present study assesses the association between intake of EGb761 (R) and cognitive function of elderly adults over a 20-year period. Methods and Findings: The data were gathered from the prospective community-based cohort study 'Paquid'. Within the study sample of 3612 non-demented participants aged 65 and over at baseline, three groups were compared: 589 subjects reporting use of EGb761 (R) at at least one of the ten assessment visits, 149 subjects reporting use of piracetam at one of the assessment visits and 2874 subjects not reporting use of either EGb761 (R) or piracetam. Decline on MMSE, verbal fluency and visual memory over the 20-year follow-up was analysed with a multivariate mixed linear effects model. A significant difference in MMSE decline over the 20-year follow-up was observed in the EGb761 (R) and piracetam treatment groups compared to the 'neither treatment' group. These effects were in opposite directions: the EGb761 (R) group declined less rapidly than the 'neither treatment' group, whereas the piracetam group declined more rapidly (beta = -0.6). Regarding verbal fluency and visual memory, no difference was observed between the EGb761 (R) group and the 'neither treatment' group (respectively, beta = 0.21 and beta = -0.03), whereas the piracetam group declined more rapidly (respectively, beta = -1.40 and beta = -0.44). When comparing the EGb761 (R) and piracetam groups directly, a different decline was observed for the three tests (respectively beta = -1.07, beta = -1.61 and beta = -0.41). Conclusion: Cognitive decline in a non-demented elderly population was lower in subjects who reported using EGb761 (R) than in those who did not. This effect may be a specific medication effect of EGb761 (R), since it was not observed for another nootropic medication, piracetam.	[Amieva, Helene; Meillon, Celine; Helmer, Catherine; Barberger-Gateau, Pascale; Dartigues, Jean Francois] Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; [Amieva, Helene] Univ Bordeaux, Dept Psychol, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Amieva, H (corresponding author), Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France.	helene.amieva@isped.u-bordeaux2.fr	DARTIGUES, Jean François/T-4513-2019; HELMER, Catherine/AAG-5126-2021; HELMER, Catherine/I-6581-2015; Amieva, Helene/T-4170-2019; Meillon, Céline/T-4487-2019; Amieva, Helene/E-4850-2014	HELMER, Catherine/0000-0002-5169-7421; Amieva, Helene/0000-0002-0119-7242; 	ARMA (Bordeaux); Caisse Nationale d'Assurance Maladie des Travailleurs Salaries (CNAMTS); Conseil General de la Dordogne; Conseil General de la Gironde; Conseil Regional d'Aquitaine; Fondation de France; France Alzheimer (Paris); GIS Longevite; Institut National de la Sante et de la Recherche Medicale (INSERM); Mutuelle Generale de l'Education Nationale (MGEN); Mutualite Sociale Agricole (MSA); NOVARTIS Pharma (France); SCOR Insurance (France)	ARMA (Bordeaux); Caisse Nationale d'Assurance Maladie des Travailleurs Salaries (CNAMTS); Conseil General de la Dordogne(Region Nouvelle-Aquitaine); Conseil General de la Gironde(Region Nouvelle-Aquitaine); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Fondation de France(Fondation de France); France Alzheimer (Paris); GIS Longevite; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Mutuelle Generale de l'Education Nationale (MGEN); Mutualite Sociale Agricole (MSA); NOVARTIS Pharma (France); SCOR Insurance (France)	Funding: The PAQUID study was supported by ARMA (Bordeaux); Caisse Nationale d'Assurance Maladie des Travailleurs Salaries (CNAMTS); Conseil General de la Dordogne; Conseil General de la Gironde; Conseil Regional d'Aquitaine; Fondation de France; France Alzheimer (Paris); GIS Longevite; Institut National de la Sante et de la Recherche Medicale (INSERM); Mutuelle Generale de l'Education Nationale (MGEN); Mutualite Sociale Agricole (MSA); NOVARTIS Pharma (France); SCOR Insurance (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Kader R, 2007, PHARMACOL RES, V56, P493, DOI 10.1016/j.phrs.2007.09.011; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Amieva H, 2008, ANN NEUROL, V64, P492, DOI 10.1002/ana.21509; Andrieu S, 2003, J GERONTOL A-BIOL, V58, P372; Backman L, 2005, NEUROPSYCHOLOGY, V19, P520, DOI 10.1037/0894-4105.19.4.520; Benton A, 1965, MANUEL APPL TEST RET; Bierman EJM, 2007, INT J GERIATR PSYCH, V22, P1194, DOI 10.1002/gps.1811; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Chen PJ, 2001, ARCH GEN PSYCHIAT, V58, P853, DOI 10.1001/archpsyc.58.9.853; Cramer C, 2008, NEUROLOGY, V71, P344, DOI 10.1212/01.wnl.0000319647.15752.7b; Dartigues JF, 2007, J AM GERIATR SOC, V55, P395, DOI 10.1111/j.1532-5415.2007.01084.x; Dartigues JF, 1997, THERAPIE, V52, P503; DARTIGUES JF, 1992, NEUROEPIDEMIOLOGY, V11, P14, DOI 10.1159/000110955; DeKosky ST, 2008, JAMA-J AM MED ASSOC, V300, P2253, DOI 10.1001/jama.2008.683; Dodge HH, 2008, NEUROLOGY, V70, P1809, DOI 10.1212/01.wnl.0000303814.13509.db; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galasko DR, 2012, ARCH NEUROL; Grodstein F, 2007, ARCH INTERN MED, V167, P2184, DOI 10.1001/archinte.167.20.2184; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Herrschaft H, 2012, J PSYCHIATR RES, V46, P716, DOI 10.1016/j.jpsychires.2012.03.003; Howieson DB, 2008, J INT NEUROPSYCH SOC, V14, P192, DOI 10.1017/S1355617708080375; Ihl R, 2010, J NEUROL SCI, V299, P184, DOI 10.1016/j.jns.2010.08.033; ISAACS B, 1973, BRIT J PSYCHIAT, V123, P467, DOI 10.1192/bjp.123.4.467; Janssen IM, 2010, WIEN MED WOCHENSCHR, V160, P539, DOI 10.1007/s10354-010-0844-8; Jia X, 2008, J HUM NUTR DIET, V21, P317, DOI 10.1111/j.1365-277X.2008.00887.x; Kang JH, 2006, ARCH INTERN MED, V166, P2462, DOI 10.1001/archinte.166.22.2462; Kehr J, 2012, INT PSYCHOGERIATR, V24, pS25, DOI 10.1017/S1041610212000567; Kesse-Guyot E, 2011, AM J CLIN NUTR, V94, P892, DOI 10.3945/ajcn.110.007815; KOLTRINGER P, 1995, CLIN HEMORHEOL, V15, P649; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Leoutsakos JMS, 2012, INT J GERIATR PSYCH, V27, P364, DOI 10.1002/gps.2723; Luo Y, 2002, P NATL ACAD SCI USA, V99, P12197, DOI 10.1073/pnas.182425199; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meinert CL, 2008, ALZHEIMERS DEMENT, V4, pS7, DOI 10.1016/j.jalz.2007.10.007; Paterniti S, 2002, J CLIN PSYCHOPHARM, V22, P285, DOI 10.1097/00004714-200206000-00009; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rockwood K, 2002, ARCH NEUROL-CHICAGO, V59, P223, DOI 10.1001/archneur.59.2.223; Rosler M, 1998, J NEURAL TRANSM-SUPP, P211; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; Schneider Lon S., 2005, Current Alzheimer Research, V2, P541, DOI 10.2174/156720505774932287; Schneider LS, 2012, LANCET NEUROL, V11, P836, DOI 10.1016/S1474-4422(12)70212-0; Small BJ, 2007, CORTEX, V43, P826, DOI 10.1016/S0010-9452(08)70682-8; Tchantchou F, 2007, FASEB J, V21, P2400, DOI 10.1096/fj.06-7649com; Trompet S, 2010, J NEUROL, V257, P85, DOI 10.1007/s00415-009-5271-7; van Vliet P, 2009, EXP GERONTOL, V44, P112, DOI 10.1016/j.exger.2008.05.004; Vellas B, 2012, LANCET NEUROL, V11, P851, DOI 10.1016/S1474-4422(12)70206-5; Weinmann S, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-14; Williams B, 2004, NEUROBIOL AGING, V25, P955, DOI 10.1016/j.neurobiolaging.2003.10.008; Wolozin B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-20; Wu YJ, 2006, J NEUROSCI, V26, P13102, DOI 10.1523/JNEUROSCI.3448-06.2006; Yaffe K, 2004, NEUROLOGY, V63, P1705, DOI 10.1212/01.WNL.0000142969.19465.8F; Yoshitake T, 2010, BRIT J PHARMACOL, V159, P659, DOI 10.1111/j.1476-5381.2009.00580.x; Zandi PP, 2005, ARCH GEN PSYCHIAT, V62, P217, DOI 10.1001/archpsyc.62.2.217	55	48	59	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52755	10.1371/journal.pone.0052755	http://dx.doi.org/10.1371/journal.pone.0052755			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326356	Green Published, gold, Green Submitted			2022-12-25	WOS:000314705800024
J	Tominaga-Wada, R; Nukumizu, Y; Sato, S; Wada, T				Tominaga-Wada, Rumi; Nukumizu, Yuka; Sato, Shusei; Wada, Takuji			Control of Plant Trichome and Root-Hair Development by a Tomato (Solanum lycopersicum) R3 MYB Transcription Factor	PLOS ONE			English	Article							EPIDERMAL-CELL FATE; CONTROLS ENDOREDUPLICATION; SPECIALIZED METABOLITES; BHLH PROTEINS; GENE ENCODES; ARABIDOPSIS; EXPRESSION; CAPRICE; SPECIFY; TT8	In Arabidopsis thaliana the CPC-like MYB transcription factors [CAPRICE (CPC), TRIPTYCHON (TRY), ENHANCER OF TRY AND CPC 1, 2, 3/CPC-LIKE MYB 3 (ETC1, ETC2, ETC3/CPL3), TRICHOMELESS 1, 2/CPC-LIKE MYB 4 (TCL1, TCL2/CPL4)] and the bHLH transcription factors [GLABRA3 (GL3) and ENHANCER OF GLABRA 3 (EGL3)] are central regulators of trichome and root-hair development. We identified TRY and GL3 homologous genes from the tomato genome and named them SlTRY and SlGL3, respectively. Phylogenic analyses revealed a close relationship between the tomato and Arabidopsis genes. Real-time reverse transcription PCR analyses showed that SlTRY and SlGL3 were predominantly expressed in aerial parts of developing tomato. After transformation into Arabidopsis, CPC::SlTRY inhibited trichome formation and enhanced root-hair differentiation by strongly repressing GL2 expression. On the other hand, GL3:: SlGL3 transformation did not show any obvious effect on trichome or non-hair cell differentiation. These results suggest that tomato and Arabidopsis partially use similar transcription factors for epidermal cell differentiation, and that a CPC-like R3 MYB may be a key common regulator of plant trichome and root-hair development.	[Tominaga-Wada, Rumi; Nukumizu, Yuka; Wada, Takuji] Miyazaki Univ, Interdisciplinary Res Org, Miyazaki, Japan; [Sato, Shusei] Kazusa DNA Res Inst, Chiba, Japan	University of Miyazaki; Kazusa DNA Research Institute	Tominaga-Wada, R (corresponding author), Miyazaki Univ, Interdisciplinary Res Org, Miyazaki, Japan.	rtominaga@cc.miyazaki-u.ac.jp	Sato, Shusei/A-3616-2015	Sato, Shusei/0000-0002-0293-5366	Ministry of Education, Culture, Sports, Science and Technology; University of Miyazaki; Japan Society for the Promotion of Science [23570057]; Ministry of Education, Culture, Sports, Science and Technology [23012035]; Grants-in-Aid for Scientific Research [23570057] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Miyazaki; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by the program "Improvement of Research Environment for Young Researchers" from the Ministry of Education, Culture, Sports, Science and Technology, a grant for Scientific Research on Priority Areas from the University of Miyazaki, a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (No. 23570057) and a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology (No. 23012035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Baudry A, 2006, PLANT J, V46, P768, DOI 10.1111/j.1365-313X.2006.02733.x; BAUR R, 1991, OECOLOGIA, V87, P219, DOI 10.1007/BF00325259; Bernhardt C, 2005, DEVELOPMENT, V132, P291, DOI 10.1242/dev.01565; Bernhardt C, 2003, DEVELOPMENT, V130, P6431, DOI 10.1242/dev.00880; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Clowes FAL, 2000, NEW PHYTOL, V146, P83, DOI 10.1046/j.1469-8137.2000.00614.x; CORMACK RGH, 1947, AM J BOT, V34, P310, DOI 10.2307/2437142; CUTTER EG, 1972, J CELL SCI, V11, P723; Dolan L, 1996, ANN BOT-LONDON, V77, P547, DOI 10.1006/anbo.1996.0069; Dolan L, 2001, J EXP BOT, V52, P413, DOI 10.1093/jexbot/52.suppl_1.413; DOLAN L, 1993, DEVELOPMENT, V119, P71; Esch JJ, 2004, PLANT J, V40, P860, DOI 10.1111/j.1365-313X.2004.02259.x; Esch JJ, 2003, DEVELOPMENT, V130, P5885, DOI 10.1242/dev.00812; GALWAY ME, 1994, DEV BIOL, V166, P740, DOI 10.1006/dbio.1994.1352; Gan LJ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-176; Girardi CL, 2006, POSTHARVEST BIOL TEC, V42, P1, DOI 10.1016/j.postharvbio.2006.06.002; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; HULSKAMP M, 1994, CELL, V76, P555, DOI 10.1016/0092-8674(94)90118-X; Hulskamp M, 2000, ADV BOT RES, P37; Ishida T, 2007, PLANT CELL, V19, P2531, DOI 10.1105/tpc.107.052274; Kang JH, 2010, PLANT PHYSIOL, V154, P262, DOI 10.1104/pp.110.160192; Kang JH, 2010, J EXP BOT, V61, P1053, DOI 10.1093/jxb/erp370; Kim DW, 2006, PLANT CELL, V18, P2958, DOI 10.1105/tpc.106.045229; Kirik V, 2004, PLANT MOL BIOL, V55, P389, DOI 10.1007/s11103-004-0893-8; Kirik V, 2004, DEV BIOL, V268, P506, DOI 10.1016/j.ydbio.2003.12.037; Koshino-Kimura Y, 2005, PLANT CELL PHYSIOL, V46, P817, DOI 10.1093/pcp/pci096; Kurata T, 2005, DEVELOPMENT, V132, P5387, DOI 10.1242/dev.02139; Leavitt RG, 1904, P BOSTON SOC NATURAL, V31, P273; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Lee MM, 2001, DEVELOPMENT, V128, P1539; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luckwill LC, 1943, ABERD U STUD, V120, P1; Marks MD, 2003, EMBO REP, V4, P24, DOI 10.1038/sj.embor.embor705; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nesi N, 2000, PLANT CELL, V12, P1863, DOI 10.1105/tpc.12.10.1863; OKADA K, 1990, SCIENCE, V250, P274, DOI 10.1126/science.250.4978.274; Payne CT, 2000, GENETICS, V156, P1349; Pemberton LMS, 2001, ANN BOT-LONDON, V87, P649, DOI 10.1006/anbo.2001.1385; Pires N, 2010, PLANT SIGNAL BEHAV, V5, P911, DOI 10.4161/psb.5.7.12100; Pires N, 2010, MOL BIOL EVOL, V27, P862, DOI 10.1093/molbev/msp288; RERIE WG, 1994, GENE DEV, V8, P1388, DOI 10.1101/gad.8.12.1388; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schellmann S, 2002, EMBO J, V21, P5036, DOI 10.1093/emboj/cdf524; Schilmiller A, 2010, PLANT J, V62, P391, DOI 10.1111/j.1365-313X.2010.04154.x; Simon M, 2007, DEV BIOL, V311, P566, DOI 10.1016/j.ydbio.2007.09.001; Szymanski DB, 1998, DEVELOPMENT, V125, P1161; Tominaga R, 2008, DEVELOPMENT, V135, P1335, DOI 10.1242/dev.017947; Tominaga R, 2007, PLANT CELL, V19, P2264, DOI 10.1105/tpc.106.045732; Tominaga-Wada R, 2012, INT J MOL SCI, V13, P3478, DOI 10.3390/ijms13033478; Tominaga-Wada R, 2011, PLANT SCI, V181, P471, DOI 10.1016/j.plantsci.2011.07.006; Tominaga-Wada R, 2009, PLANT J, V60, P564, DOI 10.1111/j.1365-313X.2009.03976.x; Wada T, 1997, SCIENCE, V277, P1113, DOI 10.1126/science.277.5329.1113; Wada T, 2002, DEVELOPMENT, V129, P5409, DOI 10.1242/dev.00111; Wang SC, 2007, DEVELOPMENT, V134, P3873, DOI 10.1242/dev.009597; Werker E, 2000, ADV BOT RES, V31, P1, DOI 10.1016/S0065-2296(00)31005-9; Yoo SY, 2005, PLANTA, V221, P523, DOI 10.1007/s00425-004-1466-4; Yoshizumi T, 2006, PLANT CELL, V18, P2452, DOI 10.1105/tpc.106.043869; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681; Zhao HT, 2012, J BIOL CHEM, V287, P14109, DOI 10.1074/jbc.M111.280735; Zhao M, 2008, DEVELOPMENT, V135, P1991, DOI 10.1242/dev.016873; [No title captured]	62	56	63	4	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54019	10.1371/journal.pone.0054019	http://dx.doi.org/10.1371/journal.pone.0054019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326563	Green Published, gold, Green Submitted			2022-12-25	WOS:000314705800102
J	Wayama, M; Ota, S; Matsuura, H; Nango, N; Hirata, A; Kawano, S				Wayama, Marina; Ota, Shuhei; Matsuura, Hazuki; Nango, Nobuhito; Hirata, Aiko; Kawano, Shigeyuki			Three-Dimensional Ultrastructural Study of Oil and Astaxanthin Accumulation during Encystment Green Alga Haematococcus pluvialis	PLOS ONE			English	Article							CHLORELLA-ZOFINGIENSIS; SECONDARY CAROTENOIDS; HIGH-LIGHT; STRESS; BIOSYNTHESIS; VOLVOCALES	Haematococcus pluvialis is a freshwater species of green algae and is well known for its accumulation of the strong antioxidant astaxanthin, which is used in aquaculture, various pharmaceuticals, and cosmetics. High levels of astaxanthin are present in cysts, which rapidly accumulate when the environmental conditions become unfavorable for normal cell growth. It is not understood, however, how accumulation of high levels of astaxanthin, which is soluble in oil, becomes possible during encystment. Here, we performed ultrastructural 3D reconstruction based on over 350 serial sections per cell to visualize the dynamics of astaxanthin accumulation and subcellular changes during the encystment of H. pluvialis. This study showcases the marked changes in subcellular elements, such as chloroplast degeneration, in the transition from green coccoid cells to red cyst cells during encystment. In green coccoid cells, chloroplasts accounted for 41.7% of the total cell volume, whereas the relative volume of astaxanthin was very low (0.2%). In contrast, oil droplets containing astaxanthin predominated in cyst cells (52.2%), in which the total chloroplast volume was markedly decreased (9.7%). Volumetric observations also demonstrated that the relative volumes of the cell wall, starch grains, pyrenoids, mitochondria, the Golgi apparatus, and the nucleus in a cyst cell are smaller than those in green coccid cells. Our data indicated that chloroplasts are degraded, resulting in a net-like morphology, but do not completely disappear, even at the red cyst stage.	[Wayama, Marina; Ota, Shuhei; Matsuura, Hazuki; Hirata, Aiko; Kawano, Shigeyuki] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Ota, Shuhei; Kawano, Shigeyuki] JST CREST, Kashiwa, Chiba, Japan; [Nango, Nobuhito] Ratoc Syst Engn Co Ltd, Tokyo, Japan; [Hirata, Aiko] Univ Tokyo, Grad Sch Frontier Sci, Bioimaging Ctr, Kashiwa, Chiba, Japan	University of Tokyo; University of Tokyo	Kawano, S (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	kawano@k.u-tokyo.ac.jp	Ota, Shuhei/AAI-1557-2020	Ota, Shuhei/0000-0003-4349-3047	CREST from the Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [24657046, 22370024, 22570084] Funding Source: KAKEN	CREST from the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by CREST from the Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2009, Japanese Journal of Phycology, V57, P1; BAR E, 1995, J PLANT PHYSIOL, V146, P527, DOI 10.1016/S0176-1617(11)82019-5; Boussiba S, 2000, PHYSIOL PLANTARUM, V108, P111, DOI 10.1034/j.1399-3054.2000.108002111x./; Damiani MC, 2010, BIORESOURCE TECHNOL, V101, P3801, DOI 10.1016/j.biortech.2009.12.136; Collins AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024302; Del Campo JA, 2004, APPL MICROBIOL BIOT, V64, P848, DOI 10.1007/s00253-003-1510-5; FAN L, 1994, J PHYCOL, V30, P829, DOI 10.1111/j.0022-3646.1994.00829.x; Grunewald K, 2001, J BIOL CHEM, V276, P6023, DOI 10.1074/jbc.M006400200; Grunewald K, 2001, J APPL PHYCOL, V13, P89, DOI 10.1023/A:1008183328839; Guerin M, 2003, TRENDS BIOTECHNOL, V21, P210, DOI 10.1016/S0167-7799(03)00078-7; Hagen C, 2002, EUR J PHYCOL, V37, P217, DOI 10.1017/S0967026202003669; Kaczor A, 2011, ANALYST, V136, P1109, DOI 10.1039/c0an00553c; KAKIZONO T, 1992, J FERMENT BIOENG, V74, P403, DOI 10.1016/0922-338X(92)90041-R; Katagiri M, 2012, J CLIN BIOCHEM NUTR, V51, P102, DOI 10.3164/jcbn.D-11-00017; KOBAYASHI M, 1992, J FERMENT BIOENG, V74, P61, DOI 10.1016/0922-338X(92)90271-U; LANG NJ, 1968, J PHYCOL, V4, P12, DOI 10.1111/j.1529-8817.1968.tb04670.x; Lemoine Y, 2010, PHOTOSYNTH RES, V106, P155, DOI 10.1007/s11120-010-9583-3; Li Y, 2008, J PLANT PHYSIOL, V165, P1783, DOI 10.1016/j.jplph.2007.12.007; Li YT, 2010, J APPL PHYCOL, V22, P253, DOI 10.1007/s10811-009-9453-6; Li YT, 2009, J PHYCOL, V45, P635, DOI 10.1111/j.1529-8817.2009.00689.x; Margalith PZ, 1999, APPL MICROBIOL BIOT, V51, P431, DOI 10.1007/s002530051413; PALOZZA P, 1992, ARCH BIOCHEM BIOPHYS, V297, P291, DOI 10.1016/0003-9861(92)90675-M; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; RISE M, 1994, J PLANT PHYSIOL, V144, P287, DOI 10.1016/S0176-1617(11)81189-2; Sarada R, 2002, PROCESS BIOCHEM, V37, P623, DOI 10.1016/S0032-9592(01)00246-1; STOREBAKKEN T, 1987, AQUACULTURE, V65, P279, DOI 10.1016/0044-8486(87)90241-9; TJAHJONO AE, 1994, BIOTECHNOL LETT, V16, P133, DOI 10.1007/BF01021659; Tominaga K, 2012, ACTA BIOCHIM POL, V59, P43; Triki A, 1997, PHYCOLOGIA, V36, P190, DOI 10.2216/i0031-8884-36-3-190.1; Zhekisheva M, 2002, J PHYCOL, V38, P325, DOI 10.1046/j.1529-8817.2002.01107.x	30	115	123	3	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53618	10.1371/journal.pone.0053618	http://dx.doi.org/10.1371/journal.pone.0053618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326471	Green Published, gold, Green Submitted			2022-12-25	WOS:000314705800063
J	Chenevert, J; Pruliere, G; Ishii, H; Sardet, C; Nishikata, T				Chenevert, Janet; Pruliere, Gerard; Ishii, Hirokazu; Sardet, Christian; Nishikata, Takahito			Purification of Mitochondrial Proteins HSP60 and ATP Synthase from Ascidian Eggs: Implications for Antibody Specificity	PLOS ONE			English	Article							CHORDATE CIONA-INTESTINALIS; CENTROSOME-ATTRACTING BODY; MATERNAL MESSENGER-RNAS; HALOCYNTHIA-RORETZI; CORTICAL REORGANIZATIONS; MONOCLONAL-ANTIBODIES; EMBRYONIC-DEVELOPMENT; POSTPLASMIC/PEM RNAS; CYTOSKELETAL DOMAIN; MUSCLE DEVELOPMENT	Use of antibodies is a cornerstone of biological studies and it is important to identify the recognized protein with certainty. Generally an antibody is considered specific if it labels a single band of the expected size in the tissue of interest, or has a strong affinity for the antigen produced in a heterologous system. The identity of the antibody target protein is rarely confirmed by purification and sequencing, however in many cases this may be necessary. In this study we sought to characterize the myoplasm, a mitochondria-rich domain present in eggs and segregated into tadpole muscle cells of ascidians (urochordates). The targeted proteins of two antibodies that label the myoplasm were purified using both classic immunoaffinity methods and a novel protein purification scheme based on sequential ion exchange chromatography followed by two-dimensional gel electrophoresis. Surprisingly, mass spectrometry sequencing revealed that in both cases the proteins recognized are unrelated to the original antigens. NN18, a monoclonal antibody which was raised against porcine spinal cord and recognizes the NF-M neurofilament subunit in vertebrates, in fact labels mitochondrial ATP synthase in the ascidian embryo. PMF-C13, an antibody we raised to and purified against PmMRF, which is the MyoD homolog of the ascidian Phallusia mammillata, in fact recognizes mitochondrial HSP60. High resolution immunolabeling on whole embryos and isolated cortices demonstrates localization to the inner mitochondrial membrane for both ATP synthase and HSP60. We discuss the general implications of our results for antibody specificity and the verification methods which can be used to determine unequivocally an antibody's target.	[Chenevert, Janet; Pruliere, Gerard; Sardet, Christian] Univ Paris 06, Villefranche Sur Mer, France; [Chenevert, Janet; Pruliere, Gerard; Sardet, Christian] CNRS, Dev Biol Unit UMR7009, Villefranche Sur Mer, France; [Ishii, Hirokazu; Nishikata, Takahito] Konan Univ, FIRST, Kobe, Hyogo, Japan; [Nishikata, Takahito] Konan Univ, FIBER, Kobe, Hyogo, Japan	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Konan University; Konan University	Chenevert, J (corresponding author), Univ Paris 06, Villefranche Sur Mer, France.	chenevert@obs-vlfr.fr		Ishii, Hirokazu/0000-0001-8391-194X	French Foundations for Research on Muscle (AFM); Cancer (ARC); French National Research Agency (ANR); MEXT; Japan Science Society	French Foundations for Research on Muscle (AFM); Cancer (ARC); French National Research Agency (ANR)(French National Research Agency (ANR)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science Society	This work was funded by grants to CS from the French Foundations for Research on Muscle (AFM), and Cancer (ARC) and the French National Research Agency (ANR), a grant to TN from MEXT, and a grant to HI from the Japan Science Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arboleda D, 2011, CELL MOL NEUROBIOL, V31, P1113, DOI 10.1007/s10571-011-9712-3; Balaratnasingam C, 2011, NEUROSCIENCE, V177, P269, DOI 10.1016/j.neuroscience.2010.12.053; Bates WR, 1996, DEV GROWTH DIFFER, V38, P307; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Burry RW, 2011, J HISTOCHEM CYTOCHEM, V59, P6, DOI 10.1369/jhc.2010.956920; Cappello F, 2008, CANCER BIOL THER, V7, P801, DOI 10.4161/cbt.7.6.6281; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Chiba S, 1999, DEV GROWTH DIFFER, V41, P265; Conklin E.G., 1905, J ACAD NAT SCI PHILA, V12, P1, DOI DOI 10.5962/BHL.TITLE.4801; Correa C, 2004, CELL TISSUE RES, V318, P609, DOI 10.1007/s00441-004-0992-5; DEBUS E, 1983, DIFFERENTIATION, V25, P193, DOI 10.1111/j.1432-0436.1984.tb01355.x; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Deutsch EW, 2008, NAT BIOTECHNOL, V26, P305, DOI 10.1038/nbt1391; Dumollard R, 2006, SEMIN CELL DEV BIOL, V17, P314, DOI 10.1016/j.semcdb.2006.02.009; Endo T, 2011, NUCLEIC ACIDS RES, V39, pD807, DOI 10.1093/nar/gkq1144; FRANKE FE, 1991, AM J PATHOL, V139, P67; Gilbert SF, 2010, DEV BIOL, P237; Goh YC, 2011, CELL MOL LIFE SCI, V68, P1581, DOI 10.1007/s00018-010-0534-0; Hughes Alis, 2011, PLoS Curr, V3, pRRN1211, DOI 10.1371/currents.RRN1211; Ishii H, 2012, DEV GROWTH DIFFER, V54, P753, DOI 10.1111/dgd.12003; Jeffery WR, 1995, CURR TOP DEV BIOL, V31, P243; JEFFERY WR, 1983, DEV BIOL, V96, P125, DOI 10.1016/0012-1606(83)90317-2; JEFFERY WR, 1985, J EMBRYOL EXP MORPH, V89, P275; JEFFERY WR, 1992, DEV BIOL, V153, P194, DOI 10.1016/0012-1606(92)90105-P; Karabinos A, 2004, GENE, V326, P123, DOI 10.1016/j.gene.2003.10.019; Kloc M, 2004, CURR TOP DEV BIOL, V59, P1, DOI 10.1016/S0070-2153(04)59001-4; Kubo A, 2010, DEVELOPMENT, V137, P1613, DOI 10.1242/dev.046789; Kugler JE, 2010, J CELL SCI, V123, P2453, DOI 10.1242/jcs.066910; Lemaire P, 2008, CURR BIOL, V18, pR620, DOI 10.1016/j.cub.2008.05.039; Marikawa, 1995, J EXP ZOOL, V271, P348; Meedel TH, 2002, DEV BIOL, V241, P238, DOI 10.1006/dbio.2001.0511; Meedel TH, 2007, DEV BIOL, V302, P333, DOI 10.1016/j.ydbio.2006.09.043; MELAN MA, 1992, J CELL SCI, V101, P731; Michel MC, 2009, N-S ARCH PHARMACOL, V379, P385, DOI 10.1007/s00210-009-0395-y; MIRANDE M, 1985, EXP CELL RES, V156, P91, DOI 10.1016/0014-4827(85)90264-2; MIYA T, 1994, DEV GROWTH DIFFER, V36, P39; Negishi T, 2007, CURR BIOL, V17, P1014, DOI 10.1016/j.cub.2007.05.047; NISHIDA H, 1992, DEVELOPMENT, V116, P521; Nishida H, 2001, NATURE, V409, P724, DOI 10.1038/35055568; Nishikata T, 1999, DEV BIOL, V209, P72, DOI 10.1006/dbio.1999.9244; NISHIKATA T, 1987, DEVELOPMENT, V100, P577; Nishikata T, 1996, DEV GENES EVOL, V206, P72, DOI 10.1007/s004270050032; Nomura M, 2009, DEV BIOL, V325, P468, DOI 10.1016/j.ydbio.2008.10.038; Ohashi S, 2009, BIOCHEM BIOPH RES CO, V385, P545, DOI 10.1016/j.bbrc.2009.05.094; Oka T, 1999, DEV GROWTH DIFFER, V41, P1; Paix A, 2011, DEV BIOL, V357, P211, DOI 10.1016/j.ydbio.2011.06.019; Paix A, 2009, DEV BIOL, V336, P96, DOI 10.1016/j.ydbio.2009.09.001; Patalano S, 2006, J CELL SCI, V119, P1592, DOI 10.1242/jcs.02873; Pfister G, 2005, J CELL SCI, V118, P1587, DOI 10.1242/jcs.02292; Prodon F, 2006, DEV BIOL, V290, P297, DOI 10.1016/j.ydbio.2005.11.025; Prodon F, 2007, DEV DYNAM, V236, P1698, DOI 10.1002/dvdy.21109; Prodon F, 2010, DEVELOPMENT, V137, P2011, DOI 10.1242/dev.047845; REVERBERI G, 1956, EXPERIENTIA, V12, P55, DOI 10.1007/BF02164674; Roegiers F, 1999, DEVELOPMENT, V126, P3101; ROEGIERS F, 1995, DEVELOPMENT, V121, P3457; Saper CB, 2009, J HISTOCHEM CYTOCHEM, V57, P1, DOI 10.1369/jhc.2008.952770; SARDET C, 1992, DEVELOPMENT, V115, P221; Sardet C, 2002, DEV BIOL, V241, P1, DOI 10.1006/dbio.2001.0474; Sardet C, 2003, DEVELOPMENT, V130, P5839, DOI 10.1242/dev.00805; Sardet C, 2007, DEV DYNAM, V236, P1716, DOI 10.1002/dvdy.21136; Sardet C, 2011, METHODS MOL BIOL, V770, P365, DOI 10.1007/978-1-61779-210-6_14; Sasakura Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S3; Satoh N, 1996, P NATL ACAD SCI USA, V93, P9315, DOI 10.1073/pnas.93.18.9315; Satoh N, 2003, NAT REV GENET, V4, P285, DOI 10.1038/nrg1042; Satoh N, 1994, DEV BIOL; Sawada K, 2005, GENE EXPR PATTERNS, V5, P429, DOI 10.1016/j.modgep.2004.09.003; SAWADA T, 1989, DEV BIOL, V132, P331, DOI 10.1016/0012-1606(89)90230-3; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/nmeth.1855, 10.1038/NMETH.1855]; Soltys BJ, 1996, EXP CELL RES, V222, P16, DOI 10.1006/excr.1996.0003; Stetler RA, 2010, PROG NEUROBIOL, V92, P184, DOI 10.1016/j.pneurobio.2010.05.002; Stolfi A, 2012, GENETICS, V192, P55, DOI 10.1534/genetics.112.140590; SWALLA BJ, 1991, DEVELOPMENT, V111, P425; Tanaka KJ, 2004, DEV BIOL, V272, P217, DOI 10.1016/j.ydbio.2004.04.032; True LD, 2008, HISTOCHEM CELL BIOL, V130, P473, DOI 10.1007/s00418-008-0481-0; Vierra DA, 2012, DEV GENES EVOL, V222, P55, DOI 10.1007/s00427-011-0386-0; Willingham MC, 1999, J HISTOCHEM CYTOCHEM, V47, P1233, DOI 10.1177/002215549904701002; ZALOKAR M, 1984, DEV BIOL, V102, P195, DOI 10.1016/0012-1606(84)90184-2; Zhou RR, 2010, CURR GENET, V56, P101, DOI 10.1007/s00294-010-0291-5	78	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e52996	10.1371/journal.pone.0052996	http://dx.doi.org/10.1371/journal.pone.0052996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326373	Green Published, gold, Green Submitted			2022-12-25	WOS:000313552400012
J	Lieu, CA; Chinta, SJ; Rane, A; Andersen, JK				Lieu, Christopher A.; Chinta, Shankar J.; Rane, Anand; Andersen, Julie K.			Age-Related Behavioral Phenotype of an Astrocytic Monoamine Oxidase-B Transgenic Mouse Model of Parkinson's Disease	PLOS ONE			English	Article							MAO-B; 3-NITROPROPIONIC ACID; BRAIN ASTROCYTES; KNOCKOUT MICE; PC12 CELLS; MPTP; DEFICIENT; NEURONS; NEUROTOXICITY; DEGENERATION	We have previously shown that increases in astrocytic monoamine oxidase-B (MAO-B) expression, mimicking that which occurs with aging and in neurodegenerative disease, in a doxycycline (dox)-inducible transgenic mouse model evokes neuropathological similarities to what is observed in the human parkinsonian brain. Additional behavioral and neuropathological studies could provide further validation for its usage as a model for Parkinson's disease (PD). In the present study, we utilized a battery of behavioral tests to evaluate age-related phenotype in this model. In the open field test, we found that dox-induction impaired motor ability with decreases in movement and ambulatory function as well as diminished stereotypical, repetitive movement episodes in both young and old mice. Older mice also showed decreased motor performance in the pole test when compared to younger mice. Furthermore, dox-induced older mice displayed severe hindlimb clasping and the most significant loss of dopamine (DA) in the striatum when compared to young and non-induced animals. Additionally, increased MAO-B activity significantly correlated with decreased expression of striatal DA. The results of our study further confirms that the dox-inducible astrocytic MAO-B transgenic mouse displays similar age-related behavioral and neuropathological features to other models of PD, and could serve as a useful tool to study PD pathophysiology and for the evaluation of therapeutic interventions.	[Lieu, Christopher A.; Chinta, Shankar J.; Rane, Anand; Andersen, Julie K.] Buck Inst Res Aging, Novato, CA USA	Buck Institute for Research on Aging	Andersen, JK (corresponding author), Buck Inst Res Aging, Novato, CA USA.	jandersen@buckinstitute.org	Rane, Anders/L-2675-2013	Andersen, Julie/0000-0003-1324-4875	PPG [AG025901]; NIH T32 fellowship [AG000266]; NATIONAL INSTITUTE ON AGING [T32AG000266, P01AG025901] Funding Source: NIH RePORTER	PPG; NIH T32 fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was made possible by PPG AG025901 (J.K.A.) and NIH T32 fellowship AG000266 (C.A.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre VM, 2011, J NEUROSCI, V31, P1170, DOI 10.1523/JNEUROSCI.3539-10.2011; Blume SR, 2009, EXP NEUROL, V219, P208, DOI 10.1016/j.expneurol.2009.05.017; COHEN G, 1984, EUR J PHARMACOL, V106, P209, DOI 10.1016/0014-2999(84)90700-3; Fernagut PO, 2004, EXP NEUROL, V185, P47, DOI 10.1016/j.expneurol.2003.09.014; Fernagut PO, 2003, NEUROSCIENCE, V116, P1123, DOI 10.1016/S0306-4522(02)00778-9; Finberg JPM, 1998, NEUROREPORT, V9, P703; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Grimsby J, 1997, NAT GENET, V17, P206, DOI 10.1038/ng1097-206; Guyenet S.J., 2010, J VIS EXP; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Klivenyi P, 2000, J NEUROSCI, V20, P1; Koppula S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/823902; Lee M, 2004, GENES BRAIN BEHAV, V3, P216, DOI 10.1111/j.1601-1848.2004.00074.x; LEVITT P, 1982, P NATL ACAD SCI-BIOL, V79, P6385, DOI 10.1073/pnas.79.20.6385; Lieu CA, 2010, PARKINSONISM RELAT D, V16, P458, DOI 10.1016/j.parkreldis.2010.04.015; Mahy N., 2000, Neurobiology (Budapest), V8, P47; Mallajosyula JK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001616; SAURA J, 1994, NEUROBIOL AGING, V15, P399, DOI 10.1016/0197-4580(94)90071-X; Siddiqui A, 2012, FREE RADIC RES; Siddiqui A, 2011, NEUROBIOL DIS, V43, P527, DOI 10.1016/j.nbd.2010.12.014; Siderowf A, 2002, ARCH NEUROL-CHICAGO, V59, P1937; Van Waes V, 2010, EUR J NEUROSCI, V32, P435, DOI 10.1111/j.1460-9568.2010.07294.x; Wei Q, 1996, J NEUROSCI RES, V46, P666; Wei QZ, 1997, J NEUROSCI RES, V50, P618	24	37	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54200	10.1371/journal.pone.0054200	http://dx.doi.org/10.1371/journal.pone.0054200			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326597	gold, Green Published, Green Submitted			2022-12-25	WOS:000313552400083
J	Ponjavic-Conte, KD; Hambrook, DA; Pavlovic, S; Tata, MS				Ponjavic-Conte, Karla D.; Hambrook, Dillon A.; Pavlovic, Sebastian; Tata, Matthew S.			Dynamics of Distraction: Competition among Auditory Streams Modulates Gain and Disrupts Inter-Trial Phase Coherence in the Human Electroencephalogram	PLOS ONE			English	Article							TRANSIENT SPATIAL ATTENTION; SELECTIVE ATTENTION; INFORMATIONAL MASKING; NEURONAL SYNCHRONIZATION; BRAIN POTENTIALS; ALPHA-ACTIVITY; VISUAL-SEARCH; OSCILLATIONS; RESPONSES; CORTEX	Auditory distraction is a failure to maintain focus on a stream of sounds. We investigated the neural correlates of distraction in a selective-listening pitch-discrimination task with high (competing speech) or low (white noise) distraction. High-distraction impaired performance and reduced the N1 peak of the auditory Event-Related Potential evoked by probe tones. In a series of simulations, we explored two theories to account for this effect: disruption of sensory gain or a disruption of inter-trial phase consistency. When compared to these simulations, our data were consistent with both effects of distraction. Distraction reduced the gain of the auditory evoked potential and disrupted the inter-trial phase consistency with which the brain responds to stimulus events. Tones at a non-target, unattended frequency were more susceptible to the effects of distraction than tones within an attended frequency band.	[Ponjavic-Conte, Karla D.; Hambrook, Dillon A.; Pavlovic, Sebastian; Tata, Matthew S.] Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Ponjavic-Conte, KD (corresponding author), Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada.	karla.ponjavic@uleth.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	A Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant to MST funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAIN C, 2006, CEREB CORTEX; Arbogast TL, 2002, J ACOUST SOC AM, V112, P2086, DOI 10.1121/1.1510141; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bregman AS, 1990, AUDITORY SCENE ANAL, pxiii; BROADBENT DE, 1952, J EXP PSYCHOL, V44, P51, DOI 10.1037/h0056491; CARHART R, 1969, J ACOUST SOC AM, V45, P694, DOI 10.1121/1.1911445; David O, 2006, NEUROIMAGE, V31, P1580, DOI 10.1016/j.neuroimage.2006.02.034; Di Lollo V, 2000, J EXP PSYCHOL GEN, V129, P481, DOI 10.1037/0096-3445.129.4.481; Doesburg SM, 2008, CEREB CORTEX, V18, P386, DOI 10.1093/cercor/bhm073; DONALD MW, 1982, EXP BRAIN RES, V46, P357; Dowdall JR, 2012, NEUROPSYCHOLOGIA, V50, P2442, DOI 10.1016/j.neuropsychologia.2012.06.015; Durlach NI, 2003, J ACOUST SOC AM, V113, P2984, DOI 10.1121/1.1570435; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2008, J NEUROSCI, V28, P4823, DOI 10.1523/JNEUROSCI.4499-07.2008; HANSEN JC, 1988, PSYCHOPHYSIOLOGY, V25, P316, DOI 10.1111/j.1469-8986.1988.tb01249.x; HARI R, 1988, EXP BRAIN RES, V71, P87; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Hoechstetter K, 2004, BRAIN TOPOGR, V16, P233; Hymel M R, 1998, J Am Acad Audiol, V9, P385; Hymel MR, 2000, NEUROSCI LETT, V283, P105, DOI 10.1016/S0304-3940(00)00915-0; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Klimesch W, 2007, NEUROSCI BIOBEHAV R, V31, P1003, DOI 10.1016/j.neubiorev.2007.03.005; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Kruglikov SY, 2003, J NEUROSCI, V23, P10122; Krumm M P, 1994, J Am Acad Audiol, V5, P127; LEEK MR, 1991, PERCEPT PSYCHOPHYS, V50, P205, DOI 10.3758/BF03206743; Low YF, 2009, PHYSIOL MEAS, V30, P821, DOI 10.1088/0967-3334/30/8/007; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Mazaheri A, 2006, P NATL ACAD SCI USA, V103, P2948, DOI 10.1073/pnas.0505785103; Min BK, 2007, INT J PSYCHOPHYSIOL, V65, P58, DOI 10.1016/j.ijpsycho.2007.03.002; Naatanen R., 2018, ATTENTION BRAIN FUNC; Obleser J., 2011, CEREB CORTEX; POLLACK I, 1976, J ACOUST SOC AM, V60, P680, DOI 10.1121/1.381139; Ponjavic-Conte KD, 2012, NEUROREPORT, V23, P240, DOI 10.1097/WNR.0b013e3283505ac6; Salmi J, 2007, EUR J NEUROSCI, V25, P3725, DOI 10.1111/j.1460-9568.2007.05616.x; Sauseng P, 2007, NEUROSCIENCE, V146, P1435, DOI 10.1016/j.neuroscience.2007.03.014; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Schroger E, 1998, NEUROREPORT, V9, P3355, DOI 10.1097/00001756-199810260-00003; Schroger E, 2000, CLIN NEUROPHYSIOL, V111, P1450, DOI 10.1016/S1388-2457(00)00337-0; SCHROGER E, 1993, NEUROREPORT, V4, P588, DOI 10.1097/00001756-199305000-00033; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Tata MS, 2005, NEUROPSYCHOLOGIA, V43, P509, DOI 10.1016/j.neuropsychologia.2004.07.019; Tata MS, 2004, PSYCHON B REV, V11, P262, DOI 10.3758/BF03196568; Tata MS, 2002, PERCEPT PSYCHOPHYS, V64, P1028, DOI 10.3758/BF03194754; Tata MS, 2001, NEUROREPORT, V12, P3679, DOI 10.1097/00001756-200112040-00015; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; TREISMAN AM, 1964, AM J PSYCHOL, V77, P533, DOI 10.2307/1420765; Watson CS, 2005, ACTA ACUST UNITED AC, V91, P502; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; WOODS DL, 1984, J EXP PSYCHOL HUMAN, V10, P761, DOI 10.1037/0096-1523.10.6.761	57	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53953	10.1371/journal.pone.0053953	http://dx.doi.org/10.1371/journal.pone.0053953			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326548	Green Published, gold			2022-12-25	WOS:000313552400064
J	Pyritz, LW; Fichtel, C; Huchard, E; Kappeler, PM				Pyritz, Lennart W.; Fichtel, Claudia; Huchard, Elise; Kappeler, Peter M.			Determinants and Outcomes of Decision-Making, Group Coordination and Social Interactions during a Foraging Experiment in a Wild Primate	PLOS ONE			English	Article							EULEMUR-FULVUS-RUFUS; CAPUCHIN MONKEYS; CONSENSUS DECISION; REDFRONTED LEMURS; GROUP MOVEMENTS; FEMALE DOMINANCE; LIFE-HISTORY; PATTERNS; LEADERSHIP; MODEL	Social animals have to coordinate joint movements to maintain group cohesion, but the latter is often compromised by diverging individual interests. A widespread behavioral mechanism to achieve coordination relies on shared or unshared consensus decision-making. If consensus costs are high, group fission represents an alternative tactic. Exploring determinants and outcomes of spontaneous group decisions and coordination of free-ranging animals is methodologically challenging. We therefore conducted a foraging experiment with a group of wild redfronted lemurs (Eulemur rufifrons) to study decision outcomes, coordination of movements, individual foraging benefits and social interactions in response to the presentation of drinking platforms with varying baiting patterns. Behavioral observations were complemented with data from recordings of motion detector cameras installed at the platforms. The animal's behavior in the experimental conditions was compared to natural group movements. We could not determine the type of consensus decision-making because the group visited platforms randomly. The group fissioned during 23.3% of platform visits, and fissioning resulted in more individuals drinking simultaneously. As under natural conditions, adult females initiated most group movements, but overtaking by individuals of different age and sex classes occurred in 67% of movements to platforms, compared to only 18% during other movements. As a result, individual resource intake at the platforms did not depend on departure position, age or sex, but on arrival order. Aggression at the platforms did not affect resource intake, presumably due to low supplanting rates. Our findings highlight the diversity of coordination processes and related consequences for individual foraging benefits in a primate group living under natural conditions.	[Pyritz, Lennart W.; Fichtel, Claudia; Huchard, Elise; Kappeler, Peter M.] German Primate Ctr, Behav Ecol & Sociobiol Unit, Gottingen, Germany; [Pyritz, Lennart W.; Fichtel, Claudia; Huchard, Elise; Kappeler, Peter M.] Univ Gottingen, Courant Res Ctr Evolut Social Behav, Gottingen, Germany	Deutsches Primatenzentrum (DPZ); University of Gottingen	Pyritz, LW (corresponding author), German Primate Ctr, Behav Ecol & Sociobiol Unit, Gottingen, Germany.	LennartPyritz@gmx.net	Huchard, Elise/G-9072-2011; Kappeler, Peter/B-6825-2012	Huchard, Elise/0000-0002-6944-449X; 	The German Research Foundation (DFG) [KA 1082/16-1]	The German Research Foundation (DFG)(German Research Foundation (DFG))	The German Research Foundation (DFG: KA 1082/16-1; http://www.dfg.de/index.jsp) provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Barthold J, 2009, AM J PHYS ANTHROPOL, V138, P1, DOI 10.1002/ajpa.20868; Bertram B.C.R., 1978, P64; Biro D, 2006, CURR BIOL, V16, P2123, DOI 10.1016/j.cub.2006.08.087; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bourjade M, 2010, BEHAV PROCESS, V84, P648, DOI 10.1016/j.beproc.2010.02.027; Bousquet CAH, 2011, ANIM BEHAV, V81, P1101, DOI 10.1016/j.anbehav.2011.02.030; Bousquet CAH, 2011, P ROY SOC B-BIOL SCI, V278, P1482, DOI 10.1098/rspb.2010.1739; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2009, PHILOS T R SOC B, V364, P719, DOI 10.1098/rstb.2008.0276; Erhart EM, 1999, INT J PRIMATOL, V20, P927, DOI 10.1023/A:1020830703012; Erwin N, 1976, APPL ANIM ETHOL, V2, P265, DOI [DOI 10.1016/0304-3762(76)90059-6, 10.1016/0304-3762(76)90059-6]; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Fichtel Claudia, 2012, P169; Fichtel C, 2011, COORDINATION IN HUMAN AND PRIMATE GROUPS, P37, DOI 10.1007/978-3-642-15355-6_3; Fischhoff IR, 2007, ANIM BEHAV, V73, P825, DOI 10.1016/j.anbehav.2006.10.012; Franks NR, 2003, P ROY SOC B-BIOL SCI, V270, P2457, DOI 10.1098/rspb.2003.2527; Gautrais J, 2010, BEHAV PROCESS, V84, P664, DOI 10.1016/j.beproc.2010.03.002; Gompper ME, 1996, BEHAV ECOL, V7, P254, DOI 10.1093/beheco/7.3.254; Harcourt JL, 2010, CURR BIOL, V20, P156, DOI 10.1016/j.cub.2009.11.045; Hawkins CE, 2008, J MAMMAL, V89, P64, DOI 10.1644/06-MAMM-A-366.1; Horvath JE, 2008, GENOME RES, V18, P489, DOI 10.1101/gr.7265208; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; JANSON CH, 1995, BEHAV ECOL, V6, P326, DOI 10.1093/beheco/6.3.326; Janson CH, 1997, BEHAV ECOL SOCIOBIOL, V41, P17, DOI 10.1007/s002650050359; Janson CH, 1998, ANIM BEHAV, V55, P1229, DOI 10.1006/anbe.1997.0688; Janson CH, 2007, ANIM COGN, V10, P341, DOI 10.1007/s10071-007-0079-2; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kappeler PM, 2008, BEHAV ECOL SOCIOBIOL, V62, P1477, DOI 10.1007/s00265-008-0577-5; Kappeler Peter M., 2012, P101; KAPPELER PM, 1991, FOLIA PRIMATOL, V57, P132, DOI 10.1159/000156575; Kerth G, 2006, P ROY SOC B-BIOL SCI, V273, P2785, DOI 10.1098/rspb.2006.3647; Kerth G, 2010, BEHAV PROCESS, V84, P662, DOI 10.1016/j.beproc.2010.02.023; King AJ, 2011, BIOL LETTERS, V7, P237, DOI 10.1098/rsbl.2010.0808; King AJ, 2010, BEHAV PROCESS, V84, P671, DOI 10.1016/j.beproc.2010.03.006; King AJ, 2008, CURR BIOL, V18, P1833, DOI 10.1016/j.cub.2008.10.048; Koenig A, 2002, INT J PRIMATOL, V23, P759, DOI 10.1023/A:1015524931226; Krause J, 2002, LIVING GROUPS; Meunier H, 2006, BEHAVIOUR, V143, P1511, DOI 10.1163/156853906779366982; Moody AL, 1996, BEHAV ECOL SOCIOBIOL, V38, P131, DOI 10.1007/s002650050225; Ostner J, 2004, ANIM BEHAV, V67, P249, DOI 10.1016/j.anbehav.2003.05.012; OVERDORFF DJ, 1993, INT J PRIMATOL, V14, P721, DOI 10.1007/BF02192188; PEREIRA ME, 1988, ETHOLOGY, V79, P195, DOI 10.1111/j.1439-0310.1988.tb00711.x; PEREIRA ME, 1990, FOLIA PRIMATOL, V55, P96, DOI 10.1159/000156505; Pereira ME, 1997, AM J PRIMATOL, V43, P239, DOI 10.1002/(SICI)1098-2345(1997)43:3<239::AID-AJP4>3.0.CO;2-Y; Petit O, 2010, BEHAV PROCESS, V84, P635, DOI 10.1016/j.beproc.2010.04.009; Pyritz L, 2010, LEMUR NEWS, V15, P15; Pyritz L, 2010, BEHAV PROCESS, V84, P681, DOI 10.1016/j.beproc.2010.02.025; Pyritz LW, 2011, INT J PRIMATOL, V32, P1325, DOI 10.1007/s10764-011-9549-0; Pyritz LW, 2011, INT J PRIMATOL, V32, P1268, DOI 10.1007/s10764-011-9524-9; Ramseyer A, 2009, ETHOLOGY, V115, P948, DOI 10.1111/j.1439-0310.2009.01686.x; Ramseyer A, 2009, J ETHOL, V27, P369, DOI 10.1007/s10164-008-0128-6; Rands SA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-51; RASA OAE, 1987, ADV STUD BEHAV, V17, P121, DOI 10.1016/S0065-3454(08)60178-3; Rasoloarison Rodin M., 1995, Ecotropica, V1, P59; Rubenstein RI, 1994, INDIVIDUALS INTERACT, P13; Scholz F, 2004, INT J PRIMATOL, V25, P599, DOI 10.1023/B:IJOP.0000023577.32587.0b; Seeley TD, 2006, AM SCI, V94, P220, DOI 10.1511/2006.59.220; Sorg JP, 1996, PRIMATE REPORT, P57; Stueckle S, 2008, ANIM BEHAV, V75, P1995, DOI 10.1016/j.anbehav.2007.12.012; Sueur C, 2008, BEHAV PROCESS, V78, P84, DOI 10.1016/j.beproc.2008.01.004; Sueur C, 2010, J EXP BIOL, V213, P1338, DOI 10.1242/jeb.039016; Sueur C, 2008, INT J PRIMATOL, V29, P1085, DOI 10.1007/s10764-008-9262-9; Sussman R.W., 1974, P75; Trillmich J, 2004, BEHAVIOUR, V141, P1103, DOI 10.1163/1568539042664579; VANSCHAIK CP, 1985, FOLIA PRIMATOL, V44, P138, DOI 10.1159/000156208; Vogel ER, 2005, BEHAV ECOL SOCIOBIOL, V58, P333, DOI 10.1007/s00265-005-0960-4; Wheeler BC, 2009, P ROY SOC B-BIOL SCI, V276, P3013, DOI 10.1098/rspb.2009.0544; Wimmer B, 2002, ANIM BEHAV, V64, P557, DOI 10.1006/anbe.2002.4003; Zuur Alain F., 2009, P1	70	8	8	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53144	10.1371/journal.pone.0053144	http://dx.doi.org/10.1371/journal.pone.0053144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326392	Green Published, gold, Green Submitted			2022-12-25	WOS:000313552400014
J	Hu, Q; Chen, BH; Zhu, ZO; Tian, JH; Zhou, Y; Zhang, XY; Zheng, X				Hu, Quan; Chen, Banghua; Zhu, Zerong; Tian, Junhua; Zhou, Yu; Zhang, Xiaoyong; Zheng, Xin			Recurrence of Japanese Encephalitis Epidemic in Wuhan, China, 2009-2010	PLOS ONE			English	Article							SOUTHEAST-ASIA; VIRUS; OUTBREAK; IMMUNIZATION; AUSTRALIA; SA14-14-2; VACCINE	Background: Japanese encephalitis (JE) was once epidemic in most areas of China, including Wuhan, a city located in the central part of China. The incidence of JE dramatically decreased due to nationwide immunization with the live attenuated JE virus (JEV) vaccine, and no JE cases were reported during 2005-2008 in Wuhan. In 2009 and 2010, 31 JE cases reoccurred in this area. In this study, we investigated the causes of JE recurrence. Methods and Findings: All JE cases were laboratory-confirmed by detecting the JEV-specific IgM antibody with an IgM-capture enzyme-linked immunosorbent assay (ELISA). All patients were children between 2 months and 9 years of age with a median age of 2 years. Of the 31 cases, 9 had received one or two doses of the JEV vaccine, 11 had not been immunized previously with the JEV vaccine, and 11 had an unclear immunization history. Through reverse transcription polymerase chain reaction (RT-PCR), sequencing, and phylogenetic analysis, two new strains of JEV were isolated from Culex tritaeniorhynchus and identified as genotype 1 JEV, rather than genotype 3, which circulated in this area previously. Conclusions: Vaccine failure or missed vaccination may have caused JE recurrence. Local centers for disease control and prevention need to improve immunization coverage, and the efficacy of the JE vaccine needs to be reevaluated in a population at risk for disease.	[Hu, Quan; Chen, Banghua; Zhu, Zerong; Tian, Junhua] Wuhan Ctr Dis Control & Prevent, Wuhan, Peoples R China; [Zhou, Yu] Childrens Hosp Philadelphia, Dept Pediat, Joseph Stokes Jr Res Inst, Div Allergy & Immunol, Philadelphia, PA 19104 USA; [Zhang, Xiaoyong] Univ Hosp Essen, Inst Virol, Essen, Germany; [Zheng, Xin] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Duisburg Essen; Huazhong University of Science & Technology	Hu, Q (corresponding author), Wuhan Ctr Dis Control & Prevent, Wuhan, Peoples R China.	powerhu21@yahoo.com; Xin11@hotmail.com		Hu, Quan/0000-0002-2483-5008	Technology & Science Youth Talent Foundation from Hubei Health Department [QJX2008-47]	Technology & Science Youth Talent Foundation from Hubei Health Department	This study was supported by the Technology & Science Youth Talent Foundation from Hubei Health Department (No. QJX2008-47). [http://dns2.yymc.edu.cn/gljg/kcy/file/zxjlzl/cgzt/08n(wst)xdqnrcjjxm(48 h).pdf] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba T, 2001, EPIDEMIOL INFECT, V126, P81, DOI 10.1017/S0950268801004769; BUESCHER EL, 1959, AM J TROP MED HYG, V8, P719, DOI 10.4269/ajtmh.1959.8.719; Campbell Grant L, 2011, B WORLD HEALTH ORGAN, V89, P766; Chen BH, 2007, J PUBLIC HLTH PREVEN, V18, P25; Chotpitayasunondh Tawee, 2011, J Med Assoc Thai, V94 Suppl 3, pS195; Endy TP, 2002, CURR TOP MICROBIOL, V267, P11; Fischer Marc, 2010, Morbidity and Mortality Weekly Report, V59, P1; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; GRESSER I, 1958, AM J TROP MED HYG, V7, P365, DOI 10.4269/ajtmh.1958.7.365; Halstead SB, 1996, LANCET, V348, P341, DOI 10.1016/S0140-6736(05)64516-3; Hanna JN, 1996, MED J AUSTRALIA, V165, P256, DOI 10.5694/j.1326-5377.1996.tb124960.x; Hennessy S, 1996, LANCET, V347, P1583, DOI 10.1016/S0140-6736(96)91075-2; [王环宇 Wang Huanyu], 2004, [中华微生物学和免疫学杂志, Chinese Journal of Microbiology and Immunology], V24, P843; Johansen CA, 2000, AM J TROP MED HYG, V62, P631, DOI 10.4269/ajtmh.2000.62.631; Keiser J, 2005, ACTA TROP, V95, P40, DOI 10.1016/j.actatropica.2005.04.012; Liu XY, 2011, VACCINE, V29, P2127, DOI 10.1016/j.vaccine.2010.12.108; Nga PT, 2004, J GEN VIROL, V85, P1625, DOI 10.1099/vir.0.79797-0; PAUL WS, 1993, J INFECT DIS, V167, P1053, DOI 10.1093/infdis/167.5.1053; Ritchie SA, 1997, AM J TROP MED HYG, V56, P80, DOI 10.4269/ajtmh.1997.56.80; ROSEN L, 1986, ANNU REV MICROBIOL, V40, P395, DOI 10.1146/annurev.mi.40.100186.002143; Sohn YM, 2000, EMERG INFECT DIS, V6, P17; Sohn YM, 2008, VACCINE, V26, P1638, DOI 10.1016/j.vaccine.2008.01.021; Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003; Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263; VAUGHN DW, 1992, EPIDEMIOL REV, V14, P197, DOI 10.1093/oxfordjournals.epirev.a036087; Wang HY, 2007, J GEN VIROL, V88, P885, DOI 10.1099/vir.0.82185-0; Wang HY, 2009, JPN J INFECT DIS, V62, P331; Wang LH, 2007, EMERG INFECT DIS, V13, P1123, DOI 10.3201/eid1307.070010; World Health Organization, 2006, WHO REC STAND SURV S; Wu SC, 2001, VIRUS RES, V76, P59, DOI 10.1016/S0168-1702(01)00246-5; Wu YC, 1999, AM J TROP MED HYG, V61, P78, DOI 10.4269/ajtmh.1999.61.78; Zhang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016418; Zhang S, 2011, PUBLIC HEALTH, V125, P79, DOI 10.1016/j.puhe.2010.10.011	33	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52687	10.1371/journal.pone.0052687	http://dx.doi.org/10.1371/journal.pone.0052687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326348	Green Published, gold, Green Submitted			2022-12-25	WOS:000313551500025
J	Sheard, JM; Ash, S; Mellick, GD; Silburn, PA; Kerr, GK				Sheard, Jamie M.; Ash, Susan; Mellick, George D.; Silburn, Peter A.; Kerr, Graham K.			Malnutrition in a Sample of Community-Dwelling People with Parkinson's Disease	PLOS ONE			English	Article							SUBJECTIVE GLOBAL ASSESSMENT; NUTRITIONAL-STATUS; WEIGHT CHANGE; BODY-COMPOSITION; OLDER-ADULTS; HOME; ASSOCIATION; PREVALENCE; PREDICTION; MORTALITY	Objective: Malnutrition results in poor health outcomes, and people with Parkinson's disease may be more at risk of malnutrition. However, the prevalence of malnutrition in Parkinson's disease is not yet well defined. The aim of this study is to provide an estimate of the extent of malnutrition in community-dwelling people with Parkinson's disease. Methods: This is a cross-sectional study of people with Parkinson's disease residing within a 2 hour driving radius of Brisbane, Australia. The Subjective Global Assessment (SGA) and scored Patient Generated Subjective Global Assessment (PG-SGA) were used to assess nutritional status. Body weight, standing or knee height, mid-arm circumference and waist circumference were measured. Results: Nineteen (15%) of the participants were moderately malnourished (SGA-B). The median PG-SGA score of the SGA-B group was 8 (4-15), significantly higher than the SGA-A group, U = 1860.5, p<.05. The symptoms most influencing intake were loss of appetite, constipation, early satiety and problems swallowing. Conclusions: As with other populations, malnutrition remains under-recognised and undiagnosed in people with Parkinson's disease. Regular screening of nutritional status in people with Parkinson's disease by health professionals with whom they have regular contact should occur to identify those who may benefit from further nutrition assessment and intervention.	Queensland Univ Technol, Sch Exercise & Nutr Sci, Brisbane, Qld 4001, Australia; [Sheard, Jamie M.; Ash, Susan; Kerr, Graham K.] Queensland Univ Technol, Sch Exercise & Nutr Sci, Brisbane, Qld 4001, Australia; [Sheard, Jamie M.; Kerr, Graham K.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Movement Neurosci Program, Brisbane, Qld 4001, Australia; [Mellick, George D.] Griffith Univ, Australia Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia; [Silburn, Peter A.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland University of Technology (QUT); Griffith University; University of Queensland	Sheard, JM (corresponding author), Queensland Univ Technol, Sch Exercise & Nutr Sci, Brisbane, Qld 4001, Australia.	jamie.sheard@qut.edu.au	Mellick, George D./A-7650-2010; Sheard, Jamie M/C-3184-2012; Kerr, Graham/I-9705-2012; Ash, Susan/I-9664-2012	Mellick, George D./0000-0002-7211-4651; Sheard, Jamie M/0000-0002-1730-4831; Kerr, Graham/0000-0002-1008-256X; Ash, Susan/0000-0003-2078-7560	Parkinson's Queensland, Inc	Parkinson's Queensland, Inc	Parkinson's Queensland, Inc (http://parkinsons-qld.org.au/) provided funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders did advertise the study in their newsletter and on their website for the purpose of recruiting participants.	Alho Letra Martins Catia Patricia, 2005, Journal of Nutrition for the Elderly, V25, P5, DOI 10.1300/J052v25n02_02; [Anonymous], 2009, NUTR DIET, V66, pS1; Banks M, 2010, NUTRITION, V26, P896, DOI 10.1016/j.nut.2009.09.024; Barbosa-Silva MCG, 2006, CURR OPIN CLIN NUTR, V9, P263, DOI 10.1097/01.mco.0000222109.53665.ed; Barichella M, 2008, NUTR NEUROSCI, V11, P128, DOI 10.1179/147683008X301441; BEYER PL, 1995, J AM DIET ASSOC, V95, P979, DOI 10.1016/S0002-8223(95)00269-3; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Chen HL, 2003, ANN NEUROL, V53, P676, DOI 10.1002/ana.10577; Chumlea WC, 1998, J AM DIET ASSOC, V98, P137, DOI 10.1016/S0002-8223(98)00036-4; Correia MITD, 2003, CLIN NUTR, V22, P235, DOI 10.1016/S0261-5614(02)00215-7; Crogan NL, 2003, J GERONTOL A-BIOL, V58, P159; DAVIDSON J, 2008, TLS TIMES LIT S 0613, P24; Deloitte Access Economics, 2011, LIV PARK DIS UPD; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108; Donini LM, 2012, J NUTR HEALTH AGING, V16, P89, DOI 10.1007/s12603-011-0073-x; Gibson R, 2005, PRINCIPLES NUTR ASSE; Jaafar AF, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-124; Janssen I, 2002, AM J CLIN NUTR, V75, P683, DOI 10.1093/ajcn/75.4.683; Johansson Y, 2009, J CLIN NURS, V18, P1354, DOI 10.1111/j.1365-2702.2008.02552.x; Lee JS, 2005, AM J CLIN NUTR, V82, P644, DOI 10.1093/ajcn/82.3.644; Leggo M, 2008, NUTR DIET, V65, P162, DOI 10.1111/j.1747-0080.2008.00239.x; Mamhidir AG, 2006, J NUTR HEALTH AGING, V10, P255; Martorell R, 1988, ANTHROPOMETRIC STAND, V24, P425; Morley JE, 1997, AM J CLIN NUTR, V66, P760, DOI 10.1093/ajcn/66.4.760; Newman AB, 2001, J AM GERIATR SOC, V49, P1309, DOI 10.1046/j.1532-5415.2001.49258.x; Ottery F, 2000, CLIN GUIDE ONCOLOGY, P11; Pai MK, 2011, BIOMED RES-INDIA, V22, P120; Pfeiffer RF, 2003, LANCET NEUROL, V2, P107, DOI 10.1016/S1474-4422(03)00307-7; Sheard JM, 2011, NUTR REV, V69, P520, DOI 10.1111/j.1753-4887.2011.00413.x; Uc EY, 2006, MOVEMENT DISORD, V21, P930, DOI 10.1002/mds.20837; Visvanathan R, 2003, J AM GERIATR SOC, V51, P1007, DOI 10.1046/j.1365-2389.2003.51317.x; Wang G, 2010, PARKINSONISM RELAT D, V16, P119, DOI 10.1016/j.parkreldis.2009.08.009; Wikby K, 2006, J NUTR HEALTH AGING, V10, P232	33	46	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53290	10.1371/journal.pone.0053290	http://dx.doi.org/10.1371/journal.pone.0053290			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326408	Green Published, gold			2022-12-25	WOS:000313551500060
J	Kumar, SM; Dai, J; Li, S; Yang, R; Yu, H; Nathanson, KL; Liu, S; Zhou, H; Guo, J; Xu, X				Kumar, S. M.; Dai, J.; Li, S.; Yang, R.; Yu, H.; Nathanson, K. L.; Liu, S.; Zhou, H.; Guo, J.; Xu, X.			Human skin neural crest progenitor cells are susceptible to BRAF(V600E)-induced transformation	ONCOGENE			English	Article						melanoma; neural crest; transformation; melanocytes; BRAF(V600E)	ONCOGENE-INDUCED SENESCENCE; STEM-CELLS; SELF-RENEWAL; EXPRESSION; CANCER; CYCLE; GENE; MAINTENANCE; MUTATIONS; PATHWAYS	Adult stem cells are multipotent and persist in small numbers in adult tissues throughout the lifespan of an organism. Unlike differentiated cells, adult stem cells are intrinsically resistant to senescence. It is unclear how adult stem cells in solid organs respond to oncogenic stimulation and whether these cells have a role in tumor initiation. We report here that expression of BRAF(V600E) in human neural crest progenitor cells (hNCPCs) did not induce growth arrest as seen in human melanocytes, but instead, increased their cell proliferation capacity. These cells (hNCPCs(V600E)) acquired anchorage-independent growth ability and were weakly tumorigenic in vivo. Unlike in human melanocytes, BRAF(V600E) expression in hNCPCs did not induce p16(INK4a) expression. BRAF(V600E) induced elevated expression of CDK2, CDK4, MITF and EST1/2 protein in hNCPCs, and also induced melanocytic differentiation of these cells. Furthermore, overexpression of MITF in hNCPCs(V600E) dramatically increased their tumorigenicity and resulted in fully transformed tumor cells. These findings indicate that hNCPCs are susceptible to BRAF(V600E)-induced transformation, and MITF potentiates the oncogenic effect of BRAF(V600E) in these progenitor cells. These results suggest that the hNCPCs are potential targets for BRAF(V600E)-induced melanocytic tumor formation.	[Kumar, S. M.; Dai, J.; Yang, R.; Yu, H.; Liu, S.; Xu, X.] Univ Penn, Perelman Sch Med, Dept Pathol, Philadelphia, PA 19104 USA; [Kumar, S. M.; Dai, J.; Yang, R.; Yu, H.; Liu, S.; Xu, X.] Univ Penn, Perelman Sch Med, Dept Lab Med, Philadelphia, PA 19104 USA; [Dai, J.; Li, S.; Guo, J.] Peking Univ, Canc Hosp & Inst, Dept Renal Canc & Melanoma, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China; [Nathanson, K. L.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Zhou, H.] Univ Penn, Perelman Sch Med, Dept Emergency Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Peking University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Guo, J (corresponding author), Peking Univ, Canc Hosp & Inst, Dept Renal Canc & Melanoma, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China.	guoj307@126.com; xug@mail.med.upenn.edu		Liu, Shujing/0000-0002-2958-093X; Yu, Hong/0000-0002-1272-4511; Nathanson, Katherine/0000-0002-6740-0901	US National Institutes of Health [AR-054593, CA-116103]; NATIONAL CANCER INSTITUTE [R21CA116103, P01CA025874, P30CA016520, P50CA174523, P01CA114046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054593] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Drs M Herlyn from the Wistar Institute, Philadelphia, PA for melanoma cell lines, R Marais from the Institute of Cancer Research, London, UK for BRAF<SUP>V600E</SUP> plasmids, S Carreira from Marie Curie Research Institute, UK for MITF promoter-luciferase plasmids, F Liu from university of California for QCXIP-MiTF and QCXIP vectors, K Huang for editing the manuscript. CHTN for providing tissues and the immunohistochemical lab at the Department of Pathology and Laboratory medicine, University of Pennsylvania for immunohistochemical stains. This work is supported by US National Institutes of Health grants AR-054593, CA-116103 to XX.	Amoh Y, 2005, P NATL ACAD SCI USA, V102, P5530, DOI 10.1073/pnas.0501263102; Baird DM, 2008, BIOCHIMIE, V90, P116, DOI 10.1016/j.biochi.2007.08.003; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Bloethner S, 2007, GENE CHROMOSOME CANC, V46, P1019, DOI 10.1002/gcc.20488; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Duband JL, 2006, ADV EXP MED BIOL, V589, P45; Elder DE, 2009, TUMORIGENIC MELANOCY; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Foroni C, 2007, CANCER RES, V67, P3725, DOI 10.1158/0008-5472.CAN-06-4577; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Greshock J, 2004, GENOME RES, V14, P179; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Hu YF, 2006, STEM CELLS, V24, P2692, DOI 10.1634/stemcells.2006-0233; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Kumar SM, 2005, AM J PATHOL, V166, P823, DOI 10.1016/S0002-9440(10)62303-6; Kumar SM, 2007, CANCER RES, V67, P3177, DOI 10.1158/0008-5472.CAN-06-3312; Li LN, 2003, P NATL ACAD SCI USA, V100, P9958, DOI 10.1073/pnas.1733025100; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Milagre C, 2010, CANCER RES, V70, P5549, DOI 10.1158/0008-5472.CAN-09-4254; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Polyak K, 2006, NAT MED, V12, P296, DOI 10.1038/nm1379; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Shiras A, 2007, STEM CELLS, V25, P1478, DOI 10.1634/stemcells.2006-0585; Sieber-Blum M, 2004, DEV DYNAM, V231, P258, DOI 10.1002/dvdy.20129; Sieber-Blum M, 2004, ANAT REC PART A, V276A, P34, DOI 10.1002/ar.a.10132; Sieber-Blum Maya, 2004, Birth Defects Res C Embryo Today, V72, P162, DOI 10.1002/bdrc.20008; Squarzoni P, 2011, DEVELOPMENT, V138, P1421, DOI 10.1242/dev.057323; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Vaquerizas JM, 2004, BIOINFORMATICS, V20, P3656, DOI 10.1093/bioinformatics/bth401; Wajapeyee N, 2010, CELL, V141, P746, DOI 10.1016/j.cell.2010.05.014; Wellbrock C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002734; Witkiewicz AK, 2011, CELL CYCLE, V10, P2497, DOI 10.4161/cc.10.15.16776; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yaswen P, 2007, CELL, V128, P233, DOI 10.1016/j.cell.2007.01.005; Yu H, 2006, AM J PATHOL, V168, P1879, DOI 10.2353/ajpath.2006.051170; Yu H, 2010, J INVEST DERMATOL, V130, P1227, DOI 10.1038/jid.2009.322; Yu H, 2009, AM J PATHOL, V174, P2367, DOI 10.2353/ajpath.2009.081057	53	10	10	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 13	2014	33	7					832	841		10.1038/onc.2012.642	http://dx.doi.org/10.1038/onc.2012.642			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB2MN	23334329	Green Accepted			2022-12-25	WOS:000331626900004
J	Moghadaszadeh, B; Rider, BE; Lawlor, MW; Childers, MK; Grange, RW; Gupta, K; Boukedes, SS; Owen, CA; Beggs, AH				Moghadaszadeh, Behzad; Rider, Branden E.; Lawlor, Michael W.; Childers, Martin K.; Grange, Robert W.; Gupta, Kushagra; Boukedes, Steve S.; Owen, Caroline A.; Beggs, Alan H.			Selenoprotein N deficiency in mice is associated with abnormal lung development	FASEB JOURNAL			English	Article						selenium; multiminicore myopathy; ryanodine receptor; alveolar enlargement; SEPN1-related myopathy	ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; RYANODINE RECEPTOR-TYPE-1; PULMONARY-EMPHYSEMA; MUSCULAR-DYSTROPHY; FIBER-TYPE; VITAMIN-E; MUSCLE; MUTATIONS; APOPTOSIS	Mutations in the human SEPN1 gene, encoding selenoprotein N (SepN), cause SEPN1-related myopathy (SEPN1-RM) characterized by muscle weakness, spinal rigidity, and respiratory insufficiency. As with other members of the selenoprotein family, selenoprotein N incorporates selenium in the form of selenocysteine (Sec). Most selenoproteins that have been functionally characterized are involved in oxidation-reduction (redox) reactions, with the Sec residue located at their catalytic site. To model SEPN1-RM, we generated a Sepn1-knockout (Sepn1(-/-)) mouse line. Homozygous Sepn1(-/-) mice are fertile, and their weight and lifespan are comparable to wild-type (WT) animals. Under baseline conditions, the muscle histology of Sepn1(-/-) mice remains normal, but subtle core lesions could be detected in skeletal muscle after inducing oxidative stress. Ryanodine receptor (RyR) calcium release channels showed lower sensitivity to caffeine in SepN deficient myofibers, suggesting a possible role of SepN in RyR regulation. SepN deficiency also leads to abnormal lung development characterized by enlarged alveoli, which is associated with decreased tissue elastance and increased quasi-static compliance of Sepn1(-/-) lungs. This finding raises the possibility that the respiratory syndrome observed in patients with SEPN1 mutations may have a primary pulmonary component in addition to the weakness of respiratory muscles.-Moghadaszadeh, B., Rider B. E., Lawlor, M. W., Childers, M. K., Grange, R. W., Gupta, K., Boukedes, S. S., Owen, C. A., Beggs, A. H. Selenoprotein N deficiency in mice is associated with abnormal lung development. FASEB J. 27, 1585-1599 (2013). www.fasebj.org	[Moghadaszadeh, Behzad; Rider, Branden E.; Lawlor, Michael W.; Beggs, Alan H.] Boston Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Moghadaszadeh, Behzad; Rider, Branden E.; Lawlor, Michael W.; Beggs, Alan H.] Boston Childrens Hosp, Program Genom, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Gupta, Kushagra; Owen, Caroline A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Boukedes, Steve S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Lung Transplant Program, Boston, MA 02115 USA; [Childers, Martin K.] Wake Forest Univ Hlth Sci, Dept Neurol, Winston Salem, NC USA; [Childers, Martin K.] Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Winston Salem, NC USA; [Grange, Robert W.] Virginia Polytech Inst & State Univ, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA; [Owen, Caroline A.] Lovelace Resp Res Inst, Albuquerque, NM USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine; Virginia Polytechnic Institute & State University; Lovelace Respiratory Research Institute	Beggs, AH (corresponding author), Boston Childrens Hosp, Div Genet, 300 Longwood Ave,CLSB 15026, Boston, MA 02115 USA.	beggs@enders.tch.harvard.edu	Owen, Caroline/H-5925-2013	Beggs, Alan/0000-0001-8818-0568; Moghadaszadeh, Behzad/0000-0001-9787-0106; Childers, Martin/0000-0003-4754-0883	Lee and Penny Anderson Family Foundation; U.S. National Institutes of Health [R01 AR044345, K08 AR059750, R21 HL111835, PO1 HL105339]; Muscular Dystrophy Association [MDA 201302]; William Randolph Hearst Foundation; BWH-Lovelace Respiratory Research Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL105339, R21HL111835, R01HL086814, T32HL007633, F32HL095276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044345, K08AR059750] Funding Source: NIH RePORTER	Lee and Penny Anderson Family Foundation; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); William Randolph Hearst Foundation; BWH-Lovelace Respiratory Research Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Nicholas Marinakis, Cynthia Hsu, Kiyomi Cho, and Kyle Schoppel for assistance with mouse experiments; Jennifer L. Cusick and Takahiro Nakajima for help with the analysis of lung sections, and Pankaj Agrawal and Vandana Gupta for their critical advice and assistance in performing enzyme and TUNEL assays. The authors also thank Suzanne White and Lena Liu (Histopathology Core Facility, Beth Israel Medical Center, Boston, MA, USA). This work was supported by a generous grant from the Lee and Penny Anderson Family Foundation, and by the U.S. National Institutes of Health, grants R01 AR044345, K08 AR059750, R21 HL111835, and PO1 HL105339; the Muscular Dystrophy Association, grant MDA 201302; the William Randolph Hearst Foundation; and the BWH-Lovelace Respiratory Research Consortium.	Aoshiba K, 2003, AM J RESP CELL MOL, V28, P555, DOI 10.1165/rcmb.2002-0090OC; Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Arbogast S, 2010, ANTIOXID REDOX SIGN, V12, P893, DOI 10.1089/ars.2009.2890; Arbogast S, 2009, ANN NEUROL, V65, P677, DOI 10.1002/ana.21644; Behne D, 2001, ANNU REV NUTR, V21, P453, DOI 10.1146/annurev.nutr.21.1.453; Boutten A, 2010, EXPERT OPIN THER TAR, V14, P329, DOI 10.1517/14728221003629750; Castets P, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-46; Clarke NF, 2006, ANN NEUROL, V59, P546, DOI 10.1002/ana.20761; Deniziak M, 2007, EXP CELL RES, V313, P156, DOI 10.1016/j.yexcr.2006.10.005; Desrumaux C, 2004, FASEB J, V18, P296, DOI 10.1096/fj.04-2400fje; Dirksen A, 2008, CLIN RESPIR J, V2, P76, DOI 10.1111/j.1752-699X.2008.00088.x; Ferreiro A, 2004, ANN NEUROL, V55, P676, DOI 10.1002/ana.20077; Ferreiro A, 2002, ANN NEUROL, V51, P750, DOI 10.1002/ana.10231; Ferreiro A, 2002, AM J HUM GENET, V71, P739, DOI 10.1086/342719; Fischer BM, 2011, INT J CHRONIC OBSTR, V6, P413, DOI 10.2147/COPD.S10770; Fishman AP., 2008, FISHMANS PULMONARY D; Geraghty P, 2011, INT J CHRONIC OBSTR, V6, P309, DOI 10.2147/COPD.S19599; Grydeland TB, 2010, AM J RESP CRIT CARE, V181, P353, DOI 10.1164/rccm.200907-1008OC; Hadaszadeh BM, 2006, PHYSIOLOGY, V21, P307, DOI 10.1152/physiol.00021.2006; Jacob C, 2003, ANGEW CHEM INT EDIT, V42, P4742, DOI 10.1002/anie.200300573; Jurynec MJ, 2008, P NATL ACAD SCI USA, V105, P12485, DOI 10.1073/pnas.0806015105; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Koike K, 2010, AM J PHYSIOL-LUNG C, V298, pL784, DOI 10.1152/ajplung.00256.2009; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lawlor MW, 2011, AM J PATHOL, V178, P784, DOI 10.1016/j.ajpath.2010.10.035; Lescure A, 1999, J BIOL CHEM, V274, P38147, DOI 10.1074/jbc.274.53.38147; Malhotra D, 2009, AM J RESP CRIT CARE, V180, P1196, DOI 10.1164/rccm.200903-0324OC; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; MENDEZ J, 1960, METABOLISM, V9, P184; Moghadaszadeh B, 2001, NAT GENET, V29, P17, DOI 10.1038/ng713; Neville H., 1973, P 2 INT C MUSCL DIS, V1, P497; Okura Y, 2009, BIOFACTORS, V35, P273, DOI 10.1002/biof.33; PARAIDATHATHU T, 1992, FREE RADICAL BIO MED, V13, P289, DOI 10.1016/0891-5849(92)90176-H; Petit N, 2003, HUM MOL GENET, V12, P1045, DOI 10.1093/hmg/ddg115; Quintero PA, 2010, J IMMUNOL, V184, P1575, DOI 10.4049/jimmunol.0900290; Rahman I, 2006, EUR J PHARMACOL, V533, P222, DOI 10.1016/j.ejphar.2005.12.087; Ravenscroft G, 2007, CELL MOTIL CYTOSKEL, V64, P727, DOI 10.1002/cm.20223; Rederstorff M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023094; ROUND JM, 1980, HISTOCHEM J, V12, P707, DOI 10.1007/BF01012026; Schara U, 2008, EUR J PAEDIATR NEURO, V12, P224, DOI 10.1016/j.ejpn.2007.08.011; Scoto M, 2011, NEUROLOGY, V76, P2073, DOI 10.1212/WNL.0b013e31821f467c; Shchedrina VA, 2010, ANTIOXID REDOX SIGN, V12, P839, DOI 10.1089/ars.2009.2865; Sitia Roberto, 2004, Sci STKE, V2004, ppe27, DOI 10.1126/stke.2392004pe27; Summermatter S, 2012, AM J PHYSIOL-CELL PH, V302, pC88, DOI 10.1152/ajpcell.00190.2011; Tagawa Y, 2008, FREE RADICAL BIO MED, V45, P50, DOI 10.1016/j.freeradbiomed.2008.03.003; Traber MG, 1996, ANNU REV NUTR, V16, P321, DOI 10.1146/annurev.nu.16.070196.001541; Treves S, 2008, CURR OPIN PHARMACOL, V8, P319, DOI 10.1016/j.coph.2008.01.005	47	27	29	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1585	1599		10.1096/fj.12-212688	http://dx.doi.org/10.1096/fj.12-212688			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23325319	Green Published			2022-12-25	WOS:000316940800029
J	Peixoto, PD; Laurent, G; Azais, T; Mosser, G				Peixoto, Paulo De Sa; Laurent, Guillaume; Azais, Thierry; Mosser, Gervaise			Solid-state NMR Study Reveals Collagen I Structural Modifications of Amino Acid Side Chains upon Fibrillogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL-SHIFTS; 2-DIMENSIONAL NMR; C-13; FIBRILS; DYNAMICS; PROTEIN; CONFORMATION; PREFERENCES; RESOLUTION; PEPTIDES	In vivo, collagen I, the major structural protein in human body, is found assembled into fibrils. In the present work, we study a high concentrated collagen sample in its soluble, fibrillar, and denatured states using one and two dimensional {H-1}-C-13 solid-state NMR spectroscopy. We interpret C-13 chemical shift variations in terms of dihedral angle conformation changes. Our data show that fibrillogenesis increases the side chain and backbone structural complexity. Nevertheless, only three to five rotameric equilibria are found for each amino acid residue, indicating a relatively low structural heterogeneity of collagen upon fibrillogenesis. Using side chain statistical data, we calculate equilibrium constants for a great number of amino acid residues. Moreover, based on a C-13 quantitative spectrum, we estimate the percentage of residues implicated in each equilibrium. Our data indicate that fibril formation greatly affects hydroxyproline and proline prolyl pucker ring conformation. Finally, we discuss the implication of these structural data and propose a model in which the attractive force of fibrillogenesis comes from a structural reorganization of 10 to 15% of the amino acids. These results allow us to further understand the self-assembling process and fibrillar structure of collagen.	[Peixoto, Paulo De Sa; Laurent, Guillaume; Azais, Thierry; Mosser, Gervaise] Univ Paris 06, CNRS, Coll France, Lab Chim Mat Condensee Paris,UMR 7574, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; Chimie ParisTech; College de France	Mosser, G (corresponding author), UPMC, CNRS, Coll France, Lab Chim Mat Condensee Paris,UMR7574, F-75005 Paris, France.	gmosser@snv.jussieu.fr	Laurent, Guillaume P./J-4328-2012; Mosser, Gervaise/M-4943-2018	Laurent, Guillaume P./0000-0002-8127-5326; Mosser, Gervaise/0000-0002-9812-5340	Ecole Doctorale Iviv 387; Universite Pierre et Marie Curie	Ecole Doctorale Iviv 387; Universite Pierre et Marie Curie	This work was supported by Ecole Doctorale Iviv 387 and the Universite Pierre et Marie Curie (to P. D. S. P.).	Aliev AE, 2005, BIOPOLYMERS, V77, P230, DOI 10.1002/bip.20217; BATCHELDER LS, 1982, P NATL ACAD SCI-BIOL, V79, P386, DOI 10.1073/pnas.79.2.386; Bella J, 2010, J STRUCT BIOL, V170, P377, DOI 10.1016/j.jsb.2010.02.003; BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053; Berisio R, 2009, J PEPT SCI, V15, P131, DOI 10.1002/psc.1082; Bolboaca S., 2007, Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Animal Science and Biotechnologies, V63/64, P311; DEDIOS AC, 1994, J AM CHEM SOC, V116, P11485, DOI 10.1021/ja00104a031; DUNBRACK RL, 1994, NAT STRUCT BIOL, V1, P334, DOI 10.1038/nsb0594-334; EJCHART A, 1977, ORG MAGN RESONANCE, V9, P351, DOI 10.1002/mrc.1270090614; Eyre DR, 2011, J BIOL CHEM, V286, P7732, DOI 10.1074/jbc.C110.195768; GIRAUDGUILLE MM, 1988, CALCIFIED TISSUE INT, V42, P167, DOI 10.1007/BF02556330; Gobeaux F, 2008, J MOL BIOL, V376, P1509, DOI 10.1016/j.jmb.2007.12.047; Hansen DF, 2010, J AM CHEM SOC, V132, P7589, DOI 10.1021/ja102090z; JELINSKI LW, 1980, J MOL BIOL, V138, P255, DOI 10.1016/0022-2836(80)90286-7; JELINSKI LW, 1980, NATURE, V284, P531, DOI 10.1038/284531a0; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; KOHDA D, 1991, BIOCHEMISTRY-US, V30, P4896, DOI 10.1021/bi00234a009; LEIKIN S, 1995, NAT STRUCT BIOL, V2, P205, DOI 10.1038/nsb0395-205; LEIKIN S, 1994, P NATL ACAD SCI USA, V91, P276, DOI 10.1073/pnas.91.1.276; LI MH, 1993, BIOCHEMISTRY-US, V32, P7377, DOI 10.1021/bi00080a007; London RE, 2008, J AM CHEM SOC, V130, P11097, DOI 10.1021/ja802729t; Massiot D, 2002, MAGN RESON CHEM, V40, P70, DOI 10.1002/mrc.984; MIKHAILOV D, 1995, BIOPHYS J, V68, P1540, DOI 10.1016/S0006-3495(95)80326-7; Mooney SD, 2002, BIOPOLYMERS, V64, P63, DOI 10.1002/bip.10123; Mosser G, 2006, MATRIX BIOL, V25, P3, DOI 10.1016/j.matbio.2005.09.002; Okuyama K, 2004, BIOPOLYMERS, V76, P367, DOI 10.1002/bip.20107; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Peixoto PD, 2011, SOFT MATTER, V7, P11203, DOI 10.1039/c1sm06076g; Reichert D, 2004, MAGN RESON CHEM, V42, P276, DOI 10.1002/mrc.1334; RICHARZ R, 1978, BIOPOLYMERS, V17, P2133, DOI 10.1002/bip.1978.360170908; SAITO H, 1984, BIOPOLYMERS, V23, P2279, DOI 10.1002/bip.360231111; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; TORCHIA DA, 1975, BIOCHEMISTRY-US, V14, P887, DOI 10.1021/bi00676a004; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Zhu PZ, 2009, J AM CHEM SOC, V131, P17064, DOI 10.1021/ja9081028	35	10	10	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7528	7535		10.1074/jbc.M112.390146	http://dx.doi.org/10.1074/jbc.M112.390146			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23341452	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000316455300009
J	Thomas, SE; Malzer, E; Ordonez, A; Dalton, LE; van 't Wout, EFA; Liniker, E; Crowther, DC; Lomas, DA; Marciniak, SJ				Thomas, Sally E.; Malzer, Elke; Ordonez, Adriana; Dalton, Lucy E.; van 't Wout, Emily F. A.; Liniker, Elizabeth; Crowther, Damian C.; Lomas, David A.; Marciniak, Stefan J.			p53 and Translation Attenuation Regulate Distinct Cell Cycle Checkpoints during Endoplasmic Reticulum (ER) Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; GLYCOGEN-SYNTHASE KINASE-3-BETA; MESSENGER-RNA TRANSLATION; DNA-DAMAGE; ATAXIA-TELANGIECTASIA; DOWN-REGULATION; IN-VIVO; APOPTOSIS; ISOFORMS; PHOSPHORYLATION	Cell cycle checkpoints ensure that proliferation occurs only under permissive conditions, but their role in linking nutrient availability to cell division is incompletely understood. Protein folding within the endoplasmic reticulum ( ER) is exquisitely sensitive to energy supply and amino acid sources because deficiencies impair luminal protein folding and consequently trigger ER stress signaling. Following ER stress, many cell types arrest within the G(1) phase, although recent studies have identified a novel ER stress G(2) checkpoint. Here, we report that ER stress affects cell cycle progression via two classes of signal: an early inhibition of protein synthesis leading to G(2) delay involving CHK1 and a later induction of G(1) arrest associated both with the induction of p53 target genes and loss of cyclin D-1. We show that substitution of p53/47 for p53 impairs the ER stress G(1) checkpoint, attenuates the recovery of protein translation, and impairs induction of NOXA, a mediator of cell death. We propose that cell cycle regulation in response to ER stress comprises redundant pathways invoked sequentially first to impair G(2) progression prior to ultimate G(1) arrest.	[Thomas, Sally E.; Malzer, Elke; Ordonez, Adriana; Dalton, Lucy E.; van 't Wout, Emily F. A.; Liniker, Elizabeth; Lomas, David A.; Marciniak, Stefan J.] Univ Cambridge, Wellcome Trust, Dept Med, Cambridge CB2 0XY, England; [Thomas, Sally E.; Malzer, Elke; Ordonez, Adriana; Dalton, Lucy E.; van 't Wout, Emily F. A.; Liniker, Elizabeth; Lomas, David A.; Marciniak, Stefan J.] Univ Cambridge, Wellcome Trust, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Malzer, Elke; Crowther, Damian C.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge	Marciniak, SJ (corresponding author), Univ Cambridge, Wellcome Trust, Dept Med, Med Res Council Bldg,Hills Rd, Cambridge CB2 0XY, England.	sjm20@cam.ac.uk	Marciniak, Stefan J/F-1855-2010	Marciniak, Stefan/0000-0001-8472-7183	Diabetes UK; Medical Research Council (MRC) (UK); British Lung Foundation; MRC [G1002610]; Medical Research Council [G1002610, G0601840, G0700990, G0901786] Funding Source: researchfish; National Institute for Health Research [ACF-2011-14-006] Funding Source: researchfish; MRC [G0700990, G0601840, G0901786] Funding Source: UKRI	Diabetes UK(Diabetes UK); Medical Research Council (MRC) (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Lung Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Diabetes UK, the Medical Research Council (MRC) (UK), and the British Lung Foundation.; An MRC Senior Clinical Fellow (Grant G1002610). To whom correspondence should be addressed. Tel.: 44-1223-762660; Fax: 44-1223-336827; E-mail: sjm20@cam.ac.uk.	Alderton GK, 2004, HUM MOL GENET, V13, P3127, DOI 10.1093/hmg/ddh335; Allagnat F, 2011, CELL DEATH DIFFER, V18, P328, DOI 10.1038/cdd.2010.105; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Baltzis D, 2007, J BIOL CHEM, V282, P31675, DOI 10.1074/jbc.M704491200; Bobrovnikova-Marjon E, 2010, ONCOGENE, V29, P3881, DOI 10.1038/onc.2010.153; Bourougaa K, 2010, MOL CELL, V38, P78, DOI 10.1016/j.molcel.2010.01.041; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Candeias MM, 2006, ONCOGENE, V25, P6936, DOI 10.1038/sj.onc.1209996; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Ganzinelli M, 2008, CLIN CANCER RES, V14, P5131, DOI 10.1158/1078-0432.CCR-08-0304; Gatei M, 2003, J BIOL CHEM, V278, P14806, DOI 10.1074/jbc.M210862200; Gilad S, 1996, HUM MOL GENET, V5, P433, DOI 10.1093/hmg/5.4.433; Grover R, 2008, CELL CYCLE, V7, P2189, DOI 10.4161/cc.7.14.6271; Grover R, 2011, RNA BIOL, V8, P132, DOI 10.4161/rna.8.1.14260; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; He L, 2009, FEBS LETT, V583, P903, DOI 10.1016/j.febslet.2009.02.002; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Irving JA, 2011, METHOD ENZYMOL, V501, P421, DOI 10.1016/B978-0-12-385950-1.00018-3; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Krastev DB, 2011, NAT CELL BIOL, V13, P809, DOI 10.1038/ncb2264; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma W, 2012, ONCOGENE, V31, P1024, DOI 10.1038/onc.2011.300; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Malzer E, 2010, J CELL SCI, V123, P2892, DOI 10.1242/jcs.070078; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Olivares-Illana V, 2010, ONCOGENE, V29, P5113, DOI 10.1038/onc.2010.266; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pluquet O, 2005, MOL CELL BIOL, V25, P9392, DOI 10.1128/MCB.25.21.9392-9405.2005; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; RABINOVITZ M, 1962, J BIOL CHEM, V237, P477; Raven JF, 2008, J BIOL CHEM, V283, P3097, DOI 10.1074/jbc.M709677200; Ray PS, 2006, EMBO REP, V7, P404, DOI 10.1038/sj.embor.7400623; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Steller H, 2000, NAT CELL BIOL, V2, pE100, DOI 10.1038/35014093; Thomas SE, 2010, DIABETES-METAB RES, V26, P611, DOI 10.1002/dmrr.1132; van Schadewijk A, 2012, CELL STRESS CHAPERON, V17, P275, DOI 10.1007/s12192-011-0306-2; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Zhang F, 2006, J BIOL CHEM, V281, P30036, DOI 10.1074/jbc.M604674200; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	58	33	33	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7606	7617		10.1074/jbc.M112.424655	http://dx.doi.org/10.1074/jbc.M112.424655			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23341460	Green Published, hybrid			2022-12-25	WOS:000316455300018
J	Bader, HL; Lambert, E; Guiraud, A; Malbouyres, M; Driever, W; Koch, M; Ruggiero, F				Bader, Hannah L.; Lambert, Elise; Guiraud, Alexandre; Malbouyres, Marilyne; Driever, Wolfgang; Koch, Manuel; Ruggiero, Florence			Zebrafish Collagen XIV Is Transiently Expressed in Epithelia and Is Required for Proper Function of Certain Basement Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-SPECIFIC EXPRESSION; EXTRACELLULAR-MATRIX; BINDING-PROPERTIES; GROWTH; EMPHASIS; UNDULIN; PROTEIN; FORM	We found that zebrafish has two differentially expressed col14a1 paralogs. col14a1a expression peaked between 18-somite stage and 24 hours postfertilization (hpf), whereas col14a1b was first expressed at 32 hpf. To uncover functions of collagen XIV (COLXIV) during early embryogenesis, we focused our study on col14a1a. We characterized the alpha 1 (XIV-A) chain as a collagenase-sensitive 200-kDa protein that formed dimer that could be reduced at high pH. As observed for the transcript, COLXIV-A protein expression peaked between 24 and 48 hpf. Using antisense probes and polyclonal antibodies, we show that col14a1a and its protein product COLXIV-A are transiently expressed in several epithelia, including epithelia undergoing shape changes, such as the fin folds. In contrast, anti-COLXII antibodies stained only connective tissues. COLXIV-A was also detected in the basement membrane (BM), where it co-localized with COLXII. At later developmental stages, COLXIV-A was not expressed in epithelia anymore but persisted in the BM. Morpholino knockdown of COLXIV-A provoked a skin detachment phenotype. Electron microscopy analysis revealed that morpholino-injected embryos lacked a lamina densa and lamina lucida at 24 hpf, and BM defects, such as gaps in the adepidermal granules, were still detected at 48 hpf. These BM defects were accompanied by a rupture of the dermis and detachment of the epidermis. Taken together, these data suggest an unexpected role of COLXIV-A in undifferentiated epithelia and in the formation of embryonic basement membranes.	[Bader, Hannah L.; Lambert, Elise; Guiraud, Alexandre; Malbouyres, Marilyne; Ruggiero, Florence] Univ Lyon 1, Ecole Normale Super Lyon, UMR CNRS 5242, Inst Genom Fonct Lyon, F-69364 Lyon 07, France; [Driever, Wolfgang] Univ Freiburg, Inst Biol 1, Dept Dev Biol, D-79104 Freiburg, Germany; [Bader, Hannah L.; Koch, Manuel] Univ Cologne, Fac Med, Ctr Mol Med Cologne, Inst Dent Res & Musculoskeletal Biol,Ctr Biochem, D-50931 Cologne, Germany	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); University of Freiburg; University of Cologne	Ruggiero, F (corresponding author), ENS Lyon, Inst Genom Fonct Lyon, 46 Allee Italie, F-69364 Lyon 07, France.	florence.ruggiero@ens-lyon.fr	Koch, Manuel/AAG-9914-2021	Koch, Manuel/0000-0002-2962-7814; RUGGIERO, Florence/0000-0003-2915-5359; Driever, Wolfgang/0000-0002-9551-9141; Guiraud, Alexandre/0000-0002-7636-9205; LAMBERT, Elise/0000-0003-1192-0112	Agence Nationale de la Recherche [10BLAN121901]; Emergence Research Program (Region Rhone-Alpes); University Lyon 1 (Bonus Qualite Recherche); University Lyon1; German Academic Exchange Service	Agence Nationale de la Recherche(French National Research Agency (ANR)); Emergence Research Program (Region Rhone-Alpes)(Region Auvergne-Rhone-Alpes); University Lyon 1 (Bonus Qualite Recherche); University Lyon1; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by Agence Nationale de la Recherche Grant 10BLAN121901 and grants from the Emergence Research Program (Region Rhone-Alpes) and from the University Lyon 1 (Bonus Qualite Recherche). Recipient of a doctoral fellowship from the University Lyon1 and the German Academic Exchange Service. Present address: Boston University School of Medicine, Dept. of Medicine, Evans Biomedical Research Bldg. X-440, Boston, MA 022118.	Agarwal P, 2012, J BIOL CHEM, V287, P22549, DOI 10.1074/jbc.M111.335935; Ansorge HL, 2009, J BIOL CHEM, V284, P8427, DOI 10.1074/jbc.M805582200; AUBERTFOUCHER E, 1992, J BIOL CHEM, V267, P15759; Bader HL, 2009, MATRIX BIOL, V28, P32, DOI 10.1016/j.matbio.2008.09.580; Bauer M, 1997, BBA-GENE STRUCT EXPR, V1354, P183, DOI 10.1016/S0167-4781(97)00131-0; BROWN JC, 1993, J CELL BIOL, V120, P557, DOI 10.1083/jcb.120.2.557; CASTAGNOLA P, 1992, EUR J CELL BIOL, V59, P340; Charvet B, 2011, CELL TISSUE RES, V346, P439, DOI 10.1007/s00441-011-1266-7; Dahm R, 2007, EXP EYE RES, V85, P74, DOI 10.1016/j.exer.2007.02.015; Ehnis T, 1996, EXP CELL RES, V229, P388, DOI 10.1006/excr.1996.0384; Furthauer M., 2001, R01RR15402 NIH; Gordon MK, 1996, DEV DYNAM, V206, P49, DOI 10.1002/(SICI)1097-0177(199605)206:1<49::AID-AJA5>3.3.CO;2-T; Haddon C, 1996, J COMP NEUROL, V365, P113, DOI 10.1002/(SICI)1096-9861(19960129)365:1<113::AID-CNE9>3.0.CO;2-6; HANSEN A, 1993, J COMP NEUROL, V333, P289, DOI 10.1002/cne.903330213; Hauptmann G, 2000, METH MOL B, V137, P139; Imhof M, 2001, J BIOL CHEM, V276, P9141, DOI 10.1074/jbc.M009148200; Izu Y, 2011, J CELL BIOL, V193, P1115, DOI 10.1083/jcb.201010010; KEENE DR, 1991, J CELL BIOL, V113, P971, DOI 10.1083/jcb.113.4.971; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klein G, 1998, MATRIX BIOL, V16, P307, DOI 10.1016/S0945-053X(98)90002-6; KOCH M, 1992, EUR J BIOCHEM, V207, P847, DOI 10.1111/j.1432-1033.1992.tb17116.x; Le Guellec D, 2004, INT J DEV BIOL, V48, P217, DOI 10.1387/ijdb.15272388; Maguen E, 1997, CORNEA, V16, P675; Ricard-Blum S, 2005, PATHOL BIOL, V53, P430, DOI 10.1016/j.patbio.2004.12.024; Schlosser G, 2006, DEV BIOL, V294, P303, DOI 10.1016/j.ydbio.2006.03.009; SCHNITTGER S, 1995, CYTOGENET CELL GENET, V68, P233, DOI 10.1159/000133920; SCHUPPAN D, 1990, J BIOL CHEM, V265, P8823; Tao G, 2012, J MOL CELL CARDIOL, V53, P626, DOI 10.1016/j.yjmcc.2012.08.002; Tomte LT, 2004, J MOL HISTOL, V35, P803, DOI 10.1007/s10735-004-1132-y; vanEeden FJM, 1996, DEVELOPMENT, V123, P255; WALCHLI C, 1994, J CELL SCI, V107, P669; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; Webb AE, 2007, DEV BIOL, V311, P369, DOI 10.1016/j.ydbio.2007.08.034; Westerfield M, 2007, ZEBRAFISH BOOK GUIDE; Young BB, 2000, DEV DYNAM, V217, P430, DOI 10.1002/(SICI)1097-0177(200004)217:4<430::AID-DVDY10>3.0.CO;2-5	35	21	21	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6777	6787		10.1074/jbc.M112.430637	http://dx.doi.org/10.1074/jbc.M112.430637			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23325806	Green Published, hybrid			2022-12-25	WOS:000316002400001
J	Kim, MK; Jeon, BN; Koh, DI; Kim, KS; Park, SY; Yun, CO; Hur, MW				Kim, Min-Kyeong; Jeon, Bu-Nam; Koh, Dong-In; Kim, Kyung-Sup; Park, So-Yoon; Yun, Chae-Ok; Hur, Man-Wook			Regulation of the Cyclin-dependent Kinase Inhibitor 1A Gene (CDKN1A) by the Repressor BOZF1 through Inhibition of p53 Acetylation and Transcription Factor Sp1 Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; FINGER ENCODING GENE; ZINC-FINGER; DNA-DAMAGE; CELL-CYCLE; PROMYELOCYTIC LEUKEMIA; IN-VITRO; P21; ACTIVATION; APOPTOSIS	The human POZ domain and Kruppel-like zinc finger (POK) family proteins play important roles in the regulation of apoptosis, cell proliferation, differentiation, development, oncogenesis, and tumor suppression. A novel POK family transcription factor, BTB/POZ and zinc finger domains factor on chromosome 1 (BOZF-1; also called ZBTB8A), contains a POZ domain and two C2H2-type Kruppel-like zinc fingers and is localized at nuclear speckles. Compared with paired normal tissues, BOZF1 expression is increased in cancer tissues of the prostate, breast, and cervix. BOZF1 repressed the transcription of p21WAF/CDKN1A by acting on the proximal promoter concentrated with Sp1-binding GC boxes. BOZF1 competed with Sp1 in binding to GC boxes 1-5/6 of the CDKN1A proximal promoter. In addition, BOZF1 interacted with p53 and decreased the acetylation of p53 by p300, which reduced the DNA binding activity of p53 at the far distal p53-binding element. BOZF1 blocked the two major molecular events that are important in both constitutive and inducible transcription activation of CDKN1A. BOZF1 is unique in that it bound to all the proximal GC boxes to repress transcription, and it inhibited p53 acetylation without affecting p53 stability. BOZF1 might be a novel proto-oncoprotein that stimulates cell proliferation.	[Kim, Min-Kyeong; Jeon, Bu-Nam; Koh, Dong-In; Kim, Kyung-Sup; Hur, Man-Wook] Yonsei Univ, Brain Korea Project Med Sci 21, Dept Biochem & Mol Biol, Severance Biomed Res Inst,Sch Med, Seoul 120752, South Korea; [Park, So-Yoon] SoonChunHyang Univ Hosp, Dept Pathol, Gumi Si 730706, Gyeongbuk, South Korea; [Yun, Chae-Ok] Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 134791, South Korea	Yonsei University; Soonchunhyang University; Soonchunhyang University Hospital; Hanyang University	Hur, MW (corresponding author), Yonsei Univ, Sch Med, Dept Biochem & Mol Biol, 134 ShinChon Dong, Seoul 120752, South Korea.	mwhur2@yuhs.ac	Yun, Chae-Ok/P-3698-2015	Hur, Man-Wook/0000-0002-3416-1334; Yun, Chae-Ok/0000-0002-9466-4531; Kim, Kyung-sup/0000-0001-8483-8537	Do-Yak Program [2011-0028817]; Midcareer Researcher Program [2009-0081294]; Medical Research Center from the National Research Foundation of Korea [2011-0030708]; Korean government (Ministry of Education, Science and Technology)	Do-Yak Program; Midcareer Researcher Program; Medical Research Center from the National Research Foundation of Korea(National Research Foundation of Korea); Korean government (Ministry of Education, Science and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by Do-Yak Program Grant 2011-0028817 (to M.-W. H.) and Midcareer Researcher Program Grant 2009-0081294) (to M.-W. H.) and in part by Medical Research Center Grant 2011-0030708) (to M.-W. H.) from the National Research Foundation of Korea, which is funded through the Korean government (Ministry of Education, Science and Technology).	Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chao C, 2006, MOL CELL BIOL, V26, P6859, DOI 10.1128/MCB.00062-06; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Choi WI, 2009, J BIOL CHEM, V284, P12633, DOI 10.1074/jbc.M809794200; Costoya Jose A., 2007, Briefings in Functional Genomics & Proteomics, V6, P8, DOI 10.1093/bfgp/elm002; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fujii H, 1998, ONCOGENE, V16, P2159, DOI 10.1038/sj.onc.1201976; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gartel AL, 2000, ONCOGENE, V19, P5182, DOI 10.1038/sj.onc.1203900; HARPER JW, 1993, CELL, V75, P805; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Jeon BN, 2012, CANCER RES, V72, P1137, DOI 10.1158/0008-5472.CAN-11-2433; Jeon BN, 2009, J BIOL CHEM, V284, P17935, DOI 10.1074/jbc.M809559200; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; King KL, 1998, ANNU REV PHYSIOL, V60, P601, DOI 10.1146/annurev.physiol.60.1.601; Koh DI, 2009, J BIOL CHEM, V284, P19856, DOI 10.1074/jbc.M109.025817; Koutsodontis G, 2001, J BIOL CHEM, V276, P29116, DOI 10.1074/jbc.M104130200; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lee DK, 2002, J BIOL CHEM, V277, P26761, DOI 10.1074/jbc.M202078200; Lee KM, 2012, ONCOGENE, V31, P1442, DOI 10.1038/onc.2011.331; Liu L, 1999, MOL CELL BIOL, V19, P1202; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; McKenzie PP, 1999, CLIN CANCER RES, V5, P4199; Melnick A, 2000, MOL CELL BIOL, V20, P6550, DOI 10.1128/MCB.20.17.6550-6567.2000; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Pessler F, 1997, MOL CELL BIOL, V17, P3786, DOI 10.1128/MCB.17.7.3786; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Prives C, 1999, J PATHOL, V187, P112; Schneider A, 1997, CURR TOP MICROBIOL, V224, P137; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; WALDMAN T, 1995, CANCER RES, V55, P5187; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Weber A, 2008, EMBO J, V27, P1563, DOI 10.1038/emboj.2008.85; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Yeyati PL, 1999, ONCOGENE, V18, P925, DOI 10.1038/sj.onc.1202375; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006	46	9	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7053	7064		10.1074/jbc.M112.416297	http://dx.doi.org/10.1074/jbc.M112.416297			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23329847	hybrid, Green Published			2022-12-25	WOS:000316002400027
J	Demmer, U; Warkentin, E; Srivastava, A; Kockelkorn, D; Potter, M; Marx, A; Fuchs, G; Ermler, U				Demmer, Ulrike; Warkentin, Eberhard; Srivastava, Ankita; Kockelkorn, Daniel; Poetter, Markus; Marx, Achim; Fuchs, Georg; Ermler, Ulrich			Structural Basis for a Bispecific NADP(+) and CoA Binding Site in an Archaeal Malonyl-Coenzyme A Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SEMIALDEHYDE DEHYDROGENASE; AUTOTROPHIC CARBON FIXATION; 3-HYDROXYPROPIONATE CYCLE; CHLOROFLEXUS-AURANTIACUS; ESCHERICHIA-COLI; CATALYTIC CYCLE; A REDUCTASE; SULFOLOBUS; CARBOXYLASE; INTERMEDIATE	Autotrophic members of the Sulfolobales (crenarchaeota) use the 3-hydroxypropionate/4-hydroxybutyrate cycle to assimilate CO2 into cell material. The product of the initial acetyl-CoA carboxylation with CO2, malonyl-CoA, is further reduced to malonic semialdehyde by an NADPH-dependent malonyl-CoA reductase (MCR); the enzyme also catalyzes the reduction of succinyl-CoA to succinic semialdehyde onwards in the cycle. Here, we present the crystal structure of Sulfolobus tokodaii malonyl-CoA reductase in the substrate-free state and in complex with NADP(+) and CoA. Structural analysis revealed an unexpected reaction cycle in which NADP(+) and CoA successively occupy identical binding sites. Both coenzymes are pressed into an S-shaped, nearly superimposable structure imposed by a fixed and preformed binding site. The template-governed cofactor shaping implicates the same binding site for the 3'- and 2'-ribose phosphate group of CoA and NADP(+), respectively, but a different one for the common ADP part: the beta-phosphate of CoA aligns with the alpha-phosphate of NADP(+). Evolution from an NADP(+) to a bispecific NADP(+) and CoA binding site involves many amino acid exchanges within a complex process by which constraints of the CoA structure also influence NADP(+) binding. Based on the paralogous aspartate-beta-semialdehyde dehydrogenase structurally characterized with a covalent Cys-aspartyl adduct, a malonyl/succinyl group can be reliably modeled into MCR and discussed regarding its binding mode, the malonyl/succinyl specificity, and the catalyzed reaction. The modified polypeptide surrounding around the absent ammonium group in malonate/succinate compared with aspartate provides the structural basis for engineering a methylmalonyl-CoA reductase applied for biotechnical polyester building block synthesis.	[Demmer, Ulrike; Warkentin, Eberhard; Srivastava, Ankita; Ermler, Ulrich] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Kockelkorn, Daniel; Fuchs, Georg] Univ Freiburg, Mikrobiol Inst Biol 2, D-79104 Freiburg, Germany; [Poetter, Markus; Marx, Achim] Evon Ind AG, D-45128 Essen, Germany	Max Planck Society; University of Freiburg	Ermler, U (corresponding author), Max Planck Inst Biophys, Max von Laue Str 3, D-60438 Frankfurt, Germany.	ulrich.ermler@biophys.mpg.de			Deutsche Forschungsgemeinschaft [Fu 118/15-4]; Evonik Industries AG	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Evonik Industries AG	This work was supported by Deutsche Forschungsgemeinschaft (Fu 118/15-4) and Evonik Industries AG.	Alber B, 2006, J BACTERIOL, V188, P8551, DOI 10.1128/JB.00987-06; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Blanco J, 2003, P NATL ACAD SCI USA, V100, P12613, DOI 10.1073/pnas.1634958100; Burton NP, 1999, ARCH MICROBIOL, V172, P349, DOI 10.1007/s002030050771; Chuakrut S, 2003, J BACTERIOL, V185, P938, DOI 10.1128/JB.185.3.938-947.2003; Ciesla J, 2006, ACTA BIOCHIM POL, V53, P11; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evguenieva-Hackenberg E, 2002, J BIOL CHEM, V277, P46145, DOI 10.1074/jbc.M208717200; Faehnle CR, 2006, J BIOL CHEM, V281, P31031, DOI 10.1074/jbc.M605926200; Faehnle CR, 2005, J MOL BIOL, V353, P1055, DOI 10.1016/j.jmb.2005.09.027; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Hugler M, 2002, J BACTERIOL, V184, P2404, DOI 10.1128/JB.184.9.2404-2410.2002; Ishii M, 1996, ARCH MICROBIOL, V166, P368, DOI 10.1007/BF01682981; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kawarabayasi Y, 2001, DNA RES, V8, P123, DOI 10.1093/dnares/8.4.123; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kockelkorn D, 2009, J BACTERIOL, V191, P6352, DOI 10.1128/JB.00794-09; Lei Y, 2008, BIOCHEMISTRY-US, V47, P6870, DOI 10.1021/bi800349k; Manjasetty BA, 2003, P NATL ACAD SCI USA, V100, P6992, DOI 10.1073/pnas.1236794100; Menendez C, 1999, J BACTERIOL, V181, P1088, DOI 10.1128/JB.181.4.1088-1098.1999; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NORRIS P, 1989, FEMS SYMP, V49, P24; Pejchal R, 2005, BIOCHEMISTRY-US, V44, P11447, DOI 10.1021/bi050533q; Ricagno S, 2003, EMBO J, V22, P3210, DOI 10.1093/emboj/cdg333; SKARZYNSKI T, 1987, J MOL BIOL, V193, P171, DOI 10.1016/0022-2836(87)90635-8; SMITH LT, 1980, ARCH BIOCHEM BIOPHYS, V203, P663, DOI 10.1016/0003-9861(80)90224-6; STORER AC, 1994, METHOD ENZYMOL, V244, P486; Suzuki T, 2002, EXTREMOPHILES, V6, P39, DOI 10.1007/s007920100221; Viola R. E., 2011, AMINO ACIDS, V2011; WOLODKO WT, 1994, J BIOL CHEM, V269, P10883; Zarzycki J, 2011, APPL ENVIRON MICROB, V77, P6181, DOI 10.1128/AEM.00705-11	31	15	20	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6363	6370		10.1074/jbc.M112.421263	http://dx.doi.org/10.1074/jbc.M112.421263			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23325803	hybrid, Green Published			2022-12-25	WOS:000315820700031
J	Watanabe, S; Sanuki, R; Ueno, S; Koyasu, T; Hasegawa, T; Furukawa, T				Watanabe, Satoshi; Sanuki, Rikako; Ueno, Shinji; Koyasu, Toshiyuki; Hasegawa, Toshiaki; Furukawa, Takahisa			Tropisms of AAV for Subretinal Delivery to the Neonatal Mouse Retina and Its Application for In Vivo Rescue of Developmental Photoreceptor Disorders	PLOS ONE			English	Article							CELL FATE DETERMINATION; CONE-ROD DYSTROPHY; HOMEOBOX GENE; NEURAL RETINA; CRX; TRANSDUCTION; EXPRESSION; MUTATIONS; PROTEIN; MICE	Background: Adeno-associated virus (AAV) is well established as a vehicle for in vivo gene transfer into the mammalian retina. This virus is promising not only for gene therapy of retinal diseases, but also for in vivo functional analysis of retinal genes. Previous reports have shown that AAV can infect various cell types in the developing mouse retina. However, AAV tropism in the developing retina has not yet been examined in detail. Methodology/Principal Findings: We subretinally delivered seven AAV serotypes (AAV2/1, 2/2, 2/5, 2/8, 2/9, 2/10, and 2/11) of AAV-CAG-mCherry into P0 mouse retinas, and quantitatively evaluated the tropisms of each serotype by its infecting degree in retinal cells. After subretinal injection of AAV into postnatal day 0 (P0) mouse retinas, various retinal cell types were efficiently transduced with different AAVs. Photoreceptor cells were efficiently transduced with AAV2/5. Retinal cells, except for bipolar and Muller glial cells, were efficiently transduced with AAV2/9. Horizontal and/or ganglion cells were efficiently transduced with AAV2/1, AAV2/2, AAV2/8, AAV2/9 and AAV2/10. To confirm the usefulness of AAV-mediated gene transfer into the P0 mouse retina, we performed AAV-mediated rescue of the Cone-rod homeobox gene knockout (Crx KO) mouse, which exhibits an outer segment formation defect, flat electroretinogram (ERG) responses, and photoreceptor degeneration. We injected an AAV expressing Crx under the control of the Crx 2kb promoter into the neonatal Crx KO retina. We showed that AAV mediated-Crx expression significantly decreased the abnormalities of the Crx KO retina. Conclusion/Significance: In the current study, we report suitable AAV tropisms for delivery into the developing mouse retina. Using AAV2/5 in photoreceptor cells, we demonstrated the possibility of gene replacement for the developmental disorder and subsequent degeneration of retinal photoreceptors caused by the absence of Crx.	[Watanabe, Satoshi; Sanuki, Rikako; Furukawa, Takahisa] Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, Suita, Osaka 565, Japan; [Watanabe, Satoshi; Sanuki, Rikako; Furukawa, Takahisa] CREST, JST, Suita, Osaka, Japan; [Watanabe, Satoshi; Sanuki, Rikako; Furukawa, Takahisa] Osaka Biosci Inst, Dept Dev Biol, Suita, Osaka 565, Japan; [Watanabe, Satoshi] Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto, Japan; [Ueno, Shinji; Koyasu, Toshiyuki] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Showa Ku, Nagoya, Aichi 4648601, Japan; [Hasegawa, Toshiaki] Osaka Univ, Res Ctr Ultra High Voltage Electron Microscopy, Ibaraki, Osaka, Japan	Osaka University; Japan Science & Technology Agency (JST); Kyoto University; Nagoya University; Osaka University	Furukawa, T (corresponding author), Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, Suita, Osaka 565, Japan.	takahisa.furukawa@protein.osaka-u.ac.jp	Ueno, Shinji/M-5063-2014; Sanuki, Rikako/AAV-7143-2021	Sanuki, Rikako/0000-0001-9862-9840; Watanabe, Satoshi/0000-0002-8129-6223	CREST; Japan Science and Technology Agency; Molecular Brain Science; Ministry of Education, Culture, Sports and Technology of Japan [20390087, 24700360]; The Takeda Science Foundation; The Uehara Memorial Foundation; Novartis Foundation [20-10]; The Naito Foundation; Senri Life Science Foundation; Kato Memorial Bioscience Foundation; Daiichi-Sankyo Foundation of Life Science; Japanese Retinitis Pigmentosa Society Foundation; Research Foundation for Opto-Science and Technology	CREST(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Molecular Brain Science; Ministry of Education, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Takeda Science Foundation(Takeda Science Foundation (TSF)); The Uehara Memorial Foundation(Uehara Memorial Foundation); Novartis Foundation(Novartis); The Naito Foundation; Senri Life Science Foundation; Kato Memorial Bioscience Foundation; Daiichi-Sankyo Foundation of Life Science; Japanese Retinitis Pigmentosa Society Foundation; Research Foundation for Opto-Science and Technology	This work was supported by CREST and from Japan Science and Technology Agency (http://www.jst.go.jp), a grant for Molecular Brain Science, Grants-in-Aid for Scientific Research on Priority Areas, and Grant-in-Aid for Scientific Research (B) (#20390087), Young Scientists (B) (#24700360) from the Ministry of Education, Culture, Sports and Technology of Japan (http://www.jsps.go.jp/), The Takeda Science Foundation (http://www.takeda-sci.or.jp/), The Uehara Memorial Foundation (http://www.ueharazaidan.com/), Novartis Foundation (#20-10, http://novartisfound.or.jp/), The Naito Foundation (http://www.naito-f.or.jp/), Senri Life Science Foundation (#S-2144, http://www.senri-life.or.jp/), Kato Memorial Bioscience Foundation (http://www.katokinen.or.jp/), Daiichi-Sankyo Foundation of Life Science; Japanese Retinitis Pigmentosa Society Foundation, and Research Foundation for Opto-Science and Technology (http://www.jrps.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocca M, 2007, J VIROL, V81, P11372, DOI 10.1128/JVI.01327-07; Auricchio A, 2001, HUM MOL GENET, V10, P3075, DOI 10.1093/hmg/10.26.3075; Bostick B, 2007, GENE THER, V14, P1605, DOI 10.1038/sj.gt.3303029; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; de Melo J, 2011, J VIS EXP, V52; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa A, 2002, J NEUROSCI, V22, P1640, DOI 10.1523/JNEUROSCI.22-05-01640.2002; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Gamsiz ED, 2012, GENOMICS, V99, P44, DOI 10.1016/j.ygeno.2011.09.003; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057; Giove TJ, 2010, EXP EYE RES, V91, P652, DOI 10.1016/j.exer.2010.08.011; Hsiau THC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000643; Koike C, 2005, J NEUROSCI, V25, P10290, DOI 10.1523/JNEUROSCI.3657-05.2005; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mori S, 2004, VIROLOGY, V330, P375, DOI 10.1016/j.virol.2004.10.012; Morrow EM, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-5; Muranishi Y, 2011, J NEUROSCI, V31, P16792, DOI 10.1523/JNEUROSCI.3109-11.2011; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Omori Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019685; Sanuki R, 2011, NAT NEUROSCI, V14, P1125, DOI 10.1038/nn.2897; Sohocki MM, 1998, AM J HUM GENET, V63, P1307, DOI 10.1086/302101; Surace EM, 2003, J VIROL, V77, P7957, DOI 10.1128/JVI.77.14.7957-7963.2003; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7	29	37	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54146	10.1371/journal.pone.0054146	http://dx.doi.org/10.1371/journal.pone.0054146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335994	Green Submitted, Green Published, gold			2022-12-25	WOS:000314707700052
J	Jaafari, N; Konopacki, FA; Owen, TF; Kantamneni, S; Rubin, P; Craig, TJ; Wilkinson, KA; Henley, JM				Jaafari, Nadia; Konopacki, Filip A.; Owen, Thomas F.; Kantamneni, Sriharsha; Rubin, Philip; Craig, Tim J.; Wilkinson, Kevin A.; Henley, Jeremy M.			SUMOylation Is Required for Glycine-Induced Increases in AMPA Receptor Surface Expression (ChemLTP) in Hippocampal Neurons	PLOS ONE			English	Article							PROTEIN SUMOYLATION; MESSENGER-RNA; CYTOPLASMIC POLYADENYLATION; SYNAPTIC PLASTICITY; PHOSPHORYLATION; TRAFFICKING; LOCALIZATION; TRANSLATION; MECHANISMS; GROWTH	Multiple pathways participate in the AMPA receptor trafficking that underlies long-term potentiation (LTP) of synaptic transmission. Here we demonstrate that protein SUMOylation is required for insertion of the GluA1 AMPAR subunit following transient glycine-evoked increase in AMPA receptor surface expression (ChemLTP) in dispersed neuronal cultures. ChemLTP increases co-localisation of SUMO-1 and the SUMO conjugating enzyme Ubc9 and with PSD95 consistent with the recruitment of SUMOylated proteins to dendritic spines. In addition, we show that ChemLTP increases dendritic levels of SUMO-1 and Ubc9 mRNA. Consistent with activity dependent translocation of these mRNAs to sites near synapses, levels of the mRNA binding and dendritic transport protein CPEB are also increased by ChemLTP. Importantly, reducing the extent of substrate protein SUMOylation by overexpressing the deSUMOylating enzyme SENP-1 or inhibiting SUMOylation by expressing dominant negative Ubc9 prevent the ChemLTP-induced increase in both AMPAR surface expression and dendritic SUMO-1 mRNA. Taken together these data demonstrate that SUMOylation of synaptic protein(s) involved in AMPA receptor trafficking is necessary for activity-dependent increases in AMPAR surface expression.	[Jaafari, Nadia; Konopacki, Filip A.; Owen, Thomas F.; Kantamneni, Sriharsha; Rubin, Philip; Craig, Tim J.; Wilkinson, Kevin A.; Henley, Jeremy M.] Univ Bristol, Sch Biochem, Bristol, Avon, England	University of Bristol	Henley, JM (corresponding author), Univ Bristol, Sch Biochem, Bristol, Avon, England.	j.m.henley@bristol.ac.uk	Kantamneni, Sriharsha/G-6504-2012; Wilkinson, Kevin/AAM-2888-2020	Kantamneni, Sriharsha/0000-0002-3750-9447; Wilkinson, Kevin/0000-0002-8115-8592; Henley, Jeremy/0000-0003-3589-8335; Konopacki, Filip/0000-0001-6679-1966	Medical Research Council; European Research Council; Wellcome Trust; BBSRC [BB/K014358/1, BB/K014366/1, BB/F00723X/1] Funding Source: UKRI; MRC [G9629038, G0601810] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K014358/1, BB/K014366/1, BB/F00723X/1] Funding Source: researchfish; Medical Research Council [G0601810, G9629038] Funding Source: researchfish; Alzheimer&quot;s Society [170] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Alzheimer&quot;s Society	Funding: The authors are grateful to the Medical Research Council, the European Research Council and the Wellcome Trust for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DB, 2009, DRUG NEWS PERSPECT, V22, P255, DOI 10.1358/dnp.2009.22.5.1378636; Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Atkins CM, 2005, J NEUROSCI, V25, P5604, DOI 10.1523/JNEUROSCI.5051-04.2005; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Chamberlain SEL, 2012, NAT NEUROSCI, V15, P845, DOI 10.1038/nn.3089; Cimarosti H, 2012, J CEREBR BLOOD F MET, V32, P17, DOI 10.1038/jcbfm.2011.146; Costa-Mattioli M, 2009, PROG MOL BIOL TRANSL, V90, P293, DOI 10.1016/S1877-1173(09)90008-4; Craig TJ, 2012, CURR OPIN NEUROBIOL, V22, P480, DOI 10.1016/j.conb.2011.10.017; Craig TJ, 2012, J BIOL CHEM, V287, P22781, DOI 10.1074/jbc.M112.356337; Henley JM, 2011, TRENDS NEUROSCI, V34, P258, DOI 10.1016/j.tins.2011.02.004; Huang YS, 2003, GENE DEV, V17, P638, DOI 10.1101/gad.1053003; Job C, 2001, NAT REV NEUROSCI, V2, P889, DOI 10.1038/35104069; Kantamneni S, 2011, BIOCHEM BIOPH RES CO, V409, P657, DOI 10.1016/j.bbrc.2011.05.060; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Konopacki FA, 2007, NEUROSCIENCE, V150, P31, DOI 10.1016/j.neuroscience.2007.08.026; Konopacki FA, 2011, P NATL ACAD SCI USA, V108, P19772, DOI 10.1073/pnas.1111575108; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Lu W, 2012, CURR OPIN NEUROBIOL, V22, P470, DOI 10.1016/j.conb.2011.09.008; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; SCHUMANN MA, 1993, J BIOL CHEM, V268, P2134; Wilkinson Kevin A, 2012, Commun Integr Biol, V5, P223, DOI 10.4161/cib.19195; Wilkinson KA, 2010, BRAIN RES REV, V64, P195, DOI 10.1016/j.brainresrev.2010.04.002; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Yudowski GA, 2007, J NEUROSCI, V27, P11112, DOI 10.1523/JNEUROSCI.2465-07.2007; Zearfoss NR, 2008, J NEUROSCI, V28, P8502, DOI 10.1523/JNEUROSCI.1756-08.2008	31	43	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52345	10.1371/journal.pone.0052345	http://dx.doi.org/10.1371/journal.pone.0052345			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326329	Green Published, Green Submitted, gold			2022-12-25	WOS:000314705800015
J	Kesel, S; Mader, A; Hofler, C; Mascher, T; Leisner, M				Kesel, Sara; Mader, Andreas; Hoefler, Carolin; Mascher, Thorsten; Leisner, Madeleine			Immediate and Heterogeneous Response of the LiaFSR Two-Component System of Bacillus subtilis to the Peptide Antibiotic Bacitracin	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION SYSTEM; GREEN FLUORESCENT PROTEIN; DEPENDENT GENE-EXPRESSION; BACTERIA; LIARS; STATE; VIRULENCE; BINDING; TARGET	Background: Two-component signal transduction systems are one means of bacteria to respond to external stimuli. The LiaFSR two-component system of Bacillus subtilis consists of a regular two-component system LiaRS comprising the core Histidine Kinase (HK) LiaS and the Response Regulator (RR) LiaR and additionally the accessory protein LiaF, which acts as a negative regulator of LiaRS-dependent signal transduction. The complete LiaFSR system was shown to respond to various peptide antibiotics interfering with cell wall biosynthesis, including bacitracin. Methodology and Principal Findings: Here we study the response of the LiaFSR system to various concentrations of the peptide antibiotic bacitracin. Using quantitative fluorescence microscopy, we performed a whole population study analyzed on the single cell level. We investigated switching from the non-induced 'OFF' state into the bacitracin-induced 'ON' state by monitoring gene expression of a fluorescent reporter from the RR-regulated liaI promoter. We found that switching into the 'ON' state occurred within less than 20 min in a well-defined switching window, independent of the bacitracin concentration. The switching rate and the basal expression rate decreased at low bacitracin concentrations, establishing clear heterogeneity 60 min after bacitracin induction. Finally, we performed time-lapse microscopy of single cells confirming the quantitative response as obtained in the whole population analysis for high bacitracin concentrations. Conclusion: The LiaFSR system exhibits an immediate, heterogeneous and graded response to the inducer bacitracin in the exponential growth phase.	[Kesel, Sara; Mader, Andreas; Leisner, Madeleine] Univ Munich, Fak Phys, Ctr NanoSci, Munich, Germany; [Hoefler, Carolin; Mascher, Thorsten] Ludwig Maximilians Univ Munchen, Dept Biol 1, Planegg Martinsried, Germany	University of Munich; University of Munich	Leisner, M (corresponding author), Univ Munich, Fak Phys, Ctr NanoSci, Munich, Germany.	madeleine.leisner@physik.uni-muenchen.de	Mascher, Thorsten/G-2074-2011	Mascher, Thorsten/0000-0002-6300-5541	excellence cluster Nano Initiative Munich; Center for Nanoscience; Deutsche Forschungsgemeinschaft [MA2873/3-1]	excellence cluster Nano Initiative Munich; Center for Nanoscience; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding to ML, the authors thank excellence cluster Nano Initiative Munich and the Center for Nanoscience for funding. Funding to TM, funding is gratefully acknowledged by the Deutsche Forschungsgemeinschaft (MA2873/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisicchia P, 2010, PLASMID, V64, P143, DOI 10.1016/j.plasmid.2010.06.002; Botella E, 2011, MICROBIOL-SGM, V157, P2470, DOI 10.1099/mic.0.049205-0; Castelli ME, 2000, J BIOL CHEM, V275, P22948, DOI 10.1074/jbc.M909335199; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Elsen S, 2003, J BACTERIOL, V185, P7111, DOI 10.1128/JB.185.24.7111-7119.2003; Fabret C, 1999, J BACTERIOL, V181, P1975, DOI 10.1128/JB.181.7.1975-1983.1999; Gebhard S, 2011, MOL MICROBIOL, V81, P581, DOI 10.1111/j.1365-2958.2011.07747.x; Ghosh S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-18; Groban ES, 2009, J MOL BIOL, V390, P380, DOI 10.1016/j.jmb.2009.05.007; Hauser K, 2000, EUR J CELL BIOL, V79, P144, DOI 10.1078/S0171-9335(04)70016-3; Hoch J.A., 1995, 2 COMPONENT SIGNAL T, DOI [10.1128/9781555818319, DOI 10.1128/9781555818319]; Izuka R, 2011, ANAL CHEM, V414, P173; Jordan S, 2008, FEMS MICROBIOL REV, V32, P107, DOI 10.1111/j.1574-6976.2007.00091.x; Jordan S, 2007, MICROBIOL-SGM, V153, P2530, DOI 10.1099/mic.0.2007/006817-0; Jordan S, 2006, J BACTERIOL, V188, P5153, DOI 10.1128/JB.00310-06; Kato A, 2007, P NATL ACAD SCI USA, V104, P12063, DOI 10.1073/pnas.0704462104; Leisner M, 2007, MOL MICROBIOL, V63, P1806, DOI 10.1111/j.1365-2958.2007.05628.x; Leisner M, 2009, BIOPHYS J, V96, P1178, DOI 10.1016/j.bpj.2008.10.034; LI JY, 1995, BIOCHEMISTRY-US, V34, P14626, DOI 10.1021/bi00045a003; Li M, 2007, P NATL ACAD SCI USA, V104, P9469, DOI 10.1073/pnas.0702159104; Li M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002080; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lucana DOD, 2009, AMINO ACIDS, V37, P479, DOI 10.1007/s00726-009-0260-9; Marmaar H, 2007, SCIENCE, V317, P525; Mascher T, 2004, ANTIMICROB AGENTS CH, V48, P2888, DOI 10.1128/AAC.48.8.2888-2896.2004; Mascher T, 2003, MOL MICROBIOL, V50, P1591, DOI 10.1046/j.1365-2958.2003.03786.x; Megerle JA, 2008, BIOPHYS J, V95, P2103, DOI 10.1529/biophysj.107.127191; Mitrophanov AY, 2007, J THEOR BIOL, V246, P113, DOI 10.1016/j.jtbi.2006.11.009; Nagasawa S, 1997, DNA RES, V4, P161; Pratt L., 1995, 2 COMPONENT SIGNAL T, P105; Ray JCJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000676; Rietkotter E, 2008, MOL MICROBIOL, V68, P768, DOI 10.1111/j.1365-2958.2008.06194.x; Scharf BE, 2010, CURR OPIN MICROBIOL, V13, P246, DOI 10.1016/j.mib.2010.01.006; Schrecke K, 2012, MOL MICROBI IN PRESS; Schrecke K, 2012, 2 COMPONENT SIGNALIN; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Staron A, 2011, ANTIMICROB AGENTS CH, V55, P515, DOI 10.1128/AAC.00352-10; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Szurmant H, 2008, P NATL ACAD SCI USA, V105, P5891, DOI 10.1073/pnas.0800247105; Toymentseva AA, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-143; Wolf D, 2012, ANTIMICROB AGENTS CH, DOI 10.1128; Wolf D, 2010, J BACTERIOL, V192, P4680, DOI 10.1128/JB.00543-10; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200	44	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53457	10.1371/journal.pone.0053457	http://dx.doi.org/10.1371/journal.pone.0053457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326432	Green Published, Green Submitted, gold			2022-12-25	WOS:000314705800046
J	Mallick, A; Barik, S; Goswami, KK; Banerjee, S; Ghosh, S; Sarkar, K; Bose, A; Baral, R				Mallick, Atanu; Barik, Subhasis; Goswami, Kuntal Kanti; Banerjee, Saptak; Ghosh, Sarbari; Sarkar, Koustav; Bose, Anamika; Baral, Rathindranath			Neem Leaf Glycoprotein Activates CD8(+) T Cells to Promote Therapeutic Anti-Tumor Immunity Inhibiting the Growth of Mouse Sarcoma	PLOS ONE			English	Article							MURINE EHRLICH CARCINOMA; ADOPTIVE IMMUNOTHERAPY; SUPPRESSOR-CELLS; DENDRITIC CELLS; TUMOR-IMMUNITY; IFN-GAMMA; NK CELLS; INDUCTION; RESTORATION; CYTOKINES	In spite of sufficient data on Neem Leaf Glycoprotein (NLGP) as a prophylactic vaccine, little knowledge currently exists to support the use of NLGP as a therapeutic vaccine. Treatment of mice bearing established sarcomas with NLGP (25 mu g/mice/week subcutaneously for 4 weeks) resulted in tumor regression or dormancy (Tumor free/Regressor, 13/24 (NLGP), 4/24 (PBS)). Evaluation of CD8(+) T cell status in blood, spleen, TDLN, VDLN and tumor revealed increase in cellular number. Elevated expression of CD69, CD44 and Ki67 on CD8(+) T cells revealed their state of activation and proliferation by NLGP. Depletion of CD8(+) T cells in mice at the time of NLGP treatment resulted in partial termination of tumor regression. An expansion of CXCR3(+) and CCR5(+) T cells was observed in the TDLN and tumor, along with their corresponding ligands. NLGP treatment enhances type 1 polarized T-bet expressing T cells with downregulation of GATA3. Treg cell population was almost unchanged. However, T: Treg ratios significantly increased with NLGP. Enhanced secretion/expression of IFN gamma was noted after NLGP therapy. In vitro culture of T cells with IL-2 and sarcoma antigen resulted in significant enhancement in cytotoxic efficacy. Consistently higher expression of CD107a was also observed in CD8(+) T cells from tumors. Reinoculation of sarcoma cells in tumor regressed NLGP-treated mice maintained tumor free status in majority. This is correlated with the increment of CD44(hi)CD62L(hi) central memory T cells. Collectively, these findings support a paradigm in which NLGP dynamically orchestrates the activation, expansion, and recruitment of CD8(+) T cells into established tumors to operate significant tumor cell lysis.	[Mallick, Atanu; Barik, Subhasis; Goswami, Kuntal Kanti; Banerjee, Saptak; Ghosh, Sarbari; Sarkar, Koustav; Bose, Anamika; Baral, Rathindranath] CNCI, Dept Immunoregulat & Immunodiagnost, Kolkata, India		Baral, R (corresponding author), CNCI, Dept Immunoregulat & Immunodiagnost, Kolkata, India.	baralrathin@hotmail.com	Sarkar, Koustav/ABE-6071-2021; Banerjee, Dr Saptak/HDO-6987-2022	Banerjee, Dr Saptak/0000-0001-9211-2074; SARKAR, KOUSTAV/0000-0002-0696-6688; Barik, Subhasis/0000-0002-0488-0434	Indian Council of Medical Research, New Delhi [Immuno/18/11/08/2006-ECD-I, 3/2/2/188/2009/NCD-III]; Council of Scientific and Industrial Research, New Delhi [8463A, 09/030(0063)/2011-EMR-I, 09/030(0050)/2008-EMR-I]; University Grant Commission, New Delhi [F.2-3/2000 (SA-1)]; Department of Science and Technology, New Delhi (INSPIRE Fellowship) [2011/188]	Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); University Grant Commission, New Delhi(University Grants Commission, India); Department of Science and Technology, New Delhi (INSPIRE Fellowship)(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines)	Funding: The work was partially supported by Indian Council of Medical Research, New Delhi (grant Immuno/18/11/08/2006-ECD-I; 3/2/2/188/2009/NCD-III to AM), Council of Scientific and Industrial Research, New Delhi (grants SRA (Scientists's Pool Scheme No: 8463A to AB); 09/030(0063)/2011-EMR-I to SB); 09/030(0050)/2008-EMR-I to SB), from University Grant Commission, New Delhi (grant F.2-3/2000 (SA-1) to KKG) and from Department of Science and Technology, New Delhi (INSPIRE Fellowship number 2011/188 to SG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angevin E, 1997, INT J CANCER, V72, P431, DOI 10.1002/(SICI)1097-0215(19970729)72:3<431::AID-IJC10>3.3.CO;2-3; Apetoh L, 2011, CURR MOL MED, V11, P365, DOI 10.2174/156652411795976574; Bailey JL, 1967, TECHNIQUES PROTEIN C, P340; Baitsch L, 2012, TRENDS IMMUNOL, V33, P364, DOI 10.1016/j.it.2012.02.006; Baral R, 2005, INT IMMUNOPHARMACOL, V5, P1343, DOI 10.1016/j.intimp.2005.03.008; Baral R, 2004, INT IMMUNOPHARMACOL, V4, P355, DOI 10.1016/j.intimp.2003.09.006; Ben-Baruch A, 2012, CANCER MICROENVIRON, V5, P151, DOI 10.1007/s12307-011-0094-3; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bose A, 2009, HUM IMMUNOL, V70, P6, DOI 10.1016/j.humimm.2008.09.004; Bose A, 2007, HUM IMMUNOL, V68, P823, DOI 10.1016/j.humimm.2007.08.002; Bose A, 2007, PHYTOTHER RES, V21, P914, DOI 10.1002/ptr.2185; Bose A, 2009, J IMMUNOTHER, V32, P42, DOI 10.1097/CJI.0b013e31818e997d; Bourgeois C, 2003, EUR J IMMUNOL, V33, P3225, DOI 10.1002/eji.200324576; Butterfield LH, 2004, GASTROENTEROLOGY, V127, pS232, DOI 10.1053/j.gastro.2004.09.038; Chakraborty K, 2008, INT IMMUNOPHARMACOL, V8, P330, DOI 10.1016/j.intimp.2007.10.015; Chakraborty K, 2012, HUM IMMUNOL, V73, P38, DOI 10.1016/j.humimm.2011.10.015; Chakraborty K, 2010, CELL MOL IMMUNOL, V7, P396, DOI 10.1038/cmi.2010.29; Chakraborty T, 2011, IMMUNOTHERAPY-UK, V3, P949, DOI [10.2217/IMT.11.81, 10.2217/imt.11.81]; Chakroborty D, 2011, P NATL ACAD SCI USA, V108, P20730, DOI 10.1073/pnas.1108696108; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Goswami S, 2010, VACCINE, V28, P1241, DOI 10.1016/j.vaccine.2009.11.018; Haque E, 2006, IMMUNOPHARM IMMUNOT, V28, P33, DOI 10.1080/08923970600623632; Haque E, 2006, IMMUNOBIOLOGY, V211, P721, DOI 10.1016/j.imbio.2006.02.005; Higham EM, 2010, J IMMUNOL, V184, P5954, DOI 10.4049/jimmunol.1000265; Kemp RA, 2001, J IMMUNOL, V167, P6497, DOI 10.4049/jimmunol.167.11.6497; Klebanoff CA, 2011, CLIN CANCER RES, V17, P5343, DOI 10.1158/1078-0432.CCR-11-0503; Kurosaki M, 2011, CANCER IMMUNOL IMMUN, V60, P207, DOI 10.1007/s00262-010-0932-z; Le XD, 2005, P NATL ACAD SCI USA, V102, P8758, DOI 10.1073/pnas.0409581102; MacGregor JN, 2006, CANCER RES, V66, P4913, DOI 10.1158/0008-5472.CAN-05-3507; Mandal-Ghosh Ishita, 2007, Cancer Immun, V7, P8; Nishimura F, 2006, CANCER RES, V66, P4478, DOI 10.1158/0008-5472.CAN-05-3825; Pan PY, 2010, CANCER RES, V70, P99, DOI 10.1158/0008-5472.CAN-09-1882; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Redmond WL, 2009, EUR J IMMUNOL, V39, P2184, DOI 10.1002/eji.200939348; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Roy S, 2011, CLIN VACCINE IMMUNOL, V18, P571, DOI 10.1128/CVI.00499-10; Sampson JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031046; Sarkar K, 2008, VACCINE, V26, P4352, DOI 10.1016/j.vaccine.2008.06.048; Sarkar K, 2010, INT IMMUNOPHARMACOL, V10, P865, DOI 10.1016/j.intimp.2010.04.024; Sarkar K, 2009, INT IMMUNOPHARMACOL, V9, P753, DOI 10.1016/j.intimp.2009.02.016; Uekusa Y, 2002, CANCER RES, V62, P3751; Wang E, 2002, CANCER RES, V62, P3581; Wang Li-Xin, 2004, J Transl Med, V2, P41, DOI 10.1186/1479-5876-2-41; Wolkers MC, 2012, BLOOD, V119, P798, DOI 10.1182/blood-2011-08-373910; Wu R, 2012, CANCER J, V18, P160, DOI 10.1097/PPO.0b013e31824d4465; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhang PS, 2007, CANCER RES, V67, P6468, DOI 10.1158/0008-5472.CAN-07-1264; Zhao X, 2011, MOL THER, V19, P805, DOI 10.1038/mt.2010.295; Zippelius A, 2004, CANCER RES, V64, P2865, DOI 10.1158/0008-5472.CAN-03-3066; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	51	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e47434	10.1371/journal.pone.0047434	http://dx.doi.org/10.1371/journal.pone.0047434			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326300	Green Submitted, gold, Green Published			2022-12-25	WOS:000314705800002
J	Quignot, N; Bois, FY				Quignot, Nadia; Bois, Frederic Y.			A Computational Model to Predict Rat Ovarian Steroid Secretion from In Vitro Experiments with Endocrine Disruptors	PLOS ONE			English	Article							GRAPHICAL SYSTEMS-MODEL; ESTROGEN-RECEPTOR-ALPHA; PITUITARY-GONADAL AXIS; AROMATASE INHIBITORS; GENE-EXPRESSION; ESTRADIOL; METHOXYCHLOR; STIMULATION; VINCLOZOLIN; CHEMICALS	A finely tuned balance between estrogens and androgens controls reproductive functions, and the last step of steroidogenesis plays a key role in maintaining that balance. Environmental toxicants are a serious health concern, and numerous studies have been devoted to studying the effects of endocrine disrupting chemicals (EDCs). The effects of EDCs on steroidogenic enzymes may influence steroid secretion and thus lead to reproductive toxicity. To predict hormonal balance disruption on the basis of data on aromatase activity and mRNA level modulation obtained in vitro on granulosa cells, we developed a mathematical model for the last gonadal steps of the sex steroid synthesis pathway. The model can simulate the ovarian synthesis and secretion of estrone, estradiol, androstenedione, and testosterone, and their response to endocrine disruption. The model is able to predict ovarian sex steroid concentrations under normal estrous cycle in female rat, and ovarian estradiol concentrations in adult female rats exposed to atrazine, bisphenol A, metabolites of methoxychlor or vinclozolin, and letrozole.	[Quignot, Nadia; Bois, Frederic Y.] Univ Technol Compiegne, Bioengn Dept, Chair Math Modeling Syst Toxicol, Compiegne, France; [Quignot, Nadia; Bois, Frederic Y.] Inst Natl Environm Ind & Risques, Verneuil En Halatte, France	Picardie Universites; Universite de Technologie de Compiegne; Institut National de l'Environnement Industriel et des Risques (INERIS)	Quignot, N (corresponding author), Univ Technol Compiegne, Bioengn Dept, Chair Math Modeling Syst Toxicol, Compiegne, France.	nadia.quignot@utc.fr	Quignot, Nadia/D-1914-2016; Bois, Frédéric/T-1954-2019; Bois, Frederic/E-9241-2012	Bois, Frédéric/0000-0002-4154-0391; Bois, Frederic/0000-0002-4154-0391; Quignot, Nadia/0000-0001-8718-1307	French Ministry of the Environment and Sustainable Development [P189-DYSHORMO]	French Ministry of the Environment and Sustainable Development	This work was supported by a grant [P189-DYSHORMO] to the National Institute of Industrial Environment and Risks from the French Ministry of the Environment and Sustainable Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinola LA, 1996, ENDOCRINOLOGY, V137, P1572, DOI 10.1210/en.137.5.1572; Andersen ME, 2005, REPROD TOXICOL, V19, P327, DOI 10.1016/j.reprotox.2004.12.004; Andersen ME, 1997, J TOXICOL ENV HEALTH, V52, P189, DOI 10.1080/009841097159656; Auvray P, 2002, EUR J BIOCHEM, V269, P1393, DOI 10.1046/j.1432-1033.2002.02779.x; Bertram R, 2008, B MATH BIOL, V70, P2211, DOI 10.1007/s11538-008-9341-2; Bois FY, 2009, BIOINFORMATICS, V25, P1453, DOI 10.1093/bioinformatics/btp162; Breen MS, 2007, ANN BIOMED ENG, V35, P970, DOI 10.1007/s10439-007-9309-7; Breen MS, 2010, ENVIRON HEALTH PERSP, V118, P265, DOI 10.1289/ehp.0901107; Charles GD, 2004, ILAR J, V45, P494, DOI 10.1093/ilar.45.4.494; Cummings AM, 1997, CRIT REV TOXICOL, V27, P367, DOI 10.3109/10408449709089899; EPA, 2007, INT SUMM REP AROM; Fan W, 2007, BIOCHEM BIOPH RES CO, V355, P1012, DOI 10.1016/j.bbrc.2007.02.062; Fang H, 2001, CHEM RES TOXICOL, V14, P280, DOI 10.1021/tx000208y; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; Gaido KW, 2000, MOL PHARMACOL, V58, P852, DOI 10.1124/mol.58.4.852; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Goldman JM, 2007, BIRTH DEFECTS RES B, V80, P84, DOI 10.1002/bdrb.20106; Gordon A, 2009, REPRODUCTION, V137, P151, DOI 10.1530/REP-08-0318; Harada N, 1999, ENDOCR-RELAT CANCER, V6, P211, DOI 10.1677/erc.0.0060211; HARGROVE JL, 1993, FASEB J, V7, P1163, DOI 10.1096/fasebj.7.12.8375615; HARGROVE JL, 1993, BIOTECHNIQUES, V15, P1096; Hiroi H, 1999, ENDOCR J, V46, P773, DOI 10.1507/endocrj.46.773; Holloway AC, 2008, J APPL TOXICOL, V28, P260, DOI 10.1002/jat.1275; Holme JA, 2002, TOXICOL LETT, V127, P135, DOI 10.1016/S0378-4274(01)00493-3; Ishikura S, 2006, J BIOCHEM, V139, P1053, DOI 10.1093/jb/mvj109; KELCE WR, 1994, TOXICOL APPL PHARM, V126, P276, DOI 10.1006/taap.1994.1117; KREKELS M D W G, 1990, Steroids, V55, P69, DOI 10.1016/0039-128X(90)90027-9; LEPHART ED, 1992, MOL CELL ENDOCRINOL, V85, P205, DOI 10.1016/0303-7207(92)90259-9; Li ZH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-63; Liebermeister W, 2005, IEE P SYST BIOL, V152, P97, DOI 10.1049/ip-syb:20045033; Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156; Maranghi F, 2012, REPROD TOXICOL, V33, P290, DOI 10.1016/j.reprotox.2012.01.009; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Molina-Molina JM, 2006, TOXICOL APPL PHARM, V216, P44, DOI 10.1016/j.taap.2006.04.005; Odum J, 2002, TOXICOL LETT, V129, P119, DOI 10.1016/S0378-4274(01)00521-5; Odum J, 2001, TOXICOL LETT, V118, P165, DOI 10.1016/S0378-4274(00)00293-9; Petkov PI, 2009, SAR QSAR ENVIRON RES, V20, P657, DOI 10.1080/10629360903438347; Plowchalk DR, 2002, TOXICOL SCI, V69, P60, DOI 10.1093/toxsci/69.1.60; Quignot N, 2012, ANAL BIOANAL CHEM, V403, P1629, DOI 10.1007/s00216-012-5990-y; Quignot N, 2012, REPROD TOXICOL, V33, P339, DOI 10.1016/j.reprotox.2012.01.004; Quignot N, 2012, TOXICOL IN VITRO, V26, P107, DOI 10.1016/j.tiv.2011.11.004; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RENWICK AGC, 1981, J BIOL CHEM, V256, P1881; Sandhoff TW, 1996, ENDOCRINE, V4, P259, DOI 10.1007/BF02738692; Sinha S, 1998, BREAST CANCER RES TR, V48, P45, DOI 10.1023/A:1005937900788; Soffker M, 2012, CRIT REV TOXICOL, V42, P653, DOI 10.3109/10408444.2012.692114; Steckelbroeck S, 2003, J STEROID BIOCHEM, V86, P79, DOI 10.1016/S0960-0760(03)00251-6; Stocco C, 2008, STEROIDS, V73, P473, DOI 10.1016/j.steroids.2008.01.017; Stokes WS, 2004, ILAR J, V45, P387, DOI 10.1093/ilar.45.4.387; Villeneuve DL, 2007, ENVIRON SCI TECHNOL, V41, P321, DOI 10.1021/es061739x; Villeneuve DL, 2012, MUTAT RES-GEN TOX EN, V746, P151, DOI 10.1016/j.mrgentox.2011.12.016; WANG C, 1981, MOL CELL ENDOCRINOL, V24, P17, DOI 10.1016/0303-7207(81)90075-7; Watanabe KH, 2009, TOXICOL SCI, V109, P180, DOI 10.1093/toxsci/kfp069; Zheng XF, 2008, REPRODUCTION, V136, P447, DOI 10.1530/REP-07-0316	54	10	13	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53891	10.1371/journal.pone.0053891	http://dx.doi.org/10.1371/journal.pone.0053891			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326527	Green Published, Green Submitted, gold			2022-12-25	WOS:000314705800083
J	Singh, N; Bajpai, S; Kumar, V; Gour, JK; Singh, RK				Singh, Nisha; Bajpai, Surabhi; Kumar, Vinod; Gour, Jalaj K.; Singh, Rakesh K.			Identification and Functional Characterization of Leishmania donovani Secretory Peroxidase: Delineating Its Role in NRAMP1 Regulation	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; IMMUNE-RESPONSE; MACROPHAGE; IRON; TRANSPORTER; CYTOKINES; CHAGASI; CLONING; LIPOPOLYSACCHARIDE; MECHANISMS	Leishmania silently evades host immune system and establish in the hostile environment of host macrophage phagolysosomes. For differentiation, growth and division parasite acquires divalent cations especially iron from the host nutritive pool. Natural resistance associated with macrophage protein1 (NRAMP1), a cation transporter that effluxes out divalent cations specifically iron from phagosomal milieu to the cytosol, to create ions deprived status for pathogenic microorganisms. The mechanisms of NRAMP1 regulation are largely unknown in leishmanial infections. In the present study, we identified a secretory Leishmania donovani peroxidase (Prx) that showed peroxidoxin like peroxidase activity and significantly reduced H2O2, O-2(-) and NO levels in LPS activated macrophages. Further, we also observed down regulated Nramp1 expression and concomitantly declined labile iron pool in activated macrophages treated with identified peroxidase. Prx also decreased levels of TNF-alpha, IFN-gamma and IL-12 in LPS activated macrophages. These observations indicate a bifunctional protective role of secretory Prx; first it reduces redox activation of macrophages, and secondly it allows iron access to Leishmania by down regulating NRAMP1 expression.	[Singh, Nisha; Bajpai, Surabhi; Kumar, Vinod; Gour, Jalaj K.; Singh, Rakesh K.] Banaras Hindu Univ, Fac Sci, Dept Biochem, Mol Immunol Lab, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Singh, RK (corresponding author), Banaras Hindu Univ, Fac Sci, Dept Biochem, Mol Immunol Lab, Varanasi 221005, Uttar Pradesh, India.	rakesh_bc@bhu.ac.in	Singh, Nisha/B-4760-2013; Singh, Nisha/ABF-6782-2020; Singh, Rakesh K./AAX-9528-2021	Singh, Nisha/0000-0003-4897-8123; Singh, Nisha/0000-0003-4897-8123; Bajpai, Surabhi/0000-0002-2093-7437	Department of Biotechnology, New Delhi [BT/PR11177/MED/29/99/2008]; DBT; CSIR; UGC; UP-CST	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); UGC(University Grants Commission, India); UP-CST	The financial support received from Department of Biotechnology, New Delhi (BT/PR11177/MED/29/99/2008) is greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors sincerely acknowledge Dr. Arvind Mishra and Dr. Monika, Department of Chemistry, BHU for their support in fluorescent studies. The authors NS, SB, VK and JKG are thankful to DBT, CSIR, UGC and UP-CST, respectively for their research fellowships.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Awasthi A, 2004, INDIAN J MED RES, V119, P238; Bacellar O, 2000, CYTOKINE, V12, P1228, DOI 10.1006/cyto.2000.0694; Balanco JMF, 1998, PARASITOLOGY, V116, P103, DOI 10.1017/S003118209700214X; Barnett PG, 2005, AM J TROP MED HYG, V73, P720, DOI 10.4269/ajtmh.2005.73.720; Barr SD, 2003, J BIOL CHEM, V278, P10816, DOI 10.1074/jbc.M212990200; Barr SD, 2001, J BIOL CHEM, V276, P34279, DOI 10.1074/jbc.M104406200; Blackwell JM, 2001, CELL MICROBIOL, V3, P773, DOI 10.1046/j.1462-5822.2001.00150.x; Bogdan C, 1998, INT J PARASITOL, V28, P121, DOI 10.1016/S0020-7519(97)00169-0; Cabantchik ZI, 1996, ANAL BIOCHEM, V233, P221, DOI 10.1006/abio.1996.0032; Cameron P, 2004, J IMMUNOL, V173, P3297, DOI 10.4049/jimmunol.173.5.3297; Castro H, 2008, EXP PARASITOL, V120, P421, DOI 10.1016/j.exppara.2008.09.002; Chakraborty R, 1996, MOL CELL BIOCHEM, V154, P23, DOI 10.1007/BF00248457; Corna G, 2010, HAEMATOL-HEMATOL J, V95, P1814, DOI 10.3324/haematol.2010.023879; Creek DJ, 2008, ANTIMICROB AGENTS CH, V52, P1291, DOI 10.1128/AAC.01033-07; Cunningham AC, 2002, EXP MOL PATHOL, V72, P132, DOI 10.1006/exmp.2002.2418; Das NK, 2009, CELL MICROBIOL, V11, P83, DOI 10.1111/j.1462-5822.2008.01241.x; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; DING AH, 1988, J IMMUNOL, V141, P2407; Ferret PJ, 2002, BMC IMMUNOL, V12, P17; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Gomez MA, 2007, J BIOL CHEM, V282, P36190, DOI 10.1074/jbc.M703140200; HECHT D, 1992, BIOCHEM BIOPH RES CO, V188, P773, DOI 10.1016/0006-291X(92)91123-8; Huynh C, 2006, J EXP MED, V203, P2363, DOI 10.1084/jem.20060559; Iles KE, 2002, IMMUNOL RES, V26, P95, DOI 10.1385/IR:26:1-3:095; Jabado N, 2000, J EXP MED, V192, P1237, DOI 10.1084/jem.192.9.1237; JOHNSTON RB, 1978, J EXP MED, V148, P115; Kamhawi S, 2006, TRENDS PARASITOL, V22, P439, DOI 10.1016/j.pt.2006.06.012; Kima PE, 2007, INT J PARASITOL, V37, P1087, DOI 10.1016/j.ijpara.2007.04.007; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafuse WP, 2000, BIOCHEM J, V351, P687, DOI 10.1042/0264-6021:3510687; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; MIRALLES GD, 1994, INFECT IMMUN, V62, P1058, DOI 10.1128/IAI.62.3.1058-1063.1994; Murray HW, 1997, J EXP MED, V185, P867, DOI 10.1084/jem.185.5.867; Nandan D, 2002, J BIOL CHEM, V277, P50190, DOI 10.1074/jbc.M209210200; Paramchuk WJ, 1997, MOL BIOCHEM PARASIT, V90, P203, DOI 10.1016/S0166-6851(97)00141-2; Rhee SG, 1999, EXP MOL MED, V31, P53, DOI 10.1038/emm.1999.9; Romao S, 2009, INT J PARASITOL, V39, P703, DOI 10.1016/j.ijpara.2008.11.009; Saha S, 2006, INDIAN J MED RES, V123, P245; Singh RK, 2012, MICROBIOL RES, V167, P445, DOI 10.1016/j.micres.2012.01.002; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Singh VP, 2010, AM J TROP MED HYG, V82, P9, DOI 10.4269/ajtmh.2010.09-0235; Soe-Lin S, 2008, EXP HEMATOL, V36, P929, DOI 10.1016/j.exphem.2008.02.013; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Srivastava A, 2012, MOL CELL BIOCHEM, V359, P359, DOI 10.1007/s11010-011-1029-5; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Valdez Y, 2008, CELL MICROBIOL, V10, P1646, DOI 10.1111/j.1462-5822.2008.01155.x; Winyard PG, 2005, TRENDS BIOCHEM SCI, V30, P453, DOI 10.1016/j.tibs.2005.06.001; World Health Organization, 2008, The global burden of disease: 2004 update; Yeung IYL, 2004, BIOCHEM SOC T, V32, P1008, DOI 10.1042/BST0321008; Zhang GL, 2000, INFECT IMMUN, V68, P1086, DOI 10.1128/IAI.68.3.1086-1093.2000	53	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53442	10.1371/journal.pone.0053442	http://dx.doi.org/10.1371/journal.pone.0053442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326430	Green Published, gold, Green Submitted			2022-12-25	WOS:000314705800044
J	Meng, R; Zhu, DL; Bi, Y; Yang, DH; Wang, YP				Meng, Ran; Zhu, Dalong; Bi, Yan; Yang, Donghui; Wang, Yaping			Erythropoietin Inhibits Gluconeogenesis and Inflammation in the Liver and Improves Glucose Intolerance in High-Fat Diet-Fed Mice	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; INDUCED INSULIN-RESISTANCE; ISCHEMIA-REPERFUSION INJURY; SIGNALING PATHWAYS; HEMODIALYSIS-PATIENTS; GENE-EXPRESSION; INDUCED OBESITY; IKK-BETA; PROTECTS; METABOLISM	Erythropoietin (EPO) has multiple biological functions, including the modulation of glucose metabolism. However, the mechanisms underlying the action of EPO are still obscure. This study is aimed at investigating the potential mechanisms by which EPO improves glucose tolerance in an animal model of type 2 diabetes. Male C57BL/6 mice were fed with high-fat diet (HFD) for 12 weeks and then treated with EPO (HFD-EPO) or vehicle saline (HFD-Con) for two week. The levels of fasting blood glucose, serum insulin and glucose tolerance were measured and the relative levels of insulin-related phosphatidylinositol 3-kinase (PI3K)/Akt, insulin receptor (IR) and IR substrate 1 (IRS1) phosphorylation were determined. The levels of phosphoenolpyruvate carboxykinase (PEPCK), glucose-6-phosphatase (G6Pase), toll like receptor 4 (TLR4), tumor necrosis factor (TNF)-alpha and IL-6 expression and nuclear factor-kappa B (NF-kappa B) and c-Jun N-terminal kinase (JNK), extracellular-signal-regulated kinase (ERK) and p38 MAPK activation in the liver were examined. EPO treatment significantly reduced the body weights and the levels of fasting blood glucose and serum insulin and improved the HFD-induced glucose intolerance in mice. EPO treatment significantly enhanced the levels of Akt, but not IR and IRS1, phosphorylation, accompanied by inhibiting the PEPCK and G6Pase expression in the liver. Furthermore, EPO treatment mitigated the HFD-induced inflammatory TNF-alpha and IL-6 production, TLR4 expression, NF-kappa B and JNK, but not ERK and p38 MAPK, phosphorylation in the liver. Therefore, our data indicated that EPO treatment improved glucose intolerance by inhibiting gluconeogenesis and inflammation in the livers of HFD-fed mice.	[Meng, Ran; Zhu, Dalong; Bi, Yan; Yang, Donghui] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Endocrinol, Nanjing 210008, Jiangsu, Peoples R China; [Meng, Ran; Wang, Yaping] Nanjing Univ, Sch Med, Dept Med Genet, Nanjing 210008, Jiangsu, Peoples R China; [Meng, Ran; Wang, Yaping] Nanjing Univ, Jiangsu Key Lab Mol Med, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University	Zhu, DL (corresponding author), Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Endocrinol, Nanjing 210008, Jiangsu, Peoples R China.	zhudldr@gmail.com; wangyap@nju.edu.cn	Bi, Yan/O-5153-2015		National Natural Science Foundation of China [81070636]; Natural Science Foundation of Jiangsu Province of China [BK2010110]; Jiangsu Province's Key Discipline/Laboratory of Medicine [XK201105]; Program for the Talents in science and education of Jiangsu Province, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Jiangsu Province's Key Discipline/Laboratory of Medicine; Program for the Talents in science and education of Jiangsu Province, China	This study was supported by National Natural Science Foundation of China (81070636), Natural Science Foundation of Jiangsu Province of China (BK2010110), Jiangsu Province's Key Discipline/Laboratory of Medicine (XK201105) and Program for the Talents in science and education of Jiangsu Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Ben-Ari Z, 2011, TRANSPLANTATION, V92, P18, DOI 10.1097/TP.0b013e31821cdea5; Buchner DA, 2011, OBESITY, V19, P917, DOI 10.1038/oby.2010.214; Burger D, 2009, Curr Mol Pharmacol, V2, P56; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cassis P, 2012, KIDNEY INT, V81, P903, DOI 10.1038/ki.2011.473; Cho GW, 2010, BRAIN RES, V1353, P1, DOI 10.1016/j.brainres.2010.06.013; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Eipel C, 2012, J SURG RES, V173, P171, DOI 10.1016/j.jss.2010.09.008; HE TC, 1993, BLOOD, V82, P3530; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hochhauser E, 2008, APOPTOSIS, V13, P77, DOI 10.1007/s10495-007-0155-8; Hojman P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005894; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Katz O, 2010, J ENDOCRINOL, V205, P87, DOI 10.1677/JOE-09-0425; Khedr E, 2009, HEMODIAL INT, V13, P340, DOI 10.1111/j.1542-4758.2009.00367.x; Kim JJ, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/212563; Kleemann R, 2003, BLOOD, V101, P545, DOI 10.1182/blood-2002-06-1762; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Morino K, 2008, DIABETES, V57, P2644, DOI 10.2337/db06-0454; Mudalagiri NR, 2008, BRIT J PHARMACOL, V153, P50, DOI 10.1038/sj.bjp.0707461; Nairz M, 2011, IMMUNITY, V34, P61, DOI 10.1016/j.immuni.2011.01.002; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; Pappo O, 2010, CAN J PHYSIOL PHARM, V88, P1130, DOI 10.1139/Y10-091; Rodrigues CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029893; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schmeding M, 2010, TRANSPLANTATION, V89, P161, DOI 10.1097/TP.0b013e3181c425fd; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Summers SA, 1999, ANN NY ACAD SCI, V892, P169, DOI 10.1111/j.1749-6632.1999.tb07795.x; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tanti JF, 2009, CURR OPIN PHARMACOL, V9, P753, DOI 10.1016/j.coph.2009.07.004; Teng RF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1526; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Tuzcu A, 2004, HORM METAB RES, V36, P716, DOI 10.1055/s-2004-826021; Wang L, 2008, J CEREBR BLOOD F MET, V28, P1361, DOI 10.1038/jcbfm.2008.32; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	39	36	41	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53557	10.1371/journal.pone.0053557	http://dx.doi.org/10.1371/journal.pone.0053557			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326455	Green Submitted, gold, Green Published			2022-12-25	WOS:000313552400028
J	Rodriguez, A; Falcon, A; Cuevas, MT; Pozo, F; Guerra, S; Garcia-Barreno, B; Martinez-Orellana, P; Perez-Brena, P; Montoya, M; Melero, JA; Pizarro, M; Ortin, J; Casas, I; Nieto, A				Rodriguez, Ariel; Falcon, Ana; Teresa Cuevas, Maria; Pozo, Francisco; Guerra, Susana; Garcia-Barreno, Blanca; Martinez-Orellana, Pamela; Perez-Brena, Pilar; Montoya, Maria; Antonio Melero, Jose; Pizarro, Manuel; Ortin, Juan; Casas, Inmaculada; Nieto, Amelia			Characterization In Vitro and In Vivo of a Pandemic H1N1 Influenza Virus from a Fatal Case	PLOS ONE			English	Article							A H1N1; FULMINANT MYOCARDITIS; MUTATIONAL ANALYSIS; PA PROTEIN; INFECTION; CCR5; HEMAGGLUTININ; PATHOGENICITY; ENDONUCLEASE; SUBSTITUTION	Pandemic 2009 H1N1 (pH1N1) influenza viruses caused mild symptoms in most infected patients. However, a greater rate of severe disease was observed in healthy young adults and children without co-morbid conditions. Here we tested whether influenza strains displaying differential virulence could be present among circulating pH1N1 viruses. The biological properties and the genotype of viruses isolated from a patient showing mild disease (M) or from a fatal case (F), both without known co-morbid conditions were compared in vitro and in vivo. The F virus presented faster growth kinetics and stronger induction of cytokines than M virus in human alveolar lung epithelial cells. In the murine model in vivo, the F virus showed a stronger morbidity and mortality than M virus. Remarkably, a higher proportion of mice presenting infectious virus in the hearts, was found in F virus-infected animals. Altogether, the data indicate that strains of pH1N1 virus with enhanced pathogenicity circulated during the 2009 pandemic. In addition, examination of chemokine receptor 5 (CCR5) genotype, recently reported as involved in severe influenza virus disease, revealed that the F virus-infected patient was homozygous for the deleted form of CCR5 receptor (CCR5 Delta 32).	[Rodriguez, Ariel; Falcon, Ana; Ortin, Juan; Nieto, Amelia] CSIC Darwin 3, Ctr Nacl Biotecnol, Madrid, Spain; [Rodriguez, Ariel; Falcon, Ana; Garcia-Barreno, Blanca; Antonio Melero, Jose; Ortin, Juan; Nieto, Amelia] Ciber Enfermedades Resp, Mallorca, Illes Balears, Spain; [Teresa Cuevas, Maria; Pozo, Francisco; Garcia-Barreno, Blanca; Perez-Brena, Pilar; Antonio Melero, Jose; Casas, Inmaculada] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain; [Guerra, Susana] Univ Autonoma Madrid, Dpto Med Prevent Salud Publ & Microbiol, Madrid, Spain; [Martinez-Orellana, Pamela; Montoya, Maria] UAB IRTA, Ctr Recerca Sanitat Anim CReSA, Barcelona, Spain; [Montoya, Maria] IRTA, Barcelona, Spain; [Pizarro, Manuel] Univ Complutense Madrid, Fac Vet, Hosp Clin Vet, Serv Anat Patol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Autonomous University of Madrid; IRTA; IRTA; Complutense University of Madrid	Nieto, A (corresponding author), CSIC Darwin 3, Ctr Nacl Biotecnol, Madrid, Spain.	anieto@cnb.csic.es	Falcon, Ana/L-8304-2018; Montoya, Maria/G-3430-2015; Garcia-Barreno, Blanca/AAF-5554-2019; Rodriguez, Ariel/B-3908-2013; Rodriguez Frandsen, Ariel/HDM-7270-2022; Casas, Inmaculada/H-9442-2015; gonzalez-nico, maria teresa cuevas/E-2001-2014; guerra, susana/K-5972-2014; Pozo, Francisco/F-4426-2012; Ortin, Juan/L-3622-2013; Casas, Inmaculada/X-7579-2019	Montoya, Maria/0000-0002-5703-7360; Rodriguez, Ariel/0000-0001-6850-5003; Rodriguez Frandsen, Ariel/0000-0001-6850-5003; Casas, Inmaculada/0000-0003-1840-1198; gonzalez-nico, maria teresa cuevas/0000-0002-4195-1975; guerra, susana/0000-0001-9067-2991; Pozo, Francisco/0000-0003-1828-733X; Casas, Inmaculada/0000-0003-1840-1198; Martinez-Orellana, Pamela/0000-0002-2025-9445; Ortin, Juan/0000-0002-6200-4678; Melero, Jose A./0000-0001-8148-6521	Instituto de Salud Carlos III (Programa especial de investigacion sobre la gripe pandemica) [GR09/0023, GR09/0040, GR09/0039]; Ciber de Enfermedades Respiratorias	Instituto de Salud Carlos III (Programa especial de investigacion sobre la gripe pandemica); Ciber de Enfermedades Respiratorias	This work was supported by Instituto de Salud Carlos III (Programa especial de investigacion sobre la gripe pandemica GR09/0023, GR09/0040, GR09/0039) and Ciber de Enfermedades Respiratorias. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi R, 2002, DIABETES, V51, P2489, DOI 10.2337/diabetes.51.8.2489; Almansa R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-232; [Anonymous], 2010, VOP VIRUSOL; Antonopoulou A, 2012, INT J INFECT DIS IJI; Baumeister E, 2010, MEDICINA-BUENOS AIRE, V70, P518; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Belser JA, 2010, J VIROL, V84, P4194, DOI 10.1128/JVI.02742-09; Bratincsak A, 2010, J AM COLL CARDIOL, V55, P928, DOI 10.1016/j.jacc.2010.01.004; Brown SM, 2011, EUR RESPIR J, V37, P112, DOI 10.1183/09031936.00008210; Carmona F, 2011, AM J CLIN PATHOL, V136, P416, DOI 10.1309/AJCP1Y6LLHWSKYHW; Chen HL, 2010, J INFECT DIS, V201, P1517, DOI 10.1086/652661; Cheng XW, 2011, RESP PHYSIOL NEUROBI, V175, P185, DOI 10.1016/j.resp.2010.11.004; Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; de Wit E, 2008, J CLIN VIROL, V41, P1, DOI 10.1016/j.jcv.2007.10.017; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Estella A, 2011, J INFECT DEV COUNTR, V5, P540, DOI 10.3855/jidc.1618; Everitt AR, 2012, NATURE; Falagas ME, 2011, EPIDEMIOL INFECT, V139, P27, DOI 10.1017/S0950268810002037; Falagas ME, 2010, EUR J CLIN MICROBIOL, V29, P1327, DOI 10.1007/s10096-010-1002-3; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gokhroo R K, 2011, J Assoc Physicians India, V59, P51; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Hulse DJ, 2004, J VIROL, V78, P9954, DOI 10.1128/JVI.78.18.9954-9964.2004; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Ison MG, 2005, CLIN INFECT DIS, V40, P415, DOI 10.1086/427282; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jorba N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000462; Keynan Y, 2010, EMERG INFECT DIS, V16, P1621, DOI 10.3201/eid1610.100108; Kilander A, 2010, EUROSURVEILLANCE, V4, P15; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kwon D, 2010, J MICROBIOL, V48, P657, DOI 10.1007/s12275-010-0120-z; Lee N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026050; Lee N, 2011, ANTIVIR THER, V16, P237, DOI 10.3851/IMP1722; Liao YC, 2011, J CHIN MED ASSOC, V74, P130, DOI 10.1016/j.jcma.2011.01.028; Louie JK, 2011, CLIN INFECT DIS, V52, P301, DOI 10.1093/cid/ciq152; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mak GC, 2010, EUROSURVEILLANCE, V15, P15; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; Meunier I, 2012, VIROLOGY, V422, P125, DOI 10.1016/j.virol.2011.10.018; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Mok CKP, 2011, J VIROL, V85, P9641, DOI 10.1128/JVI.00702-11; Nakajima N, 2011, MODERN PATHOLOGY OFF; Nakajima N, 2010, JPN J INFECT DIS, V63, P67; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nin N, 2011, INTENS CARE MED, V37, P880, DOI 10.1007/s00134-011-2183-7; Ohtsu Y, 2002, MICROBIOL IMMUNOL, V46, P167, DOI 10.1111/j.1348-0421.2002.tb02682.x; Perales B, 1996, J VIROL, V70, P1678, DOI 10.1128/JVI.70.3.1678-1686.1996; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Phung TT, 2011, MICROBIOLOGY IMMUNOL; Prasad H B, 2011, J Assoc Physicians India, V59, P498; Ru YX, 2011, ULTRASTRUCT PATHOL, V35, P155, DOI 10.3109/01913123.2011.574249; Safronetz D, 2011, J VIROL, V85, P1214, DOI 10.1128/JVI.01848-10; Sambhara S, 2010, ANNU REV MED, V61, P187, DOI 10.1146/annurev.med.050908.132031; SanzEzquerro JJ, 1996, J VIROL, V70, P1905, DOI 10.1128/JVI.70.3.1905-1911.1996; Singanayagam A, 2011, J INFECTION, V63, P243, DOI 10.1016/j.jinf.2011.07.014; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Sun RQ, 2009, INTEGR ZOOL, V4, P402, DOI 10.1111/j.1749-4877.2009.00178.x; Svitek N, 2008, VIROLOGY, V376, P53, DOI 10.1016/j.virol.2008.02.035; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Warren-Gash C, 2009, LANCET INFECT DIS, V9, P601, DOI 10.1016/S1473-3099(09)70233-6; Wasilenko JL, 2011, ARCH VIROL, V156, P37, DOI 10.1007/s00705-010-0813-y; Wiegand JA, 2011, WIEN KLIN WOCHENSCHR, V123, P120, DOI 10.1007/s00508-010-1520-0; Xu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020698; Ye JQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001145; Yu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020575, 10.1371/journal.pone.0028680]; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zachary JF., 2012, PATHOLOGICAL BASIS V, V5; Zhou B, 2011, J VIROL, V85, P357, DOI 10.1128/JVI.01694-10; Zuniga J, 2011, AUTOIMMUNITY, V44, P562, DOI 10.3109/08916934.2011.592885; Zurcher T, 1996, J GEN VIROL, V77, P1745, DOI 10.1099/0022-1317-77-8-1745	74	19	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53515	10.1371/journal.pone.0053515	http://dx.doi.org/10.1371/journal.pone.0053515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326447	Green Published, Green Submitted, gold			2022-12-25	WOS:000313552400027
J	Abe, K; Hashimoto, Y; Yatsushiro, S; Yamamura, S; Bando, M; Hiroshima, Y; Kido, J; Tanaka, M; Shinohara, Y; Ooie, T; Baba, Y; Kataoka, M				Abe, Kaori; Hashimoto, Yoshiko; Yatsushiro, Shouki; Yamamura, Shohei; Bando, Mika; Hiroshima, Yuka; Kido, Jun-ichi; Tanaka, Masato; Shinohara, Yasuo; Ooie, Toshihiko; Baba, Yoshinobu; Kataoka, Masatoshi			Simultaneous Immunoassay Analysis of Plasma IL-6 and TNF-alpha on a Microchip	PLOS ONE			English	Article							ASSAY SYSTEM; INTEGRATION; SEPARATION; BLOOD	Sandwich enzyme-linked immunosorbant assay (ELISA) using a 96-well plate is frequently employed for clinical diagnosis, but is time-and sample-consuming. To overcome these drawbacks, we performed a sandwich ELISA on a microchip. The microchip was made of cyclic olefin copolymer with 4 straight microchannels. For the construction of the sandwich ELISA for interleukin-6 (IL-6) or tumor necrosis factor-alpha (TNF-alpha), we used a piezoelectric inkjet printing system for the deposition and fixation of the 1st anti-IL-6 antibody or 1st anti-TNF-alpha antibody on the surface of the each microchannel. After the infusion of 2 mu l of sample to the microchannel and a 20 min incubation, 2 mu l of biotinylated 2nd antibody for either antigen was infused and a 10 min incubation. Then 2 mu l of avidin-horseradish peroxidase was infused; and after a 5 min incubation, the substrate for peroxidase was infused, and the luminescence intensity was measured. Calibration curves were obtained between the concentration and luminescence intensity over the range of 0 to 32 pg/ml (IL-6: R-2 = 0.9994, TNF-alpha: R-2 = 0.9977), and the detection limit for each protein was 0.28 pg/ml and 0.46 pg/ml, respectively. Blood IL-6 and TNF-alpha concentrations of 5 subjects estimated from the microchip data were compared with results obtained by the conventional method, good correlations were observed between the methods according to linear regression analysis (IL-6: R-2 = 0.9954, TNF-alpha: R-2 = 0.9928). The reproducibility of the presented assay for the determination of the blood IL-6 and TNF-alpha concentration was comparable to that obtained with the 96-well plate. Simultaneous detection of blood IL-6 and TNF-alpha was possible by the deposition and fixation of each 1st antibody on the surface of a separate microchannel. This assay enabled us to determine simultaneously blood IL-6 and TNF-alpha with accuracy, satisfactory sensitivity, time saving ability, and low consumption of sample and reagents, and will be applicable to clinic diagnosis.	[Abe, Kaori; Hashimoto, Yoshiko; Yatsushiro, Shouki; Yamamura, Shohei; Tanaka, Masato; Ooie, Toshihiko; Baba, Yoshinobu; Kataoka, Masatoshi] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa, Japan; [Bando, Mika; Hiroshima, Yuka; Kido, Jun-ichi] Univ Tokushima, Inst Hlth Biosci, Div Med Dent Dynam & Reconstruct, Dept Periodontol & Endodontol Oral & Maxillofacia, Tokushima 770, Japan; [Shinohara, Yasuo] Univ Tokushima, Fac Pharmaceut Sci, Tokushima 770, Japan; [Shinohara, Yasuo] Univ Tokushima, Inst Genome Res, Tokushima 770, Japan; [Baba, Yoshinobu] Nagoya Univ, Dept Appl Chem, Grad Sch Engn, Nagoya, Aichi 46401, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Tokushima University; Tokushima University; Tokushima University; Nagoya University	Kataoka, M (corresponding author), Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa, Japan.	m-kataoka@aist.go.jp	Kataoka, Masatoshi/M-6925-2018; Tanaka, Masato/P-6700-2016; yamamura, shohei/M-8071-2018; Ooie, Toshihiko/J-1498-2018; YATSUSHIRO, shouki/M-8155-2018	Kataoka, Masatoshi/0000-0001-9779-8319; Tanaka, Masato/0000-0002-6164-7786; yamamura, shohei/0000-0002-4971-4560; Ooie, Toshihiko/0000-0001-8725-0691; YATSUSHIRO, shouki/0000-0002-6123-1561	Japan Society for the Promotion of Science (KAKENHI) [23310093]	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science, Grand-in-Aid for Scientific Research (KAKENHI) 23310093. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briggs C, 2008, BRIT J HAEMATOL, V142, P904, DOI 10.1111/j.1365-2141.2008.07274.x; Christodoulides N, 2002, ANAL CHEM, V74, P3030, DOI 10.1021/ac011150a; Di Serio F, 2006, CLIN CHEM LAB MED, V44, P768, DOI 10.1515/CCLM.2006.125; Hasenbank MS, 2008, ANAL CHIM ACTA, V611, P80, DOI 10.1016/j.aca.2008.01.048; Ikami M, 2010, LAB CHIP, V10, P3335, DOI [10.1039/c0lc00241k, 10.1039/c01c00241k]; Maeda E, 2008, ELECTROPHORESIS, V29, P1902, DOI 10.1002/elps.200700688; Maeda E, 2007, ELECTROPHORESIS, V28, P2927, DOI 10.1002/elps.200600795; Mohamadi MR, 2007, ANAL CHEM, V79, P3667, DOI 10.1021/ac0623890; Ohashi T, 2009, LAB CHIP, V9, P991, DOI 10.1039/b815475a; PORSTMANN T, 1992, J IMMUNOL METHODS, V150, P5, DOI 10.1016/0022-1759(92)90061-W; Ramos AM, 2009, ARQ BRAS CARDIOL, V92, P233, DOI 10.1590/S0066-782X2009000300012; Sato K, 2004, LAB CHIP, V4, P570, DOI 10.1039/b411356j; Sato K, 2002, ELECTROPHORESIS, V23, P734, DOI 10.1002/1522-2683(200203)23:5<734::AID-ELPS734>3.0.CO;2-W; Sato K, 2001, ANAL CHEM, V73, P1213, DOI 10.1021/ac000991z; Sato K, 2000, ANAL CHEM, V72, P1144, DOI 10.1021/ac991151r; Sato K, 2009, LAB CHIP, V8, P1992; Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002; Smith JA, 1995, SHORT PROTOCOLS MOL, P11; St-Louis P, 2000, CLIN BIOCHEM, V33, P427, DOI 10.1016/S0009-9120(00)00138-7; Stewart Thomas N., 2009, Biotechnology Journal, V4, P206, DOI 10.1002/biot.200800234; Tachi T, 2009, ANAL SCI, V25, P149, DOI 10.2116/analsci.25.149; Tachi T, 2009, LAB CHIP, V9, P966, DOI 10.1039/b813640h; Tanaka Y, 2007, BIOSENS BIOELECTRON, V23, P449, DOI 10.1016/j.bios.2007.08.006; VOLLER A, 1978, J CLIN PATHOL, V31, P507, DOI 10.1136/jcp.31.6.507; von Lode P, 2005, CLIN BIOCHEM, V38, P591, DOI 10.1016/j.clinbiochem.2005.03.008; Wehmeier M, 2006, CLIN CHEM LAB MED, V44, P888, DOI 10.1515/CCLM.2006.141; Yasukawa T, 2007, BIOSENS BIOELECTRON, V22, P2730, DOI 10.1016/j.bios.2006.11.010; Yatsushiro S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018807	28	17	18	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53620	10.1371/journal.pone.0053620	http://dx.doi.org/10.1371/journal.pone.0053620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326472	Green Published, Green Submitted, gold			2022-12-25	WOS:000313551500087
J	Cheng, Y; Huang, LZ; Li, XX; Zhou, P; Zeng, WT; Zhang, CF				Cheng, Yong; Huang, LvZhen; Li, Xiaoxin; Zhou, Peng; Zeng, Wotan; Zhang, ChunFang			Genetic and Functional Dissection of ARMS2 in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; MESSENGER-RNA EXPRESSION; BEAVER DAM EYE; EXTENDED FAMILIES; CHROMOSOME 10Q26; GENOMEWIDE-SCAN; JAPANESE POPULATION; SUSCEPTIBILITY LOCI; VISUAL IMPAIRMENT; LINKAGE ANALYSIS	Age-related maculopathy susceptibility 2(ARMS2) was suggested to be associated with neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV) in multiple genetic studies in Caucasians and Japanese. To date, no biological properties have been attributed to the putative protein in nAMD and PCV. The complete genes of ARMS2 and HTRA1 including all exons and the promoter region were assessed using direct sequencing technology in 284 unrelated mainland northern Chinese individuals: 96 nAMD patients, 92 PCV patients and 96 controls. Significant associations with both nAMD and PCV were observed in 2 polymorphisms of ARMS2 and HTRA1 rs11200638, with different genotypic distributions between nAMD and PCV (p<0.001). After adjusting for rs11200638, ARMS2 rs10490924 remained significantly associated with nAMD and PCV (p<0.001). Then we overexpressed wild-type ARMS2 and ARMS2 A69S mutation (rs10490924) in RF/6A cells and RPE cells as in vitro study model. Cell proliferation, attachment, migration and tube formation were analyzed for the first time. Compare with wild-type ARMS2, A69S mutation resulted in a significant increase in proliferation and attachment but inhibited cell migration. Moreover, neither wild-type ARMS2 nor A69S mutation affected tube formation of RF/6A cells. There is a strong and consistent association of the ARMS2/HTRA1 locus with both nAMD and PCV, suggesting the two disorders share, at least partially, similar molecular mechanisms. Neither wild-type ARMS2 nor A69S mutation had direct association with neovascularisation in the pathogenesis of AMD.	[Cheng, Yong; Huang, LvZhen; Li, Xiaoxin] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China; [Cheng, Yong; Huang, LvZhen; Li, Xiaoxin] Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China; [Zhou, Peng] Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China; [Zeng, Wotan] Chinese Natl Human Genome Ctr, Beijing, Peoples R China; [Zhang, ChunFang] Peking Univ, Peoples Hosp, Dept Clin Epidemiol, Beijing 100871, Peoples R China	Peking University; Fudan University; Peking University	Li, XX (corresponding author), Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China.	drlixiaoxin@163.com			National Basic Research Program of China (973 Program) [2011CB510200]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	Research supported by the National Basic Research Program of China (973 Program; #2011CB510200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Barral S, 2006, INVEST OPHTH VIS SCI, V47, P5453, DOI 10.1167/iovs.06-0655; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Chan WM, 2004, OPHTHALMOLOGY, V111, P1576, DOI 10.1016/j.ophtha.2003.12.056; Chen Y, 2008, GRAEF ARCH CLIN EXP, V246, P373, DOI 10.1007/s00417-007-0728-9; Ciardella AP, 2004, SURV OPHTHALMOL, V49, P25, DOI 10.1016/j.survophthal.2003.10.007; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Fisher SA, 2005, HUM MOL GENET, V14, P2257, DOI 10.1093/hmg/ddi230; Friedrich U, 2011, HUM MOL GENET, V20, P1387, DOI 10.1093/hmg/ddr020; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Goto Asako, 2009, J Ocul Biol Dis Infor, V2, P164; Gotoh N, 2008, CLIN EXP OPHTHALMOL, V36, P437, DOI 10.1111/j.1442-9071.2008.01791.x; Gotoh N, 2009, AM J OPHTHALMOL, V147, P1037, DOI 10.1016/j.ajo.2008.12.036; Hadley D, 2010, INVEST OPHTH VIS SCI, V51, P2191, DOI 10.1167/iovs.09-3798; Hammond CJ, 2002, OPHTHALMOLOGY, V109, P730, DOI 10.1016/S0161-6420(01)01049-1; Hauswirth WW, 2000, INVEST OPHTH VIS SCI, V41, P2821; Hayashi H, 2010, INVEST OPHTH VIS SCI, V51, P5914, DOI 10.1167/iovs.10-5554; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; Huang LZ, 2009, MOL VIS, V15, P1057; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Kanda A, 2010, MOL VIS, V16, P1317; Kenealy SJ, 2004, MOL VIS, V10, P57; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; Klein ML, 2010, OPHTHALMOLOGY, V117, P1554, DOI 10.1016/j.ophtha.2009.12.012; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kondo N, 2007, AM J OPHTHALMOL, V144, P608, DOI 10.1016/j.ajo.2007.06.003; Laude A, 2010, PROG RETIN EYE RES, V29, P19, DOI 10.1016/j.preteyeres.2009.10.001; Lee KY, 2008, INVEST OPHTH VIS SCI, V49, P2613, DOI 10.1167/iovs.07-0860; Liang XY, 2012, INVEST OPHTH VIS SCI, V53, P3175, DOI 10.1167/iovs.11-8135; Lima LH, 2010, OPHTHALMOLOGY, V117, P1567, DOI 10.1016/j.ophtha.2009.12.018; Liu Ning-pu, 2009, Zhonghua Yan Ke Za Zhi, V45, P393; Liu Y, 2007, GRAEF ARCH CLIN EXP, V245, P1441, DOI 10.1007/s00417-007-0575-8; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; Meyers S M, 1994, Trans Am Ophthalmol Soc, V92, P775; Narayanan R, 2007, OPHTHALMOLOGY, V114, P1327, DOI 10.1016/j.ophtha.2006.10.035; Pascolini D, 2004, OPHTHAL EPIDEMIOL, V11, P67, DOI 10.1076/opep.11.2.67.28158; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Sayen Alexandra, 2011, Rev Prat, V61, P159; Schick JH, 2003, AM J HUM GENET, V72, P1412, DOI 10.1086/375500; Schmidt S, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-18; Scholl HPN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007418; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; Shen WY, 2003, J GENE MED, V5, P576, DOI 10.1002/jgm.375; Wang GF, 2010, HUM GENET, V127, P595, DOI 10.1007/s00439-010-0805-8; Weeks DE, 2004, AM J HUM GENET, V75, P174, DOI 10.1086/422476; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000836; Yannuzzi LA, 1999, ARCH OPHTHALMOL-CHIC, V117, P1503; Yannuzzi Lawrence A, 2012, Retina, V32 Suppl 1, P1; Yu Y, 2011, HUM MOL GENET, V20, P3699, DOI 10.1093/hmg/ddr270; Zhang TH, 2009, OPHTHALMIC RES, V41, P36, DOI 10.1159/000163220; Zhou P, 2007, CURR EYE RES, V32, P973, DOI 10.1080/02713680701658323	61	23	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53665	10.1371/journal.pone.0053665	http://dx.doi.org/10.1371/journal.pone.0053665			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326481	Green Published, gold, Green Submitted			2022-12-25	WOS:000313551500090
J	Chhabra, R; Kolli, S; Bauer, JH				Chhabra, Ria; Kolli, Santharam; Bauer, Johannes H.			Organically Grown Food Provides Health Benefits to Drosophila melanogaster	PLOS ONE			English	Article							EXTENDS LIFE-SPAN; INSULIN-RESISTANCE; OBESITY; MODEL; FLY; LONGEVITY; EXTENSION; PATHWAY; SYSTEMS; BRAIN	The "organic food'' market is the fastest growing food sector, yet it is unclear whether organically raised food is nutritionally superior to conventionally grown food and whether consuming organic food bestows health benefits. In order to evaluate potential health benefits of organic foods, we used the well-characterized fruit fly Drosophila melanogaster as a model system. Fruit flies were raised on a diets consisting of extracts of either conventionally or organically raised produce (bananas, potatoes, raisins, soy beans). Flies were then subjected to a variety of tests designed to assess overall fly health. Flies raised on diets made from organically grown produce had greater fertility and longevity. On certain food sources, greater activity and greater stress resistance was additionally observed, suggesting that organic food bestows positive effects on fly health. Our data show that Drosophila can be used as a convenient model system to experimentally test potential health effects of dietary components. Using this system, we provide evidence that organically raised food may provide animals with tangible benefits to overall health.	[Chhabra, Ria] Clark High Sch, Plano, TX USA; [Kolli, Santharam; Bauer, Johannes H.] So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA; [Kolli, Santharam; Bauer, Johannes H.] So Methodist Univ, Dedman Coll, Ctr Drug Discovery Design & Delivery, Dallas, TX 75275 USA	Southern Methodist University; Southern Methodist University	Bauer, JH (corresponding author), So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA.	jbauer@smu.edu		Bauer, Johannes/0000-0001-5539-2601	Ralph E. Powe Junior Faculty Enhancement Award	Ralph E. Powe Junior Faculty Enhancement Award	The authors thank Chris Thephachanh, Claire Coogan, Babita Jain and Sarah Morris for technical assistance and helpful discussions. JHB is a recipient of the Ralph E. Powe Junior Faculty Enhancement Award.	Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7; Bauer JH, 2011, GENETICS DIETARY MOD; Bauer JH, 2007, P NATL ACAD SCI USA, V104, P13355, DOI 10.1073/pnas.0706121104; Bauer JH, 2009, AGING-US, V1, P38; BENDINER E, 1987, HOSP PRACT, V22, P116; Bendiner E., 1987, HOSP PRACT OFF ED, V22; Bier E, 2004, GENE, V342, P1, DOI 10.1016/j.gene.2004.07.018; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Birse RT, 2010, CELL METAB, V12, P533, DOI 10.1016/j.cmet.2010.09.014; Dangour AD, 2010, AM J CLIN NUTR, V92, P203, DOI 10.3945/ajcn.2010.29269; Dionne MS, 2008, DIS MODEL MECH, V1, P43, DOI 10.1242/dmm.000307; Flatt T, 2011, EXP GERONTOL, V46, P369, DOI 10.1016/j.exger.2010.10.008; Gilden RC, 2010, JOGNN-J OBST GYN NEO, V39, P103, DOI 10.1111/j.1552-6909.2009.01092.x; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Hallmann E, 2012, J SCI FOOD AGR, V92, P2840, DOI 10.1002/jsfa.5617; Hallmann E, 2012, J SCI FOOD AGR, V92, P2409, DOI 10.1002/jsfa.5624; Haselton AT, 2010, AGING-US, V2, P523, DOI 10.18632/aging.100185; Helfand SL, 2003, ADV GENET, V49, P67, DOI 10.1016/S0065-2660(03)01002-2; Howitz KT, 2008, CELL, V133, P387, DOI 10.1016/j.cell.2008.04.019; Huber M, 2011, NJAS-WAGEN J LIFE SC, V58, P103, DOI 10.1016/j.njas.2011.01.004; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Kim T, 2005, J BIOCHEM MOL BIOL, V38, P121; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Koh E, 2012, J AGR FOOD CHEM, V60, P3144, DOI 10.1021/jf300051f; Lester GE, 2011, J AGR FOOD CHEM, V59, P10401, DOI 10.1021/jf202385x; Lu CS, 2006, ENVIRON HEALTH PERSP, V114, P260, DOI 10.1289/ehp.8418; Morris SNS, 2012, BBA-MOL BASIS DIS, V1822, P1230, DOI 10.1016/j.bbadis.2012.04.012; Musselman LP, 2011, DIS MODEL MECH, V4, P842, DOI 10.1242/dmm.007948; Palupi E, 2012, J SCI FOOD AGR, V92, P2774, DOI 10.1002/jsfa.5639; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Shepherd R, 2011, FORESIGHT GOVT OF SR, VSR12, P1; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Smith-Spangler C, 2012, ANN INTERN MED, V157, P348, DOI 10.7326/0003-4819-157-5-201209040-00007; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030	36	22	24	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52988	10.1371/journal.pone.0052988	http://dx.doi.org/10.1371/journal.pone.0052988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326371	Green Published, Green Submitted, gold			2022-12-25	WOS:000313551500040
J	Freeth, M; Foulsham, T; Kingstone, A				Freeth, Megan; Foulsham, Tom; Kingstone, Alan			What Affects Social Attention? Social Presence, Eye Contact and Autistic Traits	PLOS ONE			English	Article							SPECTRUM DISORDERS; FUNCTIONING AUTISM; VISUAL INFORMATION; GAZE ALLOCATION; PATTERNS; CONVERSATION; ENVIRONMENT; PERCEPTION; MOVEMENTS; COGNITION	Social understanding is facilitated by effectively attending to other people and the subtle social cues they generate. In order to more fully appreciate the nature of social attention and what drives people to attend to social aspects of the world, one must investigate the factors that influence social attention. This is especially important when attempting to create models of disordered social attention, e.g. a model of social attention in autism. Here we analysed participants' viewing behaviour during one-to-one social interactions with an experimenter. Interactions were conducted either live or via video (social presence manipulation). The participant was asked and then required to answer questions. Experimenter eye-contact was either direct or averted. Additionally, the influence of participant self-reported autistic traits was also investigated. We found that regardless of whether the interaction was conducted live or via a video, participants frequently looked at the experimenter's face, and they did this more often when being asked a question than when answering. Critical differences in social attention between the live and video interactions were also observed. Modifications of experimenter eye contact influenced participants' eye movements in the live interaction only; and increased autistic traits were associated with less looking at the experimenter for video interactions only. We conclude that analysing patterns of eye-movements in response to strictly controlled video stimuli and natural real-world stimuli furthers the field's understanding of the factors that influence social attention.	[Freeth, Megan] Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England; [Foulsham, Tom] Univ Essex, Dept Psychol, Colchester CO4 3SQ, Essex, England; [Kingstone, Alan] Univ British Columbia, Dept Psychol, Vancouver, BC V5Z 1M9, Canada	University of Sheffield; University of Essex; University of British Columbia	Freeth, M (corresponding author), Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England.	m.freeth@sheffield.ac.uk	Freeth, Megan/L-4512-2016	Freeth, Megan/0000-0003-0534-9095; Foulsham, Tom/0000-0002-8444-7269	Economic and Social Research Council [PTA-026-27-2283]; Wellcome Trust VIP award; Leverhulme Early Career Fellowship [ECF/2010/0592]; Commonwealth Fellowship from the Government of Canada; Natural Sciences and Engineering Research Council of Canada (NSERC) operating grant; Economic and Social Research Council [ES/G046417/1] Funding Source: researchfish; ESRC [ES/G046417/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Wellcome Trust VIP award(Wellcome Trust); Leverhulme Early Career Fellowship(Leverhulme Trust); Commonwealth Fellowship from the Government of Canada; Natural Sciences and Engineering Research Council of Canada (NSERC) operating grant; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	MF was supported by Economic and Social Research Council (PTA-026-27-2283), a Wellcome Trust VIP award and a Leverhulme Early Career Fellowship (ECF/2010/0592). TF was supported by a Commonwealth Fellowship from the Government of Canada. AK was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) operating grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranek GT, 1999, J AUTISM DEV DISORD, V29, P213, DOI 10.1023/A:1023080005650; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Bird G, 2011, J AUTISM DEV DISORD, V41, P1556, DOI 10.1007/s10803-011-1183-3; Birmingham E, 2008, Q J EXP PSYCHOL, V61, P986, DOI 10.1080/17470210701410375; Brown-Schmidt S, 2008, COGNITIVE SCI, V32, P643, DOI 10.1080/03640210802066816; Chen FS, 2011, J AUTISM DEV DISORD, V41, P1131, DOI 10.1007/s10803-010-1136-2; Csibra G, 2006, ATTENTION PERFORM, P249; Doherty-Sneddon G, 2005, MEM COGNITION, V33, P727, DOI 10.3758/BF03195338; Doherty-Sneddon G, 2002, DEV PSYCHOL, V38, P438, DOI 10.1037//0012-1649.38.3.438; Droll JA, 2009, VIS COGN, V17, P1159, DOI 10.1080/13506280902797125; ELLSWORTH PC, 1972, J PERS SOC PSYCHOL, V21, P302, DOI 10.1037/h0032323; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Fletcher-Watson S, 2009, NEUROPSYCHOLOGIA, V47, P248, DOI 10.1016/j.neuropsychologia.2008.07.016; Foulsham T, 2011, VISION RES, V51, P1920, DOI 10.1016/j.visres.2011.07.002; Foulsham T, 2010, COGNITION, V117, P319, DOI 10.1016/j.cognition.2010.09.003; Freeth M, 2010, J AUTISM DEV DISORD, V40, P534, DOI 10.1007/s10803-009-0893-2; Freeth M, 2010, J EXP CHILD PSYCHOL, V105, P20, DOI 10.1016/j.jecp.2009.10.001; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Gallup AC, 2012, BIOL LETTERS, V8, P520, DOI 10.1098/rsbl.2012.0160; Glenberg AM, 1998, MEM COGNITION, V26, P651, DOI 10.3758/BF03211385; GUERIN B, 1986, J EXP SOC PSYCHOL, V22, P38, DOI 10.1016/0022-1031(86)90040-5; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Kingstone A, 2008, BRIT J PSYCHOL, V99, P317, DOI 10.1348/000712607X251243; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Laidlaw K, J VISION IN PRESS, V11, P620; Laidlaw KEW, 2011, P NATL ACAD SCI USA, V108, P5548, DOI 10.1073/pnas.1017022108; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Nadig A, 2010, NEUROPSYCHOLOGIA, V48, P2730, DOI 10.1016/j.neuropsychologia.2010.05.020; Nakano T, 2010, P ROY SOC B-BIOL SCI, V277, P2935, DOI 10.1098/rspb.2010.0587; Norbury CF, 2009, J CHILD PSYCHOL PSYC, V50, P834, DOI 10.1111/j.1469-7610.2009.02073.x; Noris B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044144; OSTERLING J, 1994, J AUTISM DEV DISORD, V24, P247, DOI 10.1007/BF02172225; Pierce K, 2011, ARCH GEN PSYCHIAT, V68, P101, DOI 10.1001/archgenpsychiatry.2010.113; Ponkanen LM, 2011, SOC COGN AFFECT NEUR, V6, P486, DOI 10.1093/scan/nsq068; Riby DM, 2008, NEUROPSYCHOLOGIA, V46, P2855, DOI 10.1016/j.neuropsychologia.2008.05.003; Richardson DC, 2007, PSYCHOL SCI, V18, P407, DOI 10.1111/j.1467-9280.2007.01914.x; Risko EF, CAMBRIDGE H IN PRESS; Risko EF, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00143; Risko EF, 2011, ATTEN PERCEPT PSYCHO, V73, P291, DOI 10.3758/s13414-010-0042-1; Rutherford MD, 2008, J AUTISM DEV DISORD, V38, P1371, DOI 10.1007/s10803-007-0525-7; Schilbach L., BEHAV BRAIN IN PRESS; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Spezio ML, 2007, J NEUROSCI, V27, P3994, DOI 10.1523/JNEUROSCI.3789-06.2007; Stein T, 2011, COGNITION, V119, P307, DOI 10.1016/j.cognition.2011.01.008; Vatikiotis-Bateson E, 1998, PERCEPT PSYCHOPHYS, V60, P926, DOI 10.3758/BF03211929; von Hofsten C, 2009, RES AUTISM SPECT DIS, V3, P556, DOI 10.1016/j.rasd.2008.12.003	47	117	118	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53286	10.1371/journal.pone.0053286	http://dx.doi.org/10.1371/journal.pone.0053286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326407	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000313551500058
J	Gonzalez, A; Manosalva, I; Liu, TX; Kageyama, R				Gonzalez, Aitor; Manosalva, Iris; Liu, Tianxiao; Kageyama, Ryoichiro			Control of Hes7 Expression by Tbx6, the Wnt Pathway and the Chemical Gsk3 Inhibitor LiCl in the Mouse Segmentation Clock	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; PRESOMITIC MESODERM; VERTEBRATE SEGMENTATION; SOMITE; NOTCH; OSCILLATION; INITIATION; MECHANISM; ENHANCER; PROTEIN	The mouse segmentation is established from somites, which are iteratively induced every two hours from the presomitic mesoderm (PSM) by a system known as the segmentation clock. A crucial component of the segmentation clock is the gene Hes7, which is regulated by the Notch and Fgf/Mapk pathways, but its relation to other pathways is unknown. In addition, chemical alteration of the Wnt pathway changes the segmentation clock period but the mechanism is unclear. To clarify these questions, we have carried out Hes7 promoter analysis in transgenic mouse embryos and have identified an essential 400 bp region, which contains binding sites of Tbx6 and the Wnt signaling effector Lef1. We have found that the Hes7 promoter is activated by Tbx6, and normal activity of the Hes7 promoter in the mouse PSM requires Tbx6 binding sites. Our results demonstrate that Wnt pathway molecules activate the Hes7 promoter cooperatively with Tbx6 in cell culture and are necessary for its proper expression in the mouse PSM. Furthermore, it is shown that the chemical Gsk3 inhibitor LiCl lengthens the oscillatory period of Hes7 promoter activity. Our data suggest that Tbx6 and the Wnt pathway cooperatively regulate proper Hes7 expression. Furthermore, proper Hes7 promoter activity and expression is important for the normal pace of oscillation.	[Gonzalez, Aitor; Manosalva, Iris; Liu, Tianxiao; Kageyama, Ryoichiro] Kyoto Univ, Inst Virus Res, Kyoto 606, Japan; [Gonzalez, Aitor; Manosalva, Iris; Liu, Tianxiao; Kageyama, Ryoichiro] Japan Sci & Technol Agcy, CREST, Kyoto, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Gonzalez, A (corresponding author), Univ Strasbourg, INSERM, U964, IGBMC,CNRS,UMR 7104, Illkirch Graffenstaden, France.	agonzale@igbmc.fr; rkageyam@virus.kyoto-u.ac.jp	Manosalva, Iris/A-5019-2017; Manosalva, Iris/G-6316-2014; González, Aitor/A-4275-2011	González, Aitor/0000-0002-8402-1655; , Manosalva/0000-0001-5756-2109	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science [P06237]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan. AG was partly supported by postdoctoral grant P06237 awarded by the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Bessho Y, 2003, GENE DEV, V17, P1451, DOI 10.1101/gad.1092303; Bessho Y, 2001, GENES CELLS, V6, P175, DOI 10.1046/j.1365-2443.2001.00409.x; Bialecka M, 2010, DEV BIOL, V347, P228, DOI 10.1016/j.ydbio.2010.08.032; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Dubchak Inna, 2007, V395, P3; Dunty WC, 2008, DEVELOPMENT, V135, P85, DOI 10.1242/dev.009266; Galceran J, 2001, P NATL ACAD SCI USA, V98, P8668, DOI 10.1073/pnas.151258098; Gibb S, 2009, DEV BIOL, V330, P21, DOI 10.1016/j.ydbio.2009.02.035; Gonzalez A, 2009, J THEOR BIOL, V259, P176, DOI 10.1016/j.jtbi.2009.02.007; Herrgen L, 2010, CURR BIOL, V20, P1244, DOI 10.1016/j.cub.2010.06.034; Hirata H, 2004, NAT GENET, V36, P750, DOI 10.1038/ng1372; Hofmann M, 2004, GENE DEV, V18, P2712, DOI 10.1101/gad.1248604; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ikeya M, 2001, MECH DEVELOP, V103, P27, DOI 10.1016/S0925-4773(01)00338-0; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Kim W, 2011, MOL BIOL CELL, V22, P3541, DOI 10.1091/mbc.E11-02-0139; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Masui O, 2002, INT J MOL MED, V9, P489; Niwa Y, 2011, GENES DEV; Niwa Y, 2007, DEV CELL, V13, P298, DOI 10.1016/j.devcel.2007.07.013; Oginuma M, 2010, DEVELOPMENT, V137, P1515, DOI 10.1242/dev.044545; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Schroter C, 2010, CURR BIOL, V20, P1254, DOI 10.1016/j.cub.2010.05.071; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Takashima Y, 2011, P NATL ACAD SCI USA, V108, P3300, DOI 10.1073/pnas.1014418108; Uriu K, 2009, J THEOR BIOL, V257, P385, DOI 10.1016/j.jtbi.2009.01.003; Wahl MB, 2007, DEVELOPMENT, V134, P4033, DOI 10.1242/dev.009167; Wang Q, 2006, ONCOGENE, V25, P43, DOI 10.1038/sj.onc.1209004; Wittler L, 2007, EMBO REP, V8, P784, DOI 10.1038/sj.embor.7401030; Yasuhiko Y, 2006, P NATL ACAD SCI USA, V103, P3651, DOI 10.1073/pnas.0508238103; Yasuhiko Y, 2008, DEVELOPMENT, V135, P3511, DOI 10.1242/dev.027144; Znosko WA, 2010, DEV BIOL, V342, P11, DOI 10.1016/j.ydbio.2010.03.011	33	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53323	10.1371/journal.pone.0053323	http://dx.doi.org/10.1371/journal.pone.0053323			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326414	Green Published, gold, Green Submitted			2022-12-25	WOS:000313551500065
J	Lama, G; Papi, M; Angelucci, C; Maulucci, G; Sica, G; De Spirito, M				Lama, Gina; Papi, Massimiliano; Angelucci, Cristiana; Maulucci, Giuseppe; Sica, Gigliola; De Spirito, Marco			Leuprorelin Acetate Long-Lasting Effects on GnRH Receptors of Prostate Cancer Cells: An Atomic Force Microscopy Study of Agonist/Receptor Interaction	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; MESSENGER-RIBONUCLEIC-ACID; ANTIGEN GENE-EXPRESSION; HUMAN-BREAST; MEDROXYPROGESTERONE ACETATE; ANTAGONIST CETRORELIX; HUMAN ENDOMETRIAL; MOLECULAR-SIZE; IN-VITRO; LH-RH	High cell-surface GnRH receptor (GnRH-R) levels have been shown to have a major influence on the extent of GnRH agonist-mediated tumor growth inhibition. The ability of the GnRH agonist leuprorelin acetate (LA) to induce a post-transcriptional upregulation of GnRH-R at the plasma membrane of androgen-sensitive (LNCaP) and -insensitive (PC-3) prostate cancer (PCa) cells has been previously demonstrated by Western blotting. Here we performed single molecule force spectroscopy by using Atomic Force Microscopy (AFM), which has proven to be a powerful tool allowing for investigation of living cell surface biological features, such as the so far unclear GnRH agonist/receptor interaction. Thus, in the hormone-insensitive PC-3 cells, we characterized the strength of the LA-receptor binding, and the amount and distribution of the functional receptor molecules on the cell surface. The effect of a long and continuous treatment (up to 30 days) with the agonist (10(-11) and 10(-6) M) on the same parameters was also investigated. A GnRH-R increase was observed, reaching the maximum (similar to 80%) after 30 days of treatment with the highest dose of LA (10(-6) M). The analogue-induced increase in GnRH-R was also demonstrated by Western blotting. In addition, two different receptor bound strengths were detected by AFM, which suggests the existence of two GnRH-R classes. A homogeneous distribution of the unbinding events has been found on untreated and treated PC-3 cell surfaces. The persistence of high receptor levels at the membrane of these living cells may warrant the maintenance of the response to LA also in androgen-unresponsive PCa. Moreover, the determination of ligand/receptor bond strength could shed light on the poorly understood event of LA/GnRH-R interaction and/or address structural/chemical agonist optimizations.	[Lama, Gina; Angelucci, Cristiana; Sica, Gigliola] Univ Cattolica Sacro Cuore, Fac Med & Chirurg A Gemelli, Ist Istol & Embriol, Rome, Italy; [Papi, Massimiliano; Maulucci, Giuseppe; De Spirito, Marco] Univ Cattolica Sacro Cuore, Fac Med & Chirurg A Gemelli, Ist Fis, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Sica, G (corresponding author), Univ Cattolica Sacro Cuore, Fac Med & Chirurg A Gemelli, Ist Istol & Embriol, Rome, Italy.	gigliola@rm.unicatt.it	De Spirito, Marco/U-3817-2019; De Spirito, Marco/C-5386-2008; Papi, Massimiliano/AAC-3657-2022; Maulucci, Giuseppe/C-7400-2009	De Spirito, Marco/0000-0003-4260-5107; De Spirito, Marco/0000-0003-4260-5107; Papi, Massimiliano/0000-0002-0029-1309; Maulucci, Giuseppe/0000-0002-2154-319X	Takeda Italia Farmaceutici SpA	Takeda Italia Farmaceutici SpA	Takeda Italia Farmaceutici SpA partially supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ANDERSON L, 1995, ENDOCRINOLOGY, V136, P5228, DOI 10.1210/en.136.11.5228; Angelucci C, 2004, ANTICANCER RES, V24, P2729; Angelucci C, 2011, INT J ONCOL, V38, P1501, DOI 10.3892/ijo.2011.998; Angelucci C, 2009, ENDOCRINE, V36, P87, DOI 10.1007/s12020-009-9195-x; Bono AV, 2002, ANAL QUANT CYTOL, V24, P221; Brunelli R, 2007, FASEB J, V21, P3872, DOI 10.1096/fj.07-8189com; Castellon E, 2006, CANCER INVEST, V24, P261, DOI 10.1080/07357900600629591; d'Onofrio A, 2005, PHYSICA D, V208, P220, DOI 10.1016/j.physd.2005.06.032; De Spirito M, 2006, BIOPHYS J, V90, P4239, DOI 10.1529/biophysj.105.075788; De Spirito M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.041801; Dobkin-Bekman M, 2006, MOL CELL ENDOCRINOL, V252, P184, DOI 10.1016/j.mce.2006.03.035; DONDI D, 1994, CANCER RES, V54, P4091; EMONS G, 1993, J CLIN ENDOCR METAB, V77, P1458, DOI 10.1210/jc.77.6.1458; Fost C, 2011, ONCOL REP, V25, P1481, DOI 10.3892/or.2011.1188; Green S, 1999, ENDOCR-RELAT CANCER, V6, P349, DOI 10.1677/erc.0.0060349; Grundker C, 2004, EUR J ENDOCRINOL, V151, P141, DOI 10.1530/eje.0.1510141; Iacopino F, 2006, INT J ONCOL, V29, P237; Kahan Z, 1999, J CLIN ENDOCR METAB, V84, P582, DOI 10.1210/jc.84.2.582; KAIGHN ME, 1979, INVEST UROL, V17, P16; KAISER UB, 1993, ENDOCRINOLOGY, V133, P931, DOI 10.1210/en.133.2.931; Kakar SS, 1995, CANCER LETT, V98, P57, DOI 10.1016/0304-3835(95)90203-1; KAKAR SS, 1994, MOL CELL ENDOCRINOL, V106, P145, DOI 10.1016/0303-7207(94)90196-1; LABRIE F, 1995, J CLIN ENDOCR METAB, V80, P1066, DOI 10.1210/jcem.80.4.7714068; Lamharzi N, 1998, INT J ONCOL, V13, P429; LIMONTA P, 1992, J CLIN ENDOCR METAB, V75, P207, DOI 10.1210/jcem.75.1.1320049; Limonta P, 1999, ENDOCRINOLOGY, V140, P5250, DOI 10.1210/en.140.11.5250; Lin XW, 1998, MOL CELL ENDOCRINOL, V146, P27, DOI 10.1016/S0303-7207(98)00204-4; Manni A, 1999, ENDOCR-RELAT CANCER, V6, P483, DOI 10.1677/erc.0.0060483; MARINI L, 1994, ANTICANCER RES, V14, P1881; McArdle CA, 2002, J ENDOCRINOL, V173, P1, DOI 10.1677/joe.0.1730001; MILLER WR, 1985, NATURE, V313, P231, DOI 10.1038/313231a0; Moretti RM, 2003, ENDOCR-RELAT CANCER, V10, P161, DOI 10.1677/erc.0.0100161; Morgan K, 2008, CANCER RES, V68, P6331, DOI 10.1158/0008-5472.CAN-08-0197; Papi M, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2200588; Papi M, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2970963; Papi M, 2010, EUR BIOPHYS J BIOPHY, V39, P987, DOI 10.1007/s00249-009-0468-3; Papi M, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3107265; Parasassi T, 2008, FASEB J, V22, P2350, DOI 10.1096/fj.07-097774; PLOSKER GL, 1994, DRUGS, V48, P930, DOI 10.2165/00003495-199448060-00008; QAYUM A, 1990, BRIT J CANCER, V62, P96, DOI 10.1038/bjc.1990.236; Ravenna L, 2000, J ANDROL, V21, P549; Sica G, 1999, EUR UROL, V35, P2, DOI 10.1159/000052300; Sica G, 2003, ANTICANCER RES, V23, P1283; Sica G, 2001, MOL CELL ENDOCRINOL, V176, P121, DOI 10.1016/S0303-7207(01)00429-4; SICA G, 1994, J CANCER RES CLIN, V120, P605, DOI 10.1007/BF01212815; SICA G, 1992, CLIN THER, V14, P87; Soumetz FC, 2010, ULTRAMICROSCOPY, V110, P330, DOI 10.1016/j.ultramic.2010.01.005; Tieva A, 2003, BJU INT, V91, P227, DOI 10.1046/j.1464-410X.2003.03054.x; White CD, 2008, NEUROENDOCRINOLOGY, V88, P67, DOI 10.1159/000119093; WORMALD PJ, 1985, J CLIN ENDOCR METAB, V61, P1190, DOI 10.1210/jcem-61-6-1190; YASIN M, 1995, ENDOCRINOLOGY, V136, P1559, DOI 10.1210/en.136.4.1559; Zhang X, 2006, TRENDS PHARMACOL SCI, V27, P324, DOI 10.1016/j.tips.2006.04.005	52	12	13	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52530	10.1371/journal.pone.0052530	http://dx.doi.org/10.1371/journal.pone.0052530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326338	Green Published, gold, Green Submitted			2022-12-25	WOS:000313551500015
J	Menin, A; Fleith, R; Reck, C; Marlow, M; Fernandes, P; Pilati, C; Bafica, A				Menin, Alvaro; Fleith, Renata; Reck, Carolina; Marlow, Mariel; Fernandes, Paula; Pilati, Celso; Bafica, Andre			Asymptomatic Cattle Naturally Infected with Mycobacterium bovis Present Exacerbated Tissue Pathology and Bacterial Dissemination	PLOS ONE			English	Article							TUBERCULOSIS INFECTION; IMMUNE-RESPONSES; DIAGNOSIS; PATHOGENESIS; PREVALENCE; EXPRESSION; GRANULOMAS; INSIGHTS; LESIONS; TESTS	Rational discovery of novel immunodiagnostic and vaccine candidate antigens to control bovine tuberculosis (bTB) requires knowledge of disease immunopathogenesis. However, there remains a paucity of information on the Mycobacterium bovis-host immune interactions during the natural infection. Analysis of 247 naturally PPD+ M. bovis-infected cattle revealed that 92% (n = 228) of these animals were found to display no clinical signs, but presented severe as well as disseminated bTB-lesions at post-mortem examination. Moreover, dissemination of bTB-lesions positively correlated with both pathology severity score (Spearman r = 0.48; p<0.0001) and viable tissue bacterial loads (Spearman r = 0.58; p = 0.0001). Additionally, granuloma encapsulation negatively correlated with M. bovis growth as well as pathology severity, suggesting that encapsulation is an effective mechanism to control bacterial proliferation during natural infection. Moreover, multinucleated giant cell numbers were found to negatively correlate with bacterial counts (Spearman r = 0.25; p = 0.03) in lung granulomas. In contrast, neutrophil numbers in the granuloma were associated with increased M. bovis proliferation (Spearman r = 0.27; p = 0.021). Together, our findings suggest that encapsulation and multinucleated giant cells control M. bovis viability, whereas neutrophils may serve as a cellular biomarker of bacterial proliferation during natural infection. These data integrate host granuloma responses with mycobacterial dissemination and could provide useful immunopathological-based biomarkers of disease severity in natural infection with M. bovis, an important cattle pathogen.	[Menin, Alvaro; Fleith, Renata; Fernandes, Paula; Bafica, Andre] Univ Fed Santa Catarina, Immunobiol Lab, Florianopolis, SC, Brazil; [Reck, Carolina; Pilati, Celso] Univ Estado Santa Catarina, Lab Histol & Immunohistochem, Lages, SC, Brazil; [Marlow, Mariel] Univ Fed Santa Catarina, Lab Protozool, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade do Estado de Santa Catarina; Universidade Federal de Santa Catarina (UFSC)	Menin, A (corresponding author), Univ Fed Santa Catarina, Immunobiol Lab, Florianopolis, SC, Brazil.	amenin@ccb.ufsc.br; andre.bafica@ufsc.br	Bafica, Andre/ABF-5986-2020; Menin, Álvaro/D-9815-2016	Bafica, Andre/0000-0002-5148-600X; Menin, Álvaro/0000-0002-9430-9433; Reck, Carolina/0000-0002-2345-2558; Fleith, Renata Cristina/0000-0003-2874-3642	CAPES (PROCAD); CNPq (INCT/INTEV); National Institutes of Health (GRIP/Fogarty) [394]; Howard Hughes Medical Institute (ECS Program)	CAPES (PROCAD)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (INCT/INTEV)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health (GRIP/Fogarty)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (ECS Program)	This work was funded by CAPES (PROCAD), CNPq (INCT/INTEV), National Institutes of Health 394 (GRIP/Fogarty) and the Howard Hughes Medical Institute (ECS Program). AB is a CNPq 395 scientist scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameni G, 2007, VET REC, V161, P782; Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; Ameni G, 2011, VET J, V188, P359, DOI 10.1016/j.tvjl.2010.05.005; Berg S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005068; Bermingham ML, 2009, J DAIRY SCI, V92, P3447, DOI 10.3168/jds.2008-1848; Boom WH, 1996, INFECT AGENT DIS, V5, P73; Brotherstone S, 2009, J DAIRY SCI, V93, P1234; Cassidy JP, 2006, VET MICROBIOL, V112, P151, DOI 10.1016/j.vetmic.2005.11.031; Claridge J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1840; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; CORNER LA, 1994, VET MICROBIOL, V40, P53, DOI 10.1016/0378-1135(94)90046-9; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; Cosma CL, 2004, NAT IMMUNOL, V5, P828, DOI 10.1038/ni1091; de Kantor IN, 2008, TUBERCULOSIS, V88, P358, DOI 10.1016/j.tube.2007.11.007; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Dean GS, 2005, INFECT IMMUN, V73, P6467, DOI 10.1128/IAI.73.10.6467-6471.2005; Driscoll EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018806; Egen JG, 2011, IMMUNITY, V34, P807, DOI 10.1016/j.immuni.2011.03.022; Eruslanov EB, 2005, INFECT IMMUN, V73, P1744, DOI 10.1128/IAI.73.3.1744-1753.2005; Evans JT, 2007, LANCET, V369, P1270, DOI 10.1016/S0140-6736(07)60598-4; Feng CG, 2006, J IMMUNOL, V177, P7086, DOI 10.4049/jimmunol.177.10.7086; Finlay EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030545; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gil O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010030; Hlavsa MC, 2008, CLIN INFECT DIS, V47, P168, DOI 10.1086/589240; Keller C, 2006, INFECT IMMUN, V74, P4295, DOI 10.1128/IAI.00057-06; Liebana E, 2008, VET J, V176, P354, DOI 10.1016/j.tvjl.2007.07.001; MAPA-Ministerio da Agricultura Pecuaria e Abastecimento Brasil, 2006, PROGRAMA NACIONAL DE; MONAGHAN ML, 1994, VET MICROBIOL, V40, P111, DOI 10.1016/0378-1135(94)90050-7; Neill SD, 2001, TUBERCULOSIS, V81, P79, DOI 10.1054/tube.2000.0279; Norby B, 2004, J VET DIAGN INVEST, V16, P126, DOI 10.1177/104063870401600206; Palmer MV, 2007, VET PATHOL, V44, P863, DOI 10.1354/vp.44-6-863; Phillips Clive J. C., 2002, Animal Health Research Reviews, V3, P3, DOI 10.1079/AHRR200236; Pollock JM, 2002, VET J, V163, P115, DOI 10.1053/tvjl.2001.0655; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Renwick AR, 2007, EPIDEMIOL INFECT, V135, P529, DOI 10.1017/S0950268806007205; Rodriguez JG, 1999, J CLIN MICROBIOL, V37, P2330; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Seiler P, 2003, EUR J IMMUNOL, V33, P2676, DOI 10.1002/eji.200323956; Taylor G Michael, 2007, BMC Vet Res, V3, P12, DOI 10.1186/1746-6148-3-12; Thacker TC, 2007, VET IMMUNOL IMMUNOP, V119, P204, DOI 10.1016/j.vetimm.2007.05.009; The World Organization for Animal Health (OIE), 2011, THE MANUAL OF DIAGNO; Thoen C, 2006, VET MICROBIOL, V112, P339, DOI 10.1016/j.vetmic.2005.11.047; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Wangoo A, 2005, J COMP PATHOL, V133, P223, DOI 10.1016/j.jcpa.2005.05.001; WARDS BJ, 1995, VET MICROBIOL, V43, P227, DOI 10.1016/0378-1135(94)00096-F; Wedlock DN, 1999, INFECT IMMUN, V67, P2172, DOI 10.1128/IAI.67.5.2172-2177.1999; Welsh MD, 2005, IMMUNOLOGY, V114, P101, DOI 10.1111/j.1365-2567.2004.02003.x; Whipple DL, 1996, J VET DIAGN INVEST, V8, P351, DOI 10.1177/104063879600800312; Widdison S, 2009, TUBERCULOSIS, V89, P417, DOI 10.1016/j.tube.2009.09.003; World Health Organisation, 2008, GLOB TUB CONTR SURV, P1	53	36	36	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53884	10.1371/journal.pone.0053884	http://dx.doi.org/10.1371/journal.pone.0053884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326525	Green Submitted, Green Published, gold			2022-12-25	WOS:000313551500100
J	Pirozhkova, I; Barat, A; Dmitriev, P; Kim, E; Robert, T; Guegan, J; Bilhou-Nabera, C; Busato, F; Tost, J; Carnac, G; Laoudj-Chenivesse, D; Lipinski, M; Vassetzky, Y				Pirozhkova, Iryna; Barat, Ana; Dmitriev, Petr; Kim, Elena; Robert, Thomas; Guegan, Justine; Bilhou-Nabera, Chrystele; Busato, Florence; Tost, Joerg; Carnac, Gilles; Laoudj-Chenivesse, Dalila; Lipinski, Marc; Vassetzky, Yegor			Differences in Transcription Patterns between Induced Pluripotent Stem Cells Produced from the Same Germ Layer Are Erased upon Differentiation	PLOS ONE			English	Article							HUMAN FIBROBLASTS; INDUCTION; GENERATION; ALPHA	Little is known about differences between induced pluripotent stem cells produced from tissues originating from the same germ layer. We have generated human myoblast-derived iPS cells by retroviral transduction of human primary myoblasts with the OCT3/4, SOX2, KLF4 and MYC coding sequences and compared them to iPS produced from human primary fibroblasts. When cultivated in vitro, these iPS cells proved similar to human embryonic stem cells in terms of morphology, expression of embryonic stemness markers and gene promoter methylation patterns. Embryonic bodies were derived that expressed endodermal, mesodermal as well as ectodermal markers. A comparative analysis of transcription patterns revealed significant differences in the gene expression pattern between myoblast- and fibroblast-derived iPS cells. However, these differences were reduced in the mesenchymal stem cells derived from the two iPS cell types were compared.	[Pirozhkova, Iryna; Barat, Ana; Dmitriev, Petr; Kim, Elena; Bilhou-Nabera, Chrystele; Lipinski, Marc; Vassetzky, Yegor] Univ Paris 11, Inst Cancerol Gustave Roussy, UMR 8126, CNRS, Villejuif, France; [Busato, Florence; Tost, Joerg] CEA Inst Genom, Ctr Natl Genotypage, Lab Epigenet, Evry, France; [Tost, Joerg] Fdn Jean Dausset CEPH, Lab Funct Genom, Paris, France; [Dmitriev, Petr; Carnac, Gilles; Laoudj-Chenivesse, Dalila] Univ Montpellier 2, Univ Montpellier 1, INSERM U1046, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; CEA; UDICE-French Research Universities; Universite Paris Saclay; Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Vassetzky, Y (corresponding author), Univ Paris 11, Inst Cancerol Gustave Roussy, UMR 8126, CNRS, Villejuif, France.	vassetzky@igr.fr	Vassetzky, Yegor S/C-6447-2008; Tost, Joerg/H-7129-2019; Vassetzky, Yegor/M-3383-2019; Laoudj-Chenivesse, dalila/N-7097-2018; Carnac, Gilles/N-6744-2018	Vassetzky, Yegor S/0000-0003-3101-7043; Tost, Joerg/0000-0002-2683-0817; Vassetzky, Yegor/0000-0003-3101-7043; Laoudj-Chenivesse, dalila/0000-0003-4356-9187; Pirozhkova, Iryna/0000-0001-8196-7069; Carnac, Gilles/0000-0002-3518-8774	Association Francaise contre les Myopathies (AFM); FSHD Facioscapulohumeral Mulcular Dystrophy Stitching (The Netherlands)	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); FSHD Facioscapulohumeral Mulcular Dystrophy Stitching (The Netherlands)	This research was supported by grants to YSV and DL from the Association Francaise contre les Myopathies (AFM). EK was a recipient of a postdoctoral fellowship from the FSHD Facioscapulohumeral Mulcular Dystrophy Stitching (The Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Ball SG, 2007, INT J BIOCHEM CELL B, V39, P379, DOI 10.1016/j.biocel.2006.09.005; Barrero MJ, 2011, NAT CELL BIOL, V13, P523, DOI 10.1038/ncb0511-523; Barro M, 2010, J CELL MOL MED, V14, P275, DOI 10.1111/j.1582-4934.2008.00368.x; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Eisenstein M, 2010, NAT METHODS, V7, P81, DOI 10.1038/nmeth0110-81; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Klaavuniemi T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-22; Liu H, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002376; Mangeot PE, 2011, MOL THER, V19, P1656, DOI 10.1038/mt.2011.138; Mok GF, 2011, REPRODUCTION, V141, P301, DOI 10.1530/REP-10-0394; Oda Y, 2010, J BIOL CHEM, V285, P29270, DOI 10.1074/jbc.M109.055889; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Sakurai H, 2006, STEM CELLS, V24, P575, DOI 10.1634/stemcells.2005-0256; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026406; TONIN PN, 1991, CANCER RES, V51, P5100; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Trokovic R, 2012, STEM CELLS DEV; Watanabe S, 2011, STEM CELLS, V29, P505, DOI 10.1002/stem.598; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	27	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53033	10.1371/journal.pone.0053033	http://dx.doi.org/10.1371/journal.pone.0053033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326377	gold, Green Published			2022-12-25	WOS:000313551500043
J	Sandfort, TGM; Baumann, LRM; Matebeni, Z; Reddy, V; Southey-Swartz, I				Sandfort, Theo G. M.; Baumann, Linda R. M.; Matebeni, Zethu; Reddy, Vasu; Southey-Swartz, Ian			Forced Sexual Experiences as Risk Factor for Self-Reported HIV Infection among Southern African Lesbian and Bisexual Women	PLOS ONE			English	Article							GENITAL HUMAN-PAPILLOMAVIRUS; TO-FEMALE TRANSMISSION; TRANSMITTED INFECTIONS; PREVALENCE; BEHAVIORS; MEN; SEROPREVALENCE; RELIABILITY; EPIDEMIC	Even though women who have sex with women are usually understood to be at no or very low risk for HIV infection, we explored whether lesbian and bisexual women in a geographical area with high HIV prevalence (Southern Africa) get tested for HIV and whether, among those women who get tested, there are women who live with HIV/AIDS. The study was conducted in collaboration with community-based organizations in Botswana, Namibia, South Africa and Zimbabwe. Data were collected via written surveys of women who in the preceding year had had sex with a woman (18 years and older; N = 591). Most participating women identified as lesbian and black. Almost half of the women (47.2%) reported ever having had consensual heterosexual sex. Engagement in transactional sex (lifetime) was reported by 18.6% of all women. Forced sex by men or women was reported by 31.1% of all women. A large proportion of the women reported to ever have been tested for HIV (78.3%); number of lifetime female and male partners was independently associated with having been tested; women who had engaged in transactional sex with women only or with women and men were less likely to have been tested. Self-reported HIV prevalence among tested women who knew their serostatus was 9.6%. Besides age, the sole independent predictor of a positive serostatus was having experienced forced sex by men, by women, or by both men and women. Study findings indicate that despite the image of invulnerability, HIV/AIDS is a reality for lesbian and bisexual women in Southern Africa. Surprisingly, it is not sex with men per se, but rather forced sex that is the important risk factor for self-reported HIV infection among the participating women. HIV/AIDS policy should also address the needs of lesbian, bisexual and other women who have sex with women.	[Sandfort, Theo G. M.] New York State Psychiat Inst & Hosp, HIV Ctr Clin & Behav Studies, New York, NY 10032 USA; [Sandfort, Theo G. M.] Columbia Univ, New York, NY USA; [Baumann, Linda R. M.] Out Right Namibia, Windhoek, Namibia; [Matebeni, Zethu] Univ Cape Town, Inst Humanities Africa, ZA-7925 Cape Town, South Africa; [Reddy, Vasu] Human Sci Res Council, Human & Social Dev Programme, Pretoria, South Africa; [Reddy, Vasu] Univ KwaZulu Natal, Durban, South Africa; [Southey-Swartz, Ian] Open Soc Initiat So Africa, Johannesburg, South Africa	New York State Psychiatry Institute; Columbia University; University of Cape Town; Human Sciences Research Council-South Africa; University of Kwazulu Natal	Sandfort, TGM (corresponding author), New York State Psychiat Inst & Hosp, HIV Ctr Clin & Behav Studies, New York, NY 10032 USA.	tgs2001@columbia.edu	Sandfort, Theo/D-1796-2011	Sandfort, Theo/0000-0002-4986-1739; MATEBENI, Zintombizethu/0000-0002-8202-8431	Open Society Initiative for Southern Africa; United Nations Development Programme; Open Society Foundations; NIMH-center grant [P30-MH43520]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043520] Funding Source: NIH RePORTER	Open Society Initiative for Southern Africa; United Nations Development Programme; Open Society Foundations; NIMH-center grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The project was funded by the Open Society Initiative for Southern Africa (PI: Vasu Reddy, Ph.D.), with additional support from the United Nations Development Programme, and Open Society Foundations; these organizations also participated in the study. Additional support came from a NIMH-center grant (P30-MH43520; PI: Anke A. Ehrhardt, Ph.D.). Representatives of Open Society Initiative for Southern Africa contributed to the study design, interpretation of the study findings, and preparation of the manuscript. Other funders, United Nations Development Programme and Open Society Foundations, reviewed data collection tools and supported interpretation of the study findings.	[Anonymous], SOCIAL SILENCE SOCIA, DOI DOI 10.1186/s12889-016-2980-6; Arend ED, 2005, J HOMOSEXUAL, V49, P97, DOI 10.1300/J082v49n01_05; Arend Elizabeth D, 2003, J Assoc Nurses AIDS Care, V14, P37; Bailey JV, 2004, SEX TRANSM DIS, V31, P691, DOI 10.1097/01.olq.0000143093.70899.68; Bailey JV, 2003, SEX TRANSM INFECT, V79, P147, DOI 10.1136/sti.79.2.147; BEVIER PJ, 1995, AM J PUBLIC HEALTH, V85, P1366, DOI 10.2105/AJPH.85.10.1366; CHU SY, 1990, AM J PUBLIC HEALTH, V80, P1380, DOI 10.2105/AJPH.80.11.1380; Cloete A., 2011, J AIDS HIV RES, V3, P1, DOI DOI 10.5897/JAHR.9000007; COHEN H, 1993, J ACQ IMMUN DEF SYND, V6, P1173; Deren S, 1996, DRUGS SOC, V9, P97; Diamant AL, 1999, ARCH INTERN MED, V159, P2730, DOI 10.1001/archinte.159.22.2730; Diaz T, 2001, J WOMEN HEALTH GEN-B, V10, P371, DOI 10.1089/152460901750269698; Dolan KA, 2003, SOC SCI MED, V57, P25, DOI 10.1016/S0277-9536(02)00305-2; Dolcini MM, 2003, JAIDS-J ACQ IMM DEF, V33, pS115, DOI 10.1097/00126334-200306012-00008; Dworkin SL, 2005, CULT HEALTH SEX, V7, P615, DOI 10.1080/13691050500100385; Fethers K, 2000, SEX TRANSM INFECT, V76, P345, DOI 10.1136/sti.76.5.345; Fisher DG, 2007, AIDS CARE, V19, P692, DOI 10.1080/09540120601087004; Fishman Seja Joyce, 2003, J Assoc Nurses AIDS Care, V14, P48, DOI 10.1177/1055329003255591; Friedman SR, 2003, AM J PUBLIC HEALTH, V93, P902, DOI 10.2105/AJPH.93.6.902; Gorgos LM, 2011, CLIN INFECT DIS, V53, pS84, DOI 10.1093/cid/cir697; Harris A, 2003, PSYCHOTHERAPY GAY ME, p[231, xiii]; Kennedy M B, 1995, J Am Med Womens Assoc (1972), V50, P103; Knox J, 2011, INT J STD AIDS, V22, P709, DOI 10.1258/ijsa.2011.010350; Kral AH, 1997, J ACQ IMMUN DEF SYND, V16, P211, DOI 10.1097/00042560-199711010-00011; Kwakwa HA, 2003, CLIN INFECT DIS, V36, pE40, DOI 10.1086/345462; Lewis RJ, 2012, AGGRESS VIOLENT BEH, V17, P247, DOI 10.1016/j.avb.2012.02.004; Marrazzo JM, 2012, CURR INFECT DIS REP, V14, P204, DOI 10.1007/s11908-012-0244-x; Marrazzo JM, 1998, J INFECT DIS, V178, P1604, DOI 10.1086/314494; Marrazzo JM, 2005, SEX TRANSM DIS, V32, P570, DOI 10.1097/01.olq.0000175368.82940.61; Marrazzo JM, 2001, AM J PUBLIC HEALTH, V91, P947, DOI 10.2105/AJPH.91.6.947; Marrazzo JM, 2008, SEXUALLY TRANSMITTED, P219; Mercer CH, 2007, AM J PUBLIC HEALTH, V97, P1126, DOI 10.2105/AJPH.2006.086439; Montcalm D. M., 2000, J LESBIAN STUDIES, V4, P131, DOI [10.1300/J155v04n02_09., DOI 10.1300/J155V04N02_09]; MONZON OT, 1987, LANCET, V2, P40; Naughton MJ, 2009, HDB HLTH BEHAV CHANG, P253; OHanlan KA, 1996, OBSTET GYNECOL, V88, P702, DOI 10.1016/0029-7844(96)00206-2; PETERSEN LR, 1992, J ACQ IMMUN DEF SYND, V5, P853; Pinto VM, 2005, AIDS, V19, pS64, DOI 10.1097/01.aids.0000191493.43865.2a; Raiteri R, 1998, AIDS, V12, P450; REYNOLDS G, 1994, LANCET, V344, P544, DOI 10.1016/S0140-6736(94)91934-8; Richardson D., 2000, Culture, Health & Sexuality, V2, P33, DOI 10.1080/136910500300859; Richters J, 2010, SEX HEALTH, V7, P165, DOI 10.1071/SH09072; Rosario M, 1999, HEALTH PSYCHOL, V18, P272, DOI 10.1037/0278-6133.18.3.272; Mota RMS, 2011, JAIDS-J ACQ IMM DEF, V57, pS153, DOI 10.1097/QAI.0b013e31821e9c10; Shotsky WJ, 1996, WOMEN HEALTH, V24, P1, DOI 10.1300/J013v24n02_01; Singh D, 2011, AM J PUBLIC HEALTH, V101, P1284, DOI 10.2105/AJPH.2009.169631; STORMS MD, 1979, J PERS SOC PSYCHOL, V37, P1779, DOI 10.1037/0022-3514.37.10.1779; Tallis V, 2009, SOCIAL SILENCE SOCIA; Teti M, 2011, J GAY LESBIAN SOC E, V23, P69, DOI 10.1080/10538720.2010.538009; UNAIDS, 2010, REP GLOB AIDS EP; Xu FJ, 2010, SEX TRANSM DIS, V37, P407, DOI 10.1097/OLQ.0b013e3181db2e18	51	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53552	10.1371/journal.pone.0053552	http://dx.doi.org/10.1371/journal.pone.0053552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326452	Green Submitted, Green Published, gold			2022-12-25	WOS:000313551500080
J	Wang, P; Ning, SW; Wang, QH; Li, RH; Ye, JR; Zhao, ZXL; Li, Y; Huang, T; Li, X				Wang, Peng; Ning, Shangwei; Wang, Qianghu; Li, Ronghong; Ye, Jingrun; Zhao, Zuxianglan; Li, Yan; Huang, Teng; Li, Xia			mirTarPri: Improved Prioritization of MicroRNA Targets through Incorporation of Functional Genomics Data	PLOS ONE			English	Article							GENE-EXPRESSION; REGULATORY MODULES; PREDICTION; PROTEIN; IDENTIFICATION; INTERACTOME; MIRNA; TRANSCRIPTOME; TOOL; MAP	MicroRNAs (miRNAs) are a class of small (19-25 nt) non-coding RNAs. This important class of gene regulator downregulates gene expression through sequence-specific binding to the 3'untranslated regions (3'UTRs) of target mRNAs. Several computational target prediction approaches have been developed for predicting miRNA targets. However, the predicted target lists often have high false positive rates. To construct a workable target list for subsequent experimental studies, we need novel approaches to properly rank the candidate targets from traditional methods. We performed a systematic analysis of experimentally validated miRNA targets using functional genomics data, and found significant functional associations between genes that were targeted by the same miRNA. Based on this finding, we developed a miRNA target prioritization method named mirTarPri to rank the predicted target lists from commonly used target prediction methods. Leave-one-out cross validation has proved to be successful in identifying known targets, achieving an AUC score up to 0.84. Validation in high-throughput data proved that mirTarPri was an unbiased method. Applying mirTarPri to prioritize results of six commonly used target prediction methods allowed us to find more positive targets at the top of the prioritized candidate list. In comparison with other methods, mirTarPri had an outstanding performance in gold standard and CLIP data. mirTarPri was a valuable method to improve the efficacy of current miRNA target prediction methods. We have also developed a web-based server for implementing mirTarPri method, which is freely accessible at http://bioinfo.hrbmu.edu.cn/mirTarPri.	[Wang, Peng; Ning, Shangwei; Wang, Qianghu; Li, Ronghong; Ye, Jingrun; Zhao, Zuxianglan; Li, Yan; Huang, Teng; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China	Harbin Medical University	Li, X (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China.	lixia@hrbmu.edu.cn	li, xia/HHZ-7468-2022; Ye, jingrun/GSJ-2822-2022		National Natural Science Foundation of China [31100948, 61073136, 91129710, 61170154]; National Science Foundation of Heilongjiang Province [D201114, QC2009C23]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Heilongjiang Province	This work was supported by the National Natural Science Foundation of China (Grant Nos. 31100948, 61073136, 91129710 and 61170154), National Science Foundation of Heilongjiang Province (Grant Nos. D201114, QC2009C23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Ahmed FE, 2007, EXPERT REV MOL DIAGN, V7, P569, DOI 10.1586/14737159.7.5.569; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Artmann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038365; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2000, BIOINFORMATICS, V16, P465, DOI 10.1093/bioinformatics/16.5.465; Bandyopadhyay S, 2009, BIOINFORMATICS, V25, P2625, DOI 10.1093/bioinformatics/btp503; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Cheng C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001989; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Corrada D, 2011, BRIEF BIOINFORM, V12, P588, DOI 10.1093/bib/bbr062; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Enright AJ, 2004, GENOME BIOL, V5; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Frohlich H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-166; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Gennarino VA, 2009, GENOME RES, V19, P481, DOI 10.1101/gr.084129.108; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang J C, 2008, Pac Symp Biocomput, P52; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Joung JG, 2007, BIOINFORMATICS, V23, P1141, DOI 10.1093/bioinformatics/btm045; Kersey PJ, 2010, NUCLEIC ACIDS RES, V38, pD563, DOI 10.1093/nar/gkp871; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim SK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-411; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li M, 2009, WORLD J SURG, V33, P667, DOI 10.1007/s00268-008-9836-x; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Li X, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr770; Liang H, 2007, RNA, V13, P1402, DOI 10.1261/rna.634607; Lv SL, 2012, J R SOC INTERFACE, V9, P1063, DOI 10.1098/rsif.2011.0551; Mishra PJ, 2009, PHARMACOGENOMICS, V10, P399, DOI 10.2217/14622416.10.3.399; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Resnik P, 1995, INT JOINT CONF ARTIF, P448; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Saetrom O, 2005, RNA, V11, P995, DOI 10.1261/rna.7290705; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sevilla JL, 2005, IEEE ACM T COMPUT BI, V2, P330, DOI 10.1109/TCBB.2005.50; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tran DH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S5; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yoon SR, 2005, BIOINFORMATICS, V21, P93, DOI 10.1093/bioinformatics/bti1116; Yue D, 2009, CURR GENOMICS, V10, P478, DOI 10.2174/138920209789208219; Zhang CX, 2008, PHYSIOL GENOMICS, V33, P139, DOI 10.1152/physiolgenomics.00034.2008; Zhang Y, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-127	63	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53685	10.1371/journal.pone.0053685	http://dx.doi.org/10.1371/journal.pone.0053685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326485	Green Submitted, Green Published, gold			2022-12-25	WOS:000313551500092
J	Roedel, EK; Schwarz, E; Kanse, SM				Roedel, Elfie Kathrin; Schwarz, Elisabeth; Kanse, Sandip Madhav			The Factor VII-activating Protease (FSAP) Enhances the Activity of Bone Morphogenetic Protein-2 (BMP-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARBURG-I POLYMORPHISM; TGF-BETA; PLASMINOGEN-ACTIVATOR; CELL-PROLIFERATION; GROWTH; CALCIFICATION; RECEPTOR; DIFFERENTIATION; EXPRESSION; HEPARIN	Factor VII-activating protease (FSAP) is a circulating protease involved in the pathogenesis of atherosclerosis, calcification, and fibrotic processes. To understand how FSAP controls the balance of local growth factors, we have investigated its effect on the regulation of bone morphogenetic proteins (BMPs). BMP-2 is produced as a large pro-form and secreted as a mature heparin-binding growth factor after intracellular processing by proprotein convertases (PCs). In this study, we discovered that FSAP enhances the biological activity of mature BMP-2 as well as its pro-form, as shown by osteogenic differentiation of C2C12 myoblasts. These findings were complemented by knockdown of FSAP in hepatocytes, which revealed BMP-2 processing by endogenous FSAP. N-terminal sequencing indicated that pro-BMP-2 was cleaved by FSAP at the canonical PC cleavage site, giving rise to mature BMP-2 (Arg(282) down arrow Gln(283)), as well as in the N-terminal heparin binding region of mature BMP-2, generating a truncated mature BMP-2 peptide (Arg(289) down arrow Lys(290)). Similarly, mature BMP-2 was also cleaved to a truncated peptide within its N-terminal region (Arg(289) down arrow Lys(290)). Plasmin exhibited a similar activity, but it was weaker compared with FSAP. Thrombin, Factor VIIa, Factor Xa, and activated protein C were not effective. These results were further supported by the observation that the mutation of the heparin binding region of BMP-2 inhibited the processing by FSAP but not by PC. Thus, the proteolysis and activation of pro-BMP-2 and mature BMP-2 by FSAP can regulate cell differentiation and calcification in vasculature and may explain why polymorphisms in the gene encoding for FSAP are related to vascular diseases.	[Roedel, Elfie Kathrin; Kanse, Sandip Madhav] Univ Giessen, Inst Biochem, D-35392 Giessen, Germany; [Schwarz, Elisabeth] Univ Halle Wittenberg, D-06108 Halle, Germany; [Kanse, Sandip Madhav] Univ Oslo, Inst Basic Med Sci, Dept Biochem, N-0372 Oslo, Norway	Justus Liebig University Giessen; Martin Luther University Halle Wittenberg; University of Oslo	Kanse, SM (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Biochem, Sognsvannsveien 9, N-0372 Oslo, Norway.	sandip.kanse@medisin.uio.no	Center, Norwegian Transgenic/T-2512-2018	Kanse, Sandip/0000-0003-0782-9957	Deutsche Forschungsgemeinschaft Grant [Ka 1468]; Excellence Cluster in Cardiopulmonary Sciences (ECCPS); Behring Rontgen Stiftung (BRS)	Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); Excellence Cluster in Cardiopulmonary Sciences (ECCPS)(German Research Foundation (DFG)); Behring Rontgen Stiftung (BRS)	This work was supported in part by Deutsche Forschungsgemeinschaft Grant Ka 1468 and grants from the Excellence Cluster in Cardiopulmonary Sciences (ECCPS) and the Behring Rontgen Stiftung (BRS) (to S. M. K.).	Akiyama T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002549; Anderson SB, 2008, J BIOL CHEM, V283, P7027, DOI 10.1074/jbc.M706678200; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Borkham-Kamphorst E, 2013, J HEPATOL, V58, P104, DOI 10.1016/j.jhep.2012.09.007; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Cai J, 2012, FEBS LETT, V586, P1993, DOI 10.1016/j.febslet.2012.04.030; Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200; Chu TM, 1998, BIOCHEM BIOPH RES CO, V253, P128, DOI 10.1006/bbrc.1998.9760; Collett GDM, 2005, CIRC RES, V96, P930, DOI 10.1161/01.RES.0000163634.51301.0d; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; Degnin C, 2004, MOL BIOL CELL, V15, P5012, DOI 10.1091/mbc.E04-08-0673; Derwall M, 2012, ARTERIOSCL THROM VAS, V32, P613, DOI 10.1161/ATVBAHA.111.242594; Dhore CR, 2001, ARTERIOSCL THROM VAS, V21, P1998, DOI 10.1161/hq1201.100229; Ehrlich M, 2011, CELL SIGNAL, V23, P1424, DOI 10.1016/j.cellsig.2011.04.004; Etscheid M, 2004, EUR J CELL BIOL, V82, P597, DOI 10.1078/0171-9335-00349; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Gardener H, 2011, STROKE, V42, P889, DOI 10.1161/STROKEAHA.110.591065; Harrison CA, 2011, GROWTH FACTORS, V29, P174, DOI 10.3109/08977194.2011.608666; Hauburger A, 2009, FEBS J, V276, P6386, DOI 10.1111/j.1742-4658.2009.07361.x; Hillger F, 2005, J BIOL CHEM, V280, P14974, DOI 10.1074/jbc.M414413200; Hurst NJ, 2012, BIOCHEM J, V441, P909, DOI 10.1042/BJ20111020; Hyytiainen M, 2004, CRIT REV CL LAB SCI, V41, P233, DOI 10.1080/10408360490460933; Ishisaki A, 2006, CURR PHARM DESIGN, V12, P877, DOI 10.2174/138161206776056083; Israel DI, 1992, GROWTH FACTORS, V7, P139, DOI 10.3109/08977199209046403; Jenkins G, 2008, INT J BIOCHEM CELL B, V40, P1068, DOI 10.1016/j.biocel.2007.11.026; Kannemeier C, 2004, FASEB J, V18, P728, DOI 10.1096/fj.03-0898fje; Kannemeier C, 2001, EUR J BIOCHEM, V268, P3789, DOI 10.1046/j.1432-1327.2001.02285.x; Kanse SM, 2011, HAMOSTASEOLOGIE, V31, P174, DOI 10.5482/ha-1159; Kanse SM, 1997, ARTERIOSCL THROM VAS, V17, P2848, DOI 10.1161/01.ATV.17.11.2848; Kanse SM, 2004, J CELL SCI, V117, P477, DOI 10.1242/jcs.00861; Kanzaki S, 2011, PHARMACOL REP, V63, P1222, DOI 10.1016/S1734-1140(11)70642-9; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; KOENIG BB, 1994, MOL CELL BIOL, V14, P5961, DOI 10.1128/MCB.14.9.5961; Kuhfahl S, 2011, BIOCHEM BIOPH RES CO, V408, P300, DOI 10.1016/j.bbrc.2011.04.021; Lissenberg-Thunnissen SN, 2011, INT ORTHOP, V35, P1271, DOI 10.1007/s00264-011-1301-z; Lories RJU, 2003, ARTHRITIS RHEUM, V48, P2807, DOI 10.1002/art.11389; Lowery JW, 2010, CYTOKINE GROWTH F R, V21, P287, DOI 10.1016/j.cytogfr.2010.06.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Meleady P, 2008, PROTEOMICS, V8, P2611, DOI 10.1002/pmic.200700854; Miyazono K, 2009, P JPN ACAD B-PHYS, V85, P314, DOI 10.2183/pjab.85.314; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Muhl L, 2009, FEBS J, V276, P4828, DOI 10.1111/j.1742-4658.2009.07183.x; Nakagawa Y, 2010, ARTERIOSCL THROM VAS, V30, P1908, DOI 10.1161/ATVBAHA.110.206185; Posner BI, 2010, PROG BRAIN RES, V181, P1, DOI 10.1016/S0079-6123(08)81001-1; Proudfoot D, 1998, ARTERIOSCL THROM VAS, V18, P379, DOI 10.1161/01.ATV.18.3.379; Rider CC, 2010, BIOCHEM J, V429, P1, DOI 10.1042/BJ20100305; Roemisch J, 2002, BLOOD COAGUL FIBRIN, V13, P433, DOI 10.1097/00001721-200207000-00008; Romisch J, 2002, BIOL CHEM, V383, P1119, DOI 10.1515/BC.2002.121; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; Sedding D, 2006, J EXP MED, V203, P2801, DOI 10.1084/jem.20052546; Sengle G, 2011, J BIOL CHEM, V286, P5087, DOI 10.1074/jbc.M110.188615; SHANAHAN CM, 1994, J CLIN INVEST, V93, P2393, DOI 10.1172/JCI117246; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Sopory S, 2006, J BIOL CHEM, V281, P34021, DOI 10.1074/jbc.M605330200; Sopory S, 2010, DEV BIOL, V346, P102, DOI 10.1016/j.ydbio.2010.07.019; Stephan F, 2011, CRIT CARE, V15, DOI 10.1186/cc10131; Takayama K, 2009, J BONE MINER METAB, V27, P402, DOI 10.1007/s00774-009-0054-x; Trompet S, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/424759; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; Willeit J, 2003, CIRCULATION, V107, P667, DOI 10.1161/01.CIR.0000055189.18831.B1; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yamamichi S, 2011, BIOCHEM BIOPH RES CO, V409, P483, DOI 10.1016/j.bbrc.2011.05.030; Zakai NA, 2011, J THROMB HAEMOST, V9, P267, DOI 10.1111/j.1538-7836.2010.04149.x; Zhou AJ, 2012, GROWTH FACTORS, V30, P267, DOI 10.3109/08977194.2012.686497	65	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7193	7203		10.1074/jbc.M112.433029	http://dx.doi.org/10.1074/jbc.M112.433029			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23341458	Green Published, hybrid			2022-12-25	WOS:000316002400040
J	Dejima, K; Kleinschmit, A; Takemura, M; Choi, PY; Kinoshita-Toyoda, A; Toyoda, H; Nakato, H				Dejima, Katsufumi; Kleinschmit, Adam; Takemura, Masahiko; Choi, Pui Yee; Kinoshita-Toyoda, Akiko; Toyoda, Hidenao; Nakato, Hiroshi			The Role of Drosophila Heparan Sulfate 6-O-Endosulfatase in Sulfation Compensation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRAL MEMBRANE PROTEOGLYCAN; MORPHOGEN GRADIENT FORMATION; CUBITUS-INTERRUPTUS PROTEIN; HEDGEHOG; DPP; BINDING; QSULF1; GENES; ENDOSULFATASE; SPECIFICITY	The biosynthesis of heparan sulfate proteoglycans is tightly regulated by multiple feedback mechanisms, which support robust developmental systems. One of the regulatory network systems controlling heparan sulfate (HS) biosynthesis is sulfation compensation. A previous study using Drosophila HS 2-O- and 6-O-sulfotransferase (Hs2st and Hs6st) mutants showed that loss of sulfation at one position is compensated by increased sulfation at other positions, supporting normal FGF signaling. Here, we show that HS sulfation compensation rescues both Decapentaplegic and Wingless signaling, suggesting a universal role of this regulatory system in multiple pathways in Drosophila. Furthermore, we identified Sulf1, extracellular HS6-O-endosulfatase, as a novel component of HS sulfation compensation. Simultaneous loss of Hs2st and Sulf1 ledto6-O-oversulfation, leading to patterning defects, overgrowth, and lethality. These phenotypes are caused at least partly by abnormal up-regulation of Hedgehog signaling. Thus, sulfation compensation depends on the coordinated activities of Hs2st, Hs6st, and Sulf1.	[Dejima, Katsufumi; Kleinschmit, Adam; Takemura, Masahiko; Choi, Pui Yee; Nakato, Hiroshi] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Kinoshita-Toyoda, Akiko; Toyoda, Hidenao] Ritsumeikan Univ, Fac Pharmaceut Sci, Shiga 5258577, Japan	University of Minnesota System; University of Minnesota Twin Cities; Ritsumeikan University	Nakato, H (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, 321 Church St SE, Minneapolis, MN 55455 USA.	nakat003@umn.edu		Takemura, Masahiko/0000-0003-3984-4481	National Institutes of Health [R01 HD042769]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HD042769 (to H. N.).	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Akiyama T, 2008, DEV BIOL, V313, P408, DOI 10.1016/j.ydbio.2007.10.035; Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Burke R, 1996, DEVELOPMENT, V122, P2261; Dejima K, 2011, J BIOL CHEM, V286, P17103, DOI 10.1074/jbc.M110.208082; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Ferreras C, 2012, J BIOL CHEM, V287, P36132, DOI 10.1074/jbc.M112.384875; Fujise M, 2001, DEV BIOL, V235, P433, DOI 10.1006/dbio.2001.0290; Fujise M, 2003, DEVELOPMENT, V130, P1515, DOI 10.1242/dev.00379; Isidor B, 2010, AM J HUM GENET, V87, P95, DOI 10.1016/j.ajhg.2010.05.012; Jastrebova N, 2010, J BIOL CHEM, V285, P26842, DOI 10.1074/jbc.M109.093542; Kamimura K, 2001, J BIOL CHEM, V276, P17014, DOI 10.1074/jbc.M011354200; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kamimura K, 2011, GLYCOBIOLOGY, V21, P607, DOI 10.1093/glycob/cwq202; Kirkpatrick CA, 2004, DEV CELL, V7, P513, DOI 10.1016/j.devcel.2004.08.004; Kirkpatrick CA, 2007, J CELL SCI, V120, P1829, DOI 10.1242/jcs.03432; Kleinschmit A, 2010, DEV BIOL, V345, P204, DOI 10.1016/j.ydbio.2010.07.006; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Lander D, 2007, B MATH BIOL, V69, P33, DOI 10.1007/s11538-006-9152-2; Lemjabbar-Alaoui H, 2010, ONCOGENE, V29, P635, DOI 10.1038/onc.2009.365; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Merry CLR, 2002, BBA-GEN SUBJECTS, V1573, P319, DOI 10.1016/S0304-4165(02)00399-9; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; NAKATO H, 1995, DEVELOPMENT, V121, P3687; Nakato H, 2002, BBA-GEN SUBJECTS, V1573, P312, DOI 10.1016/S0304-4165(02)00398-7; Rosen SD, 2010, EXPERT OPIN THER TAR, V14, P935, DOI 10.1517/14728222.2010.504718; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Strigini M, 1997, DEVELOPMENT, V124, P4697; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Townley RA, 2011, J BIOL CHEM, V286, P16824, DOI 10.1074/jbc.M111.227926; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Wojcinski A, 2011, DEV BIOL, V358, P168, DOI 10.1016/j.ydbio.2011.07.027; You J, 2011, DEV DYNAM, V240, P640, DOI 10.1002/dvdy.22562; Yu K, 1996, DEVELOPMENT, V122, P4033	44	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6574	6582		10.1074/jbc.M112.404830	http://dx.doi.org/10.1074/jbc.M112.404830			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23339195	Green Published, hybrid			2022-12-25	WOS:000315820700050
J	Leung, JWC; Ghosal, G; Wang, WQ; Shen, X; Wang, JD; Li, L; Chen, JJ				Leung, Justin Wai-Chung; Ghosal, Gargi; Wang, Wenqi; Shen, Xi; Wang, Jiadong; Li, Lei; Chen, Junjie			Alpha Thalassemia/Mental Retardation Syndrome X-linked Gene Product ATRX Is Required for Proper Replication Restart and Cellular Resistance to Replication Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENE-INDUCED SENESCENCE; DNA-DAMAGE; MENTAL-RETARDATION; GENOMIC INTEGRITY; HISTONE CHAPERONE; S PHASE; PROTEIN; MUTATIONS; CELLS; RECOMBINATION	Alpha thalassemia/mental retardation syndrome X-linked (ATRX) is a member of the SWI/SNF protein family of DNA-dependent ATPases. It functions as a chromatin remodeler and is classified as an SNF2-like helicase. Here, we showed somatic knock-out of ATRX displayed perturbed S-phase progression as well as hypersensitivity to replication stress. ATRX is recruited to sites of DNA damage, required for efficient checkpoint activation and faithful replication restart. In addition, we identified ATRX as a binding partner of MRE11-RAD50-NBS1 (MRN) complex. Together, these results suggest a non-canonical function of ATRX in guarding genomic stability.	[Leung, Justin Wai-Chung; Ghosal, Gargi; Wang, Wenqi; Shen, Xi; Wang, Jiadong; Li, Lei; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Unit 66, 1515 Holcombe Blvd,Room Y3-6006, Houston, TX 77030 USA.	jchen8@mdanderson.org		Wang, Wenqi/0000-0003-4053-5088; Ghosal, Gargi/0000-0001-8399-5354; Leung, Justin Wai Chung/0000-0003-4601-390X	National Institutes of Health [CA089239, CA092312]; Dept. of Defense [W81XWH-05-1-0470]; NATIONAL CANCER INSTITUTE [R01CA089239, P30CA016672, R01CA092312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Grants CA089239 and CA092312 (to J. C.) from the National Institutes of Health.; Recipient of an Era of Hope Scholar award from the Dept. of Defense (W81XWH-05-1-0470) and a member of the M. D. Anderson Cancer Center (CA016672).	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Baumann C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001137; Boe SO, 2006, J CELL SCI, V119, P3284, DOI 10.1242/jcs.03068; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Cardoso C, 2000, J MED GENET, V37, P746, DOI 10.1136/jmg.37.10.746; Ciccia A, 2012, MOL CELL, V47, P396, DOI 10.1016/j.molcel.2012.05.024; De La Fuente R, 2011, REPRODUCTION, V142, P221, DOI 10.1530/REP-10-0380; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Draskovic I, 2009, P NATL ACAD SCI USA, V106, P15726, DOI 10.1073/pnas.0907689106; Falbo KB, 2009, NAT STRUCT MOL BIOL, V16, P1167, DOI 10.1038/nsmb.1686; Falck J, 2012, EMBO REP, V13, P561, DOI 10.1038/embor.2012.58; Ge XQ, 2010, J CELL BIOL, V191, P1285, DOI 10.1083/jcb.201007074; Ghosal G, 2012, J BIOL CHEM, V287, P34225, DOI 10.1074/jbc.M112.400135; Gibbons RJ, 2003, NAT GENET, V34, P446, DOI 10.1038/ng1213; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Higgs DR, 2005, ANN NY ACAD SCI, V1054, P92, DOI 10.1196/annals.1345.012; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huh MS, 2012, J CLIN INVEST, V122, P4412, DOI 10.1172/JCI63765; Iwase S, 2011, NAT STRUCT MOL BIOL, V18, P769, DOI 10.1038/nsmb.2062; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Leung JWC, 2012, P NATL ACAD SCI USA, V109, P4491, DOI 10.1073/pnas.1118720109; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Ma HT, 2011, METHODS MOL BIOL, V761, P151, DOI 10.1007/978-1-61779-182-6_10; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Picketts DJ, 1996, HUM MOL GENET, V5, P1899, DOI 10.1093/hmg/5.12.1899; Ritchie K, 2008, J CELL BIOL, V180, P315, DOI 10.1083/jcb.200706083; Tittel-Elmer M, 2009, EMBO J, V28, P1142, DOI 10.1038/emboj.2009.60; Weston R, 2012, GENE DEV, V26, P1558, DOI 10.1101/gad.193516.112; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Yuan JS, 2012, MOL CELL, V47, P410, DOI 10.1016/j.molcel.2012.05.025; Yuan JS, 2009, GENE DEV, V23, P2394, DOI 10.1101/gad.1836409; Yusufzai T, 2009, GENE DEV, V23, P2400, DOI 10.1101/gad.1831509; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	41	63	65	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6342	6350		10.1074/jbc.M112.411603	http://dx.doi.org/10.1074/jbc.M112.411603			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23329831	Green Published, hybrid			2022-12-25	WOS:000315820700029
J	Agolory, SG; Barbot, O; Averhoff, F; Weiss, D; Wilson, E; Egger, J; Miller, J; Ogbuanu, I; Walton, S; Kahn, E				Agolory, Simon G.; Barbot, Oxiris; Averhoff, Francisco; Weiss, Don; Wilson, Elisha; Egger, Joseph; Miller, Jeffery; Ogbuanu, Ikechukwu; Walton, Sabrina; Kahn, Emily			Implementation of Non-Pharmaceutical Interventions by New York City Public Schools to Prevent 2009 Influenza A	PLOS ONE			English	Article							H1N1 VIRUS-INFECTIONS; PANDEMIC INFLUENZA; ABSENTEEISM; ILLNESS; TRANSMISSION; HOUSEHOLDS; OUTBREAK; CHILDREN	Introduction: Children are important transmitters of influenza in the community and a number of non-pharmaceutical interventions (NPIs), including hand washing and use of hand sanitizer, have been recommended to mitigate the transmission of influenza, but limited information is available regarding schools' ability to implement these NPIs during an influenza outbreak. We evaluated implementation of NPIs during fall 2009 in response to H1N1 pandemic influenza (pH1N1) by New York City (NYC) public schools. Methods: From January 25 through February 9, 2010, an online survey was sent to all the 1,632 NYC public schools and principals were asked to participate in the survey or to designate a school nurse or other school official with knowledge of school policies and characteristics to do so. Results: Of 1,633 schools, 376(23%) accessed and completed the survey. Nearly all respondents (99%) implemented at least two NPIs. Schools that had a Flu Response Team (FRT) as a part of school emergency preparedness plan were more likely to implement the NPI guidelines recommended by NYC public health officials than schools that did not have a FRT. Designation of a room for isolating ill students, for example, was more common in schools with a FRT (72%) than those without (53%) (p < 0.001). Conclusions: Implementing an NPI program in a large school system to mitigate the effects of an influenza outbreak is feasible, but there is potential need for additional resources in some schools to increase capacity and adherence to all recommendations. Public health influenza-preparedness plans should include school preparedness planning and FRTs.	[Agolory, Simon G.; Miller, Jeffery; Ogbuanu, Ikechukwu] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Barbot, Oxiris] Dept Hlth, Baltimore, MD USA; [Averhoff, Francisco; Walton, Sabrina; Kahn, Emily] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA USA; [Barbot, Oxiris; Weiss, Don; Wilson, Elisha; Egger, Joseph] Dept Hlth & Mental Hyg, New York, NY USA; [Egger, Joseph] SciMetrika LLC, Res Triangle Pk, NC USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Agolory, SG (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA.	sagolory@cdc.gov	Agolory, Simon/AIF-4664-2022	Agolory, Simon/0000-0001-5023-5754; Kahn, Emily/0000-0001-7812-7958	Division of Healthcare Quality Promotion at the Centers for Disease Control and Prevention	Division of Healthcare Quality Promotion at the Centers for Disease Control and Prevention	This study was funded by the Division of Healthcare Quality Promotion at the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2010, AM J INFECT CONTROL, V38, P251, DOI 10.1016/j.ajic.2009.12.007; *CDCP, 2009, FLU ACT SURV; Center for Disease Control and Prevention, 2010, UPD CDC EST 2009 H1N; Centers for Disease Control and Prevention, 2009, MMWR-MORBID MORTAL W, V58, P435, DOI DOI 10.1007/S00134-010-2021-3; Centers for Disease Control and Prevention, 2009, CDC GUID STAT LOC PU; Centers for Disease Control and Prevention (CDC), 2009, UPD CDC EST 2009 H1N; CHIN T D, 1960, Public Health Rep, V75, P148; COLLINS SD, 1951, PUBLIC HEALTH REP, V66, P1487, DOI 10.2307/4587915; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Frost W.H., 1920, PUB HLTH REP, V35, P584, DOI DOI 10.2307/4575511; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; GLEZEN WP, 1989, VIRAL INFECTIONS HUM, P419; Hammond B, 2000, AM J INFECT CONTROL, V28, P340, DOI 10.1067/mic.2000.107276; Iuliano AD, 2011, CLIN INFECT DIS, V52, pS161, DOI 10.1093/cid/ciq032; Jordan H. T., 2009, Morbidity and Mortality Weekly Report, V58, P470; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Meadows E, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-50; Mitchell T, 2011, CLIN INFECT DIS, V52, pS138, DOI 10.1093/cid/ciq056; MONTO AS, 1975, AM J EPIDEMIOL, V102, P553, DOI 10.1093/oxfordjournals.aje.a112193; Munayco CV, 2009, EUROSURVEILLANCE, V2009, P14; Nasrullah M, 2012, INT J INFECT DIS, V16, pE382, DOI 10.1016/j.ijid.2012.01.010; Neuzil KM, 2002, ARCH PEDIAT ADOL MED, V156, P986, DOI 10.1001/archpedi.156.10.986; New York City Department of Education, SCH DEM ACC SNAPSH; New York City Department of Health and Mental Hygiene, 2010, GUID SCH K 12 RESP I; *NY CIT DEP HLTH M, 2009, ST FRANC PREP UPD SW; Office of Elementary and Secondary Education, TITL 1 A; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Ritger K. A., 2009, Morbidity and Mortality Weekly Report, V58, P913; Viboud C, 2004, BRIT J GEN PRACT, V54, P684	30	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e50916	10.1371/journal.pone.0050916	http://dx.doi.org/10.1371/journal.pone.0050916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23341877	gold, Green Published			2022-12-25	WOS:000314707700004
J	Al-Saeedi, FJ; Mathew, PM; Luqmani, YA				Al-Saeedi, Fatma J.; Mathew, Princy M.; Luqmani, Yunus A.			Assessment of Tracer Tc-99m(V)-DMSA Uptake as a Measure of Tumor Cell Proliferation In Vitro	PLOS ONE			English	Article							TC-99M DMSA UPTAKE; DIMERCAPTOSUCCINIC ACID; GROWTH-FACTOR; KINETIC-ANALYSIS; TC-99M-(V)-DMSA UPTAKE; METASTATIC CARCINOMA; MEDULLARY CARCINOMA; CANCER-CELLS; PENTAVALENT; IMATINIB	Purpose: To examine whether Tc-99m(V)-DMSA could be used as a non-invasive measure of cancer cell proliferation. Methods: Human breast cancer MCF-7, MDA-MB-231 and pII, and prostate cancer PC-3 cell lines were grown to 30, 50 and 100% confluency and pulsed with Tc-99m(V)-DMSA in media for 60 min at 37 degrees C. DNA synthesis was analysed by quantification of the S phase using flow cytometry, [methyl-H-3]thymidine incorporation and expression of proliferation markers PCNA and Ki-67 using realtime PCR. One way ANOVA was used to compare groups. Results: In all cell lines rates of Tc-99m(V)-DMSA uptake were inversely related to cell density. This was paralleled by similar trends in S phase proportions, [methyl-H-3]thymidine incorporation and expression of PCNA and Ki-67. Conclusion: Rates of Tc-99m(V)-DMSA uptake into different types of tumour cells correlate well with cell density that is useful as a non-invasive measure of tumour cellular proliferation in vivo.	[Al-Saeedi, Fatma J.; Mathew, Princy M.] Kuwait Univ, Hlth Sci Ctr, Fac Med, Dept Nucl Med, Hawally, Jabriya, Kuwait; [Luqmani, Yunus A.] Kuwait Univ, Hlth Sci Ctr, Fac Pharm, Dept Pharmaceut Chem, Hawally, Jabriya, Kuwait	Kuwait University; Kuwait University	Al-Saeedi, FJ (corresponding author), Kuwait Univ, Hlth Sci Ctr, Fac Med, Dept Nucl Med, Hawally, Jabriya, Kuwait.	fatimas@hsc.edu.kw	AL-Saeedi, Fatma/AAT-8279-2020; Alsaeedi, Fatma/AAD-8211-2021	AL-Saeedi, Fatma/0000-0003-0932-6261; 	Kuwait University Research Sector [MN 03/07];  [GM 01/01];  [GM 01/05]	Kuwait University Research Sector; ; 	The authors would like to acknowledge Research Grant MN 03/07 from Kuwait University Research Sector and for support through Grants GM 01/01 and GM 01/05 funding the Research Core Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerstaff E, 2001, CANCER RES, V61, P3599; Al Saleh S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020610; Al-Saeedi F, 2005, EUR J NUCL MED MOL I, V32, P660, DOI 10.1007/s00259-004-1707-6; Atasever T, 1997, NUKLEARMED, V36, P223; Babbar A, 1991, J Nucl Biol Med, V35, P100; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLOWER PJ, 1991, J NUCL MED, V32, P845; Buck AK, 2005, EUR J NUCL MED MOL I, V32, P525, DOI 10.1007/s00259-004-1706-7; Buck AK, 2006, CANCER RES, V66, P11055, DOI 10.1158/0008-5472.CAN-06-1955; CLARKE SEM, 1988, J NUCL MED, V29, P33; CONTI PS, 1994, NUCL MED BIOL, V21, P1045, DOI 10.1016/0969-8051(94)90176-7; DAVISON A, 1980, INORG CHEM, V19, P1988, DOI 10.1021/ic50209a031; Denoyer D, 2005, EUR J NUCL MED MOL I, V32, P820, DOI 10.1007/s00259-005-1773-4; Denoyer D, 2004, EUR J NUCL MED MOL I, V31, P77, DOI 10.1007/s00259-003-1334-7; Garnuszek P, 2012, NUCL MED REV, V15, P95, DOI 10.5603/NMR.2012.0003; Glunde K, 2006, MOL PHARMACEUT, V3, P496, DOI 10.1021/mp060067e; HELDIN CH, 1990, CELL REGUL, V1, P555, DOI 10.1091/mbc.1.8.555; HIGASHI K, 1993, J NUCL MED, V34, P414; Hirano T, 1997, J NUCL MED, V38, P1741; HIRANO T, 1995, J NUCL MED, V36, P202; Holdhoff M, 2005, BLOOD CELL MOL DIS, V34, P181, DOI 10.1016/j.bcmd.2004.11.006; International Atomic Energy Agency, 2008, INT AT EN AG TECHN R; JEGHERS O, 1986, J NUCL MED, V27, P1223; Kakita A, 2004, ATHEROSCLEROSIS, V174, P17, DOI 10.1016/j.atherosclerosis.2003.12.039; KASHYAP R, 1992, CLIN NUCL MED, V17, P119, DOI 10.1097/00003072-199202000-00011; Kilic T, 2000, CANCER RES, V60, P5143; Kirath H, 1998, JPN J OPHTHALMOL, V42, P60, DOI 10.1016/S0021-5155(97)00110-X; KOBAYASHI H, 1995, EUR J NUCL MED, V22, P559, DOI 10.1007/BF00817283; Kothari K, 1999, APPL RADIAT ISOTOPES, V51, P43, DOI 10.1016/S0969-8043(98)00194-8; Ksienski D, 2011, CLIN MED INSIGHTS-ON, V5, P365, DOI 10.4137/CMO.S4259; Lam ASK, 1997, NUCL MED COMMUN, V18, P907, DOI 10.1097/00006231-199710000-00003; LAMKI L, 1984, J NUCL MED, V25, P733; Le Jeune N, 2006, EUR J CANCER, V42, P1004, DOI 10.1016/j.ejca.2006.01.023; Luqmani YA, 2009, INT J ONCOL, V34, P231, DOI 10.3892/ijo_00000145; Mankoff DA, 1999, J NUCL MED, V40, P614; Marques FLN, 2007, J LABELLED COMP RA S, V50, pS445; Muzi M, 2005, J NUCL MED, V46, P274; Muzi M, 2006, J NUCL MED, V47, P1612; OHTA H, 1988, NUCL MED COMMUN, V9, P105; OHTA H, 1984, J NUCL MED, V25, P323; OKADA J, 1992, J NUCL MED, V33, P325; Papantoniou V, 2005, BREAST CANCER RES, V7, pR33, DOI 10.1186/bcr948; Papantoniou V, 2002, NUCL MED COMMUN, V23, P461, DOI 10.1097/00006231-200205000-00006; Papantoniou V, 2001, EUR J NUCL MED, V28, P923, DOI 10.1007/s002590100545; Papantoniou V, 1999, EUR J NUCL MED, V26, P977; Papantoniou V, 2012, IMAGING BREAST TECHN, P61; Papantoniou VJ, 2004, BREAST CANCER RES, V6, pR56, DOI 10.1186/bcr751; Park JY, 2007, NUCL MED BIOL, V34, P1029, DOI 10.1016/j.nucmedbio.2007.06.016; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raymond E, 2008, J CLIN ONCOL, V26, P4659, DOI 10.1200/JCO.2008.16.9235; Saha G.B., 1992, FUNDAMENTALS NUCL PH, V3rd edition; Saha GB, 2004, FUNDAMENTALS NUCL PH; Alexander S, 2007, SEMIN NUCL MED, V37, P429, DOI 10.1053/j.semnuclmed.2007.08.001; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Shields AF, 2006, MOL IMAGING BIOL, V8, P141, DOI 10.1007/s11307-006-0039-2; Shukla J, 2005, PHARMAZIE, V60, P583; Smith TAD, 2006, J NUCL MED, V47, P1525; Tsiouris S, 2007, J NEURO-ONCOL, V85, P291, DOI 10.1007/s11060-007-9410-7; Vesselle H, 2003, J NUCL MED, V44, P1482; WASHBURN LC, 1995, NUCL MED BIOL, V22, P689, DOI 10.1016/0969-8051(94)00145-A; WATKINSON JC, 1989, J NUCL MED, V30, P174; WESTERA G, 1985, INT J APPL RADIAT IS, V36, P311, DOI 10.1016/0020-708X(85)90091-2	62	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54361	10.1371/journal.pone.0054361	http://dx.doi.org/10.1371/journal.pone.0054361			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335999	Green Published, gold, Green Submitted			2022-12-25	WOS:000314707700057
J	Chang, HY; Shih, MH; Huang, HC; Tsai, SR; Juan, HF; Lee, SC				Chang, Hsin-Yi; Shih, Meng-Her; Huang, Hsuan-Cheng; Tsai, Shang-Ru; Juan, Hsueh-Fen; Lee, Si-Chen			Middle Infrared Radiation Induces G(2)/M Cell Cycle Arrest in A549 Lung Cancer Cells	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; OXIDATIVE STRESS; SINGLET OXYGEN; ACTION SPECTRA; HUMAN SKIN; ULTRAVIOLET; INDUCTION; PATHWAY; KINASE; REPAIR	There were studies investigating the effects of broadband infrared radiation (IR) on cancer cell, while the influences of middle-infrared radiation (MIR) are still unknown. In this study, a MIR emitter with emission wavelength band in the 3-5 mu m region was developed to irradiate A549 lung adenocarcinoma cells. It was found that MIR exposure inhibited cell proliferation and induced morphological changes by altering the cellular distribution of cytoskeletal components. Using quantitative PCR, we found that MIR promoted the expression levels of ATM (ataxia telangiectasia mutated), ATR (ataxia-telangiectasia and Rad3-related and Rad3-related), TP53 (tumor protein p53), p21 (CDKN1A, cyclin-dependent kinase inhibitor 1A) and GADD45 (growth arrest and DNA-damage inducible), but decreased the expression levels of cyclin B coding genes, CCNB1 and CCNB2, as well as CDK1 (Cyclin-dependent kinase 1). The reduction of protein expression levels of CDC25C, cyclin B1 and the phosphorylation of CDK1 at Thr-161 altogether suggest G(2)/M arrest occurred in A549 cells by MIR. DNA repair foci formation of DNA double-strand breaks (DSB) marker gamma-H2AX and sensor 53BP1 was induced by MIR treatment, it implies the MIR induced G2/M cell cycle arrest resulted from DSB. This study illustrates a potential role for the use of MIR in lung cancer therapy by initiating DSB and blocking cell cycle progression.	[Chang, Hsin-Yi; Shih, Meng-Her; Juan, Hsueh-Fen] Natl Taiwan Univ, Dept Life Sci, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Huang, Hsuan-Cheng] Natl Yang Ming Univ, Inst Biomed Informat, Ctr Syst & Synthet Biol, Taipei 112, Taiwan; [Tsai, Shang-Ru; Juan, Hsueh-Fen; Lee, Si-Chen] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Lee, Si-Chen] Natl Taiwan Univ, Dept Elect Engn, Taipei 10764, Taiwan	National Taiwan University; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University	Juan, HF (corresponding author), Natl Taiwan Univ, Dept Life Sci, Inst Mol & Cellular Biol, Taipei 10764, Taiwan.	yukijuan@ntu.edu.tw; sclee@cc.ee.ntu.edu.tw	Huang, Hsuan-Cheng/C-7266-2011	Huang, Hsuan-Cheng/0000-0002-3386-0934; JUAN, HSUEH-FEN/0000-0003-4876-3309; Lee, Si-Chen/0000-0002-3788-2030; Chang, Hsin-Yi/0000-0002-2742-0676	National Science Council, Taiwan [NSC 100-2120-M-002-014, NSC 99-2621-B-002-005-MY3, NSC 99-2621-B-010-001MY3]; National Taiwan University Cutting-Edge Steering Research Project [10R70602C3, 101R4000]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Cutting-Edge Steering Research Project	This work was supported by the National Science Council, Taiwan (NSC 100-2120-M-002-014, NSC 99-2621-B-002-005-MY3, NSC 99-2621-B-010-001MY3) and National Taiwan University Cutting-Edge Steering Research Project (10R70602C3 and 101R4000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albro PW, 1997, PHOTOCHEM PHOTOBIOL, V66, P316, DOI 10.1111/j.1751-1097.1997.tb03154.x; [Anonymous], 1980, INFRARED CHARACTERIS; Avery SV, 2011, BIOCHEM J, V434, P201, DOI 10.1042/BJ20101695; Baier J, 2006, BIOPHYS J, V91, P1452, DOI 10.1529/biophysj.106.082388; CADET J, 1992, J PHOTOCH PHOTOBIO B, V15, P277, DOI 10.1016/1011-1344(92)85135-H; Chan TA, 2000, GENE DEV, V14, P1584; Chang CH, 2011, TOXICOL SCI, V119, P84, DOI 10.1093/toxsci/kfq309; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Devasagayam T P A, 2004, J Assoc Physicians India, V52, P794; Ditch S, 2012, TRENDS BIOCHEM SCI, V37, P15, DOI 10.1016/j.tibs.2011.10.002; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FitzGerald JE, 2009, BIOCHEM SOC T, V37, P897, DOI 10.1042/BST0370897; Frank S, 2004, J INVEST DERMATOL, V123, P823, DOI 10.1111/j.0022-202X.2004.23472.x; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Graf A, 2007, MEAS SCI TECHNOL, V18, pR59, DOI 10.1088/0957-0233/18/7/E01; Hanson KM, 1998, P NATL ACAD SCI USA, V95, P10576, DOI 10.1073/pnas.95.18.10576; Harper JV, 2010, DNA REPAIR, V9, P907, DOI 10.1016/j.dnarep.2010.06.002; INOUE S, 1989, INT J BIOMETEOROL, V33, P145, DOI 10.1007/BF01084598; Ishibashi J, 2008, MED ONCOL, V25, P229, DOI 10.1007/s12032-007-9020-4; Iwabuchi K, 2003, J BIOL CHEM, V278, P36487, DOI 10.1074/jbc.M304066200; JONES CA, 1987, RADIAT RES, V110, P244, DOI 10.2307/3576902; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; KASPRZAK KS, 1995, CANCER INVEST, V13, P411, DOI 10.3109/07357909509031921; Kielbassa C, 1997, CARCINOGENESIS, V18, P811, DOI 10.1093/carcin/18.4.811; Kim MS, 2006, BRIT J DERMATOL, V155, P1131, DOI 10.1111/j.1365-2133.2006.07510.x; Kvam E, 1997, CARCINOGENESIS, V18, P2379, DOI 10.1093/carcin/18.12.2379; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lee CF, 2005, ANN NY ACAD SCI, V1042, P246, DOI 10.1196/annals.1338.027; Lin CC, 2008, ARTERIOSCL THROM VAS, V28, P739, DOI 10.1161/ATVBAHA.107.160085; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250; Menezes S, 1998, J INVEST DERMATOL, V111, P629, DOI 10.1046/j.1523-1747.1998.00338.x; Mierke CT, 2009, CELL BIOCHEM BIOPHYS, V53, P115, DOI 10.1007/s12013-009-9047-6; Milzani A, 1997, ARCH BIOCHEM BIOPHYS, V339, P267, DOI 10.1006/abbi.1996.9847; Morris JR, 2010, CANCER RES, V70, P3861, DOI 10.1158/0008-5472.CAN-10-0468; Ngan VK, 2001, MOL PHARMACOL, V60, P225, DOI 10.1124/mol.60.1.225; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Potapova TA, 2009, MOL BIOL CELL, V20, P1737, DOI 10.1091/mbc.E08-07-0771; Rau CS, 2011, PHOTOCHEM PHOTOBIOL, V87, P441, DOI 10.1111/j.1751-1097.2010.00853.x; Risinger AL, 2009, CANCER TREAT REV, V35, P255, DOI 10.1016/j.ctrv.2008.11.001; Samet JM, 2009, CLIN CANCER RES, V15, P5626, DOI 10.1158/1078-0432.CCR-09-0376; Schroeder P, 2007, FREE RADICAL BIO MED, V43, P128, DOI 10.1016/j.freeradbiomed.2007.04.002; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skovsen E, 2005, J PHYS CHEM B, V109, P8570, DOI 10.1021/jp051163i; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Squatrito M, 2010, CANCER CELL, V18, P619, DOI 10.1016/j.ccr.2010.10.034; Tanner JJ, 2011, ANTIOXID REDOX SIGN, V15, P77, DOI 10.1089/ars.2010.3611; Travis William D, 2011, Proc Am Thorac Soc, V8, P381, DOI 10.1513/pats.201107-042ST; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Valencia A, 2006, FREE RADICAL BIO MED, V41, P1704, DOI 10.1016/j.freeradbiomed.2006.09.006; Viteri G, 2003, PHOTOCHEM PHOTOBIOL, V77, P535, DOI 10.1562/0031-8655(2003)077<0535:SOTIBT>2.0.CO;2; WELLS RL, 1984, MUTAT RES, V129, P251, DOI 10.1016/0027-5107(84)90158-1; Yamashita Kikuji, 2010, Journal of Electromagnetic Analysis and Applications, V2, P382, DOI 10.4236/jemaa.2010.26050; Yu SY, 2006, PHOTODERMATOL PHOTO, V22, P78, DOI 10.1111/j.1600-0781.2006.00208.x	57	25	27	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54117	10.1371/journal.pone.0054117	http://dx.doi.org/10.1371/journal.pone.0054117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335992	gold, Green Published, Green Submitted			2022-12-25	WOS:000314707700050
J	Vellanki, RN; Zhang, LL; Volchuk, A				Vellanki, Ravi N.; Zhang, Liling; Volchuk, Allen			OASIS/CREB3L1 Is Induced by Endoplasmic Reticulum Stress in Human Glioma Cell Lines and Contributes to the Unfolded Protein Response, Extracellular Matrix Production and Cell Migration	PLOS ONE			English	Article							FAMILY TRANSCRIPTION FACTOR; ER STRESS; CREB/ATF-FAMILY; FACTOR OASIS; EXPRESSION; TRANSDUCER; APOPTOSIS; GENES; DEATH	OASIS is a transcription factor similar to ATF6 that is activated by endoplasmic reticulum stress. In this study we investigated the expression of OASIS in human glioma cell lines and the effect of OASIS knock-down on the ER stress response and cell migration. OASIS mRNA was detected in three distinct glioma cell lines (U373, A172 and U87) and expression levels were increased upon treatment with ER stress-inducing compounds in the U373 and U87 lines. OASIS protein, which is glycosylated on Asn-513, was detected in the U373 and U87 glioma lines at low levels in control cells and protein expression was induced by ER stress. Knock-down of OASIS in human glioma cell lines resulted in an attenuated unfolded protein response to ER stress (reduced GRP78/BiP and GRP94 induction) and decreased expression of chondroitin sulfate proteoglycan extracellular matrix proteins, but induction of the collagen gene Col1a1 was unaffected. Cells in which OASIS was knocked-down exhibited altered cell morphology and reduced cell migration. These results suggest that OASIS is important for the ER stress response and maintenance of some extracellular matrix proteins in human glioma cells.	[Vellanki, Ravi N.; Zhang, Liling; Volchuk, Allen] Univ Hlth Network, Toronto Gen Res Inst, Div Cellular & Mol Biol, Toronto, ON, Canada; [Volchuk, Allen] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Volchuk, Allen] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto	Volchuk, A (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Div Cellular & Mol Biol, Toronto, ON, Canada.	avolchuk@uhnres.utoronto.ca	Vellanki, Ravi/M-8738-2019	Vellanki, Ravi/0000-0002-5081-3187	Banting and Best Diabetes Centre (University of Toronto); CIHR operating grant [MOP 86641]	Banting and Best Diabetes Centre (University of Toronto)(University of Toronto); CIHR operating grant(Canadian Institutes of Health Research (CIHR))	RNV was funded by a post-doctoral fellowship from the Banting and Best Diabetes Centre (University of Toronto). This work was funded by a CIHR operating grant to AV (MOP 86641). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. James Rutka and Dr. Christian Smith (Hospital for Sick Children, Toronto) for providing the human glioma cell lines and comments on the manuscript. RNV was funded by a post-doctoral fellowship from the Banting and Best Diabetes Centre (University of Toronto).	Bailey D, 2007, ANTIOXID REDOX SIGN, V9, P2305, DOI 10.1089/ars.2007.1796; Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; BECKMAN G, 1971, HUM HERED, V21, P238, DOI 10.1159/000152408; BRISMAR T, 1995, GLIA, V15, P231, DOI 10.1002/glia.440150305; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Fox RM, 2010, J CELL BIOL, V191, P479, DOI 10.1083/jcb.201004062; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Gladson CL, 1999, J NEUROPATH EXP NEUR, V58, P1029, DOI 10.1097/00005072-199910000-00001; Hikake T, 2003, ANAT EMBRYOL, V206, P373, DOI 10.1007/s00429-003-0311-z; Hong M, 2004, J BIOL CHEM, V279, P11354, DOI 10.1074/jbc.M309804200; Honma Y, 1999, MOL BRAIN RES, V69, P93, DOI 10.1016/S0169-328X(99)00102-3; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Johnson GG, 2011, CURR PHARM DESIGN, V17, P284; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kohno K, 2007, ANTIOXID REDOX SIGN, V9, P2295, DOI 10.1089/ars.2007.1819; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Krakstad C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-135; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lander C, 1997, J NEUROSCI, V17, P1928; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Natori T, 2008, CELL MOL NEUROBIOL, V28, P857, DOI 10.1007/s10571-008-9262-5; Ogaki S, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-13; Omori Y, 2002, BIOCHEM BIOPH RES CO, V293, P470, DOI 10.1016/S0006-291X(02)00253-X; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Saito A, 2007, ANTIOXID REDOX SIGN, V9, P563, DOI 10.1089/ars.2006.1520; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Correa TCS, 2010, J CELL BIOCHEM, V110, P52, DOI 10.1002/jcb.22472; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Vellanki RN, 2010, ENDOCRINOLOGY, V151, P4146, DOI 10.1210/en.2010-0137; Wang DY, 2005, BRAIN PATHOL, V15, P318; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yang W, 2009, EXP NEUROL, V219, P376, DOI 10.1016/j.expneurol.2009.07.009; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhang LL, 2009, J BIOL CHEM, V284, P5289, DOI 10.1074/jbc.M805477200	39	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54060	10.1371/journal.pone.0054060	http://dx.doi.org/10.1371/journal.pone.0054060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335989	Green Published, Green Submitted, gold			2022-12-25	WOS:000314707700047
J	Zaccheus, MV; Ali, T; Cloeckaert, A; Zygmunt, MS; Weintraub, A; Iriarte, M; Moriyon, I; Widmalm, G				Zaccheus, Mona V.; Ali, Tara; Cloeckaert, Axel; Zygmunt, Michel S.; Weintraub, Andrej; Iriarte, Maite; Moriyon, Ignacio; Widmalm, Goran			The Epitopic and Structural Characterization of Brucella suis Biovar 2 O-Polysaccharide Demonstrates the Existence of a New M-Negative C-Negative Smooth Brucella Serovar	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; MONOCLONAL-ANTIBODIES; LIPOPOLYSACCHARIDE HETEROGENEITY; A-ANTIGENS; ABORTUS; MICE; NMR; SENSITIVITY; RESONANCE; ZOONOSIS	The brucellae are Gram-negative bacteria that cause an important zoonosis. Studies with the main Brucella species have shown that the O-antigens of the Brucella smooth lipopolysaccharide are alpha-(1 -> 2) and alpha-(1 -> 3)-linked N-formyl-perosamine polysaccharides that carry M, A and C (A = M, A>M and A<M) epitopes relevant in serodiagnosis and typing. We report that, in contrast to the B. suis biovar 1 O-antigen used as a reference or to all described Brucella O-antigens, B. suis biovar 2 O-antigen failed to bind monoclonal antibodies of C (A = M), C (M>A) and M specificities. However, the biovar 2 O-antigen bound monoclonal antibodies to the Brucella A epitope, and to the C/Y epitope shared by brucellae and Yersinia enterocolitica O:9, a bacterium that carries an N-formyl-perosamine O-antigen in exclusively alpha-(1 -> 2)-linkages. By C-13 NMR spectroscopy, B. suis biovar 1 but not B. suis biovar 2 or Y.enterocolitica O:9 polysaccharide showed the signal characteristic of alpha-(1 -> 3)-linked N-formyl-perosamine, indicating that biovar 2 may altogether lack this linkage. Taken together, the NMR spectroscopy and monoclonal antibody analyses strongly suggest a role for alpha-(1 -> 3)-linked N-formyl-perosamine in the C (A = M) and C (M>A) epitopes. Moreover, they indicate that B. suis biovar 2 O-antigen lacks some lipopolysaccharide epitopes previously thought to be present in all smooth brucellae, thus representing a new brucella serovar that is M-negative, C-negative. Serologically and structurally this new serovar is more similar to Y. enterocolitica O:9 than to other brucellae.	[Zaccheus, Mona V.; Ali, Tara; Widmalm, Goran] Stockholm Univ, Arrhenius Lab, Dept Organ Chem, S-10691 Stockholm, Sweden; [Ali, Tara; Weintraub, Andrej] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Cloeckaert, Axel; Zygmunt, Michel S.] INRA, Infectiol & Sante Publ UMR1282, F-37380 Nouzilly, France; [Cloeckaert, Axel; Zygmunt, Michel S.] Univ Tours, Infectiol & Sante Publ UMR1282, Tours, France; [Iriarte, Maite; Moriyon, Ignacio] Univ Navarra, Inst Trop Hlth, E-31080 Pamplona, Spain; [Iriarte, Maite; Moriyon, Ignacio] Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Spain	Stockholm University; Karolinska Institutet; Karolinska University Hospital; INRAE; Universite de Tours; University of Navarra; University of Navarra	Moriyon, I (corresponding author), Univ Navarra, Inst Trop Hlth, E-31080 Pamplona, Spain.	imoriyon@unav.es; gw@organ.su.se	Moriyon, Ignacio/N-4764-2016; IRIARTE, MAITE/L-9460-2014	Moriyon, Ignacio/0000-0002-4288-0195; IRIARTE, MAITE/0000-0002-6726-8920; Zygmunt, Michel/0000-0002-1389-6366; Widmalm, Goran/0000-0001-8303-4481; Weintraub, Andrej/0000-0003-3646-247X	Swedish Research Council; Knut and Alice Wallenberg Foundation; European Commission [QLK2-CT-2002-00918]; Ministerio de Ciencia y Tecnologia of Spain [AGL2008-04514]; Fundacion para la Investigacion Medica Aplicada (FIMA)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); Ministerio de Ciencia y Tecnologia of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion para la Investigacion Medica Aplicada (FIMA)	This work was supported by grants from the Swedish Research Council, The Knut and Alice Wallenberg Foundation, the European Commission (Research Contract QLK2-CT-2002-00918), Ministerio de Ciencia y Tecnologia of Spain (AGL2008-04514) and Fundacion para la Investigacion Medica Aplicada (FIMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk S, 2005, J VET MED B, V52, P444, DOI 10.1111/j.1439-0450.2005.00898.x; Aragon V, 1996, J BACTERIOL, V178, P1070, DOI 10.1128/jb.178.4.1070-1079.1996; Baucheron S, 2002, RES MICROBIOL, V153, P277, DOI 10.1016/S0923-2508(02)01317-7; BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; BUNDLE DR, 1989, INFECT IMMUN, V57, P2829, DOI 10.1128/IAI.57.9.2829-2836.1989; CAROFF M, 1984, INFECT IMMUN, V46, P384, DOI 10.1128/IAI.46.2.384-388.1984; Cloeckaert A, 1998, CLIN DIAGN LAB IMMUN, V5, P862, DOI 10.1128/CDLI.5.6.862-870.1998; CLOECKAERT A, 1993, J GEN MICROBIOL, V139, P1551, DOI 10.1099/00221287-139-7-1551; DEBEER T, 1994, FEBS LETT, V348, P1, DOI 10.1016/0014-5793(94)00547-8; DOMKE T, 1991, J MAGN RESON, V95, P174, DOI 10.1016/0022-2364(91)90334-P; DOUGLAS JT, 1988, J CLIN MICROBIOL, V26, P1353, DOI 10.1128/JCM.26.7.1353-1356.1988; FERNANDEZLAGO L, 1982, INFECT IMMUN, V38, P778, DOI 10.1128/IAI.38.2.778-780.1982; Garin-Bastuji B, 2006, P INT SOC CHEM DIS M; Godfroid J, 2005, VET RES, V36, P313, DOI 10.1051/vetres:2005003; Gonzalez D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002760; KENNE L, 1988, J CHEM SOC PERK T 1, P1183, DOI 10.1039/p19880001183; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; LIMET J, 1987, ANN INST PASTEUR IMM, V138, P417, DOI 10.1016/S0769-2625(87)80052-1; LIMET JN, 1989, J MED MICROBIOL, V30, P37, DOI 10.1099/00222615-30-1-37; Lipinski T, 2002, EUR J BIOCHEM, V269, P93, DOI 10.1046/j.0014-2956.2001.02638.x; MEIKLE PJ, 1989, INFECT IMMUN, V57, P2820, DOI 10.1128/IAI.57.9.2820-2828.1989; Moreno E, 2002, VET MICROBIOL, V90, P209, DOI 10.1016/S0378-1135(02)00210-9; Nyberg NT, 2005, MAGN RESON CHEM, V43, P971, DOI 10.1002/mrc.1698; Parella T, 1997, J MAGN RESON, V126, P274, DOI 10.1006/jmre.1997.1164; PERRY MB, 1990, ADVANCES IN BRUCELLOSIS RESEARCH, P76; PETERS T, 1990, CAN J CHEM, V68, P979, DOI 10.1139/v90-154; Porte F, 2003, INFECT IMMUN, V71, P1481, DOI 10.1128/IAI.71.3.1481-1490.2003; Soderman P, 1998, J CHEM SOC PERK T 2, P639, DOI 10.1039/a707346a; Velasco J, 2000, INFECT IMMUN, V68, P3210, DOI 10.1128/IAI.68.6.3210-3218.2000; Verger JM, 1988, TECHNIQUES BRUCELLOS; Weynants V, 1997, INFECT IMMUN, V65, P1939, DOI 10.1128/IAI.65.5.1939-1943.1997; Weynants V, 1996, CLIN DIAGN LAB IMMUN, V3, P309, DOI 10.1128/CDLI.3.3.309-314.1996; Whatmore AM, 2009, INFECT GENET EVOL, V9, P1168, DOI 10.1016/j.meegid.2009.07.001; Zheludkov MM, 2010, BIOL BULL+, V37, P709, DOI 10.1134/S106235901007006X; Zygmunt MS, 2012, CLIN VACCINE IMMUNOL, V19, P1370, DOI 10.1128/CVI.00300-12	36	19	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53941	10.1371/journal.pone.0053941	http://dx.doi.org/10.1371/journal.pone.0053941			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335981	gold, Green Published, Green Submitted			2022-12-25	WOS:000314707700039
J	Serrano, E; Coma, R; Ribes, M; Weitzmann, B; Garcia, M; Ballesteros, E				Serrano, Eduard; Coma, Rafel; Ribes, Marta; Weitzmann, Boris; Garcia, Maria; Ballesteros, Enric			Rapid Northward Spread of a Zooxanthellate Coral Enhanced by Artificial Structures and Sea Warming in the Western Mediterranean	PLOS ONE			English	Article							LONG-TERM DECLINE; CLIMATE-CHANGE; OCULINA-PATAGONICA; CLADOCORA-CAESPITOSA; BIOLOGICAL INVASIONS; ALGAL ASSEMBLAGES; MASS MORTALITY; CATALAN COAST; PHASE-SHIFTS; REEF CORALS	The hermatypic coral Oculina patagonica can drive a compositional shift in shallow water benthic marine communities in the northwestern Mediterranean. Here, we analyze a long-term, large-scale observational dataset to characterize the dynamics of the species' recent northward range shift along the coast of Catalonia and examine the main factors that could have influenced this spread. The variation in the distributional range of Oculina patagonica was examined by monitoring 223 locations including natural and artificial habitats along >400 km of coastline over the last 19 years (1992-2010). Abundance of the species increased from being present in one location in 1992 to occur on 19% of the locations in 2010, and exhibited an acceleration of its spreading over time driven by the join action of neighborhood and long-distance dispersal. However, the pattern of spread diverged between artificial and natural habitats. A short lag phase and a high slope on the exponential phase characterized the temporal pattern of spread on artificial habitats in contrast to that observed on natural ones. Northward expansion has occurred at the fastest rate (22 km year(-1)) reported for a coral species thus far, which is sufficiently fast to cope with certain climate warming predictions. The pattern of spread suggests that this process is mediated by the interplay of (i) the availability of open space provided by artificial habitats, (ii) the seawater temperature increase with the subsequent extension of the growth period, and (iii) the particular biological features of O. patagonica (current high growth rates, early reproduction, and survival to low temperature and in polluted areas). These results are indicative of an ongoing fundamental modification of temperate shallow water assemblages, which is consistent with the predictions indicating that the Mediterranean Sea is one of the most sensitive regions to global change.	[Serrano, Eduard; Coma, Rafel; Weitzmann, Boris; Garcia, Maria; Ballesteros, Enric] CSIC, CEAB, Blanes, Girona, Spain; [Serrano, Eduard; Ribes, Marta] CSIC, ICM, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Serrano, E (corresponding author), CSIC, CEAB, Blanes, Girona, Spain.	eserrano@ceab.csic.es	Serrano, Eduard/B-5269-2019; Coma, Rafel/ABF-2082-2021; Coma, Rafel/J-8987-2012; Ribes, Marta/B-2495-2013	Serrano, Eduard/0000-0001-9082-473X; Coma, Rafel/0000-0001-6107-225X; Coma, Rafel/0000-0001-6107-225X; Ribes, Marta/0000-0001-9747-295X; Garcia, Maria/0000-0002-0108-4424	Spanish Ministry of Science and Innovation [ENCHANGES (CGL2010-18466), GRACCIE (C5D2007-00067)]; European Community [287844]; "Departament de Medi Ambient" from the Generalitat de Catalunya; "Agencia Catalana de l'Aigua (ACA)" from the Generalitat de Catalunya	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Community(European Commission); "Departament de Medi Ambient" from the Generalitat de Catalunya(Generalitat de Catalunya); "Agencia Catalana de l'Aigua (ACA)" from the Generalitat de Catalunya	Financial support for this work was provided by projects ENCHANGES (CGL2010-18466) and GRACCIE (C5D2007-00067) from the Spanish Ministry of Science and Innovation, as well as European Community's project CoCoNET (FP7 Grant-Agreement: 287844), and "Departament de Medi Ambient" and "Agencia Catalana de l'Aigua (ACA)" from the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Arim M, 2006, P NATL ACAD SCI USA, V103, P374, DOI 10.1073/pnas.0504272102; Armoza-Zvuloni R, 2011, MAR ECOL PROG SER, V426, P149, DOI 10.3354/meps09018; Ballesteros, 1989, SCI MAR, V53, P3; BALLESTEROS E, 1989, Scientia Marina, V53, P357; Ballesteros E, 1992, ARXIUS SECCIO CIENCI, V101, P1; BALLESTEROS E, 1991, OECOL AQUAT, V10, P223; BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Bensoussan N, 2010, ESTUAR COAST SHELF S, V87, P431, DOI 10.1016/j.ecss.2010.01.008; Bertelsen E., 1936, Videnskabelige Meddelelser fra Dansk Naturhistorisk Forening i Kjobenhavn, V100, P237; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Bulleri F, 2010, J APPL ECOL, V47, P26, DOI 10.1111/j.1365-2664.2009.01751.x; Byers JE, 2002, OIKOS, V97, P449, DOI 10.1034/j.1600-0706.2002.970316.x; Calvo E, 2011, CLIM RES, V50, P1, DOI 10.3354/cr01040; CAMP J, 1980, INVEST PESQ, V44, P199; Carpenter RC, 2006, ECOL LETT, V9, P268, DOI 10.1111/j.1461-0248.2005.00866.x; Casado-Amezua P, 2011, J HERED, V102, P622, DOI 10.1093/jhered/esr070; Chapman MG, 2003, MAR ECOL PROG SER, V264, P21, DOI 10.3354/meps264021; Clark JS, 2003, ECOLOGY, V84, P1979, DOI 10.1890/01-0618; Coma R, 2006, MAR ECOL PROG SER, V327, P51, DOI 10.3354/meps327051; Coma R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022017; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Connell J.H., 1973, P205; CONNELL JH, 1961, ECOL MONOGR, V31, P61, DOI 10.2307/1950746; Corbacho A, 2011, HIST NATURAL DELS PA, P195; Crooks J. A., 1999, Invasive species and biodiversity management. Based on papers presented at the Norway/United Nations (UN) Conference on Alien Species, 2nd Trondheim Conference on Biodiversity, Trondheim, Norway, 1-5 July 1996., P103; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Edmunds PJ, 2001, P NATL ACAD SCI USA, V98, P5067, DOI 10.1073/pnas.071524598; EEA, 2006, 62006 EEA OPOCE; EFRON B, 1981, BIOMETRIKA, V68, P589, DOI 10.1093/biomet/68.3.589; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fine M, 2003, MAR BIOL, V142, P989, DOI 10.1007/s00227-002-0982-7; Fine M, 2001, MAR BIOL, V138, P1195; Gacia E, 2007, SCI MAR, V71, P259, DOI 10.3989/scimar.2007.71n2259; Galil BS, 2009, BIOL INVASIONS, V11, P359, DOI 10.1007/s10530-008-9253-y; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gili JM, 1985, THESIS U AUTONOMA BA; Giorgi F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025734; Glasby TM, 1999, AMBIO, V28, P595; Guinotte JM, 2003, CORAL REEFS, V22, P551, DOI 10.1007/s00338-003-0331-4; Harriott VJ, 1999, CORAL REEFS, V18, P281, DOI 10.1007/s003380050195; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Hawkins SJ, 2009, MAR ECOL PROG SER, V396, P245, DOI 10.3354/meps08378; Hilbert DW, 2001, AUSTRAL ECOL, V26, P590, DOI 10.1046/j.1442-9993.2001.01137.x; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2009, CORAL REEFS, V28, P569, DOI 10.1007/s00338-009-0508-6; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hoeksema BW, 2012, MAR ECOL PROG SER, V445, P209, DOI 10.3354/meps09460; Hughes T, 1999, LIMNOL OCEANOGR, V44, P1583; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; JOKIEL PL, 1984, CORAL REEFS, V3, P113, DOI 10.1007/BF00263761; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Kinlan BP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P381; KramarskyWinter E, 1997, NATURE, V387, P137, DOI 10.1038/387137a0; Kushmaro A, 1997, MAR ECOL PROG SER, V147, P159, DOI 10.3354/meps147159; LEVITAN DR, 1992, ECOLOGY, V73, P248, DOI 10.2307/1938736; LEWIS MA, 1993, THEOR POPUL BIOL, V43, P141, DOI 10.1006/tpbi.1993.1007; Linares C, 2008, J APPL ECOL, V45, P688, DOI 10.1111/j.1365-2664.2007.01419.x; Lirman D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023047; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9; Lyons DA, 2009, DIVERS DISTRIB, V15, P762, DOI 10.1111/j.1472-4642.2009.00580.x; Marsh L, 1993, P 7 INT COR REEF S G, V2, P1233; Maynard JA, 2008, MAR BIOL, V155, P173, DOI 10.1007/s00227-008-1015-y; McManus JW, 1998, REEFBASE GLOBAL DATA; Meiners SJ, 2004, ECOL LETT, V7, P121, DOI 10.1111/j.1461-0248.2003.00563.x; Mendez V, 2010, SPRINGER SER SYNERG, P33, DOI 10.1007/978-3-642-11443-4_2; Mihulka S, 2001, J BIOGEOGR, V28, P597, DOI 10.1046/j.1365-2699.2001.00574.x; Miller MW, 1998, OCEANOGR MAR BIOL<D>, V36, P65; Miller MW, 1996, ECOL MONOGR, V66, P323, DOI 10.2307/2963521; Millot C, 1999, J MARINE SYST, V20, P423, DOI 10.1016/S0924-7963(98)00078-5; Navarro L, 2011, ESTUAR COAST SHELF S, V95, P52, DOI 10.1016/j.ecss.2011.08.002; Neubert MG, 2000, ECOLOGY, V81, P1613, DOI 10.1890/0012-9658(2000)081[1613:DADCAS]2.0.CO;2; Nugues MM, 2003, MAR POLLUT BULL, V46, P314, DOI 10.1016/S0025-326X(02)00402-2; Occhipinti-Ambrogi A., 2010, ADV OCEANOGR LIMNOL, V1, P199, DOI [10.1080/19475721003743876, DOI 10.1080/19475721003743876]; Palacin C, 1998, J SEA RES, V39, P281, DOI 10.1016/S1385-1101(97)00061-0; Palacin C, 1998, MAR ECOL-P S Z N I, V19, P163, DOI 10.1111/j.1439-0485.1998.tb00460.x; Penuelas J, 2001, SCIENCE, V294, P793, DOI 10.1126/science.1066860; Pinedo S, 2007, MAR POLLUT BULL, V55, P126, DOI 10.1016/j.marpolbul.2006.08.044; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; PYSEK P, 1995, BIOL CONSERV, V74, P41, DOI 10.1016/0006-3207(95)00013-T; PYSEK P, 1993, J BIOGEOGR, V20, P413, DOI 10.2307/2845589; PYSEK P, 1991, FOLIA GEOBOT PHYTOTX, V26, P439, DOI 10.1007/BF02912779; QUANDT RE, 1958, J AM STAT ASSOC, V53, P873, DOI 10.2307/2281957; QUANDT RE, 1960, J AM STAT ASSOC, V55, P324, DOI 10.2307/2281745; R Core Team, 2021, R LANG ENV STAT COMP; Raitsos DE, 2010, LIMNOL OCEANOGR, V55, P1478, DOI 10.4319/lo.2010.55.4.1478; Rodolfo-Metalpa R, 2008, MAR ECOL PROG SER, V369, P103, DOI 10.3354/meps07608; Rodolfo-Metalpa R, 2006, MAR BIOL, V150, P45, DOI 10.1007/s00227-006-0329-x; Sakai K, 1998, RES POPUL ECOL, V40, P287, DOI 10.1007/BF02763460; Sala E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017356; Sammarco PW, 2004, MAR ECOL PROG SER, V280, P129, DOI 10.3354/meps280129; SAMMARI C, 1995, DEEP-SEA RES PT I, V42, P893, DOI 10.1016/0967-0637(95)00031-Z; Sanchez-Vidal A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030395, 10.1371/journal.pone.0043943]; Sartoretto S., 2008, Aquatic Invasions, V3, P173, DOI 10.3391/ai.2008.3.2.7; Serrano E, 2012, CORAL REEFS, V31, P1199, DOI 10.1007/s00338-012-0939-3; SHIGESADA N, 1995, AM NAT, V146, P229, DOI 10.1086/285796; Shigesada N, 1997, BIOL INVASIONS THEOR; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x; Thibaut T, 2005, MAR POLLUT BULL, V50, P1472, DOI 10.1016/j.marpolbul.2005.06.014; Underwood JN, 2007, MOL ECOL, V16, P771, DOI 10.1111/j.1365-294X.2006.03187.x; Uriz MJ, 1987, THESIS U AUTONOMA BA; Vargas-Angel B, 2003, CORAL REEFS, V22, P465, DOI 10.1007/s00338-003-0336-z; Vargas-Yanez M, 2010, J MARINE SYST, V82, P171, DOI 10.1016/j.jmarsys.2010.04.013; Veit RR, 1996, AM NAT, V148, P255, DOI 10.1086/285924; VERON JEN, 1995, CORALS SPACE TIME BI; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wethey DS, 2002, INTEGR COMP BIOL, V42, P872, DOI 10.1093/icb/42.4.872; Witman JD, 2001, MARINE COMMUNITY ECOLOGY, P339; Woodroffe Colin D., 2011, P813; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474; Zabala M., 1986, FAUNA DELS BRIOZOUS; Zar JH, 1999, BIOSTATISTICAL ANAL; Zenetos A, 2010, MEDITERR MAR SCI, V11, P381, DOI 10.12681/mms.87; Zibrowius H., 1983, Rapports et Proces-Verbaux des Reunions Commission Internationale pour l'Exploration Scientifique de la Mer Mediterranee Monaco, V28, P297; ZIBROWIUS H, 1974, HELGOLAND WISS MEER, V26, P153, DOI 10.1007/BF01611381; Zibrowius H, 1992, MESOGEE, V51, P83	127	37	39	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52739	10.1371/journal.pone.0052739	http://dx.doi.org/10.1371/journal.pone.0052739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341904	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400019
J	Fung, C; De Marchis, GM; Katan, M; Seiler, M; Arnold, M; Gralla, J; Raabe, A; Beck, J				Fung, Christian; De Marchis, Gian Marco; Katan, Mira; Seiler, Marleen; Arnold, Marcel; Gralla, Jan; Raabe, Andreas; Beck, Juergen			Copeptin as a Marker for Severity and Prognosis of Aneurysmal Subarachnoid Hemorrhage	PLOS ONE			English	Article							VASOPRESSIN PRECURSOR; CEREBRAL VASOSPASM; STABLE PEPTIDE; STROKE	Background: Grading of patients with aneurysmal subarachnoid hemorrhage (aSAH) is often confounded by seizure, hydrocephalus or sedation and the prediction of prognosis remains difficult. Recently, copeptin has been identified as a serum marker for outcomes in acute ischemic stroke and intracerebral hemorrhage (ICH). We investigated whether copeptin might serve as a marker for severity and prognosis in aSAH. Methods: Eighteen consecutive patients with aSAH had plasma copeptin levels measured with a validated chemiluminescence sandwich immunoassay. The primary endpoint was the association of copeptin levels at admission with the World Federation of Neurological Surgeons (WFNS) grade score after resuscitation. Levels of copeptin were compared across clinical and radiological scores as well as between patients with ICH, intraventricular hemorrhage, hydrocephalus, vasospasm and ischemia. Results: Copeptin levels were significantly associated with the severity of aSAH measured by WFNS grade (P = 0.006), the amount of subarachnoid blood (P = 0.03) and the occurrence of ICH (P = 0.02). There was also a trend between copeptin levels and functional clinical outcome at 6-months (P = 0.054). No other clinical outcomes showed any statistically significant association. Conclusions: Copeptin may indicate clinical severity of the initial bleeding and may therefore help in guiding treatment decisions in the setting of aSAH. These initial results show that copeptin might also have prognostic value for clinical outcome in aSAH.	[Fung, Christian; Raabe, Andreas; Beck, Juergen] Univ Hosp Bern, Dept Neurosurg, CH-3010 Bern, Switzerland; [De Marchis, Gian Marco; Arnold, Marcel] Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland; [Katan, Mira] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA; [Seiler, Marleen] Thermo Fisher Sci, Thermo Sci Biomarkers, Clin Diagnost, Hennigsdorf, Germany; [Gralla, Jan] Univ Hosp Bern, Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Columbia University; Thermo Fisher Scientific; University of Bern; University Hospital of Bern	Beck, J (corresponding author), Univ Hosp Bern, Dept Neurosurg, CH-3010 Bern, Switzerland.	Juergen.beck@insel.ch	De Marchis, Gian Marco/J-5414-2019	De Marchis, Gian Marco/0000-0002-0342-9780; Beck, Jurgen/0000-0002-7687-6098; Katan, Mira/0000-0002-9265-8066	Bern University Hospital	Bern University Hospital	Bern University Hospital sponsored the study. Thermo Scientific B. R. A. H. M. S., Henningsdorf, Germany provided all copeptin assays. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; DRAKE CG, 1988, J NEUROSURG, V68, P985; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Khan SQ, 2007, CIRCULATION, V115, P2103, DOI 10.1161/CIRCULATIONAHA.106.685503; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Lackner P, 2010, STROKE, V41, P2353, DOI 10.1161/STROKEAHA.110.584995; LeRoux PD, 1996, J NEUROSURG, V85, P39, DOI 10.3171/jns.1996.85.1.0039; Macdonald RL, 2010, NEUROCRIT CARE, V13, P416, DOI 10.1007/s12028-010-9433-3; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Morgenthaler NG, 2007, SHOCK, V28, P219, DOI 10.1097/SHK.0b013e318033e5da; Muller B, 2007, EUR J CLIN INVEST, V37, P145, DOI 10.1111/j.1365-2362.2007.01762.x; Stoiser B, 2006, EUR J CLIN INVEST, V36, P771, DOI 10.1111/j.1365-2362.2006.01724.x; Volpi S, 2004, STRESS, V7, P75, DOI 10.1080/10253890410001733535; Zhu XD, 2011, CRIT CARE, V15, DOI 10.1186/cc10575; Zweifel C, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-34	17	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53191	10.1371/journal.pone.0053191	http://dx.doi.org/10.1371/journal.pone.0053191			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326397	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000314705800036
J	Koyanagi, S; Levesque, CM				Koyanagi, Stephanie; Levesque, Celine M.			Characterization of a Streptococcus mutans Intergenic Region Containing a Small Toxic Peptide and Its cis-Encoded Antisense Small RNA Antitoxin	PLOS ONE			English	Article							SOS-INDUCED TOXIN; ESCHERICHIA-COLI; ENTEROCOCCUS-FAECALIS; PERSISTER CELLS; STRESS-RESPONSE; FUNCTIONAL-ANALYSIS; SYSTEMS; BACTERIAL; LOCI; FST	Toxin-antitoxin (TA) modules consist of a pair of genes that encode two components: a protein toxin and an antitoxin, which may be in the form of either a labile protein or an antisense small RNA. Here we describe, to the best of our knowledge, the first functional chromosomal type I TA system in streptococci. Our model organism is the oral pathogen Streptococcus mutans. Our results showed that the genome of S. mutans UA159 reference strain harbors a previously unannotated Fst-like toxin (Fst-Sm) and its cis-encoded small RNA antitoxin (srSm) converging towards the end of the toxin gene in IGR176, a small intergenic region of 318 nt. Fst-Sm is a small hydrophobic peptide of 32 amino acid residues with homology to the Fst toxin family. Transcripts of similar to 200 nt and similar to 70 nt specific to fst-Sm mRNA and srSm RNA, respectively, were detected by Northern blot analysis throughout S. mutans growth. The toxin mRNA was considerably more stable than its cognate antitoxin. The half-life of srSm RNA was determined to be similar to 30 min, while fst-Sm mRNA had a half-life of similar to 90 min. Both fst-Sm and srSm RNAs were transcribed across direct tandem repeats providing a region of complementarity for inhibition of toxin translation. Overproduction of Fst-Sm had a toxic effect on E. coli and S. mutans cells which can be neutralized by coexpression of srSm RNA. Deletion of fst-Sm/srSm locus or overexpression of Fst-Sm/srSm had no effect on S. mutans cell growth in liquid medium and no differences in the total biofilm biomass were noted. In contrast, mild-overproduction of Fst-Sm/srSm type I TA system decreases the levels of persister cells tolerant to bacterial cell wall synthesis inhibitors.	[Koyanagi, Stephanie; Levesque, Celine M.] Univ Toronto, Fac Dent, Dent Res Inst, Toronto, ON, Canada	University of Toronto	Levesque, CM (corresponding author), Univ Toronto, Fac Dent, Dent Res Inst, Toronto, ON, Canada.	celine.levesque@dentistry.utoronto.ca			Canadian Institutes of Health Research grant [MOP-93555]; Natural Sciences and Engineering Research Council of Canada grant [RGPIN 355968]; Canada Research Chair	Canadian Institutes of Health Research grant(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by a Canadian Institutes of Health Research grant MOP-93555 to CML and a Natural Sciences and Engineering Research Council of Canada grant RGPIN 355968 to CML. CML is a recipient of a Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas I, 2008, MICROBIOL-SGM, V154, P2275, DOI 10.1099/mic.0.2008/019265-0; Blower TR, 2012, NUCLEIC ACIDS RES, V40, P6158, DOI 10.1093/nar/gks231; Brantl S, 2002, PLASMID, V48, P165, DOI 10.1016/S0147-619X(02)00108-7; Dufour D, 2011, J BACTERIOL, V193, P6552, DOI 10.1128/JB.05968-11; Evguenieva-Hackenberg E, 2011, CURR OPIN MICROBIOL, V14, P587, DOI 10.1016/j.mib.2011.07.025; Fauvart M, 2011, J MED MICROBIOL, V60, P699, DOI 10.1099/jmm.0.030932-0; Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106; FITZGERALD R J, 1960, J Am Dent Assoc, V61, P9; Fozo EM, 2010, NUCLEIC ACIDS RES, V38, P3743, DOI 10.1093/nar/gkq054; Fozo EM, 2008, MOL MICROBIOL, V70, P1076, DOI 10.1111/j.1365-2958.2008.06394.x; Fozo EM, 2008, MICROBIOL MOL BIOL R, V72, P579, DOI 10.1128/MMBR.00025-08; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GERDES K, 1985, J BACTERIOL, V161, P292, DOI 10.1128/JB.161.1.292-298.1985; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Greenfield TJ, 2000, MOL MICROBIOL, V37, P652, DOI 10.1046/j.1365-2958.2000.02035.x; Hu Ming-Xi, 2010, Int J Microbiol, V2010, P781430, DOI 10.1155/2010/781430; Kawano M, 2002, MOL MICROBIOL, V45, P333, DOI 10.1046/j.1365-2958.2002.03042.x; Kawano M, 2007, MOL MICROBIOL, V64, P738, DOI 10.1111/j.1365-2958.2007.05688.x; Kim Y, 2010, BIOCHEM BIOPH RES CO, V391, P209, DOI 10.1016/j.bbrc.2009.11.033; Kwong SM, 2010, MICROBIOL-SGM, V156, P975, DOI 10.1099/mic.0.038323-0; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Leung V, 2012, J BACTERIOL, V194, P2265, DOI 10.1128/JB.06707-11; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Masuda H, 2012, MOL MICROBIOL, V84, P979, DOI 10.1111/j.1365-2958.2012.08068.x; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Overbeek R, 2007, CHEM REV, V107, P3431, DOI 10.1021/cr068308h; Patel S, 2006, J BACTERIOL, V188, P5374, DOI 10.1128/JB.00513-06; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Smith EG, 2012, J DENT RES, V91, P133, DOI 10.1177/0022034511415415; Syed MA, 2012, CAN J MICROBIOL, V58, P553, DOI [10.1139/w2012-025, 10.1139/W2012-025]; Syed MA, 2011, J BACTERIOL, V193, P1122, DOI 10.1128/JB.01114-10; Takahashi N, 2008, CARIES RES, V42, P409, DOI 10.1159/000159604; Tan QA, 2011, MOL MICROBIOL, V79, P109, DOI 10.1111/j.1365-2958.2010.07433.x; Unoson C, 2008, MOL MICROBIOL, V70, P258, DOI 10.1111/j.1365-2958.2008.06416.x; Van Melderen L, 2010, CURR OPIN MICROBIOL, V13, P781, DOI 10.1016/j.mib.2010.10.006; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; Wagner EGH, 2002, TRENDS GENET, V18, P223, DOI 10.1016/S0168-9525(02)02658-6; Wang XX, 2012, NAT CHEM BIOL, V8, P855, DOI 10.1038/NCHEMBIO.1062; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Weaver KE, 2003, J BACTERIOL, V185, P2169, DOI 10.1128/JB.185.7.2169-2177.2003; Weaver KE, 1996, MOL MICROBIOL, V20, P53, DOI 10.1111/j.1365-2958.1996.tb02488.x; Weaver KE, 2009, MICROBIOL-SGM, V155, P2930, DOI 10.1099/mic.0.030932-0; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412	47	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54291	10.1371/journal.pone.0054291	http://dx.doi.org/10.1371/journal.pone.0054291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326602	gold, Green Published, Green Submitted			2022-12-25	WOS:000314705800117
J	Nigam, P; Bhatt, SP; Misra, A; Vaidya, M; Dasgupta, J; Chadha, DS				Nigam, Priyanka; Bhatt, Surya P.; Misra, Anoop; Vaidya, Meera; Dasgupta, Jharna; Chadha, Davinder Singh			Non-Alcoholic Fatty Liver Disease Is Closely Associated with Sub-Clinical Inflammation: A Case-Control Study on Asian Indians in North India	PLOS ONE			English	Article							C-REACTIVE PROTEIN; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; METABOLIC SYNDROME; RISK-FACTORS; CARDIOVASCULAR-DISEASE; BODY-FAT; OBESITY; STEATOHEPATITIS; MARKERS	Objectives: Association between sub-clinical inflammation and non-alcoholic fatty liver disease (NAFLD) has not been studied in Asian Indians. In this case-control study, we aimed to analyse association of NAFLD with the sub-clinical inflammation and metabolic profile in Asian Indians in north India. Methods: Ultrasound diagnosed 120 cases of NAFLD were compared to 152 healthy controls without NAFLD. Anthropometric profile [body mass index (BMI), waist circumference (WC), hip circumference (HC)], high-sensitivity Creactive protein (hs-CRP), metabolic profile [fasting blood glucose (FBG), lipid profile] and hepatic function tests [alanine aminotransferase (ALT) and aspartate aminotransferase (AST)] were recorded. Results: Metabolic parameters [FBG, total cholesterol (TC), serum triglycerides (TG), low-density lipoprotein (LDL-c)], hs-CRP and prevalence of the metabolic syndrome were higher in cases as compared to controls (p-value, 0.05 for all). The median (range) of hs-CRP (mg/L) for cases [2.6 (0.2-13.4)] were significantly higher than in controls [1.4 (0.03-11.4), p = 0.01]. Similarly, higher values of hs-CRP were obtained when subgroups of cases with obesity, abdominal obesity and the metabolic syndrome were compared to controls [2.75 (0.03-14.3) vs. 1.52 (0.04-14.3), p = 0.0010; 2.8 (0.03-14.3) vs. 1.5 (0.06-14.3), p = 0.0014 and 2.7 (0.5-14.3) vs. 1.6 (0.06-8.5), p = 0.0013, respectively. On multivariate logistic regression analysis BMI (p = 0.001), WC (p = 0.001), FBG (p = 0.002), TC (p = 0.008), TG (p = 0.002), blood pressure (p = 0.005), metabolic syndrome (p = 0.001) and hs-CRP (p = 0.003) were significantly and independently associated with NAFLD. After adjusting for significant variables, the association between high hs-CRP and NAFLD remained large and statistically significant [adjusted OR = 1.17, 95% confidence interval (CI) = 1.05-1.29]. An increase in 1 mg/dl of hs-CRP level calculated to increase the risk of developing NAFLD by 1.7 times as compared to controls after adjusting for significant variables associated with NAFLD. Conclusions: In this cohort of Asian Indians in North India, presence of NAFLD showed independent relationships with subclinical inflammation.	[Nigam, Priyanka; Misra, Anoop; Dasgupta, Jharna] SDA, Natl Diabet Obes & Cholesterol Fdn N DOC, New Delhi, India; [Nigam, Priyanka; Vaidya, Meera] Govt MH Coll Home Sci & Sci Woman, Dept Food & Nutr, Jabalpur, India; [Bhatt, Surya P.] All India Inst Med Sci, Dept Med, New Delhi 110029, India; [Misra, Anoop] Fortis CDOC Ctr Excellence Diabet Metab Dis & End, New Delhi, India; [Chadha, Davinder Singh] AFMC, MH CTC, Dept Cardiol, Pune, Maharashtra, India; [Nigam, Priyanka; Misra, Anoop; Dasgupta, Jharna] Diabet Fdn India, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Armed Forces Medical College	Misra, A (corresponding author), SDA, Natl Diabet Obes & Cholesterol Fdn N DOC, New Delhi, India.	anoopmisra@metabolicresearchindia.com	Bhatt, Surya/K-5263-2019; Bhatt, Surya Prakash/X-5941-2018	Bhatt, Surya/0000-0001-9489-9747; Bhatt, Surya Prakash/0000-0001-9489-9747	Indian Council of Medical Research Government of India [5/9/70/2008-RHM]	Indian Council of Medical Research Government of India(Indian Council of Medical Research (ICMR))	Funding: This study was fully supported by a grant from the Indian Council of Medical Research (No. 5/9/70/2008-RHM) Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj S, 2009, INDIAN J MED RES, V129, P285; Barzilay JI, 2001, DIABETES, V50, P2384, DOI 10.2337/diabetes.50.10.2384; Blake GJ, 2002, J INTERN MED, V252, P283, DOI 10.1046/j.1365-2796.2002.01019.x; Chambers JC, 2001, CIRCULATION, V104, P145, DOI 10.1161/01.CIR.104.2.145; Chandalia M, 2003, J CLIN ENDOCR METAB, V88, P3773, DOI 10.1210/jc.2003-030301; Crespo J, 2001, HEPATOLOGY, V34, P1158, DOI 10.1053/jhep.2001.29628; Duvnjak M, 2007, WORLD J GASTROENTERO, V13, P4539, DOI 10.3748/wjg.v13.i34.4539; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Gavin JR, 1999, DIABETES CARE, V22, pS5; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hamer OW, 2006, RADIOGRAPHICS, V26, P1637, DOI 10.1148/rg.266065004; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Hsiao PJ, 2007, J GASTROEN HEPATOL, V22, P2118, DOI 10.1111/j.1440-1746.2006.04698.x; Kao PC, 2006, ANN CLIN LAB SCI, V36, P163; Kaser S, 2005, GUT, V54, P117, DOI 10.1136/gut.2003.037010; Kogiso T, 2009, J GASTROENTEROL, V44, P313, DOI 10.1007/s00535-009-0002-5; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Mathiesen UL, 2002, DIGEST LIVER DIS, V34, P516, DOI 10.1016/S1590-8658(02)80111-6; Misra A, 2004, INT J OBESITY, V28, P1217, DOI 10.1038/sj.ijo.0802704; Misra A, 2009, J Assoc Physicians India, V57, P163; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Misra A, 2009, METAB SYNDR RELAT D, V7, P497, DOI 10.1089/met.2009.0024; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Park SH, 2004, J GASTROEN HEPATOL, V19, P694, DOI 10.1111/j.1440-1746.2004.03362.x; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Petersen KF, 2006, P NATL ACAD SCI USA, V103, P18273, DOI 10.1073/pnas.0608537103; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Riquelme A, 2009, LIVER INT, V29, P82, DOI 10.1111/j.1478-3231.2008.01823.x; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Sinha S, 2009, MAGN RESON IMAGING, V27, P94, DOI 10.1016/j.mri.2008.06.001; Socha Piotr, 2007, Rocz Panstw Zakl Hig, V58, P129; Uchihara Masakatsu, 2006, Nihon Rinsho, V64, P1133; Vikram NK, 2006, INDIAN J MED RES, V124, P677; Vikram NK, 2003, ATHEROSCLEROSIS, V168, P305, DOI 10.1016/S0021-9150(03)00096-0; Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x; Yoneda M, 2007, J GASTROENTEROL, V42, P573, DOI 10.1007/s00535-007-2060-x	37	46	49	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e49286	10.1371/journal.pone.0049286	http://dx.doi.org/10.1371/journal.pone.0049286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326306	Green Submitted, Green Published, gold			2022-12-25	WOS:000314705800007
J	Vincenzi, F; Padovan, M; Targa, M; Corciulo, C; Giacuzzo, S; Merighi, S; Gessi, S; Govoni, M; Borea, PA; Varani, K				Vincenzi, Fabrizio; Padovan, Melissa; Targa, Martina; Corciulo, Carmen; Giacuzzo, Sarah; Merighi, Stefania; Gessi, Stefania; Govoni, Marcello; Borea, Pier Andrea; Varani, Katia			A(2A) Adenosine Receptors Are Differentially Modulated by Pharmacological Treatments in Rheumatoid Arthritis Patients and Their Stimulation Ameliorates Adjuvant-Induced Arthritis in Rats	PLOS ONE			English	Article							DISEASE-ACTIVITY; INFLAMMATORY ACTIVITY; CYTOKINE PRODUCTION; ANIMAL-MODELS; UP-REGULATION; EXPRESSION; INTERLEUKIN-10; CLASSIFICATION; IDENTIFICATION; LYMPHOCYTES	A(2A) adenosine receptors (ARs) play a key role in the inhibition of the inflammatory process. The purpose of this study was to evaluate the modulation of A(2A)ARs in rheumatoid arthritis (RA) patients after different pharmacological treatments and to investigate the effect of A(2A)AR stimulation in a rat model of arthritis. We investigated A(2A)AR density and functionality in RA progression by using a longitudinal study in RA patients before and after methotrexate (MTX), anti-TNF alpha agents or rituximab treatments. A(2A)ARs were analyzed by saturation binding assays in lymphocytes from RA patients throughout the 24-month study timeframe. In an adjuvant-induced arthritis model in rats we showed the efficacy of the A(2A)AR agonist, CGS 21680 in comparison with standard therapies by means of paw volume assessment, radiographic and ultrasonographic imaging. Arthritic-associated pain was investigated in mechanical allodynia and thermal hyperalgesia tests. IL-10 release following A(2A)AR stimulation in lymphocytes from RA patients and in serum from arthritic rats was measured. In lymphocytes obtained from RA patients, the A(2A)AR up-regulation was gradually reduced in function of the treatment time and the stimulation of these receptors mediated a significant increase of IL-10 production. In the same cells, CGS 21680 did not affected cell viability and did not produced cytotoxic effects. The A(2A)AR agonist CGS 21680 was highly effective, as suggested by the marked reduction of clinical signs, in rat adjuvant-induced arthritis and associated pain. This study highlighted that A(2A)AR agonists represent a physiological-like therapeutic alternative for RA treatment as suggested by the anti-inflammatory role of A(2A)ARs in lymphocytes from RA patients. The effectiveness of A(2A)AR stimulation in a rat model of arthritis supported the role of A(2A)AR agonists as potential pharmacological treatment for RA.	[Vincenzi, Fabrizio; Targa, Martina; Corciulo, Carmen; Merighi, Stefania; Gessi, Stefania; Borea, Pier Andrea; Varani, Katia] Univ Ferrara, Dept Clin & Expt Med, Pharmacol Sect, I-44100 Ferrara, Italy; [Padovan, Melissa; Govoni, Marcello] Univ Ferrara, Dept Clin & Expt Med, Rheumatol Sect, I-44100 Ferrara, Italy	University of Ferrara; University of Ferrara	Varani, K (corresponding author), Univ Ferrara, Dept Clin & Expt Med, Pharmacol Sect, I-44100 Ferrara, Italy.	vrk@unife.it	Gessi, Stefania/AAS-3844-2020; Vincenzi, Fabrizio/E-7925-2013	Govoni, Marcello/0000-0003-0499-5773; Gessi, Stefania/0000-0002-2197-5611; MERIGHI, STEFANIA/0000-0003-0839-6671; Vincenzi, Fabrizio/0000-0002-5027-1699; CORCIULO, CARMEN/0000-0002-1865-3494	Italian Ministry of Education, University and Research [MIUR-2009EE3SWA]	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the Italian Ministry of Education, University and Research (MIUR-2009EE3SWA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almarestani L, 2011, ARTHRITIS RHEUM-US, V63, P1573, DOI 10.1002/art.30303; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Backhaus M, 2001, ANN RHEUM DIS, V60, P641, DOI 10.1136/ard.60.7.641; Belavic JM, 2010, NURSE PRACT, V36, P10; Bitto A, 2011, ARTHRITIS RHEUM-US, V63, P3364, DOI 10.1002/art.30538; Bush KA, 2002, CLIN EXP IMMUNOL, V127, P423, DOI 10.1046/j.1365-2249.2002.01742.x; Cronstein B, 2010, CLIN EXP RHEUMATOL, V28, pS21; Dorner T, 2010, PHARMACOL THERAPEUT, V125, P464, DOI 10.1016/j.pharmthera.2010.01.001; Emery P, 2011, ANN RHEUM DIS, V70, P2063, DOI 10.1136/ard.2010.148015; Flogel U, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003717; Forrest CM, 2005, CLIN EXP RHEUMATOL, V23, P89; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Furst DE, 2012, ANN RHEUM DIS, V71, P2, DOI 10.1136/annrheumdis-2011-201036; Gao ZG, 2007, EXPERT OPIN EMERG DR, V12, P479, DOI 10.1517/14728214.12.3.479; Gessi S, 2011, EXPERT OPIN INV DRUG, V20, P1591, DOI 10.1517/13543784.2011.627853; Hegen M, 2008, ANN RHEUM DIS, V67, P1505, DOI 10.1136/ard.2007.076430; Himer L, 2010, FASEB J, V24, P2631, DOI 10.1096/fj.10-155192; Ishaq M, 2011, MOD RHEUMATOL, V21, P375, DOI 10.1007/s10165-010-0405-4; Joseph A, 2010, J ALLERGY CLIN IMMUN, V125, pS204, DOI 10.1016/j.jaci.2009.10.067; Kaur Shamsherjit, 2011, Inflammopharmacology, V19, P265, DOI 10.1007/s10787-011-0090-8; Kollias G, 2011, ANN RHEUM DIS, V70, P1357, DOI 10.1136/ard.2010.148551; MacKay K, 2003, RHEUMATOLOGY, V42, P149, DOI 10.1093/rheumatology/keg054; Manera C, 2010, CURR TOP MED CHEM, V10, P902, DOI 10.2174/156802610791268765; Mazzon E, 2011, J RHEUMATOL, V38, P2119, DOI 10.3899/jrheum.110111; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mediero A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003393; Meenagh G, 2008, CLIN EXP RHEUMATOL, V26, P982; Milne GR, 2011, THESCIENTIFICWORLDJO, V11, P320, DOI 10.1100/tsw.2011.22; Moore CC, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-141; Naredo E, 2005, ANN RHEUM DIS, V64, P375, DOI 10.1136/ard.2004.023929; Naredo E, 2007, ARTHRIT RHEUM-ARTHR, V57, P116, DOI 10.1002/art.22461; Nowak M, 2010, EUR J IMMUNOL, V40, P682, DOI 10.1002/eji.200939897; Ongaro A, 2012, J CELL PHYSIOL, V227, P2461, DOI 10.1002/jcp.22981; Patel HB, 2010, FASEB J, V24, P4835, DOI 10.1096/fj.10-167759; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Sakowicz-Burkiewicz M, 2010, J CELL BIOCHEM, V109, P396, DOI 10.1002/jcb.22417; Scott DL, 2012, CLIN PHARMACOL THER, V91, P30, DOI 10.1038/clpt.2011.278; Shaver TS, 2008, J RHEUMATOL, V35, P1015; Shi MQ, 2011, ARTHRITIS RHEUM-US, V63, P434, DOI 10.1002/art.30098; Singh JA, 2011, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD008794.PUB2; Soubrier M, 2011, ANN RHEUM DIS, V70, P611, DOI 10.1136/ard.2010.137695; Valls MD, 2009, BIOCHEM PHARMACOL, V77, P1117, DOI 10.1016/j.bcp.2008.11.002; Varani K, 2010, BRIT J PHARMACOL, V160, P101, DOI 10.1111/j.1476-5381.2010.00667.x; Varani K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3527; Varani K, 2010, AUTOIMMUN REV, V10, P61, DOI 10.1016/j.autrev.2010.07.019; Varani K, 2009, ARTHRITIS RHEUM-US, V60, P2880, DOI 10.1002/art.24794; Vincenzi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039317; Wood PB, 2009, CURR PAIN HEADACHE R, V13, P434, DOI 10.1007/s11916-009-0071-4; Wright DE, 2007, J PERIPHER NERV SYST, V12, P250, DOI 10.1111/j.1529-8027.2007.00144.x; Yang T, 2010, PLOS COMPUTATIONAL B, V6, P1; Zhang J, 2011, CYTOKINE, V56, P351, DOI 10.1016/j.cyto.2011.05.022	51	38	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54195	10.1371/journal.pone.0054195	http://dx.doi.org/10.1371/journal.pone.0054195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326596	Green Published, Green Submitted, gold			2022-12-25	WOS:000314705800115
J	Nijhuis, THJ; de Boer, SAS; Wahegaonkar, AL; Bishop, AT; Shin, AY; Hovius, SER; Selles, RW				Nijhuis, Tim H. J.; de Boer, Siebe A. S.; Wahegaonkar, Abhijeet L.; Bishop, Allen T.; Shin, Alexander Y.; Hovius, Steven E. R.; Selles, Ruud W.			A New Approach to Assess the Gastrocnemius Muscle Volume in Rodents Using Ultrasound; Comparison with the Gastrocnemius Muscle Index	PLOS ONE			English	Article							PERIPHERAL-NERVE REGENERATION; FOOT MUSCLES; RAT; ULTRASONOGRAPHY; PROTOCOLS; ATROPHY; REPAIR; FORCE; GAP	Introduction: The purpose of this study was to determine the reliability and validity of a new non-invasive ultrasound technique to measure gastrocnemius muscle atrophy after nerve denervation in an animal model. Methods: In sixteen rodents an eight mm sciatic nerve gap was created. In the following 8 weeks, each week, two rodents were euthanized and the gastrocnemius muscle was examined using two different ultrasound systems and two investigators. The standardized ultrasound measurement protocol consisted of identifying pre-defined anatomical landmarks: 1) the fibula, 2) the fibular nerve, and 3) the junction between the most distal point of the semitendinosus muscle and gastrocnemius muscle. Consequently, we measured the muscle thickness as the length of the line between the fibula and the junction between the two muscles, perpendicular to the fibular nerve. After the ultrasound recording, the muscle mass was determined. Results: A steep decline of muscle weight of 24% was observed after one week. In the following weeks, the weight further decreased and then remained stable from 6 weeks onwards, resulting in a maximal muscle weight decrease of 82%. The correlation coefficient was >0.96 between muscle diameter and weight using both ultrasound systems. The inter-rater reliability was excellent for both devices on the operated side (ICC of 0.99 for both ultrasound systems) and good for the non-operated site (ICC's: 0.84 & 0.89). The difference between the muscle mass ratio and the muscle thickness ratio was not more than 5% with two outliers of approximately 13%. Discussion: We have developed an innovative, highly reliable technique for quantifying muscle atrophy after nerve injury. This technique allows serial measurements in the same animal over time. This is a significant advantage compared to the conventional technique for quantifying muscle atrophy, which requires sacrificing the animal.	[Nijhuis, Tim H. J.; de Boer, Siebe A. S.; Wahegaonkar, Abhijeet L.; Hovius, Steven E. R.; Selles, Ruud W.] Univ Med Ctr, Erasmus MC, Dept Plast Reconstruct & Hand Surg, Rotterdam, Netherlands; [Bishop, Allen T.; Shin, Alexander Y.] Mayo Clin, Div Hand Surg, Dept Orthopaed Surg, Rochester, MN USA; [Wahegaonkar, Abhijeet L.] Mayo Clin, Microvasc Res Lab, Rochester, MN USA	Erasmus University Rotterdam; Erasmus MC; Mayo Clinic; Mayo Clinic	Nijhuis, THJ (corresponding author), Univ Med Ctr, Erasmus MC, Dept Plast Reconstruct & Hand Surg, Rotterdam, Netherlands.	t.nijhuis@erasmusmc.nl	Nijhuis, Tim/AAB-4559-2021; Selles, Ruud/N-9665-2019	Selles, Ruud/0000-0002-2432-6756; Shin, Alexander/0000-0001-9658-8192				Bianchi S, 2008, JOINT BONE SPINE, V75, P643, DOI 10.1016/j.jbspin.2008.07.002; Campbell WW, 2008, CLIN NEUROPHYSIOL, V119, P1951, DOI 10.1016/j.clinph.2008.03.018; Costa LM, 2009, INT REV NEUROBIOL, V87, P127, DOI 10.1016/S0074-7742(09)87007-4; Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002; Diao E, 2000, HAND CLIN, V16, P53; Fornage B D, 1993, Radiol Med, V85, P162; FORNAGE BD, 1988, RADIOLOGY, V167, P179, DOI 10.1148/radiology.167.1.3279453; Kuffler DP, 2010, J NEUROSCI METH, V188, P276, DOI 10.1016/j.jneumeth.2010.02.023; Kullmer K, 1998, ARCH ORTHOP TRAUM SU, V117, P228, DOI 10.1007/s004020050234; MILLESI H, 1995, CLIN ORTHOP RELAT R, P76; Morse CI, 2005, J APPL PHYSIOL, V99, P1050, DOI 10.1152/japplphysiol.01186.2004; Navarro X, 2009, INT REV NEUROBIOL, V87, P105, DOI 10.1016/S0074-7742(09)87006-2; Nijhuis THJ, 2011, J NEUROSCI METH, V194, P283, DOI 10.1016/j.jneumeth.2010.10.026; Nijhuis THJ, 2010, MICROSURG, V30, P639, DOI 10.1002/micr.20818; Ruiter GCW, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E5; Severinsen K, 2007, DIABETES CARE, V30, P3053, DOI 10.2337/dc07-0108; Severinsen K, 2007, CLIN NEUROPHYSIOL, V118, P2172, DOI 10.1016/j.clinph.2007.06.019; Shin RH, 2008, MICROSURG, V28, P452, DOI 10.1002/micr.20520; Siemionow M, 2010, MICROSURG, V30, P574, DOI 10.1002/micr.20799; Stokvis A, 2009, J HAND SURG-EUR VOL, V34E, P766, DOI 10.1177/1753193409102268; Sunderland IRP, 2004, ANN PLAS SURG, V53, P382, DOI 10.1097/01.sap.0000125502.63302.47; Tos P, 2009, INT REV NEUROBIOL, V87, P47, DOI 10.1016/S0074-7742(09)87004-9; Vleggeert-Lankamp CLAM, 2007, J NEUROSURG, V107, P1168, DOI 10.3171/JNS-07/12/1168	23	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54041	10.1371/journal.pone.0054041	http://dx.doi.org/10.1371/journal.pone.0054041			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326570	Green Published, gold, Green Submitted			2022-12-25	WOS:000313552400070
J	Nunes, MJ; Moutinho, M; Gama, MJ; Rodrigues, CMP; Rodrigues, E				Nunes, Maria Joao; Moutinho, Miguel; Gama, Maria Joao; Rodrigues, Cecilia M. P.; Rodrigues, Elsa			Histone Deacetylase Inhibition Decreases Cholesterol Levels in Neuronal Cells by Modulating Key Genes in Cholesterol Synthesis, Uptake and Efflux	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SP TRANSCRIPTION FACTORS; SPINAL MUSCULAR-ATROPHY; TRANSGENIC MOUSE MODEL; HUNTINGTONS-DISEASE; SODIUM-BUTYRATE; HUMAN BRAIN; C DISEASE; CYP46A1; MICE	Cholesterol is an essential component of the central nervous system and increasing evidence suggests an association between brain cholesterol metabolism dysfunction and the onset of neurodegenerative disorders. Interestingly, histone deacetylase inhibitors (HDACi) such as trichostatin A (TSA) are emerging as promising therapeutic approaches in neurodegenerative diseases, but their effect on brain cholesterol metabolism is poorly understood. We have previously demonstrated that HDACi up-regulate CYP46A1 gene transcription, a key enzyme in neuronal cholesterol homeostasis. In this study, TSA was shown to modulate the transcription of other genes involved in cholesterol metabolism in human neuroblastoma cells, namely by up-regulating genes that control cholesterol efflux and down-regulating genes involved in cholesterol synthesis and uptake, thus leading to an overall decrease in total cholesterol content. Furthermore, co-treatment with the amphipathic drug U18666A that can mimic the intracellular cholesterol accumulation observed in cells of Niemman-Pick type C patients, revealed that TSA can ameliorate the phenotype induced by pathological cholesterol accumulation, by restoring the expression of key genes involved in cholesterol synthesis, uptake and efflux and promoting lysosomal cholesterol redistribution. These results clarify the role of TSA in the modulation of neuronal cholesterol metabolism at the transcriptional level, and emphasize the idea of HDAC inhibition as a promising therapeutic tool in neurodegenerative disorders with impaired cholesterol metabolism.	[Nunes, Maria Joao; Moutinho, Miguel; Gama, Maria Joao; Rodrigues, Cecilia M. P.; Rodrigues, Elsa] Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci iMed UL, P-1699 Lisbon, Portugal; [Gama, Maria Joao; Rodrigues, Cecilia M. P.; Rodrigues, Elsa] Univ Lisbon, Fac Pharm, Dept Biochem & Human Biol, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Rodrigues, E (corresponding author), Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci iMed UL, P-1699 Lisbon, Portugal.	Elsa.Rodrigues@ff.ul.pt	iMed.ULisboa, CellFun/A-4244-2014; Moutinho, Miguel/AFR-5130-2022; Gama, Maria Joao/AAC-3089-2021; Nunes, Maria João/AAB-5062-2022; Gama, Maria João/M-7617-2013; Rodrigues, Cecilia MP/M-3572-2013; Rodrigues, Elsa/J-3100-2012; Nunes, Maria João/F-6766-2015; Moutinho, Miguel/I-4683-2015	Moutinho, Miguel/0000-0003-0525-9145; Nunes, Maria João/0000-0002-4922-633X; Gama, Maria João/0000-0002-4943-0349; Rodrigues, Cecilia MP/0000-0002-4829-754X; Rodrigues, Elsa/0000-0003-1669-365X; Nunes, Maria João/0000-0002-4922-633X; Moutinho, Miguel/0000-0003-0525-9145	FEDER (COMPETE Programme); FCT - Fundacao para a Ciencia e a Tecnologia [PTDC/SAU-NMC/110809/2009, PEst-OE/SAU/UI4013/2011, SFRH/BD/41848/2007, SFRH/BD/78041/2011]	FEDER (COMPETE Programme); FCT - Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology)	This work was supported by FEDER (COMPETE Programme) and by national funds (FCT - Fundacao para a Ciencia e a Tecnologia - projects PTDC/SAU-NMC/110809/2009 and PEst-OE/SAU/UI4013/2011, and PhD grants SFRH/BD/41848/2007 to MJN and SFRH/BD/78041/2011 to MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Bjorkhem I, 1998, J LIPID RES, V39, P1594; Camelo S, 2005, J NEUROIMMUNOL, V164, P10, DOI 10.1016/j.jneuroim.2005.02.022; Castro-Caldas M, 2009, NEUROSCI LETT, V451, P241, DOI 10.1016/j.neulet.2009.01.017; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Corcoran LJ, 2004, CURR BIOL, V14, P488, DOI 10.1016/j.cub.2004.03.003; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Fan QW, 2002, J NEUROCHEM, V80, P178, DOI 10.1046/j.0022-3042.2001.00686.x; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Goritz C, 2005, MOL CELL NEUROSCI, V29, P190, DOI 10.1016/j.mcn.2005.02.006; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Haggarty SJ, 2011, NEUROBIOL LEARN MEM, V96, P41, DOI 10.1016/j.nlm.2011.04.009; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kim SJ, 2007, BIOCHEM BIOPH RES CO, V360, P593, DOI 10.1016/j.bbrc.2007.06.116; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Milagre I, 2008, J NEUROCHEM, V106, P835, DOI 10.1111/j.1471-4159.2008.05442.x; Milagre I, 2012, NEUROCHEM INT, V60, P192, DOI 10.1016/j.neuint.2011.12.003; Milagre I, 2012, J NEUROCHEM, V120, P220, DOI 10.1111/j.1471-4159.2011.07577.x; Milagre I, 2010, J ALZHEIMERS DIS, V22, P1209, DOI 10.3233/JAD-2010-100651; Munkacsi AB, 2011, J BIOL CHEM, V286, P23842, DOI 10.1074/jbc.M111.227645; Nunes MJ, 2010, J NEUROCHEM, V113, P418, DOI 10.1111/j.1471-4159.2010.06612.x; Ohyama Y, 2006, J BIOL CHEM, V281, P3810, DOI 10.1074/jbc.M505179200; PENTCHEV PG, 1985, P NATL ACAD SCI USA, V82, P8247, DOI 10.1073/pnas.82.23.8247; Petri S, 2006, NEUROBIOL DIS, V22, P40, DOI 10.1016/j.nbd.2005.09.013; Pfrieger FW, 2003, BIOESSAYS, V25, P72, DOI 10.1002/bies.10195; Pipalia NH, 2011, P NATL ACAD SCI USA, V108, P5620, DOI 10.1073/pnas.1014890108; Rosenbaum AI, 2011, J NEUROCHEM, V116, P789, DOI 10.1111/j.1471-4159.2010.06976.x; Ryu H, 2005, J NEUROCHEM, V93, P1087, DOI 10.1111/j.1471-4159.2005.03077.x; Sato R, 2010, ARCH BIOCHEM BIOPHYS, V501, P177, DOI 10.1016/j.abb.2010.06.004; Shafaati M, 2011, J INTERN MED, V270, P377, DOI 10.1111/j.1365-2796.2011.02389.x; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Subramanian C, 2007, NEOPLASIA, V9, P495, DOI 10.1593/neo.07262; Vetrivel KS, 2010, BBA-MOL CELL BIOL L, V1801, P860, DOI 10.1016/j.bbalip.2010.03.007; Villagra A, 2007, J BIOL CHEM, V282, P35457, DOI 10.1074/jbc.M701719200; Xie CL, 1999, P NATL ACAD SCI USA, V96, P11992, DOI 10.1073/pnas.96.21.11992; Xie CL, 2003, J LIPID RES, V44, P1780, DOI 10.1194/jlr.M300164-JLR200; Xu Y, 2011, MOLECULES, V16, P7183, DOI 10.3390/molecules16097183; Zhang M, 2008, J NEUROSCI RES, V86, P2848, DOI 10.1002/jnr.21730; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	48	21	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53394	10.1371/journal.pone.0053394	http://dx.doi.org/10.1371/journal.pone.0053394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326422	Green Published, Green Submitted, gold			2022-12-25	WOS:000313552400022
J	Wu, HY; Chen, LH; Zhang, X; Zhou, QL; Li, JM; Berger, S; Borok, Z; Zhou, BY; Xiao, Z; Yin, HL; Liu, MY; Wang, Y; Jin, JP; Blackburn, MR; Xia, Y; Zhang, WZ				Wu, Hongyu; Chen, Lihe; Zhang, Xi; Zhou, Qiaoling; Li, Ju-Mei; Berger, Stefan; Borok, Zea; Zhou, Beiyun; Xiao, Zhou; Yin, Hongling; Liu, Mingyao; Wang, Ying; Jin, Jianping; Blackburn, Michael R.; Xia, Yang; Zhang, Wenzheng			Aqp5 Is a New Transcriptional Target of Dot1a and a Regulator of Aqp2	PLOS ONE			English	Article							NEPHROGENIC DIABETES-INSIPIDUS; AQUAPORIN-2 TRAFFICKING; DOWN-REGULATION; WATER CHANNELS; ENAC-ALPHA; SET DOMAIN; METHYLTRANSFERASE; MICE; METHYLATION; EXPRESSION	Dot1l encodes histone H3 K79 methyltransferase Dot1a. Mice with Dot1l deficiency in renal Aqp2-expressing cells (Dot1l (AC)) develop polyuria by unknown mechanisms. Here, we report that Aqp5 links Dot1l deletion to polyuria through Aqp2. cDNA array analysis revealed and real-time RT-qPCR validated Aqp5 as the most upregulated gene in Dot1l(AC) vs. control mice. Aqp5 protein is barely detectable in controls, but robustly expressed in the Dot1l(AC) kidneys, where it colocalizes with Aqp2. The upregulation of Aqp5 is coupled with reduced association of Dot1a and H3 dimethyl K79 with specific subregions in Aqp5 5' flanking region in Dot1l(AC) vs. control mice. In vitro studies in IMCD3, MLE-15 and 293Tcells using multiple approaches including real-time RT-qPCR, luciferase reporter assay, cell surface biotinylation assay, colocalization, and co-immunoprecipitation uncovered that Dot1a represses Aqp5. Human AQP5 interacts with AQP2 and impairs its cell surface localization. The AQP5/AQP2 complex partially resides in the ER/Golgi. Consistently, AQP5 is expressed in none of 15 normal controls, but in all of 17 kidney biopsies from patients with diabetic nephropathy. In the patients with diabetic nephropathy, AQP5 colocalizes with AQP2 in the perinuclear region and AQP5 expression is associated with impaired cellular H3 dimethyl K79. Taken together, these data for the first time identify Aqp5 as a Dot1a potential transcriptional target, and an Aqp2 binding partner and regulator, and suggest that the upregulated Aqp5 may contribute to polyuria, possibly by impairing Aqp2 membrane localization, in Dot1l(AC) mice and in patients with diabetic nephropathy.	[Wu, Hongyu; Zhang, Xi; Zhang, Wenzheng] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX USA; [Chen, Lihe; Liu, Mingyao; Jin, Jianping; Blackburn, Michael R.; Xia, Yang; Zhang, Wenzheng] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX USA; [Zhou, Qiaoling; Xiao, Zhou; Yin, Hongling] Cent S Univ, Xiangya Hosp, Dept Internal Med, Changsha, Hunan, Peoples R China; [Li, Ju-Mei; Jin, Jianping; Blackburn, Michael R.; Xia, Yang] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Houston, TX USA; [Berger, Stefan] German Canc Res Ctr, Div Mol Biol Cell 1, Heidelberg, Germany; [Borok, Zea; Zhou, Beiyun] Univ So Calif, Dept Med, Will Rogers Inst, Pulm Res Ctr,Div Pulm & Crit Care Med, Los Angeles, CA USA; [Liu, Mingyao; Wang, Ying] Texas A&M Univ Syst, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Liu, Mingyao; Wang, Ying] Texas A&M Univ Syst, Hlth Sci Ctr, Dept Mol & Cellular Med, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Central South University; University of Texas System; University of Texas Health Science Center Houston; Helmholtz Association; German Cancer Research Center (DKFZ); University of Southern California; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Zhang, WZ (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX USA.	wenzheng.zhang@uth.tmc.edu	Jin, Jianping/K-5002-2018; Chen, Lihe/N-3186-2018; Borok, Zea/J-9015-2013	Jin, Jianping/0000-0003-4175-9104; Chen, Lihe/0000-0002-6207-6364; Blackburn, Michael/0000-0002-1394-9966; Liu, Mingyao/0000-0001-7339-5048; Borok, Zea/0000-0001-8673-8177	National Institutes of Health [R01 DK080236, GM102529]; American Heart Association [0865271F]; The National Natural Science Foundation of China (NSFC) [81070552]; Welch Foundation [AU-1711]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148, TL1RR024147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102529] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); The National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Welch Foundation(The Welch Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following grants: National Institutes of Health Grants R01 DK080236 (to W.Z.Z.), American Heart Association Grant (0865271F to W.Z.Z.), and The National Natural Science Foundation of China (NSFC) grant 81070552 (to Q.L.Z.). Z. Borok is the Ralph Edgington Chair in Medicine. J.J. is supported by a grant (AU-1711) from the Welch Foundation and a grant (GM102529) from National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardoux P, 2001, DIABETOLOGIA, V44, P637, DOI 10.1007/s001250051671; Barok Z, 2000, J BIOL CHEM, V275, P26507, DOI 10.1074/jbc.M910007199; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Bichet DG, 2006, ADV CHRONIC KIDNEY D, V13, P96, DOI 10.1053/j.ackd.2006.01.006; BRODSKY WA, 1950, J CLIN INVEST, V29, P1021, DOI 10.1172/JCI102333; Chang MJ, 2010, CANCER RES, V70, P10234, DOI 10.1158/0008-5472.CAN-10-3294; Chen LH, 2011, J AM SOC NEPHROL, V22, P1076, DOI 10.1681/ASN.2010121270; de Seigneux S, 2007, AM J PHYSIOL-RENAL, V293, pF87, DOI 10.1152/ajprenal.00431.2006; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Feng Y, 2010, BLOOD, V116, P4483, DOI 10.1182/blood-2010-03-276501; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Jo SY, 2011, BLOOD, V117, P4759, DOI 10.1182/blood-2010-12-327668; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Kamsteeg EJ, 2000, J CELL BIOL, V151, P919, DOI 10.1083/jcb.151.4.919; Kamsteeg EJ, 2007, P NATL ACAD SCI USA, V104, P16696, DOI 10.1073/pnas.0708023104; Kim D, 2003, AM J PHYSIOL-RENAL, V285, pF303, DOI 10.1152/ajprenal.00438.2002; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Krane CM, 2007, MAMM GENOME, V18, P452, DOI 10.1007/s00335-007-9041-5; Krane CM, 1999, MAMM GENOME, V10, P498, DOI 10.1007/s003359901030; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Lu HAJ, 2007, J BIOL CHEM, V282, P28721, DOI 10.1074/jbc.M611101200; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Ma TH, 2000, P NATL ACAD SCI USA, V97, P4386, DOI 10.1073/pnas.080499597; McKenna K, 2000, AM J PHYSIOL-ENDOC M, V279, pE155, DOI 10.1152/ajpendo.2000.279.1.E155; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Molitoris BA, 2009, J AM SOC NEPHROL, V20, P1754, DOI 10.1681/ASN.2008111204; Muller C, 2006, J EXP BIOL, V209, P4067, DOI 10.1242/jeb.02491; Nejsum LN, 2001, AM J PHYSIOL-RENAL, V280, pF715, DOI 10.1152/ajprenal.2001.280.4.F715; Nguyen AT, 2011, GENE DEV, V25, P263, DOI 10.1101/gad.2018511; Nielsen J, 2006, AM J PHYSIOL-RENAL, V290, pF438, DOI 10.1152/ajprenal.00158.2005; Noda Y, 2004, BIOCHEM BIOPH RES CO, V322, P740, DOI 10.1016/j.bbrc.2004.07.195; Noda Y, 2004, FEBS LETT, V568, P139, DOI 10.1016/j.febslet.2004.05.021; Noda Y, 2008, J CELL BIOL, V182, P587, DOI 10.1083/jcb.200709177; Noda Y, 2010, NAT REV NEPHROL, V6, P168, DOI 10.1038/nrneph.2009.231; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Okutsu R, 2008, KIDNEY INT, V74, P1429, DOI 10.1038/ki.2008.402; RAINA S, 1995, J BIOL CHEM, V270, P1908, DOI 10.1074/jbc.270.4.1908; Reisenauer MR, 2010, AM J PHYSIOL-RENAL, V299, pF63, DOI 10.1152/ajprenal.00105.2010; Reisenauer MR, 2009, J BIOL CHEM, V284, P35659, DOI 10.1074/jbc.M109.038448; Rojek A, 2006, P NATL ACAD SCI USA, V103, P6037, DOI 10.1073/pnas.0511324103; Ronzaud C, 2007, J AM SOC NEPHROL, V18, P1679, DOI 10.1681/ASN.2006090975; Singer MS, 1998, GENETICS, V150, P613; Tamma G, 2008, PFLUG ARCH EUR J PHY, V456, P729, DOI 10.1007/s00424-008-0453-1; Tsubota K, 2001, LANCET, V357, P688, DOI 10.1016/S0140-6736(00)04140-4; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Verkman Alan S, 2009, Handb Exp Pharmacol, P359, DOI 10.1007/978-3-540-79885-9_18; Vernimmen D, 2011, GENE DEV, V25, P1583, DOI 10.1101/gad.16985411; Wang S, 2008, NEPHROL DIAL TRANSPL, V23, P2167, DOI 10.1093/ndt/gfn115; Wu H, 2012, JASN IN PRESS; Wu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027429; Yamamura Y, 2012, J CELL MOL MED, V16, P1766, DOI 10.1111/j.1582-4934.2011.01456.x; Yao CJ, 2010, AM J PATHOL, V177, P724, DOI 10.2353/ajpath.2010.090282; Zhang WZ, 2007, J CLIN INVEST, V117, P773, DOI 10.1172/JCI29850; Zhang WZ, 2006, J BIOL CHEM, V281, P18059, DOI 10.1074/jbc.M601903200; Zhang WZ, 2006, AM J PHYSIOL-CELL PH, V290, pC936, DOI 10.1152/ajpcell.00431.2005; Zhang WZ, 2004, BIOCHEM J, V377, P641, DOI 10.1042/BJ20030839; Zhou QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047360; Zwang NA, 2009, J PROTEOME RES, V8, P1540, DOI 10.1021/pr800894p	58	36	40	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53342	10.1371/journal.pone.0053342	http://dx.doi.org/10.1371/journal.pone.0053342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326416	Green Published, Green Submitted, gold			2022-12-25	WOS:000313552400018
J	Dai, K; Liao, SH; Zhang, JH; Zhang, XC; Tu, XM				Dai, Kun; Liao, Shanhui; Zhang, Jiahai; Zhang, Xuecheng; Tu, Xiaoming			Structural and Functional Insight into ADF/Cofilin from Trypanosoma brucei	PLOS ONE			English	Article							ACTIN-DEPOLYMERIZING FACTOR; FACTOR HOMOLOGY DOMAIN; PROTEINS; COFILIN; DYNAMICS; BINDING; FILAMENTS; PROGRAM; SYSTEM; SERVER	The ADF/cofilin family has been characterized as a group of actin-binding proteins critical for controlling the assembly of actin within the cells. In this study, the solution structure of the ADF/cofilin from Trypanosoma brucei (TbCof) was determined by NMR spectroscopy. TbCof adopts the conserved ADF/cofilin fold with a central beta-sheet composed of six beta-strands surrounded by five alpha-helices. Isothermal titration calorimetry experiments denoted a submicromolar affinity between TbCof and G-actin, and the affinity between TbCof and ADP-G-actin was five times higher than that between TbCof and ATP-G-actin at low ionic strength. The results obtained from electron microscopy and actin filament sedimentation assays showed that TbCof depolymerized but did not co-sediment with actin filaments and its ability of F-actin depolymerization was pH independent. Similar to actin, TbCof was distributed throughout the cytoplasm. All our data indicate a structurally and functionally conserved ADF/cofilin from Trypanosoma brucei.	[Dai, Kun; Liao, Shanhui; Zhang, Jiahai; Tu, Xiaoming] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Zhang, Xuecheng] Anhui Univ, Sch Life Sci, Hefei 230039, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui University	Tu, XM (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	xmtu@ustc.edu.cn	Liao, Shanhui/N-1628-2018; Tu, Xiaoming/G-5090-2018	Liao, Shanhui/0000-0002-5083-667X; 	National Basic Research Program of China (973 Program) [2009CB918804]; Knowledge Innovation Program of the Chinese Academy of Science [KSCX2-EW-Q-4]; Chinese National Natural Science Foundations [31270780, 30900228]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Knowledge Innovation Program of the Chinese Academy of Science(Knowledge Innovation Program of the Chinese Academy of Sciences); Chinese National Natural Science Foundations(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program), grant number 2009CB918804, the Knowledge Innovation Program of the Chinese Academy of Science, grant number KSCX2-EW-Q-4, the Chinese National Natural Science Foundations, grant number 31270780, and the Chinese National Natural Science Foundations, grant number 30900228. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamburg James R, 2010, F1000 Biol Rep, V2, P62, DOI 10.3410/B2-62; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Blondin L, 2002, EUR J BIOCHEM, V269, P4194, DOI 10.1046/j.1432-1033.2002.03101.x; Bowman GD, 2000, PROTEINS, V41, P374, DOI 10.1002/1097-0134(20001115)41:3<374::AID-PROT90>3.0.CO;2-F; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; CUNNINGHAM I, 1977, J PROTOZOOL, V24, P325, DOI 10.1111/j.1550-7408.1977.tb00987.x; Dai K, 2011, BIOMOL NMR ASSIGN, V5, P249, DOI 10.1007/s12104-011-9311-8; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Fedorov AA, 1997, NAT STRUCT BIOL, V4, P366, DOI 10.1038/nsb0597-366; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Goddard T.D., 2004, SPARKY 3; Goroncy AK, 2009, PROTEIN SCI, V18, P2384, DOI 10.1002/pro.248; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ichetovkin I, 2000, CELL MOTIL CYTOSKEL, V45, P293, DOI 10.1002/(SICI)1097-0169(200004)45:4<293::AID-CM5>3.0.CO;2-1; KABSCH W, 1992, ANNU REV BIOPH BIOM, V21, P49, DOI 10.1146/annurev.biophys.21.1.49; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liao SH, 2010, EXP CELL RES, V316, P704, DOI 10.1016/j.yexcr.2009.12.017; Maciver SK, 2002, GENOME BIOL, V3; Nolan DP, 2008, MOL BIOCHEM PARASIT, V157, P233, DOI 10.1016/j.molbiopara.2007.10.006; Ojala PJ, 2002, MOL BIOL CELL, V13, P3811, DOI 10.1091/mbc.E02-03-0157; Ono S, 1998, J BIOL CHEM, V273, P3778, DOI 10.1074/jbc.273.6.3778; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Pathak PP, 2010, J STRUCT BIOL, V172, P219, DOI 10.1016/j.jsb.2010.07.001; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Pope BJ, 2004, J BIOL CHEM, V279, P4840, DOI 10.1074/jbc.M310148200; Poukkula M, 2011, CYTOSKELETON, V68, P471, DOI 10.1002/cm.20530; Schrodinger L., 2002, PYMOL MOL GRAPHICS S; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SHETERLINE P, 1994, PROTEIN PROFILE, V1, P1; Singh BK, 2011, J BIOL CHEM, V286, P28256, DOI 10.1074/jbc.M111.211730; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Tammana TVS, 2008, MOL MICROBIOL, V70, P837, DOI 10.1111/j.1365-2958.2008.06448.x; Tu XM, 2006, J BIOL CHEM, V281, P9677, DOI 10.1074/jbc.M511504200; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yadav R, 2011, J STRUCT BIOL, V176, P97, DOI 10.1016/j.jsb.2011.07.011	46	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53639	10.1371/journal.pone.0053639	http://dx.doi.org/10.1371/journal.pone.0053639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326476	Green Published, Green Submitted, gold			2022-12-25	WOS:000313551500089
J	Hou, WG; Wang, S; Dong, HL; Jiang, HC; Briggs, BR; Peacock, JP; Huang, QY; Huang, LQ; Wu, G; Zhi, XY; Li, WJ; Dodsworth, JA; Hedlund, BP; Zhang, CL; Hartnett, HE; Dijkstra, P; Hungate, BA				Hou, Weiguo; Wang, Shang; Dong, Hailiang; Jiang, Hongchen; Briggs, Brandon R.; Peacock, Joseph P.; Huang, Qiuyuan; Huang, Liuqin; Wu, Geng; Zhi, Xiaoyang; Li, Wenjun; Dodsworth, Jeremy A.; Hedlund, Brian P.; Zhang, Chuanlun; Hartnett, Hilairy E.; Dijkstra, Paul; Hungate, Bruce A.			A Comprehensive Census of Microbial Diversity in Hot Springs of Tengchong, Yunnan Province China Using 16S rRNA Gene Pyrosequencing	PLOS ONE			English	Article							YELLOWSTONE-NATIONAL-PARK; ACIDIC GEOTHERMAL SPRINGS; COMMUNITY STRUCTURE; WEST-YUNNAN; SP NOV.; GEOCHEMISTRY; ARCHAEAL; REHAI; FIELD; BACTERIAL	The Rehai and Ruidian geothermal fields, located in Tengchong County, Yunnan Province, China, host a variety of geochemically distinct hot springs. In this study, we report a comprehensive, cultivation-independent census of microbial communities in 37 samples collected from these geothermal fields, encompassing sites ranging in temperature from 55.1 to 93.6 degrees C, in pH from 2.5 to 9.4, and in mineralogy from silicates in Rehai to carbonates in Ruidian. Richness was low in all samples, with 21-123 species-level OTUs detected. The bacterial phylum Aquificae or archaeal phylum Crenarchaeota were dominant in Rehai samples, yet the dominant taxa within those phyla depended on temperature, pH, and geochemistry. Rehai springs with low pH (2.5-2.6), high temperature (85.1-89.1 degrees C), and high sulfur contents favored the crenarchaeal order Sulfolobales, whereas those with low pH (2.6-4.8) and cooler temperature (55.1-64.5 degrees C) favored the Aquificae genus Hydrogenobaculum. Rehai springs with neutral-alkaline pH (7.2-9.4) and high temperature (>80 degrees C) with high concentrations of silica and salt ions (Na, K, and Cl) favored the Aquificae genus Hydrogenobacter and crenarchaeal orders Desulfurococcales and Thermoproteales. Desulfurococcales and Thermoproteales became predominant in springs with pH much higher than the optimum and even the maximum pH known for these orders. Ruidian water samples harbored a single Aquificae genus Hydrogenobacter, whereas microbial communities in Ruidian sediment samples were more diverse at the phylum level and distinctly different from those in Rehai and Ruidian water samples, with a higher abundance of uncultivated lineages, close relatives of the ammonia-oxidizing archaeon "Candidatus Nitrosocaldus yellowstonii'', and candidate division O1aA90 and OP1. These differences between Ruidian sediments and Rehai samples were likely caused by temperature, pH, and sediment mineralogy. The results of this study significantly expand the current understanding of the microbiology in Tengchong hot springs and provide a basis for comparison with other geothermal systems around the world.	[Hou, Weiguo; Wang, Shang; Dong, Hailiang; Jiang, Hongchen; Huang, Liuqin] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Beijing, Peoples R China; [Hou, Weiguo; Wang, Shang; Dong, Hailiang; Jiang, Hongchen; Huang, Liuqin] China Univ Geosci, Inst Earth Sci, Beijing, Peoples R China; [Dong, Hailiang; Briggs, Brandon R.; Huang, Qiuyuan] Miami Univ, Dept Geol & Environm Earth Sci, Oxford, OH 45056 USA; [Peacock, Joseph P.; Dodsworth, Jeremy A.; Hedlund, Brian P.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Wu, Geng] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Hubei Province, Peoples R China; [Zhi, Xiaoyang; Li, Wenjun] Yunnan Univ, Yunnan Inst Microbiol, Minist Educ, Key Lab Microbial Divers SW China, Kunming, Yunnan Province, Peoples R China; [Zhi, Xiaoyang; Li, Wenjun] Yunnan Univ, Yunnan Inst Microbiol, Lab Conservat & Utilizat Bioresources, Kunming, Yunnan Province, Peoples R China; [Zhang, Chuanlun] Tongji Univ, Sch Ocean Earth Sci, State Key Lab Marine Geol, Shanghai 200092, Peoples R China; [Zhang, Chuanlun] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; [Hartnett, Hilairy E.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ USA; [Hartnett, Hilairy E.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA; [Dijkstra, Paul; Hungate, Bruce A.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA	China University of Geosciences; China University of Geosciences; University System of Ohio; Miami University; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; China University of Geosciences; Yunnan University; Yunnan University; Tongji University; University System of Georgia; University of Georgia; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Northern Arizona University	Dong, HL (corresponding author), China Univ Geosci, State Key Lab Biogeol & Environm Geol, Beijing, Peoples R China.	dongh@cugb.edu.cn	Wu, Geng/G-9740-2018; Hungate, Bruce/F-8991-2011; WU, Geng/F-8840-2010; Jiang, Hongchen/Y-9471-2018; hou, wei/GWM-4800-2022; Jiang, Hongchen/I-5838-2016	Hungate, Bruce/0000-0002-7337-1887; WU, Geng/0000-0002-7259-1044; Jiang, Hongchen/0000-0003-1271-7028; Briggs, Brandon/0000-0002-3808-8269; Hartnett, Hilairy/0000-0003-0736-7844; Dong, Hailiang/0000-0002-7468-1350; Dodsworth, Jeremy/0000-0003-2014-5488; Hedlund, Brian/0000-0001-8530-0448	National Natural Science Foundation of China [41030211, 41002123, 40972211]; Scientific Research Funds for the 1000 "Talents'' Program Plan from China University of Geosciences-Beijing; National Science Foundation [OISE-0968421, ETBC-1024614, DBI REU 1005223]; Div Of Biological Infrastructure [1005223] Funding Source: National Science Foundation; Office Of The Director [0968421] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Funds for the 1000 "Talents'' Program Plan from China University of Geosciences-Beijing; National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by the National Natural Science Foundation of China grants (41030211, 41002123, 40972211), the Scientific Research Funds for the 1000 "Talents'' Program Plan from China University of Geosciences-Beijing, National Science Foundation grants (OISE-0968421, ETBC-1024614 and DBI REU 1005223). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bershaw J, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016132; Boyd ES, 2009, APPL ENVIRON MICROB, V75, P4289, DOI 10.1128/AEM.02751-08; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Brock T.D., 1978, THERMOPHILIC MICROOR; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costa KC, 2009, EXTREMOPHILES, V13, P447, DOI 10.1007/s00792-009-0230-x; Cox A, 2011, CHEM GEOL, V280, P344, DOI 10.1016/j.chemgeo.2010.11.022; da Costa M.S., 2006, PROKARYOTES, VVolume 7, P797; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; Dodsworth JA, 2011, ENVIRON MICROBIOL, V13, P2371, DOI 10.1111/j.1462-2920.2011.02508.x; Dodsworth JA, 2011, METHOD ENZYMOL, V486, P171, DOI [10.1016/S0076-6879(11)86008-8, 10.1016/B978-0-12-381294-0.00008-0]; Du JG, 2005, J VOLCANOL GEOTH RES, V142, P243, DOI 10.1016/j.jvolgeores.2004.11.009; Eder W, 2002, EXTREMOPHILES, V6, P309, DOI 10.1007/s00792-001-0259-y; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FOURNIER RO, 1989, ANNU REV EARTH PL SC, V17, P13, DOI 10.1146/annurev.ea.17.050189.000305; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hall JR, 2008, APPL ENVIRON MICROB, V74, P4910, DOI 10.1128/AEM.00233-08; Hedlund BP, 2012, GEOSCI FRONT, V3, P273, DOI 10.1016/j.gsf.2011.12.006; Huang QY, 2011, EXTREMOPHILES, V15, P549, DOI 10.1007/s00792-011-0386-z; Huber H, 2001, BERGEYS MANUAL SYSTE, P169; Huber H., 2001, BERGEYS MANUAL SYSTE, V1, P198; Inskeep W. P., 2005, GEOTHERMAL BIOL GEOC, P143; Inskeep WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009773; Jiang HC, 2010, APPL ENVIRON MICROB, V76, P4538, DOI 10.1128/AEM.00143-10; Kan JJ, 2011, ISME J, V5, P1784, DOI 10.1038/ismej.2011.56; KEMPNER ES, 1963, SCIENCE, V142, P1318, DOI 10.1126/science.142.3597.1318; Kozubal M, 2008, APPL ENVIRON MICROB, V74, P942, DOI 10.1128/AEM.01200-07; Kozubal MA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00109; Kyle JE, 2007, GEOMICROBIOL J, V24, P627, DOI 10.1080/01490450701672158; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; LIAO ZJ, 1986, GEOTHERMICS, V15, P339; [刘文杰 LIU WenJie], 2006, [生态学报, Acta Ecologica Sinica], V26, P1303, DOI 10.1016/S1872-2032(06)60022-X; Macur RE, 2004, GEOBIOLOGY, V2, P163, DOI 10.1111/j.1472-4677.2004.00032.x; Meyer-Dombard DR, 2005, GEOBIOLOGY, V3, P211, DOI 10.1111/j.1472-4669.2005.00052.x; Meyer-Dombard DR, 2011, ENVIRON MICROBIOL, V13, P2216, DOI 10.1111/j.1462-2920.2011.02476.x; Nakagawa S, 2005, INT J SYST EVOL MICR, V55, P2263, DOI 10.1099/ijs.0.63708-0; Oksanen J., 2007, VEGAN COMMUNITY ECOL, V1, P8; Pagaling E, 2012, EXTREMOPHILES, V16, P607, DOI 10.1007/s00792-012-0460-1; Pearson A, 2008, APPL ENVIRON MICROB, V74, P3523, DOI 10.1128/AEM.02450-07; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Reysenbach A.L., 2005, GEOTHERMAL BIOL GEOC, P129; Rozanski K., 1993, CLIMATE CHANGE CONTI, V78, P1, DOI DOI 10.1029/GM078P0001; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sharp JH, 2004, MAR CHEM, V84, P181, DOI 10.1016/j.marchem.2003.07.003; SHARP JH, 1993, LIMNOL OCEANOGR, V38, P1774, DOI 10.4319/lo.1993.38.8.1774; Shen M, 1982, RECORDS GEOL RES, P187; Song ZQ, 2010, EXTREMOPHILES, V14, P287, DOI 10.1007/s00792-010-0307-6; Spear JR, 2005, P NATL ACAD SCI USA, V102, P2555, DOI 10.1073/pnas.0409574102; Swingley WD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038108; Tong W., 1989, TENGCHONG GEOTHERMIC; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Vick TJ, 2010, GEOBIOLOGY, V8, P140, DOI 10.1111/j.1472-4669.2009.00228.x; Wang F, 2000, CHINESE SCI BULL, V45, P83, DOI 10.1007/BF02884910; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; Xiang XY, 2003, EXTREMOPHILES, V7, P493, DOI 10.1007/s00792-003-0355-2; Yang TT, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00130; YOSHIDA Y, 1991, GEOCHEM J, V25, P203, DOI 10.2343/geochemj.25.203; Zhang CL, 2008, APPL ENVIRON MICROB, V74, P6417, DOI 10.1128/AEM.00843-08; Zhang G, 2008, GEOTHERMICS, V37, P73, DOI 10.1016/j.geothermics.2007.09.002; ZHANG ZF, 1987, GEOTHERMICS, V16, P169; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11	64	139	151	7	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53350	10.1371/journal.pone.0053350	http://dx.doi.org/10.1371/journal.pone.0053350			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326417	Green Published, Green Submitted, gold			2022-12-25	WOS:000313551500066
J	Woods, CW; McClain, MT; Chen, MH; Zaas, AK; Nicholson, BP; Varkey, J; Veldman, T; Kingsmore, SF; Huang, YS; Lambkin-Williams, R; Gilbert, AG; Hero, AO; Ramsburg, E; Glickman, S; Lucas, JE; Carin, L; Ginsburg, GS				Woods, Christopher W.; McClain, Micah T.; Chen, Minhua; Zaas, Aimee K.; Nicholson, Bradly P.; Varkey, Jay; Veldman, Timothy; Kingsmore, Stephen F.; Huang, Yongsheng; Lambkin-Williams, Robert; Gilbert, Anthony G.; Hero, Alfred O., III; Ramsburg, Elizabeth; Glickman, Seth; Lucas, Joseph E.; Carin, Lawrence; Ginsburg, Geoffrey S.			A Host Transcriptional Signature for Presymptomatic Detection of Infection in Humans Exposed to Influenza H1N1 or H3N2	PLOS ONE			English	Article							GENE-EXPRESSION; VIRUS-INFECTION; A VIRUS; CHILDREN; PREVENTION; CHALLENGE; DIAGNOSIS; DISEASE; OSELTAMIVIR; MODULATION	There is great potential for host-based gene expression analysis to impact the early diagnosis of infectious diseases. In particular, the influenza pandemic of 2009 highlighted the challenges and limitations of traditional pathogen-based testing for suspected upper respiratory viral infection. We inoculated human volunteers with either influenza A (A/Brisbane/59/2007 (H1N1) or A/Wisconsin/67/2005 (H3N2)), and assayed the peripheral blood transcriptome every 8 hours for 7 days. Of 41 inoculated volunteers, 18 (44%) developed symptomatic infection. Using unbiased sparse latent factor regression analysis, we generated a gene signature (or factor) for symptomatic influenza capable of detecting 94% of infected cases. This gene signature is detectable as early as 29 hours post-exposure and achieves maximal accuracy on average 43 hours (p = 0.003, H1N1) and 38 hours (p-value = 0.005, H3N2) before peak clinical symptoms. In order to test the relevance of these findings in naturally acquired disease, a composite influenza A signature built from these challenge studies was applied to Emergency Department patients where it discriminates between swine-origin influenza A/H1N1 (2009) infected and non-infected individuals with 92% accuracy. The host genomic response to Influenza infection is robust and may provide the means for detection before typical clinical symptoms are apparent.	[Woods, Christopher W.; Zaas, Aimee K.; Veldman, Timothy; Lucas, Joseph E.; Ginsburg, Geoffrey S.] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27706 USA; [Woods, Christopher W.; McClain, Micah T.; Zaas, Aimee K.; Varkey, Jay] Duke Univ, Med Ctr, Div Infect Dis, Durham, NC USA; [Woods, Christopher W.; McClain, Micah T.; Nicholson, Bradly P.] Durham Vet Affairs Med Ctr, Durham, NC USA; [Chen, Minhua; Carin, Lawrence] Duke Univ, Dept Elect & Comp Engn, Durham, NC USA; [Kingsmore, Stephen F.] Natl Ctr Genome Resources, Santa Fe, NM USA; [Huang, Yongsheng; Hero, Alfred O., III] Univ Michigan, Ctr Computat Biol & Bioinformat, Ann Arobor, MI USA; [Lambkin-Williams, Robert; Gilbert, Anthony G.] Retroscreen Virol, London, England; [Ramsburg, Elizabeth] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA; [Glickman, Seth] Univ N Carolina Chapel Hill, Dept Emergency Med, Chapel Hill, NC USA	Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; National Center for Genome Resources (NCGR); University of Michigan System; University of Michigan; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Woods, CW (corresponding author), Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27706 USA.	chris.woods@duke.edu; geoffrey.ginsburg@duke.edu	Lambkin-Williams, Rob/L-2397-2019; Lambkin-Williams, Robert/P-5963-2016	Lambkin-Williams, Rob/0000-0003-2107-0174; Lambkin-Williams, Robert/0000-0003-2107-0174; Carin, Lawrence/0000-0001-6277-7948; Gilbert, Anthony Saul/0000-0002-6582-3820; Hero, Alfred/0000-0002-2531-9670; kingsmore, stephen/0000-0002-3758-4631; Kingsmore, Stephen/0000-0001-7180-2527	US Defense Advanced Research Projects Agency (DARPA) [N66001-07-C-2024]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U19HD077693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI066569] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX000611] Funding Source: NIH RePORTER	US Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	Funding for this study was provided by the US Defense Advanced Research Projects Agency (DARPA) through contract N66001-07-C-2024 (P.I., Ginsburg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett B, 2006, EUR RESPIR J, V28, P358, DOI 10.1183/09031936.06.00002606; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Boggild AK, 2010, CRIT CARE MED, V38, pE38, DOI 10.1097/CCM.0b013e3181cd7bb2; Calpin C, 1997, J ALLERGY CLIN IMMUN, V100, P452, DOI 10.1016/S0091-6749(97)70134-9; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Chen B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-552; Chiarini A, 2008, J CLIN MICROBIOL; Ehrhardt C, 2010, MICROBES INFECT, V12, P81, DOI 10.1016/j.micinf.2009.09.007; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Garvalho C, 2008, J AM STAT ASS; Gharabaghi F, 2008, J CLIN VIROL, V42, P190, DOI 10.1016/j.jcv.2008.01.013; Goldstein E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-211; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Hurt AC, 2009, INFLUENZA OTHER RESP, V3, P171, DOI 10.1111/j.1750-2659.2009.00086.x; JACKSON GG, 1958, ARCH INTERN MED, V101, P267, DOI 10.1001/archinte.1958.00260140099015; Julkunen I, 2001, CYTOKINE GROWTH F R, V12, P171, DOI 10.1016/S1359-6101(00)00026-5; Katze MG, 2008, NAT REV IMMUNOL, V8, P644, DOI 10.1038/nri2377; Kawada J, 2006, J GEN VIROL, V87, P1677, DOI 10.1099/vir.0.81670-0; Kochs G, 1999, P NATL ACAD SCI USA, V96, P2082, DOI 10.1073/pnas.96.5.2082; Lambert SB, 2008, PEDIATRICS, V122, pE615, DOI 10.1542/peds.2008-0691; Lucas JE, 2008, BAYESIAN MODELING BI; Lucas J, 2006, BAYESIAN INFERENCE FOR GENE EXPRESSION AND PROTEOMICS, P155; Memoli MJ, 2008, DRUG DISCOV TODAY, V13, P590, DOI 10.1016/j.drudis.2008.03.024; Nakaya HI, 2011, NAT IMMUNOL; Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007892; Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103; Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127; Player MR, 1998, PHARMACOL THERAPEUT, V78, P55, DOI 10.1016/S0163-7258(97)00167-8; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Ramilo O, 2009, CELL HOST MICROBE, V6, P199, DOI 10.1016/j.chom.2009.08.007; Robinson JL, 2008, CLIN INFECT DIS, V46, pE61, DOI 10.1086/529386; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Tang BMP, 2009, CRIT CARE MED, V37, P882, DOI 10.1097/CCM.0b013e31819b52fd; Turner RB, 2001, CLIN INFECT DIS, V33, P1865, DOI 10.1086/324347; Walker FDL, 2000, CLIN OTOLARYNGOL, V25, P482, DOI 10.1046/j.1365-2273.2000.00349.x; WANG Q, 2007, B INT SOC BAYESIAN A, V14, P4; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Zaas AK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000715; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006; Zhu W, 2010, VACCINE, V28, P2865, DOI 10.1016/j.vaccine.2010.01.060	41	121	121	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52198	10.1371/journal.pone.0052198	http://dx.doi.org/10.1371/journal.pone.0052198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326326	Green Published, gold, Green Submitted			2022-12-25	WOS:000313551500010
J	D'Assoro, AB; Liu, T; Quatraro, C; Amato, A; Opyrchal, M; Leontovich, A; Ikeda, Y; Ohmine, S; Lingle, W; Suman, V; Ecsedy, J; Iankov, I; Di Leonardo, A; Ayers-Ringler, J; Degnim, A; Billadeau, D; McCubrey, J; Ingle, J; Salisbury, JL; Galanis, E				D'Assoro, A. B.; Liu, T.; Quatraro, C.; Amato, A.; Opyrchal, M.; Leontovich, A.; Ikeda, Y.; Ohmine, S.; Lingle, W.; Suman, V.; Ecsedy, J.; Iankov, I.; Di Leonardo, A.; Ayers-Ringler, J.; Degnim, A.; Billadeau, D.; McCubrey, J.; Ingle, J.; Salisbury, J. L.; Galanis, E.			The mitotic kinase Aurora-A promotes distant metastases by inducing epithelial-to-mesenchymal transition in ER alpha(+) breast cancer cells	ONCOGENE			English	Article						breast cancer; stemness; metastases	P53 FUNCTION LEADS; CENTROSOME AMPLIFICATION; STEM-CELLS; ERBB2; PROGRESSION; OVEREXPRESSION; PROLIFERATION; TUMORIGENESIS; EXPRESSION; RESISTANCE	In this study, we demonstrate that constitutive activation of Raf-1 oncogenic signaling induces stabilization and accumulation of Aurora-A mitotic kinase that ultimately drives the transition from an epithelial to a highly invasive mesenchymal phenotype in estrogen receptor alpha-positive (ER alpha(+)) breast cancer cells. The transition from an epithelial- to a mesenchymal-like phenotype was characterized by reduced expression of ER alpha, HER-2/Neu overexpression and loss of CD24 surface receptor (CD24(-/low)). Importantly, expression of key epithelial-to-mesenchymal transition (EMT) markers and upregulation of the stemness gene SOX2 was linked to acquisition of stem cell-like properties such as the ability to form mammospheres in vitro and tumor self-renewal in vivo. Moreover, aberrant Aurora-A kinase activity induced phosphorylation and nuclear translocation of SMAD5, indicating a novel interplay between Aurora-A and SMAD5 signaling pathways in the development of EMT, stemness and ultimately tumor progression. Importantly, pharmacological and molecular inhibition of Aurora-A kinase activity restored a CD24(+) epithelial phenotype that was coupled to ER alpha expression, downregulation of HER-2/Neu, inhibition of EMT and impaired self-renewal ability, resulting in the suppression of distant metastases. Taken together, our findings show for the first time the causal role of Aurora-A kinase in the activation of EMT pathway responsible for the development of distant metastases in ER alpha(+) breast cancer cells. Moreover, this study has important translational implications because it highlights the mitotic kinase Aurora-A as a novel promising therapeutic target to selectively eliminate highly invasive cancer cells and improve the disease-free and overall survival of ER alpha(+) breast cancer patients resistant to conventional endocrine therapy.	[D'Assoro, A. B.; Liu, T.; Quatraro, C.; Amato, A.; Ayers-Ringler, J.; Salisbury, J. L.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [D'Assoro, A. B.; Opyrchal, M.; Suman, V.; Billadeau, D.; Ingle, J.; Galanis, E.] Mayo Clin, Coll Med, Dept Med Oncol, Rochester, MN 55905 USA; [Amato, A.; Di Leonardo, A.] Dept Cellular & Dev Biol, Palermo, Italy; [Opyrchal, M.; Ikeda, Y.; Ohmine, S.; Iankov, I.; Galanis, E.] Mayo Clin, Coll Med, Dept Mol Med, Rochester, MN 55905 USA; [Leontovich, A.] Mayo Clin, Coll Med, Dept Biomed Stat & Informat, Rochester, MN 55905 USA; [Lingle, W.] Mayo Clin, Coll Med, Dept Expt Pathol, Rochester, MN 55905 USA; [Ecsedy, J.] Millennium Pharmaceut Inc, Dept Oncol, Cambridge, MA USA; [Degnim, A.] Mayo Clin, Coll Med, Dept Gen Surg, Rochester, MN 55905 USA; [McCubrey, J.] E Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Mayo Clinic; University of North Carolina; East Carolina University	D'Assoro, AB (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.	Dassoro.antonio@mayo.edu	Di Leonardo, Aldo/AAQ-4009-2021; Di Leonardo, Aldo/F-9833-2012; Amato, Angela/T-1221-2019	Di Leonardo, Aldo/0000-0003-4760-7179; Di Leonardo, Aldo/0000-0003-4760-7179; McCubrey, James/0000-0001-6027-3156; Salisbury, Jeffrey/0000-0001-9257-4578	NCI [CA72836]; USAMRMC [BC022276]; Intramural RECDA Award; Italian Association for Cancer Research (AIRC); Mayo Clinic Breast Cancer Specialized Program of Research Excellence NIH [CA116201]; Mayo Clinic School of Medicine; Atwater Foundation; NATIONAL CANCER INSTITUTE [P50CA116201, P30CA015083, R01CA072836] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); USAMRMC(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Intramural RECDA Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Mayo Clinic Breast Cancer Specialized Program of Research Excellence NIH; Mayo Clinic School of Medicine; Atwater Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NCI CA72836 to JLS, USAMRMC BC022276 and Intramural RECDA Award to ABD, the Italian Association for Cancer Research (AIRC) to AA, the Mayo Clinic Breast Cancer Specialized Program of Research Excellence NIH CA116201 to JI and the Mayo Clinic School of Medicine. This study was also supported by the Atwater Foundation. We also wish to acknowledge the Cytogenetic Shared Resource and TACMA core facilities of the Mayo Clinic Comprehensive Cancer Center for performing SKY, routine cytogenetic and immunohistochemistry analysis and assisting us with the interpretation of the results.	Abraham BK, 2005, CLIN CANCER RES, V11, P1154; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Basaran G, 2011, MED ONCOL, V28, P726, DOI 10.1007/s12032-010-9516-1; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Beavon IRG, 2000, EUR J CANCER, V36, P1607, DOI 10.1016/S0959-8049(00)00158-1; Chang CJ, 2011, CANCER CELL, V19, P86, DOI 10.1016/j.ccr.2010.10.035; Chang H, 2009, ANN ONCOL, V20, P272, DOI 10.1093/annonc/mdn624; D'Assoro AB, 2008, ONCOGENE, V27, P3901, DOI 10.1038/onc.2008.18; D'Assoro AB, 2004, ONCOGENE, V23, P4068, DOI 10.1038/sj.onc.1207568; D'Assoro AB, 2002, BREAST CANCER RES TR, V75, P25, DOI 10.1023/A:1016550619925; D'Assoro AB, 2010, INT J ONCOL, V37, P1167, DOI 10.3892/ijo_00000768; Davis JM, 2003, CLIN CANCER RES, V9, P1161; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Eralp Y, 2008, ANN ONCOL, V19, P669, DOI 10.1093/annonc/mdm522; Ghayad SE, 2010, INT J CANCER, V126, P545, DOI 10.1002/ijc.24750; Giatromanolaki A, 2011, MED ONCOL, V28, P745, DOI 10.1007/s12032-010-9530-3; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Hwang-Verslues WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008377; Jin W, 2003, BRIT J CANCER, V89, P185, DOI 10.1038/sj.bjc.6601048; Kerkhoff E, 2000, CELL GROWTH DIFFER, V11, P185; Kim ES, 2005, CYTOKINE, V29, P84, DOI 10.1016/j.cyto.2004.10.001; Kim IY, 2009, CANCER LETT, V275, P227, DOI 10.1016/j.canlet.2008.10.013; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Korkaya H, 2010, NAT CELL BIOL, V12, P419, DOI 10.1038/ncb0510-419; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marampon F, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-31; Murohashi M, 2010, BRIT J CANCER, V102, P206, DOI 10.1038/sj.bjc.6605468; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Roesler R, 2010, LANCET ONCOL, V11, P225, DOI 10.1016/S1470-2045(09)70404-8; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Strathdee G, 2002, SEMIN CANCER BIOL, V12, P373, DOI 10.1016/S1044-579X(02)00057-3; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Turley EA, 2008, NAT CLIN PRACT ONCOL, V5, P280, DOI 10.1038/ncponc1089; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Wendt MK, 2010, ONCOGENE, V29, P6485, DOI 10.1038/onc.2010.377; Whyte J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2361; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Yu DH, 2000, BIOESSAYS, V22, P673, DOI 10.1002/1521-1878(200007)22:7<673::AID-BIES10>3.0.CO;2-A; Yu XC, 2005, NAT GENET, V37, P401, DOI 10.1038/ng1538	44	87	88	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 30	2014	33	5					599	610		10.1038/onc.2012.628	http://dx.doi.org/10.1038/onc.2012.628			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA5GW	23334326	Green Accepted			2022-12-25	WOS:000331125100008
J	Do, TV; Xiao, F; Bickel, LE; Klein-Szanto, AJ; Pathak, HB; Hua, X; Howe, C; O'Brien, SW; Maglaty, M; Ecsedy, JA; Litwin, S; Golemis, EA; Schilder, RJ; Godwin, AK; Connolly, DC				Do, T-V; Xiao, F.; Bickel, L. E.; Klein-Szanto, A. J.; Pathak, H. B.; Hua, X.; Howe, C.; O'Brien, S. W.; Maglaty, M.; Ecsedy, J. A.; Litwin, S.; Golemis, E. A.; Schilder, R. J.; Godwin, A. K.; Connolly, D. C.			Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion	ONCOGENE			English	Article						Aurora kinase A; SRC; ovarian cancer; migration; alisertib; adhesion	SMALL-MOLECULE INHIBITOR; SUPPRESSES TUMOR-GROWTH; A KINASE; ANTITUMOR-ACTIVITY; IN-VIVO; OVEREXPRESSION; CARCINOMA; METASTASIS; ACTIVATION; EXPRESSION	Aurora kinase A (AURKA) localizes to centrosomes and mitotic spindles where it mediates mitotic progression and chromosomal stability. Overexpression of AURKA is common in cancer, resulting in acquisition of alternate non-mitotic functions. In the current study, we identified a novel role for AURKA in regulating ovarian cancer cell dissemination and evaluated the efficacy of an AURKA-selective small molecule inhibitor, alisertib (MLN8237), as a single agent and combined with paclitaxel using an orthotopic xenograft model of epithelial ovarian cancer (EOC). Ovarian carcinoma cell lines were used to evaluate the effects of AURKA inhibition and overexpression on migration and adhesion. Pharmacological or RNA interference-mediated inhibition of AURKA significantly reduced ovarian carcinoma cell migration and adhesion and the activation-associated phosphorylation of the cytoskeletal regulatory protein SRC at tyrosine 416 (pSRC(Y416)). Conversely, enforced expression of AURKA resulted in increased migration, adhesion and activation of SRC in cultured cells. In vivo tumor growth and dissemination were inhibited by alisertib treatment as a single agent. Moreover, combination of alisertib with paclitaxel, an agent commonly used in treatment of EOC, resulted in more potent inhibition of tumor growth and dissemination compared with either drug alone. Taken together, these findings support a role for AURKA in EOC dissemination by regulating migration and adhesion. They also point to the potential utility of combining AURKA inhibitors with taxanes as a therapeutic strategy for the treatment of EOC patients.	[Do, T-V; Xiao, F.; Bickel, L. E.; Pathak, H. B.; Howe, C.; Schilder, R. J.; Godwin, A. K.; Connolly, D. C.] Fox Chase Canc Ctr, Womens Canc Program, Philadelphia, PA 19111 USA; [Do, T-V; Pathak, H. B.; Godwin, A. K.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Xiao, F.; O'Brien, S. W.; Maglaty, M.; Golemis, E. A.; Connolly, D. C.] Fox Chase Canc Ctr, Dev Therapeut Program, Philadelphia, PA 19111 USA; [Klein-Szanto, A. J.] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Hua, X.] Fox Chase Canc Ctr, Transgen Facil, Philadelphia, PA 19111 USA; [Ecsedy, J. A.] Millennium Pharmaceut Inc, Dept Translat Med, Cambridge, MA USA; [Litwin, S.] Fox Chase Canc Ctr, Biostat Facil, Philadelphia, PA 19111 USA; [Schilder, R. J.] Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA; [Schilder, R. J.] Thomas Jefferson Univ, Dept Gynecol Med Oncol, Philadelphia, PA 19107 USA	Fox Chase Cancer Center; University of Kansas; University of Kansas Medical Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Fox Chase Cancer Center; Fox Chase Cancer Center; Jefferson University	Connolly, DC (corresponding author), Fox Chase Canc Ctr, Dev Therapeut Program, 333 Cottman Ave,W310, Philadelphia, PA 19111 USA.	Denise.Connolly@fccc.edu		Golemis, Erica/0000-0003-3618-3673	State of Pennsylvania; Fox Chase Cancer Center; Ovarian Cancer Research Fund Program of Excellence Award; Ovarian SPORE [P50 CA083638]; Fox Chase Cancer Center Core Grant [NCI P30 CA006927];  [R01 CA136596];  [R01 CA63366];  [R01 CA140323]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052027] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA063366, R01CA140323, R01CA136596, P30CA006927, P30CA056036, P50CA083638] Funding Source: NIH RePORTER	State of Pennsylvania; Fox Chase Cancer Center; Ovarian Cancer Research Fund Program of Excellence Award; Ovarian SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fox Chase Cancer Center Core Grant; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully acknowledge Dr Maureen Murphy and Dr Timothy Yen for helpful discussions and critical review of this manuscript. We also thank Dr Maureen Murphy for providing access to the Guava EasyCyte system, and Dr Greg Enders for providing access to the Nikon Eclipse microscope. This work was supported by R01 CA136596, Tobacco Settlement funding from the State of Pennsylvania and Fox Chase Cancer Center via institutional support of the Keystone Program in Personalized Risk and Prevention (to DCC); Ovarian Cancer Research Fund Program of Excellence Award (to TVD); Ovarian SPORE P50 CA083638 (Project 4 to DCC, AKG and EAG and Pilot Award to TVD); R01 CA63366 (to EAG); R01 CA140323 (to AKG); and the Fox Chase Cancer Center Core Grant NCI P30 CA006927. The following Fox Chase Cancer Facilities were used: Laboratory Animal, Transgenic, Cell Culture, Biological Imaging, Histopathology, Biosample Repository and Biostatistics and Bioinformatics.	Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chung CM, 2005, MOL CARCINOGEN, V43, P165, DOI 10.1002/mc.20098; Connolly DC, 2003, CANCER RES, V63, P1389; Connolly DC, 2009, CURR PROTOC PHARM, V45; Do TV, 2007, MOL CANCER RES, V5, P121, DOI 10.1158/1541-7786.MCR-06-0319; Feki A, 2009, CRIT REV ONCOL HEMAT, V72, P1, DOI 10.1016/j.critrevonc.2008.12.003; Gautschi O, 2008, CLIN CANCER RES, V14, P1639, DOI 10.1158/1078-0432.CCR-07-2179; Gritsko TM, 2003, CLIN CANCER RES, V9, P1420; Guan Z, 2007, CANCER RES, V67, P10436, DOI 10.1158/0008-5472.CAN-07-1379; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hata T, 2005, CANCER RES, V65, P2899, DOI 10.1158/0008-5472.CAN-04-3981; Hsu LC, 2005, INT J CANCER, V113, P746, DOI 10.1002/ijc.20633; Hu W, 2005, ONCOL RES, V15, P49, DOI 10.3727/096504005775082101; Huck JJ, 2010, MOL CANCER RES, V8, P373, DOI 10.1158/1541-7786.MCR-09-0300; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Komlodi-Pasztor E, 2012, CLIN CANCER RES, V18, P51, DOI 10.1158/1078-0432.CCR-11-0999; Landen CN, 2007, CLIN CANCER RES, V13, P4098, DOI 10.1158/1078-0432.CCR-07-0431; Lassmann S, 2007, CLIN CANCER RES, V13, P4083, DOI 10.1158/1078-0432.CCR-06-2775; Lassus H, 2011, GYNECOL ONCOL, V120, P11, DOI 10.1016/j.ygyno.2010.09.003; Lin YG, 2008, CLIN CANCER RES, V14, P5437, DOI 10.1158/1078-0432.CCR-07-4922; Luker KE, 2008, ANTIVIR RES, V78, P179, DOI 10.1016/j.antiviral.2008.01.158; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Manfredi MG, 2011, CLIN CANCER RES, V17, P7614, DOI 10.1158/1078-0432.CCR-11-1536; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; Matsuo K, 2010, ARCH GYNECOL OBSTET, V281, P325, DOI 10.1007/s00404-009-1121-1; Mazumdar A, 2009, HEAD NECK-J SCI SPEC, V31, P625, DOI 10.1002/hed.21007; Mortlock A, 2005, CURR TOP MED CHEM, V5, P199, DOI 10.2174/1568026053507651; O'Neill GM, 2007, CANCER RES, V67, P8975, DOI 10.1158/0008-5472.CAN-07-1328; Payton M, 2010, CANCER RES, V70, P9846, DOI 10.1158/0008-5472.CAN-10-3001; Pugacheva EN, 2006, CELL CYCLE, V5, P384, DOI 10.4161/cc.5.4.2439; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Ratushny V, 2012, ONCOGENE, V31, P1217, DOI 10.1038/onc.2011.314; Reiter R, 2006, CLIN CANCER RES, V12, P5136, DOI 10.1158/1078-0432.CCR-05-1650; Shimomura T, 2010, MOL CANCER THER, V9, P157, DOI 10.1158/1535-7163.MCT-09-0609; Swift S., 2001, CURRENT PROTOCOLS IM; Tan DSP, 2006, LANCET ONCOL, V7, P925, DOI 10.1016/S1470-2045(06)70939-1; Tanaka E, 2007, CLIN CANCER RES, V13, P1331, DOI 10.1158/1078-0432.CCR-06-1192; Tanner MM, 2000, CLIN CANCER RES, V6, P1833; Tatsuka M, 2005, ONCOGENE, V24, P1122, DOI 10.1038/sj.onc.1208293; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Tong T, 2004, CLIN CANCER RES, V10, P7304, DOI 10.1158/1078-0432.CCR-04-0806; Wan XB, 2008, CARCINOGENESIS, V29, P1930, DOI 10.1093/carcin/bgn176; Wu JC, 2005, J BIOL CHEM, V280, P9013, DOI 10.1074/jbc.M411068200; Wysong DR, 2009, CELL CYCLE, V8, P876, DOI 10.4161/cc.8.6.7897; Yang H, 2006, INT J CANCER, V119, P2304, DOI 10.1002/ijc.22154; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zhang H, 2012, EUR ARCH OTO-RHINO-L, V269, P607, DOI 10.1007/s00405-011-1629-4	52	76	77	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 30	2014	33	5					539	549		10.1038/onc.2012.632	http://dx.doi.org/10.1038/onc.2012.632			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA5GW	23334327	Green Accepted			2022-12-25	WOS:000331125100002
J	Manne, BK; Getz, TM; Hughes, CE; Alshehri, O; Dangelmaier, C; Naik, UP; Watson, SP; Kunapuli, SP				Manne, Bhanu Kanth; Getz, Todd M.; Hughes, Craig E.; Alshehri, Osama; Dangelmaier, Carol; Naik, Ulhas P.; Watson, Steve P.; Kunapuli, Satya P.			Fucoidan Is a Novel Platelet Agonist for the C-type Lectin-like Receptor 2 (CLEC-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT FUCOIDAN; COLLAGEN RECEPTOR; GLYCOPROTEIN-VI; TYROSINE PHOSPHORYLATION; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; GAMMA-CHAIN; P-SELECTIN; A-BETA; SYK	Fucoidan, a sulfated polysaccharide from Fucus vesiculosus, decreases bleeding time and clotting time in hemophilia, possibly through inhibition of tissue factor pathway inhibitor. However, its effect on platelets and the receptor by which fucoidan induces cellular processes has not been elucidated. In this study, we demonstrate that fucoidan induces platelet activation in a concentration-dependent manner. Fucoidan-induced platelet activation was completely abolished by the pan-Src family kinase (SFK) inhibitor, PP2, or when Syk is inhibited. PP2 abolished phosphorylations of Syk and Phospholipase C-gamma 2. Fucoidan-induced platelet activation had a lag phase, which is reminiscent of platelet activation by collagen and CLEC-2 receptor agonists. Platelet activation by fucoidan was only slightly inhibited in FcR gamma-chain null mice, indicating that fucoidan was not acting primarily through GPVI receptor. On the other hand, fucoidan-induced platelet activation was inhibited in platelet-specific CLEC-2 knock-out murine platelets revealing CLEC-2 as a physiological target of fucoidan. Thus, our data show fucoidan as a novel CLEC-2 receptor agonist that activates platelets through a SFK-dependent signaling pathway. Furthermore, the efficacy of fucoidan in hemophilia raises the possibility that decreased bleeding times could be achieved through activation of platelets.	[Manne, Bhanu Kanth; Getz, Todd M.; Dangelmaier, Carol; Kunapuli, Satya P.] Temple Univ, Dept Physiol, Sch Med, Philadelphia, PA 19140 USA; [Manne, Bhanu Kanth; Getz, Todd M.; Dangelmaier, Carol; Kunapuli, Satya P.] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19140 USA; [Kunapuli, Satya P.] Temple Univ, Sol Sherry Thrombosis Res Ctr, Sch Med, Philadelphia, PA 19140 USA; [Hughes, Craig E.; Alshehri, Osama; Watson, Steve P.] Univ Birmingham, Ctr Cardiovasc Sci, Inst Biomed Res, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Naik, Ulhas P.] Univ Delaware, Cardiovasc Res Inst, Newark, DE 19716 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Birmingham; University of Delaware	Kunapuli, SP (corresponding author), Temple Univ, Dept Physiol, Rm 403 MRB,3420 N Broad St, Philadelphia, PA 19140 USA.	spk@temple.edu	Watson, Stephen P/Q-6292-2016	Watson, Stephen P/0000-0002-7846-7423; Hughes, Craig/0000-0002-9790-5820	National Institutes of Health [HL60683, HL93231]; National Institutes of Health Training Grant in Thrombosis [HL07777]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093231, T32HL007777, R01HL060683] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant in Thrombosis(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by Grants HL60683 and HL93231 from the National Institutes of Health (to S. P. K.).; Supported by National Institutes of Health Training Grant in Thrombosis HL07777.	Bhavaraju K, 2008, EUR J PHARMACOL, V580, P285, DOI 10.1016/j.ejphar.2007.11.009; Brandenburg LO, 2010, J NEUROCHEM, V113, P749, DOI 10.1111/j.1471-4159.2010.06637.x; Brass L, 2010, HEMATOL-AM SOC HEMAT, P387, DOI 10.1182/asheducation-2010.1.387; Broos K, 2012, THROMB RES, V129, P245, DOI 10.1016/j.thromres.2011.11.002; Christou CM, 2008, BIOCHEM J, V411, P133, DOI 10.1042/BJ20071216; Clemetson KJ, 2012, THROMB RES, V129, P220, DOI 10.1016/j.thromres.2011.11.036; Colonna M, 2000, EUR J IMMUNOL, V30, P697; Durand E, 2008, J VASC RES, V45, P529, DOI 10.1159/000129687; Durig J, 1997, THROMB RES, V85, P479, DOI 10.1016/S0049-3848(97)00037-6; Ezumi Y, 1998, J EXP MED, V188, P267, DOI 10.1084/jem.188.2.267; Finney BA, 2012, BLOOD, V119, P1747, DOI 10.1182/blood-2011-09-380709; Francischetti IMB, 1997, TOXICON, V35, P1217, DOI 10.1016/S0041-0101(97)00021-4; Gao YL, 2012, ENVIRON TOXICOL PHAR, V33, P304, DOI 10.1016/j.etap.2011.12.022; Getz TM, 2011, J THROMB HAEMOST, V9, P608, DOI 10.1111/j.1538-7836.2011.04192.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hooley E, 2008, BIOCHEMISTRY-US, V47, P7831, DOI 10.1021/bi800528t; Hsu HY, 2001, J BIOL CHEM, V276, P28719, DOI 10.1074/jbc.M011117200; Hughes CE, 2008, J THROMB HAEMOST, V6, P2152, DOI 10.1111/j.1538-7836.2008.03166.x; Hughes CE, 2010, BLOOD, V115, P2947, DOI 10.1182/blood-2009-08-237834; Jarvis GE, 2002, BRIT J PHARMACOL, V137, P107, DOI 10.1038/sj.bjp.0704834; Jhamandas JH, 2005, EUR J NEUROSCI, V21, P2649, DOI 10.1111/j.1460-9568.2005.04111.x; Kawasaki Tomihisa, 2006, Folia Pharmacologica Japonica, V128, P23, DOI 10.1254/fpj.128.23; KOEDAM JA, 1992, J CELL BIOL, V116, P617, DOI 10.1083/jcb.116.3.617; Li ZY, 2010, J BIOL CHEM, V285, P12559, DOI 10.1074/jbc.M109.098756; Liu TY, 2006, THROMB HAEMOSTASIS, V95, P68, DOI 10.1160/TH05-05-0361; May F, 2009, BLOOD, V114, P3464, DOI 10.1182/blood-2009-05-222273; Mazurov AV, 1996, EUR J HAEMATOL, V57, P38; Millet J, 1999, THROMB HAEMOSTASIS, V81, P391; PACKHAM MA, 1994, CAN J PHYSIOL PHARM, V72, P278, DOI 10.1139/y94-043; Pasquet JM, 1999, MOL CELL BIOL, V19, P8326; Prasad S, 2008, BLOOD, V111, P672, DOI 10.1182/blood-2007-07-098913; Shankar H, 2006, J THROMB HAEMOST, V4, P638, DOI 10.1111/j.1538-7836.2006.01789.x; SHUMAN MA, 1978, J CLIN INVEST, V61, P1102, DOI 10.1172/JCI109010; Sobanov Y, 2001, EUR J IMMUNOL, V31, P3493, DOI 10.1002/1521-4141(200112)31:12<3493::AID-IMMU3493>3.0.CO;2-9; Spalton JC, 2009, J THROMB HAEMOST, V7, P1192, DOI 10.1111/j.1538-7836.2009.03451.x; Speich HE, 2008, AM J PHYSIOL-CELL PH, V295, pC1045, DOI 10.1152/ajpcell.90644.2007; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2004, BIOCHEM J, V378, P1023, DOI 10.1042/BJ20031430; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Suzuki-Inoue K, 2011, J BIOCHEM, V150, P127, DOI 10.1093/jb/mvr079; Trento F, 2001, THROMB RES, V102, P457, DOI 10.1016/S0049-3848(01)00264-X; Tsuji M, 1997, J BIOL CHEM, V272, P23528, DOI 10.1074/jbc.272.38.23528; Uemura T, 2006, BRIT J PHARMACOL, V148, P61, DOI 10.1038/sj.bjp.0706711; Watson AA, 2008, PROTEIN SCI, V17, P1611, DOI 10.1110/ps.035568.108; Watson AA, 2011, TOXINS, V3, P991, DOI 10.3390/toxins3080991; Watson AA, 2009, BIOCHEMISTRY-US, V48, P10988, DOI 10.1021/bi901427d; Watson SP, 2010, J THROMB HAEMOST, V8, P1457, DOI 10.1111/j.1538-7836.2010.03875.x; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; ZIMMERMAN TS, 1985, CLIN HAEMATOL, V14, P343; ZIMMERMAN TS, 1971, J CLIN INVEST, V50, P244, DOI 10.1172/JCI106480	50	43	46	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7717	7726		10.1074/jbc.M112.424473	http://dx.doi.org/10.1074/jbc.M112.424473			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23341451	Green Published, hybrid			2022-12-25	WOS:000316455300028
J	Ngok, SP; Geyer, R; Kourtidis, A; Storz, P; Anastasiadis, PZ				Ngok, Siu P.; Geyer, Rory; Kourtidis, Antonis; Storz, Peter; Anastasiadis, Panos Z.			Phosphorylation-mediated 14-3-3 Protein Binding Regulates the Function of the Rho-specific Guanine Nucleotide Exchange Factor (RhoGEF) Syx	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; P120 CATENIN; KINASE-D; GTPASES; POLARITY; COMPLEX; GEF; 14-3-3-PROTEINS; JUNCTIONS; MOTILITY	Syx is a Rho-specific guanine nucleotide exchange factor (GEF) that localizes at cell-cell junctions and promotes junction stability by activating RhoA and the downstream effector Diaphanous homolog 1 (Dia1). Previously, we identified several molecules, including 14-3-3 proteins, as Syx-interacting partners. In the present study, we show that 14-3-3 isoforms interact with Syx at both its N- and C-terminal regions in a phosphorylation-dependent manner. We identify the protein kinase D-mediated phosphorylation of serine 92 on Syx, and additional phosphorylation at serine 938, as critical sites for 14-3-3 association. Our data indicate that the binding of 14-3-3 proteins inhibits the GEF activity of Syx. Furthermore, we show that phosphorylation-deficient, 14-3-3-uncoupled Syx exhibits increased junctional targeting and increased GEF activity, resulting in the strengthening of the circumferential junctional actin ring in Madin-Darby canine kidney cells. These findings reveal a novel means of regulating junctional Syx localization and function by phosphorylation-induced 14-3-3 binding and further support the importance of Syx function in maintaining stable cell-cell contacts.	[Ngok, Siu P.; Geyer, Rory; Kourtidis, Antonis; Storz, Peter; Anastasiadis, Panos Z.] Mayo Clin, Dept Canc Biol, Ctr Comprehens Canc, Jacksonville, FL 32224 USA	Mayo Clinic	Anastasiadis, PZ (corresponding author), Dept Canc Biol, Griffin Canc Res Bldg,Rm 307,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	anastasiadis.panos@mayo.edu		Kourtidis, Antonis/0000-0002-8128-6391	National Institutes of Health [R01 NS069753, R21 NS070117, R01 GM086435, 10BG11]; Mayo Graduate School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069753, R21NS070117] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Graduate School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS069753 and R21 NS070117 (to P. Z. A.) and R01 GM086435 and 10BG11 (to P. S.). This work was also supported by the Mayo Graduate School (to S. P. N.).	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955-0674(02)00373-3; Carramusa L, 2007, J CELL SCI, V120, P3870, DOI 10.1242/jcs.014365; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; De Toledo M, 2001, ONCOGENE, V20, P7307, DOI 10.1038/sj.onc.1204921; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874; Estevez MA, 2008, J NEUROCHEM, V106, P1287, DOI 10.1111/j.1471-4159.2008.05472.x; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Garnaas MK, 2008, CIRC RES, V103, P710, DOI 10.1161/CIRCRESAHA.108.181388; Hurd TW, 2003, CURR BIOL, V13, P2082, DOI 10.1016/j.cub.2003.11.020; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Ling C, 2010, GENE DEV, V24, P947, DOI 10.1101/gad.1896810; Liu ML, 2006, MOL BIOL CELL, V17, P1880, DOI 10.1091/mbc.E06-01-0002; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Ngok SP, 2012, J CELL BIOL, V199, P1103, DOI 10.1083/jcb.201207009; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Ryu JR, 2009, MOL CELL BIOL, V29, P1735, DOI 10.1128/MCB.01483-08; Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Tzivion G, 2006, SEMIN CANCER BIOL, V16, P203, DOI 10.1016/j.semcancer.2006.03.004; Wood NT, 2009, FEBS LETT, V583, P615, DOI 10.1016/j.febslet.2009.01.003; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yanagisawa M, 2008, J BIOL CHEM, V283, P18344, DOI 10.1074/jbc.M801192200; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022	29	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6640	6650		10.1074/jbc.M112.432682	http://dx.doi.org/10.1074/jbc.M112.432682			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23335514	Green Published, hybrid			2022-12-25	WOS:000315820700063
J	Theis, T; Mishra, B; von der Ohe, M; Loers, G; Prondzynski, M; Pless, O; Blackshear, PJ; Schachner, M; Kleene, R				Theis, Thomas; Mishra, Bibhudatta; von der Ohe, Maren; Loers, Gabriele; Prondzynski, Maksymilian; Pless, Ole; Blackshear, Perry J.; Schachner, Melitta; Kleene, Ralf			Functional Role of the Interaction between Polysialic Acid and Myristoylated Alanine-rich C Kinase Substrate at the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; MICE DEFICIENT; PSA-NCAM; PHOSPHOLIPID-MEMBRANES; CALMODULIN-BINDING; NEURITE OUTGROWTH; MARCKS DEFICIENCY; MUTANT MICE	Polysialic acid (PSA) is a homopolymeric glycan that plays crucial roles in the developing and adult nervous system. So far only a few PSA-binding proteins have been identified. Here, we identify myristoylated alanine-rich C kinase substrate (MARCKS) as novel PSA binding partner. Binding assays showed a direct interaction between PSA and a peptide comprising the effector domain of MARCKS (MARCKS-ED). Co-immunoprecipitation of PSA-carrying neural cell adhesion molecule (PSA-NCAM) with MARCKS and co-immunostaining of MARCKS and PSA at the cell membrane of hippocampal neurons confirm the interaction between PSA and MARCKS. Co-localization and an intimate interaction of PSA and MARCKS at the cell surface was seen by confocal microscopy and fluorescence resonance energy transfer (FRET) analysis after the addition of fluorescently labeled PSA or PSA-NCAM to live CHO cells or hippocampal neurons expressing MARCKS as a fusion protein with green fluorescent protein (GFP). Cross-linking experiments showed that extracellularly applied PSA or PSA-NCAM and intracellularly expressed MARCKS-GFP are in close contact, suggesting that PSA and MARCKS interact with each other at the plasma membrane from opposite sides. Insertion of PSA and MARCKS-ED peptide into lipid bilayers from opposite sides alters the electric properties of the bilayer confirming the notion that PSA and the effector domain of MARCKS interact at and/or within the plane of the membrane. The MARCKS-ED peptide abolished PSA-induced enhancement of neurite outgrowth from cultured hippocampal neurons indicating an important functional role for the interaction between MARCKS and PSA in the developing and adult nervous system.	[Theis, Thomas; Mishra, Bibhudatta; von der Ohe, Maren; Loers, Gabriele; Schachner, Melitta; Kleene, Ralf] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Schachner, Melitta] Shantou Univ, Ctr Neurosci, Coll Med, Shantou 515041, Peoples R China; [Blackshear, Perry J.] Duke Univ, Dept Med, Durham, NC 27709 USA; [Blackshear, Perry J.] Duke Univ, Dept Biochem, Durham, NC 27709 USA; [Blackshear, Perry J.] NIEHS, Lab Signal Transduct, NIH, Dept Hlth & Human Serv, Bethesda, MD USA; [Prondzynski, Maksymilian; Pless, Ole] European Screening Port GmbH, D-22525 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Shantou University; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Schachner, M (corresponding author), Shantou Univ, Ctr Neurosci, Coll Med, 22 Xin Ling Rd, Shantou 515041, Peoples R China.	schachner@stu.edu.cn	Theis, Thomas/I-4247-2019; Prondzynski, Maksymilian/AAB-5907-2021; Pless, Ole/E-8348-2016; Blackshear, Perry J./C-6206-2019	Theis, Thomas/0000-0001-5555-8501; Prondzynski, Maksymilian/0000-0002-6846-6435; Pless, Ole/0000-0002-1468-316X; Blackshear, Perry J./0000-0002-9561-8529	New Jersey Commission for Spinal Cord Research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080] Funding Source: NIH RePORTER	New Jersey Commission for Spinal Cord Research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by the New Jersey Commission for Spinal Cord Research and a consultant at the Center for Neuroscience at Shantou University Medical College, China. To whom correspondence should be addressed: Center for Neuroscience, Shantou University Medical College, 22 Xin Ling Road, Shantou 515041, China. Tel.: 86-754-88900276; Fax: 86 754 88900236; E-mail: schachner@stu.edu.cn.	ALBERT KA, 1987, P NATL ACAD SCI USA, V84, P7046, DOI 10.1073/pnas.84.20.7046; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Becker CG, 1996, J NEUROSCI RES, V45, P143, DOI 10.1002/(SICI)1097-4547(19960715)45:2<143::AID-JNR6>3.0.CO;2-A; BRISSON JR, 1992, BIOCHEMISTRY-US, V31, P4996, DOI 10.1021/bi00136a012; Brocco MA, 2006, FEBS LETT, V580, P4723, DOI 10.1016/j.febslet.2006.07.058; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Cremer H, 1998, P NATL ACAD SCI USA, V95, P13242, DOI 10.1073/pnas.95.22.13242; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; FigarellaBranger D, 1996, J CLIN ONCOL, V14, P2066, DOI 10.1200/JCO.1996.14.7.2066; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; GASCARD P, 1991, BIOCHIM BIOPHYS ACTA, V1069, P27, DOI 10.1016/0005-2736(91)90100-M; Gatlin JC, 2006, MOL BIOL CELL, V17, P5115, DOI 10.1091/mbc.E05-12-1183; GRAFF JM, 1989, J BIOL CHEM, V264, P21818; Hammond MSL, 2006, J BIOL CHEM, V281, P34859, DOI 10.1074/jbc.M602568200; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; Hussain RJ, 2006, HIPPOCAMPUS, V16, P495, DOI 10.1002/hipo.20177; Janas T, 2001, ACTA BIOCHIM POL, V48, P163; Janas T, 2000, EUR BIOPHYS J BIOPHY, V29, P507, DOI 10.1007/s002490000097; Janas T, 2010, CHEM PHYS LIPIDS, V163, P286, DOI 10.1016/j.chemphyslip.2009.12.003; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Kanato Y, 2008, GLYCOBIOLOGY, V18, P1044, DOI 10.1093/glycob/cwn084; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kochlamazashvili G, 2010, J NEUROSCI, V30, P4171, DOI 10.1523/JNEUROSCI.5806-09.2010; Kwiatkowska K, 2010, CELL MOL LIFE SCI, V67, P3927, DOI 10.1007/s00018-010-0432-5; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Li HM, 2008, MOL BIOL CELL, V19, P4804, DOI 10.1091/mbc.E08-03-0294; Li J, 2011, GLYCOBIOLOGY, V21, P1010, DOI 10.1093/glycob/cwr020; LOBAUGH LA, 1990, J BIOL CHEM, V265, P18393; Loers G, 2012, J NEUROSCI, V32, P3917, DOI 10.1523/JNEUROSCI.6165-11.2012; Makhina T, 2009, MOL CELL NEUROSCI, V41, P206, DOI 10.1016/j.mcn.2009.02.010; Markram K, 2007, NEUROSCIENCE, V144, P788, DOI 10.1016/j.neuroscience.2006.10.024; McNamara RK, 2005, HIPPOCAMPUS, V15, P675, DOI 10.1002/hipo.20089; McNamara RK, 1998, J COMP NEUROL, V397, P337; McNamara RK, 1998, P NATL ACAD SCI USA, V95, P14517, DOI 10.1073/pnas.95.24.14517; Mehanna A, 2009, BRAIN, V132, P1449, DOI 10.1093/brain/awp128; MICHON F, 1987, BIOCHEMISTRY-US, V26, P8399, DOI 10.1021/bi00399a055; Mishra B, 2010, J NEUROSCI, V30, P12400, DOI 10.1523/JNEUROSCI.6407-09.2010; Muhlenhoff M, 1998, CURR OPIN STRUC BIOL, V8, P558, DOI 10.1016/S0959-440X(98)80144-9; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Ono S, 2012, J BIOL CHEM, V287, P3710, DOI 10.1074/jbc.M111.276618; Qin ZH, 1996, BIOCHEMISTRY-US, V35, P2917, DOI 10.1021/bi9521452; Ronn LCB, 2000, INT J DEV NEUROSCI, V18, P193, DOI 10.1016/S0736-5748(99)00088-X; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Seki T, 1998, J NEUROSCI, V18, P3757; Senkov O, 2006, J NEUROSCI, V26, P10888, DOI 10.1523/JNEUROSCI.0878-06.2006; Senkov O, 2012, INT J BIOCHEM CELL B, V44, P591, DOI 10.1016/j.biocel.2012.01.008; Shiraishi M, 2006, J CELL PHYSIOL, V209, P1029, DOI 10.1002/jcp.20814; Solomonia RO, 2008, EXP BRAIN RES, V188, P323, DOI 10.1007/s00221-008-1428-3; Spizz G, 2001, J BIOL CHEM, V276, P32264, DOI 10.1074/jbc.M103960200; Stoenica L, 2006, EUR J NEUROSCI, V23, P2255, DOI 10.1111/j.1460-9568.2006.04771.x; Strekalova H, 2006, NEUROBIOL AGING, V27, P1, DOI 10.1016/j.neurobiolaging.2004.11.013; STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944; SWIERCZYNSKI SL, 1995, J BIOL CHEM, V270, P13436, DOI 10.1074/jbc.270.22.13436; Swierczynski SL, 1996, DEV BIOL, V179, P135, DOI 10.1006/dbio.1996.0246; Timofeeva OA, 2010, BRAIN RES, V1308, P147, DOI 10.1016/j.brainres.2009.10.040; Vaithianathan T, 2004, J BIOL CHEM, V279, P47975, DOI 10.1074/jbc.M407138200; Venero C, 2006, EUR J NEUROSCI, V23, P1585, DOI 10.1111/j.1460-9568.2006.04663.x; Vergeres G, 1998, BIOCHEM J, V330, P5, DOI 10.1042/bj3300005; Victor K, 1999, BIOCHEMISTRY-US, V38, P12527, DOI 10.1021/bi990847b; Vutskits L, 2001, EUR J NEUROSCI, V13, P1391, DOI 10.1046/j.0953-816x.2001.01516.x; Watterson JM, 2002, BRAIN RES, V934, P69, DOI 10.1016/S0006-8993(02)02362-4; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yamaguchi H, 2009, J CELL PHYSIOL, V220, P748, DOI 10.1002/jcp.21822	72	33	37	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6726	6742		10.1074/jbc.M112.444034	http://dx.doi.org/10.1074/jbc.M112.444034			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23329829	Green Published, hybrid			2022-12-25	WOS:000315820700070
J	Li, YQ; Yan, JP; Xu, WL; Wang, H; Xia, YJ; Wang, HJ; Zhu, YY; Huang, XJ				Li, Ya-qing; Yan, Jian-ping; Xu, Wu-lin; Wang, Hong; Xia, Ying-jie; Wang, Hui-jun; Zhu, Yue-yan; Huang, Xiao-jun			ADAM17 Mediates MMP9 Expression in Lung Epithelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; MATRIX METALLOPROTEINASES; TNF-ALPHA; LENTIVIRAL VECTORS; MATRIX-METALLOPROTEINASE-9; ACTIVATION; DEGRADATION; EMPHYSEMA; SERUM	The purposes were to study the role of lipopolysaccharide (LPS)-induced tumor necrosis factor (TNF)-alpha/nuclear factor-kappa B (NF-kappa B) signaling in matrix metalloproteinase 9 (MMP9) expression in A549 cells and to investigate the effects of lentivirus-mediated RNAi targeting of the disintegrin and metalloproteinase 17 (ADAM17) gene on LPS-induced MMP9 expression. MMP9 expression induced by LPS in A549 cells was significantly increased in a dose-and time-dependent manner (p < 0.05). Pyrrolidine dithiocarbamate (PDTC) and a TNFR1 blocking peptide (TNFR1BP) significantly inhibited LPS-induced MMP9 expression in A549 cells (p < 0.05). TNFR1BP significantly inhibited LPS-induced TNF-alpha production (p < 0.05). Both PDTC and TNFR1BP significantly inhibited the phosphorylation of I kappa B alpha and expression of phosphorylation p65 protein in response to LPS (p < 0.05), and the level of I kappa B alpha in the cytoplasm was significantly increased (p < 0.05). Lentivirus mediated RNA interference (RNAi) significantly inhibited ADAM17 expression in A549 cells. Lentivirus-mediated RNAi targeting of ADAM17 significantly inhibited TNF-alpha production in the supernatants (p < 0.05), whereas the level of TNF-alpha in the cells was increased (p < 0.05). Lentiviral ADAM17 RNAi inhibited MMP9 expression, I kappa B alpha phosphorylation and the expression of phosphorylation p65 protein in response to LPS (p < 0.05). PDTC significantly inhibited the expression of MMP9 and the phosphorylation of I kappa B alpha, as well as the expression of phosphorylation p65 protein in response to TNF-alpha (p < 0.05). Lentiviral RNAi targeting of ADAM17 down-regulates LPS-induced MMP9 expression in lung epithelial cells via inhibition of TNF-alpha/NF-kappa B signaling.	[Li, Ya-qing; Yan, Jian-ping; Xu, Wu-lin; Wang, Hong; Zhu, Yue-yan; Huang, Xiao-jun] Zhejiang Prov Peoples Hosp, Dept Resp Med, Hangzhou, Zhejiang, Peoples R China; [Xia, Ying-jie; Wang, Hui-jun] Zhejiang Prov Peoples Hosp, Zhejiang Prov Gastroenterol Key Lab, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial People's Hospital; Zhejiang Provincial People's Hospital	Xu, WL (corresponding author), Zhejiang Prov Peoples Hosp, Dept Resp Med, Hangzhou, Zhejiang, Peoples R China.	wulinxu@126.com	wang, huimin/HDM-8421-2022; wang, hui/GRS-4730-2022		National Natural Science Foundation of China [No_81000016]; Medical Science Foundation of Zhejiang Province [No_2008B007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Science Foundation of Zhejiang Province	This work was supported by grants from the National Natural Science Foundation of China (No_81000016) and the Medical Science Foundation of Zhejiang Province (No_2008B007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2011, J BIOL CHEM, V286, P20054, DOI 10.1074/jbc.M111.249326; Baud V, 2011, CURR TOP MICROBIOL, V349, P97, DOI 10.1007/82_2010_101; Bellayr IH, 2009, FUTURE MED CHEM, V1, P1095, DOI 10.4155/FMC.09.83; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Brajer B, 2008, J PHYSIOL PHARMACOL, V59, P145; Davey A, 2011, EUR RESPIR J, V38, P959, DOI 10.1183/09031936.00032111; Deshmukh HS, 2008, AM J RESP CELL MOL, V38, P446, DOI 10.1165/rcmb.2006-0339OC; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Foronjy R, 2008, AM J PHYSIOL-LUNG C, V294, pL1149, DOI 10.1152/ajplung.00481.2007; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Higashimoto Y, 2009, RESP MED, V103, P1231, DOI 10.1016/j.rmed.2009.01.021; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Johnson C, 1999, EMBO J, V18, P6682, DOI 10.1093/emboj/18.23.6682; Kanarek N, 2012, IMMUNOL REV, V246, P77, DOI 10.1111/j.1600-065X.2012.01098.x; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; Kollias G, 2002, CYTOKINE GROWTH F R, V13, P315, DOI 10.1016/S1359-6101(02)00019-9; Lee SO, 2006, BIOCHEM BIOPH RES CO, V351, P118, DOI 10.1016/j.bbrc.2006.10.006; Legrand C, 1999, J CELL BIOL, V146, P517, DOI 10.1083/jcb.146.2.517; Li YQ, 2006, ACTA PHARMACOL SIN, V27, P339, DOI 10.1111/j.1745-7254.2006.00264.x; Maclay JD, 2012, THORAX, V67, P606, DOI 10.1136/thoraxjnl-2011-200949; Martin TR, 2000, AM J RESP CELL MOL, V23, P128, DOI 10.1165/ajrcmb.23.2.f189; Mohan MJ, 2002, BIOCHEMISTRY-US, V41, P9462, DOI 10.1021/bi0260132; Mukhopadhyay S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-125; Ramos C, 2009, INHAL TOXICOL, V21, P119, DOI 10.1080/08958370802419145 ; Schambach A, 2008, CURR GENE THER, V8, P474, DOI 10.2174/156652308786848049; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Singer O, 2008, CURR GENE THER, V8, P483, DOI 10.2174/156652308786848067; Takizawa Toshihiro, 2010, Journal of Nippon Medical School, V77, P71; van Gestel Arnoldus J R, 2010, J Thorac Dis, V2, P215, DOI 10.3978/j.issn.2072-1439.2010.02.04.5; Vernooy JHJ, 2004, CHEST, V126, P1802, DOI 10.1378/chest.126.6.1802; Vlahos R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033277; Wright C, 2011, AM J PHYSIOL-LUNG C, V301, pL575, DOI 10.1152/ajplung.00226.2010; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Zheng YF, 2004, J BIOL CHEM, V279, P42898, DOI 10.1074/jbc.M403193200	34	14	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e51701	10.1371/journal.pone.0051701	http://dx.doi.org/10.1371/journal.pone.0051701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341882	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400004
J	Melo, CV; Mele, M; Curcio, M; Comprido, D; Silva, CG; Duarte, CB				Melo, Carlos V.; Mele, Miranda; Curcio, Michele; Comprido, Diogo; Silva, Carla G.; Duarte, Carlos B.			BDNF Regulates the Expression and Distribution of Vesicular Glutamate Transporters in Cultured Hippocampal Neurons	PLOS ONE			English	Article							LONG-TERM POTENTIATION; INORGANIC-PHOSPHATE COTRANSPORTER; DISTINCT SIGNALING PATHWAYS; DENDRITIC SPINE FORMATION; FIBROBLAST-GROWTH-FACTOR; OCCURRING CELL-DEATH; PROTEIN-KINASE-II; NEUROTROPHIC FACTOR; TRKB RECEPTORS; QUANTAL SIZE	BDNF is a pro-survival protein involved in neuronal development and synaptic plasticity. BDNF strengthens excitatory synapses and contributes to LTP, presynaptically, through enhancement of glutamate release, and postsynaptically, via phosphorylation of neurotransmitter receptors, modulation of receptor traffic and activation of the translation machinery. We examined whether BDNF upregulated vesicular glutamate receptor (VGLUT) 1 and 2 expression, which would partly account for the increased glutamate release in LTP. Cultured rat hippocampal neurons were incubated with 100 ng/ml BDNF, for different periods of time, and VGLUT gene and protein expression were assessed by real-time PCR and immunoblotting, respectively. At DIV7, exogenous application of BDNF rapidly increased VGLUT2 mRNA and protein levels, in a dose-dependent manner. VGLUT1 expression also increased but only transiently. However, at DIV14, BDNF stably increased VGLUT1 expression, whilst VGLUT2 levels remained low. Transcription inhibition with actinomycin-D or alpha-amanitine, and translation inhibition with emetine or anisomycin, fully blocked BDNF-induced VGLUT upregulation. Fluorescence microscopy imaging showed that BDNF stimulation upregulates the number, integrated density and intensity of VGLUT1 and VGLUT2 puncta in neurites of cultured hippocampal neurons (DIV7), indicating that the neurotrophin also affects the subcellular distribution of the transporter in developing neurons. Increased VGLUT1 somatic signals were also found 3 h after stimulation with BDNF, further suggesting an increased de novo transcription and translation. BDNF regulation of VGLUT expression was specifically mediated by BDNF, as no effect was found upon application of IGF-1 or bFGF, which activate other receptor tyrosine kinases. Moreover, inhibition of TrkB receptors with K252a and PLC gamma signaling with U-73122 precluded BDNF-induced VGLUT upregulation. Hippocampal neurons express both isoforms during embryonic and neonatal development in contrast to adult tissue expressing only VGLUT1. These results suggest that BDNF regulates VGLUT expression during development and its effect on VGLUT1 may contribute to enhance glutamate release in LTP.	[Melo, Carlos V.; Mele, Miranda; Curcio, Michele; Comprido, Diogo; Silva, Carla G.; Duarte, Carlos B.] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Curcio, Michele] Univ Sannio, Dept Biol & Environm Sci, Benevento, Italy; [Duarte, Carlos B.] Univ Coimbra, Dept Life Sci, Coimbra, Portugal	Universidade de Coimbra; University of Sannio; Universidade de Coimbra	Duarte, CB (corresponding author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal.	cbduarte@ci.uc.pt	Mele, Miranda/L-7788-2014; Duarte, Carlos B/K-6358-2013	Mele, Miranda/0000-0002-8627-4883; Duarte, Carlos B/0000-0002-1474-0208; Silva, Carla Sofia Gomes/0000-0002-1265-7531; Vieira Melo, Carlos/0000-0001-5392-1258	FCT (Fundacao para a Ciencia e a Tecnologia); FEDER (Fundo Europeu de Desenvolvimento Regional, Portugal) [PTDC/SAU-NMC/120144/2010, PTDC/SAU-NEU/104297/2008]	FCT (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology); FEDER (Fundo Europeu de Desenvolvimento Regional, Portugal)	FCT (Fundacao para a Ciencia e a Tecnologia) and FEDER (Fundo Europeu de Desenvolvimento Regional, Portugal) (grants PTDC/SAU-NMC/120144/2010 and PTDC/SAU-NEU/104297/2008) funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara Y, 2000, J NEUROCHEM, V74, P2622, DOI 10.1046/j.1471-4159.2000.0742622.x; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Amaral MD, 2007, J NEUROSCI, V27, P5179, DOI 10.1523/JNEUROSCI.5499-06.2007; Amaral MD, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/203536; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Balschun D, 2010, CEREB CORTEX, V20, P684, DOI 10.1093/cercor/bhp133; Bamji SX, 2006, J CELL BIOL, V174, P289, DOI 10.1083/jcb.200601087; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Butts BD, 2005, MOL CELL NEUROSCI, V30, P279, DOI 10.1016/j.mcn.2005.07.011; Caldeira MV, 2007, MOL CELL NEUROSCI, V35, P208, DOI 10.1016/j.mcn.2007.02.019; Caldeira MV, 2007, J BIOL CHEM, V282, P12619, DOI 10.1074/jbc.M700607200; Chen GQ, 1999, J NEUROSCI, V19, P7983; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Crozier RA, 1999, LEARN MEMORY, V6, P257; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; Dal Bo G, 2008, NEUROSCIENCE, V156, P59, DOI 10.1016/j.neuroscience.2008.07.032; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; Datta R, 1997, J BIOL CHEM, V272, P20317, DOI 10.1074/jbc.272.33.20317; Dorsey SG, 2002, J NEUROSCI, V22, P2571, DOI 10.1523/JNEUROSCI.22-07-02571.2002; Du JL, 2004, NATURE, V429, P878, DOI 10.1038/nature02618; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; FERRER I, 1990, NEUROSCIENCE, V39, P451, DOI 10.1016/0306-4522(90)90281-8; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; Gartner A, 2006, J NEUROSCI, V26, P3496, DOI 10.1523/JNEUROSCI.3792-05.2006; Giralt A, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-71; Gomes RA, 2006, J NEUROSCI, V26, P11487, DOI 10.1523/JNEUROSCI.2364-06.2006; GOULD E, 1991, J COMP NEUROL, V304, P408, DOI 10.1002/cne.903040306; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Gruart A, 2007, LEARN MEMORY, V14, P54, DOI 10.1101/lm.428307; He HB, 2012, J NEUROSCI, V32, P15886, DOI 10.1523/JNEUROSCI.4505-11.2012; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Hong J, 2002, J NEUROCHEM, V81, P922, DOI 10.1046/j.1471-4159.2002.00882.x; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; IP NY, 1993, J NEUROSCI, V13, P3394; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Katsuki H, 2000, BRAIN RES, V885, P240, DOI 10.1016/S0006-8993(00)02953-X; Kawasaki A, 2006, NEUROSCI RES, V56, P124, DOI 10.1016/j.neures.2006.05.008; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Ko GYP, 2001, NEURON, V29, P255, DOI 10.1016/S0896-6273(01)00195-7; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Kwon M, 2011, J NEUROSCI, V31, P9735, DOI 10.1523/JNEUROSCI.6785-10.2011; Kwon YK, 1997, MOL CELLS, V7, P320; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; LESSMANN V, 1994, NEUROREPORT, V6, P21; Li T, 2008, GASTROENTEROLOGY, V134, P1994, DOI 10.1053/j.gastro.2008.02.076; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; Linnarsson S, 1997, EUR J NEUROSCI, V9, P2581, DOI 10.1111/j.1460-9568.1997.tb01687.x; Liu IYC, 2004, J NEUROSCI, V24, P7958, DOI 10.1523/JNEUROSCI.1948-04.2004; LU B, 1989, EXP NEUROL, V104, P191, DOI 10.1016/0014-4886(89)90029-0; Manadas B, 2009, J PROTEOME RES, V8, P4536, DOI 10.1021/pr900366x; Mark KA, 2007, J NEUROSCI, V27, P6823, DOI 10.1523/JNEUROSCI.0013-07.2007; Matsumoto T, 2006, MOL CELL NEUROSCI, V31, P70, DOI 10.1016/j.mcn.2005.09.002; McCusker RH, 2006, J NEUROIMMUNOL, V179, P186, DOI 10.1016/j.jneuroim.2006.06.014; Messaoudi E, 2002, J NEUROSCI, V22, P7453; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; Moechars D, 2006, J NEUROSCI, V26, P12055, DOI 10.1523/JNEUROSCI.2556-06.2006; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Murray Patrick S, 2011, Int J Pept, V2011, P654085, DOI 10.1155/2011/654085; Nelson TJ, 2008, EUR J PHARMACOL, V585, P76, DOI 10.1016/j.ejphar.2008.01.051; NI BH, 1994, P NATL ACAD SCI USA, V91, P5607, DOI 10.1073/pnas.91.12.5607; Numakawa T, 2002, J BIOL CHEM, V277, P6520, DOI 10.1074/jbc.M109139200; Numakawa T, 2009, P NATL ACAD SCI USA, V106, P647, DOI 10.1073/pnas.0800888106; NYE SH, 1992, MOL BIOL CELL, V3, P677, DOI 10.1091/mbc.3.6.677; Ouyang Y, 1997, J NEUROSCI, V17, P5416; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Pereira DB, 2006, J NEUROSCI RES, V83, P832, DOI 10.1002/jnr.20784; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; Santos AR, 2010, PROG NEUROBIOL, V92, P505, DOI 10.1016/j.pneurobio.2010.08.004; Santos MS, 2009, NEUROSCIENCE, V158, P189, DOI 10.1016/j.neuroscience.2008.03.029; Schinder AF, 2000, NEURON, V25, P151, DOI 10.1016/S0896-6273(00)80879-X; Smith RE, 2001, NEUROREPORT, V12, P2885, DOI 10.1097/00001756-200109170-00026; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Tartaglia N, 2001, J BIOL CHEM, V276, P37585, DOI 10.1074/jbc.M101683200; Tordera RM, 2007, EUR J NEUROSCI, V25, P281, DOI 10.1111/j.1460-9568.2006.05259.x; Tordera RM, 2005, J NEUROCHEM, V94, P875, DOI 10.1111/j.1471-4159.2005.03192.x; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Wallen-Mackenzie A, 2006, J NEUROSCI, V26, P12294, DOI 10.1523/JNEUROSCI.3855-06.2006; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Weston MC, 2011, NEURON, V69, P1147, DOI 10.1016/j.neuron.2011.02.002; Wilson NR, 2005, J NEUROSCI, V25, P6221, DOI 10.1523/JNEUROSCI.3003-04.2005; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Yelamanchili SV, 2006, J BIOL CHEM, V281, P15671, DOI 10.1074/jbc.M600378200; Yokota S, 2001, J NEUROCHEM, V77, P618, DOI 10.1046/j.1471-4159.2001.00270.x; Yoshii A, 2007, NAT NEUROSCI, V10, P702, DOI 10.1038/nn1903; Zhang GR, 2011, BRAIN RES, V1377, P1, DOI 10.1016/j.brainres.2010.12.040; Zhang GR, 2010, BRAIN RES, V1331, P12, DOI 10.1016/j.brainres.2010.03.053; Zheng WH, 2004, J NEUROCHEM, V89, P844, DOI 10.1111/j.1471-4159.2004.02350.x	101	48	51	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53793	10.1371/journal.pone.0053793	http://dx.doi.org/10.1371/journal.pone.0053793			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326507	Green Submitted, Green Published, gold			2022-12-25	WOS:000314705800075
J	Millet, B; Dondaine, T; Reymann, JM; Bourguignon, A; Naudet, F; Jaafari, N; Drapier, D; Turmel, V; Mesbah, H; Verin, M; Le Jeune, F				Millet, Bruno; Dondaine, Thibaut; Reymann, Jean-Michel; Bourguignon, Aurelie; Naudet, Florian; Jaafari, Nematollah; Drapier, Dominique; Turmel, Valerie; Mesbah, Habiba; Verin, Marc; Le Jeune, Florence			Obsessive Compulsive Disorder Networks: Positron Emission Tomography and Neuropsychology Provide New Insights	PLOS ONE			English	Article							GLUCOSE METABOLIC RATES; PREFRONTAL CORTEX; DECISION-MAKING; STIMULATION; RELIABILITY; DYSFUNCTIONS; METAANALYSIS; PERFORMANCE; INTERRATER; INTERVIEW	Background: Deep brain stimulation has shed new light on the central role of the prefrontal cortex (PFC) in obsessive compulsive disorder (OCD). We explored this structure from a functional perspective, synchronizing neuroimaging and cognitive measures. Methods and Findings: This case-control cross-sectional study compared 15 OCD patients without comorbidities and not currently on serotonin reuptake inhibitors or cognitive behavioural therapy with 15 healthy controls (matched for age, sex and education level) on resting-state (18)FDG-PET scans and a neuropsychological battery assessing executive functions. We looked for correlations between metabolic modifications and impaired neuropsychological scores. Modifications in glucose metabolism were found in frontal regions (orbitofrontal cortex and dorsolateral cortices), the cingulate gyrus, insula and parietal gyrus. Neuropsychological differences between patients and controls, which were subtle, were correlated with the metabolism of the prefrontal, parietal, and temporal cortices. Conclusion: As expected, we confirmed previous reports of a PFC dysfunction in OCD patients, and established a correlation with cognitive deficits. Other regions outside the prefrontal cortex, including the dorsoparietal cortex and the insula, also appeared to be implicated in the pathophysiology of OCD, providing fresh insights on the complexity of OCD syndromes.	[Millet, Bruno; Dondaine, Thibaut; Bourguignon, Aurelie; Naudet, Florian; Drapier, Dominique] Guillaume Regnier Hosp, Univ Dept Adult Psychiat, Rennes, France; [Millet, Bruno; Dondaine, Thibaut; Naudet, Florian; Drapier, Dominique; Verin, Marc; Le Jeune, Florence] Univ Hosp, Behav & Basal Ganglia Res Unit, EA 4712, Rennes, France; [Millet, Bruno; Dondaine, Thibaut; Reymann, Jean-Michel; Naudet, Florian; Drapier, Dominique; Turmel, Valerie; Verin, Marc; Le Jeune, Florence] Univ Rennes 1, Rennes, France; [Reymann, Jean-Michel; Naudet, Florian; Turmel, Valerie] Univ Hosp, Clin Pharmacol Unit, INSERM 0203, Clin Invest Ctr, Rennes, France; [Jaafari, Nematollah] Team Psychobiol Compuls Disorders, Expt & Clin Neurosci Lab, INSERM, Poitiers, France; [Jaafari, Nematollah] Univ Hosp Poitiers, INSERM, CIC U802, Poitiers, France; [Jaafari, Nematollah] Univ Poitiers, Poitiers, France; [Dondaine, Thibaut; Jaafari, Nematollah] Ctr Hosp Henri Laborit, Unite Rech Clin Intersectorielle Psychiat, Poitiers, France; [Mesbah, Habiba] Eugene Marquis Ctr, Dept Med Informat, Rennes, France; [Verin, Marc] Rennes Univ Hosp, Pontchaillou Hosp, Dept Neurol, Rennes, France; [Le Jeune, Florence] Eugene Marquis Ctr, Dept Nucl Med, Rennes, France	CHU Rennes; CHU Rennes; Universite de Rennes; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Universite de Poitiers; UNICANCER; Centre Eugene Marquis; CHU Rennes; Universite de Rennes; UNICANCER; Centre Eugene Marquis	Naudet, F (corresponding author), Guillaume Regnier Hosp, Univ Dept Adult Psychiat, Rennes, France.	floriannaudet@gmail.com	Naudet, Florian/H-5644-2019; Le Jeune, Florence/ABC-6983-2020; Verin, Marc/ABC-6924-2020	Naudet, Florian/0000-0003-3760-3801; Dondaine, Thibaut/0000-0002-8778-5079; MESBAH, Habiba/0000-0003-1540-6321	French "Programme Hospitalier de Recherche Clinique" (PHRC); Fondation Pierre Deniker; "Unite de Recherche Clinique Intersectorielle en Psychiatrie" du Centre Hospitalier Henri Laborit; Agence Regionale de la Sante de Poitou-Charentes; "bourse chercheur invite", of the Region Poitou-Charentes	French "Programme Hospitalier de Recherche Clinique" (PHRC); Fondation Pierre Deniker; "Unite de Recherche Clinique Intersectorielle en Psychiatrie" du Centre Hospitalier Henri Laborit; Agence Regionale de la Sante de Poitou-Charentes(Region Nouvelle-Aquitaine); "bourse chercheur invite", of the Region Poitou-Charentes(Region Nouvelle-Aquitaine)	This study was supported by a grant from the French "Programme Hospitalier de Recherche Clinique" (PHRC) and by a grant from the "Fondation Pierre Deniker". This study was partially supported by the "Unite de Recherche Clinique Intersectorielle en Psychiatrie" du Centre Hospitalier Henri Laborit, which received financial support from the Agence Regionale de la Sante de Poitou-Charentes. N. Jaafari was supported by the financial support, "bourse chercheur invite", of the Region Poitou-Charentes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Aouizerate B, 2004, PROG NEUROBIOL, V72, P195, DOI 10.1016/j.pneurobio.2004.02.004; Aycicegi A, 2003, EUR PSYCHIAT, V18, P241, DOI 10.1016/S0924-9338(03)00065-8; Banich MT, 2009, NEUROSCI BIOBEHAV R, V33, P613, DOI 10.1016/j.neubiorev.2008.09.010; BAXTER LR, 1988, AM J PSYCHIAT, V145, P1560; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Denys D, 2010, ARCH GEN PSYCHIAT, V67, P1061, DOI 10.1001/archgenpsychiatry.2010.122; Eisen JL, 1998, AM J PSYCHIAT, V155, P102, DOI 10.1176/ajp.155.1.102; First M. B., 2014, SCID 5 105 STRUCTURE; FREEDMAN M, 1990, BRAIN COGNITION, V14, P134, DOI 10.1016/0278-2626(90)90025-J; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Goodman W., 1989, ARCH GEN PSYCHIAT, V48, P1006; Guy W, 1976, ECDEU ASSESSMENT MAN; Hesse S, 2011, INT J NEUROPSYCHOPH, V14, P606, DOI 10.1017/S1461145710001604; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Kunde W, 2012, ADV COGN PSYCHOL, V8, P9, DOI [10.2478/v10053-008-0097-x, 10.5709/acp-0097-x]; Kwon JS, 2003, PSYCHIAT RES-NEUROIM, V122, P37, DOI 10.1016/S0925-4927(02)00104-X; Lamm C, 2010, BRAIN STRUCT FUNCT, V214, P579, DOI 10.1007/s00429-010-0251-3; Le Jeune F, 2010, BIOL PSYCHIAT, V68, P1016, DOI 10.1016/j.biopsych.2010.06.033; Maffei C, 1997, J PERS DISORD, V11, P279, DOI 10.1521/pedi.1997.11.3.279; Mallet L, 2008, NEW ENGL J MED, V359, P2121, DOI 10.1056/NEJMoa0708514; MARTINOT JL, 1990, ACTA PSYCHIAT SCAND, V82, P233, DOI 10.1111/j.1600-0447.1990.tb03059.x; Mattis S, 1988, DEMENTIA RATING SCAL; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Moncrieff J, 2002, BRIT J PSYCHIAT, V180, P193, DOI 10.1192/bjp.180.3.193; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; NORDAHL TE, 1989, NEUROPSYCHOPHARMACOL, V2, P23, DOI 10.1016/0893-133X(89)90003-1; Osterrieth P, 1944, ARCH PSYCHOL, P205; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; PERANI D, 1995, BRIT J PSYCHIAT, V166, P244, DOI 10.1192/bjp.166.2.244; Preisig M, 1999, EUR ARCH PSY CLIN N, V249, P174, DOI 10.1007/s004060050084; Ray RD, 2012, NEUROSCI BIOBEHAV R, V36, P479, DOI 10.1016/j.neubiorev.2011.08.005; Reitan R, 1958, PERCEPT MOTOR SKILL, P271; Rey A, 1942, ARCH PSYCHOL, P286; Rieu D, 2006, REV NEUROL-FRANCE, V162, P721, DOI 10.1016/S0035-3787(06)75069-X; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Russell A, 2003, J CHILD ADOL PSYCHOP, V13, pS31, DOI 10.1089/104454603322126322; Sachdev PS, 2005, AUST NZ J PSYCHIAT, V39, P757, DOI 10.1080/j.1440-1614.2005.01680.x; Schwartz JM, 1996, ARCH GEN PSYCHIAT, V53, P109; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; SWEDO SE, 1989, ARCH GEN PSYCHIAT, V46, P518; van den Heuvel OA, 2009, BRAIN, V132, P853, DOI 10.1093/brain/awn267; Wagner S, 2012, ACTA PSYCHIAT SCAND, V125, P281, DOI 10.1111/j.1600-0447.2011.01762.x; Whiteside SP, 2004, PSYCHIAT RES-NEUROIM, V132, P69, DOI 10.1016/j.pscychresns.2004.07.001	49	29	33	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53241	10.1371/journal.pone.0053241	http://dx.doi.org/10.1371/journal.pone.0053241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326403	gold, Green Submitted, Green Published			2022-12-25	WOS:000314705800039
J	Schachtschneider, KM; Yeoman, CJ; Isaacson, RE; White, BA; Schook, LB; Pieters, M				Schachtschneider, Kyle M.; Yeoman, Carl J.; Isaacson, Richard E.; White, Bryan A.; Schook, Lawrence B.; Pieters, Maria			Modulation of Systemic Immune Responses through Commensal Gastrointestinal Microbiota	PLOS ONE			English	Article							MYCOPLASMA-HYOPNEUMONIAE INFECTION; ACUTE-PHASE PROTEIN; C-REACTIVE PROTEIN; GUT MICROBIOTA; PROINFLAMMATORY CYTOKINES; INTESTINAL MICROBIOTA; EXPRESSION; BACTERIA; DISEASE; HYGIENE	Colonization of the gastrointestinal (GI) tract is initiated during birth and continually seeded from the individual's environment. Gastrointestinal microorganisms play a central role in developing and modulating host immune responses and have been the subject of investigation over the last decades. Animal studies have demonstrated the impact of GI tract microbiota on local gastrointestinal immune responses; however, the full spectrum of action of early gastrointestinal tract stimulation and subsequent modulation of systemic immune responses is poorly understood. This study explored the utility of an oral microbial inoculum as a therapeutic tool to affect porcine systemic immune responses. For this study a litter of 12 pigs was split into two groups. One group of pigs was inoculated with a non-pathogenic oral inoculum (modulated), while another group (control) was not. DNA extracted from nasal swabs and fecal samples collected throughout the study was sequenced to determine the effects of the oral inoculation on GI and respiratory microbial communities. The effects of GI microbial modulation on systemic immune responses were evaluated by experimentally infecting with the pathogen Mycoplasma hyopneumoniae. Coughing levels, pathology, toll-like receptors 2 and 6, and cytokine production were measured throughout the study. Sequencing results show a successful modulation of the GI and respiratory microbiomes through oral inoculation. Delayed type hypersensitivity responses were stronger (p = 0.07), and the average coughing levels and respiratory TNF-alpha variance were significantly lower in the modulated group (p < 0.0001 and p = 0.0153, respectively). The M. hyopneumoniae infection study showed beneficial effects of the oral inoculum on systemic immune responses including antibody production, severity of infection and cytokine levels. These results suggest that an oral microbial inoculation can be used to modulate microbial communities, as well as have a beneficial effect on systemic immune responses as demonstrated with M. hyopneumoniae infection.	[Schachtschneider, Kyle M.; White, Bryan A.; Schook, Lawrence B.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Yeoman, Carl J.; White, Bryan A.; Schook, Lawrence B.; Pieters, Maria] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Yeoman, Carl J.] Montana State Univ, Dept Anim & Range Sci, Bozeman, MT USA; [Isaacson, Richard E.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Montana State University System; Montana State University Bozeman; University of Minnesota System; University of Minnesota Twin Cities	Schook, LB (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	schook@illinois.edu	Yeoman, Carl/ABA-1906-2021	Yeoman, Carl/0000-0002-8775-7879; Schook, Lawrence/0000-0002-6580-8364; Schachtschneider, Kyle/0000-0002-7293-8642	USDA [AG 2009-34480-19875, 2008-35205-18769, 538 AG58-5438-7-317l, 2007-35212-18046]	USDA(United States Department of Agriculture (USDA))	This project was conducted with funding from the USDA (AG 2009-34480-19875, 2008-35205-18769, 538 AG58-5438-7-317l, and 2007-35212-18046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandrick M, 2008, CLIN VACCINE IMMUNOL, V15, P540, DOI 10.1128/CVI.00466-07; Bauer Eva, 2006, Current Issues in Intestinal Microbiology, V7, P35; Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; Calsamiglia M, 1999, J VET DIAGN INVEST, V11, P246, DOI 10.1177/104063879901100307; Calsamiglia M, 2000, VET MICROBIOL, V76, P299, DOI 10.1016/S0378-1135(00)00245-5; Calus D, 2010, J MICROBIOL METH, V83, P335, DOI 10.1016/j.mimet.2010.09.001; Campbell JH, 2012, ISME J, V6, P2033, DOI 10.1038/ismej.2012.54; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Chao A, 2001, J AM STAT ASSOC, V87, P210; Chen K, 2006, GENE, V384, P62, DOI 10.1016/j.gene.2006.07.009; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fano E, 2005, CAN J VET RES, V69, P223; FELD NC, 1992, VET MICROBIOL, V30, P35, DOI 10.1016/0378-1135(92)90092-8; Heegaard PMH, 1998, COMP BIOCHEM PHYS B, V119, P365, DOI 10.1016/S0305-0491(97)00362-3; Hrncir T, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-65; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Hwang MH, 2011, VET RES COMMUN, V35, P21, DOI 10.1007/s11259-010-9447-5; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kirjavainen PV, 1999, ANN MED, V31, P288, DOI 10.3109/07853899908995892; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Mattila E, 2012, GASTROENTEROLOGY, V142, P490, DOI 10.1053/j.gastro.2011.11.037; MOXON ER, 1979, J INFECT DIS, V140, P471, DOI 10.1093/infdis/140.4.471; Mulder IE, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-79; Muneta Y, 2003, J INTERF CYTOK RES, V23, P583, DOI 10.1089/107999003322485080; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Parra MD, 2006, J VET MED B, V53, P488, DOI 10.1111/j.1439-0450.2006.01002.x; Pieters M, 2009, VET MICROBIOL, V134, P261, DOI 10.1016/j.vetmic.2008.08.016; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Riboulet-Bisson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031113; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sears CL, 2005, ANAEROBE, V11, P247, DOI 10.1016/j.anaerobe.2005.05.001; Shirkey TW, 2006, EXP BIOL MED, V231, P1333, DOI 10.1177/153537020623100807; Sibila M, 2009, VET J, V181, P221, DOI 10.1016/j.tvjl.2008.02.020; Silverman MS, 2010, CLIN GASTROENTEROL H, V8, P471, DOI 10.1016/j.cgh.2010.01.007; Staubach F, 2012, ISME J, V6, P1345, DOI 10.1038/ismej.2011.204; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; TAJIMA M, 1984, AM J VET RES, V45, P1928; Thacker E, 2012, DIS SWINE; Thacker EL, 2006, DIS SWINE, P701; Thanawongnuwech R, 2004, CLIN DIAGN LAB IMMUN, V11, P901, DOI 10.1128/CDLI.11.5.901-908.2004; Thomas DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016577; Thompson CL, 2008, ISME J, V2, P739, DOI 10.1038/ismej.2008.29; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Willing BP, 2010, LIVEST SCI, V133, P82, DOI 10.1016/j.livsci.2010.06.031; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579	60	39	39	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53969	10.1371/journal.pone.0053969	http://dx.doi.org/10.1371/journal.pone.0053969			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326551	gold, Green Published			2022-12-25	WOS:000314705800094
J	Ye, L; Zhang, S; Greder, L; Dutton, J; Keirstead, SA; Lepley, M; Zhang, LY; Kaufman, D; Zhang, JY				Ye, Lei; Zhang, Sophia; Greder, Lucas; Dutton, James; Keirstead, Susan A.; Lepley, Mike; Zhang, Liying; Kaufman, Dan; Zhang, Jianyi			Effective Cardiac Myocyte Differentiation of Human Induced Pluripotent Stem Cells Requires VEGF	PLOS ONE			English	Article							SOMATIC-CELLS; CARDIOMYOCYTE DIFFERENTIATION; FUNCTIONAL CONSEQUENCES; EPIGENETIC MEMORY; TRANSPLANTATION; FIBROBLASTS; INDUCTION	Perhaps one of the most significant achievements in modern science is the discovery of human induced pluripotent stem cells (hiPSCs), which have paved the way for regeneration therapy using patients' own cells. Cardiomyocytes differentiated from hiPSCs (hiPSC-CMs) could be used for modelling patients with heart failure, for testing new drugs, and for cellular therapy in the future. However, the present cardiomyocyte differentiation protocols exhibit variable differentiation efficiency across different hiPSC lines, which inhibit the application of this technology significantly. Here, we demonstrate a novel myocyte differentiation protocol that can yield a significant, high percentage of cardiac myocyte differentiation (>85%) in 2 hiPSC lines, which makes the fabrication of a human cardiac muscle patch possible. The established hiPSCs cell lines being examined include the transgene integrated UCBiPS7 derived from cord blood cells and non-integrated PCBC16iPS from skin fibroblasts. The results indicate that hiPSC-CMs derived from established hiPSC lines respond to adrenergic or acetylcholine stimulation and beat regularly for greater than 60 days. This data also demonstrates that this novel differentiation protocol can efficiently generate hiPSC-CMs from iPSC lines that are derived not only from fibroblasts, but also from blood mononuclear cells.	[Ye, Lei; Zhang, Sophia; Zhang, Liying; Zhang, Jianyi] Univ Minnesota, Sch Med, Dept Med, Div Cardiol, Minneapolis, MN 55455 USA; [Ye, Lei; Greder, Lucas; Dutton, James; Keirstead, Susan A.; Lepley, Mike; Zhang, Liying; Kaufman, Dan; Zhang, Jianyi] Univ Minnesota, Sch Med, Stem Cell Inst, Minneapolis, MN 55455 USA; [Dutton, James] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Keirstead, Susan A.] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN USA; [Zhang, Jianyi] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Zhang, JY (corresponding author), Univ Minnesota, Sch Med, Dept Med, Div Cardiol, Minneapolis, MN 55455 USA.	zhang047@umn.edu	Zhang, Jianyi/N-1949-2018	Zhang, Jianyi/0000-0002-3955-6554; Kaufman, Dan/0000-0002-2003-2494; Ye, Lei/0000-0001-5039-6224; Zhang, Sophia/0000-0002-8717-8084	U.S. Public Health Service [NIH RO1 HL67828, HL95077, HL114120]; National Institutes of Health Grant [UO1 HL100407]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114120, R01HL095077, R01HL067828, U01HL100407] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by U.S. Public Health Service Grants NIH RO1 HL67828, HL95077, HL114120, and National Institutes of Health Grant UO1 HL100407. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bolognese L, 2002, CIRCULATION, V106, P2351, DOI 10.1161/01.CIR.0000036014.90197.FA; Chen Y, 2006, AM J PHYSIOL-HEART C, V291, pH1653, DOI 10.1152/ajpheart.00363.2005; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Hu QS, 2006, AM J PHYSIOL-HEART C, V291, pH648, DOI 10.1152/ajpheart.01387.2005; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491; Murry CE, 2002, COLD SPRING HARB SYM, V67, P519, DOI 10.1101/sqb.2002.67.519; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Reinecke H, 2002, J MOL CELL CARDIOL, V34, P251, DOI 10.1006/jmcc.2001.1494; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Wang XH, 2009, CIRCULATION, V120, pS238, DOI 10.1161/CIRCULATIONAHA.109.885236; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Xiong Q, 2012, CIRC RES; Xiong Q, 2012, CIRC RES, V111, P455, DOI 10.1161/CIRCRESAHA.112.269894; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Ye L, 2007, EXP BIOL MED, V232, P1477, DOI 10.3181/0706-RM-175; Ye L, 2011, BIOMATERIALS, V32, P2424, DOI 10.1016/j.biomaterials.2010.12.008; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeng LP, 2007, CIRCULATION, V115, P1866, DOI 10.1161/CIRCULATIONAHA.106.659730; Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9; Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289; Zhang G, 2007, TISSUE ENG, V13, P2063, DOI 10.1089/ten.2006.0013; Zhang J, 2012, CIRC RES; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120	36	53	53	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53764	10.1371/journal.pone.0053764	http://dx.doi.org/10.1371/journal.pone.0053764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326500	Green Published, Green Submitted, gold			2022-12-25	WOS:000313552400042
J	Bhatnagar, A; Unal, H; Jagannathan, R; Kaveti, S; Duan, ZH; Yong, S; Vasanji, A; Kinter, M; Desnoyer, R; Karnik, SS				Bhatnagar, Anushree; Unal, Hamiyet; Jagannathan, Rajaganapathi; Kaveti, Suma; Duan, Zhong-Hui; Yong, Sandro; Vasanji, Amit; Kinter, Michael; Desnoyer, Russell; Karnik, Sadashiva S.			Interaction of G-Protein beta gamma Complex with Chromatin Modulates GPCR-Dependent Gene Regulation	PLOS ONE			English	Article							5-HT2A SEROTONIN RECEPTORS; ANGIOTENSIN-II; STRUCTURAL BASIS; INDUCED HYPERTROPHY; CARDIAC MYOCYTES; SUBUNIT; RECOGNITION; NUCLEUS	Heterotrimeric G-protein signal transduction initiated by G-protein-coupled receptors (GPCRs) in the plasma membrane is thought to propagate through protein-protein interactions of subunits, G alpha and G beta gamma in the cytosol. In this study, we show novel nuclear functions of G beta gamma through demonstrating interaction of G beta(2) with integral components of chromatin and effects of G beta(2) depletion on global gene expression. Agonist activation of several GPCRs including the angiotensin II type 1 receptor specifically augmented G beta(2) levels in the nucleus and G beta(2) interacted with specific nucleosome core histones and transcriptional modulators. Depletion of G beta(2) repressed the basal and angiotensin II-dependent transcriptional activities of myocyte enhancer factor 2. G beta(2) interacted with a sequence motif that was present in several transcription factors, whose genome-wide binding accounted for the G beta(2)-dependent regulation of approximately 2% genes. These findings suggest a wide-ranging mechanism by which direct interaction of G beta gamma with specific chromatin bound transcription factors regulates functional gene networks in response to GPCR activation in cells.	[Bhatnagar, Anushree; Unal, Hamiyet; Jagannathan, Rajaganapathi; Duan, Zhong-Hui; Yong, Sandro; Desnoyer, Russell; Karnik, Sadashiva S.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA; [Kaveti, Suma; Kinter, Michael] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44106 USA; [Vasanji, Amit] Cleveland Clin, Lerner Res Inst, Biomed Imaging & Anal Core, Cleveland, OH 44106 USA; [Duan, Zhong-Hui] Univ Akron, Dept Comp Sci, Akron, OH 44325 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Akron	Karnik, SS (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA.	karniks@ccf.org	Karnik, Sadashiva/Y-2477-2019	Karnik, Sadashiva/0000-0003-0746-2753; Kinter, Michael/0000-0001-7409-8918	National Institutes of Health grants [R01 HL-057470, R01 HL-083243, R21 HL110043, F32 HL088893, T32 HL007914]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL088893, R01HL083243, R01HL057470, T32HL007914, R21HL110043] Funding Source: NIH RePORTER	National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health grants R01 HL-057470, R01 HL-083243, R21 HL110043 (to S.S.K.); F32 HL088893 (to A.B.) and T32 HL007914 (H.U.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 1999, J BIOL CHEM, V274, P16646, DOI 10.1074/jbc.274.23.16646; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bhatnagar A, 2004, J BIOL CHEM, V279, P34614, DOI 10.1074/jbc.M404673200; Bhatnagar A, 2001, J BIOL CHEM, V276, P8269, DOI 10.1074/jbc.M006968200; Billet S, 2008, KIDNEY INT, V74, P1379, DOI 10.1038/ki.2008.358; Boivin B, 2008, J RECEPT SIG TRANSD, V28, P15, DOI [10.1080/10799890801941889, 10.1080/10799890801941889 ]; Chakraborty S, 2006, J BIOL CHEM, V281, P35070, DOI 10.1074/jbc.M602474200; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; DeSilva H, 1998, GENETICS, V148, P657; DORING HJ, 1990, PHYSIOL BOHEMOSLOV, V39, P481; DYNLACHT BD, 1993, NATURE, V363, P176, DOI 10.1038/363176a0; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Hepler John R, 2005, Sci STKE, V2005, ppe38, DOI 10.1126/stke.2942005pe38; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; KANAYA N, 1998, ANESTHESIOLOGY, V84, P397; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Kino T, 2005, J CELL BIOL, V169, P885, DOI 10.1083/jcb.200409150; Kinter M., 2000, PROTEIN SEQUENCING I, DOI 10.1002/0471721980; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; Lambert NA, 2008, SCI SIGNAL, V1, P1; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Martinez-Balbas MA, 1998, P NATL ACAD SCI USA, V95, P132, DOI 10.1073/pnas.95.1.132; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; NODA K, 1995, J BIOL CHEM, V270, P2284, DOI 10.1074/jbc.270.5.2284; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Paradis P, 2000, P NATL ACAD SCI USA, V97, P931, DOI 10.1073/pnas.97.2.931; Park JG, 1999, EMBO J, V18, P4004, DOI 10.1093/emboj/18.14.4004; Rezaul K, 2005, MOL CELL PROTEOMICS, V4, P169, DOI 10.1074/mcp.M400115-MCP200; Robitaille M, 2010, CELL SIGNAL, V22, P1254, DOI 10.1016/j.cellsig.2010.04.005; SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; Saini DK, 2009, TRENDS PHARMACOL SCI, V30, P278, DOI 10.1016/j.tips.2009.04.001; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; Song JJ, 2008, GENE DEV, V22, P1313, DOI 10.1101/gad.1653308; Spiegelberg BD, 2005, J BIOL CHEM, V280, P41769, DOI 10.1074/jbc.M504066200; Suka N, 2006, NUCLEIC ACIDS RES, V34, P3555, DOI 10.1093/nar/gkl487; Tang WY, 2007, REV ENDOCR METAB DIS, V8, P173, DOI 10.1007/s11154-007-9042-4; Yaffe MB, 2004, ANNU REV BIOPH BIOM, V33, P225, DOI 10.1146/annurev.biophys.33.110502.133346; Yong Sandro L., 2006, V129, P127; Zakynthinos E, 2005, ANGIOLOGY, V56, P439, DOI 10.1177/000331970505600412; Zhang QH, 2000, MOL CELL BIOL, V20, P4970, DOI 10.1128/MCB.20.14.4970-4978.2000; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	46	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52689	10.1371/journal.pone.0052689	http://dx.doi.org/10.1371/journal.pone.0052689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326349	gold, Green Published, Green Submitted			2022-12-25	WOS:000313551500026
J	Chuang, LC; Kao, CF; Shih, WL; Kuo, PH				Chuang, Li-Chung; Kao, Chung-Feng; Shih, Wei-Liang; Kuo, Po-Hsiu			Pathway Analysis Using Information from Allele-Specific Gene Methylation in Genome-Wide Association Studies for Bipolar Disorder	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; DNA METHYLATION; NEUROTROPHIC-FACTOR; SCHIZOPHRENIA; POLYMORPHISMS; HERITABILITY; VARIANTS; COMPLEX	Bipolar disorder (BPD) is a complex psychiatric trait with high heritability. Despite efforts through conducting genome-wide association (GWA) studies, the success of identifying susceptibility loci for BPD has been limited, which is partially attributed to the complex nature of its pathogenesis. Pathway-based analytic strategy is a powerful tool to explore joint effects of gene sets within specific biological pathways. Additionally, to incorporate other aspects of genomic data into pathway analysis may further enhance our understanding for the underlying mechanisms for BPD. Patterns of DNA methylation play important roles in regulating gene expression and function. A commonly observed phenomenon, allele-specific methylation (ASM) describes the associations between genetic variants and DNA methylation patterns. The present study aimed to identify biological pathways that are involve in the pathogenesis of BPD while incorporating brain specific ASM information in pathway analysis using two large-scale GWA datasets in Caucasian populations. A weighting scheme was adopted to take ASM information into consideration for each pathway. After multiple testing corrections, we identified 88 and 15 enriched pathways for their biological relevance for BPD in the Genetic Association Information Network (GAIN) and the Wellcome Trust Case Control Consortium dataset, respectively. Many of these pathways were significant only when applying the weighting scheme. Three ion channel related pathways were consistently identified in both datasets. Results in the GAIN dataset also suggest for the roles of extracellular matrix in brain for BPD. Findings from Gene Ontology (GO) analysis exhibited functional enrichment among genes of non-GO pathways in activity of gated channel, transporter, and neurotransmitter receptor. We demonstrated that integrating different data sources with pathway analysis provides an avenue to identify promising and novel biological pathways for exploring the underlying molecular mechanisms for bipolar disorder. Further basic research can be conducted to target the biological mechanisms for the identified genes and pathways.	[Chuang, Li-Chung; Kao, Chung-Feng; Shih, Wei-Liang; Kuo, Po-Hsiu] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan; [Chuang, Li-Chung; Kao, Chung-Feng; Shih, Wei-Liang; Kuo, Po-Hsiu] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chuang, Li-Chung] Cardinal Tien Coll Healthcare & Management, Dept Nursing, Ilan, Taiwan; [Kuo, Po-Hsiu] Natl Taiwan Univ, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Kuo, PH (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan.	phkuo@ntu.edu.tw	Kuo, Po-Hsiu/H-9882-2013	SHIH, WEI-LIANG/0000-0002-4160-7541; Kuo, Po-Hsiu/0000-0003-0365-3587	National Science Council [NSC 99-2314-B-002-140-MY3]; National Health Research Institute [NHRI-EX99-9918NC]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan)	This research was supported by National Science Council (NSC 99-2314-B-002-140-MY3) and National Health Research Institute (NHRI-EX99-9918NC) grants to Dr. P-H Kuo (PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askland K, 2009, HUM GENET, V125, P63, DOI 10.1007/s00439-008-0600-y; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berk M, 2007, ACTA PSYCHIAT SCAND, V116, P41, DOI 10.1111/j.1600-0447.2007.01058.x; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Deng GF, 2011, J MOL NEUROSCI, V44, P115, DOI 10.1007/s12031-011-9492-8; Drago A, 2011, AM J MED GENET B, V156B, P975, DOI 10.1002/ajmg.b.31245; Edvardsen J, 2008, J AFFECT DISORDERS, V106, P229, DOI 10.1016/j.jad.2007.07.001; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Fridley BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012693; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Grube S, 2011, EMBO MOL MED, V3, P309, DOI 10.1002/emmm.201100135; Hartz SM, 2011, PSYCHIAT GENET, V21, P77, DOI 10.1097/YPG.0b013e32834135eb; Hashimoto K, 2010, PSYCHIAT CLIN NEUROS, V64, P341, DOI 10.1111/j.1440-1819.2010.02113.x; Jia PL, 2010, SCHIZOPHR RES, V122, P38, DOI 10.1016/j.schres.2010.07.001; Kao CF, 2012, INT J NEUROPSYCHOPH, P1; Kato T, 2007, PSYCHIAT CLIN NEUROS, V61, P3, DOI 10.1111/j.1440-1819.2007.01604.x; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Lee MTM, 2011, MOL PSYCHIATR, V16, P548, DOI 10.1038/mp.2010.43; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Lydall GJ, 2011, PSYCHIAT GENET, V21, P294, DOI 10.1097/YPG.0b013e32834915c2; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Menashe I, 2010, CANCER RES, V70, P4453, DOI 10.1158/0008-5472.CAN-09-4502; O'Dushlaine C, 2011, MOL PSYCHIATR, V16, P286, DOI 10.1038/mp.2010.7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Saito A, 2007, NEUROSCI LETT, V411, P168, DOI 10.1016/j.neulet.2006.08.042; SANES JR, 1983, ANNU REV PHYSIOL, V45, P581, DOI 10.1146/annurev.ph.45.030183.003053; Sarras H, 2010, SCHIZOPHR RES, V120, P236, DOI 10.1016/j.schres.2010.03.002; Saus E, 2010, J PSYCHIATR RES, V44, P971, DOI 10.1016/j.jpsychires.2010.03.007; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Squassina A, 2011, PHARMACOGENOMICS, V12, P1559, DOI [10.2217/PGS.11.102, 10.2217/pgs.11.102]; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sui L, 2012, NEUROBIOL LEARN MEM, V97, P425, DOI 10.1016/j.nlm.2012.03.007; Tintle Nathan L, 2009, BMC Proc, V3 Suppl 7, pS96; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Xu Z, 2012, J PSYCHOPHARMACOL, V26, P349, DOI 10.1177/0269881111414452; Yang W, 2011, EUR J HUM GENET, V19, P893, DOI 10.1038/ejhg.2011.46; Zaykin DV, 2007, PHARM STAT, V6, P217, DOI 10.1002/pst.304; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005; Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131	50	18	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53092	10.1371/journal.pone.0053092	http://dx.doi.org/10.1371/journal.pone.0053092			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326387	Green Submitted, Green Published, gold			2022-12-25	WOS:000313551500049
J	Staines, K; Young, JR; Butter, C				Staines, Karen; Young, John R.; Butter, Colin			Expression of Chicken DEC205 Reflects the Unique Structure and Function of the Avian Immune System	PLOS ONE			English	Article							ANTIVIMENTIN MONOCLONAL-ANTIBODY; MACROPHAGE MANNOSE RECEPTOR; SOMATIC MAMMALIAN CELLS; DENDRITIC CELLS; T-CELLS; EPITHELIAL-CELLS; B-CELLS; FABRICIUS; DEC-205; BURSA	The generation of appropriate adaptive immune responses relies critically on dendritic cells, about which relatively little is known in chickens, a vital livestock species, in comparison with man and mouse. We cloned and sequenced chicken DEC205 cDNA and used this knowledge to produce quantitative PCR assays and monoclonal antibodies to study expression of DEC205 as well as CD83. The gene structure of DEC205 was identical to those of other species. Transcripts of both genes were found at higher levels in lymphoid tissues and the expression of DEC205 in normal birds had a characteristic distribution in the primary lymphoid organs. In spleen, DEC205 was seen on cells ideally located to trap antigen. In thymus it was found on cells thought to participate in the education of T cells, and in the bursa on cells that may be involved in presentation of antigen to B cells and regulation of B cell migration. The expression of DEC205 on cells other than antigen presenting cells (APC) is also described. Isolated splenocytes strongly expressing DEC205 but not the KUL01 antigen have morphology similar to mammalian dendritic cells and the distinct expression of DEC205 within the avian-specific Bursa of Fabricius alludes to a unique function in this organ of B cell diversification.	[Staines, Karen; Young, John R.; Butter, Colin] Pirbright Inst, Compton Lab, Avian Viral Dis Programme, Newbury, Berks, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Butter, C (corresponding author), Pirbright Inst, Compton Lab, Avian Viral Dis Programme, Newbury, Berks, England.	colin.butter@avianimmunology.org			BBSRC (Biotechnology and Biological Sciences Research Council) as part of the Institute Strategic Programme Grant [BBS/E/I/00001423]; BBSRC [BBS/E/I/00001423] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001423] Funding Source: researchfish	BBSRC (Biotechnology and Biological Sciences Research Council) as part of the Institute Strategic Programme Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the BBSRC (Biotechnology and Biological Sciences Research Council) under grant number BBS/E/I/00001423 as part of the Institute Strategic Programme Grant to the Avian Viral Diseases Programme at the IAH (Institute for Animal Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; Baaten BJG, 2009, VIRAL IMMUNOL, V22, P431, DOI 10.1089/vim.2009.0047; Balfour B M, 1981, Ciba Found Symp, V84, P281; Betts M. J., 2003, BIOINFORMATICS GENET, DOI 10.1002/0470867302.ch14; BIGGS P. M., 1957, ACTA ANAT, V29, P36; Butter C, 2007, AVIAN PATHOL, V36, P93, DOI 10.1080/03079450601156075; Cheong C, 2010, BLOOD, V116, P3828, DOI 10.1182/blood-2010-06-288068; DELCACHO E, 1995, ANAT REC, V241, P105, DOI 10.1002/ar.1092410114; Flores-Mendoza L, 2010, DEV COMP IMMUNOL, V34, P715, DOI 10.1016/j.dci.2010.02.010; GLICK B, 1956, POULTRY SCI, V35, P224, DOI 10.3382/ps.0350224; GLICK B, 1993, POULTRY SCI, V72, P1262, DOI 10.3382/ps.0721262; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Gross GM, 1988, AVIAN LYMPHATIC SYST; Hansell C, 2007, J IMMUNOL, V179, P5117, DOI 10.4049/jimmunol.179.8.5117; INABA K, 1995, CELL IMMUNOL, V163, P148, DOI 10.1006/cimm.1995.1109; JEURISSEN SHM, 1991, RES IMMUNOL, V142, P352, DOI 10.1016/0923-2494(91)90090-6; JEURISSEN SHM, 1992, IMMUNOLOGY, V77, P75; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; KAO FT, 1968, P NATL ACAD SCI USA, V60, P1275, DOI 10.1073/pnas.60.4.1275; Kaspers B, 2008, AVIAN IMMUNOLOGY, P183, DOI 10.1016/B978-012370634-8.50012-3; Kato M, 2006, INT IMMUNOL, V18, P857, DOI 10.1093/intimm/dxl022; KRAAL G, 1986, J EXP MED, V163, P981, DOI 10.1084/jem.163.4.981; KRUISBEEK AM, 1984, J EXP MED, V160, P839, DOI 10.1084/jem.160.3.839; LASSILA O, 1989, EUR J IMMUNOL, V19, P955, DOI 10.1002/eji.1830190527; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; Mahnke K, 2003, TRENDS IMMUNOL, V24, P646, DOI 10.1016/j.it.2003.09.012; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; MOTYKA B, 1991, EUR J IMMUNOL, V21, P1951, DOI 10.1002/eji.1830210825; OLAH I, 1982, AM J ANAT, V165, P445, DOI 10.1002/aja.1001650408; OLAH I, 1979, DEV COMP IMMUNOL, V3, P101, DOI 10.1016/S0145-305X(79)80010-5; OLAH I, 1992, ANAT RECORD, V232, P121, DOI 10.1002/ar.1092320113; OLAH I, 1978, EXPERIENTIA, V34, P1642, DOI 10.1007/BF02034727; OLAH I, 1992, ANAT RECORD, V233, P111, DOI 10.1002/ar.1092330115; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Ratcliffe MJH, 2006, DEV COMP IMMUNOL, V30, P101, DOI 10.1016/j.dci.2005.06.018; Shrimpton RE, 2009, MOL IMMUNOL, V46, P1229, DOI 10.1016/j.molimm.2008.11.016; Small M, 2003, INT IMMUNOL, V15, P197, DOI 10.1093/intimm/dxg024; Snell D, 2000, CELL SURFACE MOL DEV; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; SWIGGARD WJ, 1995, CELL IMMUNOL, V165, P302, DOI 10.1006/cimm.1995.1218; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; TAYLOR ME, 1993, J BIOL CHEM, V268, P399; Tregaskes CA, 1996, IMMUNOGENETICS, V44, P212, DOI 10.1007/BF02602587; Tregaskes CA, 2005, DEV COMP IMMUNOL, V29, P361, DOI 10.1016/j.dci.2004.09.001; VANDEWATER J, 1990, CLIN IMMUNOL IMMUNOP, V56, P169, DOI 10.1016/0090-1229(90)90139-H; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; White R. G., 1981, Avian immunology. Proceedings of the 16th Poultry Science Symposium, P21; Wu ZG, 2011, IMMUNOBIOLOGY, V216, P1177, DOI 10.1016/j.imbio.2011.05.012; Wu ZG, 2011, DEV COMP IMMUNOL, V35, P563, DOI 10.1016/j.dci.2010.12.015; Wu ZG, 2010, DEV COMP IMMUNOL, V34, P183, DOI 10.1016/j.dci.2009.09.007; Wu ZG, 2010, IMMUNOLOGY, V129, P133, DOI 10.1111/j.1365-2567.2009.03129.x; YOUNG JR, 1994, J IMMUNOL, V152, P3848; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588	54	30	32	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e51799	10.1371/journal.pone.0051799	http://dx.doi.org/10.1371/journal.pone.0051799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326318	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000313551500008
J	Hu, XY; Schlanger, R; He, WX; Macklin, WB; Yan, RQ				Hu, Xiangyou; Schlanger, Rita; He, Wanxia; Macklin, Wendy B.; Yan, Riqiang			Reversing hypomyelination in BACE1-null mice with Akt-DD overexpression	FASEB JOURNAL			English	Article						BACE1; Alzheimer's beta-secretase; neuregulin-1; ErbB4; dominant gain of function	AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE; AXONAL-TRANSPORT; MYELINATION; NEUREGULIN-1; CLEAVAGE; PATHWAY	beta-Site amyloid precursor protein convertase enzyme 1 (BACE1), a type I transmembrane aspartyl protease required to cleave amyloid precursor protein for releasing a toxic amyloid peptide, also cleaves type I and type III neuregulin-1 (Nrg-1). BACE1 deficiency in mice causes hypomyelination during development and impairs remyelination if injured. In BACE1-null mice, the abolished cleavage of neuregulin-1 by BACE1 is speculated to cause reduced myelin sheath thickness in both the central nervous system and peripheral nervous system because reduced cleavage of Nrg-1 correlates with reduced Akt phosphorylation, a downstream signaling molecule of the Nrg-1/ErbB pathway. Here we tested specifically whether increasing Akt activity alone in oligodendrocytes would be sufficient to reverse the hypomyelination phenotype in BACE1-null mice. BACE1-null mice were bred with transgenic mice expressing constitutively active Akt (Akt-DD; mutations with (DT)-T-308 and (DS)-S-473) in oligodendrocytes. Relative to littermate BACE1-null controls, BACE1(-/-)/Akt-DD mice exhibited enhanced expression of myelin basic protein and promoter of proteolipid protein. The elevated expression of myelin proteins correlated with a thicker myelin sheath in optic nerves; comparison of quantified g ratios with statistic significance was used to confirm this reversion. However, it appeared that myelin sheath thickness in the sciatic nerves was not increased in BACE1(-/-)/Akt-DD mice, as the g ratio was not significantly different from the control. Hence, increased Akt activity in BACE1-null myelinating cells only compensates for the loss of BACE1 activity in the central nervous system, which is consistent with the observation that overexpression of Akt-DD in Schwann cells did not induce hypermyelination. Our results suggest that signaling activity other than Akt may also contribute to proper myelination in peripheral nerves.	[Hu, Xiangyou; Schlanger, Rita; He, Wanxia; Yan, Riqiang] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA; [Macklin, Wendy B.] Univ Colorado, Denver Hlth Sci Ctr, Dept Cell & Dev Biol, Aurora, CO USA	Cleveland Clinic Foundation; University of Colorado System; University of Colorado Anschutz Medical Campus	Yan, RQ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Neurosci, 9500 Euclid Ave NC30, Cleveland, OH 44195 USA.	yanr@ccf.org		Yan, Riqiang/0000-0001-7195-7617	U.S. National Institutes of Health [NS-074256]; National Multiple Sclerosis Society [RG-4012A1/1]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056417, R01NS074256, R01NS025304] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank M. Yin (Electron Microscopy Facility, Cleveland Clinic Foundation, Cleveland, OH, USA) for assistance in electron microscopic analysis. This study was supported by U.S. National Institutes of Health grant NS-074256 (to R.Y.) and National Multiple Sclerosis Society grant RG-4012A1/1 (to R.Y.). The authors declare no conflicts of interests.	Altiok N, 1997, EMBO J, V16, P717, DOI 10.1093/emboj/16.4.717; Barros CS, 2009, DEVELOPMENT, V136, P2717, DOI 10.1242/dev.038679; Brinkmann BG, 2008, NEURON, V59, P581, DOI 10.1016/j.neuron.2008.06.028; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Chen S, 2006, J NEUROSCI, V26, P3079, DOI 10.1523/JNEUROSCI.3785-05.2006; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; Cotter L, 2010, SCIENCE, V328, P1415, DOI 10.1126/science.1187735; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Flores AI, 2008, J NEUROSCI, V28, P7174, DOI 10.1523/JNEUROSCI.0150-08.2008; Goebbels S, 2012, EMBO MOL MED, V4, P486, DOI 10.1002/emmm.201200227; Goebbels S, 2010, J NEUROSCI, V30, P8953, DOI 10.1523/JNEUROSCI.0219-10.2010; HAASS C, 1995, ARZNEIMITTEL-FORSCH, V45-1, P398; Hu XY, 2008, FASEB J, V22, P2970, DOI 10.1096/fj.08-106666; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; La Marca R, 2011, NAT NEUROSCI, V14, P857, DOI 10.1038/nn.2849; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Lemke G., 2006, SCI STKE, V2006, pe11; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo XY, 2011, J BIOL CHEM, V286, P23967, DOI 10.1074/jbc.M111.251538; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Macklin WB, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3140pe32; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Narayanan SP, 2009, J NEUROSCI, V29, P6860, DOI 10.1523/JNEUROSCI.0232-09.2009; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Newbern J, 2010, SEMIN CELL DEV BIOL, V21, P922, DOI 10.1016/j.semcdb.2010.08.008; Park SK, 2001, DEV NEUROSCI-BASEL, V23, P327, DOI 10.1159/000048716; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; SISODIA SS, 1995, FASEB J, V9, P366, DOI 10.1096/fasebj.9.5.7896005; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Syed Neeraja, 2010, Mol Cell Pharmacol, V2, P161; Tao YM, 2009, P NATL ACAD SCI USA, V106, P9477, DOI 10.1073/pnas.0901844106; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Taveggia C, 2008, GLIA, V56, P284, DOI 10.1002/glia.20612; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107	43	14	14	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2013	27	5					1868	1873		10.1096/fj.12-224212	http://dx.doi.org/10.1096/fj.12-224212			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23335052	Green Published			2022-12-25	WOS:000318226100007
J	Younan, ND; Sarell, CJ; Davies, P; Brown, DR; Viles, JH				Younan, Nadine D.; Sarell, Claire J.; Davies, Paul; Brown, David R.; Viles, John H.			The cellular prion protein traps Alzheimer's A beta in an oligomeric form and disassembles amyloid fibers	FASEB JOURNAL			English	Article						PrP; structure; NMR; electron microscopy; IR; antiparallel beta sheet	DISEASE; TOXICITY; BINDING; IONS; A-BETA(1-42); ASSOCIATION; IMPAIRMENT; PARKINSONS; PLASTICITY; CLEAVAGE	There is now strong evidence to show that the presence of the cellular prion protein (PrPC) mediates amyloid-beta (A beta) neurotoxicity in Alzheimer's disease (AD). Here, we probe the molecular details of the interaction between PrPC and A beta and discover that substoichiometric amounts of PrPC, as little as 1/20, relative to A beta will strongly inhibit amyloid fibril formation. This effect is specific to the unstructured N-terminal domain of PrPC. Electron microscopy indicates PrPC is able to trap A beta in an oligomeric form. Unlike fibers, this oligomeric A beta contains antiparallel beta sheet and binds to a oligomer specific conformational antibody. Our NMR studies show that a specific region of PrPC, notably residues 95-113, binds to A beta oligomers, but only once A beta misfolds. The ability of PrPC to trap and concentrate A beta in an oligomeric form and disassemble mature fibers suggests a mechanism by which PrPC might confer A beta toxicity in AD, as oligomers are thought to be the toxic form of A beta. Identification of a specific recognition site on PrPC that traps A beta in an oligomeric form is potentially a therapeutic target for the treatment of Alzheimer's disease.-Younan, N. D., Sarell, C. J., Davies, P., Brown, D. R., Viles, J. H. The cellular prion protein traps Alzheimer's A beta in an oligomeric form and disassembles amyloid fibers. FASEB J. 27, 1847-1858 (2013). www.fasebj.org	[Younan, Nadine D.; Sarell, Claire J.; Viles, John H.] Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Davies, Paul; Brown, David R.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of London; University of Bath	Viles, JH (corresponding author), Univ London, Mile End Rd, London E1 4NS, England.	j.viles@qmul.ac.uk		Davies, Paul/0000-0001-8022-2719	Wellcome Trust project [093241/Z/10/Z]; UK Biotechnology and Biological Sciences Research Council Quota studentships; Biotechnology and Biological Sciences Research Council [BB/D005027/1, 978364] Funding Source: researchfish; Medical Research Council [MC_U117533887] Funding Source: researchfish; BBSRC [BB/D005027/1] Funding Source: UKRI; MRC [MC_U117533887] Funding Source: UKRI	Wellcome Trust project(Wellcome Trust); UK Biotechnology and Biological Sciences Research Council Quota studentships(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Wellcome Trust project grant (093241/Z/10/Z) and UK Biotechnology and Biological Sciences Research Council Quota studentships. The authors thank Harold Toms (Queen Mary, University of London) and the UK National Institute for Medical Research for NMR support, and Graham McPhail for assistance with TEM.	Andreetto E, 2010, ANGEW CHEM INT EDIT, V49, P3081, DOI 10.1002/anie.200904902; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Bate C, 2011, J BIOL CHEM, V286, P37955, DOI 10.1074/jbc.M111.248724; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Caetano FA, 2011, J NEUROCHEM, V117, P538, DOI 10.1111/j.1471-4159.2011.07225.x; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Calero O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022090; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Cisse M, 2011, J NEUROSCI, V31, P10427, DOI 10.1523/JNEUROSCI.1459-11.2011; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Ferrer I, 2001, ACTA NEUROPATHOL, V101, P49; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gacia M, 2006, J NEURAL TRANSM, V113, P1747, DOI 10.1007/s00702-006-0540-4; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Gunther EC, 2010, J MOL MED, V88, P331, DOI 10.1007/s00109-009-0568-7; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herms J, 1999, J NEUROSCI, V19, P8866, DOI 10.1523/JNEUROSCI.19-20-08866.1999; Hyeon JW, 2012, BIOCHEM BIOPH RES CO, V424, P214, DOI 10.1016/j.bbrc.2012.06.056; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Klewpatinond M, 2008, J BIOL CHEM, V283, P1870, DOI 10.1074/jbc.M708472200; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; MIYAZAWA T, 1961, J AM CHEM SOC, V83, P712, DOI 10.1021/ja01464a042; Morales R, 2010, J NEUROSCI, V30, P4528, DOI 10.1523/JNEUROSCI.5924-09.2010; Muramoto T, 1996, P NATL ACAD SCI USA, V93, P15457, DOI 10.1073/pnas.93.26.15457; Nadal RC, 2009, BIOCHEMISTRY-US, V48, P8929, DOI 10.1021/bi9011397; Nieznanski K, 2012, J BIOL CHEM, V287, P33104, DOI 10.1074/jbc.C112.400614; O'Sullivan DBD, 2007, BIOCHEM J, V401, P533, DOI 10.1042/BJ20060668; O'Sullivan DBD, 2009, PROTEIN SCI, V18, P410, DOI 10.1002/pro.44; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355; Sarell CJ, 2009, BIOCHEMISTRY-US, V48, P4388, DOI 10.1021/bi900254n; Stanyon HF, 2012, J BIOL CHEM, V287, P28163, DOI 10.1074/jbc.C112.360800; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Viles JH, 2001, BIOCHEMISTRY-US, V40, P2743, DOI 10.1021/bi002898a; Viles JH, 2012, COORDIN CHEM REV, V256, P2271, DOI 10.1016/j.ccr.2012.05.003; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Watt NT, 2005, J BIOL CHEM, V280, P35914, DOI 10.1074/jbc.M507327200; Wuthrich K, 2001, ADV PROTEIN CHEM, V57, P55; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Younan ND, 2011, J MOL BIOL, V410, P369, DOI 10.1016/j.jmb.2011.05.013; Zou WQ, 2011, J BIOL CHEM, V286, P15095, DOI 10.1074/jbc.M110.199356	54	76	76	0	44	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2013	27	5					1847	1858		10.1096/fj.12-222588	http://dx.doi.org/10.1096/fj.12-222588			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23335053	Green Published, hybrid			2022-12-25	WOS:000318226100005
J	De, G; Yip, WK; Ionita-Laza, I; Laird, N				De, Gourab; Yip, Wai-Ki; Ionita-Laza, Iuliana; Laird, Nan			Rare Variant Analysis for Family-Based Design	PLOS ONE			English	Article							COMBINING DEPENDENT TESTS; ASSOCIATION TESTS; COMMON DISEASES; COMPLEX TRAITS; POPULATIONS; INFORMATION; ARRAY	Genome-wide association studies have been able to identify disease associations with many common variants; however most of the estimated genetic contribution explained by these variants appears to be very modest. Rare variants are thought to have larger effect sizes compared to common SNPs but effects of rare variants cannot be tested in the GWAS setting. Here we propose a novel method to test for association of rare variants obtained by sequencing in family-based samples by collapsing the standard family-based association test (FBAT) statistic over a region of interest. We also propose a suitable weighting scheme so that low frequency SNPs that may be enriched in functional variants can be upweighted compared to common variants. Using simulations we show that the family-based methods perform at par with the population-based methods under no population stratification. By construction, family-based tests are completely robust to population stratification; we show that our proposed methods remain valid even when population stratification is present.	[De, Gourab; Yip, Wai-Ki; Laird, Nan] Harvard Univ, Dept Biostat, Boston, MA 02115 USA; [Ionita-Laza, Iuliana] Columbia Univ, Dept Biostat, New York, NY USA	Harvard University; Columbia University	De, G (corresponding author), Harvard Univ, Dept Biostat, Boston, MA 02115 USA.	gde@post.harvard.edu			FBAT (Family Based Association Tests) grant; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095797] Funding Source: NIH RePORTER	FBAT (Family Based Association Tests) grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	FBAT (Family Based Association Tests) grant was used to fund this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Balding DJ, 1995, GENETICA, V2, P3; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Gorlov IP, 2011, CLIN GENET, V79, P199, DOI 10.1111/j.1399-0004.2010.01535.x; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Hao K, 2004, GENOMICS, V84, P623, DOI 10.1016/j.ygeno.2004.05.003; Hoffmann TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013584; Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; Lange C, 2002, AM J HUM GENET, V71, P575, DOI 10.1086/342406; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015., 10.1016/j.ajhg.2011.07.015]; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Murphy A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000197; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Rakovski CS, 2007, GENET EPIDEMIOL, V31, P9, DOI 10.1002/gepi.20186; Saunders IW, 2007, GENOMICS, V90, P291, DOI 10.1016/j.ygeno.2007.05.011; Steen LV, 2005, NAT GENET, V37, P683; WEI LJ, 1985, BIOMETRIKA, V72, P359; Xu X, 2003, BIOSTATISTICS, V4, P223, DOI 10.1093/biostatistics/4.2.223; Xu X, 2006, GENET EPIDEMIOL, V30, P620, DOI 10.1002/gepi.20174; Yip Wai-Ki, 2011, BMC Proc, V5 Suppl 9, pS21, DOI 10.1186/1753-6561-5-S9-S21; Zhu XF, 2010, GENET EPIDEMIOL, V34, P171, DOI 10.1002/gepi.20449; [No title captured]	30	60	63	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e48495	10.1371/journal.pone.0048495	http://dx.doi.org/10.1371/journal.pone.0048495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23341868	Green Published, Green Submitted, gold			2022-12-25	WOS:000314707700002
J	Burke, BJ; Peterson, WT; Beckman, BR; Morgan, C; Daly, EA; Litz, M				Burke, Brian J.; Peterson, William T.; Beckman, Brian R.; Morgan, Cheryl; Daly, Elizabeth A.; Litz, Marisa			Multivariate Models of Adult Pacific Salmon Returns	PLOS ONE			English	Article							COHO ONCORHYNCHUS-KISUTCH; SIZE-SELECTIVE MORTALITY; EARLY MARINE RESIDENCE; SPRING CHINOOK SALMON; COLUMBIA RIVER; INTERANNUAL VARIABILITY; JUVENILE SALMON; OCEAN GROWTH; TSHAWYTSCHA; CALIFORNIA	Most modeling and statistical approaches encourage simplicity, yet ecological processes are often complex, as they are influenced by numerous dynamic environmental and biological factors. Pacific salmon abundance has been highly variable over the last few decades and most forecasting models have proven inadequate, primarily because of a lack of understanding of the processes affecting variability in survival. Better methods and data for predicting the abundance of returning adults are therefore required to effectively manage the species. We combined 31 distinct indicators of the marine environment collected over an 11-year period into a multivariate analysis to summarize and predict adult spring Chinook salmon returns to the Columbia River in 2012. In addition to forecasts, this tool quantifies the strength of the relationship between various ecological indicators and salmon returns, allowing interpretation of ecosystem processes. The relative importance of indicators varied, but a few trends emerged. Adult returns of spring Chinook salmon were best described using indicators of bottom-up ecological processes such as composition and abundance of zooplankton and fish prey as well as measures of individual fish, such as growth and condition. Local indicators of temperature or coastal upwelling did not contribute as much as large-scale indicators of temperature variability, matching the spatial scale over which salmon spend the majority of their ocean residence. Results suggest that effective management of Pacific salmon requires multiple types of data and that no single indicator can represent the complex early-ocean ecology of salmon.	[Burke, Brian J.] Natl Ocean & Atmospher Adm, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Fish Ecol Div, Washington, DC USA; [Peterson, William T.] Natl Ocean & Atmospher Adm, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Fish Ecol Div, Newport, OR USA; [Beckman, Brian R.] Natl Ocean & Atmospher Adm, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Resource Enhancement & Utilizat Div, Seattle, WA USA; [Morgan, Cheryl; Daly, Elizabeth A.; Litz, Marisa] Oregon State Univ, Cooperat Inst Marine Resources Studies, Newport, OR USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University	Burke, BJ (corresponding author), Natl Ocean & Atmospher Adm, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Fish Ecol Div, Washington, DC USA.	brian.burke@noaa.gov			Bonneville Power Administration [1998-014-00]; National Oceanic and Atmospheric Administration - Comparative Analysis of Marine Ecosystem Organization [NA09NMF4720182]; National Oceanic and Atmospheric Administration - Global Ocean Ecosystems Dynamics [NA67RJ0151]	Bonneville Power Administration; National Oceanic and Atmospheric Administration - Comparative Analysis of Marine Ecosystem Organization; National Oceanic and Atmospheric Administration - Global Ocean Ecosystems Dynamics	Funding for this came from Bonneville Power Administration, project #1998-014-00 (http://www.bpa.gov/), National Oceanic and Atmospheric Administration - Comparative Analysis of Marine Ecosystem Organization grant #NA09NMF4720182 (http://cameo.noaa.gov/), and National Oceanic and Atmospheric Administration - Global Ocean Ecosystems Dynamics grant #NA67RJ0151 (http://www.usglobec.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JJ, 2009, ECOL APPL, V19, P1989, DOI 10.1890/08-0477.1; Beamish RJ, 2001, PROG OCEANOGR, V49, P423, DOI 10.1016/S0079-6611(01)00034-9; Bi HS, 2011, FISH OCEANOGR, V20, P125, DOI 10.1111/j.1365-2419.2011.00573.x; Biro PA, 2005, P ROY SOC B-BIOL SCI, V272, P1443, DOI 10.1098/rspb.2005.3096; Bograd SJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035933; Brodeur RD, 2005, MAR ECOL PROG SER, V298, P41, DOI 10.3354/meps298041; Brodeur RD, 2007, FISH OCEANOGR, V16, P395, DOI 10.1111/j.1365-2419.2007.00438.x; Burnham K.P., 2010, MODEL SELECTION MULT; Cross AD, 2009, MAR COAST FISH, V1, P57, DOI 10.1577/C08-005.1; Daly EA, 2012, ENVIRON BIOL FISH, V94, P117, DOI 10.1007/s10641-011-9857-4; Daly EA, 2009, T AM FISH SOC, V138, P1420, DOI 10.1577/T08-226.1; Duffy EJ, 2009, FACTORS EARLY MARINE; Emmett RL, 2006, PROG OCEANOGR, V68, P1, DOI 10.1016/j.pocean.2005.08.001; Emmett RL, 2008, T AM FISH SOC, V137, P657, DOI 10.1577/T06-058.1; Ford MJ, 2010, STATUS REV UPDATE PA; Geiger HJ, 1997, RUN FORECASTS HARVES; Haeseker SL, 2008, N AM J FISH MANAGE, V28, P12, DOI 10.1577/M06-287.1; Hare SR, 2004, CLIMATE CHANGE NO FI; Hinke JT, 2005, MAR ECOL PROG SER, V304, P207, DOI 10.3354/meps304207; HOLTBY LB, 1990, CAN J FISH AQUAT SCI, V47, P2181, DOI 10.1139/f90-243; Hooff RC, 2006, LIMNOL OCEANOGR, V51, P2607, DOI 10.4319/lo.2006.51.6.2607; Hyun SY, 2005, CAN J FISH AQUAT SCI, V62, P1665, DOI 10.1139/F05-071; Jolliffe, 2002, PRINCIPAL COMPONENT; Keister JE, 2011, GLOBAL CHANGE BIOL, V17, P2498, DOI 10.1111/j.1365-2486.2010.02383.x; Koslow JA, 2002, FISH OCEANOGR, V11, P65, DOI 10.1046/j.1365-2419.2002.00187.x; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Litz MNC, 2008, ECOLOGY NO SUBPOPULA; Logerwell EA, 2003, FISH OCEANOGR, V12, P554, DOI 10.1046/j.1365-2419.2003.00238.x; Martin F, 2009, ECOL FRESHW FISH, V18, P406, DOI 10.1111/j.1600-0633.2009.00357.x; Mazur MM, 2006, J FISH BIOL, V69, P151, DOI 10.1111/j.1095-8649.2006.01075.x; McKinnell S, 2012, CAN J FISH AQUAT SCI, V69, P1499, DOI 10.1139/F2012-078; Moss JH, 2005, T AM FISH SOC, V134, P1313, DOI 10.1577/T05-054.1; Nelson G C, 2005, DRIVERS ECOSYSTEM CH; NOAKES D J, 1990, North American Journal of Fisheries Management, V10, P46, DOI 10.1577/1548-8675(1990)010<0046:ACOPFM>2.3.CO;2; ODFW WDFW, 2012, 2012 JOINT STAFF REP; Pearcy W. G., 1992, OCEAN ECOLOGY N PACI; Peres-Neto PR, 2003, ECOLOGY, V84, P2347, DOI 10.1890/00-0634; Peterman RM, 2009, AM FISH S S, V71, P125; PETERMAN RM, 1982, CAN J FISH AQUAT SCI, V39, P1444, DOI 10.1139/f82-195; Peterson WT, 2010, FISH OCEANOGR, V19, P508, DOI 10.1111/j.1365-2419.2010.00560.x; Peterson WT, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017528; Peterson WT, 2012, NOAA FISHERIES; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Rupp DE, 2012, FISH OCEANOGR, V21, P1, DOI 10.1111/j.1365-2419.2011.00605.x; Scheuerell MD, 2005, FISH OCEANOGR, V14, P448, DOI 10.1111/j.1365-2419.2005.00346.x; Schreck CB, 2006, T AM FISH SOC, V135, P457, DOI 10.1577/T05-184.1; Sih A., 1987, P203; Tomaro LM, 2012, MAR ECOL PROG SER, V452, P237, DOI 10.3354/meps09620; Trudel M, 2009, T AM FISH SOC, V138, P1369, DOI 10.1577/T08-181.1; Tucker S, 2011, T AM FISH SOC, V140, P1101, DOI 10.1080/00028487.2011.607035; Wang SZ, 2009, N AM J FISH MANAGE, V29, P423, DOI 10.1577/M07-055.1; Weitkamp LA, 2012, US FISHERY B; Weitkamp LA, 2010, T AM FISH SOC, V139, P147, DOI 10.1577/T08-225.1; Wells BK, 2006, FISH OCEANOGR, V15, P67, DOI 10.1111/j.1365-2419.2005.00361.x; Wells BK, 2008, FISH OCEANOGR, V17, P101, DOI 10.1111/j.1365-2419.2008.00467.x; Westad F, 2002, MULTIVARIATE DATA AN; Zhou SJ, 2003, N AM J FISH MANAGE, V23, P48, DOI 10.1577/1548-8675(2003)023<0048:AOANNF>2.0.CO;2	57	75	77	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54134	10.1371/journal.pone.0054134	http://dx.doi.org/10.1371/journal.pone.0054134			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326586	Green Published, gold			2022-12-25	WOS:000314705800111
J	Chang, SH; Chen, CC; Hsieh, MJ; Wang, CY; Lee, CH; Hsieh, IC				Chang, Shang-Hung; Chen, Chun-Chi; Hsieh, Ming-Jer; Wang, Chao-Yung; Lee, Cheng-Hung; Hsieh, I-Chang			Lesion Length Impacts Long Term Outcomes of Drug-Eluting Stents and Bare Metal Stents Differently	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY LESIONS; 3-YEAR FOLLOW-UP; RANDOMIZED-TRIAL; CLINICAL-OUTCOMES; MULTILINK STENT; RESTENOSIS; SIROLIMUS; IMPLANTATION; MULTICENTER	Background: Long lesions have been associated with adverse outcomes in percutaneous coronary interventions with bare metal stents (BMS). However, the exact impact of lesion length on the short-and long-term outcomes of drug-eluting stent (DES) implantations is not as clear. Methods and Results: This study compared the impact of lesion length on angiographic and clinical outcomes of BMS and DES in a single-center prospective registry. Lesion length was divided into tertiles. The primary endpoints were angiographically defined binary in-stent restenosis (ISR) rate and major adverse cardiac event (MACE). Of the 4,312 de novo lesions in 3,447 consecutive patients in the CAPTAIN registry, 2,791 lesions (of 2,246 patients) received BMS, and the remaining 1,521 lesions (of 1,201 patients) received DES. The mean follow-up duration was 4.5 years. The longer the lesion, the higher the ISR rate (14%, 18%, and 29%, p < 0.001) and the lower the MACE-free survivals (p = 0.007) in the BMS group. However, lesion length showed no such correlation with ISR rates (4.7%, 3.3%, and 7.8%, p = 0.67) or MACE-free survivals (p = 0.19) in the DES group. Conclusions: In our single-center prospective registry, lesion length defined in tertiles has no impact on the short-term (ISR) or long-term (MACE) outcomes of patients implanted with DES. In contrast, longer lesion correlates with higher ISR and MACE rates in BMS group.	[Hsieh, I-Chang] Chang Gung Mem Hosp, Sect Cardiol 2, Taipei 10591, Taiwan; Chang Gung Mem Hosp, Percutaneous Coronary Intervent Ctr, Dept Med, Taipei 10591, Taiwan; Chang Gung Univ, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Hsieh, IC (corresponding author), Chang Gung Mem Hosp, Sect Cardiol 2, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	hsiehic@ms28.hinet.net	Wang, Chao-Yung/ABA-6757-2021; Hsieh, Ming-Jer/M-1340-2013	Wang, Chao-Yung/0000-0003-1546-7298; Hsieh, Ming-Jer/0000-0002-0148-8357; Chang, Shang-hung/0000-0003-0462-2344	Chang Gung Memorial Hospital [CMRPG350214]; Taiwan National Science Council [98-2314-B-182-060]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	Shang-Hung Chang was supported by a grant from Chang Gung Memorial Hospital (CMRPG350214). I-Chang Hsieh was supported by a grant from the Taiwan National Science Council (98-2314-B-182-060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boden WE, 2007, AM J CARDIOL, V99, P208, DOI 10.1016/j.amjcard.2006.07.082; Caputo RP, 2012, AM J CARDIOL, V110, P350, DOI 10.1016/j.amjcard.2012.03.031; Cutlip DE, 2002, J AM COLL CARDIOL, V40, P2082, DOI 10.1016/S0735-1097(02)02597-4; Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028; Dawkins KD, 2005, CIRCULATION, V112, P3306, DOI 10.1161/CIRCULATIONAHA.105.552190; de Feyter PJ, 1999, CIRCULATION, V100, P1777, DOI 10.1161/01.CIR.100.17.1777; Dibra A, 2007, J AM COLL CARDIOL, V49, P616, DOI 10.1016/j.jacc.2006.10.049; Foley DP, 2001, EUR HEART J, V22, P1585, DOI 10.1053/euhj.2001.2752; Grube E, 2009, EUROINTERVENTION, V4, P572, DOI 10.4244/EIJV4I5A97; Holmes DR, 2004, CIRCULATION, V109, P634, DOI 10.1161/01.CIR.0000112572.57794.22; Hsieh IC, 2006, INT J CARDIOL, V111, P209, DOI 10.1016/j.ijcard.2005.07.005; Hsieh IC, 2004, CATHETER CARDIO INTE, V62, P453, DOI 10.1002/ccd.20116; Kang SJ, 2011, CIRC-CARDIOVASC INTE, V4, P9, DOI 10.1161/CIRCINTERVENTIONS.110.940320; Kastrati A, 1999, AM J CARDIOL, V83, P1617, DOI 10.1016/S0002-9149(99)00165-4; Kereiakes D, 2000, AM J CARDIOL, V86, P336, DOI 10.1016/S0002-9149(00)00928-0; Kim YH, 2006, CIRCULATION, V114, P2148, DOI 10.1161/CIRCULATIONAHA.106.666396; Kimura T, 2002, CIRCULATION, V105, P2986, DOI 10.1161/01.CIR.0000019743.11941.3B; Kimura T, 1996, NEW ENGL J MED, V334, P561, DOI 10.1056/NEJM199602293340903; Kobayashi Y, 1999, J AM COLL CARDIOL, V34, P651, DOI 10.1016/S0735-1097(99)00303-4; Koh AS, 2011, CORONARY ARTERY DIS, V22, P96, DOI 10.1097/MCA.0b013e32834236d0; Liistro F, 2002, CIRCULATION, V105, P1883, DOI 10.1161/01.CIR.0000016042.69606.61; Mauri L, 2005, AM J CARDIOL, V95, P1140, DOI 10.1016/j.amjcard.2005.01.039; Mauri L, 2004, AM J CARDIOL, V93, P1340, DOI 10.1016/j.amjcard.2004.02.027; Mehran R, 1999, CIRCULATION, V100, P1872, DOI 10.1161/01.CIR.100.18.1872; Menichelli M, 2007, J AM COLL CARDIOL, V49, P1924, DOI 10.1016/j.jacc.2007.01.081; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Park KW, 2010, AM HEART J, V159, P446, DOI 10.1016/j.ahj.2010.01.001; Raber L, 2010, J AM COLL CARDIOL, V55, P1178, DOI 10.1016/j.jacc.2009.11.052; Rathore S, 2009, EUROINTERVENTION, V5, P349, DOI 10.4244/V5I3A55; Rozenman Y, 2009, EUROINTERVENTION, V5, P219, DOI 10.4244/EIJV5I2A34; Shirai S, 2010, JACC-CARDIOVASC INTE, V3, P180, DOI 10.1016/j.jcin.2009.11.009; Tcheng JE, 2009, CIRC-CARDIOVASC INTE, V2, P43, DOI 10.1161/CIRCINTERVENTIONS.108.809285; Teirstein PS, 2010, CIRCULATION, V122, P5, DOI 10.1161/CIRCULATIONAHA.110.962423; Violini R, 2010, J AM COLL CARDIOL, V55, P810, DOI 10.1016/j.jacc.2009.09.046	34	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53207	10.1371/journal.pone.0053207	http://dx.doi.org/10.1371/journal.pone.0053207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326399	Green Submitted, gold, Green Published			2022-12-25	WOS:000314705800038
J	Decelle, J; Martin, P; Paborstava, K; Pond, DW; Tarling, G; Mahe, F; de Vargas, C; Lampitt, R; Not, F				Decelle, Johan; Martin, Patrick; Paborstava, Katsiaryna; Pond, David W.; Tarling, Geraint; Mahe, Frederic; de Vargas, Colomban; Lampitt, Richard; Not, Fabrice			Diversity, Ecology and Biogeochemistry of Cyst-Forming Acantharia (Radiolaria) in the Oceans	PLOS ONE			English	Article							VERTICAL-DISTRIBUTION; COMMUNITY STRUCTURE; SEAWATER STRONTIUM; SURFACE WATERS; PARTICLE-FLUX; ABUNDANCE; PATTERNS; SEDIMENTATION; ENCYSTMENT; ATLANTIC	Marine planktonic organisms that undertake active vertical migrations over their life cycle are important contributors to downward particle flux in the oceans. Acantharia, globally distributed heterotrophic protists that are unique in building skeletons of celestite (strontium sulfate), can produce reproductive cysts covered by a heavy mineral shell that sink rapidly from surface to deep waters. We combined phylogenetic and biogeochemical analyses to explore the ecological and biogeochemical significance of this reproductive strategy. Phylogenetic analysis of the 18S and 28S rRNA genes of different cyst morphotypes collected in different oceans indicated that cyst-forming Acantharia belong to three early diverging and essentially non symbiotic clades from the orders Chaunacanthida and Holacanthida. Environmental high-throughput V9 tag sequences and clone libraries of the 18S rRNA showed that the three clades are widely distributed in the Indian, Atlantic and Pacific Oceans at different latitudes, but appear prominent in regions of higher primary productivity. Moreover, sequences of cyst-forming Acantharia were distributed evenly in both the photic and mesopelagic zone, a vertical distribution that we attribute to their life cycle where flagellated swarmers are released in deep waters from sinking cysts. Bathypelagic sediment traps in the subantarctic and oligotrophic subtropical Atlantic Ocean showed that downward flux of Acantharia was only large at high-latitudes and during a phytoplankton bloom. Their contribution to the total monthly particulate organic matter flux can represent up to 3%. High organic carbon export in cold waters would be a putative nutritional source for juveniles ascending in the water column. This study improves our understanding of the life cycle and biogeochemical contribution of Acantharia, and brings new insights into a remarkable reproductive strategy in marine protists.	[Decelle, Johan; Mahe, Frederic; de Vargas, Colomban; Not, Fabrice] Univ Paris 06, Stn Biol Roscoff, EPPO, CNRS,UMR 7144, Roscoff, France; [Martin, Patrick; Paborstava, Katsiaryna; Lampitt, Richard] Natl Oceanog Ctr, Southampton, Hants, England; [Pond, David W.; Tarling, Geraint] British Antarctic Survey, Cambridge CB3 0ET, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; NERC National Oceanography Centre; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Decelle, J (corresponding author), Univ Paris 06, Stn Biol Roscoff, EPPO, CNRS,UMR 7144, Pl Georges Teissier, Roscoff, France.	decelle@sb-roscoff.fr	Martin, Patrick/F-6263-2017; Mahé, Frédéric/AAR-8568-2021	Martin, Patrick/0000-0001-8008-5558; Mahé, Frédéric/0000-0002-2808-0984; Decelle, Johan/0000-0002-4343-8358; de Vargas, Colomban/0000-0002-6476-6019	PhD fellowship DIPHOPE from the Region Bretagne [044763]; SYMFORAD project from the Region Bretagne; EGIDE program; French ANR [POSEIDON 09-BLAN-0348]; NERC [bas0100025, noc010009] Funding Source: UKRI; Natural Environment Research Council [bas0100025, noc010009] Funding Source: researchfish	PhD fellowship DIPHOPE from the Region Bretagne; SYMFORAD project from the Region Bretagne; EGIDE program; French ANR(French National Research Agency (ANR)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the PhD fellowship DIPHOPE (044763) and SYMFORAD project from the Region Bretagne, as well as, the EGIDE program and the French ANR (POSEIDON 09-BLAN-0348). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amacher J, 2009, DEEP-SEA RES PT I, V56, P2206, DOI 10.1016/j.dsr.2009.08.007; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; ANDERSON OR, 1990, PHILOS T ROY SOC B, V329, P81, DOI 10.1098/rstb.1990.0152; ANTIA AN, 1993, J PLANKTON RES, V15, P99, DOI 10.1093/plankt/15.1.99; Aristegui J, 2009, LIMNOL OCEANOGR, V54, P1501, DOI 10.4319/lo.2009.54.5.1501; BEERS JR, 1970, LIMNOL OCEANOGR, V15, P825, DOI 10.4319/lo.1970.15.5.0825; BERNSTEIN RE, 1992, GEOCHIM COSMOCHIM AC, V56, P3273, DOI 10.1016/0016-7037(92)90304-2; BERNSTEIN RE, 1987, SCIENCE, V237, P1490, DOI 10.1126/science.237.4821.1490; BIDWELL JP, 1986, BIOL BULL, V170, P75, DOI 10.2307/1541382; Bottazzi E.M., 1973, Rendiconti Ist Lomb Sci Lett (B), V107, P3; Countway PD, 2007, ENVIRON MICROBIOL, V9, P1219, DOI 10.1111/j.1462-2920.2007.01243.x; De Deckker P, 2004, HYDROBIOLOGIA, V517, P1, DOI 10.1023/B:HYDR.0000027333.02017.50; de Villiers S, 1999, EARTH PLANET SC LETT, V171, P623, DOI 10.1016/S0012-821X(99)00174-0; Decelle J, 2012, SYMBIOSIS, V58, P233, DOI 10.1007/s13199-012-0195-x; Decelle J, 2012, P NATL ACAD SCI USA, V109, P18000, DOI 10.1073/pnas.1212303109; Decelle J, 2012, PROTIST, V163, P435, DOI 10.1016/j.protis.2011.10.002; Dennett MR, 2002, J PLANKTON RES, V24, P797, DOI 10.1093/plankt/24.8.797; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edgcomb V, 2011, ISME J, V5, P1344, DOI 10.1038/ismej.2011.6; Edgcomb VP, 2002, P NATL ACAD SCI USA, V99, P7658, DOI 10.1073/pnas.062186399; Febvre Colette, 2002, P783; Febvre J, 2001, ACANTHARIA, DOI DOI 10.1038/NPG.ELS.0002102; Gilg IC, 2010, PROTIST, V161, P197, DOI 10.1016/j.protis.2009.09.002; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guillou L, 2013, NUCLEIC ACIDS RES, V41, pD597, DOI 10.1093/nar/gks1160; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haeckel E, 1888, MONOGRAPHIE DRITTER, P33; HANLON RT, 1989, J EXP BIOL, V141, P187; Hewson I, 2006, LIMNOL OCEANOGR, V51, P1274, DOI 10.4319/lo.2006.51.3.1274; HOLLANDE A, 1957, CR HEBD ACAD SCI, V244, P508; Hollande A ., 1965, Protistologica, V1, P91; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Kremp A, 2009, LIMNOL OCEANOGR, V54, P1125, DOI 10.4319/lo.2009.54.4.1125; Kwon EY, 2009, NAT GEOSCI, V2, P630, DOI 10.1038/NGEO612; Lamborg CH, 2008, DEEP-SEA RES PT II, V55, P1540, DOI 10.1016/j.dsr2.2008.04.011; Lampitt RS, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003221; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Lopez-Garcia P, 2003, P NATL ACAD SCI USA, V100, P697, DOI 10.1073/pnas.0235779100; Martin P, 2011, DEEP-SEA RES PT I, V58, P338, DOI 10.1016/j.dsr.2011.01.006; Martin P, 2010, LIMNOL OCEANOGR, V55, P604, DOI 10.4319/lo.2009.55.2.0604; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; MICHAELS AF, 1995, J PLANKTON RES, V17, P131, DOI 10.1093/plankt/17.1.131; MICHAELS AF, 1988, MAR BIOL, V97, P559, DOI 10.1007/BF00391052; Muller H, 1999, AQUAT MICROB ECOL, V17, P37, DOI 10.3354/ame017037; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Not F, 2007, ENVIRON MICROBIOL, V9, P1233, DOI 10.1111/j.1462-2920.2007.01247.x; Not F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007143; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Popofsky A, 1908, ZOOLOGIE 2, V10, P183; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; REID PC, 1987, MAR BIOL, V95, P221, DOI 10.1007/BF00409009; Richardson TL, 1998, J PLANKTON RES, V20, P219, DOI 10.1093/plankt/20.2.219; Salani FS, 2012, ISME J, V6, P713, DOI 10.1038/ismej.2011.138; Salter I, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003977; SCHEWIAKOFF W., 1926, FAUNA E FLORA DEL GOLFO NAPOLI MONOGR, V37, P1; Schiebel R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001459; Schiebel Ralf, 2005, Palaeontologische Zeitschrift, V79, P135; Schnetzer A, 2011, DEEP-SEA RES PT I, V58, P16, DOI 10.1016/j.dsr.2010.10.003; Shaked Y, 2006, MAR ECOL PROG SER, V325, P59, DOI 10.3354/meps325059; SMETACEK VS, 1985, MAR BIOL, V84, P239, DOI 10.1007/BF00392493; SPINDLER M, 1990, MAR MICROPALEONTOL, V15, P209, DOI 10.1016/0377-8398(90)90011-A; Suzuki Noritoshi, 2009, Bulletin of the National Museum of Nature and Science Series B-Botany, V35, P169; SWANBERG NR, 1991, J PLANKTON RES, V13, P287, DOI 10.1093/plankt/13.2.287; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan Z., 1989, Studia Marina Sinica, P127; Vaidya G, CLADISTICS IN PRESS; VILLAREAL TA, 1993, NATURE, V363, P709, DOI 10.1038/363709a0; von Dassow P, 2011, J PLANKTON RES, V33, P3, DOI 10.1093/plankt/fbq137; Whitehouse MJ, 2012, DEEP-SEA RES PT II, V59, P47, DOI 10.1016/j.dsr2.2011.05.010	70	41	43	3	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53598	10.1371/journal.pone.0053598	http://dx.doi.org/10.1371/journal.pone.0053598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326463	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000314705800057
J	Hou, L; Zhao, XH; Wang, P; Ning, Q; Meng, M; Liu, CG				Hou, Lei; Zhao, Xinhan; Wang, Pei; Ning, Qian; Meng, Min; Liu, Caigang			Antitumor Activity of Antimicrobial Peptides Containing CisoDGRC in CD13 Negative Breast Cancer Cells	PLOS ONE			English	Article							TUMOR PROGRESSION; NGR; ISOASPARTATE; MEMBRANE; INTEGRIN; BINDING; ISODGR; ALPHA(V)BETA(3); ANGIOGENESIS	Backgroud: isoAsp-Gly-Arg (isoDGR) is a derivative of the Asn-Gly-Arg (NGR) motif, which is used as a targeted delivery tool to aminopeptidase N (CD13) positive cells. Recent studies have shown that cyclic isoDGR (CisoDGRC) has a more efficient affinity with alpha(v)beta(3), a type of integrin that overexpresses in tumor cells. Antimicrobial peptides (AMPs) are an efficient antitumor peptide that specifically kills tumor cells. In the present study, we designed antimicrobial peptides containing the CisoDGRC motif (CDAK) and assessed its antitumor activity for CD13(-)/alpha(v)beta(+)(3) breast cancer cells (MCF-7 and MDA-MB-231) in vitro and in vivo. Methods: In vitro: We assessed the cytotoxicity of CDAK for MCF-7 and MDA-MB-231 breast cancer cells, the human umbilical vein endothelial cell (HUVEC), and human foreskin fibroblasts (HFF). We performed an apoptosis assay using Annexin-V/PI, DNA ladder, mitochondrial membrane potential, and Caspase-3 and Bcl-2. The effect on cell cycles and affinity with cell were tested using flow cytometry and fluorescent microscopy and the effect on invasion was analyzed using an invasion assay. CDAK was injected intravenously into tumor-bearing athymic nude mice in vivo experiment. Results: CDAK showed cytotoxic activity in MCF-7 and MDA-MB-231 cells, whereas HUVEC and HFF were less sensitive to the peptides. CDAK induced apoptosis, reduced mitochondrial membrane potential, promoted Caspase-3, and inhibited Bcl-2 expression in the two breast cancer cell lines. In addition, CDAK inhibited proliferation of cancer cell through S phase arrest, and own selective affinity with MCF-7 and MDA-MB-231cells, inhibited the invasion of MDA-MB-231 cells. In vivo, CDAK significant inhibited the progression of the tumor and the generation of neovascularization. Conclusion: Antimicrobial peptides containing the CisoDGRC (CDAK) motif could efficiently exhibit the antitumor activity for CD13(-)/alpha(v)beta(+)(3) breast cancer cells.	[Hou, Lei; Zhao, Xinhan; Wang, Pei; Ning, Qian; Meng, Min] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Oncol, Xian 710049, Shaanxi Provinc, Peoples R China; [Liu, Caigang] China Med Univ, Hosp 1, Dept Breast Surg, Shenyang, Liaoning Provin, Peoples R China	Xi'an Jiaotong University; China Medical University	Zhao, XH (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Oncol, Xian 710049, Shaanxi Provinc, Peoples R China.	zhaoxinhanprof@163.com	Liu, Caigang/C-7179-2018; meng, meng/GWZ-7461-2022	Liu, Caigang/0000-0003-2083-235X; 	national natural science foundation of China [30772112.]	national natural science foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant of the national natural science foundation of China (30772112.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braun K, 2010, INT J MED SCI, V7, P326; Carraway KL, 2007, CURR TOP DEV BIOL, V78, P1, DOI 10.1016/S0070-2153(06)78001-2; Chen YC, 2010, MOL THER, V18, P828, DOI 10.1038/mt.2009.291; Colombo G, 2002, J BIOL CHEM, V277, P47891, DOI 10.1074/jbc.M207500200; Corti A, 2010, J ONCOL, V2010, DOI 10.1155/2010/732680; Corti A, 2011, J CELL SCI, V124, P515, DOI 10.1242/jcs.077172; Curnis F, 2008, CANCER RES, V68, P7073, DOI 10.1158/0008-5472.CAN-08-1272; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; Curnis F, 2010, J BIOL CHEM, V285, P9114, DOI 10.1074/jbc.M109.044297; Eliceiri BP, 1999, J CLIN INVEST, V103, P1227, DOI 10.1172/JCI6869; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Gasparini G, 1998, CLIN CANCER RES, V4, P2625; Gregorc V, 2011, CLIN CANCER RES, V17, P1964, DOI 10.1158/1078-0432.CCR-10-1376; Haier J, 2002, CLIN EXP METASTAS, V19, P665, DOI 10.1023/A:1021316531912; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Kawamoto M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-359; Law B, 2006, MOL CANCER THER, V5, P1944, DOI 10.1158/1535-7163.MCT-05-0509; Mai JC, 2001, CANCER RES, V61, P7709; Ranogajec I, 2012, MED ONCOL, V29, P561, DOI 10.1007/s12032-011-9984-y; Rizzardi GP, 2009, BLOOD, V113, P5366, DOI 10.1182/blood-2009-02-207068; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Spitaleri A, 2008, J BIOL CHEM, V283, P19757, DOI 10.1074/jbc.M710273200; Sulochana KN, 2007, CURR PHARM DESIGN, V13, P2074; van Wijngaarden P, 2005, JAMA-J AM MED ASSOC, V293, P1509, DOI 10.1001/jama.293.12.1509; von Wallbrunn A, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2839046; Wu JH, 2012, BIOCONJUGATE CHEM, V23, P796, DOI 10.1021/bc2006576; Zhang Z, 2005, PHARM RES-DORDR, V22, P381, DOI 10.1007/s11095-004-1875-x; Zhou TY, 2011, INT J NANOMED, V6, P1527, DOI 10.2147/IJN.S15239	28	11	14	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53491	10.1371/journal.pone.0053491	http://dx.doi.org/10.1371/journal.pone.0053491			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326440	gold, Green Submitted, Green Published			2022-12-25	WOS:000314705800049
J	Amitani, H; Asakawa, A; Cheng, KC; Amitani, M; Kaimoto, K; Nakano, M; Ushikai, M; Li, YX; Tsai, ML; Li, JB; Terashi, M; Chaolu, H; Kamimura, R; Inui, A				Amitani, Haruka; Asakawa, Akihiro; Cheng, Kaichun; Amitani, Marie; Kaimoto, Kaori; Nakano, Masako; Ushikai, Miharu; Li, Yingxiao; Tsai, Minglun; Li, Jiang-Bo; Terashi, Mutsumi; Chaolu, Huhe; Kamimura, Ryozo; Inui, Akio			Hydrogen Improves Glycemic Control in Type1 Diabetic Animal Model by Promoting Glucose Uptake into Skeletal Muscle	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GROWTH FACTOR-I; MOLECULAR-HYDROGEN; OXIDATIVE STRESS; N-ACETYLCYSTEINE; INSULIN-RECEPTOR; LEPTIN RECEPTOR; RICH WATER; VITAMIN-C; ANTIOXIDANT	Hydrogen (H-2) acts as a therapeutic antioxidant. However, there are few reports on H-2 function in other capacities in diabetes mellitus (DM). Therefore, in this study, we investigated the role of H-2 in glucose transport by studying cultured mouse C2C12 cells and human hepatoma Hep-G2 cells in vitro, in addition to three types of diabetic mice [Streptozotocin (STZ)-induced type 1 diabetic mice, high-fat diet-induced type 2 diabetic mice, and genetically diabetic db/db mice] in vivo. The results show that H-2 promoted 2-[C-14]-deoxy-D-glucose (2-DG) uptake into C2C12 cells via the translocation of glucose transporter Glut4 through activation of phosphatidylinositol-3-OH kinase (PI3K), protein kinase C (PKC), and AMP-activated protein kinase (AMPK), although it did not stimulate the translocation of Glut2 in Hep G2 cells. H-2 significantly increased skeletal muscle membrane Glut4 expression and markedly improved glycemic control in STZ-induced type 1 diabetic mice after chronic intraperitoneal (i.p.) and oral (p.o.) administration. However, long-term p.o. administration of H-2 had least effect on the obese and non-insulin-dependent type 2 diabetes mouse models. Our study demonstrates that H-2 exerts metabolic effects similar to those of insulin and may be a novel therapeutic alternative to insulin in type 1 diabetes mellitus that can be administered orally.	[Amitani, Haruka; Asakawa, Akihiro; Cheng, Kaichun; Amitani, Marie; Kaimoto, Kaori; Nakano, Masako; Ushikai, Miharu; Li, Yingxiao; Tsai, Minglun; Li, Jiang-Bo; Terashi, Mutsumi; Chaolu, Huhe; Inui, Akio] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychosomat Internal Med, Kagoshima 890, Japan; [Kamimura, Ryozo] Kagoshima Univ, Grad Sch Med & Dent Sci, Inst Lab Anim, Kagoshima 890, Japan	Kagoshima University; Kagoshima University	Asakawa, A (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychosomat Internal Med, Kagoshima 890, Japan.	asakawa@m2.kufm.kagoshima-u.ac.jp			Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research is partially funded by the Young Researcher Overseas Visits Program for Vitalizing Brain Circulation of the Japan Society for the Promotion of Science. The authors gratefully acknowledge VANA Co., Ltd. (Yamanashi, Japan) for the generous gift of natural hydrogen water. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Bak MJ, 2012, INT J MOL SCI, V13, P2314, DOI 10.3390/ijms13022314; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chang CJ, 1996, J AUTONOM NERV SYST, V61, P191; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chen H, 2010, BIOCHEM BIOPH RES CO, V393, P308, DOI 10.1016/j.bbrc.2010.02.005; Chen HC, 2002, J BIOL CHEM, V277, P23554, DOI 10.1074/jbc.M201152200; Childs A, 2001, FREE RADICAL BIO MED, V31, P745, DOI 10.1016/S0891-5849(01)00640-2; DeFronzo RA, 1997, DIABETES REV, V5, P177; Delaney CA, 1995, BIOCHEM PHARMACOL, V50, P2015, DOI 10.1016/0006-2952(95)02102-7; Dong J, 2006, ENDOCRINOLOGY, V147, P2634, DOI 10.1210/en.2005-1335; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Elsner M, 2000, DIABETOLOGIA, V43, P1528, DOI 10.1007/s001250051564; Farese RV, 2002, AM J PHYSIOL-ENDOC M, V283, pE1, DOI 10.1152/ajpendo.00045.2002; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; Frystyk J, 2005, HORM METAB RES, V37, pS44, DOI 10.1055/s-2005-861362; Fu Y, 2009, NEUROSCI LETT, V453, P81, DOI 10.1016/j.neulet.2009.02.016; Fujita K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007247; Galley HF, 1996, FREE RADICAL BIO MED, V20, P139, DOI 10.1016/0891-5849(95)02022-5; GAMMELTOFT S, 1986, BIOCHEM J, V235, P1; Garg Vishvas, 2011, Indian J Endocrinol Metab, V15, pS5, DOI 10.4103/2230-8210.83053; Gharib B, 2001, CR ACAD SCI III-VIE, V324, P719, DOI 10.1016/S0764-4469(01)01350-6; Ghoshal UC, 2011, J NEUROGASTROENTEROL, V17, P312, DOI 10.5056/jnm.2011.17.3.312; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; GULER HP, 1987, NEW ENGL J MED, V317, P137, DOI 10.1056/NEJM198707163170303; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Herbert V, 1996, J NUTR, V126, pS1213, DOI 10.1093/jn/126.suppl_4.1213S; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Inui A, 2001, NAT REV NEUROSCI, V2, P551, DOI 10.1038/35086018; Ishii S, 2002, ENDOCRINOLOGY, V143, P4934, DOI 10.1210/en.2002-220612; Itoh T, 2009, BIOCHEM BIOPH RES CO, V389, P651, DOI 10.1016/j.bbrc.2009.09.047; Kajiyama S, 2008, NUTR RES, V28, P137, DOI 10.1016/j.nutres.2008.01.008; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Kamimura N, 2011, OBESITY, V19, P1396, DOI 10.1038/oby.2011.6; Kelly G S, 1998, Altern Med Rev, V3, P114; KLIP A, 1990, DIABETES CARE, V13, P228, DOI 10.2337/diacare.13.3.228; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; KRONCKE KD, 1995, BIOL CHEM H-S, V376, P179, DOI 10.1515/bchm3.1995.376.3.179; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; LEVITT MD, 1969, NEW ENGL J MED, V281, P122, DOI 10.1056/NEJM196907172810303; MARKS JL, 1990, ENDOCRINOLOGY, V127, P3234, DOI 10.1210/endo-127-6-3234; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; MORGAN NG, 1994, BIOSCIENCE REP, V14, P243, DOI 10.1007/BF01209729; Murdolo G, 2003, DIABETES, V52, P2923, DOI 10.2337/diabetes.52.12.2923; Nagata K, 2009, NEUROPSYCHOPHARMACOL, V34, P501, DOI 10.1038/npp.2008.95; Nakao A, 2010, J CLIN BIOCHEM NUTR, V46, P140, DOI 10.3164/jcbn.09-100; Nakashima-Kamimura N, 2009, CANCER CHEMOTH PHARM, V64, P753, DOI 10.1007/s00280-008-0924-2; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; NeuschwanderTetri BA, 1996, BIOCHEM J, V320, P1005, DOI 10.1042/bj3201005; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ohsawa I, 2008, BIOCHEM BIOPH RES CO, V377, P1195, DOI 10.1016/j.bbrc.2008.10.156; Oikawa S, 1999, CARCINOGENESIS, V20, P1485, DOI 10.1093/carcin/20.8.1485; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; Sagrista ML, 2002, FREE RADICAL RES, V36, P329, DOI 10.1080/10715760290019354; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Siu PM, 2009, LIFE SCI, V84, P468, DOI 10.1016/j.lfs.2009.01.014; Song MC, 2004, J PHARMACOL EXP THER, V308, P307, DOI 10.1124/jpet.103.056622; Su MH, 2006, FEBS LETT, V580, P4136, DOI 10.1016/j.febslet.2006.06.060; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tanno M, 2010, J BIOL CHEM, V285, P8375, DOI 10.1074/jbc.M109.090266; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Wang AL, 2006, HEPATOL RES, V34, P199, DOI 10.1016/j.hepres.2005.12.005; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Xie KL, 2010, SHOCK, V34, P90, DOI 10.1097/SHK.0b013e3181cdc4ae; Xu Y, 2011, ANN NY ACAD SCI, V1243, P1, DOI 10.1111/j.1749-6632.2011.06248.x; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	72	28	31	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53913	10.1371/journal.pone.0053913	http://dx.doi.org/10.1371/journal.pone.0053913			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326534	Green Published, Green Submitted, gold			2022-12-25	WOS:000313552400057
J	Cederlund, A; Kai-Larsen, Y; Printz, G; Yoshio, H; Alvelius, G; Lagercrantz, H; Stromberg, R; Jornvall, H; Gudmundsson, GH; Agerberth, B				Cederlund, Andreas; Kai-Larsen, Ylva; Printz, Gordana; Yoshio, Hiroyuki; Alvelius, Gunvor; Lagercrantz, Hugo; Stromberg, Roger; Jornvall, Hans; Gudmundsson, Gudmundur H.; Agerberth, Birgitta			Lactose in Human Breast Milk an Inducer of Innate Immunity with Implications for a Role in Intestinal Homeostasis	PLOS ONE			English	Article							ANTIBACTERIAL PEPTIDE LL-37; ANTIMICROBIAL PEPTIDES; IMMUNOLOGICAL COMPONENTS; 1ST LINE; EXPRESSION; INFANTS; DEFENSE; CELLS; OLIGOSACCHARIDES; GROWTH	Postpartum, infants have not yet established a fully functional adaptive immune system and are at risk of acquiring infections. Hence, newborns are dependent on the innate immune system with its antimicrobial peptides (AMPs) and proteins expressed at epithelial surfaces. Several factors in breast milk are known to confer immune protection, but which the decisive factors are and through which manner they work is unknown. Here, we isolated an AMP-inducing factor from human milk and identified it by electrospray mass spectrometry and NMR to be lactose. It induces the gene (CAMP) that encodes the only human cathelicidin LL-37 in colonic epithelial cells in a dose- and time-dependent manner. The induction was suppressed by two different p38 antagonists, indicating an effect via the p38-dependent pathway. Lactose also induced CAMP in the colonic epithelial cell line T84 and in THP-1 monocytes and macrophages. It further exhibited a synergistic effect with butyrate and phenylbutyrate on CAMP induction. Together, these results suggest an additional function of lactose in innate immunity by upregulating gastrointestinal AMPs that may lead to protection of the neonatal gut against pathogens and regulation of the microbiota of the infant.	[Cederlund, Andreas; Kai-Larsen, Ylva; Alvelius, Gunvor; Jornvall, Hans; Agerberth, Birgitta] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Printz, Gordana; Lagercrantz, Hugo] Karolinska Univ Hosp, Dept Woman & Child Hlth, Stockholm, Sweden; [Yoshio, Hiroyuki] St Marianna Univ, Dept Neonatol, Sch Med, Miyamae Ku, Kawasaki, Kanagawa, Japan; [Stromberg, Roger] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Gudmundsson, Gudmundur H.] Univ Iceland, Inst Biol, Biomed Ctr, Reykjavik, Iceland	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Saint Marianna University; Karolinska Institutet; University of Iceland	Kai-Larsen, Y (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	ylva.kai-larsen@ki.se	Gudmundsson, Gudmundur H/K-9178-2015; Stromberg, Roger/C-2960-2013	Gudmundsson, Gudmundur H/0000-0001-5793-0565; 	Swedish Research Council [11217, 3532]; Swedish Foundation for Strategic Research; Torsten and Ragnar Soderbergs Foundation; Swedish Cancer Society; Karolinska Institutet; Icelandic Centre for Research (RANNIS); University of Iceland	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Torsten and Ragnar Soderbergs Foundation; Swedish Cancer Society(Swedish Cancer Society); Karolinska Institutet(Karolinska Institutet); Icelandic Centre for Research (RANNIS); University of Iceland	The authors are supported by the Swedish Research Council (11217, 3532), the Swedish Foundation for Strategic Research, the Torsten and Ragnar Soderbergs Foundation, the Swedish Cancer Society, Karolinska Institutet, the Icelandic Centre for Research (RANNIS) and the University of Iceland Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Armogida SA, 2004, ALLERGY ASTHMA PROC, V25, P297; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Blewett HJH, 2008, ADV FOOD NUTR RES, V54, P45, DOI 10.1016/S1043-4526(07)00002-2; Bode L, 2009, NUTR REV, V67, pS183, DOI 10.1111/j.1753-4887.2009.00239.x; Bowdish DME, 2005, CURR PROTEIN PEPT SC, V6, P35, DOI 10.2174/1389203053027494; Brown AC, 2011, EXPERT REV GASTROENT, V5, P411, DOI [10.1586/EGH.11.29, 10.1586/egh.11.29]; Cederlund A, 2011, FEBS J, V278, P3942, DOI 10.1111/j.1742-4658.2011.08302.x; Cederlund A, 2010, J INNATE IMMUN, V2, P508, DOI 10.1159/000317665; Chu H, 2012, SCIENCE; COUNAHAN R, 1976, ARCH DIS CHILD, V51, P517, DOI 10.1136/adc.51.7.517; COWLAND JB, 1995, FEBS LETT, V368, P173, DOI 10.1016/0014-5793(95)00634-L; Dai DW, 2000, J PEDIATR GASTR NUTR, V30, pS23, DOI 10.1097/00005176-200003002-00005; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Eadala P, 2011, ALIMENT PHARM THER, V34, P735, DOI 10.1111/j.1365-2036.2011.04799.x; Field CJ, 2000, J PEDIATR GASTR NUTR, V31, P291, DOI 10.1097/00005176-200009000-00017; Field CJ, 2005, J NUTR, V135, P1; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; Halldorsson S, 2007, IN VITRO CELL DEV-AN, V43, P283, DOI 10.1007/s11626-007-9050-4; Hanson LA, 2002, ADV EXP MED BIOL, V503, P99; Hase K, 2003, GASTROENTEROLOGY, V125, P1613, DOI 10.1053/j.gastro.2003.08.028; Hawkes JS, 2006, EUR J CLIN NUTR, V60, P254, DOI 10.1038/sj.ejcn.1602310; He T, 2006, J NUTR, V136, P58, DOI 10.1093/jn/136.1.58; Heyman MB, 2006, PEDIATRICS, V118, P1279, DOI 10.1542/peds.2006-1721; Jiang TA, 1997, J NUTR, V127, P1489, DOI 10.1093/jn/127.8.1489; Kai-Larsen Y, 2007, PEDIATR RES, V61, P530, DOI 10.1203/pdr.0b013e318045be83; Kuntz S, 2008, BRIT J NUTR, V99, P462, DOI 10.1017/S0007114507824068; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1537S; LU X, 1992, CANCER RES, V52, P3718; LUCAS A, 1990, LANCET, V336, P1519, DOI 10.1016/0140-6736(90)93304-8; Mallow EB, 1996, J BIOL CHEM, V271, P4038; Marchini G, 2002, BRIT J DERMATOL, V147, P1127, DOI 10.1046/j.1365-2133.2002.05014.x; Marcobal A, 2011, CELL HOST MICROBE, V10, P507, DOI 10.1016/j.chom.2011.10.007; Murakami M, 2005, PEDIATR RES, V57, P10, DOI 10.1203/01.PDR.0000148068.32201.50; Murray IA, 2000, BRIT J NUTR, V83, P241, DOI 10.1017/S0007114500000313; Nilsson MF, 1999, INFECT IMMUN, V67, P2561, DOI 10.1128/IAI.67.5.2561-2566.1999; Obata T, 2000, CRIT CARE MED, V28, pN67, DOI 10.1097/00003246-200004001-00008; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Quigley MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002971.pub2; Raqib R, 2006, P NATL ACAD SCI USA, V103, P9178, DOI 10.1073/pnas.0602888103; SAINT L, 1984, BRIT J NUTR, V52, P87, DOI 10.1079/BJN19840074; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Schaller-Bals S, 2002, AM J RESP CRIT CARE, V165, P992, DOI 10.1164/ajrccm.165.7.200110-020; Schauber J, 2003, GUT, V52, P735, DOI 10.1136/gut.52.5.735; Schauber J, 2006, EUR J GASTROEN HEPAT, V18, P615, DOI 10.1097/00042737-200606000-00007; Schelonka RL, 1998, SEMIN PERINATOL, V22, P2, DOI 10.1016/S0146-0005(98)80003-7; Steinmann J, 2009, ANTIMICROB AGENTS CH, V53, P5127, DOI 10.1128/AAC.00818-09; Stockinger S, 2011, CELL MOL LIFE SCI, V68, P3699, DOI 10.1007/s00018-011-0831-2; Tollin M, 2003, PEPTIDES, V24, P523, DOI 10.1016/S0196-9781(03)00114-1; Vesa TH, 2000, J AM COLL NUTR, V19, p165S, DOI 10.1080/07315724.2000.10718086; Wan M, 2011, FASEB J, V25, P1697, DOI 10.1096/fj.10-175687; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Weizman Z, 2005, PEDIATRICS, V115, P5, DOI 10.1542/peds.2004-1815; Yoshio H, 2004, SEMIN PERINATOL, V28, P304, DOI 10.1053/j.semperi.2004.08.008	57	57	60	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53876	10.1371/journal.pone.0053876	http://dx.doi.org/10.1371/journal.pone.0053876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326523	Green Published, Green Submitted, gold			2022-12-25	WOS:000313552400053
J	Inauen, J; Hossain, MM; Johnston, RB; Mosler, HJ				Inauen, Jennifer; Hossain, Mohammad Mojahidul; Johnston, Richard B.; Mosler, Hans-Joachim			Acceptance and Use of Eight Arsenic-Safe Drinking Water Options in Bangladesh	PLOS ONE			English	Article							MITIGATION; BEHAVIOR; HEALTH; EXPERIENCE; BELIEFS; NORMS	Arsenic contamination of drinking water is a serious public health threat. In Bangladesh, eight major safe water options provide an alternative to contaminated shallow tubewells: piped water supply, deep tubewells, pond sand filters, community arsenic-removal, household arsenic removal, dug wells, well-sharing, and rainwater harvesting. However, it is uncertain how well these options are accepted and used by the at-risk population. Based on the RANAS model (risk, attitudes, norms, ability, and self-regulation) this study aimed to identify the acceptance and use of available safe water options. Cross-sectional face-to-face interviews were used to survey 1,268 households in Bangladesh in November 2009 (n = 872), and December 2010 (n = 396). The questionnaire assessed water consumption, acceptance factors from the RANAS model, and socioeconomic factors. Although all respondents had access to at least one arsenic-safe drinking water option, only 62.1% of participants were currently using these alternatives. The most regularly used options were household arsenic removal filters (92.9%) and piped water supply (85.6%). However, the former result may be positively biased due to high refusal rates of household filter owners. The least used option was household rainwater harvesting (36.6%). Those who reported not using an arsenic-safe source differed in terms of numerous acceptance factors from those who reported using arsenic-safe sources: non-users were characterized by greater vulnerability; showed less preference for the taste and temperature of alternative sources; found collecting safe water quite time-consuming; had lower levels of social norms, self-efficacy, and coping planning; and demonstrated lower levels of commitment to collecting safe water. Acceptance was particularly high for piped water supplies and deep tubewells, whereas dug wells and well-sharing were the least accepted sources. Intervention strategies were derived from the results in order to increase the acceptance and use of each arsenic-safe water option.	[Inauen, Jennifer; Hossain, Mohammad Mojahidul; Mosler, Hans-Joachim] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Syst Anal Integrated Assessment & Modelling, Dubendorf, Switzerland; [Johnston, Richard B.] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Water & Sanitat Developing Countries Sandec, Dubendorf, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Inauen, J (corresponding author), Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Syst Anal Integrated Assessment & Modelling, Dubendorf, Switzerland.	jennifer.inauen@eawag.ch		Inauen, Jennifer/0000-0002-7884-3222	Eawag; Swiss Federal Institute of Aquatic Science and Technology	Eawag; Swiss Federal Institute of Aquatic Science and Technology	This research was funded by Eawag, the Swiss Federal Institute of Aquatic Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MF, 2006, SCIENCE, V314, P1687, DOI 10.1126/science.1133146; Albarracin D, 2005, PSYCHOL BULL, V131, P856, DOI 10.1037/0033-2909.131.6.856; Argos M, 2010, LANCET, V376, P252, DOI 10.1016/S0140-6736(10)60481-3; Armitage CJ, 2005, HEALTH PSYCHOL, V24, P235, DOI 10.1037/0278-6133.24.3.235; DELEON IG, 1995, ENVIRON BEHAV, V27, P233, DOI 10.1177/0013916595272007; DPHE/BGS/MML, 2000, PHAS 2 NAT HYDR SURV; Fishbein M, 2010, PREDICTING CHANGING, DOI 10.4324/9780203838020; Flanagan SV, 2012, B WORLD HEALTH ORGAN, V90, P839, DOI 10.2471/BLT.11.101253; Frick J, 2004, PERS INDIV DIFFER, V37, P1597, DOI 10.1016/j.paid.2004.02.015; Government of Bangladesh, 2004, NAT POL ARS MIT; Government of Bangladesh, 2004, IMPL PLAN ARS MIT; Hoffmeyer-Zlotnik J.H.P, 2003, DEV APPL STAT; Hoque BA, 2004, PUBLIC HEALTH, V118, P70, DOI 10.1016/S0033-3506(03)00135-5; Howard G, 2006, J HEALTH POPUL NUTR, V24, P346; Huber AC, 2012, J PUBLIC HEALTH-HEID, V20, P269, DOI 10.1007/s10389-011-0445-z; Huber AC, 2013, INT J ENVIRON HEAL R, V23, P96, DOI 10.1080/09603123.2012.699032; Johnston RB, 2007, J ENVIRON SCI HEAL A, V42, P1889, DOI 10.1080/10934520701567155; Kabir A, 2007, INT J ENVIRON HEAL R, V17, P207, DOI 10.1080/09603120701254904; Marsh RL, 1998, MEM COGNITION, V26, P633, DOI 10.3758/BF03211383; Mosler HJ, 2012, INT J ENVIRON HEAL R, V22, P431, DOI 10.1080/09603123.2011.650156; Mosler HJ, 2010, J ENVIRON MANAGE, V91, P1316, DOI 10.1016/j.jenvman.2010.02.012; Opar A, 2007, HEALTH PLACE, V13, P164, DOI 10.1016/j.healthplace.2005.11.004; Orbell S, 2009, HEALTH PSYCHOL, V28, P753, DOI 10.1037/a0016943; Park HS, 2007, HUM COMMUN RES, V33, P194, DOI 10.1111/j.1468-2958.2007.00296.x; Paul BK, 2004, SOC SCI MED, V59, P1741, DOI 10.1016/j.socscimed.2004.01.037; Schwarzer R, 2008, APPL PSYCHOL-INT REV, V57, P1, DOI 10.1111/j.1464-0597.2007.00325.x; Severtson DJ, 2006, RISK ANAL, V26, P353, DOI 10.1111/j.1539-6924.2006.00737.x; Smith AH, 2009, ANNU REV PUBL HEALTH, V30, P107, DOI 10.1146/annurev.publhealth.031308.100143; Smith JR, 2008, J SOC PSYCHOL, V148, P311, DOI 10.3200/SOCP.148.3.311-334; Trafimow D, 1998, J EXP SOC PSYCHOL, V34, P378, DOI 10.1006/jesp.1998.1356; van Geen A, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001617; van Geen A, 2002, B WORLD HEALTH ORGAN, V80, P732; Yuan Y, 2007, AM J EPIDEMIOL, V166, P1381, DOI 10.1093/aje/kwm238	33	51	51	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53640	10.1371/journal.pone.0053640	http://dx.doi.org/10.1371/journal.pone.0053640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YV	23326477	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000313552400033
J	Welsh, AH; Lindenmayer, DB; Donnelly, CF				Welsh, Alan H.; Lindenmayer, David B.; Donnelly, Christine F.			Fitting and Interpreting Occupancy Models	PLOS ONE			English	Article							SPECIES OCCURRENCE; ABUNDANCE	We show that occupancy models are more difficult to fit than is generally appreciated because the estimating equations often have multiple solutions, including boundary estimates which produce fitted probabilities of zero or one. The estimates are unstable when the data are sparse, making them difficult to interpret, and, even in ideal situations, highly variable. As a consequence, making accurate inference is difficult. When abundance varies over sites (which is the general rule in ecology because we expect spatial variance in abundance) and detection depends on abundance, the standard analysis suffers bias (attenuation in detection, biased estimates of occupancy and potentially finding misleading relationships between occupancy and other covariates), asymmetric sampling distributions, and slow convergence of the sampling distributions to normality. The key result of this paper is that the biases are of similar magnitude to those obtained when we ignore non-detection entirely. The fact that abundance is subject to detection error and hence is not directly observable, means that we cannot tell when bias is present (or, equivalently, how large it is) and we cannot adjust for it. This implies that we cannot tell which fit is better: the fit from the occupancy model or the fit ignoring the possibility of detection error. Therefore trying to adjust occupancy models for non-detection can be as misleading as ignoring non-detection completely. Ignoring non-detection can actually be better than trying to adjust for it.	[Welsh, Alan H.] Australian Natl Univ, Ctr Math & Its Applicat, Canberra, ACT, Australia; [Lindenmayer, David B.; Donnelly, Christine F.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia	Australian National University; Australian National University	Welsh, AH (corresponding author), Australian Natl Univ, Ctr Math & Its Applicat, Canberra, ACT, Australia.	Alan.Welsh@anu.edu.au	Lindenmayer, David B/P-7183-2017	Lindenmayer, David B/0000-0002-4766-4088; Welsh, Alan/0000-0002-3165-9559	Australian Research Council	Australian Research Council(Australian Research Council)	Funding was received from the Australian Research Council to support this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL HL, 1980, EMU, V80, P227, DOI 10.1071/MU9800227; Carroll R., 1995, MEASUREMENT ERROR NO; Chambers RL, 2012, MONOGR STAT APPL PRO, V125, P1; Hines, 2017, OCCUPANCY ESTIMATION; Lindenmayer DB, 2008, ECOL MONOGR, V78, P567, DOI 10.1890/07-0945.1; Lindenmayer DB, 2001, BIOL CONSERV, V101, P157, DOI 10.1016/S0006-3207(01)00061-1; Mackenzie DI, 2009, ECOLOGY, V90, P823, DOI 10.1890/08-0141.1; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McCullagh P, 1989, GEN LINEAR MODELS; MULLAHY J, 1986, J ECONOMETRICS, V33, P341, DOI 10.1016/0304-4076(86)90002-3; Pacifici K, 2008, AUK, V125, P600, DOI 10.1525/auk.2008.07078; Royle JA, 2006, BIOMETRICS, V62, P97, DOI 10.1111/j.1541-0420.2005.00439.x; Royle JA, 2005, ECOLOGY, V86, P2505, DOI 10.1890/04-1802; Royle JA, 2004, CONSERV BIOL, V18, P1378, DOI 10.1111/j.1523-1739.2004.00147.x; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Schieck J, 1997, CONDOR, V99, P179, DOI 10.2307/1370236; Simons TR, 2007, AUK, V124, P986, DOI 10.1642/0004-8038(2007)124[986:EAOTAD]2.0.CO;2; Welsh A.H., 1996, ASPECTS STAT INFEREN; Wenger SJ, 2008, ECOLOGY, V89, P2953, DOI 10.1890/07-1127.1; Yee TW, 2008, R NEWS, V8, P28	20	122	122	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e52015	10.1371/journal.pone.0052015	http://dx.doi.org/10.1371/journal.pone.0052015			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326323	Green Submitted, Green Published, gold			2022-12-25	WOS:000313552400006
J	Brooks, TM; Unterweger, D; Bachmann, V; Kostiuk, B; Pukatzki, S				Brooks, Teresa M.; Unterweger, Daniel; Bachmann, Verena; Kostiuk, Benjamin; Pukatzki, Stefan			Lytic Activity of the Vibrio cholerae Type VI Secretion Toxin VgrG-3 Is Inhibited by the Antitoxin TsaB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEM; REQUIRES; EFFECTOR; PROTEIN	The type VI secretion system (T6SS) of Gram-negative bacteria has been implicated in microbial competition; however, which components serve purely structural roles, and which serve as toxic effectors remains unresolved. Here, we present evidence that VgrG-3 of the Vibrio cholerae T6SS has both structural and toxin activity. Specifically, we demonstrate that the C-terminal extension of VgrG-3 acts to degrade peptidoglycan and hypothesize that this assists in the delivery of accessory T6SS toxins of V. cholerae. To avoid self-intoxication, V. cholerae expresses an anti-toxin encoded immediately downstream of vgrG-3 that inhibits VgrG-3-mediated lysis through direct interaction.	[Brooks, Teresa M.; Unterweger, Daniel; Bachmann, Verena; Kostiuk, Benjamin; Pukatzki, Stefan] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada	University of Alberta	Pukatzki, S (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada.	spukatzki@ualberta.ca	Unterweger, Daniel/AAP-6082-2021; Unterweger, Daniel/J-6867-2017	Unterweger, Daniel/0000-0001-7459-6386; Unterweger, Daniel/0000-0002-3021-0960	Canadian Institute for Health Research Operating Grant [MOP-84473]; Alberta Innovates-Health Solutions; Alberta Heritage Foundation for Medical Research Endowment Fund; Canadian Foundation for Innovation [LOFS1-21139]	Canadian Institute for Health Research Operating Grant(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; Alberta Heritage Foundation for Medical Research Endowment Fund; Canadian Foundation for Innovation(Canada Foundation for Innovation)	This work was supported by Canadian Institute for Health Research Operating Grant MOP-84473 and Alberta Innovates-Health Solutions (funded by the Alberta Heritage Foundation for Medical Research Endowment Fund).; We thank Sarah Miyata and Cory Brooks for helpful discussions, Marcia Craig for critically reviewing the manuscript, and the laboratory of Joel Weiner for the gift of the pBAD24-LS plasmid. The Leica Microsystems microscope was purchased with funds from the Canadian Foundation for Innovation (LOFS1-21139).	Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Basler M, 2012, SCIENCE, V337, P815, DOI 10.1126/science.1222901; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Blondel CJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-354; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; HOYLE BD, 1984, CAN J MICROBIOL, V30, P204, DOI 10.1139/m84-031; Kanamaru S, 1999, J BACTERIOL, V181, P2739, DOI 10.1128/JB.181.9.2739-2744.1999; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Li M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002613; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Miyata ST, 2011, INFECT IMMUN, V79, P2941, DOI 10.1128/IAI.01266-10; Moran AP, 2011, GUT, V60, P1412, DOI 10.1136/gut.2010.212704; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schmelcher M, 2012, APPL MICROBIOL BIOT, V93, P633, DOI 10.1007/s00253-011-3372-6; Son B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-33; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Wilkesman Jeff, 2009, Recent Pat Biotechnol, V3, P175; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Zahrl D, 2005, MICROBIOL-SGM, V151, P3455, DOI 10.1099/mic.0.28141-0; Zhang H, 2013, J BIOL CHEM, V288, P5928, DOI 10.1074/jbc.M112.434357; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876	26	117	123	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7618	7625		10.1074/jbc.M112.436725	http://dx.doi.org/10.1074/jbc.M112.436725			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23341465	hybrid, Green Published			2022-12-25	WOS:000316455300019
J	Gourlaouen, M; Welti, JC; Vasudev, NS; Reynolds, AR				Gourlaouen, Morgane; Welti, Jonathan C.; Vasudev, Naveen S.; Reynolds, Andrew R.			Essential Role for Endocytosis in the Growth Factor-stimulated Activation of ERK1/2 in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE INHIBITOR; SIGNAL-TRANSDUCTION; ANTIANGIOGENESIS THERAPY; TUMOR ANGIOGENESIS; TARGETED THERAPY; FACTOR RECEPTOR; PROTEIN-KINASE; GENE DELIVERY; SOLID TUMORS; PHASE-I	Vascular endothelial growth factor (VEGF) stimulates angiogenesis by binding to VEGF receptor 2 (VEGFR2) on endothelial cells (ECs). Downstream activation of the extracellular related kinases 1/2 (ERK1/2) is important for angiogenesis to proceed. Receptor internalization has been implicated in VEGFR2 signaling, but its role in the activation of ERK1/2 is unclear. To explore this question we utilized pitstop and dynasore, two small molecule inhibitors of endocytosis. First, we confirmed that both inhibitors block the internalization of VEGFR2 in ECs. We then stimulated ECs with VEGF in the presence and absence of the inhibitors and examined VEGFR2 signaling to ERK1/2. Activation of VEGFR2 and C-Raf still occurred in the presence of the inhibitors, whereas the activation of MEK1/2 and ERK1/2 was abrogated. Therefore, although internalization is not required for activation of either VEGFR2 or C-Raf in ECs stimulated with VEGF, internalization is necessary to activate the more distal kinases in the cascade. Importantly, inhibition of internalization also prevented activation of ERK1/2 when ECs were stimulated with other pro-angiogenic growth factors, namely fibroblast growth factor 2 and hepatocyte growth factor. In contrast, the same inhibitors did not block ERK1/2 activation in fibroblasts or cancer cells stimulated with growth factors. Finally, we show that these small molecule inhibitors of endocytosis block angiogenesis in vitro and in vivo. Therefore, receptor internalization may be a generic requirement for pro-angiogenic growth factors to activate ERK1/2 signaling in human ECs, and targeting receptor trafficking may present a therapeutic opportunity to block tumor angiogenesis.	[Gourlaouen, Morgane; Welti, Jonathan C.; Vasudev, Naveen S.; Reynolds, Andrew R.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, Tumour Biol Team, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Reynolds, AR (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, Tumour Biol Team, 237 Fulham Rd, London SW3 6JB, England.	andrew.reynolds@icr.ac.uk		Vasudev, Naveen/0000-0001-8470-7481; Welti, Jonathan/0000-0002-9433-8138	Breakthrough Breast Cancer; Royal Marsden NIHR Biomedical Research Centre	Breakthrough Breast Cancer; Royal Marsden NIHR Biomedical Research Centre(Royal Society of New ZealandMarsden Fund (NZ))	This work was supported by Breakthrough Breast Cancer and the Royal Marsden NIHR Biomedical Research Centre.	Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Anderson SM, 2011, INTEGR BIOL-UK, V3, P887, DOI 10.1039/c1ib00037c; Azam F, 2010, EUR J CANCER, V46, P1323, DOI 10.1016/j.ejca.2010.02.020; Ballmer-Hofer K, 2011, BLOOD, V118, P816, DOI 10.1182/blood-2011-01-328773; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bottsford-Miller JN, 2012, J CLIN ONCOL, V30, P4026, DOI 10.1200/JCO.2012.41.9242; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; Carmeliet P, 2009, NAT REV CLIN ONCOL, V6, P315, DOI 10.1038/nrclinonc.2009.64; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; da Silva RG, 2010, AM J PATHOL, V177, P1534, DOI 10.2353/ajpath.2010.100043; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Duval M, 2003, J BIOL CHEM, V278, P20091, DOI 10.1074/jbc.M301410200; Eichmann A, 2012, CURR OPIN CELL BIOL, V24, P188, DOI 10.1016/j.ceb.2012.02.002; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Ewan LC, 2006, TRAFFIC, V7, P1270, DOI 10.1111/j.1600-0854.2006.00462.x; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Jonker DJ, 2011, ANN ONCOL, V22, P1413, DOI 10.1093/annonc/mdq599; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kerbel RS, 2005, CANCER CELL, V8, P269, DOI 10.1016/j.ccr.2005.09.016; Kermorgant S, 2005, CELL CYCLE, V4, P352, DOI 10.4161/cc.4.3.1519; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Kopetz S, 2010, J CLIN ONCOL, V28, P453, DOI 10.1200/JCO.2009.24.8252; Kurzrock R, 2011, J CLIN ONCOL, V29, P2660, DOI 10.1200/JCO.2010.32.4145; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Luwor RB, 2012, GROWTH FACTORS, V30, P220, DOI 10.3109/08977194.2012.683189; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MAHADEVAN V, 1989, CANCER RES, V49, P415; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Murdaca J, 2004, J BIOL CHEM, V279, P26754, DOI 10.1074/jbc.M311802200; Nakatsu MN, 2008, METHOD ENZYMOL, V443, P65, DOI 10.1016/S0076-6879(08)02004-1; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Porta C, 2013, ONCOLOGY-BASEL, V84, P115, DOI 10.1159/000342099; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; Reynolds AR, 2003, TRENDS MOL MED, V9, P2, DOI 10.1016/S1471-4914(02)00004-7; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Sarker D, 2008, CLIN CANCER RES, V14, P2075, DOI 10.1158/1078-0432.CCR-07-1466; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Scott A, 2009, BIOCHEM SOC T, V37, P1184, DOI 10.1042/BST0371184; Sennino B, 2012, NAT REV CANCER, V12, P699, DOI 10.1038/nrc3366; Shojaei F, 2010, CANCER RES, V70, P10090, DOI 10.1158/0008-5472.CAN-10-0489; SILVAGNO F, 1995, ARTERIOSCL THROM VAS, V15, P1857, DOI 10.1161/01.ATV.15.11.1857; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Sousa LP, 2012, P NATL ACAD SCI USA, V109, P4419, DOI 10.1073/pnas.1200164109; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wei G, 2009, BLOOD, V114, P1123, DOI 10.1182/blood-2009-03-211391; Welti JC, 2011, ONCOGENE, V30, P1183, DOI 10.1038/onc.2010.503; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603	64	54	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7467	7480		10.1074/jbc.M112.446401	http://dx.doi.org/10.1074/jbc.M112.446401			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23341459	Green Published, hybrid			2022-12-25	WOS:000316455300004
J	Lim, JH; Gerhart-Hines, Z; Dominy, JE; Lee, Y; Kim, S; Tabata, M; Xiang, YK; Puigserver, P				Lim, Ji-Hong; Gerhart-Hines, Zachary; Dominy, John E.; Lee, Yoonjin; Kim, Sungjin; Tabata, Mitsuhisa; Xiang, Yang K.; Puigserver, Pere			Oleic Acid Stimulates Complete Oxidation of Fatty Acids through Protein Kinase A-dependent Activation of SIRT1-PGC1 alpha Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; TRANSCRIPTIONAL COACTIVATOR; MITOCHONDRIAL BIOGENESIS; PGC-1-ALPHA EXPRESSION; METABOLIC-CONTROL; SIRT1; REGULATOR; AMPK; PATHWAY	Fatty acids are essential components of the dynamic lipid metabolism in cells. Fatty acids can also signal to intracellular pathways to trigger a broad range of cellular responses. Oleic acid is an abundant monounsaturated omega-9 fatty acid that impinges on different biological processes, but the mechanisms of action are not completely understood. Here, we report that oleic acid stimulates the cAMP/protein kinase A pathway and activates the SIRT1-PGC1 alpha transcriptional complex to modulate rates of fatty acid oxidation. In skeletal muscle cells, oleic acid treatment increased intracellular levels of cyclic adenosine monophosphate (cAMP) that turned on protein kinase A activity. This resulted in SIRT1 phosphorylation at Ser-434 and elevation of its catalytic deacetylase activity. A direct SIRT1 substrate is the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1 alpha), which became deacetylated and hyperactive after oleic acid treatment. Importantly, oleic acid, but not other long chain fatty acids such as palmitate, increased the expression of genes linked to fatty acid oxidation pathway in a SIRT1-PGC1 alpha-dependent mechanism. As a result, oleic acid potently accelerated rates of complete fatty acid oxidation in skeletal muscle cells. These results illustrate how a single long chain fatty acid specifically controls lipid oxidation through a signaling/transcriptional pathway. Pharmacological manipulation of this lipid signaling pathway might provide therapeutic possibilities to treat metabolic diseases associated with lipid dysregulation.	[Lim, Ji-Hong; Gerhart-Hines, Zachary; Dominy, John E.; Lee, Yoonjin; Tabata, Mitsuhisa; Puigserver, Pere] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Lim, Ji-Hong; Gerhart-Hines, Zachary; Dominy, John E.; Lee, Yoonjin; Tabata, Mitsuhisa; Puigserver, Pere] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Kim, Sungjin; Xiang, Yang K.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California Davis	Puigserver, P (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave,CLSB-11144, Boston, MA 02215 USA.	pere_puigserver@dfci.harvard.edu			Dana-Farber Cancer Institute; American Diabetes Association; Department of Defense; National Institutes of Health/NIDDK [RO1 069966]; National Institutes of Health [RO1-HL82846]; American Heart Association [12EIA841007]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069966] Funding Source: NIH RePORTER	Dana-Farber Cancer Institute; American Diabetes Association(American Diabetes Association); Department of Defense(United States Department of Defense); National Institutes of Health/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Dana-Farber Cancer Institute, the American Diabetes Association, the Department of Defense, National Institutes of Health/NIDDK Grant RO1 069966 (to P. P.) as well as National Institutes of Health Grant RO1-HL82846 and American Heart Association Grant 12EIA841007 (to Y. K. X.).; Supported by an American Diabetes Association mentor supported post-doctoral fellowship.; Supported in part by a fellowship from the American Heart Association.; Supported in part by an National Research Service Award Kirschstein fellowship from the National Institutes of Health.	Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200; De Arcangelis V, 2010, MOL PHARMACOL, V78, P340, DOI 10.1124/mol.110.064444; Dominy JE, 2011, COLD SH Q B, V76, P203, DOI 10.1101/sqb.2012.76.010843; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Foster DW, 2012, J CLIN INVEST, V122, P1958, DOI 10.1172/JCI63967; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; de Albuquerque CFG, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/601032; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kien CL, 2009, CURR DIABETES REP, V9, P43, DOI 10.1007/s11892-009-0009-6; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nohturfft A, 2009, ANNU REV CELL DEV BI, V25, P539, DOI 10.1146/annurev.cellbio.24.110707.175344; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Postic C, 2008, DIABETES METAB, V34, P643, DOI 10.1016/S1262-3636(08)74599-3; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Raatz SK, 2001, J NUTR, V131, P231; Rasmussen BB, 1999, ANNU REV NUTR, V19, P463, DOI 10.1146/annurev.nutr.19.1.463; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Schreurs M, 2010, OBES REV, V11, P380, DOI 10.1111/j.1467-789X.2009.00642.x; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Tardif N, 2011, CLIN NUTR, V30, P799, DOI 10.1016/j.clnu.2011.05.009; Tholstrup T, 2001, AM J CLIN NUTR, V73, P198; Van Den Branden C, 2003, ADV EXP MED BIOL, V544, P307; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Zhang PX, 2005, FEBS LETT, V579, P1446, DOI 10.1016/j.febslet.2005.01.046	40	119	128	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7117	7126		10.1074/jbc.M112.415729	http://dx.doi.org/10.1074/jbc.M112.415729			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23329830	Green Published, hybrid			2022-12-25	WOS:000316002400033
J	Rodriguez, G; Ross, JA; Nagy, ZS; Kirken, RA				Rodriguez, Georgialina; Ross, Jeremy A.; Nagy, Zsuzsanna S.; Kirken, Robert A.			Forskolin-inducible cAMP Pathway Negatively Regulates T-cell Proliferation by Uncoupling the Interleukin-2 Receptor Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADENOSINE-MONOPHOSPHATE; SIGNAL TRANSDUCER; SERINE PHOSPHORYLATION; TYROSINE PHOSPHORYLATION; CONSTITUTIVE ACTIVATION; FEEDBACK INHIBITION; DNA-BINDING; STAT5; RECEPTOR; MODULATION	Cytokine-mediated regulation of T-cell activity involves a complex interplay between key signal transduction pathways. Determining how these signaling pathways cross-talk is essential to understanding T-cell function and dysfunction. In this work, we provide evidence that cross-talk exists between at least two signaling pathways: the Jak3/Stat5 and cAMP-mediated cascades. The adenylate cyclase activator forskolin (Fsk) significantly increased intracellular cAMP levels and reduced proliferation of the human T-cells via inhibition of cell cycle regulatory genes but did not induce apoptosis. To determine this inhibitory mechanism, effects of Fsk on IL-2 signaling was investigated. Fsk treatment of MT-2 and Kit 225 T-cells inhibited IL-2-induced Stat5a/b tyrosine and serine phosphorylation, nuclear translocation, and DNA binding activity. Fsk treatment also uncoupled IL-2 induced association of the iL-2R beta and gamma(c) chain, consequently blocking Jak3 activation. Interestingly, phosphoamino acid analysis revealed that Fsk-treated cells resulted in elevated serine phosphorylation of Jak3 but not Stat5, suggesting that Fsk can negatively regulate Jak3 activity possibly mediated through PKA. Indeed, in vitro kinase assays and small molecule inhibition studies indicated that PKA can directly serine phosphorylate and functionally inactivate Jak3. Taken together, these findings suggest that Fsk activation of adenylate cyclase and PKA can negatively regulate IL-2 signaling at multiple levels that include IL-2R complex formation and Jak3/Stat5 activation.	[Rodriguez, Georgialina; Ross, Jeremy A.; Nagy, Zsuzsanna S.; Kirken, Robert A.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79902 USA	University of Texas System; University of Texas El Paso	Kirken, RA (corresponding author), Univ Texas El Paso, Dept Biol Sci, 500 W Univ Ave, El Paso, TX 79968 USA.	rkirken@utep.edu			Lizanell and Colbert Coldwell Foundation; Edward N. and Margaret G. Marsh Foundation; National Institutes on Minority Health and Health Disparities, National Institutes of Health [G12MD007592]; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	Lizanell and Colbert Coldwell Foundation; Edward N. and Margaret G. Marsh Foundation; National Institutes on Minority Health and Health Disparities, National Institutes of Health; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants from the Lizanell and Colbert Coldwell Foundation, the Edward N. and Margaret G. Marsh Foundation, and Grant G12MD007592 from the National Institutes on Minority Health and Health Disparities, National Institutes of Health.	ANTONYSAMY MA, 1995, J IMMUNOL, V155, P2813; BARTIK MM, 1993, CELL IMMUNOL, V148, P408, DOI 10.1006/cimm.1993.1122; Behbod F, 2003, J IMMUNOL, V171, P3919, DOI 10.4049/jimmunol.171.8.3919; Biel Martin, 2009, V191, P111, DOI 10.1007/978-3-540-68964-5_7; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; BURY TB, 1992, ALLERGY, V47, P624, DOI 10.1111/j.1398-9995.1992.tb02385.x; Chai SK, 1997, J IMMUNOL, V159, P4720; Cheng H, 2008, MOL CELL BIOL, V28, P2271, DOI 10.1128/MCB.01789-07; Cone RE, 1996, CELL IMMUNOL, V173, P246, DOI 10.1006/cimm.1996.0274; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Ekholm D, 1999, BIOCHEM PHARMACOL, V58, P935, DOI 10.1016/S0006-2952(99)00188-4; Ellery JM, 2002, CYTOKINE GROWTH F R, V13, P27, DOI 10.1016/S1359-6101(01)00023-5; ELLIOTT L, 1992, CELL MOL NEUROBIOL, V12, P411, DOI 10.1007/BF00711542; ESSAYAN DM, 1994, J IMMUNOL, V153, P3408; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Grandoch M, 2010, BRIT J PHARMACOL, V159, P265, DOI 10.1111/j.1476-5381.2009.00458.x; HORI T, 1987, BLOOD, V70, P1069; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Huang S, 1997, BLOOD, V90, P1600, DOI 10.1182/blood.V90.4.1600.1600_1600_1610; Ivashkiv LB, 2008, NAT REV IMMUNOL, V8, P816, DOI 10.1038/nri2396; KAMMER GM, 1988, P NATL ACAD SCI USA, V85, P792, DOI 10.1073/pnas.85.3.792; Kirken RA, 1999, J LEUKOCYTE BIOL, V65, P891, DOI 10.1002/jlb.65.6.891; KIRKEN RA, 1995, CYTOKINE, V7, P689, DOI 10.1006/cyto.1995.0081; Kirken RA, 1997, J BIOL CHEM, V272, P15459, DOI 10.1074/jbc.272.24.15459; Lee IH, 1999, J EXP MED, V190, P1263, DOI 10.1084/jem.190.9.1263; Leonard WJ, 1996, NAT MED, V2, P968, DOI 10.1038/nm0996-968; Lin JX, 1996, J BIOL CHEM, V271, P10738, DOI 10.1074/jbc.271.18.10738; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; LINGK DS, 1990, J IMMUNOL, V145, P449; MACA RD, 1984, IMMUNOPHARMACOLOGY, V8, P53, DOI 10.1016/0162-3109(84)90043-2; Malabarba MG, 1996, BIOCHEM J, V319, P865, DOI 10.1042/bj3190865; Mitra A, 2012, J BIOL CHEM, V287, P16596, DOI 10.1074/jbc.M111.319756; MIYOSHI I, 1981, GANN, V72, P978; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Mosenden R, 2011, CELL SIGNAL, V23, P1009, DOI 10.1016/j.cellsig.2010.11.018; Mullen P, 2004, METH MOLEC MED, V88, P171; Nagy ZS, 2002, J LEUKOCYTE BIOL, V72, P819; Nagy ZS, 2006, J IMMUNOL, V177, P5032, DOI 10.4049/jimmunol.177.8.5032; Nagy ZS, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-67; NOKTA M, 1991, VIROLOGY, V181, P211, DOI 10.1016/0042-6822(91)90486-U; NOKTA MA, 1992, AIDS RES HUM RETROV, V8, P1255, DOI 10.1089/aid.1992.8.1255; Park SH, 2001, MOL ENDOCRINOL, V15, P2157, DOI 10.1210/me.15.12.2157; Ross JA, 2008, J BIOL CHEM, V283, P4699, DOI 10.1074/jbc.M708232200; Ross JA, 2010, J BIOL CHEM, V285, P3582, DOI 10.1074/jbc.M109.053843; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Tasken K, 2006, BIOCHEM SOC T, V34, P476, DOI 10.1042/BST0340476; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Vandamme J, 2012, CELL SIGNAL, V24, P1610, DOI 10.1016/j.cellsig.2012.04.001; Weaver AM, 2007, BIOCHEM BIOPH RES CO, V362, P1026, DOI 10.1016/j.bbrc.2007.08.087; Weaver AM, 2006, MOL ENDOCRINOL, V20, P2392, DOI 10.1210/me.2005-0418; WeberNordt RM, 1996, BLOOD, V88, P809; Xue HH, 2002, INT IMMUNOL, V14, P1263, DOI 10.1093/intimm/dxf101; Zambon AC, 2005, P NATL ACAD SCI USA, V102, P8561, DOI 10.1073/pnas.0503363102; Zhang H, 2004, J IMMUNOL, V173, P932, DOI 10.4049/jimmunol.173.2.932; Zhou YJ, 1997, P NATL ACAD SCI USA, V94, P13850, DOI 10.1073/pnas.94.25.13850; Zhu JF, 2000, J EXP MED, V192, P1125, DOI 10.1084/jem.192.8.1125	60	32	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7137	7146		10.1074/jbc.M112.408765	http://dx.doi.org/10.1074/jbc.M112.408765			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23341462	Green Published, hybrid			2022-12-25	WOS:000316002400035
J	Chen, M; Herring, BP				Chen, Meng; Herring, B. Paul			Regulation of MicroRNAs by Brahma-related Gene 1 (Brg1) in Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWI/SNF COMPLEXES; IN-VIVO; EXPRESSION; PROLIFERATION; MYOCARDIN; DIFFERENTIATION; PHENOTYPE; PROTEINS; MIR-145; TARGET	MicroRNAs are involved in phenotypic switching of smooth muscle cells (SMCs). Brg1-containing SWI/SNF chromatin-remodeling complexes also play an important role in controlling the phenotype of SMCs. We thus determined whether Brg1 influences the transcription of microRNAs in SMCs. Microarray and quantitative RT-PCR analysis of smooth muscle from mice harboring smooth muscle-specific deletion of Brg1 revealed altered expression of several microRNAs, including miRs-143/145 and miR-133. Ablation of Brg1 in SMCs in vitro either by expression of dominant negative Brg1 or Brg1 knock-out attenuated miRs-143/145 expression. Knockdown of serum response factor (SRF) in SMCs significantly reduced the expression levels of miRs-143/145 and miR-133, whereas knockdown of myocardin only attenuated miRs-143/145 expression. Myocardin induced expression of miRs-143/145 and miR-133a and increased SRF binding to these genes in 10T1/2 cells. This myocardin-mediated induction was attenuated by dominant negative Brg1. In Brg1-null SW13 cells, miRs-143/145 were dramatically induced by myocardin only in the presence of Brg1, whereas miR-133 was not induced by myocardin in a Brg1-dependent manner. Chromatin immunoprecipitation assays demonstrated that in the presence of Brg1, myocardin increased SRF binding to both the miRs-143/145 and miR-133a loci. Together, these data suggest a mechanism in which Brg1-containing SWI/SNF complexes are required for myocardin to induce expression of miRs-143/145 in smooth muscle cells. In contrast, miR-133 expression appears to be regulated by Brg1-containing chromatin remodeling complexes in a partially SRF-dependent, although largely myocardin-independent manner. SWI/SNF-mediated chromatin remodeling thus regulates the phenotype of smooth muscle by affecting expression of protein-coding genes and microRNAs.	[Chen, Meng; Herring, B. Paul] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Herring, BP (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	pherring@iupui.edu			National Institutes of Health [DK63110, RR02576]; Indiana Clinical and Translational Sciences Institute; Indiana University School of Medicine; American Heart Association	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana Clinical and Translational Sciences Institute; Indiana University School of Medicine; American Heart Association(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grant DK63110. This work was also supported by a grant from the Indiana Clinical and Translational Sciences Institute funded, in part, by Grant RR02576 from the National Institutes of Health and by a Biomedical Research Grant and Elwert award from the Indiana University School of Medicine.; Supported by an American Heart Association predoctoral fellowship.	Albinsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018869; Albinsson S, 2010, ARTERIOSCL THROM VAS, V30, P1118, DOI 10.1161/ATVBAHA.109.200873; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen YH, 2001, J BIOL CHEM, V276, P47658, DOI 10.1074/jbc.M108678200; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; de Lange WJ, 2008, PHYSIOL GENOMICS, V35, P1, DOI 10.1152/physiolgenomics.90284.2008; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Gebuhr TC, 2003, J EXP MED, V198, P1937, DOI 10.1084/jem.20030714; Indra AK, 2005, DEVELOPMENT, V132, P4533, DOI 10.1242/dev.02019; Kumar MS, 2003, CIRC RES, V92, P840, DOI 10.1161/01.RES.0000069031.55281.7C; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Mallappa C, 2010, MOL CELL BIOL, V30, P3176, DOI 10.1128/MCB.00214-10; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Park C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018628; Rangrez AY, 2011, CIRC-CARDIOVASC GENE, V4, P197, DOI 10.1161/CIRCGENETICS.110.958702; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Torella D, 2011, CIRC RES, V109, P880, DOI 10.1161/CIRCRESAHA.111.240150; Touw K, 2012, AM J PHYSIOL-GASTR L, V302, pG66, DOI 10.1152/ajpgi.00183.2011; Wang XB, 2010, J BIOL CHEM, V285, P23239, DOI 10.1074/jbc.M109.084673; Xin HB, 2002, PHYSIOL GENOMICS, V10, P211, DOI 10.1152/physiolgenomics.00054.2002; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Zhang M, 2007, J BIOL CHEM, V282, P25708, DOI 10.1074/jbc.M701925200; Zhang M, 2011, MOL CELL BIOL, V31, P2618, DOI 10.1128/MCB.01338-10; Zhou JL, 2009, ARTERIOSCL THROM VAS, V29, P921, DOI 10.1161/ATVBAHA.109.187229; Zhou JL, 2005, J BIOL CHEM, V280, P10861, DOI 10.1074/jbc.M411586200	33	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6397	6408		10.1074/jbc.M112.409474	http://dx.doi.org/10.1074/jbc.M112.409474			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23339192	Green Published, hybrid			2022-12-25	WOS:000315820700034
J	Millers, EKI; Johnson, LA; Birrell, GW; Masci, PP; Lavin, MF; de Jersey, J; Guddat, LW				Millers, Emma-Karin I.; Johnson, Lambro A.; Birrell, Geoff W.; Masci, Paul P.; Lavin, Martin F.; de Jersey, John; Guddat, Luke W.			The structure of Human Microplasmin in Complex with Textilinin-1, an Aprotinin-like Inhibitor from the Australian Brown Snake	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; PROTEASE INHIBITOR; RISK; PROTEINS; BINDING; ENZYME; VENOM	Textilinin-1 is a Kunitz-type serine protease inhibitor from Australian brown snake venom. Its ability to potently and specifically inhibit human plasmin (K-i = 0.44 nM) makes it a potential therapeutic drug as a systemic anti-bleeding agent. The crystal structures of the human microplasmin-textilinin-1 and the trypsin-textilinin-1 complexes have been determined to 2.78 angstrom and 1.64 angstrom resolution respectively, and show that textilinin-1 binds to trypsin in a canonical mode but to microplasmin in an atypical mode with the catalytic histidine of microplasmin rotated out of the active site. The space vacated by the histidine side-chain in this complex is partially occupied by a water molecule. In the structure of microplasminogen the chi(1) dihedral angle of the side-chain of the catalytic histidine is rotated by 67 degrees from its "active" position in the catalytic triad, as exemplified by its location when microplasmin is bound to streptokinase. However, when textilinin-1 binds to microplasmin the chi(1) dihedral angle of this amino acid residue changes by -157 degrees (i.e. in the opposite rotation direction compared to microplasminogen). The unusual mode of interaction between textilinin-1 and plasmin explains textilinin-1's selectivity for human plasmin over plasma kallikrein. This difference can be exploited in future drug design efforts.	[Millers, Emma-Karin I.; de Jersey, John; Guddat, Luke W.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Johnson, Lambro A.; Masci, Paul P.] Princess Alexandra Hosp, Dept Med, Woolloongabba, Qld 4102, Australia; [Birrell, Geoff W.; Lavin, Martin F.] Univ Queensland, Royal Brisbane Hosp, Queensland Inst Med Res, Queensland Canc Fund Res Unit, Brisbane, Qld, Australia	University of Queensland; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland	Guddat, LW (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.	luke.guddat@uq.edu.au	Guddat, Luke/AAI-2930-2021; Lavin, Martin F/F-5961-2014	Lavin, Martin F/0000-0002-5940-4769; Johnson, Lambro/0000-0001-9746-7771; Birrell, Geoff/0000-0002-6593-1514; Guddat, Luke/0000-0002-8204-8408	ARC-Linkage grant; Australian Research Council; QRxPharma Pty Ltd	ARC-Linkage grant(Australian Research Council); Australian Research Council(Australian Research Council); QRxPharma Pty Ltd	This work was supported by an ARC-Linkage grant funded by the Australian Research Council and by QRxPharma Pty Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beattie WS, 2011, J CARDIOTHOR VASC AN, V25, P3, DOI 10.1053/j.jvca.2010.11.018; Birrell GW, 2007, MOL CELL PROTEOMICS, V6, P973, DOI 10.1074/mcp.M600419-MCP200; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CHASE T, 1970, METHOD ENZYMOL, V19, P20; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dietrich W, 2007, ANN THORAC SURG, V84, P1144, DOI 10.1016/j.athoracsur.2007.05.015; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fergusson DA, 2008, NEW ENGL J MED, V358, P2319, DOI 10.1056/NEJMoa0802395; Filippovich I, 2002, BRIT J HAEMATOL, V119, P376, DOI 10.1046/j.1365-2141.2002.03878.x; Flight S, 2005, PATHOPHYSIOL HAEMO T, V34, P188, DOI 10.1159/000092421; Flight SM, 2009, BRIT J HAEMATOL, V145, P207, DOI 10.1111/j.1365-2141.2009.07605.x; FRITZ H, 1983, ARZNEIMITTELFORSCH, V33-1, P479; Fry BG, 2008, MOL CELL PROTEOMICS, V7, P215, DOI 10.1074/mcp.M700094-MCP200; Gaffney PJ, 2001, ANN NY ACAD SCI, V936, P594; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hanson WM, 2007, J MOL BIOL, V366, P230, DOI 10.1016/j.jmb.2006.11.003; Jing H, 1998, J MOL BIOL, V282, P1061, DOI 10.1006/jmbi.1998.2089; KEZDY FJ, 1970, METHOD ENZYMOL, V19, P3; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; Lawrence MG, 2010, ENDOCR REV, V31, P407, DOI 10.1210/er.2009-0034; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Levy Jerrold H, 2005, Curr Hematol Rep, V4, P368; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Lundwall A, 2006, BIOL CHEM, V387, P637, DOI 10.1515/BC.2006.082; Mangano DT, 2006, NEW ENGL J MED, V354, P353, DOI 10.1056/NEJMoa051379; Millers EKI, 2009, FEBS J, V276, P3163, DOI 10.1111/j.1742-4658.2009.07034.x; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; RUHLMANN A, 1973, J MOL BIOL, V77, P417, DOI 10.1016/0022-2836(73)90448-8; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Scheule AM, 2000, ANESTH ANALG, V90, P262, DOI 10.1097/00000539-200002000-00005; Schneeweiss S, 2008, NEW ENGL J MED, V358, P771, DOI 10.1056/NEJMoa0707571; Shaw AD, 2008, NEW ENGL J MED, V358, P784, DOI 10.1056/NEJMoa0707768; SIEKMANN J, 1989, BIOL CHEM H-S, V370, P677, DOI 10.1515/bchm3.1989.370.2.677; Sotiropoulou G, 2009, J BIOL CHEM, V284, P32989, DOI 10.1074/jbc.R109.027946; Tang J, 2005, J BIOL CHEM, V280, P41077, DOI 10.1074/jbc.M506766200; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; Wang XQ, 2000, J MOL BIOL, V295, P903, DOI 10.1006/jmbi.1999.3397; Williams JC, 1999, PROTEIN ENG, V12, P243, DOI 10.1093/protein/12.3.243	43	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54104	10.1371/journal.pone.0054104	http://dx.doi.org/10.1371/journal.pone.0054104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335990	gold, Green Published, Green Submitted			2022-12-25	WOS:000314707700048
J	Muller, A; Kleinau, G; Piechowski, CL; Muller, TD; Finan, B; Pratzka, J; Gruters, A; Krude, H; Tschop, M; Biebermann, H				Mueller, Anne; Kleinau, Gunnar; Piechowski, Carolin L.; Mueller, Timo D.; Finan, Brian; Pratzka, Juliane; Grueters, Annette; Krude, Heiko; Tschoep, Matthias; Biebermann, Heike			G-Protein Coupled Receptor 83 (GPR83) Signaling Determined by Constitutive and Zinc(II)-Induced Activity	PLOS ONE			English	Article							GLUCOCORTICOID-INDUCED RECEPTOR; TOGGLE SWITCH MODEL; JP05 MESSENGER-RNA; EXTRACELLULAR LOOPS; MOLECULAR-MECHANISM; STRUCTURAL BIOLOGY; CRYSTAL-STRUCTURES; HOMOLOGY MODEL; CYCLIC-AMP; T-CELLS	The G-protein coupled receptor 83 (GPR83) is an orphan G-protein coupled receptor for which the natural ligand(s) and signaling pathway(s) remain to be identified. Previous studies suggest a role of GPR83 in the regulation of thermogenesis and the control of circulating adiponectin. The aim of this study was to gain insights into the molecular underpinnings underlying GPR83 signaling. In particular, we aimed to assess the underlying G-protein activated signaling pathway of GPR83 and how this pathway is affected by mutational activation and zinc(II) challenge. Finally, we assessed the capacity of GPR83 for homodimerization. Our results show for the first time that mouse (m) GPR83 has high basal Gq/11 activity without affecting Gi or Gs signaling. Furthermore, we found that, under physiological conditions, zinc(II) (but not calcium(II) and magnesium(II)) potently activates mGPR83, thus identifying zinc(II) as an endogenous molecule with agonistic capability to activate mGPR83. In line with the observation that zinc(II)-ions activate mGPR83, we identified a cluster of ion-binding sensitive amino acids (e.g. His145, His204, Cys207, Glu217) in an activation sensitive receptor region of mGPR83. The occurrence of a constitutive activating mutant and a zinc(II)-binding residue at the N-terminal part corroborate the importance of this region in mGPR83 signal regulation. Finally, our results indicate that mGPR83 forms homodimers, which extend the current knowledge and molecular facets of GPR83 signaling.	[Mueller, Anne; Kleinau, Gunnar; Piechowski, Carolin L.; Pratzka, Juliane; Grueters, Annette; Krude, Heiko; Biebermann, Heike] Charite, Inst Expt Pediat Endocrinol, D-13353 Berlin, Germany; [Mueller, Timo D.; Finan, Brian; Tschoep, Matthias] German Res Ctr Environm Hlth GmbH, Helmholtz Ctr Munich, Inst Diabet & Obes, Munich, Germany; [Tschoep, Matthias] Tech Univ Munich, Dept Metab Dis, D-80290 Munich, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Biebermann, H (corresponding author), Charite, Inst Expt Pediat Endocrinol, D-13353 Berlin, Germany.	heike.biebermann@charite.de	Müller, Timo D./AAZ-4445-2020; Kleinau, Gunnar/GPX-6330-2022; Tschoep, Matthias H/I-5443-2014	Muller, Anne/0000-0002-6256-8860; Biebermann, Heike/0000-0002-2024-7778; Muller, Timo/0000-0002-0624-9339; Tschoep, Matthias/0000-0002-4744-371X	Deutsche Forschungsgemeinschaft (DFG) [BI893/5-1, 893/6-2, KL2334/2-1]; Graduate College 1208: Hormonal Regulation of Energy Metabolism, Body Weight and Growth [TP1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Graduate College 1208: Hormonal Regulation of Energy Metabolism, Body Weight and Growth	This work was supported by the Deutsche Forschungsgemeinschaft (DFG; www.dfg.de): BI893/5-1, 893/6-2, KL2334/2-1 and Graduate College 1208: Hormonal Regulation of Energy Metabolism, Body Weight and Growth (www.endogk.de/en/), TP1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams F, 2003, MOL BRAIN RES, V117, P39, DOI 10.1016/S0169-328X(03)00280-8; Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Alexander SPH, 2011, BRIT J PHARMACOL, V164, pS1, DOI 10.1111/j.1476-5381.2011.01649_1.x; ALLGEIER A, 1994, J BIOL CHEM, V269, P13733; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barwell J, 2012, BIOCHEM SOC T, V40, P433, DOI 10.1042/BST20110726; BAUGHMAN G, 1991, MOL ENDOCRINOL, V5, P637, DOI 10.1210/mend-5-5-637; Biebermann H, 1997, J CLIN ENDOCR METAB, V82, P3471, DOI 10.1210/jc.82.10.3471; Biebermann H, 2012, J CLIN ENDOCR METAB, V97, pE228, DOI 10.1210/jc.2011-2106; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Brezillon S, 2001, BRAIN RES, V921, P21, DOI 10.1016/S0006-8993(01)03068-2; Brock C, 2007, J BIOL CHEM, V282, P33000, DOI 10.1074/jbc.M702542200; BROWN EM, 1991, PHYSIOL REV, V71, P371, DOI 10.1152/physrev.1991.71.2.371; Carlsson J, 2011, NAT CHEM BIOL, V7, P769, DOI 10.1038/nchembio.662; Ciolek J, 2011, EUR J PHARMACOL, V655, P1, DOI 10.1016/j.ejphar.2010.12.042; Costanzi Stefano, 2012, Methods Mol Biol, V857, P259, DOI 10.1007/978-1-61779-588-6_11; Costanzi S, 2010, CHIM OGGI, V28, P26; Dubins JS, 2012, METABOLISM IN PRESS; Elinder F, 2003, Q REV BIOPHYS, V36, P373, DOI 10.1017/S0033583504003932; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; Fowler CB, 2004, BIOCHEMISTRY-US, V43, P8700, DOI 10.1021/bi036067r; Frazer A., 1999, BASIC NEUROCHEMISTRY, P263; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; HARRIGAN MT, 1991, MOL ENDOCRINOL, V5, P1331, DOI 10.1210/mend-5-9-1331; HARRIGAN MT, 1989, MOL CELL BIOL, V9, P3438, DOI 10.1128/MCB.9.8.3438; Holst B, 2002, J BIOL CHEM, V277, P47662, DOI 10.1074/jbc.M202103200; Holst B, 2007, ENDOCRINOLOGY, V148, P13, DOI 10.1210/en.2006-0933; Kleinau G, 2007, J BIOL CHEM, V282, P518, DOI 10.1074/jbc.M606176200; Kleinau G, 2009, ENDOCR REV, V30, P133, DOI 10.1210/er.2008-0044; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Kontoyianni M, 2012, CURR MED CHEM, V19, P544, DOI 10.2174/092986712798918824; Lu LF, 2007, MOL CELL BIOL, V27, P8065, DOI 10.1128/MCB.01075-07; Mason JS, 2012, TRENDS PHARMACOL SCI, V33, P249, DOI 10.1016/j.tips.2012.02.005; Massotte D, 2005, NAT STRUCT MOL BIOL, V12, P287, DOI 10.1038/nsmb0405-287; NICHOLSON C, 1977, P NATL ACAD SCI USA, V74, P1287, DOI 10.1073/pnas.74.3.1287; Norgaard-Nielsen K, 2006, HANDB EXP PHARM, V175, P1; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Parnot C, 2002, TRENDS ENDOCRIN MET, V13, P336, DOI 10.1016/S1043-2760(02)00628-8; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Pesini P, 1998, MOL BRAIN RES, V57, P281, DOI 10.1016/S0169-328X(98)00099-0; Rediger A, 2009, OBESITY FACTS, V2, P80, DOI 10.1159/000209862; Rosenkilde MM, 1998, FEBS LETT, V439, P35, DOI 10.1016/S0014-5793(98)01331-3; Sah R, 2005, NEUROSCIENCE, V133, P281, DOI 10.1016/j.neuroscience.2005.01.066; Sah R, 2007, PEPTIDES, V28, P302, DOI 10.1016/j.peptides.2006.11.013; Schetz JA, 1999, J PHARMACOL EXP THER, V289, P956; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Schulz A, 2000, J BIOL CHEM, V275, P2381, DOI 10.1074/jbc.275.4.2381; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shoichet BK, 2012, TRENDS PHARMACOL SCI, V33, P268, DOI 10.1016/j.tips.2012.03.007; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Staubert C, 2007, ENDOCRINOLOGY, V148, P4642, DOI 10.1210/en.2007-0138; Storjohann L, 2008, FEBS LETT, V582, P2583, DOI 10.1016/j.febslet.2008.06.030; Swaminath G, 2003, J BIOL CHEM, V278, P352, DOI 10.1074/jbc.M206424200; Swaminath G, 2002, MOL PHARMACOL, V61, P65, DOI 10.1124/mol.61.1.65; Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P399, DOI 10.1016/S0753-3322(03)00081-7; Thiel G, 2012, ENDOCRINOLOGY, V153, P4716, DOI 10.1210/en.2012-1343; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; VANSANDE J, 1990, MOL CELL ENDOCRINOL, V74, pR1, DOI 10.1016/0303-7207(90)90209-Q; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Wheatley M, 2007, BIOCHEM SOC T, V35, P717, DOI 10.1042/BST0350717; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; Winkler F, 2010, J CLIN ENDOCR METAB, V95, P3605, DOI 10.1210/jc.2010-0112; Worth CL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-185; Worth CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007011; XIE XM, 1994, PFLUG ARCH EUR J PHY, V427, P481, DOI 10.1007/BF00374264; Zhao Q, 2012, ACTA PHARMACOL SIN, V33, P324, DOI 10.1038/aps.2011.187	70	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53347	10.1371/journal.pone.0053347	http://dx.doi.org/10.1371/journal.pone.0053347			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335960	Green Published, gold, Green Submitted			2022-12-25	WOS:000314707700014
J	Pell, C; Menaca, A; Were, F; Afrah, NA; Chatio, S; Manda-Taylor, L; Hamel, MJ; Hodgson, A; Tagbor, H; Kalilani, L; Ouma, P; Pool, R				Pell, Christopher; Menaca, Arantza; Were, Florence; Afrah, Nana A.; Chatio, Samuel; Manda-Taylor, Lucinda; Hamel, Mary J.; Hodgson, Abraham; Tagbor, Harry; Kalilani, Linda; Ouma, Peter; Pool, Robert			Factors Affecting Antenatal Care Attendance: Results from Qualitative Studies in Ghana, Kenya and Malawi	PLOS ONE			English	Article							MATERNAL MORTALITY; PREGNANCY; PERSPECTIVES; STRATEGIES; MALARIA; BIRTH	Background: Antenatal care (ANC) is a key strategy to improve maternal and infant health. However, survey data from sub-Saharan Africa indicate that women often only initiate ANC after the first trimester and do not achieve the recommended number of ANC visits. Drawing on qualitative data, this article comparatively explores the factors that influence ANC attendance across four sub-Saharan African sites in three countries (Ghana, Kenya and Malawi) with varying levels of ANC attendance. Methods: Data were collected as part of a programme of qualitative research investigating the social and cultural context of malaria in pregnancy. A range of methods was employed interviews, focus groups with diverse respondents and observations in local communities and health facilities. Results: Across the sites, women attended ANC at least once. However, their descriptions of ANC were often vague. General ideas about pregnancy care - checking the foetus' position or monitoring its progress - motivated women to attend ANC; as did, especially in Kenya, obtaining the ANC card to avoid reprimands from health workers. Women's timing of ANC initiation was influenced by reproductive concerns and pregnancy uncertainties, particularly during the first trimester, and how ANC services responded to this uncertainty; age, parity and the associated implications for pregnancy disclosure; interactions with healthcare workers, particularly messages about timing of ANC; and the cost of ANC, including charges levied for ANC procedures - in spite of policies of free ANC - combined with ideas about the compulsory nature of follow-up appointments. Conclusion: In these socially and culturally diverse sites, the findings suggest that 'supply' side factors have an important influence on ANC attendance: the design of ANC and particularly how ANC deals with the needs and concerns of women during the first trimester has implications for timing of initiation.	[Pell, Christopher; Pool, Robert] Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands; [Pell, Christopher; Menaca, Arantza; Pool, Robert] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Were, Florence; Ouma, Peter] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Afrah, Nana A.; Tagbor, Harry] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Community Hlth, Kumasi, Ghana; [Chatio, Samuel; Hodgson, Abraham] Navrongo Hlth Res Ctr, Navrongo, Upper East Regi, Ghana; [Manda-Taylor, Lucinda; Kalilani, Linda] Univ Malawi, Coll Med, Blantyre, Malawi; [Tagbor, Harry] London Sch Hyg & Trop Med, Dept Infect & Trop Med, London WC1, England; [Hamel, Mary J.; Ouma, Peter] Ctr Dis Control & Prevent, Div Parasit Dis, Natl Ctr Infect Dis, Atlanta, GA USA	University of Amsterdam; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Kenya Medical Research Institute; Kwame Nkrumah University Science & Technology; Navrongo Health Research Center; University of Malawi; University of London; London School of Hygiene & Tropical Medicine; Centers for Disease Control & Prevention - USA	Pell, C (corresponding author), Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands.	c.l.pell@uva.nl	Manda-Taylor, Lucinda/AAK-2116-2021; Tagbor, Harry/B-9312-2018	Manda-Taylor, Lucinda/0000-0001-8149-0897; Tagbor, Harry/0000-0002-9300-665X; Pell, Christopher/0000-0001-9405-5851	Malaria in Pregnancy (MiP) Consortium; Bill and Melinda Gates Foundation [OPP46099]	Malaria in Pregnancy (MiP) Consortium; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was supported and endorsed by the Malaria in Pregnancy (MiP) Consortium, which is funded by a grant from the Bill and Melinda Gates Foundation (www.gatesfoundation.org), Grant OPP46099. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Zahr CL, 2003, ANTENATAL CARE DEV C; Allen DR, 2004, MANAGING MOTHERHOOD; Anya Samuel E, 2008, BMC Pregnancy Childbirth, V8, P9, DOI 10.1186/1471-2393-8-9; Bergsjo P, 1997, ACTA OBSTET GYN SCAN, V76, P15, DOI 10.3109/00016349709047779; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Carroli G, 2001, PAEDIATR PERINAT EP, V15, P1; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Centre National de la Statistique et destudes Etudes Economiques (CNSEE) and ORC Macro, 2006, ENQ DEM SANT CONG 20; Chapman RR, 2003, SOC SCI MED, V57, P355, DOI 10.1016/S0277-9536(02)00363-5; Conrad P, 2012, TROP MED INT HEALTH, V17, P300, DOI 10.1111/j.1365-3156.2011.02923.x; Dowswell T, 2010, COCHRANE DATABASE SY, P10; Gamble C, 2007, PLOS MED, V4, P506, DOI 10.1371/journal.pmed.0040107; Ghana Statistical Service (GSS) Ghana Health Service (GHS) ICF Macro., 2009, GHAN DEM HLTH SURV 2; Gross K, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-36; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Lambert H, 2002, BRIT MED J, V325, P210, DOI 10.1136/bmj.325.7357.210; Magoma M, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-64; Magoma M, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-13; Mathole T, 2004, MIDWIFERY, V20, P122, DOI 10.1016/j.midw.2003.10.003; Menendez C, 2007, LANCET INFECT DIS, V7, P126, DOI 10.1016/S1473-3099(07)70024-5; Myer L, 2003, J MIDWIFERY WOM HEAL, V48, P268, DOI 10.1016/S1526-9523(02)00421-X; National Statistical Office (NSO) and ICF Macro, 2011, MAL DEM HLTH SURV 20; Nikiema B, 2009, HEALTH POLICY PLANN, V24, P367, DOI 10.1093/heapol/czp017; NPC and ICF Macro, 2009, NIG DEM HLTH SURV 20; Pell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022452; Service GS, 2008, GHAN POP HOUS CENS 2; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Smith LA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-18; Stanton C, 2007, J BIOSOC SCI, V39, P109, DOI 10.1017/S0021932006001271; Stokes E, 2008, BJOG-INT J OBSTET GY, V115, P1641, DOI 10.1111/j.1471-0528.2008.01950.x; Strauss A., 1997, GROUNDED THEORY PRAC; Wang W, 2011, DHS COMP REPORTS, P85; World Health Organization, 2002, ANT CAR RAND TRIAL M; World Health Organization, 2010, IMPAC INT MAN PREG C; World Health Organization, 2007, PROV EFF ANT CAR STA; World Health Organization, 2011, WHO STAT ANT CAR	38	196	197	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53747	10.1371/journal.pone.0053747	http://dx.doi.org/10.1371/journal.pone.0053747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086SQ	23335973	gold, Green Published, Green Accepted			2022-12-25	WOS:000314707700029
J	Kim, H; Cruz, M; Bourdeau, A; Dumont, DJ				Kim, Harold; Cruz, Maribelle; Bourdeau, Annie; Dumont, Daniel J.			Cell-Cell Interactions Influence Vascular Reprogramming by Prox1 during Embryonic Development	PLOS ONE			English	Article							ARTERIAL ENDOTHELIAL-CELLS; LYMPHATIC VASCULATURE; MOLECULAR-MECHANISMS; NOTCH PATHWAY; COUP-TFII; EXPRESSION; BLOOD; LYMPHANGIOGENESIS; DIFFERENTIATION; HETEROGENEITY	Lymphangiogenesis is a highly regulated process that involves the reprogramming of venous endothelial cells into early lymphatic endothelial cells. This reprogramming not only displays a polarized expression pattern from the cardinal vein, but also demonstrates vascular specificity; early lymphatics only develop from the cardinal vein and not the related dorsal aorta. In our transgenic model of lymphangiogenesis, we demonstrate that Prox1 overexpression has the ability to reprogram venous endothelium but not early arterial endothelial cells in vivo, in spite of the fact that Prox1 expression is forced onto both vascular beds. Our observations suggest that this specificity during embryogenesis may be due to cell-cell interactions between the developing arterial endothelial cells and smooth muscle cells. These conclusions have far reaching implications on how we understand the vascular specificity of lymphangiogenesis.	[Kim, Harold; Cruz, Maribelle; Dumont, Daniel J.] Univ Toronto, Dept Med Biophys, Sunnybrook Res Inst, Toronto, ON, Canada; [Bourdeau, Annie] Univ Toronto, Dept Immunol, Sunnybrook Res Inst, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Dumont, DJ (corresponding author), Univ Toronto, Dept Med Biophys, Sunnybrook Res Inst, Toronto, ON, Canada.	dan.dumont@sri.utoronto.ca			Heart and Stroke Foundation of Canada [T-7097]; Susan G. Komen Foundation USA [PDF0600259]	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Susan G. Komen Foundation USA	Funding for this study was provided by the Heart and Stroke Foundation of Canada (T-7097). HK was awarded a Postdoctoral Fellowship from the Susan G. Komen Foundation USA (PDF0600259). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatschek S, 2007, BLOOD, V109, P4777, DOI 10.1182/blood-2006-10-053280; Carlson TR, 2005, P NATL ACAD SCI USA, V102, P9884, DOI 10.1073/pnas.0504391102; Cooley LS, 2010, J CELL SCI, V123, P3808, DOI 10.1242/jcs.064279; Dellinger M, 2008, DEV BIOL, V319, P309, DOI 10.1016/j.ydbio.2008.04.024; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Francois M, 2011, PHYSIOLOGY, V26, P146, DOI 10.1152/physiol.00053.2010; Harvey NL, 2005, NAT GENET, V37, P1072, DOI 10.1038/ng1642; High FA, 2008, P NATL ACAD SCI USA, V105, P1955, DOI 10.1073/pnas.0709663105; Hong YK, 2002, DEV DYNAM, V225, P351, DOI 10.1002/dvdy.10163; Johnson NC, 2008, GENE DEV, V22, P3282, DOI 10.1101/gad.1727208; Kang J, 2010, BLOOD, V116, P140, DOI 10.1182/blood-2009-11-252270; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kawai Yoshiko, 2008, Lymphatic Research and Biology, V6, P15, DOI 10.1089/lrb.2007.1019; Kilic N, 2007, BLOOD, V110, P4223, DOI 10.1182/blood-2007-06-097592; Kim H, 2003, CLIN GENET, V64, P282, DOI 10.1034/j.1399-0004.2003.00152.x; Kim HM, 2010, INT IMMUNOPHARMACOL, V10, P72, DOI 10.1016/j.intimp.2009.09.024; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lee S, 2009, BLOOD, V113, P1856, DOI 10.1182/blood-2008-03-145789; Miceli-Libby L, 2008, J VASC RES, V45, P1, DOI 10.1159/000109072; Nguyen VPKH, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-10; Nguyen VPKH, 2010, PROTEOMICS, V10, P1658, DOI 10.1002/pmic.200900594; Niessen K, 2011, BLOOD, V118, P1989, DOI 10.1182/blood-2010-11-319129; Petrova TV, 2004, NAT MED, V10, P974, DOI 10.1038/nm1094; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Saaristo A, 2002, J EXP MED, V196, P719, DOI 10.1084/jem.20020587; Sarao R, 1998, TRANSGENIC RES, V7, P421, DOI 10.1023/A:1008837410485; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Srinivasan RS, 2011, GENE DEV, V25, P2187, DOI 10.1101/gad.16974811; Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Veikkola T, 2003, FASEB J, V17, P2006, DOI 10.1096/fj.03-0179com; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Zheng W, 2011, BLOOD, V118, P1154, DOI 10.1182/blood-2010-11-317800; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599	40	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52197	10.1371/journal.pone.0052197	http://dx.doi.org/10.1371/journal.pone.0052197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341894	gold, Green Submitted, Green Published			2022-12-25	WOS:000314759400011
J	Hartlieb, E; Kempf, B; Partilla, M; Vigh, B; Spindler, V; Waschke, J				Hartlieb, Eva; Kempf, Bettina; Partilla, Miriam; Vigh, Balazs; Spindler, Volker; Waschke, Jens			Desmoglein 2 Is Less Important than Desmoglein 3 for Keratinocyte Cohesion	PLOS ONE			English	Article							PEMPHIGUS-VULGARIS; CELL-ADHESION; DSG2; INHIBITION; EXPRESSION; PHENOTYPE; DESMOSOME; IDENTIFICATION; DISSOCIATION; REGULATOR	Desmosomes provide intercellular adhesive strength required for integrity of epithelial and some non-epithelial tissues. Within the epidermis, the cadherin-type adhesion molecules desmoglein (Dsg) 1-4 and desmocollin (Dsc) 1-3 build the adhesive core of desmosomes. In keratinocytes, several isoforms of these proteins are co-expressed. However, the contribution of specific isoforms to overall cell cohesion is unclear. Therefore, in this study we investigated the roles of Dsg2 and Dsg3, the latter of which is known to be essential for keratinocyte adhesion based on its autoantibody-induced loss of function in the autoimmune blistering skin disease pemphigus vulgaris (PV). The pathogenic PV antibody AK23, targeting the Dsg3 adhesive domain, led to profound loss of cell cohesion in human keratinocytes as revealed by the dispase-based dissociation assays. In contrast, an antibody against Dsg2 had no effect on cell cohesion although the Dsg2 antibody was demonstrated to interfere with Dsg2 transinteraction by single molecule atomic force microscopy and was effective to reduce cell cohesion in intestinal epithelial Caco-2 cells which express Dsg2 as the only Dsg isoform. To substantiate these findings, siRNA-mediated silencing of Dsg2 or Dsg3 was performed in keratinocytes. In contrast to Dsg3-depleted cells, Dsg2 knockdown reduced cell cohesion only under conditions of increased shear. These experiments indicate that specific desmosomal cadherins contribute differently to keratinocyte cohesion and that Dsg2 compared to Dsg3 is less important in this context.	[Hartlieb, Eva; Partilla, Miriam; Vigh, Balazs; Spindler, Volker; Waschke, Jens] Univ Munich, Inst Anat & Cell Biol, Munich, Germany; [Kempf, Bettina] Univ Wurzburg, Inst Anat & Cell Biol, D-97070 Wurzburg, Germany	University of Munich; University of Wurzburg	Waschke, J (corresponding author), Univ Munich, Inst Anat & Cell Biol, Munich, Germany.	jens.waschke@med.uni-muenchen.de	Spindler, Volker/G-1704-2019	Spindler, Volker/0000-0002-1302-5421	Deutsche Forschungsgemeinschaft [SFB487, TP B5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft SFB487, TP B5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner W, 2003, J CELL SCI, V116, P1001, DOI 10.1242/jcs.00322; Bazzi H, 2006, DIFFERENTIATION, V74, P129, DOI 10.1111/j.1432-0436.2006.00061.x; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Brennan D, 2012, ONCOGENE, V31, P1636, DOI 10.1038/onc.2011.346; Brennan D, 2007, J CELL SCI, V120, P758, DOI 10.1242/jcs.03392; Brennan D, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/410278; Brennan D, 2009, CELL ADHES MIGR, V3, P148, DOI 10.4161/cam.3.2.7539; Chen JL, 2008, J CELL SCI, V121, P2844, DOI 10.1242/jcs.031518; Cirillo N, 2010, EXP CELL RES, V316, P580, DOI 10.1016/j.yexcr.2009.10.005; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; Dusek RL, 2007, J DERMATOL SCI, V45, P7, DOI 10.1016/j.jdermsci.2006.10.006; Eshkind L, 2002, EUR J CELL BIOL, V81, P592, DOI 10.1078/0171-9335-00278; Garrod DR, 2005, J CELL SCI, V118, P5743, DOI 10.1242/jcs.02700; Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356; Getsios Spiro, 2010, J Invest Dermatol, V130, P1764, DOI 10.1038/jid.2010.111; Gliem M, 2010, AM J PHYSIOL-CELL PH, V299, pC606, DOI 10.1152/ajpcell.00075.2010; Heupel WM, 2008, J IMMUNOL, V181, P1825, DOI 10.4049/jimmunol.181.3.1825; Heupel WM, 2009, J BIOL CHEM, V284, P8589, DOI 10.1074/jbc.M808813200; Heupel WM, 2009, AM J PATHOL, V174, P475, DOI 10.2353/ajpath.2009.080392; Jennings JM, 2011, J INVEST DERMATOL, V131, P706, DOI 10.1038/jid.2010.389; Jolly PS, 2010, J BIOL CHEM, V285, P8936, DOI 10.1074/jbc.M109.087999; Kimura TE, 2007, J INVEST DERMATOL, V127, P775, DOI 10.1038/sj.jid.5700643; Koch PJ, 1997, J CELL BIOL, V137, P1091, DOI 10.1083/jcb.137.5.1091; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mahoney MG, 2006, EXP DERMATOL, V15, P101, DOI 10.1111/j.1600-0625.2006.00391.x; Mahoney MG, 1999, J CLIN INVEST, V103, P461, DOI 10.1172/JCI5252; Man Tsang S, 2012, EXP CELL RES; Mao XM, 2011, J BIOL CHEM, V286, P1283, DOI 10.1074/jbc.M110.172874; Nava P, 2007, MOL BIOL CELL, V18, P4565, DOI 10.1091/mbc.E07-05-0426; Nie ZX, 2011, J BIOL CHEM, V286, P2143, DOI 10.1074/jbc.M110.192245; Pan M, 2011, CLIN EXP DERMATOL, V36, P703, DOI 10.1111/j.1365-2230.2011.04092.x; Schafer S, 1996, DIFFERENTIATION, V60, P99, DOI 10.1046/j.1432-0436.1996.6020099.x; SCHAFER S, 1994, EXP CELL RES, V211, P391, DOI 10.1006/excr.1994.1103; Schlegel N, 2010, AM J PHYSIOL-GASTR L, V298, pG774, DOI 10.1152/ajpgi.00239.2009; Spindler V, 2007, AM J PATHOL, V171, P906, DOI 10.2353/ajpath.2007.070028; Spindler V, 2011, AM J PATHOL, V179, P1905, DOI 10.1016/j.ajpath.2011.06.043; Spindler V, 2011, ANN ANAT, V193, P177, DOI 10.1016/j.aanat.2011.02.003; Spindler V, 2010, J IMMUNOL, V185, P6831, DOI 10.4049/jimmunol.1002675; Spindler V, 2009, J BIOL CHEM, V284, P30556, DOI 10.1074/jbc.M109.024810; Stanley JR, 2006, NEW ENGL J MED, V355, P1800, DOI 10.1056/NEJMra061111; Tsang SM, 2012, J PATHOL, V227, P81, DOI 10.1002/path.3982; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170; Wadhawan V, 2012, BIOCH J; Waschke J, 2005, J CLIN INVEST, V115, P3157, DOI 10.1172/JCI23475; Waschke J, 2008, HISTOCHEM CELL BIOL, V130, P21, DOI 10.1007/s00418-008-0420-0; Waschke J, 2006, J CELL BIOL, V175, P721, DOI 10.1083/jcb.200605125; Wu H, 2003, J INVEST DERMATOL, V120, P1152	48	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53739	10.1371/journal.pone.0053739	http://dx.doi.org/10.1371/journal.pone.0053739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326495	gold, Green Published, Green Submitted			2022-12-25	WOS:000314705800073
J	Hong, Y; Ge, ZJ; Jing, CR; Shi, J; Dong, X; Zhou, FY; Wang, ML; Zhang, ZD; Gong, WD				Hong, Yan; Ge, Zhijun; Jing, Changrui; Shi, Jun; Dong, Xiao; Zhou, Fengying; Wang, Meilin; Zhang, Zhengdong; Gong, Weida			Functional Promoter-308G > A Variant in Tumor Necrosis Factor alpha Gene Is Associated with Risk and Progression of Gastric Cancer in a Chinese Population	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; SQUAMOUS-CELL CARCINOMA; TNF-ALPHA; PROMOTER POLYMORPHISM; SUSCEPTIBILITY; ADENOCARCINOMA; TRANSCRIPTION; METAANALYSIS	Background: Tumor necrosis factor-alpha (TNF-alpha) plays a crucial role in the development and progression of gastric cancer. A functional polymorphism, -308 G>A (rs1800629), which is located in the promoter of TNFA gene, has been suggested to alter the production of TNF-alpha and influence cancer risk. In the present study, we sought to investigate whether this polymorphism has effects on the risk and progression of gastric cancer in a Chinese population. Methods: We genotyped the TNFA -308 G>A polymorphism using the TaqMan method in a two-stage case-control study comprising a total of 1686 gastric cancer patients and 1895 cancer-free subjects. The logistic regression was used to assess the genetic associations with occurrence and progression of gastric cancer. Results: We found a significant association between the variant genotypes and increased risk of gastric cancer [P = 0.034, odds ratio (OR) = 1.39, 95% confidence interval (CI) = 1.01-1.67, GA/AA vs. GG]. Similar results were observed in the follow-up replication study. When combined the data from the two studies, we found a more significant association (P = 0.001, OR = 1.34, 95%CI = 1.13-1.59), especially for older subjects (>65 years). Furthermore, the patients carrying the variant genotypes had a significantly greater prevalence of T4 stage of disease (P = 0.001, OR = 2.19, 95%CI = 1.39-3.47) and distant metastasis (P = 0.013, OR = 1.61, 95%CI = 1.10-2.35). Conclusions: Our results suggest that the functional promoter -308 G>A polymorphism in TNFA influence the susceptibility and progression of gastric cancer in the Chinese population.	[Hong, Yan; Ge, Zhijun; Shi, Jun; Gong, Weida] Yixing Peoples Hosp, Dept Surg, Yixing, Peoples R China; [Jing, Changrui] Wuxi 2 Peoples Hosp, Dept Plast Surg, Wuxi, Peoples R China; [Dong, Xiao; Gong, Weida] Yixing Canc Hosp, Dept Surg, Yixing, Peoples R China; [Zhou, Fengying] Wuxi Maternal & Child Hlth Hosp, Dept Breast Surg, Wuxi, Peoples R China; [Wang, Meilin; Zhang, Zhengdong] Nanjing Med Univ, Sch Publ Hlth, Dept Mol & Genet Toxicol, Nanjing, Jiangsu, Peoples R China; [Gong, Weida] Nanjing Med Univ, Ctr Canc, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Gong, WD (corresponding author), Yixing Peoples Hosp, Dept Surg, Yixing, Peoples R China.	gongweida2010@gmail.com	zhang, zheng/HCH-9684-2022		"the Six Talent Summit" Project of Jiangsu Province [SWYY-71-028]; National Natural Science Foundation of Jiangsu [BK2011194]; National Natural Science Foundation of China [30872084, 30972444, 81001274]	"the Six Talent Summit" Project of Jiangsu Province; National Natural Science Foundation of Jiangsu; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by "the Six Talent Summit" Project of Jiangsu Province (SWYY-71-028), the National Natural Science Foundation of Jiangsu (BK2011194) and the National Natural Science Foundation of China (30872084, 30972444, and 81001274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Correa GTB, 2011, ORAL ONCOL, V47, P888, DOI 10.1016/j.oraloncology.2011.07.001; Crew KD, 2004, SEMIN ONCOL, V31, P450, DOI 10.1053/j.seminoncol.2004.04.021; Fei BY, 2004, WORLD J GASTROENTERO, V10, P1256; FUJIKI H, 1994, CANCER DETECT PREV, V18, P1; Fujiki H, 2011, ANTI-CANCER AGENT ME, V11, P4, DOI 10.2174/187152011794941163; Ginaldi L, 1999, IMMUNOL RES, V20, P109, DOI 10.1007/BF02786467; Gorouhi F, 2008, BRIT J CANCER, V98, P1443, DOI 10.1038/sj.bjc.6604277; Grimm M, 2010, ANAL CELL PATHOL, V33, P151, DOI [10.1155/2010/891869, 10.3233/ACP-CLO-2010-0539]; Guo W, 2005, CHINESE MED J-PEKING, V118, P1870; Harris PR, 1996, GASTROENTEROLOGY, V111, P419, DOI 10.1053/gast.1996.v111.pm8690207; Hohenberger P, 2003, LANCET, V362, P305, DOI 10.1016/S0140-6736(03)13975-X; KOMORI A, 1993, CANCER RES, V53, P1982; Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7; Li C, 2005, AM J GASTROENTEROL, V100, P290, DOI 10.1111/j.1572-0241.2005.40806.x; Lu WL, 2005, CARCINOGENESIS, V26, P631, DOI 10.1093/carcin/bgh349; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pawelec G, 2002, FRONT BIOSCI-LANDMRK, V7, pD1056; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Raabe T, 1998, J BIOL CHEM, V273, P974, DOI 10.1074/jbc.273.2.974; Senthilkumar C, 2011, J CANCER RES CLIN, V137, P577, DOI 10.1007/s00432-010-0921-9; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Thalmaier U, 2002, INFECT IMMUN, V70, P3149, DOI 10.1128/IAI.70.6.3149-3155.2002; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Wang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031932; Wu MS, 2002, J INFECT DIS, V185, P106, DOI 10.1086/324771; Yea SS, 2001, J CLIN PATHOL, V54, P703, DOI 10.1136/jcp.54.9.703; Yoshida T, 2010, CANCER SCI, V101, P1582, DOI 10.1111/j.1349-7006.2010.01590.x; You WC, 2000, J NATL CANCER I, V92, P1607, DOI 10.1093/jnci/92.19.1607; Zhang JY, 2008, J HUM GENET, V53, P479, DOI 10.1007/s10038-008-0273-3; Zhou F, 2012, DNA CELL BIOL	31	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e50856	10.1371/journal.pone.0050856	http://dx.doi.org/10.1371/journal.pone.0050856			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326309	gold, Green Published, Green Submitted			2022-12-25	WOS:000313552400002
J	Keren-Shaul, H; Lev-Maor, G; Ast, G				Keren-Shaul, Hadas; Lev-Maor, Galit; Ast, Gil			Pre-mRNA Splicing Is a Determinant of Nucleosome Organization	PLOS ONE			English	Article							POLYMERASE-II; MICROCOCCAL NUCLEASE; PLASMID DNA; CROSS-TALK; U1 SNRNP; TRANSCRIPTION; CHROMATIN; RECRUITMENT; ELONGATION; METHYLATION	Chromatin organization affects alternative splicing and previous studies have shown that exons have increased nucleosome occupancy compared with their flanking introns. To determine whether alternative splicing affects chromatin organization we developed a system in which the alternative splicing pattern switched from inclusion to skipping as a function of time. Changes in nucleosome occupancy were correlated with the change in the splicing pattern. Surprisingly, strengthening of the 5' splice site or strengthening the base pairing of U1 snRNA with an internal exon abrogated the skipping of the internal exons and also affected chromatin organization. Over-expression of splicing regulatory proteins also affected the splicing pattern and changed nucleosome occupancy. A specific splicing inhibitor was used to show that splicing impacts nucleosome organization endogenously. The effect of splicing on the chromatin required a functional U1 snRNA base pairing with the 5' splice site, but U1 pairing was not essential for U1 snRNA enhancement of transcription. Overall, these results suggest that splicing can affect chromatin organization.	[Keren-Shaul, Hadas; Lev-Maor, Galit; Ast, Gil] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Ast, G (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	gilast@post.tau.ac.il			Israel Science Foundation [ISF 61/09, ISF bikura 838/10]; Joint Germany-Israeli Research Program [ca-139]; Deutsche-Israel Project [DIP MI-1317]; Israel Cancer Research Foundation	Israel Science Foundation(Israel Science Foundation); Joint Germany-Israeli Research Program; Deutsche-Israel Project; Israel Cancer Research Foundation	This work was supported by a grant from the Israel Science Foundation (ISF 61/09; ISF bikura 838/10); Joint Germany-Israeli Research Program (ca-139); Deutsche-Israel Project (DIP MI-1317); and Israel Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert BJ, 2007, J AM CHEM SOC, V129, P2648, DOI 10.1021/ja067870m; Albert BJ, 2009, MOL CANCER THER, V8, P2308, DOI 10.1158/1535-7163.MCT-09-0051; Alexander R, 2010, BIOCHEM SOC T, V38, P1251, DOI 10.1042/BST0381251; Allan J, 2012, J MOL BIOL, V417, P152, DOI 10.1016/j.jmb.2012.01.043; Allemand E, 2008, CURR OPIN GENET DEV, V18, P145, DOI 10.1016/j.gde.2008.01.006; Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; BARSOUM J, 1985, J BIOL CHEM, V260, P7688; Baserga SJ, 1993, RNA WORLD, P359; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Capranico G, 2010, BBA-REV CANCER, V1806, P240, DOI 10.1016/j.bbcan.2010.06.003; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Damgaard CK, 2008, MOL CELL, V29, P271, DOI 10.1016/j.molcel.2007.11.035; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; de Almeida SF, 2011, NAT STRUCT MOL BIOL, V18, P977, DOI 10.1038/nsmb.2123; de Almeida SF, 2012, TRENDS BIOCH SCI; de la Mata M, 2011, GENET RES INT, V2011, DOI 10.4061/2011/309865; de la Mata M, 2010, RNA, V16, P904, DOI 10.1261/rna.1993510; Dutertre M, 2010, NAT STRUCT MOL BIOL, V17, P1358, DOI 10.1038/nsmb.1912; Furger A, 2002, GENE DEV, V16, P2792, DOI 10.1101/gad.983602; Hnilicova J, 2011, NUCLEUS-PHILA, V2, P182, DOI 10.4161/nucl.2.3.15876; Hnilicova J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016727; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Ip JY, 2011, GENOME RES, V21, P390, DOI 10.1101/gr.111070.110; JEONG SW, 1994, NUCLEIC ACIDS RES, V22, P370, DOI 10.1093/nar/22.3.370; Jobert L, 2009, EMBO REP, V10, P494, DOI 10.1038/embor.2009.24; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; KESSEL D, 1971, CANCER RES, V31, P1883; Kim E, 2008, TRENDS GENET, V24, P7, DOI 10.1016/j.tig.2007.10.001; Kim E, 2008, BIOESSAYS, V30, P38, DOI 10.1002/bies.20692; Kim S, 2011, N KOREAN REV, V7, P3; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kornblihtt AR, 2006, NAT STRUCT MOL BIOL, V13, P5, DOI 10.1038/nsmb0106-5; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Kulaeva OI, 2007, MUTAT RES-FUND MOL M, V618, P116, DOI 10.1016/j.mrfmmm.2006.05.040; Kwek KY, 2002, NAT STRUCT BIOL, V9, P800, DOI 10.1038/nsb862; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Listerman I, 2006, NAT STRUCT MOL BIOL, V13, P815, DOI 10.1038/nsmb1135; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Luco RF, 2011, CURR OPIN GENET DEV, V21, P366, DOI 10.1016/j.gde.2011.03.004; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Martins SB, 2011, NAT STRUCT MOL BIOL, V18, P1115, DOI 10.1038/nsmb.2124; Mladenova V, 2009, BIOTECHNOL BIOTEC EQ, V23, P1044, DOI 10.1080/13102818.2009.10817609; Monneret C, 2005, EUR J MED CHEM, V40, P1, DOI 10.1016/j.ejmech.2004.10.001; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200; Oesterreich FC, 2011, TRENDS CELL BIOL, V21, P328, DOI 10.1016/j.tcb.2011.03.002; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; REEVES R, 1985, NUCLEIC ACIDS RES, V13, P3599, DOI 10.1093/nar/13.10.3599; Saint-Andre V, 2011, NAT STRUCT MOL BIOL, V18, P337, DOI 10.1038/nsmb.1995; Schor IE, 2009, P NATL ACAD SCI USA, V106, P4325, DOI 10.1073/pnas.0810666106; Schwartz S, 2010, EMBO J, V29, P1629, DOI 10.1038/emboj.2010.71; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Spiluttini B, 2010, J CELL SCI, V123, P2084, DOI 10.1242/jcs.061358; Subtil-Rodriguez A, 2011, RNA BIOL, V8, P389, DOI 10.4161/rna.8.3.14334; Subtil-Rodriguez A, 2010, EMBO REP, V11, P751, DOI 10.1038/embor.2010.131; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Tyagi A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000470; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508; Zhou HL, 2011, P NATL ACAD SCI USA, V108, pE627, DOI 10.1073/pnas.1103344108; Zorio DAR, 2004, EXP CELL RES, V296, P91, DOI 10.1016/j.yexcr.2004.03.019	72	20	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53506	10.1371/journal.pone.0053506	http://dx.doi.org/10.1371/journal.pone.0053506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326444	gold, Green Published			2022-12-25	WOS:000313552400025
J	Mithu, VS; Bakthavatsalam, S; Madhu, PK				Mithu, Venus Singh; Bakthavatsalam, Subha; Madhu, Perunthiruthy K.			C-13-C-13 Homonuclear Recoupling in Solid-State Nuclear Magnetic Resonance at a Moderately High Magic-Angle-Spinning Frequency	PLOS ONE			English	Article							NMR-SPECTROSCOPY; ROTATIONAL RESONANCE; CROSS-POLARIZATION; DIFFUSION; FIELD	Two-dimensional C-13-C-13 correlation experiments are widely employed in structure determination of protein assemblies using solid-state nuclear magnetic resonance. Here, we investigate the process of C-13-C-13 magnetisation transfer at a moderate magic-angle-spinning frequency of 30 kHz using some of the prominent second-order dipolar recoupling schemes. The effect of isotropic chemical-shift difference and spatial distance between two carbons and amplitude of radio frequency on H-1 channel on the magnetisation transfer efficiency of these schemes is discussed in detail.	[Mithu, Venus Singh; Bakthavatsalam, Subha; Madhu, Perunthiruthy K.] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Madhu, PK (corresponding author), Tata Inst Fundamental Res, Dept Chem Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	madhu@tifr.res.in	Bakthavatsalam, Subha/N-2577-2018	Bakthavatsalam, Subha/0000-0002-1347-1480; Mithu, Venus Singh/0000-0003-2869-9776	Department of Science and Technology, India under SERC scheme [SR/S1/PC/27/2009]	Department of Science and Technology, India under SERC scheme(Department of Science & Technology (India))	PKM acknowledges assistance from Department of Science and Technology, India, for funding under SERC scheme, SR/S1/PC/27/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayro MJ, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3089370; Bennett AE, 1998, J CHEM PHYS, V108, P9463, DOI 10.1063/1.476420; de Lacaillerie JBD, 2005, SOLID STATE NUCL MAG, V28, P225, DOI 10.1016/j.ssnmr.2005.09.005; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Grommek A, 2006, CHEM PHYS LETT, V427, P404, DOI 10.1016/j.cplett.2006.07.005; Hohwy M, 1999, J CHEM PHYS, V110, P7983, DOI 10.1063/1.478702; Hou GJ, 2011, J AM CHEM SOC, V133, P3943, DOI 10.1021/ja108650x; Hu BW, 2011, J MAGN RESON, V212, P320, DOI 10.1016/j.jmr.2011.07.011; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Ladizhansky V, 2009, SOLID STATE NUCL MAG, V36, P119, DOI 10.1016/j.ssnmr.2009.07.003; Lafon O, 2011, CHEM COMMUN, V47, P6930, DOI 10.1039/c1cc11705j; Lalli D, 2011, J BIOMOL NMR, V51, P477, DOI 10.1007/s10858-011-9578-1; LEVITT MH, 1990, J CHEM PHYS, V92, P6347, DOI 10.1063/1.458314; Linser R, 2011, ANGEW CHEM INT EDIT, V50, P4508, DOI 10.1002/anie.201008244; Manolikas T, 2008, J AM CHEM SOC, V130, P3959, DOI 10.1021/ja078039s; Marin-Montesinos I, 2006, CHEM PHYS LETT, V432, P572, DOI 10.1016/j.cplett.2006.10.101; McDermott A, 2009, ANNU REV BIOPHYS, V38, P385, DOI 10.1146/annurev.biophys.050708.133719; METZ G, 1994, J MAGN RESON SER A, V110, P219, DOI 10.1006/jmra.1994.1208; Mithu VS, 2011, BIOPHYS J, V101, P2825, DOI 10.1016/j.bpj.2011.10.023; Morcombe CR, 2004, J AM CHEM SOC, V126, P7196, DOI 10.1021/ja047919t; Paepe GD, 2008, J CHEM PHYS, V128; Paravastu AK, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2192516; Ramachandran R, 2003, J AM CHEM SOC, V125, P15623, DOI 10.1021/ja037761x; Renault M, 2010, ANGEW CHEM INT EDIT, V49, P8346, DOI 10.1002/anie.201002823; Scholz I, 2008, CHEM PHYS LETT, V460, P278, DOI 10.1016/j.cplett.2008.05.058; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Sun SJ, 2012, METHODS MOL BIOL, V831, P303, DOI 10.1007/978-1-61779-480-3_17; SZEVERENYI NM, 1982, J MAGN RESON, V47, P462, DOI 10.1016/0022-2364(82)90213-X; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Thakur RS, 2006, CHEM PHYS LETT, V426, P459, DOI 10.1016/j.cplett.2006.06.007; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Verel R, 1998, CHEM PHYS LETT, V287, P421, DOI 10.1016/S0009-2614(98)00172-9; Weingarth M, 2010, CHEM PHYS LETT, V488, P10, DOI 10.1016/j.cplett.2010.01.072; Weingarth M, 2009, J AM CHEM SOC, V131, P13937, DOI 10.1021/ja9036143; Weingarth M, 2009, CHEM PHYS LETT, V469, P342, DOI 10.1016/j.cplett.2008.12.084; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; Yang J, 2008, J AM CHEM SOC, V130, P5798, DOI 10.1021/ja711304e; Zhao X, 2001, CHEM PHYS LETT, V342, P353, DOI 10.1016/S0009-2614(01)00593-0	38	7	7	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e50504	10.1371/journal.pone.0050504	http://dx.doi.org/10.1371/journal.pone.0050504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326308	Green Submitted, Green Published, gold			2022-12-25	WOS:000313552400001
J	Song, YJ; Xue, YF; Ma, YH				Song, Yajian; Xue, Yanfen; Ma, Yanhe			Global Microarray Analysis of Carbohydrate Use in Alkaliphilic Hemicellulolytic Bacterium Bacillus sp N16-5	PLOS ONE			English	Article							DIFFERENT CARBON-SOURCES; CLOSTRIDIUM-THERMOCELLUM; THERMOTOGA-MARITIMA; ABC TRANSPORTERS; FUEL ETHANOL; CELLULOSOME; EXPRESSION; ENZYMES; BIOMASS; DEGRADATION	The alkaliphilic hemicellulolytic bacterium Bacillus sp. N16-5 has a broad substrate spectrum and exhibits the capacity to utilize complex carbohydrates such as galactomannan, xylan, and pectin. In the monosaccharide mixture, sequential utilization by Bacillus sp. N16-5 was observed. Glucose appeared to be its preferential monosaccharide, followed by fructose, mannose, arabinose, xylose, and galactose. Global transcription profiles of the strain were determined separately for growth on six monosaccharides (glucose, fructose, mannose, galactose, arabinose, and xylose) and four polysaccharides (galactomannan, xylan, pectin, and sodium carboxymethylcellulose) using one-color microarrays. Numerous genes potentially related to polysaccharide degradation, sugar transport, and monosaccharide metabolism were found to respond to a specific substrate. Putative gene clusters for different carbohydrates were identified according to transcriptional patterns and genome annotation. Identification and analysis of these gene clusters contributed to pathway reconstruction for carbohydrate utilization in Bacillus sp. N16-5. Several genes encoding putative sugar transporters were highly expressed during growth on specific sugars, suggesting their functional roles. Two phosphoenolpyruvate-dependent phosphotransferase systems were identified as candidate transporters for mannose and fructose, and a major facilitator superfamily transporter was identified as a candidate transporter for arabinose and xylose. Five carbohydrate uptake transporter 1 family ATP-binding cassette transporters were predicted to participate in the uptake of hemicellulose and pectin degradation products. Collectively, microarray data improved the pathway reconstruction involved in carbohydrate utilization of Bacillus sp. N16-5 and revealed that the organism precisely regulates gene transcription in response to fluctuations in energy resources.	[Song, Yajian; Xue, Yanfen; Ma, Yanhe] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China; [Song, Yajian; Xue, Yanfen; Ma, Yanhe] Chinese Acad Sci, Inst Microbiol, Natl Engn Lab Ind Enzymes, Beijing, Peoples R China; [Song, Yajian] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ma, YH (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China.	mayanhe@im.ac.cn	MA, YAN/HHN-2912-2022		Ministry of Sciences and Technology of China [2011CBA00800, 2011AA02A206, 2012AA022100, 2007CB707801]	Ministry of Sciences and Technology of China(Ministry of Science and Technology, China)	This work was supported by the Ministry of Sciences and Technology of China (Grant No. 2011CBA00800, 2011AA02A206, 2012AA022100 and 2007CB707801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adav SS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012419; Ajdic D, 2007, J BACTERIOL, V191, P6415; Barrangou R, 2006, P NATL ACAD SCI USA, V103, P3816, DOI 10.1073/pnas.0511287103; BAYER EA, 1985, J BACTERIOL, V163, P552, DOI 10.1128/JB.163.2.552-559.1985; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chhabra SR, 2003, J BIOL CHEM, V278, P7540, DOI 10.1074/jbc.M211748200; Conners SB, 2005, J BACTERIOL, V187, P7267, DOI 10.1128/JB.187.21.7267-7282.2005; Dahl MK, 2002, J MOL MICROB BIOTECH, V4, P315; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; Gold ND, 2007, J BACTERIOL, V189, P6787, DOI 10.1128/JB.00882-07; Han SO, 2004, J BACTERIOL, V186, P4218, DOI 10.1128/JB.186.13.4218-4227.2004; Inacio JM, 2008, MICROBIOL-SGM, V154, P2719, DOI 10.1099/mic.0.2008/018978-0; Jojima T, 2010, APPL MICROBIOL BIOT, V85, P471, DOI 10.1007/s00253-009-2292-1; Kumar R, 2008, J IND MICROBIOL BIOT, V35, P377, DOI 10.1007/s10295-008-0327-8; Li G, 2011, SCI CHINA LIFE SCI, V54, P90, DOI 10.1007/s11427-010-4106-1; Li G, 2010, J MICROBIOL BIOTECHN, V20, P670, DOI 10.4014/jmb.0911.11019; Lynd LR, 1996, ANNU REV ENERG ENV, V21, P403, DOI 10.1146/annurev.energy.21.1.403; Ma YH, 2004, EXTREMOPHILES, V8, P447, DOI 10.1007/s00792-004-0405-4; McKendry P, 2002, BIORESOURCE TECHNOL, V83, P37, DOI 10.1016/S0960-8524(01)00118-3; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Nagy T, 2007, J MOL BIOL, V373, P612, DOI 10.1016/j.jmb.2007.08.007; Newcomb M, 2007, P NATL ACAD SCI USA, V104, P3747, DOI 10.1073/pnas.0700087104; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Perez J., 2002, International Microbiology, V5, P53, DOI 10.1007/s10123-002-0062-3; Richard P, 2009, APPL MICROBIOL BIOT, V82, P597, DOI 10.1007/s00253-009-1870-6; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Saier MH, 1998, BIOTECHNOL BIOENG, V58, P170, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<170::AID-BIT9>3.0.CO;2-I; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; Schlosser A, 1997, J BACTERIOL, V179, P2092, DOI 10.1128/jb.179.6.2092-2095.1997; Schneider E, 2001, RES MICROBIOL, V152, P303, DOI 10.1016/S0923-2508(01)01201-3; Schwarz WH, 2001, APPL MICROBIOL BIOT, V56, P634, DOI 10.1007/s002530100710; Servinsky MD, 2010, MICROBIOL-SGM, V156, P3478, DOI 10.1099/mic.0.037085-0; Shulami S, 2011, J BACTERIOL, V193, P2838, DOI 10.1128/JB.00222-11; TEUNISSEN MJ, 1991, ARCH MICROBIOL, V156, P290, DOI 10.1007/BF00263000; VanFossen AL, 2009, APPL ENVIRON MICROB, V75, P7718, DOI 10.1128/AEM.01959-09; Webb AJ, 2008, J BACTERIOL, V190, P168, DOI 10.1128/JB.01509-07; Wooley R, 1999, BIOTECHNOL PROGR, V15, P794, DOI 10.1021/bp990107u; Zaldivar J, 2001, APPL MICROBIOL BIOT, V56, P17, DOI 10.1007/s002530100624	40	11	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54090	10.1371/journal.pone.0054090	http://dx.doi.org/10.1371/journal.pone.0054090			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326578	Green Published, Green Submitted, gold			2022-12-25	WOS:000313552400077
J	Bryson, RW; Riddle, BR; Graham, MR; Smith, BT; Prendini, L				Bryson, Robert W., Jr.; Riddle, Brett R.; Graham, Matthew R.; Smith, Brian Tilston; Prendini, Lorenzo			As Old as the Hills: Montane Scorpions in Southwestern North America Reveal Ancient Associations between Biotic Diversification and Landscape History	PLOS ONE			English	Article							SPECIATION; GULF; PHYLOGEOGRAPHY; BIOGEOGRAPHY; SYSTEMATICS; CHELICERATA; POPULATIONS; EVOLUTION; EXPANSION; ALIGNMENT	Background:The age of lineages has become a fundamental datum in studies exploring the interaction between geological transformation and biotic diversification. However, phylogeographical studies are often biased towards lineages that are younger than the geological features of the landscapes they inhabit. A temporally deeper historical biogeography framework may be required to address episodes of biotic diversification associated with geologically older landscape changes. Signatures of such associations may be retained in the genomes of ecologically specialized (stenotopic) taxa with limited vagility. In the study presented here, genetic data from montane scorpions in the Vaejovis vorhiesi group, restricted to humid rocky habitats in mountains across southwestern North America, were used to explore the relationship between scorpion diversification and regional geological history. Results: Strong phylogeographical signal was evident within the vorhiesi group, with 27 geographically cohesive lineages inferred from a mitochondrial phylogeny. A time-calibrated multilocus species tree revealed a pattern of Miocene and Pliocene (the Neogene period) lineage diversification. An estimated 21 out of 26 cladogenetic events probably occurred prior to the onset of the Pleistocene, 2.6 million years ago. The best-fit density-dependent model suggested diversification rate in the vorhiesi group gradually decreased through time. Conclusions: Scorpions of the vorhiesi group have had a long history in the highlands of southwestern North America. Diversification among these stenotopic scorpions appears to have occurred almost entirely within the Neogene period, and is temporally consistent with the dynamic geological history of the Basin and Range, and Colorado Plateau physiographical provinces. The persistence of separate lineages at small spatial scales suggests that a combination of ecological stenotopy and limited vagility may make these scorpions particularly valuable indicators of geomorphological evolution.	[Bryson, Robert W., Jr.; Riddle, Brett R.; Graham, Matthew R.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Bryson, Robert W., Jr.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Bryson, Robert W., Jr.] Univ Washington, Burke Museum Nat Hist & Culture, Seattle, WA 98195 USA; [Smith, Brian Tilston] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Prendini, Lorenzo] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Louisiana State University System; Louisiana State University; American Museum of Natural History (AMNH)	Bryson, RW (corresponding author), Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA.	brysonjr@uw.edu	Prendini, Lorenzo/AAY-6611-2021	Prendini, Lorenzo/0000-0001-8727-7106	University of Nevada, Las Vegas Graduate and Professional Student Association; National Science Foundation [DEB 0413453]; Richard Lounsbery Foundation	University of Nevada, Las Vegas Graduate and Professional Student Association; National Science Foundation(National Science Foundation (NSF)); Richard Lounsbery Foundation	Funding for the first author was provided in part by the University of Nevada, Las Vegas Graduate and Professional Student Association. Aspects of the work conducted at the AMNH were funded by National Science Foundation grant DEB 0413453, and by a grant from the Richard Lounsbery Foundation to the last author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Ayoub NA, 2004, MOL ECOL, V13, P3453, DOI 10.1111/j.1365-294X.2004.02335.x; Badgley C, 2010, ECOGRAPHY, V33, P220, DOI 10.1111/j.1600-0587.2010.06282.x; Bertheau C, 2011, MOL ECOL RESOUR, V11, P1056, DOI 10.1111/j.1755-0998.2011.03050.x; Borges A, 2010, TOXICON, V55, P436, DOI 10.1016/j.toxicon.2009.09.011; Brand P., 2011, TERTIARY EXTENSION F; Bryson RW, 2011, J BIOGEOGR, V38, P2299, DOI 10.1111/j.1365-2699.2011.02565.x; Bryson RW, 2012, MOL PHYLOGENET EVOL, V62, P447, DOI 10.1016/j.ympev.2011.10.014; Burbrink FT, 2010, EVOLUTION, V64, P934, DOI 10.1111/j.1558-5646.2009.00888.x; Coddington JA, 2004, ASSEMBLING THE TREE OF LIFE, P296; Cody S, 2010, ECOGRAPHY, V33, P326, DOI 10.1111/j.1600-0587.2010.06327.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; FERRARI L, 1995, GEOLOGY, V23, P751, DOI 10.1130/0091-7613(1995)023<0751:MSATNB>2.3.CO;2; Gantenbein B, 2003, MOL PHYLOGENET EVOL, V28, P119, DOI 10.1016/S1055-7903(03)00031-9; Graham MR, 2012, J ARACHNOL, V40, P281, DOI 10.1636/Ha11-78.1; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Henry CD, 2000, TECTONOPHYSICS, V318, P1, DOI 10.1016/S0040-1951(99)00304-2; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Knowles LL, 2009, ANNU REV ECOL EVOL S, V40, P593, DOI 10.1146/annurev.ecolsys.38.091206.095702; Knowles LL, 2001, P ROY SOC B-BIOL SCI, V268, P319, DOI 10.1098/rspb.2000.1364; Kozak KH, 2006, P ROY SOC B-BIOL SCI, V273, P539, DOI 10.1098/rspb.2005.3326; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; Lourenco W. R., 2000, BIODIVERSIDAD TAXONO, V2, P115; McCormack JE, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-28; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; Menges C. M., 1989, GEOLOGIC EVOLUTION A, V17, P649; Morrone J.J., 2009, EVOLUTIONARY BIOGEOG; Moulton MJ, 2010, MOL ECOL RESOUR, V10, P615, DOI 10.1111/j.1755-0998.2009.02823.x; Mulcahy DG, 2009, MOL PHYLOGENET EVOL, V53, P537, DOI 10.1016/j.ympev.2009.05.037; Nylander J. A. A., 2004, MRMODELTEST V2; Oskin M, 2003, GEOLOGY, V31, P23, DOI 10.1130/0091-7613(2003)031<0023:MISWPB>2.0.CO;2; Parmakelis A, 2006, MOL ECOL, V15, P2883, DOI 10.1111/j.1365-294X.2006.02982.x; Parmakelis A, 2006, J BIOGEOGR, V33, P251, DOI 10.1111/j.1365-2699.2005.01386.x; Pigot AL, 2010, SYST BIOL, V59, P660, DOI 10.1093/sysbio/syq058; Prendini L, 2005, AFRICAN BIODIVERSITY: MOLECULES, ORGANISMS, ECOSYSTEMS, P25, DOI 10.1007/0-387-24320-8_2; Prendini L, 2005, ORG DIVERS EVOL, V5, P203, DOI 10.1016/j.ode.2004.12.004; Prendini L, 2003, INVERTEBR SYST, V17, P185, DOI 10.1071/IS02016; Prendini Lorenzo, 2001, P113; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Rambaut A., 2012, TRACER V1 5; Retallack GJ, 1997, PALAIOS, V12, P380, DOI 10.2307/3515337; Retallack GJ, 2001, J GEOL, V109, P407, DOI 10.1086/320791; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sabels BE, 1962, GUIDEBOOK MOGOLLON R, P100; SEAGER WR, 1984, GEOL SOC AM BULL, V95, P87, DOI 10.1130/0016-7606(1984)95<87:NKDFBA>2.0.CO;2; Shafiqullah M., 1980, ARIZONA GEOLOGICAL S, VXII, P201; Sissom W. David, 2005, P122; Sissom WD, 2012, AM MUS NOVIT, P1, DOI 10.1206/3742.2; Smith BT, 2010, ECOGRAPHY, V33, P333, DOI 10.1111/j.1600-0587.2009.06335.x; Sousa P, 2010, J ARACHNOL, V38, P206, DOI 10.1636/H08-98.1; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stockwell SA, 1989, THESIS; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Thomas GH, 2008, GLOBAL ECOL BIOGEOGR, V17, P340, DOI 10.1111/j.1466-8238.2008.00384.x; Tully T, 2006, PEDOBIOLOGIA, V50, P95, DOI 10.1016/j.pedobi.2005.11.003; Van Devender T.R., 1990, PACKRAT MIDDENS LAST; Wiens JJ, 2007, P ROY SOC B-BIOL SCI, V274, P919, DOI 10.1098/rspb.2006.0301; Wiens JJ, 2011, PHILOS T R SOC B, V366, P2336, DOI 10.1098/rstb.2011.0059; Wilson JS, 2010, PROG PHYS GEOG, V34, P419, DOI 10.1177/0309133310363991; Wood DA, 2011, MOL ECOL, V20, P3856, DOI 10.1111/j.1365-294X.2011.05211.x	69	52	52	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52822	10.1371/journal.pone.0052822	http://dx.doi.org/10.1371/journal.pone.0052822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326361	Green Published, gold, Green Submitted			2022-12-25	WOS:000313551500032
J	Chen, Z; Zhou, P; Yang, ZQ; Li, Y; Luo, YC; He, Y; Li, NN; Xie, CQ; Lai, C; Fang, XL; Chen, X				Chen, Zhi; Zhou, Peng; Yang, Zhong-Qing; Li, Yang; Luo, Yan-Cheng; He, Yao; Li, Nan-Nan; Xie, Chao-Qun; Lai, Chen; Fang, Xiao-Long; Chen, Xiang			Transperitoneal Mini-Laparoscopic Pyeloplasty and Concomitant Ureteroscopy-Assisted Pyelolithotomy for Ureteropelvic Junction Obstruction Complicated by Renal Caliceal Stones	PLOS ONE			English	Article							ANTEGRADE ENDOPYELOTOMY; MANAGEMENT; NEPHROLITHOTOMY; EXPERIENCE; OUTCOMES; CALCULI; LASER; LONG	Objective: To present our experience of combining transperitoneal mini-laparoscopic pyeloplasty (mini-LP) and concomitant ureteroscopy-assisted pyelolithotomy (U-P) for ureteropelvic junction obstruction (UPJO) complicated by renal caliceal stones in the same session. Methods: Between May 2007 and December 2011, mini-LP and concomitant U-P was performed in nine patients with UPJO and ipsilateral renal caliceal stones. Stone location and burden were preoperatively assessed. After pyelotomy with appropriate length (about 4 mm), a 16-Fr catheter sheath replaced the uppermost or lowermost laparoscopic trocar and was introduced directly into the renal pelvis under the guidance of a guide wire and laparoscopic vision. A 7.5F rigid ureteroscopy passed through the catheter sheath into the plevis. Intracorporeal lithotripsy and/or pressure irrigation via a pump was used for caliceal stone removal. Subsequently, laparoscopic pyeloplasty was performed in a standard fashion. Postoperative imaging was assessed. Results: The calculi sizes ranged from 2 to 11 mm (mean, 7.1 mm) and an average of 3 stones per patient was removed (range, 1 to 6 stones). Complete stone clearance confirmed by postoperative imaging was achieved in all patients. Mean operative time was 210 minutes, and estimated blood loss was 20 mL. Mean hospital stay was 5 days (4-7). Stent was removed after 4-8 weeks. No intraoperative or postoperative complications were noted during a mean follow-up of 18.5 months (range, 6 to 24 months). Conclusions: Mini-LP and concomitant U-P are simple and effective alternatives for the simultaneous management of UPJO complicated by coexisting ipsilateral renal caliceal stones.	[Chen, Zhi; Yang, Zhong-Qing; Li, Yang; Luo, Yan-Cheng; He, Yao; Li, Nan-Nan; Xie, Chao-Qun; Lai, Chen; Fang, Xiao-Long; Chen, Xiang] Cent S Univ, Xiangya Hosp, Dept Urol, Changsha, Hunan, Peoples R China; [Zhou, Peng] Cent S Univ, Xiangya Hosp, Dept Gen Surg, Changsha, Hunan, Peoples R China	Central South University; Central South University	Chen, X (corresponding author), Cent S Univ, Xiangya Hosp, Dept Urol, Changsha, Hunan, Peoples R China.	cxiang1007@126.com						Agarwal A, 2008, J ENDOUROL, V22, P2251, DOI 10.1089/end.2008.9726; Atug F, 2005, BJU INT, V96, P1365, DOI 10.1111/j.1464-410X.2005.05819.x; Ball Adam J, 2004, JSLS, V8, P223; Berkman DS, 2009, J ENDOUROL, V23, P1409, DOI 10.1089/end.2009.0379; Bernardo NO, 2008, J ENDOUROL, V22, P1893, DOI 10.1089/end.2008.9782; Boylu U, 2012, J LAPAROENDOSC ADV A; Dimarco DS, 2006, J ENDOUROL, V20, P707, DOI 10.1089/end.2006.20.707; Doo CK, 2007, J ENDOUROL, V21, P158, DOI 10.1089/end.2006.0191; El-Nahas AR, 2006, J UROLOGY, V175, P614, DOI 10.1016/S0022-5347(05)00142-4; Gupta M, 1997, J UROLOGY, V157, P1613, DOI 10.1016/S0022-5347(01)64808-0; Inagaki T, 2005, BJU INT, V95, P102, DOI 10.1111/j.1464-410X.2005.05208.x; Jacobs BL, 2012, J ENDOUROL; Micali S, 1997, J UROLOGY, V157, P463, DOI 10.1016/S0022-5347(01)65173-5; Minervini A, 2006, EUR UROL, V49, P536, DOI 10.1016/j.eururo.2005.11.025; Nambirajan T, 2005, J ENDOUROL, V19, P353, DOI 10.1089/end.2005.19.353; Ost MC, 2005, UROLOGY, V66, P47, DOI 10.1016/j.urology.2005.06.115; Ramakumar S, 2002, J UROLOGY, V167, P1378, DOI 10.1016/S0022-5347(05)65305-0; Riachy E, 2012, J UROL; Samarasekera D, 2011, CUAJ-CAN UROL ASSOC, V5, P134, DOI 10.5489/cuaj.11032; Shalhav AL, 1998, J UROLOGY, V160, P685, DOI 10.1016/S0022-5347(01)62755-1; Srivastava A, 2008, UROL INT, V80, P306, DOI 10.1159/000127347; Stein RJ, 2008, J ENDOUROL, V22, P1251, DOI 10.1089/end.2008.0003; Stilling NM, 2009, SCAND J UROL NEPHROL, V43, P68, DOI 10.1080/00365590802473164	23	4	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e55026	10.1371/journal.pone.0055026	http://dx.doi.org/10.1371/journal.pone.0055026			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326607	Green Submitted, Green Published, gold			2022-12-25	WOS:000313551500113
J	Heathcote, AJ; Filstrup, CT; Downing, JA				Heathcote, Adam J.; Filstrup, Christopher T.; Downing, John A.			Watershed Sediment Losses to Lakes Accelerating Despite Agricultural Soil Conservation Efforts	PLOS ONE			English	Article							LAND-USE; SURFACE WATERS; PHOSPHORUS; BIOMASS; RATES	Agricultural soil loss and deposition in aquatic ecosystems is a problem that impairs water quality worldwide and is costly to agriculture and food supplies. In the US, for example, billions of dollars have subsidized soil and water conservation practices in agricultural landscapes over the past decades. We used paleolimnological methods to reconstruct trends in sedimentation related to human-induced landscape change in 32 lakes in the intensively agricultural region of the Midwestern United States. Despite erosion control efforts, we found accelerating increases in sediment deposition from erosion; median erosion loss since 1800 has been 15.4 tons ha(-1). Sediment deposition from erosion increased >6-fold, from 149 g m(-2) yr(-1) in 1850 to 986 g m(-2) yr(-1) by 2010. Average time to accumulate one mm of sediment decreased from 631 days before European settlement (ca. 1850) to 59 days mm(-1) at present. Most of this sediment was deposited in the last 50 years and is related to agricultural intensification rather than land clearance or predominance of agricultural lands. In the face of these intensive agricultural practices, traditional soil conservation programs have not decelerated downstream losses. Despite large erosion control subsidies, erosion and declining water quality continue, thus new approaches are needed to mitigate erosion and water degradation.	[Heathcote, Adam J.; Filstrup, Christopher T.; Downing, John A.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA	Iowa State University	Heathcote, AJ (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	aheathco@iastate.edu	Heathcote, Adam J./I-9253-2019	Heathcote, Adam J./0000-0002-9633-9548; Downing, John/0000-0001-8547-0789	Iowa Department of Natural Resources [08-39HA-18-05]	Iowa Department of Natural Resources	This work was funded by a research grant from the Iowa Department of Natural Resources (Contract #: 08-39HA-18-05) (http://www.iowadnr.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby P.G., 1978, CATENA, V5, P1, DOI 10.1016/S0341-8162(78)80002-2; Beach T., 1994, ANN ASSOC AM GEOGR, V8, P5; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Cleveland W.S., 1992, LOCAL REGRESSION MOD, P309; DAVIS M B, 1976, Environmental Conservation, V3, P139, DOI 10.1017/S0376892900018269; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; ENGSTROM DR, 1999, TRENDS ATMOSPHERIC M; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Heathcote AJ, 2012, ECOSYSTEMS, V15, P60, DOI 10.1007/s10021-011-9488-9; JONES JR, 1978, HYDROBIOLOGIA, V57, P267, DOI 10.1007/BF00014580; MCCAULEY E, 1981, CAN J FISH AQUAT SCI, V38, P458, DOI 10.1139/f81-063; Pavelis G., 2011, SOIL WATER CONSERVAT; PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117; Renwick WH, 2006, IAHS-AISH P, V306, P341; SHARPLEY AN, 1994, J ENVIRON QUAL, V23, P437, DOI 10.2134/jeq1994.00472425002300030006x; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Trimble S., 1982, 1234 GEOL SURV; TRIMBLE SW, 1981, SCIENCE, V214, P181, DOI 10.1126/science.214.4517.181; Trimble SW, 2000, SCIENCE, V289, P248, DOI 10.1126/science.289.5477.248; WATSON S, 1988, CAN J FISH AQUAT SCI, V45, P915, DOI 10.1139/f88-112; Winsten JR, 2011, J SOIL WATER CONSERV, V66, p111A, DOI 10.2489/jswc.66.4.111A; Wren DG, 2008, J SOIL WATER CONSERV, V63, P129, DOI 10.2489/63.3.129; Wren DG, 2011, J SOIL WATER CONSERV, V66, P313, DOI 10.2489/jswc.66.5.313	23	52	55	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53554	10.1371/journal.pone.0053554	http://dx.doi.org/10.1371/journal.pone.0053554			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326454	Green Published, Green Submitted, gold			2022-12-25	WOS:000313551500082
J	Thompson, B; Tjan, BS; Liu, ZL				Thompson, Benjamin; Tjan, Bosco S.; Liu, Zili			Perceptual Learning of Motion Direction Discrimination with Suppressed and Unsuppressed MT in Humans: An fMRI Study	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; AREA MT; ORIENTATION DISCRIMINATION; CORTICAL AREA; V1 NEURONS; TEXTURE-DISCRIMINATION; TRANSPARENT MOTION; BRAIN ACTIVITY; MONKEY; PERFORMANCE	The middle temporal area of the extrastriate visual cortex (area MT) is integral to motion perception and is thought to play a key role in the perceptual learning of motion tasks. We have previously found, however, that perceptual learning of a motion discrimination task is possible even when the training stimulus contains locally balanced, motion opponent signals that putatively suppress the response of MT. Assuming at least partial suppression of MT, possible explanations for this learning are that 1) training made MT more responsive by reducing motion opponency, 2) MT remained suppressed and alternative visual areas such as V1 enabled learning and/or 3) suppression of MT increased with training, possibly to reduce noise. Here we used fMRI to test these possibilities. We first confirmed that the motion opponent stimulus did indeed suppress the BOLD response within hMT+ compared to an almost identical stimulus without locally balanced motion signals. We then trained participants on motion opponent or non-opponent stimuli. Training with the motion opponent stimulus reduced the BOLD response within hMT+ and greater reductions in BOLD response were correlated with greater amounts of learning. The opposite relationship between BOLD and behaviour was found at V1 for the group trained on the motion-opponent stimulus and at both V1 and hMT+ for the group trained on the non-opponent motion stimulus. As the average response of many cells within MT to motion opponent stimuli is the same as their response to non-directional flickering noise, the reduced activation of hMT+ after training may reflect noise reduction.	[Thompson, Benjamin] Univ Auckland, Dept Optometry & Vis Sci, Auckland 1, New Zealand; [Tjan, Bosco S.] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Tjan, Bosco S.] Univ So Calif, Grad Program Neurosci, Los Angeles, CA USA; [Liu, Zili] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA	University of Auckland; University of Southern California; University of Southern California; University of California System; University of California Los Angeles	Thompson, B (corresponding author), Univ Auckland, Dept Optometry & Vis Sci, Auckland 1, New Zealand.	b.thompson@auckland.ac.nz		Thompson, Benjamin/0000-0002-3902-2712	US NSF grant [BCS 0617628]; NEI grant [RO1 EY01 7707]; NATIONAL EYE INSTITUTE [R01EY017707] Funding Source: NIH RePORTER	US NSF grant(National Science Foundation (NSF)); NEI grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a US NSF grant to Z.L. (BCS 0617628) and an NEI grant to B.S.T. (RO1 EY01 7707). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adab HZ, 2011, CURR BIOL, V21, P1661, DOI 10.1016/j.cub.2011.08.037; BALL K, 1987, VISION RES, V27, P953, DOI 10.1016/0042-6989(87)90011-3; Bao M, 2010, J NEUROSCI, V30, P15080, DOI 10.1523/JNEUROSCI.5703-09.2010; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chen N, 2012, VSS 2012; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Epstein W., 1967, VARIETIES PERCEPTUAL; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; Furmanski CS, 2004, CURR BIOL, V14, P573, DOI 10.1016/j.cub.2004.03.032; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; Gibson E. J., 1991, ODYSSEY LEARNING PER; Gibson Eleanor Jack, 1969, PRINCIPLES PERCEPTUA; GILBERT CD, 1994, P NATL ACAD SCI USA, V91, P1195, DOI 10.1073/pnas.91.4.1195; GLASS L, 1969, NATURE, V223, P578, DOI 10.1038/223578a0; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Hotson JR, 1999, NEUROPSYCHOLOGIA, V37, P169; Hua TM, 2010, CURR BIOL, V20, P887, DOI 10.1016/j.cub.2010.03.066; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Kourtzi Z, 2005, PLOS BIOL, V3, P1317, DOI 10.1371/journal.pbio.0030204; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Li W, 2008, NEURON, V57, P442, DOI 10.1016/j.neuron.2007.12.011; Lu HJ, 2004, VISION RES, V44, P1817, DOI 10.1016/j.visres.2004.03.002; MISHKIN M, 1954, J COMP PHYSIOL PSYCH, V47, P187, DOI 10.1037/h0057551; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Mukai I, 2007, J NEUROSCI, V27, P11401, DOI 10.1523/JNEUROSCI.3002-07.2007; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petrov AA, 2005, PSYCHOL REV, V112, P715, DOI 10.1037/0033-295X.112.4.715; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; QIAN N, 1994, J NEUROSCI, V14, P7367; Raiguel S, 2006, J NEUROSCI, V26, P6589, DOI 10.1523/JNEUROSCI.0457-06.2006; Rainer G, 2004, PLOS BIOL, V2, P275, DOI 10.1371/journal.pbio.0020044; Rudolph K, 1999, CEREB CORTEX, V9, P90, DOI 10.1093/cercor/9.1.90; Schiltz C, 2001, CORTEX, V37, P243, DOI 10.1016/S0010-9452(08)70571-9; Schiltz C, 1999, NEUROIMAGE, V9, P46, DOI 10.1006/nimg.1998.0394; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; Seitz AR, 2011, CURR BIOL, V21, pR814, DOI 10.1016/j.cub.2011.08.042; Shibata K, 2011, SCIENCE, V334, P1413, DOI 10.1126/science.1212003; SNOWDEN RJ, 1991, J NEUROSCI, V11, P2768; Thompson B, 2006, VISION RES, V46, P2110, DOI 10.1016/j.visres.2006.01.005; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; Vaina LM, 1998, P NATL ACAD SCI USA, V95, P12657, DOI 10.1073/pnas.95.21.12657; Villeneuve MY, 2012, EUR J NEUROSCI; Walker MP, 2005, CEREB CORTEX, V15, P1666, DOI 10.1093/cercor/bhi043; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004; Yotsumoto Y, 2008, NEURON, V57, P827, DOI 10.1016/j.neuron.2008.02.034; Zhang JX, 2010, J NEUROSCI, V30, P14127, DOI 10.1523/JNEUROSCI.2204-10.2010; ZOHARY E, 1994, SCIENCE, V263, P1289, DOI 10.1126/science.8122114	54	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53458	10.1371/journal.pone.0053458	http://dx.doi.org/10.1371/journal.pone.0053458			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326433	Green Submitted, Green Published, gold			2022-12-25	WOS:000313551500073
J	Shiu, KK; Wetterskog, D; Mackay, A; Natrajan, R; Lambros, M; Sims, D; Bajrami, I; Brough, R; Frankum, J; Sharpe, R; Marchio, C; Horlings, H; Reyal, F; van der Vijver, M; Turner, N; Reis-Filho, JS; Lord, CJ; Ashworth, A				Shiu, K-K; Wetterskog, D.; Mackay, A.; Natrajan, R.; Lambros, M.; Sims, D.; Bajrami, I.; Brough, R.; Frankum, J.; Sharpe, R.; Marchio, C.; Horlings, H.; Reyal, F.; van der Vijver, M.; Turner, N.; Reis-Filho, J. S.; Lord, C. J.; Ashworth, A.			Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies	ONCOGENE			English	Article						HER2-positive breast cancer; microarrays; gene expression; comparative genomic hybridization; siRNA screens; TFAP2C	COMPARATIVE GENOMIC HYBRIDIZATION; PLUS ADJUVANT CHEMOTHERAPY; COPY-NUMBER ALTERATIONS; TRANSCRIPTION FACTOR; EXPRESSION LEVELS; FOLLOW-UP; TRASTUZUMAB; RESISTANCE; RECEPTOR; LAPATINIB	Overexpression of the receptor tyrosine kinase ERBB2 (also known as HER2) occurs in around 15% of breast cancers and is driven by amplification of the ERBB2 gene. ERBB2 amplification is a marker of poor prognosis, and although anti-ERBB2-targeted therapies have shown significant clinical benefit, de novo and acquired resistance remains an important problem. Genomic profiling has demonstrated that ERBB2+ve breast cancers are distinguished from ER+ve and 'triple-negative' breast cancers by harbouring not only the ERBB2 amplification on 17q12, but also a number of co-amplified genes on 17q12 and amplification events on other chromosomes. Some of these genes may have important roles in influencing clinical outcome, and could represent genetic dependencies in ERBB2+ve cancers and therefore potential therapeutic targets. Here, we describe an integrated genomic, gene expression and functional analysis to determine whether the genes present within amplicons are critical for the survival of ERBB2+ve breast tumour cells. We show that only a fraction of the ERBB2-amplified breast tumour lines are truly addicted to the ERBB2 oncogene at the mRNA level and display a heterogeneous set of additional genetic dependencies. These include an addiction to the transcription factor gene TFAP2C when it is amplified and overexpressed, suggesting that TFAP2C represents a genetic dependency in some ERBB2+ve breast cancer cells.	[Shiu, K-K; Wetterskog, D.; Mackay, A.; Natrajan, R.; Lambros, M.; Sims, D.; Bajrami, I.; Brough, R.; Frankum, J.; Turner, N.; Reis-Filho, J. S.; Lord, C. J.; Ashworth, A.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Marchio, C.] Univ Turin, Dept Biomed Sci & Human Oncol, I-10124 Turin, Italy; [Horlings, H.; Reyal, F.; van der Vijver, M.] Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Turin; University of Amsterdam; Academic Medical Center Amsterdam	Reis-Filho, JS (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, 237 Fulham Rd, London SW3 6JB, England.	Jorge.Reis-Filho@icr.ac.uk; Chris.Lord@icr.ac.uk; Alan.Ashworth@icr.ac.uk	Lord, Christopher/AAX-7130-2021; Marchio, Caterina/J-9152-2016; Lord, Christopher J/B-3295-2012	Marchio, Caterina/0000-0003-2024-6131; Lord, Christopher J/0000-0002-3226-0515; Natrajan, Rachael/0000-0002-9987-2946; Turner, Nicholas/0000-0001-8937-0873	Cancer Research UK; AACR as part of the Stand Up To Cancer Breast Cancer Dream Team Initiative; Breakthrough Breast Cancer	Cancer Research UK(Cancer Research UK); AACR as part of the Stand Up To Cancer Breast Cancer Dream Team Initiative; Breakthrough Breast Cancer	This work was supported by grants from Cancer Research UK, AACR as part of the Stand Up To Cancer Breast Cancer Dream Team Initiative, and Breakthrough Breast Cancer. Dr Kai-Keen Shiu is an Avon Clinical Fellow.	Arriola E, 2008, LAB INVEST, V88, P491, DOI 10.1038/labinvest.2008.19; Baselga J, 2010, J CLIN ONCOL, V28, P1138, DOI 10.1200/JCO.2009.24.2024; BOSHER JM, 1995, P NATL ACAD SCI USA, V92, P744, DOI 10.1073/pnas.92.3.744; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Brough R, 2011, CANCER DISCOV, V1, P260, DOI 10.1158/2159-8290.CD-11-0107; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin SF, 2007, ONCOGENE, V26, P1959, DOI 10.1038/sj.onc.1209985; Cleator SJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1506; Dave B, 2011, J CLIN ONCOL, V29, P166, DOI 10.1200/JCO.2009.27.7814; Delacroix L, 2005, DNA CELL BIOL, V24, P582, DOI 10.1089/dna.2005.24.582; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Gee JMW, 2009, J PATHOL, V217, P32, DOI 10.1002/path.2430; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Gianni L, 2011, LANCET ONCOL, V12, P236, DOI 10.1016/S1470-2045(11)70033-X; Guler G, 2007, CLIN CANCER RES, V13, P6115, DOI 10.1158/1078-0432.CCR-07-1282; Gunnarsson R, 2008, GENE CHROMOSOME CANC, V47, P697, DOI 10.1002/gcc.20575; Harris LN, 2007, CLIN CANCER RES, V13, P1198, DOI 10.1158/1078-0432.CCR-06-1304; He AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-279; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Kao J, 2006, GENE CHROMOSOME CANC, V45, P761, DOI 10.1002/gcc.20339; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Lambros MBK, 2006, LAB INVEST, V86, P398, DOI 10.1038/labinvest.3700390; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Mackay A, 2009, BREAST CANCER RES TR, V118, P481, DOI 10.1007/s10549-008-0296-7; Marchio C, 2008, J PATHOL, V216, P399, DOI 10.1002/path.2423; Natrajan R, 2010, BREAST CANCER RES TR, V121, P575, DOI 10.1007/s10549-009-0501-3; Natrajan R, 2009, CLIN CANCER RES, V15, P2711, DOI 10.1158/1078-0432.CCR-08-1878; O'Brien NA, 2010, MOL CANCER THER, V9, P1489, DOI 10.1158/1535-7163.MCT-09-1171; Perez EA, 2011, J CLIN ONCOL, V29, P3366, DOI 10.1200/JCO.2011.35.0868; Pietersen AM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2214; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Santarius T, 2009, NAT REV, V10, P59; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Scaltriti M, 2011, P NATL ACAD SCI USA, V108, P3761, DOI 10.1073/pnas.1014835108; Schoeberl B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000352; Shiu KK, 2010, FUTURE ONCOL, V6, P967, DOI [10.2217/fon.10.56, 10.2217/FON.10.56]; Sims D, 2010, BREAST CANCER RES TR, V124, P567, DOI 10.1007/s10549-010-0945-5; Sircoulomb F, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-539; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Staaf J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2568; Tan DSR, 2008, PATHOBIOLOGY, V75, P63, DOI 10.1159/000123844; Turner BC, 1998, CANCER RES, V58, P5466; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Vernimmen D, 2003, BIOCHEM J, V370, P323, DOI 10.1042/BJ20021238; Vogel C, 2001, EUR J CANCER, V37, pS25, DOI 10.1016/S0959-8049(00)00405-6; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Williams CMJ, 2009, EMBO J, V28, P3591, DOI 10.1038/emboj.2009.290; Woodfield GW, 2010, GENE CHROMOSOME CANC, V49, P948, DOI 10.1002/gcc.20807; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao C, 2003, CANCER, V98, P18, DOI 10.1002/cncr.11482	54	22	22	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 30	2014	33	5					619	631		10.1038/onc.2012.625	http://dx.doi.org/10.1038/onc.2012.625			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA5GW	23334330	Green Submitted			2022-12-25	WOS:000331125100010
J	Quail, DF; Zhang, G; Findlay, SD; Hess, DA; Postovit, LM				Quail, D. F.; Zhang, G.; Findlay, S. D.; Hess, D. A.; Postovit, L-M			Nodal promotes invasive phenotypes via a mitogen-activated protein kinase-dependent pathway	ONCOGENE			English	Article						Nodal; invasion; EMT; cancer; metastasis	EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; BREAST-CANCER; MAP KINASE; TROPHOBLAST MIGRATION; STEM-CELLS; EXPRESSION; ALK7; PHOSPHORYLATION; PLASTICITY	The progression of cancer from localized to invasive disease is requisite for metastasis, and is often characterized by epithelial-to-mesenchymal transition (EMT) and alterations in cellular adhesion and migration. Studies have shown that this transition is associated with an upregulation of embryonic stem cell-associated genes, resulting in a dedifferentiated phenotype and poor patient prognosis. Nodal is an embryonic factor that plays a critical role in promoting early invasive events during development. Nodal is silenced as stem cells differentiate; however, it re-emerges in adult life during placentation and mammary gland development, and is aberrantly expressed in many cancers. Here, we show that Nodal overexpression, in poorly invasive breast cancer and choriocarcinoma cells, causes increased invasion and migration in vitro. Furthermore, we show that Nodal overexpression in these epithelial cancer types induces an EMT-like event concomitant with the internalization of E-Cadherin. This ability of Nodal to promote cellular invasion and EMT-like phenomena is dependent upon the phosphorylation of ERK1/2. As Nodal normally signals through SMADs, these findings lend insight into an alternative pathway that is hijacked by this protein in cancer. To evaluate the clinical implications of our results, we show that Nodal inhibition reduces liver tumor burden in a model of spontaneous breast cancer metastasis in vivo, and that Nodal loss-of-function in aggressive breast cancer lines results in a decrease in invasive phenotypes. Our results demonstrate that Nodal is involved in promoting invasion in multiple cellular contexts, and that Nodal inhibition may be useful as a therapeutic target for patients with progressive disease.	[Quail, D. F.; Zhang, G.; Findlay, S. D.; Postovit, L-M] Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada; [Hess, D. A.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Zhang, G.; Findlay, S. D.; Hess, D. A.; Postovit, L-M] Univ Western Ontario, Robarts Res Inst, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Postovit, LM (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat & Cell Biol, Med Sci Bldg,Room 438, London, ON N6A 5C1, Canada.	Lynne.Postovit@schulich.uwo.ca	Hess, David A/M-2828-2013; zhang, guihua/GVU-4494-2022; Findlay, Scott D/AAP-9554-2021	Findlay, Scott D/0000-0002-0393-1623; Postovit, Lynne-Marie/0000-0002-8088-4197	Canadian Institutes for Health Research [MOP 89714, MOP 119589, PLS 95381]; Cancer Research Society; Canadian Breast Cancer Foundation; CIHR; Premier New Investigator Award from the CIHR; new investigator award; MacDonald Scholarship; Alberta Innovates [201300495] Funding Source: researchfish	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research Society; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); CIHR(Canadian Institutes of Health Research (CIHR)); Premier New Investigator Award from the CIHR(Canadian Institutes of Health Research (CIHR)); new investigator award; MacDonald Scholarship; Alberta Innovates	We thank LA Walsh and SD Findlay for making the Nodal expression construct, and M Jewer and A Cloutier-Bosworth for assisting with tissue scoring. This work was supported by the Canadian Institutes for Health Research (MOP 89714, MOP 119589 and PLS 95381) and the Cancer Research Society to LMP. DQ is supported by fellowships from the Canadian Breast Cancer Foundation, and a CIHR training grant. LMP is the recipient of the Premier New Investigator Award from the CIHR. DAH is the recipient of a new investigator award and MacDonald Scholarship for the Canadian Heart and Stroke Foundation.	Beck S, 2002, NAT CELL BIOL, V4, P981, DOI 10.1038/ncb890; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bokobza SM, 2011, MOL CELL BIOCHEM, V349, P33, DOI 10.1007/s11010-010-0657-5; Cavallari C, 2013, ONCOGENE, V32, P819, DOI 10.1038/onc.2012.114; Chakraborty C, 2002, CAN J PHYSIOL PHARM, V80, P116, DOI 10.1139/Y02-016; CLEMENTS M, 2011, TLS TIMES LIT S 0325, P21; Davies M, 2005, J CELL BIOCHEM, V95, P918, DOI 10.1002/jcb.20458; Dhasarathy A, 2007, MOL ENDOCRINOL, V21, P2907, DOI 10.1210/me.2007-0293; Drasin DJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3037; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kannan S, 1997, J BIOL CHEM, V272, P3330, DOI 10.1074/jbc.272.6.3330; Kelber JA, 2009, ONCOGENE, V28, P2324, DOI 10.1038/onc.2009.97; Kolosova I, 2011, J CELL PHYSIOL, V226, P1248, DOI 10.1002/jcp.22448; Lawrence MG, 2011, PROSTATE, V71, P1198, DOI 10.1002/pros.21335; Lee CC, 2010, ONCOGENE, V29, P3110, DOI 10.1038/onc.2010.55; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Li QW, 2008, NEOPLASIA, V10, P1444, DOI 10.1593/neo.08968; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Munir S, 2004, J BIOL CHEM, V279, P31277, DOI 10.1074/jbc.M400641200; Nadeem L, 2011, AM J PATHOL, V178, P1177, DOI 10.1016/j.ajpath.2010.11.066; Papageorgiou I, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-122; Postovit LM, 2008, PIGM CELL MELANOMA R, V21, P348, DOI 10.1111/j.1755-148X.2008.00463.x; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Postovit LM, 2007, EXPERT OPIN THER TAR, V11, P497, DOI 10.1517/14728222.11.4.497; Quail DF, 2012, CANCER RES, V72, P3851, DOI 10.1158/0008-5472.CAN-11-3951; Quail DF, 2012, J BIOMOL SCREEN, V17, P1088, DOI 10.1177/1087057112449863; Quail DF, 2011, MOL BIOL CELL, V22, P4809, DOI 10.1091/mbc.E11-03-0263; Rangel MC, 2012, AM J PATHOL, V180, P2188, DOI 10.1016/j.ajpath.2012.02.031; Roberts HJ, 2003, BIOL REPROD, V68, P1719, DOI 10.1095/biolreprod.102.013045; Scherbakov AM, 2012, J CELL BIOCHEM, V113, P2147, DOI 10.1002/jcb.24087; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schier AF, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003459; Strizzi L, 2004, J CELL PHYSIOL, V201, P266, DOI 10.1002/jcp.20062; Strizzi L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3185; Strizzi L, 2011, LAB INVEST, V91, P819, DOI 10.1038/labinvest.2011.63; Strizzi Luigi, 2008, Breast Dis, V29, P91; Strizzi Luigi, 2009, Expert Rev Dermatol, V4, P67, DOI 10.1586/17469872.4.1.67; Tabaries S, 2011, ONCOGENE, V30, P1318, DOI 10.1038/onc.2010.518; Taylor MA, 2010, J MAMMARY GLAND BIOL, V15, P169, DOI 10.1007/s10911-010-9181-1; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; Vicovac L, 1996, ACTA ANAT, V156, P202; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	47	34	36	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 23	2014	33	4					461	473		10.1038/onc.2012.608	http://dx.doi.org/10.1038/onc.2012.608			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	296VX	23334323	Green Accepted, Green Submitted			2022-12-25	WOS:000330214600007
J	Wang, P; Chen, L; Zhang, J; Chen, H; Fan, J; Wang, K; Luo, J; Chen, Z; Meng, Z; Liu, L				Wang, P.; Chen, L.; Zhang, J.; Chen, H.; Fan, J.; Wang, K.; Luo, J.; Chen, Z.; Meng, Z.; Liu, L.			Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1	ONCOGENE			English	Article						miR-124; pancreatic cancer; methylation; prognosis; Rac1	HEPATOCELLULAR-CARCINOMA; TUMOR-SUPPRESSOR; DNA METHYLATION; MICRORNA; EXPRESSION; ADENOCARCINOMA; PATTERNS; SURVIVAL; GTPASES	Previous studies have demonstrated that microRNA (miRNA) expression is altered in human cancer. However, the molecular mechanism underlying these changes in miRNA expression remains unclear. In this study, we investigated the epigenetic modification of miR-124 genes and the potential function of miR-124 in pancreatic cancer. Using pyrosequencing analysis, we found that miR-124 genes (including miR-124-1, miR-124-2 and miR-124-3) are highly methylated in pancreatic cancer tissues compared with in non-cancerous tissues. Hypermethylation mediated the silencing of miR-124, which was a frequent event in pancreatic duct adenocarcinoma (PDAC). Furthermore, miR-124 downregulation was significantly associated with worse survival of PDAC patients. Functional studies showed that miR-124 inhibited cell proliferation, invasion and metastasis. Furthermore, we characterized Rac1 as a direct target of miR-124, and miR-124 interacted with the 3'-untranslated region of Rac1, which we showed to be a putative tumor promoter in pancreatic cancer. Thus, the miR-124-mediated downregulation of Rac1 led to the inactivation of the MKK4-JNK-c-Jun pathway. Therefore, our study demonstrates that miR-124 is a tumor suppressor miRNA that is epigenetically silenced in pancreatic cancer. Our findings suggest a previously unidentified molecular mechanism involved in the progression and metastasis of pancreatic cancer.	[Wang, P.; Chen, L.; Zhang, J.; Chen, H.; Wang, K.; Chen, Z.; Meng, Z.; Liu, L.] Fudan Univ, Shanghai Canc Ctr, Dept Integrat Oncol, Shanghai 200032, Peoples R China; [Wang, P.; Chen, L.; Zhang, J.; Chen, H.; Wang, K.; Chen, Z.; Meng, Z.; Liu, L.] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Fan, J.] Fudan Univ, Huashan Hosp, Dept Pathol, Shanghai 200032, Peoples R China; [Luo, J.] Fudan Univ, Shanghai Canc Ctr, Cent Lab, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Chen, Z (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Integrat Oncol, 270 Dong An Rd, Shanghai 200032, Peoples R China.	cz.chenzhen@gmail.com; mengzhq@sh163.net; llm1010@yahoo.com.cn	Meng, Zhiqiang/ABE-7747-2021	Chen, Zhen/0000-0002-4502-0801	Science Fundation of China [81001061]; Shanghai Nature Science Fund, Shanghai, China [09ZR1406800]; Doctoral Programs Foundation of Ministry of Education of China [20090071120076]; Shanghai Science and Technology Committee Rising-Star Program [11QA1401300]; Medical Talents Training Program of Health Bureau of Shanghai [XYQ2011008]; 985 research grants	Science Fundation of China; Shanghai Nature Science Fund, Shanghai, China; Doctoral Programs Foundation of Ministry of Education of China(Ministry of Education, China); Shanghai Science and Technology Committee Rising-Star Program; Medical Talents Training Program of Health Bureau of Shanghai; 985 research grants	The authors would like to thank Professor Zude Xu from Department of Pathology, Huashan Hospital, Fudan University, Shanghai for providing human pancreatic cancer samples. This study was supported by National Science Fundation of China (81001061); Shanghai Nature Science Fund, Shanghai, China (09ZR1406800); Doctoral Programs Foundation of Ministry of Education of China (20090071120076); Shanghai Science and Technology Committee Rising-Star Program (11QA1401300); and Medical Talents Training Program of Health Bureau of Shanghai (XYQ2011008) and 985 research grants.	Ando T, 2009, INT J CANCER, V124, P2367, DOI 10.1002/ijc.24219; Azuma H, 2005, JNCI-J NATL CANCER I, V97, P1734, DOI 10.1093/jnci/dji399; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Chan AY, 2005, ONCOGENE, V24, P7821, DOI 10.1038/sj.onc.1208909; Chen LL, 2010, J CLIN INVEST, V120, P1178, DOI 10.1172/JCI40665; Deprez RHL, 2002, ANAL BIOCHEM, V307, P63, DOI 10.1016/S0003-2697(02)00021-0; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; GRIFFIN JF, 1990, CANCER, V66, P56, DOI 10.1002/1097-0142(19900701)66:1<56::AID-CNCR2820660112>3.0.CO;2-6; Grijelmo C, 2007, CELL SIGNAL, V19, P1722, DOI 10.1016/j.cellsig.2007.03.008; Hanoun N, 2010, CLIN CHEM, V56, P1107, DOI 10.1373/clinchem.2010.144709; Heid I, 2011, GASTROENTEROLOGY, V141, P719, DOI 10.1053/j.gastro.2011.04.043; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jamieson NB, 2012, CLIN CANCER RES, V18, P534, DOI 10.1158/1078-0432.CCR-11-0679; Kanwal R, 2012, J APPL PHYSIOL, V109, P598; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kong KL, 2012, GUT, V61, P33, DOI 10.1136/gutjnl-2011-300178; Kubo T, 2011, CLIN CANCER RES, V17, P4965, DOI 10.1158/1078-0432.CCR-10-3040; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li XH, 2010, GUT, V59, P579, DOI 10.1136/gut.2008.175497; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Mardin W, 2009, ANN SURG ONCOL, V16, P3183, DOI 10.1245/s10434-009-0623-1; Medina PP, 2009, NAT METHODS, V6, P37, DOI 10.1038/nmeth0109-37; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Murphy JD, 2007, INT J RADIAT ONCOL, V68, P801, DOI 10.1016/j.ijrobp.2006.12.053; Nuovo GJ, 2009, NAT PROTOC, V4, P107, DOI 10.1038/nprot.2008.215; Ouyang HQ, 2011, PANCREAS, V40, P120, DOI 10.1097/MPA.0b013e3181e6e398; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; Rathinam R, 2011, FRONT BIOSCI-LANDMRK, V16, P2561, DOI 10.2741/3872; Shi WD, 2009, CANCER LETT, V283, P84, DOI 10.1016/j.canlet.2009.03.030; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Takai Daiya, 2003, In Silico Biology, V3, P235; Wang P, 2009, CARCINOGENESIS, V30, P1497, DOI 10.1093/carcin/bgp154; Wilting SM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-167; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhang SY, 2011, CARCINOGENESIS, V32, P1183, DOI 10.1093/carcin/bgr105; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhao WG, 2010, CARCINOGENESIS, V31, P1726, DOI 10.1093/carcin/bgq160; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145	47	165	182	3	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 23	2014	33	4					514	524		10.1038/onc.2012.598	http://dx.doi.org/10.1038/onc.2012.598			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	296VX	23334332				2022-12-25	WOS:000330214600012
J	Hur, JK; Zinchenko, MK; Djuranovic, S; Green, R				Hur, Junho K.; Zinchenko, Michelle K.; Djuranovic, Sergej; Green, Rachel			Regulation of Argonaute Slicer Activity by Guide RNA 3 ' End Interactions with the N-terminal Lobe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; TRANSLATIONAL REPRESSION; TARGET RECOGNITION; PROTEINS; MICRORNA; GW182; CLEAVAGE; REQUIRES; COMPLEX; DEGRADATION	Structural studies indicate that binding of both the guide RNA(siRNA and miRNA) and the target mRNA trigger substantial conformational changes in the Argonaute proteins. Here we explore the role of the N-terminal lobe (and its PAZ domain) in these conformational changes using biochemical and cell culture-based approaches. In vitro, whereas deletion (or mutation) of the N-terminal lobe of DmAgo1 and DmAgo2 had no effect on binding affinity to guide RNAs, we observed a loss of protection of the 3' end of the guide RNA and decreased target RNA binding; consistent with this, in cells, loss of function DmAgo1 PAZ variant proteins (PAZ6 and Delta N-PAZ) still bind RNA, although the RNAs are shorter than normal. We also find that deletion of the N-terminal lobe results in constitutive activation of endogenous PIWI domain-based cleavage activity in vitro, providing insights into how cleavage activity may be regulated in vivo in response to different types of pairing interactions with the target mRNAs.	[Hur, Junho K.; Zinchenko, Michelle K.; Djuranovic, Sergej; Green, Rachel] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, 725 N Wolfe St, Baltimore, MD 21205 USA.	ragreen@jhmi.edu	Hur, Junho/ADK-0757-2022	Hur, Junho/0000-0003-3794-1149; Djuranovic, Sergej/0000-0002-9417-0822	Howard Hughes Medical Institute; Samsung Foundation of Culture	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Samsung Foundation of Culture(Samsung)	This work was supported by funding from the Howard Hughes Medical Institute (to R. G.).; Supported in part by the Samsung Foundation of Culture.	Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Boland A, 2011, P NATL ACAD SCI USA, V108, P10466, DOI 10.1073/pnas.1103946108; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Djuranovic S, 2010, NAT STRUCT MOL BIOL, V17, P144, DOI 10.1038/nsmb.1736; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Enright AJ, 2004, GENOME BIOL, V5; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Eulalio A, 2009, RNA, V15, P1067, DOI 10.1261/rna.1605509; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Fukaya T, 2012, MOL CELL, V48, P825, DOI 10.1016/j.molcel.2012.09.024; Gu S, 2012, CURR BIOL, V22, P1536, DOI 10.1016/j.cub.2012.06.040; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; Huntzinger E, 2013, NUCLEIC ACIDS RES, V41, P978, DOI 10.1093/nar/gks1078; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lund E, 2011, GENE DEV, V25, P1121, DOI 10.1101/gad.2038811; Milligan J. F., 1989, METHOD ENZYMOL, V180, P51; Miyoshi K, 2009, RNA, V15, P1282, DOI 10.1261/rna.1541209; Miyoshi Keita, 2008, V442, P29, DOI 10.1007/978-1-59745-191-8_3; Nahvi A, 2009, RNA, V15, P814, DOI 10.1261/rna.1565109; Parker JS, 2009, MOL CELL, V33, P204, DOI 10.1016/j.molcel.2008.12.012; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Wang BB, 2009, NAT STRUCT MOL BIOL, V16, P1259, DOI 10.1038/nsmb.1712; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428	41	27	29	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7829	7840		10.1074/jbc.M112.441030	http://dx.doi.org/10.1074/jbc.M112.441030			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23329841	Green Published, hybrid			2022-12-25	WOS:000316455300037
J	Lossi, NS; Manoli, E; Forster, A; Dajani, R; Pape, T; Freemont, P; Filloux, A				Lossi, Nadine S.; Manoli, Eleni; Foerster, Andreas; Dajani, Rana; Pape, Tillmann; Freemont, Paul; Filloux, Alain			The HsiB1C1 (TssB-TssC) Complex of the Pseudomonas aeruginosa Type VI Secretion System Forms a Bacteriophage Tail Sheathlike Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN HOMOLOGY DETECTION; ESCHERICHIA-COLI; PHAGE; GENES; MECHANISM; MACHINE; TARGETS; ICMF; DNA	Protein secretion systems in Gram-negative bacteria evolved into a variety of molecular nanomachines. They are related to cell envelope complexes, which are involved in assembly of surface appendages or transport of solutes. They are classified as types, the most recent addition being the type VI secretion system (T6SS). The T6SS displays similarities to bacteriophage tail, which drives DNA injection into bacteria. The Hcp protein is related to the T4 bacteriophage tail tube protein gp19, whereas VgrG proteins structurally resemble the gp27/gp5 puncturing device of the phage. The tube and spike of the phage are pushed through the bacterial envelope upon contraction of a tail sheath composed of gp18. In Vibrio cholerae it was proposed that VipA and VipB assemble into a tail sheathlike structure. Here we confirm these previous data by showing that HsiB1 and HsiC1 of the Pseudomonas aeruginosa H1-T6SS assemble into tubules resulting from stacking of cogwheel-like structures showing predominantly 12-fold symmetry. The internal diameter of the cogwheels is similar to 100 angstrom, which is large enough to accommodate an Hcp tube whose external diameter has been reported to be 85 angstrom. The N-terminal 212 residues of HsiC1 are sufficient to form a stable complex with HsiB1, but the C terminus of HsiC1 is essential for the formation of the tubelike structure. Bioinformatics analysis suggests that HsiC1 displays similarities to gp18-like proteins in its C-terminal region. In conclusion, we provide further structural and mechanistic insights into the T6SS and show that a phage sheathlike structure is likely to be a conserved element across all T6SSs.	[Lossi, Nadine S.; Manoli, Eleni; Dajani, Rana; Filloux, Alain] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Mol Bacteriol & Infect, Div Cell & Mol Biol, London SW7 2AZ, England; [Foerster, Andreas; Pape, Tillmann; Freemont, Paul] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England	Imperial College London; Imperial College London	Filloux, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Mol Bacteriol & Infect, Div Cell & Mol Biol, London SW7 2AZ, England.	a.filloux@imperial.ac.uk		Freemont, Paul/0000-0002-5658-8486; Pape, Tillmann/0000-0002-0612-3568; Forster, Andreas/0000-0003-1472-3990	Medical Research Council (MRC) [G0800171/ID86344]; Wellcome Trust [WT091939]; MRC [G0800171/ID86344]; MRC [MR/J006874/1, G0800171, MR/K001930/1] Funding Source: UKRI; Medical Research Council [G0800171, MR/K001930/1] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by Medical Research Council (MRC) Grant G0800171/ID86344.; Supported by Wellcome Trust Grant WT091939.; Supported by MRC Grant G0800171/ID86344 and Wellcome Trust Grant WT091939. To whom correspondence should be addressed: MRC Centre for Molecular Bacteriology and Infection (MRC-CMBI), Division of Cell and Molecular Biology, Imperial College London, London SW7 2AZ, UK. Tel.: 44-20-7594-9651; Fax: 44-20-7594-3069; E-mail: a.filloux@imperial.ac.uk.	Aksyuk AA, 2009, EMBO J, V28, P821, DOI 10.1038/emboj.2009.36; ARISAKA F, 1990, BIOCHEMISTRY-US, V29, P5057, DOI 10.1021/bi00473a009; Aschtgen MS, 2010, VIRULENCE, V1, P535, DOI 10.4161/viru.1.6.13732; Aschtgen MS, 2010, MOL MICROBIOL, V75, P886, DOI 10.1111/j.1365-2958.2009.07028.x; Aubert D, 2010, J BIOL CHEM, V285, P35988, DOI 10.1074/jbc.M110.120402; Basler M, 2012, SCIENCE, V337, P815, DOI 10.1126/science.1222901; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; Broms JE, 2009, J BACTERIOL, V191, P2431, DOI 10.1128/JB.01759-08; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Efimov AV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1366, DOI 10.1023/A:1021857926152; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Filloux A, 2009, EMBO J, V28, P309, DOI 10.1038/emboj.2008.301; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Goodman AL, 2009, GENE DEV, V23, P249, DOI 10.1101/gad.1739009; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Jones AM, 2010, CHEST, V137, P1405, DOI 10.1378/chest.09-2406; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kostyuchenko VA, 2005, NAT STRUCT MOL BIOL, V12, P810, DOI 10.1038/nsmb975; Kuznetsova TA, 1998, BIOCHEMISTRY-MOSCOW+, V63, P702; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leiman PG, 2012, ADV EXP MED BIOL, V726, P93, DOI 10.1007/978-1-4614-0980-9_5; Leiman PG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-355; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Lossi NS, 2012, MOL MICROBIOL, V86, P437, DOI 10.1111/j.1365-2958.2012.08204.x; Lossi NS, 2011, MICROBIOL-SGM, V157, P3292, DOI 10.1099/mic.0.051987-0; Ma LS, 2012, J BIOL CHEM, V287, P15610, DOI 10.1074/jbc.M111.301630; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MOODY MF, 1973, J MOL BIOL, V80, P613, DOI 10.1016/0022-2836(73)90200-3; Moscoso JA, 2011, ENVIRON MICROBIOL, V13, P3128, DOI 10.1111/j.1462-2920.2011.02595.x; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Nakayama K, 2000, MOL MICROBIOL, V38, P213, DOI 10.1046/j.1365-2958.2000.02135.x; Pederson DM, 2001, J MOL BIOL, V309, P401, DOI 10.1006/jmbi.2001.4685; Poglazov BF, 1999, J STRUCT BIOL, V127, P224, DOI 10.1006/jsbi.1999.4164; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Sexton JA, 2004, INFECT IMMUN, V72, P5983, DOI 10.1128/IAI.72.10.5983-5992.2004; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Vasseur P, 2005, MICROBIOL-SGM, V151, P985, DOI 10.1099/mic.0.27410-0; Williams SR, 2008, APPL ENVIRON MICROB, V74, P3868, DOI 10.1128/AEM.00141-08; WOOD WB, 1966, J MOL BIOL, V16, P118, DOI 10.1016/S0022-2836(66)80267-X	59	64	66	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7536	7548		10.1074/jbc.M112.439273	http://dx.doi.org/10.1074/jbc.M112.439273			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23341461	Green Published, hybrid			2022-12-25	WOS:000316455300010
J	Kouri, VP; Olkkonen, J; Kaivosoja, E; Ainola, M; Juhila, J; Hovatta, I; Konttinen, YT; Mandelin, J				Kouri, Vesa-Petteri; Olkkonen, Juri; Kaivosoja, Emilia; Ainola, Mari; Juhila, Juuso; Hovatta, Iiris; Konttinen, Yrjo T.; Mandelin, Jami			Circadian Timekeeping Is Disturbed in Rheumatoid Arthritis at Molecular Level	PLOS ONE			English	Article							GENE-EXPRESSION; TNF-ALPHA; CLOCK; TRANSCRIPTION; SYSTEM; SYMPTOMS; DISORDER; FATIGUE; IMMUNE; CELLS	Introduction: Patients with rheumatoid arthritis (RA) have disturbances in the hypothalamic-pituitary-adrenal (HPA) axis. These are reflected in altered circadian rhythm of circulating serum cortisol, melatonin and IL-6 levels and in chronic fatigue. We hypothesized that the molecular machinery responsible for the circadian timekeeping is perturbed in RA. The aim of this study was to investigate the expression of circadian clock in RA. Methods: Gene expression of thirteen clock genes was analyzed in the synovial membrane of RA and control osteoarthritis (OA) patients. BMAL1 protein was detected using immunohistochemistry. Cell autonomous clock oscillation was started in RA and OA synovial fibroblasts using serum shock. The effect of pro-inflammatory stimulus on clock gene expression in synovial fibroblasts was studied using IL-6 and TNF-alpha. Results: Gene expression analysis disclosed disconcerted circadian timekeeping and immunohistochemistry revealed strong cytoplasmic localization of BMAL1 in RA patients. Perturbed circadian timekeeping is at least in part inflammation independent and cell autonomous, because RA synovial fibroblasts display altered circadian expression of several clock components, and perturbed circadian production of IL-6 and IL-1 beta after clock resetting. However, inflammatory stimulus disturbs the rhythm in cultured fibroblasts. Throughout the experiments ARNTL2 and NPAS2 appeared to be the most affected clock genes in human immune-inflammatory conditions. Conclusion: We conclude that the molecular machinery controlling the circadian rhythm is disturbed in RA patients.	[Kouri, Vesa-Petteri; Olkkonen, Juri; Kaivosoja, Emilia; Ainola, Mari; Konttinen, Yrjo T.; Mandelin, Jami] Univ Helsinki, Inst Clin Med, Dept Med, Helsinki, Finland; [Kouri, Vesa-Petteri] Univ Helsinki, Inst Biomed, Dept Anat, Helsinki, Finland; [Ainola, Mari; Konttinen, Yrjo T.; Mandelin, Jami] Univ Helsinki, Cent Hosp, Dept Med Invartes Med, Helsinki, Finland; [Juhila, Juuso; Hovatta, Iiris] Univ Helsinki, Haartman Inst, Res Program Mol Neurol, Helsinki, Finland; [Juhila, Juuso; Hovatta, Iiris] Univ Helsinki, Haartman Inst, Dept Med Genet, Helsinki, Finland; [Hovatta, Iiris] Natl Inst Hlth & Welf, Dept Mental Hlth & Substance Abuse Serv, Helsinki, Finland; [Konttinen, Yrjo T.; Mandelin, Jami] ORTON Fdn, ORTON Orthoped Hosp, Helsinki, Finland; [Konttinen, Yrjo T.] COXA Hosp Joint Replacement, Tampere, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; Coxa Hospital for Joint Replacement	Mandelin, J (corresponding author), Univ Helsinki, Inst Clin Med, Dept Med, Helsinki, Finland.	jami.mandelin@helsinki.fi	Kouri, Vesa-Petteri/M-7436-2015; Peltola, Emilia/L-9969-2013; Ainola, Mari-Mia/T-8035-2017; Mandelin, Jami/A-7943-2008; Hovatta, Iiris/D-6871-2012	Kouri, Vesa-Petteri/0000-0001-6256-0642; Peltola, Emilia/0000-0002-8868-9273; Ainola, Mari-Mia/0000-0003-2853-5851; Hovatta, Iiris/0000-0002-5990-7892	Academy of Finland; Finnish Society for Rheumatology; Finska Lakaresallskapet; ORTON Orthopaedic Hospital of the ORTON Foundation; Danish Council for Strategic Research; Scandinavian Rheumatology Research Foundation; Paulo Foundation; University of Helsinki; National Graduate School of Musculoskeletal Disorders and Biomaterials; Orion-Farmos Research Fund	Academy of Finland(Academy of Finland); Finnish Society for Rheumatology; Finska Lakaresallskapet; ORTON Orthopaedic Hospital of the ORTON Foundation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Scandinavian Rheumatology Research Foundation; Paulo Foundation; University of Helsinki; National Graduate School of Musculoskeletal Disorders and Biomaterials; Orion-Farmos Research Fund	This work was supported by the Academy of Finland, Finnish Society for Rheumatology, Finska Lakaresallskapet, ORTON Orthopaedic Hospital of the ORTON Foundation, Danish Council for Strategic Research, Scandinavian Rheumatology Research Foundation, Paulo Foundation, University of Helsinki, National Graduate School of Musculoskeletal Disorders and Biomaterials and Orion-Farmos Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; CHIKANZA IC, 1992, ARTHRITIS RHEUM, V35, P1281, DOI 10.1002/art.1780351107; Cutolo M, 2005, AUTOIMMUN REV, V4, P497, DOI 10.1016/j.autrev.2005.04.019; Delerive P, 2001, EMBO REP, V2, P42, DOI 10.1093/embo-reports/kve007; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; DURUM SK, 1985, ANNU REV IMMUNOL, V3, P263; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; GUDEWILL S, 1992, EUR ARCH PSY CLIN N, V242, P53, DOI 10.1007/BF02190343; Hashiramoto A, 2010, J IMMUNOL, V184, P1560, DOI 10.4049/jimmunol.0903284; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Hewlett S, 2005, ARTHRIT RHEUM-ARTHR, V53, P697, DOI 10.1002/art.21450; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; KOWANKO IC, 1981, BRIT J CLIN PHARMACO, V11, P477, DOI 10.1111/j.1365-2125.1981.tb01153.x; Kwon I, 2006, MOL CELL BIOL, V26, P7318, DOI 10.1128/MCB.00337-06; Lange T, 2010, ANN NY ACAD SCI, V1193, P48, DOI 10.1111/j.1749-6632.2009.05300.x; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Repping-Wuts H, 2009, RHEUMATOLOGY, V48, P207, DOI 10.1093/rheumatology/ken399; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; STETSON MH, 1976, SCIENCE, V191, P197, DOI 10.1126/science.942799; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; Tak PP, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/ar3096, 10.1186/1478-6354-13-S1-S5]; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yang XO, 2009, NAT IMMUNOL, V10, P1260, DOI 10.1038/ni.1821	30	57	68	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54049	10.1371/journal.pone.0054049	http://dx.doi.org/10.1371/journal.pone.0054049			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335987	gold, Green Published, Green Submitted			2022-12-25	WOS:000314707700045
J	Pletzer, B; Kronbichler, M; Nuerk, HC; Kerschbaum, H				Pletzer, Belinda; Kronbichler, Martin; Nuerk, Hans-Christoph; Kerschbaum, Hubert			Sex Differences in the Processing of Global vs. Local Stimulus Aspects in a Two-Digit Number Comparison Task - An fMRI Study	PLOS ONE			English	Article							MENSTRUAL-CYCLE; DEFAULT MODE; BRAIN; ACTIVATION; MEMORY; LATERALIZATION	It has been debated for several decades, whether number magnitudes are processed global/holistically (whole number magnitudes) or in a local/decomposed fashion (digit magnitudes). However, while it has been suggested that men attend stronger to the global level, while women attend stronger to the local level, the question has never been studied with regards to sex differences. In two-digit number comparison men should engage a more holistic processing strategy, while women should engage a more decomposed strategy. To test this hypothesis, we employed number comparison stimuli of varying decade crossing and unit-decade compatibility in men (n = 16) and women (n = 16) during their early follicular and mid-luteal cycle phase. In within-decade (WD) items both numbers had the same decade digits. Non-WD items were unit-decade-compatible, if the smaller number contained the smaller unit-digit and incompatible otherwise. In incompatible items the two local features require different responses. Thus, processing of the local level should result in a compatibility effect in RT and recruitment of differential neural networks for compatible and incompatible items. The results support the view of a holistic strategy in men and a decomposed strategy in women. In men RT and BOLD-response did not differ for incompatible compared to compatible items. Women respond slower to incompatible compared to compatible items. They show a BOLD-response compatibility effect in regions of the default mode network during their follicular phase and in prefrontal areas involved in inhibitory control during their luteal phase. Furthermore, lateralization indices interacted with decade crossing and menstrual cycle phase in a way consistent with the hypothesis of progesterone-mediated interhemispheric decoupling.	[Pletzer, Belinda; Kerschbaum, Hubert] Salzburg Univ, Dept Cell Biol, A-5020 Salzburg, Austria; [Pletzer, Belinda; Kronbichler, Martin] Salzburg Univ, Dept Psychol, A-5020 Salzburg, Austria; [Pletzer, Belinda; Kronbichler, Martin; Kerschbaum, Hubert] Salzburg Univ, Ctr Neurocognit Res, A-5020 Salzburg, Austria; [Pletzer, Belinda] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA; [Kronbichler, Martin] Paracelsus Med Univ, Christian Doppler Clin, Neurosci Inst, Salzburg, Austria; [Kronbichler, Martin] Paracelsus Med Univ, Christian Doppler Clin, Dept Neurol, Salzburg, Austria; [Nuerk, Hans-Christoph] Univ Tubingen, Dept Psychol, Tubingen, Germany; [Kerschbaum, Hubert] Knowledge Media Res Ctr, Tubingen, Germany	Salzburg University; Salzburg University; Salzburg University; University of California System; University of California Irvine; Paracelsus Private Medical University; Paracelsus Private Medical University; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Leibniz Institut fur Wissensmedien	Pletzer, B (corresponding author), Salzburg Univ, Dept Cell Biol, A-5020 Salzburg, Austria.	Belinda.Pletzer@sbg.ac.at	Pletzer, Belinda/GXV-3186-2022; Kronbichler, Martin/A-5599-2008; Kronbichler, Martin/AAY-1519-2021	Kronbichler, Martin/0000-0003-2240-2812; Kronbichler, Martin/0000-0003-2240-2812; Pletzer, Belinda/0000-0002-7277-0923	DOC fFORTE program of the Austrian Academy of Sciences [22192]	DOC fFORTE program of the Austrian Academy of Sciences	This research was funded by the DOC fFORTE program of the Austrian Academy of Sciences (http://www.oeaw.ac.at) supporting Belinda Pletzer (Nr: 22192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Barkley CL, 2007, BEHAV NEUROSCI, V121, P291, DOI 10.1037/0735-7044.121.2.291; Bell EC, 2006, NEUROIMAGE, V30, P529, DOI 10.1016/j.neuroimage.2005.09.049; Cahill L, 2004, LEARN MEMORY, V11, P261, DOI 10.1101/lm.70504; Cahill L, 2003, NEUROBIOL LEARN MEM, V79, P81, DOI 10.1016/S1074-7427(02)00019-9; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; Colzato LS, 2010, NEUROSCIENCE, V167, P709, DOI 10.1016/j.neuroscience.2010.02.029; Dehaene S, 1996, NEUROPSYCHOLOGIA, V34, P1097, DOI 10.1016/0028-3932(96)00027-9; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; DEHAENE S, 1990, J EXP PSYCHOL HUMAN, V16, P626, DOI 10.1037/0096-1523.16.3.626; Fink GR, 1996, NATURE, V382, P626, DOI 10.1038/382626a0; Fink GR, 1997, P ROY SOC B-BIOL SCI, V264, P487, DOI 10.1098/rspb.1997.0070; Forster J, 2010, PSYCHOL INQ, V21, P175, DOI 10.1080/1047840X.2010.487849; Friston KJ, 2002, NEUROIMAGE, V16, P465, DOI 10.1006/nimg.2002.1090; GALEA LAM, 1993, PERS INDIV DIFFER, V14, P53, DOI 10.1016/0191-8869(93)90174-2; Hatta T, 2009, ARCH SEX BEHAV, V38, P821, DOI 10.1007/s10508-008-9445-7; Hausmann M, 2000, NEUROPSYCHOLOGIA, V38, P1362, DOI 10.1016/S0028-3932(00)00045-2; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Jordan K, 2002, NEUROPSYCHOLOGIA, V40, P2397, DOI 10.1016/S0028-3932(02)00076-3; Keita L, 2011, LATERALITY, V16, P333, DOI 10.1080/13576501003671603; Kimura Doreen, 2002, Neuro Endocrinol Lett, V23 Suppl 4, P67; Kramer JH, 1996, NEUROPSYCHOLOGY, V10, P402, DOI 10.1037/0894-4105.10.3.402; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Lawton CA, 1996, ENVIRON BEHAV, V28, P204, DOI 10.1177/0013916596282003; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Menon V, 2000, NEUROIMAGE, V12, P357, DOI 10.1006/nimg.2000.0613; Merkley R, 2010, EXP BRAIN RES, V206, P455, DOI 10.1007/s00221-010-2419-8; Muller-Oehring EM, 2007, BRAIN RES, V1142, P189, DOI 10.1016/j.brainres.2007.01.062; Munakata Y, 2011, TRENDS COGN SCI, V15, P453, DOI 10.1016/j.tics.2011.07.011; Nielsen SE, 2011, NEUROBIOL LEARN MEM, V96, P378, DOI 10.1016/j.nlm.2011.06.013; Nuerk HC, 2001, COGNITION, V82, pB25, DOI 10.1016/S0010-0277(01)00142-1; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Pletzer B, 2010, BRAIN RES, V1348, P55, DOI 10.1016/j.brainres.2010.06.019; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Razumnikova O M, 2011, Fiziol Cheloveka, V37, P14; Renteria ME, 2012, TWIN RES HUM GENET, V15, P401, DOI 10.1017/thg.2012.13; Roalf D, 2006, BRAIN COGNITION, V60, P32, DOI 10.1016/j.bandc.2005.09.008; Roberts GMP, 2008, BRAIN RES, V1224, P79, DOI 10.1016/j.brainres.2008.05.061; ROBERTSON LC, 1991, COGNITIVE PSYCHOL, V23, P299, DOI 10.1016/0010-0285(91)90012-D; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Weis S, 2010, NEUROSCIENTIST, V16, P132, DOI 10.1177/1073858409341481; Weis S, 2008, J NEUROSCI, V28, P13401, DOI 10.1523/JNEUROSCI.4392-08.2008; Wilke M, 2007, J NEUROSCI METH, V163, P128, DOI 10.1016/j.jneumeth.2007.01.026; Wood G, 2006, NEUROIMAGE, V29, P358, DOI 10.1016/j.neuroimage.2005.07.056; Yarkoni T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004257	46	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53824	10.1371/journal.pone.0053824	http://dx.doi.org/10.1371/journal.pone.0053824			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335976	Green Published, gold			2022-12-25	WOS:000314707700033
J	Whelan, A; Mitchell, R; Staudhammer, C; Starr, G				Whelan, Andrew; Mitchell, Robert; Staudhammer, Christina; Starr, Gregory			Cyclic Occurrence of Fire and Its Role in Carbon Dynamics along an Edaphic Moisture Gradient in Longleaf Pine Ecosystems	PLOS ONE			English	Article							STOMATAL CONDUCTANCE; WIREGRASS SAVANNAS; FLUX MEASUREMENTS; PRESCRIBED FIRE; PONDEROSA PINE; GAS-EXCHANGE; FOREST; PRODUCTIVITY; SOIL; DIOXIDE	Fire regulates the structure and function of savanna ecosystems, yet we lack understanding of how cyclic fire affects savanna carbon dynamics. Furthermore, it is largely unknown how predicted changes in climate may impact the interaction between fire and carbon cycling in these ecosystems. This study utilizes a novel combination of prescribed fire, eddy covariance (EC) and statistical techniques to investigate carbon dynamics in frequently burned longleaf pine savannas along a gradient of soil moisture availability (mesic, intermediate and xeric). This research approach allowed us to investigate the complex interactions between carbon exchange and cyclic fire along the ecological amplitude of longleaf pine. Over three years of EC measurement of net ecosystem exchange (NEE) show that the mesic site was a net carbon sink (NEE = -2.48 tonnes C ha 21), while intermediate and xeric sites were net carbon sources (NEE = 1.57 and 1.46 tonnes C ha(-1), respectively), but when carbon losses due to fuel consumption were taken into account, all three sites were carbon sources (10.78, 7.95 and 9.69 tonnes C ha(-1) at the mesic, intermediate and xeric sites, respectively). Nonetheless, rates of NEE returned to pre-fire levels 1-2 months following fire. Consumption of leaf area by prescribed fire was associated with reduction in NEE post-fire, and the system quickly recovered its carbon uptake capacity 30-60 days post fire. While losses due to fire affected carbon balances on short time scales (instantaneous to a few months), drought conditions over the final two years of the study were a more important driver of net carbon loss on yearly to multi-year time scales. However, longer-term observations over greater environmental variability and additional fire cycles would help to more precisely examine interactions between fire and climate and make future predictions about carbon dynamics in these systems.	[Whelan, Andrew; Staudhammer, Christina; Starr, Gregory] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Whelan, Andrew; Mitchell, Robert] Jones Ecol Res Ctr, Newton, GA USA	University of Alabama System; University of Alabama Tuscaloosa	Starr, G (corresponding author), Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA.	gstarr@ua.edu			Joseph W. Jones Ecological Research Station; University of Alabama	Joseph W. Jones Ecological Research Station; University of Alabama	Funding for the project comes from the Joseph W. Jones Ecological Research Station and the University of Alabama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington RN, 2006, PLANT CELL ENVIRON, V29, P535, DOI 10.1111/j.1365-3040.2005.01430.x; Addington RN, 2004, TREE PHYSIOL, V24, P561, DOI 10.1093/treephys/24.5.561; ALLEN LH, 1971, AGR METEOROL, V8, P5, DOI 10.1016/0002-1571(71)90091-4; Anderson RC, 1997, AM J BOT, V84, P938, DOI 10.2307/2446284; Aubrey DP, 2012, THESIS U GEORGIA ATH; Baldocchi DD, 2003, GLOBAL CHANGE BIOL, V9, P479, DOI 10.1046/j.1365-2486.2003.00629.x; Beringer J, 2003, INT J WILDLAND FIRE, V12, P333, DOI 10.1071/WF03023; Beringer J, 2007, GLOBAL CHANGE BIOL, V13, P990, DOI 10.1111/j.1365-2486.2007.01334.x; Binford MW, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006820; BIRCH H. F., 1958, Plant and Soil, V10, P9, DOI 10.1007/BF01343734; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; BOYER WD, 1973, ECOLOGY, V54, P420, DOI 10.2307/1934351; Brooks JR, 1997, TREE PHYSIOL, V17, P1; Campbell Gaylon S., 1998; Campbell JL, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002236; Carpenter SR, 1998, ECOSYSTEMS, V1, P335, DOI 10.1007/s100219900025; Cernusak LA, 2006, PLANT CELL ENVIRON, V29, P632, DOI 10.1111/j.1365-3040.2005.01442.x; Certini G, 2005, OECOLOGIA, V143, P1, DOI 10.1007/s00442-004-1788-8; Christensen N.L., 1981, P C FIR REG EC PROP, P112; Christensen NL, 1981, FIRE REGIMES SE ECOS; Clark KL, 1999, ECOL APPL, V9, P936, DOI 10.1890/1051-0761(1999)009[0936:ECONEO]2.0.CO;2; Clement R., 1999, EDIRE DATA SOFTWARE; Coe MT, 2011, BIOGEOCHEMISTRY, V105, P119, DOI 10.1007/s10533-011-9582-2; de Araujo AC, 2008, ECOL APPL, V18, P1406, DOI 10.1890/06-0982.1; Edwards L, 2012, US DROUGHT MONITOR; Emmerich WE, 2003, AGR FOREST METEOROL, V116, P91, DOI 10.1016/S0168-1923(02)00231-9; Ewers BE, 2001, TREE PHYSIOL, V21, P841, DOI 10.1093/treephys/21.12-13.841; Fesenmyer KA, 2010, ECOLOGY, V91, P662, DOI 10.1890/09-0230.1; Foken T, 2004, AGR FOREST METEOROL, V127, P223, DOI 10.1016/j.agrformet.2004.07.015; Foken T, 1996, AGR FOREST METEOROL, V78, P83, DOI 10.1016/0168-1923(95)02248-1; Foken T., 2008, MICROMETEOROLOGY; Ford CR, 2008, CAN J FOREST RES, V38, P2118, DOI 10.1139/X08-061; FROST CC, 1993, P TALL TIMB FIR EC C, V18, P17; Girod CM, 2007, EARTH INTERACT, V11; Goebel P.C., 1997, FIELD GUIDE LANDSCAP; Goebel PC, 2001, J TORREY BOT SOC, V128, P47, DOI 10.2307/3088659; Goulden ML, 1996, GLOBAL CHANGE BIOL, V2, P169, DOI 10.1111/j.1365-2486.1996.tb00070.x; Grace J, 2006, J BIOGEOGR, V33, P387, DOI 10.1111/j.1365-2699.2005.01448.x; Guo DL, 2004, OECOLOGIA, V140, P450, DOI 10.1007/s00442-004-1596-1; HALL DO, 1991, ANN BOT-LONDON, V67, P49, DOI 10.1093/oxfordjournals.aob.a088208; Hogberg P, 2008, NEW PHYTOL, V177, P220, DOI 10.1111/j.1469-8137.2007.02238.x; Hogberg P, 2006, TRENDS ECOL EVOL, V21, P548, DOI 10.1016/j.tree.2006.06.004; Houghton RA, 2000, GLOBAL ECOL BIOGEOGR, V9, P145, DOI 10.1046/j.1365-2699.2000.00164.x; Janssens IA, 2001, GLOBAL CHANGE BIOL, V7, P269, DOI 10.1046/j.1365-2486.2001.00412.x; Jarvis P, 2007, TREE PHYSIOL, V27, P929, DOI 10.1093/treephys/27.7.929; Jimenez KL, J GEOPHYS RES BIOGEO; Kanniah KD, 2010, PROG PHYS GEOG, V34, P459, DOI 10.1177/0309133310364933; Kirkman LK, 2001, AM J BOT, V88, P2119, DOI 10.2307/3558437; Kowalski AS, 2008, AGR FOREST METEOROL, V148, P1045, DOI 10.1016/j.agrformet.2008.02.004; Kramer P.J., 1983, WATER RELATIONS PLAN; Laurance WF, 2011, BIOL CONSERV, V144, P1472, DOI 10.1016/j.biocon.2011.01.016; Lavigne MB, 1997, J GEOPHYS RES-ATMOS, V102, P28977, DOI 10.1029/97JD01173; Lavoie M, 2010, NAT AREA J, V30, P82, DOI 10.3375/043.030.0109; Law BE, 1999, GLOBAL CHANGE BIOL, V5, P169, DOI 10.1046/j.1365-2486.1999.00214.x; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Loescher HW, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006932; Loescher HW, 2006, J APPL METEOROL CLIM, V45, P1127, DOI 10.1175/JAM2388.1; Massman WJ, 2004, ATMOS ENVIRON, V38, P2323, DOI 10.1016/j.atmosenv.2003.09.079; Mielnick P, 2005, J ARID ENVIRON, V60, P423, DOI 10.1016/j.jaridenv.2004.06.001; Mitchell RJ, 1999, CAN J FOREST RES, V29, P743, DOI 10.1139/cjfr-29-6-743; Moffat AM, 2007, AGR FOREST METEOROL, V147, P209, DOI 10.1016/j.agrformet.2007.08.011; Moncrieff J. B., 1997, Journal of Hydrology (Amsterdam), V188-189, P589, DOI 10.1016/S0022-1694(96)03194-0; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NCDC, 2011, MONTHL STAT NORM TEM; Noormets A, 2010, GLOBAL CHANGE BIOL, V16, P272, DOI 10.1111/j.1365-2486.2009.01928.x; O'Brien JJ, 2010, FIRE ECOL, V6, P1, DOI 10.4996/fireecology.0602001; Ocheltree TW, 2007, J ATMOS OCEAN TECH, V24, P1389, DOI 10.1175/JTECH2064.1; Ottmar RD, 2007, CAN J FOREST RES, V37, P2383, DOI 10.1139/X07-077; Panek JA, 2001, TREE PHYSIOL, V21, P337, DOI 10.1093/treephys/21.5.337; Powell TL, 2008, GLOBAL CHANGE BIOL, V14, P2523, DOI 10.1111/j.1365-2486.2008.01675.x; Randerson JT, 2002, ECOL APPL, V12, P937, DOI 10.1890/1051-0761(2002)012[0937:NEPACM]2.0.CO;2; Reichstein M, 2007, DETERMINANTS TERREST; Richardson AD, 2005, AGR FOREST METEOROL, V131, P191, DOI 10.1016/j.agrformet.2005.05.008; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; SCHOCH P, 1986, FOREST ECOL MANAG, V14, P13, DOI 10.1016/0378-1127(86)90049-6; Serrano-Ortiz P, 2010, AGR FOREST METEOROL, V150, P321, DOI 10.1016/j.agrformet.2010.01.002; Sheffield MCP, 2003, FOREST ECOL MANAG, V179, P157, DOI 10.1016/S0378-1127(02)00523-6; Starr G, FIRES ROLE IN PRESS; Stephan K, 2012, FOREST ECOL MANAG, V263, P240, DOI 10.1016/j.foreco.2011.09.013; Unger S, 2012, AGR FOREST METEOROL, V154, P9, DOI 10.1016/j.agrformet.2011.10.007; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; Van Wagner CE, 2006, FOREST SCI, V52, P704; WALKER J, 1984, VEGETATIO, V55, P163, DOI 10.1007/BF00045019; Way AG, 2006, ENVIRON HIST, V11, P500, DOI 10.1093/envhis/11.3.500; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; WERNER PA, 1990, J BIOGEOGR, V17, P343, DOI 10.2307/2845362; Wiedinmyer C, 2010, ENVIRON SCI TECHNOL, V44, P1926, DOI 10.1021/es902455e; Wilson CA, 1999, CAN J FOREST RES, V29, P752, DOI 10.1139/cjfr-29-6-752; Wright JK, MEASURING MODE UNPUB	93	33	33	1	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54045	10.1371/journal.pone.0054045	http://dx.doi.org/10.1371/journal.pone.0054045			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335986	Green Submitted, gold, Green Published			2022-12-25	WOS:000314707700044
J	Fordyce, SL; Avila-Arcos, MC; Rasmussen, M; Cappellini, E; Romero-Navarro, JA; Wales, N; Alquezar-Planas, DE; Penfield, S; Brown, TA; Vielle-Calzada, JP; Montiel, R; Jorgensen, T; Odegaard, N; Jacobs, M; Arriaza, B; Higham, TFG; Ramsey, CB; Willersiev, E; Gilbert, MTP				Fordyce, Sarah L.; Avila-Arcos, Maria C.; Rasmussen, Morten; Cappellini, Enrico; Romero-Navarro, J. Alberto; Wales, Nathan; Alquezar-Planas, David E.; Penfield, Steven; Brown, Terence A.; Vielle-Calzada, Jean-Philippe; Montiel, Rafael; Jorgensen, Tina; Odegaard, Nancy; Jacobs, Michael; Arriaza, Bernardo; Higham, Thomas F. G.; Ramsey, Christopher Bronk; Willersiev, Eske; Gilbert, M. Thomas P.			Deep Sequencing of RNA from Ancient Maize Kernels	PLOS ONE			English	Article							MESSENGER-RNA; ARTIFICIAL SELECTION; SEED-GERMINATION; DNA-SEQUENCES; GENOME; DOMESTICATION; TRANSCRIPTOME; ALIGNMENT; TOOL; NEANDERTHAL	The characterization of biomolecules from ancient samples can shed otherwise unobtainable insights into the past. Despite the fundamental role of transcriptomal change in evolution, the potential of ancient RNA remains unexploited - perhaps due to dogma associated with the fragility of RNA. We hypothesize that seeds offer a plausible refuge for long-term RNA survival, due to the fundamental role of RNA during seed germination. Using RNA-Seq on cDNA synthesized from nucleic acid extracts, we validate this hypothesis through demonstration of partial transcriptomal recovery from two sources of ancient maize kernels. The results suggest that ancient seed transcriptomics may offer a powerful new tool with which to study plant domestication.	[Fordyce, Sarah L.; Avila-Arcos, Maria C.; Rasmussen, Morten; Cappellini, Enrico; Romero-Navarro, J. Alberto; Wales, Nathan; Alquezar-Planas, David E.; Jorgensen, Tina; Willersiev, Eske; Gilbert, M. Thomas P.] Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Romero-Navarro, J. Alberto] Univ Nacl Autonoma Mexico, Cuernavaca 62191, Morelos, Mexico; [Wales, Nathan] Univ Connecticut, Dept Anthropol, Storrs, CT USA; [Penfield, Steven] Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England; [Brown, Terence A.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England; [Vielle-Calzada, Jean-Philippe; Montiel, Rafael] CINVESTAV IPN, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico; [Odegaard, Nancy; Jacobs, Michael] Univ Arizona, Arizona State Museum, Tucson, AZ 85721 USA; [Arriaza, Bernardo] Univ Tarapaca, Ctr Invest Hombre Desierto, Dept Antropol, Inst Alta Invest, Arica, Chile; [Higham, Thomas F. G.; Ramsey, Christopher Bronk] Univ Oxford Archaeol & Hist Art Res Lab, Oxford, England	Universidad Nacional Autonoma de Mexico; University of Connecticut; University of York - UK; University of Manchester; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Arizona State University; University of Arizona; Universidad de Tarapaca; University of Oxford	Gilbert, MTP (corresponding author), Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark.	mtpgilbert@gmail.com	Ramsey, Christopher Bronk/A-3277-2012; Willerslev, Eske/AAA-5686-2019; Willerslev, Eske/A-9619-2011; Ávila-Arcos, Maria C./AGZ-3897-2022; Martin, Sarah Louise/AAE-7701-2021; Vielle-Calzada, Jean-Philippe/AAG-4036-2019; Higham, Tom/Y-2707-2019; Montiel, Rafael/A-6774-2008; Wales, Nathan/B-4263-2015; Ramsey, Christopher Bronk/AAQ-2227-2021; Cappellini, Enrico/F-9346-2013; Gilbert, Marcus/A-8936-2013	Ramsey, Christopher Bronk/0000-0002-8641-9309; Willerslev, Eske/0000-0002-7081-6748; Ávila-Arcos, Maria C./0000-0003-1691-1696; Martin, Sarah Louise/0000-0002-1741-4387; Higham, Tom/0000-0002-5949-598X; Montiel, Rafael/0000-0001-8052-0679; Wales, Nathan/0000-0003-0359-8450; Ramsey, Christopher Bronk/0000-0002-8641-9309; Cappellini, Enrico/0000-0001-7885-7811; Vielle-Calzada, Jean-Philippe/0000-0002-3017-2490; Penfield, Steven/0000-0001-6340-1731; Gilbert, Marcus/0000-0002-5805-7195	Danish Natural Science Research Council; Danish National Research Foundations; Natural Environment Research Council [NRCF010002] Funding Source: researchfish; NERC [NRCF010002] Funding Source: UKRI	Danish Natural Science Research Council(Danish Natural Science Research Council); Danish National Research Foundations; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding: The authors thank the Danish Natural Science Research Council and Danish National Research Foundations for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOGUERA C, 1992, PLANT MOL BIOL, V19, P781, DOI 10.1007/BF00027074; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], REPEATMODELER OP 1 0; Avila-Arcos MC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00074; Bannister Bryant, 1968, TREE RING DATES ARIZ; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; BUESCHER PJ, 1984, BIOCHEM GENET, V22, P923, DOI 10.1007/BF00499483; Buitink J, 2006, PLANT J, V47, P735, DOI 10.1111/j.1365-313X.2006.02822.x; DURE L, 1965, SCIENCE, V147, P410, DOI 10.1126/science.147.3656.410; Freitas FO, 2003, J ARCHAEOL SCI, V30, P901, DOI 10.1016/S0305-4403(02)00269-8; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; HAMMETT JR, 1975, BIOCHEMISTRY-US, V14, P4375, DOI 10.1021/bi00691a005; Holdsworth MJ, 2008, TRENDS PLANT SCI, V13, P7, DOI 10.1016/j.tplants.2007.11.002; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jaenicke-Despres V, 2003, SCIENCE, V302, P1206, DOI 10.1126/science.1089056; Kan YC, 2006, J CEREAL SCI, V44, P75, DOI 10.1016/j.jcs.2006.04.004; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Masaki S, 2008, BIOTECHNOL LETT, V30, P955, DOI 10.1007/s10529-007-9619-8; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; ODonoghue K, 1996, P ROY SOC B-BIOL SCI, V263, P541, DOI 10.1098/rspb.1996.0082; Prioul JL, 2008, PLANT BIOTECHNOL J, V6, P855, DOI 10.1111/j.1467-7652.2008.00368.x; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; ROLLO F, 1991, GENET RES, V58, P193, DOI 10.1017/S0016672300029943; Rollo F, 1985, THEOR APPL GENET, V41, P330; Sallon S, 2008, SCIENCE, V320, P1464, DOI 10.1126/science.1153600; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Studer A, 2011, NAT GENET, V43, P1160, DOI 10.1038/ng.942; VENANZI FM, 1990, NATURE, V343, P25, DOI 10.1038/343025b0; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yamasaki M, 2005, PLANT CELL, V17, P2859, DOI 10.1105/tpc.105.037242	39	29	30	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e50961	10.1371/journal.pone.0050961	http://dx.doi.org/10.1371/journal.pone.0050961			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326310	Green Published, Green Submitted, gold			2022-12-25	WOS:000314705800008
J	Lamb, LS; Bowersock, J; Dasgupta, A; Gillespie, GY; Su, Y; Johnson, A; Spencer, HT				Lamb, Lawrence S., Jr.; Bowersock, Joscelyn; Dasgupta, Anindya; Gillespie, G. Yancey; Su, Yun; Johnson, Austin; Spencer, H. Trent			Engineered Drug Resistant gamma delta T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy	PLOS ONE			English	Article							MALIGNANT GLIOMA; RECOMBINANT INTERLEUKIN-2; ADOPTIVE IMMUNOTHERAPY; RECURRENT GLIOBLASTOMA; IMMUNOGENE THERAPY; IMMUNE-RESPONSE; LAK CELLS; LYMPHOCYTES; CANCER; RECEPTOR	Classical approaches to immunotherapy that show promise in some malignancies have generally been disappointing when applied to high-grade brain tumors such as glioblastoma multiforme (GBM). We recently showed that ex vivo expanded/activated gamma delta T cells recognize NKG2D ligands expressed on malignant glioma and are cytotoxic to glioma cell lines and primary GBM explants. In addition, gamma delta T cells extend survival and slow tumor progression when administered to immunodeficient mice with intracranial human glioma xenografts. We now show that temozolomide (TMZ), a principal chemotherapeutic agent used to treat GBM, increases the expression of stress-associated NKG2D ligands on TMZ-resistant glioma cells, potentially rendering them vulnerable to gamma delta T cell recognition and lysis. TMZ is also highly toxic to gamma delta T cells, however, and to overcome this cytotoxic effect gamma delta T cells were genetically modified using a lentiviral vector encoding the DNA repair enzyme O(6)-alkylguanine DNA alkyltransferase (AGT) from the O(6)-methylguanine methyltransferase (MGMT) cDNA, which confers resistance to TMZ. Genetic modification of gamma delta T cells did not alter their phenotype or their cytotoxicity against GBM target cells. Importantly, gene modified gamma delta T cells showed greater cytotoxicity to two TMZ resistant GBM cell lines, U373(TMZ-R) and SNB-19(TMZ-R) cells, in the presence of TMZ than unmodified cells, suggesting that TMZ exposed more receptors for gamma delta T cell-targeted lysis. Therefore, TMZ resistant gamma delta T cells can be generated without impairing their anti-tumor functions in the presence of high concentrations of TMZ. These results provide a mechanistic basis for combining chemotherapy and gamma delta T cell-based drug resistant cellular immunotherapy to treat GBM.	[Lamb, Lawrence S., Jr.; Bowersock, Joscelyn; Su, Yun; Johnson, Austin] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Lamb, Lawrence S., Jr.; Gillespie, G. Yancey] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Dasgupta, Anindya; Spencer, H. Trent] Emory Univ, Sch Med, Dept Pediat, Aflac Canc Ctr, Atlanta, GA USA; [Dasgupta, Anindya; Spencer, H. Trent] Blood Disorders Serv, Atlanta, GA USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Emory University	Lamb, LS (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	Lawrence.Lamb@ccc.uab.edu; hspence@emory.edu		Gillespie, George/0000-0001-6436-9542; Lamb, Lawrence/0000-0001-7180-0994	CURE Childhood Cancer; NATIONAL CANCER INSTITUTE [P20CA151129] Funding Source: NIH RePORTER	CURE Childhood Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This work was supported by grants from CURE Childhood Cancer to HTS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonia SJ, 2006, CLIN CANCER RES, V12, P878, DOI 10.1158/1078-0432.CCR-05-2013; Arlen PM, 2006, CLIN CANCER RES, V12, P1260, DOI 10.1158/1078-0432.CCR-05-2059; Banissi C, 2009, CANCER IMMUNOL IMMUN, V58, P1627, DOI 10.1007/s00262-009-0671-1; BARBA D, 1989, J NEUROSURG, V70, P175, DOI 10.3171/jns.1989.70.2.0175; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; BOIARDI A, 1994, CANCER IMMUNOL IMMUN, V39, P193, DOI 10.1007/BF01533386; Bryant N.A., 2010, VET MICROBIOL; Bryant NL, 2011, J NEURO-ONCOL, V101, P179, DOI 10.1007/s11060-010-0245-2; Bryant NL, 2009, NEURO-ONCOLOGY, V11, P357, DOI 10.1215/15228517-2008-111; Castro MG, 2003, PHARMACOL THERAPEUT, V98, P71, DOI 10.1016/S0163-7258(03)00014-7; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Dasgupta A, 2012, HUM GENE THER; Dasgupta A, 2010, BIOCHEM BIOPH RES CO, V391, P170, DOI 10.1016/j.bbrc.2009.11.026; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Dillman RO, 2004, J IMMUNOTHER, V27, P398, DOI 10.1097/00002371-200409000-00009; Doering CB, 2009, MOL THER, V17, P1145, DOI 10.1038/mt.2009.35; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; FARKKILA M, 1994, BRIT J CANCER, V70, P138, DOI 10.1038/bjc.1994.263; Fridlender ZG, 2010, MOL THER, V18, P1947, DOI 10.1038/mt.2010.159; Friese MA, 2003, CANCER RES, V63, P8996; Gonzalez S, 2008, TRENDS IMMUNOL, V29, P397, DOI 10.1016/j.it.2008.04.007; GROSS JL, 1988, CANCER RES, V48, P291; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Gulley JL, 2007, VACCINE, V25, pB89, DOI 10.1016/j.vaccine.2007.04.091; Hanawa H, 2004, BLOOD, V103, P4062, DOI 10.1182/blood-2004-01-0045; HAYES RL, 1995, CANCER-AM CANCER SOC, V76, P840, DOI 10.1002/1097-0142(19950901)76:5<840::AID-CNCR2820760519>3.0.CO;2-R; Kato Y, 2001, J IMMUNOL, V167, P5092, DOI 10.4049/jimmunol.167.9.5092; Komatsu F, 2000, ONCOL RES, V12, P17; Kruse CA, 1997, CANCER IMMUNOL IMMUN, V45, P77, DOI 10.1007/s002620050405; Lake RA, 2005, NAT REV CANCER, V5, P397, DOI 10.1038/nrc1613; Lamb LS, 2009, IMMUNOL RES, V45, P85, DOI 10.1007/s12026-009-8114-9; Liseth K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/692097; Ma YT, 2011, J EXP MED, V208, P491, DOI 10.1084/jem.20100269; MAHALEY MS, 1988, J NEUROSURG, V69, P826, DOI 10.3171/jns.1988.69.6.0826; McMillin DW, 2006, HUM GENE THER, V17, P798, DOI 10.1089/hum.2006.17.798; MERCHANT RE, 1990, J NEURO-ONCOL, V8, P173; Merchant RE, 1997, NEUROL RES, V19, P145; Mitchell MS, 2003, CANCER IMMUNOL IMMUN, V52, P686, DOI 10.1007/s00262-003-0427-2; Plautz GE, 1998, J NEUROSURG, V89, P42, DOI 10.3171/jns.1998.89.1.0042; Poggi A, 2004, BLOOD, V103, P2205, DOI 10.1182/blood-2003-08-2928; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; Rainov NG, 2000, GENE THER, V7, P1853, DOI 10.1038/sj.gt.3301311; Ramakrishnan R, 2008, CANCER IMMUNOL IMMUN, V57, P1523, DOI 10.1007/s00262-008-0531-4; Ramakrishnan R, 2010, J CLIN INVEST, V120, P1111, DOI 10.1172/JCI40269; Read SB, 2003, J INTERF CYTOK RES, V23, P379, DOI 10.1089/107999003322226032; SARIS SC, 1989, J NEUROSURG, V71, P169, DOI 10.3171/jns.1989.71.2.0169; van der Most RG, 2008, CELL DEATH DIFFER, V15, P13, DOI 10.1038/sj.cdd.4402255; van der Most Robbert G, 2005, Discov Med, V5, P265; WELCH WC, 1995, IN VITRO CELL DEV-AN, V31, P610; Wischhusen J, 2005, J NEUROPATH EXP NEUR, V64, P523, DOI 10.1093/jnen/64.6.523; Wu J, 2002, J IMMUNOL, V169, P1236, DOI 10.4049/jimmunol.169.3.1236; Yu JS, 2004, CANCER RES, V64, P4973, DOI 10.1158/0008-5472.CAN-03-3505; Zhang JH, 2010, ONCOLOGY-BASEL, V78, P103, DOI 10.1159/000306139; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	54	51	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e51805	10.1371/journal.pone.0051805	http://dx.doi.org/10.1371/journal.pone.0051805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326319	gold, Green Published			2022-12-25	WOS:000314705800011
J	Hanke, A				Hanke, Andreas			Non-Equilibrium Casimir Force between Vibrating Plates	PLOS ONE			English	Article							RENORMALIZATION-GROUP TREATMENT; CRITICAL-DYNAMICS; SPHERE; FLUID	We study the fluctuation-induced, time-dependent force between two plates confining a correlated fluid which is driven out of equilibrium mechanically by harmonic vibrations of one of the plates. For a purely relaxational dynamics of the fluid we calculate the fluctuation-induced force generated by the vibrating plate on the plate at rest. The time-dependence of this force is characterized by a positive lag time with respect to the driving. We obtain two distinctive contributions to the force, one generated by diffusion of stress in the fluid and another related to resonant dissipation in the cavity. The relation to the dynamic Casimir effect of the electromagnetic field and possible experiments to measure the time-dependent Casimir force are discussed.	Univ Texas Brownsville, Dept Phys, Brownsville, TX 78520 USA	University of Texas System; University of Texas Rio Grande Valley	Hanke, A (corresponding author), Univ Texas Brownsville, Dept Phys, Brownsville, TX 78520 USA.	hanke@phys.utb.edu			Air Force Office of Scientific Research [FA9550-10-1-0408]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by the Air Force Office of Scientific Research under Grant No. FA9550-10-1-0408. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolo D, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.061112; Bialynicki-Birula I, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.042109; Bitbol AF, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061107; Bordag M, 2009, INT J MOD PHYS A, V24, P1743, DOI 10.1142/S0217751X09045315; Bordag M., 2009, ADV CASIMIR EFFECT, DOI [10.1093/acprof:oso/9780199238743.001.0001, DOI 10.1093/ACPROF:OSO/9780199238743.001.0001]; BRAY AJ, 1994, ADV PHYS, V43, P357, DOI 10.1080/00018739400101505; Brito R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011113; Buenzli PR, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.020102; Canaguier-Durand A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.230404; Capasso F, 2007, IEEE J SEL TOP QUANT, V13, P400, DOI 10.1109/JSTQE.2007.893082; Casimir H. B. G, 1948, P KON NED AKAD WET, V51, P793; Cattuto C, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.178001; Chadwick RS, 2008, SIAM REV, V50, P313, DOI 10.1137/06067763X; Chan HB, 2001, SCIENCE, V291, P1941, DOI 10.1126/science.1057984; Chan HB, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.211801; Chandler D., 1987, INTRO MODERN STAT ME; Clarke RJ, 2005, J FLUID MECH, V545, P397, DOI 10.1017/S0022112005006907; Collins Harry, 2004, GRAVITYS SHADOW SEAR; Davies P, 1996, NATURE, V382, P761, DOI 10.1038/382761a0; Dean DS, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041126; Dean DS, 2009, J STAT MECH-THEORY E, V81; Demery V, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.010103; Demery V, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.080601; Emig T, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.022114; Emig T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.160801; Emig T, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.260402; Emig T, 2009, NONLINEAR DYNAMICS N; FISHER ME, 1978, CR ACAD SCI B PHYS, V287, P207; Folk R, 2006, J PHYS A-MATH GEN, V39, pR207, DOI 10.1088/0305-4470/39/24/R01; Gambassi A, 2006, J STAT PHYS, V123, P929, DOI 10.1007/s10955-006-9089-8; Gies H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.220405; Golestanian R, 1997, PHYS REV LETT, V78, P3421, DOI 10.1103/PhysRevLett.78.3421; Golestanian R, 1998, PHYS REV A, V58, P1713, DOI 10.1103/PhysRevA.58.1713; HALPERIN BI, 1976, PHYS REV B, V13, P1299, DOI 10.1103/PhysRevB.13.1299; Hanke A, 1998, PHYS REV LETT, V81, P1885, DOI 10.1103/PhysRevLett.81.1885; Hanke A, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.046121; Hanke A, 2001, PHYS REV LETT, V86, P4596, DOI 10.1103/PhysRevLett.86.4596; Hertlein C, 2008, NATURE, V451, P172, DOI 10.1038/nature06443; Kardar M, 1999, REV MOD PHYS, V71, P1233, DOI 10.1103/RevModPhys.71.1233; Krech M., 1994, CASIMIR EFFECT CRITI; Kruger M, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/21002; Kruger M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.210404; Lambrecht A, 1996, PHYS REV LETT, V77, P615, DOI 10.1103/PhysRevLett.77.615; Lamoreaux SK, 1997, PHYS REV LETT, V78, P5, DOI 10.1103/PhysRevLett.78.5; Lauga E, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/9/096601; LI H, 1992, PHYS REV A, V46, P6490, DOI 10.1103/PhysRevA.46.6490; McMullin E, 2002, PHYS PERSPECT, V4, P13, DOI 10.1007/s00016-002-8357-5; Milonni P. W., 1993, QUANTUM VACUUM INTRO; Milton K. A., 2001, CASIMIR EFFECT; Mohideen U, 1998, PHYS REV LETT, V81, P4549, DOI 10.1103/PhysRevLett.81.4549; Najafi A, 2004, EUROPHYS LETT, V68, P776, DOI 10.1209/epl/i2004-10275-5; Reid MTH, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.040401; Rodriguez AW, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.012115; Rodriguez-Lopez P, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.031102; Rousseau E, 2009, NAT PHOTONICS, V3, P514, DOI 10.1038/NPHOTON.2009.144; Scheel S, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.042902; Schlesener F, 2003, J STAT PHYS, V110, P981, DOI 10.1023/A:1022184508016; Shen S, 2009, NANO LETT, V9, P2909, DOI 10.1021/nl901208v; SIGGIA ED, 1976, PHYS REV B, V13, P2110, DOI 10.1103/PhysRevB.13.2110; Sushkov AO, 2011, NAT PHYS, V7, P230, DOI [10.1038/nphys1909, 10.1038/NPHYS1909]; Vasilyev O, 2009, REV REV E, V79	61	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53228	10.1371/journal.pone.0053228	http://dx.doi.org/10.1371/journal.pone.0053228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326401	gold, Green Published, Green Submitted			2022-12-25	WOS:000313552400017
J	Laalami, S; Bessieres, P; Rocca, A; Zig, L; Nicolas, P; Putzer, H				Laalami, Soumaya; Bessieres, Philippe; Rocca, Anna; Zig, Lena; Nicolas, Pierre; Putzer, Harald			Bacillus subtilis RNase Y Activity In Vivo Analysed by Tiling Microarrays	PLOS ONE			English	Article							MESSENGER-RNA; OXALATE DECARBOXYLASE; FUNCTIONAL-ANALYSIS; ESCHERICHIA-COLI; SIGMA-FACTOR; EXPRESSION; IDENTIFICATION; INITIATION; PROTEIN; GENES	RNase Y is a key endoribonuclease affecting global mRNA stability in Bacillus subtilis. Its characterization provided the first evidence that endonucleolytic cleavage plays a major role in the mRNA metabolism of this organism. RNase Y shares important functional features with the RNA decay initiating RNase E from Escherichia coli, notably a similar cleavage specificity and a preference for 59 monophosphorylated substrates. We used high-resolution tiling arrays to analyze the effect of RNase Y depletion on RNA abundance covering the entire genome. The data confirm that this endoribonuclease plays a key role in initiating the decay of a large number of mRNAs as well as non coding RNAs. The downstream cleavage products are likely to be degraded by the 59 exonucleolytic activity of RNases J1/J2 as we show for a specific case. Comparison of the data with that of two other recent studies revealed very significant differences. About two thirds of the mRNAs upregulated following RNase Y depletion were different when compared to either one of these studies and only about 10% were in common in all three studies. This highlights that experimental conditions and data analysis play an important role in identifying RNase Y substrates by global transcriptional profiling. Our data confirmed already known RNase Y substrates and due to the precision and reproducibility of the profiles allow an exceptionally detailed view of the turnover of hundreds of new RNA substrates.	[Laalami, Soumaya; Rocca, Anna; Zig, Lena; Putzer, Harald] Univ Paris Diderot, Inst Biol Physicochim, CNRS UPR 9073, Paris, France; [Bessieres, Philippe; Nicolas, Pierre] INRA UR1077, Jouy En Josas, France	UDICE-French Research Universities; Universite Paris Cite; INRAE	Putzer, H (corresponding author), Univ Paris Diderot, Inst Biol Physicochim, CNRS UPR 9073, Paris, France.	putzer@ibpc.fr	Putzer, Harald/GRY-6203-2022		CNRS [UPR 9073]; Univ Paris Diderot; Sorbonne Paris Cite; Agence Nationale de la Recherche ANR	CNRS(Centre National de la Recherche Scientifique (CNRS)); Univ Paris Diderot; Sorbonne Paris Cite; Agence Nationale de la Recherche ANR(French National Research Agency (ANR))	This work was supported by funds from the CNRS (UPR 9073), Univ Paris Diderot, Sorbonne Paris Cite and the Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/) ANR grant RNAJAY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antelmann H, 2007, J PROTEOME RES, V6, P897, DOI 10.1021/pr060440a; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Bayle L, 2011, MOL MICROBIOL, V82, P904, DOI 10.1111/j.1365-2958.2011.07862.x; Bhavsar AP, 2006, MOL MICROBIOL, V60, P1077, DOI 10.1111/j.1365-2958.2006.05169.x; Bruscella P, 2011, MOL MICROBIOL, V81, P1526, DOI 10.1111/j.1365-2958.2011.07793.x; Carpousis AJ, 2009, PROG MOL BIOL TRANSL, V85, P91, DOI 10.1016/S0079-6603(08)00803-9; Christensen QH, 2011, MOL MICROBIOL, V80, P350, DOI 10.1111/j.1365-2958.2011.07598.x; Commichau FM, 2009, MOL CELL PROTEOMICS, V8, P1350, DOI 10.1074/mcp.M800546-MCP200; de la Sierra-Gallay IL, 2008, NAT STRUCT MOL BIOL, V15, P206, DOI 10.1038/nsmb.1376; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Diethmaier C, 2011, J BACTERIOL, V193, P5997, DOI 10.1128/JB.05360-11; Durand S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002520; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Gaballa A, 2002, J BACTERIOL, V184, P6508, DOI 10.1128/JB.184.23.6508-6514.2002; Gardner PP, 2011, NUCLEIC ACIDS RES, V39, pD141, DOI 10.1093/nar/gkq1129; Garrey SM, 2011, MOL MICROBIOL, V80, P1613, DOI 10.1111/j.1365-2958.2011.07670.x; Guillouard I, 2002, J BACTERIOL, V184, P4681, DOI 10.1128/JB.184.17.4681-4689.2002; Hunt A, 2006, MICROBIOL-SGM, V152, P2895, DOI 10.1099/mic.0.29152-0; Ibrahim M, 2007, MICROBIOL-SGM, V153, P3631, DOI 10.1099/mic.0.2007/006205-0; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Kime L, 2010, MOL MICROBIOL, V76, P590, DOI 10.1111/j.1365-2958.2009.06935.x; Laalami Soumaya, 2011, Biomol Concepts, V2, P491, DOI 10.1515/BMC.2011.042; Lehnik-Habrink M, 2011, J BACTERIOL, V193, P5431, DOI 10.1128/JB.05500-11; Lehnik-Habrink M, 2011, MOL MICROBIOL, V81, P1459, DOI 10.1111/j.1365-2958.2011.07777.x; MacLellan SR, 2008, MOL MICROBIOL, V69, P954, DOI 10.1111/j.1365-2958.2008.06331.x; MacLellan SR, 2009, J BACTERIOL, V191, P931, DOI 10.1128/JB.01435-08; Mader U, 2008, MOL MICROBIOL, V70, P183, DOI 10.1111/j.1365-2958.2008.06400.x; Marincola G, 2012, MOL MICROBIOL, V85, P817, DOI 10.1111/j.1365-2958.2012.08144.x; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; Mathy N, 2010, MOL MICROBIOL, V75, P489, DOI 10.1111/j.1365-2958.2009.07004.x; Naville M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r97; Newman JA, 2012, J MOL BIOL, V416, P121, DOI 10.1016/j.jmb.2011.12.024; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Nicolas P, 2009, BIOINFORMATICS, V25, P2341, DOI 10.1093/bioinformatics/btp395; Ogura Y, 2001, J BACTERIOL, V183, P3833, DOI 10.1128/JB.183.13.3833-3841.2001; Petit MA, 1998, MOL MICROBIOL, V29, P261, DOI 10.1046/j.1365-2958.1998.00927.x; PUTZER H, 1992, EMBO J, V11, P3117, DOI 10.1002/j.1460-2075.1992.tb05384.x; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Richards J, 2011, MOL CELL, V43, P940, DOI 10.1016/j.molcel.2011.07.023; Shahbabian K, 2009, EMBO J, V28, P3523, DOI 10.1038/emboj.2009.283; Silvaggi JM, 2005, J BACTERIOL, V187, P6641, DOI 10.1128/JB.187.19.6641-6650.2005; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P407; Sterk P, 2006, OMICS, V10, P114, DOI 10.1089/omi.2006.10.114; Strimmer K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-303; Tanner A, 2001, J BIOL CHEM, V276, P43627, DOI 10.1074/jbc.M107202200; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Yao SY, 2010, J BACTERIOL, V192, P3279, DOI 10.1128/JB.00230-10	47	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54062	10.1371/journal.pone.0054062	http://dx.doi.org/10.1371/journal.pone.0054062			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326572	gold, Green Published, Green Submitted			2022-12-25	WOS:000313552400071
J	Opulente, DA; Morales, CM; Carey, LB; Rest, JS				Opulente, Dana A.; Morales, Christopher M.; Carey, Lucas B.; Rest, Joshua S.			Coevolution Trumps Pleiotropy: Carbon Assimilation Traits Are Independent of Metabolic Network Structure in Budding Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL REGULATION; DUPLICATION; EVOLUTION; GENOMICS; REVEALS; STRAINS; COPY	Phenotypic traits may be gained and lost together because of pleiotropy, the involvement of common genes and networks, or because of simultaneous selection for multiple traits across environments (multiple-trait coevolution). However, the extent to which network pleiotropy versus environmental coevolution shapes shared responses has not been addressed. To test these alternatives, we took advantage of the fact that the genus Saccharomyces has variation in habitat usage and diversity in the carbon sources that a given strain can metabolize. We examined patterns of gain and loss in carbon utilization traits across 488 strains of Saccharomyces to investigate whether the structure of metabolic pathways or selection pressure from common environments may have caused carbon utilization traits to be gained and lost together. While most carbon sources were gained and lost independently of each other, we found four clusters that exhibit non-random patterns of gain and loss across strains. Contrary to the network pleiotropy hypothesis, we did not find that these patterns are explained by the structure of metabolic pathways or shared enzymes. Consistent with the hypothesis that common environments shape suites of phenotypes, we found that the environment a strain was isolated from partially predicts the carbon sources it can assimilate.	[Opulente, Dana A.; Morales, Christopher M.; Rest, Joshua S.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Carey, Lucas B.] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Weizmann Institute of Science	Rest, JS (corresponding author), SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA.	joshua.rest@stonybrook.edu	Carey, Lucas/L-8547-2014	Carey, Lucas/0000-0002-7245-6379; Opulente, Dana/0000-0003-3224-7510; Rest, Joshua/0000-0002-9582-1041	Stony Brook University	Stony Brook University	This work was supported by startup funds from Stony Brook University to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames RM, 2010, GENOME BIOL EVOL, V2, P591, DOI 10.1093/gbe/evq043; Carreto L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-524; Centraalbureau voor Schimmelcultures Fungal Biodiversity Centre, 2012, YEAST STRAIN DAT; Conant GC, 2002, NUCLEIC ACIDS RES, V30, P3378, DOI 10.1093/nar/gkf449; Conner JK, 2002, NATURE, V420, P407, DOI 10.1038/nature01105; Dunn B, 2012, GENOME RES, V22, P908, DOI 10.1101/gr.130310.111; Gerlee P, 2009, J R SOC INTERFACE, V6, P1233, DOI 10.1098/rsif.2008.0514; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kim PM, 2007, P NATL ACAD SCI USA, V104, P20274, DOI 10.1073/pnas.0710183104; Landry CR, 2006, MOL ECOL, V15, P575, DOI 10.1111/j.1365-294X.2006.02778.x; Landry CR, 2006, GENE, V366, P343, DOI 10.1016/j.gene.2005.10.042; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; Ma M, 2012, BIOENERG RES, V5, P459, DOI 10.1007/s12155-011-9176-9; Marland E, 2004, J MOL EVOL, V59, P806, DOI 10.1007/s00239-004-0068-x; Muller LAH, 2011, FEMS YEAST RES, V11, P587, DOI 10.1111/j.1567-1364.2011.00748.x; Saxer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014184; Streisfeld MA, 2009, NEW PHYTOL, V183, P751, DOI 10.1111/j.1469-8137.2009.02929.x; Turcotte B, 2010, FEMS YEAST RES, V10, P2, DOI 10.1111/j.1567-1364.2009.00555.x; Vivier MA, 1997, CRIT REV BIOCHEM MOL, V32, P405, DOI 10.3109/10409239709082675; Walker G.M., 1998, YEAST PHYSL BIOTECHN; Wang Z, 2009, GENOME BIOL EVOL, V1, P23, DOI 10.1093/gbe/evp002; Warringer J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002111; Wong D, 2010, IND BIOTECHNOL, V6, P112; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787	25	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54403	10.1371/journal.pone.0054403	http://dx.doi.org/10.1371/journal.pone.0054403			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326606	Green Published, gold, Green Submitted			2022-12-25	WOS:000313552400088
J	Shao, HY; Hsu, HY; Wu, KS; Hee, SW; Chuang, LM; Yeh, JI				Shao, Hsiao-Yun; Hsu, Hsue-Yin; Wu, Kuan-Sju; Hee, Siow-Wey; Chuang, Lee-Ming; Yeh, Jih-I			Prolonged Induction Activates Cebp alpha Independent Adipogenesis in NIH/3T3 Cells	PLOS ONE			English	Article							C/EBP-ALPHA; INSULIN SENSITIVITY; ADIPOCYTE DIFFERENTIATION; PPAR-GAMMA; BLOOD-PRESSURE; EXPRESSION; THIAZOLIDINEDIONE; PATHWAY; CULTURE; LINE	Background: 3T3-L1 cells are widely used to study adipogenesis and insulin response. Their adipogenic potential decreases with time in the culture. Expressing exogenous genes in 3T3-L1 cells can be challenging. This work tries to establish and characterize an alternative model of cultured adipocytes that is easier to work with than the 3T3-L1 cells. Methodology/Principal Findings: Induced cells were identified as adipocytes based on the following three characteristics: (1) Accumulation of triglyceride droplets as demonstrated by oil red O stain. (2) Transport rate of 2-deoxyglucose increased after insulin stimulation. (3) Expression of fat specific genes such as Fabp4 (aP2), Slc2a4 (Glut4) and Pparg (PPAR gamma). Among the cell lines induced under different conditions in this study, only NIH/3T3 cells differentiated into adipocytes after prolonged incubation in 3T3-L1 induction medium containing 20% instead of 10% fetal bovine serum. Rosiglitazone added to the induction medium shortened the incubation period from 14 to 7 days. The PI3K/AKT pathway showed similar changes upon insulin stimulation in these two adipocytes. C/EBP alpha mRNA was barely detectable in NIH/3T3 adipocytes. NIH/3T3 adipocytes induced in the presence of rosiglitazone showed higher 2-deoxyglucose transport rate after insulin stimulation, expressed less Agt (angiotensinogen) and more PPAR gamma. Knockdown of C/EBP alpha using shRNA blocked 3T3-L1 but not NIH/3T3 cell differentiation. Mouse adipose tissues from various anatomical locations showed comparable levels of C/EBPa mRNA. Conclusions/Significance: NIH/3T3 cells were capable of differentiating into adipocytes without genetic engineering. They were an adipocyte model that did not require the reciprocal activation between C/EBP alpha and PPAR gamma to differentiate. Future studies in the C/EBP alpha independent pathways leading to insulin responsiveness may reveal new targets to diabetes treatment.	[Shao, Hsiao-Yun; Yeh, Jih-I] Tzu Chi Univ, Grad Inst Mol & Cell Biol, Hualien, Taiwan; [Hsu, Hsue-Yin] Tzu Chi Univ, Dept & Grad Inst Life Sci, Hualien, Taiwan; [Wu, Kuan-Sju] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Hee, Siow-Wey; Chuang, Lee-Ming] Natl Taiwan Univ, Inst Mol Med, Taipei 10764, Taiwan; [Yeh, Jih-I] Tzu Chi Univ, Dept Family Med, Hualien, Taiwan; [Yeh, Jih-I] Buddhist Tzu Chi Gen Hosp, Dept Family Med, Hualien, Taiwan	Tzu Chi University; Tzu Chi University; Tzu Chi University; National Taiwan University; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Yeh, JI (corresponding author), Tzu Chi Univ, Grad Inst Mol & Cell Biol, Hualien, Taiwan.	jihiyeh@mail.tcu.edu.tw	Chuang, Lee-Ming/AAF-3324-2019	CHUANG, LEE-MING/0000-0003-0978-2662	Tzu Chi University [TCIRP 96005-04Y1]; Buddhist Tzu Chi General Hospital [TCRD 101-20]; National Research Program for Genomic Medicine Grants of NSC [NSC97-3112-B-001-016]	Tzu Chi University; Buddhist Tzu Chi General Hospital; National Research Program for Genomic Medicine Grants of NSC	Part of this work was funded by Tzu Chi University (TCIRP 96005-04Y1) and Buddhist Tzu Chi General Hospital (TCRD 101-20). The RNAi reagents obtained from Academia Sinica was supported by the National Research Program for Genomic Medicine Grants of NSC (NSC97-3112-B-001-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bakris G, 2003, J HUM HYPERTENS, V17, P7, DOI 10.1038/sj.jhh.1001444; Chen SS, 2000, MOL CELL BIOL, V20, P7292, DOI 10.1128/MCB.20.19.7292-7299.2000; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; El-Jack AK, 1999, J BIOL CHEM, V274, P7946, DOI 10.1074/jbc.274.12.7946; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Guo W, 2009, CELL RES, V19, P216, DOI 10.1038/cr.2008.319; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; KANEKO T, 1978, CANCER RES, V38, P2084; Lambe KG, 1996, EUR J BIOCHEM, V239, P1, DOI 10.1111/j.1432-1033.1996.0001u.x; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Payne VA, 2007, J BIOL CHEM, V282, P21005, DOI 10.1074/jbc.M702871200; Raji A, 2003, DIABETES CARE, V26, P172, DOI 10.2337/diacare.26.1.172; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Sarafidis PA, 2004, J HYPERTENS, V22, P1769, DOI 10.1097/00004872-200409000-00022; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; WANG M, 1995, J IMMUNOL, V154, P4685; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001	24	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e51459	10.1371/journal.pone.0051459	http://dx.doi.org/10.1371/journal.pone.0051459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326314	Green Submitted, Green Published, gold			2022-12-25	WOS:000313552400004
J	Fulton, CJ; Johansen, JL; Steffensen, JF				Fulton, Christopher J.; Johansen, Jacob L.; Steffensen, John F.			Energetic Extremes in Aquatic Locomotion by Coral Reef Fishes	PLOS ONE			English	Article							DIFFERENT SWIMMING SPEEDS; OXYGEN-CONSUMPTION; PERFORMANCE; COST; TEMPERATURE; PROPULSION; TUNA; JAPONICUS; MACKEREL; SCHOOL	Underwater locomotion is challenging due to the high friction and resistance imposed on a body moving through water and energy lost in the wake during undulatory propulsion. While aquatic organisms have evolved streamlined shapes to overcome such resistance, underwater locomotion has long been considered a costly exercise. Recent evidence for a range of swimming vertebrates, however, has suggested that flapping paired appendages around a rigid body may be an extremely efficient means of aquatic locomotion. Using intermittent flow-through respirometry, we found exceptional energetic performance in the Bluelined wrasse Stethojulis bandanensis, which maintains tuna-like optimum cruising speeds (up to 1 metre s(-1)) while using 40% less energy than expected for their body size. Displaying an exceptional aerobic scope (22-fold above resting), streamlined rigid-body posture, and wing-like fins that generate lift-based thrust, S. bandanensis literally flies underwater to efficiently maintain high optimum swimming speeds. Extreme energetic performance may be key to the colonization of highly variable environments, such as the wave-swept habitats where S. bandanensis and other wing-finned species tend to occur. Challenging preconceived notions of how best to power aquatic locomotion, biomimicry of such lift-based fin movements could yield dramatic reductions in the power needed to propel underwater vehicles at high speed.	[Fulton, Christopher J.] Australian Natl Univ, Res Sch Biol, ARC Ctr Excellence Coral Reef Studies, Canberra, ACT, Australia; [Johansen, Jacob L.] James Cook Univ, Sch Marine & Trop Biol, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Steffensen, John F.] Univ Copenhagen, Dept Biol, Marine Biol Sect, Helsingor, Denmark	Australian National University; James Cook University; University of Copenhagen	Fulton, CJ (corresponding author), Australian Natl Univ, Res Sch Biol, ARC Ctr Excellence Coral Reef Studies, Canberra, ACT, Australia.	christopher.fulton@anu.edu.au	Steffensen, John F/F-6778-2010; Johansen, Jacob/F-9189-2011; Fulton, Christopher/A-5971-2008	Steffensen, John F/0000-0002-4477-8039; Fulton, Christopher/0000-0002-1140-1999	Australian Research Council; Danish Agency for Science, Technology and Innovation	Australian Research Council(Australian Research Council); Danish Agency for Science, Technology and Innovation	Funding was provided by the Australian Research Council (to CJF) and the Danish Agency for Science, Technology and Innovation (to JFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RM, 2005, J EXP BIOL, V208, P1645, DOI 10.1242/jeb.01484; BAUDINETTE RV, 1985, J COMP PHYSIOL B, V155, P373, DOI 10.1007/BF00687481; Bell WH, 1970, J FISH RES BD CAN TE; Bishop CM, 1999, P ROY SOC B-BIOL SCI, V266, P2275, DOI 10.1098/rspb.1999.0919; BRETT JR, 1965, J FISH RES BOARD CAN, V22, P1491, DOI 10.1139/f65-128; Claireaux G, 2006, J EXP BIOL, V209, P3420, DOI 10.1242/jeb.02346; Clark TD, 2006, J EXP BIOL, V209, P3940, DOI 10.1242/jeb.02440; DEWAR H, 1994, J EXP BIOL, V192, P13; Donelson JM, 2011, GLOBAL CHANGE BIOL, V17, P1712, DOI 10.1111/j.1365-2486.2010.02339.x; Fish FE, 1996, AM ZOOL, V36, P628, DOI 10.1093/icb/36.6.628; Fitzgibbon QP, 2007, AQUACULTURE, V270, P358, DOI 10.1016/j.aquaculture.2007.04.038; Fulton CJ, 2007, CORAL REEFS, V26, P217, DOI 10.1007/s00338-007-0195-0; Fulton C. J., 2010, FISH LOCOMOTION ECOE, P333; Fulton CJ, 2005, P ROY SOC B-BIOL SCI, V272, P827, DOI 10.1098/rspb.2004.3029; GOODING RM, 1981, FISH B-NOAA, V79, P31; GRAHAM JB, 1989, EXP BIOL, V48, P89; Hein AM, 2012, BIOL LETTERS, V8, P266, DOI 10.1098/rsbl.2011.0885; Herskin J, 1998, J FISH BIOL, V53, P366, DOI 10.1006/jfbi.1998.0708; Johansen JL, 2011, GLOBAL CHANGE BIOL, V17, P2971, DOI 10.1111/j.1365-2486.2011.02436.x; Korsmeyer KE, 2002, J EXP BIOL, V205, P1253; KORSMEYER KE, 2001, TUNA PHYSL ECOLOGY E, P35; Long JH, 2006, BIOINSPIR BIOMIM, V1, P20, DOI 10.1088/1748-3182/1/1/003; SCHMIDTNIELSEN K, 1972, SCIENCE, V177, P222, DOI 10.1126/science.177.4045.222; Sepulveda C, 2000, J EXP BIOL, V203, P3089; Sepulveda CA, 2003, J EXP BIOL, V206, P2739, DOI 10.1242/jeb.00497; STEFFENSEN JF, 1984, COMP BIOCHEM PHYS A, V79, P437, DOI 10.1016/0300-9629(84)90541-3; STEFFENSEN JF, 1989, FISH PHYSIOL BIOCHEM, V6, P49, DOI 10.1007/BF02995809; STEFFENSEN JF, 1994, POLAR BIOL, V14, P49; VIDELER JJ, 1990, COMP BIOCHEM PHYS A, V97, P91, DOI 10.1016/0300-9629(90)90155-L; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; Vogel S., 1994, LIFE MOVING FLUIDS P; Wainwright PC, 2002, ENVIRON BIOL FISH, V65, P47, DOI 10.1023/A:1019671131001; Walker JA, 2002, INTEGR COMP BIOL, V42, P1032, DOI 10.1093/icb/42.5.1032; Walker JA, 2002, J EXP BIOL, V205, P177; Wardle CS, 1996, J FISH BIOL, V49, P854, DOI 10.1111/j.1095-8649.1996.tb00084.x; WEBB PW, 1994, MECHANICS AND PHYSIOLOGY OF ANIMAL SWIMMING, P45; Wyneken Jeanette, 1997, P165; Young IR, 2011, SCIENCE, V332, P451, DOI 10.1126/science.1197219	38	26	26	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e54033	10.1371/journal.pone.0054033	http://dx.doi.org/10.1371/journal.pone.0054033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326566	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000313551500108
J	Watts, AO; Verkaar, F; van der Lee, MMC; Timmerman, CAW; Kuijer, M; van Offenbeek, J; van Lith, LHCJ; Smit, MJ; Leurs, R; Zaman, GJR; Vischer, HF				Watts, Anne O.; Verkaar, Folkert; van der Lee, Miranda M. C.; Timmerman, Claudia A. W.; Kuijer, Martien; van Offenbeek, Jody; van Lith, Lambertus H. C. J.; Smit, Martine J.; Leurs, Rob; Zaman, Guido J. R.; Vischer, Henry F.			beta-Arrestin Recruitment and G Protein Signaling by the Atypical Human Chemokine Decoy Receptor CCX-CKR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTORS; CRYSTAL-STRUCTURE; CELLS; CXCR7; CAMP; IDENTIFICATION; TRANSDUCTION; INVOLVEMENT; TRAFFICKING; ACTIVATION	Chemokine receptors form a large subfamily of G protein-coupled receptors that predominantly activate heterotrimeric G(i) proteins and are involved in immune cell migration. CCX-CKR is an atypical chemokine receptor with high affinity for CCL19, CCL21, and CCL25 chemokines, but is not known to activate intracellular signaling pathways. However, CCX-CKR acts as decoy receptor and efficiently internalizes these chemokines, thereby preventing their interaction with other chemokine receptors, like CCR7 and CCR9. Internalization of fluorescently labeled CCL19 correlated with beta-arrestin2-GFP translocation. Moreover, recruitment of beta-arrestins to CCX-CKR in response to CCL19, CCL21, and CCL25 was demonstrated using enzyme-fragment complementation and bioluminescence resonance energy transfer methods. To unravel why CCX-CKR is unable to activate G(i) signaling, CCX-CKR chimeras were constructed by substituting its intracellular loops with the corresponding CCR7 or CCR9 domains. The signaling properties of chimeric CCX-CKR receptors were characterized using a cAMP-responsive element (CRE)-driven reporter gene assay. Unexpectedly, wild type CCX-CKR and a subset of the chimeras induced an increase in CRE activity in response to CCL19, CCL21, and CCL25 in the presence of the G(i) inhibitor pertussis toxin. CCX-CKR signaling to CRE required an intact DRY motif. These data suggest that inactive G(i) proteins impair CCX-CKR signaling most likely by hindering the interaction of this receptor with pertussis toxin-insensitive G proteins that transduce signaling to CRE. On the other hand, recruitment of the putative signaling scaffold beta-arrestin to CCX-CKR in response to chemokines might allow activation of yet to be identified signal transduction pathways.	[Watts, Anne O.; Verkaar, Folkert; Kuijer, Martien; van Offenbeek, Jody; Smit, Martine J.; Leurs, Rob; Vischer, Henry F.] Vrije Univ Amsterdam, Fac Sci, Div Med Chem, NL-1081 HV Amsterdam, Netherlands; [Verkaar, Folkert; van der Lee, Miranda M. C.; Timmerman, Claudia A. W.; van Offenbeek, Jody; van Lith, Lambertus H. C. J.] Merck Res Labs, Mol Pharmacol & DMPK, NL-5340 BH Oss, Netherlands; [Zaman, Guido J. R.] Netherlands Translat Res Ctr BV, NL-5340 AG Oss, Netherlands	Vrije Universiteit Amsterdam; Merck & Company	Vischer, HF (corresponding author), Vrije Univ Amsterdam, De Boelelaan 1083, NL-1081 HV Amsterdam, Netherlands.	h.f.vischer@vu.nl	Leurs, Rob/ABB-4299-2021; Leurs, Rob/AAC-8508-2022	Leurs, Rob/0000-0003-1354-2848; Smit, Martine/0000-0003-2713-0238	Dutch Top Institute Pharma initiative program [D1-105]	Dutch Top Institute Pharma initiative program	This work was supported by the Dutch Top Institute Pharma initiative program D1-105.	Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Bahia DS, 1998, BIOCHEMISTRY-US, V37, P11555, DOI 10.1021/bi980284o; Comerford I, 2006, EUR J IMMUNOL, V36, P1904, DOI 10.1002/eji.200535716; Comerford I, 2010, BLOOD, V116, P4130, DOI 10.1182/blood-2010-01-264390; DeFea KA, 2011, CELL SIGNAL, V23, P621, DOI 10.1016/j.cellsig.2010.10.004; Feng LY, 2009, CLIN CANCER RES, V15, P2962, DOI 10.1158/1078-0432.CCR-08-2495; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Gosling J, 2000, J IMMUNOL, V164, P2851, DOI 10.4049/jimmunol.164.6.2851; Haraldsen G, 2006, EUR J IMMUNOL, V36, P1659, DOI 10.1002/eji.200636327; Heinzel K, 2007, P NATL ACAD SCI USA, V104, P8421, DOI 10.1073/pnas.0608274104; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Khoja H, 2000, GENE, V246, P229, DOI 10.1016/S0378-1119(00)00076-7; Kong MMC, 2007, MOL PHARMACOL, V72, P1157, DOI 10.1124/mol.107.034769; Kriegova E, 2006, INFLAMM RES, V55, P441, DOI 10.1007/s00011-006-6019-9; Kumar R, 2012, CELL IMMUNOL, V272, P230, DOI 10.1016/j.cellimm.2011.09.015; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Liggett SB, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002331; Luker KE, 2009, FASEB J, V23, P823, DOI 10.1096/fj.08-116749; Manson ME, 2011, BIOCHEMISTRY-US, V50, P6022, DOI 10.1021/bi200015h; Maruko T, 2005, N-S ARCH PHARMACOL, V372, P153, DOI 10.1007/s00210-005-0001-x; McCulloch CV, 2008, J BIOL CHEM, V283, P7972, DOI 10.1074/jbc.M710128200; Nijmeijer S, 2010, J BIOL CHEM, V285, P29632, DOI 10.1074/jbc.M110.115618; O'Hayre M, 2008, BIOCHEM J, V409, P635, DOI 10.1042/BJ20071493; Pabst O, 2004, J EXP MED, V199, P411, DOI 10.1084/jem.20030996; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rode I, 2012, P NATL ACAD SCI USA, V109, P3463, DOI 10.1073/pnas.1118823109; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Scholten DJ, 2012, BRIT J PHARMACOL, V166, P898, DOI 10.1111/j.1476-5381.2011.01648.x; Scholten DJ, 2012, BRIT J PHARMACOL, V165, P1617, DOI 10.1111/j.1476-5381.2011.01551.x; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Townson JR, 2002, EUR J IMMUNOL, V32, P1230, DOI 10.1002/1521-4141(200205)32:5<1230::AID-IMMU1230>3.0.CO;2-L; Ulvmar MH, 2011, EXP CELL RES, V317, P556, DOI 10.1016/j.yexcr.2011.01.012; Van der Lee MMC, 2008, J BIOMOL SCREEN, V13, P986, DOI 10.1177/1087057108326144; van Lith LHC, 2009, J BIOMOL SCREEN, V14, P1067, DOI 10.1177/1087057109341407; Vickery RG, 1999, J CELL BIOL, V144, P31, DOI 10.1083/jcb.144.1.31; Vischer HF, 2008, BIOCHEM BIOPH RES CO, V377, P93, DOI 10.1016/j.bbrc.2008.09.082; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Xiao KH, 2010, P NATL ACAD SCI USA, V107, P15299, DOI 10.1073/pnas.1008461107; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106	46	35	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7169	7181		10.1074/jbc.M112.406108	http://dx.doi.org/10.1074/jbc.M112.406108			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23341447	hybrid, Green Published			2022-12-25	WOS:000316002400038
J	Kejnovsky, E; Michalovova, M; Steflova, P; Kejnovska, I; Manzano, S; Hobza, R; Kubat, Z; Kovarik, J; Jamilena, M; Vyskot, B				Kejnovsky, Eduard; Michalovova, Monika; Steflova, Pavlina; Kejnovska, Iva; Manzano, Susana; Hobza, Roman; Kubat, Zdenek; Kovarik, Jan; Jamilena, Manuel; Vyskot, Boris			Expansion of Microsatellites on Evolutionary Young Y Chromosome	PLOS ONE			English	Article							DNA MOTIF D(TG)30; SEX-CHROMOSOMES; DINUCLEOTIDE MICROSATELLITES; HOMOLOGOUS RECOMBINATION; SILENE-LATIFOLIA; REPETITIVE DNA; REPEATS; INTEGRATION; SEQUENCES; ELEMENTS	Sex chromosomes are an ideal system to study processes connected with suppressed recombination. We found evidence of microsatellite expansion, on the relatively young Y chromosome of the dioecious plant sorrel (Rumex acetosa, XY1Y2 system), but no such expansion on the more ancient Y chromosomes of liverwort (Marchantia polymorpha) and human. The most expanding motifs were AC and AAC, which also showed periodicity of array length, indicating the importance of beginnings and ends of arrays. Our data indicate that abundance of microsatellites in genomes depends on the inherent expansion potential of specific motifs, which could be related to their stability and ability to adopt unusual DNA conformations. We also found that the abundance of microsatellites is higher in the neighborhood of transposable elements (TEs) suggesting that microsatellites are probably targets for TE insertions. This evidence suggests that microsatellite expansion is an early event shaping the Y chromosome where this process is not opposed by recombination, while accumulation of TEs and chromosome shrinkage predominate later.	[Kejnovsky, Eduard] Acad Sci Czech Republ, Inst Biophys, Lab Plant Dev Genet, Dept Plant Dev Genet, CS-61265 Brno, Czech Republic; [Kejnovsky, Eduard; Steflova, Pavlina; Kubat, Zdenek] CEITEC Cent European Inst Technol, Lab Genome Dynam, Brno, Czech Republic; [Kejnovska, Iva] Acad Sci Czech Republ, Inst Biophys, Dept CD Spect Nucle Acids, CS-61265 Brno, Czech Republic; [Manzano, Susana; Jamilena, Manuel] Univ Almeria, Escuela Polytecn Super, Dept Biol Aplicada, Almeria, Spain; [Hobza, Roman] Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, Lab Mol Cytogenet & Cytometry, Olomouc, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Universidad de Almeria; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Kejnovsky, E (corresponding author), Acad Sci Czech Republ, Inst Biophys, Lab Plant Dev Genet, Dept Plant Dev Genet, Kralovopolska 135, CS-61265 Brno, Czech Republic.	kejnovsk@ibp.cz	Jamilena, Manuel/K-3331-2014; Hobza, Roman/G-3119-2014; Vyskot, Boris/H-1962-2014; Hobza, Roman/I-4297-2014; Jamilena, Manuel/ABE-9137-2020; Kejnovsky, Eduard/D-8878-2012; Kubát, Zdeněk/D-9221-2012; Kejnovska, Iva/G-9767-2014; Manzano, Susana/M-1372-2015; Cechova, Monika/AAJ-4459-2020	Jamilena, Manuel/0000-0001-7072-0458; Jamilena, Manuel/0000-0001-7072-0458; Kubát, Zdeněk/0000-0001-8278-9495; Cechova, Monika/0000-0002-7420-2663; Hobza, Roman/0000-0003-3062-2962	Grant Agency of the Czech Republic [P305/10/0930, P501/10/0102, P501/12/2220, P501/12/G090]; Academy of Sciences of the Czech Republic [AV0Z50040702]; European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; project OPVK [CZ.1.07/2.3.00/20.0045]; Centre of the Region Hana for Biotechnological and Agricultural Research [ED0007/01/01]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); European Regional Development Fund(European Commission); project OPVK; Centre of the Region Hana for Biotechnological and Agricultural Research	This work was supported by the Grant Agency of the Czech Republic (grants P305/10/0930 to E.K., P501/10/0102 to B.V., P501/12/2220 to R.H., P501/12/G090 to B.V.), grant No AV0Z50040702 from the Academy of Sciences of the Czech Republic, by the project "CEITEC - Central European Institute of Technology'' (CZ.1.05/1.1.00/02.0068) from European Regional Development Fund, by the project OPVK (CZ.1.07/2.3.00/20.0045) and grant No. ED0007/01/01 Centre of the Region Hana for Biotechnological and Agricultural Research.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; ARCOT SS, 1995, GENOMICS, V29, P136, DOI 10.1006/geno.1995.1224; Bachtrog D, 1999, MOL BIOL EVOL, V16, P602, DOI 10.1093/oxfordjournals.molbev.a026142; Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Baller JA, 2011, P NATL ACAD SCI USA, V108, P20351, DOI 10.1073/pnas.1103665108; Cermak T, 2008, CHROMOSOME RES, V16, P961, DOI 10.1007/s10577-008-1254-2; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; CROTHERS DM, 1990, J BIOL CHEM, V265, P7093; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Gangadharan S, 2010, P NATL ACAD SCI USA, V107, P21966, DOI 10.1073/pnas.1016382107; Graves JAM, 2002, TRENDS GENET, V18, P259, DOI 10.1016/S0168-9525(02)02666-5; GRAY DM, 1995, METHOD ENZYMOL, V246, P19; Hobza R, 2007, MOL GENET GENOMICS, V278, P633, DOI 10.1007/s00438-007-0279-0; Hrabcova I, 2003, BIOCHEM BIOPH RES CO, V300, P824, DOI 10.1016/S0006-291X(02)02940-6; Kejnovska I, 2001, BBA-GEN SUBJECTS, V1527, P73, DOI 10.1016/S0304-4165(01)00150-7; Kejnovsky E, 2009, HEREDITY, V102, P533, DOI 10.1038/hdy.2009.17; Kelkar YD, 2011, GENOME RES, V21, P2038, DOI 10.1101/gr.122937.111; Koren Z, 2011, J MOL EVOL, V72, P232, DOI 10.1007/s00239-010-9425-0; Kubat Z, 2008, GENOME, V51, P350, DOI 10.1139/G08-024; Majewski J, 2000, GENOME RES, V10, P1108, DOI 10.1101/gr.10.8.1108; Marais GAB, 2008, CURR BIOL, V18, P545, DOI 10.1016/j.cub.2008.03.023; Mariotti B, 2009, MOL GENET GENOMICS, V281, P249, DOI 10.1007/s00438-008-0405-7; Matula M, 1999, J BIOMOL STRUCT DYN, V17, P275, DOI 10.1080/07391102.1999.10508360; Mayer C, 2006, PHOBOS 3 3 11; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Nadir E, 1996, P NATL ACAD SCI USA, V93, P6470, DOI 10.1073/pnas.93.13.6470; Navajas-Perez R, 2005, MOL BIOL EVOL, V22, P1929, DOI 10.1093/molbev/msi186; Pearson CE, 1998, CURR OPIN STRUC BIOL, V8, P321, DOI 10.1016/S0959-440X(98)80065-1; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramsay L, 1999, PLANT J, V17, P415, DOI 10.1046/j.1365-313X.1999.00392.x; Renciuk D, 2011, BIOPOLYMERS, V95, P174, DOI 10.1002/bip.21555; Rizzon C, 2002, GENOME RES, V12, P400, DOI 10.1101/gr.210802; Schlotterer C, 2000, CHROMOSOMA, V109, P365, DOI 10.1007/s004120000089; Shinde D, 2003, NUCLEIC ACIDS RES, V31, P974, DOI 10.1093/nar/gkg178; Smit A, 1996, REPEATMASKER OPEN 30; TAUTZ D, 1986, NATURE, V322, P652, DOI 10.1038/322652a0; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; ULANOVSKY L, 1986, P NATL ACAD SCI USA, V83, P862, DOI 10.1073/pnas.83.4.862; Varela MA, 2008, J MOL EVOL, V66, P575, DOI 10.1007/s00239-008-9107-3; VORLICKOVA M, 1982, NUCLEIC ACIDS RES, V10, P1071, DOI 10.1093/nar/10.3.1071; Vyskot B, 2004, TRENDS GENET, V20, P432, DOI 10.1016/j.tig.2004.06.006; WAHLS WP, 1990, MOL CELL BIOL, V10, P785, DOI 10.1128/MCB.10.2.785; WAHLS WP, 1990, MOL CELL BIOL, V10, P794, DOI 10.1128/MCB.10.2.794; Wilder J, 2001, MOL BIOL EVOL, V18, P384, DOI 10.1093/oxfordjournals.molbev.a003814; Yamato KT, 2007, P NATL ACAD SCI USA, V104, P6472, DOI 10.1073/pnas.0609054104; Yant SR, 2005, MOL CELL BIOL, V25, P2085, DOI 10.1128/MCB.25.6.2085-2094.2005; Zayed H, 2003, NUCLEIC ACIDS RES, V31, P2313, DOI 10.1093/nar/gkg341; Zhu YX, 2003, P NATL ACAD SCI USA, V100, P5891, DOI 10.1073/pnas.1036705100	50	49	50	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e45519	10.1371/journal.pone.0045519	http://dx.doi.org/10.1371/journal.pone.0045519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341866	gold, Green Published, Green Submitted			2022-12-25	WOS:000313682700001
J	Luo, XL; Wu, JH; Li, YB; Nan, ZR; Guo, X; Wang, YX; Zhang, AH; Wang, ZA; Xia, GX; Tian, YC				Luo, Xiaoli; Wu, Jiahe; Li, Yuanbao; Nan, Zhirun; Guo, Xing; Wang, Yixue; Zhang, Anhong; Wang, Zhian; Xia, Guixian; Tian, Yingchuan			Synergistic Effects of GhSOD1 and GhCAT1 Overexpression in Cotton Chloroplasts on Enhancing Tolerance to Methyl Viologen and Salt Stresses	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; ASCORBATE PEROXIDASE; HYDROGEN-PEROXIDE; TOBACCO PLANTS; BACTERIAL CATALASE; NICOTIANA-TABACUM; TRANSGENIC PLANTS; OVER-EXPRESSION; ANTIPORTER GENE	In plants, CuZn superoxide dismutase (CuZnSOD, EC l. 15.1.1), ascorbate peroxidase (APX, EC 1.11.1.11), and catalase (CAT, EC l. 11.1.6) are important scavengers of reactive oxygen species (ROS) to protect the cell from damage. In the present study, we isolated three homologous genes (GhSOD1, GhAPX1, and GhCAT1) from Gossypium hirsutum. Overexpressing cassettes containing chimeric GhSOD1, GhAPX1, or GhCAT1 were introduced into cotton plants by Agrobacterium transformation, and overexpressed products of these genes were transported into the chloroplasts by transit peptide, as expected. The five types of transgenic cotton plants that overexpressed GhSOD1, GhAPX1, GhCAT1, GhSOD1 and GhAPX1 stack ( SAT), and GhSOD1 and GhCAT1 stack (SCT) were developed. Analyses in the greenhouse showed that the transgenic plants had higher tolerance to methyl viologen (MV) and salinity than WT plants. Interestingly, SCT plants suffered no damage under stress conditions. Based on analyses of enzyme activities, electrolyte leakage, chlorophyll content, photochemical yield (Fv/Fm), and biomass accumulation under stresses, the SCT plants that simultaneously overexpressed GhSOD1 and GhCAT1 appeared to benefit from synergistic effects of two genes and exhibited the highest tolerance to MV and salt stress among the transgenic lines, while the SAT plants simultaneously overexpressing GhSOD1 and GhAPX1 did not. In addition, transgenic plants overexpressing antioxidant enzymes in their chloroplasts had higher tolerance to salt stress than those expressing the genes in their cytoplasms, although overall enzyme activities were almost the same. Therefore, the synergistic effects of GhSOD1 and GhCAT1 in chloroplasts provide a new strategy for enhancing stress tolerance to avoid yield loss.	[Luo, Xiaoli; Wu, Jiahe; Li, Yuanbao; Nan, Zhirun; Guo, Xing; Wang, Yixue; Xia, Guixian; Tian, Yingchuan] Chinese Acad Sci, Inst Microbiol, State Key Lab Plant Genom, Beijing, Peoples R China; [Luo, Xiaoli; Zhang, Anhong; Wang, Zhian] Shanxi Acad Agr Sci, Inst Cotton Res, Yuncheng, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Shanxi Agricultural University	Wu, JH (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Plant Genom, Beijing, Peoples R China.	wujiahe@im.ac.cn			Special Fund of Agro-Scientific Research in Public Interest [201103026-2]; Sustentation Fund of Chinese Academy of Sciences [Y02B011HH1]	Special Fund of Agro-Scientific Research in Public Interest; Sustentation Fund of Chinese Academy of Sciences	The current research project was supported by Special Fund of Agro-Scientific Research in Public Interest (201103026-2) and by Sustentation Fund of Chinese Academy of Sciences (Y02B011HH1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Allen RD, 1997, FREE RADICAL BIO MED, V23, P473, DOI 10.1016/S0891-5849(97)00107-X; ALLEN RD, 1995, PLANT PHYSIOL, V107, P1049, DOI 10.1104/pp.107.4.1049; [Anonymous], 2000, SAS SYST WIND SOFTW; Aono M, 1995, PLANT CELL PHYSIOL, V36, P1687; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; ASADA K, 1992, PHYSIOL PLANTARUM, V85, P235, DOI 10.1111/j.1399-3054.1992.tb04728.x; Asencio C, 2003, FASEB J, V17, P1135, DOI 10.1096/fj.02-1022fje; Ashraf M, 2009, BIOTECHNOL ADV, V27, P84, DOI 10.1016/j.biotechadv.2008.09.003; Ashraf M, 2004, PLANT SCI, V166, P3, DOI 10.1016/j.plantsci.2003.10.024; BABBS CF, 1989, PLANT PHYSIOL, V90, P1267, DOI 10.1104/pp.90.4.1267; Badawi GH, 2004, PLANT SCI, V166, P919, DOI 10.1016/j.plantsci.2003.12.007; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BOWLER C, 1991, EMBO J, V10, P1723, DOI 10.1002/j.1460-2075.1991.tb07696.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chabregas SM, 2001, PLANT MOL BIOL, V46, P639, DOI 10.1023/A:1011628510711; Chen HJ, 2012, J PLANT PHYSIOL, V169, P86, DOI 10.1016/j.jplph.2011.08.002; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; del Rio LA, 2006, PLANT PHYSIOL, V141, P330, DOI 10.1104/pp.106.078204; Fernandez-Ocana A, 2011, J PLANT PHYSIOL, V168, P1303, DOI 10.1016/j.jplph.2011.01.020; Iannone MF, 2012, BIOL TRACE ELEM RES, V146, P246, DOI 10.1007/s12011-011-9244-1; FOYER C, 1983, PLANTA, V157, P239, DOI 10.1007/BF00405188; FOYER CH, 1994, PLANT CELL ENVIRON, V17, P507, DOI 10.1111/j.1365-3040.1994.tb00146.x; Grover A, 2003, CURR SCI INDIA, V84, P355; GUPTA AS, 1993, P NATL ACAD SCI USA, V90, P1629, DOI 10.1073/pnas.90.4.1629; He CX, 2005, PLANT CELL PHYSIOL, V46, P1848, DOI 10.1093/pcp/pci201; HOSSAIN MA, 1984, PLANT CELL PHYSIOL, V25, P1285; Khanna-Chopra R, 2011, BIOCHEM BIOPH RES CO, V412, P522, DOI 10.1016/j.bbrc.2011.06.179; Kiddle G, 2003, ANTIOXID REDOX SIGN, V5, P23, DOI 10.1089/152308603321223513; Kim MD, 2010, PHYSIOL PLANTARUM, V140, P153, DOI 10.1111/j.1399-3054.2010.01392.x; Kitajima S, 2010, BIOSCI BIOTECH BIOCH, V74, P1501, DOI 10.1271/bbb.100218; Kwon SY, 2002, PLANT CELL ENVIRON, V25, P873, DOI 10.1046/j.1365-3040.2002.00870.x; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; LI TY, 1994, SCI CHINA SER B, V37, P1479; Lin KH, 2010, PLANT CELL REP, V29, P575, DOI 10.1007/s00299-010-0846-4; Mathews H, 2003, PLANT CELL, V15, P1689, DOI 10.1105/tpc.012963; McKersie BD, 1996, PLANT PHYSIOL, V111, P1177, DOI 10.1104/pp.111.4.1177; Mhamdi A, 2010, J EXP BOT, V61, P4197, DOI 10.1093/jxb/erq282; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mohamed EA, 2003, PLANT CELL ENVIRON, V26, P2037, DOI 10.1046/j.0016-8025.2003.01121.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; OGREN WL, 1984, ANNU REV PLANT PHYS, V35, P415, DOI 10.1146/annurev.pp.35.060184.002215; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Payton P, 1997, PHOTOSYNTH RES, V52, P233, DOI 10.1023/A:1005873105596; Payton P, 2001, J EXP BOT, V52, P2345, DOI 10.1093/jexbot/52.365.2345; Pena LB, 2011, J TRACE ELEM MED BIO, V25, P125, DOI 10.1016/j.jtemb.2011.05.001; PITCHER LH, 1991, PLANT PHYSIOL, V97, P452, DOI 10.1104/pp.97.1.452; Prashanth SR, 2008, TRANSGENIC RES, V17, P281, DOI 10.1007/s11248-007-9099-6; Rhoades J. D., 1990, Agronomy, P1089; Sambrook J., 2001, MOL CLONING LAB MANU; Shigeoka S, 2002, J EXP BOT, V53, P1305, DOI 10.1093/jexbot/53.372.1305; Shikanai T, 1998, FEBS LETT, V428, P47, DOI 10.1016/S0014-5793(98)00483-9; Singh BK, 2010, J GENET, V89, P217, DOI 10.1007/s12041-010-0028-8; Singh S, 2012, MOL PLANT MICROBE IN, V25, P569, DOI 10.1094/MPMI-08-11-0217; SLOOTEN L, 1995, PLANT PHYSIOL, V107, P737, DOI 10.1104/pp.107.3.737; Tang DQ, 2005, J BIOSCIENCE, V30, P101; Tang L, 2008, TRANSGENIC RES, V17, P705, DOI 10.1007/s11248-007-9155-2; Tang L, 2006, PLANT CELL REP, V25, P1380, DOI 10.1007/s00299-006-0199-1; TEPPERMAN JM, 1990, PLANT MOL BIOL, V14, P501, DOI 10.1007/BF00027496; Tseng MJ, 2007, PLANT PHYSIOL BIOCH, V45, P822, DOI 10.1016/j.plaphy.2007.07.011; VANCAMP W, 1994, BIO-TECHNOL, V12, P165, DOI 10.1038/nbt0294-165; VanCamp W, 1996, PLANT PHYSIOL, V112, P1703, DOI 10.1104/pp.112.4.1703; Wang L, 2003, WATER SALT EVOLUTION, P147; Wang NY, 2007, MOL GENET GENOMICS, V277, P13, DOI 10.1007/s00438-006-0170-4; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Wu J, 2005, PLANT BREEDING, V124, P142, DOI 10.1111/j.1439-0523.2004.01056.x; Wu JH, 2011, TRANSGENIC RES, V20, P963, DOI 10.1007/s11248-011-9483-0; Xu XM, 2010, J CELL SCI, V123, P1644, DOI 10.1242/jcs.063222; Zhou SF, 2008, BIOTECHNOL LETT, V30, P369, DOI 10.1007/s10529-007-9548-6	71	39	45	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54002	10.1371/journal.pone.0054002	http://dx.doi.org/10.1371/journal.pone.0054002			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335985	Green Submitted, gold, Green Published			2022-12-25	WOS:000314707700043
J	Sullivan, AK; Raben, D; Reekie, J; Rayment, M; Mocroft, A; Esser, S; Leon, A; Begovac, J; Brinkman, K; Zangerle, R; Grzeszczuk, A; Vassilenko, A; Hadziosmanovic, V; Krasnov, M; Sonnerborg, A; Clumeck, N; Gatell, J; Gazzard, B; Monforte, AD; Rockstroh, J; Lundgren, JD				Sullivan, Ann K.; Raben, Dorthe; Reekie, Joanne; Rayment, Michael; Mocroft, Amanda; Esser, Stefan; Leon, Agathe; Begovac, Josip; Brinkman, Kees; Zangerle, Robert; Grzeszczuk, Anna; Vassilenko, Anna; Hadziosmanovic, Vesna; Krasnov, Maksym; Sonnerborg, Anders; Clumeck, Nathan; Gatell, Jose; Gazzard, Brian; Monforte, Antonella d'Arminio; Rockstroh, Juergen; Lundgren, Jens D.			Feasibility and Effectiveness of Indicator ConditionGuided Testing for HIV: Results from HIDES I (HIV Indicator Diseases across Europe Study)	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; COST-EFFECTIVENESS; UNITED-STATES; INFECTION; CONSEQUENCES; TRANSMISSION; DIAGNOSIS; TIME; CARE; MEN	Improved methods for targeting HIV testing among patients most likely to be infected are required; HIDES I aimed to define the methodology of a European wide study of HIV prevalence in individuals presenting with one of eight indicator conditions/diseases (ID); sexually transmitted infection, lymphoma, cervical or anal cancer/dysplasia, herpes zoster, hepatitis B/C, mononucleosis-like illness, unexplained leukocytopenia/thrombocytopenia and seborrheic dermatitis/exanthema, and to identify those with an HIV prevalence of > 0.1%, a level determined to be cost effective. A staff questionnaire was performed. From October 2009-February 2011, individuals, not known to be HIV positive, presenting with one of the ID were offered an HIV test; additional information was collected on previous HIV testing behaviour and recent medical history. A total of 3588 individuals from 16 centres were included. Sixty-six tested positive for HIV, giving an HIV prevalence of 1.8% [95% CI: 1.42-2.34]; all eight ID exceeded 0.1% prevalence. Of those testing HIV positive, 83% were male, 58% identified as MSM and 9% were injecting drug users. Twenty percent reported previously having potentially HIV-related symptoms and 52% had previously tested HIV negative (median time since last test: 1.58 years); which together with the median CD4 count at diagnosis (400 cell/uL) adds weight to this strategy being effective in diagnosing HIV at an earlier stage. A positive test was more likely for non-white individuals, MSM, injecting drug users and those testing in non-Northern regions. HIDES I describes an effective strategy to detect undiagnosed HIV infection. All eight ID fulfilled the > 0.1% criterion for cost effectiveness. All individuals presenting to any health care setting with one of these ID should be strongly recommended an HIV test. A strategy is being developed in collaboration with ECDC and WHO Europe to guide the implementation of this novel public health initiative across Europe.	[Sullivan, Ann K.; Rayment, Michael; Gazzard, Brian] Chelsea & Westminster NHS Fdn Trust, Directorate Sexual Hlth & HIV Med, London, England; [Raben, Dorthe; Lundgren, Jens D.] Univ Copenhagen, Copenhagen HIV Programme, Copenhagen, Denmark; [Reekie, Joanne; Mocroft, Amanda] UCL, Dept Infect Populat Hlth, London, England; [Esser, Stefan] Univ Hosp Essen, Clin Dermatol & Venerol, Essen, Germany; [Leon, Agathe; Gatell, Jose] Hosp Clin Barcelona, Dept Infect Dis, Barcelona, Spain; [Begovac, Josip] Univ Hosp Infect Dis, Zagreb, Croatia; [Brinkman, Kees] Onze Lieve Vrouw Hosp, Dept Internal Med, Amsterdam, Netherlands; [Zangerle, Robert] Med Univ Innsbruck, Dept Dermatol & Venereol, A-6020 Innsbruck, Austria; [Grzeszczuk, Anna] Med Univ Bialystok, Dept Infect Dis & Hepatol, Bialystok, Poland; [Vassilenko, Anna] Belorussian State Med Univ, Dept Infect Dis, Minsk, BELARUS; [Hadziosmanovic, Vesna] Univ Sarajevo, Infect Dis Clin, Ctr Clin, Sarajevo 71000, Bosnia & Herceg; [Krasnov, Maksym] Kharkov Reg Clin Infect Dis, Kharkov, Ukraine; [Sonnerborg, Anders] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Clumeck, Nathan] St Pierre Univ Hosp, Dept Infect Dis, Brussels, Belgium; [Monforte, Antonella d'Arminio] Univ Milan, San Paolo Hosp, Infect Dis Unit, Milan, Italy; [Rockstroh, Juergen] Univ Bonn, Dept Med 1, Bonn, Germany; [Lundgren, Jens D.] Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark	Imperial College London; University of Copenhagen; University of London; University College London; University of Duisburg Essen; University of Barcelona; Hospital Clinic de Barcelona; Onze Lieve Vrouwe Gasthuis Hospital; Medical University of Innsbruck; Medical University of Bialystok; University of Sarajevo; Karolinska Institutet; Karolinska University Hospital; Universite Libre de Bruxelles; Vrije Universiteit Brussel; San Paolo-Polo Universitaria Hospital; University of Milan; University of Bonn; Rigshospitalet; University of Copenhagen	Raben, D (corresponding author), Univ Copenhagen, Copenhagen HIV Programme, Copenhagen, Denmark.	dra@cphiv.dk	Lundgren, Jens/AAE-6876-2019; , Felipe/F-4242-2014; Gatell, Jose M/ABC-3607-2020; Leon, Agathe/K-9851-2015; Begovac, Josip/AAI-5672-2021; Grzeszczuk, Anna/R-7844-2018; Vassilenko, Anna/AAB-4152-2021; Sönnerborg, Anders/W-2011-2019; Mitsura, Viktar/G-2457-2017	, Felipe/0000-0001-7658-5832; Leon, Agathe/0000-0002-1198-5090; Begovac, Josip/0000-0003-2641-4327; Grzeszczuk, Anna/0000-0002-6420-5545; Sönnerborg, Anders/0000-0001-8928-3374; Mitsura, Viktar/0000-0002-0449-5026; Lundgren, Jens/0000-0001-8901-7850; d'Arminio Monforte, Antonella/0000-0003-0073-1789; Anna, Vassilenko/0000-0003-1907-2322	HIV in Europe initiative; Gilead Sciences; Merck; Tibotec; Pfizer; Schering-Plough; Abbott; BoehringerIngelheim; Bristol-Myers Squibb; GlaxoSmithKline; ViiVHealthcare	HIV in Europe initiative; Gilead Sciences(Gilead Sciences); Merck(Merck & Company); Tibotec; Pfizer(Pfizer); Schering-Plough(Merck & CompanySchering Plough Corporation); Abbott(Abbott Laboratories); BoehringerIngelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); ViiVHealthcare	The HIDES study was funded by the HIV in Europe initiative which has received funding from Gilead Sciences, Merck, Tibotec, Pfizer, Schering-Plough, Abbott, BoehringerIngelheim, Bristol-Myers Squibb, GlaxoSmithKline, ViiVHealthcare. The operational procedures within the initiative include the following in order to maintain the autonomy of the initiative. The Steering Committee is the governing body and sponsors do not have representation on the Steering Committee. Furthermore, data, records, reports, Intellectual Property Rights and Know How generated as result of the initiative shall be deemed vested in and the property of the Steering Committee, represented by the co-chairs affiliations (AIDS Fonds Netherlands and Copenhagen HIV Programme). The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TIM TEST HIV EXP HEA; Bander Dorota, 2009, Przegl Epidemiol, V63, P61; Bannister WP, 2006, JAIDS-J ACQ IMM DEF, V42, P229, DOI 10.1097/01.qai.0000214815.95786.31; British HIV Association British Association of Sexual Health and HIV British Infection Society, 2008, UK NAT GUID HIV TEST; Chadborn TR, 2005, AIDS, V19, P513, DOI 10.1097/01.aids.0000162340.43310.08; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; European Centre for Disease Prevention and Control, 2006, HIV PREV EUR ACT NEE; European Centre for Disease Prevention and Control, 2010, ECDC GUID HIV TEST I; European Centre for Disease Prevention and Control, 2011, HIV AIDS SURV EUR 20; Fisher M, 2008, CURR OPIN INFECT DIS, V21, P1, DOI 10.1097/QCO.0b013e3282f2d8fb; Fleishman JA, 2010, MED CARE, V48, P1071, DOI 10.1097/MLR.0b013e3181f81c4a; Fox J, 2009, HIV MED, V10, P432, DOI 10.1111/j.1468-1293.2009.00708.x; Gazzard B, 2008, HIV MED, V9, P34, DOI 10.1111/j.1468-1293.2008.00592.x; Hamers FF, 2008, HIV MED, V9, P6, DOI 10.1111/j.1468-1293.2008.00584.x; Health Protection Agency, 2011, HIV UK 2011 REP; Lanoy E, 2007, ANTIVIR THER, V12, P89; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Menacio I, 2012, COMP OPT IN VERSUS O; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Pinkerton SD, 2008, JAIDS-J ACQ IMM DEF, V47, P354, DOI 10.1097/QAI.0b013e318160d57e; Rayment M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039530; Sabin CA, 2012, AIDS, V24, P723; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schackman BR, 2002, ARCH INTERN MED, V162, P2478, DOI 10.1001/archinte.162.21.2478; Thornton AC, 2012, SEX TRANSM INFECT, V88, P601, DOI 10.1136/sextrans-2012-050584; UNAIDS, 2011, UNAIDS GLOB REP 2010; Uy J, 2009, J ACQUIRED INFECT DI, V195, P951; Yazdanpanah Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013132	29	119	119	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e52845	10.1371/journal.pone.0052845	http://dx.doi.org/10.1371/journal.pone.0052845			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23341910	Green Published, Green Submitted, gold			2022-12-25	WOS:000314707700009
J	Woods, K; a'Bhaird, NN; Dooley, C; Perez-Morga, D; Nolan, DP				Woods, Katherine; a'Bhaird, Noirin Nic; Dooley, Clodagh; Perez-Morga, David; Nolan, Derek P.			Identification and Characterization of a Stage Specific Membrane Protein Involved in Flagellar Attachment in Trypanosoma brucei	PLOS ONE			English	Article							POLY-N-ACETYLLACTOSAMINE; BLOOD-STREAM FORMS; CELL-DIVISION; CYTOSKELETON; ADHESION; ZONE; CYCLE; GLYCOPROTEIN; ARCHITECTURE; CYTOKINESIS	Flagellar attachment is a visibly striking morphological feature of African trypanosomes but little is known about the requirements for attachment at a molecular level. This study characterizes a previously undescribed membrane protein, FLA3, which plays an essential role in flagellar attachment in Trypanosoma brucei. FLA3 is heavily N-glycosylated, locates to the flagellar attachment zone and appears to be a bloodstream stage specific protein. Ablation of the FLA3 mRNA rapidly led to flagellar detachment and a concomitant failure of cytokinesis in the long slender bloodstream form but had no effect on the procyclic form. Flagellar detachment was obvious shortly after induction of the dsRNA and the newly synthesized flagellum was often completely detached after it emerged from the flagellar pocket. Within 12 h most cells possessed detached flagella alongside the existing attached flagellum. These results suggest that proteins involved in attachment are not shared between the new and old attachment zones. In other respects the detached flagella appear normal, they beat rapidly although directional motion was lost, and they possess an apparently normal axoneme and paraflagellar rod structure. The flagellar attachment zone appeared to be disrupted when FLA3 was depleted. Thus, while flagellar attachment is a constitutive feature of the life cycle of trypanosomes, attachment requires stage specific elements at the protein level.	[Woods, Katherine; a'Bhaird, Noirin Nic; Nolan, Derek P.] Univ Dublin Trinity Coll, Mol Parasitol Grp, Sch Biochem & Immunol, Dublin 2, Ireland; [Dooley, Clodagh] Univ Dublin Trinity Coll, Ctr Microscopy & Anal, Dublin 2, Ireland; [Perez-Morga, David] Univ Libre Bruxelles, Mol Parasitol Lab, Gosselies, Belgium	Trinity College Dublin; Trinity College Dublin; Universite Libre de Bruxelles	Nolan, DP (corresponding author), Univ Dublin Trinity Coll, Mol Parasitol Grp, Sch Biochem & Immunol, Dublin 2, Ireland.	denolan@tcd.ie		Nolan, Derek/0000-0002-3742-4304; Perez-Morga, David/0000-0002-7168-1865; Woods, Katherine/0000-0003-3474-3104	Welcome Trust UK [WT061205MF]; Science Foundation Ireland [07/RFP/BICF358]	Welcome Trust UK(Wellcome Trust); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was support by a senior fellowship award to DPN (WT061205MF) from the Welcome Trust UK (www.wellcome.ac.uk/) and a Research Frontiers Programme award (07/RFP/BICF358) from Science Foundation Ireland (www.sfi.ie/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastin P, 2000, MICROBES INFECT, V2, P1865, DOI 10.1016/S1286-4579(00)01344-7; Briggs LJ, 2004, J CELL SCI, V117, P1641, DOI 10.1242/jcs.00995; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; BROOKS AS, 1978, T AM MICROSC SOC, V97, P287, DOI 10.2307/3225982; BRUN R, 1979, ACTA TROP, V36, P289; Carrington M, 1998, MOL BIOCHEM PARASIT, V91, P153, DOI 10.1016/S0166-6851(97)00190-4; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Graham SA, 2011, J BIOL CHEM, V286, P24336, DOI 10.1074/jbc.M111.244772; Hill KL, 2010, CURR OPIN MICROBIOL, V13, P459, DOI 10.1016/j.mib.2010.05.015; HIRUMI H, 1994, PARASITOL TODAY, V10, P80, DOI 10.1016/0169-4758(94)90402-2; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Kohl L, 2005, INT REV CYTOL, V244, P227, DOI 10.1016/S0074-7696(05)44006-1; Kohl L, 1998, MOL BIOCHEM PARASIT, V93, P1, DOI 10.1016/S0166-6851(98)00014-0; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; MERKLE RK, 1987, J BIOL CHEM, V262, P8179; Moreira-Leite FF, 2001, SCIENCE, V294, P610, DOI 10.1126/science.1063775; Muramatsu T, 2004, GLYCOCONJUGATE J, V21, P41, DOI 10.1023/B:GLYC.0000043746.77504.28; Nolan DP, 1999, CURR BIOL, V9, P1169, DOI 10.1016/S0960-9822(00)80018-4; Nozaki T, 1996, MOL BIOCHEM PARASIT, V82, P245, DOI 10.1016/0166-6851(96)02741-7; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; Oberholzer M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000739; Ralston KS, 2008, INT J PARASITOL, V38, P869, DOI 10.1016/j.ijpara.2008.03.003; Ralston KS, 2006, PLOS PATHOG, V2, P873, DOI 10.1371/journal.ppat.0020101; Rubotham J, 2005, J BIOL CHEM, V280, P10410, DOI 10.1074/jbc.M409375200; RUIZMORENO L, 1995, EXP PARASITOL, V80, P605, DOI 10.1006/expr.1995.1076; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; Spitznagel D, 2009, FEBS J, V276, P7187, DOI 10.1111/j.1742-4658.2009.07432.x; Taylor ME, 2007, CURR OPIN CELL BIOL, V19, P572, DOI 10.1016/j.ceb.2007.09.004; Turnock DC, 2007, J BIOL CHEM, V282, P28853, DOI 10.1074/jbc.M704742200; Vaughan S, 2008, PROTIST, V159, P127, DOI 10.1016/j.protis.2007.08.005; Vaughan S, 2010, CURR OPIN MICROBIOL, V13, P453, DOI 10.1016/j.mib.2010.05.006; VICKERMAN K, 1969, J CELL SCI, V5, P163; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; VOORHEIS HP, 1979, BIOCHEM J, V180, P11, DOI 10.1042/bj1800011; WOODS A, 1989, J CELL SCI, V93, P501; WOODS A, 1989, J CELL SCI, V93, P491; WOODWARD R, 1995, PARASITOLOGY, V111, P77, DOI 10.1017/S0031182000064623; Zhou Q, 2011, J CELL SCI, V124, P3848, DOI 10.1242/jcs.087676	40	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e52846	10.1371/journal.pone.0052846	http://dx.doi.org/10.1371/journal.pone.0052846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335957	Green Published, gold, Green Submitted			2022-12-25	WOS:000314707700010
J	Jin, HJ; Xie, XL; Ye, JM; Li, CG				Jin, Hyou-Ju; Xie, Xiao-Liang; Ye, Ji-Ming; Li, Chun-Guang			TanshinoneIIA and Cryptotanshinone Protect against Hypoxia-Induced Mitochondrial Apoptosis in H9c2 Cells	PLOS ONE			English	Article							PERMEABILITY TRANSITION; ISCHEMIA/REPERFUSION INJURY; CARDIAC MYOCYTES; INDUCED TOXICITY; IIA; MECHANISMS; PATHWAY; EXPRESSION; ISCHEMIA; INHIBITION	Mitochondrial apoptosis pathway is an important target of cardioprotective signalling. Tanshinones, a group of major bioactive compounds isolated from Salvia miltiorrhiza, have been reported with actions against inflammation, oxidative stress, and myocardial ischemia reperfusion injury. However, the actions of these compounds on the chronic hypoxia-related mitochondrial apoptosis pathway have not been investigated. In this study, we examined the effects and molecular mechanisms of two major tanshonones, tanshinone IIA (TIIA) and cryptotanshinone (CT) on hypoxia induced apoptosis in H9c2 cells. Cultured H9c2 cells were treated with TIIA and CT (0.3 and 3 mu M) 2 hr before and during an 8 hr hypoxic period. Chronic hypoxia caused a significant increase in hypoxia inducible factor 1 alpha expression and the cell late apoptosis rate, which was accompanied with an increase in caspase 3 activity, cytochrome c release, mitochondria membrane potential and expression of pro-apoptosis proteins (Bax and Bak). TIIA and CT (0.3 and 3 mu M), in concentrations without affecting the cell viability, significantly inhibited the late apoptosis and the changes of caspase 3 activity, cytochrome c release, and mitochondria membrane potential induced by chronic hypoxia. These compounds also suppressed the overexpression of Bax and reduced the ratio of Bax/Bcl-2. The results indicate that TIIA and CT protect against chronic hypoxia induced cell apoptosis by regulating the mitochondrial apoptosis signaling pathway, involving inhibitions of mitochondria hyperpolarization, cytochrome c release and caspase 3 activity, and balancing anti-and pro-apoptotic proteins in Bcl-2 family proteins.	[Jin, Hyou-Ju; Ye, Ji-Ming; Li, Chun-Guang] RMIT Univ, Sch Hlth Sci, RMIT Hlth Innovat Res Inst, Tradit & Complementary Med Program, Bundoora, Vic, Australia; [Xie, Xiao-Liang] Hebei Acad Agr & Forestry Sci, Med Herb Res Ctr, Shijiazhuang, Peoples R China; [Li, Chun-Guang] Univ Western Sydney, Natl Inst Complementary Med, Ctr Complementary Med Res, Penrith, NSW 1797, Australia	Royal Melbourne Institute of Technology (RMIT); Hebei Academy of Agricultural & Forestry Sciences; Western Sydney University	Li, CG (corresponding author), RMIT Univ, Sch Hlth Sci, RMIT Hlth Innovat Res Inst, Tradit & Complementary Med Program, Bundoora, Vic, Australia.	C.Li@uws.edu.au		Li, Chun Guang/0000-0002-7789-2209; Jin, Hyou-Ju/0000-0003-1735-7551	National Institute of Complementary Medicine; RMIT University, Australia; Hebei Academy of Agriculture and Forestry Sciences, China; RMIT University International Research Scholarship from RMIT University	National Institute of Complementary Medicine; RMIT University, Australia; Hebei Academy of Agriculture and Forestry Sciences, China; RMIT University International Research Scholarship from RMIT University	This work was supported by grants from National Institute of Complementary Medicine, RMIT University, Australia and Hebei Academy of Agriculture and Forestry Sciences, China and Hyou-Ju Jin was supported by a RMIT University International Research Scholarship from RMIT University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cadieux N, 2011, MICROBIOL-SGM, V157, P793, DOI 10.1099/mic.0.041996-0; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cassavaugh J, 2011, J CELL BIOCHEM, V112, P735, DOI 10.1002/jcb.22956; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Chen YL, 2012, BIOL PHARM BULL, V35, P164, DOI 10.1248/bpb.35.164; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Ekhterae D, 1999, CIRC RES, V85, pE70; Fischer U, 2005, PHARMACOL REV, V57, P187, DOI 10.1124/pr.57.2.6; Fu JJ, 2007, EUR J PHARMACOL, V568, P213, DOI 10.1016/j.ejphar.2007.04.031; Gao M, 2008, TRANSL RES, V151, P79, DOI [10.1016/j.trs1.2007.11.005, 10.1016/j.trsl.2007.11.005]; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Guo K, 2001, CELL DEATH DIFFER, V8, P367, DOI 10.1038/sj.cdd.4400810; Gustafsson AB, 2007, CARDIOVASCULAR RES; Han JY, 2008, PHARMACOL THERAPEUT, V117, P280, DOI 10.1016/j.pharmthera.2007.09.008; Hand SC, 2008, J EXP BIOL, V211, P1829, DOI 10.1242/jeb.000299; Hochhauser E, 2003, AM J PHYSIOL-HEART C, V284, pH2351, DOI 10.1152/ajpheart.00783.2002; Hong H-J, INT J CARDI IN PRESS; Hong HJ, 2012, INT J CARDIOL, V157, P174, DOI 10.1016/j.ijcard.2010.12.012; Hong HJ, 2010, ACTA PHARMACOL SIN, V31, P1569, DOI 10.1038/aps.2010.176; Huang SG, 2002, J BIOMOL SCREEN, V7, P383, DOI 10.1177/108705710200700411; Jin YC, 2009, EUR J PHARMACOL, V614, P91, DOI 10.1016/j.ejphar.2009.04.038; Jung F, 2001, BIOCHEM BIOPH RES CO, V286, P419, DOI 10.1006/bbrc.2001.5406; Kim MJ, 2005, EUR J PHARMACOL, V525, P1, DOI 10.1016/j.ejphar.2005.09.043; Lam FFY, 2008, EUR J PHARMACOL, V578, P253, DOI 10.1016/j.ejphar.2007.09.040; Lemasters JJ, 1997, MOL CELL BIOCHEM, V174, P159, DOI 10.1023/A:1006827601337; Liu T, 2010, NEUROPHARMACOLOGY, V59, P595, DOI 10.1016/j.neuropharm.2010.08.013; Mahesh R, 2012, PHYTOTHERAPY RES; Malhotra R, 1999, J BIOL CHEM, V274, P12567, DOI 10.1074/jbc.274.18.12567; Mayorga M, 2004, J BIOL CHEM, V279, P34882, DOI 10.1074/jbc.M404616200; Meng XF, 2006, ACTA PHARMACOL SIN, V27, P659, DOI 10.1111/j.1745-7254.2006.00324.x; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Rakhit RD, 2000, AM J PHYSIOL-HEART C, V278, pH1211, DOI 10.1152/ajpheart.2000.278.4.H1211; Reeve JLV, 2007, J CELL MOL MED, V11, P509, DOI 10.1111/j.1582-4934.2007.00042.x; Ren ZH, 2010, PHYTOMEDICINE, V17, P212, DOI 10.1016/j.phymed.2009.08.010; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; Skulachev VP, 2009, BBA-BIOENERGETICS, V1787, P437, DOI 10.1016/j.bbabio.2008.12.008; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wu B, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004295.pub3; Xu M, 2011, AM J RESP CELL MOL, V45, P1028, DOI 10.1165/rcmb.2011-0113OC; Zhang DX, 2007, AM J PHYSIOL-HEART C, V292, pH2023, DOI 10.1152/ajpheart.01283.2006; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630; Zhou Z, 2006, BBA-GEN SUBJECTS, V1760, P1, DOI 10.1016/j.bbagen.2005.09.009	45	58	65	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e51720	10.1371/journal.pone.0051720	http://dx.doi.org/10.1371/journal.pone.0051720			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341883	gold, Green Published, Green Submitted			2022-12-25	WOS:000314759400005
J	Correia, B; Valledor, L; Meijon, M; Rodriguez, JL; Dias, MC; Santos, C; Canal, MJ; Rodriguez, R; Pinto, G				Correia, Barbara; Valledor, Luis; Meijon, Monica; Rodriguez, Jose Luis; Dias, Maria Celeste; Santos, Conceicao; Canal, Maria Jesus; Rodriguez, Roberto; Pinto, Gloria			Is the Interplay between Epigenetic Markers Related to the Acclimation of Cork Oak Plants to High Temperatures?	PLOS ONE			English	Article							DNA METHYLATION; CLIMATIC ADAPTATION; HEAT-STRESS; HISTONE; PHOTOSYNTHESIS; DIFFERENTIATION; ACETYLATION; EXTRACTION; RESPONSES; DYNAMICS	Trees necessarily experience changes in temperature, requiring efficient short-term strategies that become crucial in environmental change adaptability. DNA methylation and histone posttranslational modifications have been shown to play a key role in both epigenetic control and plant functional status under stress by controlling the functional state of chromatin and gene expression. Cork oak (Quercus suber L.) is a key stone of the Mediterranean region, growing at temperatures of 45 degrees C. This species was subjected to a cumulative temperature increase from 25 degrees C to 55 degrees C under laboratory conditions in order to test the hypothesis that epigenetic code is related to heat stress tolerance. Electrolyte leakage increased after 35 degrees C, but all plants survived to 55 degrees C. DNA methylation and acetylated histone H3 (AcH3) levels were monitored by HPCE (high performance capillary electrophoresis), MS-RAPD (methylation-sensitive random-amplified polymorphic DNA) and Protein Gel Blot analysis and the spatial distribution of the modifications was assessed using a confocal microscope. DNA methylation analysed by HPCE revealed an increase at 55 degrees C, while MS-RAPD results pointed to dynamic methylation-demethylation patterns over stress. Protein Gel Blot showed the abundance index of AcH3 decreasing from 25 degrees C to 45 degrees C. The immunohistochemical detection of 5-mC (5-methyl-2'-deoxycytidine) and AcH3 came upon the previous results. These results indicate that epigenetic mechanisms such as DNA methylation and histone H3 acetylation have opposite and particular dynamics that can be crucial for the stepwise establishment of this species into such high stress (55 degrees C), allowing its acclimation and survival. This is the first report that assesses epigenetic regulation in order to investigate heat tolerance in forest trees.	[Correia, Barbara; Dias, Maria Celeste; Santos, Conceicao; Pinto, Gloria] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Correia, Barbara; Dias, Maria Celeste; Santos, Conceicao; Pinto, Gloria] Univ Aveiro, Ctr Environm & Marine Studies, P-3800 Aveiro, Portugal; [Valledor, Luis; Meijon, Monica; Rodriguez, Jose Luis; Canal, Maria Jesus; Rodriguez, Roberto] Univ Inst Biotechnol, Epiphysage Res Grp, Biol Organisms & Syst Dept, Oviedo, Spain; [Valledor, Luis; Meijon, Monica; Rodriguez, Jose Luis; Canal, Maria Jesus; Rodriguez, Roberto] Univ Oviedo, Oviedo, Spain; [Valledor, Luis] Univ Vienna, Mol Syst Biol Dept, Vienna, Austria; [Meijon, Monica] Austrian Acad Sci, Gregor Mendel Inst Plant Mol Biol, A-1010 Vienna, Austria	Universidade de Aveiro; Universidade de Aveiro; University of Oviedo; University of Vienna; Austrian Academy of Sciences	Pinto, G (corresponding author), Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal.	gpinto@ua.pt	Cañal, María Jesús/L-1005-2014; Pinto, Glória Catarina/B-1271-2011; Santos, Conceição LV/A-8651-2008; Valledor, Luis/E-8881-2017; Meijón, Mónica/N-6285-2014; santos, conceição/GQQ-7378-2022; Lorenzo, José Luis Rodriguez/H-1907-2014; Meijón, Mónica/G-7366-2016; Dias, Maria Celeste/K-7622-2015; Correia, Barbara/I-2146-2014; Santos, Conceição/ABE-6172-2020; Valledor, Luis/B-4791-2010	Cañal, María Jesús/0000-0002-1639-9672; Pinto, Glória Catarina/0000-0001-7735-5131; Santos, Conceição LV/0000-0003-4129-6381; Meijón, Mónica/0000-0003-1563-5554; Lorenzo, José Luis Rodriguez/0000-0003-2566-3102; Meijón, Mónica/0000-0003-1563-5554; Dias, Maria Celeste/0000-0002-3083-6218; Correia, Barbara/0000-0002-8277-7061; Santos, Conceição/0000-0003-4129-6381; Valledor, Luis/0000-0002-0636-365X	FEDER through COMPETE (Programa Operacional Factores de Competitividade); FCT project [PTDC/AGR-CFL/112996/2009]; Human Potential Operational Programme (National Strategic Reference Framework); European Social Fund (EU); FCT [SFRH/BPD/41700/2007]; Marie Curie Action of the European Union (FP7-PEOPLE-IEF); Fundação para a Ciência e a Tecnologia [PTDC/AGR-CFL/112996/2009] Funding Source: FCT	FEDER through COMPETE (Programa Operacional Factores de Competitividade); FCT project(Portuguese Foundation for Science and Technology); Human Potential Operational Programme (National Strategic Reference Framework); European Social Fund (EU)(European Social Fund (ESF)European Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Marie Curie Action of the European Union (FP7-PEOPLE-IEF); Fundação para a Ciência e a Tecnologia	This work is supported by FEDER through COMPETE (Programa Operacional Factores de Competitividade) and by the FCT project PTDC/AGR-CFL/112996/2009. G. Pinto is hired under the programme Ciencia 2008 (FCT, Portugal), co-funded by the Human Potential Operational Programme (National Strategic Reference Framework 2007-2013) and European Social Fund (EU). FCT supported the fellowship of M. C. Dias (SFRH/BPD/41700/2007). L. Valledor fellow was supported by a Marie Curie Action of the European Union (FP7-PEOPLE-IEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Ramirez-Valiente JA, 2011, TREE GENET GENOMES, V7, P285, DOI 10.1007/s11295-010-0331-9; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Angers B, 2010, MOL ECOL, V19, P1283, DOI 10.1111/j.1365-294X.2010.04580.x; Bender J, 2004, ANNU REV PLANT BIOL, V55, P41, DOI 10.1146/annurev.arplant.55.031903.141641; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Boyko A, 2008, ENVIRON MOL MUTAGEN, V49, P61, DOI 10.1002/em.20347; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; Chaves I, 2011, J PLANT PHYSIOL, V168, P1729, DOI 10.1016/j.jplph.2011.05.013; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; COCCONCELLI PS, 1995, LETT APPL MICROBIOL, V21, P376, DOI 10.1111/j.1472-765X.1995.tb01085.x; Daas C, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008002; Faria T, 1996, J EXP BOT, V47, P1755, DOI 10.1093/jxb/47.11.1755; Ghouil H, 2003, TREE PHYSIOL, V23, P1031, DOI 10.1093/treephys/23.15.1031; Haldimann P, 2004, PLANT CELL ENVIRON, V27, P1169, DOI 10.1111/j.1365-3040.2004.01222.x; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; Hasbun R, 2007, ACTA HORTIC, P563, DOI 10.17660/ActaHortic.2007.760.80; Kim JM, 2010, PLANT CELL ENVIRON, V33, P604, DOI 10.1111/j.1365-3040.2009.02076.x; Kovalchuk O, 2003, MUTAT RES-FUND MOL M, V529, P13, DOI 10.1016/S0027-5107(03)00103-9; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Lauria M, 2011, BBA-GENE REGUL MECH, V1809, P369, DOI 10.1016/j.bbagrm.2011.03.002; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Meijon M, 2011, PHYSIOL PLANTARUM, V143, P82, DOI 10.1111/j.1399-3054.2011.01485.x; Meijon M, 2011, PHYSIOL PLANTARUM, V141, P276, DOI 10.1111/j.1399-3054.2010.01430.x; Meijon M, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-10; Meijon M, 2009, J PLANT PHYSIOL, V166, P1624, DOI 10.1016/j.jplph.2009.04.014; Mirouze M, 2011, CURR OPIN PLANT BIOL, V14, P267, DOI 10.1016/j.pbi.2011.03.004; Mishkind M, 2009, PLANT J, V60, P10, DOI 10.1111/j.1365-313X.2009.03933.x; Monteuuis O, 2009, SILVAE GENET, V58, P287, DOI 10.1515/sg-2009-0037; Pecinka A, 2010, PLANT CELL, V22, P3118, DOI 10.1105/tpc.110.078493; Penuelas J, 2002, NEW PHYTOL, V155, P227, DOI 10.1046/j.1469-8137.2002.00457.x; Pinto G, 2010, ANT TURK 24 IUFRO C; Ramirez-Valiente JA, 2009, MOL ECOL, V18, P3803, DOI 10.1111/j.1365-294X.2009.04317.x; Ribeiro T, 2009, SEX PLANT REPROD, V22, P1, DOI 10.1007/s00497-008-0083-y; Salmon A, 2008, PLANT SCI, V174, P61, DOI 10.1016/j.plantsci.2007.09.012; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Tan MP, 2010, PLANT PHYSIOL BIOCH, V48, P21, DOI 10.1016/j.plaphy.2009.10.005; Tariq M, 2004, TRENDS GENET, V20, P244, DOI 10.1016/j.tig.2004.04.005; Tetievsky A, 2010, J APPL PHYSIOL, V109, P1552, DOI 10.1152/japplphysiol.00469.2010; THOMAS MR, 1993, THEOR APPL GENET, V86, P173, DOI 10.1007/BF00222076; Tittel-Elmer M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001175; Tsuji H, 2006, PLANT CELL PHYSIOL, V47, P995, DOI 10.1093/pcp/pcj072; Vaillant I, 2007, CURR OPIN PLANT BIOL, V10, P528, DOI 10.1016/j.pbi.2007.06.008; Valledor L, 2009, J PLANT BIOCHEM BIOT, V18, P229, DOI 10.1007/BF03263325; Valledor L, 2012, PHYSL PLANTARUM; Valledor L, 2007, PLANT CELL TISS ORG, V91, P75, DOI 10.1007/s11240-007-9262-z; Valledor L, 2010, J PLANT PHYSIOL, V167, P351, DOI 10.1016/j.jplph.2009.09.018; Vanyushin BF, 2006, CURR TOP MICROBIOL, V301, P67; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Yakovlev IA, 2011, PLANT SCI, V180, P132, DOI 10.1016/j.plantsci.2010.07.004; Yakovlev IA, 2010, NEW PHYTOL, V187, P1154, DOI 10.1111/j.1469-8137.2010.03341.x	52	57	62	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53543	10.1371/journal.pone.0053543	http://dx.doi.org/10.1371/journal.pone.0053543			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326451	Green Published, gold, Green Submitted			2022-12-25	WOS:000314705800054
J	Ford, CE; Jary, E; Ma, SSQ; Nixdorf, S; Heinzelmann-Schwarz, VA; Ward, RL				Ford, Caroline E.; Jary, Eve; Ma, Sean Si Qian; Nixdorf, Sheri; Heinzelmann-Schwarz, Viola A.; Ward, Robyn L.			The Wnt Gatekeeper SFRP4 Modulates EMT, Cell Migration and Downstream Wnt Signalling in Serous Ovarian Cancer Cells	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEINS; INHIBITS PROLIFERATION; MESENCHYMAL TRANSITION; PATHWAY; CATENIN; EXPRESSION; CONDUCTIN/AXIN2; SURVIVAL; THERAPY; GENE	Aberrant Wnt signalling is implicated in numerous human cancers, and understanding the effects of modulation of pathway members may lead to the development of novel therapeutics. Expression of secreted frizzled related protein 4 (SFRP4), an extracellular modulator of the Wnt signalling pathway, is progressively lost in more aggressive ovarian cancer phenotypes. Here we show that recombinant SFRP4 (rSFRP4) treatment of a serous ovarian cancer cell line results in inhibition of beta-catenin dependent Wnt signalling as measured by TOP/FOP Wnt reporter assay and decreased transcription of Wnt target genes, Axin2, CyclinD1 and Myc. In addition, rSFRP4 treatment significantly increased the ability of ovarian cancer cells to adhere to collagen and fibronectin, and decreased their ability to migrate across an inflicted wound. We conclude that these changes in cell behaviour may be mediated via mesenchymal to epithelial transition (MET), as rSFRP4 treatment also resulted in increased expression of the epithelial marker E-cadherin, and reduced expression of Vimentin and Twist. Combined, these results indicate that modulation of a single upstream gatekeeper of Wnt signalling can have effects on downstream Wnt signalling and ovarian cancer cell behaviour, as mediated through epithelial to mesenchymal plasticity (EMP). This raises the possibility that SFRP4 may be used both diagnostically and therapeutically in epithelial ovarian cancer.	[Ford, Caroline E.; Jary, Eve; Ma, Sean Si Qian; Ward, Robyn L.] Univ New S Wales, Wnt Signalling & Metastasis Grp, Lowy Canc Res Ctr, Prince Wales Clin Sch, Sydney, NSW, Australia; [Nixdorf, Sheri; Heinzelmann-Schwarz, Viola A.] Univ NSW, Prince Wales Clin Sch, Ovarian Canc Grp, Lowy Canc Res Ctr, Sydney, NSW, Australia; [Nixdorf, Sheri; Heinzelmann-Schwarz, Viola A.] Univ NSW, Sch Womens & Childrens Hlth, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Ford, CE (corresponding author), Univ New S Wales, Wnt Signalling & Metastasis Grp, Lowy Canc Res Ctr, Prince Wales Clin Sch, Sydney, NSW, Australia.	caroline.ford@unsw.edu.au	Nixdorf, Sheri/F-3269-2013; Ward, Robyn L/I-2313-2013; Ford, Caroline E/A-7850-2010	Ward, Robyn L/0000-0002-6877-8906; Ford, Caroline E/0000-0002-4438-2309; Heinzelmann-Schwarz, Viola/0000-0002-4056-3225	Cure Cancer Australia Foundation [1008633]; National Health and Medical Research Council CJ Martin Fellowship [466005]; Cancer Institute NSW [09/CRF/2-02]; William Maxwell Trust; Royal Australian and New Zealand College of Obstetricians and Gynaecologists	Cure Cancer Australia Foundation; National Health and Medical Research Council CJ Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW; William Maxwell Trust; Royal Australian and New Zealand College of Obstetricians and Gynaecologists	This research was funded in part by grants from the Cure Cancer Australia Foundation (#1008633, CEF), National Health and Medical Research Council CJ Martin Fellowship (#466005, CEF), Cancer Institute NSW (# 09/CRF/2-02, VHS), William Maxwell Trust (VHS) and the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (VHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Banerjee S, 2011, EUR J CANCER, V47, pS116, DOI 10.1016/S0959-8049(11)70155-1; Barbolina MV, 2011, BIOCHEM J, V437, P1, DOI 10.1042/BJ20110112; Berns EMJJ, 2012, CANCER RES, V72, P2701, DOI 10.1158/0008-5472.CAN-11-3911; Bolton KL, 2012, J INTERN MED; Bovicelli A, 2011, J CELL PHYSIOL, V226, P2500, DOI 10.1002/jcp.22662; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Carmon KS, 2008, MOL CANCER RES, V6, P1017, DOI 10.1158/1541-7786.MCR-08-0039; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dubeau L, 2008, LANCET ONCOL, V9, P1191, DOI 10.1016/S1470-2045(08)70308-5; Hadjihannas MV, 2010, EMBO REP, V11, P317, DOI 10.1038/embor.2010.23; Hashiguchi Y, 2004, HUM PATHOL, V35, P165, DOI 10.1016/j.humpath.2003.07.018; Helland A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018064; Hiss D, 2012, J ONCOL, V2012, DOI 10.1155/2012/737981; Horvath LG, 2007, PROSTATE, V67, P1081, DOI 10.1002/pros.20607; Huang J, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-126; Jacob F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031885; Jost E, 2009, CANCER LETT, V281, P24, DOI 10.1016/j.canlet.2009.02.002; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Karve TM, 2012, FUNCT INTEGR GENOMIC, V12, P63, DOI 10.1007/s10142-011-0251-2; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kogan Y, 2012, BIOCHEM J, V444, P115, DOI 10.1042/BJ20111887; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Mii Y, 2011, DEV GROWTH DIFFER, V53, P911, DOI 10.1111/j.1440-169X.2011.01299.x; Rask K, 2003, BRIT J CANCER, V89, P1298, DOI 10.1038/sj.bjc.6601265; Schmid S, 2011, INT J GYNECOL CANCER, V21, P975, DOI 10.1097/IGC.0b013e31821caa6f; Shi Y, 2007, ACTA PHARMACOL SIN, V28, P1499, DOI 10.1111/j.1745-7254.2007.00692.x; Skirnisdottir IA, 2011, INT J GYNECOL CANCER, V21, P236, DOI 10.1097/IGC.0b013e31820986e5; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veeck J, 2012, BBA-REV CANCER, V1825, P18, DOI 10.1016/j.bbcan.2011.09.003; von Marschall Z, 2010, BIOCHEM BIOPH RES CO, V400, P299, DOI 10.1016/j.bbrc.2010.08.043; Wu ZQ, 2012, P NATL ACAD SCI US; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Ying Y, 2009, EPIGENETICS-US, V4, P307, DOI 10.4161/epi.4.5.9371; Yoshioka S, 2012, MOL CANCER RES, V10, P469, DOI 10.1158/1541-7786.MCR-11-0177	40	71	79	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54362	10.1371/journal.pone.0054362	http://dx.doi.org/10.1371/journal.pone.0054362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326605	Green Published, Green Submitted, gold			2022-12-25	WOS:000314705800118
J	Valdivia, N; Gonzalez, AE; Manzur, T; Broitman, BR				Valdivia, Nelson; Gonzalez, Andres E.; Manzur, Tatiana; Broitman, Bernardo R.			Mesoscale Variation of Mechanisms Contributing to Stability in Rocky Shore Communities	PLOS ONE			English	Article							GEOGRAPHIC-VARIATION; BOTTOM-UP; TOP-DOWN; TEMPORAL VARIABILITY; SPECIES INTERACTIONS; ECOSYSTEM FUNCTION; BIOMASS PRODUCTION; BIODIVERSITY LOSS; SPATIAL SCALE; DIVERSITY	Environmental fluctuations can generate asynchronous species' fluctuations and community stability, due to compensatory dynamics of species with different environmental tolerances. We tested this hypothesis in intertidal hard-bottom communities of north-central Chile, where a persistent upwelling centre maintains a mosaic in sea surface temperatures (SST) over 10s of kilometres along the shore. Coastal upwelling implies colder and temporally more stable SST relative to downstream sites. Uni- and multivariate analyses of multiyear timeseries of SST and species abundances showed more asynchronous fluctuations and higher stability in sites characterised by warmer and more variable SST. Nevertheless, these effects were weakened after including data obtained in sites affected by less persistent upwelling centres. Further, dominant species were more stable in sites exposed to high SST variability. The strength of other processes that can influence community stability, chiefly statistical averaging and overyielding, did not vary significantly between SST regimes. Our results provide observational evidence supporting the idea that exogenously driven compensatory dynamics and the stabilising effects of dominant species can determine the stability of ecosystems facing environmental fluctuations.	[Valdivia, Nelson] Univ Austral Chile, Inst Ciencias Marinas & Limnol, Lab Costero Recursos Acuat Calfuco, Valdivia, Chile; [Gonzalez, Andres E.; Manzur, Tatiana; Broitman, Bernardo R.] Univ Catolica Norte, CEAZA, Fac Ciencias Mar, Larrondo 1281, Coquimbo, Chile	Universidad Austral de Chile; Universidad Catolica del Norte	Valdivia, N (corresponding author), Univ Austral Chile, Inst Ciencias Marinas & Limnol, Lab Costero Recursos Acuat Calfuco, Campus Isla Teja, Valdivia, Chile.	nelson.valdivia@uach.cl	Valdivia, Nelson A/C-3613-2009; Broitman, Bernardo R/D-6007-2013	Valdivia, Nelson A/0000-0002-5394-2072; Broitman, Bernardo R/0000-0001-6582-3188	Fondo Nacional de Desarrollo Cientco y Tecnologico (FONDECYT) [3100014, 090488, 1120988]; Consejo Nacional de Ciencia y Tecnologico (CONICYT) through Becas Chile [21110859]; Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (MECESUP) through Fortalecimiento de las Ciencias Ecologicas y Evolutivas en la UACh [AUS0805]	Fondo Nacional de Desarrollo Cientco y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Consejo Nacional de Ciencia y Tecnologico (CONICYT) through Becas Chile; Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (MECESUP) through Fortalecimiento de las Ciencias Ecologicas y Evolutivas en la UACh	This study was financially supported by the Fondo Nacional de Desarrollo Cientco y Tecnologico (FONDECYT) through grants # 3100014 (NV), # 1090488 (BRB), and # 1120988 (BRB), by the Consejo Nacional de Ciencia y Tecnologico (CONICYT) through Becas Chile doctoral grant # 21110859 to AEG, and by the Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (MECESUP) through grant # AUS0805 Fortalecimiento de las Ciencias Ecologicas y Evolutivas en la UACh to N.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Bertness MD, 1999, ECOLOGY, V80, P2711, DOI 10.1890/0012-9658(1999)080[2711:TTRCOP]2.0.CO;2; Blanchette CA, 2006, MAR BIOL, V149, P689, DOI 10.1007/s00227-005-0239-3; Box GE., 1978, STAT EXPT; Broitman BR, 2009, OIKOS, V118, P219, DOI 10.1111/j.1600-0706.2008.17075.x; Broitman BR, 2011, REV CHIL HIST NAT, V84, P143, DOI 10.4067/S0716-078X2011000100011; Broitman BR, 2001, MAR ECOL PROG SER, V224, P21, DOI 10.3354/meps224021; Bulleri F, 2012, OIKOS, V121, P1801, DOI 10.1111/j.1600-0706.2011.19967.x; Campbell V, 2011, OIKOS, V120, P399, DOI 10.1111/j.1600-0706.2010.18768.x; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cavanaugh KC, 2010, MAR ECOL PROG SER, V403, P13, DOI 10.3354/meps08467; Chapman MG, 2002, J EXP MAR BIOL ECOL, V275, P95, DOI 10.1016/S0022-0981(02)00134-X; CHESSON P, 1994, THEOR POPUL BIOL, V45, P227, DOI 10.1006/tpbi.1994.1013; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chesson P, 2001, FUNCTIONAL CONSEQUEN; CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; Connolly SR, 2003, ECOLOGY, V84, P2979, DOI 10.1890/02-0347; Cottingham KL, 2001, ECOL LETT, V4, P72, DOI 10.1046/j.1461-0248.2001.00189.x; DETHIER MN, 1993, MAR ECOL PROG SER, V96, P93, DOI 10.3354/meps096093; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Downing AL, 2008, ECOLOGY, V89, P3204, DOI 10.1890/07-1652.1; Elton S. C., 1958, ECOLOGY INVASIONS AN; Espoz C, 2004, REV CHIL HIST NAT, V77, P257; Garreaud RD, 2011, ATMOS CHEM PHYS, V11, P2015, DOI 10.5194/acp-11-2015-2011; Garreaud RD, 2005, MON WEATHER REV, V133, P2246, DOI 10.1175/MWR2972.1; Gonzalez A, 2009, ANNU REV ECOL EVOL S, V40, P393, DOI 10.1146/annurev.ecolsys.39.110707.173349; Grman E, 2010, ECOL LETT, V13, P1400, DOI 10.1111/j.1461-0248.2010.01533.x; Hoffmann A., 1997, FLORA MARINA CHILE C; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hormazabal S, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001956; Houlahan JE, 2007, P NATL ACAD SCI USA, V104, P3273, DOI 10.1073/pnas.0603798104; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Ives AR, 1999, SCIENCE, V286, P542, DOI 10.1126/science.286.5439.542; Kilpatrick AM, 2003, NATURE, V422, P65, DOI 10.1038/nature01471; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Lagos NA, 2008, ECOL MONOGR, V78, P245, DOI 10.1890/07-0041.1; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Loreau M, 2008, AM NAT, V172, pE48, DOI 10.1086/589746; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; Menge BA, 2000, J EXP MAR BIOL ECOL, V250, P257, DOI 10.1016/S0022-0981(00)00200-8; MENGE BA, 1978, OECOLOGIA, V34, P17, DOI 10.1007/BF00346238; Munoz RC, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009957; Navarrete SA, 2005, P NATL ACAD SCI USA, V102, P18046, DOI 10.1073/pnas.0509119102; Navarrete SA, 2008, ECOLOGY, V89, P2005, DOI 10.1890/07-1231.1; Nielsen KJ, 2004, ECOL LETT, V7, P31, DOI 10.1046/j.1461-0248.2003.00542.x; Norberg J, 2001, P NATL ACAD SCI USA, V98, P11376, DOI 10.1073/pnas.171315998; Nybakken J., 2005, MARINE BIOL ECOLOGIC; Oliva D., 1992, GAYANA ZOOLOGIA, V56, P77; Pandit S. N., 2012, OECOLOGIA, V171, P1; Pimm SL, 1991, BALANCE NATURE ECOLO; Polley HW, 2007, OIKOS, V116, P2044, DOI 10.1111/j.2007.0030-1299.16080.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2012, R LANG ENV STAT COMP; Rahn DA, 2011, MON WEATHER REV, V139, P3628, DOI 10.1175/MWR-D-11-00059.1; Rivadeneira MM, 2002, MAR ECOL PROG SER, V245, P123, DOI 10.3354/meps245123; Rutllant J, 2002, REV CHIL HIST NAT, V75, P217, DOI 10.4067/S0716-078X2002000100020; SANTELICES B, 1990, HYDROBIOLOGIA, V192, P35, DOI 10.1007/BF00006226; Smale DA, 2010, DIVERS DISTRIB, V16, P985, DOI 10.1111/j.1472-4642.2010.00709.x; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; STENECK RS, 1986, ANNU REV ECOL SYST, V17, P273, DOI 10.1146/annurev.es.17.110186.001421; Strub P.T., 1998, SEA; Tapia FJ, 2009, PROG OCEANOGR, V83, P278, DOI 10.1016/j.pocean.2009.07.035; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; Thibaut LM, 2012, ECOL LETT; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Torres R, 2009, ESTUAR COAST SHELF S, V83, P126, DOI 10.1016/j.ecss.2009.02.030; Valdivia N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036541; Valdivia N, 2009, AQUAT BIOL, V4, P263, DOI 10.3354/ab00114; Valone TJ, 2008, ECOLOGY, V89, P522, DOI 10.1890/07-0153.1; Vargas CA, 2006, J MAR BIOL ASSOC UK, V86, P1057, DOI 10.1017/S0025315406014032; Wieters EA, 2005, MAR ECOL PROG SER, V301, P43, DOI 10.3354/meps301043; Wieters EA, 2009, LIMNOL OCEANOGR, V54, P1060, DOI 10.4319/lo.2009.54.4.1060	80	16	16	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54159	10.1371/journal.pone.0054159	http://dx.doi.org/10.1371/journal.pone.0054159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326592	Green Published, gold, Green Submitted			2022-12-25	WOS:000314705800113
J	Williams, C; Wilson, P; Morrison, J; McMahon, A; Andrew, W; Allan, L; McConnachie, A; McNeill, Y; Tansey, L				Williams, Christopher; Wilson, Philip; Morrison, Jill; McMahon, Alex; Andrew, Walker; Allan, Lesley; McConnachie, Alex; McNeill, Yvonne; Tansey, Louise			Guided Self-Help Cognitive Behavioural Therapy for Depression in Primary Care: A Randomised Controlled Trial	PLOS ONE			English	Article							CLINICAL EFFECTIVENESS	Background: Access to Cognitive behavioural therapy (CBT) for depression is limited. One solution is CBT self-help books. Trial Objectives: To assess the impact of a guided self-help CBT book (GSH-CBT) on mood, compared to treatment as usual (TAU). Hypotheses: 1. GSH-CBT will have improved mood and knowledge of the causes and treatment of depression compared to the control receiving TAU 2. Guided self-help will be acceptable to patients and staff. Methods and Findings: Participants: Adults attending seven general practices in Glasgow, UK with a BDI-II score of >= 14. 141 randomised to GSH-CBT and 140 to TAU. Interventions: RCT comparing 'Overcoming Depression: A Five Areas Approach' book plus 3-4 short face to face support appointments totalling up to 2 hours of guided support, compared with general practitioner TAU. Primary outcome: The BDI (II) score at 4 months. Numbers analysed: 281 at baseline, 203 at 4 months (primary outcome), 117 at 12 months. Outcome: Mean BDI-II scores were lower in the GSH-CBT group at 4 months by 5.3 points (2.6 to 7.9, p<0.001). At 4 and 12 months there were also significantly higher proportions of participants achieving a 50% reduction in BDI-II in the GSH-CBT arm. The mean support was 2 sessions with 42.7 minutes for session 1, 41.4 minutes for session 2 and 40.2 minutes of support for session 3. Adverse effects/Harms: Significantly less deterioration in mood in GSH-CBT (2.0% compared to 9.8% in the TAU group for BDI-II category change). Limitations: Weaknesses: Our follow-up rate of 72.2% at 4 months is better than predicted but is poorer at 12 months (41.6%). In the GSH-CBT arm, around 50% of people attended 2 or fewer sessions. 22% failed to take up treatment. Conclusions: GSH-CBT is substantially more effective than TAU.	[Williams, Christopher; Wilson, Philip; Morrison, Jill; Andrew, Walker; Allan, Lesley; McNeill, Yvonne; Tansey, Louise] Univ Glasgow, Inst Hlth & Wellbeing, Strathclyde, Scotland; [McMahon, Alex] Univ Glasgow, Sch Dent, Strathclyde, Scotland; [McConnachie, Alex] Univ Glasgow, Robertson Ctr, Strathclyde, Scotland	University of Glasgow; University of Glasgow; University of Glasgow	Williams, C (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Strathclyde, Scotland.	chris.williams@glasgow.ac.uk	Wilson, Philip/V-6519-2019	Wilson, Philip/0000-0002-4123-8248	Chief Scientist Office; National Health Service Greater Glasgow and Clyde [CZH/4/61]	Chief Scientist Office; National Health Service Greater Glasgow and Clyde	Funding: The authors acknowledge the Chief Scientist Office and National Health Service Greater Glasgow and Clyde for funding and supporting this study Ref CZH/4/61. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 2005, BRIT J GEN PRACT, V55, P387; Barnhofer T, 2009, BEHAV RES THER, V47, P366, DOI 10.1016/j.brat.2009.01.019; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Carstairs V., 1991, DEPRIVATION HLTH SCO; de Graaf LE, 2009, BRIT J PSYCHIAT, V195, P73, DOI 10.1192/bjp.bp.108.054429; Evans C, 2002, BRIT J PSYCHIAT, V180, P51, DOI 10.1192/bjp.180.1.51; Gellatly J, 2007, PSYCHOL MED, V37, P1217, DOI 10.1017/S0033291707000062; Jorm AF, 2000, BRIT J PSYCHIAT, V177, P396, DOI 10.1192/bjp.177.5.396; Larsen D L, 1979, Eval Program Plann, V2, P197, DOI 10.1016/0149-7189(79)90094-6; Martinez R, 2008, BEHAV COGN PSYCHOTH, V36, P89, DOI 10.1017/S1352465807004067; McLoone P., 1994, CARSTAIRS SCORES SCO; National Institute for Clinical Excellence, 2009, PART UPD CG23 DEPR M; Richards A, 2003, BRIT J GEN PRACT, V53, P764; Ward E, 2000, BRIT MED J, V321, P1383, DOI 10.1136/bmj.321.7273.1383; Whitfield GE, 2001, BEHAV COGN PSYCHOTH, V29, P333, DOI 10.1017/S135246580100306X; Williams C, 2001, BRIT MED BULL, V57, P133, DOI 10.1093/bmb/57.1.133; WILLIAMS C, 2001, OVERCOMING DEPRESSIO; Williams C, 2010, CLIN GUIDE USING 5 A, P179	18	37	40	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52735	10.1371/journal.pone.0052735	http://dx.doi.org/10.1371/journal.pone.0052735			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086RY	23326352	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000314705800023
J	Krebs, RM; Boehler, CN; Appelbaum, LG; Woldorff, MG				Krebs, Ruth M.; Boehler, Carsten N.; Appelbaum, Lawrence G.; Woldorff, Marty G.			Reward Associations Reduce Behavioral Interference by Changing the Temporal Dynamics of Conflict Processing	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MEDIAL FRONTAL-CORTEX; COGNITIVE CONTROL; STROOP TASK; HUMAN BRAIN; ANTERIOR CINGULATE; PREFRONTAL CORTEX; ACTION SELECTION; MONETARY REWARD; ATTENTION	Associating stimuli with the prospect of reward typically facilitates responses to those stimuli due to an enhancement of attentional and cognitive-control processes. Such reward-induced facilitation might be especially helpful when cognitive-control mechanisms are challenged, as when one must overcome interference from irrelevant inputs. Here, we investigated the neural dynamics of reward effects in a color-naming Stroop task by employing event-related potentials (ERPs). We found that behavioral facilitation in potential-reward trials, as compared to no-reward trials, was paralleled by early ERP modulations likely indexing increased attention to the reward-predictive stimulus. Moreover, reward changed the temporal dynamics of conflict-related ERP components, which may be a consequence of an early access to the various stimulus features and their relationships. Finally, although word meanings referring to potential-reward colors were always task-irrelevant, they caused greater interference compared to words referring to no-reward colors, an effect that was accompanied by a relatively early fronto-central ERP modulation. This latter observation suggests that task-irrelevant reward information can undermine goal-directed behavior at an early processing stage, presumably reflecting priming of a goal-incompatible response. Yet, these detrimental effects of incongruent reward-related words were absent in potential-reward trials, apparently due to the prioritized processing of task-relevant reward information. Taken together, the present data demonstrate that reward associations can influence conflict processing by changing the temporal dynamics of stimulus processing and subsequent cognitive-control mechanisms.	[Krebs, Ruth M.; Boehler, Carsten N.; Appelbaum, Lawrence G.; Woldorff, Marty G.] Duke Univ, Ctr Cognit Neurosci, Durham, NC 27706 USA; [Krebs, Ruth M.; Boehler, Carsten N.] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; [Appelbaum, Lawrence G.; Woldorff, Marty G.] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA; [Woldorff, Marty G.] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA	Duke University; Ghent University; Duke University; Duke University	Krebs, RM (corresponding author), Duke Univ, Ctr Cognit Neurosci, Durham, NC 27706 USA.	ruthmkrebs@gmail.com	Boehler, Carsten/J-8619-2015; Krebs, Ruth M/E-9042-2016	Boehler, Carsten/0000-0001-5963-2780; Krebs, Ruth M/0000-0002-0676-7611; Woldorff, Marty/0000-0002-2683-4551; Appelbaum, Lawrence/0000-0002-3184-6725	National Institutes of Health [R01-051048, R01-060415]; Research Foundation Flanders [FWO11/PDO/016]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Foundation Flanders(FWO)	This work was supported by National Institutes of Health grants R01-051048 and R01-060415 awarded to M.G.W. (http://grants.nih.gov/grants/oer.htm) and Research Foundation Flanders grant FWO11/PDO/016 awarded to R.M.K. (http://www.fwo.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelbaum LG, 2009, CEREB CORTEX, V19, P2508, DOI 10.1093/cercor/bhp036; Appelbaum LG, 2012, J COGNITIVE NEUROSCI, V24, P1834, DOI 10.1162/jocn_a_00209; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bruchmann M, 2010, NEUROIMAGE, V49, P1800, DOI 10.1016/j.neuroimage.2009.09.032; Bunzeck N, 2009, CURR BIOL, V19, P1294, DOI 10.1016/j.cub.2009.06.021; Codispoti M, 2006, NEUROIMAGE, V32, P583, DOI 10.1016/j.neuroimage.2006.04.180; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Donohue SE, 2012, COGN AFFECT BEHAV NE, V12, P1, DOI 10.3758/s13415-011-0060-z; Doucet C, 1999, PSYCHOPHYSIOLOGY, V36, P351, DOI 10.1017/S0048577299980563; DUNCANJOHNSON CC, 1981, SCIENCE, V214, P938, DOI 10.1126/science.7302571; Feng CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029668; Goldstein RZ, 2006, INT J PSYCHOPHYSIOL, V62, P272, DOI 10.1016/j.ijpsycho.2006.05.006; Greenham SL, 2000, BIOL PSYCHOL, V55, P79, DOI 10.1016/S0301-0511(00)00070-3; Gruber MJ, 2010, J NEUROSCI, V30, P9793, DOI 10.1523/JNEUROSCI.0915-10.2010; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Herbert C, 2006, PSYCHOPHYSIOLOGY, V43, P197, DOI 10.1111/j.1469-8986.2006.00385.x; Hickey C, 2010, J NEUROSCI, V30, P11096, DOI 10.1523/JNEUROSCI.1026-10.2010; Ilan AB, 1999, CLIN NEUROPHYSIOL, V110, P367, DOI 10.1016/S0168-5597(98)00053-7; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Funes MJ, 2010, J EXP PSYCHOL HUMAN, V36, P147, DOI 10.1037/a0017598; Kanske P, 2011, CEREB CORTEX, V21, P911, DOI 10.1093/cercor/bhq157; Kanske P, 2010, NEUROPSYCHOLOGIA, V48, P3661, DOI 10.1016/j.neuropsychologia.2010.07.021; Kim H, 2006, PLOS BIOL, V4, P1453, DOI 10.1371/journal.pbio.0040233; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Krebs RM, 2012, CEREB CORTEX, V22, P607, DOI 10.1093/cercor/bhr134; Krebs RM, 2011, J NEUROSCI, V31, P9752, DOI 10.1523/JNEUROSCI.0732-11.2011; Krebs RM, 2010, COGNITION, V117, P341, DOI 10.1016/j.cognition.2010.08.018; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; Locke HS, 2008, COGN AFFECT BEHAV NE, V8, P99, DOI 10.3758/CABN.8.1.99; LOGAN GD, 1979, MEM COGNITION, V7, P166, DOI 10.3758/BF03197535; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Marini F, 2011, COGN AFFECT BEHAV NE, V11, P627, DOI 10.3758/s13415-011-0057-7; Mars RB, 2009, J NEUROSCI, V29, P6926, DOI 10.1523/JNEUROSCI.1396-09.2009; Murty VP, 2012, J NEUROSCI, V32, P8969, DOI 10.1523/JNEUROSCI.0094-12.2012; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Padmala S, 2011, J COGNITIVE NEUROSCI, V23, P3419, DOI 10.1162/jocn_a_00011; POLICH J, 1987, ELECTROEN CLIN NEURO, V68, P311, DOI 10.1016/0168-5597(87)90052-9; Potts GF, 2011, INT J PSYCHOPHYSIOL, V81, P324, DOI 10.1016/j.ijpsycho.2011.07.020; Ridderinkhof KR, 2011, WIRES COGN SCI, V2, P174, DOI 10.1002/wcs.99; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Rutherford HJV, 2010, PSYCHON B REV, V17, P536, DOI 10.3758/PBR.17.4.536; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Scott GG, 2009, BIOL PSYCHOL, V80, P95, DOI 10.1016/j.biopsycho.2008.03.010; Tillman CM, 2011, PSYCHOPHYSIOLOGY, V48, P1405, DOI 10.1111/j.1469-8986.2011.01203.x; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; van den Wildenberg WPM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00222; West R, 2000, BRAIN RES, V873, P102, DOI 10.1016/S0006-8993(00)02530-0; West R, 2005, EXP BRAIN RES, V167, P38, DOI 10.1007/s00221-005-2366-y; Wu Y, 2009, BRAIN RES, V1286, P114, DOI 10.1016/j.brainres.2009.06.032; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004	55	52	52	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53894	10.1371/journal.pone.0053894	http://dx.doi.org/10.1371/journal.pone.0053894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YV	23326530	Green Published, gold			2022-12-25	WOS:000313552400055
J	Bisana, S; Kumar, S; Rismiller, P; Nicol, SC; Lefevre, C; Nicholas, KR; Sharp, JA				Bisana, Swathi; Kumar, Satish; Rismiller, Peggy; Nicol, Stewart C.; Lefevre, Christophe; Nicholas, Kevin R.; Sharp, Julie A.			Identification and Functional Characterization of a Novel Monotreme- Specific Antibacterial Protein Expressed during Lactation	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; O-LINKED POLYLACTOSAMINOGLYCANS; AMINO-ACID-SEQUENCE; TAMMAR WALLABY; HUMAN-MILK; STAPHYLOCOCCUS-EPIDERMIDIS; ALPHA-LACTALBUMIN; MAMMARY-GLAND; EVOLUTION; GLYCOSYLATION	Monotremes are the only oviparous mammals and exhibit a fascinating combination of reptilian and mammalian characters. They represent a component of synapsidal reproduction by laying shelled eggs which are incubated outside the mother's body. This is accompanied by a prototherian lactation process, marking them as representatives of early mammals. The only extant monotremes are the platypus, and the short- and long- beaked echidnas, and their distributions are limited to Australia and New Guinea. Apart for a short weaning period, milk is the sole source of nutrition and protection for the hatchlings which are altricial and immunologically naive. The duration of lactation in these mammals is prolonged relative to the gestational length and period of incubation of eggs. Much of the development of monotreme young occurs in the non-sterile ex-utero environment. Therefore the role of milk in the growth, development and disease protection of the young is of significant interest. By sequencing the cDNA of cells harvested from monotreme milk, we have identified a novel monotreme-specific transcript, and the corresponding gene was designated as the EchAMP. The expression profile of this gene in various tissues revealed that it is highly expressed in milk cells. The peptides corresponding to the EchAMP protein have been identified in a sample of echidna milk In silico analysis indicated putative antimicrobial potential for the cognate protein of EchAMP. This was further confirmed by in vitro assays using a host of bacteria. Interestingly, EchAMP did not display any activity against a commensal gut floral species. These results support the hypothesis of enhancement of survival of the young by antimicrobial bioactives of mammary gland origin and thus emphasize the protective, non- nutritional role of milk in mammals.	[Bisana, Swathi; Lefevre, Christophe; Nicholas, Kevin R.; Sharp, Julie A.] Deakin Univ, Ctr Chem & Biotechnol, Geelong, Vic 3217, Australia; [Bisana, Swathi; Kumar, Satish] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Rismiller, Peggy] Univ Adelaide, Adelaide, SA, Australia; [Rismiller, Peggy] Pelican Lagoon Res & Wildlife Ctr, Penneshaw, SA, Australia; [Nicol, Stewart C.] Univ Tasmania, Sch Zool, Hobart, Tas, Australia	Deakin University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of Adelaide; University of Tasmania	Bisana, S (corresponding author), Deakin Univ, Ctr Chem & Biotechnol, Geelong, Vic 3217, Australia.	swathib@ccmb.res.in		Sharp, Julie/0000-0002-4481-5223	in-house funds of Deakin University, Australia; CSIR- Centre for Cellular and Molecular Biology, India	in-house funds of Deakin University, Australia; CSIR- Centre for Cellular and Molecular Biology, India	This project has been carried out with support from the in-house funds of Deakin University, Australia and CSIR- Centre for Cellular and Molecular Biology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barkema HW, 2009, J DAIRY SCI, V92, P4717, DOI 10.3168/jds.2009-2347; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; BLACKBURN DG, 1989, MAMMAL REV, V19, P1, DOI 10.1111/j.1365-2907.1989.tb00398.x; Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Borm AA, 2006, J DAIRY SCI, V89, P2090, DOI 10.3168/jds.S0022-0302(06)72279-2; Bradley AJ, 2001, J CLIN MICROBIOL, V39, P1845, DOI 10.1128/JCM.39.5.1845-1849.2001; Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp; DELEAGE G, 1987, PROTEIN ENG, V1, P289, DOI 10.1093/protein/1.4.289; DeVinney R, 1999, CELL MOL LIFE SCI, V55, P961, DOI 10.1007/s000180050347; Fanaro S, 2003, ACTA PAEDIATR, V92, P48; Finlay BB, 1996, ANN NY ACAD SCI, V797, P26, DOI 10.1111/j.1749-6632.1996.tb52946.x; Gewolb IH, 1999, ARCH DIS CHILD-FETAL, V80, pF167, DOI 10.1136/fn.80.3.F167; GILLIN FD, 1983, SCIENCE, V221, P1290, DOI 10.1126/science.6310751; Gopinath S, 2012, TRENDS MICROBIOL, V20, P320, DOI 10.1016/j.tim.2012.04.004; Griffiths M., 1978, BIOL MONOTREMES; Guss JM, 1997, ACTA CRYSTALLOGR D, V53, P355, DOI 10.1107/S0907444996015831; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; HANISCH FG, 1989, J BIOL CHEM, V264, P872; HANISCH FG, 1990, GLYCOCONJUGATE J, V7, P525, DOI 10.1007/BF01189075; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; HAYSSEN V, 1985, EVOLUTION, V39, P1147, DOI 10.1111/j.1558-5646.1985.tb00454.x; HAYSSEN V, 1993, J DAIRY SCI, V76, P3213, DOI 10.3168/jds.S0022-0302(93)77659-6; HEIKKONEN L, 1986, ANN CLIN RES, V18, P80; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Iwamori T, 2010, J VET MED SCI, V72, P621, DOI 10.1292/jvms.08-0331; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kerr KG, 2009, J HOSP INFECT, V73, P338, DOI 10.1016/j.jhin.2009.04.020; Kloos W, 1986, BERGYS MANUAL SYSTEM, V2; KOZARSKY K, 1988, P NATL ACAD SCI USA, V85, P4335, DOI 10.1073/pnas.85.12.4335; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lefevre CM, 2010, ANNU REV GENOM HUM G, V11, P219, DOI 10.1146/annurev-genom-082509-141806; Lefevre CM, 2009, REPROD FERT DEVELOP, V21, P1015, DOI 10.1071/RD09083; LINDQUIST S, 1994, BIOTECHNIQUES, V17, P692; Magallon S., 2009, TIMETREE LIFE, P133; Manzoni P, 2012, PEDIATRICS, V129, P116, DOI 10.1542/peds.2011-0279; MCORIST S, 1986, J WILDLIFE DIS, V22, P375, DOI 10.7589/0090-3558-22.3.375; Messer M, 1997, COMP BIOCHEM PHYS B, V118, P403, DOI 10.1016/S0305-0491(97)00162-4; Morrow GE, AUSTR J ZOO IN PRESS; Munday BL, 1998, PHILOS T ROY SOC B, V353, P1093, DOI 10.1098/rstb.1998.0268; Nel-Themaat L, 2007, REPROD FERT DEVELOP, V19, P576, DOI 10.1071/RD06153; Nicholas K, 1997, J MAMMARY GLAND BIOL, V2, P299, DOI 10.1023/A:1026392623090; Nicol S, 2003, COMP BIOCHEM PHYS A, V136, P795, DOI 10.1016/S1095-6433(03)00281-2; OEDING P, 1952, ACTA PATHOL MIC SC, V31, P145; Oftedal OT, 2012, ANIMAL, V6, P355, DOI 10.1017/S1751731111001935; Oftedal OT, 2002, J MAMMARY GLAND BIOL, V7, P225, DOI 10.1023/A:1022896515287; Ordonez GR, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r81; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; PAAPE MJ, 1966, J DAIRY SCI, V49, P265, DOI 10.3168/jds.S0022-0302(66)87847-5; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Plata K, 2009, ACTA BIOCHIM POL, V56, P597; Sambrook J., 2001, MOL CLONING LAB MANU; Sharp JA, 2007, EVOL DEV, V9, P378, DOI 10.1111/j.1525-142X.2007.00175.x; SHAW DC, 1993, BIOCHIM BIOPHYS ACTA, V1161, P177, DOI 10.1016/0167-4838(93)90211-9; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Thompson JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0203S00; Tyndale-Biscoe CH, 1988, DEV MARSUPIAL MODELS; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024030; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Wanyonyi SS, 2011, COMP BIOCHEM PHYS A, V160, P431, DOI 10.1016/j.cbpa.2011.07.015; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Watt AP, 2012, DEV COMP IMMUNOL, V36, P584, DOI 10.1016/j.dci.2011.10.001; WILLIAMS REO, 1959, BMJ-BRIT MED J, V2, P658, DOI 10.1136/bmj.2.5153.658; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Witte W, 1999, CHEMOTHERAPY, V45, P135, DOI 10.1159/000007174; YADAV M, 1972, J GEN MICROBIOL, V70, P437, DOI 10.1099/00221287-70-3-437; YOLKEN RH, 1992, J CLIN INVEST, V90, P1984, DOI 10.1172/JCI116078	68	15	15	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53686	10.1371/journal.pone.0053686	http://dx.doi.org/10.1371/journal.pone.0053686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326486	Green Published, gold			2022-12-25	WOS:000313551500093
J	Li, WX; Zhou, M; Ren, HY; Hu, HM; Lu, LW; Cao, M; Wang, LX				Li, Weixia; Zhou, Meng; Ren, Hongyan; Hu, Hong-Ming; Lu, Liwei; Cao, Meng; Wang, Li-xin			Tumor-Derived Autophagosomes (DRibbles) Induce B Cell Activation in a TLR2-MyD88 Dependent Manner	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; CROSS-PRESENTATION; IMMUNE-RESPONSES; DENDRITIC CELLS; T-CELLS; ANTIGENS; LYMPHOCYTES; DIFFERENTIATION; STIMULATION; LYMPHOMAS	Previously, we have documented that isolated autophagosomes from tumor cells could efficiently cross-prime tumor-reactive naive T cells and mediate tumor regression in preclinical mouse models. However, the effect of tumor-derived autophagosomes, here we refer as to DRibbles, on B cells has not been studied so far. At present study, we found that DRibbles generated from a murine hepatoma cell line Hep1-6, induced B-cell activation after intravenous injection into mice. B-cell populations were significantly expanded and the production of Hep1-6 tumor-specific antibodies was successfully induced. Moreover, in vitro studies showed that DRibbles could induce more efficient B-cell proliferation and activation, antibody production, and cytokine secretion than whole tumor cell lysates. Notably, we found that B-cell activation required proteins but not DNA in the DRibbles. We further showed that B cells could capture DRibbles and present antigens in the DRibbles to directly induce T cell activation. Furthermore, we found that B-cell activation, antibody production, cytokine secretion and antigen cross-presentation were TLR2-MyD88 pathway dependent. Taken together, the present studies demonstrated that tumor-derived autophagosomes (DRibbles) efficiently induced B cells activation, antibody production, cytokine secretion and antigen cross-presentation mainly depending on their protein component via TLR2/MyD88 dependent manner.	[Li, Weixia; Zhou, Meng; Ren, Hongyan; Cao, Meng; Wang, Li-xin] Southeast Univ, Sch Med, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China; [Ren, Hongyan; Hu, Hong-Ming; Wang, Li-xin] Southeast Univ, Affiliated Hosp 2, Canc Res & Biotherapy Ctr, Nanjing, Jiangsu, Peoples R China; [Hu, Hong-Ming] Providence Portland Med Ctr, Earle A Chiles Res Inst, Lab Canc Immunobiol, Portland, OR USA; [Lu, Liwei] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Lu, Liwei] Univ Hong Kong, Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China	Southeast University - China; Southeast University - China; Providence Portland Medical Center; University of Hong Kong; University of Hong Kong	Cao, M (corresponding author), Southeast Univ, Sch Med, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China.	mcao1979@yahoo.com.cn; wanglx66@yahoo.com.cn	Zhou, Meng/M-7954-2019; Lu, Liwei/C-4357-2009	Hu, Hong-Ming/0000-0002-2206-3470; Lu, Liwei/0000-0002-8634-0967	National Natural Science Foundation of China [31170857, 30972783, 300771999, 81001299]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is funded by National Natural Science Foundation of China (31170857, 30972783, 300771999, 81001299) (http://www.nsfc.gov.cn/Portal0/default166.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich H, 2000, J CELL BIOL, V151, P1025, DOI 10.1083/jcb.151.5.1025; Agrawal S, 2011, J CLIN IMMUNOL, V31, P472, DOI [10.1007/s10875-010-9456-8, 10.1007/s10875-010-9507-1]; Airoldi I, 2001, CANCER RES, V61, P1285; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barnes N, 2002, IMMUNITY, V16, P379, DOI 10.1016/S1074-7613(02)00287-X; Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Bekeredjian-Ding I, 2009, IMMUNOLOGY, V128, P311, DOI 10.1111/j.1365-2567.2009.03173.x; Bolhassani A, 2008, EXPERT REV VACCINES, V7, P1185, DOI 10.1586/14760584.7.8.1185; Carrasco YR, 2006, CURR OPIN IMMUNOL, V18, P286, DOI 10.1016/j.coi.2006.03.013; Crampton SR, 2010, ANN NY ACAD SCI, V1183, P58, DOI 10.1111/j.1749-6632.2009.05123.x; de Wit J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013016; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; Gantner F, 2003, EUR J IMMUNOL, V33, P1576, DOI 10.1002/eji.200323444; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; GOSSELIN EJ, 1988, J IMMUNOL, V140, P1408; Gray D, 2007, EUR J IMMUNOL, V37, P3304, DOI 10.1002/eji.200737728; Grivel J C, 1994, Immunomethods, V4, P223, DOI 10.1006/immu.1994.1024; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Ke Y, 1996, J EXP MED, V184, P1179, DOI 10.1084/jem.184.3.1179; KINDLER V, 1995, EUR J IMMUNOL, V25, P1239, DOI 10.1002/eji.1830250516; Kouskoff V, 1998, J EXP MED, V188, P1453, DOI 10.1084/jem.188.8.1453; Li YH, 2011, CLIN CANCER RES, V17, P1; Li YH, 2008, CANCER RES, V68, P6889, DOI 10.1158/0008-5472.CAN-08-0161; Li YH, 2009, AUTOPHAGY, V5, P576, DOI 10.4161/auto.5.4.8366; Lu HT, 2011, TOXICOL APPL PHARM, V255, P251, DOI 10.1016/j.taap.2011.06.026; Menard LC, 2007, J IMMUNOL, V179, P4857, DOI 10.4049/jimmunol.179.7.4857; Neller MA, 2008, SEMIN IMMUNOL, V20, P286, DOI 10.1016/j.smim.2008.09.006; OGARRA A, 1990, INT IMMUNOL, V2, P821, DOI 10.1093/intimm/2.9.821; Ohnishi E, 1997, J INTERF CYTOK RES, V17, P597, DOI 10.1089/jir.1997.17.597; Peng SL, 2005, CURR OPIN IMMUNOL, V17, P230, DOI 10.1016/j.coi.2005.03.003; Pistoia V, 1997, IMMUNOL TODAY, V18, P343, DOI 10.1016/S0167-5699(97)01080-3; Rozkova D, 2010, INT J CANCER, V126, P1132, DOI 10.1002/ijc.24832; Sartori A, 1997, METHODS, V11, P116, DOI 10.1006/meth.1996.0395; Serre K, 1998, J IMMUNOL, V161, P6059; SINGER DF, 1990, J CELL BIOL, V111, P55, DOI 10.1083/jcb.111.1.55; Skok J, 1999, J IMMUNOL, V163, P4284; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Twitty CG, 2011, CLIN CANCER RES, V17, P6467, DOI 10.1158/1078-0432.CCR-11-0812; Vidard L, 1996, J IMMUNOL, V156, P2809; Vos Q, 2000, IMMUNOL REV, V176, P154; Wagle NM, 1999, VACCINE, V18, P376, DOI 10.1016/S0264-410X(99)00207-8; Yang M, 2010, J IMMUNOL, V184, P3321, DOI 10.4049/jimmunol.0902551; Zhang P, 2007, MOL IMMUNOL, V44, P332, DOI 10.1016/j.molimm.2006.02.030; Zhao FS, 2010, VACCINE, V28, P2846, DOI 10.1016/j.vaccine.2010.01.057	45	13	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53564	10.1371/journal.pone.0053564	http://dx.doi.org/10.1371/journal.pone.0053564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326458	gold, Green Published, Green Submitted			2022-12-25	WOS:000313551500084
J	Linares, LO; Martinez-Martin, N; Castellanos, FX				Linares, L. Oriana; Martinez-Martin, Nuria; Castellanos, F. Xavier			Stimulant and Atypical Antipsychotic Medications For Children Placed in Foster Homes	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DIAGNOSTIC INTERVIEW SCHEDULE; DISRUPTIVE BEHAVIOR DISORDERS; COMMERCIAL HEALTH PLANS; MEDICAID MANAGED CARE; MENTAL-HEALTH; PSYCHOTROPIC MEDICATION; PSYCHIATRIC-DISORDERS; PSYCHOPHARMACOLOGICAL TREATMENT; DISC-IV	Objectives: The purpose of this study is to examine the use of prescribed psychoactive medications in a prospective cohort of children shortly after they entered foster homes; and to identify demographics, maltreatment history, psychiatric diagnoses including ADHD comorbidity, and level of aggression that contribute to prescribed use of stimulant and atypical antipsychotic medication over time. Methods: The sample included N = 252 children (nested in 95 sibling groups) followed for three years up to 4 yearly waves. Results: Nearly all (89%) met criteria for at least one of eight psychiatric diagnoses and 31% (75/252) used one or more prescribed psychoactive medications. Over half (55%) were diagnosed with Attention Deficit Hyperactivity Disorder (ADHD); of these 38% used stimulants and 36% used atypical antipsychotics. Of the 75 medicated children, 19% received >= 3 different classes of drugs over the course of the study. Stimulants (69%) and atypical antipsychotics (65%) were the most frequently used drugs among medicated children. Adjusted odds ratios (AOR) showed that male gender (AOR = 3.2; 95% CI = 1.5-9.3), African American vs Latino ethnicity (AOR = 5.4; 95% CI = 2.1-14.2), ADHD regardless of Oppositional Defiant (ODD) or Conduct (CD) comorbidity (AOR = 6.0, 95% CI = 1.3-27.5), ODD or CD (AOR = 11.1, 95% CI = 2.1-58.6), and Separation Anxiety (AOR = 2.0, 95% CI = 1.0-4.0) psychiatric disorders were associated with the use of prescribed stimulants; while male gender (AOR = 3.8, 95% CI = 1.5-9.3), African American vs Latino (AOR = 5.1, 95% CI = 1.2-9.2) or Mixed/Other ethnicity (AOR = 3.3, 95% CI = 1.9-13.7), ADHD regardless of ODD or CD comorbidity (AOR = 5.8, 95% CI = 1.2-28.7), ODD or CD (AOR = 13.9, 95% CI = 3.3-58.5), Major Depression/Dysthymia (AOR = 2.8, 95% CI = 1.1-6.7) psychiatric disorders, and history of sexual abuse (AOR = 4.6, 95% CI = 1.3-18.4) were associated with the use of prescribed atypical antipsychotics. Conclusion: The aggressive use of atypical antipsychotics, which has unknown metabolic risks, suggests that the efficacy and safety of such treatment strategies for psychiatrically ill children in foster care should be monitored.	[Linares, L. Oriana] Mt Sinai Sch Med, Adolescent Hlth Ctr, New York, NY USA; [Martinez-Martin, Nuria; Castellanos, F. Xavier] NYU, Sch Med, Ctr Child Study, New York, NY USA; [Castellanos, F. Xavier] Nathan S Kline Inst Psychiat Res, Orangeburg, NY USA	Icahn School of Medicine at Mount Sinai; New York University; Nathan Kline Institute for Psychiatric Research	Linares, LO (corresponding author), Mt Sinai Sch Med, Adolescent Hlth Ctr, New York, NY USA.	oriana.linares@mountsinai.org	Castellanos, Francisco Xavier/K-1892-2014	Castellanos, Francisco Xavier/0000-0001-9192-9437; Martinez-Martin, Nuria/0000-0001-9211-0896	United States Office of Abuse and Neglect [9OCA1687]; Centers for Disease Control [R49CE000205]; Alicia Koplowitz Foundation of Madrid Spain; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL [R49CE000205] Funding Source: NIH RePORTER	United States Office of Abuse and Neglect; Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Alicia Koplowitz Foundation of Madrid Spain; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by grants from the United States Office of Abuse and Neglect (9OCA1687) and the Centers for Disease Control (R49CE000205) to LOL and by a Fellowship Award from the Alicia Koplowitz Foundation of Madrid Spain to NMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angold A, 2000, J AM ACAD CHILD PSY, V39, P975, DOI 10.1097/00004583-200008000-00009; [Anonymous], 2007, PHYS DESK REFERENCE; Aparasu RR, 2007, CURR MED RES OPIN, V23, P48, DOI 10.1185/030079906X158075; Aparasu RR, 2005, PSYCHIAT SERV, V56, P904, DOI 10.1176/appi.ps.56.8.904; Arizona Department of Health Services, 2006, PSYCH MED CHILDR AD; Armenteros JL, 2007, J AM ACAD CHILD PSY, V46, P558, DOI 10.1097/chi.0b013e3180323354; Bartnett D, 1991, DEV PSYCHOPATHOL, V3, P19; Bellows NM, 2008, HEALTH SERV RES, V43, P582, DOI 10.1111/j.1475-6773.2007.00769.x; Boles M, 2001, J CHILD ADOL PSYCHOP, V11, P43, DOI 10.1089/104454601750143429; Bravo M, 2001, J ABNORM CHILD PSYCH, V29, P433, DOI 10.1023/A:1010499520090; Children's Bureau, 2010, CHILD WELF OUTC 2007; Comer JS, 2010, J AM ACAD CHILD PSY, V49, P1001, DOI 10.1016/j.jaac.2010.07.007; Correll CU, 2008, INT REV PSYCHIATR, V20, P195, DOI 10.1080/09540260801889179; Correll CU, 2008, J AM ACAD CHILD PSY, V47, P9, DOI 10.1097/chi.0b013e31815b5cb1; Correll CU, 2006, J AM ACAD CHILD PSY, V45, P771, DOI 10.1097/01.chi.0000220851.94392.30; DosReis S, 2004, PSYCHIAT SERV, V55, P1041, DOI 10.1176/appi.ps.55.9.1041; Eyberg S.M., 1999, EYBERG CHILD BEHAV I; Findling RL, 2008, J CLIN PSYCHIAT, V69, P9; Froehlich TE, 2007, ARCH PEDIAT ADOL MED, V161, P857, DOI 10.1001/archpedi.161.9.857; Garland AF, 2001, J AM ACAD CHILD PSY, V40, P409, DOI 10.1097/00004583-200104000-00009; Hardin J., 2003, GEN ESTIMATING EQUAT; Health and Human Services Commission, 2006, US PSYCH MED TEX FOS; Hurlburt MS, 2004, ARCH GEN PSYCHIAT, V61, P1217, DOI 10.1001/archpsyc.61.12.1217; Ipser J, 2007, PSYCHOPHARMACOLOGY, V191, P127, DOI 10.1007/s00213-006-0537-6; Jensen PS, 1999, J AM ACAD CHILD PSY, V38, P797, DOI 10.1097/00004583-199907000-00008; Landon BE, 2008, AM J MANAG CARE, V14, P377; Landon BE, 2007, JAMA-J AM MED ASSOC, V298, P1674, DOI 10.1001/jama.298.14.1674; Leslie LK, 2011, CHILD ABUSE NEGLECT, V35, P333, DOI 10.1016/j.chiabu.2011.01.012; Leslie LK, 2005, J DEV BEHAV PEDIATR, V26, P140, DOI 10.1097/00004703-200504000-00011; Leslie LK, 2003, J AM ACAD CHILD PSY, V42, P1433, DOI 10.1097/00004583-200312000-00010; Linares LO, 2007, J FAM PSYCHOL, V21, P736, DOI 10.1037/0893-3200.21.4.736; Linares LO, 2010, PEDIATRICS, V125, pE489, DOI 10.1542/peds.2009-1285; Linares LO, 2006, AGGRESS VIOLENT BEH, V11, P95, DOI 10.1016/j.avb.2005.07.001; McMillen JC, 2005, J AM ACAD CHILD PSY, V44, P88, DOI 10.1097/01.chi.0000145806.24274.d2; National Institute of Mental Health, 2002, MED; Piacentini J, 1999, J ABNORM CHILD PSYCH, V27, P417, DOI 10.1023/A:1021923808118; PIACENTINI JC, 1992, J ABNORM CHILD PSYCH, V20, P51, DOI 10.1007/BF00927116; Raghavan R, 2005, J CHILD ADOL PSYCHOP, V15, P97, DOI 10.1089/cap.2005.15.97; Reich W, 2006, J AM ACAD CHILD PSY, V45, P801, DOI 10.1097/01.chi.0000219833.00979.c3; Rubin D, 2012, CHILD YOUTH SERV REV, V34, P1492, DOI 10.1016/j.childyouth.2012.04.006; Ruths S, 2004, PEDIATR ANN, V33, P318, DOI 10.3928/0090-4481-20040501-10; Safer DJ, 2003, AM J PSYCHIAT, V160, P438, DOI 10.1176/appi.ajp.160.3.438; Schneiderman Janet U, 2003, Contemp Nurse, V14, P123; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Shin L, 2008, HARVARD REV PSYCHIAT, V16, P69, DOI 10.1080/10673220802073915; Silver J, 2007, CHILD WELFARE, V86, P35; Staller JA, 2007, PROG NEURO-PSYCHOPH, V31, P131, DOI 10.1016/j.pnpbp.2006.08.009; Staudt Marlys M, 2003, Child Maltreat, V8, P195, DOI 10.1177/1077559503254138; Swann AC, 2003, J CLIN PSYCHIAT, V64, P26; Tang MH, 2008, HEALTH SERV RES, V43, P882, DOI 10.1111/j.1475-6773.2007.00811.x; Tarren-Sweeney M, 2008, CURR OPIN PSYCHIATR, V21, P345, DOI 10.1097/YCO.0b013e32830321fa; Texas Department of State Health Services, 2007, PSYCH MED PAR FOST C; Tremmery S, 2007, EUR CHILD ADOLES PSY, V16, P327, DOI 10.1007/s00787-007-0604-5; US Department of Health and Human Services: Administration for Children and Families' Office of Planning Research and Evaluation, 2005, NAT SURV CHILD AD WE; Zito JM, 1998, J CHILD ADOL PSYCHOP, V8, P99, DOI 10.1089/cap.1998.8.99; Zito JM, 2008, PEDIATRICS, V121, pE157, DOI 10.1542/peds.2007-0212	56	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e54152	10.1371/journal.pone.0054152	http://dx.doi.org/10.1371/journal.pone.0054152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326588	gold, Green Published			2022-12-25	WOS:000313551500111
J	Lindsey, PA; Havemann, CP; Lines, R; Palazy, L; Price, AE; Retief, TA; Rhebergen, T; Van der Waal, C				Lindsey, Peter Andrew; Havemann, Carl Peter; Lines, Robin; Palazy, Lucille; Price, Aaron Ernest; Retief, Tarryn Anne; Rhebergen, Tiemen; Van der Waal, Cornelis			Determinants of Persistence and Tolerance of Carnivores on Namibian Ranches: Implications for Conservation on Southern African Private Lands	PLOS ONE			English	Article							DOG LYCAON-PICTUS; HUMAN-WILDLIFE CONFLICT; LIONS PANTHERA-LEO; LIVESTOCK PREDATION; HUMAN DENSITIES; ATTITUDES; POPULATION; MANAGEMENT; DEPREDATION; PATTERNS	Changing land use patterns in southern Africa have potential to dramatically alter the prospects for carnivore conservation. Understanding these influences is essential for conservation planning. We interviewed 250 ranchers in Namibia to assess human tolerance towards and the distribution of large carnivores. Cheetahs (Acinonyx jubatus), leopards (Panthera pardus) and brown hyaenas (Hyaena brunnea) were widely distributed on Namibian farmlands, spotted hyaenas (Crocuta crocuta) had a narrower distribution, and wild dogs (Lycaon pictus) and lions (Panthera leo) are largely limited to areas near source populations. Farmers were most tolerant of leopards and least tolerant of lions, wild dogs and spotted hyaenas. Several factors relating to land use correlated consistently with carnivore-presence and landowner tolerance. Carnivores were more commonly present and/or tolerated where; wildlife diversity and biomass were higher; income from wildlife was higher; income from livestock was lower; livestock biomass was lower; in conservancies; game fencing was absent; and financial losses from livestock depredation were lower. Efforts to create conditions whereby the costs associated with carnivores are lowest, and which confer financial value to them are likely to be the most effective means of promoting carnivore conservation. Such conditions are achieved where land owners pool land to create conservancies where livestock are replaced with wildlife (or where livestock husbandry is improved) and where wildlife generates a significant proportion of ranch income. Additional measures, such as promoting improved livestock husbandry and educational outreach efforts may also help achieve coexistence with carnivores. Our findings provide insights into conditions more conducive to the persistence of and tolerance towards large carnivores might be increased on private (and even communal) lands in Namibia, elsewhere in southern and East Africa and other parts of the world where carnivore conservation is being attempted on private lands.	[Lindsey, Peter Andrew; Havemann, Carl Peter; Retief, Tarryn Anne] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Lindsey, Peter Andrew] Panthera, New York, NY USA; [Lines, Robin] Namibian Nat Fdn, Windhoek, Namibia; [Price, Aaron Ernest] Nebraska Dept Environm Qual, Lincoln, NE USA; [Rhebergen, Tiemen] Wageningen Univ, Dept Plant Prod Syst, NL-6700 AP Wageningen, Netherlands; [Van der Waal, Cornelis] Vanderwaal & Associates Agriecol Serv, Omaruru, Namibia	University of Pretoria; Wageningen University & Research	Lindsey, PA (corresponding author), Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa.	palindsey@gmail.com		Rhebergen, Tiemen/0000-0002-1175-8672	German Federal Ministry for Economic Cooperation and Development; African Wildlife Conservation Fund	German Federal Ministry for Economic Cooperation and Development; African Wildlife Conservation Fund	The authors thank TRAFFIC East/Southern Africa and Tom Milliken, and thank the German Federal Ministry for Economic Cooperation and Development and African Wildlife Conservation Fund for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beinart W, 1998, PAST PRESENT, P172; Casey Anne L., 2005, Human Dimensions of Wildlife, V10, P29, DOI 10.1080/10871200590904860; CHILDES SL, 1988, BIOL CONSERV, V44, P301, DOI 10.1016/0006-3207(88)90022-5; COE MJ, 1976, OECOLOGIA, V22, P341, DOI 10.1007/BF00345312; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Creel S., 2002, AFRICAN WILD DOG BEH; Davies-Mostert H, 2009, CRITICAL ASSESSMENT; Ericsson G, 2003, BIOL CONSERV, V111, P149, DOI 10.1016/S0006-3207(02)00258-6; Graham K, 2005, BIOL CONSERV, V122, P159, DOI 10.1016/j.biocon.2004.06.006; Gusset M, 2009, ORYX, V43, P67, DOI 10.1017/S0030605308990475; Hanks J., 2003, Journal of Sustainable Forestry, V17, P127, DOI 10.1300/J091v17n01_08; Hayward MW, 2007, ORYX, V41, P205, DOI 10.1017/S0030605307001767; Hemson G, 2009, BIOL CONSERV, V142, P2718, DOI 10.1016/j.biocon.2009.06.024; Hofer Heribert, 1996, P117; Holmern T, 2007, BIOL CONSERV, V135, P518, DOI 10.1016/j.biocon.2006.10.049; Hunter LTB, 2007, ORYX, V41, P196, DOI 10.1017/S003060530700172X; IUCN, 2007, REG CONS STRAT CHEET; Karanth KU, 2009, ORYX, V43, P1, DOI 10.1017/S003060530843106X; Kelly MJ, 1988, J ZOOL, V244, P473; Lagendijk DDG, 2008, ENVIRON MANAGE, V42, P971, DOI 10.1007/s00267-008-9204-5; Lindner J. R., 2002, J INT AGR EXTENSION, V9, P55; Lindsey P, 2011, ORYX, V45, P587, DOI 10.1017/S003060531000150X; Lindsey P., 2008, EVOLUTION INNOVATION, P163; Lindsey P, ORYX IN PRESS; Lindsey PA, 2007, BIOL CONSERV, V134, P455, DOI 10.1016/j.biocon.2006.09.005; Lindsey PA, 2005, BIOL CONSERV, V125, P113, DOI 10.1016/j.biocon.2005.03.015; Lindsey PA, 2005, BIOL CONSERV, V123, P339, DOI 10.1016/j.biocon.2004.12.002; Lindsey Peter A., 2007, Journal of Ecotourism, V6, P19, DOI 10.2167/joe133.0; Lindsey Peter A., 2009, P321, DOI 10.1002/9781444312034.ch15; Lindsey PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029332; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; Marker Laurie, 2007, Cat News, P4; Marker Laurie, 2004, Human Dimensions of Wildlife, V9, P297, DOI 10.1080/10871200490505729; Marker LL, 2003, CONSERV BIOL, V17, P1290, DOI 10.1046/j.1523-1739.2003.02077.x; Marker LL, 2003, BIOL CONSERV, V114, P401, DOI 10.1016/S0006-3207(03)00068-5; Marnewick K., 2007, CAT NEWS, V3, P27; Marnewick Kelly, 2009, P282, DOI 10.1002/9781444312034.ch13; Mendelsohn J., 2006, FARMING SYSTEMS NAMI; Mills M.G.L., 1998, STATUS SURVEY CONSER; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1500, DOI 10.1111/j.1523-1739.2003.00060.x; Ogada MO, 2003, CONSERV BIOL, V17, P1521, DOI 10.1111/j.1523-1739.2003.00061.x; Purchase G, 2007, CAT NEWS SI, VSI3, P44; Rasmussen GSA, 1999, BIOL CONSERV, V88, P133, DOI 10.1016/S0006-3207(98)00006-8; Ray J, 2005, SETTING CONSERVATION, P24; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Romanach SS, 2007, ORYX, V41, P185, DOI 10.1017/S0030605307001779; Roskaft E, 2003, EVOL HUM BEHAV, V24, P184, DOI 10.1016/S1090-5138(03)00011-4; SAS Institute, 2000, JMPIN 4 0 2; Schumann M, 2008, S AFR J WILDL RES, V38, P123, DOI 10.3957/0379-4369-38.2.123; Stander F, 2005, REV CONFLICT HUMANS, P33; Stein AB, 2010, ANIM CONSERV, V13, P419, DOI 10.1111/j.1469-1795.2010.00364.x; Stein AB, 2011, AFR J ECOL, V49, P383, DOI 10.1111/j.1365-2028.2011.01267.x; Swanepoel LH, 2008, ECOLOGY CONSERVATION; Tempest K, 2011, STATUS CONSERVATION; Thorn M, 2012, BIOL CONSERV, V150, P23, DOI 10.1016/j.biocon.2012.02.017; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe R, 2005, ANIM CONSERV, V8, P91, DOI 10.1017/S1367943004001829; Woodroffe R, 2005, CONSERV BIOL SER, V9, P1; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126	59	37	37	2	194	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52458	10.1371/journal.pone.0052458	http://dx.doi.org/10.1371/journal.pone.0052458			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326333	Green Published, gold, Green Submitted			2022-12-25	WOS:000313551500014
J	Sharma, P; Dube, D; Sinha, M; Yadav, S; Kaur, P; Sharma, S; Singh, TP				Sharma, Pradeep; Dube, Divya; Sinha, Mau; Yadav, Savita; Kaur, Punit; Sharma, Sujata; Singh, Tej P.			Structural Insights into the Dual Strategy of Recognition by Peptidoglycan Recognition Protein, PGRP-S: Structure of the Ternary Complex of PGRP-S with Lipopolysaccharide and Stearic Acid	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; INNATE IMMUNITY; ANGSTROM RESOLUTION; BINDING PROTEINS; EXPRESSION; INFECTION; SITE	Peptidoglycan recognition proteins (PGRPs) are part of the innate immune system. The 19 kDa Short PGRP (PGRP-S) is one of the four mammalian PGRPs. The concentration of PGRP-S in camel (CPGRP-S) has been shown to increase considerably during mastitis. The structure of CPGRP-S consists of four protein molecules designated as A, B, C and D forming stable intermolecular contacts, A-B and C-D. The A-B and C-D interfaces are located on the opposite sides of the same monomer leading to the the formation of a linear chain with alternating A-B and C-D contacts. Two ligand binding sites, one at C-D contact and another at A-B contact have been observed. CPGRP-S binds to the components of bacterial cell wall molecules such as lipopolysaccharide (LPS), lipoteichoic acid (LTA), and peptidoglycan (PGN) from both Gram-positive and Gram-negative bacteria. It also binds to fatty acids including mycolic acid of the Mycobacterium tuberculosis (Mtb). Previous structural studies of binary complexes of CPGRP-S with LPS and stearic acid (SA) have shown that LPS binds to CPGRP-S at C-D contact (Site-1) while SA binds to it at the A-B contact (Site-2). The binding studies using surface plasmon resonance showed that LPS and SA bound to CPGRP-S in the presence of each other. The structure determination of the ternary complex showed that LPS and SA bound to CPGRP-S at Site-1 and Site-2 respectively. LPS formed 13 hydrogen bonds and 159 van der Waals contacts (distances <= 4.2 angstrom) while SA formed 56 van der Waals contacts. The ELISA test showed that increased levels of productions of pro-inflammatory cytokines TNF-alpha and IFN-gamma due to LPS and SA decreased considerably upon the addition of CPGRP-S.	[Sharma, Pradeep; Dube, Divya; Sinha, Mau; Yadav, Savita; Kaur, Punit; Sharma, Sujata; Singh, Tej P.] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Singh, TP (corresponding author), All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.	tpsingh.aiims@gmail.com		SINHA, MAU/0000-0003-3011-9160	Department of Science and Technology (DST), Ministry of Science and Technology, New Delhi; Department of Biotechnology (DBT), Ministry of Science and Technology, New Delhi; DST for the INSPIRE Faculty; Department of Science and Technology for INSPIRE-Faculty	Department of Science and Technology (DST), Ministry of Science and Technology, New Delhi(Department of Science & Technology (India)); Department of Biotechnology (DBT), Ministry of Science and Technology, New Delhi(Department of Science & Technology (India)Department of Biotechnology (DBT) India); DST for the INSPIRE Faculty; Department of Science and Technology for INSPIRE-Faculty	The authors acknowledge financial support from the Department of Science and Technology (DST), Ministry of Science and Technology, New Delhi. TPS thanks the Department of Biotechnology (DBT), Ministry of Science and Technology, New Delhi for the award of Distinguished Biotechnology research professorship to him. PS thanks the DST for the INSPIRE Faculty award to him. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; TPS thanks the Department of Biotechnology (DBT), Ministry of science and Technology, New Delhi for the award of Distinguished Biotechnology research professorship to him. PS thanks Department of Science and Technology for INSPIRE-Faculty award to him.	Cho S, 2007, P NATL ACAD SCI USA, V104, P8761, DOI 10.1073/pnas.0701453104; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ginsburg I, 2002, LANCET INFECT DIS, V2, P171, DOI 10.1016/S1473-3099(02)00226-8; Guan RJ, 2006, PROTEIN SCI, V15, P1199, DOI 10.1110/ps.062077606; Guan RJ, 2005, J MOL BIOL, V347, P683, DOI 10.1016/j.jmb.2005.01.070; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kappeler SR, 2004, J DAIRY SCI, V87, P2660, DOI 10.3168/jds.S0022-0302(04)73392-5; Kolter T, 2005, J BIOL CHEM, V280, P41125, DOI 10.1074/jbc.R500015200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Lo D, 2003, CELL IMMUNOL, V224, P8, DOI 10.1016/S0008-8749(03)00155-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Sharma P, 2012, ARCH BIOCH IN PRESS; Sharma P, 2008, J MOL BIOL, V378, P923, DOI 10.1016/j.jmb.2008.03.018; Sharma P, 2012, J BIOL CHEM, V287, P22153, DOI 10.1074/jbc.M111.321307; Sharma Pradeep, 2012, Int J Biochem Mol Biol, V3, P86; Sharma P, 2011, J BIOL CHEM, V286, P31723, DOI 10.1074/jbc.M111.264374; Sharma P, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.228163; Shockman GD, 1996, MICROB DRUG RESIST, V2, P95, DOI 10.1089/mdr.1996.2.95; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; WISE EM, 1965, P NATL ACAD SCI USA, V54, P75, DOI 10.1073/pnas.54.1.75; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y	27	11	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53756	10.1371/journal.pone.0053756	http://dx.doi.org/10.1371/journal.pone.0053756			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326499	Green Published, gold, Green Submitted			2022-12-25	WOS:000313551500095
J	Thom, JM; Clayton, NS				Thom, James M.; Clayton, Nicola S.			Re-caching by Western Scrub-Jays (Aphelocoma californica) Cannot Be Attributed to Stress	PLOS ONE			English	Article							STRATEGIES; EVOLUTION; BEHAVIOR	Western scrub-jays (Aphelocoma californica) live double lives, storing food for the future while raiding the stores of other birds. One tactic scrub-jays employ to protect stores is "re-caching"-relocating caches out of sight of would-be thieves. Recent computational modelling work suggests that re-caching might be mediated not by complex cognition, but by a combination of memory failure and stress. The "Stress Model" asserts that re-caching is a manifestation of a general drive to cache, rather than a desire to protect existing stores. Here, we present evidence strongly contradicting the central assumption of these models: that stress drives caching, irrespective of social context. In Experiment (i), we replicate the finding that scrub-jays preferentially relocate food they were watched hiding. In Experiment (ii) we find no evidence that stress increases caching. In light of our results, we argue that the Stress Model cannot account for scrub-jay re-caching.	[Thom, James M.; Clayton, Nicola S.] Univ Cambridge, Dept Psychol, Cambridge, England	University of Cambridge	Clayton, NS (corresponding author), Univ Cambridge, Dept Psychol, Cambridge, England.	nsc22@cam.ac.uk		Clayton, Nicola/0000-0003-1835-423X	University of Cambridge; MRC doctoral training grant; BBSRC [BB/I000690/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I000690/1] Funding Source: researchfish	University of Cambridge(University of Cambridge); MRC doctoral training grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Research was financially supported by the University of Cambridge. J. M. Thom was funded by an MRC doctoral training grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Dally JM, 2006, ANIM BEHAV, V72, P13, DOI 10.1016/j.anbehav.2005.08.020; Dally JM, 2006, SCIENCE, V312, P1662, DOI 10.1126/science.1126539; de Kort SR, 2007, J EXP PSYCHOL ANIM B, V33, P361, DOI 10.1037/0097-7403.33.4.361; Emery NJ, 2009, ANNU REV PSYCHOL, V60, P87, DOI 10.1146/annurev.psych.60.110707.163526; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Emery NJ, 2004, ANIM COGN, V7, P37, DOI 10.1007/s10071-003-0178-7; Emery NJ, 2001, NATURE, V414, P443, DOI 10.1038/35106560; van der Vaart E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032904; van der Vaart E, 2011, J EXP PSYCHOL-ANIM B, V37, P330, DOI 10.1037/a0022988; Watanabe S, 2007, J ETHOL, V25, P271, DOI 10.1007/s10164-006-0023-y	11	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52936	10.1371/journal.pone.0052936	http://dx.doi.org/10.1371/journal.pone.0052936			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326366	gold, Green Published, Green Submitted			2022-12-25	WOS:000313551500036
J	Jiang, JF; Wang, YG; Hu, J; Lei, F; Kheir, MM; Wang, XP; Chai, YS; Yuan, ZY; Lu, X; Xing, DM; Du, F; Du, LJ				Jiang, Jing-Fei; Wang, Yu-Gang; Hu, Jun; Lei, Fan; Kheir, Michael M.; Wang, Xin-Pei; Chai, Yu-Shuang; Yuan, Zhi-Yi; Lu, Xi; Xing, Dong-Ming; Du, Feng; Du, Li-Jun			Novel Effect of Berberine on Thermoregulation in Mice Model Induced by Hot and Cold Environmental Stimulation	PLOS ONE			English	Article							HEAT-SHOCK; APOPTOSIS; HSP70; CELLS; THERMOTOLERANCE; RESPONSES; PROMOTER; NEURONS; STRESS; MCF-7	The purpose of this study was to assess the effects of berberine (BBR) on thermoregulation in mice exposed to hot (40 degrees C) and cold (4 degrees C) environmental conditions. Four groups of mice were assembled with three different dosages of BBR (0.2, 0.4, and 0.8 mg/kg) and normal saline (control). In room temperature, our largest dosage of BBR (0.8 mg/kg) can reduce rectal temperatures (Tc) of normal mice. In hot conditions, BBR can antagonize the increasing core body temperature and inhibit the expression of HSP70 and TNF alpha in mice; conversely, in cold conditions, BBR can antagonize the decreasing core body temperature and enhance the expression of TRPM8. This study demonstrates the dual ability of BBR in maintaining thermal balance, which is of great relevance to the regulation of HSP70, TNF alpha and TRPM8.	[Jiang, Jing-Fei; Wang, Yu-Gang; Hu, Jun; Lei, Fan; Wang, Xin-Pei; Chai, Yu-Shuang; Yuan, Zhi-Yi; Lu, Xi; Xing, Dong-Ming; Du, Li-Jun] Tsinghua Univ, Sch Life Sci, Lab Mol Pharmacol & Pharmaceut Sci, Prot Sci Lab,Minist Educ, Beijing 100084, Peoples R China; [Jiang, Jing-Fei; Wang, Yu-Gang; Hu, Jun; Lei, Fan; Wang, Xin-Pei; Chai, Yu-Shuang; Yuan, Zhi-Yi; Lu, Xi; Xing, Dong-Ming; Du, Li-Jun] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Kheir, Michael M.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Du, Feng] Tulane Univ, Dept Math, New Orleans, LA 70118 USA	Tsinghua University; Tsinghua University; University of Pennsylvania; Pennsylvania Medicine; Tulane University	Du, LJ (corresponding author), Tsinghua Univ, Sch Life Sci, Lab Mol Pharmacol & Pharmaceut Sci, Prot Sci Lab,Minist Educ, Beijing 100084, Peoples R China.	lijundu@tsinghua.edu.cn	Kheir, Michael/ABA-5760-2021	Kheir, Michael/0000-0001-6469-6746	National Natural Science Foundation of China [30973896, 30801523, 81073092]; National S&T Major Special Project for New Drug R&D Program of China [2012ZX09103-201-041, 2011ZX09101-002-11, 2012ZX09102-201-008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S&T Major Special Project for New Drug R&D Program of China	This work was supported by the National Natural Science Foundation of China (30973896, 30801523 and 81073092) and the National S&T Major Special Project for New Drug R&D Program of China (2012ZX09103-201-041, 2011ZX09101-002-11 and 2012ZX09102-201-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharti S, 2012, BIOCHIM BIOPHYS ACTA, DOI [10.1016/j.bbadis.2012.05.011, DOI 10.1016/J.BBADIS.2012.05.011]; Blondin DP, 2010, J APPL PHYSIOL, V109, P654, DOI 10.1152/japplphysiol.00440.2010; Bolcskei K, 2007, EUR J PHARMACOL, V564, P80, DOI 10.1016/j.ejphar.2007.01.097; Cai CQ, 2012, NEUROSCI LETT, V506, P336, DOI 10.1016/j.neulet.2011.11.041; Chang XX, 2010, J LIPID RES, V51, P2504, DOI 10.1194/jlr.M001958; Clark BJ, 2006, PHYSIOL BEHAV, V87, P805, DOI 10.1016/j.physbeh.2006.01.026; Cok A, 2011, BIOCHIMIE, V93, P1187, DOI 10.1016/j.biochi.2011.04.013; Cui GL, 2009, J BIOL CHEM, V284, P28420, DOI 10.1074/jbc.M109.012674; Drai D, 2001, NEUROSCI BIOBEHAV R, V25, P409, DOI 10.1016/S0149-7634(01)00022-7; Drai D, 2001, BEHAV BRAIN RES, V125, P133, DOI 10.1016/S0166-4328(01)00290-X; Drai D, 2000, J NEUROSCI METH, V96, P119, DOI 10.1016/S0165-0270(99)00194-6; Fetsch CR, 2006, J THERM BIOL, V31, P40, DOI 10.1016/j.jtherbio.2005.12.001; Flouris AD, 2009, J APPL PHYSIOL, V106, P1264, DOI 10.1152/japplphysiol.91426.2008; Gong WJ, 2006, GENETICS, V172, P275, DOI 10.1534/genetics.105.048793; Grosman B, 2011, J APPL PHYSIOL, V111, P938, DOI 10.1152/japplphysiol.00519.2010; Hascoet M, 1997, PHARMACOL BIOCHEM BE, V58, P1131, DOI 10.1016/S0091-3057(97)00093-2; Ho YT, 2009, ANTICANCER RES, V29, P4063; Hu J, 2012, EUR J PHARMACOL, V674, P132, DOI 10.1016/j.ejphar.2011.11.014; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kheir MM, 2010, FOOD CHEM TOXICOL, V48, P1105, DOI 10.1016/j.fct.2010.01.033; Kim HS, 2012, BIOCHEM PHARMACOL, V83, P385, DOI 10.1016/j.bcp.2011.11.008; Kim JB, 2010, PHYTOMEDICINE, V17, P436, DOI 10.1016/j.phymed.2009.08.012; Kim JM, 2010, J ETHNOPHARMACOL, V130, P354, DOI 10.1016/j.jep.2010.05.022; Kim SM, 2012, J SURG RES, pe1; Kim WS, 2009, AM J PHYSIOL-ENDOC M, V296, pE812, DOI 10.1152/ajpendo.90710.2008; Koishi M, 2001, CLIN CANCER RES, V7, P215; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Kupeli E, 2002, LIFE SCI, V72, P645, DOI 10.1016/S0024-3205(02)02200-2; Lee CL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037897, 10.1371/journal.pone.0030077]; Leon LR, 2010, AM J PHYSIOL-REG I, V299, pR241, DOI 10.1152/ajpregu.00309.2009; Leon LR, 2008, TOXICOL APPL PHARM, V233, P146, DOI 10.1016/j.taap.2008.01.012; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Liu ZQ, 1991, CHINESE J PATHOPHYSI, V7, P264; Lu BA, 2010, TOXICOL IN VITRO, V24, P1482, DOI 10.1016/j.tiv.2010.07.017; Marais M, 2011, J THERM BIOL, V36, P116, DOI 10.1016/j.jtherbio.2010.12.004; Mendoza KC, 2010, ENCYCLOPEDIA OF BEHAVIORAL NEUROSCIENCE, VOL 3: P-Z, P400; Michel V, 2007, BRAIN RES, V1164, P63, DOI 10.1016/j.brainres.2007.06.011; MILTON AS, 1971, J PHYSIOL-LONDON, V218, P325, DOI 10.1113/jphysiol.1971.sp009620; Morrison SF, 2008, EXP PHYSIOL, V93, P773, DOI 10.1113/expphysiol.2007.041848; Patil JB, 2010, EUR J PHARMACOL, V645, P70, DOI 10.1016/j.ejphar.2010.07.037; Singh T, 2011, CARCINOGENESIS, V32, P86, DOI 10.1093/carcin/bgq215; Tang J, 2009, J ETHNOPHARMACOL, V126, P5, DOI 10.1016/j.jep.2009.08.009; Vinkers CH, 2009, PHYSIOL BEHAV, V98, P37, DOI 10.1016/j.physbeh.2009.04.004; Wang Y, 2012, MUTATION RES; Wang YG, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023495, 10.1371/journal.pone.0020422]; Xia Jianzhong, 2004, J Tradit Chin Med, V24, P208; Yan KQ, 2011, EUR J PHARMACOL, V661, P1, DOI 10.1016/j.ejphar.2011.04.021; Yu L, 1997, CHINESE PHARMACOL B, V13, P223; Yudin Y, 2012, MOL CELL ENDOCRINOL, V353, P68, DOI 10.1016/j.mce.2011.10.023	49	36	41	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54234	10.1371/journal.pone.0054234	http://dx.doi.org/10.1371/journal.pone.0054234			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335996	gold, Green Submitted, Green Published			2022-12-25	WOS:000314707700054
J	McCoy, AN; Araujo-Perez, F; Azcarate-Peril, A; Yeh, JJ; Sandler, RS; Keku, TO				McCoy, Amber N.; Araujo-Perez, Felix; Azcarate-Peril, Andrea; Yeh, Jen Jen; Sandler, Robert S.; Keku, Temitope O.			Fusobacterium Is Associated with Colorectal Adenomas	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; GUT MICROBIOTA; COLON-CANCER; NUCLEATUM; CELLS; BACTERIA; BUTYRATE; HEALTH; PH	The human gut microbiota is increasingly recognized as a player in colorectal cancer (CRC). While particular imbalances in the gut microbiota have been linked to colorectal adenomas and cancer, no specific bacterium has been identified as a risk factor. Recent studies have reported a high abundance of Fusobacterium in CRC subjects compared to normal subjects, but this observation has not been reported for adenomas, CRC precursors. We assessed the abundance of Fusobacterium species in the normal rectal mucosa of subjects with (n = 48) and without adenomas (n = 67). We also confirmed previous reports on Fusobacterium and CRC in 10 CRC tumor tissues and 9 matching normal tissues by pyrosequencing. We extracted DNA from rectal mucosal biopsies and measured bacterial levels by quantitative PCR of the 16S ribosomal RNA gene. Local cytokine gene expression was also determined in mucosal biopsies from adenoma cases and controls by quantitative PCR. The mean log abundance of Fusobacterium or cytokine gene expression between cases and controls was compared by t-test. Logistic regression was used to compare tertiles of Fusobacterium abundance. Adenoma subjects had a significantly higher abundance of Fusobacterium species compared to controls (p = 0.01). Compared to the lowest tertile, subjects with high abundance of Fusobacterium were significantly more likely to have adenomas (OR 3.66, 95% CI 1.37-9.74, p-trend 0.005). Cases but not controls had a significant positive correlation between local cytokine gene expression and Fusobacterium abundance. Among cases, the correlation for local TNF-alpha and Fusobacterium was r = 0.33, p = 0.06 while it was 0.44, p = 0.01 for Fusobacterium and IL-10. These results support a link between the abundance of Fusobacterium in colonic mucosa and adenomas and suggest a possible role for mucosal inflammation in this process.	[McCoy, Amber N.; Araujo-Perez, Felix; Sandler, Robert S.; Keku, Temitope O.] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27515 USA; [Sandler, Robert S.; Keku, Temitope O.] Univ N Carolina, Div Gastroenterol & Hepatol, Dept Med, Chapel Hill, NC USA; [Azcarate-Peril, Andrea] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Microbiome Core Facil, Chapel Hill, NC USA; [Azcarate-Peril, Andrea] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC USA; [Yeh, Jen Jen] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Surg, Chapel Hill, NC 27599 USA; [Yeh, Jen Jen] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Keku, TO (corresponding author), Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27515 USA.	tokeku@med.unc.edu	Azcarate-Peril, M. Andrea/ABH-5508-2020; Ariel, Pablo/AGJ-4118-2022; Core, UNC Microbiome/AAB-3304-2022; Azcarate-Peril, M. Andrea/AFO-7157-2022; Azcarate-Peril, M. Andrea/AAA-9056-2022	Azcarate-Peril, M. Andrea/0000-0003-0325-1289; Azcarate-Peril, M. Andrea/0000-0003-0325-1289; Azcarate-Peril, M. Andrea/0000-0003-0325-1289	National Institutes of Health [NIH R01 CA04468, R01 CA136887, P50 CA106991, P30 DK034987]; NATIONAL CANCER INSTITUTE [P50CA106991, R01CA136887, P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health NIH R01 CA04468, R01 CA136887, P50 CA106991 and P30 DK034987. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Vercoe E, 2011, GUT MICROBES, P2; Arthur JC, 2011, INFLAMM BOWEL DIS, V17, P396, DOI 10.1002/ibd.21354; Azcarate-Peril MA, 2011, AM J PHYSIOL-GASTR L, V301, pG401, DOI 10.1152/ajpgi.00110.2011; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chow J, 2010, ADV IMMUNOL, V107, P243, DOI [10.1016/B978-0-12-381300-8.00008-3, 10.1016/S0065-2776(10)07001-X]; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Degirolamo C, 2011, TRENDS MOL MED, V17, P564, DOI 10.1016/j.molmed.2011.05.010; Dharmani P, 2011, INFECT IMMUN, V79, P2597, DOI 10.1128/IAI.05118-11; Edwards AM, 2006, INFECT IMMUN, V74, P654, DOI 10.1128/IAI.74.1.654-662.2006; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; GRIFFITHS JR, 1991, BRIT J CANCER, V64, P425, DOI 10.1038/bjc.1991.326; Hakansson A, 2011, NUTRIENTS, V3, P637, DOI 10.3390/nu3060637; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Han YW, 2005, J BACTERIOL, V187, P5330, DOI 10.1128/JB.187.15.5330-5340.2005; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Barrasa JI, 2011, APOPTOSIS, V16, P1054, DOI 10.1007/s10495-011-0633-x; Jovov B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030168; Kaur N, 2011, GUT MICROBES, V2, P211, DOI 10.4161/gmic.2.4.17863; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Liu HQ, 2007, J IMMUNOL, V179, P2501, DOI 10.4049/jimmunol.179.4.2501; Marchesi JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020447; McGarr SE, 2005, J CLIN GASTROENTEROL, V39, P98; Mutch DM, 2004, PHYSIOL GENOMICS, V19, P22, DOI 10.1152/physiolgenomics.00105.2004; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; NEWMARK HL, 1990, NUTR CANCER, V14, P161, DOI 10.1080/01635589009514091; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1111/j.1574-6968.2002.tb11467.x; Resmer KL, 2011, MOL BIOSYST, V7, P2220, DOI 10.1039/c1mb05105a; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Rogler G, 2010, INT J INFLAMMATION, V2010, P1; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sanapareddy N, 2012, ISME J, P1; Sasaki Maiko, 2012, J Signal Transduct, V2012, P704953, DOI 10.1155/2012/704953; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Sears CL, 2011, J INFECT DIS, V203, P306, DOI 10.1093/jinfdis/jiq061; Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Strauss J, 2008, ANAEROBE, V14, P301, DOI 10.1016/j.anaerobe.2008.12.003; Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; Tanaka Takuji, 2009, J Carcinog, V8, P5; Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Uronis JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006026; Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005; Walter J, 2011, MICROBIAL ECOLOGY HL, P14; Wang F, 2012, DIGESTIVE DIS SCI; Weiss EI, 2000, ORAL MICROBIOL IMMUN, V15, P371, DOI 10.1034/j.1399-302x.2000.150606.x	48	330	352	3	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53653	10.1371/journal.pone.0053653	http://dx.doi.org/10.1371/journal.pone.0053653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335968	Green Published, gold, Green Submitted			2022-12-25	WOS:000314707700024
J	Jaramillo, J; Setamou, M; Muchugu, E; Chabi-Olaye, A; Jaramillo, A; Mukabana, J; Maina, J; Gathara, S; Borgemeister, C				Jaramillo, Juliana; Setamou, Mamoudou; Muchugu, Eric; Chabi-Olaye, Adenirin; Jaramillo, Alvaro; Mukabana, Joseph; Maina, Johnson; Gathara, Simon; Borgemeister, Christian			Climate Change or Urbanization? Impacts on a Traditional Coffee Production System in East Africa over the Last 80 Years	PLOS ONE			English	Article							HYPOTHENEMUS-HAMPEI COLEOPTERA; LAND-USE CHANGE; BERRY BORER; SHADE COFFEE; AGROFORESTRY MANAGEMENT; GLOBAL CLIMATE; ARABICA L.; TEMPERATURE; BIODIVERSITY; EMERGENCE	Global environmental changes (GEC) such as climate change (CC) and climate variability have serious impacts in the tropics, particularly in Africa. These are compounded by changes in land use/land cover, which in turn are driven mainly by economic and population growth, and urbanization. These factors create a feedback loop, which affects ecosystems and particularly ecosystem services, for example plant-insect interactions, and by consequence agricultural productivity. We studied effects of GEC at a local level, using a traditional coffee production area in greater Nairobi, Kenya. We chose coffee, the most valuable agricultural commodity worldwide, as it generates income for 100 million people, mainly in the developing world. Using the coffee berry borer, the most serious biotic threat to global coffee production, we show how environmental changes and different production systems (shaded and sun-grown coffee) can affect the crop. We combined detailed entomological assessments with historic climate records (from 1929-2011), and spatial and demographic data, to assess GEC's impact on coffee at a local scale. Additionally, we tested the utility of an adaptation strategy that is simple and easy to implement. Our results show that while interactions between CC and migration/urbanization, with its resultant landscape modifications, create a feedback loop whereby agroecosystems such as coffee are adversely affected, bio-diverse shaded coffee proved far more resilient and productive than coffee grown in monoculture, and was significantly less harmed by its insect pest. Thus, a relatively simple strategy such as shading coffee can tremendously improve resilience of agro-ecosystems, providing small-scale farmers in Africa with an easily implemented tool to safeguard their livelihoods in a changing climate.	[Jaramillo, Juliana] Leibniz Univ Hannover, Inst Plant Dis & Plant Protect, D-30167 Hannover, Germany; [Jaramillo, Juliana; Muchugu, Eric; Chabi-Olaye, Adenirin; Borgemeister, Christian] Int Ctr Insect Physiol & Ecol, Nairobi, Kenya; [Jaramillo, Alvaro] Ctr Nacl Invest Cafe Cenicafe, Manizales, Colombia; [Setamou, Mamoudou] Texas A&M Univ, Kingsville Citrus Ctr, Weslaco, TX USA; [Mukabana, Joseph; Maina, Johnson; Gathara, Simon] Kenya Meteorol Dept, Nairobi, Kenya	Leibniz University Hannover; International Centre of Insect Physiology & Ecology (ICIPE); Texas A&M University System; Texas A&M University Kingsville	Jaramillo, J (corresponding author), Leibniz Univ Hannover, Inst Plant Dis & Plant Protect, D-30167 Hannover, Germany.	jjaramillo@icipe.org			German Research Foundation - Deutsche Forschungsgemeinschaft (DFG); Finnish Ministry of Foreign Affairs through the CHIESA project	German Research Foundation - Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Finnish Ministry of Foreign Affairs through the CHIESA project	This research was funded by the German Research Foundation - Deutsche Forschungsgemeinschaft (DFG) and partly supported by the Finnish Ministry of Foreign Affairs through the CHIESA project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assad ED, 2004, PESQUI AGROPECU BRAS, V39, P1057, DOI 10.1590/S0100-204X2004001100001; BAKER PS, 1992, B ENTOMOL RES, V82, P145, DOI 10.1017/S000748530005166X; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; BARNES C, 1979, AFR ECON HIST, P198, DOI 10.2307/3601565; Barrios S, 2006, J URBAN ECON, V60, P357, DOI 10.1016/j.jue.2006.04.005; Beer J, 1997, AGROFOREST SYST, V38, P139, DOI 10.1023/A:1005956528316; Brown O, 2008, IOM INT ORG MIGRATIO; C.R.A, 2011, COUNT FACT SHEETS MA; Cardoso IM, 2003, AGROFOREST SYST, V58, P55, DOI 10.1023/A:1025436908000; Carr MKV, 2001, EXP AGR, V37, P1, DOI 10.1017/S0014479701001090; DaMatta Fábio M., 2006, Braz. J. Plant Physiol., V18, P55, DOI 10.1590/S1677-04202006000100006; Damon A, 2000, B ENTOMOL RES, V90, P453, DOI 10.1017/S0007485300000584; Davis AP, 2006, BOT J LINN SOC, V152, P465, DOI 10.1111/j.1095-8339.2006.00584.x; Eitzinger A, 2010, CIAT INT CTR TROPICA; EVANS D. E., 1965, Kenya Coffee, V30, P335; Fall S, 2010, INT J CLIMATOL, V30, P1980, DOI 10.1002/joc.1996; Feddema JJ, 2005, SCIENCE, V310, P1674, DOI 10.1126/science.1118160; Field C.B., 2014, CLIM CHANG 2014 IMP, P1, DOI [DOI 10.1038/446727A, 10.1017/CBO9781107415379]; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Forister ML, 2010, P NATL ACAD SCI USA, V107, P2088, DOI 10.1073/pnas.0909686107; Geromel C, 2008, PLANT PHYSIOL BIOCH, V46, P569, DOI 10.1016/j.plaphy.2008.02.006; Gordon CE, 2009, BASIC APPL ECOL, V10, P246, DOI 10.1016/j.baae.2008.04.004; Greenberg R, 1997, BIOTROPICA, V29, P501, DOI 10.1111/j.1744-7429.1997.tb00044.x; Gregory PJ, 2009, J EXP BOT, V60, P2827, DOI 10.1093/jxb/erp080; Hope KR, 2009, INT J SUST DEV WORLD, V16, P451, DOI 10.1080/13504500903354424; Jaramillo J, 2006, B ENTOMOL RES, V96, P223, DOI 10.1079/BER2006434; Jaramillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024528; Jaramillo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006487; Kalnay E, 2003, NATURE, V423, P528, DOI 10.1038/nature01675; Kamau M, 2011, NEW REGIONS TAKE COF; Kauth R. J., 1976, LARS S, P41; Kirkpatrick T. W., 1937, Transactions of the Royal Entomological Society of London, V86, P247; Kirkpatrick TW, 1935, E AFR AGR RES STA AM; Lin BB, 2008, BIOSCIENCE, V58, P847, DOI 10.1641/B580911; Lin BB, 2007, AGR FOREST METEOROL, V144, P85, DOI 10.1016/j.agrformet.2006.12.009; Lin BB, 2011, BIOSCIENCE, V61, P183, DOI 10.1525/bio.2011.61.3.4; Mathieu F, 1998, J AGR FOOD CHEM, V46, P1106, DOI 10.1021/jf970851z; Mathieu F, 1999, J APPL ENTOMOL, V123, P535, DOI 10.1046/j.1439-0418.1999.00400.x; McDonald J, 1937, COFFEE KENYA COLONY; Moore S, 2012, RED TAPE SNAGS KENYA; Muller C, 2011, P NATL ACAD SCI USA, V108, P4313, DOI 10.1073/pnas.1015078108; NOAA, 2012, HIST LA NIN EV 1950; OKE TR, 1981, J CLIMATOL, V1, P237, DOI 10.1002/joc.3370010304; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Patz JA, 2008, MED CLIN N AM, V92, P1473, DOI 10.1016/j.mcna.2008.07.007; Perfecto I, 2005, ECOL ECON, V54, P435, DOI 10.1016/j.ecolecon.2004.10.009; Perfecto I, 1996, BIOSCIENCE, V46, P598, DOI 10.2307/1312989; Pielke RA, 2005, SCIENCE, V310, P1625, DOI 10.1126/science.1120529; Pielke RA, 2002, PHILOS T ROY SOC A, V360, P1705, DOI 10.1098/rsta.2002.1027; Preston K, 2008, GLOBAL CHANGE BIOL, V14, P2501, DOI 10.1111/j.1365-2486.2008.01671.x; Robinet C, 2010, INTEGR ZOOL, V5, P132, DOI 10.1111/j.1749-4877.2010.00196.x; Rosenthal E, 2011, NY TIMES; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; SAS Institute, 1999, SAS STAT US GUID; Schroth G, 2009, MITIG ADAPT STRAT GL, V14, P605, DOI 10.1007/s11027-009-9186-5; Staver C, 2001, AGROFOREST SYST, V53, P151, DOI 10.1023/A:1013372403359; Teodoro A, 2009, AGR FOREST ENTOMOL, V125, P120; Teodoro A, 2008, AGR ECOSYST ENVIRON, V125, P120, DOI 10.1016/j.agee.2007.12.004; UNPD, 2008, WORLD URB PROSP 2007; Vaast P, 2006, J SCI FOOD AGR, V86, P197, DOI 10.1002/jsfa.2338; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; WALLER J.M, 2007, COFFEE PESTS DIS THE; Wolff C, 2011, SCIENCE, V333, P743, DOI 10.1126/science.1203724; Zhou XL, 2011, GEOGR RES-AUST, V49, P23, DOI 10.1111/j.1745-5871.2010.00686.x	64	37	38	5	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e51815	10.1371/journal.pone.0051815	http://dx.doi.org/10.1371/journal.pone.0051815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341884	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400006
J	La Rosa, G; Fratini, M; Accardi, L; D'Oro, G; Della Libera, S; Muscillo, M; Di Bonito, P				La Rosa, Giuseppina; Fratini, Marta; Accardi, Luisa; D'Oro, Graziana; Della Libera, Simonetta; Muscillo, Michele; Di Bonito, Paola			Mucosal and Cutaneous Human Papillomaviruses Detected in Raw Sewages	PLOS ONE			English	Article							URBAN SEWAGE; MOLECULAR-DETECTION; TREATMENT PLANTS; ENTERIC VIRUSES; WASTE-WATER; INFECTIONS; PCR; POLYOMAVIRUSES; SURVEILLANCE; NOROVIRUSES	Epitheliotropic viruses can find their way into sewage. The aim of the present study was to investigate the occurrence, distribution, and genetic diversity of Human Papillomaviruses (HPVs) in urban wastewaters. Sewage samples were collected from treatment plants distributed throughout Italy. The DNA extracted from these samples was analyzed by PCR using five PV-specific sets of primers targeting the L1 (GP5/GP6, MY09/MY11, FAP59/64, SKF/SKR) and E1 regions (PM-A/PM-B), according to the protocols previously validated for the detection of mucosal and cutaneous HPV genotypes. PCR products underwent sequencing analysis and the sequences were aligned to reference genomes from the Papillomavirus Episteme database. Phylogenetic analysis was then performed to assess the genetic relationships among the different sequences and between the sequences of the samples and those of the prototype strains. A broad spectrum of sequences related to mucosal and cutaneous HPV types was detected in 81% of the sewage samples analyzed. Surprisingly, sequences related to the anogenital HPV6 and 11 were detected in 19% of the samples, and sequences related to the "high risk" oncogenic HPV16 were identified in two samples. Sequences related to HPV9, HPV20, HPV25, HPV76, HPV80, HPV104, HPV110, HPV111, HPV120 and HPV145 beta Papillomaviruses were detected in 76% of the samples. In addition, similarity searches and phylogenetic analysis of some sequences suggest that they could belong to putative new genotypes of the beta genus. In this study, for the first time, the presence of HPV viruses strongly related to human cancer is reported in sewage samples. Our data increases the knowledge of HPV genomic diversity and suggests that virological analysis of urban sewage can provide key information useful in supporting epidemiological studies.	[La Rosa, Giuseppina; Fratini, Marta; D'Oro, Graziana; Della Libera, Simonetta; Muscillo, Michele] Ist Super Sanita, Dept Environm & Primary Prevent, I-00161 Rome, Italy; [Accardi, Luisa; Di Bonito, Paola] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS)	La Rosa, G (corresponding author), Ist Super Sanita, Dept Environm & Primary Prevent, Viale Regina Elena 299, I-00161 Rome, Italy.	giuseppina.larosa@iss.it; paola.dibonito@iss.it	Di Bonito, Paola/A-6675-2013; Di Bonito, Paola/AAI-3583-2021; Accardi, Luisa/C-2945-2016; La Rosa, Giuseppina/I-8532-2016	Di Bonito, Paola/0000-0002-4737-374X; Di Bonito, Paola/0000-0002-4737-374X; Accardi, Luisa/0000-0002-5091-9272; La Rosa, Giuseppina/0000-0002-2657-100X; della libera, simonetta/0000-0001-6882-3140; Fratini, Marta/0000-0003-0934-3854	Ministry of Health; joint Italia-USA project "Assessing the Impact of GIV Norovirus on Human Health: a Molecular Epidemiological Investigation on Environmental and Clinical Samples as a Basis for the Design of Novel Diagnostic Tools for an Emerging Pathogen"	Ministry of Health; joint Italia-USA project "Assessing the Impact of GIV Norovirus on Human Health: a Molecular Epidemiological Investigation on Environmental and Clinical Samples as a Basis for the Design of Novel Diagnostic Tools for an Emerging Pathogen"	This work was partially funded by the Ministry of Health, AIDS projects 2009-2012, and partially supported by the joint Italia-USA project "Assessing the Impact of GIV Norovirus on Human Health: a Molecular Epidemiological Investigation on Environmental and Clinical Samples as a Basis for the Design of Novel Diagnostic Tools for an Emerging Pathogen". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, IARC MONOGRAPHS EVAL; Antonsson A, 2012, J MED VIROL, V84, P814, DOI 10.1002/jmv.23257; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bertrand I, 2012, J APPL MICROBIOL, P10; Bofill-Mas S, 2000, APPL ENVIRON MICROB, V66, P238, DOI 10.1128/AEM.66.1.238-245.2000; Bofill-Mas S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-141; Cantalupo PG, 2011, MBIO, V2, DOI 10.1128/mBio.00180-11; de Koning M, 2006, J CLIN MICROBIOL, V44, P1792, DOI 10.1128/JCM.44.5.1792-1800.2006; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; de Villiers EM, 2009, J GEN VIROL, V90, P1999, DOI 10.1099/vir.0.011478-0; Di Bonito P., 2006, INFECT AGENTS CANCER, V1, P1; Ferlay J, 2010, GLOBOCAN 2008 V1 2, V1.2; Forslund O, 1999, J GEN VIROL, V80, P2437, DOI 10.1099/0022-1317-80-9-2437; Frega A, 2003, CANCER LETT, V194, P21, DOI 10.1016/S0304-3835(03)00048-X; Ghittoni R, 2010, VIRUS GENES, V40, P1, DOI 10.1007/s11262-009-0412-8; Hazard K, 2007, J INVEST DERMATOL, V127, P116, DOI 10.1038/sj.jid.5700570; Heijnen L, 2011, J WATER HEALTH, V9, P434, DOI 10.2166/wh.2011.019; Hsu JYC, 2009, J MED VIROL, V81, P1444, DOI 10.1002/jmv.21529; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Iwai M, 2009, APPL ENVIRON MICROB, V75, P1264, DOI 10.1128/AEM.01166-08; Jayaprakash V, 2011, ORAL ONCOL, V47, P1048, DOI 10.1016/j.oraloncology.2011.07.009; Kokkinos PA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-195; La Rosa G, 2010, WATER RES, V44, P1777, DOI 10.1016/j.watres.2009.11.055; La Rosa G, 2010, ANN I SUPER SANITA, V46, P266, DOI 10.4415/ANN_10_03_07; La Rosa G, 2010, APPL ENVIRON MICROB, V76, P5870, DOI 10.1128/AEM.00336-10; MANOS MM, 1989, CANCER CEL, V7, P209; Meleg E, 2008, APPL ENVIRON MICROB, V74, P3394, DOI 10.1128/AEM.02895-07; Meys R, 2010, BRIT J DERMATOL, V162, P6, DOI 10.1111/j.1365-2133.2009.09365.x; Okoh AI, 2010, INT J ENV RES PUB HE, V7, P2620, DOI 10.3390/ijerph7062620; Orlando PA, 2012, J INFECT DIS, V205, P272, DOI 10.1093/infdis/jir717; Pinto RM, 2007, EPIDEMIOL INFECT, V135, P270, DOI 10.1017/S0950268806006753; Reynolds KA, 2012, TAP VIRUSES CANC POT, V54; Sasagawa T, 2012, J MED VIROL, V84, P138, DOI 10.1002/jmv.22195; Sinclair RG, 2008, ADV APPL MICROBIOL, V65, P249, DOI 10.1016/S0065-2164(08)00609-6; Syrjanen S, 2010, ANN ONCOL, V21, P243, DOI 10.1093/annonc/mdq454; Syrjanen S., 2000, PAPILLOMAVIRUS INFEC; Syrjanen S, 2010, APMIS, V118, P494, DOI 10.1111/j.1600-0463.2010.02620.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vasiljevic N, 2008, J GEN VIROL, V89, P2467, DOI 10.1099/vir.0.2008/001925-0; Viarisio D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002125; Waterboer T, 2008, BRIT J DERMATOL, V159, P457, DOI 10.1111/j.1365-2133.2008.08621.x	41	24	24	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52391	10.1371/journal.pone.0052391	http://dx.doi.org/10.1371/journal.pone.0052391			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341898	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400015
J	Schmiegelow, C; Minja, D; Oesterholt, M; Pehrson, C; Suhrs, HE; Bostrom, S; Lemnge, M; Magistrado, P; Rasch, V; Nielsen, BB; Lusingu, J; Theander, TG				Schmiegelow, Christentze; Minja, Daniel; Oesterholt, Mayke; Pehrson, Caroline; Suhrs, Hannah Elena; Bostrom, Stephanie; Lemnge, Martha; Magistrado, Pamela; Rasch, Vibeke; Nielsen, Birgitte Bruun; Lusingu, John; Theander, Thor G.			Malaria and Fetal Growth Alterations in the 3rd Trimester of Pregnancy: A Longitudinal Ultrasound Study	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; RAPID DIAGNOSTIC-TESTS; INTRAUTERINE GROWTH; PERINATAL-MORTALITY; SERIAL ULTRASOUND; MATERNAL MALARIA; BLOOD-FLOW; INFECTION; ANEMIA; RETARDATION	Background: Pregnancy associated malaria is associated with decreased birth weight, but in-utero evaluation of fetal growth alterations is rarely performed. The objective of this study was to investigate malaria induced changes in fetal growth during the 3rd trimester using trans-abdominal ultrasound. Methods: An observational study of 876 pregnant women (398 primi- and secundigravidae and 478 multigravidae) was conducted in Tanzania. Fetal growth was monitored with ultrasound and screening for malaria was performed regularly. Birth weight and fetal weight were converted to z-scores, and fetal growth evaluated as fetal weight gain from the 26th week of pregnancy. Results: Malaria infection only affected birth weight and fetal growth among primi- and secundigravid women. Forty-eight of the 398 primi- and secundigravid women had malaria during pregnancy causing a reduction in the newborns z-score of -0.50 (95% CI: -0.86, in -0.13, P = 0.008, multiple linear regression). Fifty-eight percent (28/48) of the primi- and secundigravidae had malaria in the first half of pregnancy, but an effect on fetal growth was observed in the 3rd trimester with an OR of 4.89 for the fetal growth rate belonging to the lowest 25% in the population (95% CI: 2.03-11.79, P<0.001, multiple logistic regression). At an individual level, among the primi- and secundigravidae, 27% experienced alterations of fetal growth immediately after exposure but only for a short interval, 27% only late in pregnancy, 16.2% persistently from exposure until the end of pregnancy, and 29.7% had no alterations of fetal growth. Conclusions: The effect of malaria infections was observed during the 3rd trimester, despite infections occurring much earlier in pregnancy, and different mechanisms might operate leading to different patterns of growth alterations. This study highlights the need for protection against malaria throughout pregnancy and the recognition that observed changes in fetal growth might be a consequence of an infection much earlier in pregnancy.	[Schmiegelow, Christentze; Minja, Daniel; Pehrson, Caroline; Suhrs, Hannah Elena; Magistrado, Pamela; Lusingu, John; Theander, Thor G.] Univ Copenhagen, Ctr Med Parasitol, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Minja, Daniel; Lemnge, Martha; Lusingu, John] Tanga Med Res Ctr, Natl Inst Med Res, Tanga, Tanzania; [Oesterholt, Mayke] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Pehrson, Caroline] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Bostrom, Stephanie] Stockholm Univ, Wenner Gren Inst, Dept Immunol, S-10691 Stockholm, Sweden; [Rasch, Vibeke] Odense Univ Hosp, Dept Obstet & Gynecol, DK-5000 Odense, Denmark; [Nielsen, Birgitte Bruun] Aarhus Univ Hosp, Dept Obstet & Gynecol, Skejby, Denmark; [Schmiegelow, Christentze; Minja, Daniel; Pehrson, Caroline; Suhrs, Hannah Elena; Magistrado, Pamela; Lusingu, John; Theander, Thor G.] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen, Denmark	University of Copenhagen; National Institute of Medical Research; Radboud University Nijmegen; University of Copenhagen; Stockholm University; University of Southern Denmark; Odense University Hospital; Aarhus University; University of Copenhagen	Schmiegelow, C (corresponding author), Univ Copenhagen, Ctr Med Parasitol, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	chsch@sund.ku.dk	Theander, Thor/F-6714-2015; Rasch, Vibeke/G-9393-2019; Lusingu, John P. A./GSJ-3228-2022	Theander, Thor/0000-0002-3509-7514; Rasch, Vibeke/0000-0001-6557-0985; Lusingu, John P. A./0000-0002-9407-0602; Pehrson, Caroline/0000-0002-5736-4847; shmiegelow, christentze/0000-0002-9360-9741	European Union Framework 7 (STOPPAM, Tanzania) [200889]; Copenhagen University PhD school; Novo Nordisk Fonden [NNF12OC0002118] Funding Source: researchfish	European Union Framework 7 (STOPPAM, Tanzania); Copenhagen University PhD school; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by European Union Framework 7 (STOPPAM, Tanzania) [contract number 200889] (URL: http://cordis.europa.eu/fp7/capacities/research-sme_en.html) and by the Copenhagen University PhD school (URL: http://healthsciences.ku.dk/phd). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Huynh BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035342; Huynh BT, 2011, AM J TROP MED HYG, V85, P214, DOI 10.4269/ajtmh.2011.11-0103; CHANG TC, 1993, OBSTET GYNECOL, V82, P230; CHITTY LS, 1994, BRIT J OBSTET GYNAEC, V101, P35, DOI 10.1111/j.1471-0528.1994.tb13007.x; Christensen DL, 2011, INT J GYNECOL OBSTET, V115, pS16, DOI 10.1016/S0020-7292(11)60006-4; Claris O, 2010, SEMIN PERINATOL, V34, P207, DOI 10.1053/j.semperi.2010.02.005; Cottrell G, 2007, AM J TROP MED HYG, V76, P849, DOI 10.4269/ajtmh.2007.76.849; de Jong CLD, 1999, ULTRASOUND OBST GYN, V13, P86, DOI 10.1046/j.1469-0705.1999.13020086.x; de Jong CLD, 1998, ULTRASOUND OBST GYN, V11, P39, DOI 10.1046/j.1469-0705.1998.11010039.x; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Dorman EK, 2002, ULTRASOUND OBST GYN, V19, P165, DOI 10.1046/j.0960-7692.2001.00545.x; Figueras F, 2011, AM J OBSTET GYNECOL, V204, P288, DOI 10.1016/j.ajog.2010.08.055; Griffin JB, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-319; HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4; HADLOCK FP, 1992, RADIOLOGY, V182, P501, DOI 10.1148/radiology.182.2.1732970; Hemachandra AH, 2006, AM J HUM BIOL, V18, P791, DOI 10.1002/ajhb.20552; Hendrix N, 2008, SEMIN PERINATOL, V32, P161, DOI 10.1053/j.semperi.2008.02.004; Ishaque S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S3; Kalanda BF, 2006, EPIDEMIOL INFECT, V134, P659, DOI 10.1017/S0950268805005285; Kalanda BF, 2005, ARCH DIS CHILD-FETAL, V90, P161, DOI 10.1136/adc.2004.054650; Kalilani L, 2010, T ROY SOC TROP MED H, V104, P416, DOI 10.1016/j.trstmh.2010.01.013; Kramer MS, 2003, J NUTR, V133, p1592S, DOI 10.1093/jn/133.5.1592S; Kyabayinze DJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-306; Lampl M, 2003, AM J HUM BIOL, V15, P667, DOI 10.1002/ajhb.10204; Landis SH, 2009, EPIDEMIOL INFECT, V137, P294, DOI 10.1017/S0950268808000915; Mahajan S, 2008, BRIT J NUTR, V100, P408, DOI 10.1017/S000711450889438X; McGready R, 2011, LANCET INFECT DIS; MEURIS S, 1993, AM J TROP MED HYG, V48, P603, DOI 10.4269/ajtmh.1993.48.603; Minja DTR, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-211; Mirghani HM, 2005, J OBSTET GYNAECOL RE, V31, P409, DOI 10.1111/j.1447-0756.2005.00311.x; Mmbando BP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-216; Mondry A, 2005, ULTRASOUND OBST GYN, V26, P634, DOI 10.1002/uog.2598; Muehlenbachs A, 2006, PLOS MED, V3, P2124, DOI 10.1371/journal.pmed.0030446; Nahum GG, 2003, AM J OBSTET GYNECOL, V188, P566, DOI 10.1067/mob.2003.155; Ott WJ, 2006, CLIN OBSTET GYNECOL, V49, P295, DOI 10.1097/00003081-200606000-00011; Ott WJ, 2002, AM J PERINAT, V19, P133, DOI 10.1055/s-2002-25313; Owen P, 1996, BRIT J OBSTET GYNAEC, V103, P60, DOI 10.1111/j.1471-0528.1996.tb09516.x; Rijken MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031411; Rijken MJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-5; Rogerson SJ, 2000, AM J TROP MED HYG, V62, P335, DOI 10.4269/ajtmh.2000.62.335; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Rogerson SJ, 2007, AM J TROP MED HYG, V77, P14; Schmiegelow C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044773; Schmiegelow C, 2012, ACTA OBSTET GYN SCAN, V91, P1061, DOI 10.1111/j.1600-0412.2012.01478.x; Scifres CM, 2009, J PHYSIOL-LONDON, V587, P3453, DOI 10.1113/jphysiol.2009.173252; Scioscia M, 2008, OBSTET GYNECOL, V111, P57, DOI 10.1097/01.AOG.0000296656.81143.e6; Shulman CE, 1996, T ROY SOC TROP MED H, V90, P535, DOI 10.1016/S0035-9203(96)90312-0; Shulman CE, 2001, TROP MED INT HEALTH, V6, P770, DOI 10.1046/j.1365-3156.2001.00786.x; Steketee RW, 1996, AM J TROP MED HYG, V55, P33, DOI 10.4269/ajtmh.1996.55.33; Sullivan AD, 1999, J INFECT DIS, V179, P1580, DOI 10.1086/314752; TAHA TE, 1993, AM J EPIDEMIOL, V138, P318, DOI 10.1093/oxfordjournals.aje.a116861; Umbers AJ, 2011, TRENDS PARASITOL; Umbers AJ, 2011, J INFECT DIS, V203, P561, DOI 10.1093/infdis/jiq080; Valea I, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-71; Verhoeff FH, 2001, EUR J CLIN NUTR, V55, P682, DOI 10.1038/sj.ejcn.1601200; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233	57	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53794	10.1371/journal.pone.0053794	http://dx.doi.org/10.1371/journal.pone.0053794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326508	Green Submitted, Green Published, gold			2022-12-25	WOS:000314705800076
J	Suzuki, M; Yoshimine, H; Harada, Y; Tsuchiya, N; Shimada, I; Ariyoshi, K; Inoue, K				Suzuki, Motoi; Yoshimine, Hiroyuki; Harada, Yoshitaka; Tsuchiya, Naho; Shimada, Ikumi; Ariyoshi, Koya; Inoue, Kenichiro			Estimating the Influenza Vaccine Effectiveness against Medically Attended Influenza in Clinical Settings: A Hospital-Based Case-Control Study with a Rapid Diagnostic Test in Japan	PLOS ONE			English	Article							AUSTRALIA; EFFICACY; DESIGNS; VIRUS	Background: Influenza vaccine effectiveness (VE) studies are usually conducted by specialized agencies and require time and resources. The objective of this study was to estimate the influenza VE against medically attended influenza using a test-negative case-control design with rapid influenza diagnostic tests (RIDT) in a clinical setting. Methods: A prospective study was conducted at a community hospital in Nagasaki, western Japan during the 2010/11 influenza season. All outpatients aged 15 years and older with influenza-like illnesses (ILI) who had undergone RIDT were enrolled. A test-negative case-control design was applied to estimate the VEs: the cases were ILI patients with positive RIDT results and the controls were ILI patients with negative RIDT results. Information on patient characteristics, including vaccination histories, was collected using questionnaires and medical records. Results: Between December 2010 and April 2011, 526 ILI patients were tested with RIDT, and 476 were eligible for the analysis. The overall VE estimate against medically attended influenza was 47.6%, after adjusting for the patients' age groups, presence of chronic conditions, month of visit, and smoking and alcohol use. The seasonal influenza vaccine reduced the risk of medically attended influenza by 60.9% for patients less than 50 years of age, but a significant reduction was not observed for patients 50 years of age and older. A sensitivity analysis provided similar figures. Conclusion: The test-negative case-control study using RIDT provided moderate influenza VE consistent with other reports. Utilizing the commonly used RIDT to estimate VE provides rapid assessment of VE; however, it may require validation with more specific endpoint.	[Suzuki, Motoi; Harada, Yoshitaka; Tsuchiya, Naho; Shimada, Ikumi; Ariyoshi, Koya] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki 852, Japan; [Yoshimine, Hiroyuki; Harada, Yoshitaka; Inoue, Kenichiro] Inoue Hosp, Nagasaki, Japan	Nagasaki University	Ariyoshi, K (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki 852, Japan.	kari@nagasaki-u.ac.jp		Suzuki, Motoi/0000-0002-8340-0880	"Improvement of Research Environment for Young Researchers" program	"Improvement of Research Environment for Young Researchers" program	Funding: This work was supported by the "Improvement of Research Environment for Young Researchers" program organized by the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose CS, 2011, INFLUENZA OTHER RESP, V5, P67, DOI 10.1111/j.1750-2659.2010.00183.x; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Castilla J, 2011, EURO SURVEILL, V16; Center IDS, 2011, 2010 11 INFL SEAS; Cheng AC, 2011, VACCINE, V29, P7320, DOI 10.1016/j.vaccine.2011.07.087; Chu H, 2011, INFLUENZA OTHER RESP; Diseases NESoV-P, 2010, AGE DISTRIBUTION INF; Ferdinands JM, 2011, CLIN INFECT DIS; Fielding JE, 2011, EMERG INFECT DIS, V17, P1181, DOI 10.3201/eid1707.101959; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Griffin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023085; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Jackson LA, 2006, INT J EPIDEMIOL, V35, P345, DOI 10.1093/ije/dyi275; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub3; Katayose M, 2011, VACCINE, V29, P1844, DOI 10.1016/j.vaccine.2010.12.049; Mahmud S, 2011, VACCINE, V29, P7975, DOI 10.1016/j.vaccine.2011.08.068; Michiels B, 2011, VACCINE, V29, P9159, DOI 10.1016/j.vaccine.2011.08.008; Ministry of Health LaW Japan, 2010, VACC PAND INFL A H1N; Mori M, 2008, VACCINE, V26, P6459, DOI 10.1016/j.vaccine.2008.06.040; Ndifon W, 2009, VACCINE, V27, P2447, DOI 10.1016/j.vaccine.2009.02.047; NESVPD, 2011, AG DISTR INFL VACC H; Nishiura H, 2011, EMERG INFECT DIS, V17, P746, DOI [10.3201/eid1704.100525, 10.3201/eid1706.100525]; Ochiai H, 2009, VACCINE, V27, P7031, DOI 10.1016/j.vaccine.2009.09.067; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; Osterholm MT, 2011, LANCET INFECT DIS; Park AW, 2007, LANCET INFECT DIS, V7, P543, DOI 10.1016/S1473-3099(07)70186-X; Petrie JG, 2011, J INFECT DIS, V203, P1309, DOI 10.1093/infdis/jir015; Skowronski DM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7297; Steens A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-196; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Valenciano M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000388; Valenciano M, 2010, VACCINE, V28, P7381, DOI 10.1016/j.vaccine.2010.09.010	35	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52103	10.1371/journal.pone.0052103	http://dx.doi.org/10.1371/journal.pone.0052103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326324	gold, Green Published, Green Submitted			2022-12-25	WOS:000314705800013
J	Gulde, PE; Christen, L; Brown, SV; Williams, N				Gulde, Paul E.; Christen, Linda; Brown, Silvia V.; Williams, Noreen			Three Distinct Isoforms of ATP Synthase Subunit c Are Expressed in T. brucei and Assembled into the Mitochondrial ATP Synthase Complex	PLOS ONE			English	Article							BLOOD-STREAM FORMS; TRYPANOSOMA-BRUCEI; GENE; RING; F-0; SEQUENCES; PROTEINS	One striking feature of the biology of trypanosomes is the changes in mitochondrial structure and function that occur as these parasites transition from one life cycle stage to another. Our laboratory has been interested in the role the mitochondrial ATP synthase plays in mitochondrial changes through the life cycle. Analysis of the recently completed T. brucei genome suggested that there may be multiple putative genes encoding ATP synthase subunit c. While homologous in their 39 ends, these genes differ in their 59 ends and, if expressed, would result in three distinct proteins. Our analysis showed that all three of the possible transcripts were detected in both procyclic and bloodstream stages, although the c-3 transcript was less abundant than that for c-1 or c-2. The three isoforms of subunit c are produced in both the bloodstream and procyclic stages and their mature protein products possess distinct N-terminal regions of the protein as found within mitochondria. All three isoforms are also incorporated into the assembled ATP synthase complex from procyclic cells. Although multiple subunit c genes have been found in other organisms, they produce identical polypeptides and the finding of significant differences in the mature proteins is unique to T. brucei.	[Williams, Noreen] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Williams, N (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA.	nw1@buffalo.edu			National Institutes of Health [AI-48845]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grant AI-48845 to NW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Andersson U, 1997, BIOCHEM J, V323, P379, DOI 10.1042/bj3230379; Baker LA, 2012, P NATL ACAD SCI USA, V109, P11675, DOI 10.1073/pnas.1204935109; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Brenndorfer M, 2010, MOL BIOCHEM PARASIT, V172, P52, DOI 10.1016/j.molbiopara.2010.03.007; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Brown SV, 2006, EUKARYOT CELL, V5, P45, DOI 10.1128/EC.5.1.45-53.2006; Brown SV, 2001, MOL BIOCHEM PARASIT, V115, P177, DOI 10.1016/S0166-6851(01)00282-1; Chi TB, 1998, MOL BIOCHEM PARASIT, V92, P29, DOI 10.1016/S0166-6851(97)00222-3; CLAYTON C, 1995, MICROBIOL REV, V59, P325, DOI 10.1128/MMBR.59.3.325-344.1995; COLLINSON IR, 1994, BIOCHEMISTRY-US, V33, P7971, DOI 10.1021/bi00191a026; CUNNINGHAM I, 1977, J PROTOZOOL, V24, P325, DOI 10.1111/j.1550-7408.1977.tb00987.x; De Grassi A, 2006, GENE, V371, P224, DOI 10.1016/j.gene.2005.11.022; Devenish RJ, 2008, INT REV CEL MOL BIO, V267, P1, DOI 10.1016/S1937-6448(08)00601-1; DYER MR, 1993, BIOCHEM J, V293, P51, DOI 10.1042/bj2930051; Fisk JC, 2008, J BIOL CHEM, V283, P23016, DOI 10.1074/jbc.M801021200; GAY NJ, 1985, EMBO J, V4, P3519, DOI 10.1002/j.1460-2075.1985.tb04111.x; GIRVIN ME, 1993, BIOCHEMISTRY-US, V32, P12167, DOI 10.1021/bi00096a029; Hausler T, 1997, EUR J CELL BIOL, V73, P240; HENSGENS LAM, 1979, P NATL ACAD SCI USA, V76, P1663, DOI 10.1073/pnas.76.4.1663; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matthews KR, 1999, PARASITOL TODAY, V15, P76, DOI 10.1016/S0169-4758(98)01381-7; Meier T, 2007, MOL MICROBIOL, V65, P1181, DOI 10.1111/j.1365-2958.2007.05857.x; NOLAN DP, 1992, EUR J BIOCHEM, V209, P207, DOI 10.1111/j.1432-1033.1992.tb17278.x; Nolan DP, 1991, SOC T, V18, P735; Pogoryelov D, 2012, P NATL ACAD SCI USA, V109, pE1599, DOI 10.1073/pnas.1120027109; PRIEST JW, 1995, BBA-MOL CELL RES, V1269, P201, DOI 10.1016/0167-4889(95)00154-6; Rak M, 2009, BBA-MOL CELL RES, V1793, P108, DOI 10.1016/j.bbamcr.2008.07.001; Schemidt RA, 1998, J BACTERIOL, V180, P3205, DOI 10.1128/JB.180.12.3205-3208.1998; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Symersky J, 2012, P NATL ACAD SCI USA, V109, P13961, DOI 10.1073/pnas.1207912109; Symersky J, 2012, NAT STRUCT MOL BIOL, V19, P485, DOI 10.1038/nsmb.2284; van Hellemond JJ, 2005, BIOCHEM SOC T, V33, P967, DOI 10.1042/BST20050967; VERCESI AE, 1992, MOL BIOCHEM PARASIT, V56, P251, DOI 10.1016/0166-6851(92)90174-I; Vives-Bauza C, 2010, MOL BIOL CELL, V21, P131, DOI 10.1091/mbc.E09-06-0483; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; WILLIAMS N, 1994, J BIOENERG BIOMEMBR, V26, P173, DOI 10.1007/BF00763066; WILLIAMS N, 1991, ARCH BIOCHEM BIOPHYS, V288, P509, DOI 10.1016/0003-9861(91)90228-B; WILLIAMS N, 1990, MOL BIOCHEM PARASIT, V43, P125, DOI 10.1016/0166-6851(90)90137-B; Wittig I, 2007, ELECTROPHORESIS, V28, P3811, DOI 10.1002/elps.200700367; Zikova A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000436	44	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54039	10.1371/journal.pone.0054039	http://dx.doi.org/10.1371/journal.pone.0054039			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326569	gold, Green Published, Green Submitted			2022-12-25	WOS:000313552400069
J	Duarte, M; Wang, LL; Calderwood, MA; Adelmant, G; Ohashi, M; Roecklein-Canfield, J; Marto, JA; Hill, DE; Deng, HY; Johannsen, E				Duarte, Melissa; Wang, Lili; Calderwood, Michael A.; Adelmant, Guillaume; Ohashi, Makoto; Roecklein-Canfield, Jennifer; Marto, Jarrod A.; Hill, David E.; Deng, Hongyu; Johannsen, Eric			An RS Motif within the Epstein-Barr Virus BLRF2 Tegument Protein Is Phosphorylated by SRPK2 and Is Important for Viral Replication	PLOS ONE			English	Article							MURINE GAMMAHERPESVIRUS-68; GENE-EXPRESSION; SM PROTEIN; KINASES; SEQUENCE; ORF52; IDENTIFICATION; HERPESVIRUS; ENRICHMENT; INHIBITION	Epstein-Barr virus (EBV) is a gammaherpesvirus that causes infectious mononucleosis, B cell lymphomas, and nasopharyngeal carcinoma. Many of the genes required for EBV virion morphogenesis are found in all herpesviruses, but some are specific to gammaherpesviruses. One of these gamma-specific genes, BLRF2, encodes a tegument protein that has been shown to be essential for replication in other gammaherpesviruses. In this study, we identify BLRF2 interacting proteins using binary and co-complex protein assays. Serine/Arginine-rich Protein Kinase 2 (SRPK2) was identified by both assays and was further shown to phosphorylate an RS motif in the BLRF2 C-terminus. Mutation of this RS motif (S148A+S150A) abrogated the ability of BLRF2 to support replication of a murine gammaherpesvirus 68 genome lacking the BLRF2 homolog (ORF52). We conclude that the BLRF2 RS motif is phosphorylated by SRPK2 and is important for viral replication.	[Duarte, Melissa; Calderwood, Michael A.; Johannsen, Eric] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; [Duarte, Melissa; Calderwood, Michael A.; Roecklein-Canfield, Jennifer; Hill, David E.] Dana Farber Canc Inst, CCSB, Boston, MA 02115 USA; [Duarte, Melissa; Calderwood, Michael A.; Roecklein-Canfield, Jennifer; Hill, David E.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Wang, Lili; Deng, Hongyu] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China; [Calderwood, Michael A.; Hill, David E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Adelmant, Guillaume; Marto, Jarrod A.] Dana Farber Canc Inst, Blais Prote Ctr, Dept Canc Biol, Boston, MA 02115 USA; [Adelmant, Guillaume; Marto, Jarrod A.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Ohashi, Makoto; Johannsen, Eric] Univ Wisconsin, Dept Med, Madison, WI USA; [Roecklein-Canfield, Jennifer] Simmons Coll, Dept Chem & Phys, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Chinese Academy of Sciences; Institute of Biophysics, CAS; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison; Simmons University	Johannsen, E (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA.	ejohannsen@medicine.wisc.edu	Calderwood, Mike/B-2475-2014; Wang, Lili/AAJ-8511-2020; Hill, David E/B-6617-2011	Calderwood, Mike/0000-0001-6475-1418; Wang, Lili/0000-0002-8315-531X; 	Center of Excellence in Genomic Science (CEGS) grant from the National Human Genome Research Institute (NHGRI) [P50HG004233]; Howard Hughes Medical Institute Physician-Scientist Early Career Award; National Natural Science Foundation of China [30930007, 81171582]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004233] Funding Source: NIH RePORTER	Center of Excellence in Genomic Science (CEGS) grant from the National Human Genome Research Institute (NHGRI); Howard Hughes Medical Institute Physician-Scientist Early Career Award(Howard Hughes Medical Institute); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Melissa Duarte was post-baccalaureate trainee as part of a Center of Excellence in Genomic Science (CEGS) grant P50HG004233 from the National Human Genome Research Institute (NHGRI) awarded to Marc Vidal (PI). Eric Johannsen is the recipient of a Howard Hughes Medical Institute Physician-Scientist Early Career Award. Part of the research was supported by grants No. 30930007 and 81171582 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askenazi M, 2010, PROTEOMICS, V10, P1880, DOI 10.1002/pmic.200900723; Benach J, 2007, J BIOL CHEM, V282, P31534, DOI 10.1074/jbc.M705637200; Bortz E, 2007, J VIROL, V81, P10137, DOI 10.1128/JVI.01233-06; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Daub H, 2002, J VIROL, V76, P8124, DOI 10.1128/JVI.76.16.8124-8137.2002; Ding JH, 2006, MOL BIOL CELL, V17, P876, DOI 10.1091/mbc.E05-10-0963; Ficarro SB, 2009, ANAL CHEM, V81, P4566, DOI 10.1021/ac9004452; Fukuhara T, 2006, P NATL ACAD SCI USA, V103, P11329, DOI 10.1073/pnas.0604616103; Giannakouros T, 2011, FEBS J, V278, P570, DOI 10.1111/j.1742-4658.2010.07987.x; Gore M, 2009, VIROLOGY, V383, P162, DOI 10.1016/j.virol.2008.10.010; Hatzivassiliou E, 1997, BIOCHEMISTRY-US, V36, P9221, DOI 10.1021/bi963145k; Hinderer W, 1999, J CLIN MICROBIOL, V37, P3239, DOI 10.1128/JCM.37.10.3239-3244.1999; Hong Y, 2011, J BIOL CHEM, V286, P777, DOI 10.1074/jbc.M110.193441; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jang SW, 2009, J BIOL CHEM, V284, P24512, DOI 10.1074/jbc.M109.026237; Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101; Karakama Y, 2010, ANTIMICROB AGENTS CH, V54, P3179, DOI 10.1128/AAC.00113-10; Kieff E, 2007, FIELDS VIROLOGY, P2603; Kutok JL, 2006, ANNU REV PATHOL-MECH, V1, P375, DOI 10.1146/annurev.pathol.1.110304.100209; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Lee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002297; Loesing JB, 2009, J GEN VIROL, V90, P1440, DOI 10.1099/vir.0.009571-0; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Parikh JR, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-364; Rickinson AB, 2007, FIELDS VIROLOGY, V2, P2655; Rivailler P, 2002, J VIROL, V76, P12055, DOI 10.1128/JVI.76.23.12055-12068.2002; Rivailler P, 2002, J VIROL, V76, P421, DOI 10.1128/JVI.76.1.421-426.2002; Rozen R, 2008, J VIROL, V82, P4742, DOI 10.1128/JVI.02745-07; Rozenblatt-Rosen O, 2012, NATURE, V487, P491, DOI 10.1038/nature11288; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Sathish N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000332; Sciabica KS, 2003, EMBO J, V22, P1608, DOI 10.1093/emboj/cdg166; Song MJ, 2005, P NATL ACAD SCI USA, V102, P3805, DOI 10.1073/pnas.0404521102; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsai K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002376; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Verma D, 2010, J VIROL, V84, P11781, DOI 10.1128/JVI.01359-10; Verma D, 2009, J VIROL, V83, P8041, DOI 10.1128/JVI.00382-09; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Wang LL, 2012, J VIROL, V86, P1348, DOI 10.1128/JVI.05497-11; Young LS, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P461	43	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53512	10.1371/journal.pone.0053512	http://dx.doi.org/10.1371/journal.pone.0053512			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326445	Green Published, Green Submitted, gold			2022-12-25	WOS:000313551500079
J	Menzies, KJ; Singh, K; Saleem, A; Hood, DA				Menzies, Keir J.; Singh, Kaustabh; Saleem, Ayesha; Hood, David A.			Sirtuin 1-mediated Effects of Exercise and Resveratrol on Mitochondrial Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CHRONIC CONTRACTILE ACTIVITY; NAD(+) SALVAGE PATHWAY; SKELETAL-MUSCLE; GLUCOSE-HOMEOSTASIS; METABOLIC ADAPTATION; CALORIC RESTRICTION; AUTOREGULATORY LOOP; ENERGY-METABOLISM; OXIDATIVE STRESS	The purpose of this study was to evaluate the role of sirtuin 1 (SirT1) in exercise-and resveratrol (RSV)-induced skeletal muscle mitochondrial biogenesis. Using muscle-specific SirT1-deficient (KO) mice and a cell culture model of differentiated myotubes, we compared the treatment of resveratrol, an activator of SirT1, with that of exercise in inducing mitochondrial biogenesis. These experiments demonstrated that SirT1 plays a modest role in maintaining basal mitochondrial content and a larger role in preserving mitochondrial function. Furthermore, voluntary exercise and RSV treatment induced mitochondrial biogenesis in a SirT1-independent manner. However, when RSV and exercise were combined, a SirT1-dependent synergistic effect was evident, leading to enhanced translocation ofPGC-1 alpha and SirT1 to the nucleus and stimulation of mitochondrial biogenesis. Thus, the magnitude of the effect of RSV on muscle mitochondrial biogenesis is reliant on SirT1, as well as the cellular environment, such as that produced by repeated bouts of exercise.	[Singh, Kaustabh; Saleem, Ayesha; Hood, David A.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 1P3, Canada; [Menzies, Keir J.; Hood, David A.] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; [Menzies, Keir J.; Singh, Kaustabh; Saleem, Ayesha; Hood, David A.] York Univ, Muscle Hlth Res Ctr, Toronto, ON M3J 1P3, Canada	York University - Canada; York University - Canada; York University - Canada	Hood, DA (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Farquharson Life Sci Bldg, Toronto, ON M3J 1P3, Canada.	dhood@yorku.ca	Saleem, Ayesha/J-6685-2019	Saleem, Ayesha/0000-0003-2146-5379; Menzies, Keir J/0000-0002-1873-8500	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by grants from the Canadian Institutes of Health Research (to D. A. H.).	Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE748, DOI 10.1152/ajpendo.00311.2006; Amat R, 2009, J BIOL CHEM, V284, P21872, DOI 10.1074/jbc.M109.022749; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Chabi B, 2009, J APPL PHYSIOL, V107, P1730, DOI 10.1152/japplphysiol.91451.2008; Chen Q, 2008, AM J PHYSIOL-CELL PH, V294, pC460, DOI 10.1152/ajpcell.00211.2007; Dal-Pan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016581; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gibala MJ, 2009, J APPL PHYSIOL, V106, P929, DOI 10.1152/japplphysiol.90880.2008; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Harper CE, 2007, CARCINOGENESIS, V28, P1946, DOI 10.1093/carcin/bgm144; Horn TL, 2007, FOOD CHEM TOXICOL, V45, P55, DOI 10.1016/j.fct.2006.07.015; Irrcher I, 2003, SPORTS MED, V33, P783, DOI 10.2165/00007256-200333110-00001; Irrcher I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003614; Irrcher I, 2009, AM J PHYSIOL-CELL PH, V296, pC116, DOI 10.1152/ajpcell.00267.2007; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Joseph AM, 2012, EXP DIABETES RES, DOI 10.1155/2012/642038; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, pE463, DOI 10.1152/ajpendo.00666.2007; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Ljubicic V, 2008, AM J PHYSIOL-ENDOC M, V295, pE195, DOI 10.1152/ajpendo.90276.2008; Menzies KJ, 2012, MITOCHONDRION, V12, P5, DOI 10.1016/j.mito.2011.03.001; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; O'Leary MFN, 2008, J APPL PHYSIOL, V105, P114, DOI 10.1152/japplphysiol.00724.2007; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Philp A, 2011, J BIOL CHEM, V286, P30561, DOI 10.1074/jbc.M111.261685; Pogozelski AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007934; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Ramadori G, 2011, CELL METAB, V14, P301, DOI 10.1016/j.cmet.2011.06.014; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rowe GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041817; Saleem A, 2009, PHYSIOL GENOMICS, V37, P58, DOI 10.1152/physiolgenomics.90346.2008; Silveira LR, 2006, BBA-MOL CELL RES, V1763, P969, DOI 10.1016/j.bbamcr.2006.06.010; Slinker BK, 1998, J MOL CELL CARDIOL, V30, P723, DOI 10.1006/jmcc.1998.0655; Summermatter S, 2013, DIABETES, V62, P85, DOI 10.2337/db12-0291; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Uguccioni G, 2011, AM J PHYSIOL-ENDOC M, V300, pE361, DOI 10.1152/ajpendo.00292.2010; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469; Zuin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002842	57	123	130	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6968	6979		10.1074/jbc.M112.431155	http://dx.doi.org/10.1074/jbc.M112.431155			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23329826	hybrid, Green Published			2022-12-25	WOS:000316002400019
J	Nayak, MK; Kulkarni, PP; Dash, D				Nayak, Manasa K.; Kulkarni, Paresh P.; Dash, Debabrata			Regulatory Role of Proteasome in Determination of Platelet Life Span	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; KAPPA-B; APOPTOSIS; DEGRADATION; SURVIVAL; RECEPTOR; BETA; BAX; MECHANISMS; SENESCENCE	Limit of platelet life span (8-10 days) is determined by the activity of a putative "internal clock" composed of Bcl-2 family proteins, whereas the role of other molecular players in this process remains obscure. Here, we sought to establish a central role of proteasome in platelet life span regulation. Administration of mice with inhibitors of proteasome peptidase activity induced significant thrombocytopenia. This was associated with enhanced clearance of biotin-labeled platelets from circulation and reduction in average platelet half-life from 66 to 37 h. Cells pretreated in vitro with proteasome inhibitors exhibited augmented annexin V binding and a drop in mitochondrial transmembrane potential indicative of apoptotic cell death and decreased platelet life span. These cells were preferentially phagocytosed by monocyte-derived macrophages, thus linking proteasome activity with platelet survival. The decisive role of proteasome in this process was underscored from enhanced expression of conformationally active Bax in platelets with attenuated proteasome activity, which was consistent with proapoptotic phenotype of these cells. The present study establishes a critical role of proteasome in delimiting platelet life span ostensibly through constitutive elimination of the conformationally active Bax. These findings bear potential implications in clinical settings where proteasome peptidase activities are therapeutically targeted.	[Nayak, Manasa K.; Kulkarni, Paresh P.; Dash, Debabrata] Banaras Hindu Univ, Inst Med Sci, Dept Biochem, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Dash, D (corresponding author), Banaras Hindu Univ, Inst Med Sci, Dept Biochem, Varanasi 221005, Uttar Pradesh, India.	ddass@satyam.net.in	Kulkarni, Paresh P/AAB-3190-2019; Nayak, Manasa/AAZ-9439-2021; DASH, DEBABRATA/AAF-1837-2020; Dash, Debabrata/F-3774-2014	Kulkarni, Paresh P/0000-0002-9108-0485; Nayak, Manasa/0000-0001-6461-0543	Council of Scientific and Industrial Research; Department of Biotechnology; Department of Science and Technology, Government of India	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology; Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by grants from the Council of Scientific and Industrial Research, the Department of Biotechnology, and the Department of Science and Technology, Government of India (all to D. D.).	Avcu F, 2008, THROMB RES, V121, P567, DOI 10.1016/j.thromres.2007.06.013; Berger G, 1998, BLOOD, V92, P4446, DOI 10.1182/blood.V92.11.4446; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Bross PF, 2004, CLIN CANCER RES, V10, P3954, DOI 10.1158/1078-0432.CCR-03-0781; Brown SB, 2000, J BIOL CHEM, V275, P5987, DOI 10.1074/jbc.275.8.5987; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Dowling MR, 2010, BLOOD, V116, P1776, DOI 10.1182/blood-2009-12-259663; Er E, 2006, BBA-BIOENERGETICS, V1757, P1301, DOI 10.1016/j.bbabio.2006.05.032; Falcieri E, 2000, ANAT RECORD, V258, P90, DOI 10.1002/(SICI)1097-0185(20000101)258:1<90::AID-AR10>3.0.CO;2-G; Ferraro-Peyret C, 2002, J IMMUNOL, V169, P4805, DOI 10.4049/jimmunol.169.9.4805; Fu NY, 2009, MOL CELL, V33, P15, DOI 10.1016/j.molcel.2008.11.025; Gaczynska M, 2001, MECH AGEING DEV, V122, P235, DOI 10.1016/S0047-6374(00)00246-3; HARKER LA, 1977, CLIN HAEMATOL, V6, P671; Hideshima T, 2003, BLOOD, V101, P1530, DOI 10.1182/blood-2002-08-2543; Huang L, 2009, CURR MED CHEM, V16, P931, DOI 10.2174/092986709787581860; Ji LL, 2008, TOXICOL APPL PHARM, V231, P393, DOI 10.1016/j.taap.2008.05.015; Kodama T, 2011, J BIOL CHEM, V286, P13905, DOI 10.1074/jbc.M110.195370; Kourtis N, 2011, EMBO J, V30, P2520, DOI 10.1038/emboj.2011.162; Li CY, 2010, J BIOL CHEM, V285, P16096, DOI 10.1074/jbc.M109.072694; Lin A, 2003, SEMIN CANCER BIOL, V13, P107, DOI 10.1016/S1044-579X(02)00128-1; Lopez JJ, 2007, J THROMB HAEMOST, V5, P1283, DOI 10.1111/j.1538-7836.2007.02505.x; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; MURPHY EA, 1971, THROMB DIATH HAEMOST, V26, P431, DOI 10.1055/s-0038-1653696; MURPHY EA, 1971, THROMB DIATH HAEMOST, V25, P53, DOI 10.1055/s-0038-1654280; MUSTARD JF, 1966, BRIT J HAEMATOL, V12, P1, DOI 10.1111/j.1365-2141.1966.tb00121.x; Nayak MK, 2011, THROMB HAEMOSTASIS, V106, P624, DOI 10.1160/TH11-03-0178; Nayak MK, 2011, CELL CALCIUM, V49, P226, DOI 10.1016/j.ceca.2011.02.005; Nussbaum AK, 1998, P NATL ACAD SCI USA, V95, P12504, DOI 10.1073/pnas.95.21.12504; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Ostrowska JK, 2004, THROMB HAEMOSTASIS, V92, P171, DOI 10.1160/TH03-11-0707; Pereira J, 1999, THROMB HAEMOSTASIS, V82, P1318; Perfettini JL, 2002, INFECT IMMUN, V70, P55, DOI 10.1128/IAI.70.1.55-61.2002; Richardson JL, 2005, BLOOD, V106, P4066, DOI 10.1182/blood-2005-06-2206; Sunwoo JB, 2001, CLIN CANCER RES, V7, P1419; Vanags DM, 1997, BRIT J HAEMATOL, V99, P824, DOI 10.1046/j.1365-2141.1997.4813284.x; Varshavsky A, 1989, Biotechnology, V13, P109; Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com; Wadhawan V, 2004, ARCH BIOCHEM BIOPHYS, V422, P183, DOI 10.1016/j.abb.2003.12.024; Wolf BB, 1999, BLOOD, V94, P1683, DOI 10.1182/blood.V94.5.1683.417k37_1683_1692; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; YUKAWA M, 1993, J BIOCHEM-TOKYO, V114, P317, DOI 10.1093/oxfordjournals.jbchem.a124174; Zhang H, 2007, CELL DEATH DIFFER, V14, P943, DOI 10.1038/sj.cdd.4402081; Zhang WL, 2012, THROMB RES, V130, P81, DOI 10.1016/j.thromres.2012.02.013	44	37	37	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6826	6834		10.1074/jbc.M112.403154	http://dx.doi.org/10.1074/jbc.M112.403154			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23329846	hybrid, Green Published			2022-12-25	WOS:000316002400005
J	Breard, E; Lara, E; Comtet, L; Viarouge, C; Doceul, V; Desprat, A; Vitour, D; Pozzi, N; Cay, AB; De Regge, N; Pourquier, P; Schirrmeier, H; Hoffmann, B; Beer, M; Sailleau, C; Zientara, S				Breard, Emmanuel; Lara, Estelle; Comtet, Loic; Viarouge, Cyril; Doceul, Virginie; Desprat, Alexandra; Vitour, Damien; Pozzi, Nathalie; Cay, Ann Brigitte; De Regge, Nick; Pourquier, Philippe; Schirrmeier, Horst; Hoffmann, Bernd; Beer, Martin; Sailleau, Corinne; Zientara, Stephan			Validation of a Commercially Available Indirect Elisa Using a Nucleocapside Recombinant Protein for Detection of Schmallenberg Virus Antibodies	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; G1-GLYCOPROTEIN; EPITOPES; ASSAY	A newly developed Enzym Like Immuno Sorbant Assay (ELISA) based on the recombinant nucleocapsid protein (N) of Schmallenberg virus (SBV) was evaluated and validated for the detection of SBV-specific IgG antibodies in ruminant sera by three European Reference Laboratories. Validation data sets derived from sheep, goat and bovine sera collected in France and Germany (n = 1515) in 2011 and 2012 were categorized according to the results of a virus neutralization test (VNT) or an indirect immuno-flurorescence assay (IFA). The specificity was evaluated with 1364 sera from sheep, goat and bovine collected in France and Belgium before 2009. Overall agreement between VNT and ELISA was 98.9% and 98.3% between VNT and IFA, indicating a very good concordance between the different techniques. Although cross-reactions with other Orthobunyavirus from the Simbu serogroup viruses might occur, it is a highly sensitive, specific and robust ELISA-test validated to detect anti-SBV antibodies. This test can be applied for SBV sero-diagnostics and disease-surveillance studies in ruminant species in Europe.	[Breard, Emmanuel; Lara, Estelle; Viarouge, Cyril; Doceul, Virginie; Desprat, Alexandra; Vitour, Damien; Sailleau, Corinne; Zientara, Stephan] French Agcy Food Environm & Occupat Hlth & Safety, Virol Unit, Maisons Alfort, France; [Comtet, Loic; Pourquier, Philippe] IDVet Soc, Montpellier, France; [Schirrmeier, Horst; Hoffmann, Bernd; Beer, Martin] Friedrich Loeffler Inst, Diagnost Virol Unit, Riems, Germany; [Pozzi, Nathalie] Natl Lab Control Breeding Anim, Maisons Alfort, France; [Cay, Ann Brigitte; De Regge, Nick] Vet & Agrochem Res Ctr, Enzoot & Reemerging Dis Unit, Brussels, Belgium	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); Friedrich Loeffler Institute; Ecole Nationale Veterinaire d'Alfort (ENVA)	Breard, E (corresponding author), French Agcy Food Environm & Occupat Hlth & Safety, Virol Unit, Maisons Alfort, France.	emmanuel.breard@anses.fr	Zientara, Stephan/A-5336-2016; Zientara, Stephan/AAA-7661-2021; breard, emmanuel/E-2123-2011	Zientara, Stephan/0000-0003-0089-8175; Zientara, Stephan/0000-0002-6733-8503; 				Bilk S, 2012, VET MICROBIOL, V159, P236, DOI 10.1016/j.vetmic.2012.03.035; Breard E, 2011, VACCINE, V29, P2495, DOI 10.1016/j.vaccine.2010.12.105; Elbers ARW, 2012, EMERG INFECT DIS, V18, P1065, DOI 10.3201/eid1807.120323; Elliott RM, 2011, BUNYAVIRIDAE: MOLECULAR AND CELLULAR BIOLOGY, P1; Gonzalez-Scarano F, 1983, Prog Clin Biol Res, V123, P145; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Kim HJ, 2012, J VET MED SCI, V74, P321, DOI 10.1292/jvms.11-0259; KINGSFORD L, 1983, VIROLOGY, V129, P443, DOI 10.1016/0042-6822(83)90182-4; KINGSFORD L, 1990, J GEN VIROL, V71, P523, DOI 10.1099/0022-1317-71-3-523; Loeffen W, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-44; Nakauchi M, 2009, CLIN VACCINE IMMUNOL, V16, P1132, DOI 10.1128/CVI.00163-09; Nicacio CD, 2001, J GEN VIROL, V82, P129, DOI 10.1099/0022-1317-82-1-129; Parsonson I. M., 1982, Viral diseases in South-East Asia and the Western Pacific. Proceedings of an International Seminar, Canberra, Australia, 8-12 February 1982, P644; PEKOSZ A, 1995, J VIROL, V69, P3475, DOI 10.1128/JVI.69.6.3475-3481.1995; Rasmussen LD, 2012, EMERG INFECT DIS, V18, P1204, DOI 10.3201/eid1807.120385; Saijo M, 2002, J CLIN MICROBIOL, V40, P1587, DOI 10.1128/JCM.40.5.1587-1591.2002; Saijo M, 2007, CLIN VACCINE IMMUNOL, V14, P1182, DOI 10.1128/CVI.00101-07; VAPALAHTI O, 1995, J MED VIROL, V46, P293, DOI 10.1002/jmv.1890460402; Yanase T, 2012, ARCH VIROL, V157, P1611, DOI 10.1007/s00705-012-1341-8; Yoshida K, 1998, CLIN DIAGN LAB IMMUN, V5, P192, DOI 10.1128/CDLI.5.2.192-198.1998	20	58	68	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53446	10.1371/journal.pone.0053446	http://dx.doi.org/10.1371/journal.pone.0053446			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335964	Green Published, gold			2022-12-25	WOS:000314707700018
J	Kwena, ZA; Camlin, CS; Shisanya, CA; Mwanzo, I; Bukusi, EA				Kwena, Zachary A.; Camlin, Carol S.; Shisanya, Chris A.; Mwanzo, Isaac; Bukusi, Elizabeth A.			Short-Term Mobility and the Risk of HIV Infection among Married Couples in the Fishing Communities along Lake Victoria, Kenya	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; TANZANIAN COUPLES; DOUBLE-STANDARD; BEHAVIOR; MEN; PREVALENCE; MIGRATION; WOMEN; POPULATION; FISHERFOLK	Objective: Mobility has long been associated with high HIV prevalence. We sought to assess sex differences in the relationship between mobility and risk for HIV infection among married couples in the fishing communities. Methods: We conducted 1090 gender-matched interviews and rapid HIV testing with 545 couples proportionally representing all the different sizes of the fish-landing beaches in Kisumu County. We contacted a random sample of fishermen as our index participants and asked them to enrol in the study together with their spouses. The consenting couples were separated into different private rooms for concurrent interviews and thereafter reunited for couple rapid HIV counselling and testing. In addition to socio-economic and behavioural data, we collected information on overnight travels and divided couples in 4 groups as follows both partners not mobile, both partners mobile, only woman mobile, and only man mobile. Other than descriptive statistics, we used X-2 and U tests to compare groups of variables and multivariate logistic regression to measure association between mobility and HIV infection. Results: We found significant differences in the number of trips women travelled in the preceding month (mean 4.6, SD 7.1) compared to men (mean 3.3, SD 4.9; p<0.01) and when the women did travel, they were more likely to spend more days away from home than their male partners (mean 5.2 [SD 7.2] versus 3.4 SD 5.6; p = 0.01). With an HIV prevalence of 22.7% in women compared to 20.9% among men, mobile women who had non-mobile spouses had 2.1 times the likelihood of HIV infection compared to individuals in couples where both partners were non-mobile. Conclusion: The mobility of fishermen's spouses is associated with HIV infection that is not evident among fishermen themselves. Therefore, interventions in this community could be a combination of sex-specific programming that targets women and combined programming for couples.	[Kwena, Zachary A.; Bukusi, Elizabeth A.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Kisumu, Kenya; [Camlin, Carol S.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Shisanya, Chris A.] Kenyatta Univ, Dept Geog, Nairobi, Kenya; [Mwanzo, Isaac] Kenyatta Univ, Dept Publ Hlth, Nairobi, Kenya	Kenya Medical Research Institute; University of California System; University of California San Francisco; Kenyatta University; Kenyatta University	Kwena, ZA (corresponding author), Kenya Govt Med Res Ctr, Ctr Microbiol Res, Kisumu, Kenya.	zkwena@kemri-ucsf.org	Allan, Chrsitopher Shisanya/ABE-7816-2020	Allan, Chrsitopher Shisanya/0000-0002-2137-0372	Consortium for National Health Research (CNHR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH093205] Funding Source: NIH RePORTER	Consortium for National Health Research (CNHR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was funded by the Consortium for National Health Research (CNHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MG, 2003, J SEX RES, V40, P27, DOI 10.1080/00224490309552164; Allison EH, 2004, FISH FISH, V5, P215, DOI 10.1111/j.1467-2679.2004.00153.x; Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; [Anonymous], 2008, RESH EC GEOGR; Asiki G, 2011, SEX TRANSM INFECT, V87, P511, DOI 10.1136/sti.2010.046805; Bloor M, 1998, LANCET, V352, P1664, DOI 10.1016/S0140-6736(98)09414-8; Camlin CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011539; Chappell L, 2009, MAXIMISING DEV OUTCO; Clark S, 2011, INT PERSPECT SEX R H, V37, P181, DOI 10.1363/3718111; Collinson M., 2006, AFRICA MOVE AFRICAN, P194; Crawford M, 2003, J SEX RES, V40, P13, DOI 10.1080/00224490309552163; Croughs M, 2008, J TRAVEL MED, V15, P6, DOI 10.1111/j.1708-8305.2007.00160.x; Deane KD, 2010, TROP MED INT HEALTH, V15, P1458, DOI 10.1111/j.1365-3156.2010.02647.x; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Gupta K, 2010, AIDS BEHAV, V14, P18, DOI 10.1007/s10461-010-9738-4; Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3; Hunter M, 2010, HEALTH PLACE, V16, P25, DOI 10.1016/j.healthplace.2009.08.003; KAIS (Kenya AIDS Indicator Survey), 2009, KEN AIDS IND SURV 20; Katz J, 2000, SEX ROLES, V42, P781, DOI 10.1023/A:1007051131544; Kishamawe C, 2006, AIDS, V20, P601, DOI 10.1097/01.aids.0000210615.83330.b2; Kissling E, 2005, AIDS, V19, P1939, DOI 10.1097/01.aids.0000191925.54679.94; Kramer MA, 2008, SEX TRANSM INFECT, V84, P554, DOI 10.1136/sti.2008.032094; Kwena ZA, 2010, INT J STD AIDS, V21, P708, DOI 10.1258/ijsa.2010.010160; Kwena ZA, 2010, AIDS RES TREAT, V2010, DOI 10.1155/2010/865903; Lippman SA, 2007, SOC SCI MED, V65, P2464, DOI 10.1016/j.socscimed.2007.07.002; Lyons H, 2011, J SEX RES, V48, P437, DOI 10.1080/00224499.2010.506679; Marks MJ, 2006, SEX ROLES, V54, P19, DOI 10.1007/s11199-006-8866-9; Markussen M., 2002, COPING UNCERTAINTY W; Mercer CH, 2007, SEX TRANSM INFECT, V83, P517, DOI 10.1136/sti.2007.026377; Ministry of Planning and National Development, 2008, KIS E DISTR DEV PLAN; NACC, 2009, KEN AN HIV PREV RESP; NACC and NASCOP, 2009, KEN 2007 HIV AIDS ES; Nagoli J, 2010, AJAR-AFR J AIDS RES, V9, P71, DOI 10.2989/16085906.2010.484575; Nepal B, 2007, J HEALTH POPUL NUTR, V25, P267; Ng'ayo MO, 2008, SEX TRANSM INFECT, V84, P140, DOI 10.1136/sti.2007.028795; PISON G, 1993, J ACQ IMMUN DEF SYND, V6, P196; Saggurti N, 2009, AIDS BEHAV, V13, P921, DOI 10.1007/s10461-009-9564-8; SMITH TW, 1992, SOC BIOL, V39, P203; Sopheab H, 2006, JAIDS-J ACQ IMM DEF, V41, P81, DOI 10.1097/01.qai.0000174654.25535.f7; Sprecher S, 1998, J SEX RES, V12, P45; Uretsky E, 2008, CULT HEALTH SEX, V10, P801, DOI 10.1080/13691050802380966; Vissers DCJ, 2008, SEX TRANSM DIS, V35, P714, DOI 10.1097/OLQ.0b013e3181723d93; Voeten HACM, 2010, SEX TRANSM DIS, V37, P240, DOI 10.1097/OLQ.0b013e3181c3f2d0; Ward BJ, 2006, J TRAVEL MED, V13, P300, DOI 10.1111/j.1708-8305.2006.00061.x	44	62	63	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54523	10.1371/journal.pone.0054523	http://dx.doi.org/10.1371/journal.pone.0054523			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086SQ	23336005	Green Published, gold			2022-12-25	WOS:000314707700063
J	Masubuchi, Y; Nakagawa, Y; Ma, JH; Sasaki, T; Kitamura, T; Yamamoto, Y; Kurose, H; Kojima, I; Shibata, H				Masubuchi, Yosuke; Nakagawa, Yuko; Ma, Jinhui; Sasaki, Tsutomu; Kitamura, Tadahiro; Yamamoto, Yoritsuna; Kurose, Hitoshi; Kojima, Itaru; Shibata, Hiroshi			A Novel Regulatory Function of Sweet Taste-Sensing Receptor in Adipogenic Differentiation of 3T3-L1 Cells	PLOS ONE			English	Article							PROTEIN ALPHA-SUBUNIT; GTP-BINDING PROTEIN; ENTEROENDOCRINE CELLS; SIGNAL-TRANSDUCTION; MAMMALIAN SWEET; RAT ADIPOCYTES; ACTIVATION; ENDOTHELIN-1; EXPRESSION; GUSTDUCIN	Background: Sweet taste receptor is expressed not only in taste buds but also in nongustatory organs such as enteroendocrine cells and pancreatic beta-cells, and may play more extensive physiological roles in energy metabolism. Here we examined the expression and function of the sweet taste receptor in 3T3-L1 cells. Methodology/Principal Findings: In undifferentiated preadipocytes, both T1R2 and T1R3 were expressed very weakly, whereas the expression of T1R3 but not T1R2 was markedly up-regulated upon induction of differentiation (by 83.0 and 3.8-fold, respectively at Day 6). The alpha subunits of Gs (G alpha s) and G14 (G alpha 14) but not gustducin were expressed throughout the differentiation process. The addition of sucralose or saccharin during the first 48 hours of differentiation considerably reduced the expression of peroxisome proliferator activated receptor gamma (PPAR gamma and CCAAT/enhancer-binding protein alpha (C/EBP alpha at Day 2, the expression of aP2 at Day 4 and triglyceride accumulation at Day 6. These anti-adipogenic effects were attenuated by short hairpin RNA-mediated gene-silencing of T1R3. In addition, overexpression of the dominant-negative mutant of Gas but not YM-254890, an inhibitor of G alpha 14, impeded the effects of sweeteners, suggesting a possible coupling of Gs with the putative sweet taste-sensing receptor. In agreement, sucralose and saccharin increased the cyclic AMP concentration in differentiating 3T3-L1 cells and also in HEK293 cells heterologously expressing T1R3. Furthermore, the anti-adipogenic effects of sweeteners were mimicked by Gs activation with cholera toxin but not by adenylate cyclase activation with forskolin, whereas small interfering RNA-mediated knockdown of Gas had the opposite effects. Conclusions: 3T3-L1 cells express a functional sweet taste-sensing receptor presumably as a T1R3 homomer, which mediates the anti-adipogenic signal by a Gs-dependent but cAMP-independent mechanism.	[Masubuchi, Yosuke; Nakagawa, Yuko; Ma, Jinhui; Kojima, Itaru; Shibata, Hiroshi] Gunma Univ, Dept Cell Biol, Inst Mol & Cellular Regulat, Maebashi, Gunma 371, Japan; [Sasaki, Tsutomu; Kitamura, Tadahiro] Gunma Univ, Metabol Signal Res Ctr, Inst Mol & Cellular Regulat, Maebashi, Gunma 371, Japan; [Yamamoto, Yoritsuna] Natl Def Med Coll, Def Med Res Inst, Div Environm Med, Tokorozawa, Saitama 359, Japan; [Kurose, Hitoshi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Fukuoka 812, Japan	Gunma University; Gunma University; National Defense Medical College - Japan; Kyushu University	Shibata, H (corresponding author), Gunma Univ, Dept Cell Biol, Inst Mol & Cellular Regulat, Maebashi, Gunma 371, Japan.	hshibata@gunma-u.ac.jp		Sasaki, Tsutomu/0000-0001-8041-1915	Global Centers of Excellence Program "Signal Transduction in the Regulatory System and Its Disorders"; Ministry of Education, Culture, Sports, Science and Technology of Japan	Global Centers of Excellence Program "Signal Transduction in the Regulatory System and Its Disorders"; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Global Centers of Excellence Program "Signal Transduction in the Regulatory System and Its Disorders" and grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya I, 2006, FEBS LETT, V580, P5765, DOI 10.1016/j.febslet.2006.09.032; Bose A, 2001, MOL CELL BIOL, V21, P5262, DOI 10.1128/MCB.21.15.5262-5275.2001; Bystrova MF, 2010, J CELL SCI, V123, P972, DOI 10.1242/jcs.061879; Damak S, 2006, CHEM SENSES, V31, P253, DOI 10.1093/chemse/bjj027; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; Danilova V, 2006, CHEM SENSES, V31, P573, DOI 10.1093/chemse/bjj062; Dave RH, 2009, NEUROSIGNALS, V17, P100, DOI 10.1159/000186693; Delay ER, 2006, CHEM SENSES, V31, P351, DOI 10.1093/chemse/bjj039; DJIAN P, 1985, J CELL PHYSIOL, V124, P554, DOI 10.1002/jcp.1041240327; Gabriel AS, 2009, BIOCHEM BIOPH RES CO, V378, P414, DOI 10.1016/j.bbrc.2008.11.060; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Hattori H, 2006, BIOCHEM BIOPH RES CO, V343, P1118, DOI 10.1016/j.bbrc.2006.03.061; Hewavitharana T, 2012, CELL SIGNAL, V24, P25, DOI 10.1016/j.cellsig.2011.08.014; Imamura T, 1999, J BIOL CHEM, V274, P33691, DOI 10.1074/jbc.274.47.33691; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; JONES DT, 1987, J BIOL CHEM, V262, P14241; Kojima I, 2011, DIABETES METAB J, V35, P451, DOI 10.4093/dmj.2011.35.5.451; Kokrashvili Z, 2009, AM J CLIN NUTR, V90, p822S, DOI 10.3945/ajcn.2009.27462T; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kusakabe Y, 2000, CHEM SENSES, V25, P525, DOI 10.1093/chemse/25.5.525; Lawrence JTR, 2001, MOL CELL BIOL, V21, P5276, DOI 10.1128/MCB.21.15.5276-5285.2001; LEE E, 1992, J BIOL CHEM, V267, P1212; Liu LB, 2007, DIABETES, V56, P1977, DOI 10.2337/db06-1100; Liu XX, 1998, J BIOL CHEM, V273, P11685, DOI 10.1074/jbc.273.19.11685; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Maruyama Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034489; MILLER RT, 1988, NATURE, V334, P712, DOI 10.1038/334712a0; NAIM M, 1991, COMP BIOCHEM PHYS B, V100, P455, DOI 10.1016/0305-0491(91)90203-P; Nakagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005106; Nakashima K, 1999, CELL PHYSIOL BIOCHEM, V9, P90, DOI 10.1159/000016305; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; Ohsu T, 2010, J BIOL CHEM, V285, P1016, DOI 10.1074/jbc.M109.029165; OLANSKY L, 1983, P NATL ACAD SCI-BIOL, V80, P6547, DOI 10.1073/pnas.80.21.6547; Petersen RK, 2008, MOL CELL BIOL, V28, P3804, DOI 10.1128/MCB.00709-07; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; RODBELL M, 1964, J BIOL CHEM, V239, P375; Roper SD, 2007, PFLUG ARCH EUR J PHY, V454, P759, DOI 10.1007/s00424-007-0247-x; SHIBATA H, 1995, J BIOL CHEM, V270, P11489, DOI 10.1074/jbc.270.19.11489; Shindo Y, 2008, BIOCHEM BIOPH RES CO, V376, P504, DOI 10.1016/j.bbrc.2008.09.035; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; STRIEM BJ, 1989, BIOCHEM J, V260, P121, DOI 10.1042/bj2600121; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; TANAHASHI T, 1991, BIOCHEM BIOPH RES CO, V177, P854, DOI 10.1016/0006-291X(91)91868-D; Tizzano M, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-110; Trubey KR, 2006, AM J PHYSIOL-CELL PH, V291, pC237, DOI 10.1152/ajpcell.00303.2005; WANG HY, 1992, NATURE, V358, P334, DOI 10.1038/358334a0; Wang HY, 1996, J BIOL CHEM, V271, P22022, DOI 10.1074/jbc.271.36.22022; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Zhang L, 2009, J ENDOCRINOL, V202, P207, DOI 10.1677/JOE-09-0099; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zheng B, 2004, MOL BIOL CELL, V15, p322A, DOI 10.1091/mbc.e04-06-0446	53	70	70	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54500	10.1371/journal.pone.0054500	http://dx.doi.org/10.1371/journal.pone.0054500			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23336004	Green Published, Green Submitted, gold			2022-12-25	WOS:000314707700062
J	Su, LJ; Chang, CC; Yang, CH; Hsieh, SJ; Wu, YC; Lai, JM; Tseng, TL; Huang, CYF; Hsu, SL				Su, Li-Jen; Chang, Chia-Chuan; Yang, Chih-Hsueh; Hsieh, Shur-Jong; Wu, Yi-Chin; Lai, Jin-Mei; Tseng, Tzu-Ling; Huang, Chi-Ying F.; Hsu, Shih-Lan			Graptopetalum Paraguayense Ameliorates Chemical-Induced Rat Hepatic Fibrosis In Vivo and Inactivates Stellate Cells and Kupffer Cells In Vitro	PLOS ONE			English	Article							LIVER-INJURY; CARBON-TETRACHLORIDE; GENE-EXPRESSION; INTERLEUKIN-10; MECHANISMS; COLLAGEN; DIMETHYLNITROSAMINE; ALCOHOL; HEPATOTOXICITY; SENSITIZATION	Background: Graptopetalum paraguayense (GP) is a folk herbal medicine with hepatoprotective effects that is used in Taiwan. The aim of this study was to evaluate the hepatoprotective and antifibrotic effects of GP on experimental hepatic fibrosis in both dimethylnitrosamine (DMN)- and carbon tetrachloride (CCl4)-induced liver injury rats. Methods: Hepatic fibrosis- induced rats were fed with the methanolic extract of GP (MGP) by oral administration every day. Immunohistochemistry, biochemical assays, and Western blot analysis were performed. The effects of MGP on the expression of fibrotic markers and cytokines in the primary cultured hepatic stellate cells (HSCs) and Kupffer cells, respectively, were evaluated. Results: Oral administration of MGP significantly alleviated DMN- or CCl4-induced liver inflammation and fibrosis. High levels of alanine transaminase, aspartate transaminase, bilirubin, prothrombin activity and mortality rates also decreased in rats treated with MGP. There were significantly decreased hydroxyproline levels in therapeutic rats compared with those of the liver-damaged rats. Collagen I and alpha smooth muscle actin (alpha-SMA) expression were all reduced by incubation with MGP in primary cultured rat HSCs. Furthermore, MGP induced apoptotic cell death in activated HSCs. MGP also suppressed lipopolysaccharide-stimulated rat Kupffer cell activation by decreasing nitric oxide, tumor necrosis factor-alpha and interleukin-6 production, and increasing interleukin-10 expression. Conclusions: The results show that the administration of MGP attenuated toxin-induced hepatic damage and fibrosis in vivo and inhibited HSC and Kupffer cell activation in vitro, suggesting that MGP might be a promising complementary or alternative therapeutic agent for liver inflammation and fibrosis.	[Su, Li-Jen] Natl Cent Univ, Inst Syst Biol & Bioinformat, Jhongli, Taiwan; [Chang, Chia-Chuan] Natl Res Inst Chinese Med, Div Med Chem, Taipei, Taiwan; [Yang, Chih-Hsueh; Hsieh, Shur-Jong; Wu, Yi-Chin; Hsu, Shih-Lan] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan; [Lai, Jin-Mei] Fu Jen Catholic Univ, Dept Life Sci, Taipei Cty, Taiwan; [Tseng, Tzu-Ling] Ind Technol Res Inst, Biomed Technol & Device Res Labs, Biomarker Technol Dev Div, Hsinchu, Taiwan; [Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan	National Central University; National Research Institute of Chinese Medicine; Taichung Veterans General Hospital; Fu Jen Catholic University; Industrial Technology Research Institute - Taiwan; National Yang Ming Chiao Tung University	Huang, CYF (corresponding author), Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan.	cyhuang5@ym.edu.tw; h2326@vghtc.gov.tw	Chang, Chia-Chuan/A-5518-2009; Lai, Jin-Mei/AAM-4119-2020; Huang, Chi-Ying/AAG-7672-2022; Huang, Chi-Ying/AFL-7729-2022	Chang, Chia-Chuan/0000-0002-1297-9602; Huang, Chi-Ying/0000-0003-4898-4937; Huang, Chi-Ying/0000-0003-4898-4937; Su, Li-Jen/0000-0002-8342-9800	National Science Council [NSC100-2627-B-010-005, NSC99-2112-M-008-012, NSC99-2811-M-008-053, NSC101-2320-B-008-001-MY3, NSC99-2627-B-030-001]; National Health Research Institutes [NHRI-EX101-10029BI]; Ministry of Economic Affairs [100-EC-17-A-17-S1-152]; Ministry of Education, Aim for the Top University Plan (National Yang Ming University); Committee on Chinese Medicine and Pharmacy [CCMP-RD-047, CCMP-95-RD-208, 94DOH028]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan); Ministry of Economic Affairs; Ministry of Education, Aim for the Top University Plan (National Yang Ming University); Committee on Chinese Medicine and Pharmacy	This research was supported by grants from the National Science Council (NSC100-2627-B-010-005), the National Health Research Institutes (NHRI-EX101-10029BI), Ministry of Economic Affairs (100-EC-17-A-17-S1-152) and the Ministry of Education, Aim for the Top University Plan (National Yang Ming University) to CYH. This work was supported in part by the grants from the Committee on Chinese Medicine and Pharmacy (CCMP-RD-047; CCMP-95-RD-208; 94DOH028) to SLH, the grants from National Science Council (NSC99-2112-M-008-012, NSC99-2811-M-008-053 and NSC101-2320-B-008-001-MY3) to LJS, and (NSC99-2627-B-030-001) to JML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1994, HEPATOLOGY, V20, P453, DOI 10.1002/hep.1840200227; Andres D, 2003, BIOCHEM PHARMACOL, V66, P917, DOI 10.1016/S0006-2952(03)00443-X; ARAI T, 1995, J IMMUNOL, V155, P5743; Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; Brenner David A, 2009, Trans Am Clin Climatol Assoc, V120, P361; Chen SJ, 2008, AM J CHINESE MED, V36, P369, DOI 10.1142/S0192415X08005837; Chen SJ, 2007, FOOD CHEM, V100, P5; Chung YC, 2005, FOOD CHEM, V91, P419, DOI 10.1016/j.foodchem.2004.06.022; Enomoto N, 2001, ALCOHOL CLIN EXP RES, V25, p51S, DOI 10.1097/00000374-200106001-00012; Enomoto N, 1998, GASTROENTEROLOGY, V115, P443, DOI 10.1016/S0016-5085(98)70211-2; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; GANDHI CR, 1990, J BIOL CHEM, V265, P18234; GASCONBARRE M, 1989, J HISTOCHEM CYTOCHEM, V37, P377, DOI 10.1177/37.3.2465335; Heymann Felix, 2009, Inflammation & Allergy Drug Targets, V8, P307; Huang B, 2010, J ETHNOPHARMACOL, V131, P276, DOI 10.1016/j.jep.2010.06.029; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; JEZEQUEL AM, 1987, J HEPATOL, V5, P174, DOI 10.1016/S0168-8278(87)80570-6; Kaplowitz N, 1997, GASTROENTEROLOGY, V113, P1408, DOI 10.1053/gast.1997.v113.agast971131408; Kisseleva T, 2007, J GASTROEN HEPATOL, V22, pS73, DOI 10.1111/j.1440-1746.2006.04658.x; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; LASKIN DL, 1990, SEMIN LIVER DIS, V10, P293, DOI 10.1055/s-2008-1040485; LIN JM, 1993, AM J CHINESE MED, V21, P59, DOI 10.1142/S0192415X9300008X; LISSOOS TW, 1992, J PEDIATR GASTR NUTR, V15, P225, DOI 10.1097/00005176-199210000-00001; Louis H, 1997, GASTROENTEROLOGY, V112, P935, DOI 10.1053/gast.1997.v112.pm9041256; Louis H, 1998, HEPATOLOGY, V28, P1607, DOI 10.1002/hep.510280621; Louis H, 1997, HEPATOLOGY, V25, P1382, DOI 10.1002/hep.510250614; MAVIER P, 1995, J HEPATOL, V22, P111; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Pines M, 1997, J HEPATOL, V27, P391, DOI 10.1016/S0168-8278(97)80186-9; Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2; RECKNAGEL RO, 1989, PHARMACOL THERAPEUT, V43, P139, DOI 10.1016/0163-7258(89)90050-8; REITAMO S, 1994, J CLIN INVEST, V94, P2489, DOI 10.1172/JCI117618; ROJKIND M, 1974, ANAL BIOCHEM, V57, P1, DOI 10.1016/0003-2697(74)90043-8; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001; Su LJ, 2006, GENE EXPRESSION, V13, P107, DOI 10.3727/000000006783991872; Suzuki S, 1996, HEPATOLOGY, V24, P219; Tacke F, 2009, CLIN REV ALLERG IMMU, V36, P4, DOI 10.1007/s12016-008-8091-0; Thompson K, 1998, HEPATOLOGY, V28, P1597, DOI 10.1002/hep.510280620; VANVLASSELAER P, 1994, J CELL BIOL, V124, P569, DOI 10.1083/jcb.124.4.569; WINWOOD PJ, 1993, SEMIN LIVER DIS, V13, P50, DOI 10.1055/s-2007-1007337	42	22	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53988	10.1371/journal.pone.0053988	http://dx.doi.org/10.1371/journal.pone.0053988			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335984	Green Published, Green Submitted, gold			2022-12-25	WOS:000314707700042
J	Skowronski, DM; Moser, FS; Janjua, NZ; Davoudi, B; English, KM; Purych, D; Petric, M; Pourbohloul, B				Skowronski, Danuta M.; Moser, Flavia S.; Janjua, Naveed Z.; Davoudi, Bahman; English, Krista M.; Purych, Dale; Petric, Martin; Pourbohloul, Babak			H3N2v and Other Influenza Epidemic Risk Based on Age-Specific Estimates of Sero-Protection and Contact Network Interactions	PLOS ONE			English	Article							PANDEMIC H1N1; VIRUS; TRANSMISSION; VACCINATION; PREVALENCE; ANTIBODY; IMMUNE; SURVEILLANCE; STRATEGIES; EMERGENCE	Cases of a novel swine-origin influenza A(H3N2) variant (H3N2v) have recently been identified in the US, primarily among children. We estimated potential epidemic attack rates (ARs) based on age-specific estimates of sero-susceptibility and social interactions. A contact network model previously established for the Greater Vancouver Area (GVA), Canada was used to estimate average epidemic (infection) ARs for the emerging H3N2v and comparator viruses (H1N1pdm09 and an extinguished H3N2 seasonal strain) based on typical influenza characteristics, basic reproduction number (R-0), and effective contacts taking into account age-specific sero-protection rates (SPRs). SPRs were assessed in sera collected from the GVA in 2009 or earlier (pre-H1N1pdm09) and fall 2010 (post-H1N1pdm09, seasonal A/Brisbane/10/2007(H3N2), and H3N2v) by hemagglutination inhibition (HI) assay. SPR was assigned per convention based on proportion with HI antibody titre >= 40 (SPR40). Recognizing that the HI titre >= 40 was established as the 50% sero-protective threshold we also explored for 1/2SPR40, SPR80 and a blended gradient defined as: 1/4SPR20, 1/2SPR40, 3/4SPR80, SPR160. Base case analysis assumed R-0 = 1.40, but we also explored R-0 as high as 1.80. With R-0 = 1.40 and SPR40, simulated ARs were well aligned with field observations for H1N1pdm09 incidence (AR: 32%), sporadic detections without a third epidemic wave post-H1N1pdm09 (negligible AR < 0.1%) as well as A/Brisbane/10/2007(H3N2) seasonal strain extinction and antigenic drift replacement (negligible AR < 0.1%). Simulated AR for the novel swine-origin H3N2v was 6%, highest in children 6-11years (16%). However, with modification to SPR thresholds per above, H3N2v AR >= 20% became possible. At SPR40, H3N2v AR >= 10%, >= 15% or >= 30%, occur if R-0 >= 1.48, >= 1.56 or >= 1.86, respectively. Based on conventional assumptions, the novel swine-origin H3N2v does not currently pose a substantial pandemic threat. If H3N2v epidemics do occur, overall community ARs are unlikely to exceed typical seasonal influenza experience. However risk assessment may change with time and depends crucially upon the validation of epidemiological features of influenza, notably the serologic correlate of protection and R-0.	[Skowronski, Danuta M.; Moser, Flavia S.; Janjua, Naveed Z.; Pourbohloul, Babak] British Columbia Ctr Dis Control, Communicable Dis Prevent & Control Serv, Vancouver, BC, Canada; [Skowronski, Danuta M.; Janjua, Naveed Z.; Davoudi, Bahman; English, Krista M.; Pourbohloul, Babak] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Purych, Dale] BC Biomed Labs Ltd, Surrey, BC, Canada; [Petric, Martin] British Columbia Ctr Dis Control, Publ Hlth Microbiol & Reference Lab, Vancouver, BC, Canada; [Petric, Martin] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Skowronski, DM (corresponding author), British Columbia Ctr Dis Control, Communicable Dis Prevent & Control Serv, Vancouver, BC, Canada.	danuta.skowronski@bccdc.ca	Zafar, Naveed/A-2712-2008	Zafar, Naveed/0000-0001-5681-719X	Canadian Institutes of Health Research [PTL-97126]; Michael Smith Foundation for Health Research [CI-SSH-00931(06-1), 20R45696]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by the Canadian Institutes of Health Research (PTL-97126) and the Michael Smith Foundation for Health Research (Grant numbers CI-SSH-00931(06-1) and 20R45696). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achonu C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026427; Allwinn R, 2010, MED MICROBIOL IMMUN, V199, P117, DOI 10.1007/s00430-010-0143-4; ANDERSON R M, 1991; Bansal S, 2006, PLOS MED, V3, P1816, DOI 10.1371/journal.pmed.0030387; Bansal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009360; BC Centre for Disease Control, BC CDC INFL SURV REP; Belshe RB, 2005, NEW ENGL J MED, V353, P2209, DOI 10.1056/NEJMp058281; BLACK SC, 2011, AM POETRY REV, V40, P30; Branch Alicia, 2012, Morbidity and Mortality Weekly Report, V61, P237; Centers for Disease Control and Prevention, 2012, 1 H3N2 VAR VIR INF R; Centers for Disease Control and Prevention, 2012, INFL A H3N2 VAR VIR; Centers for Disease Control and Prevention, FLUV 2010 2011 INFL; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V60, P1741; Committee for Proprietary Medicinal Products [CPMP], 1997, CPMPBWP21496, P1; Conway JM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-932; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Dudareva S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021340; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Ganatra Rahul, 2012, Morbidity and Mortality Weekly Report, V61, P414; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hardelid P, 2010, HEALTH TECHNOL ASSES, V14, P115, DOI 10.3310/hta14550-03; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; Katz JM, 2011, EXPERT REV ANTI-INFE, V9, P669, DOI [10.1586/ERI.11.51, 10.1586/eri.11.51]; Lina B, 2011, EUROSURVEILLANCE, V16, P2; Lindstrom S, 2012, EMERG INFECT DIS, V18, P834, DOI 10.3201/eid1805.111922; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Matrajt L, 2012, EPIDEMICS-NETH, V4, P22, DOI 10.1016/j.epidem.2011.11.003; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Meyers LA, 2006, J THEOR BIOL, V240, P400, DOI 10.1016/j.jtbi.2005.10.004; Mikolajczyk RT, 2008, EPIDEMIOL INFECT, V136, P813, DOI 10.1017/S0950268807009181; Nalluswami Kumar, 2011, Morbidity and Mortality Weekly Report, V60, P1213; National Advisory Committee on Immunization, 2012, STAT SEAS INFL VACC; Nguyen-Van-Tam JS, 1998, TXB INFLUENZA, P181; Nicholson KG, 1998, TXB INFLUENZA, P221; Pearce MB, 2012, P NATL ACAD SCI USA, V109, P3944, DOI 10.1073/pnas.1119945109; Potter C., 1998, TXB INFLUENZA, P3; Pourbohloul B, 2005, EMERG INFECT DIS, V11, P1249; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; Public Health Agency of Canada, FLUWATCH; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; Ross Ted M, 2011, PLoS Curr, V3, pRRN1265, DOI 10.1371/currents.RRN1265; Scholtissek C., 1998, TXB INFLUENZA, P137; Skowronski DM, 2012, EUROSURVEILLANCE, V17, P2; Skowronski DM, 2012, J INFECT DIS, V206, P1852, DOI 10.1093/infdis/jis500; Skowronski DM, 2011, J INFECT DIS, V203, P158, DOI 10.1093/infdis/jiq039; Skowronski DM, 2010, CAN MED ASSOC J, V182, P1851, DOI 10.1503/cmaj.100910; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Steens A, 2011, AM J EPIDEMIOL, V174, P1307, DOI 10.1093/aje/kwr245; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; Van Kerkhove MD, 2013, INFLUENZA O IN PRESS; Waalen K, 2012, EURO SURVEILL, V17; Wong KK, 2012, EMERG INFECT DIS, V18, P1937, DOI 10.3201/eid1812.121097; World Health Organization, WHO REC COMP INFL VI; World Health Organization, 2011, STAND TERM VAR A H3N; Zimmer SM, 2009, NEW ENGL J MED, V361, P279, DOI 10.1056/NEJMra0904322; [No title captured]	61	15	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54015	10.1371/journal.pone.0054015	http://dx.doi.org/10.1371/journal.pone.0054015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326561	Green Published, gold, Green Submitted			2022-12-25	WOS:000314705800100
J	Haugen, MH; Johansen, HT; Pettersen, SJ; Solberg, R; Brix, K; Flatmark, K; Maelandsmo, GM				Haugen, Mads H.; Johansen, Harald T.; Pettersen, Solveig J.; Solberg, Rigmor; Brix, Klaudia; Flatmark, Kjersti; Maelandsmo, Gunhild M.			Nuclear Legumain Activity in Colorectal Cancer	PLOS ONE			English	Article							CYSTEINE PROTEINASE-INHIBITOR; CATHEPSIN-L; MAMMALIAN LEGUMAIN; CYSTATIN-M/E; ENDOPEPTIDASE; ACTIVATION; EXPRESSION; IDENTIFICATION; LOCALIZATION; DEGRADATION	The cysteine protease legumain is involved in several biological and pathological processes, and the protease has been found over-expressed and associated with an invasive and metastatic phenotype in a number of solid tumors. Consequently, legumain has been proposed as a prognostic marker for certain cancers, and a potential therapeutic target. Nevertheless, details on how legumain advances malignant progression along with regulation of its proteolytic activity are unclear. In the present work, legumain expression was examined in colorectal cancer cell lines. Substantial differences in amounts of pro- and active legumain forms, along with distinct intracellular distribution patterns, were observed in HCT116 and SW620 cells and corresponding subcutaneous xenografts. Legumain is thought to be located and processed towards its active form primarily in the endo-lysosomes; however, the subcellular distribution remains largely unexplored. By analyzing subcellular fractions, a proteolytically active form of legumain was found in the nucleus of both cell lines, in addition to the canonical endo-lysosomal residency. In situ analyses of legumain expression and activity confirmed the endo-lysosomal and nuclear localizations in cultured cells and, importantly, also in sections from xenografts and biopsies from colorectal cancer patients. In the HCT116 and SW620 cell lines nuclear legumain was found to make up approximately 13% and 17% of the total legumain, respectively. In similarity with previous studies on nuclear variants of related cysteine proteases, legumain was shown to process histone H3.1. The discovery of nuclear localized legumain launches an entirely novel arena of legumain biology and functions in cancer.	[Haugen, Mads H.; Pettersen, Solveig J.; Flatmark, Kjersti; Maelandsmo, Gunhild M.] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway; [Haugen, Mads H.; Brix, Klaudia] Jacobs Univ Bremen, Sch Sci & Engn, Res Ctr MOLIFE Mol Life Sci, Bremen, Germany; [Johansen, Harald T.; Solberg, Rigmor] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway; [Flatmark, Kjersti] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Gastrointestinal Surg, Oslo, Norway; [Maelandsmo, Gunhild M.] Univ Tromso, Fac Hlth Sci, Dept Pharm, Tromso, Norway	University of Oslo; Jacobs University; University of Oslo; University of Oslo; UiT The Arctic University of Tromso	Haugen, MH (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway.	mads.haugen@rr-research.no	Brix, Klaudia/F-5072-2013; Mælandsmo, Gunhild Mari/AFV-4446-2022	Brix, Klaudia/0000-0002-4476-0357; Johansen, Harald Thidemann/0000-0001-6617-1732; Solberg, Rigmor/0000-0001-7205-4401	South-East regional health authorities [HSO] [2011142]; Norwegian Research Council under the Functional Genomics Program [FUGE] [158954/S10]; Soren and Jeanette Bothners legacy; Norwegian Cancer Society [PR-2006-0272]; University of Oslo; Anders Jahres foundation for the Promotion of Science; Astrid and Birger Torsteds Foundation; Nansen Foundation	South-East regional health authorities [HSO]; Norwegian Research Council under the Functional Genomics Program [FUGE]; Soren and Jeanette Bothners legacy; Norwegian Cancer Society(Norwegian Cancer Society); University of Oslo; Anders Jahres foundation for the Promotion of Science; Astrid and Birger Torsteds Foundation; Nansen Foundation	This work has been generously supported by grants from South-East regional health authorities [HSO, #2011142], www.helse-sorost.no; The Norwegian Research Council under the Functional Genomics Program [FUGE, #158954/S10], www.forskningsradet.no/fuge; Soren and Jeanette Bothners legacy and the Norwegian Cancer Society [#PR-2006-0272], www.kreftforeningen.no; The University of Oslo; Anders Jahres foundation for the Promotion of Science; Astrid and Birger Torsteds Foundation; and the Nansen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Fernandez M, 1999, J BIOL CHEM, V274, P19195, DOI 10.1074/jbc.274.27.19195; Andrade V, 2011, J HEPATOL, V55, P626, DOI 10.1016/j.jhep.2010.12.022; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briggs JJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-17; Brix K, 1996, ENDOCRINOLOGY, V137, P1963, DOI 10.1210/en.137.5.1963; Brix K, 2008, BIOCHIMIE, V90, P194, DOI 10.1016/j.biochi.2007.07.024; Chan CB, 2009, P NATL ACAD SCI USA, V106, P468, DOI 10.1073/pnas.0809824105; CHANTRET I, 1994, J CELL SCI, V107, P213; Chen JM, 2001, BIOL CHEM, V382, P777, DOI 10.1515/BC.2001.093; Chen JM, 1997, J BIOL CHEM, V272, P8090, DOI 10.1074/jbc.272.12.8090; Chen JM, 2000, BIOCHEM J, V352, P327, DOI 10.1042/0264-6021:3520327; Cheng T, 2006, J BIOL CHEM, V281, P15893, DOI 10.1074/jbc.M600694200; Dall E, 2012, ACTA CRYSTALLOGR F, V68, P24, DOI 10.1107/S1744309111048020; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; Flatmark K, 2004, EUR J CANCER, V40, P1593, DOI 10.1016/j.ejca.2004.02.023; Flatmark K, 2003, J PATHOL, V200, P589, DOI 10.1002/path.1381; Gawenda J, 2007, BREAST CANCER RES TR, V102, P1, DOI 10.1007/s10549-006-9311-z; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; HARANISHIMURA I, 1993, PLANT CELL, V5, P1651, DOI 10.1105/tpc.5.11.1651; Herskowitz JH, 2012, PROTEOMICS, V12, P2455, DOI 10.1002/pmic.201200006; Ishidoh K, 2002, BIOL CHEM, V383, P1827, DOI 10.1515/BC.2002.206; Jedeszko C, 2004, BIOL CHEM, V385, P1017, DOI 10.1515/BC.2004.132; Jedeszko C., 2008, CURR PROTOC CELL BIO; Johansen HT, 1999, ANAL BIOCHEM, V273, P278, DOI 10.1006/abio.1999.4221; Jordans S, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-23; Kamada S, 2005, J BIOL CHEM, V280, P857, DOI 10.1074/jbc.C400538200; KEMBHAVI AA, 1993, ARCH BIOCHEM BIOPHYS, V303, P208, DOI 10.1006/abbi.1993.1274; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Lecaille F, 2004, BIOL CHEM, V385, P511, DOI 10.1515/BC.2004.060; Liao D, 2011, NANOMED-NANOTECHNOL, V7, P665, DOI 10.1016/j.nano.2011.03.001; Liu C, 2003, CANCER RES, V63, P2957; Liu YH, 2011, LOCATION, LOCALIZATION, AND LOCALIZABILITY: LOCATION-AWARENESS TECHNOLOGY FOR WIRELESS NETWORKS, P9, DOI 10.1007/978-1-4419-7371-9_2; Liu ZX, 2008, MOL CELL, V29, P665, DOI 10.1016/j.molcel.2008.02.017; Maehr R, 2005, J IMMUNOL, V174, P7066, DOI 10.4049/jimmunol.174.11.7066; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; Miller G, 2011, FASEB J, V25, P1606, DOI 10.1096/fj.10-172312; Murthy RV, 2005, CLIN CANCER RES, V11, P2293, DOI 10.1158/1078-0432.CCR-04-1642; Ni DTN, 2003, J BIOL CHEM, V278, P38980, DOI 10.1074/jbc.M305930200; Ni J, 1997, J BIOL CHEM, V272, P10853; Ong PC, 2007, J BIOL CHEM, V282, P36980, DOI 10.1074/jbc.M706991200; Overbye A, 2011, AUTOPHAGY, V7, P1011, DOI 10.4161/auto.7.9.16436; Patel N, 2009, J CLIN INVEST, V119, P1964, DOI 10.1172/JCI37977; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Shirahama-Noda K, 2003, J BIOL CHEM, V278, P33194, DOI 10.1074/jbc.M302742200; Smith R, 2012, BIOCHIMIE, V94, P2590, DOI 10.1016/j.biochi.2012.07.026; Sotiropoulou G, 1997, J BIOL CHEM, V272, P903, DOI 10.1074/jbc.272.2.903; Sullivan S, 2009, INT J CANCER, V125, P54, DOI 10.1002/ijc.24275; Tedelind S, 2010, BIOL CHEM, V391, P923, DOI 10.1515/BC.2010.109; TOM BH, 1976, IN VITRO CELL DEV B, V12, P180; Wu BH, 2010, J BIOL CHEM, V285, P1790, DOI 10.1074/jbc.M109.049064; Yamane T, 2002, BBA-PROTEIN STRUCT M, V1596, P108, DOI 10.1016/S0167-4838(02)00209-1; Zeeuwen PLJM, 2009, J INVEST DERMATOL, V129, P1327, DOI 10.1038/jid.2009.40; Zeeuwen PLJM, 2004, HUM MOL GENET, V13, P1069, DOI 10.1093/hmg/ddh115; Zeeuwen PLJM, 2010, FASEB J, P10; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	58	57	58	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e52980	10.1371/journal.pone.0052980	http://dx.doi.org/10.1371/journal.pone.0052980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326369	Green Published, Green Submitted, gold			2022-12-25	WOS:000313552400011
J	Sriyudthsak, K; Shiraishi, F; Hirai, MY				Sriyudthsak, Kansuporn; Shiraishi, Fumihide; Hirai, Masami Yokota			Identification of a Metabolic Reaction Network from Time-Series Data of Metabolite Concentrations	PLOS ONE			English	Article							BIOCHEMICAL SYSTEMS-ANALYSIS; LACTIC-ACID BACTERIA; IN-VIVO; LACTOCOCCUS-LACTIS; KINETICS; LAW; BOTTLENECK	Recent development of high-throughput analytical techniques has made it possible to qualitatively identify a number of metabolites simultaneously. Correlation and multivariate analyses such as principal component analysis have been widely used to analyse those data and evaluate correlations among the metabolic profiles. However, these analyses cannot simultaneously carry out identification of metabolic reaction networks and prediction of dynamic behaviour of metabolites in the networks. The present study, therefore, proposes a new approach consisting of a combination of statistical technique and mathematical modelling approach to identify and predict a probable metabolic reaction network from time-series data of metabolite concentrations and simultaneously construct its mathematical model. Firstly, regression functions are fitted to experimental data by the locally estimated scatter plot smoothing method. Secondly, the fitted result is analysed by the bivariate Granger causality test to determine which metabolites cause the change in other metabolite concentrations and remove less related metabolites. Thirdly, S-system equations are formed by using the remaining metabolites within the framework of biochemical systems theory. Finally, parameters including rate constants and kinetic orders are estimated by the Levenberg-Marquardt algorithm. The estimation is iterated by setting insignificant kinetic orders at zero, i.e., removing insignificant metabolites. Consequently, a reaction network structure is identified and its mathematical model is obtained. Our approach is validated using a generic inhibition and activation model and its practical application is tested using a simplified model of the glycolysis of Lactococcus lactis MG1363, for which actual time-series data of metabolite concentrations are available. The results indicate the usefulness of our approach and suggest a probable pathway for the production of lactate and acetate. The results also indicate that the approach pinpoints a probable strong inhibition of lactate on the glycolysis pathway.	[Sriyudthsak, Kansuporn; Hirai, Masami Yokota] RIKEN Plant Sci Ctr, Yokohama, Kanagawa, Japan; [Sriyudthsak, Kansuporn; Hirai, Masami Yokota] CREST, JST, Kawaguchi, Saitama, Japan; [Shiraishi, Fumihide] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 812, Japan	RIKEN; Japan Science & Technology Agency (JST); Kyushu University	Shiraishi, F (corresponding author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 812, Japan.	fumishira@brs.kyushu-u.ac.jp; myhirai@psc.riken.jp	Sriyudthsak, Kansuporn/C-3664-2017; Hirai, Masami Y/D-5319-2009	Sriyudthsak, Kansuporn/0000-0001-9070-4092; Hirai, Masami Y/0000-0003-0802-6208	Japan Science and Technology Agency, CREST	Japan Science and Technology Agency, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by Japan Science and Technology Agency, CREST to MYH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bujara M, 2011, NAT CHEM BIOL, V7, P271, DOI 10.1038/nchembio.541; Chou IC, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-25; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Gavin H, 2011, ENV ENG, P1; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hoefnagel MHN, 2002, MICROBIOL-SGM, V148, P1003, DOI 10.1099/00221287-148-4-1003; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kutalik Z, 2007, IET SYST BIOL, V1, P174, DOI 10.1049/iet-syb:20060064; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; Marino Simeone, 2006, Journal of Bioinformatics and Computational Biology, V4, P665, DOI 10.1142/S0219720006002259; Marquardt D., 1963, INT J COMPUT VISION, V11, P431, DOI DOI 10.1137/0111030; Neves AR, 1999, BIOTECHNOL BIOENG, V64, P200, DOI 10.1002/(SICI)1097-0290(19990720)64:2&lt;200::AID-BIT9&gt;3.0.CO;2-K; Neves AR, 2002, J BIOL CHEM, V277, P28088, DOI 10.1074/jbc.M202573200; Neves AR, 2002, APPL ENVIRON MICROB, V68, P6332, DOI 10.1128/AEM.68.12.6332-6342.2002; Neves AR, 2005, FEMS MICROBIOL REV, V29, P531, DOI 10.1016/j.femsre.2005.04.005; Oliveira AP, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-39; Papagianni M, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-16; Ramos A, 2002, ANTON LEEUW INT J G, V82, P249, DOI 10.1023/A:1020664422633; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P370, DOI 10.1016/S0022-5193(69)80027-5; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P365, DOI 10.1016/S0022-5193(69)80026-3; SAVAGEAU MA, 1970, J THEOR BIOL, V26, P215, DOI 10.1016/S0022-5193(70)80013-3; Sawada Y, 2009, PLANT CELL PHYSIOL, V50, P37, DOI 10.1093/pcp/pcn183; Shuler M. L., 2002, BIOPROCESS ENG BASIC; Sriyudthsak K, 2010, MATH BIOSCI, V228, P1, DOI 10.1016/j.mbs.2010.08.001; Sriyudthsak K, 2010, IND ENG CHEM RES, V49, P9738, DOI 10.1021/ie100911h; Vilela M, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-47; Voet D., 2010, BIOCHEMISTRY; Voit EO, 2006, IEE P SYST BIOL, V153, P286, DOI 10.1049/ip-syb:20050087; Voit E. O., 2000, COMPUTATIONAL ANAL B; Walther D, 2010, OMICS, V14, P261, DOI 10.1089/omi.2010.0010	31	17	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e51212	10.1371/journal.pone.0051212	http://dx.doi.org/10.1371/journal.pone.0051212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326311	gold, Green Submitted, Green Published			2022-12-25	WOS:000313552400003
J	Ahn, SH; Tsalik, EL; Cyr, DD; Zhang, YR; van Velkinburgh, JC; Langley, RJ; Glickman, SW; Cairns, CB; Zaas, AK; Rivers, EP; Otero, RM; Veldman, T; Kingsmore, SF; Lucas, J; Woods, CW; Ginsburg, GS; Fowler, VG				Ahn, Sun Hee; Tsalik, Ephraim L.; Cyr, Derek D.; Zhang, Yurong; van Velkinburgh, Jennifer C.; Langley, Raymond J.; Glickman, Seth W.; Cairns, Charles B.; Zaas, Aimee K.; Rivers, Emanuel P.; Otero, Ronny M.; Veldman, Tim; Kingsmore, Stephen F.; Lucas, Joseph; Woods, Christopher W.; Ginsburg, Geoffrey S.; Fowler, Vance G., Jr.			Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; CRITICALLY-ILL PATIENTS; GRAM-NEGATIVE BACTERIA; CELL-WALL COMPONENTS; SEPTIC SHOCK; ANIMAL-MODELS; INFLAMMATORY RESPONSE; EMERGENCY-DEPARTMENT; POSITIVE SEPSIS; HUMAN MONOCYTES	Staphylococcus aureus causes a spectrum of human infection. Diagnostic delays and uncertainty lead to treatment delays and inappropriate antibiotic use. A growing literature suggests the host's inflammatory response to the pathogen represents a potential tool to improve upon current diagnostics. The hypothesis of this study is that the host responds differently to S. aureus than to E. coli infection in a quantifiable way, providing a new diagnostic avenue. This study uses Bayesian sparse factor modeling and penalized binary regression to define peripheral blood gene-expression classifiers of murine and human S. aureus infection. The murine-derived classifier distinguished S. aureus infection from healthy controls and Escherichia coli-infected mice across a range of conditions (mouse and bacterial strain, time post infection) and was validated in outbred mice (AUC>0.97). A S. aureus classifier derived from a cohort of 94 human subjects distinguished S. aureus blood stream infection (BSI) from healthy subjects (AUC 0.99) and E. coli BSI (AUC 0.84). Murine and human responses to S. aureus infection share common biological pathways, allowing the murine model to classify S. aureus BSI in humans (AUC 0.84). Both murine and human S. aureus classifiers were validated in an independent human cohort (AUC 0.95 and 0.92, respectively). The approach described here lends insight into the conserved and disparate pathways utilized by mice and humans in response to these infections. Furthermore, this study advances our understanding of S. aureus infection; the host response to it; and identifies new diagnostic and therapeutic avenues.	[Ahn, Sun Hee; Tsalik, Ephraim L.; Zhang, Yurong; Zaas, Aimee K.; Woods, Christopher W.; Fowler, Vance G., Jr.] Duke Univ, Dept Med, Div Infect Dis & Int Hlth, Durham, NC USA; [Tsalik, Ephraim L.; Woods, Christopher W.] Durham Vet Affairs Med Ctr, Infect Dis Sect, Durham, NC USA; [Cyr, Derek D.; Zaas, Aimee K.; Veldman, Tim; Woods, Christopher W.; Ginsburg, Geoffrey S.; Fowler, Vance G., Jr.] Duke Univ, Duke Inst Genome Sci & Policy, Durham, NC 27706 USA; [van Velkinburgh, Jennifer C.] van Velkinburgh Initiat Collaborat BioMed Res, Santa Fe, NM USA; [Langley, Raymond J.] Lovelace Resp Res Inst, Div Immunol, Albuquerque, NM USA; [Glickman, Seth W.; Cairns, Charles B.] Univ N Carolina, Sch Med, Dept Emergency Med, Chapel Hill, NC USA; [Rivers, Emanuel P.; Otero, Ronny M.] Wayne State Univ, Henry Ford Hosp, Dept Emergency Med, Detroit, MI USA; [Kingsmore, Stephen F.] Childrens Mercy Hosp & Clin, Ctr Pediat Genom Med, Kansas City, MO USA; [Fowler, Vance G., Jr.] Duke Clin Res Inst, Durham, NC USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Lovelace Respiratory Research Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Henry Ford Health System; Henry Ford Hospital; Wayne State University; Children's Mercy Hospital; Duke University	Ginsburg, GS (corresponding author), Duke Univ, Duke Inst Genome Sci & Policy, Durham, NC 27706 USA.	Geoffrey.ginsburg@duke.edu; vance.fowler@duke.edu	Ha, Dat Thinh/D-4995-2015; Fowler, Vance/AAW-2017-2021; van Velkinburgh, Jennifer/D-7205-2015	Ha, Dat Thinh/0000-0003-4260-4876; Kingsmore, Stephen/0000-0001-7180-2527; kingsmore, stephen/0000-0002-3758-4631; Tsalik, Ephraim/0000-0002-6417-2042; van Velkinburgh, Jennifer/0000-0002-4592-2397	National Institute of Allergy and Infectious Diseases [R01-AI068804, K24-AI093969, 5U01AI066569-05, 3U01AI066569-05S1]; Wallace H. Coulter Foundation; Novartis Vaccines and Diagnostics, Inc.; Cubist Pharmaceuticals; Novartis Pharmaceuticals; Roche Molecular Diagnostics; Veterans Affairs Career Development Award; Astellas Pharma US; Merck; Theravance; Cerexa; Pfizer; Novartis; MedImmune; Advance Liquid Logic; National Institutes of Health; Agennix AG; Alere Corporation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U19HD077693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068804, U01AI066569, K24AI093969] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wallace H. Coulter Foundation; Novartis Vaccines and Diagnostics, Inc.; Cubist Pharmaceuticals; Novartis Pharmaceuticals(Novartis); Roche Molecular Diagnostics; Veterans Affairs Career Development Award; Astellas Pharma US(Astellas Pharmaceuticals); Merck(Merck & Company); Theravance; Cerexa; Pfizer(Pfizer); Novartis(Novartis); MedImmune(AstraZenecaMedimmune); Advance Liquid Logic; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agennix AG; Alere Corporation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by R01-AI068804 and K24-AI093969 from the National Institute of Allergy and Infectious Diseases (VGF), 5U01AI066569-05 and 3U01AI066569-05S1 from the National Institute of Allergy and Infectious Diseases (SFK), and the Wallace H. Coulter Foundation (AKZ and GSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: CBC and CWW have served as consultants for bioMerieux Inc. ELT, CWW, and GSG received research funding from Novartis Vaccines and Diagnostics, Inc. In the past 12 months, CWW has served as a consultant to Becton, Dickinson and Company, and Gilead Sciences; and has received research or grant support from Cubist Pharmaceuticals, Novartis Pharmaceuticals, and Roche Molecular Diagnostics. ELT is supported by a Veterans Affairs Career Development Award. In the past 12 months, VGF has received grant or research support from Astellas Pharma US, Merck, Theravance, Cerexa, Pfizer, Novartis, MedImmune, Advance Liquid Logic, and the National Institutes of Health; has served as a consultant for Achaogen, Merck, Novartis, Pfizer, NovaDigm Therapeutics, The Medicines Company, Durata Therapeutics, Galderma, and Biosynexus; and is on the Advisory Committee for Cubist Pharmaceuticals. AKZ is a consultant for Covance. EPR receives research support from Agennix AG, Alere Corporation, and National Institutes of Health; and has previously served as a consultant for Agennix AG, Eisai Pharmaceuticals, Idaho Technology, AstraZeneca, Masimo, and Sangard. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ahn SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001088; Ardura MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005446; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Carvalho CM, 2008, J AM STAT ASSOC, V103, P1438, DOI 10.1198/016214508000000869; Chang JT, 2009, MOL CELL, V34, P104, DOI 10.1016/j.molcel.2009.02.030; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chen M, 2011, J AM STAT A IN PRESS; Chen MH, 2011, IEEE T BIO-MED ENG, V58, P468, DOI 10.1109/TBME.2010.2059702; Chin CY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-672; Cross ML, 2004, FEMS IMMUNOL MED MIC, V42, P173, DOI 10.1016/j.femsim.2004.04.001; Cyr DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021854; Deitch EA, 1998, SHOCK, V9, P1, DOI 10.1097/00024382-199801000-00001; Desai KV, 2002, ENDOCR-RELAT CANCER, V9, P207, DOI 10.1677/erc.0.0090207; Downey T, 2006, METHOD ENZYMOL, V411, P256, DOI 10.1016/S0076-6879(06)11013-7; Dressman HK, 2007, PLOS MED, V4, P690, DOI 10.1371/journal.pmed.0040106; Dyson A, 2009, CRIT CARE MED, V37, pS30, DOI 10.1097/CCM.0b013e3181922bd3; Dziarski R, 2001, J IMMUNOL, V166, P1938, DOI 10.4049/jimmunol.166.3.1938; Esmon CT, 2004, CRIT CARE MED, V32, pS219, DOI 10.1097/01.CCM.0000127036.27343.48; Feezor RJ, 2003, INFECT IMMUN, V71, P5803, DOI 10.1128/IAI.71.10.5803-5813.2003; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; Glickman SW, 2010, ACAD EMERG MED, V17, P383, DOI 10.1111/j.1553-2712.2010.00664.x; Hans C, 2007, J AM STAT ASSOC, V102, P507, DOI 10.1198/016214507000000121; He M, 2010, CLIN CANCER RES, V16, P249, DOI 10.1158/1078-0432.CCR-09-1602; Hessle CC, 2005, CYTOKINE, V30, P311, DOI 10.1016/j.cyto.2004.05.008; Kawada J, 2006, J GEN VIROL, V87, P1677, DOI 10.1099/vir.0.81670-0; Kim HS, 2005, INFECT IMMUN, V73, P3714, DOI 10.1128/IAI.73.6.3714-3724.2005; KIM JH, 1989, AM J MED, V87, P201; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Kollef MH, 1999, CHEST, V115, P462, DOI 10.1378/chest.115.2.462; Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087; LaBreche HG, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-61; Larsson O, 2004, CANCER RES, V64, P482, DOI 10.1158/0008-5472.CAN-03-1872; Lee A, 2007, J CLIN MICROBIOL, V45, P3546, DOI 10.1128/JCM.01555-07; Lucas J, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1436; Lucas JE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000920; Lytkin NI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020662; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McDunn JE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001564; Meadows SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011535; Merl D, 2009, OXFORD HDB APPL BAYE; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; MILLER RL, 1972, BIOCHEMISTRY-US, V11, P4723, DOI 10.1021/bi00775a014; MOHLER KM, 1993, J IMMUNOL, V151, P1548; Mueller A, 2003, P NATL ACAD SCI USA, V100, P1292, DOI 10.1073/pnas.242741699; Nau GJ, 2003, J IMMUNOL, V170, P5203, DOI 10.4049/jimmunol.170.10.5203; Ng HH, 2005, GENOMICS, V86, P657, DOI 10.1016/j.ygeno.2005.07.005; Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127; Raftery AE, 1997, J AM STAT ASSOC, V92, P179, DOI 10.2307/2291462; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Rice KC, 2003, J BACTERIOL, V185, P2635, DOI 10.1128/JB.185.8.2635-2643.2003; Shanley TP, 2007, MOL MED, V13, P495, DOI 10.2119/2007-00065.Shanley; Sriskandan S, 1999, INFECT DIS CLIN N AM, V13, P397, DOI 10.1016/S0891-5520(05)70082-9; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tang BMP, 2008, CRIT CARE MED, V36, P1125, DOI 10.1097/CCM.0b013e3181692c0b; Thakker M, 1998, INFECT IMMUN, V66, P5183, DOI 10.1128/IAI.66.11.5183-5189.1998; Timofeeva AV, 2009, KARDIOLOGIYA, V49, P27; Tsalik EL, 2010, J CLIN MICROBIOL, V48, P26, DOI 10.1128/JCM.01447-09; Unsinger J, 2009, J LEUKOCYTE BIOL, V86, P219, DOI 10.1189/jlb.1008615; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; von Kockritz-Blickwede M, 2008, AM J PATHOL, V173, P1657, DOI 10.2353/ajpath.2008.080337; Voora D, 2010, CIRCULATION, V122; WANG Q, 2007, B INT SOC BAYESIAN A, V14, P4; Weindruch R, 2001, J NUTR, V131, p918S, DOI 10.1093/jn/131.3.918S; Wennmalm K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r109; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Yu SL, 2004, AM J RESP CRIT CARE, V169, P1135, DOI 10.1164/rccm.200211-1278OC; Zaas AK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000715; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006; Zeni F, 1997, CRIT CARE MED, V25, P1095, DOI 10.1097/00003246-199707000-00001; Zhang H, 2006, MICROBES INFECT, V8, P2172, DOI 10.1016/j.micinf.2006.04.018	73	39	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e48979	10.1371/journal.pone.0048979	http://dx.doi.org/10.1371/journal.pone.0048979			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326304	Green Submitted, Green Published, gold			2022-12-25	WOS:000313551500002
J	Chen, F; Griffith, A; Cottrell, A; Wong, YL				Chen, Frederick; Griffith, Amanda; Cottrell, Allin; Wong, Yue-Ling			Behavioral Responses to Epidemics in an Online Experiment: Using Virtual Diseases to Study Human Behavior	PLOS ONE			English	Article							PUBLIC PERCEPTIONS; RISK; VACCINATION; POPULATION; PREVALENCE; AVOIDANCE; DYNAMICS; DECLINES; MODEL	We report the results of a study we conducted using a simple multiplayer online game that simulates the spread of an infectious disease through a population composed of the players. We use our virtual epidemics game to examine how people respond to epidemics. The analysis shows that people's behavior is responsive to the cost of self-protection, the reported prevalence of disease, and their experiences earlier in the epidemic. Specifically, decreasing the cost of self-protection increases the rate of safe behavior. Higher reported prevalence also raises the likelihood that individuals would engage in self-protection, where the magnitude of this effect depends on how much time has elapsed in the epidemic. Individuals' experiences in terms of how often an infection was acquired when they did not engage in self-protection are another factor that determines whether they will invest in preventive measures later on. All else being equal, individuals who were infected at a higher rate are more likely to engage in self-protective behavior compared to those with a lower rate of infection. Lastly, fixing everything else, people's willingness to engage in safe behavior waxes or wanes over time, depending on the severity of an epidemic: when prevalence is high, people are more likely to adopt self-protective measures as time goes by; when prevalence is low, a 'self-protection fatigue' effect sets in whereby individuals are less willing to engage in safe behavior over time.	[Chen, Frederick; Griffith, Amanda; Cottrell, Allin] Wake Forest Univ, Dept Econ, Winston Salem, NC 27109 USA; [Wong, Yue-Ling] Wake Forest Univ, Dept Comp Sci, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest University	Chen, F (corresponding author), Wake Forest Univ, Dept Econ, Winston Salem, NC 27109 USA.	chenfh@wfu.edu		Chen, Frederick/0000-0003-4746-0752	Wake Forest University	Wake Forest University	This work was funded by Wake Forest University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althouse BM, 2010, P NATL ACAD SCI USA, V107, P1696, DOI 10.1073/pnas.0906078107; ANDERSON R M, 1991; Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101; Breban R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031127; Bults M, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-2, 10.1186/1471-2458-11-165]; Chapman GB, 1999, PREV MED, V29, P249, DOI 10.1006/pmed.1999.0535; Chen FH, 2004, THEOR POPUL BIOL, V66, P307, DOI 10.1016/j.tpb.2004.07.004; Chen FH, 2006, J MATH BIOL, V53, P253, DOI 10.1007/s00285-006-0006-1; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; Falk A, 2009, SCIENCE, V326, P535, DOI 10.1126/science.1168244; Fenichel EP, 2011, P NATL ACAD SCI USA, V108, P6306, DOI 10.1073/pnas.1011250108; Gordon R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S13; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Hallett TB, 2006, SEX TRANSM INFECT, V82, pI1, DOI 10.1136/sti.2005.016014; Ibuka Y, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-296; Kagel J., 1997, HDB EXPT EC; Lau JTF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-139; Lau JTF, 2010, AM J INFECT CONTROL, V38, P374, DOI 10.1016/j.ajic.2010.03.002; Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864; Plott C.R., 2008, HDB EXPT EC RESULTS, V1; Reluga TC, 2006, MATH BIOSCI, V204, P185, DOI 10.1016/j.mbs.2006.08.015; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Shim E, 2012, J THEOR BIOL, V295, P194, DOI 10.1016/j.jtbi.2011.11.005; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; UNAIDS, 2001, HIV PREVENTION NEEDS; UNAIDS, 2010, GLOBAL REPORT UNAIDS; Warner L, 2006, SEX TRANSM DIS, V33, P36, DOI 10.1097/01.olq.0000187908.42622.fd; Wells CR, 2012, EPIDEMICS-NETH, V4, P139, DOI 10.1016/j.epidem.2012.06.002; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2007, THE WORLD HEALTH REP	30	27	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52814	10.1371/journal.pone.0052814	http://dx.doi.org/10.1371/journal.pone.0052814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326360	Green Submitted, gold, Green Published			2022-12-25	WOS:000313551500031
J	Gomez-Valdes, J; Hunemeier, T; Quinto-Sanchez, M; Paschetta, C; de Azevedo, S; Gonzalez, MF; Martinez-Abadias, N; Esparza, M; Pucciarelli, HM; Salzano, FM; Bau, CHD; Bortolini, MC; Gonzalez-Jose, R				Gomez-Valdes, Jorge; Huenemeier, Tabita; Quinto-Sanchez, Mirsha; Paschetta, Carolina; de Azevedo, Soledad; Gonzalez, Marina F.; Martinez-Abadias, Neus; Esparza, Mireia; Pucciarelli, Hector M.; Salzano, Francisco M.; Bau, Claiton H. D.; Bortolini, Maria Catira; Gonzalez-Jose, Rolando			Lack of Support for the Association between Facial Shape and Aggression: A Reappraisal Based on a Worldwide Population Genetics Perspective	PLOS ONE			English	Article							WEST CRANIAL DIFFERENTIATION; STRUCTURE PREDICTS; CRANIOMETRIC VARIATION; SEXUAL SELECTION; FACE; TESTOSTERONE; COMPETITION; VIOLENCE; WIDTH; MEN	Antisocial and criminal behaviors are multifactorial traits whose interpretation relies on multiple disciplines. Since these interpretations may have social, moral and legal implications, a constant review of the evidence is necessary before any scientific claim is considered as truth. A recent study proposed that men with wider faces relative to facial height (fWHR) are more likely to develop unethical behaviour mediated by a psychological sense of power. This research was based on reports suggesting that sexual dimorphism and selection would be responsible for a correlation between fWHR and aggression. Here we show that 4,960 individuals from 94 modern human populations belonging to a vast array of genetic and cultural contexts do not display significant amounts of fWHR sexual dimorphism. Further analyses using populations with associated ethnographical records as well as samples of male prisoners of the Mexico City Federal Penitentiary condemned by crimes of variable level of inter-personal aggression (homicide, robbery, and minor faults) did not show significant evidence, suggesting that populations/individuals with higher levels of bellicosity, aggressive behaviour, or power-mediated behaviour display greater fWHR. Finally, a regression analysis of fWHR on individual's fitness showed no significant correlation between this facial trait and reproductive success. Overall, our results suggest that facial attributes are poor predictors of aggressive behaviour, or at least, that sexual selection was weak enough to leave a signal on patterns of between- and within-sex and population facial variation.	[Gomez-Valdes, Jorge] Univ Nacl Autonoma Mexico, Fac Med, Dept Anat, Mexico City 04510, DF, Mexico; [Huenemeier, Tabita; Salzano, Francisco M.; Bau, Claiton H. D.; Bortolini, Maria Catira] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil; [Quinto-Sanchez, Mirsha; Paschetta, Carolina; de Azevedo, Soledad; Gonzalez, Marina F.; Gonzalez-Jose, Rolando] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Puerto Madryn, Argentina; [Martinez-Abadias, Neus] Univ Pompeu Fabra, Ctr Genom Regulat, EMBL CRG Syst Biol Res Unit, Barcelona, Spain; [Esparza, Mireia] Univ Barcelona, Dept Biol Anim, Seccio Antropol, Barcelona, Spain; [Pucciarelli, Hector M.] Consejo Nacl Invest Cient & Tecn, Div Antropol, Museo La Plata, La Plata, Buenos Aires, Argentina	Universidad Nacional Autonoma de Mexico; Universidade Federal do Rio Grande do Sul; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Barcelona; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata	Gonzalez-Jose, R (corresponding author), Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Puerto Madryn, Argentina.	rolando@cenpat.edu.ar	Esparza, Mireia/L-5059-2014; Bau, Claiton Henrique Dotto/C-9980-2013; Salzano, Francisco M/L-7916-2015; Hünemeier, Tábita/F-4181-2011; Martinez-Abadias, Neus/H-2029-2015	Esparza, Mireia/0000-0002-3925-4142; Bau, Claiton Henrique Dotto/0000-0001-5644-3845; Paschetta, Carolina/0000-0002-5869-3570; Hunemeier, Tabita/0000-0002-3156-2079; Martinez-Abadias, Neus/0000-0003-3061-2123; Gonzalez-Jose, Rolando/0000-0002-8128-9381				Abbink JG, 1999, ETHNOLOGY, V38, P227, DOI 10.2307/3773815; Andersson Malte, 1994; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Bautista J, 1998, CRANEOMETRIA DE REOS; Bowles S, 2009, SCIENCE, V324, P1293, DOI 10.1126/science.1168112; Carre JM, 2009, PSYCHOL SCI, V20, P1194, DOI 10.1111/j.1467-9280.2009.02423.x; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; Cicchetti D., 2006, DEV PSYCHOPATHOL, V2, P1; de Azevedo S, 2011, AM J PHYS ANTHROPOL, V146, P539, DOI 10.1002/ajpa.21564; Deaner RO, 2012, J RES PERS, V46, P235, DOI 10.1016/j.jrp.2012.01.005; FOLEY RA, 1991, ORIGINS HUMAN BEHAV, P25; GALL FJ, 1835, ON THE FUNCTIONS OF; Gonzalez-Jose R, 2004, AM J PHYS ANTHROPOL, V123, P69, DOI 10.1002/ajpa.10302; Gonzalez-Jose R, 2001, AM J PHYS ANTHROPOL, V116, P154, DOI 10.1002/ajpa.1108; Gonzalez-Jose R, 2008, AM J PHYS ANTHR, V137; Gonzalez-Jose RG, 2003, NATURE, V425, P62, DOI 10.1038/nature01816; Gonzalez-Jose R, 2007, P ROY SOC B-BIOL SCI, V274, P681, DOI 10.1098/rspb.2006.0151; Haselhuhn MP, 2012, P ROY SOC B-BIOL SCI, V279, P571, DOI 10.1098/rspb.2011.1193; Howells W.W., 1989, PAPERS PEABODY MUSEU; Howells WW, 1973, PAPERS OF THE PEABOD; Jablonka E, 2005, EVOLUTION 4 DIMENSIO; Jones AG, 2005, INTEGR COMP BIOL, V45, P874, DOI 10.1093/icb/45.5.874; Jose RG, 2002, AM J HUM BIOL, V14, P308, DOI 10.1002/ajhb.10033; Kramer RSS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042705; Lefevre CE, 2012, EVOL HUM BEHAV IN PR; Lombroso C., 1876, LUOMO DELINQUENTE; Martinez-Abadias N, 2012, EVOLUTION, V66, P1010, DOI 10.1111/j.1558-5646.2011.01496.x; Martinez-Abadias N, 2009, J ANAT, V214, P19, DOI 10.1111/j.1469-7580.2008.01015.x; Murdoch GP, 1967, ETHNOGRAPHIC ATLAS A; Ozener B, 2012, EVOL HUM BEHAV, V33, P169, DOI 10.1016/j.evolhumbehav.2011.08.001; Paschetta C, 2010, AM J PHYS ANTHROPOL, V141, P297, DOI 10.1002/ajpa.21151; Peskin M, 2004, PERCEPTION, V33, P147, DOI 10.1068/p5028; PINKER S, 2011, THE BETTER ANGELS OF; Pound N, 2009, P ROY SOC B-BIOL SCI, V276, P153, DOI 10.1098/rspb.2008.0990; Price ME, 2012, EVOL HUM BEHAV, V33, P174, DOI 10.1016/j.evolhumbehav.2011.08.004; Pucciarelli HM, 2008, J HUM EVOL, V54, P296, DOI 10.1016/j.jhevol.2007.08.011; Pucciarelli HM, 2006, HOMO, V57, P133, DOI 10.1016/j.jchb.2005.12.003; Pucciarelli HM, 2003, QUATERN INT, V109, P123, DOI 10.1016/S1040-6182(02)00208-2; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Relethford JH, 1997, HUM BIOL, V69, P443; RELETHFORD JH, 1994, AM J PHYS ANTHROPOL, V95, P249; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Scott IML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013585; Stirrat M, 2012, PSYCHOL SCI, V23, P718, DOI 10.1177/0956797611435133; Stirrat M, 2012, EVOL HUM BEHAV, V33, P551, DOI 10.1016/j.evolhumbehav.2012.02.002; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; Travis CB, 2003, EVOLUTION GENDER AND; Weston EM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000710; Weston EM, 2004, P ROY SOC B-BIOL SCI, V271, pS416, DOI 10.1098/rsbl.2004.0203; Wong EM, 2011, PSYCHOL SCI, V22, P1478, DOI 10.1177/0956797611418838	50	43	45	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52317	10.1371/journal.pone.0052317	http://dx.doi.org/10.1371/journal.pone.0052317			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326328	Green Published, Green Submitted, gold			2022-12-25	WOS:000313551500012
J	Jing, SS; Yin, AT; Shi, LZ; Liu, JN				Jing, Shanshan; Yin, Aitian; Shi, Lizheng; Liu, Jinan			Whether New Cooperative Medical Schemes Reduce the Economic Burden of Chronic Disease in Rural China	PLOS ONE			English	Article							CATASTROPHIC HEALTH EXPENDITURE; IMPOVERISHMENT; CARE	Background: The New Cooperative Medical Scheme (NCMS) provides health insurance coverage for rural populations in China. This study aimed to evaluate changes in household catastrophic health expenditure (CHE) due to chronic disease before and after the reimbursement policies for services of chronic disease were implemented to provide additional financial support. Methods: The study used data from the household surveys conducted in Shandong Province and Ningxia Hui Autonomous Region in 2006 and 2008. The study sample in village-level units was divided into two groups: 36 villages which implemented the NCMS reimbursement policies for chronic diseases as the intervention group, and 72 villages which did not as the control group. Health care expenditure of more than 40% of household's non-food expenditure was defined as a household with CHE (i.e., impoverishment). The conceptual framework was established based on the Andersen socio-behavioral model of health care utilization to explore how the NCMS reimbursement policies impacted health expenditures. A difference-in-difference model was employed to compare the change in the proportion of households incurring CHE due to chronic disease between the two groups over time. Results: The households that participated in the NCMS were less likely to become impoverished (P<0.05). In addition, the households with both male household head and higher income level were protective factors to prevent CHE (P<0.05). Young households with preschool children suffered less from CHE (P<0.05). The effect of the NCMS reimbursement policies for chronic disease on the CHE was negative, yet not statistically significant (p = 0.814). Conclusions: The NCMS coverage showed financial protection for households with chronic disease. However, the NCMS reimbursement policies should be strengthened in the future.	[Jing, Shanshan; Yin, Aitian] Shandong Univ, Ctr Hlth Management & Policy, Jinan 250100, Shandong, Peoples R China; [Shi, Lizheng; Liu, Jinan] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA 70118 USA	Shandong University; Tulane University	Shi, LZ (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA 70118 USA.	lshi1@tulane.edu			European Commission (Specific Targeted Research Project); Liverpool School of Tropical Medicine [015305]; China Scholarship Council	European Commission (Specific Targeted Research Project); Liverpool School of Tropical Medicine; China Scholarship Council(China Scholarship Council)	The data used for the paper were derived from the study conducted as part of a project entitled "Bringing health care to the vulnerable: developing equitable and sustainable rural health insurance in China and Vietnam (RHINCAV)'' funded by the European Commission (Specific Targeted Research Project) and coordinated by the Liverpool School of Tropical Medicine (grant number 015305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to all the participants. The government scholarship support from China Scholarship Council and comments from Jacob E Kendall on an earlier draft of this paper are equally appreciated. We also thank the comments from four anonymous reviewers.	[Anonymous], 2005, PREV CHRON DIS VIT I; Carrin G, 1999, SOC SCI MED, V48, P961, DOI 10.1016/S0277-9536(98)00396-7; Carrin G, 2004, REACHING UNIVERSAL C; Carrin G, 2005, ACHIEVING UNIVERSAL; Center for health statistics and information MOH, 2009, AN REP NAT HLTH SERV, P8; Committee CGPG, 2002, DEC CENTR COMM COMM; FENG XS, 1995, SOC SCI MED, V41, P1111; Hu J, 2007, CHIN J PREVCONTRCHRO, V15, P189; Jing S, 2010, CHINESE HLTH SERVICE, V2, P76; Liu YL, 2003, J HEALTH POPUL NUTR, V21, P216; Qian D, 2007, CHINESE HLTH MANAGEM, V225, P194; Sun Q, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-42; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; Wagstaff A, 2009, J HEALTH ECON, V28, P1, DOI 10.1016/j.jhealeco.2008.10.007; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; Wang Y, 2011, J NANJING AGR U SOCI, V11, P33; WYSZEWIANSKI L, 1986, INQUIRY-J HEALTH CAR, V23, P382; WYSZEWIANSKI L, 1986, HEALTH SERV RES, V21, P617; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Yardim MS, 2010, HEALTH POLICY, V94, P26, DOI 10.1016/j.healthpol.2009.08.006; Yin A, 2010, CHINESE HLTH EC, V2, P38; Yip W, 2009, SOC SCI MED, V68, P201, DOI 10.1016/j.socscimed.2008.09.066; Yu BR, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-116; Zhang LY, 2010, TROP MED INT HEALTH, V15, P468, DOI 10.1111/j.1365-3156.2010.02469.x	24	39	44	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53062	10.1371/journal.pone.0053062	http://dx.doi.org/10.1371/journal.pone.0053062			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326382	Green Published, Green Submitted, gold			2022-12-25	WOS:000313551500048
J	Lei, WB; Jiang, AY; Chai, LP; Zhu, XL; Wang, ZF; Wen, YH; Su, ZZ; Wen, WP				Lei, Wen-bin; Jiang, Ai-yun; Chai, Li-ping; Zhu, Xiao-lin; Wang, Zhang-feng; Wen, Yi-hui; Su, Zhen-zhong; Wen, Wei-ping			Middle Frontal Horizontal Partial Laryngectomy (MFHPL): A Treatment for Stage T1b Squamous Cell Carcinoma of the Glottic Larynx Involving Anterior Vocal Commissure	PLOS ONE			English	Article							CANCER; RADIOTHERAPY; SURGERY	Objective: The therapeutic effect of middle frontal horizontal partial laryngectomy (MFHPL) in treating stage T1b squamous cell carcinoma of the glottic larynx involving anterior vocal commissure (AVC) was compared with that of the anterior frontolateral vertical partial laryngectomy (AFVPL). The feasibility and practical significance of MFHPL in clinical application was discussed in the present study. Methods: From January 1996 to January 2010, a total of 65 patients diagnosed with stage T1bN0M0 glottic laryngeal cancer were treated with MFHPL or AFVPL. The postoperative complications, glottic reconstruction, recurrence rate, voice quality and survival rates were evaluated and compared between two treatments. Results: AFVPL and MFHPL were performed in 34 and 31 patients, respectively. Flexible fiberoptic laryngoscopy revealed that in the MFHPL-treated patients the reconstructed glottis was spacious and symmetric. In contrast, AFVPL treatment resulted in irregular glottic area with poor symmetry and tubular glottis. The incidence of postoperative laryngeal stenosis significantly differed between the MFHPL- and AFVPL-treated groups (P = 0.025). No significant difference was detected in the 3- and 5-year overall-or tumor-free survival rates between two treatments. The Voice Handicap Index (VHI) and maximum phonation time (MPT) after surgery were 51.0 +/- 12.99 and 12.42 +/- 3.44 sec in the AFVPL-treated group; while in the MFHPL-treated patients they were 31.81 +/- 7.48 and 7.65 +/- 1.98 sec, respectively. Both differences in VHI (P = 0.012) and MPT (P = 0.024) were significant between two treatments. Conclusions: MFHPL was comparable to AFVPL with respect to postoperative complications, recurrence rate and survival rates, but possessed advantages over AFVPL in terms of the incidence of laryngeal stenosis and voice quality. Our study indicated that MFHPL has a potential value in clinical practice of treating stage T1b squamous cell carcinoma of the glottic larynx involving AVC.	[Lei, Wen-bin; Jiang, Ai-yun; Chai, Li-ping; Zhu, Xiao-lin; Wang, Zhang-feng; Wen, Yi-hui; Su, Zhen-zhong; Wen, Wei-ping] Sun Yat Sen Univ, Affiliated Hosp 1, Natl Key Dept Otorhinolaryngol Peoples Republ Chi, Otorhinolaryngol Hosp,Otorhinolaryngol Inst, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Su, ZZ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Natl Key Dept Otorhinolaryngol Peoples Republ Chi, Otorhinolaryngol Hosp,Otorhinolaryngol Inst, Guangzhou 510275, Guangdong, Peoples R China.	szhzh@163.com; wwp1901@yahoo.com.cn	温, 家琦/GYV-3177-2022		National Natural Science Foundation of China [81072224]; Young Faculty Cultivation Project of Sun Yat-sen University [10ykpy10]; Science and Technology Planning Project of Guangdong Province [2009B030801109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Faculty Cultivation Project of Sun Yat-sen University; Science and Technology Planning Project of Guangdong Province	This study was supported by National Natural Science Foundation of China (81072224), Young Faculty Cultivation Project of Sun Yat-sen University (10ykpy10) and Science and Technology Planning Project of Guangdong Province (2009B030801109): 1) National Natural Science Foundation of China, http://www.nsfc.gov.cn/Portal0/default166.htm; 2) Science and Technology Planning Project of Guangdong Province, http://pro.gdstc.gov.cn/stms/main.jsp; 3) Young Faculty Cultivation Project of Sun Yat-sen University, http://mso.sysu.edu.cn/sysufund/Index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey BJ, 1985, SURGERY LARYNX, P257; Bradley PJ, 2006, EUR ARCH OTO-RHINO-L, V263, P879, DOI 10.1007/s00405-006-0138-3; Chone CT, 2007, ARCH OTOLARYNGOL, V133, P882, DOI 10.1001/archotol.133.9.882; Dong P, 2009, OTOLARYNG HEAD NECK, V141, P70, DOI 10.1016/j.otohns.2009.02.007; Ganly I, 2009, HEAD NECK-J SCI SPEC, V31, P338, DOI 10.1002/hed.20975; Herranz J, 2007, ACTA OTORRINOLAR ESP, V58, P367, DOI 10.1016/S0001-6519(07)74947-6; Jacobson BH, 1997, AM J SPEECH LANGUAGE, V6, P66, DOI DOI 10.1044/1058-0360.0603.66; Jaworowska E, 1998, Ann Acad Med Stetin, V44, P175; Kocaturk S, 2005, OTOLARYNG HEAD NECK, V132, P581, DOI 10.1016/j.otohns.2004.09.133; Laccourreye H, 1987, Ann Otolaryngol Chir Cervicofac, V104, P163; Lawson G, 2001, HEAD NECK-J SCI SPEC, V23, P871, DOI 10.1002/hed.1126; Batalla FN, 2008, EUR ARCH OTO-RHINO-L, V265, P543, DOI 10.1007/s00405-007-0512-9; OLSEN KD, 1990, AM J OTOLARYNG, V11, P153, DOI 10.1016/0196-0709(90)90030-Y; Rucci L, 2010, HEAD NECK-J SCI SPEC, V32, P392, DOI 10.1002/hed.21200; Silver CE, 2009, EUR ARCH OTO-RHINO-L, V266, P1333, DOI 10.1007/s00405-009-1028-2; Smee RI, 2010, HEAD NECK-J SCI SPEC, V32, P850, DOI 10.1002/hed.21262; Xu W, 2001, Zhonghua Er Bi Yan Hou Ke Za Zhi, V36, P454; Xu Wen, 2008, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V43, P670; Yu F, 2001, Zhonghua Er Bi Yan Hou Ke Za Zhi, V36, P213	19	6	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52723	10.1371/journal.pone.0052723	http://dx.doi.org/10.1371/journal.pone.0052723			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326350	Green Published, Green Submitted, gold			2022-12-25	WOS:000313551500027
J	Minion, J; Gallant, V; Wolfe, J; Jamieson, F; Long, R				Minion, Jessica; Gallant, Victor; Wolfe, Joyce; Jamieson, Frances; Long, Richard			Multidrug and Extensively Drug-resistant Tuberculosis in Canada 1997-2008: Demographic and Disease Characteristics	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS	Setting: Nationwide Canadian public health surveillance. Objective: Description of demographic features and disease characteristics of drug-resistant tuberculosis (TB) in Canada over a 12 year period. Design: Continuous surveillance of all cases of culture-confirmed TB in Canada. Demographic and microbiologic features were analyzed and comparisons between drug-susceptible, multidrug-resistant (MDR), and drug-resistant not-MDR were made. Cases of extensively drug resistant TB are described. Results: 15,993 cases of culture-confirmed TB were reported during the study period. There were 5 cases of XDR-TB, 177 cases of MDR-TB, and 1,234 cases of first-line drug resistance not-MDR. The majority of drug-resistant cases were reported in foreign-born individuals, with drug-resistant cases diagnosed earlier post-arrival in Canada compared to drug-susceptible cases. In MDR-TB isolates, there was a high rate of drug-resistance to other first- and second-line drugs, making reliable empiric therapeutic recommendations for MDR-TB difficult. There was a statistically significant association between both MDR and drug-resistance not-MDR, and the risk of a negative treatment outcome (defined as treatment failure, absconded, or treatment ongoing >3 yrs). Conclusion: Drug-resistance complicates TB management even in developed nations with well-established TB control programs. The predominantly international origin of drug-resistant cases highlights the need for global strategies to combat TB.	[Minion, Jessica] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Gallant, Victor] Publ Hlth Agcy Canada, HIV AIDS & TB Core Surveillance, Ottawa, ON, Canada; [Wolfe, Joyce] Natl Reference Ctr Mycobacteriol, Natl Microbiol Lab, Winnipeg, MB, Canada; [Jamieson, Frances] Publ Hlth Ontario, Publ Hlth Labs, Toronto, ON, Canada; [Long, Richard] Univ Alberta, Dept Med, Div Pulm Med, Edmonton, AB, Canada	University of Alberta; Public Health Agency of Canada; University of Alberta	Long, R (corresponding author), Univ Alberta, Dept Med, Div Pulm Med, Edmonton, AB, Canada.	richard.long@ualberta.ca						Angeby K, 2012, B WORLD HEALTH ORGAN, V90, P693, DOI 10.2471/BLT.11.096644; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Avendano M, 2000, Can Respir J, V7, P383; CLSI, 2003, M24A CLSI; Dalton T, 2012, LANCET, V380, P1406, DOI 10.1016/S0140-6736(12)60734-X; Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611; Fay MP, 2010, BIOSTATISTICS, V11, P373, DOI 10.1093/biostatistics/kxp050; Hah NS, 2005, INT J TUBERC LUNG D, V9, pS77; Hersi A, 1999, Can Respir J, V6, P155; Long R, 1999, AM J RESP CRIT CARE, V159, P2014, DOI 10.1164/ajrccm.159.6.9809076; Long R, 2012, CAN J PUBLI IN PRESS; Long R., 2007, CANADIAN TUBERCULOSI, V6th; Marras TK, 2003, CHEST, V124, P915, DOI 10.1378/chest.124.3.915; Nathanson E, 2010, NEW ENGL J MED, V363, P1050, DOI 10.1056/NEJMra0908076; Pai M, 2010, CURR OPIN PULM MED, V16, P271, DOI 10.1097/MCP.0b013e328338094f; Seoudi N, 2012, THORAX, V67, P361, DOI 10.1136/thoraxjnl-2011-200610; Sharma M, 2011, J CLIN MICROBIOL, V49, P4112, DOI 10.1128/JCM.05195-11; World Health Organization, 2006, GLOB PLAN STOP TB 20; World Health organization, 2008, POL GUID DRUG SUSC T; Wright A., 2006, Morbidity and Mortality Weekly Report, V55, P301	20	30	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53466	10.1371/journal.pone.0053466	http://dx.doi.org/10.1371/journal.pone.0053466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326436	gold, Green Published, Green Submitted			2022-12-25	WOS:000313551500076
J	Wada, S; Chiba, S				Wada, Shinichiro; Chiba, Satoshi			The Dual Protection of a Micro Land Snail against a Micro Predatory Snail	PLOS ONE			English	Article							TRADE-OFFS; SHELL SCULPTURE; EVOLUTION; DEFENSE; SHAPE; SIZE; FORM	Defense against a single predatory attack strategy may best be achieved not by a single trait but by a combination of different traits. We tested this hypothesis experimentally by examining the unique shell traits (the protruded aperture and the denticles within the aperture) of the micro land snail Bensonella plicidens. We artificially altered shell characteristics by removing the denticles and/or cutting the protruded aperture. These snails were offered to the carnivorous micro land snail Indoennea bicolor, which preys on the snails by gaining entry to their shell. B. plicidens exhibited the best defence when both of the traits studied were present; the defensive ability of B. plicidens decreased if either trait was removed and was further reduced if both traits were removed. These results suggest that a combination of different traits provides more effective defence against attack by the predator than either single trait by itself.	[Wada, Shinichiro; Chiba, Satoshi] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan	Tohoku University	Wada, S (corresponding author), Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan.	b0bd3011@s.tohoku.ac.jp		Chiba, Satoshi/0000-0001-9273-0307	Global COE program of Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan [J03]	Global COE program of Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan	This study was partly supported by the Global COE program J03 of Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abbott RT., 1989, COMPENDIUM LANDSHELL; Agrawal AA, 2007, TRENDS ECOL EVOL, V22, P103, DOI 10.1016/j.tree.2006.10.012; Agrawal AA, 2006, ECOLOGY, V87, pS132, DOI 10.1890/0012-9658(2006)87[132:PDS]2.0.CO;2; Allen John A., 2004, P1, DOI 10.1079/9780851993195.0001; [Anonymous], 2007, LME4 LINEAR MIXED EF; Barker Gary M., 2004, P279, DOI [10.1079/9780851993195.0279, 10.1079/9780851993195.0000]; BERTNESS MD, 1981, J EXP MAR BIOL ECOL, V50, P213, DOI 10.1016/0022-0981(81)90051-4; Boeing WJ, 2006, J PLANKTON RES, V28, P571, DOI 10.1093/plankt/fbi142; Bourdeau PE, 2010, OECOLOGIA, V162, P987, DOI 10.1007/s00442-009-1488-5; Bourdeau PE, 2009, ECOLOGY, V90, P1659, DOI 10.1890/08-1653.1; Brodie ED, 1999, BIOSCIENCE, V49, P557, DOI 10.2307/1313476; Coupland James B., 2004, P85, DOI 10.1079/9780851993195.0085; Cressler CE, 2010, AM NAT, V176, P276, DOI 10.1086/655425; DEMEESTER L, 1995, NATURE, V378, P483; DeWitt TJ, 2000, EVOL ECOL RES, V2, P129; Donovan DA, 1999, J EXP MAR BIOL ECOL, V236, P235, DOI 10.1016/S0022-0981(98)00200-7; Feeny P., 1976, BIOCHEMICAL INTERACT, V10, P1, DOI [10.1007/978-1-4684-2646-5_1, DOI 10.1007/978-1-4684-2646-5_1]; Gittenberger E, 1996, NETH J ZOOL, V46, P191, DOI 10.1163/156854295X00159; GOODFRIEND GA, 1986, SYST ZOOL, V35, P204, DOI 10.2307/2413431; Hoso M, 2008, AM NAT, V172, P726, DOI 10.1086/591681; Johnson SG, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-50; Konuma J, 2007, AM NAT, V170, P90, DOI 10.1086/518182; Laforsch C, 2004, ECOLOGY, V85, P2302, DOI 10.1890/03-0286; Lovegrove BG, 2001, EVOLUTION, V55, P1464; Norman MD, 2001, P ROY SOC B-BIOL SCI, V268, P1755, DOI 10.1098/rspb.2001.1708; PALMER AR, 1979, EVOLUTION, V33, P697, DOI 10.1111/j.1558-5646.1979.tb04722.x; Panha S, 2005, MALACOL REV, V37, P1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REIMCHEN TE, 1983, EVOLUTION, V37, P931, DOI 10.1111/j.1558-5646.1983.tb05622.x; RETTENMEYER CW, 1970, ANNU REV ENTOMOL, V15, P43, DOI 10.1146/annurev.en.15.010170.000355; Rundle SD, 2004, ROYAL SOC, V271, P67; Schilthuizen M, 2006, EVOLUTION, V60, P1851, DOI 10.1554/06-114.1; Schilthuizen Menno, 2004, Journal of Conchology Special Publication, V3, P149; SOLEM A, 1972, Veliger, V15, P81; Sparkes TC, 1996, BEHAV ECOL SOCIOBIOL, V39, P411, DOI 10.1007/s002650050308; Steiner UK, 2007, AM NAT, V169, P118, DOI 10.1086/509939; Stuart-Fox DM, 2004, EVOLUTION, V58, P1549; Trussell GC, 2002, ECOLOGY, V83, P1635, DOI 10.2307/3071984; Trussell GC, 1996, EVOLUTION, V50, P448, DOI 10.1111/j.1558-5646.1996.tb04507.x; TWEEDIE M. W. F., 1961, BULL RAFFLES MUS, V26, P49; Vermeij G.J., 1993, NATURAL HIST SHELLS; VERMEIJ GJ, 1978, AM NAT, V112, P833, DOI 10.1086/283326; VERMEIJ GJ, 1982, MALACOLOGIA, V23, P1; Vermeulen J. J., 1994, Basteria, V58, P75; Wada S, 2012, J BIOGEOGR, V39, P69, DOI 10.1111/j.1365-2699.2011.02559.x; Winsor Leigh, 2004, P227, DOI 10.1079/9780851993195.0227; [No title captured]	47	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e54123	10.1371/journal.pone.0054123	http://dx.doi.org/10.1371/journal.pone.0054123			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326582	Green Submitted, Green Published, gold			2022-12-25	WOS:000313551500109
J	Turner-Ivey, B; Manevich, Y; Schulte, J; Kistner-Griffin, E; Jezierska-Drutel, A; Liu, Y; Neumann, CA				Turner-Ivey, B.; Manevich, Y.; Schulte, J.; Kistner-Griffin, E.; Jezierska-Drutel, A.; Liu, Y.; Neumann, C. A.			Role for Prdx1 as a specific sensor in redox-regulated senescence in breast cancer	ONCOGENE			English	Article						redox signaling; peroxiredoxin; senescence; oxidative stress; protein tyrosine phosphatases; p38MAPK	ACTIVATED PROTEIN-KINASE; N-TERMINAL KINASE; MAP KINASE; CATALYTIC ACTIVATION; PREMATURE SENESCENCE; P38; CELLS; PHOSPHATASE-1; PEROXIREDOXIN; STRESS	Recent studies suggest that Peroxiredoxin 1 (Prdx1), in addition to its known H2O2-scavenging function, mediates cell signaling through redox-specific protein-protein interactions. Our data illustrate how Prdx1 specifically coordinates p38MAPK-induced signaling through regulating p38MAPK alpha phosphatases in an H2O2 dose-dependent manner. MAPK phosphatases (MKP-1 and/or MKP-5), which are known to dephosphorylate and deactivate the senescence-inducing MAPK p38 alpha, belong to a group of redox-sensitive phosphatases (protein tyrosine phosphatases) characterized by a low pKa cysteine in their active sites. We found that Prdx1 bound to both MKP-1 and MKP-5, but dissociated from MKP-1 when the Prdx1 peroxidatic cysteine Cys52 was over-oxidized to sulfonic acid, which in turn resulted in MKP-1 oxidation-induced oligomerization and inactivity toward p38MAPK alpha. Conversely, over-oxidation of Prdx1-Cys52 was enhancing in the Prdx1:MKP-5 complex with increasing amounts of H2O2 concentrations and correlated with a protection from oxidation-induced oligomerization and inactivation of MKP-5 so that activation toward p38MAPK was maintained. Further examination of this Prdx1-specific mechanism in a model of reactive oxygen species-induced senescence of human breast epithelial cells revealed the specific activation of MKP-5, resulting in decreased p38MAPK alpha activity. Taken together, our data suggest that Prdx1 orchestrates redox signaling in an H2O2 dose-dependent manner through the oxidation status of its peroxidatic cysteine Cys52.	[Turner-Ivey, B.] Med Univ S Carolina, Dept Pathol, Charleston, SC 29425 USA; [Manevich, Y.; Schulte, J.; Jezierska-Drutel, A.; Neumann, C. A.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut Med, Charleston, SC 29425 USA; [Kistner-Griffin, E.] Med Univ S Carolina, Dept Biostat & Epidemiol, Charleston, SC 29425 USA; [Liu, Y.] Nationwide Childrens Hosp, Res Inst, Dept Pediat, Columbus, OH USA; [Neumann, C. A.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Neumann, C. A.] UPCI, Magee Womens Res Inst, Pittsburgh, PA 15213 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Neumann, CA (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, E1340 Thomas E Starzl Biomed Sci Tower 200 Lothro, Pittsburgh, PA 15261 USA.	neumannc@upmc.edu	Liu, Yusen/E-3527-2011	Neumann, Carola/0000-0003-2801-9531	 [K22 ES012985-01];  [W81XWH-07-1-0691];  [R01 CA131350];  [CCSG P30 CA138313];  [5T32CA119945-05]; NATIONAL CANCER INSTITUTE [P30CA138313, T32CA119945, R01CA131350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES012985] Funding Source: NIH RePORTER	; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We would like to thank Dr Eisuke Nishida for providing the MKP-5 cDNA; Dr Yusen Liu for providing MKP-1 WT and MKP-1 C258S cDNA; and Dr Steve Rosenzweig and Dr Scott Eblen for fruitful discussions. This work has been funded by K22 ES012985-01 (CAN), W81XWH-07-1-0691 (CAN), R01 CA131350, CCSG P30 CA138313 (HCC) and 5T32CA119945-05 (BT).	Bar-Shira A, 2002, ONCOGENE, V21, P849, DOI 10.1038/sj.onc.1205127; Bowers RR, 2012, BIOCHEMISTRY-US, V51, P7740, DOI 10.1021/bi301006w; Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Coppe JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009188; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Cross JV, 2006, ANTIOXID REDOX SIGN, V8, P1819, DOI 10.1089/ars.2006.8.1819; Dasari A, 2006, CANCER RES, V66, P10805, DOI 10.1158/0008-5472.CAN-06-1236; Dasgupta J, 2010, J CELL PHYSIOL, V225, P52, DOI 10.1002/jcp.22193; Day AM, 2012, MOL CELL, V45, P398, DOI 10.1016/j.molcel.2011.11.027; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007; Han YH, 2005, FEBS LETT, V579, P4897, DOI 10.1016/j.febslet.2005.07.049; Hou N, 2008, ENDOCRINOLOGY, V149, P1654, DOI 10.1210/en.2007-0988; Hutter D, 2000, BIOCHEM J, V352, P155, DOI 10.1042/0264-6021:3520155; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Jeong DG, 2006, J MOL BIOL, V360, P946, DOI 10.1016/j.jmb.2006.05.059; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kim YJ, 2006, CANCER RES, V66, P7136, DOI 10.1158/0008-5472.CAN-05-4446; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lee JJ, 2010, ONCOGENE, V29, P561, DOI 10.1038/onc.2009.355; LIU YS, 1995, J BIOL CHEM, V270, P8377, DOI 10.1074/jbc.270.15.8377; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Neumann CA, 1998, BLOOD, V92, p215A; Neumann CA, 2009, CELL CYCLE, V8, P4072, DOI 10.4161/cc.8.24.10242; Neumann CA, 2007, CURR OPIN PHARMACOL, V7, P375, DOI 10.1016/j.coph.2007.04.007; Nonn L, 2006, CANCER RES, V66, P4516, DOI 10.1158/0008-5472.CAN-05-3796; Nonn L, 2007, CARCINOGENESIS, V28, P1188, DOI 10.1093/carcin/bgl241; Parra E, 2010, ONCOL REP, V24, P1339, DOI 10.3892/or_00000991; Peters GH, 1998, BIOCHEMISTRY-US, V37, P5383, DOI 10.1021/bi971187i; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Schilder YDC, 2009, FREE RADICAL BIO MED, V46, P1598, DOI 10.1016/j.freeradbiomed.2009.03.013; Schindler EM, 2009, CANCER RES, V69, P4648, DOI 10.1158/0008-5472.CAN-08-4455; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; Staples CJ, 2010, J BIOL CHEM, V285, P25928, DOI 10.1074/jbc.M110.117911; Tanoue T, 2001, J BIOL CHEM, V276, P26629, DOI 10.1074/jbc.M101981200; Tanoue T, 2001, EMBO J, V20, P466, DOI 10.1093/emboj/20.3.466; Tephly LA, 2007, AM J RESP CELL MOL, V37, P366, DOI 10.1165/rcmb.2006-0268OC; Theodosiou A, 1999, ONCOGENE, V18, P6981, DOI 10.1038/sj.onc.1203185; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Trost TM, 2005, CANCER RES, V65, P840; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Wang ZQ, 2008, J BIOL CHEM, V283, P21011, DOI 10.1074/jbc.M802229200; Weyemi U, 2012, ONCOGENE, V31, P1117, DOI 10.1038/onc.2011.327; Zhou JY, 2006, CANCER RES, V66, P4888, DOI 10.1158/0008-5472.CAN-05-4229	50	59	64	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 7	2013	32	45					5302	5314		10.1038/onc.2012.624	http://dx.doi.org/10.1038/onc.2012.624			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	251IS	23334324	hybrid, Green Accepted			2022-12-25	WOS:000326922100006
J	Summers, DW; Wolfe, KJ; Ren, HY; Cyr, DM				Summers, Daniel W.; Wolfe, Katie J.; Ren, Hong Yu; Cyr, Douglas M.			The Type II Hsp40 Sis1 Cooperates with Hsp70 and the E3 Ligase Ubr1 to Promote Degradation of Terminally Misfolded Cytosolic Protein	PLOS ONE			English	Article							QUALITY CONTROL DEGRADATION; TUMOR-SUPPRESSOR COMPLEX; MOLECULAR CHAPERONES; CO-CHAPERONE; SACCHAROMYCES-CEREVISIAE; PRION TOXICITY; IN-VIVO; DNAJ; SPECIFICITY; MECHANISM	Mechanisms for cooperation between the cytosolic Hsp70 system and the ubiquitin proteasome system during protein triage are not clear. Herein, we identify new mechanisms for selection of misfolded cytosolic proteins for degradation via defining functional interactions between specific cytosolic Hsp70/Hsp40 pairs and quality control ubiquitin ligases. These studies revolved around the use of S. cerevisiae to elucidate the degradation pathway of a terminally misfolded reporter protein, short-lived GFP (slGFP). The Type I Hsp40 Ydj1 acts with Hsp70 to suppress slGFP aggregation. In contrast, the Type II Hsp40 Sis1 is required for proteasomal degradation of slGFP. Sis1 and Hsp70 operate sequentially with the quality control E3 ubiquitin ligase Ubr1 to target slGFP for degradation. Compromise of Sis1 or Ubr1 function leads slGFP to accumulate in a Triton X-100-soluble state with slGFP degradation intermediates being concentrated into perinuclear and peripheral puncta. Interestingly, when Sis1 activity is low the slGFP that is concentrated into puncta can be liberated from puncta and subsequently degraded. Conversely, in the absence of Ubr1, slGFP and the puncta that contain slGFP are relatively stable. Ubr1 mediates proteasomal degradation of slGFP that is released from cytosolic protein handling centers. Pathways for proteasomal degradation of misfolded cytosolic proteins involve functional interplay between Type II Hsp40/Hsp70 chaperone pairs, PQC E3 ligases, and storage depots for misfolded proteins.	[Summers, Daniel W.; Wolfe, Katie J.; Ren, Hong Yu; Cyr, Douglas M.] Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Cyr, DM (corresponding author), Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27515 USA.	dmcyr@med.unc.edu		Cyr, Douglas/0000-0002-4928-3414; Summers, Daniel/0000-0001-7228-8849	National Institutes of Health [5F31AG032790-02, 5F31NS074777-02, 5R01GM067785-08]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS074777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG032790] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from the National Institutes of Health including 5F31AG032790-02 to DS, 5F31NS074777-02 to KW, and 5R01GM067785-08 to DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; CAPLAN AJ, 1992, CELL, V71, P1143, DOI 10.1016/S0092-8674(05)80063-7; CAPLAN AJ, 1992, J BIOL CHEM, V267, P18890; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Douglas PM, 2009, MOL BIOL CELL, V20, P4162, DOI 10.1091/mbc.E09-02-0170; Douglas PM, 2008, P NATL ACAD SCI US; Douglas PM, 2009, PRION, V3; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Fan CY, 2004, MOL BIOL CELL, V15, P761, DOI 10.1091/mbc.E03-03-0146; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; Grove DE, 2011, MOL BIOL CELL, V22, P301, DOI 10.1091/mbc.E10-09-0760; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Higurashi T, 2008, P NATL ACAD SCI USA, V105, P16596, DOI 10.1073/pnas.0808934105; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kota P, 2009, P NATL ACAD SCI USA, V106, P11073, DOI 10.1073/pnas.0900746106; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Lewis MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005038; Lu Z, 1998, J BIOL CHEM, V273, P5970, DOI 10.1074/jbc.273.10.5970; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Melville MW, 2003, MOL CELL BIOL, V23, P3141, DOI 10.1128/MCB.23.9.3141-3151.2003; Metzger MB, 2008, J BIOL CHEM, V283, P32302, DOI 10.1074/jbc.M806424200; Nillegoda NB, 2010, MOL BIOL CELL, V21, P2102, DOI 10.1091/mbc.E10-02-0098; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Ramos CHI, 2008, J MOL BIOL, V383, P155, DOI 10.1016/j.jmb.2008.08.019; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Schoenfeld AR, 2000, P NATL ACAD SCI USA, V97, P8507, DOI 10.1073/pnas.97.15.8507; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Sondheimer N, 2001, EMBO J, V20, P2435, DOI 10.1093/emboj/20.10.2435; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Summers DW, 2009, J BIOL CHEM, V284, P3628, DOI 10.1074/jbc.M807369200; Tipton KA, 2008, MOL CELL, V32, P584, DOI 10.1016/j.molcel.2008.11.003; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Weisberg SJ, 2012, P NATL ACAD SCI USA, V109, P15811, DOI 10.1073/pnas.1205829109; Winkler J, 2012, J CELL BIOL, V198, P387, DOI 10.1083/jcb.201201074; Yan W, 1998, EMBO J, V17, P4809, DOI 10.1093/emboj/17.16.4809; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584	48	58	58	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e52099	10.1371/journal.pone.0052099	http://dx.doi.org/10.1371/journal.pone.0052099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341891	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700012
J	Wignall, AE; Herberstein, ME				Wignall, Anne E.; Herberstein, Marie E.			The Influence of Vibratory Courtship on Female Mating Behaviour in Orb-Web Spiders (Argiope keyserlingi, Karsch 1878)	PLOS ONE			English	Article							SEXUAL CANNIBALISM; SPERM COMPETITION; ARANEAE; COPULATION; VIBRATIONS; GENITALIA; PATERNITY; SUCCESS; MALES	Web-building spiders are important models for sexual selection. While our understanding of post-copulatory mechanisms including sperm competition and cryptic female choice is considerable, our knowledge of courtship and how it influences male and female mating decisions is still extremely poor. Here, we provide the first comprehensive description of male courtship behaviour and vibrations generated in the web by the orb-web spider, Argiope keyserlingi - a recognised model species. We identified three main elements of male courtship: shudders, abdominal wags and mating thread dances (including both plucks and bounces). The vibrations generated by these behaviours are described in detail. Male shuddering behaviour appears to have a strong influence on female latency to mate acceptance, with males that shudder at high rates without compromising shudder duration being preferred. Shuddering behaviour may also mediate female aggressive behaviour, with males that generate long shudders less likely to be cannibalised after copulation. Male abdominal wagging behaviour, however, appears to have only limited influence on female mating decisions. This study provides avenues for future work that synthesises pre- and post-copulatory mechanisms in web-building spiders to generate an all-encompassing model of how sexual selection operates.	[Wignall, Anne E.; Herberstein, Marie E.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia	Macquarie University	Wignall, AE (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.	anne.wignall@mq.edu.au	Herberstein, Marie E./D-2042-2011	Herberstein, Marie E./0000-0001-5071-2952; Wignall, Anne/0000-0002-0152-8312	Australia & Pacific Science Foundation [APSF 11/5]	Australia & Pacific Science Foundation	This study was supported by the Australia & Pacific Science Foundation (APSF 11/5) and a Macquarie University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahtiainen JJ, 2004, BEHAV ECOL, V15, P602, DOI 10.1093/beheco/arh062; Barrantes G, 2008, J ARACHNOL, V36, P606, DOI 10.1636/St07-13.1; Barth FG, 1998, SPR HDB AUD, V10, P228; Blumstein DT, 2006, JWATCHER WEBSITE; Eberhard WG, 1998, J ARACHNOL, V26, P342; ELGAR MA, 1991, EVOLUTION, V45, P444, DOI 10.1111/j.1558-5646.1991.tb04419.x; Elgar MA, 2003, ANIM BEHAV, V66, P211, DOI 10.1006/anbe.2003.2189; Elgar MA, 2000, P ROY SOC B-BIOL SCI, V267, P2439, DOI 10.1098/rspb.2000.1303; Fromhage L, 2005, BEHAV ECOL, V16, P377, DOI 10.1093/beheco/ari011; Gaskett AC, 2004, BEHAVIOUR, V141, P1197, DOI 10.1163/1568539042729676; Gibson JS, 2012, ANIM BEHAV, V84, P85, DOI 10.1016/j.anbehav.2012.04.010; Herberstein ME, 2012, BEHAV ECOL, V23, P1140, DOI 10.1093/beheco/ars088; Herberstein ME, 2011, BEHAV ECOL, V22, P692, DOI 10.1093/beheco/arr053; Herberstein Marie E., 2011, P1; Herberstein ME, 2005, ETHOLOGY, V111, P1050, DOI 10.1111/j.1439-0310.2005.01114.x; Herberstein ME, 2002, BEHAV ECOL SOCIOBIOL, V51, P440, DOI 10.1007/s00265-002-0460-8; Herberstein ME, 2011, SPIDER BEHAV FLEXIBI, P1; Hill P.S., 2008, VIBRATIONAL COMMUNIC, DOI DOI 10.4159/9780674273825; Huber BA, 2005, BIOL REV, V80, P363, DOI 10.1017/S1464793104006700; Huber BA, 2004, J MORPHOL, V261, P364, DOI 10.1002/jmor.10255; JACKSON R R, 1985, Journal of Zoology Series B, V1, P175; JACKSON RR, 1992, J ZOOL, V228, P509, DOI 10.1111/j.1469-7998.1992.tb04451.x; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Landolfa MA, 1996, J COMP PHYSIOL A, V179, P493, DOI 10.1007/BF00192316; Maklakov AA, 2003, ANIM BEHAV, V66, P623, DOI 10.1006/anbe.2003.2245; Montgomery TH., 1903, ACAD NAT SCI, V55, P59; Robinson M.H., 1980, Pacific Insects Monograph, V36, P1; ROBINSON MH, 1982, ANNU REV ENTOMOL, V27, P1, DOI 10.1146/annurev.en.27.010182.000245; Schneider JM, 2000, J EVOLUTION BIOL, V13, P939, DOI 10.1046/j.1420-9101.2000.00238.x; Schneider JM, 2008, P ROY SOC LOND B BIO, V276, P3105; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Shamble PS, 2009, BEHAV ECOL, V20, P1242, DOI 10.1093/beheco/arp116; Singer F, 2000, BEHAVIOUR, V137, P93, DOI 10.1163/156853900501890; Snow LSE, 2004, BEHAV ECOL, V15, P785, DOI 10.1093/beheco/arh080; Stoltz JA, 2008, BEHAV ECOL SOCIOBIOL, V62, P689, DOI 10.1007/s00265-007-0493-0; Stoltz JA, 2009, ANIM BEHAV, V77, P79, DOI 10.1016/j.anbehav.2008.09.012; SUTER RB, 1984, J ARACHNOL, V12, P37; Uhl Gabriele, 2011, P127; WATSON PJ, 1991, ANIM BEHAV, V41, P343, DOI 10.1016/S0003-3472(05)80486-5; Whitehouse MEA, 1998, J ZOOL, V244, P95, DOI 10.1111/j.1469-7998.1998.tb00011.x; Wignall AE, 2011, P ROY SOC B-BIOL SCI, V278, P1427, DOI 10.1098/rspb.2010.2060; Wilder SM, 2009, ANNU REV ECOL EVOL S, V40, P21, DOI 10.1146/annurev.ecolsys.110308.120238; Wilgers DJ, 2011, CURR ZOOL, V57, P175, DOI 10.1093/czoolo/57.2.175	43	26	26	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53057	10.1371/journal.pone.0053057	http://dx.doi.org/10.1371/journal.pone.0053057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341922	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700019
J	Marinelli, L; Trompetto, C; Mori, L; Vigo, G; Traverso, E; Colombano, F; Abbruzzese, G				Marinelli, Lucio; Trompetto, Carlo; Mori, Laura; Vigo, Gabriele; Traverso, Elisabetta; Colombano, Federica; Abbruzzese, Giovanni			Manual Linear Movements to Assess Spasticity in a Clinical Setting	PLOS ONE			English	Article							BOTULINUM TOXIN; PARKINSONS-DISEASE; STRETCH REFLEXES; LIMB SPASTICITY; RIGIDITY; ASHWORTH	In a clinical setting, where motor-driven systems are not readily available, the major difficulty in the assessment of the stretch reflex lies in the control of passive limb displacement velocity. A potential approach to this problem arises from the use of manual sinusoidal movements (made by continuous alternating flexions and extensions) paced by an external stimulus. Unfortunately, there are conditions in which sinusoidal movements induce interfering phenomena such as the shortening reaction or postactivation depression. In the present paper, a novel manual method to control the velocity of passive linear movements is described and the results obtained from both healthy subjects and spastic patients are reported. This method is based on the synchronisation of movements with tones played by a metronome at different speeds. In a first set of experiments performed in healthy subjects, we demonstrated consistent control of velocity during passive limb movements using this method. Four joints usually examined during muscle tone assessment were tested: wrist, elbow, knee and ankle joints. Following this, we conducted a longitudinal assessment of the stretch reflex amplitude in wrist flexor muscles in patients with spasticity treated with botulinum toxin type A. The evaluators were not only able to vary the movement velocity based on the metronome speed, but also could reproduce the respective speeds two weeks later, despite the changing degree of hypertonia. This method is easy to perform in a clinical setting and hardware requirements are minimal, making it an attractive and robust procedure for the widespread clinical assessment of reflex hypertonia.	[Marinelli, Lucio; Trompetto, Carlo; Mori, Laura; Vigo, Gabriele; Traverso, Elisabetta; Colombano, Federica; Abbruzzese, Giovanni] Univ Genoa, Clin Neurol, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy	University of Genoa	Marinelli, L (corresponding author), Univ Genoa, Clin Neurol, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy.	lucio.marinelli@unige.it	Marinelli, Lucio/K-3141-2012; Mori, Laura/K-2450-2018; Trompetto, Carlo/AAC-3550-2022	Marinelli, Lucio/0000-0003-0620-7654; Mori, Laura/0000-0003-2762-8327; Trompetto, Carlo/0000-0003-3419-0669				Biering-Sorensen F, 2006, SPINAL CORD, V44, P708, DOI 10.1038/sj.sc.3101928; Delwaide PJ, 2001, FUNCT NEUROL, V16, P147; DIETZ V, 1981, BRAIN, V104, P431, DOI 10.1093/brain/104.3.431; FELDMAN AG, 1986, J MOTOR BEHAV, V18, P17; Grey MJ, 2008, EXP BRAIN RES, V185, P189, DOI 10.1007/s00221-007-1142-6; Marinelli L, 2010, 6 WORLD C NEUR MED I; MEARA RJ, 1992, BRAIN, V115, P1167, DOI 10.1093/brain/115.4.1167; Miscio G, 2004, J NEUROL, V251, P189, DOI 10.1007/s00415-004-0297-3; Pandyan AD, 1999, CLIN REHABIL, V13, P373, DOI 10.1191/026921599677595404; Pandyan AD, 2003, CLIN REHABIL, V17, P290, DOI 10.1191/0269215503cr610oa; Phadke CP, 2012, DISABIL REHABIL, V34, P91, DOI 10.3109/09638288.2011.591882; RACK PMH, 1990, J PHYSIOL-LONDON, V425, pP83; Schuster C, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-75; Sheean G, 2002, EUR J NEUROL, V9, P3, DOI 10.1046/j.1468-1331.2002.0090s1003.x; Sorinola IO, 2009, NEUROREHAB NEURAL RE, V23, P287, DOI 10.1177/1545968308321778; THILMANN AF, 1991, BRAIN, V114, P233; Thompson AJ, 2005, J NEUROL NEUROSUR PS, V76, P459, DOI 10.1136/jnnp.2004.035972; Trompetto C, 2008, EUR J NEUROL, V15, P367, DOI 10.1111/j.1468-1331.2008.02076.x; Voerman GE, 2005, DISABIL REHABIL, V27, P33, DOI 10.1080/09638280400014600	19	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53627	10.1371/journal.pone.0053627	http://dx.doi.org/10.1371/journal.pone.0053627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086SQ	23335966	Green Published, Green Submitted, gold			2022-12-25	WOS:000314707700022
J	McNaghten, AD; Valverde, EE; Blair, JM; Johnson, CH; Freedman, MS; Sullivan, PS				McNaghten, A. D.; Valverde, Eduardo E.; Blair, Janet M.; Johnson, Christopher H.; Freedman, Mark S.; Sullivan, Patrick S.			Routine HIV Testing among Providers of HIV Care in the United States, 2009	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FOR-DISEASE-CONTROL; ANTIRETROVIRAL THERAPY; COST-EFFECTIVENESS; RECOMMENDATIONS; HEALTH	In 2006, CDC recommended HIV screening as part of routine medical care for all persons aged 13-64 years. We examined adherence to the recommendations among a sample of HIV care providers in the US to determine if known providers of HIV care are offering routine HIV testing in outpatient settings. Data were from the CDC's Medical Monitoring Project Provider Survey, administered to physicians, nurse practitioners and physician assistants from June-September 2009. We assessed bivariate associations between testing behaviors and provider and practice characteristics and used multivariate regression to determine factors associated with offering HIV screening to all patients aged 13-64 years. Sixty percent of providers reported offering HIV screening to all patients 13 to 64 years of age. Being a nurse practitioner (aOR = 5.6, 95% CI = 2.6-11.9) compared to physician, age <39 (aOR = 1.9, 95% CI = 1.0-3.5) or 39-49 (aOR = 2.1, 95% CI = 1.4-3.3) compared with >= 50 years, and black race (aOR = 2.6, 95% CI = 1.2-6.0) compared with white race was associated with offering testing to all patients. Providers with low (aOR = 0.2, 95% CI = 0.1-0.3) or medium (aOR = 0.4, 95% CI = 0.2-0.6) HIV-infected patient loads were less likely to offer HIV testing to all patients compared with providers with high patient loads. Many providers of HIV care are still conducting risk-based rather than routine testing. We found that provider profession, age, race, and HIV-infected patient load were associated with offering HIV testing. Health care providers should use patient encounters as an opportunity to offer routine HIV testing to patients as outlined in CDC's revised recommendations for HIV testing in health care settings.	[McNaghten, A. D.; Valverde, Eduardo E.; Blair, Janet M.; Johnson, Christopher H.; Freedman, Mark S.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Sullivan, Patrick S.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health	McNaghten, AD (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	a.d.mcnaghten@emory.edu		Sullivan, Patrick Sean/0000-0002-7728-0587	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This project was funded exclusively by the Centers for Disease Control and Prevention, which conceived the project, developed project-associated materials including data collection instruments, provided oversight of implementation, conducted analytic procedures, and developed this report.	Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P845; [Anonymous], 1999, Pediatrics, V104, P128; [Anonymous], 1978, MAIL TELEPHONE SURVE; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Bartlett JG, 2008, JAMA-J AM MED ASSOC, V300, P945, DOI 10.1001/jama.300.8.945; Bayer R, 2006, NEW ENGL J MED, V355, P647, DOI 10.1056/NEJMp068153; Bernstein KT, 2008, AIDS PATIENT CARE ST, V22, P649, DOI 10.1089/apc.2007.0261; Bokhour BG, 2009, J GEN INTERN MED, V24, P1109, DOI 10.1007/s11606-009-1078-6; Brown J, 2007, J ACQ IMMUN DEF SYND, V46, P381; Burke RC, 2007, AIDS, V21, P1617, DOI 10.1097/QAD.0b013e32823f91ff; CDC, 2010, 6 CDC; CDC, 2006, MMWR-MORBID MORTAL W, V55; CDC, 2010, HIV SURV REP 2008, V20; Centers for Disease Control, 2001, Morbidity and Mortality Weekly Report, V50, P59; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1013; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P538; Centers for Disease Control and Prevention (CDC) , 1995, MMWR MORB MORTAL WKL, V44; Centers for Disease Control (CDC), 1987, MMWR Morb Mortal Wkly Rep, V36, P509; Chen Z, 1998, SEX TRANSM DIS, V25, P539, DOI 10.1097/00007435-199811000-00008; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Frankel Martin R, 2012, Open AIDS J, V6, P67, DOI 10.2174/1874613601206010067; Gostin LO, 2006, JAMA-J AM MED ASSOC, V296, P2023, DOI 10.1001/jama.296.16.2023; Hanssens C, 2007, CLIN INFECT DIS, V45, pS232, DOI 10.1086/522543; Haukoos JS, 2008, ANN EMERG MED, V51, P303, DOI 10.1016/j.annemergmed.2007.10.028; Haukoos JS, 2010, JAMA-J AM MED ASSOC, V304, P284, DOI 10.1001/jama.2010.953; Herrera J. L., 1993, Morbidity and Mortality Weekly Report, V42, P1; Holtgrave DR, 2007, PLOS MED, V4, P1011, DOI 10.1371/journal.pmed.0040194; Jain CL, 2009, AIDS PATIENT CARE ST, V23, P167, DOI 10.1089/apc.2008.0130; Jenkins TC, 2006, SEX TRANSM DIS, V33, P329, DOI 10.1097/01.olq.0000194617.91454.3f; Johnson A. Satcher, 2010, Morbidity and Mortality Weekly Report, V59, P1550; Mahajan AP, 2009, ANN INTERN MED, V150, P263, DOI 10.7326/0003-4819-150-4-200902170-00007; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; McNaghten AD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000550; Myers JJ, 2009, J GEN INTERN MED, V24, P1269, DOI 10.1007/s11606-009-1070-1; National HIV/AIDS Clinicians' Consultation Center, 2010, COMP 2010 STAT TEST; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Possi PH, 1983, HDB SURVEY RES; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Scott Victor F, 2009, Trans Am Clin Climatol Assoc, V120, P429; Siegel M, 2009, J ACQ IMMUN DEF SYND, V55, P205; The Office of National AIDS Policy, NAT HIV AIDS STRAT U; Valdiserri RO, 2010, J COMMUN HEALTH, V35, P215, DOI 10.1007/s10900-010-9233-x; Walensky R. P., 2004, Morbidity and Mortality Weekly Report, V53, P523; Walensky RP, 2007, CLIN INFECT DIS, V45, pS248, DOI 10.1086/522546; Wall Kristin M, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P284, DOI 10.1177/1545109710379051; Weis KE, 2009, AIDS PATIENT CARE ST, V23, P251, DOI 10.1089/apc.2008.0167	49	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e51231	10.1371/journal.pone.0051231	http://dx.doi.org/10.1371/journal.pone.0051231			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	087KE	23341880	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400003
J	Aurit, MD; Peterson, RO; Blanford, JI				Aurit, Mark D.; Peterson, Robert O.; Blanford, Justine I.			A GIS Analysis of the Relationship between Sinkholes, Dry-Well Complaints and Groundwater Pumping for Frost-Freeze Protection of Winter Strawberry Production in Florida	PLOS ONE			English	Article							SPATIAL-ANALYSIS; KARST; USA	Florida is riddled with sinkholes due to its karst topography. Sometimes these sinkholes can cause extensive damage to infrastructure and homes. It has been suggested that agricultural practices, such as sprinkler irrigation methods used to protect crops, can increase the development of sinkholes, particularly when temperatures drop below freezing, causing groundwater levels to drop quickly during groundwater pumping. In the strawberry growing region, Dover/Plant City, Florida, the effects have caused water shortages resulting in dry-wells and ground subsidence through the development of sinkholes that can be costly to maintain and repair. In this study, we look at how frost-freeze events have affected West Central Florida over the past 25 years with detailed comparisons made between two cold-years (with severe frost-freeze events) and a warm year (no frost-freeze events). We analyzed the spatial and temporal correlation between strawberry farming freeze protection practices and the development of sinkholes/dry well complaints, and assessed the economic impact of such events from a water management perspective by evaluating the cost of repairing and drilling new wells and how these compared with using alternative crop-protection methods. We found that the spatial distribution of sinkholes was non-random during both frost-freeze events. A strong correlation between sinkhole occurrence and water extraction and minimum temperatures was found. Furthermore as temperatures fall below 41 degrees F and water levels decrease by more than 20 ft, the number of sinkholes increase greatly (N>10). At this time alternative protection methods such as freeze-cloth are cost prohibitive in comparison to repairing dry wells. In conclusion, the findings from this study are applicable in other agricultural areas and can be used to develop comprehensive water management plans in areas where the abstraction of large quantities of water occur.	[Aurit, Mark D.] Tampa Bay Water, Clearwater, FL USA; [Peterson, Robert O.] SW Florida Water Management Dist, Water Resources Bur, Brooksville, FL USA; [Blanford, Justine I.] Penn State Univ, Dept Geog, GeoVISTA Ctr, University Pk, PA 16802 USA; [Blanford, Justine I.] Penn State Univ, Dutton E Educ Inst, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Blanford, JI (corresponding author), Penn State Univ, Dept Geog, GeoVISTA Ctr, University Pk, PA 16802 USA.	jib18@psu.edu		Blanford, Justine/0000-0003-0844-9390				[Anonymous], 2009, CRIME MAPPING J RES; Ardaman and Associates I, 2011, GEOT ENG GEM; BECK BF, 1986, ENVIRON GEOL WATER S, V8, P5, DOI 10.1007/BF02525554; BENGTSSON TO, 1989, ENVIRON GEOL WATER S, V14, P43, DOI 10.1007/BF01740584; Boriss H., 2010, AGR MARKETING RES CE; DEP_FL, 2009, FLOR DROUGHT COND FR; Doctor KZ, 2008, 11 MULT C SINKH ENG, P100; Eck J, 2008, SECUR J, P4; EDLING RJ, 1992, AGR FOREST METEOROL, V60, P101, DOI 10.1016/0168-1923(92)90077-H; ESRI, 2010, AV NEAR NEIGHB SPAT; Evens RG, 2000, P ASEV 50 ANN M SEAT, P60; FAN, 2011, SINKH IMC AGR GYPS S; FAO, 2005, REC METH FROST PROT; FGS, 2011, FGS SUBS INC REP; Fleury S, 2009, KARST PROCESSES LAND; Fleury S, 2008, SE GEOGRAPHER, V48, P38; Fraisse CW, 2006, PROC FL STATE HORTIC, V119, P94; Galloway D.L., 1999, LAND SUBSIDENCE US, P23; Galloway DL, 1999, 1182 US GEOL SURV, P175; Hall LE, 1978, SINKHOLE COLLAPSE IN; Ingebritsen S.E., 1999, LAND SUBSIDENCE US, P15; Jackson JL, 2009, CITRUS COLD WEATHER; Jammal SE, 1982, WINTER PARK SINKHOLE, P585; Jammal SE, 2009, WINTER PARK SINKHOLE, P19; Johnson N, 2010, COST PLANT CITY SINK; Knox JW, 1997, AGR WATER MANAGE, V33, P1, DOI 10.1016/S0378-3774(96)01285-1; Newman GH, 2011, CITY TRANSFERS 70000; NOAA, 2011, NNDC CLIM DAT ONL GL; OMAFRA, 2009, FREEZ PROT METH CROP; PANNO SV, 1994, ENVIRON GEOL, V23, P214, DOI 10.1007/BF00771791; Peres NA, 2010, STRAWBERRY PRODUCTIO; Peterson RO, 2012, RESOURCE EVALUATION, P91; Poly-Tex, 2010, ACC; Powell AA, 2000, METHODS FREEZE PROTE, P1; Scheidt J., 2005, ENV GEOSCIENCES, V12, P207, DOI [10.1306/eg.05130404009, DOI 10.1306/EG.05130404009]; Scott, 2011, SPATIAL STAT BEST PR; Scott L.M., 2010, HDB APPL SPATIAL ANA; Sinclair W.C., 1982, SINKHOLE DEV RESULTI, P81; Snyder RL., 2005, FROST PROTECTION FUN, P2; SWFWMD, 2010, DOV PLANT CIT FREEZ; SWFWMD, 2011, DOV PLANT CIT FREEZ; SWFWMD, 2011, STAT EST REG COSTS D; SWFWMD, 2011, SHAP LIB REG; Tampa_Bay_Water, 2011, WATER SUPPLY; Tihansky A.B., 1999, LAND SUBSIDENCE US U, V1182, P121; Unwin D, 2003, GEOGRAPHIC INFORM AN; USDA, 2007, CENS AGR COUNT DAT; USFIFAS, 2005, WAT QUAL QUANT BEST; Waltham T, 2008, Q J ENG GEOL HYDROGE, V41, P291, DOI 10.1144/1470-9236/07-211; Watson Company, 1973, LONG RANG STUD CIT T; Weatherbase, 2011, WEATHERBASE WEATHER; Whitman D, 1999, PHOTOGRAMM ENG REM S, V65, P1169; WILSON WL, 1992, GROUND WATER, V30, P918, DOI 10.1111/j.1745-6584.1992.tb01575.x; Wing MG, 2006, J FOREST, V104, P293; Zektser S, 2005, ENVIRON GEOL, V47, P396, DOI 10.1007/s00254-004-1164-3; Zhang Y, 2010, ENVIRON EARTH SCI, V61, P1135, DOI 10.1007/s12665-009-0433-6	56	17	17	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53832	10.1371/journal.pone.0053832	http://dx.doi.org/10.1371/journal.pone.0053832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326518	Green Published, gold, Green Submitted			2022-12-25	WOS:000314705800080
J	Lien, YC; Ou, TY; Lin, YT; Kuo, PC; Lin, HJ				Lien, Yi-Chin; Ou, Ting-Yu; Lin, Yu-Tzu; Kuo, Po-Chih; Lin, Han-Jia			Duplication and Diversification of the Spermidine/Spermine N-1-acetyltransferase 1 Genes in Zebrafish	PLOS ONE			English	Article							POLYAMINE ANALOGS; ACETYLTRANSFERASE; IDENTIFICATION; THIALYSINE; EXPRESSION; EVOLUTION; SEQUENCE; BINDS; MICE; UBIQUITINATION	Spermidine/spermine N-1-acetyltransferase 1 (Ssat1) is a key enzyme in the polyamine interconversion pathway, which maintains polyamine homeostasis. In addition, mammalian Ssat1 is also involved in many physiological and pathological events such as hypoxia, cell migration, and carcinogenesis. Using cross-genomic bioinformatic analysis in 10 deuterostomes, we found that ssat1 only exists in vertebrates. Comparing with mammalian, zebrafish, an evolutionarily distant vertebrate, contains 3 homologous ssat1 genes, named ssat1a, ssat1b, and ssat1c. All zebrafish homologues could be transcribed and produce active enzymes. Despite the long history since their evolutionary diversification, some features of human SSAT1 are conserved and subfunctionalized in the zebrafish family of Ssat1 proteins. The polyamine-dependent protein synthesis was only found in Ssat1b and Ssat1c, not in Ssat1a. Further study indicated that both 5' and 3' sequences of ssat1b mediate such kind of translational regulation inside the open reading frame (ORF). The polyamine-dependent protein stabilization was only observed in Ssat1b. The last 70 residues of Ssat1b were crucial for its rapid degradation and polyamine-induced stabilization. It is worth noting that only Ssat1b and Ssat1c, but not the polyamine-insensitive Ssat1a, were able to interact with integrin alpha 9 and Hif-1 alpha. Thus, Ssat1b and Ssat1c might not only be a polyamine metabolic enzyme but also simultaneously respond to polyamine levels and engage in cross-talk with other signaling pathways. Our data revealed some correlations between the sequences and functions of the zebrafish family of Ssat1 proteins, which may provide valuable information for studies of their translational regulatory mechanism, protein stability, and physiological functions.	[Lien, Yi-Chin; Ou, Ting-Yu; Lin, Yu-Tzu; Kuo, Po-Chih; Lin, Han-Jia] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan; [Lin, Han-Jia] Natl Taiwan Ocean Univ, Ctr Excellence Marine Bioenvironm & Biotechnol, Keelung, Taiwan	National Taiwan Ocean University; National Taiwan Ocean University	Lin, HJ (corresponding author), Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan.	hanjia@ntou.edu.tw		Lin, Han-Jia/0000-0002-4929-6573	National Science Council (Taipei, Taiwan) [NSC 99-2313-B-019-010-MY3, NSC 100-2627-B-019-005]	National Science Council (Taipei, Taiwan)(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants NSC 99-2313-B-019-010-MY3 and NSC 100-2627-B-019-005 from the National Science Council (Taipei, Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-Dalo B, 2004, BIOCHEM J, V384, P129, DOI 10.1042/BJ20040789; Agostinelli E, 2010, AMINO ACIDS, V38, P353, DOI 10.1007/s00726-009-0431-8; Agostinelli E, 2012, AMINO ACIDS, V42, P397, DOI 10.1007/s00726-011-1129-2; Alhonen L, 2002, BIOCHEM J, V362, P149, DOI 10.1042/0264-6021:3620149; Baek JH, 2007, J BIOL CHEM, V282, P33358, DOI 10.1074/jbc.M705627200; Bai LP, 2011, BIOCHIMIE, V93, P1401, DOI 10.1016/j.biochi.2011.04.014; Bewley MC, 2006, P NATL ACAD SCI USA, V103, P2063, DOI 10.1073/pnas.0511008103; Butcher NJ, 2007, J BIOL CHEM, V282, P28530, DOI 10.1074/jbc.M701265200; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Chen C, 2004, J CELL BIOL, V167, P161, DOI 10.1083/jcb.200312166; COLEMAN CS, 1995, BIOCHEMISTRY-US, V34, P13423, DOI 10.1021/bi00041a020; Coleman CS, 2004, BIOCHEM J, V384, P139, DOI 10.1042/BJ20040790; Coleman CS, 1997, J BIOL CHEM, V272, P12164, DOI 10.1074/jbc.272.18.12164; Coleman CS, 2001, BIOCHEM J, V358, P137, DOI 10.1042/0264-6021:3580137; Dehart GW, 2008, P NATL ACAD SCI USA, V105, P7188, DOI 10.1073/pnas.0708044105; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FogelPetrovic M, 1996, BIOCHEMISTRY-US, V35, P14436, DOI 10.1021/bi9612273; Force A, 1999, GENETICS, V151, P1531; Forouhar F, 2005, J BIOL CHEM, V280, P40328, DOI 10.1074/jbc.M505332200; FUKUCHI J, 1994, J BIOL CHEM, V269, P22581; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Han LP, 2009, INT J CARDIOL, V132, P142, DOI 10.1016/j.ijcard.2007.07.163; Huang XZ, 2000, MOL CELL BIOL, V20, P5208, DOI 10.1128/MCB.20.14.5208-5215.2000; Hyvonen MT, 2007, BIOCHEM SOC T, V35, P326, DOI 10.1042/BST0350326; Hyvonen MT, 2006, RNA, V12, P1569, DOI 10.1261/rna.39806; Hyvonen MT, 2012, AMINO ACIDS, V42, P485, DOI 10.1007/s00726-011-1027-7; Jell J, 2007, J BIOL CHEM, V282, P8404, DOI 10.1074/jbc.M610265200; Johnson MS, 2009, BBA-BIOMEMBRANES, V1788, P779, DOI 10.1016/j.bbamem.2008.12.013; KAMMANN M, 1989, NUCLEIC ACIDS RES, V17, P5404, DOI 10.1093/nar/17.13.5404; Kim K, 2005, BIOCHEM BIOPH RES CO, V331, P78, DOI 10.1016/j.bbrc.2005.03.121; Kurian L, 2011, NATURE, V477, P490, DOI 10.1038/nature10393; Lee SB, 2010, J BIOL CHEM, V285, P15548, DOI 10.1074/jbc.M109.092007; Lin HJ, 2010, ANAL BIOCHEM, V407, P226, DOI 10.1016/j.ab.2010.07.036; Liu BS, 2005, J BIOL CHEM, V280, P16659, DOI 10.1074/jbc.M414008200; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; Luersen K, 2005, FEBS LETT, V579, P5347, DOI 10.1016/j.febslet.2005.08.063; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Montemayor EJ, 2008, BIOCHEMISTRY-US, V47, P9145, DOI 10.1021/bi8009357; Niiranen K, 2006, J CELL MOL MED, V10, P933, DOI 10.2755/jcmm010.004.02; Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008; Perez-Leal O, 2012, MOL CELL BIOL, V32, P1453, DOI 10.1128/MCB.06444-11; Perez-Leal O, 2012, AMINO ACIDS, V42, P611, DOI 10.1007/s00726-011-1036-6; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Rao AM, 2000, J NEUROCHEM, V74, P1106; ROM E, 1994, P NATL ACAD SCI USA, V91, P3959, DOI 10.1073/pnas.91.9.3959; Singh P, 2009, J INVEST DERMATOL, V129, P217, DOI 10.1038/jid.2008.201; Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uimari A, 2012, AMINO ACIDS, V42, P461, DOI 10.1007/s00726-011-1025-9; Vreede J, 2003, J BIOL CHEM, V278, P18434, DOI 10.1074/jbc.M301701200; Vujcic S, 2002, BIOCHEM J, V367, P665, DOI 10.1042/BJ20020720; Wang YL, 1999, J BIOL CHEM, V274, P22095, DOI 10.1074/jbc.274.31.22095; Wang YL, 1998, J BIOL CHEM, V273, P34623, DOI 10.1074/jbc.273.51.34623; Woolridge DP, 1999, BIOCHEM J, V340, P753, DOI 10.1042/0264-6021:3400753; Yokosaki Y, 1998, J BIOL CHEM, V273, P11423, DOI 10.1074/jbc.273.19.11423; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; Zahedi K, 2003, AM J PHYSIOL-RENAL, V284, pF1046, DOI 10.1152/ajprenal.00318.2002; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	58	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54017	10.1371/journal.pone.0054017	http://dx.doi.org/10.1371/journal.pone.0054017			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326562	Green Published, Green Submitted, gold			2022-12-25	WOS:000314705800101
J	Park, JK; Kim, HS; Uh, KJ; Choi, KH; Kim, HM; Lee, T; Yang, BC; Kim, HJ; Ka, HH; Kim, H; Lee, CK				Park, Jin-Kyu; Kim, Hye-Sun; Uh, Kyung-Jun; Choi, Kwang-Hwan; Kim, Hyeong-Min; Lee, Taeheon; Yang, Byung-Chul; Kim, Hyun-Jong; Ka, Hak-Hyun; Kim, Heebal; Lee, Chang-Kyu			Primed Pluripotent Cell Lines Derived from Various Embryonic Origins and Somatic Cells in Pig	PLOS ONE			English	Article							EPIBLAST STEM-CELLS; IN-VITRO; PORCINE EMBRYO; BLASTOCYSTS; DERIVATION; GENERATION; CULTURE; VIVO; EXPRESSION; ESTABLISHMENT	Since pluripotent embryonic stem cell (ESC) lines were first derived from the mouse, tremendous efforts have been made to establish ESC lines in several domestic species including the pig; however, authentic porcine ESCs have not yet been established. It has proven difficult to maintain an ESC-like state in pluripotent porcine cell lines due to the frequent occurrence of spontaneous differentiation into an epiblast stem cell (EpiSC)-like state during culture. We have been able to derive EpiSC-like porcine ESC (pESC) lines from blastocyst stage porcine embryos of various origins, including in vitro fertilized (IVF), in vivo derived, IVF aggregated, and parthenogenetic embryos. In addition, we have generated induced pluripotent stem cells (piPSCs) via plasmid transfection of reprogramming factors (Oct4, Sox2, Klf4, and c-Myc) into porcine fibroblast cells. In this study, we analyzed characteristics such as marker expression, pluripotency and the X chromosome inactivation status in female of our EpiSC-like pESC lines along with our piPSC line. Our results show that these cell lines demonstrate the expression of genes associated with the Activin/Nodal and FGF2 pathways along with the expression of pluripotent markers Oct4, Sox2, Nanog, SSEA4, TRA 1-60 and TRA 1-81. Furthermore all of these cell lines showed in vitro differentiation potential, the X chromosome inactivation in female and a normal karyotype. Here we suggest that the porcine species undergoes reprogramming into a primed state during the establishment of pluripotent stem cell lines.	[Park, Jin-Kyu; Kim, Hye-Sun; Uh, Kyung-Jun; Choi, Kwang-Hwan; Kim, Hyeong-Min; Lee, Taeheon; Kim, Heebal; Lee, Chang-Kyu] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Park, Jin-Kyu; Kim, Hye-Sun; Uh, Kyung-Jun; Choi, Kwang-Hwan; Kim, Hyeong-Min; Lee, Taeheon; Kim, Heebal; Lee, Chang-Kyu] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Yang, Byung-Chul; Kim, Hyun-Jong] RDA, Natl Inst Anim Sci, Suwon, South Korea; [Ka, Hak-Hyun] Yonsei Univ, Dept Biol Resources & Technol, Wonju, South Korea	Seoul National University (SNU); Seoul National University (SNU); National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Yonsei University	Lee, CK (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	leeck@snu.ac.kr	Kim, Heebal/A-8889-2016	Kim, Heebal/0000-0003-3064-1303; Choi, Kwang-Hwan/0000-0003-3919-7413	Next BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ0081382011]	Next BioGreen 21 Program, Rural Development Administration, Republic of Korea	Funding: This work was supported by the Next BioGreen 21 Program (PJ0081382011), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberio R, 2010, STEM CELLS DEV, V19, P1627, DOI 10.1089/scd.2010.0012; Anderson GB, 1996, ANIM REPROD SCI, V45, P231, DOI 10.1016/S0378-4320(96)01581-3; Blomberg LA, 2008, MOL REPROD DEV, V75, P450, DOI 10.1002/mrd.20780; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brevini TAL, 2007, THERIOGENOLOGY, V68, pS206, DOI 10.1016/j.theriogenology.2007.05.043; Brevini TAL, 2007, THERIOGENOLOGY, V67, P54, DOI 10.1016/j.theriogenology.2006.09.019; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Buehr M, 2003, BIOL REPROD, V68, P222, DOI 10.1095/biolreprod.102.006197; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; du Puy L, 2011, THERIOGENOLOGY, V75, P513, DOI 10.1016/j.theriogenology.2010.09.019; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hall V, 2008, STEM CELL REV, V4, P275, DOI 10.1007/s12015-008-9040-2; Hall VJ, 2009, DEV DYNAM, V238, P2014, DOI 10.1002/dvdy.22027; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Heins N, 2004, STEM CELLS, V22, P367, DOI 10.1634/stemcells.22-3-367; Kim S, 2010, ZYGOTE, V18, P93, DOI 10.1017/S0967199409990372; Lee SG, 2007, MOL REPROD DEV, V74, P1436, DOI 10.1002/mrd.20728; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Li M, 2004, ZYGOTE, V12, P43, DOI 10.1017/S0967199404002679; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Montserrat N, 2012, CELL TRANSPLANT, V21, P815, DOI 10.3727/096368911X601019; Munoz M, 2009, STEM CELL REV REP, V5, P6, DOI 10.1007/s12015-009-9052-6; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Oestrup O, 2009, REPROD DOMEST ANIM, V44, P39, DOI 10.1111/j.1439-0531.2009.01482.x; Okita K, 2010, NAT PROTOC, V5, P418, DOI 10.1038/nprot.2009.231; Park CH, 2009, GENOMICS, V93, P179, DOI 10.1016/j.ygeno.2008.10.002; PIEDRAHITA JA, 1990, THERIOGENOLOGY, V34, P879, DOI 10.1016/0093-691X(90)90559-C; PIEDRAHITA JA, 1990, THERIOGENOLOGY, V34, P865, DOI 10.1016/0093-691X(90)90558-B; SAITO S, 1992, ROUX ARCH DEV BIOL, V201, P134, DOI 10.1007/BF00188711; Son HY, 2009, ASIAN AUSTRAL J ANIM, V22, P26, DOI 10.5713/ajas.2009.80343; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Talbot NC, 2008, STEM CELL REV, V4, P235, DOI 10.1007/s12015-008-9026-0; Tan G, 2011, ZYGOTE, P1; Telugu Bhanu Prakash V L, 2011, J Biol Chem, V286, P28948, DOI 10.1074/jbc.M111.229468; Telugu BPVL, 2010, STEM CELL REV REP, V6, P31, DOI 10.1007/s12015-009-9101-1; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, CURR TOP DEV BIOL, V38, P133; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vackova I, 2007, J REPROD DEVELOP, V53, P1137, DOI 10.1262/jrd.19108; Vackova I, 2011, J REPROD DEVELOP, V57, P594, DOI 10.1262/jrd.10-184H; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vassiliev I, 2011, CELL REPROGRAM, V13, P205, DOI 10.1089/cell.2010.0102; Vassiliev I, 2010, J REPROD DEVELOP, V56, P546, DOI 10.1262/jrd.09-197A; Vassiliev I, 2010, CELL REPROGRAM, V12, P223, DOI 10.1089/cell.2009.0053; Warnes G, LUMLEY T GPLOTS VARI; West FD, 2011, STEM CELLS, V29, P1640, DOI 10.1002/stem.713; West FD, 2010, STEM CELLS DEV, V19, P1211, DOI 10.1089/scd.2009.0458; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003	57	58	62	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52481	10.1371/journal.pone.0052481	http://dx.doi.org/10.1371/journal.pone.0052481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326334	gold, Green Published, Green Submitted			2022-12-25	WOS:000314705800018
J	Balkenhol, T; Wallhausser-Franke, E; Delb, W				Balkenhol, Tobias; Wallhaeusser-Franke, Elisabeth; Delb, Wolfgang			Psychoacoustic Tinnitus Loudness and Tinnitus-Related Distress Show Different Associations with Oscillatory Brain Activity	PLOS ONE			English	Article							GAMMA OSCILLATIONS; NUCLEUS-ACCUMBENS; EEG; INHIBITION; POWER; PERCEPTION; MECHANISMS; DIAGNOSIS; INTENSITY; RELEVANCE	Background: The phantom auditory perception of subjective tinnitus is associated with aberrant brain activity as evidenced by magneto- and electroencephalographic studies. We tested the hypotheses (1) that psychoacoustically measured tinnitus loudness is related to gamma oscillatory band power, and (2) that tinnitus loudness and tinnitus-related distress are related to distinct brain activity patterns as suggested by the distinction between loudness and distress experienced by tinnitus patients. Furthermore, we explored (3) how hearing impairment, minimum masking level, and (4) psychological comorbidities are related to spontaneous oscillatory brain activity in tinnitus patients. Methods and Findings: Resting state oscillatory brain activity recorded electroencephalographically from 46 male tinnitus patients showed a positive correlation between gamma band oscillations and psychoacoustic tinnitus loudness determined with the reconstructed tinnitus sound, but not with the other psychoacoustic loudness measures that were used. Tinnitus-related distress did also correlate with delta band activity, but at electrode positions different from those associated with tinnitus loudness. Furthermore, highly distressed tinnitus patients exhibited a higher level of theta band activity. Moreover, mean hearing loss between 0.125 kHz and 16 kHz was associated with a decrease in gamma activity, whereas minimum masking levels correlated positively with delta band power. In contrast, psychological comorbidities did not express significant correlations with oscillatory brain activity. Conclusion: Different clinically relevant tinnitus characteristics show distinctive associations with spontaneous brain oscillatory power. Results support hypothesis (1), but exclusively for the tinnitus loudness derived from matching to the reconstructed tinnitus sound. This suggests to preferably use the reconstructed tinnitus spectrum to determine psychoacoustic tinnitus loudness. Results also support hypothesis (2). Moreover, hearing loss and minimum masking level correlate with oscillatory power in distinctive frequency bands. The lack of an association between psychological comorbidities and oscillatory power may be attributed to the overall low level of mental health problems in the present sample.	[Balkenhol, Tobias; Wallhaeusser-Franke, Elisabeth; Delb, Wolfgang] Heidelberg Univ, Med Fac Mannheim, Dept Phoniatr & Audiol, Mannheim, Germany	Ruprecht Karls University Heidelberg	Delb, W (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Phoniatr & Audiol, Mannheim, Germany.	wolfgang.delb@medma.uni-heidelberg.de						Adjamian P, 2012, JARO-J ASSOC RES OTO, V13, P715, DOI 10.1007/s10162-012-0340-5; Andersson G, 1999, CLIN OTOLARYNGOL, V24, P404, DOI 10.1046/j.1365-2273.1999.00278.x; Basar E, 2000, INT J PSYCHOPHYSIOL, V35, P95, DOI 10.1016/S0167-8760(99)00047-1; Belouchrani A, 1997, IEEE T SIGNAL PROCES, V45, P434, DOI 10.1109/78.554307; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buehlmann A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000934; CAUDARELLA M, 1987, BRAIN RES, V435, P202, DOI 10.1016/0006-8993(87)91602-7; CHANG AYW, 1995, SYNAPSE, V21, P149, DOI 10.1002/syn.890210208; D'Amelio R, 2004, HNO, V52, P599, DOI 10.1007/s00106-003-0944-5; De Ridder D., 2011, PLOS ONE, V6; Delb W, 1999, P 6 INT TINN SEM, P446; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Derogatis L., 1994, SCL 90 R SYMPTOM CHE; DIEROFF HG, 1976, AUDIOLOGY, V15, P152; Dominguez-Borras J, 2012, BIOL PSYCHOL, V89, P545, DOI 10.1016/j.biopsycho.2011.12.014; Fastl H., 2007, PSYCHOACOUSTICS FACT, V3rd; FERGER B, 1994, PSYCHOPHARMACOLOGY, V114, P297, DOI 10.1007/BF02244852; Fontani G, 1997, ARCH ITAL BIOL, V135, P49; Fowler E. P., 1942, LARYNGOSCOPE, V52, P275; Fowler EP, 1940, ARCHIV OTOLARYNGOL, V32, P903; Franke G.H., 2002, SCL 90 R SYMPTOM CHE, V2nd; Gibbons J. D., 2010, NONPARAMETRIC STAT I, DOI DOI 10.5005/JP/BOOKS/10313_14; Goebel G, 1998, TINNITUS FRAGEBOGEN; Gordon JA, 2005, J NEUROSCI, V25, P6509, DOI 10.1523/JNEUROSCI.1211-05.2005; Gourevitch B, 2011, EUR J NEUROSCI, V34, P1953, DOI 10.1111/j.1460-9568.2011.07905.x; GRACE AA, 1995, DRUG ALCOHOL DEPEN, V37, P111, DOI 10.1016/0376-8716(94)01066-T; Gray J. A., 2003, NEUROPSYCHOLOGY ANXI; Grin-Yatsenko VA, 2010, CLIN NEUROPHYSIOL, V121, P281, DOI 10.1016/j.clinph.2009.11.015; HALLAM RS, 1988, BRIT J CLIN PSYCHOL, V27, P213, DOI 10.1111/j.2044-8260.1988.tb00778.x; Hiller W, 2006, ARCH OTOLARYNGOL, V132, P1323, DOI 10.1001/archotol.132.12.1323; Hoffman LD, 1998, BIOL PSYCHOL, V48, P139, DOI 10.1016/S0301-0511(98)00010-6; JASTREBOFF PJ, 1994, HEARING RES, V80, P216, DOI 10.1016/0378-5955(94)90113-9; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Kahlbrock N, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-4; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Knyazev GG, 2007, NEUROSCI BIOBEHAV R, V31, P377, DOI 10.1016/j.neubiorev.2006.10.004; Kohler S, 2011, INT PSYCHOGERIATR, V23, P141, DOI 10.1017/S1041610210001250; Krog NH, 2010, J PSYCHOSOM RES, V69, P289, DOI 10.1016/j.jpsychores.2010.03.008; Kuo S. M., 1996, ACTIVE NOISE CONTROL; Langenbach M, 2005, GEN HOSP PSYCHIAT, V27, P73, DOI 10.1016/j.genhosppsych.2004.08.008; Langguth B, 2011, WORLD J BIOL PSYCHIA, V12, P489, DOI 10.3109/15622975.2011.575178; Leaver AM, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00021; Lehtela L, 1997, NEUROSCI LETT, V222, P111, DOI 10.1016/S0304-3940(97)13361-4; LEUNG LS, 1993, CAN J PHYSIOL PHARM, V71, P311, DOI 10.1139/y93-049; Llinas R, 2005, TRENDS NEUROSCI, V28, P325, DOI 10.1016/j.tins.2005.04.006; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Lorenz I, 2009, NEUROSCI LETT, V453, P225, DOI 10.1016/j.neulet.2009.02.028; McNaughton N, 2000, J AFFECT DISORDERS, V61, P161, DOI 10.1016/S0165-0327(00)00344-X; McNaughton N, 2007, BEHAV PHARMACOL, V18, P329, DOI 10.1097/FBP.0b013e3282ee82e3; Meikle MB, 2012, EAR HEARING, V33, P153, DOI 10.1097/AUD.0b013e31822f67c0; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Mitra P., 2007, OBSERVED BRAIN DYNAM; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Norena A, 2002, AUDIOL NEURO-OTOL, V7, P358, DOI 10.1159/000066156; Norena AJ, 2011, NEUROSCI BIOBEHAV R, V35, P1089, DOI 10.1016/j.neubiorev.2010.11.003; ODONNELL P, 1995, J NEUROSCI, V15, P3622; Ortmann M, 2011, EUR J NEUROSCI, V33, P568, DOI 10.1111/j.1460-9568.2010.07542.x; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Rosenhall U, 2003, Noise Health, V5, P47; Schlee W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-80; Schroeder CE, 2009, BRAIN TOPOGR, V22, P24, DOI 10.1007/s10548-009-0080-y; Sindhusake D, 2003, EAR HEARING, V24, P501, DOI 10.1097/01.AUD.0000100204.08771.3D; Siok CJ, 2009, NEUROPHARMACOLOGY, V56, P379, DOI 10.1016/j.neuropharm.2008.09.013; Sukov W, 1998, J NEUROPHYSIOL, V79, P2875, DOI 10.1152/jn.1998.79.6.2875; Tang YY, 2011, IEEE ENG MED BIO, P1717, DOI 10.1109/IEMBS.2011.6090492; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; TYLER RS, 1983, J SPEECH HEAR RES, V26, P59, DOI 10.1044/jshr.2601.59; Tyler RS, 1989, J SPEECH LANG HEAR R, V42, P52; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; van der Loo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007396; van Lier H, 2004, NEUROPHARMACOLOGY, V47, P163, DOI 10.1016/j.neuropharm.2004.03.017; Vanneste S, 2011, NEUROSCIENCE, V199, P481, DOI 10.1016/j.neuroscience.2011.07.067; Vanneste S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031182; Vanneste S, 2011, CLIN NEUROPHYSIOL, V122, P578, DOI 10.1016/j.clinph.2010.07.022; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Wallhausser-Franke E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034583; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Weisz N, 2005, PLOS MED, V2, P546, DOI 10.1371/journal.pmed.0020153; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007; Weisz N, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00073; Weisz N, 2007, PROG BRAIN RES, V166, P61, DOI 10.1016/S0079-6123(07)66006-3	82	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53180	10.1371/journal.pone.0053180	http://dx.doi.org/10.1371/journal.pone.0053180			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326394	Green Published, gold, Green Submitted			2022-12-25	WOS:000313552400015
J	Cano, PM; Seeboth, J; Meurens, F; Cognie, J; Abrami, R; Oswald, IP; Guzylack-Piriou, L				Cano, Patricia M.; Seeboth, Julie; Meurens, Francois; Cognie, Juliette; Abrami, Roberta; Oswald, Isabelle P.; Guzylack-Piriou, Laurence			Deoxynivalenol as a New Factor in the Persistence of Intestinal Inflammatory Diseases: An Emerging Hypothesis through Possible Modulation of Th17-Mediated Response	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; T-CELLS; BARRIER FUNCTION; PROTEIN EXPRESSION; GENE-EXPRESSION; DENDRITIC CELLS; T(H)17 CELLS; TGF-BETA; INDUCTION; ACTIVATION	Background/Aims: Deoxynivalenol (DON) is a mycotoxin produced by Fusarium species which is commonly found in temperate regions worldwide as a natural contaminant of cereals. It is of great concern not only in terms of economic losses but also in terms of animal and public health. The digestive tract is the first and main target of this food contaminant and it represents a major site of immune tolerance. A finely tuned cross-talk between the innate and the adaptive immune systems ensures the homeostatic equilibrium between the mucosal immune system and commensal microorganisms. The aim of this study was to analyze the impact of DON on the intestinal immune response. Methodology: Non-transformed intestinal porcine epithelial cells IPEC-1 and porcine jejunal explants were used to investigate the effect of DON on the intestinal immune response and the modulation of naive T cells differentiation. Transcriptomic proteomic and flow cytometry analysis were performed. Results: DON induced a pro-inflammatory response with a significant increase of expression of mRNA encoding for IL-8, IL-1 alpha and IL-1 beta, TNF-alpha in all used models. Additionally, DON significantly induced the expression of genes involved in the differentiation of Th17 cells (STAT3, IL-17A, IL-6, IL-1 beta) at the expenses of the pathway of regulatory T cells (Treg) (FoxP3, RALDH1). DON also induced genes related to the pathogenic Th17 cells subset such as IL-23A, IL-22 and IL-21 and not genes related to the regulatory Th17 cells (rTh17) such as TGF-beta and IL-10. Conclusion: DON triggered multiple immune modulatory effects which could be associated with an increased susceptibility to intestinal inflammatory diseases.	[Cano, Patricia M.; Seeboth, Julie; Abrami, Roberta; Oswald, Isabelle P.; Guzylack-Piriou, Laurence] INRA, UMR1331, Res Ctr Food Toxicol, Toxalim, F-31931 Toulouse, France; [Cano, Patricia M.; Seeboth, Julie; Abrami, Roberta; Oswald, Isabelle P.; Guzylack-Piriou, Laurence] Univ Toulouse, INPT, UMR1331, Toxalim, Toulouse, France; [Meurens, Francois] INRA, Infectiol & Sante Publ UMR1282, F-37380 Nouzilly, France; [Cognie, Juliette] INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France; [Abrami, Roberta] Univ Estadual Londrina, Lab Patol Anim, Londrina, Brazil; [Meurens, Francois] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada	INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Universidade Estadual de Londrina; University of Saskatchewan	Oswald, IP (corresponding author), INRA, UMR1331, Res Ctr Food Toxicol, Toxalim, F-31931 Toulouse, France.	isabelle.oswald@toulouse.inra.fr; laurence.guzylack@toulouse.inra.fr	OSWALD, Isabelle P/A-8497-2013; Meurens, Francois JMA/J-3829-2019; OSWALD, Isabelle/GPP-1123-2022	OSWALD, Isabelle P/0000-0001-9918-277X; Meurens, Francois JMA/0000-0002-0353-4871; OSWALD, Isabelle/0000-0001-9918-277X; Juliette, Cognie/0000-0003-0908-9833	INRA; ANSES (France); Ministry for Education and Research (France); CAPES-COFECUB (Brazil); EU [FP7-KBBE-KBBE-2008-2B, FP7-KBBE-2007-2A]; INRA-Division of animal health	INRA; ANSES (France); Ministry for Education and Research (France); CAPES-COFECUB (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); EU(European Commission); INRA-Division of animal health	Patricia Cano, Julie Seeboth and Roberta Abrami were supported by a doctoral fellowships financed by INRA and ANSES (France), the Ministry for Education and Research (France), CAPES-COFECUB (Brazil) respectively. This study was supported by the EU projects INTERPLAY (FP7-KBBE-KBBE-2008-2B), MycoRed (FP7-KBBE-2007-2A) and by a grant for newly recruited scientist from INRA-Division of animal health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUZIED MM, 1991, APPL ENVIRON MICROB, V57, P672, DOI 10.1128/AEM.57.3.672-677.1991; Amuzie CJ, 2009, TOXICOL SCI, V111, P277, DOI 10.1093/toxsci/kfp150; Avantaggiato G, 2004, FOOD CHEM TOXICOL, V42, P817, DOI 10.1016/j.fct.2004.01.004; Bouhet S, 2004, TOXICOL SCI, V77, P165, DOI 10.1093/toxsci/kfh006; Bracarense APFL, 2012, BRIT J NUTR, V107, P1776, DOI 10.1017/S0007114511004946; Bruel T, 2010, DEV COMP IMMUNOL, V34, P562, DOI 10.1016/j.dci.2009.12.017; Bryden WL, 2007, ASIA PAC J CLIN NUTR, V16, P95; Caprioli F, 2008, J CROHNS COLITIS, V2, P291, DOI 10.1016/j.crohns.2008.05.004; CAST, 2003, COUNCIL AGR SC TECHN, V138, P136; Chassaing B, 2011, GASTROENTEROLOGY, V140, P1720, DOI 10.1053/j.gastro.2011.01.054; Comerford I, 2010, BIOESSAYS, V32, P1067, DOI 10.1002/bies.201000063; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x; Delgado-Ortega M, 2011, VET IMMUNOL IMMUNOP, V144, P493, DOI 10.1016/j.vetimm.2011.08.002; Doll S, 2011, PREV VET MED, V102, P132, DOI 10.1016/j.prevetmed.2011.04.008; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gerdts V, 2001, J IMMUNOL METHODS, V256, P19, DOI 10.1016/S0022-1759(01)00429-X; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; GonzalezVallina R, 1996, AM J PHYSIOL-GASTR L, V271, pG249, DOI 10.1152/ajpgi.1996.271.2.G249; Grenier B, 2011, MOL NUTR FOOD RES, V55, P761, DOI 10.1002/mnfr.201000402; Haverson K, 2000, IMMUNOLOGY, V101, P492, DOI 10.1046/j.1365-2567.2000.00128.x; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kaser T, 2008, VET IMMUNOL IMMUNOP, V125, P92, DOI 10.1016/j.vetimm.2008.05.007; Kaser T, 2008, VET IMMUNOL IMMUNOP, V122, P153, DOI 10.1016/j.vetimm.2007.08.002; Kaser T, 2012, CYTOKINE, V60, P400, DOI 10.1016/j.cyto.2012.07.007; Kaser T, 2012, VET IMMUNOL IMMUNOP, V148, P136, DOI 10.1016/j.vetimm.2011.05.035; Kaser T, 2011, DEV COMP IMMUNOL, V35, P1166, DOI 10.1016/j.dci.2011.04.006; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Kiros TG, 2011, VET IMMUNOL IMMUNOP, V144, P448, DOI 10.1016/j.vetimm.2011.08.021; Kolf-Clauw M, 2009, TOXICOL IN VITRO, V23, P1580, DOI 10.1016/j.tiv.2009.07.015; Kolls JK, 2010, CYTOKINE GROWTH F R, V21, P443, DOI 10.1016/j.cytogfr.2010.11.002; Ledger TN, 2004, CLIN DIAGN LAB IMMUN, V11, P691, DOI 10.1128/CDLI.11.4.691-698.2004; Levast B, 2010, VET IMMUNOL IMMUNOP, V137, P261, DOI 10.1016/j.vetimm.2010.06.004; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Maresca M, 2002, J NUTR, V132, P2723, DOI 10.1093/jn/132.9.2723; Maresca M, 2010, TOXICON, V56, P282, DOI 10.1016/j.toxicon.2010.04.016; Matricon J, 2010, M S-MED SCI, V26, P405, DOI 10.1051/medsci/2010264405; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Meissonnier GM, 2008, TOXICOL APPL PHARM, V231, P142, DOI 10.1016/j.taap.2008.04.004; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Meurens F, 2009, VET RES, V40, DOI 10.1051/vetres:2008043; Miossec P, 2009, EUR J IMMUNOL, V39, P667, DOI 10.1002/eji.200839088; Oswald IP, 2006, VET RES, V37, P359, DOI 10.1051/vetres:2006006; Oswald IP, 2005, FOOD ADDIT CONTAM A, V22, P354, DOI 10.1080/02652030500058320; Oswald IP, 1998, REV MED VET-TOULOUSE, V149, P585; Ouyang W, 2008, MUCOSAL IMMUNOL, V1, P335, DOI 10.1038/mi.2008.26; Patterson JK, 2008, EXP BIOL MED, V233, P651, DOI 10.3181/0709-MR-262; Paul G, 2012, EUR J CLIN INVEST, V42, P95, DOI 10.1111/j.1365-2362.2011.02552.x; Pestka J, 2006, TOXICOL SCI, V92, P445, DOI 10.1093/toxsci/kfl012; Pestka JJ, 2008, FOOD CHEM TOXICOL, V46, P2826, DOI 10.1016/j.fct.2008.05.016; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; Pestka JJ, 2004, TOXICOL LETT, V153, P61, DOI 10.1016/j.toxlet.2004.04.023; Pinton P, 2012, TOXICOL SCI, V130, P180, DOI 10.1093/toxsci/kfs239; Pinton P, 2010, J NUTR, V140, P1956, DOI 10.3945/jn.110.123919; Pinton P, 2009, TOXICOL APPL PHARM, V237, P41, DOI 10.1016/j.taap.2009.03.003; Rotter BA, 1996, J TOXICOL ENV HEALTH, V48, P1, DOI 10.1080/009841096161447; Royaee AR, 2004, VET IMMUNOL IMMUNOP, V102, P199, DOI 10.1016/j.vetimm.2004.09.018; Saurer L, 2007, J IMMUNOL, V179, P3504, DOI 10.4049/jimmunol.179.6.3504; SCOOP, 2003, COLL OCC DAT FUS TOX; Seeboth J, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-35; TRUCKSESS MW, 1995, J AOAC INT, V78, P631; Vandenbroucke V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023871; Wache YJ, 2009, TOXICOLOGY, V262, P239, DOI 10.1016/j.tox.2009.06.014; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Zanello G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018573; Zelante T, 2009, MED MYCOL, V47, pS162, DOI 10.1080/13693780802140766; Zhou HR, 2003, TOXICOL SCI, V72, P130, DOI 10.1093/toxsci/kfg006; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138	71	86	88	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53647	10.1371/journal.pone.0053647	http://dx.doi.org/10.1371/journal.pone.0053647			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326479	Green Published, gold			2022-12-25	WOS:000313552400034
J	Hager, SB; Cosentino, BJ; Mckay, KJ; Monson, C; Zuurdeeg, W; Blevins, B				Hager, Stephen B.; Cosentino, Bradley J.; McKay, Kelly J.; Monson, Cathleen; Zuurdeeg, Walt; Blevins, Brian			Window Area and Development Drive Spatial Variation in Bird-Window Collisions in an Urban Landscape	PLOS ONE			English	Article							RELATIVE IMPORTANCE; HABITAT; MORTALITY; SCALE; URBANIZATION; COMPLEXITY; DIVERSITY; LANDBIRDS; COMMUNITY	Collisions with windows are an important human-related threat to birds in urban landscapes. However, the proximate drivers of collisions are not well understood, and no study has examined spatial variation in mortality in an urban setting. We hypothesized that the number of fatalities at buildings varies with window area and habitat features that influence avian community structure. In 2010 we documented bird-window collisions (BWCs) and characterized avian community structure at 20 buildings in an urban landscape in northwestern Illinois, USA. For each building and season, we conducted 21 daily surveys for carcasses and nine point count surveys to estimate relative abundance, richness, and diversity. Our sampling design was informed by experimentally estimated carcass persistence times and detection probabilities. We used linear and generalized linear mixed models to evaluate how habitat features influenced community structure and how mortality was affected by window area and factors that correlated with community structure. The most-supported model was consistent for all community indices and included effects of season, development, and distance to vegetated lots. BWCs were related positively to window area and negatively to development. We documented mortalities for 16/72 (22%) species (34 total carcasses) recorded at buildings, and BWCs were greater for juveniles than adults. Based on the most-supported model of BWCs, the median number of annual predicted fatalities at study buildings was 3 (range = 0-52). These results suggest that patchily distributed environmental resources and levels of window area in buildings create spatial variation in BWCs within and among urban areas. Current mortality estimates place little emphasis on spatial variation, which precludes a fundamental understanding of the issue. To focus conservation efforts, we illustrate how knowledge of the structural and environmental factors that influence bird-window collisions can be used to predict fatalities in the broader landscape.	[Hager, Stephen B.] Augustana Coll, Dept Biol, Rock Isl, IL 61201 USA; [Cosentino, Bradley J.] Hobart & William Smith Coll, Dept Biol, Geneva, NY 14456 USA; [McKay, Kelly J.] BioEco Res & Monitoring Ctr, Hampton, IL USA		Hager, SB (corresponding author), Augustana Coll, Dept Biol, Rock Isl, IL 61201 USA.	stevehager@augustana.edu			Quad City Audubon Society; Augustana College	Quad City Audubon Society; Augustana College	The authors received $2,400 from the Quad City Audubon Society (www.quadcityaudubon.org/) for travel expenses for carcass surveys. There is no grant number. The lead author (SBH) was awarded $ 1,000 Presidential Scholarship from Augustana College (www.augustana.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Arnold TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024708; Ausprey IJ, 2011, AUK, V128, P293, DOI 10.1525/auk.2011.10158; Balogh AL, 2011, J ORNITHOL, V152, P717, DOI 10.1007/s10336-011-0648-7; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Blair R, 2004, ECOL SOC, V9; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Blair RB, 2008, LANDSCAPE ECOL, V23, P1157, DOI 10.1007/s10980-008-9267-y; Blair Robert B., 2001, P459; Blaustein AR, 2011, ANN NY ACAD SCI, V1223, P108, DOI 10.1111/j.1749-6632.2010.05909.x; Bonter DN, 2009, CONSERV BIOL, V23, P440, DOI 10.1111/j.1523-1739.2008.01085.x; Borden W. Calvin, 2010, Ohio Journal of Science, V110, P44; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Drewitt AL, 2008, ANN NY ACAD SCI, V1134, P233, DOI 10.1196/annals.1439.015; DUNN EH, 1993, J FIELD ORNITHOL, V64, P302; Evans-Ogden LJ, 1996, COLLISION COURSE THE; Fair J.M., 2010, GUIDELINES USE WILD; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Fuller RA, 2008, DIVERS DISTRIB, V14, P131, DOI 10.1111/j.1472-4642.2007.00439.x; Gehring J, 2009, ECOL APPL, V19, P505, DOI 10.1890/07-1708.1; Hager SB, 2008, WILSON J ORNITHOL, V120, P550, DOI 10.1676/07-075.1; Hager SB, 2012, J FIELD ORNITHOL, V83, P203, DOI 10.1111/j.1557-9263.2012.00370.x; Hennings LA, 2003, CONDOR, V105, P288, DOI 10.1650/0010-5422(2003)105[0288:RBCSIP]2.0.CO;2; Illinois Department of Agriculture, 2009, LAND COVER DATA FOR; Jenkins AR, 2010, BIRD CONSERV INT, V20, P263, DOI 10.1017/S0959270910000122; Johnson DH, 2008, J WILDLIFE MANAGE, V72, P857, DOI 10.2193/2007-294; Kalinowski RS, 2010, CONDOR, V112, P274, DOI 10.1525/cond.2010.090037; Klem D, 2004, WILSON BULL, V116, P69, DOI 10.1676/0043-5643(2004)116[0069:EOWAFP]2.0.CO;2; KLEM D, 1989, WILSON BULL, V101, P606; KLEM D, 1990, J FIELD ORNITHOL, V61, P120; Klem D, 2009, WILSON J ORNITHOL, V121, P126, DOI 10.1676/08-068.1; Lang RE, 2009, URBAN GEOGR, V30, P726, DOI 10.2747/0272-3638.30.7.726; Longcore T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034025; Loss SR, 2012, FRONT ECOL ENVIRON, V10, P357, DOI 10.1890/110251; Loss SR, 2009, BIOL CONSERV, V142, P2578, DOI 10.1016/j.biocon.2009.06.004; MacGregor-Fors I, 2011, BASIC APPL ECOL, V12, P372, DOI 10.1016/j.baae.2011.04.003; Maechler M., 2011, LME4 LINEAR MIXED EF; Mannan R. William, 2008, Urban Ecosystems, V11, P141, DOI 10.1007/s11252-008-0056-9; Martin GR, 2011, IBIS, V153, P239, DOI 10.1111/j.1474-919X.2011.01117.x; Matthews SN, 2010, LANDSCAPE ECOL, V25, P955, DOI 10.1007/s10980-010-9475-0; Melles S, 2003, CONSERV ECOL, V7; O'connell Timothy J., 2001, Raven, V72, P141; Pennington DN, 2008, BIOL CONSERV, V141, P1235, DOI 10.1016/j.biocon.2008.02.021; Pyle P., 1997, IDENTIFICATION GUI 1; Ralph CJ, 1995, FOREST SERVICE GENER; Ramalho CE, 2012, TRENDS ECOL EVOL, V27, P179, DOI 10.1016/j.tree.2011.10.008; Ruth JM, 2006, PARTNERS IN FLIGHT U; San Francisco Planning Department, 2012, STANDARDS FOR BIRD S; Schramm M, 2007, MEADOWLARK, V16, P122; Seewagen CL, 2011, CONDOR, V113, P284, DOI 10.1525/cond.2011.100136; Seto KC, 2010, ANNU REV ENV RESOUR, V35, P167, DOI 10.1146/annurev-environ-100809-125336; Shannon Claude E, 1963, MATH THEORY COMMUNIC; Shochat E, 2015, URBAN ECOSYSTEM ECOL, P75; Team RDC, 2012, R LANG ENV STAT COMP; Thompson C., 2009, P 4 INT PARTN FLIGHT, P244; Whittaker KA, 2009, AUK, V126, P288, DOI 10.1525/auk.2009.07136	58	51	56	3	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53371	10.1371/journal.pone.0053371	http://dx.doi.org/10.1371/journal.pone.0053371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326420	Green Submitted, Green Published, gold			2022-12-25	WOS:000313551500067
J	Leppanen, T; Korhonen, R; Laavola, M; Nieminen, R; Tuominen, RK; Moilanen, E				Leppanen, Tiina; Korhonen, Riku; Laavola, Mirka; Nieminen, Riina; Tuominen, Raimo K.; Moilanen, Eeva			Down-Regulation of Protein Kinase C delta Inhibits Inducible Nitric Oxide Synthase Expression through IRF1	PLOS ONE			English	Article							DESTABILIZING MESSENGER-RNA; TRANSCRIPTION FACTOR IRF-1; INDUCED LUNG INJURY; INTERFERON-GAMMA; ACTIVATED MACROPHAGES; TARGETED DISRUPTION; TREATED MACROPHAGES; INOS EXPRESSION; FACTOR-I; GENE	In inflammation, pro-inflammatory cytokines and bacterial products induce the production of high amounts of NO by inducible nitric oxide synthase (iNOS) in inflammatory and tissue cells. NO is an effector molecule in innate immunity, and it also has regulatory and pro-inflammatory/destructive effects in the inflammatory process. Protein kinase C delta (PKC delta) is an important signaling protein regulating B lymphocyte functions, but less is known about its effects in innate immunity and inflammatory gene expression. In the present study we investigated the role of PKC delta in the regulation of iNOS expression in inflammatory conditions. NO production and iNOS expression were induced by LPS or a combination of cytokines IFN gamma, IL-1b, and TNF alpha. Down-regulation of PKC delta by siRNA and inhibition of PKCd by rottlerin suppressed NO production and iNOS expression in activated macrophages and fibroblasts. PKC delta directed siRNA and inhibition of PKCd by rottlerin suppressed also the expression of transcription factor IRF1, possibly through inhibition of STAT1 activation. Accordingly, down-regulation of IRF1 by siRNA reduced iNOS expression in response to inflammatory stimuli. In addition, inhibition of PKC delta showed anti-inflammatory effects in carrageenan induced paw inflammation in mice as did iNOS inhibitor L-NIL. These results suggest that inhibitors of PKC delta have anti-inflammatory effects in disease states complicated by enhanced NO production through iNOS pathway.	[Leppanen, Tiina; Korhonen, Riku; Laavola, Mirka; Nieminen, Riina; Moilanen, Eeva] Univ Tampere, Sch Med, Immunopharmacol Res Grp, FIN-33101 Tampere, Finland; [Leppanen, Tiina; Korhonen, Riku; Laavola, Mirka; Nieminen, Riina; Moilanen, Eeva] Tampere Univ Hosp, Tampere, Finland; [Tuominen, Raimo K.] Univ Helsinki, Fac Pharm, Div Pharmacol & Toxicol, Helsinki, Finland	Tampere University; Tampere University; Tampere University Hospital; University of Helsinki	Moilanen, E (corresponding author), Univ Tampere, Sch Med, Immunopharmacol Res Grp, FIN-33101 Tampere, Finland.	eeva.moilanen@uta.fi		Korhonen, Riku/0000-0002-7264-517X	Finnish Funding Agency for Technology and Innovation; Medical Research Fund of Tampere University Hospital; Finnish Cultural Foundation - Pirkanmaa Regional Fund; National Programme of Musculoskeletal Disorders and Biomaterials	Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Medical Research Fund of Tampere University Hospital; Finnish Cultural Foundation - Pirkanmaa Regional Fund; National Programme of Musculoskeletal Disorders and Biomaterials	This study was supported by grants from The Finnish Funding Agency for Technology and Innovation, The Medical Research Fund of Tampere University Hospital, Finnish Cultural Foundation - Pirkanmaa Regional Fund and The National Programme of Musculoskeletal Disorders and Biomaterials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bhatt KH, 2010, MOL IMMUNOL, V47, P861, DOI 10.1016/j.molimm.2009.10.029; Blair LA, 2002, J BIOL CHEM, V277, P359, DOI 10.1074/jbc.M109819200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Delgado M, 1999, J IMMUNOL, V162, P4685; Dugo L, 2004, BRIT J PHARMACOL, V141, P979, DOI 10.1038/sj.bjp.0705683; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Faggioli L, 1997, EUR J IMMUNOL, V27, P3022, DOI 10.1002/eji.1830271140; Felley-Bosco E, 2000, P NATL ACAD SCI USA, V97, P14334, DOI 10.1073/pnas.250406797; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fujimura M, 1997, BRAIN RES, V759, P247, DOI 10.1016/S0006-8993(97)00264-3; Gao JJ, 1998, J IMMUNOL, V161, P4803; Gao JJ, 1997, J BIOL CHEM, V272, P1226, DOI 10.1074/jbc.272.2.1226; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Handy RLC, 1998, BRIT J PHARMACOL, V123, P1119, DOI 10.1038/sj.bjp.0701735; Harkin DW, 2004, J SURG RES, V120, P230, DOI 10.1016/j.jss.2004.03.011; Hofmann J, 2004, CURR CANCER DRUG TAR, V4, P125, DOI 10.2174/1568009043481579; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Kilpatrick LE, 2011, J LEUKOCYTE BIOL, V89, P3, DOI 10.1189/jlb.0510281; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; Korhonen R, 2002, MOL PHARMACOL, V62, P698, DOI 10.1124/mol.62.3.698; Korhonen R, 2007, MOL PHARMACOL, V71, P1427, DOI 10.1124/mol.106.033449; Korhonen Riku, 2005, Current Drug Targets - Inflammation and Allergy, V4, P471, DOI 10.2174/1568010054526359; Lahti A, 2003, MOL PHARMACOL, V64, P308, DOI 10.1124/mol.64.2.308; Lee MR, 2008, EXPERT OPIN THER TAR, V12, P535, DOI 10.1517/14728222.12.5.535 ; Leitges M, 2001, J CLIN INVEST, V108, P1505; Leppanen T, 2010, EUR J PHARMACOL, V628, P220, DOI 10.1016/j.ejphar.2009.11.014; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; LOWENSTEIN CJ, 1992, P NATL ACAD SCI USA, V89, P6711, DOI 10.1073/pnas.89.15.6711; LYONS CR, 1992, J BIOL CHEM, V267, P6370; Mecklenbrauker I, 2002, NATURE, V416, P860, DOI 10.1038/416860a; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Musial A, 2001, J BIOL CHEM, V276, P24268, DOI 10.1074/jbc.M100725200; Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598; Paukkeri EL, 2007, BRIT J PHARMACOL, V152, P1081, DOI 10.1038/sj.bjp.0707477; Pautz A, 2010, NITRIC OXIDE-BIOL CH, V23, P75, DOI 10.1016/j.niox.2010.04.007; Peng XQ, 2005, AM J RESP CRIT CARE, V172, P470, DOI 10.1164/rccm.200411-1547OC; Romeo G, 2002, J INTERF CYTOK RES, V22, P39, DOI 10.1089/107999002753452647; Salonen T, 2006, BRIT J PHARMACOL, V147, P790, DOI 10.1038/sj.bjp.0706672; Salvemini D, 1996, BRIT J PHARMACOL, V118, P829, DOI 10.1111/j.1476-5381.1996.tb15475.x; Sato M, 2001, CYTOKINE GROWTH F R, V12, P133, DOI 10.1016/S1359-6101(00)00032-0; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shiraishi A, 1997, J IMMUNOL, V159, P3549; Sittipunt C, 2001, AM J RESP CRIT CARE, V163, P503, DOI 10.1164/ajrccm.163.2.2004187; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Tinker AC, 2006, CURR TOP MED CHEM, V6, P77, DOI 10.2174/156802606775270297; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P443, DOI 10.1111/j.1574-695X.2007.00329.x; Vuolteenaho K, 2007, SCAND J RHEUMATOL, V36, P247, DOI 10.1080/03009740701483014; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yamagishi S, 2011, PHARMACOL RES, V64, P187, DOI 10.1016/j.phrs.2011.05.009	56	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52741	10.1371/journal.pone.0052741	http://dx.doi.org/10.1371/journal.pone.0052741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326354	Green Published, Green Submitted, gold			2022-12-25	WOS:000313551500030
J	Huang, H; Daniluk, J; Liu, Y; Chu, J; Li, Z; Ji, B; Logsdon, CD				Huang, H.; Daniluk, J.; Liu, Y.; Chu, J.; Li, Z.; Ji, B.; Logsdon, C. D.			Oncogenic K-Ras requires activation for enhanced activity	ONCOGENE			English	Article						cancer; Ras-GTP	PANCREATIC-CANCER; GENE MUTATION; MICE; PROGRESSION; EXPRESSION; INDUCTION; KRAS	Oncogenic Ras mutations are widely considered to be locked in a permanent 'On' state and 'constitutively active'. Yet, many healthy people have cells possessing mutant Ras without apparent harm, and in animal models mutant Ras causes transformation only after upregulation of Ras activity. Here, we demonstrate that oncogenic K-Ras is not constitutively active but can be readily activated by upstream stimulants to lead to prolonged strong Ras activity. These data indicate that in addition to targeting K-Ras downstream effectors, interventions to reduce K-Ras activation may have important cancer-preventive value, especially in patients with oncogenic Ras mutations. As other small G proteins are regulated in a similar manner, this concept is likely to apply broadly to the entire Ras family of molecules.	[Huang, H.; Daniluk, J.; Liu, Y.; Chu, J.; Logsdon, C. D.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Huang, H.; Li, Z.] Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Daniluk, J.] Med Univ Bialystok, Dept Gastroenterol & Internal Med, Bialystok, Poland; [Ji, B.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Logsdon, C. D.] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Naval Medical University; Medical University of Bialystok; Mayo Clinic; University of Texas System; UTMD Anderson Cancer Center	Ji, B (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.	ji.baoan@mayo.edu; clogsdon@mdanderson.org	Daniluk, Jaroslaw/T-3437-2018	Daniluk, Jaroslaw/0000-0002-0787-1461	NIH [DK052067, CA016672, P20 CA101936, CA155165, P50 CA102701]; Lockton Endowment; National Natural Science Foundation of China [30910103911]; NATIONAL CANCER INSTITUTE [P20CA101936, K12CA090628, P50CA102701, R21CA155165, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052067] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lockton Endowment; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr David Tuveson (UK Cambridge Research Institute) for providing the mouse pancreatic cancer cell line K8484. This work was supported by NIH DK052067, CA016672, P20 CA101936, CA155165, P50 CA102701 and the Lockton Endowment. The work was supported in part by grant 30910103911 (to Z Li) from the National Natural Science Foundation of China.	Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Carriere C, 2009, BIOCHEM BIOPH RES CO, V382, P561, DOI 10.1016/j.bbrc.2009.03.068; Daniluk J, 2012, J CLIN INVEST, V122, P1519, DOI 10.1172/JCI59743; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Ji BA, 2008, GENESIS, V46, P390, DOI 10.1002/dvg.20411; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; KOEFFLER HP, 1991, WESTERN J MED, V155, P505; Lu XH, 2002, CHINESE MED J-PEKING, V115, P1632; Parsons BL, 2009, BIOMARK MED, V3, P757, DOI 10.2217/BMM.09.95; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Siveke JT, 2007, CANCER CELL, V12, P266, DOI 10.1016/j.ccr.2007.08.002; SPAARGAREN M, 1995, GENE EXPRESSION, V4, P345; Tada M, 1996, GASTROENTEROLOGY, V110, P227, DOI 10.1053/gast.1996.v110.pm8536861; WILLIAMS JA, 1978, AM J PHYSIOL, V235, pE517, DOI 10.1152/ajpendo.1978.235.5.E517; Yakubovskaya MS, 1995, INT J CANCER, V63, P810, DOI 10.1002/ijc.2910630611; Yan L, 2005, GASTROENTEROLOGY, V128, P2124, DOI 10.1053/j.gastro.2005.03.006	21	94	96	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 23	2014	33	4					532	535		10.1038/onc.2012.619	http://dx.doi.org/10.1038/onc.2012.619			4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	296VX	23334325	Green Accepted			2022-12-25	WOS:000330214600014
J	Whiteman, P; de Madrid, BH; Taylor, P; Li, DM; Heslop, R; Viticheep, N; Tan, JZ; Shimizu, H; Callaghan, J; Masiero, M; Li, JL; Banham, AH; Harris, AL; Lea, SM; Redfield, C; Baron, M; Handford, PA				Whiteman, Pat; de Madrid, Beatriz Hernandez; Taylor, Paul; Li, Demin; Heslop, Rebecca; Viticheep, Nattnee; Tan, Joyce Zi; Shimizu, Hideyuki; Callaghan, Juliana; Masiero, Massimo; Li, Ji Liang; Banham, Alison H.; Harris, Adrian L.; Lea, Susan M.; Redfield, Christina; Baron, Martin; Handford, Penny A.			Molecular Basis for Jagged-1/Serrate Ligand Recognition by the Notch Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEOLYTIC ACTIVATION; BINDING; FRINGE; DOMAIN; ANTIBODIES; CLEAVAGE; JAGGED1; MODULATION; MUTATIONS; SERRATE	We have mapped a Jagged/Serrate-binding site to specific residues within the 12th EGF domain of human and Drosophila Notch. Two critical residues, involved in a hydrophobic interaction, provide a ligand-binding platform and are adjacent to a Fringe-sensitive residue that modulates Notch activity. Our data suggest that small variations within the binding site fine-tune ligand specificity, which may explain the observed sequence heterogeneity in mammalian Notch paralogues, and should allow the development of paralogue-specific ligand-blocking antibodies. As a proof of principle, we have generated a Notch-1-specific monoclonal antibody that blocks binding, thus paving the way for antibody tools for research and therapeutic applications.	[Whiteman, Pat; Taylor, Paul; Heslop, Rebecca; Viticheep, Nattnee; Callaghan, Juliana; Redfield, Christina; Handford, Penny A.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [de Madrid, Beatriz Hernandez; Shimizu, Hideyuki; Baron, Martin] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Tan, Joyce Zi; Lea, Susan M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Li, Demin; Masiero, Massimo; Banham, Alison H.] Univ Oxford, Nuffield Dept Clin Lab Sci, Oxford Natl Inst Hlth Res NIHR, Biomed Res Ctr,John Radcliffe Hosp, Oxford OX3 9DU, England; [Masiero, Massimo; Li, Ji Liang; Harris, Adrian L.] Univ Oxford, Weatherall Inst Mol Med, Mol Oncol Labs, Dept Oncol,John Radcliffe Hosp, Oxford OX3 9DU, England	University of Oxford; University of Manchester; University of Oxford; University of Oxford; University of Oxford	Handford, PA (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	penny.handford@bioch.ox.ac.uk	Banham, Alison H/B-2966-2009; Harris, Adrian L/ABA-3343-2020; Li, Demin/O-4065-2019; Lea, Susan M/B-7678-2009	Harris, Adrian L/0000-0003-1376-8409; Li, Demin/0000-0002-7118-3401; Lea, Susan M/0000-0001-9287-8053; Redfield, Christina/0000-0001-7297-7708; Banham, Alison/0000-0002-3197-273X	Wellcome Trust [087928, 079440]; Cancer Research UK [A10702]; Biotechnology and Biological Sciences Research Council; BBSRC [BB/E002285/1, BB/H000976/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H000976/1, BB/C503162/1, BB/E002285/1] Funding Source: researchfish; Cancer Research UK [10702, 11359] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by The Wellcome Trust Grants 087928 (to P. A. H., S. M. L., and M. B.) and 079440 (to C. R.), Cancer Research UK Programme Grant A10702 (to A. H. B., A. L. H., P. H., and S. M. L.), and Biotechnology and Biological Sciences Research Council studentship (to P. T.).	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Aste-Amezaga M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009094; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; Cordle J, 2008, J BIOL CHEM, V283, P11785, DOI 10.1074/jbc.M708424200; Falk R, 2012, METHODS, V58, P69, DOI 10.1016/j.ymeth.2012.07.008; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; FLEMING RJ, 1990, GENE DEV, V4, P2188, DOI 10.1101/gad.4.12a.2188; Fleming RJ, 1998, SEMIN CELL DEV BIOL, V9, P599, DOI 10.1006/scdb.1998.0260; HANDFORD PA, 1990, EMBO J, V9, P475, DOI 10.1002/j.1460-2075.1990.tb08133.x; Hansson EM, 2004, SEMIN CANCER BIOL, V14, P320, DOI 10.1016/j.semcancer.2004.04.011; HARRIS RJ, 1993, BIOCHEMISTRY-US, V32, P6539, DOI 10.1021/bi00077a007; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hofmann JJ, 2010, DEVELOPMENT, V137, P4061, DOI 10.1242/dev.052118; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Li K, 2008, J BIOL CHEM, V283, P8046, DOI 10.1074/jbc.M800170200; Mason DY, 1983, TECHNIQUES IMMUNOCYT, VII, P175; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Parks AL, 2000, DEVELOPMENT, V127, P1373; Peters N, 2004, EXP CELL RES, V299, P454, DOI 10.1016/j.yexcr.2004.06.004; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Sanchez-Irizarry C, 2004, MOL CELL BIOL, V24, P9265, DOI 10.1128/MCB.24.21.9265-9273.2004; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sharma A, 2012, MOL CANCER THER, V11, P77, DOI 10.1158/1535-7163.MCT-11-0508; Shimizu K, 2001, J BIOL CHEM, V276, P25753, DOI 10.1074/jbc.M103473200; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Suk JY, 2004, J BIOL CHEM, V279, P51258, DOI 10.1074/jbc.M408156200; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878	35	23	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7305	7312		10.1074/jbc.M112.428854	http://dx.doi.org/10.1074/jbc.M112.428854			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23339193	Green Published, hybrid			2022-12-25	WOS:000316002400050
J	Borel, JC; Burel, B; Tamisier, R; Dias-Domingos, S; Baguet, JP; Levy, P; Pepin, JL				Borel, Jean-Christian; Burel, Benoit; Tamisier, Renaud; Dias-Domingos, Sonia; Baguet, Jean-Philippe; Levy, Patrick; Pepin, Jean-Louis			Comorbidities and Mortality in Hypercapnic Obese under Domiciliary Noninvasive Ventilation	PLOS ONE			English	Article							POSITIVE-PRESSURE VENTILATION; OBSTRUCTIVE SLEEP-APNEA; HYPOVENTILATION SYNDROME; ADULTS; PREVALENCE; PREDICTORS; COMMUNITY; SURVIVAL; OUTCOMES; THERAPY	Background: The higher mortality rate in untreated patients with obesity-associated hypoventilation is a strong rationale for long-term noninvasive ventilation (NIV). The impacts of comorbidities, medications and NIV compliance on survival of these patients remain largely unexplored. Methods: Observational cohort of hypercapnic obese patients initiated on NIV between March 2003 and July 2008. Survival curves were estimated by the Kaplan-Meier method. Anthropometric measurements, pulmonary function, blood gases, nocturnal SpO(2) indices, comorbidities, medications, conditions of NIV initiation and NIV compliance were used as covariates. Univariate and multivariate Cox models allowed to assess predictive factors of mortality. Results: One hundred and seven patients (56% women), in whom NIV was initiated in acute (36%) or chronic conditions, were followed during 43 +/- 14 months. The 1, 2, 3 years survival rates were 99%, 94%, and 89%, respectively. In univariate analysis, death was associated with older age (>61 years), low FEV1 (<66% predicted value), male gender, BMIxtime, concomitant COPD, NIV initiation in acute condition, use of inhaled corticosteroids, beta-blockers, nonthiazide diuretics, angiotensin-converting enzyme inhibitors and combination of cardiovascular drugs (one diuretic and at least one other cardiovascular agent). In multivariate analysis, combination of cardiovascular agents was the only factor independently associated with higher risk of death (HR = 5.3; 95% CI 1.18; 23.9). Female gender was associated with lower risk of death. Conclusion: Cardiovascular comorbidities represent the main factor predicting mortality in patient with obesity-associated hypoventilation treated by NIV. In this population, NIV should be associated with a combination of treatment modalities to reduce cardiovascular risk.	[Borel, Jean-Christian; Tamisier, Renaud; Dias-Domingos, Sonia; Levy, Patrick; Pepin, Jean-Louis] Univ Grenoble 1, Fac Med, INSERM, Lab HP2,U1042, Grenoble, France; [Baguet, Jean-Philippe] CHU Grenoble, Hop A Michallon, Dept Cardiol, F-38043 Grenoble, France; [Borel, Jean-Christian] AGIRadom, Dept Res & Dev, Meylan, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Borel, JC (corresponding author), Univ Grenoble 1, Fac Med, INSERM, Lab HP2,U1042, Grenoble, France.	j.borel@agiradom.com; jpepin@chu-grenoble.fr	Tamisier, Renaud/M-6858-2014; Borel, Jean Christian/AAC-5950-2019; LEVY, Patrick/AAX-2802-2020; Borel, Jean Christian JC/M-7135-2014; Lévy, Patrick/M-6903-2014; PEPIN, Jean-Louis/M-6549-2014; Baguet, Jean-Philippe/M-5536-2014	Tamisier, Renaud/0000-0003-1128-6529; Borel, Jean Christian/0000-0003-4140-6210; LEVY, Patrick/0000-0003-3174-7935; Lévy, Patrick/0000-0003-3632-1327; Pepin, Jean Louis/0000-0003-3832-2358				Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Berg G, 2001, CHEST, V120, P377, DOI 10.1378/chest.120.2.377; Borel JC, 2011, RESPIROLOGY; Borel JC, 2012, CHEST, V141, P692, DOI 10.1378/chest.10-2531; Budweiser S, 2007, J INTERN MED, V261, P375, DOI 10.1111/j.1365-2796.2007.01765.x; Chaouat A, 2001, EUR RESPIR J, V17, P848, DOI 10.1183/09031936.01.17508480; Chaouat A, 1999, EUR RESPIR J, V13, P1091, DOI 10.1034/j.1399-3003.1999.13e25.x; Garcia-Aymerich J, 2011, THORAX, V66, P430, DOI 10.1136/thx.2010.154484; Heinemann F, 2007, RESP MED, V101, P1229, DOI 10.1016/j.rmed.2006.10.027; Kessler R, 2001, CHEST, V120, P369, DOI 10.1378/chest.120.2.369; Laub M, 2007, RESP MED, V101, P1074, DOI 10.1016/j.rmed.2006.10.007; Lee R, 2011, CURR OPIN PULM MED, V17, P79, DOI 10.1097/MCP.0b013e32834317bb; Machado MCL, 2010, EUR RESPIR J, V35, P132, DOI 10.1183/09031936.00192008; Marin JM, 2010, AM J RESP CRIT CARE, V182, P325, DOI 10.1164/rccm.200912-1869OC; Mokhlesi B, 2007, SLEEP BREATH, V11, P117, DOI 10.1007/s11325-006-0092-8; Mokhlesi B, 2010, RESP CARE, V55, P1347; Nowbar S, 2004, AM J MED, V116, P1, DOI 10.1016/j.amjmed.2003.08.022; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Priou P, 2010, CHEST, V138, P84, DOI 10.1378/chest.09-2472; Quint JK, 2007, THORAX, V62, P462, DOI 10.1136/thx.2006.074245; Sanders MH, 2003, AM J RESP CRIT CARE, V167, P7, DOI 10.1164/rccm.2203046; Sharma SK, 2011, NEW ENGL J MED, V365, P2277, DOI 10.1056/NEJMoa1103944; Weber MA, 2012, J HYPERTENS, V30, P2213, DOI 10.1097/HJH.0b013e3283582ed6; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Young T, 2002, ARCH INTERN MED, V162, P893, DOI 10.1001/archinte.162.8.893; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Zhang YQ, 2012, J HYPERTENS, V30, P2202, DOI 10.1097/HJH.0b013e3283582eec	27	50	50	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e52006	10.1371/journal.pone.0052006	http://dx.doi.org/10.1371/journal.pone.0052006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341888	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700011
J	McCallum, J; Hall, S; Lissone, I; Anderson, J; Huynen, L; Lambert, DM				McCallum, Jonathan; Hall, Samantha; Lissone, Iman; Anderson, Jennifer; Huynen, Leon; Lambert, David M.			Highly Informative Ancient DNA 'Snippets' for New Zealand Moa	PLOS ONE			English	Article							MITOCHONDRIAL CONTROL REGION; EVOLUTIONARY HISTORY; SEQUENCES; REMAINS; BIRDS; DECAY	Background: Analysis of ancient DNA has provided invaluable information on past ecologies, ancient populations, and extinct species. We used a short snippet of highly variable mitochondrial control region sequence from New Zealand's moa to characterise a large number of bones previously intractable to DNA analysis as well as bone fragments from swamps to gain information about the haplotype diversity and phylogeography that existed in five moa species. Methodology/Principal Findings: By targeting such 'snippets', we show that moa populations differed substantially in geographic structure that is likely to be related to population mobility and history. We show that populations of Pachyornis geranoides, Dinornis novaezealandiae, and Dinornis robustus were highly structured and some appear to have occupied the same geographic location for hundreds of thousands of years. In contrast, populations of the moa Anomalopteryx didiformis and Euryapteryx curtus were widespread, with specific populations of the latter occupying both the North and South Islands of New Zealand. We further show that for a specific area, in this case a North Island swamp, complete haplotype diversity and even sex can be recovered from collections of small, often discarded, bone fragments. Conclusions/Significance: Short highly variable mitochondrial 'snippets' allow successful typing of environmentally damaged and fragmented skeletal material, and can provide useful information about ancient population diversity and structure without the need to sample valuable, whole bones often held by museums.	[McCallum, Jonathan; Hall, Samantha; Huynen, Leon; Lambert, David M.] Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia; [McCallum, Jonathan; Hall, Samantha; Huynen, Leon; Lambert, David M.] Griffith Univ, Sch Biomol & Phys Sci, Nathan, Qld 4111, Australia; [Lissone, Iman; Anderson, Jennifer] Massey Univ, Inst Nat Resources, N Shore City, New Zealand	Griffith University; Griffith University; Massey University	Lambert, DM (corresponding author), Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia.	d.lambert@griffith.edu.au		Lambert, David/0000-0002-5821-3637	Australian Research Council Discovery [DP110101364]	Australian Research Council Discovery(Australian Research Council)	The work was funded by the Australian Research Council Discovery grant (www.arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allentoft ME, 2010, QUATERNARY SCI REV, V29, P753, DOI 10.1016/j.quascirev.2009.11.022; Anderson A.J., 1989, PRODIGIOUS BIRDS MOA; Baker AJ, 2005, P NATL ACAD SCI USA, V102, P8257, DOI 10.1073/pnas.0409435102; Binladen J, 2006, GENETICS, V172, P733, DOI 10.1534/genetics.105.049718; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Bunce M, 2003, NATURE, V425, P172, DOI 10.1038/nature01871; Bunce M, 2009, P NATL ACAD SCI USA, V106, P20646, DOI 10.1073/pnas.0906660106; Campos PF, 2012, ANN ANAT, V194, P7, DOI 10.1016/j.aanat.2011.07.003; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cooper A, 2000, SCIENCE, V289, P1139; Debruyne R, 2005, CLADISTICS, V21, P31, DOI 10.1111/j.1096-0031.2004.00044.x; Gundry RL, 2007, J FORENSIC SCI, V52, P562, DOI 10.1111/j.1556-4029.2007.00425.x; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; Huynen L, 2003, NATURE, V425, P175, DOI 10.1038/nature01838; Huynen L, 2010, P NATL ACAD SCI USA, V107, P16201, DOI 10.1073/pnas.0914096107; Huynen L, 2008, J ROY SOC NEW ZEAL, V38, P231, DOI 10.1080/03014220809510557; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Marota I, 2002, AM J PHYS ANTHROPOL, V117, P310, DOI 10.1002/ajpa.10045; Omura Y, 1995, JPN J PHARMACOL, V69, P293, DOI 10.1254/jjp.69.293; Orlando L, 2009, P NATL ACAD SCI USA, V106, P21754, DOI 10.1073/pnas.0903672106; Oskam CL, 2010, P ROY SOC B-BIOL SCI, V277, P1991, DOI 10.1098/rspb.2009.2019; Poinar H, 2003, CURR BIOL, V13, P1150, DOI 10.1016/S0960-9822(03)00450-0; QUINN TW, 1993, J MOL EVOL, V37, P417; Randi E, 1998, J MOL EVOL, V47, P449, DOI 10.1007/PL00006402; Rawlings LH, 2004, AUST J ZOOL, V52, P215, DOI 10.1071/ZO03030; Ruokonen M, 2002, MOL PHYLOGENET EVOL, V23, P422, DOI 10.1016/S1055-7903(02)00021-0; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Schwarz C, 2009, NUCLEIC ACIDS RES, V37, P3215, DOI 10.1093/nar/gkp159; Trewick SA, 2001, NEW ZEAL J ZOOL, V28, P291, DOI 10.1080/03014223.2001.9518271; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; WORTHY TH, 2002, LOST WORLD MOA; Zhang AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027750; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	35	4	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e50732	10.1371/journal.pone.0050732	http://dx.doi.org/10.1371/journal.pone.0050732			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341875	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700005
J	Zheng, LX; Hedrick, TL; Mittal, R				Zheng, Lingxiao; Hedrick, Tyson L.; Mittal, Rajat			Time-Varying Wing-Twist Improves Aerodynamic Efficiency of Forward Flight in Butterflies	PLOS ONE			English	Article							IMMERSED BOUNDARY METHOD; INSECT FLIGHT; FLYING BUTTERFLIES; DESERT LOCUST; DEFORMATION; HOVERFLIES; MECHANISMS; KINEMATICS; FORCES; MOTION	Insect wings can undergo significant chordwise (camber) as well as spanwise (twist) deformation during flapping flight but the effect of these deformations is not well understood. The shape and size of butterfly wings leads to particularly large wing deformations, making them an ideal test case for investigation of these effects. Here we use computational models derived from experiments on free-flying butterflies to understand the effect of time-varying twist and camber on the aerodynamic performance of these insects. High-speed videogrammetry is used to capture the wing kinematics, including deformation, of a Painted Lady butterfly (Vanessa cardui) in untethered, forward flight. These experimental results are then analyzed computationally using a high-fidelity, three-dimensional, unsteady Navier-Stokes flow solver. For comparison to this case, a set of non-deforming, flat-plate wing (FPW) models of wing motion are synthesized and subjected to the same analysis along with a wing model that matches the time-varying wing-twist observed for the butterfly, but has no deformation in camber. The simulations show that the observed butterfly wing (OBW) outperforms all the flat-plate wings in terms of usable force production as well as the ratio of lift to power by at least 29% and 46%, respectively. This increase in efficiency of lift production is at least three-fold greater than reported for other insects. Interestingly, we also find that the twist-only-wing (TOW) model recovers much of the performance of the OBW, demonstrating that wing-twist, and not camber is key to forward flight in these insects. The implications of this on the design of flapping wing micro-aerial vehicles are discussed.	[Zheng, Lingxiao; Mittal, Rajat] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Hedrick, Tyson L.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill	Mittal, R (corresponding author), Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA.	mittal@jhu.edu	Hedrick, Tyson/GZH-3140-2022	Hedrick, Tyson/0000-0002-6573-9602; Mittal, Rajat/0000-0002-8107-9499	National Science Foundation (NSF) [0943425, TG-CTS100002, NSF-OCI-108849]; Air-Force Office of Scientific Research [FA9550-10-1-006]	National Science Foundation (NSF)(National Science Foundation (NSF)); Air-Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	RM and LZ acknowledge support from the National Science Foundation (NSF) under Grant No. 0943425. RM and TH also acknowledge support from Air-Force Office of Scientific Research grant FA9550-10-1-006 monitored by Dr. Douglas Smith. Computational time for this research is provided by NSF under Grant Nos. TG-CTS100002 and NSF-OCI-108849. Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian RJ, 2000, EXP FLUIDS, V29, P275, DOI 10.1007/s003489900087; Aono H, 2010, 48 AER SCI M INCL NE; BAKER PS, 1981, J COMP PHYSIOL, V141, P233, DOI 10.1007/BF01342669; Birch JM, 2001, NATURE, V412, P729, DOI 10.1038/35089071; Bomphrey RJ, 2002, PHYS FLUIDS, V14, P1079; BRODSKY AK, 1991, J EXP BIOL, V161, P77; CLOUPEAU M, 1979, J EXP BIOL, V80, P1; Combes SA, 2003, J EXP BIOL, V206, P2999, DOI 10.1242/jeb.00502; Combes SA, 2003, J EXP BIOL, V206, P2979, DOI 10.1242/jeb.00523; Dai H, 2012, J FLUID MECH, V693, P473, DOI 10.1017/jfm.2011.543; Du G, 2010, J EXP BIOL, V213, P2273, DOI 10.1242/jeb.040295; Dudley R., 2000, BIOMECHANICS INSECT; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P17, DOI 10.1098/rstb.1984.0050; ENNOS AR, 1988, J EXP BIOL, V140, P161; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; Heathcote S, 2008, J FLUID STRUCT, V24, P183, DOI 10.1016/j.jfluidstructs.2007.08.003; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; Lin T, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/4/044002; Lu Y, 2007, AIAA J, V45, P615, DOI 10.2514/1.22088; Miller LA, 2009, J EXP BIOL, V212, P3076, DOI 10.1242/jeb.028662; Mittal R, 2008, J COMPUT PHYS, V227, P4825, DOI 10.1016/j.jcp.2008.01.028; Mittal R, 2005, ANNU REV FLUID MECH, V37, P239, DOI 10.1146/annurev.fluid.37.061903.175743; Mountcastle AM, 2009, EXP FLUIDS, V46, P873, DOI 10.1007/s00348-008-0607-0; Nakata T, 2012, P ROY SOC B-BIOL SCI, V279, P722, DOI 10.1098/rspb.2011.1023; Seo JH, 2011, J COMPUT PHYS, V230, P7347, DOI 10.1016/j.jcp.2011.06.003; Srygley RB, 2002, NATURE, V420, P660, DOI 10.1038/nature01223; Sunada S, 2002, JSME INT J B-FLUID T, V45, P836, DOI 10.1299/jsmeb.45.836; Walker SM, 2010, J R SOC INTERFACE, V7, P131, DOI 10.1098/rsif.2009.0120; Walker SM, 2009, J R SOC INTERFACE, V6, P735, DOI 10.1098/rsif.2008.0435; WEISFOGH T, 1952, PHILOS T ROY SOC B, V237, P1, DOI 10.1098/rstb.1952.0011; WOOTTON RJ, 1993, J EXP BIOL, V180, P105; Young J, 2009, SCIENCE, V325, P1549, DOI 10.1126/science.1175928; ZENG L, 2000, OPT COMMUN, V183, P19, DOI DOI 10.1016/S0030-4018(00)00888-9; Zhang XW, 2012, P I MECH ENG G-J AER, V226, P3, DOI 10.1177/0954410011408763; Zhao L, 2009, OPT COMMUN, V183, P19; Zheng L, 2012, THESIS J HOPKINS U	37	70	71	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53060	10.1371/journal.pone.0053060	http://dx.doi.org/10.1371/journal.pone.0053060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341923	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700020
J	Blomqvist, K; Albrecht, L; Quintana, MD; Angeletti, D; Joannin, N; Chene, A; Moll, K; Wahlgren, M				Blomqvist, Karin; Albrecht, Letusa; del Pilar Quintana, Maria; Angeletti, Davide; Joannin, Nicolas; Chene, Arnaud; Moll, Kirsten; Wahlgren, Mats			A Sequence in Subdomain 2 of DBL1 alpha of Plasmodium falciparum Erythrocyte Membrane Protein 1 Induces Strain Transcending Antibodies	PLOS ONE			English	Article							VARIANT ANTIGENS; INFECTED ERYTHROCYTES; SEVERE MALARIA; HETEROLOGOUS STRAINS; IN-VIVO; SURFACE; BINDING; PFEMP1; ACQUISITION; RECOGNITION	Immunity to severe malaria is the first level of immunity acquired to Plasmodium falciparum. Antibodies to the variant antigen PfEMP1 (P. falciparum erythrocyte membrane protein 1) present at the surface of the parasitized red blood cell (pRBC) confer protection by blocking microvascular sequestration. Here we have generated antibodies to peptide sequences of subdomain 2 of PfEMP1-DBL1 alpha previously identified to be associated with severe or mild malaria. A set of sera generated to the amino acid sequence KLQTLTLHQVREYWWALNRKEVWKA, containing the motif ALNRKE, stained the live pRBC. 50% of parasites tested (7/14) were positive both in flow cytometry and immunofluorescence assays with live pRBCs including both laboratory strains and in vitro adapted clinical isolates. Antibodies that reacted selectively with the sequence REYWWALNRKEVWKA in a 15-mer peptide array of DBL1 alpha-domains were also found to react with the pRBC surface. By utilizing a peptide array to map the binding properties of the elicited anti-DBL1 alpha antibodies, the amino acids WxxNRx were found essential for antibody binding. Complementary experiments using 135 degenerate RDSM peptide sequences obtained from 93 Ugandan patient-isolates showed that antibody binding occurred when the amino acids WxLNRKE/D were present in the peptide. The data suggests that the ALNRKE sequence motif, associated with severe malaria, induces strain-transcending antibodies that react with the pRBC surface.	[Blomqvist, Karin; Albrecht, Letusa; del Pilar Quintana, Maria; Angeletti, Davide; Moll, Kirsten; Wahlgren, Mats] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [del Pilar Quintana, Maria] Univ Rosario, Fac Ciencias Nat & Matemat, Escuela Med & Ciencias Salud, Bogota, Colombia; [Joannin, Nicolas] Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Kyoto 606, Japan; [Chene, Arnaud] Inst Pasteur, Paris, France	Karolinska Institutet; Universidad del Rosario; Kyoto University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Wahlgren, M (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden.	mats.wahlgren@ki.se	Chene, Arnaud/O-4397-2017; Angeletti, Davide/H-7350-2019; Albrecht, Letusa/I-1837-2012	Chene, Arnaud/0000-0002-6551-4382; Angeletti, Davide/0000-0002-5256-1972; Albrecht, Letusa/0000-0001-6406-2057; Quintana, Maria del Pilar/0000-0001-6190-3324	Swedish Research Council (VR); The Swedish Academy of Sciences (KVA); The Swedish Academy of Sciences (Soderberg foundation); Karolinska Institutet-DPA; EU Network of Excellence EviMalar	Swedish Research Council (VR)(Swedish Research Council); The Swedish Academy of Sciences (KVA); The Swedish Academy of Sciences (Soderberg foundation); Karolinska Institutet-DPA(Karolinska Institutet); EU Network of Excellence EviMalar	This work was supported by Swedish Research Council (VR), The Swedish Academy of Sciences (KVA, Soderberg foundation), Karolinska Institutet-DPA and the EU Network of Excellence EviMalar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ahuja S, 2006, VACCINE, V24, P6140, DOI 10.1016/j.vaccine.2006.05.030; Albrecht L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-17; Angeletti D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050758; [Anonymous], 2008, METHODS MALARIA RES; Avril M, 2012, P NATL ACAD SCI USA, V109, pE1782, DOI 10.1073/pnas.1120534109; Avril M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-36; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; Blomqvist K, 2010, MOL BIOCHEM PARASIT, V170, P74, DOI 10.1016/j.molbiopara.2009.12.002; Bull PC, 1999, INFECT IMMUN, V67, P733, DOI 10.1128/IAI.67.2.733-739.1999; Bull PC, 2007, MOL BIOCHEM PARASIT, V154, P98, DOI 10.1016/j.molbiopara.2007.03.011; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; Cham GKK, 2010, INFECT IMMUN, V78, P4653, DOI 10.1128/IAI.00593-10; Chen Q, 1998, J EXP MED, V187, P15, DOI 10.1084/jem.187.1.15; Chen QJ, 2000, J EXP MED, V192, P1, DOI 10.1084/jem.192.1.1; Chootong P, 2010, INFECT IMMUN, V78, P1089, DOI 10.1128/IAI.01036-09; Claessens A, 2012, P NATL ACAD SCI USA, V109, pE1772, DOI 10.1073/pnas.1120461109; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dahlback M, 2006, PLOS PATHOG, V2, P1069, DOI 10.1371/journal.ppat.0020124; Dodoo D, 2001, INFECT IMMUN, V69, P3713, DOI 10.1128/IAI.69.6.3713-3718.2001; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Gaseitsiwe S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003840; Ghumra A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002665; Ghumra A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016414; Giha HA, 1999, INFECT IMMUN, V67, P4092, DOI 10.1128/IAI.67.8.4092-4098.1999; Giha HA, 1999, PARASITOLOGY, V119, P7, DOI 10.1017/S0031182099004485; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Haeggstrom M, 2004, MOL BIOCHEM PARASIT, V133, P1, DOI 10.1016/j.molbiopara.2003.07.006; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; JEFFERY GM, 1966, B WORLD HEALTH ORGAN, V35, P873; Joergensen L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001083; Jones TR, 2000, AM J TROP MED HYG, V62, P675, DOI 10.4269/ajtmh.2000.62.675; Juillerat A, 2011, P NATL ACAD SCI USA, V108, P5243, DOI 10.1073/pnas.1018692108; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Knuepfer E, 2005, BLOOD, V105, P4078, DOI 10.1182/blood-2004-12-4666; Lavstsen T, 2012, P NATL ACAD SCI USA, V109, pE1791, DOI 10.1073/pnas.1120455109; MCGREGOR IA, 1974, B WORLD HEALTH ORGAN, V50, P259; Moll K, 2007, INFECT IMMUN, V75, P211, DOI 10.1128/IAI.00749-06; Nielsen MA, 2002, J IMMUNOL, V168, P3444, DOI 10.4049/jimmunol.168.7.3444; Normark J, 2007, P NATL ACAD SCI USA, V104, P15835, DOI 10.1073/pnas.0610485104; Ofori MF, 2002, INFECT IMMUN, V70, P2982, DOI 10.1128/IAI.70.6.2982-2988.2002; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Staalsoe T, 2001, J INFECT DIS, V184, P618, DOI 10.1086/322809; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; UDOMSANGPETCH R, 1989, J EXP MED, V169, P1835, DOI 10.1084/jem.169.5.1835; Vigan-Womas I, 2008, INFECT IMMUN, V76, P5565, DOI 10.1128/IAI.00901-08; Vigan-Womas I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016544; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Williams TN, 2003, CYTOM PART A, V56A, P96, DOI 10.1002/cyto.a.10088; Yeka A, 2005, PLOS MED, V2, P654, DOI 10.1371/journal.pmed.0020190	57	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e52679	10.1371/journal.pone.0052679	http://dx.doi.org/10.1371/journal.pone.0052679			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335956	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000314707700008
J	Singh, TP; Schon, MP; Wallbrecht, K; Gruber-Wackernagel, A; Wang, XJ; Wolf, P				Singh, Tej Pratap; Schoen, Michael P.; Wallbrecht, Katrin; Gruber-Wackernagel, Alexandra; Wang, Xiao-Jing; Wolf, Peter			Involvement of IL-9 in Th17-Associated Inflammation and Angiogenesis of Psoriasis	PLOS ONE			English	Article							CHRONIC PLAQUE PSORIASIS; ACTIVATED MAST-CELLS; REGULATORY T-CELLS; TRANSGENIC MICE; TGF-BETA; ALLERGIC INFLAMMATION; PLUS ULTRAVIOLET; SKIN DISORDER; TH17 CELLS; THERAPY	It is thought that a Th1/Th17-weighted immune response plays a predominant role in the pathogenesis of psoriasis. Our findings now indicate a link between IL-9, a Th2 and Th9 cytokine, and Th17 pathway in psoriasis. In K5.hTGF-beta 1 transgenic mice, exhibiting a psoriasis-like phenotype, we found increased IL-9R and IL-9 expression in the skin and intradermal IL-9 injection induced Th17-related inflammation. IL-9 also promoted angiogenesis and VEGF and CD31 overexpression in mice in vivo and increased tube formation of human endothelial cells in vitro. Injecting anti-IL-9 antibody into K5.hTGF-beta 1 transgenic mice not only diminished inflammation (including skin infiltration by T cells, monocytes/macrophages, and mast cells) and angiogenesis but also delayed the psoriasis-like skin phenotype. Notably, injection of anti-psoriatic acting anti-IL17 antibody reduced skin IL-9 mRNA and serum IL-9 protein levels in K5.hTGF-beta 1 transgenic mice and prevented IL-9-induced epidermal hyperplasia and inflammation of the skin of wild type mice. In addition, we observed that IL-9R expression in lesional skin from psoriasis patients was markedly higher than in healthy skin from control subjects. Moreover, IL-9 significantly enhanced IL-17A production by cultured human peripheral blood mononuclear cells or CD4+ T cells, especially in psoriasis patients. Thus, IL-9 may play a role in the development of psoriatic lesions through Th17-associated inflammation and angiogenesis.	[Singh, Tej Pratap; Gruber-Wackernagel, Alexandra; Wolf, Peter] Med Univ Graz, Dept Dermatol, Res Unit Photodermatol, Graz, Austria; [Singh, Tej Pratap] Med Univ Graz, Med Res Ctr, Graz, Austria; [Schoen, Michael P.; Wallbrecht, Katrin] Univ Med Ctr Gottingen, Dept Dermatol Venereol & Allergol, Gottingen, Germany; [Wang, Xiao-Jing] Univ Colorado Denver, Dept Pathol, Aurora, CO USA; [Wang, Xiao-Jing] Univ Colorado Denver, Dept Otolaryngol, Aurora, CO USA; [Wang, Xiao-Jing] Univ Colorado Denver, Dept Dermatol, Aurora, CO USA; [Wang, Xiao-Jing] Univ Colorado Denver, Dept Craniofacial Biol Head & Neck Canc Res, Aurora, CO USA	Medical University of Graz; Medical University of Graz; University of Gottingen; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Wolf, P (corresponding author), Med Univ Graz, Dept Dermatol, Res Unit Photodermatol, Graz, Austria.	peter.wolf@medunigraz.at		Schon, Michael/0000-0002-0698-4130; Singh, Tej Pratap/0000-0002-0122-1089	Oesterreichische Nationalbank (Anniversary Fund) [11729, 13279]; Austrian Society for Dermatology and Venereology; PhD Program in Molecular Medicine of the Medical University of Graz, Austria; Austrian Society of Dermatology and Venereology; European Union (Angioskin) [LSH-2003-512127]	Oesterreichische Nationalbank (Anniversary Fund); Austrian Society for Dermatology and Venereology; PhD Program in Molecular Medicine of the Medical University of Graz, Austria; Austrian Society of Dermatology and Venereology; European Union (Angioskin)(European Commission)	This work was supported by funds of the Oesterreichische Nationalbank (Anniversary Fund, project numbers 11729 and 13279) and the Austrian Society for Dermatology and Venereology. T.P.S. was supported by the PhD Program in Molecular Medicine of the Medical University of Graz, Austria, and by a research grant from the Austrian Society of Dermatology and Venereology. M.P.S. and K.W. were supported by a grant from the European Union (Angioskin, LSH-2003-512127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelilah SG, 2001, J IMMUNOL, V166, P2768, DOI 10.4049/jimmunol.166.4.2768; Akman A, 2009, CLIN EXP DERMATOL, V34, pE202, DOI 10.1111/j.1365-2230.2008.02991.x; Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Asarch A, 2008, J DERMATOL TREAT, V19, P259, DOI 10.1080/09546630802206686; Beriou G, 2010, J IMMUNOL, V185, P46, DOI 10.4049/jimmunol.1000356; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Cheng G, 2002, AM J RESP CRIT CARE, V166, P409, DOI 10.1164/rccm.2105079; Chua RA, 2009, AUTOIMMUNITY, V42, P574, DOI 10.1080/08916930903002461; Coimbra S, 2010, BRIT J DERMATOL, V163, P1282, DOI 10.1111/j.1365-2133.2010.09992.x; Costanzo A, 2010, J DERMATOL SCI, V60, P61, DOI 10.1016/j.jdermsci.2010.08.016; Crawshaw AA, 2012, EXPERT OPIN INV DRUG, V21, P33, DOI 10.1517/13543784.2012.636351; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Eller K, 2011, J IMMUNOL, V186, P83, DOI 10.4049/jimmunol.1001183; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Friberg C, 2006, J INVEST DERMATOL, V126, P998, DOI 10.1038/sj.jid.5700194; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; Halin C, 2008, METHOD ENZYMOL, V445, P1, DOI 10.1016/S0076-6879(08)03001-2; Han GW, 2012, INT J BIOL SCI, V8, P228, DOI 10.7150/ijbs.8.228; Hauber HP, 2004, INT ARCH ALLERGY IMM, V134, P79, DOI 10.1159/000078384; Heidenreich R, 2009, INT J EXP PATHOL, V90, P232, DOI 10.1111/j.1365-2613.2009.00669.x; Inzinger M, 2011, BRIT J DERMATOL, V165, P640, DOI 10.1111/j.1365-2133.2011.10396.x; Inzinger M, 2012, ACTA DERM-VENEREOL, V92, P357, DOI 10.2340/00015555-1243; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Kearley J, 2010, AM J RESP CRIT CARE; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Li AG, 2004, EMBO J, V23, P1770, DOI 10.1038/sj.emboj.7600183; Li HM, 2010, J IMMUNOL, V185, P4095, DOI 10.4049/jimmunol.1000986; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Mabuchi T, 2011, J IMMUNOL, V187, P5026, DOI 10.4049/jimmunol.1101817; Matsuzawa S, 2003, J IMMUNOL, V170, P3461, DOI 10.4049/jimmunol.170.7.3461; Nickoloff BJ, 1997, NAT MED, V3, P475, DOI 10.1038/nm0597-475b; Nickoloff BJ, 2007, NAT MED, V13, P242, DOI 10.1038/nm0307-242; Noelle RJ, 2010, NAT REV IMMUNOL, V10, P683, DOI 10.1038/nri2848; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Pittelkow MR, 2005, NAT MED, V11, P17, DOI 10.1038/nm0105-17; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Simonetti O, 2006, INT J IMMUNOPATH PH, V19, P751, DOI 10.1177/039463200601900405; Singh TP, 2012, EXP DERMATOL, V21, P228, DOI 10.1111/j.1600-0625.2011.01437.x; Singh TP, 2011, AM J PATHOL, V178, P699, DOI 10.1016/j.ajpath.2010.10.008; Singh TP, 2010, J IMMUNOL, V184, P7257, DOI 10.4049/jimmunol.0903719; Stassen M, 2001, J IMMUNOL, V166, P4391, DOI 10.4049/jimmunol.166.7.4391; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Steenwinckel V, 2007, J IMMUNOL, V178, P3244, DOI 10.4049/jimmunol.178.5.3244; Swindell WR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018266; Theoharides TC, 2010, P NATL ACAD SCI USA, V107, P4448, DOI 10.1073/pnas.1000803107; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Wiener Z, 2004, CYTOKINE, V26, P122, DOI 10.1016/j.cyto.2004.01.006; Zibert JR, 2011, J CLIN INVEST, V121, P410, DOI 10.1172/JCI41295	52	121	137	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e51752	10.1371/journal.pone.0051752	http://dx.doi.org/10.1371/journal.pone.0051752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335955	gold, Green Published, Green Submitted			2022-12-25	WOS:000314707700006
J	Spaulding, AB; Radi, D; Macleod, H; Lynfield, R; Larson, M; Hyduke, T; Dehnel, P; DeVries, AS				Spaulding, Alicen B.; Radi, Deborah; Macleod, Heather; Lynfield, Ruth; Larson, Michelle; Hyduke, Terri; Dehnel, Peter; DeVries, Aaron S.			Satisfaction and Public Health Cost of a Statewide Influenza Nurse Triage Line in Response to Pandemic H1N1 Influenza	PLOS ONE			English	Article							CARE	Background: The 2009 H1N1 pandemic strained healthcare systems. There was a need for supportive services, rapid antiviral access, and minimization of unnecessary healthcare contacts particularly face-to-face interactions. In response, the Minnesota Department of Health (MDH) launched a telephone-based nurse triage line (NTL) called the Minnesota FluLine coordinating all major MN healthcare systems with NTLs to form a single toll-free number triage service. Callers were evaluated for symptoms of influenza-like illness (ILI) and were prescribed an antiviral if indicated, using nurse administered protocols. Methods: To determine caller outcomes, associated healthcare seeking, and satisfaction a telephone survey of Minnesota FluLine callers was conducted using a 5% random sample of those who completed the protocol and those who did not. Results: Of 6,122 callers with ILI who began the nurse protocol administered by the contract NTL, 1,221 people were contacted for the survey and 325 agreed to participate; response rate was 26%. Of those who completed the nurse protocol 73% said they would have sought healthcare without the Minnesota FluLine, 89% reported the service was moderately or very helpful, and 91% reported being satisfied or very satisfied. Of those not completing the protocol, 50% reported the service was moderately or very helpful and 50% reported being satisfied or very satisfied. 72% of qualitative responses to open-ended questions were positive regarding the MN FluLine. Cost to MDH for operating the Minnesota FluLine service was $331,226 to service 27,391 callers ($12.09/call). Discussion: The Minnesota FluLine diverted patients with mild ILI symptoms away from acute care visits at low cost and had a high rate of satisfaction among callers. Early intervention likely prevented morbidity and possibly additional cases. NTLs are powerful and flexible tools for pandemic response and should be considered as an important tool for future emergency responses.	[Spaulding, Alicen B.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [Spaulding, Alicen B.; Radi, Deborah; Lynfield, Ruth; Larson, Michelle; DeVries, Aaron S.] Minnesota Dept Hlth, St Paul, MN USA; [Macleod, Heather; Hyduke, Terri; Dehnel, Peter] Childrens Phys Network, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Minnesota Department of Health (MHD)	DeVries, AS (corresponding author), Minnesota Dept Hlth, St Paul, MN USA.	aaron.devries@state.mn.us		DeVries, Aaron/0000-0001-9211-0722	CDC grant [1H75TP000348-01, 5U01CI000313-05]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000313] Funding Source: NIH RePORTER	CDC grant; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	CDC grant # 1H75TP000348-01-Revise providing funding for the MN FluLine program and CDC grant # 5U01CI000313-05 provided funding for the program evaluation presented in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel LJ, 2011, NEW ENGL J MED, V365, P1959, DOI 10.1056/NEJMoa1108660; Azarmina P, 2007, J TELEMED TELECARE, V13, pS3; Bunn F, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD004180.PUB2, 10.1002/14651858.CD004180.pub2]; Cariello Francesca P, 2003, J Ambul Care Manage, V26, P124; CDC, 2009, UPD CDC EST 2009 H1N; Clancy Terry, 2009, Am J Disaster Med, V4, P253; Cleary Vivien, 2010, J Bus Contin Emer Plan, V4, P154; Como-Sabetti Kathryn, 2010, Minn Med, V93, P36; Kempe A, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.6.e111; Lilly CM, 2011, JAMA-J AM MED ASSOC, V305, P2175, DOI 10.1001/jama.2011.697; Minnesota Department of Health, 2010, 2009 H1N1 INFL MINN; North F, 2011, J TELEMED TELECARE, V17, P417, DOI 10.1258/jtt.2011.110301; North F, 2010, TELEMED J E-HEALTH, V16, P1012, DOI 10.1089/tmj.2010.0102; Rubin GJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-451; Smith EC, 2009, DISASTER MED PUBLIC, V3, pS154, DOI 10.1097/DMP.0b013e3181be8250; Spaulding AB, 2012, PUBLIC HEALTH REP, V127, P532, DOI 10.1177/003335491212700509; Venn M J, 1996, Eur J Cancer Care (Engl), V5, P38, DOI 10.1111/j.1365-2354.1996.tb00204.x	17	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e50492	10.1371/journal.pone.0050492	http://dx.doi.org/10.1371/journal.pone.0050492			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335953	gold, Green Published			2022-12-25	WOS:000314707700003
J	Dinari, A; Niazi, A; Afsharifar, AR; Ramezani, A				Dinari, Ali; Niazi, Ali; Afsharifar, Ali Reza; Ramezani, Amin			Identification of Upregulated Genes under Cold Stress in Cold-Tolerant Chickpea Using the cDNA-AFLP Approach	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; MESSENGER-RNA; PLANT; ACCLIMATION; PROTEINS; METABOLISM; RESPONSES; DROUGHT	Low temperature injury is one of the most significant causes of crop damage worldwide. Cold acclimatization processes improve the freezing tolerance of plants. To identify genes of potential importance for acclimatzation to the cold and to elucidate the pathways that regulate this process, global transcriptome expression of the chickpea (Cicer arietinum L), a species of legume, was analyzed using the cDNA-AFLP technique. In total, we generated 4800 transcript-derived fragments (TDFs) using cDNA-AFLP in conjunction with 256 primer combinations. We only considered those cDNA fragments that seemed to be up-regulated during cold acclimatization. Of these, 102 TDFs with differential expression patterns were excised from gels and re-amplified by PCR. Fifty-four fragments were then cloned and sequenced. BLAST search of the GenBank non-redundant (nr) sequence database demonstrated that 77 percent of the TDFs belonged to known sequences with putative functions related to metabolism (31), transport (10), signal transduction pathways (15) and transcription factors (21). The last group of expressed transcripts showed homology to genes of unknown function (22). To further analyze and validate our cDNA-AFLP experiments, the expression of 9 TDFs during cold acclimatzatiion was confirmed using real time RT-PCR. The results of this research show that cDNA-AFLP is a powerful technique for investigating the expression pattern of chickpea genes under low-temperature stress. Moreover, our findings will help both to elucidate the molecular basis of low-temperature effects on the chickpea genome and to identify those genes that could increase the cold tolerance of the chickpea plant.	[Dinari, Ali; Niazi, Ali] Shiraz Univ, Inst Biotechnol, Shiraz, Iran; [Afsharifar, Ali Reza] Shiraz Univ, Coll Agr, Plant Virol Res Ctr, Shiraz, Iran; [Ramezani, Amin] Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Med Biotechnol, Shiraz, Iran	Shiraz University; Shiraz University; Shiraz University of Medical Science	Niazi, A (corresponding author), Shiraz Univ, Inst Biotechnol, Shiraz, Iran.	niazi@shirazu.ac.ir	Ramezani, Amin/AID-2677-2022; Ramezani, Amin/S-1035-2017	Ramezani, Amin/0000-0001-5655-8722; Ramezani, Amin/0000-0001-5655-8722; Niazi, Ali/0000-0002-9902-9422				Ahn JW, 2006, J BIOL CHEM, V281, P13708, DOI 10.1074/jbc.M512403200; Bachem CWB, 1998, PLANT MOL BIOL REP, V16, P157, DOI 10.1023/A:1007468801806; Bachem CWB, 2001, PLANT J, V25, P595, DOI 10.1046/j.1365-313x.2001.00993.x; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Botton A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-347; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Chinnusamy V, 2006, PHYSIOL PLANTARUM, V126, P52, DOI 10.1111/j.1399-3054.2006.00596.x; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; DIVECHA N, 1995, CELL, V80, P269, DOI 10.1016/0092-8674(95)90409-3; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Heidarvand L, 2010, ACTA PHYSIOL PLANT, V32, P419, DOI 10.1007/s11738-009-0451-8; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Li TW, 2004, P NATL ACAD SCI USA, V101, P8551, DOI 10.1073/pnas.0402889101; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mantri NL, 2010, ENVIRON EXP BOT, V69, P286, DOI 10.1016/j.envexpbot.2010.05.003; MAYER RR, 1990, PLANT PHYSIOL, V94, P796, DOI 10.1104/pp.94.2.796; MCKERSIE BD, 1997, ACTIVE OXYGEN FREEZI, P203; Nishizawa-Yokoi A, 2010, PLANT CELL PHYSIOL, V51, P486, DOI 10.1093/pcp/pcq015; Polesani M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-142; Ravanel S, 1998, BIOCHEM J, V331, P639, DOI 10.1042/bj3310639; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Roberts MR, 2003, TRENDS PLANT SCI, V8, P218, DOI 10.1016/S1360-1385(03)00056-6; Rodriguez M., 2005, BIOTECNOL APL, V22, P1, DOI DOI 10.1007/S00284-005-4515-8; Roudier F, 2002, PLANT PHYSIOL, V130, P538, DOI 10.1104/pp.007468; Sun MM, 2007, J BIOCHEM MOL BIOL, V40, P986; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Viswanathan C, 2002, PHILOS T ROY SOC B, V357, P877, DOI 10.1098/rstb.2002.1076; Vuylsteke M, 2007, NAT PROTOC, V2, P1399, DOI 10.1038/nprot.2007.174; Wang WX, 2001, ACTA HORTIC, P285; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010; Zhu T, 2003, CAN J BOT, V81, P1168, DOI [10.1139/b03-115, 10.1139/B03-115]	38	17	18	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52757	10.1371/journal.pone.0052757	http://dx.doi.org/10.1371/journal.pone.0052757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341906	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400021
J	Trask, JS; George, D; Houghton, P; Kanthaswamy, S; Smith, DG				Trask, Jessica Satkoski; George, Debra; Houghton, Paul; Kanthaswamy, Sree; Smith, David Glenn			Population and Landscape Genetics of an Introduced Species (M-fascicularis) on the Island of Mauritius	PLOS ONE			English	Article							CRAB-EATING MACAQUES; MITOCHONDRIAL-DNA; CYNOMOLGUS MACAQUES; LONGTAIL MACAQUES; NUCLEAR; ORIGIN; DIVERSITY; LIFE	The cynomolgus macaque, Macaca fascicularis, was introduced onto the island of Mauritius in the early 17th century. The species experienced explosive population growth, and currently exists at high population densities. Anecdotes collected from nonhuman primate trappers on the island of Mauritius allege that animals from the northern portion of the island are larger in body size than and superior in condition to their conspecifics in the south. Although previous genetic studies have reported Mauritian cynomolgus macaques to be panmictic, the individuals included in these studies were either from the southern/central or an unknown portion of the island. In this study, we sampled individuals broadly throughout the entire island of Mauritius and used spatial principle component analysis to measure the fine-scale correlation between geographic and genetic distance in this population. A stronger correlation between geographic and genetic distance was found among animals in the north than in those in the southern and central portions of the island. We found no difference in body weight between the two groups, despite anecdotal evidence to the contrary. We hypothesize that the increased genetic structure among populations in the north is related to a reduction in dispersal distance brought about by human habitation and tourist infrastructure, but too recent to have produced true genetic differentiation.	[Trask, Jessica Satkoski; George, Debra; Smith, David Glenn] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Trask, Jessica Satkoski; Kanthaswamy, Sree; Smith, David Glenn] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Houghton, Paul] Primate Prod Inc, Immokalee, FL USA; [Kanthaswamy, Sree] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Trask, JS (corresponding author), Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA.	jasatkoski@ucdavis.edu		Trask, Jessica/0000-0002-9902-8753	NIH [RR05090, RR025871]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR005090, R24RR025871] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work has been supported by NIH grants RR05090 and RR025871 to D.G.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1988, AM J PRIMATOL, V15, P213, DOI 10.1002/ajp.1350150304; ARCHIE JW, 1985, EVOLUTION, V39, P623, DOI 10.1111/j.1558-5646.1985.tb00399.x; Blancher A, 2006, IMMUNOGENETICS, V58, P269, DOI 10.1007/s00251-006-0102-9; Blancher A, 2008, J HERED, V99, P254, DOI 10.1093/jhered/esn003; Bonhomme M, 2008, MOL ECOL, V17, P1009, DOI 10.1111/j.1365-294X.2007.03645.x; Budde ML, 2010, IMMUNOGENETICS, V62, P773, DOI 10.1007/s00251-010-0481-9; Creager HM, 2011, IMMUNOGENETICS; Education CoBaSSa, 1993, MAUR POP LAND US PRO, P98; Fooden J., 1995, FIELDIANA ZOOLOGY, V81, P1, DOI DOI 10.5962/BHL.TITLE.3456; Fuentes A, 2008, AM J PRIMATOL, V70, P879, DOI 10.1002/ajp.20575; HARVEY PH, 1985, EVOLUTION, V39, P559, DOI 10.1111/j.1558-5646.1985.tb00395.x; HOLM S, 1979, SCAND J STAT, V6, P65; Houghton P., 1988, Lab Animal (New York), V17, P36; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kanthaswamy S, 2012, AM J PRIMAT IN PRESS; Kanthaswamy S, 2008, INT J PRIMATOL, V29, P1295, DOI 10.1007/s10764-008-9295-0; Kawamoto Y, 2008, J MED PRIMATOL, V37, P45, DOI 10.1111/j.1600-0684.2007.00225.x; KONDO M, 1993, AM J PRIMATOL, V29, P167, DOI 10.1002/ajp.1350290303; Krebs KC, 2005, J IMMUNOL, V175, P5230, DOI 10.4049/jimmunol.175.8.5230; KURLAND J A, 1973, Primates, V14, P245, DOI 10.1007/BF01730823; LAWLER SH, 1995, AM J PHYS ANTHROPOL, V96, P133, DOI 10.1002/ajpa.1330960203; Leuchte N, 2004, TISSUE ANTIGENS, V63, P529, DOI 10.1111/j.0001-2815.2004.0222.x; Lutz W, 1991, POPULATION EC ENV MA; MATSUBAYASHI K, 1992, PRIMATES, V33, P281, DOI 10.1007/BF02382759; MITTERMEIER RA, 1987, PRIMATE CONSERVATION, P109; MURUTHI P, 1991, OECOLOGIA, V87, P467, DOI 10.1007/BF00320408; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Pavlin BI, 2009, EMERGING INFECT DIS, V15; Richard AF, 1989, INT J PRIMATOLOGY, V10; Rodman P.S., 1973, P171; Sha JCM, 2009, BIODIVERS CONSERV, V18, P2909, DOI 10.1007/s10531-009-9616-4; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Smith DG, 2007, AM J PRIMATOL, V69, P182, DOI 10.1002/ajp.20337; Stevison LS, 2008, J MED PRIMATOL, V37, P311, DOI 10.1111/j.1600-0684.2008.00292.x; SUSSMAN RW, 1986, FOLIA PRIMATOL, V46, P28, DOI 10.1159/000156234; Sussman RW, 2011, MONKEYS EDGE ECOLOGY; TATTERSALL I, 1981, AM J PRIMATOL, V1, P413, DOI 10.1002/ajp.1350010406; Team R. D. C, 2011, R LANG ENV STAT COMP; Tosi AJ, 2006, MOL PHYLOGE IN PRESS; Weir B., 1984, EVOLUTION, V28, P1358, DOI DOI 10.2307/2408641; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269	42	9	9	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53001	10.1371/journal.pone.0053001	http://dx.doi.org/10.1371/journal.pone.0053001			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341917	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400028
J	Dacevic, M; Isakovic, A; Podolski-Renic, A; Isakovic, AM; Stankovic, T; Milosevic, Z; Rakic, L; Ruzdijic, S; Pesic, M				Dacevic, Mirjana; Isakovic, Aleksandra; Podolski-Renic, Ana; Isakovic, Andelka M.; Stankovic, Tijana; Milosevic, Zorica; Rakic, Ljubisav; Ruzdijic, Sabera; Pesic, Milica			Purine Nucleoside Analog - Sulfinosine Modulates Diverse Mechanisms of Cancer Progression in Multi-Drug Resistant Cancer Cell Lines	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; POLYMERASE CHAIN-REACTION; LUNG-CARCINOMA; MESSENGER-RNA; GLIOMA-CELLS; IN-VITRO; EXPRESSION; APOPTOSIS; INHIBITION; DIFFERENTIATION	Achieving an effective treatment of cancer is difficult, particularly when resistance to conventional chemotherapy is developed. P-glycoprotein (P-gp) activity governs multi-drug resistance (MDR) development in different cancer cell types. Identification of anti-cancer agents with the potential to kill cancer cells and at the same time inhibit MDR is important to intensify the search for novel therapeutic approaches. We examined the effects of sulfinosine (SF), a quite unexplored purine nucleoside analog, in MDR (P-gp over-expressing) non-small cell lung carcinoma (NSCLC) and glioblastoma cell lines (NCI-H460/R and U87-TxR, respectively). SF showed the same efficacy against MDR cancer cell lines and their sensitive counterparts. However, it was non-toxic for normal human keratinocytes (HaCaT). SF induced caspase-dependent apoptotic cell death and autophagy in MDR cancer cells. After SF application, reactive oxygen species (ROS) were generated and glutathione (GSH) concentration was decreased. The expression of key enzyme for GSH synthesis, gamma Glutamylcysteine-synthetase (cGCS) was decreased as well as the expression of gst-pi mRNA. Consequently, SF significantly decreased the expression of hif-1 alpha, mdr1 and vegf mRNAs even in hypoxic conditions. SF caused the inhibition of P-gp (coded by mdr1) expression and activity. The accumulation of standard chemotherapeutic agent - doxorubicin (DOX) was induced by SF in concentration-and time-dependent manner. The best effect of SF was obtained after 72 h when it attained the effect of known P-gp inhibitors (Dex-verapamil and tariquidar). Accordingly, SF sensitized the resistant cancer cells to DOX in subsequent treatment. Furthermore, SF decreased the experssion of vascular endothelial growth factor (VEGF) on mRNA and protein level and modulated its secretion. In conclusion, the effects on P-gp (implicated in pharmacokinetics and MDR), GSH (implicated in detoxification) and VEGF (implicated in tumor-angiogenesis and progression) qualify SF as multi-potent anti-cancer agent, which use must be considered, in particular for resistant malignancies.	[Dacevic, Mirjana; Isakovic, Aleksandra; Isakovic, Andelka M.] Univ Belgrade, Fac Med, Belgrade, Serbia; [Podolski-Renic, Ana; Stankovic, Tijana; Milosevic, Zorica; Ruzdijic, Sabera; Pesic, Milica] Univ Belgrade, Inst Biol Res, Dept Neurobiol, Belgrade, Serbia; [Rakic, Ljubisav] Serbian Acad Arts & Sci, Belgrade, Serbia	University of Belgrade; University of Belgrade; Serbian Academy of Sciences & Arts	Pesic, M (corresponding author), Univ Belgrade, Inst Biol Res, Dept Neurobiol, Bulevar Despota Stefana 142, Belgrade, Serbia.	vtbvtm@sbb.rs	Pešić, Milica/I-4727-2019; Stanković, Tijana/F-1228-2016	Pešić, Milica/0000-0002-9045-8239; Stanković, Tijana/0000-0001-5623-0612; Isakovic, Andjelka/0000-0001-5270-709X; Podolski-Renic, Ana/0000-0001-7412-3685	Ministry of Education, Science and Technological Development of Serbia [III 41031, III 41025]	Ministry of Education, Science and Technological Development of Serbia(Ministry of Education, Science & Technological Development, Serbia)	Ministry of Education, Science and Technological Development of Serbia (grant numbers III 41031 and III 41025) supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andjelkovic T, 2008, CANCER BIOL THER, V7, P1024, DOI 10.4161/cbt.7.7.6036; AVERY TL, 1990, CANCER RES, V50, P2625; Bosch S, 1997, ANTICANCER RES, V17, P4595; Bosch TM, 2006, CLIN PHARMACOKINET, V45, P253, DOI 10.2165/00003088-200645030-00003; Chang CY, 2011, J NEURO-ONCOL, V105, P507, DOI 10.1007/s11060-011-0632-3; Dunne G, 2011, INVEST NEW DRUG, V29, P1284, DOI 10.1007/s10637-010-9482-7; Eimer S, 2011, CANCER BIOL THER, V11, P1017, DOI 10.4161/cbt.11.12.15693; Fontanini G, 1997, CLIN CANCER RES, V3, P861; FUJITAKI J M, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P596; Ghibelli L, 1999, FASEB J, V13, P2031, DOI 10.1096/fasebj.13.14.2031; Gridelli C, 2003, ONCOGENE, V22, P6629, DOI 10.1038/sj.onc.1206957; Harada H, 1999, CANCER RES, V59, P3783; Hawkins BT, 2010, J NEUROSCI, V30, P1417, DOI 10.1523/JNEUROSCI.5103-09.2010; Horn L, 2009, CLIN LUNG CANCER, V10, pS7, DOI 10.3816/CLC.2009.s.002; Jansen M, 2004, BRAIN RES REV, V45, P143, DOI 10.1016/j.brainresrev.2004.03.001; Jin WS, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-61; Kang WQ, 2005, CARCINOGENESIS, V26, P1129, DOI 10.1093/carcin/bgi045; Li GF, 2011, J BIOL CHEM, V286, P20251, DOI 10.1074/jbc.M110.211771; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Menon SG, 2007, ONCOGENE, V26, P1101, DOI 10.1038/sj.onc.1209895; Nardinocchi L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-1; NicAmhlaoibh R, 1999, INT J CANCER, V82, P368, DOI 10.1002/(SICI)1097-0215(19990730)82:3<368::AID-IJC10>3.0.CO;2-E; Nies AT, 2007, CANCER LETT, V254, P11, DOI 10.1016/j.canlet.2006.12.023; Nobili S, 2012, MED RES REV, V32, P1220, DOI 10.1002/med.20239; ODRISCOLL L, 1993, CYTOTECHNOLOGY, V12, P289, DOI 10.1007/BF00744669; Pesic M, 2006, J CHEMOTHERAPY, V18, P66, DOI 10.1179/joc.2006.18.1.66; Pesic M, 2010, INVEST NEW DRUG, V28, P482, DOI 10.1007/s10637-009-9277-x; Pesic M, 2009, INVEST NEW DRUG, V27, P99, DOI 10.1007/s10637-008-9140-5; Podolski-Renic A, 2011, BIOMED PHARMACOTHER, V65, P345, DOI 10.1016/j.biopha.2011.04.015; Presta M, 2002, LEUKEMIA, V16, P1490, DOI 10.1038/sj.leu.2402646; REVANKAR GR, 1990, J MED CHEM, V33, P121, DOI 10.1021/jm00163a020; RILEY T A, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P599; Rudin CM, 2003, CANCER RES, V63, P312; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; SOKOLOSKI JA, 1987, CANCER RES, V47, P6283; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Underiner TL, 2004, CURR MED CHEM, V11, P731, DOI 10.2174/0929867043455756; Voss V, 2010, MOL CANCER RES, V8, P1002, DOI 10.1158/1541-7786.MCR-09-0562; Walbert T, 2011, J NEURO-ONCOL, V102, P273, DOI 10.1007/s11060-010-0313-7; WONG H, 1994, ANAL BIOCHEM, V223, P251, DOI 10.1006/abio.1994.1581; Xu Y, 2008, ONCOGENE, V27, P3501, DOI 10.1038/sj.onc.1211023; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4	44	17	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54044	10.1371/journal.pone.0054044	http://dx.doi.org/10.1371/journal.pone.0054044			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326571	Green Submitted, Green Published, gold			2022-12-25	WOS:000314705800105
J	Ohno, Y; Yasunaga, S; Janmohamed, S; Ohtsubo, M; Saeki, K; Kurogi, T; Mihara, K; Iscove, NN; Takihara, Y				Ohno, Yoshinori; Yasunaga, Shin'ichiro; Janmohamed, Salima; Ohtsubo, Motoaki; Saeki, Keita; Kurogi, Toshiaki; Mihara, Keichiro; Iscove, Norman N.; Takihara, Yoshihiro			Hoxa9 Transduction Induces Hematopoietic Stem and Progenitor Cell Activity through Direct Down-Regulation of Geminin Protein	PLOS ONE			English	Article							GENE-EXPRESSION PROFILE; POLYCOMB-GROUP GENES; DNA-REPLICATION; MYELOID-LEUKEMIA; TRANSCRIPTION FACTOR; PLURIPOTENT CELLS; MICE; IDENTIFICATION; PROLIFERATION; NUP98-HOXA9	Hoxb4, a 3'-located Hox gene, enhances hematopoietic stem cell (HSC) activity, while a subset of 5'-located Hox genes is involved in hematopoiesis and leukemogenesis, and some of them are common translocation partners for Nucleoporin 98 (Nup98) in patients with leukemia. Although these Hox gene derivatives are believed to act as transcription regulators, the molecular involvement of the Hox gene derivatives in hematopoiesis and leukemogenesis remains largely elusive. Since we previously showed that Hoxb4 forms a complex with a Roc1-Ddb1-Cul4a ubiquitin ligase core component and functions as an E3 ubiquitin ligase activator for Geminin, we here examined the E3 ubiquitin ligase activities of the 5'-located Hox genes, Hoxa9 and Hoxc13, and Nup98-Hoxa9. Hoxa9 formed a similar complex with the Roc1-Ddb1-Cul4a component to induce ubiquitination of Geminin, but the others did not. Retroviral transduction-mediated overexpression or siRNA-mediated knock-down of Hoxa9 respectively down-regulated or up-regulated Geminin in hematopoietic cells. And Hoxa9 transduction-induced repopulating and clonogenic activities were suppressed by Geminin supertransduction. These findings suggest that Hoxa9 and Hoxb4 differ from Hoxc13 and Nup98-Hoxa9 in their molecular role in hematopoiesis, and that Hoxa9 induces the activity of HSCs and hematopoietic progenitors at least in part through direct down-regulation of Geminin.	[Ohno, Yoshinori; Yasunaga, Shin'ichiro; Ohtsubo, Motoaki; Saeki, Keita; Kurogi, Toshiaki; Takihara, Yoshihiro] Hiroshima Univ, Dept Stem Cell Biol, Res Inst Radiat Biol & Med, Hiroshima, Japan; [Janmohamed, Salima; Iscove, Norman N.] Univ Toronto, Ontario Canc Inst, McEwen Ctr Regenerat Med, Dept Med Biophys, Toronto, ON, Canada; [Janmohamed, Salima; Iscove, Norman N.] Univ Toronto, Ontario Canc Inst, McEwen Ctr Regenerat Med, Dept Immunol, Toronto, ON, Canada; [Ohtsubo, Motoaki] Beppu Univ, Fac Food Sci & Nutr, Dept Food & Fermentat Sci, Beppu, Oita, Japan; [Mihara, Keichiro] Hiroshima Univ, Dept Hematol & Oncol, Res Inst Radiat Biol & Med, Hiroshima, Japan	Hiroshima University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Hiroshima University	Takihara, Y (corresponding author), Hiroshima Univ, Dept Stem Cell Biol, Res Inst Radiat Biol & Med, Hiroshima, Japan.	takihara@hiroshima-u.ac.jp	Mihara, Keichiro/L-5167-2019	ohtsubo, motoaki/0000-0002-2479-3178	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science Summer program; Ube Foundation; Takeda Science Foundation; Tsuchiya Medical Foundation; Children's Cancer Foundation of Japan; Mitsubishi Pharma Research Foundation; Daiwa Securities Health Foundation; Novartis Pharma Japan; Okinaka Memorial Institute for Medical Research	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science Summer program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ube Foundation(UBE Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Tsuchiya Medical Foundation; Children's Cancer Foundation of Japan; Mitsubishi Pharma Research Foundation; Daiwa Securities Health Foundation; Novartis Pharma Japan; Okinaka Memorial Institute for Medical Research	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Japan Society for the Promotion of Science Summer program, the Ube Foundation, the Takeda Science Foundation, the Tsuchiya Medical Foundation, the Children's Cancer Foundation of Japan, the Mitsubishi Pharma Research Foundation and the Daiwa Securities Health Foundation, Novartis Pharma Japan and Okinaka Memorial Institute for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bijl J, 2006, BLOOD, V108, P116, DOI 10.1182/blood-2005-06-2245; Blow JJ, 2002, TRENDS CELL BIOL, V12, P72, DOI 10.1016/S0962-8924(01)02203-6; Brun ACM, 2004, BLOOD, V103, P4126, DOI 10.1182/blood-2003-10-3557; Chen HX, 2005, J BIOL CHEM, V280, P19373, DOI 10.1074/jbc.M413528200; Chung KY, 2006, CANC RES, V66, P11781; Comelli L, 2009, CELL CYCLE, V8, P454, DOI 10.4161/cc.8.3.7649; Del Bene F, 2004, NATURE, V427, P745, DOI 10.1038/nature02292; Di-Poi N, 2010, DEV BIOL, V341, P488, DOI 10.1016/j.ydbio.2010.03.006; Faber J, 2009, BLOOD, V113, P2375, DOI 10.1182/blood-2007-09-113597; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gonzalez MA, 2006, GENE DEV, V20, P1880, DOI 10.1101/gad.379706; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Iwasaki M, 2005, BLOOD, V105, P784, DOI 10.1182/blood-2004-04-1508; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kim MY, 2006, P NATL ACAD SCI USA, V103, P13074, DOI 10.1073/pnas.0601915103; Kroll KL, 1998, DEVELOPMENT, V125, P3247; Kroon E, 2001, EMBO J, V20, P350, DOI 10.1093/emboj/20.3.350; Lawrence HJ, 2005, BLOOD, V106, P3988, DOI 10.1182/blood-2005-05-2003; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; Lebert-Ghali CE, 2010, EXP HEMATOL, V38, P1074, DOI 10.1016/j.exphem.2010.07.006; Lei HY, 2005, P NATL ACAD SCI USA, V102, P2420, DOI 10.1073/pnas.0409700102; LEVINE M, 1988, CELL, V55, P537, DOI 10.1016/0092-8674(88)90209-7; Lin YW, 2005, BLOOD, V106, P287, DOI 10.1182/blood-2004-12-4794; Luo LF, 2004, NATURE, V427, P749, DOI 10.1038/nature02305; Lutzmann M, 2006, EMBO J, V25, P5764, DOI 10.1038/sj.emboj.7601436; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0; Milne TA, 2005, CANCER RES, V65, P11367, DOI 10.1158/0008-5472.CAN-05-1041; Moore MAS, 2005, EXP HEMATOL, V33, P719, DOI 10.1016/j.exphem.2005.04.011; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P21529, DOI 10.1073/pnas.1011054107; Ohta H, 2002, J EXP MED, V195, P759, DOI 10.1084/jem.20011911; OHTSUBO M, 1989, J CELL BIOL, V109, P1389, DOI 10.1083/jcb.109.4.1389; Ohtsubo M, 2008, P NATL ACAD SCI USA, V105, P10396, DOI 10.1073/pnas.0800672105; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Oshima M, 2011, BLOOD, V117, pE142, DOI 10.1182/blood-2010-12-323212; Pineault N, 2003, BLOOD, V101, P4529, DOI 10.1182/blood-2002-08-2484; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Schiedlmeier B, 2007, P NATL ACAD SCI USA, V104, P16952, DOI 10.1073/pnas.0703082104; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Shinnick KM, 2010, J CLIN INVEST, V120, P4303, DOI 10.1172/JCI43556; Takihara Y, 2000, INT J HEMATOL, V72, P165; Takihara Y, 2008, INT J HEMATOL, V87, P25, DOI 10.1007/s12185-007-0006-y; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yamada T, 2008, EXP CELL RES, V314, P847, DOI 10.1016/j.yexcr.2007.11.005; Yang VS, 2011, CURR BIOL, V21, P692, DOI 10.1016/j.cub.2011.03.026; Zhang Y, 2003, EMBO J, V22, P6057, DOI 10.1093/emboj/cdg577	52	14	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53161	10.1371/journal.pone.0053161	http://dx.doi.org/10.1371/journal.pone.0053161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326393	Green Published, gold, Green Submitted			2022-12-25	WOS:000314705800034
J	Valva, P; Casciato, P; Lezama, C; Galoppo, M; Gadano, A; Galdame, O; Galoppo, MC; Mullen, E; De Matteo, E; Preciado, MV				Valva, Pamela; Casciato, Paola; Lezama, Carol; Galoppo, Marcela; Gadano, Adrian; Galdame, Omar; Cristina Galoppo, Maria; Mullen, Eduardo; De Matteo, Elena; Victoria Preciado, Maria			Serum Apoptosis Markers Related to Liver Damage in Chronic Hepatitis C: sFas as a Marker of Advanced Fibrosis in Children and Adults While M30 of Severe Steatosis Only in Children	PLOS ONE			English	Article							CHRONIC VIRAL-HEPATITIS; SOLUBLE FAS LEVELS; VIRUS-INFECTION; CELL-DEATH; CASPASE ACTIVATION; BIOPSY; EXPRESSION; DIAGNOSIS; DISEASE; BIOMARKERS	Background: Liver biopsy represents the gold standard for evaluating damage and progression in patients with chronic hepatitis C (CHC); however, developing noninvasive tests that can predict liver injury represents a growing medical need. Considering that hepatocyte apoptosis plays a role in CHC pathogenesis; the aim of our study was to evaluate the presence of different apoptosis markers that correlate with liver injury in a cohort of pediatric and adult patients with CHC. Methods: Liver biopsies and concomitant serum samples from 22 pediatric and 22 adult patients with CHC were analyzed. Histological parameters were evaluated. In serum samples soluble Fas (sFas), caspase activity and caspase-generated neoepitope of the CK-18 proteolytic fragment (M30) were measured. Results: sFas was associated with fibrosis severity in pediatric (significant fibrosis p = 0.03, advanced fibrosis p = 0.01) and adult patients (advanced fibrosis p = 0.02). M30 levels were elevated in pediatric patients with severe steatosis (p = 0.01) while in adults no relation with any histological variable was observed. Caspase activity levels were higher in pediatric samples with significant fibrosis (p = 0.03) and they were associated with hepatitis severity (p = 0.04) in adult patients. The diagnostic accuracy evaluation demonstrated only a good performance for sFas to evaluate advanced fibrosis both in children (AUROC: 0.812) and adults (AUROC: 0.800) as well as for M30 to determine steatosis severity in children (AUROC: 0.833). Conclusions: Serum sFas could be considered a possible marker of advanced fibrosis both in pediatric and adult patient with CHC as well as M30 might be a good predictor of steatosis severity in children.	[Valva, Pamela; De Matteo, Elena; Victoria Preciado, Maria] Hosp Ninos Dr Ricardo Gutierrez, Div Pathol, Mol Biol Lab, Buenos Aires, DF, Argentina; [Casciato, Paola; Gadano, Adrian; Galdame, Omar] Hosp Italiano Buenos Aires, Liver Unit, Buenos Aires, DF, Argentina; [Lezama, Carol; Galoppo, Marcela; Cristina Galoppo, Maria] Univ Buenos Aires, Liver Unit, Hosp Ninos Ricardo Gutierrez, Buenos Aires, DF, Argentina; [Mullen, Eduardo] Hosp Italiano Buenos Aires, Div Pathol, Buenos Aires, DF, Argentina	Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; Hospital Italiano de Buenos Aires; University of Buenos Aires; Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; Hospital Italiano de Buenos Aires; University of Buenos Aires	Valva, P (corresponding author), Hosp Ninos Dr Ricardo Gutierrez, Div Pathol, Mol Biol Lab, Buenos Aires, DF, Argentina.	valvapamela@yahoo.com		Preciado, Maria Victoria/0000-0003-4082-0698	International Society for Infectious Diseases; National Agency for Scientific and Technology Promotion (PICT) [25344]; National Research Council (CONICET) [PIP2010 1392/11]	International Society for Infectious Diseases; National Agency for Scientific and Technology Promotion (PICT); National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was funded by grants from the International Society for Infectious Diseases, the National Agency for Scientific and Technology Promotion (PICT 2004 No25344) National Research Council (CONICET) (PIP2010 1392/11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Afdhal NH, 2004, AM J GASTROENTEROL, V99, P1160, DOI 10.1111/j.1572-0241.2004.30110.x; Ahmad W, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-44; Ahmad W, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-53; Bantel H, 2003, CELL DEATH DIFFER, V10, pS48, DOI 10.1038/sj.cdd.4401119; Bantel H, 2004, HEPATOLOGY, V40, P1078, DOI 10.1002/hep.20411; Bantel H, 2001, HEPATOLOGY, V34, P758, DOI 10.1053/jhep.2001.28229; Bortolami M, 2008, J VIRAL HEPATITIS, V15, P515, DOI 10.1111/j.1365-2893.2008.00974.x; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Canbay A, 2004, HEPATOLOGY, V39, P273, DOI 10.1002/hep.20051; Castera L, 2010, GUT, V59, P861, DOI 10.1136/gut.2010.214650; Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0; Consenso Argentino de Hepatitis C, 2007, DOC FIN CONS ARG HEP; El Bassiouny A.E., 2008, MEDSCAPE J MED, V10, P130; El Sayed Zaki M, 2008, IMMUNOL INVEST, V37, P163, DOI 10.1080/08820130801897352; El-Bassiouni A, 2006, APMIS, V114, P420, DOI 10.1111/j.1600-0463.2006.apm_323.x; El-Shabrawi MH, 2010, EUR J GASTROEN HEPAT, V22, P946, DOI 10.1097/MEG.0b013e328336ec84; Feldstein AE, 2009, HEPATOLOGY, V50, P1072, DOI 10.1002/hep.23050; Fischer R, 2007, WORLD J GASTROENTERO, V13, P4865, DOI 10.3748/wjg.v13.i36.4865; Fitzpatrick E, 2010, J PEDIATR GASTR NUTR, V51, P500, DOI 10.1097/MPG.0b013e3181e376be; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Gebo KA, 2002, HEPATOLOGY, V36, pS161, DOI 10.1053/jhep.2002.36989; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Ghavami S, 2005, MED SCI MONITOR, V11, pRA337; Hermeziu B, 2010, GASTROEN CLIN BIOL, V34, P16, DOI 10.1016/j.gcb.2009.06.007; Joka D, 2012, HEPATOLOGY, V55, P455, DOI 10.1002/hep.24734; Kakiuchi Y, 2004, J GASTROENTEROL, V39, P1189, DOI 10.1007/s00535-004-1470-2; Kanto T, 2006, INTERNAL MED, V45, P183, DOI 10.2169/internalmedicine.45.1530; KERR JFR, 1979, LANCET, V2, P827; Kershenobich D, 2011, LIVER INT, V31, P18, DOI 10.1111/j.1478-3231.2011.02538.x; Kiyici M, 2003, EUR J GASTROEN HEPAT, V15, P1079, DOI 10.1097/00042737-200310000-00003; Lapinski TW, 2004, WORLD J GASTROENTERO, V10, P3650, DOI 10.3748/wjg.v10.i24.3650; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lebensztejn DM, 2011, ACTA BIOCHIM POL, V58, P563; Macias J, 2011, HIV MED, V12, P14, DOI 10.1111/j.1468-1293.2010.00836.x; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Martinez SM, 2011, HEPATOLOGY, V53, P325, DOI 10.1002/hep.24013; Mengshol JA, 2007, NAT CLIN PRACT GASTR, V4, P622, DOI 10.1038/ncpgasthep0961; Mohan N, 2010, J PEDIATR GASTR NUTR, V50, P123, DOI 10.1097/MPG.0b013e3181c61995; Moreno S, 2009, J VIRAL HEPATITIS, V16, P249, DOI 10.1111/j.1365-2893.2009.01088.x; Ozaslan E, 2003, J INT MED RES, V31, P384; Panasiuk A, 2010, LIVER INT, V30, P472, DOI 10.1111/j.1478-3231.2009.02159.x; Papatheodoridis GV, 2010, J CLIN GASTROENTEROL, V44, pE87, DOI 10.1097/MCG.0b013e3181c0945a; PATEL T, 1995, HEPATOLOGY, V21, P1725, DOI 10.1002/hep.1840210635; Poynard T, 2007, ALIMENT PHARM THER, V25, P733, DOI 10.1111/j.1365-2036.2007.03252.x; Poynard T, 2005, GASTROENTEROLOGY, V128, P1146, DOI 10.1053/j.gastro.2005.02.056; Que FG, 1996, GASTROENTEROLOGY, V110, P1238, DOI 10.1053/gast.1996.v110.pm8613014; Raghuraman S, 2005, J CLIN VIROL, V34, P63, DOI 10.1016/j.jcv.2005.01.009; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Rust C, 2000, AM J MED, V108, P567, DOI 10.1016/S0002-9343(00)00370-3; Sebastiani G, 2011, ALIMENT PHARM THER, V34, P1202, DOI 10.1111/j.1365-2036.2011.04861.x; Sebastiani G, 2006, WORLD J GASTROENTERO, V12, P3682, DOI 10.3748/wjg.v12.i23.3682; Seidel N, 2005, HEPATOLOGY, V42, P113, DOI 10.1002/hep.20747; Tamimi TIAR, 2011, J HEPATOL, V54, P1224, DOI 10.1016/j.jhep.2010.08.023; Thampanitchawong P, 1999, WORLD J GASTROENTERO, V5, P301; THEISE N, 2007, MACSWEENS PATHOLOGY, P418; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Toyoda M, 2000, LIVER, V20, P305, DOI 10.1034/j.1600-0676.2000.020004305.x; Valva P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023218; Valva P, 2010, J MED VIROL, V82, P949, DOI 10.1002/jmv.21699; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yilmaz Y, 2007, WORLD J GASTROENTERO, V13, P837, DOI 10.3748/wjg.v13.i6.837; Zekri Abdel-Rahman N, 2011, Comp Hepatol, V10, P4, DOI 10.1186/1476-5926-10-4; Zekri Abdel-Rahman N, 2010, Comp Hepatol, V9, P1, DOI 10.1186/1476-5926-9-1	64	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53519	10.1371/journal.pone.0053519	http://dx.doi.org/10.1371/journal.pone.0053519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326448	Green Published, Green Submitted, gold			2022-12-25	WOS:000314705800051
J	Zheng, ZG; Guan, HX; Leal, F; Grey, PH; Oppenheimer, DG				Zheng, Zhengui; Guan, Hexin; Leal, Francisca; Grey, Paris H.; Oppenheimer, David G.			Mediator Subunit18 Controls Flowering Time and Floral Organ Identity in Arabidopsis	PLOS ONE			English	Article							RNA-POLYMERASE-II; COMPLEX SUBUNIT PFT1; MEDIATOR COMPLEX; LOCUS-C; TRANSCRIPTIONAL REGULATION; GENETIC INTERACTIONS; AUTONOMOUS PATHWAY; BINDING PROTEINS; PLANT MEDIATOR; HOMEOTIC GENES	Mediator is a conserved multi-protein complex that plays an important role in regulating transcription by mediating interactions between transcriptional activator proteins and RNA polymerase II. Much evidence exists that Mediator plays a constitutive role in the transcription of all genes transcribed by RNA polymerase II. However, evidence is mounting that specific Mediator subunits may control the developmental regulation of specific subsets of RNA polymerase II-dependent genes. Although the Mediator complex has been extensively studied in yeast and mammals, only a few reports on Mediator function in flowering time control of plants, little is known about Mediator function in floral organ identity. Here we show that in Arabidopsis thaliana, MEDIATOR SUBUNIT 18 (MED18) affects flowering time and floral organ formation through FLOWERING LOCUS C (FLC) and AGAMOUS (AG). A MED18 loss-of-function mutant showed a remarkable syndrome of later flowering and altered floral organ number. We show that FLC and AG mRNA levels and AG expression patterns are altered in the mutant. Our results support parallels between the regulation of FLC and AG and demonstrate a developmental role for Mediator in plants.	[Zheng, Zhengui; Guan, Hexin; Leal, Francisca; Grey, Paris H.; Oppenheimer, David G.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Zheng, Zhengui] Univ Florida, Dept Mol Genet & Microbiol, Howard Hughes Med Inst, Gainesville, FL USA	State University System of Florida; University of Florida; Howard Hughes Medical Institute; State University System of Florida; University of Florida	Zheng, ZG (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	patrickz@ufl.edu; oppenhe@ufl.edu		Zheng, Zhengui/0000-0003-0997-2976	National Science Foundation [DBI-0115684]; University of Florida	National Science Foundation(National Science Foundation (NSF)); University of Florida(University of Florida)	This work was supported by National Science Foundation grant DBI-0115684 to DGO. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Autran D, 2002, EMBO J, V21, P6036, DOI 10.1093/emboj/cdf614; Backstrom S, 2007, MOL CELL, V26, P717, DOI 10.1016/j.molcel.2007.05.007; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Blazek E, 2005, CHROMOSOMA, V113, P399, DOI 10.1007/s00412-005-0329-5; Boube M, 2002, CELL, V110, P143, DOI 10.1016/S0092-8674(02)00830-9; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; BOWMAN JL, 1991, PLANT CELL, V3, P749, DOI 10.1105/tpc.3.8.749; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; Casamassimi A, 2007, BIOCHIMIE, V89, P1439, DOI 10.1016/j.biochi.2007.08.002; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; Cevik V, 2012, PLANT PHYSIOL, V160, P541, DOI 10.1104/pp.112.202697; Chen R, 2012, PLANT CELL, V24, P2898, DOI 10.1105/tpc.112.098277; Cheng YL, 2003, DEV CELL, V4, P53, DOI 10.1016/S1534-5807(02)00399-4; Chon ML, 1999, PLANT CELL PHYSIOL, V40, P702, DOI 10.1093/oxfordjournals.pcp.a029596; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Dhawan R, 2009, PLANT CELL, V21, P1000, DOI 10.1105/tpc.108.062364; DREWS GN, 1991, CELL, V65, P991, DOI 10.1016/0092-8674(91)90551-9; Elfving N, 2011, P NATL ACAD SCI USA, V108, P8245, DOI 10.1073/pnas.1002981108; Gillmor CS, 2010, DEVELOPMENT, V137, P113, DOI 10.1242/dev.043174; Gonzalez D, 2007, MOL CELL BIOL, V27, P5306, DOI 10.1128/MCB.01912-06; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; Helliwell CA, 2006, PLANT J, V46, P183, DOI 10.1111/j.1365-313X.2006.02686.x; Hong RL, 2003, PLANT CELL, V15, P1296, DOI 10.1105/tpc.009548; Inigo S, 2012, PLANT J, V69, P601, DOI 10.1111/j.1365-313X.2011.04815.x; Ito J, 2011, PLANT CELL PHYSIOL, V52, P539, DOI 10.1093/pcp/pcr013; Ito T, 2004, NATURE, V430, P356, DOI 10.1038/nature02733; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kidd BN, 2009, PLANT CELL, V21, P2237, DOI 10.1105/tpc.109.066910; Kim YJ, 2011, EMBO J, V30, P814, DOI 10.1038/emboj.2011.3; Klose C, 2012, PLANT PHYSIOL, V160, P289, DOI 10.1104/pp.112.197319; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; LEEBENSMACK JH, 2006, DEV GENETICS FLOWER; Lenhard M, 2001, CELL, V105, P805, DOI 10.1016/S0092-8674(01)00390-7; Mathur S, 2011, PLANT PHYSIOL, V157, P1609, DOI 10.1104/pp.111.188300; MEYEROWITZ EM, 1991, DEVELOPMENT, P157; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Mukundan B, 2011, J BIOL CHEM, V286, P37053, DOI 10.1074/jbc.C111.295915; Ni WM, 2004, PLANT PHYSIOL, V134, P1574, DOI 10.1104/pp.103.031971; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Ou B, 2011, MOL PLANT, V4, P546, DOI 10.1093/mp/ssr002; Park SO, 2005, DEVELOPMENT, V132, P841, DOI 10.1242/dev.01654; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Seifert AW, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1020; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Sheldon CC, 2002, PLANT CELL, V14, P2527, DOI 10.1105/tpc.004564; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Simpson GG, 2004, CURR OPIN PLANT BIOL, V7, P570, DOI 10.1016/j.pbi.2004.07.002; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Suzuki E, 2009, P NATL ACAD SCI USA, V106, P3818, DOI 10.1073/pnas.0809819106; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Wathugala DL, 2012, NEW PHYTOL, V195, P217, DOI 10.1111/j.1469-8137.2012.04138.x; Xu R, 2011, DEVELOPMENT, V138, P4545, DOI 10.1242/dev.071423; Yu H, 2004, P NATL ACAD SCI USA, V101, P7827, DOI 10.1073/pnas.0402377101; Yu J, 2002, GENOME RES, V12, P1185, DOI 10.1101/gr.224602; Zhou Y, 2009, DEV BIOL, V331, P50, DOI 10.1016/j.ydbio.2009.04.023	67	39	41	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53924	10.1371/journal.pone.0053924	http://dx.doi.org/10.1371/journal.pone.0053924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326539	Green Published, Green Submitted, gold			2022-12-25	WOS:000314705800088
J	Lyska, D; Engelmann, K; Meierhoff, K; Westhoff, P				Lyska, Dagmar; Engelmann, Kerstin; Meierhoff, Karin; Westhoff, Peter			pAUL: A Gateway-Based Vector System for Adaptive Expression and Flexible Tagging of Proteins in Arabidopsis	PLOS ONE			English	Article							BETA-GLUCURONIDASE; GENE; PURIFICATION; PLANTS; THALIANA; COMPLEX; PROMOTER; IDENTIFICATION; ACCUMULATION; TRANSLATION	Determination of protein function requires tools that allow its detection and/or purification. As generation of specific antibodies often is laborious and insufficient, protein tagging using epitopes that are recognized by commercially available antibodies and matrices appears more promising. Also, proper spatial and temporal expression of tagged proteins is required to prevent falsification of results. We developed a new series of binary Gateway cloning vectors named pAUL1-20 for C- and N-terminal in-frame fusion of proteins to four different tags: a single (i) HA epitope and (ii) Strep-tagIII, (iii) both epitopes combined to a double tag, and (iv) a triple tag consisting of the double tag extended by a Protein A tag possessing a 3C protease cleavage site. Expression can be driven by either the 35 S CaMV promoter or, for C- terminal fusions, promoters from genes encoding the chloroplast biogenesis factors HCF107, HCF136, or HCF173. Fusions of the four promoters to the GUS gene showed that endogenous promoter sequences are functional and drive expression more moderately and consistently throughout different transgenic lines when compared to the 35 S CaMV promoter. By testing complementation of mutations affected in chloroplast biogenesis factors HCF107 and HCF208, we found that the effect of different promoters and tags on protein function strongly depends on the protein itself. Single-step and tandem affinity purification of HCF208 via different tags confirmed the integrity of the cloned tags.	[Lyska, Dagmar; Engelmann, Kerstin; Meierhoff, Karin; Westhoff, Peter] Univ Dusseldorf, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Lyska, D (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	dalyska@lbl.gov			Deutsche Forschungsgemeinschaft (DFG) through Sonderforschungsbereich Transregio TR1	Deutsche Forschungsgemeinschaft (DFG) through Sonderforschungsbereich Transregio TR1	The work described here was supported by the Deutsche Forschungsgemeinschaft (DFG) through Sonderforschungsbereich Transregio TR1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATTRAW MJ, 1990, PLANT MOL BIOL, V15, P527, DOI 10.1007/BF00017828; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Daxinger L, 2008, TRENDS PLANT SCI, V13, P4, DOI 10.1016/j.tplants.2007.10.007; DEPICKER A, 1982, Journal of Molecular and Applied Genetics, V1, P561; Felder S, 2001, PLANT CELL, V13, P2127, DOI 10.1105/tpc.13.9.2127; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Junttila MR, 2005, PROTEOMICS, V5, P1199, DOI 10.1002/pmic.200400991; Karimi M, 2007, PLANT PHYSIOL, V145, P1144, DOI 10.1104/pp.107.106989; KOSUGI S, 1990, PLANT SCI, V70, P133, DOI 10.1016/0168-9452(90)90042-M; Kuras R, 2007, P NATL ACAD SCI USA, V104, P9906, DOI 10.1073/pnas.0702340104; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; Laufs P, 2003, DEVELOPMENT, V130, P785, DOI 10.1242/dev.00295; Lezhneva L, 2008, J BIOL CHEM, V283, P24608, DOI 10.1074/jbc.M803869200; Lyska D, 2007, PLANT CELL PHYSIOL, V48, P1737, DOI 10.1093/pcp/pcm146; Meurer J, 1998, EMBO J, V17, P5286, DOI 10.1093/emboj/17.18.5286; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Pang SZ, 1996, PLANT PHYSIOL, V112, P893, DOI 10.1104/pp.112.3.893; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rohila JS, 2004, PLANT J, V38, P172, DOI 10.1111/j.1365-313X.2004.02031.x; Rubio V, 2005, PLANT J, V41, P767, DOI 10.1111/j.1365-313X.2004.02328.x; Saint-Marcoux D, 2009, J CELL BIOL, V185, P1195, DOI 10.1083/jcb.200812025; Sane AP, 2005, PLANT J, V42, P720, DOI 10.1111/j.1365-313X.2005.02409.x; Sato MH, 1997, BIOTECHNIQUES, V23, P254, DOI 10.2144/97232bm17; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schult K, 2007, PLANT CELL, V19, P1329, DOI 10.1105/tpc.106.042895; Shen Y, 2007, PLANT PHYSIOL, V145, P1043, DOI 10.1104/pp.107.105601; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Stoppel R, 2012, NUCLEIC ACIDS RES, V40, P8593, DOI 10.1093/nar/gks613; van Leeuwen W, 2001, J EXP BOT, V52, P949, DOI 10.1093/jexbot/52.358.949; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xu XL, 2010, PROTEIN EXPRES PURIF, V72, P149, DOI 10.1016/j.pep.2010.04.009; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	37	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53787	10.1371/journal.pone.0053787	http://dx.doi.org/10.1371/journal.pone.0053787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326506	Green Published, Green Submitted, gold			2022-12-25	WOS:000313552400046
J	Janssens, E; Gaublomme, D; De Groef, L; Darras, VM; Arckens, L; Delorme, N; Claes, F; Van Hove, I; Moons, L				Janssens, Els; Gaublomme, Djoere; De Groef, Lies; Darras, Veerle M.; Arckens, Lut; Delorme, Nathalie; Claes, Filip; Van Hove, Inge; Moons, Lieve			Matrix Metalloproteinase 14 in the Zebrafish: An Eye on Retinal and Retinotectal Development	PLOS ONE			English	Article							VISUAL-SYSTEM; CRANIOFACIAL DEVELOPMENT; EMBRYONIC-DEVELOPMENT; VERTEBRATE RETINA; CELL-MIGRATION; HOMEOBOX GENE; OPTIC TECTUM; DANIO-RERIO; EXPRESSION; NEUROGENESIS	Background: Matrix metalloproteinases (MMPs) are members of the metzincin superfamily of proteinases that cleave structural elements of the extracellular matrix and many molecules involved in signal transduction. Although there is evidence that MMPs promote the proper development of retinotectal projections, the nature and working mechanisms of specific MMPs in retinal development remain to be elucidated. Here, we report a role for zebrafish Mmp14a, one of the two zebrafish paralogs of human MMP14, in retinal neurogenesis and retinotectal development. Results: Whole mount in situ hybridization and immunohistochemical stainings for Mmp14a in developing zebrafish embryos reveal expression in the optic tectum, in the optic nerve and in defined retinal cell populations, including retinal ganglion cells (RGCs). Furthermore, Mmp14a loss-of-function results in perturbed retinoblast cell cycle kinetics and consequently, in a delayed retinal neurogenesis, differentiation and lamination. These Mmp14a-dependent retinal defects lead to microphthalmia and a significantly reduced innervation of the optic tectum (OT) by RGC axons. Mmp14b, on the contrary, does not appear to alter retinal neurogenesis or OT innervation. As mammalian MMP14 is known to act as an efficient MMP2-activator, we also explored and found a functional link and a possible co-involvement of Mmp2 and Mmp14a in zebrafish retinotectal development. Conclusion: Both the Mmp14a expression in the developing visual system and the Mmp14a loss-of-function phenotype illustrate a critical role for Mmp14a activity in retinal and retinotectal development.	[Janssens, Els; Gaublomme, Djoere; De Groef, Lies; Delorme, Nathalie; Claes, Filip; Van Hove, Inge; Moons, Lieve] Katholieke Univ Leuven, Dept Biol, Res Grp Neural Circuit Dev & Regenerat, Louvain, Belgium; [Darras, Veerle M.] Katholieke Univ Leuven, Dept Biol, Lab Comparat Endocrinol, Louvain, Belgium; [Arckens, Lut] Katholieke Univ Leuven, Dept Biol, Lab Neuroplast & Neuroprote, Louvain, Belgium	KU Leuven; KU Leuven; KU Leuven	Moons, L (corresponding author), Katholieke Univ Leuven, Dept Biol, Res Grp Neural Circuit Dev & Regenerat, Louvain, Belgium.	lieve.moons@bio.kuleuven.be	Arckens, Lutgarde/C-3822-2016; De Groef, Lies/K-3296-2015	Arckens, Lutgarde/0000-0002-2909-8449; Van Hove, Inge/0000-0002-3125-0438; Moons, Lieve (Godelieve)/0000-0003-0186-1411; De Groef, Lies/0000-0002-3329-3474	National Institutes of Health-National Center for Research Resources [P40 RR012546]; Research Council of KU Leuven [KU Leuven BOF-OT/10/033]; Research Foundation Flanders (FWO) [FWO G.0369.09N]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012546] Funding Source: NIH RePORTER	National Institutes of Health-National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Research Council of KU Leuven(KU Leuven); Research Foundation Flanders (FWO)(FWO); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The antisera were obtained from ZIRC, supported by grant P40 RR012546 from the National Institutes of Health-National Center for Research Resources. This work was supported by national grants from the Research Council of KU Leuven [KU Leuven BOF-OT/10/033] and the Research Foundation Flanders (FWO) [FWO G.0369.09N]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapova OA, 2003, BRAIN RES, V967, P132, DOI 10.1016/S0006-8993(02)04234-8; Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; Ahmed F, 2004, INVEST OPHTH VIS SCI, V45, P1247, DOI 10.1167/iovs.03-1123; AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Avanesov A, 2004, METHODS CELL BIOL, V76, P333; Bai S, 2005, MATRIX BIOL, V24, P247, DOI 10.1016/j.matbio.2005.03.007; Bovolenta P, 1997, J NEUROSCI, V17, P4243; Coyle RC, 2008, EXP CELL RES, V314, P2150, DOI 10.1016/j.yexcr.2008.03.010; Detry B, 2012, BLOOD; Diekmann H, 2009, J COMP NEUROL, V513, P38, DOI 10.1002/cne.21928; Easter SS, 2002, RES PRO CEL, V40, P346; Erickson T, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-22; Gariano RF, 2006, GENE EXPR PATTERNS, V6, P187, DOI 10.1016/j.modgep.2005.06.008; Glass AS, 2004, OPHTHALMIC RES, V36, P4, DOI 10.1159/000076105; Haupt C, 2008, FRONT BIOSCI-LANDMRK, V13, P3136, DOI 10.2741/2915; Hehr CL, 2005, DEVELOPMENT, V132, P3371, DOI 10.1242/dev.01908; Hever AM, 2006, CLIN GENET, V69, P459, DOI 10.1111/j.1399-0004.2006.00619.x; Hillegass JM, 2008, TOXICOL SCI, V102, P413, DOI 10.1093/toxsci/kfn010; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hughes David P., 2011, BMC Ecology, V11, P13, DOI 10.1186/1472-6785-11-13; Huh MI, 2007, J CELL BIOCHEM, V101, P1222, DOI 10.1002/jcb.21246; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Karlstrom RO, 1996, DEVELOPMENT, V123, P427; Kay JN, 2005, DEVELOPMENT, V132, P2573, DOI 10.1242/dev.01831; Keow JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043434; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; LI YB, 1994, MECH DEVELOP, V48, P229, DOI 10.1016/0925-4773(94)90062-0; Liu YH, 2001, INVEST OPHTH VIS SCI, V42, P481; Llano E, 2002, J BIOL CHEM, V277, P23321, DOI 10.1074/jbc.M200121200; Malicki J, 2002, METHODS, V28, P427, DOI 10.1016/S1046-2023(02)00262-1; Martinez-Morales JR, 2005, DEV CELL, V8, P565, DOI 10.1016/j.devcel.2005.01.022; Mosig RA, 2007, HUM MOL GENET, V16, P1113, DOI 10.1093/hmg/ddm060; Nakada C, 2006, MOL CELL BIOL, V26, P7246, DOI 10.1128/MCB.00429-06; Nakayama Y, 2008, DEV BIOL, V313, P752, DOI 10.1016/j.ydbio.2007.11.013; Neumann CJ, 2000, SCIENCE, V289, P2137, DOI 10.1126/science.289.5487.2137; Nevin LM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-126; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Paridaen JTML, 2011, DEV BIOL, V355, P286, DOI 10.1016/j.ydbio.2011.04.028; Renninger SL, 2011, NEUROGENETICS, V12, P97, DOI 10.1007/s10048-011-0273-x; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; Robles E, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00001; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; SCHILLING TF, 1994, DEVELOPMENT, V120, P483; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Serluca FC, 2002, CURR BIOL, V12, P492, DOI 10.1016/S0960-9822(02)00694-2; Sivak JM, 2002, PROG RETIN EYE RES, V21, P1, DOI 10.1016/S1350-9462(01)00015-5; Smine A, 1997, CURR EYE RES, V16, P925, DOI 10.1076/ceyr.16.9.925.5044; Stenkamp DL, 2007, INT REV CYTOL, V259, P173, DOI 10.1016/S0074-7696(06)59005-9; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tucker B, 2008, INVEST OPHTH VIS SCI, V49, P1686, DOI 10.1167/iovs.07-1058; Uribe RA, 2007, CSH PROTOC; Uribe RA, 2010, DEVELOPMENT, V137, P3763, DOI 10.1242/dev.050484; Van Hove I, 2012, MOL NEUROBIOL, V45, P17, DOI 10.1007/s12035-011-8215-z; Vinothkumar S, 2008, DEV BIOL, V314, P200, DOI 10.1016/j.ydbio.2007.11.034; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Walpita CN, 2009, ENDOCRINOLOGY, V150, P530, DOI 10.1210/en.2008-0457; Webber CA, 2002, J NEUROSCI, V22, P8091; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Zhang HQ, 2010, NEUROSCIENTIST, V16, P156, DOI 10.1177/1073858409355830; Zhang JS, 2003, DEV GENES EVOL, V213, P382, DOI 10.1007/s00427-003-0333-9; Zhang JS, 2003, MATRIX BIOL, V22, P279, DOI 10.1016/S0945-053X(03)00020-9; Zhang JS, 2003, DEV GENES EVOL, V213, P456, DOI 10.1007/s00427-003-0346-4; Zhao XPC, 2006, INVEST OPHTH VIS SCI, V47, P4341, DOI 10.1167/iovs.05-1611; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	67	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52915	10.1371/journal.pone.0052915	http://dx.doi.org/10.1371/journal.pone.0052915			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326364	gold, Green Submitted, Green Published			2022-12-25	WOS:000313551500035
J	Zhou, WH; Suntharalingam, K; Brand, NJ; Barton, PJR; Vilar, R; Ying, LM				Zhou, Wenhua; Suntharalingam, Kogularamanan; Brand, Nigel J.; Barton, Paul J. R.; Vilar, Ramon; Ying, Liming			Possible Regulatory Roles of Promoter G-Quadruplexes in Cardiac Function-Related Genes - Human Tnlc as a Model	PLOS ONE			English	Article							TELOMERIC G-QUADRUPLEX; I-MOTIF STRUCTURES; SUSCEPTIBILITY LOCUS IDDM2; POLYMORPHIC REGION ADOPTS; C-MYC; METAL-COMPLEXES; FORMING REGION; DNA-STRUCTURE; GENOME; EXPRESSION	G-quadruplexes (G4s) are four-stranded DNA secondary structures, which are involved in a diverse range of biological processes. Although the anti-cancer potential of G4s in oncogene promoters has been thoroughly investigated, the functions of promoter G4s in non-cancer-related genes are not well understood. We have explored the possible regulatory roles of promoter G4s in cardiac function-related genes using both computational and a wide range of experimental approaches. According to our bioinformatics results, it was found that potential G4-forming sequences are particularly enriched in the transcription regulatory regions (TRRs) of cardiac function-related genes. Subsequently, the promoter of human cardiac troponin I (Tnlc) was chosen as a model, and G4s found in this region were subjected to biophysical characterisations. The chromosome 19 specific minisatellite G4 sequence (MNSG4) and near transcription start site (TSS) G4 sequence (-80 G4) adopt anti-parallel and parallel structures respectively in 100 mM KCl, with stabilities comparable to those of oncogene G4s. It was also found that Tnlc G4s act cooperatively as enhancers in gene expression regulation in HEK293 cells, when stabilised by a synthetic G4-binding ligand. This study provides the first evidence of the biological significance of promoter G4s in cardiac function-related genes. The feasibility of using a single ligand to target multiple G4s in a particular gene has also been discussed.	[Zhou, Wenhua; Ying, Liming] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Suntharalingam, Kogularamanan; Vilar, Ramon] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AY, England; [Brand, Nigel J.; Barton, Paul J. R.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Harefield Heart Sci Ctr, Middlesex, England; [Barton, Paul J. R.] Royal Brompton & Harefield NHS Trust, NIHR Cardiovasc Biomed Res Unit, London, England	Imperial College London; Imperial College London; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital	Ying, LM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	l.ying@imperial.ac.uk	Vilar, Ramon/U-3746-2019; Ying, Liming/G-7999-2011	Vilar, Ramon/0000-0003-2992-199X; Ying, Liming/0000-0001-9752-6292; Barton, Paul/0000-0002-1165-7767	National Heart and Lung Institute Foundation PhD studentship; British Heart Foundation [PG/11/81/29130]; UK's Engineering and Physical Sciences Research Council (EPSRC) [EP/H005285/1]; National Institutes of Health Research (NIHR) Cardiovascular Biomedical Research Unit at the Royal Brompton; Harefield NHS Foundation Trust; Imperial College London; Engineering and Physical Sciences Research Council [EP/H005285/1] Funding Source: researchfish; EPSRC [EP/H005285/1] Funding Source: UKRI	National Heart and Lung Institute Foundation PhD studentship; British Heart Foundation(British Heart Foundation); UK's Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institutes of Health Research (NIHR) Cardiovascular Biomedical Research Unit at the Royal Brompton; Harefield NHS Foundation Trust; Imperial College London(General Electric); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by a National Heart and Lung Institute Foundation PhD studentship (to WZ) and the British Heart Foundation (grant No.PG/11/81/29130). KS and RV thank the UK's Engineering and Physical Sciences Research Council (EPSRC) for funding (grant number: EP/H005285/1). PB is supported by the National Institutes of Health Research (NIHR) Cardiovascular Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; BALAGURUMOORTHY P, 1994, J BIOL CHEM, V269, P21858; Barton PJR, 1999, GENOMICS, V57, P102, DOI 10.1006/geno.1998.5702; Baumann P., 2009, G QUADRUPLEX DNA MET; Bhavsar PK, 1996, GENOMICS, V35, P11, DOI 10.1006/geno.1996.0317; Bhavsar PK, 2000, J MOL CELL CARDIOL, V32, P95, DOI 10.1006/jmcc.1999.1058; BHAVSAR PK, 1991, FEBS LETT, V292, P5, DOI 10.1016/0014-5793(91)80820-S; Brooks Tracy A, 2010, Genes Cancer, V1, P641; Bryan TM, 2011, MOL BIOTECHNOL, V49, P198, DOI 10.1007/s12033-011-9395-5; Chaires JB, 2010, FEBS J, V277, P1098, DOI 10.1111/j.1742-4658.2009.07462.x; Cogoi S, 2008, NUCLEIC ACIDS RES, V36, P3765, DOI 10.1093/nar/gkn120; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Dai JX, 2006, NUCLEIC ACIDS RES, V34, P5133, DOI 10.1093/nar/gkl610; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; Dapic V, 2003, NUCLEIC ACIDS RES, V31, P2097, DOI 10.1093/nar/gkg316; DAS HK, 1987, J BIOL CHEM, V262, P4787; De Armond R, 2005, BIOCHEMISTRY-US, V44, P16341, DOI 10.1021/bi051618u; Dexheimer TS, 2006, J AM CHEM SOC, V128, P5404, DOI 10.1021/ja0563861; Dixon IM, 2007, J AM CHEM SOC, V129, P1502, DOI 10.1021/ja065591t; DROGE P, 1994, BIOESSAYS, V16, P91, DOI 10.1002/bies.950160205; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; Du Z, 2008, GENOME RES, V18, P233, DOI 10.1101/gr.6905408; Du Z, 2007, BIOCHEM BIOPH RES CO, V354, P1067, DOI 10.1016/j.bbrc.2007.01.093; Du Z, 2009, NUCLEIC ACIDS RES, V37, P6784, DOI 10.1093/nar/gkp710; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Fegan A, 2010, CHEM COMMUN, V46, P946, DOI 10.1039/b920680a; Fernando H, 2006, BIOCHEMISTRY-US, V45, P7854, DOI 10.1021/bi0601510; Gallo P, 2008, GENE THER, V15, P161, DOI 10.1038/sj.gt.3303017; Georgiades SN, 2010, ANGEW CHEM INT EDIT, V49, P4020, DOI 10.1002/anie.200906363; Gomez D, 2004, NUCLEIC ACIDS RES, V32, P371, DOI 10.1093/nar/gkh181; Gomez D, 2002, CANCER RES, V62, P3365; Gonzalez V, 2009, J BIOL CHEM, V284, P23622, DOI 10.1074/jbc.M109.018028; Grand CL, 2002, MOL CANCER THER, V1, P565; Green JJ, 2003, J AM CHEM SOC, V125, P3763, DOI 10.1021/ja029149w; Gunaratnam M, 2009, J MED CHEM, V52, P3774, DOI 10.1021/jm900424a; Guo K, 2007, J AM CHEM SOC, V129, P10220, DOI 10.1021/ja072185g; HAMMONDKOSACK MCU, 1993, J MOL ENDOCRINOL, V10, P121, DOI 10.1677/jme.0.0100121; HAMMONDKOSACK MCU, 1992, FEBS LETT, V301, P79, DOI 10.1016/0014-5793(92)80214-2; HAMMONDKOSACK MCU, 1992, NUCLEIC ACIDS RES, V20, P231, DOI 10.1093/nar/20.2.231; HENDERSON E, 1987, CELL, V51, P899, DOI 10.1016/0092-8674(87)90577-0; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; Hsu STD, 2009, J AM CHEM SOC, V131, P13399, DOI 10.1021/ja904007p; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Huppert JL, 2008, NUCLEIC ACIDS RES, V36, P6260, DOI 10.1093/nar/gkn511; KENNEDY GC, 1995, NAT GENET, V9, P293, DOI 10.1038/ng0395-293; Kojima T, 2001, BIOCHEM BIOPH RES CO, V284, P1039, DOI 10.1006/bbrc.2001.5080; Kumar N, 2004, BIOCHEM BIOPH RES CO, V319, P759, DOI 10.1016/j.bbrc.2004.05.052; Kumar N, 2008, NUCLEIC ACIDS RES, V36, P5610, DOI 10.1093/nar/gkn543; Kumar P, 2011, NUCLEIC ACIDS RES, V39, P8005, DOI 10.1093/nar/gkr536; Kuryavyi V, 2010, NUCLEIC ACIDS RES, V38, P6757, DOI 10.1093/nar/gkq558; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Lee JY, 2005, P NATL ACAD SCI USA, V102, P18938, DOI 10.1073/pnas.0506144102; Leem SH, 2004, GENOME RES, V14, P239, DOI 10.1101/gr.1929904; Lew A, 2000, P NATL ACAD SCI USA, V97, P12508, DOI 10.1073/pnas.97.23.12508; Li W, 2002, FEBS LETT, V526, P77, DOI 10.1016/S0014-5793(02)03118-6; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; MCCARTHY JG, 1987, NUCLEIC ACIDS RES, V15, P8069, DOI 10.1093/nar/15.19.8069; Mergny JL, 1998, FEBS LETT, V435, P74, DOI 10.1016/S0014-5793(98)01043-6; Michelotti GA, 1996, MOL CELL BIOL, V16, P2656, DOI 10.1128/mcb.16.6.2656; Monchaud D, 2008, ORG BIOMOL CHEM, V6, P627, DOI 10.1039/b714772b; MURCHIE AIH, 1992, NUCLEIC ACIDS RES, V20, P49, DOI 10.1093/nar/20.1.49; Neidle S, 2010, FEBS J, V277, P1118, DOI 10.1111/j.1742-4658.2009.07463.x; PADMANABHAN K, 1993, J BIOL CHEM, V268, P17651; Park GH, 1998, BLOOD, V92, P4138, DOI 10.1182/blood.V92.11.4138.423k44_4138_4149; Phan AT, 2007, J AM CHEM SOC, V129, P4386, DOI 10.1021/ja068739h; Phan AT, 2002, NUCLEIC ACIDS RES, V30, P4618, DOI 10.1093/nar/gkf597; Qin Y, 2008, BIOCHIMIE, V90, P1149, DOI 10.1016/j.biochi.2008.02.020; Qin Y, 2007, NUCLEIC ACIDS RES, V35, P7698, DOI 10.1093/nar/gkm538; RAGHURAMAN MK, 1990, NUCLEIC ACIDS RES, V18, P4543, DOI 10.1093/nar/18.15.4543; Rawal P, 2006, GENOME RES, V16, P644, DOI 10.1101/gr.4508806; Riou JF, 2002, P NATL ACAD SCI USA, V99, P2672, DOI 10.1073/pnas.052698099; Risebro CA, 2006, DEVELOPMENT, V133, P4595, DOI 10.1242/dev.02625; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; Shklover J, 2010, NUCLEIC ACIDS RES, V38, P2369, DOI 10.1093/nar/gkp1208; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Sun D, 2008, MOL CANCER THER, V7, P880, DOI 10.1158/1535-7163.MCT-07-2119; Sun DK, 2011, NUCLEIC ACIDS RES, V39, P1256, DOI 10.1093/nar/gkq926; Sun D, 2010, METHODS MOL BIOL, V613, P223, DOI 10.1007/978-1-60327-418-0_14; Sun D, 2009, J MED CHEM, V52, P2863, DOI 10.1021/jm900055s; Sun DY, 2005, NUCLEIC ACIDS RES, V33, P6070, DOI 10.1093/nar/gki917; Suntharalingam K, 2010, INORG CHEM, V49, P8371, DOI 10.1021/ic100884p; Suntharalingam K, 2009, INORG CHEM, V48, P9427, DOI 10.1021/ic901319n; Thygesen K, 2007, EUR HEART J, V28, P2525; Todd AK, 2008, NUCLEIC ACIDS RES, V36, P2700, DOI 10.1093/nar/gkn078; Todd AK, 2007, NUCLEIC ACIDS RES, V35, P5799, DOI 10.1093/nar/gkm609; Verma A, 2008, J MED CHEM, V51, P5641, DOI 10.1021/jm800448a; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Xu Y, 2006, NUCLEIC ACIDS RES, V34, P949, DOI 10.1093/nar/gkj485; Xu Yan, 2005, Nucleic Acids Symp Ser (Oxf), P177, DOI 10.1093/nass/49.1.177; Ying LM, 2003, P NATL ACAD SCI USA, V100, P14629, DOI 10.1073/pnas.2433350100; Zhao YQ, 2007, FEBS LETT, V581, P1951, DOI 10.1016/j.febslet.2007.04.017; Zhou WH, 2011, J CARDIOVASC TRANSL, V4, P256, DOI 10.1007/s12265-011-9258-2	95	8	8	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53137	10.1371/journal.pone.0053137	http://dx.doi.org/10.1371/journal.pone.0053137			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326389	gold, Green Published, Green Submitted			2022-12-25	WOS:000313551500051
J	Khan, M; Rozhon, W; Bigeard, J; Pflieger, D; Husar, S; Pitzschke, A; Teige, M; Jonak, C; Hirt, H; Poppenberger, B				Khan, Mamoona; Rozhon, Wilfried; Bigeard, Jean; Pflieger, Delphine; Husar, Sigrid; Pitzschke, Andrea; Teige, Markus; Jonak, Claudia; Hirt, Heribert; Poppenberger, Brigitte			Brassinosteroid-regulated GSK3/Shaggy-like Kinases Phosphorylate Mitogen-activated Protein (MAP) Kinase Kinases, Which Control Stomata Development in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL FATE; SIGNAL-TRANSDUCTION; PLANT-GROWTH; GSK3; PATHWAY; PATTERN; TRANSFORMATION; BIOSYNTHESIS; ELONGATION; SPEECHLESS	Brassinosteroids (BRs) are steroid hormones that coordinate fundamental developmental programs in plants. In this study we show that in addition to the well established roles of BRs in regulating cell elongation and cell division events, BRs also govern cell fate decisions during stomata development in Arabidopsis thaliana. In wild-type A. thaliana, stomatal distribution follows the one-cell spacing rule; that is, adjacent stomata are spaced by at least one intervening pavement cell. This rule is interrupted in BR-deficient and BR signaling-deficient A. thaliana mutants, resulting in clustered stomata. We demonstrate that BIN2 and its homologues, GSK3/Shaggy-like kinases involved in BR signaling, can phosphorylate the MAPK kinases MKK4 and MKK5, which are members of the MAPK module YODA-MKK4/5-MPK3/6 that controls stomata development and patterning. BIN2 phosphorylates a GSK3/Shaggy-like kinase recognition motif in MKK4, which reduces MKK4 activity against its substrate MPK6 in vitro. In vivo we show that MKK4 and MKK5 act downstream of BR signaling because their overexpression rescued stomata patterning defects in BR-deficient plants. A model is proposed in which GSK3-mediated phosphorylation of MKK4 and MKK5 enables for a dynamic integration of endogenous or environmental cues signaled by BRs into cell fate decisions governed by the YODA-MKK4/5-MPK3/6 module.	[Khan, Mamoona; Rozhon, Wilfried; Poppenberger, Brigitte] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Inst Biotechnol Hort Crops, D-85354 Freising Weihenstephan, Germany; [Khan, Mamoona; Rozhon, Wilfried; Husar, Sigrid; Poppenberger, Brigitte] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Bigeard, Jean; Poppenberger, Brigitte] Unite Rech Genom Vegetale Plant Genom 2, F-91057 Evry, France; [Pflieger, Delphine] Univ Evry, CNRS, Lab Anal & Modelisat Biol & Environm, F-91025 Evry, France; [Pitzschke, Andrea] Univ Nat Resources & Appl Life Sci, Dept Appl Genet & Cell Biol, A-1190 Vienna, Austria; [Teige, Markus] Univ Vienna, Dept Mol Syst Biol, A-1090 Vienna, Austria; [Jonak, Claudia] Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, A-1030 Vienna, Austria; [Hirt, Heribert] King Saud Univ, Coll Sci, Riyadh 11451, Saudi Arabia	Technical University of Munich; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); UDICE-French Research Universities; Universite Paris Saclay; CEA; CY Cergy Paris Universite; Centre National de la Recherche Scientifique (CNRS); University of Natural Resources & Life Sciences, Vienna; University of Vienna; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); King Saud University	Poppenberger, B (corresponding author), Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Liesel Beckmann Str 1, D-85354 Freising Weihenstephan, Germany.	brigitte.poppenberger@wzw.tum.de	Jonak, Claudia/G-1362-2016; Rozhon, Wilfried/AFK-4445-2022; Teige, Markus/R-6443-2016; Rozhon, Wilfried/AAG-3162-2022; Pflieger, Delphine/ABD-1496-2021	Rozhon, Wilfried/0000-0003-0659-0593; Teige, Markus/0000-0001-7204-1379; Rozhon, Wilfried/0000-0003-0659-0593; Pitzschke, Andrea/0000-0002-3451-1429; Jonak, Claudia/0000-0001-9605-6751; Khan, Mamoona/0000-0003-3301-9536	Austrian Science Fund FWF [P19948, P22734]; Higher Education Commission of Pakistan; Hertha-Firnberg fellowship of the FWF; Austrian Science Fund (FWF) [P 25359, P 23435, P 22734] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Hertha-Firnberg fellowship of the FWF; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Fund FWF (Projects P19948 and P22734) and by a Ph.D. fellowship of the Higher Education Commission of Pakistan (to M. K.) and a Hertha-Firnberg fellowship of the FWF (to B. P.).	Albrecht C, 2012, P NATL ACAD SCI USA, V109, P303, DOI 10.1073/pnas.1109921108; Altmann T, 1998, CURR OPIN PLANT BIOL, V1, P378, DOI 10.1016/S1369-5266(98)80259-8; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; Azpiroz R, 1998, PLANT CELL, V10, P219, DOI 10.1105/tpc.10.2.219; Belkhadir Y, 2012, P NATL ACAD SCI USA, V109, P297, DOI 10.1073/pnas.1112840108; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Bergmann DC, 2004, CURR OPIN PLANT BIOL, V7, P26, DOI 10.1016/j.pbi.2003.10.001; Bergmann D, 2006, CURR OPIN PLANT BIOL, V9, P478, DOI 10.1016/j.pbi.2006.07.001; Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023; Cardinale F, 2002, PLANT CELL, V14, P703, DOI 10.1105/tpc.010256; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Costa S, 2006, NATURE, V439, P493, DOI 10.1038/nature04269; Dal Santo S, 2012, PLANT CELL, V24, P3380, DOI 10.1105/tpc.112.101279; De Rybel B, 2009, CHEM BIOL, V16, P594, DOI 10.1016/j.chembiol.2009.04.008; Dong JA, 2010, CURR TOP DEV BIOL, V91, P267, DOI 10.1016/S0070-2153(10)91009-0; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fukuda H, 1997, CELL DEATH DIFFER, V4, P684, DOI 10.1038/sj.cdd.4400310; Geisler M, 2000, PLANT CELL, V12, P2075, DOI 10.1105/tpc.12.11.2075; Gonzalez-Garcia MP, 2011, DEVELOPMENT, V138, P849, DOI 10.1242/dev.057331; GROVE MD, 1979, NATURE, V281, P216, DOI 10.1038/281216a0; Gudesblat GE, 2012, NAT CELL BIOL, V14, P548, DOI 10.1038/ncb2471; Hacham Y, 2011, DEVELOPMENT, V138, P839, DOI 10.1242/dev.061804; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hu YX, 2000, PLANT J, V24, P693, DOI 10.1046/j.1365-313x.2000.00915.x; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; IWASAKI T, 1991, PLANT CELL PHYSIOL, V32, P1007, DOI 10.1093/oxfordjournals.pcp.a078163; Jaillais Y, 2010, NAT STRUCT MOL BIOL, V17, P642, DOI 10.1038/nsmb0610-642; Kim TW, 2012, NATURE, V482, P419, DOI 10.1038/nature10794; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Kuppusamy KT, 2009, P NATL ACAD SCI USA, V106, DOI 10.1073/pnas.0811633106; Lampard GR, 2008, SCIENCE, V322, P1113, DOI 10.1126/science.1162263; Lampard GR, 2009, PLANT CELL, V21, P3506, DOI 10.1105/tpc.109.070110; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 2001, PLANT PHYSIOL, V127, P14, DOI 10.1104/pp.127.1.14; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Nadeau JA, 2003, TRENDS PLANT SCI, V8, P294, DOI 10.1016/S1360-1385(03)00102-X; Nakaya M, 2002, PLANT CELL PHYSIOL, V43, P239, DOI 10.1093/pcp/pcf024; Poppenberger B, 2011, EMBO J, V30, P1149, DOI 10.1038/emboj.2011.35; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Rozhon W, 2010, PLANT J, V62, P215, DOI 10.1111/j.1365-313X.2010.04145.x; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wang ZY, 2012, P NATL ACAD SCI USA, V109, P7, DOI 10.1073/pnas.1118600109; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111	55	115	126	0	81	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7519	7527		10.1074/jbc.M112.384453	http://dx.doi.org/10.1074/jbc.M112.384453			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23341468	hybrid, Green Published			2022-12-25	WOS:000316455300008
J	Sahoo, SK; Shaikh, SA; Sopariwala, DH; Bal, NC; Periasamy, M				Sahoo, Sanjaya K.; Shaikh, Sana A.; Sopariwala, Danesh H.; Bal, Naresh C.; Periasamy, Muthu			Sarcolipin Protein Interaction with Sarco(endo) plasmic Reticulum Ca2+ ATPase (SERCA) Is Distinct from Phospholamban Protein, and Only Sarcolipin Can Promote Uncoupling of the SERCA Pump	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; CALCIUM-PUMP; FUNCTIONAL CONSEQUENCES; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE HELIX; HEAT-PRODUCTION; CROSS-LINKING; CA2+-ATPASE; TRANSPORT	Sarco(endo) plasmic reticulum Ca2+ ATPase (SERCA) pump activity is modulated by phospholamban (PLB) and sarcolipin (SLN) in cardiac and skeletal muscle. Recent data suggest that SLN could play a role in muscle thermogenesis by promoting uncoupling of the SERCA pump( Lee, A. G.(2002) Curr. Opin. Struct. Biol. 12, 547-554 and Bal, N. C., Maurya, S. K., Sopariwala, D. H., Sahoo, S. K., Gupta, S. C., Shaikh, S. A., Pant, M., Rowland, L. A., Bombardier, E., Goonasekera, S. A., Tupling, A. R., Molkentin, J. D., and Periasamy, M.(2012) Nat. Med. 18, 1575-1579), but the mechanistic details are unknown. To better define how binding of SLN to SERCA promotes uncoupling of SERCA, we compared SLN and SERCA1 interaction with that of PLB in detail. The homo-bifunctional cross-linker (1,6-bismaleimidohexane) was employed to detect dynamic protein interaction during the SERCA cycle. Our studies reveal that SLN differs significantly from PLB: 1) SLN primarily affects the V-max of SERCA-mediated Ca2+ uptake but not the pump affinity for Ca2+; 2) SLN can bind to SERCA in the presence of high Ca2+, but PLB can only interact to the ATP-bound Ca2+ -free E2 state; and 3) unlike PLB, SLN interacts with SERCA throughout the kinetic cycle and promotes uncoupling of the SERCA pump. Using SERCA transmembrane mutants, we additionally show that PLB and SLN can bind to the same groove but interact with a different set of residues on SERCA. These data collectively suggest that SLN is functionally distinct from PLB;its ability to interact with SERCA in the presence of Ca2+ causes uncoupling of the SERCA pump and increased heat production.	[Sahoo, Sanjaya K.; Shaikh, Sana A.; Sopariwala, Danesh H.; Bal, Naresh C.] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Periasamy, Muthu] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Periasamy, M (corresponding author), 304 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	periasamy.1@osu.edu	Bal, Naresh/E-9377-2011	Periasamy, Muthu/0000-0001-8834-5975	National Institutes of Health [R01 HL080551]; American Heart Association [10POST3360007]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL080551 (to M. P.). Supported by a postdoctoral fellowship from the American Heart Association (10POST3360007).	Akin BL, 2010, J BIOL CHEM, V285, P28540, DOI 10.1074/jbc.M110.151779; ANDERSEN JP, 1995, J BIOL CHEM, V270, P908, DOI 10.1074/jbc.270.2.908; ANDERSEN JP, 1992, J BIOL CHEM, V267, P19383; Asahi M, 1999, J BIOL CHEM, V274, P32855, DOI 10.1074/jbc.274.46.32855; Asahi M, 2000, J BIOL CHEM, V275, P15034, DOI 10.1074/jbc.275.20.15034; Asahi M, 2004, P NATL ACAD SCI USA, V101, P9199, DOI 10.1073/pnas.0402596101; Asahi M, 2003, TRENDS CARDIOVAS MED, V13, P152, DOI 10.1016/S1050-1738(03)00037-9; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Asahi M, 2002, J BIOL CHEM, V277, P26725, DOI 10.1074/jbc.C200269200; Autry JM, 2011, J BIOL CHEM, V286, P31697, DOI 10.1074/jbc.M111.246843; Babu GJ, 2007, P NATL ACAD SCI USA, V104, P17867, DOI 10.1073/pnas.0707722104; Babu GJ, 2007, J MOL CELL CARDIOL, V43, P215, DOI 10.1016/j.yjmcc.2007.05.009; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bhupathy P, 2007, J MOL CELL CARDIOL, V42, P903, DOI 10.1016/j.yjmcc.2007.03.738; Buffy JJ, 2006, J MOL BIOL, V358, P420, DOI 10.1016/j.jmb.2006.02.005; Butler J, 2007, CARDIOVASC RES, V74, P114, DOI 10.1016/j.cardiores.2007.01.006; Chen ZH, 2003, J BIOL CHEM, V278, P48348, DOI 10.1074/jbc.M309545200; Chen ZH, 2006, J BIOL CHEM, V281, P14163, DOI 10.1074/jbc.M601338200; Chen ZH, 2010, J BIOL CHEM, V285, P3253, DOI 10.1074/jbc.M109.080820; Chu GX, 2000, J BIOL CHEM, V275, P38938, DOI 10.1074/jbc.M004079200; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Gramolini AO, 2004, P NATL ACAD SCI USA, V101, P16807, DOI 10.1073/pnas.0407815101; Hughes E, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M611668200; Hughes G, 1996, BIOCHEM J, V318, P973, DOI 10.1042/bj3180973; INESI G, 1980, J BIOL CHEM, V255, P3025; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; Inesi G, 2006, BIOCHEMISTRY-US, V45, P13769, DOI 10.1021/bi061255d; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; Ji Y, 1999, ANAL BIOCHEM, V269, P236, DOI 10.1006/abio.1999.4059; Jones LR, 2002, J BIOL CHEM, V277, P28319, DOI 10.1074/jbc.M204085200; Lee AG, 2002, CURR OPIN STRUC BIOL, V12, P547, DOI 10.1016/S0959-440X(02)00360-3; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; MacLennan DH, 2003, ANN NY ACAD SCI, V986, P472, DOI 10.1111/j.1749-6632.2003.tb07231.x; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Mall S, 2006, J BIOL CHEM, V281, P36597, DOI 10.1074/jbc.M606869200; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Morita T, 2008, BIOCHEM BIOPH RES CO, V369, P188, DOI 10.1016/j.bbrc.2007.11.098; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; Periasamy M, 2008, CARDIOVASC RES, V77, P265, DOI 10.1093/cvr/cvm056; Reddy LG, 1999, J BIOL CHEM, V274, P7649, DOI 10.1074/jbc.274.12.7649; Reis M, 2001, J BIOL CHEM, V276, P42793, DOI 10.1074/jbc.M107625200; SAGARA Y, 1992, J BIOL CHEM, V267, P12606; SCARPA A, 1972, J GEN PHYSIOL, V60, P735, DOI 10.1085/jgp.60.6.735; Smith WS, 2002, BIOCHEM J, V361, P277, DOI 10.1042/0264-6021:3610277; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Traaseth NJ, 2008, BIOCHEMISTRY-US, V47, P3, DOI 10.1021/bi701668v; Tupling AR, 2011, AM J PHYSIOL-CELL PH, V301, pC841, DOI 10.1152/ajpcell.00409.2010; Tupling AR, 2002, J BIOL CHEM, V277, P44740, DOI 10.1074/jbc.M206171200; Vangheluwe P, 2005, BIOCHEM J, V389, P151, DOI 10.1042/BJ20050068; Xu C, 2004, J BIOL CHEM, V279, P17973, DOI 10.1074/jbc.M313263200	55	74	75	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6881	6889		10.1074/jbc.M112.436915	http://dx.doi.org/10.1074/jbc.M112.436915			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23341466	Green Published, hybrid			2022-12-25	WOS:000316002400009
J	Tate, CM; Blosser, W; Wyss, L; Evans, G; Xue, Q; Pan, Y; Stancato, L				Tate, Courtney M.; Blosser, Wayne; Wyss, Lisa; Evans, Glenn; Xue, Qi; Pan, Yong; Stancato, Louis			LY2228820 Dimesylate, a Selective Inhibitor of p38 Mitogen-activated Protein Kinase, Reduces Angiogenic Endothelial Cord Formation in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC CARDIOVASCULAR DEVELOPMENT; GROWTH-FACTOR; MAP KINASE; CELL-MIGRATION; PROLIFERATION; PATHWAY; P38-ALPHA; EXPRESSION; SURVIVAL; VEGF	LY2228820 dimesylate is a highly selective small molecule inhibitor of p38 alpha and p38 beta mitogen-activated protein kinases (MAPKs) that is currently under clinical investigation for human malignancies. p38 MAPK is implicated in a wide range of biological processes, in particular those that support tumorigenesis. One such process, angiogenesis, is required for tumor growth and metastasis, and many new cancer therapies are therefore directed against the tumor vasculature. Using an in vitro co-culture endothelial cord formation assay, a surrogate of angiogenesis, we investigated the role of p38 MAPK in growth factor-and tumor-driven angiogenesis using LY2228820 dimesylate treatment and by shRNA gene knockdown. p38 MAPK was activated in endothelial cells upon growth factor stimulation, with inhibition by LY2228820 dimesylate treatment causing a significant decrease in VEGF-, bFGF-, EGF-, and IL-6-induced endothelial cord formation and an even more dramatic decrease in tumor-driven cord formation. In addition to involvement in downstream cytokine signaling, p38 MAPK was important for VEGF, bFGF, EGF, IL-6, and other proangiogenic cytokine secretion in stromal and tumor cells. LY2228820 dimesylate results were substantiated using p38 alpha MAPK-specific shRNA and shRNA against the downstream p38 MAPK effectors MAPKAPK-2 and HSP27. Using in vivo models of functional neoangiogenesis, LY2228820 dimesylate treatment reduced hemoglobin content in a plug assay and decreased VEGF-A-stimulated vascularization in a mouse ear model. Thus, p38 alpha MAPK is implicated in tumor angiogenesis through direct tumoral effects and through reduction of proangiogenic cytokine secretion via the microenvironment.	[Tate, Courtney M.; Blosser, Wayne; Evans, Glenn; Stancato, Louis] Eli Lilly & Co, Lilly Corp Ctr, Oncol, Indianapolis, IN 46285 USA; [Wyss, Lisa] Discovery Res, Adv Testing Lab, Cincinnati, OH 45242 USA; [Xue, Qi; Pan, Yong] ImClone Syst, New York, NY 10016 USA	Eli Lilly; Eli Lilly	Stancato, L (corresponding author), Eli Lilly & Co, Lilly Corp Ctr, Oncol Res, Indianapolis, IN 46285 USA.	stancato_louis@lilly.com		Stancato, Louis/0000-0002-6242-5771				Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; Ennis BW, 2005, J PHARMACOL EXP THER, V313, P325, DOI 10.1124/jpet.104.078873; Evans IM, 2008, CELL SIGNAL, V20, P1375, DOI 10.1016/j.cellsig.2008.03.002; Fan F, 2012, J ONCOL, V2012, DOI 10.1155/2012/281261; Folkman J, 1997, EXS, V79, P1; Gee E, 2010, J CELL PHYSIOL, V222, P120, DOI 10.1002/jcp.21924; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; Hirschi K K, 1997, EXS, V79, P419; Hirschi KK, 1999, CIRC RES, V84, P298, DOI 10.1161/01.RES.84.3.298; HORAK ER, 1992, LANCET, V340, P1120, DOI 10.1016/0140-6736(92)93150-L; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Ishitsuka K, 2008, BRIT J HAEMATOL, V141, P598, DOI 10.1111/j.1365-2141.2008.07044.x; Jackson JR, 1998, J PHARMACOL EXP THER, V284, P687; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; McMullen M, 2004, ONCOGENE, V23, P1275, DOI 10.1038/sj.onc.1207243; McMullen ME, 2005, J BIOL CHEM, V280, P20995, DOI 10.1074/jbc.M407060200; Meier T, 2011, MOL CANCER THER, V10, P2168, DOI 10.1158/1535-7163.MCT-11-0323; Merfeld-Clauss S, 2010, TISSUE ENG PT A, V16, P2953, DOI [10.1089/ten.tea.2009.0635, 10.1089/ten.TEA.2009.0635]; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; NICOSIA RF, 1995, LAB INVEST, V73, P658; Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013; Prasain N, 2012, JOVE-J VIS EXP, DOI 10.3791/3872; Rajashekhar G, 2011, J CELL PHYSIOL, V226, P800, DOI 10.1002/jcp.22404; Reinmuth N, 2001, FASEB J, V15, P1239, DOI 10.1096/fj.00-0693fje; Rocic P, 2007, AM J PHYSIOL-HEART C, V292, pH2729, DOI 10.1152/ajpheart.01330.2006; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Sodhi A, 2000, CANCER RES, V60, P4873; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Tanaka K, 1999, JPN J CANCER RES, V90, P647, DOI 10.1111/j.1349-7006.1999.tb00796.x; Tenhunen O, 2006, FASEB J, V20, P1907, DOI 10.1096/fj.05-5618fje; Thuraisingam T, 2010, J INVEST DERMATOL, V130, P278, DOI 10.1038/jid.2009.209; Traktuev DO, 2009, CIRC RES, V104, P1410, DOI 10.1161/CIRCRESAHA.108.190926; Ventura J., 2007, NAT GENET, V128, P295; Xue Q, 2009, ARTERIOSCL THROM VAS, V29, P1172, DOI 10.1161/ATVBAHA.109.185918; Yang JH, 2000, NAT GENET, V24, P309, DOI 10.1038/73550; Yang SY, 2001, ARTERIOSCL THROM VAS, V21, P1934, DOI 10.1161/hq1201.099432; Ye J, 2007, BIOSCI BIOTECH BIOCH, V71, P1162, DOI 10.1271/bbb.60617; Yoshino Y, 2006, INT J ONCOL, V29, P981; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhu WH, 2003, J VASC RES, V40, P140, DOI 10.1159/000070711	50	37	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6743	6753		10.1074/jbc.M112.425553	http://dx.doi.org/10.1074/jbc.M112.425553			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23335506	Green Published, hybrid			2022-12-25	WOS:000315820700071
J	Branco, R; Cristovao, A; Morais, PV				Branco, Rita; Cristovao, Armando; Morais, Paula V.			Highly Sensitive, Highly Specific Whole-Cell Bioreporters for the Detection of Chromate in Environmental Samples	PLOS ONE			English	Article							HEAVY-METAL BIOAVAILABILITY; ALCALIGENES-EUTROPHUS; BACTERIAL BIOSENSORS; RESISTANCE; CHROMIUM; STRAIN; SENSORS; GFP; TOXICITY; CADMIUM	Microbial bioreporters offer excellent potentialities for the detection of the bioavailable portion of pollutants in contaminated environments, which currently cannot be easily measured. This paper describes the construction and evaluation of two microbial bioreporters designed to detect the bioavailable chromate in contaminated water samples. The developed bioreporters are based on the expression of gfp under the control of the chr promoter and the chrB regulator gene of TnOtChr determinant from Ochrobactrum tritici 5bvl1. pCHRGFP1 Escherichia coli reporter proved to be specific and sensitive, with minimum detectable concentration of 100 nM chromate and did not react with other heavy metals or chemical compounds analysed. In order to have a bioreporter able to be used under different environmental toxics, O. tritici type strain was also engineered to fluoresce in the presence of micromolar levels of chromate and showed to be as specific as the first reporter. Their applicability on environmental samples (spiked Portuguese river water) was also demonstrated using either freshly grown or cryo-preserved cells, a treatment which constitutes an operational advantage. These reporter strains can provide on-demand usability in the field and in a near future may become a powerful tool in identification of chromate-contaminated sites.	[Branco, Rita; Morais, Paula V.] IMAR, P-3004517 Coimbra, Portugal; [Branco, Rita] Escola Univ Vasco da Gama, Coimbra, Portugal; [Cristovao, Armando] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3000 Coimbra, Portugal; [Cristovao, Armando; Morais, Paula V.] Univ Coimbra, FCTUC, Dept Life Sci, P-3000 Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	Morais, PV (corresponding author), IMAR, P-3004517 Coimbra, Portugal.	pvmorais@ci.uc.pt	Cristóvão, Armando J/N-2612-2013; Branco, Rita/AAQ-4007-2021; Morais, Paula Vasconcelos/C-9756-2014	Cristóvão, Armando J/0000-0002-4090-3269; Branco, Rita/0000-0003-0291-8029; Morais, Paula Vasconcelos/0000-0002-1939-6389	Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/MAR/109057/2008]; FCT [SFRH/BPD/48330/2008]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by Fundacao para a Ciencia e Tecnologia (FCT) under the PTDC/MAR/109057/2008 project. Rita Branco was supported by a grant, SFRH/BPD/48330/2008, from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branco R, 2004, CAN J MICROBIOL, V50, P697, DOI [10.1139/w04-048, 10.1139/W04-048]; Branco R, 2008, J BACTERIOL, V190, P6996, DOI 10.1128/JB.00289-08; Cervantes C, 2001, FEMS MICROBIOL REV, V25, P335, DOI 10.1111/j.1574-6976.2001.tb00581.x; Corbisier P, 1999, ANAL CHIM ACTA, V387, P235, DOI 10.1016/S0003-2670(98)00725-9; E.C, 1998, OFFIC J EUR COMMUN L, VL330; Hakkila K, 2002, ANAL BIOCHEM, V301, P235, DOI 10.1006/abio.2001.5517; Hansen LH, 2001, MICROBIAL ECOL, V42, P483, DOI 10.1007/s00248-001-0025-9; He ZG, 2009, J HAZARD MATER, V163, P869, DOI 10.1016/j.jhazmat.2008.07.041; Heath Association World, 1993, GUID DRINK WAT QUAL, V1, P45; Hillson NJ, 2007, APPL ENVIRON MICROB, V73, P7615, DOI 10.1128/AEM.01566-07; Ivask A, 2002, SOIL BIOL BIOCHEM, V34, P1439, DOI 10.1016/S0038-0717(02)00088-3; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lebuhn M, 2000, INT J SYST EVOL MICR, V50, P2207, DOI 10.1099/00207713-50-6-2207; Liang B, 2010, CURR MICROBIOL, V61, P226, DOI 10.1007/s00284-010-9603-8; Liao VHC, 2006, ENVIRON POLLUT, V142, P17, DOI 10.1016/j.envpol.2005.09.021; Liu XM, 2010, SENSORS-BASEL, V10, P1377, DOI 10.3390/s100201377; Magrisso S, 2008, MICROB BIOTECHNOL, V1, P320, DOI 10.1111/j.1751-7915.2008.00022.x; MERGEAY M, 1985, J BACTERIOL, V162, P328, DOI 10.1128/JB.162.1.328-334.1985; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Morais PV, 2011, BIOMETALS, V24, P401, DOI 10.1007/s10534-011-9446-1; Peitzsch N, 1998, APPL ENVIRON MICROB, V64, P453; Philp J, 2004, HANDB ENVIRON CHEM, V5, P165, DOI 10.1007/b97179; Riether KB, 2001, APPL MICROBIOL BIOT, V57, P712, DOI 10.1007/s00253-001-0852-0; Roberto FF, 2002, TALANTA, V58, P181, DOI 10.1016/S0039-9140(02)00266-7; Rodriguez-Mozaz S, 2006, ANAL BIOANAL CHEM, V386, P1025, DOI 10.1007/s00216-006-0574-3; Ron EZ, 2007, CURR OPIN BIOTECH, V18, P252, DOI 10.1016/j.copbio.2007.05.005; Sambrook J, 2001, MOL CLONING LAB MANU; SELIFONOVA O, 1993, APPL ENVIRON MICROB, V59, P3083, DOI 10.1128/AEM.59.9.3083-3090.1993; Stiner L, 2002, APPL ENVIRON MICROB, V68, P1962, DOI 10.1128/AEM.68.4.1962-1971.2002; Stocker J, 2003, ENVIRON SCI TECHNOL, V37, P4743, DOI 10.1021/es034258b; Su LA, 2011, BIOSENS BIOELECTRON, V26, P1788, DOI 10.1016/j.bios.2010.09.005; Tauriainen S, 1998, BIOSENS BIOELECTRON, V13, P931, DOI 10.1016/S0956-5663(98)00027-X; Tauriainen SM, 2000, WATER RES, V34, P2661, DOI 10.1016/S0043-1354(00)00005-1; Tecon R, 2008, SENSORS-BASEL, V8, P4062, DOI 10.3390/s8074062; Tibazarwa C, 2001, ENVIRON POLLUT, V113, P19, DOI 10.1016/S0269-7491(00)00177-9; Tom-Petersen A, 2001, FEMS MICROBIOL ECOL, V38, P59, DOI 10.1111/j.1574-6941.2001.tb00882.x; Trang PTK, 2005, ENVIRON SCI TECHNOL, V39, P7625, DOI 10.1021/es050992e; U.S. EPA, 2002, NAT PRIM DRINK WAT R; Verma N, 2005, BIOMETALS, V18, P121, DOI 10.1007/s10534-004-5787-3; Yagi K, 2007, APPL MICROBIOL BIOT, V73, P1251, DOI 10.1007/s00253-006-0718-6	40	32	33	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54005	10.1371/journal.pone.0054005	http://dx.doi.org/10.1371/journal.pone.0054005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326558	Green Submitted, gold, Green Published			2022-12-25	WOS:000314705800097
J	Lamb, R; Ambler, CA				Lamb, Rebecca; Ambler, Carrie A.			Keratinocytes Propagated in Serum-Free, Feeder-Free Culture Conditions Fail to Form Stratified Epidermis in a Reconstituted Skin Model	PLOS ONE			English	Article							XENOBIOTIC-FREE CULTURE; TERMINAL DIFFERENTIATION; CLINICAL-USE; CELLS; CALCIUM; LAYER; FIBROBLASTS; COMMITMENT; EXPRESSION; INVOLUCRIN	Primary human epidermal stem cells isolated from skin tissues and subsequently expanded in tissue culture are used for human therapeutic use to reconstitute skin on patients and to generate artificial skin in culture for academic and commercial research. Classically, epidermal cells, known as keratinocytes, required fibroblast feeder support and serum-containing media for serial propagation. In alignment with global efforts to remove potential animal contaminants, many serum-free, feeder-free culture methods have been developed that support derivation and growth of these cells in 2-dimensional culture. Here we show that keratinocytes grown continually in serum-free and feeder-free conditions were unable to form into a stratified, mature epidermis in a skin equivalent model. This is not due to loss of cell potential as keratinocytes propagated in serum-free, feeder-free conditions retain their ability to form stratified epidermis when reintroduced to classic serum-containing media. Extracellular calcium supplementation failed to improve epidermis development. In contrast, the addition of serum to commercial, growth media developed for serum-free expansion of keratinocytes facilitated 3-dimensional stratification in our skin equivalent model. Moreover, the addition of heat-inactivated serum improved the epidermis structure and thickness, suggesting that serum contains factors that both aid and inhibit stratification.	[Lamb, Rebecca; Ambler, Carrie A.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Ambler, Carrie A.] Univ Durham, Biophys Sci Inst, Durham, England	Durham University; Durham University	Ambler, CA (corresponding author), Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham, England.	c.a.ambler@durham.ac.uk		Ambler, Carrie/0000-0002-2697-7376	British Skin Foundation [2010S]; BBSRC [BB/H02431X/1]; Durham University Faculty of Science; Biotechnology and Biological Sciences Research Council [BB/H02431X/1] Funding Source: researchfish	British Skin Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Durham University Faculty of Science; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding: This work was funded by the British Skin Foundation (2010S; www.britishskinfoundation.org.uk), BBSRC (BB/H02431X/1; www.bbsrc.ac.uk) and Durham University Faculty of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambler CA, 2010, DEVELOPMENT, V137, P3569, DOI 10.1242/dev.050310; Bullock AJ, 2006, TISSUE ENG, V12, P245, DOI 10.1089/ten.2006.12.245; CARROLL JM, 1993, P NATL ACAD SCI USA, V90, P10270, DOI 10.1073/pnas.90.21.10270; Coolen NA, 2007, CELL TRANSPLANT, V16, P649, DOI 10.3727/000000007783465046; De Corte P, 2012, CELL TISSUE BANK, V13, P175, DOI 10.1007/s10561-011-9247-3; Doupe DP, 2012, EXP DERMATOL, V21, P249, DOI 10.1111/j.1600-0625.2012.01447.x; El Ghalbzouri A, 2002, CELL TISSUE RES, V310, P189, DOI 10.1007/s00441-002-0621-0; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; Ghadially R, 2012, J INVEST DERMATOL, V132, P797, DOI 10.1038/jid.2011.434; GREEN H, 1977, CELL, V11, P405, DOI 10.1016/0092-8674(77)90058-7; GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665; Green H, 1977, Prog Clin Biol Res, V17, P493; Guo AH, 2009, EXP DERMATOL, V18, P720, DOI 10.1111/j.1600-0625.2009.00900.x; HAWLEYNELSON P, 1982, EXP CELL RES, V137, P155, DOI 10.1016/0014-4827(82)90017-9; HEFTON JM, 1983, LANCET, V2, P428; HENNINGS H, 1983, EXP CELL RES, V143, P127, DOI 10.1016/0014-4827(83)90115-5; Higham MC, 2003, TISSUE ENG, V9, P919, DOI 10.1089/107632703322495565; IshidaYamamoto A, 1997, J INVEST DERMATOL, V108, P12, DOI 10.1111/1523-1747.ep12285611; Janes SM, 2009, CELL RES, V19, P328, DOI 10.1038/cr.2008.281; Jean J, 2011, TISSUE ENG PT A, V17, P877, DOI [10.1089/ten.tea.2010.0256, 10.1089/ten.TEA.2010.0256]; Levy L, 2000, MOL BIOL CELL, V11, P453, DOI 10.1091/mbc.11.2.453; MacNeil S, 2011, METHODS MOL BIOL, V695, P129, DOI 10.1007/978-1-60761-984-0_9; POUMAY Y, 1995, J INVEST DERMATOL, V104, P271, DOI 10.1111/1523-1747.ep12612810; PRUNEIRAS M, 1983, J INVEST DERMATOL, V81, P28; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; ROGUET R, 1994, TOXICOL IN VITRO, V8, P635, DOI 10.1016/0887-2333(94)90033-7; Shah G, 1999, Dev Biol Stand, V99, P17; Sun T, 2004, WOUND REPAIR REGEN, V12, P626, DOI 10.1111/j.1067-1927.2004.12609.x; TRINKAUSRANDALL V, 1984, J CELL BIOL, V98, P1565, DOI 10.1083/jcb.98.4.1565; VALNES K, 1985, J HISTOCHEM CYTOCHEM, V33, P755, DOI 10.1177/33.8.3926864; WATT FM, 1984, J CELL BIOL, V99, P2211, DOI 10.1083/jcb.99.6.2211; WATT FM, 1984, J CELL BIOL, V98, P16, DOI 10.1083/jcb.98.1.16; WATT FM, 1987, J CELL SCI, P313; Watt FM, 1983, J INVEST DERMATOL, V81, P100; WEISS L, 1959, EXP CELL RES, V17, P499, DOI 10.1016/0014-4827(59)90070-9	35	46	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52494	10.1371/journal.pone.0052494	http://dx.doi.org/10.1371/journal.pone.0052494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326335	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000314705800019
J	Omumbo, JA; Noor, AM; Fall, IS; Snow, RW				Omumbo, Judy A.; Noor, Abdisalan M.; Fall, Ibrahima S.; Snow, Robert W.			How Well Are Malaria Maps Used to Design and Finance Malaria Control in Africa?0	PLOS ONE			English	Article							GEOGRAPHICAL PATTERNS; TRANSMISSION; RISK; PREVALENCE; PREDICTORS; PROGRESS; MODELS	Introduction: Rational decision making on malaria control depends on an understanding of the epidemiological risks and control measures. National Malaria Control Programmes across Africa have access to a range of state-of-the-art malaria risk mapping products that might serve their decision-making needs. The use of cartography in planning malaria control has never been methodically reviewed. Materials and Methods: An audit of the risk maps used by NMCPs in 47 malaria endemic countries in Africa was undertaken by examining the most recent national malaria strategies, monitoring and evaluation plans, malaria programme reviews and applications submitted to the Global Fund. The types of maps presented and how they have been used to define priorities for investment and control was investigated. Results: 91% of endemic countries in Africa have defined malaria risk at sub-national levels using at least one risk map. The range of risk maps varies from maps based on suitability of climate for transmission; predicted malaria seasons and temperature/altitude limitations, to representations of clinical data and modelled parasite prevalence. The choice of maps is influenced by the source of the information. Maps developed using national data through in-country research partnerships have greater utility than more readily accessible web-based options developed without inputs from national control programmes. Although almost all countries have stratification maps, only a few use them to guide decisions on the selection of interventions allocation of resources for malaria control. Conclusion: The way information on the epidemiology of malaria is presented and used needs to be addressed to ensure evidence-based added value in planning control. The science on modelled impact of interventions must be integrated into new mapping products to allow a translation of risk into rational decision making for malaria control. As overseas and domestic funding diminishes, strategic planning will be necessary to guide appropriate financing for malaria control.	[Omumbo, Judy A.; Noor, Abdisalan M.; Snow, Robert W.] Univ Oxford, Wellcome Trust Res Programme, Kenya Med Res Inst, Malaria Publ Hlth Dept, Nairobi, Kenya; [Omumbo, Judy A.; Noor, Abdisalan M.; Snow, Robert W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Fall, Ibrahima S.] World Hlth Org, Reg Off Africa, Brazzaville, Rep Congo	Kenya Medical Research Institute; University of Oxford; World Health Organization	Omumbo, JA (corresponding author), Univ Oxford, Wellcome Trust Res Programme, Kenya Med Res Inst, Malaria Publ Hlth Dept, Nairobi, Kenya.	judyomumbo@gmail.com	Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088; Omumbo, Judy/0000-0002-9475-9346	Wellcome Trust [079080, 095127]	Wellcome Trust(Wellcome TrustEuropean Commission)	RWS is supported by the Wellcome Trust as a Principal Research Fellow (#079080). This fellowship also supports JAO. AMN is supported by the Wellcome Trust as an Intermediate Research Fellow (#095127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegana VA, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-6; Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-213; Craig MH, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-44; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Gemperli A, 2006, AM J EPIDEMIOL, V163, P289, DOI 10.1093/aje/kwj026; Gething PW, 2008, GEOGR ANAL, V40, P167, DOI 10.1111/j.1538-4632.2008.00718.x; Giardina F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032625; Gosoniu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0023966; Gosoniu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009322; Griffin JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012618; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hay SI, 2006, PLOS MED, V3, P2204, DOI 10.1371/journal.pmed.0030473; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hill J, 2006, TROP MED INT HEALTH, V11, P409, DOI 10.1111/j.1365-3156.2006.01585.x; Kazembe Lawrence N, 2006, Int J Health Geogr, V5, P41, DOI 10.1186/1476-072X-5-41; Kleinschmidt I, 2000, INT J EPIDEMIOL, V29, P355, DOI 10.1093/ije/29.2.355; Kleinschmidt I, 2001, TROP MED INT HEALTH, V6, P779, DOI 10.1046/j.1365-3156.2001.00790.x; Le Sueur D, 1997, Afr Health, V19, P23; Lysenko A, 1968, GEOGRAPHY MALARIA ME; MARA/ARMA, 1999, ATL MAL RISK AFR 1 T; METSELAAR D., 1959, Tropical and Geographical Medicine, V11, P157; Noor AM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-180; Noor AM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-159; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; Raso G, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-160; Riedel N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-37; Roll Back Malaria (RBM)/World Health Organization (WHO), 2008, GLOB MAL ACT PLAN 2; Smith DL, 2009, TRENDS PARASITOL, V25, P511, DOI 10.1016/j.pt.2009.08.002; Snow R.W., 2010, ESTIMATING DISTRIBUT; Snow RW, 2012, ADV PARASIT, V78, P169, DOI 10.1016/B978-0-12-394303-3.00010-4; Snow RW, 2010, LANCET, V376, P1409, DOI 10.1016/S0140-6736(10)61340-2; Snow RW, 1996, PARASITOL TODAY, V12, P455, DOI 10.1016/S0169-4758(96)30032-X; Stensgaard AS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-298; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; Taylor SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016420; Thomson MC, 2005, AM J TROP MED HYG, V73, P214, DOI 10.4269/ajtmh.2005.73.214; UNICEF/RBM/Global Fund, 1999, MAL CHILDR PROGR INT; van Eijk AM, 2011, LANCET INFECT DIS, V11, P190, DOI 10.1016/S1473-3099(10)70295-4; WHO, 2000, AB DECL PLAN ACT EXT; WHO Regional Office for Africa, 2011, MAN DEV NAT MAL STRA, P64; World Health Organization, 2010, MAN MAL PROGR PERF R	43	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53198	10.1371/journal.pone.0053198	http://dx.doi.org/10.1371/journal.pone.0053198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326398	gold, Green Published, Green Submitted			2022-12-25	WOS:000314705800037
J	Qi, RF; Zhang, LJ; Zhong, JH; Zhang, ZQ; Ni, L; Jiao, Q; Liao, W; Zheng, G; Lu, GM				Qi, Rongfeng; Zhang, Long Jiang; Zhong, Jianhui; Zhang, Zhiqiang; Ni, Ling; Jiao, Qing; Liao, Wei; Zheng, Gang; Lu, Guangming			Altered Effective Connectivity Network of the Basal Ganglia in Low-Grade Hepatic Encephalopathy: A Resting-State fMRI Study with Granger Causality Analysis	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; BRAIN ACTIVITY; FUNCTIONAL CONNECTIVITY; REGIONAL HOMOGENEITY; TEMPORAL GYRUS; CIRRHOSIS; METABOLISM; IMPAIRMENT; DISEASE; ANATOMY	Background: The basal ganglia often show abnormal metabolism and intracranial hemodynamics in cirrhotic patients with hepatic encephalopathy (HE). Little is known about how the basal ganglia affect other brain system and is affected by other brain regions in HE. The purpose of this study was to investigate whether the effective connectivity network associated with the basal ganglia is disturbed in HE patients by using resting-state functional magnetic resonance imaging (rs-fMRI). Methodology/Principal Findings: Thirty five low-grade HE patients and thirty five age-and gender-matched healthy controls participated in the rs-fMRI scans. The effective connectivity networks associated with the globus pallidus, the primarily affected region within basal ganglia in HE, were characterized by using the Granger causality analysis and compared between HE patients and healthy controls. Pearson correlation analysis was performed between the abnormal effective connectivity and venous blood ammonia levels and neuropsychological performances of all HE patients. Compared with the healthy controls, patients with low-grade HE demonstrated mutually decreased influence between the globus pallidus and the anterior cingulate cortex (ACC), cuneus, bi-directionally increased influence between the globus pallidus and the precuneus, and either decreased or increased influence from and to the globus pallidus in many other frontal, temporal, parietal gyri, and cerebellum. Pearson correlation analyses revealed that the blood ammonia levels in HE patients negatively correlated with effective connectivity from the globus pallidus to ACC, and positively correlated with that from the globus pallidus to precuneus; and the number connectivity test scores in patients negatively correlated with the effective connectivity from the globus pallidus to ACC, and from superior frontal gyrus to globus pallidus. Conclusions/Significance: Low-grade HE patients had disrupted effective connectivity network of basal ganglia. Our findings may help to understand the neurophysiological mechanisms underlying the HE.	[Qi, Rongfeng; Zhang, Long Jiang; Zhang, Zhiqiang; Ni, Ling; Jiao, Qing; Zheng, Gang; Lu, Guangming] Nanjing Univ, Coll Med, Sch Clin, Dept Med Imaging,Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Zhong, Jianhui] Zhejiang Univ, Dept Biomed Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Liao, Wei] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Liao, Wei] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China	Nanjing University; Zhejiang University; Hangzhou Normal University; Hangzhou Normal University	Zhang, LJ (corresponding author), Nanjing Univ, Coll Med, Sch Clin, Dept Med Imaging,Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China.	kevinzhanglongjiang@yahoo.com.cn; cjr.luguangming@vip.163.com	Zhong, Jianhui/AAE-6061-2020		Natural Scientific Foundation of China [30700194, 81230032, 30800264, 30971019, 81101039]; Chinese Key Program [BWS11J063, 10z026]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Key Program	This work was supported by the grants from the Natural Scientific Foundation of China [Grant No. 30700194 and No. 81230032 for Long Jiang Zhang, Grant No. 30800264 for Zhiqiang Zhang, and Grant No. 30971019 for Qing Jiao, Grant No. 81101039 for Gang Zheng], and Chinese Key Program (Grant No. BWS11J063 and No. 10z026 for Guangming Lu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj JS, 2011, ALIMENT PHARM THER, V33, P739, DOI 10.1111/j.1365-2036.2011.04590.x; Bajaj JS, 2008, WORLD J GASTROENTERO, V14, P3609, DOI 10.3748/wjg.14.3609; Bajaj JS, 2008, HEPATOLOGY, V47, P596, DOI 10.1002/hep.22032; Bigler ED, 2007, DEV NEUROPSYCHOL, V31, P217, DOI 10.1080/87565640701190841; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Catafau AM, 2000, J NUCL MED, V41, P405; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chen HJ, 2012, NEUROSCI LETT, V507, P5, DOI 10.1016/j.neulet.2011.11.033; Ding L, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P3670; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Giewekemeyer K, 2007, J HEPATOL, V46, P1034, DOI 10.1016/j.jhep.2007.01.038; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Groeneweg M, 1998, HEPATOLOGY, V28, P45, DOI 10.1002/hep.510280108; Hamilton JP, 2011, MOL PSYCHIATR, V16, P763, DOI 10.1038/mp.2010.46; Hesse W, 2003, J NEUROSCI METH, V124, P27, DOI 10.1016/S0165-0270(02)00366-7; Jiao Q, 2011, HUM BRAIN MAPP, V32, P154, DOI 10.1002/hbm.21065; Kappus MR, 2012, CLIN GASTROENTEROL H, V10, P1208, DOI 10.1016/j.cgh.2012.05.026; Keiding S, 2006, HEPATOLOGY, V43, P42, DOI 10.1002/hep.21001; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015238; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; LOCKWOOD AH, 1991, J CEREBR BLOOD F MET, V11, P331, DOI 10.1038/jcbfm.1991.66; LOCKWOOD AH, 1993, HEPATOLOGY, V18, P1061; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McPhail MJW, 2012, CLIN LIVER DIS, V16, P57, DOI 10.1016/j.cld.2011.12.001; Miao XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025546; Munoz SJ, 2008, MED CLIN N AM, V92, P795, DOI 10.1016/j.mcna.2008.03.009; Ni L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042016; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Prasad S, 2007, HEPATOLOGY, V45, P549, DOI 10.1002/hep.21533; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046681; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037400; Qi RF, 2012, RADIOLOGY, V264, P187, DOI 10.1148/radiol.12111429; Qiu YW, 2011, RADIOLOGY, V261, P551, DOI 10.1148/radiol.11102466; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Scheff SW, 2011, J ALZHEIMERS DIS, V24, P547, DOI 10.3233/JAD-2011-101782; Sidhu SS, 2011, AM J GASTROENTEROL, V106, P307, DOI 10.1038/ajg.2010.455; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Spahr L, 2002, METAB BRAIN DIS, V17, P399, DOI 10.1023/A:1021974321874; Stephan KE, 2012, NEUROIMAGE, V62, P856, DOI 10.1016/j.neuroimage.2012.01.034; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Weissenborn K, 2001, J HEPATOL, V34, P768, DOI 10.1016/S0168-8278(01)00026-5; Zafiris O, 2004, NEUROIMAGE, V22, P541, DOI 10.1016/j.neuroimage.2004.01.038; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zang ZX, 2012, J NEUROSCI METH, V203, P418, DOI 10.1016/j.jneumeth.2011.10.006; Zhang HY, 2010, RADIOLOGY, V256, P598, DOI 10.1148/radiol.10091701; Zhang LJ, 2012, AJNR AM J NEURORADIO; Zhang LJ, 2012, RADIOLOGY, V265, P528, DOI 10.1148/radiol.12120185; Zhang LJ, 2010, HEPATOL RES, V40, P777, DOI 10.1111/j.1872-034X.2010.00681.x	53	16	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53677	10.1371/journal.pone.0053677	http://dx.doi.org/10.1371/journal.pone.0053677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326484	Green Published, Green Submitted, gold			2022-12-25	WOS:000314705800068
J	Sims, RE; Wu, HHT; Dale, N				Sims, Robert Edward; Wu, Houdini Ho Tin; Dale, Nicholas			Sleep-Wake Sensitive Mechanisms of Adenosine Release in the Basal Forebrain of Rodents: An In Vitro Study	PLOS ONE			English	Article							ACTIVITY-DEPENDENT RELEASE; CENTRAL-NERVOUS-SYSTEM; EXTRACELLULAR ADENOSINE; RECOVERY SLEEP; HOMEOSTATIC REGULATION; PROLONGED WAKEFULNESS; CHOLINERGIC NEURONS; RAT HIPPOCAMPUS; A(1) RECEPTOR; MESSENGER-RNA	Adenosine acting in the basal forebrain is a key mediator of sleep homeostasis. Extracellular adenosine concentrations increase during wakefulness, especially during prolonged wakefulness and lead to increased sleep pressure and subsequent rebound sleep. The release of endogenous adenosine during the sleep-wake cycle has mainly been studied in vivo with microdialysis techniques. The biochemical changes that accompany sleep-wake status may be preserved in vitro. We have therefore used adenosine-sensitive biosensors in slices of the basal forebrain (BFB) to study both depolarization-evoked adenosine release and the steady state adenosine tone in rats, mice and hamsters. Adenosine release was evoked by high K+, AMPA, NMDA and mGlu receptor agonists, but not by other transmitters associated with wakefulness such as orexin, histamine or neurotensin. Evoked and basal adenosine release in the BFB in vitro exhibited three key features: the magnitude of each varied systematically with the diurnal time at which the animal was sacrificed; sleep deprivation prior to sacrifice greatly increased both evoked adenosine release and the basal tone; and the enhancement of evoked adenosine release and basal tone resulting from sleep deprivation was reversed by the inducible nitric oxide synthase (iNOS) inhibitor, 1400 W. These data indicate that characteristics of adenosine release recorded in the BFB in vitro reflect those that have been linked in vivo to the homeostatic control of sleep. Our results provide methodologically independent support for a key role for induction of iNOS as a trigger for enhanced adenosine release following sleep deprivation and suggest that this induction may constitute a biochemical memory of this state.	[Sims, Robert Edward; Wu, Houdini Ho Tin; Dale, Nicholas] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Sims, RE (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	r.e.sims@warwick.ac.uk	Dale, Nicholas/C-7772-2011	Dale, Nicholas/0000-0003-2196-2949; Sims, Robert/0000-0003-1373-7514	Wellcome Trust [WT087968MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust, grant WT087968MA, www.wellcome.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanko LO, 2004, NEUROREPORT, V15, P2133, DOI 10.1097/00001756-200409150-00027; ALONSO A, 1994, J NEUROSCI, V14, P5778; BALLARIN M, 1991, ACTA PHYSIOL SCAND, V142, P97, DOI 10.1111/j.1748-1716.1991.tb09133.x; Basheer R, 1999, MOL BRAIN RES, V73, P1, DOI 10.1016/S0169-328X(99)00219-3; Basheer R, 2004, PROG NEUROBIOL, V73, P379, DOI 10.1016/j.pneurobio.2004.06.004; Basheer R, 2001, NEUROREPORT, V12, P1577, DOI 10.1097/00001756-200106130-00013; Bjorness TE, 2009, J NEUROSCI, V29, P1267, DOI 10.1523/JNEUROSCI.2942-08.2009; CULLINAN WE, 1991, J COMP NEUROL, V306, P631, DOI 10.1002/cne.903060408; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; DUNWIDDIE TV, 1982, J PHARMACOL EXP THER, V220, P70; ENKVIST MOK, 1989, GLIA, V2, P397, DOI 10.1002/glia.440020602; Etherington LAV, 2004, EUR J NEUROSCI, V19, P2539, DOI 10.1111/j.0953-816X.2004.03355.x; FARKAS RH, 1994, P NATL ACAD SCI USA, V91, P2853, DOI 10.1073/pnas.91.7.2853; FRANKEN P, 1991, AM J PHYSIOL, V261, pR198, DOI 10.1152/ajpregu.1991.261.1.R198; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Frenguelli BG, 2007, J NEUROCHEM, V101, P1400, DOI 10.1111/j.1471-4159.2006.04425.x; GLAUM SR, 1990, P NATL ACAD SCI USA, V87, P3454, DOI 10.1073/pnas.87.9.3454; Greco MA, 2000, NEUROREPORT, V11, P437, DOI 10.1097/00001756-200002280-00002; Grivel J, 2005, J NEUROSCI, V25, P4127, DOI 10.1523/JNEUROSCI.0666-05.2005; Halassa MM, 2009, NEUROPHARMACOLOGY, V57, P343, DOI 10.1016/j.neuropharm.2009.06.031; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; HAULICA I, 1973, J NEUROCHEM, V21, P1019, DOI 10.1111/j.1471-4159.1973.tb07549.x; HOFFMAN JC, 1973, AM J PHYSIOL, V224, P245, DOI 10.1152/ajplegacy.1973.224.2.245; Hohmann CF, 1998, INT J DEV NEUROSCI, V16, P645, DOI 10.1016/S0736-5748(98)00075-6; Huang ZL, 2005, NAT NEUROSCI, V8, P858, DOI 10.1038/nn1491; Kalinchuk AV, 2006, J NEUROCHEM, V99, P483, DOI 10.1111/j.1471-4159.2006.04077.x; Kalinchuk AV, 2006, EUR J NEUROSCI, V24, P1443, DOI 10.1111/j.1460-9568.2006.05019.x; Kalinchuk AV, 2011, J NEUROCHEM, V116, P260, DOI 10.1111/j.1471-4159.2010.07100.x; Khateb A, 1997, NEUROSCIENCE, V81, P47, DOI 10.1016/S0306-4522(97)00167-X; Kiyashchenko LI, 2002, J NEUROSCI, V22, P5282; Klyuch BP, 2012, J NEUROSCI, V32, P3842, DOI 10.1523/JNEUROSCI.6052-11.2012; Klyuch BP, 2011, J PHYSIOL-LONDON, V589, P283, DOI 10.1113/jphysiol.2010.198986; Lee MG, 2005, J NEUROSCI, V25, P4365, DOI 10.1523/JNEUROSCI.0178-05.2005; Llaudet E, 2003, BIOSENS BIOELECTRON, V18, P43, DOI 10.1016/S0956-5663(02)00106-9; Longordo F, 2009, EUR J NEUROSCI, V29, P1810, DOI 10.1111/j.1460-9568.2009.06719.x; Lovatt D, 2012, P NATL ACAD SCI USA, V109, P6265, DOI 10.1073/pnas.1120997109; Madsen P L, 1993, Acta Neurol Scand Suppl, V148, P3; Manns ID, 2000, J NEUROSCI, V20, P1505; MAQUET P, 1992, BRAIN RES, V571, P149, DOI 10.1016/0006-8993(92)90522-B; MCILWAIN H, 1972, J PHYSIOL-LONDON, V221, pP9; McKenna JT, 2007, NEUROSCIENCE, V146, P1462, DOI 10.1016/j.neuroscience.2007.03.009; Minor TR, 2001, BEHAV BRAIN RES, V120, P203, DOI 10.1016/S0166-4328(00)00376-4; MITCHELL JB, 1993, J NEUROSCI, V13, P3439; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Murillo-Rodriguez E, 2004, NEUROSCIENCE, V123, P361, DOI 10.1016/j.neuroscience.2003.09.015; Newman EA, 2001, J NEUROSCI, V21, P2215, DOI 10.1523/JNEUROSCI.21-07-02215.2001; Palchykova S, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-9; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Porkka-Heiskanen T, 2000, NEUROSCIENCE, V99, P507, DOI 10.1016/S0306-4522(00)00220-7; Porkka-Heiskanen T, 1999, ANN MED, V31, P125, DOI 10.3109/07853899908998788; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Porter JT, 1996, J NEUROSCI, V16, P5073; RADULOVACKI M, 1984, J PHARMACOL EXP THER, V228, P268; Ramesh V, 2004, BEHAV BRAIN RES, V152, P271, DOI 10.1016/j.bbr.2003.10.031; ROMANO C, 1995, J COMP NEUROL, V355, P455, DOI 10.1002/cne.903550310; Schmitt LI, 2012, J NEUROSCI, V32, P4417, DOI 10.1523/JNEUROSCI.5689-11.2012; SCIOTTI VM, 1993, BRAIN RES, V613, P16, DOI 10.1016/0006-8993(93)90448-V; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; SHIGEMOTO R, 1992, J COMP NEUROL, V322, P121, DOI 10.1002/cne.903220110; Stenberg D, 2003, J SLEEP RES, V12, P283, DOI 10.1046/j.0962-1105.2003.00367.x; Thakkar MM, 2003, J NEUROSCI, V23, P4278; TICHO SR, 1991, PHARMACOL BIOCHEM BE, V40, P33, DOI 10.1016/0091-3057(91)90317-U; van den Top M, 2003, J PHYSIOL-LONDON, V549, P809, DOI 10.1113/jphysiol.2002.033290; VANWYLEN DGL, 1986, J CEREBR BLOOD F MET, V6, P522, DOI 10.1038/jcbfm.1986.97; VIRUS RM, 1983, NEUROPHARMACOLOGY, V22, P1401, DOI 10.1016/0028-3908(83)90231-9; Wall M, 2008, CURR NEUROPHARMACOL, V6, P329, DOI 10.2174/157015908787386087; Wall MJ, 2007, J PHYSIOL-LONDON, V581, P553, DOI 10.1113/jphysiol.2006.126417; Wigren HK, 2007, NEUROSCIENCE, V147, P811, DOI 10.1016/j.neuroscience.2007.04.046; Xu CQ, 2004, J PHYSIOL-LONDON, V561, P657, DOI 10.1113/jphysiol.2004.071712	70	28	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53814	10.1371/journal.pone.0053814	http://dx.doi.org/10.1371/journal.pone.0053814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326515	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000314705800078
J	Stotz, GC; Suarez, LH; Gonzales, WL; Gianoli, E				Stotz, Gisela C.; Suarez, Lorena H.; Gonzales, Wilfredo L.; Gianoli, Ernesto			Local Host Adaptation and Use of a Novel Host in the Seed Beetle Megacerus eulophus	PLOS ONE			English	Article							EGG SIZE PLASTICITY; TRADE-OFFS; ECOLOGICAL GENETICS; LARVAL HOST; BEAN WEEVIL; COLEOPTERA; EVOLUTION; FITNESS; BRUCHIDAE; SPECIALIZATION	Spatial variation in host plant availability may lead to specialization in host use and local host adaptation in herbivorous insects, which may involve a cost in performance on other hosts. We studied two geographically separated populations of the seed beetle Megacerus eulophus (Coleoptera: Bruchidae) in central Chile: a population from the host Convolvulus chilensis (in Auco) and a population from C. bonariensis (in Algarrobo). In Auco C. chilensis is the only host plant, while in Algarrobo both C. bonariensis and C. chilensis are available. We tested local adaptation to these native host plants and its influence on the use of another, exotic host plant. We hypothesized that local adaptation would be verified, particularly for the one-host population (Auco), and that the Auco population would be less able to use an alternative, high-quality host. We found evidence of local adaptation in the population from C. chilensis. Thus, when reared on C. chilensis, adults from the C. chilensis population were larger and lived longer than individuals from the C. bonariensis population, while bruchids from the two populations had the same body size and longevity when reared on C. bonariensis. Overall, bruchids from the C. chilensis population showed greater performance traits than those from the C. bonariensis population. There were no differences between the bruchid populations in their ability to use the alternative, exotic host Calystegia sepium, as shown by body size and longevity patterns. Results suggest that differences in local adaptation might be explained by differential host availability in the study populations.	[Stotz, Gisela C.; Suarez, Lorena H.; Gianoli, Ernesto] Univ Concepcion, Dept Bot, Concepcion, Chile; [Gonzales, Wilfredo L.] Univ Peruana Cayetano Heredia, Dept Ciencias Biol & Fisiol, Lima, Peru; [Gianoli, Ernesto] Univ La Serena, Dept Biol, La Serena, Chile	Universidad de Concepcion; Universidad Peruana Cayetano Heredia; Universidad de La Serena	Stotz, GC (corresponding author), Univ Concepcion, Dept Bot, Concepcion, Chile.	gstotz@udec.cl	Stotz, Gisela/E-2197-2017; Gianoli, Ernesto/A-7984-2015	Stotz, Gisela/0000-0001-8687-7361; Gianoli, Ernesto/0000-0003-4246-8640; GONZALES, WILFREDO/0000-0002-8885-5972				Agrawal AA, 2000, ECOLOGY, V81, P500, DOI 10.1890/0012-9658(2000)081[0500:HREAAT]2.0.CO;2; Amarillo-Suarez AR, 2006, OECOLOGIA, V150, P247, DOI 10.1007/s00442-006-0516-y; Ballabeni P, 2003, OIKOS, V101, P70, DOI 10.1034/j.1600-0706.2003.12569.x; Barriga X, 1990, THESIS U CHILE SANTI; Carroll SP, 2001, GENETICA, V112, P257, DOI 10.1023/A:1013354830907; CENTER TD, 1974, ECOLOGY, V55, P1096, DOI 10.2307/1940359; EHRLICH PR, 1988, ECOLOGY, V69, P908, DOI 10.2307/1941244; ERNST WHO, 1992, J INSECT PHYSIOL, V38, P831, DOI 10.1016/0022-1910(92)90093-S; Fox, 1998, MATERNAL EFFECTS ADA; Fox CW, 2000, ANNU REV ENTOMOL, V45, P341, DOI 10.1146/annurev.ento.45.1.341; FOX CW, 1994, OECOLOGIA, V99, P329, DOI 10.1007/BF00627746; Fox CW, 1996, OECOLOGIA, V107, P541, DOI 10.1007/BF00333946; Fox CW, 1997, AM NAT, V149, P149, DOI 10.1086/285983; Fox CW, 2000, ECOLOGY, V81, P3, DOI 10.2307/177128; FOX LR, 1981, SCIENCE, V211, P887, DOI 10.1126/science.211.4485.887; Friberg M, 2009, OECOLOGIA, V159, P127, DOI 10.1007/s00442-008-1206-8; Fry JD, 1996, AM NAT, V148, pS84, DOI 10.1086/285904; Fuentes N., 2012, BIOL INVASIONS, DOI [DOI 10.1007/S10530-012-0334-6, 10.1007/s10530-012-0334-6]; Futuyma D. J., 1998, EVOLUTIONARY BIOL; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; GATEHOUSE AMR, 1987, J INSECT PHYSIOL, V33, P843, DOI 10.1016/0022-1910(87)90032-1; Gianoli E, 2007, ENTOMOL EXP APPL, V122, P233, DOI 10.1111/j.1570-7458.2006.00506.x; Gonzalez-Teuber M, 2008, NATURWISSENSCHAFTEN, V95, P609, DOI 10.1007/s00114-008-0361-4; Gonzalez-Teuber M, 2008, J ECOL, V96, P122, DOI 10.1111/j.1365-2745.2007.01321.x; Hendry AP, 2007, FUNCT ECOL, V21, P455, DOI 10.1111/j.1365-2435.2007.01240.x; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.ecolsys.21.1.243; JANZEN DH, 1977, ECOLOGY, V58, P921, DOI 10.2307/1936229; JANZEN DH, 1980, J ECOL, V68, P929, DOI 10.2307/2259466; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kuussaari M, 2000, ECOLOGY, V81, P2177, DOI 10.1890/0012-9658(2000)081[2177:LSALLI]2.0.CO;2; Logarzo GA, 2011, OECOLOGIA, V165, P387, DOI 10.1007/s00442-010-1782-2; Matsubayashi KW, 2010, ENTOMOL EXP APPL, V134, P1, DOI 10.1111/j.1570-7458.2009.00916.x; Matthei J, 1995, MANUAL MALEZAS QUE C; MITCHELL R, 1975, ECOLOGY, V56, P696, DOI 10.2307/1935504; MOUSSEAU TA, 1991, ANNU REV ENTOMOL, V36, P511, DOI 10.1146/annurev.en.36.010191.002455; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Nosil P, 2002, NATURE, V417, P440, DOI 10.1038/417440a; Nosil P, 2006, J EVOLUTION BIOL, V19, P929, DOI 10.1111/j.1420-9101.2005.01035.x; ODONELL CA, 1957, B SOC ARGENT BOT, V6, P144; Or K, 2004, J CHEM ECOL, V30, P2297, DOI 10.1023/B:JOEC.0000048790.85830.79; PFAFFENBERGER G S, 1984, Coleopterists Bulletin, V38, P1; Price PW., 1997, INSECT ECOLOGY, V3rd edn; Rova E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014628; Savalli UM, 2002, ANN ENTOMOL SOC AM, V95, P724, DOI 10.1603/0013-8746(2002)095[0724:PMIESP]2.0.CO;2; SIEMENS DH, 1990, OECOLOGIA, V82, P408, DOI 10.1007/BF00317490; SORK VL, 1993, AM NAT, V142, P928, DOI 10.1086/285581; Souza AJ, 2011, CROP PROT, V30, P651, DOI 10.1016/j.cropro.2010.12.014; Suarez LH, 2004, REV CHIL HIST NAT, V77, P581; Takakura KI, 2004, ANN ENTOMOL SOC AM, V97, P346, DOI 10.1603/0013-8746(2004)097[0346:VIESWA]2.0.CO;2; Teran AL, 1977, REVISION GENERO MEGA; Teran Arturo L., 1992, Acta Zoologica Lilloana, V42, P19; Thompson JN, 1996, ENTOMOL EXP APPL, V80, P133, DOI 10.1007/BF00194742; Thompson JN, 1994, COEVOLUTIONARY PROCE; Vamosi SM, 2005, FUNCT ECOL, V19, P859, DOI 10.1111/j.1365-2435.2005.01029.x; Van Zandt PA, 1998, AM NAT, V152, P595, DOI 10.1086/286192; VIA S, 1990, ANNU REV ENTOMOL, V35, P421, DOI 10.1146/annurev.en.35.010190.002225	57	6	7	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53892	10.1371/journal.pone.0053892	http://dx.doi.org/10.1371/journal.pone.0053892			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326528	Green Submitted, gold, Green Published			2022-12-25	WOS:000314705800084
J	Zhang, J; Zhang, BG; Zhang, XM; Sun, YG; Wei, XL; McNutt, MA; Lu, SJ; Liu, YQ; Zhang, DH; Wang, MY; Lin, ZJ; Niu, N				Zhang, Jie; Zhang, Baogang; Zhang, Xumei; Sun, Yingui; Wei, Xiaolong; McNutt, Michael A.; Lu, Shijun; Liu, Yuqing; Zhang, Donghong; Wang, Mingyu; Lin, Zhijuan; Niu, Na			SATB1 Expression Is Associated with Biologic Behavior in Colorectal Carcinoma In Vitro and In Vivo	PLOS ONE			English	Article							CLINICOPATHOLOGICAL FEATURES; CELL-PROLIFERATION; SERRATED POLYPS; DNA METHYLATION; GENE-EXPRESSION; MOLECULAR-BASIS; CANCER; GROWTH; MUTATIONS; PROTEIN	There is increasing evidence that Special AT-rich sequence-binding protein 1 (SATB1) is aberrantly expressed in several cancers and is correlated with clinicopathologic parameters in these tumors. In this study, we showed over-expression of SATB1 in 80 cases of colorectal cancer and in 3 colorectal cancer cell lines and found expression levels were strongly associated with tumor differentiation and stage. Expression levels of SATB1 protein were higher in poorly-differentiated as compared with well-differentiated cell lines, and both quantity and distribution patterns of SATB1 were associated with tumor differentiation and pTNM stage. Strikingly, we further investigated the effect of down regulation of SATB1 expression on malignant phenotypic features in colorectal cancer cells in vitro, and showed that SABT1 down-regulation negatively affected growth potential, anchorage-independent colony formation and cancer cell invasion, and resulted in increased apoptosis. SATB1 expression was positively associated with the expression of various biological and genetic markers, including Cyclin D1, MMP-2, NF-kappa B, and PCNA, and was associated with loss of APC and BRAF(V600E). These findings suggest that SATB1 is involved in the carcinogenesis, development and progression of colorectal cancer.	[Zhang, Jie] Weifang Med Univ, Dept Human Anat, Weifang, Peoples R China; [Zhang, Baogang; Lu, Shijun; Liu, Yuqing; Niu, Na] Weifang Med Univ, Dept Pathol, Weifang, Peoples R China; [Zhang, Xumei] Weifang Med Univ, Affiliated Hosp, Dept Pathol, Weifang, Peoples R China; [Sun, Yingui] Weifang Med Univ, Dept Anesthesia, Weifang, Peoples R China; [Wei, Xiaolong] Shantou Univ, Coll Med, Canc Hosp, Dept Pathol, Shantou, Peoples R China; [McNutt, Michael A.] Peking Univ, Sch Basic Med Sci, Dept Pathol, Beijing 100871, Peoples R China; [Zhang, Donghong] Beijing Union Med Coll Hosp, Dept Clin Lab, Beijing, Peoples R China; [Zhang, Donghong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Mingyu] Weifang Med Univ, Dept Neurol, Weifang, Peoples R China; [Lin, Zhijuan] Weifang Med Univ, Univ Shandong Prov, Key Lab Immunol, Weifang, Peoples R China	Weifang Medical University; Weifang Medical University; Weifang Medical University; Weifang Medical University; Shantou University; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Weifang Medical University; Weifang Medical University	Niu, N (corresponding author), Weifang Med Univ, Dept Pathol, Weifang, Peoples R China.	naniubjmu@gmail.com	Liu, LiuYuqing/GWZ-5665-2022; Niu, Na/A-2915-2016	Niu, Na/0000-0003-1016-7851	Young and Middle-Aged Scientists Research Awards Fundation of Shandong Province [BS2011SW051, 2010BSB14050]; National Natural Science Foundation of China [81100885, 81072068]	Young and Middle-Aged Scientists Research Awards Fundation of Shandong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by grants from the Young and Middle-Aged Scientists Research Awards Fundation of Shandong Province to Na Niu (No. BS2011SW051) and Baogang Zhang (No. 2010BSB14050), and National Natural Science Foundation of China to Na Niu (No. 81100885) and Baogang Zhang (No. 81072068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnen DJ, 2011, AM J GASTROENTEROL, V106, P190, DOI 10.1038/ajg.2010.423; Alvarez JD, 2000, GENE DEV, V14, P521; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Chen HX, 2011, J DERMATOL SCI, V64, P39, DOI 10.1016/j.jdermsci.2011.06.007; Cheng C, 2010, APMIS, V118, P855, DOI 10.1111/j.1600-0463.2010.02673.x; Debska S, 2012, POSTEP HIG MED DOSW, V66, P311; Fernandez SV, 2012, INT J ONCOL, V41, P369, DOI 10.3892/ijo.2012.1444; Flatmark K, 2004, EUR J CANCER, V40, P1593, DOI 10.1016/j.ejca.2004.02.023; Forma E, 2012, GINEKOL POL, V83, P363; Galande S, 2007, CURR OPIN GENET DEV, V17, P408, DOI 10.1016/j.gde.2007.08.003; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Ioachim E, 2008, INT J CLIN PRACT, V62, P1736, DOI 10.1111/j.1742-1241.2006.01105.x; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; Laulier C, 2012, MUTAT RES; Levidou G, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-47; Liu Chun-xiao, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P1389; Maloney EK, 2003, CANCER RES, V63, P5073; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Markowitz SD, 2002, CANCER CELL, V1, P233, DOI 10.1016/S1535-6108(02)00053-3; Meng WJ, 2012, INT J COLORECTAL DIS, V27, P143, DOI 10.1007/s00384-011-1302-9; Nie H, 2008, MOL IMMUNOL, V46, P207, DOI 10.1016/j.molimm.2008.07.007; Niu N, 2011, INT J BIOCHEM CELL B, V43, P556, DOI 10.1016/j.biocel.2010.12.012; Niu N, 2011, CELL MOL LIFE SCI, V68, P2481, DOI 10.1007/s00018-010-0572-7; Niu N, 2009, LAB INVEST, V89, P636, DOI 10.1038/labinvest.2009.28; Parsons MT, 2012, J MED GENET, V49, P151, DOI 10.1136/jmedgenet-2011-100714; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Peng Zheng-kui, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P1207; Qiu XY, 2003, CANCER RES, V63, P6488; Rigakos G, 2012, ONCOLOGIST, V17, P956, DOI 10.1634/theoncologist.2012-0028; Stecklein SR, 2012, TRANSL RES, V160, P178, DOI 10.1016/j.trsl.2012.01.022; Sun XF, 1996, INT J CANCER, V69, P5, DOI 10.1002/(SICI)1097-0215(19960220)69:1<5::AID-IJC2>3.0.CO;2-8; Tanikawa C, 2012, NEOPLASIA, V14, P141, DOI 10.1593/neo.111700; Turnbull CL, 2012, MUTAGENESIS, V27, P233, DOI 10.1093/mutage/ger069; Velho S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-255; Webber MM, 1995, CLIN CANCER RES, V1, P1089; Wen J, 2005, BLOOD, V105, P3330, DOI 10.1182/blood-2004-08-2988; Zhao Xiao-lan, 2011, Sichuan Da Xue Xue Bao Yi Xue Ban, V42, P82; Zhao XD, 2010, ORL-J OTO-RHIN-LARYN, V72, P1, DOI 10.1159/000264777; Zheng H, 2007, CELL BIOL INT, V31, P82, DOI 10.1016/j.cellbi.2006.09.009; Zlobec I, 2008, J CLIN PATHOL, V61, P561, DOI 10.1136/jcp.2007.054858	42	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e47902	10.1371/journal.pone.0047902	http://dx.doi.org/10.1371/journal.pone.0047902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326301	Green Submitted, gold, Green Published			2022-12-25	WOS:000314705800003
J	Khatri, B; Fielder, M; Jones, G; Newell, W; Abu-Oun, M; Wheeler, PR				Khatri, Bhagwati; Fielder, Mark; Jones, Gareth; Newell, William; Abu-Oun, Manal; Wheeler, Paul R.			High Throughput Phenotypic Analysis of Mycobacterium tuberculosis and Mycobacterium bovis Strains' Metabolism Using Biolog Phenotype Microarrays	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; IN-VIVO GROWTH; LIPID-METABOLISM; ACID RESISTANCE; GENE; MUTANTS; ASSAY; BIOSYNTHESIS; TRANSPORT; VIRULENCE	Tuberculosis is a major human and animal disease of major importance worldwide. Genetically, the closely related strains within the Mycobacterium tuberculosis complex which cause disease are well-characterized but there is an urgent need better to understand their phenotypes. To search rapidly for metabolic differences, a working method using Biolog Phenotype MicroArray analysis was developed. Of 380 substrates surveyed, 71 permitted tetrazolium dye reduction, the readout over 7 days in the method. By looking for >= 5-fold differences in dye reduction, 12 substrates differentiated M. tuberculosis H37Rv and Mycobacterium bovis AF2122/97. H37Rv and a Beijing strain of M. tuberculosis could also be distinguished in this way, as could field strains of M. bovis; even pairs of strains within one spoligotype could be distinguished by 2 to 3 substrates. Cluster analysis gave three clear groups: H37Rv, Beijing, and all the M. bovis strains. The substrates used agreed well with prior knowledge, though an unexpected finding that AF2122/97 gave greater dye reduction than H37Rv with hexoses was investigated further, in culture flasks, revealing that hexoses and Tween 80 were synergistic for growth and used simultaneously rather than in a diauxic fashion. Potential new substrates for growth media were revealed, too, most promisingly N-acetyl glucosamine. Osmotic and pH arrays divided the mycobacteria into two groups with different salt tolerance, though in contrast to the substrate arrays the groups did not entirely correlate with taxonomic differences. More interestingly, these arrays suggested differences between the amines used by the M. tuberculosis complex and enteric bacteria in acid tolerance, with some hydrophobic amino acids being highly effective. In contrast, gamma-aminobutyrate, used in the enteric bacteria, had no effect in the mycobacteria. This study proved principle that Phenotype MicroArrays can be used with slow-growing pathogenic mycobacteria and already has generated interesting data worthy of further investigation.	[Khatri, Bhagwati; Wheeler, Paul R.] Anim Hlth Vet Labs Weybridge, Dept Bovine TB, New Haw, Surrey, England; [Fielder, Mark] Kingston Univ London, Sch Life Sci, Kingston Upon Thames, Surrey, England; [Jones, Gareth; Newell, William] Anim Hlth Vet Labs Weybridge, Specialist Sci Serv Dept, New Haw, Surrey, England; [Abu-Oun, Manal] Anim Hlth Vet Labs Weybridge, Dept Bacteriol, New Haw, Surrey, England	Kingston University	Wheeler, PR (corresponding author), Anim Hlth Vet Labs Weybridge, Dept Bovine TB, New Haw, Surrey, England.	Paul.Wheeler@ahvla.gsi.gov.uk			AHVLA's Seedcorn programme [SC0205]	AHVLA's Seedcorn programme	Funding for this work was provided though the AHVLA's (http://ahvlaintranet/) Seedcorn programme, SC0205. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate G, 1998, INT J TUBERC LUNG D, V2, P1011; Banu S, 2004, J CLIN MICROBIOL, V42, P674, DOI 10.1128/JCM.42.2.674-682.2004; Berney M, 2012, MOL MICROBIOL, V84, P664, DOI 10.1111/j.1365-2958.2012.08053.x; Beste DJV, 2005, J BACTERIOL, V187, P1677, DOI 10.1128/JB.187.5.1677-1684.2005; Blomberg A, 2000, FEMS MICROBIOL LETT, V182, P1; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; CAMARGO EE, 1982, INT J LEPROSY, V50, P200; CAMARGO EE, 1987, NUCL MED BIOL, V14, P43; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Carvalho LPS, 2010, CHEM BIOL, V17, P1122, DOI 10.1016/j.chembiol.2010.08.009; Deol P, 2005, J BACTERIOL, V187, P3415, DOI 10.1128/JB.187.10.3415-3420.2005; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; HARTMANN T, 1972, PHYTOCHEMISTRY, V11, P1327, DOI 10.1016/S0031-9422(00)90081-5; Hondalus MK, 2000, INFECT IMMUN, V68, P2888, DOI 10.1128/IAI.68.5.2888-2898.2000; Kairo SK, 1999, VACCINE, V17, P2423, DOI 10.1016/S0264-410X(99)00023-7; Keating LA, 2005, MOL MICROBIOL, V56, P163, DOI 10.1111/j.1365-2958.2005.04524.x; Lee S, 2006, INFECT IMMUN, V74, P6491, DOI 10.1128/IAI.00531-06; Martinez-Gamboa A, 2008, ARCH MED RES, V39, P809, DOI 10.1016/j.arcmed.2008.08.006; Morita YS, 2010, J BIOL CHEM, V285, P16643, DOI 10.1074/jbc.M110.119263; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; Oh YK, 2007, J BIOL CHEM, V282, P28791, DOI 10.1074/jbc.M703759200; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Parish T, 1999, MICROBIOL-SGM, V145, P3497, DOI 10.1099/00221287-145-12-3497; Pethe K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1060; Ratledge C., 1982, BIOL MYCOBACTERIA, P186; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Richard HT, 2003, ADV APPL MICROBIOL, V52, P167, DOI 10.1016/S0065-2164(03)01007-4; SIDDIQI SH, 1984, AM REV RESPIR DIS, V130, P634; Sinsimer D, 2008, INFECT IMMUN, V76, P3027, DOI 10.1128/IAI.01663-07; Sleator RD, 2002, FEMS MICROBIOL REV, V26, P49, DOI 10.1111/j.1574-6976.2002.tb00598.x; Smith DA, 2001, INFECT IMMUN, V69, P1142, DOI 10.1128/IAI.69.2.1442-1150.2001; Smith NH, 2003, P NATL ACAD SCI USA, V100, P15271, DOI 10.1073/pnas.2036554100; SUTTON CR, 1962, ARCH BIOCHEM BIOPHYS, V96, P360, DOI 10.1016/0003-9861(62)90421-6; Titgemeyer F, 2007, J BACTERIOL, V189, P5903, DOI 10.1128/JB.00257-07; Vandal OH, 2009, J BACTERIOL, V191, P4714, DOI 10.1128/JB.00305-09; Wheeler PR, 2008, MICROBIOL-SGM, V154, P3731, DOI 10.1099/mic.0.2008/022269-0; Wheeler PR, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P309; Winder CL, 2006, MICROBIOL-SGM, V152, P2757, DOI 10.1099/mic.0.28986-0	43	28	33	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e52673	10.1371/journal.pone.0052673	http://dx.doi.org/10.1371/journal.pone.0052673			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326347	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000313552400008
J	Koupparis, AM; Kokkinos, V; Kostopoulos, GK				Koupparis, Andreas M.; Kokkinos, Vasileios; Kostopoulos, George K.			Spindle Power Is Not Affected after Spontaneous K-Complexes during Human NREM Sleep	PLOS ONE			English	Article							SYMPATHETIC-NERVE ACTIVITY; EEG; FREQUENCY; MUSCLE; DESYNCHRONIZATION; SYNCHRONIZATION; FLUNITRAZEPAM; AROUSAL	K-complexes and sleep spindles often grouped together characterize the second stage of NREM sleep and interest has been raised on a possible interaction of their underlying mechanisms. The reported inhibition of spindles power for about 15 seconds following evoked K-complexes has implications on their role in arousal. Our objective was to assess this inhibition following spontaneous K-complexes. We used time-frequency analysis of spontaneous K-complexes selected from whole-night EEG recordings of normal subjects. Our results show that spindles are most often observed at the positive phase following the peak of a spontaneous KC (70%). At latencies of 1-3 s following the peak of the K-complex, spindles almost disappear. Compared to long-term effects described for evoked KCs, sleep spindle power is not affected by spontaneous KCs for latencies of 5-15 s. Observation of the recurrence rate of sporadic spindles suggests that the reduction of power at 1-3 s most likely reflects a refractory period of spindles lasting for 1-2 s, rather than an effect of KCs. These results suggest that the mechanisms underlying spontaneous KCs do not affect spindle power as in the case of evoked KCs.	[Koupparis, Andreas M.; Kokkinos, Vasileios; Kostopoulos, George K.] Univ Patras, Sch Med, Dept Physiol, Neurophysiol Unit, Rion, Greece	University of Patras	Kostopoulos, GK (corresponding author), Univ Patras, Sch Med, Dept Physiol, Neurophysiol Unit, Rion, Greece.	gkkostop@med.upatras.gr	Koupparis, Andreas/H-2656-2012; Kokkinos, Vasileios/N-1470-2018	Koupparis, Andreas/0000-0002-0737-2347; Kokkinos, Vasileios/0000-0002-4309-5455	European Commission under the Seventh Framework Programme [ARMOR]; European Union (European Social Fund - ESF); National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II; European Social Fund	European Commission under the Seventh Framework Programme; European Union (European Social Fund - ESF)(European Social Fund (ESF)); National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II; European Social Fund(European Social Fund (ESF))	The work was partially funded by the European Commission under the Seventh Framework Programme (FP7/2007-2013) with grant ARMOR, agreement number 287720. Andreas Koupparis has been co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; Amzica F, 2002, SLEEP MED REV, V6, P139, DOI 10.1053/smrv.2001.0181; Anderer P, 2001, NEUROSCIENCE, V103, P581, DOI 10.1016/S0306-4522(01)00028-8; Bastien CH, 2000, CAN J EXP PSYCHOL, V54, P255, DOI 10.1037/h0087345; Bonjean M, 2012, J NEUROSCI, V32, P5250, DOI 10.1523/JNEUROSCI.6141-11.2012; Bonjean M, 2011, J NEUROSCI, V31, P9124, DOI 10.1523/JNEUROSCI.0077-11.2011; BONNET MH, 1992, SLEEP, V15, P526; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; CHURCH MW, 1978, ELECTROEN CLIN NEURO, V45, P443, DOI 10.1016/0013-4694(78)90289-4; Colrain IM, 2005, SLEEP, V28, P255, DOI 10.1093/sleep/28.2.255; Crowley K, 2004, CLIN NEUROPHYSIOL, V115, P471, DOI 10.1016/j.clinph.2003.10.014; Crunelli V, 2006, CELL CALCIUM, V40, P175, DOI 10.1016/j.ceca.2006.04.022; Curcio G, 2003, CLIN NEUROPHYSIOL, V114, P2279, DOI 10.1016/S1388-2457(03)00276-1; De Gennaro L, 2000, NEUROSCI LETT, V291, P41, DOI 10.1016/S0304-3940(00)01366-5; De Gennaro L, 2003, SLEEP MED REV, V7, P423, DOI 10.1053/smrv.2002.0252; Durka PJ, 2004, IEEE T BIO-MED ENG, V51, P1167, DOI 10.1109/TBME.2004.827341; EHRHART J, 1981, SLEEP, V4, P400; EVANS BM, 1995, J SLEEP RES, V4, P196, DOI 10.1111/j.1365-2869.1995.tb00169.x; Ferrarelli F, 2007, AM J PSYCHIAT, V164, P483, DOI 10.1176/appi.ajp.164.3.483; Fogel SM, 2011, NEUROSCI BIOBEHAV R, V35, P1154, DOI 10.1016/j.neubiorev.2010.12.003; GAILLARD JM, 1975, INT PHARMACOPSYCHIAT, V10, P199, DOI 10.1159/000468195; Gibbs F., 1950, ATLAS ELECTROENCEPHA, V1; HALASZ P, 1993, PHYSIOL BEHAV, V54, P795, DOI 10.1016/0031-9384(93)90094-V; Halasz P, 2005, SLEEP MED REV, V9, P391, DOI 10.1016/j.smrv.2005.04.003; HORNYAK M, 1991, BRAIN, V114, P1281, DOI 10.1093/brain/114.3.1281; JOHNSON LC, 1976, ELECTROEN CLIN NEURO, V40, P67, DOI 10.1016/0013-4694(76)90180-2; Kokkinos V, 2011, J SLEEP RES, V20, P57, DOI 10.1111/j.1365-2869.2010.00830.x; Kokkinos V, 2009, J NEUROSCI METH, V185, P29, DOI 10.1016/j.jneumeth.2009.09.002; Kostopoulos GK, 2000, CLIN NEUROPHYSIOL, V111, pS27, DOI 10.1016/S1388-2457(00)00399-0; KUBICKI S, 1987, EEG-EMG-Z ELEK ELEKT, V18, P61; Loomis AL, 1938, J NEUROPHYSIOL, V1, P413, DOI 10.1152/jn.1938.1.5.413; Loomis AL, 1936, J EXP PSYCHOL, V19, P249, DOI 10.1037/h0062089; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; NAITOH P, 1982, SLEEP, V5, P58, DOI 10.1093/sleep/5.1.58; OKADA H, 1991, NEUROLOGY, V41, P1961, DOI 10.1212/WNL.41.12.1961; Pal I, 1985, SLEEP 84, P232; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Rodenbeck R., 2006, SOMNOLOGIE, V10, P159, DOI [DOI 10.1111/J.1439-054X.2006.00101.X, DOI 10.1111/J]; Rossetti AO, 2005, NEUROPHYSIOL CLIN, V35, P19, DOI 10.1016/j.neucli.2004.12.003; ROTH M, 1956, ELECTROEN CLIN NEURO, V8, P385, DOI 10.1016/0013-4694(56)90004-9; Schabus M, 2007, P NATL ACAD SCI USA, V104, P13164, DOI 10.1073/pnas.0703084104; Si Y, 2010, EPILEPSY RES, V92, P219, DOI 10.1016/j.eplepsyres.2010.10.002; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Swihart BJ, 2010, EPIDEMIOLOGY, V21, P621, DOI 10.1097/EDE.0b013e3181e5b06a; TAKEUCHI S, 1994, J AUTONOM NERV SYST, V47, P121, DOI 10.1016/0165-1838(94)90073-6; Tank J, 2003, AM J PHYSIOL-REG I, V285, pR208, DOI 10.1152/ajpregu.00013.2003; Urakami Y, 2012, CLIN EEG NEUROSCI, V43, P39, DOI 10.1177/1550059411428718; Werth E, 1997, ELECTROEN CLIN NEURO, V103, P535, DOI 10.1016/S0013-4694(97)00070-9; YAMADORI A, 1971, Kobe Journal of Medical Sciences, V17, P97; Zygierewicz J, 2009, ACTA NEUROBIOL EXP, V69, P254	52	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54343	10.1371/journal.pone.0054343	http://dx.doi.org/10.1371/journal.pone.0054343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326604	Green Submitted, Green Published, gold			2022-12-25	WOS:000313552400087
J	Lee, RY; Reiner, D; Dekan, G; Moore, AE; Higgins, TJV; Epstein, MM				Lee, Rui-Yun; Reiner, Daniela; Dekan, Gerhard; Moore, Andrew E.; Higgins, T. J. V.; Epstein, Michelle M.			Genetically Modified alpha-Amylase Inhibitor Peas Are Not Specifically Allergenic in Mice	PLOS ONE			English	Article							PHASEOLUS-VULGARIS; TRANSGENIC EXPRESSION; SEEDS; IMMUNOGENICITY; ARCELIN; LEGUMES	Weevils can devastate food legumes in developing countries, but genetically modified peas (Pisum sativum), chickpeas and cowpeas expressing the gene for alpha-amylase inhibitor-1 (alpha AI) from the common bean (Phaseolus vulgaris) are completely protected from weevil destruction. alpha AI is seed-specific, accumulated at high levels and undergoes post-translational modification as it traverses the seed endomembrane system. This modification was thought to be responsible for the reported allergenicity in mice of the transgenic pea but not the bean. Here, we observed that transgenic alpha AI peas, chickpeas and cowpeas as well as non-transgenic beans were all allergenic in BALB/c mice. Even consuming non-transgenic peas lacking alpha AI led to an anti-alpha AI response due to a cross-reactive response to pea lectin. Our data demonstrate that alpha AI transgenic peas are not more allergenic than beans or non-transgenic peas in mice. This study illustrates the importance of repeat experiments in independent laboratories and the potential for unexpected cross-reactive allergic responses upon consumption of plant products in mice.	[Lee, Rui-Yun; Reiner, Daniela; Epstein, Michelle M.] Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, Vienna, Austria; [Dekan, Gerhard] Med Univ Vienna, Inst Clin Pathol, Vienna, Austria; [Moore, Andrew E.; Higgins, T. J. V.] CSIRO, Plant Ind, Canberra, ACT, Australia	Medical University of Vienna; Medical University of Vienna; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Epstein, MM (corresponding author), Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, Vienna, Austria.	michelle.epstein@meduniwien.ac.at	Higgins, Thomas JV/F-8360-2010	Higgins, Thomas JV/0000-0002-4445-1327; Epstein, Michelle/0000-0002-4755-0224	GMSAFOOD project through the 7th Framework grant [211820]	GMSAFOOD project through the 7th Framework grant	Funding for this research was provided the GMSAFOOD project (grant nu,ber 211820), through the 7th Framework grant, administered by the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, NAT BIOTECH, V24, P2; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Campbell PM, 2011, J AGR FOOD CHEM, V59, P6047, DOI 10.1021/jf200456j; GATEHOUSE JA, 1986, PHILOS T ROY SOC B, V314, P367, DOI 10.1098/rstb.1986.0059; Higgins T, 2012, INSECT PROT IN PRESS; HIGGINS TJV, 1983, J BIOL CHEM, V258, P9544; James C., 2004, GLOBAL STATUS COMMER; MARSHALL JJ, 1975, J BIOL CHEM, V250, P8030; MIRKOV TE, 1994, PLANT MOL BIOL, V26, P1103, DOI 10.1007/BF00040692; Mojtabavi N, 2002, J IMMUNOL, V169, P4788, DOI 10.4049/jimmunol.169.9.4788; Prescott VE, 2006, J LEUKOCYTE BIOL, V80, P258, DOI 10.1189/jlb.1105637; Prescott VE, 2005, J AGR FOOD CHEM, V53, P9023, DOI 10.1021/jf050594v; ROUGE P, 1993, BIOCHEM SYST ECOL, V21, P695, DOI 10.1016/0305-1978(93)90074-2; Sarmah BK, 2004, MOL BREEDING, V14, P73, DOI 10.1023/B:MOLB.0000037996.01494.12; SCHROEDER HE, 1995, PLANT PHYSIOL, V109, P1129; SHADE RE, 1994, BIO-TECHNOL, V12, P793, DOI 10.1038/nbt0894-793	16	20	22	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52972	10.1371/journal.pone.0052972	http://dx.doi.org/10.1371/journal.pone.0052972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326368	Green Published, gold			2022-12-25	WOS:000313551500038
J	Wang, L; Zheng, YB; Xu, HW; Yan, XF; Chang, XT				Wang, Lin; Zheng, Yabing; Xu, Hengwei; Yan, Xinfeng; Chang, Xiaotian			Investigate Pathogenic Mechanism of TXNDC5 in Rheumatoid Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; T-CELLS; ADIPONECTIN; MICE; LYMPHOCYTES; EXPRESSION; INDUCER; RATIO; IL-1	Hypoxia stimulates synovial hypoperfusion in rheumatoid arthritis (RA). TXNDC5 stimulates cellular proliferation in hypoxic conditions. We previously detected increased TXNDC5 expression in synovial tissues and blood from RA patients and demonstrated that the gene encoding TXNDC5 increased RA risk. The present study investigated the pathogenic roles of TXNDC5 in RA. Transgenic mice that over-expressed TXNDC5 (TXNDC5-Tg) were generated using C57BL/6J mice and treated with bovine collagen II to induce arthritis (CIA). Synovial fibroblasts from RA patients (RASFs) were cultured and incubated with TXNDC5-siRNA or CoCl2, a chemical that induces hypoxia. CIA was observed in 80% of the TXNDC5-Tg, but only 20% of the wild-type mice (WT) developed CIA. The clinical arthritis scores reached 5 in the TXNDC5-Tg, but this index only reached 2 in the control mice. CIA TXNDC5-Tg exhibited clear pannus proliferation and bone erosion in joint tissues. A significant increase in CD4 T cells was observed in the thymus and spleen of TXNDC5-Tg during CIA. Serum levels of anti-collagen II IgG, IgG1 and IgG2a antibodies were significantly elevated in the mice. Increased cell proliferation, cell migration and TXNDC5 expression were observed in RASFs following incubation with 1 mu M CoCl2. However, this effect was diminished when TXNDC5 expression was inhibited with 100 nM siRNA. TNF-alpha, IL-1 alpha, IL-1 beta and IL-17 levels were significantly increased in the blood of TXNDC5-Tg mice, but the levels of these cytokines declined in the supernatant of RASFs that were treated with TXNDC5 siRNA. The expression of adiponectin, a cytokine-like mediator, decreased significantly in RASFs following TXNDC5 siRNA treatment. These results suggest that TXNDC5-over-expressing mice were susceptible to CIA. This study also suggests that hypoxia induced TXCNDC5 expression, which contributed to adiponectin expression, cytokine production and the cellular proliferation and migration of fibroblasts in RA.	[Wang, Lin] Shandong Acad Med Sci, Med Biotechnol Res Ctr, Jinan, Shandong, Peoples R China; [Wang, Lin] Shandong Univ, Dept Pathol, Sch Med, Jinan 250100, Shandong, Peoples R China; [Zheng, Yabing; Yan, Xinfeng; Chang, Xiaotian] Shandong Univ, Shandong Prov Qianfoshan Hosp, Med Res Ctr, Jinan 250100, Shandong, Peoples R China; [Xu, Hengwei] Shandong Tumor Hosp, Dept Pharm, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences	Chang, XT (corresponding author), Shandong Univ, Shandong Prov Qianfoshan Hosp, Med Res Ctr, Jinan 250100, Shandong, Peoples R China.	changxt@126.com		Wang, Lin/0000-0002-0503-9727	National Basic Research Program of China [2010CB529105]; Shandong Taishan Scholarship	National Basic Research Program of China(National Basic Research Program of China); Shandong Taishan Scholarship	This study was supported by the National Basic Research Program of China (2010CB529105) and the Shandong Taishan Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson SM, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3867; Brenner M, 2007, MOL MED, V13, P277, DOI 10.2119/2007-00003.Brenner; CANTAGREL A, 1988, J RHEUMATOL, V15, P899; Chabaud M, 2001, J IMMUNOL, V167, P6015, DOI 10.4049/jimmunol.167.10.6015; Chang XT, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3429; Chang XT, 2009, J RHEUMATOL, V36, P872, DOI 10.3899/jrheum.080939; Charlton HK, 2010, BIOCHEM BIOPH RES CO, V392, P234, DOI 10.1016/j.bbrc.2010.01.029; Chen LM, 2010, J IMMUNOL, V184, P4455, DOI 10.4049/jimmunol.0900525; Choi HM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2844; EMERY P, 1987, ARTHRITIS RHEUM, V30, P849, DOI 10.1002/art.1780300802; Evans DM, 2004, GENES IMMUN, V5, P548, DOI 10.1038/sj.gene.6364126; Frommer KW, 2010, ARTHRITIS RHEUM-US, V62, P2886, DOI 10.1002/art.27616; Huan J, 2008, J IMMUNOL, V180, P1249, DOI 10.4049/jimmunol.180.2.1249; KADOWAKI KM, 1994, CLIN EXP IMMUNOL, V97, P212; Kanda Hiroko, 2007, Mod Rheumatol, V17, P364, DOI 10.1007/s10165-007-0589-4; Karmakar S, 2010, RHEUM DIS CLIN N AM, V36, P385, DOI 10.1016/j.rdc.2010.03.003; Kim KW, 2005, ARTHRITIS RES THER, V7, pR139, DOI 10.1186/ar1470; Koenders MI, 2006, ANN RHEUM DIS, V65, P29, DOI 10.1136/ard.2006.058529; Lee SW, 2012, BIOMATERIALS, V33, P1563, DOI 10.1016/j.biomaterials.2011.10.079; Li ZH, 2011, PROTEIN CELL, V2, P604, DOI 10.1007/s13238-011-1083-5; Lundy SK, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2107; Malfait AM, 2000, P NATL ACAD SCI USA, V97, P9561, DOI 10.1073/pnas.160105897; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Muz B, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2568; Nakamura H, 2004, ANTIOXID REDOX SIGN, V6, P15, DOI 10.1089/152308604771978309; Oh S, 2010, IMMUNOL REV, V233, P97, DOI 10.1111/j.0105-2896.2009.00848.x; Piret JP, 2002, ANN NY ACAD SCI, V973, P443, DOI 10.1111/j.1749-6632.2002.tb04680.x; Ravlic-Gulan J, 2005, COLLEGIUM ANTROPOL, V29, P661; SEKI N, 1988, J IMMUNOL, V140, P1477; Senolt L, 2006, CYTOKINE, V35, P247, DOI 10.1016/j.cyto.2006.09.002; Sullivan DC, 2003, J BIOL CHEM, V278, P47079, DOI 10.1074/jbc.M308124200; TAYLOR PC, 1995, EUR J IMMUNOL, V25, P763, DOI 10.1002/eji.1830250321; WOOLEY PH, 1985, J IMMUNOL, V135, P2443; Zhang L, 2010, J CANCER RES CLIN, V136, P1497, DOI 10.1007/s00432-010-0807-x; Zwerina J, 2005, ANN NY ACAD SCI, V1051, P716, DOI 10.1196/annals.1361.116	35	22	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53301	10.1371/journal.pone.0053301	http://dx.doi.org/10.1371/journal.pone.0053301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326410	Green Submitted, Green Published, gold			2022-12-25	WOS:000313551500062
J	Zeymer, C; Werbeck, ND; Schlichting, I; Reinstein, J				Zeymer, Cathleen; Werbeck, Nicolas D.; Schlichting, Ilme; Reinstein, Jochen			The Molecular Mechanism of Hsp100 Chaperone Inhibition by the Prion Curing Agent Guanidinium Chloride	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAINS; PROTEINS; CLPB; THERMOTOLERANCE; DISAGGREGATION; HYDROCHLORIDE; ELIMINATION; PROPAGATION; STABILITY; MOTOR	The Hsp100 chaperones ClpB and Hsp104 utilize the energy from ATP hydrolysis to reactivate aggregated proteins in concert with the DnaK/Hsp70 chaperone system, thereby playing an important role in protein quality control. They belong to the family of AAA+ proteins (ATPases associated with various cellular activities), possess two nucleotide binding domains per monomer (NBD1 and NBD2), and oligomerize into hexameric ring complexes. Furthermore, Hsp104 is involved in yeast prion propagation and inheritance. It is well established that low concentrations of guanidinium chloride (GdmCl) inhibit the ATPase activity of Hsp104, leading to so called "prion curing," the loss of prion-related phenotypes. Here, we present mechanistic details about the Hsp100 chaperone inhibition by GdmCl using the Hsp104 homolog ClpB from Thermus thermophilus. Initially, we demonstrate that NBD1 of ClpB, which was previously considered inactive as a separately expressed construct, is a fully active ATPase on its own. Next, we show that only NBD1, but not NBD2, is affected by GdmCl. We present a crystal structure of ClpB NBD1 in complex with GdmCl and ADP, showing that the Gdm(+) ion binds specifically to the active site of NBD1. A conserved essential glutamate residue is involved in this interaction. Additionally, Gdm(+) interacts directly with the nucleotide, thereby increasing the nucleotide binding affinity of NBD1. We propose that both the interference with the essential glutamate and the modulation of nucleotide binding properties in NBD1 is responsible for the GdmCl-specific inhibition of Hsp100 chaperones.	[Zeymer, Cathleen; Werbeck, Nicolas D.; Schlichting, Ilme; Reinstein, Jochen] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany	Max Planck Society	Reinstein, J (corresponding author), Max Planck Inst Med Res, Dept Biomol Mech, Jahnstr 29, D-69120 Heidelberg, Germany.	jochen.reinstein@mpimf-heidelberg.mpg.de	Schlichting, Ilme/I-1339-2013	Zeymer, Cathleen/0000-0001-7138-381X	Max Planck Society; German National Academic Foundation	Max Planck Society(Max Planck Society); German National Academic Foundation	This work was supported by the Max Planck Society and a Ph.D. scholarship (to C. Z.) from the German National Academic Foundation.	Fernandez-Higuero JA, 2011, J BIOL CHEM, V286, P25547, DOI 10.1074/jbc.M111.231365; Beinker P, 2005, J BIOL CHEM, V280, P37965, DOI 10.1074/jbc.M506672200; Beinker P, 2002, J BIOL CHEM, V277, P47160, DOI 10.1074/jbc.M207853200; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CLARKE J, 1993, BIOCHEMISTRY-US, V32, P4322, DOI 10.1021/bi00067a022; Cochran JC, 2005, J BIOL CHEM, V280, P12658, DOI 10.1074/jbc.M413140200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DeSantis ME, 2012, BBA-MOL CELL RES, V1823, P29, DOI 10.1016/j.bbamcr.2011.07.014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Franzmann TM, 2011, J BIOL CHEM, V286, P17992, DOI 10.1074/jbc.M110.216176; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Grimminger V, 2004, J BIOL CHEM, V279, P7378, DOI 10.1074/jbc.M312403200; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Hodson S, 2012, J STRUCT BIOL, V179, P161, DOI 10.1016/j.jsb.2012.05.015; Jung GM, 2002, P NATL ACAD SCI USA, V99, P9936, DOI 10.1073/pnas.152333299; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Klostermeier D, 1999, J MOL BIOL, V287, P511, DOI 10.1006/jmbi.1999.2636; Lad L, 2008, BIOCHEMISTRY-US, V47, P3576, DOI 10.1021/bi702061g; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miot M, 2011, P NATL ACAD SCI USA, V108, P6915, DOI 10.1073/pnas.1102828108; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAGLAK TJ, 1992, BIOTECHNOL BIOENG, V39, P732, DOI 10.1002/bit.260390706; Nowicki L, 2012, CELL STRESS CHAPERON, V17, P361, DOI 10.1007/s12192-011-0312-4; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schlee S, 2001, J MOL BIOL, V306, P889, DOI 10.1006/jmbi.2001.4455; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Thrall SH, 1996, BIOCHEMISTRY-US, V35, P4609, DOI 10.1021/bi9526387; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; TUITE MF, 1981, GENETICS, V98, P691; Watanabe YH, 2009, BIOCHEM J, V421, P71, DOI 10.1042/BJ20082238; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wendler P, 2010, BIOCHEM CELL BIOL, V88, P89, DOI [10.1139/O09-164, 10.1139/o09-164]; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026; Werbeck ND, 2011, BIOCHEMISTRY-US, V50, P899, DOI 10.1021/bi1018286; Werbeck ND, 2009, BIOCHEMISTRY-US, V48, P7240, DOI 10.1021/bi900880c; Winkler J, 2012, J STRUCT BIOL, V179, P152, DOI 10.1016/j.jsb.2012.05.002; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yan YW, 2004, J MOL BIOL, V335, P547, DOI 10.1016/j.jmb.2003.10.074	47	15	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7065	7076		10.1074/jbc.M112.432583	http://dx.doi.org/10.1074/jbc.M112.432583			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23341453	Green Published, hybrid			2022-12-25	WOS:000316002400028
J	Yang, F; Zhang, WM; Li, D; Zhan, QM				Yang, Fang; Zhang, Weimin; Li, Dan; Zhan, Qimin			Gadd45a Suppresses Tumor Angiogenesis via Inhibition of the mTOR/STAT3 Protein Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE PHOSPHORYLATION; MAXIMAL ACTIVATION; BETA-CATENIN; STAT3; EXPRESSION; CANCER; RAPAMYCIN; KINASE; TARGET; TRANSCRIPTION	Gadd45a, a p53-regulated and DNA damage-inducible gene, is implicated in protection against tumor malignancy, although the underlying mechanism remains to be defined further. Here we demonstrate that Gadd45a plays an important role in suppression of tumor angiogenesis. Gadd45a deletion significantly increases microvessel density in tumors and stimulates an angiogenic response in a chicken embryo chorioallantoic membrane assay. Disruption of endogenous Gadd45a promotes tube formation and migration of endothelial cells. We further show that Gadd45a deletion increases phosphorylation of STAT3 at Ser-727 and, in turn, elevates the STAT3 transcriptional activity. This process substantially induces both expression and secretion of VEGFa, a STAT3 responsive gene, and promotes tumor angiogenesis. Interestingly, Gadd45a is able to physically associate with mammalian target of rapamycin (mTOR), a kinase that mediates Ser-727 phosphorylation of STAT3. The interaction of Gadd45a with mTOR suppresses STAT3 phosphorylation at Ser-727 and leads to down-regulated expression of VEGFa. Further analysis reveals that Gadd45a overexpression attenuates the association between mTOR and STAT3, whereas Gadd45a disruption strengthens this interaction, indicating that Gadd45a suppression of STAT3 phosphorylation is mainly through the dissociation of mTOR with STAT3. Taken together, these findings provide the first evidence that Gadd45a inhibits tumor angiogenesis via blocking of the mTOR/STAT3 pathway.	Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhan, QM (corresponding author), Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	zhanqimin@pumc.edu.cn			973 National Key Fundamental Research Program of China [2009CB521801]; National Natural Science Foundation of China [81021061]	973 National Key Fundamental Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by 973 National Key Fundamental Research Program of China Grant 2009CB521801 and National Natural Science Foundation of China Grant 81021061.	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Balasubramanian SP, 2002, BRIT J CANCER, V87, P1057, DOI 10.1038/sj.bjc.6600625; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Cao RH, 2002, FASEB J, V16, P1575, DOI 10.1096/fj.02-0319com; Carrier F, 1999, MOL CELL BIOL, V19, P1673; Chen CL, 2007, BRIT J CANCER, V96, P591, DOI 10.1038/sj.bjc.6603597; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hildesheim J, 2004, ONCOGENE, V23, P1829, DOI 10.1038/sj.onc.1207301; Hildesheim J, 2002, CANCER RES, V62, P7305; Hollander MC, 2001, CANCER RES, V61, P2487; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Ji J, 2007, ONCOGENE, V26, P6396, DOI 10.1038/sj.onc.1210469; Jin SQ, 2000, J BIOL CHEM, V275, P16602, DOI 10.1074/jbc.M000284200; Liu AMF, 2006, J BIOL CHEM, V281, P35812, DOI 10.1074/jbc.M605288200; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Ramachandran K, 2009, CANCER RES, V69, P1527, DOI 10.1158/0008-5472.CAN-08-3609; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schuringa JJ, 2001, FEBS LETT, V495, P71, DOI 10.1016/S0014-5793(01)02354-7; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Tong T, 2005, MOL CELL BIOL, V25, P4488, DOI 10.1128/MCB.25.11.4488-4500.2005; Wang W, 2005, ONCOGENE, V24, P2705, DOI 10.1038/sj.onc.1208464; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yamasawa K, 2002, CLIN CANCER RES, V8, P2563; Yan S, 2008, CANCER LETT, V271, P85, DOI 10.1016/j.canlet.2008.05.035; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995	30	56	62	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6552	6560		10.1074/jbc.M112.418335	http://dx.doi.org/10.1074/jbc.M112.418335			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23329839	Green Published, hybrid			2022-12-25	WOS:000315820700048
J	Horvat, T; Dezeljin, M; Redzic, I; Barisic, D; Bosnar, MH; Lauc, G; Zoldos, V				Horvat, Tomislav; Dezeljin, Martina; Redzic, Irma; Barisic, Darko; Bosnar, Maja Herak; Lauc, Gordan; Zoldos, Vlatka			Reversibility of Membrane N-Glycome of HeLa Cells upon Treatment with Epigenetic Inhibitors	PLOS ONE			English	Article							HUMAN BREAST-CANCER; DNA METHYLATION; PERICENTRIC HETEROCHROMATIN; MOLECULAR-BASIS; EXPRESSION; ZEBULARINE; GLYCOSYLATION; TRICHOSTATIN; GLYCANS; REACTIVATION	Glycans are essential regulators of protein function and are now in the focus of research in many physiological and pathophysiological processes. There are numerous modes of regulating their biosynthesis, including epigenetic mechanisms implicated in the expression of glyco-genes. Since N-glycans located at the cell membrane define intercellular communication as well as a cellular response to a given environment, we developed a method to preferentially analyze this fraction of glycans. The method is based on incorporation of living cells into polyacrylamide gels, partial denaturation of membrane proteins with 3 M urea and subsequent release of N-glycans with PNGase F followed by HPLC analysis. Using this newly developed method, we revealed multiple effects of epigenetic inhibitors Trichostatin A, sodium butyrate and zebularine on the composition of N-glycans in human cells. The induced changes were found to be reversible after inhibitor removal. Given that many epigenetic inhibitors are currently explored as a therapeutic strategy in treatment of cancer, wherein surface glycans play an important role, the presented work contributes to our understanding of their efficiency in altering the N-glycan profile of cancer cells in culture.	[Horvat, Tomislav; Barisic, Darko; Zoldos, Vlatka] Univ Zagreb, Fac Sci, Zagreb 41000, Croatia; [Dezeljin, Martina; Bosnar, Maja Herak] Rudjer Boskovic Inst, Zagreb, Croatia; [Redzic, Irma; Lauc, Gordan] Univ Zagreb, Fac Pharm & Biochem, Zagreb 41000, Croatia; [Lauc, Gordan] Genos Ltd, Glycobiol Lab, Zagreb, Croatia; [Lauc, Gordan] Edith Cowan Univ, Perth, WA, Australia	University of Zagreb; Rudjer Boskovic Institute; University of Zagreb; Edith Cowan University	Lauc, G (corresponding author), Univ Zagreb, Fac Pharm & Biochem, Zagreb 41000, Croatia.	glauc@pharma.hr; vzoldos@biol.pmf.hr	Lauc, Gordan/K-5864-2012; Bosnar, Maja Herak/AAN-6122-2020	Lauc, Gordan/0000-0003-1840-9560; 	Croatian Ministry of Science, Education and Sport [309-0061194-2023, 119-1191196-1224, 098-0982464-2513]; European Commission GlycoBioM [259869]; European Commission HighGlycan [278535]; AUF PSCI Grant (Agence universitaire de la Francophonie)	Croatian Ministry of Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia); European Commission GlycoBioM; European Commission HighGlycan; AUF PSCI Grant (Agence universitaire de la Francophonie)	This work was supported by the Croatian Ministry of Science, Education and Sport grants #309-0061194-2023 (to GL), #119-1191196-1224 (to VZ) and #098-0982464-2513 (to MHB); by the European Commission GlycoBioM (contract #259869) and HighGlycan (contract #278535) grants and by AUF PSCI Grant (Agence universitaire de la Francophonie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KL, 2008, PROTEOMICS, V8, P3210, DOI 10.1002/pmic.200800157; Alavi A, 2008, RHEUMATOLOGY, V47, P760, DOI 10.1093/rheumatology/ken081; Andersen JB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001338; Balch C, 2005, MOL CANCER THER, V4, P1505, DOI 10.1158/1535-7163.MCT-05-0216; Billam M, 2010, BREAST CANCER RES TR, V120, P581, DOI 10.1007/s10549-009-0420-3; Champion C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012388; Chen M, 2012, MOL CANCER THER, V11, P370, DOI 10.1158/1535-7163.MCT-11-0458; Cheng JC, 2003, J NATL CANCER I, V95, P399, DOI 10.1093/jnci/95.5.399; Cheng JC, 2004, CANCER CELL, V6, P151, DOI 10.1016/j.ccr.2004.06.023; Chiurazzi P, 1999, HUM MOL GENET, V8, P2317, DOI 10.1093/hmg/8.12.2317; Craig JM, 2003, EMBO J, V22, P2495, DOI 10.1093/emboj/cdg232; Dannenberg LO, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-181; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; Diehl GE, 2004, IMMUNITY, V21, P877, DOI 10.1016/j.immuni.2004.11.008; Gornik O, 2009, GLYCOBIOLOGY, V19, P1547, DOI 10.1093/glycob/cwp134; Gornik O, 2008, DIS MARKERS, V25, P267, DOI 10.1155/2008/493289; Hellebrekers DMEI, 2006, MOL CANCER THER, V5, P467, DOI 10.1158/1535-7163.MCT-05-0417; Herranz M, 2006, BLOOD, V107, P1174, DOI 10.1182/blood-2005-05-2033; Horvat T, 2012, BBA-GEN SUBJECTS, V1820, P1412, DOI 10.1016/j.bbagen.2011.12.007; Horvat T, 2011, CLIN EPIGENETICS, V2, P425, DOI 10.1007/s13148-011-0039-1; Ide Y, 2006, BIOCHEM BIOPH RES CO, V341, P478, DOI 10.1016/j.bbrc.2005.12.208; Jitsuhara Y, 2002, J BIOCHEM, V132, P803, DOI 10.1093/oxfordjournals.jbchem.a003290; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kannagi R, 1997, GLYCOCONJUGATE J, V14, P577, DOI 10.1023/A:1018532409041; Kawamura YI, 2008, GASTROENTEROLOGY, V135, P142, DOI 10.1053/j.gastro.2008.03.031; Knezevic A, 2009, J PROTEOME RES, V8, P694, DOI 10.1021/pr800737u; Lebrilla CB, 2009, MOL BIOSYST, V5, P17, DOI 10.1039/b811781k; Listinsky JJ, 2011, AM J TRANSL RES, V3, P292; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; Mariadason JM, 2000, CANCER RES, V60, P4561; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Miyoshi E, 2012, BIOMOLECULES, V2, P34, DOI 10.3390/biom2010034; Moriwaki K, 2010, GLYCOCONJUGATE J, V27, P649, DOI 10.1007/s10719-010-9310-5; Moriwaki K, 2009, GASTROENTEROLOGY, V137, P188, DOI 10.1053/j.gastro.2009.04.002; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; Packer NH, 2008, PROTEOMICS, V8, P8, DOI 10.1002/pmic.200700917; Pajak B, 2007, ADV MED SCI-POLAND, V52, P83; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pucic M, 2010, GLYCOBIOLOGY, V20, P970, DOI 10.1093/glycob/cwq052; RADEMACHER TW, 1994, P NATL ACAD SCI USA, V91, P6123, DOI 10.1073/pnas.91.13.6123; Royle L, 2008, ANAL BIOCHEM, V376, P1, DOI 10.1016/j.ab.2007.12.012; Schraen-Maschke S, 2003, BIOCHIMIE, V85, P219, DOI 10.1016/S0300-9084(03)00018-X; Selker EU, 1998, P NATL ACAD SCI USA, V95, P9430, DOI 10.1073/pnas.95.16.9430; Serpa J, 2006, CANCER LETT, V242, P191, DOI 10.1016/j.canlet.2005.11.009; Sharma V, 2011, J BIOL CHEM, V286, P10193, DOI 10.1074/jbc.M110.194241; Syrbe U, 2004, BLOOD, V104, P3243, DOI 10.1182/blood-2003-09-3047; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Taddei A, 2005, EMBO REP, V6, P520, DOI 10.1038/sj.embor.7400441; Taniguchi N, 1999, BBA-MOL BASIS DIS, V1455, P287, DOI 10.1016/S0925-4439(99)00066-6; Taniguchi N., 2002, HDB GLYCOSYLTRANSFER; Tempel W, 2004, J BIOL CHEM, V279, P29774, DOI 10.1074/jbc.M403065200; Vanderschaeghe D, 2010, ANAL CHEM, V82, P7408, DOI 10.1021/ac101560a; VanLint C, 1996, GENE EXPRESSION, V5, P245; Wuhrer M, 2007, EXPERT REV PROTEOMIC, V4, P135, DOI 10.1586/14789450.4.2.135; Yoo CB, 2004, BIOCHEM SOC T, V32, P910, DOI 10.1042/BST0320910; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Zoldos V, 2012, EPIGENETICS-US, V7, P164, DOI 10.4161/epi.7.2.18918; Zoldos Vlatka, 2010, Biomol Concepts, V1, P253, DOI 10.1515/bmc.2010.027	61	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54672	10.1371/journal.pone.0054672	http://dx.doi.org/10.1371/journal.pone.0054672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23336012	Green Published, gold			2022-12-25	WOS:000314707700070
J	Thuille, N; Wachowicz, K; Hermann-Kleiter, N; Kaminski, S; Fresser, F; Lutz-Nicoladoni, C; Leitges, M; Thome, M; Massoumi, R; Baier, G				Thuille, Nikolaus; Wachowicz, Katarzyna; Hermann-Kleiter, Natascha; Kaminski, Sandra; Fresser, Friedrich; Lutz-Nicoladoni, Christina; Leitges, Michael; Thome, Margot; Massoumi, Ramin; Baier, Gottfried			PKC theta/beta and CYLD Are Antagonistic Partners in the NF kappa B and NFAT Transactivation Pathways in Primary Mouse CD3(+) T Lymphocytes	PLOS ONE			English	Article							KINASE-C-THETA; TUMOR-SUPPRESSOR CYLD; DEUBIQUITINATING ENZYME CYLD; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; NEGATIVE REGULATOR; CELL-ACTIVATION; DEFICIENT MICE; IMMUNOLOGICAL SYNAPSE; IN-VIVO; MALT1	In T cells PKC theta mediates the activation of critical signals downstream of TCR/CD28 stimulation. We investigated the molecular mechanisms by which PKC theta regulates NF kappa B transactivation by examining PKC theta/beta single and double knockout mice and observed a redundant involvement of PKCh and PKC beta in this signaling pathway. Mechanistically, we define a PKC theta-CYLD protein complex and an interaction between the positive PKC theta/beta and the negative CYLD signaling pathways that both converge at the level of TAK1/IKK/I-kB alpha/NF kappa B and NFAT transactivation. In Jurkat leukemic T cells, CYLD is endoproteolytically processed in the initial minutes of stimulation by the paracaspase MALT1 in a PKC-dependent fashion, which is required for robust IL-2 transcription. However, in primary T cells, CYLD processing occurs with different kinetics and an altered dependence on PKC. The formation of a direct PKC theta/CYLD complex appears to regulate the short-term spatial distribution of CYLD, subsequently affecting NF kappa B and NFAT repressional activity of CYLD prior to its MALT1dependent inactivation. Taken together, our study establishes CYLD as a new and critical PKC theta interactor in T cells and reveals that antagonistic PKC theta/beta-CYLD crosstalk is crucial for the adjustment of immune thresholds in primary mouse CD3(+) T cells.	[Thuille, Nikolaus; Wachowicz, Katarzyna; Hermann-Kleiter, Natascha; Kaminski, Sandra; Fresser, Friedrich; Lutz-Nicoladoni, Christina; Baier, Gottfried] Med Univ Innsbruck, Dept Pharmacol & Genet, A-6020 Innsbruck, Austria; [Leitges, Michael] Biotechnol Ctr Oslo, Oslo, Norway; [Thome, Margot] Univ Lausanne, Dept Biochem, Lausanne, Switzerland; [Massoumi, Ramin] Lund Univ, Dept Lab Med, Malmo, Sweden	Medical University of Innsbruck; University of Lausanne; Lund University	Baier, G (corresponding author), Med Univ Innsbruck, Dept Pharmacol & Genet, A-6020 Innsbruck, Austria.	Gottfried.Baier@i-med.ac.at	Massoumi, Ramin/AAG-4786-2019; Kleiter, Natascha/I-5101-2018; Kaminski, Sandra/AAM-6134-2021; Thome, Margot/F-8167-2011; Leitges, Michael/AAN-1953-2021	Kleiter, Natascha/0000-0003-4389-9813; Thome, Margot/0000-0002-5656-2139; Baier, Gottfried/0000-0002-2085-8325; Leitges, Michael/0000-0003-4203-6995; Thuille, Nikolaus/0000-0002-2253-3946	FWF Austrian Science Fund [SFB-021, MCBO-DK, P23537, P25044]; Austrian BM:WF; European Community Program SYBILLA [HEALTH-F4-2008-201106]; Austrian Science Fund (FWF) [P 23537, P 25044] Funding Source: researchfish	FWF Austrian Science Fund(Austrian Science Fund (FWF)); Austrian BM:WF; European Community Program SYBILLA; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from the FWF Austrian Science Fund (SFB-021, MCBO-DK, P23537, and P25044), funds from the Austrian BM:WF and the European Community Program SYBILLA under grant agreement HEALTH-F4-2008-201106. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2011, NAT IMMUNOL, V12, P1176, DOI 10.1038/ni.2157; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Giannoni F, 2005, J VIROL, V79, P6808, DOI 10.1128/JVI.79.11.6808-6813.2005; Gruber T, 2008, MOL IMMUNOL, V45, P117, DOI 10.1016/j.molimm.2007.05.003; Gruber T, 2010, IMMUNOL LETT, V132, P6, DOI 10.1016/j.imlet.2010.04.008; Gruber T, 2009, MOL IMMUNOL, V46, P2071, DOI 10.1016/j.molimm.2009.02.030; Hayashi K, 2007, PHARMACOL RES, V55, P537, DOI 10.1016/j.phrs.2007.04.009; Hermann-Kleiter N, 2006, BLOOD, V107, P4841, DOI 10.1182/blood-2005-10-4044; Jono H, 2004, J BIOL CHEM, V279, P36171, DOI 10.1074/jbc.M406638200; Kingeter LM, 2008, J IMMUNOL, V181, P6244, DOI 10.4049/jimmunol.181.9.6244; Koga T, 2008, J BIOL CHEM, V283, P12546, DOI 10.1074/jbc.M710518200; Kong KF, 2011, NAT IMMUNOL, V12, P1105, DOI 10.1038/ni.2120; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Lim JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001032; Lim JH, 2007, IMMUNITY, V27, P349, DOI 10.1016/j.immuni.2007.07.011; Marsland BJ, 2008, TRENDS IMMUNOL, V29, P179, DOI 10.1016/j.it.2008.01.005; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Morley SC, 2008, J IMMUNOL, V181, P4696, DOI 10.4049/jimmunol.181.7.4696; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Reiley W, 2004, J BIOL CHEM, V279, P55161, DOI 10.1074/jbc.M411049200; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Salek-Ardakani S, 2005, J IMMUNOL, V175, P7635, DOI 10.4049/jimmunol.175.11.7635; Sedwick CE, 2004, MOL IMMUNOL, V41, P675, DOI 10.1016/j.molimm.2004.01.007; Staal J, 2011, EMBO J, V30, P1742, DOI 10.1038/emboj.2011.85; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tan SL, 2006, J IMMUNOL, V176, P2872, DOI 10.4049/jimmunol.176.5.2872; Thuille N, 2004, MOL IMMUNOL, V41, P385, DOI 10.1016/j.molimm.2004.03.007; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Volkov Y, 1998, J IMMUNOL, V161, P6487; Volkov Y, 2001, NAT IMMUNOL, V2, P508, DOI 10.1038/88700; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wickstrom SA, 2010, EMBO J, V29, P131, DOI 10.1038/emboj.2009.317; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746	43	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53709	10.1371/journal.pone.0053709	http://dx.doi.org/10.1371/journal.pone.0053709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335970	Green Published, gold, Green Submitted			2022-12-25	WOS:000314707700026
J	Xia, CA; Chen, H; Wang, W; Deng, Y; Wen, B; Ruan, L; Tan, WJ				Xia Chuai; Chen, Hong; Wang, Wen; Deng, Yao; Wen, Bo; Ruan, Li; Tan, Wenjie			Poly(I:C)/Alum Mixed Adjuvant Priming Enhances HBV Subunit Vaccine-Induced Immunity in Mice When Combined with Recombinant Adenoviral-Based HBV Vaccine Boosting	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; IMMUNOSTIMULATORY PHOSPHOROTHIOATE OLIGONUCLEOTIDE; SURFACE-ANTIGEN; ANTIBODY-RESPONSES; DIRECT STIMULATION; BACTERIAL-DNA; CPG MOTIFS; T-CELLS; HEALTHY; OLIGODEOXYNUCLEOTIDE	Background: Virus-specific cellular immune responses play a critical role in virus clearance during acute or chronic HBV infection. Currently, the commercially available HBV vaccine is combined with alum adjuvant, which stimulates mainly Th2 immune responses. Therefore, development of new therapeutic HBV vaccine adjuvants and immune strategies that also promote Th1 and CTL responses is urgently needed. Methodology/Principal findings: To improve the immunity induced by the novel HBSS1 HBV vaccine, we evaluated the ability of adjuvants, including alum, CpG and polyriboinosinic polyribocytidylic acid [poly(I:C)], to enhance the response when boosted with the recombinant adenoviral vector vaccine rAdSS1. The immune responses to different adjuvant combinations were assessed in C57BL/6 mice by enzyme-linked immunosorbent assay (ELISA), ELISpot and cytokine release assays. Among the combinations tested, a HBV protein particle vaccine with CpG/alum and poly(I:C)/alum priming combinations accelerated specific seroconversion and produced high antibody (anti-PreS1, anti-S antibody) titres with a Th1 bias. After boosting with recombinant adenoviral vector vaccine rAdSS1, both groups produced a strong multi-antigen (S and PreS1)-specific cellular immune response. HBSS1 immunisation with poly(I:C)/alum priming also generated high-level CD4(+) and CD8(+) T cell responses in terms of Th1 cytokines (IFN-gamma and IL-2). Conclusions: The protein-vaccine HBSS1 with mixed poly(I:C)/alum adjuvant priming, followed by a rAdSS1 vaccine boost, maximises specific antibody and Th1-biased cellular immune responses. This regime might prove useful in the development of HBV therapeutic vaccines. Furthermore, this promising strategy might be applied to vaccines against other persistent infections, such as human immunodeficiency virus and tuberculosis.	[Xia Chuai; Chen, Hong; Wang, Wen; Deng, Yao; Wen, Bo; Ruan, Li; Tan, Wenjie] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Xia Chuai] Hebei Med Univ, Dept Microbiol, Shijiazhuang, Heibei Province, Peoples R China; [Wen, Bo] Jilin Univ, Coll Life Sci, Changchun 130023, Jinlin Province, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Hebei Medical University; Jilin University	Tan, WJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	tanwj28@yahoo.cn			China Mega-projects of Science Research for the RD of New Drugs [2009ZX09102-237]	China Mega-projects of Science Research for the RD of New Drugs	The present study was supported by the China Mega-projects of Science Research for the R&D of New Drugs (No. 2009ZX09102-237). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertoletti Antonio, 2009, Expert Rev Gastroenterol Hepatol, V3, P561, DOI 10.1586/egh.09.48; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Bungener L, 2008, VACCINE, V26, P2350, DOI 10.1016/j.vaccine.2008.02.063; Chen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043730; Chen Hong, 2010, Sheng Wu Gong Cheng Xue Bao, V26, P74; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.29; Conforti VA, 2008, VACCINE, V26, P907, DOI 10.1016/j.vaccine.2007.12.010; Cooper CL, 2005, AIDS, V19, P1473, DOI 10.1097/01.aids.0000183514.37513.d2; Cooper CL, 2004, J CLIN IMMUNOL, V24, P693, DOI 10.1007/s10875-004-6244-3; Davis HL, 1998, J IMMUNOL, V160, P870; Forte G, 2012, J IMMUNOL, V188, P5357, DOI 10.4049/jimmunol.1103811; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Guan J, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-506; Halperin SA, 2006, VACCINE, V24, P20, DOI 10.1016/j.vaccine.2005.08.095; Halperin SA, 2003, VACCINE, V21, P2461, DOI 10.1016/S0264-410X(03)00045-8; Hoft DF, 2007, J IMMUNOL, V179, P6889, DOI 10.4049/jimmunol.179.10.6889; Ishii KJ, 2007, J CLIN IMMUNOL, V27, P363, DOI 10.1007/s10875-007-9087-x; Klinman DM, 1996, P NATL ACAD SCI USA, V93, P2879, DOI 10.1073/pnas.93.7.2879; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Lasaro MO, 2009, MOL THER, V17, P1333, DOI 10.1038/mt.2009.130; Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074; Le Bon A, 2006, J IMMUNOL, V176, P4682, DOI 10.4049/jimmunol.176.8.4682; Lipford GB, 1997, EUR J IMMUNOL, V27, P2340, DOI 10.1002/eji.1830270931; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Michel ML, 2011, J HEPATOL, V54, P1286, DOI 10.1016/j.jhep.2010.12.031; Pasare C, 2004, SEMIN IMMUNOL, V16, P23, DOI 10.1016/j.smim.2003.10.006; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; SCHIRMBECK R, 1994, J IMMUNOL, V152, P1110; Siegrist CA, 2004, VACCINE, V23, P615, DOI 10.1016/j.vaccine.2004.07.014; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; [田淑芳 Tian Shufang], 2002, [病毒学报, Chinese Journal of Virology], V18, P312; Verthelyi D, 2004, AIDS, V18, P1003, DOI 10.1097/00002030-200404300-00007; Yuen M F, 2001, Lancet Infect Dis, V1, P232, DOI 10.1016/S1473-3099(01)00118-9; Zhang XC, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-78	36	11	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54126	10.1371/journal.pone.0054126	http://dx.doi.org/10.1371/journal.pone.0054126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335993	Green Published, Green Submitted, gold			2022-12-25	WOS:000314707700051
J	Ishida, Y; Ishibashi, J; Leal, WS				Ishida, Yuko; Ishibashi, Jun; Leal, Walter S.			Fatty Acid Solubilizer from the Oral Disk of the Blowfly	PLOS ONE			English	Article							PHEROMONE-BINDING-PROTEIN; PHORMIA-REGINA; CRYSTAL-STRUCTURE; CORPUS ALLATUM; DROSOPHILA-MELANOGASTER; EXPRESSION PATTERNS; ANOPHELES-GAMBIAE; JUVENILE-HORMONE; SILKWORM MOTH; RELEASE	Background: Blowflies are economic pests of the wool industry and potential vectors for epidemics. The establishment of a pesticide-free, environmentally friendly blowfly control strategy is necessary. Blowflies must feed on meat in order to initiate the cascade of events that are involved in reproduction including juvenile hormone synthesis, vitellogenesis, and mating. During feeding blowflies regurgitate salivary lipase, which may play a role in releasing fatty acids from triglycerides that are found in food. However, long-chain fatty acids show low solubility in aqueous solutions. In order to solubilize and ingest the released hydrophobic fatty acids, the blowflies must use a solubilizer. Methodology: We applied native PAGE, Edman degradation, cDNA cloning, and RT-PCR to characterize a protein that accumulated in the oral disk of the black blowfly, Phormia regina. In situ hybridization was carried out to localize the expression at the cellular level. A fluorescence competitive binding assay was used to identify potential ligands of this protein. Conclusion: A protein newly identified from P. regina (PregOBP56a) belonged to the classic odorant-binding protein (OBP) family. This gene was expressed in a cluster of cells that was localized between pseudotracheae on the oral disk, which are not accessory cells of the taste peg chemosensory sensilla that normally synthesize OBPs. At pH 7 and pH 6, PregOBP56a bound palmitic, stearic, oleic, and linoleic acids, that are mainly found in chicken meat. The binding affinity of PregOBP56a decreased at pH 5. We propose that PregOBP56a is a protein that solubilizes fatty acids during feeding and subsequently helps to deliver the fatty acids to the midgut where it may help in the process of reproduction. As such, PregOBP56a is a potential molecular target for controlling the blowfly.	[Ishida, Yuko] Kobe Univ, Grad Sch Sci, Dept Biol, Nada Ku, Kobe, Hyogo 657, Japan; [Ishibashi, Jun] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Leal, Walter S.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	Kobe University; National Institute of Agrobiological Sciences - Japan; University of California System; University of California Davis	Ishida, Y (corresponding author), Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama, Japan.	y-ishida@pu-toyama.ac.jp	Leal, Walter/ABC-6940-2021	Leal, Walter/0000-0002-6800-1240; Leal Filho, Walter/0000-0002-1241-5225	Global COE program for Global Center for Education and Research in Integrative Membrane Biology; KAKENHI [23580070]; National Institutes of Health [1RO1AIO95514-01A1]	Global COE program for Global Center for Education and Research in Integrative Membrane Biology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: This work was partly supported by the Global COE program for Global Center for Education and Research in Integrative Membrane Biology, Grant-in-Aid for Scientific Research (C) and KAKENHI (23580070) (to YI) and National Institutes of Health (1RO1AIO95514-01A1) to (WSL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrese EL, 2001, INSECT BIOCHEM MOLEC, V31, P7, DOI 10.1016/S0965-1748(00)00102-8; Ban L, 2003, INSECT MOL BIOL, V12, P125, DOI 10.1046/j.1365-2583.2003.00394.x; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; Biessmann H, 2005, INSECT MOL BIOL, V14, P575, DOI 10.1111/j.1365-2583.2005.00590.x; Almeida Jussara Carnevale de, 2006, Rev. Bras. Cienc. Farm., V42, P109, DOI 10.1590/S1516-93322006000100012; Coronado-Gonzalez PA, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.7301; Dethier VG, 1976, HUNGRY FLY; Galindo K, 2001, GENETICS, V159, P1059; Ghafouri B, 2003, PROTEOMICS, V3, P1003, DOI 10.1002/pmic.200300426; Graham-Smith GS, 1911, J HYG-CAMBRIDGE, V11, P390, DOI 10.1017/S0022172400016843; HANSENBAY CM, 1978, J EXP BIOL, V75, P189; Hayashi Toshihiko, 2012, Medical Entomology and Zoology, V63, P85; Hekmat-Scafe DS, 2000, GENETICS, V155, P117; Ishida Y, 2002, INSECT BIOCHEM MOLEC, V32, P1775, DOI 10.1016/S0965-1748(02)00136-4; Ishida Y, 2011, NATURWISSENSCHAFTEN, V98, P635, DOI 10.1007/s00114-011-0806-z; KERLIN RL, 1992, MED VET ENTOMOL, V6, P121, DOI 10.1111/j.1365-2915.1992.tb00587.x; KNIPLING E. F., 1937, Journal of Parasitology, V23, P451, DOI 10.2307/3272391; Lartigue A, 2004, J BIOL CHEM, V279, P4459, DOI 10.1074/jbc.M311212200; Lartigue A, 2003, J BIOL CHEM, V278, P30213, DOI 10.1074/jbc.M304688200; Leal Walter S., 2003, P447, DOI 10.1016/B978-012107151-6/50017-7; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003045; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; LEVOT GW, 1995, INT J PARASITOL, V25, P1355, DOI 10.1016/0020-7519(95)00070-I; LIU MA, 1988, PHYSIOL ENTOMOL, V13, P69, DOI 10.1111/j.1365-3032.1988.tb00910.x; Mao Y, 2010, P NATL ACAD SCI USA, V107, P19102, DOI 10.1073/pnas.1012274107; Nisimura T, 2005, J NEUROSCI, V25, P7507, DOI 10.1523/JNEUROSCI.1862-05.2005; ORR CWM, 1964, J INSECT PHYSIOL, V10, P53, DOI 10.1016/0022-1910(64)90093-9; ORR CWM, 1964, J INSECT PHYSIOL, V10, P103, DOI 10.1016/0022-1910(64)90099-X; OZAKI M, 1995, EUR J BIOCHEM, V230, P298; Park SK, 2000, CELL TISSUE RES, V300, P181, DOI 10.1007/s004410050059; Pelletier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006237; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; QIN WH, 1995, J INSECT PHYSIOL, V41, P617, DOI 10.1016/0022-1910(94)00135-4; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Savenije B, 2002, POULTRY SCI, V81, P699, DOI 10.1093/ps/81.5.699; Sawabe Kyoko, 2011, Influenza Res Treat, V2011, P652652, DOI 10.1155/2011/652652; Scaloni A, 1999, BIOCHEM BIOPH RES CO, V266, P386, DOI 10.1006/bbrc.1999.1791; Shanbhag SR, 2001, CELL TISSUE RES, V304, P423, DOI 10.1007/s004410100388; STOFFOLANO JG, 1995, ANN ENTOMOL SOC AM, V88, P240, DOI 10.1093/aesa/88.2.240; Sukontason K, 2008, MICRON, V39, P190, DOI 10.1016/j.micron.2007.01.004; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAYLOR CW, 1985, AM J PHYSIOL, V249, pR209, DOI 10.1152/ajpregu.1985.249.2.R209; Tellam RL, 1997, INT J PARASITOL, V27, P261, DOI 10.1016/S0020-7519(96)00174-9; Tsitsanou KE, 2012, CELL MOL LIFE SCI, V69, P283, DOI 10.1007/s00018-011-0745-z; Vandermoten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023608; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; VORUM H, 1992, BIOCHIM BIOPHYS ACTA, V1126, P135, DOI 10.1016/0005-2760(92)90283-2; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Xu W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015403; Yin CM, 1999, J INSECT PHYSIOL, V45, P815, DOI 10.1016/S0022-1910(99)00047-5; ZOU BX, 1989, PHYSIOL ENTOMOL, V14, P233, DOI 10.1111/j.1365-3032.1989.tb00956.x	54	37	41	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e51779	10.1371/journal.pone.0051779	http://dx.doi.org/10.1371/journal.pone.0051779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326317	gold, Green Submitted, Green Published			2022-12-25	WOS:000314705800010
J	Toutain, J; Prochazkova-Carlotti, M; Cappellen, D; Jarne, A; Chevret, E; Ferrer, J; Idrissi, Y; Pelluard, F; Carles, D; Maugey-Laulon, B; Lacombe, D; Horovitz, J; Merlio, JP; Saura, R				Toutain, Jerome; Prochazkova-Carlotti, Martina; Cappellen, David; Jarne, Ana; Chevret, Edith; Ferrer, Jacky; Idrissi, Yamina; Pelluard, Fanny; Carles, Dominique; Maugey-Laulon, Brigitte; Lacombe, Didier; Horovitz, Jacques; Merlio, Jean-Philippe; Saura, Robert			Reduced Placental Telomere Length during Pregnancies Complicated by Intrauterine Growth Restriction	PLOS ONE			English	Article							PRENATAL-DIAGNOSIS; MESENCHYMAL CORE; ABNORMALITIES; EXPRESSION; FISH; PCR	Objectives: Recent studies have shown that telomere length was significantly reduced in placentas collected at delivery from pregnancies complicated by intrauterine growth restriction secondary to placental insufficiency. Placental telomere length measurement during ongoing pregnancies complicated by intrauterine growth restriction has never been reported. This was the main objective of our study. Methods: In our center, late chorionic villus samplings were performed between 18 and 37 weeks of amenorrhea in 24 subjects with severe intrauterine growth restriction (cases) and in 28 subjects with other indications for prenatal diagnosis (controls). Placental insufficiency was assessed by histo-pathological examination. Relative measurement of telomere length was carried out prospectively by quantitative Fluorescent In Situ Hybridization using fluorescent Peptide Nucleic Acid probes on interphase nuclei obtained from long-term cultured villi and with an automated epifluorescent microscope. A quantitative Polymerase Chain Reaction technique was performed to confirm the quantitative Fluorescent In Situ Hybridization results. The number of copies of gene loci encoding the RNA template (hTERC) and the catalytic subunit (hTERT) of the enzyme complex telomerase were also estimated in these placentas by Fluorescent In Situ Hybridization. Results: Mean fluorescence intensity of telomere probes estimated by quantitative Fluorescent In Situ Hybridization was significantly less for cases compared to controls (p < 0.001). This result indicated that mean telomere length was significantly reduced in placentas during pregnancies complicated by intrauterine growth restriction. Reduced telomere length was confirmed by the quantitative Polymerase Chain Reaction technique. No copy number variation of the hTERC and hTERT loci was noticed for cases, or for controls. Conclusion: This study clearly demonstrates a reduction of placental telomere length in ongoing pregnancies (from 18 to 37 weeks of amenorrhea) complicated by severe intrauterine growth restriction secondary to placental insufficiency.	[Toutain, Jerome; Prochazkova-Carlotti, Martina; Cappellen, David; Chevret, Edith; Ferrer, Jacky; Idrissi, Yamina; Pelluard, Fanny; Merlio, Jean-Philippe] Univ Bordeaux Segalen, EA 2406 Histol & Pathol Mol Tumeurs, Bordeaux, France; [Toutain, Jerome; Lacombe, Didier; Saura, Robert] CHU Bordeaux, Serv Genet Med, Bordeaux, France; [Cappellen, David; Merlio, Jean-Philippe] CHU Bordeaux, Serv Biol Tumeurs, Bordeaux, Pessac, France; [Jarne, Ana] Univ Bordeaux Segalen, ISPED, INSERM, U897 Equipe Biostat, Bordeaux, France; [Pelluard, Fanny; Carles, Dominique] CHU Bordeaux, Serv Pathol, Bordeaux, France; [Maugey-Laulon, Brigitte] CHU Bordeaux, Serv Imagerie Antenatale Enfant & Femme, Bordeaux, France; [Lacombe, Didier] Univ Bordeaux Segalen, EA 4576 Malad Rares Genet & Metab, Bordeaux, France; [Horovitz, Jacques] CHU Bordeaux, Serv Gynecol Obstet & Med Foetale, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Toutain, J (corresponding author), Univ Bordeaux Segalen, EA 2406 Histol & Pathol Mol Tumeurs, Bordeaux, France.	jerome.toutain@chu-bordeaux.fr	lacombe, didier/K-7967-2014	Lacombe, Didier/0000-0002-8956-2207; Toutain, Jerome/0000-0003-1236-1551; Prochazkova-Carlotti, Martina/0000-0002-7719-7679				Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; Backes CH, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/214365; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; Biron-Shental T, 2011, EARLY HUM DEV, V87, P73, DOI 10.1016/j.earlhumdev.2010.08.024; Biron-Shental T, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.036; Brun JL, 2003, PRENATAL DIAG, V23, P295, DOI 10.1002/pd.578; Carles D, 2009, B ACAD NAT MED PARIS, V193, P675, DOI 10.1016/S0001-4079(19)32559-2; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Davy P, 2009, PLACENTA, V30, P539, DOI 10.1016/j.placenta.2009.03.005; Figueras F, 2011, AM J OBSTET GYNECOL, V204, P288, DOI 10.1016/j.ajog.2010.08.055; Ghidini A, 1996, Obstet Gynecol Surv, V51, P376, DOI 10.1097/00006254-199606000-00023; Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001; Izutsu T, 2006, ACTA OBSTET GYN SCAN, V85, P3, DOI 10.1080/00016340500317096; Menon R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031136; Militello Mariapia, 2009, J Prenat Med, V3, P6; Miller J, 2008, SEMIN PERINATOL, V32, P274, DOI 10.1053/j.semperi.2008.04.010; NEWPORT M, 1986, PRENATAL DIAG, V6, P265, DOI 10.1002/pd.1970060406; Nicholls C, 2011, PROTEIN CELL, V2, P726, DOI 10.1007/s13238-011-1093-3; Nishi H, 1999, PLACENTA, V20, P317, DOI 10.1053/plac.1998.0386; O'Sullivan JN, 2004, CYTOM PART A, V58A, P120, DOI 10.1002/cyto.a.20006; Prochazkova M, 2007, GENE CHROMOSOME CANC, V46, P828, DOI 10.1002/gcc.20469; Roberts DJ, 2008, J CLIN PATHOL, V61, P1254, DOI 10.1136/jcp.2008.055236; Sankaran S, 2009, BEST PRACT RES CL OB, V23, P765, DOI 10.1016/j.bpobgyn.2009.05.003; Saura R, 2010, PRENATAL DIAG, V30, P387, DOI 10.1002/pd.2476; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Sukenik-Halevy R, 2011, CYTOGENET GENOME RES, V135, P12, DOI 10.1159/000329714; Tomas SZ, 2010, EUR J OBSTET GYN R B, V152, P39, DOI 10.1016/j.ejogrb.2010.05.006; Toutain J, 2010, EUR J OBSTET GYN R B, V149, P143, DOI 10.1016/j.ejogrb.2009.12.015; Toutain J, 2011, PRENATAL DIAG, V31, P1111, DOI 10.1002/pd.2776; Toutain J, 2010, PRENATAL DIAG, V30, P1155, DOI 10.1002/pd.2631; Tsatsaris V, 2008, J GYNECOL OBST BIO R, V37, P16, DOI 10.1016/j.jgyn.2007.08.003; Tuuli MG, 2011, PLACENTA, V32, pS109, DOI 10.1016/j.placenta.2010.12.013; Vedmedovska N, 2011, EUR J OBSTET GYN R B, V155, P36, DOI 10.1016/j.ejogrb.2010.11.017; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Zhu HD, 2011, CLIN SCI, V120, P427, DOI 10.1042/CS20100385	37	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54013	10.1371/journal.pone.0054013	http://dx.doi.org/10.1371/journal.pone.0054013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326560	gold, Green Published, Green Submitted			2022-12-25	WOS:000314705800099
J	Falter, JL; Lowe, RJ; Zhang, ZL; McCulloch, M				Falter, James L.; Lowe, Ryan J.; Zhang, Zhenlin; McCulloch, Malcolm			Physical and Biological Controls on the Carbonate Chemistry of Coral Reef Waters: Effects of Metabolism, Wave Forcing, Sea Level, and Geomorphology	PLOS ONE			English	Article							GREAT-BARRIER-REEF; OCEAN ACIDIFICATION; COMMUNITY METABOLISM; TUAMOTU ARCHIPELAGO; DRIVEN CIRCULATION; CO2 SYSTEM; BORA BAY; CALCIFICATION; DIOXIDE; LAGOON	We present a three-dimensional hydrodynamic-biogeochemical model of a wave-driven coral-reef lagoon system using the circulation model ROMS (Regional Ocean Modeling System) coupled with the wave transformation model SWAN (Simulating WAves Nearshore). Simulations were used to explore the sensitivity of water column carbonate chemistry across the reef system to variations in benthic reef metabolism, wave forcing, sea level, and system geomorphology. Our results show that changes in reef-water carbonate chemistry depend primarily on the ratio of benthic metabolism to the square root of the onshore wave energy flux as well as on the length and depth of the reef flat; however, they are only weakly dependent on channel geometry and the total frictional resistance of the reef system. Diurnal variations in pCO(2), pH, and aragonite saturation state (Omega(ar)) are primarily dependent on changes in net production and are relatively insensitive to changes in net calcification; however, net changes in pCO(2), pH, and Omega(ar) are more strongly influenced by net calcification when averaged over 24 hours. We also demonstrate that a relatively simple one-dimensional analytical model can provide a good description of the functional dependence of reef-water carbonate chemistry on benthic metabolism, wave forcing, sea level, reef flat morphology, and total system frictional resistance. Importantly, our results indicate that any long-term (weeks to months) net offsets in reef-water pCO(2) relative to offshore values should be modest for reef systems with narrow and/or deep lagoons. Thus, the long-term evolution of water column pCO(2) in many reef environments remains intimately connected to the regional-scale oceanography of offshore waters and hence directly influenced by rapid anthropogenically driven increases in pCO(2).	[Falter, James L.; Lowe, Ryan J.; Zhang, Zhenlin; McCulloch, Malcolm] Univ Western Australia, Sch Earth & Environm, Perth, WA 6009, Australia; [Falter, James L.; Zhang, Zhenlin; McCulloch, Malcolm] Univ Western Australia, ARC Ctr Excellence Coral Reef Studies, Perth, WA 6009, Australia; [Falter, James L.; Lowe, Ryan J.; Zhang, Zhenlin; McCulloch, Malcolm] Univ Western Australia, UWA Oceans Inst, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia; University of Western Australia	Falter, JL (corresponding author), Univ Western Australia, Sch Earth & Environm, Perth, WA 6009, Australia.	jim.falter@uwa.edu.au	Lowe, Ryan/A-5032-2012; McCulloch, Malcolm T/C-3651-2009	Lowe, Ryan/0000-0002-7080-8406; McCulloch, Malcolm T/0000-0003-1538-1558	Australian Research Council (ARC) Centre of Excellence for Coral Reef Studies; ARC Future Fellows program; ARC Super Science Fellowship program; iVEC	Australian Research Council (ARC) Centre of Excellence for Coral Reef Studies(Australian Research Council); ARC Future Fellows program(Australian Research Council); ARC Super Science Fellowship program(Australian Research Council); iVEC	Support for JLF and MM was provided by the Australian Research Council (ARC) Centre of Excellence for Coral Reef Studies. Support for RJL was provided by the ARC Future Fellows program. Support for ZZ was provided by the ARC Super Science Fellowship program. All use of supercomputing resources was supported through iVEC (http://www.ivec.org/about-ivec). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AJ, 2012, ANNU REV MAR SCI, V5; Andrefouet S, 2001, CORAL REEFS, V20, P399, DOI 10.1007/s00338-001-0190-9; Andrefouet S, 2001, CORAL REEFS, V19, P259; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P3655, DOI 10.1111/j.1365-2486.2011.02510.x; Atkinson MJ, 2008, MAR ECOL PROG SER, V373, P249, DOI 10.3354/meps07867; ATKINSON MJ, 1984, CORAL REEFS, V3, P13, DOI 10.1007/BF00306136; BARNES DJ, 1984, J EXP MAR BIOL ECOL, V79, P213, DOI 10.1016/0022-0981(84)90196-5; Bates NR, 2010, BIOGEOSCIENCES, V7, P2509, DOI 10.5194/bg-7-2509-2010; Bonneton P, 2007, J COASTAL RES, P762; Booij N, 1999, J GEOPHYS RES-OCEANS, V104, P7649, DOI 10.1029/98JC02622; Broecker W.S., 1982, TRACERS SEA, V690; BROECKER WS, 1966, J GEOPHYS RES, V71, P1575, DOI 10.1029/JZ071i006p01575; Broecker WS, 2001, GLOBAL BIOGEOCHEM CY, V15, P589, DOI 10.1029/2000GB001350; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Chan NCS, 2012, GLOBAL CHANGE BIOL, P1; Charpy L, 2012, MAR POLLUT BULL, V65, P471, DOI 10.1016/j.marpolbul.2011.12.026; Clavier J, 1999, MAR ECOL PROG SER, V191, P79, DOI 10.3354/meps191079; Dean R. G., 1991, WATER WAVE MECH ENG, V2; DELESALLE B, 1992, CONT SHELF RES, V12, P939, DOI 10.1016/0278-4343(92)90053-M; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Dickson AG, 1990, DEEP-SEA RES, V40, P107; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dumas F, 2012, MAR POLLUT BULL, V65, P425, DOI 10.1016/j.marpolbul.2012.05.041; Falter JL, 2011, CORAL REEFS, V30, P53, DOI 10.1007/s00338-010-0671-9; Falter JL, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007268; Falter JL, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004663; Falter JL, 2004, LIMNOL OCEANOGR, V49, P1820, DOI 10.4319/lo.2004.49.5.1820; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Frankignoulle M, 1996, MAR ECOL PROG SER, V145, P123, DOI 10.3354/meps145123; FRANKIGNOULLE M, 1994, LIMNOL OCEANOGR, V39, P458, DOI 10.4319/lo.1994.39.2.0458; Friedrich T, 2012, NAT CLIM CHANGE, V2, P167, DOI [10.1038/NCLIMATE1372, 10.1038/nclimate1372]; Gattuso JP, 1996, MAR ECOL PROG SER, V145, P109, DOI 10.3354/meps145109; GATTUSO JP, 1993, MAR ECOL PROG SER, V96, P259, DOI 10.3354/meps096259; Gattuso JP, 1999, P NATL ACAD SCI USA, V96, P13017, DOI 10.1073/pnas.96.23.13017; Gledhill DK, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004629; Glud RN, 2008, LIMNOL OCEANOGR, V53, P1014, DOI 10.4319/lo.2008.53.3.1014; Gourlay MR, 2005, COAST ENG, V52, P353, DOI 10.1016/j.coastaleng.2004.11.007; Hearn CJ, 1999, J GEOPHYS RES, V104; Hearn GJ, 1988, HYDRODYNAMIC PROCESS, P497; Hench JL, 2008, LIMNOL OCEANOGR, V53, P2681, DOI 10.4319/lo.2008.53.6.2681; Hochberg EJ, 2008, CORAL REEFS, V27, P49, DOI 10.1007/s00338-007-0289-8; Hoegh-Guldberg O, 2007, SCIENCE, V318; Hoeke R, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006170; Jouon A, 2006, CONT SHELF RES, V26, P1395, DOI 10.1016/j.csr.2005.11.014; Kaniewska P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034659; KAYANNE H, 1995, SCIENCE, V269, P214, DOI 10.1126/science.269.5221.214; Kinsey D.W., 1985, P 5 INT COR REEF S, V4, P505; Kinsey D.W., 1972, P 1 INT S COR COR RE, P13; Kinsey DW, 1974, EFFECTS FERTILIZATIO, P49; Kinsey DW, 1979, THESIS U HAWAII MANO; Kinsey DW, 1977, SEASONALITY ZONATION, P383; Kleypas J. A., 2006, CORAL REEFS CLIMATE, V61, P73, DOI DOI 10.1029/61CE06; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Kleypas JA, 2011, GLOBAL CHANGE BIOL, V17, P3667, DOI 10.1111/j.1365-2486.2011.02530.x; KOHN AJ, 1957, LIMNOL OCEANOGR, V2, P241, DOI 10.1002/lno.1957.2.3.0241; Kraines S, 1997, MAR ECOL PROG SER, V156, P1, DOI 10.3354/meps156001; Kraines S, 1996, LIMNOL OCEANOGR, V41, P1790, DOI 10.4319/lo.1996.41.8.1790; Kraines SB, 1999, J GEOPHYS RES-OCEANS, V104, P15635, DOI 10.1029/1999JC900065; Kraines SB, 1998, CORAL REEFS, V17, P133, DOI 10.1007/s003380050107; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Lee K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027207; Lewis ER, 1998, ESS-DIVE, DOI 10.15485/1464255; LIMER ET, 1976, SEARCH, V7, P463; Lowe RJ, 2009, J PHYS OCEANOGR, V39, P873, DOI 10.1175/2008JPO3958.1; Lowe RJ, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005753; Lowe RJ, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005081; Lowe RJ, 2008, LIMNOL OCEANOGR, V53, P2668, DOI 10.4319/lo.2008.53.6.2668; Manzello DP, 2010, LIMNOL OCEANOGR, V55, P239, DOI 10.4319/lo.2010.55.1.0239; Maragos J.E., 1978, Monographs on Oceanographic Methodology, P353; Marsh J.A. Jr., 1974, Proceedings int Coral Reef Symp, V2, P139; Marubini F, 2008, CORAL REEFS, V27, P491, DOI 10.1007/s00338-008-0375-6; Mass T, 2007, MAR ECOL PROG SER, V334, P93, DOI 10.3354/meps334093; McCulloch M, 2012, NATURE CLIMATE CHANG; McDonald CB, 2006, LIMNOL OCEANOGR, V51, P1294, DOI 10.4319/lo.2006.51.3.1294; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Mioche D, 2000, COMMUNITY METABOLISM; Mucci CN, 1971, AM J SCI, V283, P781; Munday PL, 2010, P NATL ACAD SCI USA, V107, P12930, DOI 10.1073/pnas.1004519107; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; NUGENT LE, 1946, GEOL SOC AM BULL, V57, P735, DOI 10.1130/0016-7606(1946)57[735:CRITGM]2.0.CO;2; ODUM HT, 1955, ECOL MONOGR, V25, P291, DOI 10.2307/1943285; Ohde S, 1999, B MAR SCI, V65, P559; PICHON M, 1985, CR ACAD SCI III-VIE, V300, P99; Pichon M, 1985, ORGANIC PRODUCTION C, P173; QASIM S Z, 1972, Internationale Revue der Gesamten Hydrobiologie, V57, P207, DOI 10.1002/iroh.19720570203; Rosman JH, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006892; SARGENT M. C., 1949, TRANS AMER GEOPHYS UNION, V30, P245; Shamberger KEF, 2011, MAR CHEM, V127, P64, DOI 10.1016/j.marchem.2011.08.003; Shaw EC, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007655; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Silverman J, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003770; Silverman J, 2007, BIOGEOCHEMISTRY, V84, P67, DOI 10.1007/s10533-007-9075-5; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; SMITH SV, 1973, LIMNOL OCEANOGR, V18, P106, DOI 10.4319/lo.1973.18.1.0106; SMITH SV, 1973, LIMNOL OCEANOGR, V18, P953, DOI 10.4319/lo.1973.18.6.0953; Smith SV, 1995, REFLECTIONS MEASUREM; Smith SV, 1989, EST COAST SHELF SCI, V29; Soulsby RL, 1995, ADV COASTAL MORPHODY, P20; Suzuki A, 2001, GEOPHYS RES LETT, V28, P1243, DOI 10.1029/2000GL011875; Suzuki A, 1997, REEF WATER CO2 SYSTE, P971; SYMONDS G, 1995, J GEOPHYS RES-OCEANS, V100, P2639, DOI 10.1029/94JC02736; Taebi S, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006439; Tambutte S, 2011, J EXP MAR BIOL ECOL, V408, P58, DOI 10.1016/j.jembe.2011.07.026; Uthicke S, 1998, MAR ECOL PROG SER, V169, P1, DOI 10.3354/meps169001; WARE JR, 1992, CORAL REEFS, V11, P127, DOI 10.1007/BF00255465; Warner JC, 2008, COMPUT GEOSCI-UK, V34, P1284, DOI 10.1016/j.cageo.2008.02.012; Wiens Herald J., 1962, ATOLL ENV ECOLOGY; YOUNG IR, 1989, J GEOPHYS RES-OCEANS, V94, P9779, DOI 10.1029/JC094iC07p09779; Zhang Z, 2012, J GEOPHYS RES, V117; Zhang ZL, 2011, ECOL MODEL, V222, P1456, DOI 10.1016/j.ecolmodel.2011.01.014	111	87	87	1	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53303	10.1371/journal.pone.0053303	http://dx.doi.org/10.1371/journal.pone.0053303			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326411	Green Published, Green Submitted, gold			2022-12-25	WOS:000313551500063
J	Ochoa-Callejero, L; Perez-Martinez, L; Rubio-Mediavilla, S; Oteo, JA; Martinez, A; Blanco, JR				Ochoa-Callejero, Laura; Perez-Martinez, Laura; Rubio-Mediavilla, Susana; Oteo, Jose A.; Martinez, Alfredo; Blanco, Jose R.			Maraviroc, a CCR5 Antagonist, Prevents Development of Hepatocellular Carcinoma in a Mouse Model	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; CHEMOKINE RECEPTOR 5; CHOLINE-DEFICIENT; LIVER INFLAMMATION; OVAL CELLS; CANCER; MIGRATION; PROMOTES; INJURY; PROLIFERATION	Chronic liver disease may result in a sequential progression through fibrosis, cirrhosis and lead, eventually, to hepatocellular carcinoma (HCC). Hepatic stellate cells (HSC) seem to be responsible for the fibrogenic response through the activation of an autocrine loop involving the chemokine receptor, CCR5. However, the role of CCR5 in HCC remains poorly understood. Since this receptor is also one of the main ports of entry for the human immunodeficiency virus (HIV), several CCR5 inhibitors are being used in the clinic to reduce viral load. We used one of these inhibitors, maraviroc (MVC), in a mouse model of diet-induced HCC to investigate whether this intervention would reduce disease progression. Animals treated with MVC on top of a normal control diet did not present any evidence of toxicity or any morphological change when compared with non-treated mice. Animals treated with MVC presented higher survival, less liver fibrosis, lower levels of liver injury markers and chemokines, less apoptosis, lower proliferation index, and lower tumor burden than their counterparts receiving only the hepatotoxic diet. In addition, MVC inhibits HSC activation markers such as phosphorylation of p38 and ERK, and increases hepatocyte survival. This study suggests that MVC, a well tolerated and clinically characterized drug, may be used as a preventative treatment for HCC. Clinical studies are needed to demonstrate the efficacy of this drug, or other CCR5 inhibitors, in patients with high risk of developing HCC.	[Ochoa-Callejero, Laura; Martinez, Alfredo] Ctr Biomed Res La Rioja CIBIR, Oncol Area, Logrono, Spain; [Perez-Martinez, Laura; Oteo, Jose A.; Blanco, Jose R.] Ctr Biomed Res La Rioja CIBIR, Infect Dis Area, Logrono, Spain; [Rubio-Mediavilla, Susana] Hosp San Pedro, Pathol Serv, Logrono, Spain		Martinez, A (corresponding author), Ctr Biomed Res La Rioja CIBIR, Oncol Area, Logrono, Spain.	amartinezr@riojasalud.es	Ochoa-Callejero, Laura/K-2560-2012; Oteo, Jose A./AAB-3134-2020; Blanco, Jose-Ramon/L-6768-2018; Perez, Laura/AAC-8394-2020; Martinez, Alfredo/GQH-5998-2022	Ochoa-Callejero, Laura/0000-0001-5366-6613; Oteo, Jose A./0000-0001-7080-6542; Blanco, Jose-Ramon/0000-0002-4268-0150; Martinez, Alfredo/0000-0003-4882-4044; Perez-Martinez, Laura/0000-0002-1384-024X	Fundacion Rioja Salud (FRS)	Fundacion Rioja Salud (FRS)	This study was supported by a grant from Fundacion Rioja Salud (FRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affo S, 2011, J HEPATOL, V55, P936, DOI 10.1016/j.jhep.2011.04.023; Akhurst B, 2001, HEPATOLOGY, V34, P519, DOI 10.1053/jhep.2001.26751; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732; Bonacchi A, 2001, J BIOL CHEM, V276, P9945, DOI 10.1074/jbc.M010303200; Budhu A, 2006, J LEUKOCYTE BIOL, V80, P1197, DOI 10.1189/jlb.0506297; Chew V, 2012, GUT, V61, P427, DOI 10.1136/gutjnl-2011-300509; Chuang JY, 2009, J CELL PHYSIOL, V220, P418, DOI 10.1002/jcp.21783; Conde MV, 2011, AM J PHYSIOL-HEART C, V301, pH1153, DOI 10.1152/ajpheart.00886.2010; Davies RA, 2006, CARCINOGENESIS, V27, P1607, DOI 10.1093/carcin/bgi365; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dufour DR, 2000, CLIN CHEM, V46, P2027; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Hong F, 2009, HEPATOLOGY, V49, P2055, DOI 10.1002/hep.22890; Iser DM, 2010, J VIROL, V84, P5860, DOI 10.1128/JVI.02594-09; Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166; Jiang DS, 2011, PRIMARY CARE, V38, P483, DOI 10.1016/j.pop.2011.05.005; Kirk GD, 2006, CARCINOGENESIS, V27, P2070, DOI 10.1093/carcin/bgl060; Knight B, 2005, IMMUNOL CELL BIOL, V83, P364, DOI 10.1111/j.1440-1711.2005.01346.x; Knight B, 2008, GASTROENTEROLOGY, V135, P969, DOI 10.1053/j.gastro.2008.05.077; Lalezari J, 2011, JAIDS-J ACQ IMM DEF, V57, P118, DOI 10.1097/QAI.0b013e318213c2c0; Lee JM, 2010, ONCOLOGY-BASEL, V78, P167, DOI 10.1159/000315246; Lenz JCC, 2010, EXPERT OPIN DRUG MET, V6, P1139, DOI 10.1517/17425255.2010.510833; Lu PR, 2003, AM J PATHOL, V162, P1249, DOI 10.1016/S0002-9440(10)63921-1; Macias J, 2012, EUR J CLIN MICROBIOL, V31, P2083, DOI 10.1007/s10096-012-1546-5; Marrero JA, 2005, J HEPATOL, V42, P218, DOI 10.1016/j.jhep.2004.10.005; Moody MD, 2001, BIOTECHNIQUES, V31, P186, DOI 10.2144/01311dd03; NAKAE D, 1992, CANCER RES, V52, P5042; Neff CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015257; Nichols WG, 2008, ANTIMICROB AGENTS CH, V52, P858, DOI 10.1128/AAC.00821-07; Parra J, 2011, CLIN DRUG INVEST, V31, P527, DOI 10.2165/11590700-000000000-00000; Pinzani M, 2001, SEMIN LIVER DIS, V21, P397, DOI 10.1055/s-2001-17554; Ruddell RG, 2009, HEPATOLOGY, V49, P227, DOI 10.1002/hep.22597; Schwabe RF, 2003, AM J PHYSIOL-GASTR L, V285, pG949, DOI 10.1152/ajpgi.00215.2003; Seeff LB, 2004, GASTROENTEROLOGY, V127, pS1, DOI 10.1053/j.gastro.2004.09.010; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Shin N, 2011, J PHARMACOL EXP THER, V338, P228, DOI 10.1124/jpet.111.179531; SHINOZUKA H, 1978, CANCER RES, V38, P1092; Svegliati-Baroni G, 2008, LIVER INT, V28, P1052, DOI 10.1111/j.1478-3231.2008.01825.x; Tangkijvanich P, 2002, J CELL PHYSIOL, V191, P351, DOI 10.1002/jcp.10112; Tiong L, 2011, BRIT J SURG, V98, P1210, DOI 10.1002/bjs.7669; Troia-Cancio P, 2011, EXPERT REV ANTI-INFE, V9, P649, DOI [10.1586/eri.11.52, 10.1586/ERI.11.52]; van Deventer HW, 2005, CANCER RES, V65, P3374, DOI 10.1158/0008-5472.CAN-04-2616; Wang P, 2009, LIVER INT, V29, P575, DOI 10.1111/j.1478-3231.2009.01992.x; Wasmuth HE, 2010, SEMIN LIVER DIS, V30, P215, DOI 10.1055/s-0030-1255351; Wu Y, 2008, J IMMUNOL, V181, P6384, DOI 10.4049/jimmunol.181.9.6384; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yao ZX, 2009, CANCER BIOL THER, V8, P1691, DOI 10.4161/cbt.8.18.9843; Yates MS, 2007, ACTA PHARMACOL SIN, V28, P1331, DOI 10.1111/j.1745-7254.2007.00688.x; Zhang XP, 2010, BIOORG MED CHEM LETT, V20, P4627, DOI 10.1016/j.bmcl.2010.06.003	53	68	72	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53992	10.1371/journal.pone.0053992	http://dx.doi.org/10.1371/journal.pone.0053992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326556	Green Published, gold, Green Submitted			2022-12-25	WOS:000313551500106
J	Saunders, TJ; Tremblay, MS; Despres, JP; Bouchard, C; Tremblay, A; Chaput, JP				Saunders, Travis J.; Tremblay, Mark S.; Despres, Jean-Pierre; Bouchard, Claude; Tremblay, Angelo; Chaput, Jean-Philippe			Sedentary Behaviour, Visceral Fat Accumulation and Cardiometabolic Risk in Adults: A 6-Year Longitudinal Study from the Quebec Family Study	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; ADIPOSE-TISSUE; PLASMA-GLUCOSE; BODY-FAT; TIME; OBESITY; HEALTH; LIPOPROTEINS	Background: Sedentary behaviour has recently emerged as a unique risk factor for chronic disease morbidity and mortality. One factor that may explain this relationship is visceral adiposity, which is prospectively associated with increased cardiometabolic risk and mortality. The objective of the present study was to determine whether sedentary behaviour was associated with increased accumulation of visceral fat or other deleterious changes in cardiometabolic risk over a 6-year follow-up period among adult participants in the Quebec Family Study. Methods: The current study included 123 men and 153 women between the ages of 18 and 65. Total sedentary time and physical activity were assessed by self-report questionnaire. Cross-sectional areas of visceral and subcutaneous abdominal adipose tissue were assessed using computed tomography. Cardiometabolic biomarkers including fasting insulin, glucose, blood lipids, HOMA-Insulin Resistance, and oral glucose tolerance were also measured. All variables of interest were collected at both baseline and follow-up. Results: After adjustment for age, sex, baseline BMI, physical activity, energy intake, smoking, education, income and menopausal status, baseline sedentary behaviour was not associated with changes in visceral adiposity or any other marker of cardiometabolic risk. In the longitudinal model which adjusted for all studied covariates, every 15-minute increase in sedentary behaviour from baseline to follow-up was associated with a 0.13 cm increase in waist circumference (95% CI = 0.02, 0.25). However, there was no association between changes in sedentary behaviour and changes in visceral adiposity or other markers of cardiometabolic risk. Conclusion: These results suggest that neither baseline sedentary behaviour nor changes in sedentary behaviour are associated with longitudinal changes in visceral adiposity in adult men and women. With the exception of waist circumference, the present study did not find evidence of a relationship between sedentary behaviour and any marker of cardiometabolic risk in this population.	[Saunders, Travis J.; Tremblay, Mark S.; Chaput, Jean-Philippe] Childrens Hosp Eastern Ontario, Res Inst, Hlth Act Living & Obes Res Grp, Ottawa, ON K1H 8L1, Canada; [Saunders, Travis J.; Tremblay, Mark S.; Chaput, Jean-Philippe] Univ Ottawa, Fac Hlth Sci, Sch Human Kinet, Ottawa, ON, Canada; [Tremblay, Mark S.; Chaput, Jean-Philippe] Univ Ottawa, Dept Pediat, Fac Med, Ottawa, ON K1N 6N5, Canada; [Despres, Jean-Pierre] Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Dept Cardiol, Quebec City, PQ, Canada; [Despres, Jean-Pierre; Tremblay, Angelo] Univ Laval, Fac Med, Dept Kinesiol, Quebec City, PQ G1K 7P4, Canada; [Bouchard, Claude] Pennington Biomed Res Ctr, Human Genom Lab, Baton Rouge, LA USA	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; Laval University; Laval University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Saunders, TJ (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, Hlth Act Living & Obes Res Grp, Ottawa, ON K1H 8L1, Canada.	tsaunders@cheo.on.ca	Bouchard, Claude/AAE-2035-2019; Tremblay, Mark/AAF-2981-2019; Bouchard, Claude/A-7637-2009; Chaput, Jean-Philippe/ABE-6307-2020; Tremblay, Mark/ABI-5477-2020	Bouchard, Claude/0000-0002-0048-491X; Chaput, Jean-Philippe/0000-0002-5607-5736; 	Medical Research Council of Canada; Canadian Institutes for Health Research [PG-11811, MT-13960, GR-15187]; government of Quebec; government of Canada; Canadian Diabetes Association; University of Ottawa; John W. Barton Sr. Chair in Genetics and Nutrition; Canada Research Chair in Environment and Energy Balance	Medical Research Council of Canada(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); government of Quebec; government of Canada(CGIAR); Canadian Diabetes Association; University of Ottawa; John W. Barton Sr. Chair in Genetics and Nutrition; Canada Research Chair in Environment and Energy Balance(Canada Research Chairs)	The Quebec Family Study was supported over the years by multiple grants from the Medical Research Council of Canada and the Canadian Institutes for Health Research (www.cihr.ca) (PG-11811, MT-13960 and GR-15187) as well as other agencies from the governments of Quebec and Canada. TJS is the recipient of a Doctoral Research Award from the Canadian Diabetes Association and an Excellence Scholarship from the University of Ottawa. JPC holds a Junior Research Chair in Healthy Active Living and Obesity Research from the Children's Hospital of Eastern Ontario Research Institute. JPD is Scientific Director of the International Chair on Cardiometabolic Risk held at Universite Laval. CB is partially supported by the John W. Barton Sr. Chair in Genetics and Nutrition. AT is partially funded by the Canada Research Chair in Environment and Energy Balance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Behnke AR, 1974, EVALUATION REGULATIO; BOUCHARD C, 1983, AM J CLIN NUTR, V37, P461, DOI 10.1093/ajcn/37.3.461; Bouchard C, 1996, PROGR OBESITY RES, V7, P33; Bowman Shanthy A, 2006, Prev Chronic Dis, V3, pA38; Carson V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-274; Chaput JP, 2011, OBES REV, V12, pe12, DOI 10.1111/j.1467-789X.2010.00772.x; Chaput JP, 2007, PHYSIOL BEHAV, V90, P66, DOI 10.1016/j.physbeh.2006.08.030; Chaput JP, 2012, JAMA-J AM MED ASSOC, V307, P2024, DOI 10.1001/jama.2012.3629; Despres JP, 2001, BMJ-BRIT MED J, V322, P716, DOI 10.1136/bmj.322.7288.716; DESPRES JP, 1991, AM J CLIN NUTR, V54, P471, DOI 10.1093/ajcn/54.3.471; Ekelund U, 2009, DIABETES CARE, V32, P1081, DOI 10.2337/dc08-1895; Goldfield Gary S, 2011, PLoS One, V6, pe26643, DOI 10.1371/journal.pone.0026643; Government of Canada HC, 2005, CAN NUTR FIL; Harris JL, 2009, HEALTH PSYCHOL, V28, P404, DOI 10.1037/a0014399; Helmerhorst HJF, 2009, DIABETES, V58, P1776, DOI 10.2337/db08-1773; Henderson M, 2012, DIABETES CARE, V35, P1272, DOI 10.2337/dc11-1785; Katzmarzyk PT, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000828; Koh-Banerjee P, 2003, AM J CLIN NUTR, V78, P719, DOI 10.1093/ajcn/78.4.719; Kuk JL, 2006, OBESITY, V14, P336, DOI 10.1038/oby.2006.43; Lohman T.J., 1988, ANTHROPOMETRIC STAND; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McGuire KA, 2012, OBESITY, V20, P576, DOI 10.1038/oby.2011.278; McNeely MJ, 2012, DIABETES CARE, V35, P296, DOI 10.2337/dc11-1193; MENEELY GR, 1949, J CLIN INVEST, V28, P129, DOI 10.1172/JCI102041; OPPERT JM, 1995, METABOLISM, V44, P96, DOI 10.1016/0026-0495(95)90295-3; PERUSSE L, 1989, ARTERIOSCLEROSIS, V9, P308, DOI 10.1161/01.ATV.9.3.308; Perusse L, 1997, ARTERIOSCL THROM VAS, V17, P3263, DOI 10.1161/01.ATV.17.11.3263; Rice T, 1996, DIABETOLOGIA, V39, P1357, DOI 10.1007/s001250050583; Saunders TJ, 2012, BRIT J NUTR, V108, P946, DOI 10.1017/S0007114512002644; Schoen RE, 1998, INT J OBESITY, V22, P338, DOI 10.1038/sj.ijo.0800591; SIRI W E, 1956, Adv Biol Med Phys, V4, P239; SJOSTROM L, 1986, AM J PHYSIOL, V250, pE736, DOI 10.1152/ajpendo.1986.250.6.E736; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; TREMBLAY A, 1983, NUTR RES, V3, P819, DOI 10.1016/S0271-5317(83)80035-9; Tremblay MS, 2010, APPL PHYSIOL NUTR ME, V35, P725, DOI 10.1139/H10-079; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; Wijndaele K, 2010, MED SCI SPORT EXER, V42, P1511, DOI 10.1249/MSS.0b013e3181d322ac; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z	39	23	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e54225	10.1371/journal.pone.0054225	http://dx.doi.org/10.1371/journal.pone.0054225			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326600	gold, Green Published			2022-12-25	WOS:000313551500112
J	Sinniger, F; Ocana, OV; Baco, AR				Sinniger, Frederic; Ocana, Oscar V.; Baco, Amy R.			Diversity of Zoanthids (Anthozoa: Hexacorallia) on Hawaiian Seamounts: Description of the Hawaiian Gold Coral and Additional Zoanthids	PLOS ONE			English	Article							DEEP-WATER CORALS; MOLECULAR CHARACTERIZATION; REPRODUCTIVE-BIOLOGY; PRECIOUS CORALS; SEA CORALS; ZOANTHARIA; CNIDARIA; GENUS; ABYSSOANTHUS; GERARDIA	The Hawaiian gold coral has a history of exploitation from the deep slopes and seamounts of the Hawaiian Islands as one of the precious corals commercialised in the jewellery industry. Due to its peculiar characteristic of building a scleroproteic skeleton, this zoanthid has been referred as Gerardia sp. (a junior synonym of Savalia Nardo, 1844) but never formally described or examined by taxonomists despite its commercial interest. While collection of Hawaiian gold coral is now regulated, globally seamounts habitats are increasingly threatened by a variety of anthropogenic impacts. However, impact assessment studies and conservation measures cannot be taken without consistent knowledge of the biodiversity of such environments. Recently, multiple samples of octocoral-associated zoanthids were collected from the deep slopes of the islands and seamounts of the Hawaiian Archipelago. The molecular and morphological examination of these zoanthids revealed the presence of at least five different species including the gold coral. Among these only the gold coral appeared to create its own skeleton, two other species are simply using the octocoral as substrate, and the situation is not clear for the final two species. Phylogenetically, all these species appear related to zoanthids of the genus Savalia as well as to the octocoral-associated zoanthid Corallizoanthus tsukaharai, suggesting a common ancestor to all octocoral-associated zoanthids. The diversity of zoanthids described or observed during this study is comparable to levels of diversity found in shallow water tropical coral reefs. Such unexpected species diversity is symptomatic of the lack of biological exploration and taxonomic studies of the diversity of seamount hexacorals.	[Sinniger, Frederic] Japan Agcy Marine Earth Sci & Technol, Submarine Resources Project, Yokosuka, Kanagawa 2370061, Japan; [Sinniger, Frederic] Japan Agcy Marine Earth Sci & Technol, Global Oceanog Data Ctr, Nago, Okinawa, Japan; [Sinniger, Frederic] Japan Agcy Marine Earth Sci & Technol, Inst Biogeosci, Marine Biodivers Program, Yokosuka, Kanagawa 2370061, Japan; [Sinniger, Frederic] Univ Ryukyus, Trop Biosphere Res Ctr, Motobu, Okinawa, Japan; [Ocana, Oscar V.] Fdn Museo Mar, Dept Biol Marina, Ceuta, North Africa, Spain; [Baco, Amy R.] Florida State Univ, Dept Oceanog, Tallahassee, FL 32306 USA	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of the Ryukyus; State University System of Florida; Florida State University	Sinniger, F (corresponding author), Japan Agcy Marine Earth Sci & Technol, Submarine Resources Project, 2-15 Natsushimacho, Yokosuka, Kanagawa 2370061, Japan.	fredsinniger@hotmail.com		Sinniger, Frederic/0000-0002-4175-5931; Ocana Vicente, Oscar/0000-0002-4594-8642	Hawaii Undersea Research Laboratory and Hawaii SeaGrant; National Oceanic and Atmospheric Administration (NOAA) Office of Ocean Exploration Grant [NA04OAR4600071, NA0OAR4600108, NA03OAR4600110]	Hawaii Undersea Research Laboratory and Hawaii SeaGrant; National Oceanic and Atmospheric Administration (NOAA) Office of Ocean Exploration Grant	Specimens were collected by ARB through grants from the Hawaii Undersea Research Laboratory and Hawaii SeaGrant and by the National Oceanic and Atmospheric Administration (NOAA) Office of Ocean Exploration Grant numbers NA04OAR4600071, NA0OAR4600108, and NA03OAR4600110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apakupakul K, 1999, MOL PHYLOGENET EVOL, V12, P350, DOI 10.1006/mpev.1999.0639; Auster PJ, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P93; Baco AR, 2007, OCEANOGRAPHY, V20, P108, DOI 10.5670/oceanog.2007.11; Baco AR, 2005, ERLANGEN EARTH C SER, P663, DOI 10.1007/3-540-27673-4_33; Bertoloni A., 1819, AMOENITATES ITALICAE; Cairns SD, 2007, B MAR SCI, V81, P311; Carlgren Oskar, 1913, The Danish Ingolf Expedition, V5; Carreiro-Silva M, 2011, ICES J MAR SCI, V68, P408, DOI 10.1093/icesjms/fsq073; Clark MR, 2011, INT SEABED AUTHORITY; CUTRESS CHARLES E., 1960, PACIFIC SCI, V14, P89; den Hartog J.C., 1993, Zoologische Verhandelingen (Leiden), V282, P1; den Hartog J.C., 1984, Zoologische Verhandelingen (Leiden), P1; DENHARTOG JC, 1980, ZOOL VERH-LEIDEN, V176, P1; DRUFFEL ERM, 1995, GEOCHIM COSMOCHIM AC, V59, P5031, DOI 10.1016/0016-7037(95)00373-8; Etnoyer P, 2005, ERLANGEN EARTH C SER, P331, DOI 10.1007/3-540-27673-4_16; Fujii T, 2011, ZOOL SCR, V40, P418, DOI 10.1111/j.1463-6409.2011.00479.x; Goodfriend GA, 1997, GEOCHIM COSMOCHIM AC, V61, P1931, DOI 10.1016/S0016-7037(97)00067-7; Grigg R.W., 1974, Proceedings int Coral Reef Symp, V2, P235; Grigg R. W., 1976, UNIHISEAGRANTTR7703; Grigg Richard W., 1994, U S National Marine Fisheries Service Marine Fisheries Review, V55, P50; Grigg Richard W., 2002, U S National Marine Fisheries Service Marine Fisheries Review, V64, P13; GRIGG RW, 1976, PAC SCI, V30, P167; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Haussermann V, 2003, MITTELMEER BESTIMMUN, P501; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Krieger KJ, 2002, HYDROBIOLOGIA, V471, P83, DOI 10.1023/A:1016597119297; Lwowsky Fritz F., 1913, Zoologische Jahrbuecher Jena Abteilungen f Systematik, V34; Marschal C, 2004, CORAL REEFS, V23, P423, DOI 10.1007/s00338-004-0398-6; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Miller K, 2009, MAR ECOL PROG SER, V397, P1, DOI 10.3354/meps08452; MUIRHEAD A, 1986, J MAR BIOL ASSOC UK, V66, P131, DOI 10.1017/S0025315400039709; Ocana Oscar, 2007, Vieraea, V35, P163; Ocaû£a O., 2004, REV ACAD CANARIA CIE, V15, P159; Parrish FA, 2002, MAR MAMMAL SCI, V18, P244, DOI 10.1111/j.1748-7692.2002.tb01031.x; PARRISH FA, 2007, STATE DEEP CORAL ECO, P155; Parrish FA, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P185; Parrish FA, 2009, MAR ECOL PROG SER, V397, P163, DOI 10.3354/meps08299; Parrish Frank A., 2006, Atoll Research Bulletin, P425; Poche F., 1914, Archiv fuer Naturgeschichte Berlin for, V1914, P47; Previati M, 2010, MAR ECOL-EVOL PERSP, V31, P555, DOI 10.1111/j.1439-0485.2010.00390.x; Reimer JD, 2008, CORAL REEFS, V27, P641, DOI 10.1007/s00338-008-0376-5; Reimer JD, 2007, INVERTEBR SYST, V21, P255, DOI 10.1071/IS06008; Reimer JD, 2010, CAH BIOL MAR, V51, P451; Reimer JD, 2006, ZOOL SCI, V23, P261, DOI 10.2108/zsj.23.261; Reimer James Davis, 2010, Marine Biodiversity, V40, P249, DOI 10.1007/s12526-010-0045-0; Reimer JD, 2010, ZOOL SCI, V27, P729, DOI 10.2108/zsj.27.729; Ritt B, 2010, DEEP-SEA RES PT I, V57, P1120, DOI 10.1016/j.dsr.2010.05.011; Roark EB, 2006, MAR ECOL PROG SER, V327, P1, DOI 10.3354/meps327001; Roark EB, 2009, P NATL ACAD SCI USA, V106, P5204, DOI 10.1073/pnas.0810875106; Roberts J.M., 2009, COLD WATER CORALS BI; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ryland JS, 2004, HYDROBIOLOGIA, V530, P179, DOI 10.1007/s10750-004-2685-1; Ryland JS, 2004, J NAT HIST, V38, P1193, DOI 10.1080/0022293031000155179; Sanamyan N.P., 2007, Zoologiya Bespozvonochnykh, V4, P83; SCHMIDT H, 1972, Zoologica (Stuttgart), V42, P1; Sinniger F, 2005, MAR BIOL, V147, P1121, DOI 10.1007/s00227-005-0016-3; Sinniger F, 2010, CAH BIOL MAR, V51, P475; Sinniger Frederic, 2010, Marine Biodiversity, V40, P57, DOI 10.1007/s12526-009-0034-3; Sinniger F, 2009, ORG DIVERS EVOL, V9, P23, DOI 10.1016/j.ode.2008.10.003; Sinniger F, 2008, ZOOL SCI, V25, P1253, DOI 10.2108/zsj.25.1253; Swain TD, 2010, MOL ECOL, V19, P2587, DOI 10.1111/j.1365-294X.2010.04672.x; Swain TD, 2009, ZOOTAXA, P41, DOI 10.11646/zootaxa.2051.1.3; Tracy DM, 2011, NZ AQUATIC ENV BIODI; Wagner D, 2011, P ROY SOC B-BIOL SCI, V278, P1323, DOI 10.1098/rspb.2010.1681; Waller RG, 2007, B MAR SCI, V81, P533; WALSH GE, 1971, ZOOL J LINN SOC-LOND, V50, P161, DOI 10.1111/j.1096-3642.1971.tb00757.x; WEILL ROBERT, 1934, TRAV STAT ZOOL WIMEREUX, V10, P1	67	46	49	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52607	10.1371/journal.pone.0052607	http://dx.doi.org/10.1371/journal.pone.0052607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326345	Green Published, Green Submitted, gold			2022-12-25	WOS:000313551500023
J	Woodcock, J; Givoni, M; Morgan, AS				Woodcock, James; Givoni, Moshe; Morgan, Andrei Scott			Health Impact Modelling of Active Travel Visions for England and Wales Using an Integrated Transport and Health Impact Modelling Tool (ITHIM)	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; LEISURE-TIME; MORTALITY; RISK; BENEFITS; METAANALYSIS; WALKING; DISEASE; CAR; PREVENTION	Background: Achieving health benefits while reducing greenhouse gas emissions from transport offers a potential policy win-win; the magnitude of potential benefits, however, is likely to vary. This study uses an Integrated Transport and Health Impact Modelling tool (ITHIM) to evaluate the health and environmental impacts of high walking and cycling transport scenarios for English and Welsh urban areas outside London. Methods: Three scenarios with increased walking and cycling and lower car use were generated based upon the Visions 2030 Walking and Cycling project. Changes to carbon dioxide emissions were estimated by environmental modelling. Health impact assessment modelling was used to estimate changes in Disability Adjusted Life Years (DALYs) resulting from changes in exposure to air pollution, road traffic injury risk, and physical activity. We compare the findings of the model with results generated using the World Health Organization's Health Economic Assessment of Transport (HEAT) tools. Results: This study found considerable reductions in disease burden under all three scenarios, with the largest health benefits attributed to reductions in ischemic heart disease. The pathways that produced the largest benefits were, in order, physical activity, road traffic injuries, and air pollution. The choice of dose response relationship for physical activity had a large impact on the size of the benefits. Modelling the impact on all-cause mortality rather than through individual diseases suggested larger benefits. Using the best available evidence we found fewer road traffic injuries for all scenarios compared with baseline but alternative assumptions suggested potential increases. Conclusions: Methods to estimate the health impacts from transport related physical activity and injury risk are in their infancy; this study has demonstrated an integration of transport and health impact modelling approaches. The findings add to the case for a move from car transport to walking and cycling, and have implications for empirical and modelling research.	[Woodcock, James] Univ Cambridge, Inst Publ Hlth, UKCRC Ctr Diet & Activ Res CEDAR, Cambridge, England; [Givoni, Moshe] Tel Aviv Univ, Dept Geog & Human Environm, IL-69978 Tel Aviv, Israel; [Morgan, Andrei Scott] UCL, Inst Womens Hlth, London, England	University of Cambridge; Tel Aviv University; University of London; University College London	Woodcock, J (corresponding author), Univ Cambridge, Inst Publ Hlth, UKCRC Ctr Diet & Activ Res CEDAR, Cambridge, England.	jw745@medschl.cam.ac.uk	Woodcock, James/AAH-6753-2021	Morgan, Andrei/0000-0003-4143-1977; Woodcock, James/0000-0003-4769-5375	British Heart Foundation; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust; UK Clinical Research Collaboration; UK Engineering and Physical Sciences Research Council on 'Visions of the Role of Walking and Cycling' [EP/G000468/1]; EPSRC [EP/G000468/1] Funding Source: UKRI; ESRC [ES/G007462/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/G000468/1] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); UK Clinical Research Collaboration; UK Engineering and Physical Sciences Research Council on 'Visions of the Role of Walking and Cycling'(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The health impact modelling was undertaken at the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence. Funding from the British Heart Foundation, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. This study was partly funded through the UK Engineering and Physical Sciences Research Council (http://www.epsrc.ac.uk/Pages/default.aspx) on 'Visions of the Role of Walking and Cycling in 2030' (Grant reference:EP/G000468/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman F, 2011, ECONOMICS, V40, P2011; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Ainsworth BE, COMPENDIUM PHYS ACTI; Aldred J, 2006, LAND ECON, V82, P141, DOI 10.3368/le.82.2.141; Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621; Besson H, 2008, MED SCI SPORT EXER, V40, P1909, DOI 10.1249/MSS.0b013e318180bcad; Bhalla K, 2007, RISK ANAL, V27, P125, DOI 10.1111/j.1539-6924.2006.00864.x; Bhatia R, 2011, ACCIDENT ANAL PREV, V43, P235, DOI 10.1016/j.aap.2010.08.015; Byberg L, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b688; Cameron MH, 2010, ACCIDENT ANAL PREV, V42, P1908, DOI 10.1016/j.aap.2010.05.012; COMMITTEE ON THE MEDICAL EFFECTS OF AIR POLLUTANTS (COMEAP), 2010, MORT EFF LONG TERM E; de Hartog JJ, 2010, ENVIRON HEALTH PERSP, V118, P1109, DOI 10.1289/ehp.0901747; DEFRA, 2010, NAT ATM EM INV DAT W; DEFRA, 2011, 2008 BAS BACKGR MAPS; Department for Transport, 2008, GUID APPR WALK CYCL; Department for Transport, 2009, NAT TRAV SURV 2008; Elvik R, 2009, ACCIDENT ANAL PREV, V41, P849, DOI 10.1016/j.aap.2009.04.009; Europe WHO, WHO EUR RAL RISK EST; Grabow ML, 2012, ENVIRON HEALTH PERSP, V120, P68, DOI 10.1289/ehp.1103440; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; Hamer M, 2008, BRIT J SPORT MED, V42, P238, DOI 10.1136/bjsm.2007.039974; Hamer M, 2008, PREV MED, V46, P9, DOI 10.1016/j.ypmed.2007.03.006; Holm AL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001135; Jarrett J, 2012, LANCET, V379, P2198, DOI 10.1016/S0140-6736(12)60766-1; Jeon CY, 2007, DIABETES CARE, V30, P744, DOI 10.2337/dc06-1842; Lindsay G, 2010, AUSTR NZ J PUBLIC HL, DOI [10.1111/j.1753-6405.2010.00621, DOI 10.1111/J.1753-6405.2010.00621]; Maizhsh N, 2013, AM J PUBLIC IN PRESS; Mathers C. D., 2002, SUMMARY MEASURES POP; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Matthews CE, 2007, AM J EPIDEMIOL, V165, P1343, DOI 10.1093/aje/kwm088; Metz D, 2008, TRANSPORT REV, V28, P321, DOI 10.1080/01441640701642348; Monninkhof EM, 2007, EPIDEMIOLOGY, V18, P137, DOI 10.1097/01.ede.0000251167.75581.98; Morgan AS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-699; Office for National Statistics Rural and Urban Statistics in England, GUID NOT; Olabarria M, 2013, EUR J PUBLIC HEALTH, V23, P217, DOI 10.1093/eurpub/cks015; Ostro B, 2004, OUTDOOR AIR POLLUTIO; PAFFENBARGER RS, 1994, ACTA PSYCHIAT SCAND, V89, P16, DOI 10.1111/j.1600-0447.1994.tb05796.x; Panis LI, 2010, ATMOS ENVIRON, V44, P2263, DOI 10.1016/j.atmosenv.2010.04.028; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Rabl A, 2012, TRANSPORT POLICY, V19, P121, DOI 10.1016/j.tranpol.2011.09.008; Rojas-Rueda D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4521; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Tight M, 2011, J TRANSP GEOGR, V19, P1580, DOI 10.1016/j.jtrangeo.2011.03.011; Transport for London, 2011, TRAV LOND SUPPL REP; Walker H, 2011, ROAD TRANSPORT EMISS; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; Ward H, 2002, REPORTING ROAD TRAFF; WHO Europe, 2011, HLTH EC ASSESSMENT T; Wolin KY, 2009, BRIT J CANCER, V100, P611, DOI 10.1038/sj.bjc.6604917; Woodcock J, 2007, LANCET, V370, P1078, DOI 10.1016/S0140-6736(07)61254-9; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; World Health Organization, 2009, GLOB HLTH RISKS MORT	53	143	143	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e51462	10.1371/journal.pone.0051462	http://dx.doi.org/10.1371/journal.pone.0051462			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326315	Green Published, Green Submitted, gold			2022-12-25	WOS:000313551500005
J	Yuan, HR; Niu, YM; Liu, XL; Yang, FY; Niu, WY; Fu, L				Yuan, Hairui; Niu, Yanmei; Liu, Xiaolei; Yang, Fengying; Niu, Wenyan; Fu, Li			Proteomic Analysis of Skeletal Muscle in Insulin-Resistant Mice: Response to 6-Week Aerobic Exercise	PLOS ONE			English	Article							ACID-BINDING PROTEIN; MITOCHONDRIAL-FUNCTION; METABOLIC SYNDROME; C57BL/6 MICE; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; TRANSGENIC MICE; CHAPERONIN; ALPHA; FAT	Aerobic exercise has beneficial effects on both weight control and skeletal muscle insulin sensitivity through a number of specific signaling proteins. To investigate the targets by which exercise exerts its effects on insulin resistance, an approach of proteomic screen was applied to detect the potential different protein expressions from skeletal muscle of insulin-resistant mice after prolonged aerobic exercise training and their sedentary controls. Eighteen C57BL/6 mice were divided into two groups: 6 mice were fed normal chow (NC) and 12 mice were fed high-fat diet (HFD) for 10 weeks to produce an IR model. The model group was then subdivided into HFD sedentary control (HC, n = 6) and HFD exercise groups (HE, n = 6). Mice in HE group underwent 6 weeks of treadmill running. After 6 weeks, mice were sacrificed and skeletal muscle was dissected. Total protein (n = 6, each group) was extracted and followed by citrate synthase, 2D proteome profile analysis and immunoblot. Fifteen protein spots were altered between the NC and HC groups and 23 protein spots were changed between the HC and HE groups significantly. The results provided an array of changes in protein abundance in exercise-trained skeletal muscle and also provided the basis for a new hypothesis regarding the mechanism of exercise ameliorating insulin resistance.	[Yuan, Hairui; Niu, Yanmei; Liu, Xiaolei; Yang, Fengying; Fu, Li] Tianjin Med Univ, Dept Rehabil & Sports Med, Tianjin, Peoples R China; [Niu, Wenyan] Tianjin Med Univ, Sch Basic Med Sci, Dept Immunol, Tianjin, Peoples R China; [Fu, Li] Tianjin Med Univ, Sch Basic Med Sci, Dept Physiol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Fu, L (corresponding author), Tianjin Med Univ, Dept Rehabil & Sports Med, Tianjin, Peoples R China.	lifu@tijmu.edu.cn			National Natural Science Foundation of China (NSFC) [30871213, 31100856]; Tianjin Municipal Science and Technology Commission [09JCZDJC17400, 09ZCZDSF04500]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission	This work was supported by grants from the National Natural Science Foundation of China (NSFC) 30871213 (to LF), 31100856 (to YMN), Tianjin Municipal Science and Technology Commission 09JCZDJC17400 (to LF) and 09ZCZDSF04500 (to WYN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/476279; Abe Y, 2009, J BIOL CHEM, V284, P14939, DOI 10.1074/jbc.M900097200; Boluyt MO, 2006, PROTEOMICS, V6, P3154, DOI 10.1002/pmic.200401356; Cabre A, 2008, J LIPID RES, V49, P1746, DOI 10.1194/jlr.M800102-JLR200; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Choi KM, 2009, CLIN ENDOCRINOL, V70, P569, DOI 10.1111/j.1365-2265.2008.03374.x; Cuellar J, 2008, NAT STRUCT MOL BIOL, V15, P858, DOI 10.1038/nsmb.1464; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Egan B, 2011, PROTEOMICS, V11, P1413, DOI 10.1002/pmic.201000597; Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; FERNANDO P, 1993, CAN J PHYSIOL PHARM, V71, P854, DOI 10.1139/y93-128; Fischer H, 2006, BIOCHEM BIOPH RES CO, V346, P125, DOI 10.1016/j.bbrc.2006.05.083; Fisher G, 2012, J APPL PHYSIOL, V112, P688, DOI 10.1152/japplphysiol.00843.2011; Fu L, 2012, METABOLISM, V61, P146, DOI 10.1016/j.metabol.2011.06.017; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; Hertzel AV, 2006, AM J PHYSIOL-ENDOC M, V290, pE814, DOI 10.1152/ajpendo.00465.2005; Holloway KV, 2009, PROTEOMICS, V9, P5155, DOI 10.1002/pmic.200900068; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Hwang H, 2010, DIABETES, V59, P33, DOI 10.2337/db09-0214; Jastrzebski K, 2011, CELL SIGNAL, V23, P1338, DOI 10.1016/j.cellsig.2011.03.016; Kim SY, 2009, PROTEOMICS, V9, P5056, DOI 10.1002/pmic.200800779; Kolb H, 2010, DIABETOLOGIA, V53, P10, DOI 10.1007/s00125-009-1573-7; Lapolla A, 2008, J MASS SPECTROM, V43, P74, DOI 10.1002/jms.1274; Lee CS, 2010, CELL DEATH DIFFER, V17, P1254, DOI 10.1038/cdd.2010.1; Lettner A, 2008, CURR DIABETES REP, V8, P185, DOI 10.1007/s11892-008-0032-z; Liu XL, 2012, BBA-MOL BASIS DIS, V1822, P1716, DOI 10.1016/j.bbadis.2012.07.008; Llorca O, 1999, NATURE, V402, P693, DOI 10.1038/45294; Lumini JA, 2008, SPORTS MED, V38, P735, DOI 10.2165/00007256-200838090-00003; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Meex RCR, 2010, DIABETES, V59, P572, DOI 10.2337/db09-1322; Meigs JB, 2007, DIABETES CARE, V30, P1219, DOI 10.2337/dc06-2484; Niu YM, 2010, INT J SPORT NUTR EXE, V20, P370, DOI 10.1123/ijsnem.20.5.370; Park YM, 1998, J CELL PHYSIOL, V174, P27, DOI 10.1002/(SICI)1097-4652(199801)174:1<27::AID-JCP4>3.0.CO;2-I; Reaven G, 2005, CIRCULATION, V112, P3030, DOI 10.1161/CIRCULATIONAHA.105.504670; Ribas V, 2010, AM J PHYSIOL-ENDOC M, V298, pE304, DOI 10.1152/ajpendo.00504.2009; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Silva LA, 2009, EUR J APPL PHYSIOL, V105, P861, DOI 10.1007/s00421-008-0971-8; SPIEGELMAN BM, 1980, J BIOL CHEM, V255, P8811; van der Heijden GJ, 2009, J CLIN ENDOCR METAB, V94, P4292, DOI 10.1210/jc.2009-1379; Wolfrum C, 2007, CELL MOL LIFE SCI, V64, P2465, DOI 10.1007/s00018-007-7279-4; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503	44	44	48	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53887	10.1371/journal.pone.0053887	http://dx.doi.org/10.1371/journal.pone.0053887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326526	Green Submitted, Green Published, gold			2022-12-25	WOS:000313551500101
J	Wan, E; Kushner, JS; Zakharov, S; Nui, XW; Chudasama, N; Kelly, C; Waase, M; Doshi, D; Liu, GX; Iwata, S; Shiomi, T; Katchman, A; D'Armiento, J; Homma, S; Marx, SO				Wan, Elaine; Kushner, Jared S.; Zakharov, Sergey; Nui, Xiao-wei; Chudasama, Neelesh; Kelly, Christopher; Waase, Marc; Doshi, Darshan; Liu, Guoxia; Iwata, Shinichi; Shiomi, Takayuki; Katchman, Alexander; D'Armiento, Jeanine; Homma, Shunichi; Marx, Steven O.			Reduced vascular smooth muscle BK channel current underlies heart failure-induced vasoconstriction in mice	FASEB JOURNAL			English	Article						calcium; myogenic tone; membrane potential	CA2+-ACTIVATED K+ CHANNELS; LARGE-CONDUCTANCE; MYOGENIC CONSTRICTION; CORONARY-ARTERY; BETA-1 SUBUNIT; MYOCARDIAL-ISCHEMIA; INDUCED CONTRACTION; MESENTERIC-ARTERY; BLOOD-PRESSURE; WALL CA2+	Excessively increased peripheral vasoconstriction is a hallmark of heart failure (HF). Here, we show that in mice with systolic HF post-myocardial infarction, the myogenic tone of third-order mesenteric resistance vessels is increased, the vascular smooth muscle (VSM) membrane potential is depolarized by similar to 20 mV, and vessel wall intracellular [Ca2+] is elevated relative to that in sham-operated control mice. Despite the increased [Ca2+], the frequency and amplitude of spontaneous transient outward currents (STOCs), mediated by large conductance, Ca2+-activated BK channels, were reduced by nearly 80% (P<0.01) and 25% (P<0.05), respectively, in HF. The expression of the BK alpha and beta 1 subunits was reduced in HF mice compared to controls (65 and 82% lower, respectively, P<0.01). Consistent with the importance of a reduction in BK channel expression and function in mediating the HF-induced increase in myogenic tone are two further findings: a blunting of paxilline-induced increase in myogenic tone in HF mice compared to controls (0.9 vs. 10.9%, respectively), and that HF does not alter the increased myogenic tone of BK beta 1-null mice. These findings identify electrical dysregulation within VSM, specifically the reduction of BK currents, as a key molecular mechanism sensitizing resistance vessels to pressure-induced vasoconstriction in systolic HF.	[Wan, Elaine; Kushner, Jared S.; Zakharov, Sergey; Nui, Xiao-wei; Chudasama, Neelesh; Kelly, Christopher; Waase, Marc; Doshi, Darshan; Liu, Guoxia; Iwata, Shinichi; Katchman, Alexander; Homma, Shunichi; Marx, Steven O.] Columbia Univ, Coll Phys & Surg, Div Cardiol, New York, NY USA; [Shiomi, Takayuki; D'Armiento, Jeanine] Columbia Univ, Coll Phys & Surg, Dept Med, Div Mol Med, New York, NY USA; [Marx, Steven O.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY USA	Columbia University; Columbia University; Columbia University	Marx, SO (corresponding author), Columbia Univ Coll Phys & Surg, PH Ctr 3, 630 W 168th St, New York, NY 10032 USA.	sm460@columbia.edu	Shiomi, Takayuki/A-2228-2014; Zakharov, Sergey/O-2896-2019; Zakharov, Sergey/L-8511-2014	Shiomi, Takayuki/0000-0002-4250-1204; Zakharov, Sergey/0000-0001-9864-8304; Zakharov, Sergey/0000-0001-9864-8304; Kushner, Jared S./0000-0003-4821-0990	U.S. National Heart, Lung, and Blood Institute (NHLBI) [P01 HL081172]; NHLBI [T32HL007854]; Howard Hughes Medical Institute Medical Research Fellowship; Arlene and Arnold Goldstein Family Foundation; Lewis Katz Cardiovascular Research Prize; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007854, P01HL081172] Funding Source: NIH RePORTER	U.S. National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute Medical Research Fellowship(Howard Hughes Medical Institute); Arlene and Arnold Goldstein Family Foundation; Lewis Katz Cardiovascular Research Prize; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. George Osol, Dr. Natalia Gokina, and Dr. Mark Nelson (University of Vermont, Burlington, VT, USA), as well as their laboratories. These studies were supported by U.S. National Heart, Lung, and Blood Institute (NHLBI) grant P01 HL081172 (S.O.M. and J.M.D.), NHLBI grant T32HL007854 (E.W.), a Howard Hughes Medical Institute Medical Research Fellowship (J.K.), the Arlene and Arnold Goldstein Family Foundation, and the Lewis Katz Cardiovascular Research Prize. The authors declare no conflicts of interest.	Amberg GC, 2003, J CLIN INVEST, V112, P717, DOI 10.1172/JC1200318684; Amberg GC, 2003, CIRC RES, V93, P965, DOI 10.1161/01.RES.0000100068.43006.36; Ambroisine ML, 2007, CIRCULATION, V116, P2435, DOI 10.1161/CIRCULATIONAHA.107.722009; Bagi Z, 2005, ARTERIOSCL THROM VAS, V25, P1610, DOI 10.1161/01.ATV.0000172688.26838.9f; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; CHRISTENSEN KL, 1993, J VASC RES, V30, P73, DOI 10.1159/000158978; Dong L, 2008, J CEREBR BLOOD F MET, V28, P377, DOI 10.1038/sj.jcbfm.9600536; Dong L, 2009, CLIN EXP PHARMACOL P, V36, pe57, DOI 10.1111/j.1440-1681.2009.05222.x; Duncker DJ, 2008, MED BIOL ENG COMPUT, V46, P485, DOI 10.1007/s11517-008-0315-1; Earley S, 2010, CLIN SCI, V119, P19, DOI 10.1042/CS20090641; Emter CA, 2011, AM J PHYSIOL-HEART C, V301, pH1687, DOI 10.1152/ajpheart.00610.2011; Fernandez-Tenorio M, 2011, CIRC RES, V108, P1348, DOI 10.1161/CIRCRESAHA.111.240127; Gschwend S, 2003, BRIT J PHARMACOL, V139, P1317, DOI 10.1038/sj.bjp.0705367; Gschwend S, 2003, EUR J HEART FAIL, V5, P147, DOI 10.1016/S1388-9842(02)00248-9; Hannah RM, 2011, J CEREBR BLOOD F MET, V31, P1175, DOI 10.1038/jcbfm.2010.214; Hill MA, 2006, CLIN HEMORHEOL MICRO, V34, P67; Hill MA, 2009, TRENDS PHARMACOL SCI, V30, P363, DOI 10.1016/j.tips.2009.04.008; Hoefer J, 2010, CIRC RES, V107, P923, DOI 10.1161/CIRCRESAHA.110.226464; KATZ SD, 1992, J AM COLL CARDIOL, V19, P918, DOI 10.1016/0735-1097(92)90271-N; Kim N, 2003, CIRC RES, V93, P541, DOI 10.1161/01.RES.0000090087.66390.F2; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P199, DOI 10.1111/j.1469-7793.1998.199br.x; Kotecha N, 2005, AM J PHYSIOL-HEART C, V289, pH1326, DOI 10.1152/ajpheart.00323.2005; Lagaud GJL, 2001, J VASC RES, V38, P578, DOI 10.1159/000051094; Liu YP, 2009, BASIC RES CARDIOL, V104, P211, DOI 10.1007/s00395-009-0775-y; Lohn M, 2001, J APPL PHYSIOL, V91, P1350, DOI 10.1152/jappl.2001.91.3.1350; Lu T, 2008, BIOPHYS J, V95, P5165, DOI 10.1529/biophysj.108.138339; McCarron JG, 1997, J PHYSIOL-LONDON, V498, P371, DOI 10.1113/jphysiol.1997.sp021864; McGahon MK, 2007, CIRC RES, V100, P703, DOI 10.1161/01.RES.0000260182.36481.c9; McGahon Mary K, 2007, Channels (Austin), V1, P141; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; Mita M, 2002, BIOCHEM J, V364, P431, DOI 10.1042/BJ20020191; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Nieves-Cintron M, 2008, P NATL ACAD SCI USA, V105, P15623, DOI 10.1073/pnas.0808759105; Nieves-Cintron M, 2007, J BIOL CHEM, V282, P3231, DOI 10.1074/jbc.M608822200; OSOL G, 1993, AM J OBSTET GYNECOL, V168, P268, DOI 10.1016/S0002-9378(12)90924-2; Perez GJ, 1999, J GEN PHYSIOL, V113, P229, DOI 10.1085/jgp.113.2.229; Phillips SA, 2005, AM J PHYSIOL-REG I, V288, pR522, DOI 10.1152/ajpregu.00655.2004; Pluger S, 2000, CIRC RES, V87, pE53, DOI 10.1161/01.RES.87.11.e53; Sakamoto K, 2003, J PHARMACOL SCI, V92, P56; Schrier RW, 1999, NEW ENGL J MED, V341, P577, DOI 10.1056/NEJM199908193410806; Sorop O, 2008, CIRC RES, V102, P795, DOI 10.1161/CIRCRESAHA.108.172528; Tomaselli GF, 2004, CIRC RES, V95, P754, DOI 10.1161/01.RES.0000145047.14691.db; Urban NH, 2003, AM J PHYSIOL-CELL PH, V285, pC1377, DOI 10.1152/ajpcell.00501.2002; van den Heuvel AFM, 2002, CARDIOVASC RES, V55, P97, DOI 10.1016/S0008-6363(02)00331-0; van den Heuvel AFM, 2000, J AM COLL CARDIOL, V35, P19, DOI 10.1016/S0735-1097(99)00499-4; van Veldhuisen DJ, 1998, J CARDIOVASC PHARM, V32, pS46, DOI 10.1097/00005344-199800003-00008; Xu H, 2011, AM J PHYSIOL-HEART C, V300, pH476, DOI 10.1152/ajpheart.00975.2010; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Xu Y, 2007, EUR J HEART FAIL, V9, P144, DOI 10.1016/j.ejheart.2006.05.003; Xu Y, 2009, EUR J HEART FAIL, V11, P246, DOI 10.1093/eurjhf/hfn027; ZELIS R, 1982, PROG CARDIOVASC DIS, V24, P437, DOI 10.1016/0033-0620(82)90012-3	53	19	19	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2013	27	5					1859	1867		10.1096/fj.12-223511	http://dx.doi.org/10.1096/fj.12-223511			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23325318	Green Published, Bronze			2022-12-25	WOS:000318226100006
J	Ashraf, M; Sreejith, P; Yadav, U; Komath, SS				Ashraf, Mohammad; Sreejith, Perinthottathil; Yadav, Usha; Komath, Sneha Sudha			Catalysis by N-Acetyl-D-glucosaminylphosphatidylinositol De-N-acetylase (PIG-L) from Entamoeba histolytica NEW ROLES FOR CONSERVED RESIDUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCHOR BIOSYNTHESIS; GLYCOSYLPHOSPHATIDYLINOSITOL; PROTEIN; CELLS	We showed previously that Entamoeba histolytica PIG-L exhibits a novel metal-independent albeit metal-stimulated activity. Using mutational and biochemical analysis, here we identify Asp-46 and His-140 of the enzyme as being important for catalysis. We show that these mutations neither affect the global conformational of the enzyme nor alter its metal binding affinity. The defect in catalysis, due to the mutations, is specifically due to an effect on V-max and not due to altered substrate affinity (or K-m). We propose a general acid-base pair mechanism to explain our results.	[Ashraf, Mohammad; Sreejith, Perinthottathil; Yadav, Usha; Komath, Sneha Sudha] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Komath, SS (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	sskomath@mail.jnu.ac.in	Peri, Sreejith/AAY-9076-2021	Peri, Sreejith/0000-0001-5445-3265; KOMATH, SNEHA SUDHA/0000-0002-0491-7102	Council for Scientific and Industrial Research (CSIR) [37(1441)/10/EMR-II]; Department of Science and Technology-Promotion of University Research and Scientific Excellence (DST-PURSE); CSIR	Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology-Promotion of University Research and Scientific Excellence (DST-PURSE); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Council for Scientific and Industrial Research (CSIR) Research Grant 37(1441)/10/EMR-II (to S. S. K.), publication support through Department of Science and Technology-Promotion of University Research and Scientific Excellence (DST-PURSE), and CSIR fellowships (to M. A. and U. Y.).	Ashraf M, 2011, J BIOL CHEM, V286, P2543, DOI 10.1074/jbc.C110.178343; de Macedo CS, 2003, BIOCHIMIE, V85, P465, DOI 10.1016/S0300-9084(03)00065-8; Eisenhaber B, 2003, BIOESSAYS, V25, P367, DOI 10.1002/bies.10254; Hernick M, 2005, J BIOL CHEM, V280, P16969, DOI 10.1074/jbc.M413560200; Jain R, 2010, CELL MICROBIOL, V12, P432, DOI 10.1111/j.1462-5822.2009.01406.x; Kinoshita T, 2000, CURR OPIN CHEM BIOL, V4, P632, DOI 10.1016/S1367-5931(00)00151-4; Martinez-Lopez R, 2004, MICROBIOL-SGM, V150, P3341, DOI 10.1099/mic.0.27320-0; McCarthy AA, 2004, J MOL BIOL, V335, P1131, DOI 10.1016/j.jmb.2003.11.034; Nagamune K, 2000, P NATL ACAD SCI USA, V97, P10336, DOI 10.1073/pnas.180230697; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Urbaniak MD, 2005, J BIOL CHEM, V280, P22831, DOI 10.1074/jbc.M502402200; Vats D, 2005, INFECT IMMUN, V73, P8381, DOI 10.1128/IAI.73.12.8381-8392.2005	12	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7590	7595		10.1074/jbc.M112.427245	http://dx.doi.org/10.1074/jbc.M112.427245			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23341455	Green Published, hybrid			2022-12-25	WOS:000316455300016
J	Sulaiman, P; Xu, Y; Fina, ME; Tummala, SR; Ramakrishnan, H; Dhingra, A; Vardi, N				Sulaiman, Pyroja; Xu, Ying; Fina, Marie E.; Tummala, Shanti R.; Ramakrishnan, Hariharasubramanian; Dhingra, Anuradha; Vardi, Noga			Kir2.4 Surface Expression and Basal Current Are Affected by Heterotrimeric G-Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-BETA-GAMMA; RECTIFYING POTASSIUM CHANNELS; K+ CHANNEL; BIPOLAR CELLS; PLASMA-MEMBRANE; LIGHT RESPONSE; SUBUNITS; ACTIVATION; ORGANIZATION; TRANSPORT	Kir2.4, a strongly rectifying potassium channel that is localized to neurons and is especially abundant in retina, was fished with yeast two-hybrid screen using a constitutively active G alpha(o1). Here, we wished to determine whether and how G alpha(o) affects this channel. Using transfected HEK 293 cells and retinal tissue, we showed that Kir2.4 interacts with G alpha(o), and this interaction is stronger with the GDP-bound form of G alpha(o). Using two-electrode voltage clamp, we recorded from oocytes that were injected with Kir2.4 mRNA and a combination of G-protein subunit mRNAs. We found that the wild type and the inactive mutant of G alpha(o) reduce the Kir2.4 basal current, whereas the active mutant has little effect. Other pertussis-sensitive G alpha subunits also reduce this current, whereas G alpha(s) increases it. G beta gamma increases the current, whereas m-phosducin, which binds G beta gamma without affecting the state of G alpha, reduces it. We then tested the effect of G-protein subunits on the surface expression of the channel fused to cerulean by imaging the plasma membranes of the oocytes. We found that the surface expression is affected, with effects paralleling those seen with the basal current. This suggests that the observed effects on the current are mainly indirect and are due to surface expression. Similar results were obtained in transfected HEK cells. Moreover, we show that in retinal ON bipolar cells lacking G beta 3, localization of Kir2.4 in the dendritic tips is reduced. We conclude that G beta gamma targets Kir2.4 to the plasma membrane, and G alpha(o) slows this down by binding G beta gamma.	[Sulaiman, Pyroja; Fina, Marie E.; Tummala, Shanti R.; Ramakrishnan, Hariharasubramanian; Dhingra, Anuradha; Vardi, Noga] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Xu, Ying] Jinan Univ, Joint Lab Brain Funct & Hlth, Guangzhou 510632, Guangdong, Peoples R China; [Xu, Ying] Jinan Univ, Univ Hong Kong, Guangzhou 510632, Guangdong, Peoples R China	University of Pennsylvania; Pennsylvania Medicine; Jinan University; Jinan University; University of Hong Kong	Vardi, N (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.	noga@mail.med.upenn.edu		Tummala, Shanti/0000-0003-2428-6771; Xu, Ying/0000-0002-9987-2057; ramakrishnan, hari/0000-0003-3613-1822	National Institutes of Health [EY11105]; NEI [P30 EY01583]; NATIONAL EYE INSTITUTE [R01EY011105, P30EY001583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants EY11105 (to N. V.) and NEI P30 EY01583 (Vision Research Core of the University of Pennsylvania).	Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Block BM, 1996, J GEN PHYSIOL, V107, P473, DOI 10.1085/jgp.107.4.473; BOMSEL M, 1992, MOL BIOL CELL, V3, P1317, DOI 10.1091/mbc.3.12.1317; Dascal N, 2001, TRENDS ENDOCRIN MET, V12, P391, DOI 10.1016/S1043-2760(01)00475-1; Dascal N., 1992, PROTOCOLS MOL NEUROB, P205; de Boer TP, 2010, ACTA PHYSIOL, V199, P243, DOI 10.1111/j.1748-1716.2010.02108.x; Dhingra A, 2004, J NEUROSCI, V24, P5684, DOI 10.1523/JNEUROSCI.0492-04.2004; Dhingra A, 2002, J NEUROSCI, V22, P4878, DOI 10.1523/JNEUROSCI.22-12-04878.2002; Dhingra A, 2000, J NEUROSCI, V20, P9053; Dhingra A, 2008, J COMP NEUROL, V510, P484, DOI 10.1002/cne.21807; Dhingra A, 2012, J NEUROSCI, V32, P11343, DOI 10.1523/JNEUROSCI.1436-12.2012; DOUPNIK CA, 1995, CURR OPIN NEUROBIOL, V5, P268, DOI 10.1016/0959-4388(95)80038-7; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; Hofherr A, 2005, J CELL SCI, V118, P1935, DOI 10.1242/jcs.02322; Holzapfel HP, 2002, EUR J ENDOCRINOL, V147, P109, DOI 10.1530/eje.0.1470109; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Hughes BA, 2000, AM J PHYSIOL-CELL PH, V279, pC771, DOI 10.1152/ajpcell.2000.279.3.C771; Irannejad R, 2010, J BIOL CHEM, V285, P32393, DOI 10.1074/jbc.M110.154963; Isomoto S, 1997, JPN J PHYSIOL, V47, P11, DOI 10.2170/jjphysiol.47.11; Ivanina T, 2004, J BIOL CHEM, V279, P17260, DOI 10.1074/jbc.M313425200; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jamora C, 1997, CELL, V91, P617, DOI 10.1016/S0092-8674(00)80449-3; Jordan JD, 2005, J BIOL CHEM, V280, P11413, DOI 10.1074/jbc.M411521200; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Ma YP, 2003, J NEUROPHYSIOL, V90, P3479, DOI 10.1152/jn.00426.2003; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; PERLMAN I, 1988, J NEUROPHYSIOL, V60, P1322, DOI 10.1152/jn.1988.60.4.1322; Pruss H, 2005, MOL BRAIN RES, V139, P63, DOI 10.1016/j.molbrainres.2005.05.006; Rubinstein M, 2007, J PHYSIOL-LONDON, V581, P17, DOI 10.1113/jphysiol.2006.125864; Rubinstein M, 2009, J PHYSIOL-LONDON, V587, P3473, DOI 10.1113/jphysiol.2009.173229; Schram G, 2002, J PHYSIOL-LONDON, V544, P337, DOI 10.1113/jphysiol.2002.026047; Shen W, 2007, NAT NEUROSCI, V10, P1458, DOI 10.1038/nn1972; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; Topert C, 1998, J NEUROSCI, V18, P4096; Vardi N., 2012, ARVO ABSTR 4314 A540; Wang JS, 2011, CRIT REV EUKAR GENE, V21, P303, DOI 10.1615/CritRevEukarGeneExpr.v21.i4.10; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; Yi BA, 2001, P NATL ACAD SCI USA, V98, P11016, DOI 10.1073/pnas.191351798	40	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7420	7429		10.1074/jbc.M112.412791	http://dx.doi.org/10.1074/jbc.M112.412791			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23339194	Green Published, hybrid			2022-12-25	WOS:000316002400060
J	Cornelius, F; Kanai, R; Toyoshima, C				Cornelius, Flemming; Kanai, Ryuta; Toyoshima, Chikashi			A Structural View on the Functional Importance of the Sugar Moiety and Steroid Hydroxyls of Cardiotonic Steroids in Binding to Na,K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ADENOSINE-TRIPHOSPHATASE; DISSOCIATION RATE CONSTANTS; HIGH-AFFINITY BINDING; CARDIAC GLYCOSIDE; GASTRIC H,K-ATPASE; RECTAL GLANDS; ION PATHWAY; K+-ATPASE; POTASSIUM; OUABAIN	The Na,K-ATPase is specifically inhibited by cardiotonic steroids (CTSs) like digoxin and is of significant therapeutic value in the treatment of congestive heart failure and arrhythmia. Recently, new interest has arisen in developing Na,K-ATPase inhibitors as anticancer agents. In the present study, we compare the potency and rate of inhibition as well as the reactivation of enzyme activity following inhibition by various cardiac glycosides and their aglycones at different pH values using shark Na, K-ATPase stabilized in the E2MgP(i) or in the E2BeF(x) conformations. The effects of the number and nature of various sugar residues as well as changes in the positions of hydroxyl groups on the beta-side of the steroid core of cardiotonic steroids were investigated by comparing various cardiac glycoside compounds like ouabain, digoxin, digitoxin, and gitoxin with their aglycones. The results confirm our previous hypothesis that CTS binds primarily to the E2-P ground state through an extracellular access channel and that binding of extracellular Na+ ions to K+ binding sites relieved the CTS inhibition. This reactivation depended on the presence or absence of the sugar moiety on the CTS, and a single sugar is enough to impede reactivation. Finally, increasing the number of hydroxyl groups of the steroid was sterically unfavorable and was found to decrease the inhibitory potency and to confer high pH sensitivity, depending on their position on the steroid beta-face. The results are discussed with reference to the recent crystal structures of Na,K-ATPase in the unbound and ouabain-bound states.	[Cornelius, Flemming] Univ Aarhus, Dept Biomed, DK-8000 Aarhus C, Denmark; [Kanai, Ryuta; Toyoshima, Chikashi] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan	Aarhus University; University of Tokyo	Cornelius, F (corresponding author), Univ Aarhus, Dept Biomed, Ole Worms Alle 6, DK-8000 Aarhus C, Denmark.	fc@biophys.au.dk	Cornelius, Flemming/C-1912-2019; Toyoshima, Chikashi/R-4153-2019	Cornelius, Flemming/0000-0003-1566-0020; Toyoshima, Chikashi/0000-0001-9640-0778	Danish Medical Research Foundation; Danish Agency for Science Technology and Innovation; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Science and Technology Agency	Danish Medical Research Foundation; Danish Agency for Science Technology and Innovation; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by The Danish Medical Research Foundation and by an FI/Danish-Japanese cooperation program from the Danish Agency for Science Technology and Innovation (to F. C.); by a Specially Promoted Project Grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and by a Strategic Japanese-Danish Cooperative Program Grant from Japan Science and Technology Agency (to C. T.).	AHMED K, 1983, J BIOL CHEM, V258, P8092; AKERA T, 1971, J PHARMACOL EXP THER, V176, P545; BAGINSKI ES, 1967, CLIN CHIM ACTA, V15, P155, DOI 10.1016/0009-8981(67)90340-3; BROWN L, 1983, BIOCHEM PHARMACOL, V32, P2767, DOI 10.1016/0006-2952(83)90090-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cornelius F, 2011, J BIOL CHEM, V286, P29882, DOI 10.1074/jbc.M111.259663; Cornelius F, 2009, BIOCHEMISTRY-US, V48, P10056, DOI 10.1021/bi901212r; DEPOVER A, 1982, N-S ARCH PHARMACOL, V321, P135, DOI 10.1007/BF00518481; Dostanic-Larson I, 2005, P NATL ACAD SCI USA, V102, P15845, DOI 10.1073/pnas.0507358102; Farr CD, 2002, BIOCHEMISTRY-US, V41, P1137, DOI 10.1021/bi011511g; FENG JN, 1994, BIOCHEMISTRY-US, V33, P4218, DOI 10.1021/bi00180a015; Fiske CH, 1925, J BIOL CHEM, V66, P375; FULLERTON DS, 1979, SCIENCE, V205, P917, DOI 10.1126/science.224455; FULLERTON DS, 1983, CURR TOP MEMBR TRANS, V19, P257; GO K, 1980, ACTA CRYSTALLOGR B, V36, P3034, DOI 10.1107/S0567740880010746; Grell E, 2004, J THERM ANAL CALORIM, V77, P471, DOI 10.1023/B:JTAN.0000038987.75618.33; Grell E, 2001, THERMOCHIM ACTA, V380, P245, DOI 10.1016/S0040-6031(01)00678-5; GRIFFIN JF, 1986, MOL PHARMACOL, V29, P270; HASHIMOTO T, 1986, J MED CHEM, V29, P997, DOI 10.1021/jm00156a017; Kamano Y, 1998, BIOORGAN MED CHEM, V6, P1103, DOI 10.1016/S0968-0896(98)00067-4; Katz A, 2010, J BIOL CHEM, V285, P19582, DOI 10.1074/jbc.M110.119248; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; Lingrel JB, 1997, ANN NY ACAD SCI, V834, P194, DOI 10.1111/j.1749-6632.1997.tb52251.x; LINGREL JB, 1991, SOC GEN PHY, V46, P1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahmmoud YA, 2000, J BIOL CHEM, V275, P35969, DOI 10.1074/jbc.M005168200; Mijatovic T, 2012, CURR MED CHEM, V19, P627, DOI 10.2174/092986712798992075; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Paula S, 2005, BIOCHEMISTRY-US, V44, P498, DOI 10.1021/bi048680w; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; PRICE EM, 1990, J BIOL CHEM, V265, P6638; Qiu LY, 2006, J BIOL CHEM, V281, P13533, DOI 10.1074/jbc.M600551200; Qiu LY, 2005, J BIOL CHEM, V280, P32349, DOI 10.1074/jbc.M505168200; Qiu LY, 2003, J BIOL CHEM, V278, P47240, DOI 10.1074/jbc.M308833200; Radkov R, 2007, BIOCHEM BIOPH RES CO, V356, P142, DOI 10.1016/j.bbrc.2007.02.119; REPKE K, 1985, TRENDS PHARMACOL SCI, V6, P275, DOI 10.1016/0165-6147(85)90126-9; Rodacker V, 2006, J BIOL CHEM, V281, P18539, DOI 10.1074/jbc.M601780200; SCHATZMANN HJ, 1953, HELV PHYSIOL PHARM A, V11, P346; Schneeberger A, 2001, J MEMBRANE BIOL, V179, P263, DOI 10.1007/s002320010051; SKOU JC, 1988, METHOD ENZYMOL, V156, P43; THOMAS R, 1974, J PHARMACOL EXP THER, V191, P219; TOBIN T, 1972, BIOCHEM PHARMACOL, V21, P1553, DOI 10.1016/0006-2952(72)90305-X; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2011, STRUCTURE, V19, P1732, DOI 10.1016/j.str.2011.10.016; Wang HYL, 2012, EXPERT OPIN THER PAT, V22, P587, DOI 10.1517/13543776.2012.690033; WOODCOCK BG, 1985, TRENDS PHARMACOL SCI, V6, P273, DOI 10.1016/0165-6147(85)90125-7; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004; YODA A, 1982, MOL PHARMACOL, V22, P700; YODA A, 1978, MOL PHARMACOL, V14, P624; YODA A, 1977, MOL PHARMACOL, V13, P352; YODA A, 1973, MOL PHARMACOL, V9, P766; YODA A, 1973, MOL PHARMACOL, V9, P51; YODA S, 1975, MOL PHARMACOL, V11, P647	56	53	53	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6602	6616		10.1074/jbc.M112.442137	http://dx.doi.org/10.1074/jbc.M112.442137			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23341448	hybrid, Green Published			2022-12-25	WOS:000315820700060
J	Wauquier, F; Philippe, C; Leotoing, L; Mercier, S; Davicco, MJ; Lebecque, P; Guicheux, J; Pilet, P; Miot-Noirault, E; Poitout, V; Alquier, T; Coxam, V; Wittrant, Y				Wauquier, Fabien; Philippe, Claire; Leotoing, Laurent; Mercier, Sylvie; Davicco, Marie-Jeanne; Lebecque, Patrice; Guicheux, Jerome; Pilet, Paul; Miot-Noirault, Elisabeth; Poitout, Vincent; Alquier, Thierry; Coxam, Veronique; Wittrant, Yohann			The Free Fatty Acid Receptor G Protein-coupled Receptor 40 (GPR40) Protects from Bone Loss through Inhibition of Osteoclast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETION; PPAR-GAMMA; IN-VIVO; EXPRESSION; CELLS; ACTIVATION; MICE; OSTEOBLASTS; MODULATION; LIGANDS	The mechanisms linking fat intake to bone loss remain unclear. By demonstrating the expression of the free fatty acid receptor G-coupled protein receptor 40 (GPR40) in bone cells, we hypothesized that this receptor may play a role in mediating the effects of fatty acids on bone remodeling. Using micro-CT analysis, we showed that GPR40(-/-) mice exhibit osteoporotic features suggesting a positive role of GPR40 on bone density. In primary cultures of bone marrow, we showed that GW9508, a GRP40 agonist, abolished bone-resorbing cell differentiation. This alteration of the receptor activator of NF-kappa B ligand (RANKL)-induced osteoclast differentiation occurred via the inhibition of the nuclear factor kappa B (NF-kappa B) signaling pathway as demonstrated by decrease in gene reporter activity, inhibitor of kappa B kinase (IKK-/-) activation, inhibitor of kappa B (IkB alpha) phosphorylation, and nuclear factor of activated T cells 1 (NFATc1) expression. The GPR40-dependent effect of GW9508 was confirmed using shRNA interference in osteoclast precursors and GPR40(-/-) primary cell cultures. In addition, in vivo administration of GW9508 counteracted ovariectomy-induced bone loss in wild-type but not GPR40(-/-) mice, enlightening the obligatory role of the GPR40 receptor. Then, in a context of growing prevalence of metabolic and age-related bone disorders, our results demonstrate for the first time in translational approaches that GPR40 is a relevant target for the design of new nutritional and therapeutic strategies to counter bone complications.	[Wauquier, Fabien; Philippe, Claire; Leotoing, Laurent; Mercier, Sylvie; Davicco, Marie-Jeanne; Lebecque, Patrice; Coxam, Veronique; Wittrant, Yohann] Ctr Rech Nutr Humaine Auvergne, Unite Nutr Humaine, Unite Mixte Rech 1019, Inst Natl Rech Agron, F-63009 Clermont Ferrand, France; [Wauquier, Fabien; Philippe, Claire; Leotoing, Laurent; Mercier, Sylvie; Davicco, Marie-Jeanne; Lebecque, Patrice; Miot-Noirault, Elisabeth; Coxam, Veronique; Wittrant, Yohann] Univ Auvergne, Clermont Univ, Unite Nutr Humaine, F-63000 Clermont Ferrand, France; [Wauquier, Fabien; Philippe, Claire; Leotoing, Laurent; Mercier, Sylvie; Davicco, Marie-Jeanne; Lebecque, Patrice; Coxam, Veronique; Wittrant, Yohann] Equipe Alimentat Squelette & Metab, F-44042 Nantes, France; [Guicheux, Jerome] INSERM, UMR S791, Lab Ingn Osteoarticulaire & Dent, F-44042 Nantes, France; [Guicheux, Jerome] Univ Nantes, Pole Rech & Enseignement Super Univ Nantes Angers, Unite Format & Rech Odontol, F-44042 Nantes, France; [Miot-Noirault, Elisabeth] INSERM, UMR 990, F-63000 Clermont Ferrand, France; [Poitout, Vincent; Alquier, Thierry] CRCHUM, Ctr Rech Diabet Montreal, Montreal, PQ H3T 1J4, Canada; [Poitout, Vincent; Alquier, Thierry] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada	INRAE; Universite Clermont Auvergne (UCA); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montreal; Universite de Montreal	Wittrant, Y (corresponding author), Univ Auvergne, Clermont Univ, CRNH Auvergne, INRA,UNH,UMR 1019, BP 10448, F-63000 Clermont Ferrand, France.	yohann.wittrant@clermont.inra.fr	Alquier, Thierry/Z-1917-2019; Miot-Noirault, Elisabeth/Y-2272-2019; Paul, Pilet/A-3755-2015; guicheux, Jerome/F-7767-2013	Alquier, Thierry/0000-0001-8171-802X; guicheux, Jerome/0000-0003-2754-3024; Poitout, Vincent/0000-0002-6555-5053	Canadian Institutes of Health Research [MOP 177381]; Canadian Diabetes Association	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association	This work was supported in part by the Canadian Institutes of Health Research Grant MOP 177381 (to V. P.).; Supported by a postdoctoral fellowship from the Canadian Diabetes Association.	Alquier T, 2009, DIABETES, V58, P2607, DOI 10.2337/db09-0362; Araki T, 2012, DIABETES OBES METAB, V14, P271, DOI 10.1111/j.1463-1326.2011.01525.x; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Berger J, 1996, ENDOCRINOLOGY, V137, P4189, DOI 10.1210/en.137.10.4189; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Chan BY, 2007, BONE, V40, P149, DOI 10.1016/j.bone.2006.07.029; Coenen KR, 2009, DIABETOLOGIA, V52, P318, DOI 10.1007/s00125-008-1221-7; Cornish J, 2008, ENDOCRINOLOGY, V149, P5688, DOI 10.1210/en.2008-0111; Corwin RL, 2003, PROSTAG LEUKOTR ESS, V68, P379, DOI 10.1016/S0952-3278(03)00062-0; Covington DK, 2006, BIOCHEM SOC T, V34, P770, DOI 10.1042/BST0340770; Diascro DD, 1998, J BONE MINER RES, V13, P96, DOI 10.1359/jbmr.1998.13.1.96; Gras D, 2009, AM J PHYSIOL-LUNG C, V296, pL970, DOI 10.1152/ajplung.90219.2008; Himes RW, 2010, FASEB J, V24, P731, DOI 10.1096/fj.09-141929; Hounoki H, 2008, BONE, V42, P765, DOI 10.1016/j.bone.2007.11.016; Hwang D, 2001, FASEB J, V15, P2556, DOI 10.1096/fj.01-0432com; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jeon MJ, 2003, J BIOL CHEM, V278, P23270, DOI 10.1074/jbc.M211610200; Johnson GB, 2004, FASEB J, V18, P1282, DOI 10.1096/fj.04-1572fje; Kotarsky K, 2003, PHARMACOL TOXICOL, V93, P249, DOI 10.1111/j.1600-0773.2003.pto930601.x; LANEUVILLE O, 1995, J BIOL CHEM, V270, P19330, DOI 10.1074/jbc.270.33.19330; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Mano H, 2000, J BIOL CHEM, V275, P8126, DOI 10.1074/jbc.275.11.8126; Maurin AC, 2005, CALCIFIED TISSUE INT, V76, P385, DOI 10.1007/s00223-004-0108-y; Mieczkowska A, 2012, J BIOL CHEM, V287, P23517, DOI 10.1074/jbc.M111.324814; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Oh SR, 2010, J LIPID RES, V51, P892, DOI [10.1194/jlr.M800626-JLR200, 10.1194/jlr.M800626]; Ono K, 2005, J BONE MINER RES, V20, P23, DOI 10.1359/JBMR.041027; RAISZ LG, 1989, PROSTAG OTH LIPID M, V37, P615, DOI 10.1016/0090-6980(89)90076-2; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Smith NJ, 2009, J BIOL CHEM, V284, P17527, DOI 10.1074/jbc.M109.012849; Still K, 2008, CALCIFIED TISSUE INT, V83, P285, DOI 10.1007/s00223-008-9175-9; Tsutsumi R, 2009, J BONE MINER RES, V24, P1753, DOI [10.1359/JBMR.090412, 10.1359/jbmr.090412]; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Wittrant Y, 2008, BONE, V42, P1122, DOI 10.1016/j.bone.2008.02.006	37	64	69	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6542	6551		10.1074/jbc.M112.429084	http://dx.doi.org/10.1074/jbc.M112.429084			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23335512	Green Published, hybrid			2022-12-25	WOS:000315820700047
J	Bai, LP; Ho, HM; Ma, DL; Yang, H; Fu, WC; Jiang, ZH				Bai, Li-Ping; Ho, Hing-Man; Ma, Dik-Lung; Yang, Hui; Fu, Wai-Chung; Jiang, Zhi-Hong			Aminoglycosylation Can Enhance the G-Quadruplex Binding Activity of Epigallocatechin	PLOS ONE			English	Article							REPEAT-CONTAINING RNA; GREEN TEA; DNA; RECOGNITION; POLYPHENOL; LIGANDS; TARGETS; DESIGN; REGION; EGCG	With the aim of enhancing G-quadruplex binding activity, two new glucosaminosides (16, 18) of penta-methylated epigallocatechin were synthesized by chemical glycosylation. Subsequent ESI-TOF-MS analysis demonstrated that these two glucosaminoside derivatives exhibit much stronger binding activity to human telomeric DNA and RNA G-quadruplexes than their parent structure (i.e., methylated EGC) (14) as well as natural epigallocatechin (EGC, 6). The DNA G-quadruplex binding activity of 16 and 18 is even more potent than strong G-quadruplex binder quercetin, which has a more planar structure. These two synthetic compounds also showed a higher binding strength to human telomeric RNA G-quadruplex than its DNA counterpart. Analysis of the structure-activity relationship revealed that the more basic compound, 16, has a higher binding capacity with DNA and RNA G-quadruplexes than its N-acetyl derivative, 18, suggesting the importance of the basicity of the aminoglycoside for G-quadruplex binding activity. Molecular docking simulation predicted that the aromatic ring of 16 pi-stacks with the aromatic ring of guanine nucleotides, with the glucosamine moiety residing in the groove of G-quadruplex. This research indicates that glycosylation of natural products with aminosugar can significantly enhance their G-quadruplex binding activities, thus is an effective way to generate small molecules targeting G-quadruplexes in nucleic acids. In addition, this is the first report that green tea catechin can bind to nucleic acid G-quadruplex structures.	[Bai, Li-Ping; Jiang, Zhi-Hong] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Taipa, Peoples R China; [Bai, Li-Ping; Jiang, Zhi-Hong] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, Taipa, Peoples R China; [Bai, Li-Ping; Ho, Hing-Man] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon, Hong Kong, Peoples R China; [Ma, Dik-Lung; Yang, Hui; Fu, Wai-Chung] Hong Kong Baptist Univ, Dept Chem, Kowloon, Hong Kong, Peoples R China	Macau University of Science & Technology; Macau University of Science & Technology; Hong Kong Baptist University; Hong Kong Baptist University	Jiang, ZH (corresponding author), Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Taipa, Peoples R China.	zhjiang@must.edu.mo	Fu, Wai-Chung/C-4487-2013; BAI, Li-Ping/O-5691-2016; Fu, Wai Chung/HGC-1135-2022	Fu, Wai-Chung/0000-0002-7181-0057; BAI, Li-Ping/0000-0002-2806-6883; Fu, Wai Chung/0000-0002-7181-0057; Ma, Dik-Lung/0000-0002-9515-340X; Jiang, Zhi-Hong/0000-0002-7956-2481	Macao Foundation [0205, 0199]	Macao Foundation	This work was financially supported by a grant from the Macao Foundation (grant numbers 0205 and 0199). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arola A, 2008, CURR TOP MED CHEM, V8, P1405, DOI 10.2174/156802608786141106; Arya DP, 2011, ACCOUNTS CHEM RES, V44, P134, DOI 10.1021/ar100113q; Arya DP, 2003, J AM CHEM SOC, V125, P8070, DOI 10.1021/ja034241t; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Bai LP, 2008, CHEMBIOCHEM, V9, P2583, DOI 10.1002/cbic.200800256; Bai LP, 2008, ANAL BIOANAL CHEM, V392, P709, DOI 10.1007/s00216-008-2302-7; Baker ES, 2006, INT J MASS SPECTROM, V253, P225, DOI 10.1016/j.ijms.2006.03.016; Balasubramanian S, 2004, J BIOL CHEM, V279, P24007, DOI 10.1074/jbc.M314331200; Cao YH, 1999, NATURE, V398, P381, DOI 10.1038/18793; Collie G, 2009, CHEM COMMUN, P7482, DOI 10.1039/b901889a; Collie GW, 2010, J AM CHEM SOC, V132, P9328, DOI 10.1021/ja100345z; Cuesta J, 2003, MINI-REV MED CHEM, V3, P11, DOI 10.2174/1389557033405502; Daniel JM, 2002, INT J MASS SPECTROM, V216, P1, DOI 10.1016/S1387-3806(02)00585-7; Deng SJ, 1999, J ORG CHEM, V64, P7265, DOI 10.1021/jo990603x; Dexheimer TS, 2006, J AM CHEM SOC, V128, P5404, DOI 10.1021/ja0563861; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Fang MZ, 2003, CANCER RES, V63, P7563; Gabelica V, 1999, J MASS SPECTROM, V34, P1328, DOI 10.1002/(SICI)1096-9888(199912)34:12<1328::AID-JMS889>3.0.CO;2-F; Gunaherath GMKB, 1981, J NAT PRODUCTS, V45, P140; He H, 2012, BIOORG MED CHEM LETT, V22, P1582, DOI 10.1016/j.bmcl.2011.12.143; Hurley LH, 2002, NAT REV CANCER, V2, P188, DOI 10.1038/nrc749; Ikeda T, 1997, J NAT PROD, V60, P102, DOI 10.1021/np960556t; Khan N, 2008, CANCER LETT, V269, P269, DOI 10.1016/j.canlet.2008.04.014; Kuzuhara T, 2006, J BIOL CHEM, V281, P17446, DOI 10.1074/jbc.M601196200; La Ferla B, 2011, NAT PROD REP, V28, P630, DOI 10.1039/c0np00055h; Lambert JD, 2010, ARCH BIOCHEM BIOPHYS, V501, P65, DOI 10.1016/j.abb.2010.06.013; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Liu LL, 2008, TETRAHEDRON, V64, P5885, DOI 10.1016/j.tet.2008.04.047; Luke B, 2009, EMBO J, V28, P2503, DOI 10.1038/emboj.2009.166; Ma DL, 2008, CHEMMEDCHEM, V3, P881, DOI 10.1002/cmdc.200700342; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; Neidle S, 2003, CURR OPIN STRUC BIOL, V13, P275, DOI 10.1016/S0959-440X(03)00072-1; Paeschke K, 2005, NAT STRUCT MOL BIOL, V12, P847, DOI 10.1038/nsmb982; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Phan AT, 2010, FEBS J, V277, P1107, DOI 10.1111/j.1742-4658.2009.07464.x; Phosrithong N, 2010, MED CHEM RES, V19, P817, DOI 10.1007/s00044-009-9233-5; Rahman MA, 2010, NUTR CANCER, V62, P973, DOI 10.1080/01635581.2010.509538; Ranjan N, 2010, BIOCHEMISTRY-US, V49, P9891, DOI 10.1021/bi101517e; Schmidt CA, 2010, J NAT PROD, V73, P2035, DOI 10.1021/np100523s; Schoeftner S, 2009, EMBO J, V28, P2323, DOI 10.1038/emboj.2009.197; Shaw NN, 2008, BIOORG MED CHEM LETT, V18, P4142, DOI 10.1016/j.bmcl.2008.05.090; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010; Sun HX, 2006, BIOORG MED CHEM LETT, V16, P3586, DOI 10.1016/j.bmcl.2006.03.087; Tan JH, 2008, MINI-REV MED CHEM, V8, P1163, DOI 10.2174/138955708785909880; Todd AK, 2007, NUCLEIC ACIDS RES, V35, P5799, DOI 10.1093/nar/gkm609; Vuong QV, 2011, FOOD REV INT, V27, P227, DOI 10.1080/87559129.2011.563397; Wan KX, 2000, J AM CHEM SOC, V122, P300, DOI 10.1021/ja990684e; Willis B, 2010, BIOCHEMISTRY-US, V49, P452, DOI 10.1021/bi9016796; Wrodnigg TM, 2006, J CARBOHYD CHEM, V25, P33, DOI 10.1080/07328300500495795; Xi Z, 2002, CHEM BIOL, V9, P925, DOI 10.1016/S1074-5521(02)00188-6; Xu Y, 2010, P NATL ACAD SCI USA, V107, P14579, DOI 10.1073/pnas.1001177107; Xue L, 2002, CHEM COMMUN, P70, DOI 10.1039/b108171c; Xue LA, 2011, BIOCHEMISTRY-US, V50, P2838, DOI 10.1021/bi1017304; Xue LA, 2010, BIOCHEMISTRY-US, V49, P5540, DOI 10.1021/bi100071j; Yang CS, 2010, NUTR CANCER, V62, P931, DOI 10.1080/01635581.2010.509536; Zhang HY, 2012, MOL BIOSYST, V8, P3208, DOI 10.1039/c2mb25126d	57	20	21	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53962	10.1371/journal.pone.0053962	http://dx.doi.org/10.1371/journal.pone.0053962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335983	Green Submitted, Green Published, gold			2022-12-25	WOS:000314707700041
J	de Almeida, RA; Fogli, A; Gaillard, M; Scheper, GC; Boesflug-Tanguy, O; Pavitt, GD				de Almeida, Rogerio A.; Fogli, Anne; Gaillard, Marina; Scheper, Gert C.; Boesflug-Tanguy, Odile; Pavitt, Graham D.			A Yeast Purification System for Human Translation Initiation Factors eIF2 and eIF2B epsilon and Their Use in the Diagnosis of CACH/VWM Disease	PLOS ONE			English	Article							GUANINE-NUCLEOTIDE-EXCHANGE; VANISHING WHITE-MATTER; FACTOR 2B COMPLEX; CHILDHOOD ATAXIA; IN-VIVO; MULTIFACTOR COMPLEX; CATALYTIC DOMAIN; NATURAL-HISTORY; EPSILON-SUBUNIT; PHOSPHORYLATION	Recessive inherited mutations in any of five subunits of the general protein synthesis factor eIF2B are responsible for a white mater neurodegenerative disease with a large clinical spectrum. The classical form is called Childhood Ataxia with CNS hypomyelination (CACH) or Vanishing White Matter Leukoencephalopathy (VWM). eIF2B-related disorders affect glial cells, despite the fact that eIF2B is a ubiquitous protein that functions as a guanine-nucleotide exchange factor (GEF) for its partner protein eIF2 in the translation initiation process in all eukaryotic cells. Decreased eIF2B activity measured by a GEF assay in patients' immortalised lymphocytic cells provides a biochemical diagnostic assay but is limited by the availability of eIF2 protein, which is classically purified from a mammalian cell source by column chromatography. Here we describe the generation of a recombinant expression system to produce purified human eIF2 from yeast cells. We demonstrate that human eIF2 can function in yeast cells in place of the equivalent yeast factor. We purify human eIF2 and the C-terminal domain of human eIF2B epsilon using affinity chromatography from engineered yeast cells and find that both function in a GEF assay: the first demonstration that this human eIF2Be domain has GEF function. We show that CACH/VWM mutations within this domain reduce its activity. Finally we demonstrate that the recombinant eIF2 functions similarly to eIF2 purified from rat liver in GEF assays with CACH/VWM eIF2B-mutated patient derived lymphocytic cells.	[de Almeida, Rogerio A.; Pavitt, Graham D.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Fogli, Anne; Gaillard, Marina] INSERM U1103 CNRS 6293, Lab GReD Genet Reprod & Dev, Fac Med, Clermont Ferrand, France; [Fogli, Anne] Univ Clermont, UFR Med, Clermont Ferrand, France; [Fogli, Anne] CHU Clermont Ferrand, Serv Biochim Med & Biol Mol, Clermont Ferrand, France; [Scheper, Gert C.] Vrije Univ Amsterdam Med Ctr, Dept Pediat, Amsterdam, Netherlands; [Boesflug-Tanguy, Odile] Hop Robert Debre, INSERM, U676, F-75019 Paris, France; [Boesflug-Tanguy, Odile] Univ Paris Diderot, UMR U676, Paris, France; [Boesflug-Tanguy, Odile] Hop Robert Debre, APHP, Reference Ctr Leukodystrophies, F-75019 Paris, France	University of Manchester; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Clermont Ferrand; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Pavitt, GD (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	graham.pavitt@manchester.ac.uk	Scheper, Gert C/D-7001-2014; Fogli, Anne/AAL-6640-2020; Pavitt, Graham D/A-1363-2010	Fogli, Anne/0000-0002-2651-7441; Pavitt, Graham D/0000-0002-8593-2418	European Leukodystrophy association (ELA) [ELA 2009-034I5]; European Union EU-FP7 Health project Leukotreat [241622]	European Leukodystrophy association (ELA); European Union EU-FP7 Health project Leukotreat	European Leukodystrophy association (ELA) ela-asso.com; grant: ELA 2009-034I5 to GDP, and The European Union EU-FP7 Health project Leukotreat 241622; http://www.leukotreat.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; Boesen T, 2004, J BIOL CHEM, V279, P10584, DOI 10.1074/jbc.M311055200; Bugiani M, 2011, J NEUROPATH EXP NEUR, V70, P69, DOI 10.1097/NEN.0b013e318203ae74; Carter Z, 2010, YEAST, V27, P765, DOI 10.1002/yea.1774; DEVER TE, 1995, MOL CELL BIOL, V15, P6351; Dietrich J, 2005, NAT MED, V11, P277, DOI 10.1038/nm1195; Elsby R, 2011, J VIROL, V85, P9716, DOI 10.1128/JVI.05146-11; Erickson FL, 1996, EMBO J, V15, P6311, DOI 10.1002/j.1460-2075.1996.tb01021.x; Fabian JR, 1997, J BIOL CHEM, V272, P12359, DOI 10.1074/jbc.272.19.12359; Fogli A, 2004, NEUROLOGY, V62, P1509, DOI 10.1212/01.WNL.0000123259.67815.DB; Fogli A, 2006, BIOCHEM SOC T, V34, P22, DOI 10.1042/BST0340022; Fogli A, 2004, EUR J HUM GENET, V12, P561, DOI 10.1038/sj.ejhg.5201189; Fogli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042688; Geva M, 2010, BRAIN, V133, P2448, DOI 10.1093/brain/awq180; Gomez E, 2002, EMBO J, V21, P5292, DOI 10.1093/emboj/cdf515; Gomez E, 2000, MOL CELL BIOL, V20, P3965, DOI 10.1128/MCB.20.11.3965-3976.2000; GOSS DJ, 1984, J BIOL CHEM, V259, P7374; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Horzinski L, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-94; Horzinski L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008318; Huyghe A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038264; Jennings Martin D, 2010, Small GTPases, V1, P118, DOI 10.4161/sgtp.1.2.13783; Jennings MD, 2010, NATURE, V465, P378, DOI 10.1038/nature09003; Kaczorowska M, 2006, EUR J PAEDIATR NEURO, V10, P192, DOI 10.1016/j.ejpn.2006.05.008; KIMBALL SR, 1987, J BIOL CHEM, V262, P2220; Kimball SR, 1998, J BIOL CHEM, V273, P12841, DOI 10.1074/jbc.273.21.12841; Labauge P, 2009, BRAIN, V132, P2161, DOI 10.1093/brain/awp171; Leegwater PAJ, 2001, NAT GENET, V29, P383, DOI 10.1038/ng764; Leng XR, 2011, J HUM GENET, V56, P300, DOI 10.1038/jhg.2011.9; Li W, 2004, MOL CELL BIOL, V24, P3295, DOI 10.1128/MCB.24.8.3295-3306.2004; Liu AR, 2011, HUM MUTAT; Lorsch JR, 2010, J BIOL CHEM, V285, P21203, DOI 10.1074/jbc.R110.119743; Miller CA, 1998, NUCLEIC ACIDS RES, V26, P3577, DOI 10.1093/nar/26.15.3577; Mohammad-Qureshi SS, 2007, MOL CELL BIOL, V27, P5225, DOI 10.1128/MCB.00495-07; OLDFIELD S, 1992, EUR J BIOCHEM, V208, P73, DOI 10.1111/j.1432-1033.1992.tb17160.x; Pavitt GD, 2005, BIOCHEM SOC T, V33, P1487, DOI 10.1042/BST0331487; Pavitt GD, 1997, MOL CELL BIOL, V17, P1298, DOI 10.1128/MCB.17.3.1298; Pavitt GD, 1998, GENE DEV, V12, P514, DOI 10.1101/gad.12.4.514; Pavitt GD, 2009, BIOCHEM SOC T, V37, P1298, DOI 10.1042/BST0371298; Pronk JC, 2006, MENT RETARD DEV D R, V12, P123, DOI 10.1002/mrdd.20104; Reid PJ, 2012, J BIOL CHEM, V287, P8275, DOI 10.1074/jbc.M111.331645; Richardson JP, 2004, MOL CELL BIOL, V24, P2352, DOI 10.1128/MCB.24.6.2352-2363.2004; SCHIFFMANN R, 1994, ANN NEUROL, V35, P331, DOI 10.1002/ana.410350314; Schmitt E, 2010, FEBS LETT, V584, P405, DOI 10.1016/j.febslet.2009.11.002; Shin BS, 2011, NAT STRUCT MOL BIOL, V18, P1227, DOI 10.1038/nsmb.2133; Singh CR, 2007, J MOL BIOL, V370, P315, DOI 10.1016/j.jmb.2007.04.034; Singh CR, 2006, EMBO J, V25, P4537, DOI 10.1038/sj.emboj.7601339; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Valasek L, 2002, EMBO J, V21, P5886, DOI 10.1093/emboj/cdf563; van der Lei HDW, 2010, NEUROLOGY, V75, P1555, DOI 10.1212/WNL.0b013e3181f962ae; van Kollenburg B, 2006, J NEUROPATH EXP NEUR, V65, P707, DOI 10.1097/01.jnen.0000228201.27539.50; vanderKnaap MS, 1997, NEUROLOGY, V48, P845, DOI 10.1212/WNL.48.4.845; Vanderver A, 2005, CLIN CHEM, V51, P2031, DOI 10.1373/clinchem.2005.055053; Wei J, 2010, PROTEIN CELL, V1, P595, DOI 10.1007/s13238-010-0070-6; Williams DD, 2001, J BIOL CHEM, V276, P3733, DOI 10.1074/jbc.M008041200; Wong K, 2000, ACTA NEUROPATHOL, V100, P635, DOI 10.1007/s004010000234	59	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53958	10.1371/journal.pone.0053958	http://dx.doi.org/10.1371/journal.pone.0053958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335982	Green Published, gold, Green Submitted			2022-12-25	WOS:000314707700040
J	Lin, HV; Chen, DL; Shen, Z; Zhu, L; Ouyang, XS; Vongs, A; Kan, YQ; Levorse, JM; Kowalik, EJ; Szeto, DM; Yao, XR; Xiao, JY; Chen, S; Liu, J; Garcia-Calvo, M; Shin, MK; Pinto, S				Lin, Hua V.; Chen, Dunlu; Shen, Zhu; Zhu, Lei; Ouyang, Xuesong; Vongs, Aurawan; Kan, Yanqing; Levorse, John M.; Kowalik, Edward J., Jr.; Szeto, Daphne M.; Yao, Xiaorui; Xiao, Jianying; Chen, Shirley; Liu, Jinqi; Garcia-Calvo, Marga; Shin, Myung K.; Pinto, Shirly			Diacylglycerol Acyltransferase-1 (DGAT1) Inhibition Perturbs Postprandial Gut Hormone Release	PLOS ONE			English	Article							FED HIGH-FAT; TRIGLYCERIDE SYNTHESIS; OBESITY RESISTANCE; MICE; POTENT; METABOLISM; ABSORPTION; EXPRESSION; STEATOSIS; INTESTINE	Diacylglycerol acyltransferase-1 (DGAT1) is a potential therapeutic target for treatment of obesity and related metabolic diseases. However, the degree of DGAT1 inhibition required for metabolic benefits is unclear. Here we show that partial DGAT1 deficiency in mice suppressed postprandial triglyceridemia, led to elevations in glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) only following meals with very high lipid content, and did not protect from diet-induced obesity. Maximal DGAT1 inhibition led to enhanced GLP-1 and PYY secretion following meals with physiologically relevant lipid content. Finally, combination of DGAT1 inhibition with dipeptidyl-peptidase-4 (DPP-4) inhibition led to further enhancements in active GLP-1 in mice and dogs. The current study suggests that targeting DGAT1 to enhance postprandial gut hormone secretion requires maximal inhibition, and suggests combination with DPP-4i as a potential strategy to develop DGAT1 inhibitors for treatment of metabolic diseases.	[Lin, Hua V.; Chen, Dunlu; Shen, Zhu; Zhu, Lei; Vongs, Aurawan; Kan, Yanqing; Levorse, John M.; Kowalik, Edward J., Jr.; Szeto, Daphne M.; Yao, Xiaorui; Xiao, Jianying; Chen, Shirley; Liu, Jinqi; Garcia-Calvo, Marga; Shin, Myung K.; Pinto, Shirly] Merck Res Labs, Rahway, NJ USA	Merck & Company	Pinto, S (corresponding author), Merck Res Labs, Rahway, NJ USA.	shirly_pinto@merck.com		Lin, Hua/0000-0001-5001-5567				Ables GP, 2012, J LIPID RES; Birch AM, 2009, J MED CHEM, V52, P1558, DOI 10.1021/jm801507v; Bray GA, 2008, J CLIN ENDOCR METAB, V93, pS81, DOI 10.1210/jc.2008-1294; Buhman KK, 2002, J BIOL CHEM, V277, P25474, DOI 10.1074/jbc.M202013200; Cao J, 2011, J BIOL CHEM; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chen HC, 2003, J CLIN INVEST, V111, P1715, DOI [10.1172/JCI15859, 10.1172/JCI200315859]; Chen HC, 2003, AM J PHYSIOL-ENDOC M, V284, pE213, DOI 10.1152/ajpendo.00248.2002; Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI0213880; Donovan MJ, 2007, PHYSIOL BEHAV, V92, P969, DOI 10.1016/j.physbeh.2007.07.003; Dow RL, 2011, ACS MED CHEM LETT, V2, P407, DOI 10.1021/ml200051p; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Enayetallah AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027009; Haas JT, 2012, J CLIN INVEST; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; KRASPER H, 1970, DIGESTION, V3, P321, DOI 10.1159/000197052; Lee B, 2010, J LIPID RES, V51, P1770, DOI 10.1194/jlr.M002311; Liu JGJ, 2012, OBESITY IN PRESS, DOI [10.1002/oby.20193, DOI 10.1002/0BY.20193]; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Migoya EM, 2010, CLIN PHARMACOL THER, V88, P801, DOI 10.1038/clpt.2010.184; Novartis, 2011, 12 WEEK MULT RAND DO; Okawa M, 2009, BIOCHEM BIOPH RES CO, V390, P377, DOI 10.1016/j.bbrc.2009.08.167; Richard CD, 2011, EUR J PHARMACOL, V660, P131, DOI 10.1016/j.ejphar.2010.12.022; ROTH KA, 1990, J CELL BIOL, V110, P1791, DOI 10.1083/jcb.110.5.1791; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Thornberry NA, 2009, BEST PRACT RES CL EN, V23, P479, DOI 10.1016/j.beem.2009.03.004; WILSON MD, 1994, J LIPID RES, V35, P943; Xue YB, 2009, GASTROENTEROLOGY, V136, P1317, DOI 10.1053/j.gastro.2008.12.051; Yamamoto T, 2010, EUR J PHARMACOL, V640, P243, DOI 10.1016/j.ejphar.2010.04.050; Zhao G, 2008, J MED CHEM, V51, P380, DOI 10.1021/jm7013887	31	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54480	10.1371/journal.pone.0054480	http://dx.doi.org/10.1371/journal.pone.0054480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23336002	Green Published, gold, Green Submitted			2022-12-25	WOS:000314707700060
J	SanGiovanni, JP; Chen, J; Sapieha, P; Aderman, CM; Stahl, A; Clemons, TE; Chew, EY; Smith, LEH				SanGiovanni, John Paul; Chen, Jing; Sapieha, Przemyslaw; Aderman, Christopher M.; Stahl, Andreas; Clemons, Traci E.; Chew, Emily Y.; Smith, Lois E. H.			DNA Sequence Variants in PPARGC1A, a Gene Encoding a Coactivator of the omega-3 LCPUFA Sensing PPAR-RXR Transcription Complex, Are Associated with NV AMD and AMD-Associated Loci in Genes of Complement and VEGF Signaling Pathways	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ACTIVATED-RECEPTOR-GAMMA; GENOME-WIDE ASSOCIATION; MACULAR DEGENERATION; CHOROIDAL NEOVASCULARIZATION; MESSENGER-RNA; FATTY-ACIDS; POLYMORPHISMS; RISK; EXPRESSION	Background: Increased intake of omega-3 long-chain polyunsaturated fatty acids (LCPUFAs) and use of peroxisome proliferator activator receptor (PPAR)-activating drugs are associated with attenuation of pathologic retinal angiogenesis. omega-3 LCPUFAs are endogenous agonists of PPARs. We postulated that DNA sequence variation in PPAR gamma (PPARG) co-activator 1 alpha (PPARGC1A), a gene encoding a co-activator of the LCPUFA-sensing PPARG-retinoid X receptor (RXR) transcription complex, may influence neovascularization (NV) in age-related macular degeneration (AMD). Methods: We applied exact testing methods to examine distributions of DNA sequence variants in PPARGC1A for association with NV AMD and interaction of AMD-associated loci in genes of complement, lipid metabolism, and VEGF signaling systems. Our sample contained 1858 people from 3 elderly cohorts of western European ancestry. We concurrently investigated retinal gene expression profiles in 17-day-old neonatal mice on a 2% LCPUFA feeding paradigm to identify LCPUFA-regulated genes both associated with pathologic retinal angiogenesis and known to interact with PPARs or PPARGC1A. Results: A DNA coding variant (rs3736265) and a 3'UTR-resident regulatory variant (rs3774923) in PPARGC1A were independently associated with NV AMD (exact P = 0.003, both SNPs). SNP-SNP interactions existed for NV AMD (P<0.005) with rs3736265 and a AMD-associated variant in complement factor B (CFB, rs512559). PPARGC1A influences activation of the AMD-associated complement component 3 (C3) promoter fragment and CFB influences activation and proteolysis of C3. We observed interaction (P <= 0.003) of rs3736265 with a variant in vascular endothelial growth factor A (VEGFA, rs3025033), a key molecule in retinal angiogenesis. Another PPARGC1A coding variant (rs8192678) showed statistical interaction with a SNP in the VEGFA receptor fms-related tyrosine kinase 1 (FLT1, rs10507386; P <= 0.003). C3 expression was down-regulated 2-fold in retinas of omega-3 LCPUFA-fed mice - these animals also showed 70% reduction in retinal NV (P <= 0.001). Conclusion: Ligands and co-activators of the omega-3 LCPUFA sensing PPAR-RXR axis may influence retinal angiogenesis in NV AMD via the complement and VEGF signaling systems. We have linked the co-activator of a lipid-sensing transcription factor (PPARG co-activator 1 alpha, PPARGC1A) to age-related macular degeneration (AMD) and AMD-associated genes.	[SanGiovanni, John Paul; Chew, Emily Y.] NEI, Clin Trials Branch, NIH, Bethesda, MD 20892 USA; [Chen, Jing; Aderman, Christopher M.; Smith, Lois E. H.] Harvard Univ, Childrens Hosp, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; [Sapieha, Przemyslaw] Univ Montreal, Dept Ophthalmol, Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ, Canada; [Stahl, Andreas] Univ Eye Hosp Freiburg, Dept Ophthalmol, Freiburg, Germany; [Clemons, Traci E.] EMMES Corp, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Harvard University; Boston Children's Hospital; Harvard Medical School; Universite de Montreal; University of Freiburg; Emmes Corporation	SanGiovanni, JP (corresponding author), NEI, Clin Trials Branch, NIH, Bethesda, MD 20892 USA.	jpsangio@post.harvard.edu	SanGiovanni, John Paul/AAU-3895-2020		National Eye Institute; Research to Prevent Blindness; Children's Hospital Ophthalmology Foundation; Charles H. Hood Foundation; Canadian Institues of Health Research (Institute of Nutrition, Metabolism and Diabetes); Deutsche Forschungsgemeinschaft; Freifrau von Nauendorf Stiftung; Deutsche Ophthalmologische Gesellschaft; National Institutes of Health [NIH-P50-NS40828, NIH-P30-HD18655];  [EY017017]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022275, R01EY017017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS040828] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Children's Hospital Ophthalmology Foundation; Charles H. Hood Foundation; Canadian Institues of Health Research (Institute of Nutrition, Metabolism and Diabetes)(Canadian Institutes of Health Research (CIHR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Freifrau von Nauendorf Stiftung; Deutsche Ophthalmologische Gesellschaft; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding support for NEI-AMD was provided by the National Eye Institute (JPSG); EY017017 and Research to Prevent Blindness (RPB) Senior Investigator Award (LEHS). Additional support was provided by Children's Hospital Ophthalmology Foundation and Charles H. Hood Foundation (JC), the Canadian Institues of Health Research (Institute of Nutrition, Metabolism and Diabetes) (PS) and the Deutsche Forschungsgemeinschaft, Freifrau von Nauendorf Stiftung and Deutsche Ophthalmologische Gesellschaft (AS). Mouse microarray studies were performed by the Molecular Genetics Core Facility at Children's Hospital Boston supported by National Institutes of Health NIH-P50-NS40828, and NIH-P30-HD18655. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida LN, 2012, GRAEF ARCH CLIN EXP, V250, P185, DOI 10.1007/s00417-011-1807-5; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Anderson SP, 2004, MOL PHARMACOL, V66, P1440, DOI 10.1124/mol.104.005496; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Barger PM, 2001, J BIOL CHEM, V276, P44495, DOI 10.1074/jbc.M105945200; Bazan NG, 2010, J LIPID RES, V51, P2018, DOI 10.1194/jlr.R001131; Bird AC, 2010, J CLIN INVEST, V120, P3033, DOI 10.1172/JCI42437; Brion M, 2011, ACTA OPHTHALMOL, V89, pE12, DOI 10.1111/j.1755-3768.2010.02040.x; Cano MD, 2008, PPAR RES, V2008, DOI 10.1155/2008/821592; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Chong EWT, 2008, ARCH OPHTHALMOL-CHIC, V126, P826, DOI 10.1001/archopht.126.6.826; Churchill AJ, 2006, HUM MOL GENET, V15, P2955, DOI 10.1093/hmg/ddl238; Cipriani V, 2012, HUM MOL GENET, V21, P4138, DOI 10.1093/hmg/dds225; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Fauconnet S, 2002, J BIOL CHEM, V277, P23534, DOI 10.1074/jbc.M200172200; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Galan A, 2010, OPHTHALMOLOGY, V117, P1769, DOI 10.1016/j.ophtha.2010.01.030; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Hageman G.S., 2008, WEBVISION ORG RETINA; Halapin NA, 2010, NEUROCHEM RES, V35, P1944, DOI 10.1007/s11064-010-0351-8; Ho L, 2011, ARCH OPHTHALMOL-CHIC, V129, P758, DOI 10.1001/archophthalmol.2011.141; Keech AC, 2007, LANCET, V370, P1687, DOI 10.1016/S0140-6736(07)61607-9; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kopplin LJ, 2010, GENES IMMUN, V11, P609, DOI 10.1038/gene.2010.39; Koto T, 2007, INVEST OPHTH VIS SCI, V48, P4328, DOI 10.1167/iovs.06-1148; Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200; Lee Y, 2002, P NATL ACAD SCI USA, V99, P11848, DOI 10.1073/pnas.182420899; Leuenberger N, 2009, J CLIN INVEST, V119, P3138, DOI 10.1172/JCI39019; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; McGill JK, 2006, CELL, V127, P465, DOI 10.1016/j.cell.2006.10.023; Menon G, 2009, EYE, V23, pS1, DOI 10.1038/eye.2009.13; Miura S, 2003, J BIOL CHEM, V278, P31385, DOI 10.1074/jbc.M304312200; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Mori K, 2010, OPHTHALMOLOGY, V117, P928, DOI 10.1016/j.ophtha.2009.10.001; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Murata T, 2000, INVEST OPHTH VIS SCI, V41, P2309; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Pershadsingh HA, 2008, PPAR RES, V2008, DOI 10.1155/2008/164273; Prevent Blindness America [PBA], 2017, EC IMPACT VISION PRO; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Qu Y, 2011, OPHTHALMIC RES, V45, P142, DOI 10.1159/000319543; Richardson AJ, 2007, MOL VIS, V13, P2148; Rufibach LE, 2006, J LIPID RES, V47, P1463, DOI 10.1194/jlr.M600082-JLR200; SanGiovanni JP, 2009, AM J CLIN NUTR, V90, P1601, DOI 10.3945/ajcn.2009.27594; SanGiovanni JP, 2009, ARCH OPHTHALMOL-CHIC, V127, P110, DOI 10.1001/archophthalmol.2008.518; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Sapieha P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001571; Sheets KG, 2010, MOL VIS, V16, P320; Smailhodzic D, 2012, OPHTHALMOLOGY; Son NH, 2007, J CLIN INVEST, V117, P2791, DOI 10.1172/JCI30335; Stahl A, 2010, CIRC RES, V107, P495, DOI 10.1161/CIRCRESAHA.110.221317; Subramanian ML, 2009, AM J OPHTHALMOL, V148, P875, DOI 10.1016/j.ajo.2009.07.009; Takeda AL, 2007, BRIT J OPHTHALMOL, V91, P1177, DOI 10.1136/bjo.2007.118562; Vanden Heuvel JP, 2012, PROG MOL BIOL TRANSL, V108, P75, DOI 10.1016/B978-0-12-398397-8.00004-6; Vedula SS, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005139.pub2; Wang JJ, 2009, AM J EPIDEMIOL, V169, P633, DOI 10.1093/aje/kwn358; Weikel KA, 2012, MOL ASPECTS MED, V33, P318, DOI 10.1016/j.mam.2012.03.005; Yano M, 2007, CIRC RES, V100, P1442, DOI 10.1161/01.RES.0000268411.49545.9c; Yu Y, 2011, INVEST OPHTH VIS SCI, V52, P4663, DOI 10.1167/iovs.10-7070	61	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53155	10.1371/journal.pone.0053155	http://dx.doi.org/10.1371/journal.pone.0053155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335958	Green Published, Green Submitted, gold			2022-12-25	WOS:000314707700012
J	Gomaa, F; Mitchell, EAD; Lara, E				Gomaa, Fatma; Mitchell, Edward A. D.; Lara, Enrique			Amphitremida (Poche, 1913) Is a New Major, Ubiquitous Labyrinthulomycete Clade	PLOS ONE			English	Article							EUKARYOTES; PHYLOGENY; DIVERSITY; INFERENCE	Micro-eukaryotic diversity is poorly documented at all taxonomic levels and the phylogenetic affiliation of many taxa - including many well-known and common organisms - remains unknown. Among these incertae sedis taxa are Archerella flavum (Loeblich and Tappan, 1961) and Amphitrema wrightianum (Archer, 1869) (Amphitremidae), two filose testate amoebae commonly found in Sphagnum peatlands. To clarify their phylogenetic position, we amplified and sequenced the SSU rRNA gene obtained from four independent DNA extractions of A. flavum and three independent DNA extractions of A. wrightianum. Our molecular data demonstrate that genera Archerella and Amphitrema form a fully supported deep-branching clade within the Labyrinthulomycetes (Stramenopiles), together with Diplophrys sp. (ATCC50360) and several environmental clones obtained from a wide range of environments. This newly described clade we named Amphitremida is diverse genetically, ecologically and physiologically. Our phylogenetic analysis suggests that osmotrophic species evolved most likely from phagotrophic ancestors and that the bothrosome, an organelle that produces cytoplasmic networks used for attachment to the substratum and to absorb nutrients from the environments, appeared lately in labyrithulomycete evolution.	[Gomaa, Fatma; Mitchell, Edward A. D.; Lara, Enrique] Univ Neuchatel, Lab Soil Biol, CH-2000 Neuchatel, Switzerland; [Gomaa, Fatma] Ain Shams Univ, Fac Sci, Dept Zool, Cairo, Egypt	University of Neuchatel; Egyptian Knowledge Bank (EKB); Ain Shams University	Gomaa, F (corresponding author), Univ Neuchatel, Lab Soil Biol, CH-2000 Neuchatel, Switzerland.	fatma.gomaa@unine.ch; enrique.lara@unine.ch	Mitchell, Edward AD/B-7259-2013; Lara, Enrique/N-3679-2017	Mitchell, Edward AD/0000-0003-0358-506X; Lara, Enrique/0000-0001-8500-522X; Gomaa, Fatma/0000-0001-5697-7118	Swiss National Fund (SNF) Ambizione [PZ00P2_122042]	Swiss National Fund (SNF) Ambizione	Funding for EL comes from the Swiss National Fund (SNF) Ambizione PZ00P2_122042. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson OR, 2012, J ACTA PROT IN PRESS; Barker J, 1868, Q J MICROSC SCI, V8, P123; BONNET L, 1981, PROTISTOLOGICA, V17, P225; Booth RK, 2008, J QUATERNARY SCI, V23, P43, DOI 10.1002/jqs.1114; Charman DJ, 2001, QUATERNARY RES, V55, P223, DOI 10.1006/qres.2000.2190; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cuvelier ML, 2008, ENVIRON MICROBIOL, V10, P1621, DOI 10.1111/j.1462-2920.2008.01580.x; de SAEDELEER HENRI, 1934, MEM MUS ROY HIST NAT BELGIQUE, V60, P1; Dopheide A, 2008, APPL ENVIRON MICROB, V74, P1740, DOI 10.1128/AEM.01438-07; DUBOIS GEORGES, 1943, BULL GEOL SOC GEOL FRANCE, V13, P21; DYKSTRA MJ, 1975, MYCOLOGIA, V67, P873, DOI 10.2307/3758346; Edgcomb V, 2011, ISME J, V5, P1344, DOI 10.1038/ismej.2011.6; Fahrni JF, 2003, MOL BIOL EVOL, V20, P1881, DOI 10.1093/molbev/msg201; Grant J, 2009, PROTIST, V160, P376, DOI 10.1016/j.protis.2009.01.001; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Lahr DJG, 2012, BIOL J LINN SOC, V107, P469, DOI 10.1111/j.1095-8312.2012.01962.x; Lara E, 2006, J EUKARYOT MICROBIOL, V53, P112, DOI 10.1111/j.1550-7408.2005.00081.x; Lara E, 2008, PROTIST, V159, P165, DOI 10.1016/j.protis.2007.09.003; Lara E, 2011, PROTIST, V162, P14, DOI 10.1016/j.protis.2010.05.003; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Meisterfeld R., 2002, ILLUSTRATED GUIDE PR, P1054; Meisterfeld R, 2002, ILLUSTRATED GUIDE PR, P827; Mitchell EAD, 2008, BIODIVERS CONSERV, V17, P2115, DOI 10.1007/s10531-007-9221-3; Nikolaev SI, 2005, PROTIST, V156, P191, DOI 10.1016/j.protis.2005.03.002; Nikolaev SI, 2004, P NATL ACAD SCI USA, V101, P8066, DOI 10.1073/pnas.0308602101; Nikolaev SI, 2003, ACTA PROTOZOOL, V42, P183; Nusslin O, 1884, WISSENSEH ZOOLOGIE, V40, P720; Patterson DJ, 1999, AM NAT, V154, pS96, DOI 10.1086/303287; Penard E., 1902, HENRY KUNDIG, DOI DOI 10.1017/CBO9781107415324.004; Penard E, 1903, ARCH PROTISTENKD, P283; PERKINS FO, 1972, ARCH MIKROBIOL, V84, P95, DOI 10.1007/BF00412431; Poche Franz, 1913, Archiv fuer Protistenkunde Jena, V30; PORTER D, 1972, PROTOPLASMA, V74, P427, DOI 10.1007/BF01281960; RAGHUKUMAR S, 1992, MAR BIOL, V113, P165, DOI 10.1007/BF00367650; Raghukumar S, 2011, BOT MAR, V54, P3, DOI 10.1515/BOT.2011.008; Scharer L, 2007, MAR BIOL, V152, P1095, DOI 10.1007/s00227-007-0755-4; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Tekle YI, 2009, BIOSCIENCE, V59, P471, DOI 10.1525/bio.2009.59.6.5; TOLONEN K, 1992, ARCH PROTISTENKD, V142, P119, DOI 10.1016/S0003-9365(11)80076-X; Tsui CKM, 2009, MOL PHYLOGENET EVOL, V50, P129, DOI 10.1016/j.ympev.2008.09.027; van Oye P., 1958, HYDROBIOLOGIA, V10, P85, DOI [10.1007/BF00142183, DOI 10.1007/BF00142183]; Wailes GH, 1915, BRIT FRESHWATER EHIZ; Zettler LAA, 2001, J EUKARYOT MICROBIOL, V48, P293, DOI 10.1111/j.1550-7408.2001.tb00317.x	47	44	44	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53046	10.1371/journal.pone.0053046	http://dx.doi.org/10.1371/journal.pone.0053046			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341921	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400030
J	Hashemi, M; Fazaeli, A; Ghavami, S; Eskandari-Nasab, E; Arbabi, F; Mashhadi, MA; Taheri, M; Chaabane, W; Jain, MV; Los, MJ				Hashemi, Mohammad; Fazaeli, Aliakbar; Ghavami, Saeid; Eskandari-Nasab, Ebrahim; Arbabi, Farshid; Mashhadi, Mohammad Ali; Taheri, Mohsen; Chaabane, Wiem; Jain, Mayur V.; Los, Marek J.			Functional Polymorphisms of FAS and FASL Gene and Risk of Breast Cancer - Pilot Study of 134 Cases	PLOS ONE			English	Article							DEATH PATHWAY GENES; SQUAMOUS-CELL CARCINOMA; DRUG-INDUCED APOPTOSIS; LIGAND EXPRESSION; RHEUMATOID-ARTHRITIS; PROMOTER REGION; IMMUNE ESCAPE; ACTIVATION; CD95; MECHANISM	Fas/Fas ligand (FasL) system is one of the key apoptotic signaling entities in the extrinsic apoptotic pathway. De-regulation of this pathway, i.e. by mutations may prevent the immune system from the removal of newly-formed tumor cells, and thus lead to tumor formation. The present study investigated the association between -1377 G/A (rs2234767) and -670 A/G (rs1800682) polymorphisms in Fas as well as single nucleotide polymorphisms INV2nt -124 A/G (rs5030772) and -844 C/T (rs763110) in FasL in a sample of Iranian patients with breast cancer. This case-control study was done on 134 breast cancer patients and 152 normal women. Genomic DNA was extracted from whole blood samples. The polymorphisms were determined by using tetra-ARMS-PCR method. There was no significant difference in the genotype distribution of FAS rs2234767 polymorphism between cases and controls. FAS rs1800682, FASL rs5030772, and FASL rs763110 genotypes showed significant associations with an increasing risk of breast cancer (odds ratio OR = 3.18, P = 0.019; OR = 5.08, P = 0.012; OR = 2.40, P = 0.024, respectively). In conclusion, FAS rs2234767 was not associated with breast cancer risk. Though, FAS rs1800682, FASL rs5030772, and FASL rs763110 polymorphisms were associated with the risk of breast cancer in the examined population.	[Hashemi, Mohammad] Zahedan Univ Med Sci, Cellular & Mol Res Ctr, Zahedan, Iran; [Hashemi, Mohammad; Fazaeli, Aliakbar; Eskandari-Nasab, Ebrahim] Zahedan Univ Med Sci, Sch Med, Dept Clin Biochem, Zahedan, Iran; [Eskandari-Nasab, Ebrahim; Arbabi, Farshid; Mashhadi, Mohammad Ali] Zahedan Univ Med Sci, Sch Med, Dept Internal Med, Zahedan, Iran; [Ghavami, Saeid] Manitoba Inst Child Hlth, Biol Breathing Grp, Winnipeg, MB, Canada; [Ghavami, Saeid] Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada; [Taheri, Mohsen] Zahedan Univ Med Sci, Genet Non Communicable Dis Res Ctr, Zahedan, Iran; [Chaabane, Wiem; Jain, Mayur V.; Los, Marek J.] Linkoping Univ, Div Cell Biol, Dept Clin & Expt Med, Integrat Regenerat Med Ctr IGEN, Linkoping, Sweden; [Chaabane, Wiem] Univ Tunis, Fac Sci, Dept Biol, Tunis, Tunisia; [Los, Marek J.] BioApplicat Enterprises, Winnipeg, MB, Canada	Zahedan University of Medical Sciences; Zahedan University of Medical Sciences; Zahedan University of Medical Sciences; University of Manitoba; Zahedan University of Medical Sciences; Linkoping University; Universite de Tunis; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST)	Los, MJ (corresponding author), Linkoping Univ, Div Cell Biol, Dept Clin & Expt Med, Integrat Regenerat Med Ctr IGEN, Linkoping, Sweden.	marek.los@liu.se	fazaeli, aliakbar/B-1952-2019; Hashemi, Mohammad/H-2446-2016; Fazaeli, Aliakbar/AAL-7819-2020; Ghavami, Saeid/GLT-0606-2022; Ghavami, Saeid/Q-8918-2016; Mashhadi, Mohammad Ali/N-4579-2016; taheri, mohsen/I-2567-2016; Eskandari, Ebrahim/O-7398-2016	Hashemi, Mohammad/0000-0002-6074-7101; Fazaeli, Aliakbar/0000-0001-7860-3950; Ghavami, Saeid/0000-0001-5948-508X; Mashhadi, Mohammad Ali/0000-0002-7226-4633; taheri, mohsen/0000-0002-1110-4417; Eskandari, Ebrahim/0000-0001-7789-4194; Los, Marek/0000-0001-9518-1411	Parker B. Francis Fellowship in Respiratory Disease; Linkoping University; Integrative Regenerative Medicine Center (IGEN); Cancerfonden [CAN 2011/521]	Parker B. Francis Fellowship in Respiratory Disease; Linkoping University; Integrative Regenerative Medicine Center (IGEN); Cancerfonden(Swedish Cancer Society)	SG was supported by Parker B. Francis Fellowship in Respiratory Disease. ML, WC, and MVJ kindly acknowledge the core/startup support from Linkoping University, from Integrative Regenerative Medicine Center (IGEN), and from Cancerfonden (CAN 2011/521). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavian SM, 2011, J VIRAL HEPATITIS, V18, P821, DOI 10.1111/j.1365-2893.2011.01530.x; Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; Babu GR, 2011, ASIAN PAC J CANCER P, V12, P1647; Bebenek M, 2008, ADV MED SCI-POLAND, V53, P49, DOI 10.2478/v10039-008-0015-y; Bebenek M, 2007, ANTICANCER RES, V27, P215; Brando C, 2005, J LEUKOCYTE BIOL, V78, P359, DOI 10.1189/jlb.0604360; Crew KD, 2007, CARCINOGENESIS, V28, P2548, DOI 10.1093/carcin/bgm211; Das H, 2000, BRIT J CANCER, V82, P1682; Dufournet C, 2006, J REPROD IMMUNOL, V70, P151, DOI 10.1016/j.jri.2005.11.003; Eberl LP, 1999, INT J CANCER, V81, P772, DOI 10.1002/(SICI)1097-0215(19990531)81:5<772::AID-IJC18>3.0.CO;2-S; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fulda S, 2010, PLANTA MED, V76, P1075, DOI 10.1055/s-0030-1249961; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Ghavami S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016523; Ghavami S, 2009, BBA-MOL CELL RES, V1793, P546, DOI 10.1016/j.bbamcr.2009.01.002; Gurevich-Panigrahi T, 2009, CURR MED CHEM, V16, P506, DOI 10.2174/092986709787315568; Gutierrez LS, 1999, BREAST CANCER RES TR, V54, P245, DOI 10.1023/A:1006102601215; Hashemi M, 2010, GENET MOL RES, V9, P1735, DOI 10.4238/vol9-3gmr893; Hashemi M, 2010, GENET MOL RES, V9, P333, DOI 10.4238/vol9-1gmr728; Hashemi M, 2012, NUCLEOS NUCLEOT NUCL, V31, P55, DOI 10.1080/15257770.2011.643846; Huang QR, 1997, MOL IMMUNOL, V34, P577, DOI 10.1016/S0161-5890(97)00081-3; Koshkina NV, 2007, J PEDIAT HEMATOL ONC, V29, P815, DOI 10.1097/MPH.0b013e3181581506; Krippl P, 2004, J NATL CANCER I, V96, P1478, DOI 10.1093/jnci/djh289; Kurooka M, 2002, CANCER RES, V62, P1261; Lee SH, 2001, HUM PATHOL, V32, P250, DOI 10.1053/hupa.2001.22769; LEITHAUSER F, 1993, LAB INVEST, V69, P415; Liu KB, 2005, CANCER RES, V65, P4376, DOI 10.1158/0008-5472.CAN-04-4269; Los M, 1999, IMMUNITY, V10, P629, DOI 10.1016/S1074-7613(00)80062-X; LOS M, 1995, NATURE, V375, P81, DOI 10.1038/375081a0; Los M, 1997, BLOOD, V90, P3118, DOI 10.1182/blood.V90.8.3118; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P214, DOI 10.1513/pats.200504-031AC; Mottolese M, 2000, INT J CANCER, V89, P127, DOI 10.1002/(SICI)1097-0215(20000320)89:2<127::AID-IJC5>3.0.CO;2-4; Mousavi SM, 2007, BREAST J, V13, P383, DOI 10.1111/j.1524-4741.2007.00446.x; Muschen M, 2000, IMMUNOLOGY, V99, P69, DOI 10.1046/j.1365-2567.2000.00921.x; Ni X, 2001, CLIN CANCER RES, V7, P2682; Nordgard SH, 2008, INT J CANCER, V123, P577, DOI 10.1002/ijc.23541; O'Brien DI, 2005, EXPERT OPIN THER TAR, V9, P1031, DOI 10.1517/14728222.9.5.1031; OConnell J, 1996, J EXP MED, V184, P1075, DOI 10.1084/jem.184.3.1075; Rashedi I, 2007, CURR MED CHEM, V14, P3139, DOI 10.2174/092986707782793952; Reimer T, 2000, CANCER RES, V60, P822; Sibley K, 2003, CANCER RES, V63, P4327; Stecklein Shane R, 2012, Front Biosci (Elite Ed), V4, P934, DOI 10.2741/E431; Sun T, 2004, JNCI-J NATL CANCER I, V96, P1030, DOI 10.1093/jnci/djh187; Sun T, 2005, J EXP MED, V202, P967, DOI 10.1084/jem.20050707; TAKAHASHI T, 1994, INT IMMUNOL, V6, P1567, DOI 10.1093/intimm/6.10.1567; Villa-Morales M, 2012, EXPERT OPIN THER TAR; Wesselborg S, 1999, BLOOD, V93, P3053, DOI 10.1182/blood.V93.9.3053; Wiechec E, 2011, EXPERT REV MOL DIAGN, V11, P445, DOI [10.1586/erm.11.21, 10.1586/ERM.11.21]; Wiechec E, 2011, CANCER EPIDEM BIOMAR, V20, P397, DOI 10.1158/1055-9965.EPI-10-0514; Wiechec E, 2009, EUR J PHARMACOL, V625, P122, DOI 10.1016/j.ejphar.2009.08.045; Wieder T, 2001, BLOOD, V97, P1378, DOI 10.1182/blood.V97.5.1378; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Wu JM, 2003, J IMMUNOL, V170, P132, DOI 10.4049/jimmunol.170.1.132; Yang M, 2008, CLIN CANCER RES, V14, P3230, DOI 10.1158/1078-0432.CCR-08-0177; Zhang BL, 2007, CARCINOGENESIS, V28, P1067, DOI 10.1093/carcin/bgl250; Zhang X, 2005, J MED GENET, V42, P479, DOI 10.1136/jmg.2004.030106; Zhang ZZ, 2009, EUR J HUM GENET, V17, P1294, DOI 10.1038/ejhg.2009.45; Zhou RM, 2010, J GASTROEN HEPATOL, V25, P555, DOI 10.1111/j.1440-1746.2009.06116.x	58	60	67	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53075	10.1371/journal.pone.0053075	http://dx.doi.org/10.1371/journal.pone.0053075			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326385	gold, Green Published			2022-12-25	WOS:000314705800031
J	Lancellotti, TES; Boarelli, PV; Romero, AA; Funes, AK; Cid-Barria, M; Cabrillana, ME; Monclus, MA; Simon, L; Vicenti, AE; Fornes, MW				Lancellotti, Tania E. Saez; Boarelli, Paola V.; Romero, Aida A.; Funes, Abi K.; Cid-Barria, Macarena; Cabrillana, Maria E.; Monclus, Maria A.; Simon, Layla; Vicenti, Amanda E.; Fornes, Miguel W.			Semen Quality and Sperm Function Loss by Hypercholesterolemic Diet Was Recovered by Addition of Olive Oil to Diet in Rabbit	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; BODY-MASS INDEX; MEDIATED SIGNAL-TRANSDUCTION; CHOLESTEROL CONTENT; ARTIFICIAL VAGINA; ACROSOME REACTION; MAMMALIAN SPERM; MALE OBESITY; IN-VITRO; MEMBRANE	Fat increment (0.05% cholesterol, chol) in standard diet promoted a significant increase in serum and sperm membrane chol, which ultimately altered membrane-coupled sperm specific functions: osmotic resistance, acrosomal reaction, and sperm capacitation in White New Zealand rabbits. These changes were also associated with a reduction in motility percentage and appearance of abnormal sperm morphology. The present study was carried out to evaluate the effect of dietary olive oil (OO, 7% v/w) administration to several male hypercholesterolemic rabbits (hypercholesterolemic rabbits, HCR) with altered fertility parameters. These HCR males were achieved by feeding normal rabbits with a high-fat diet (0.05% chol). HCR were associated with a modest non-significant increase in body weight (standard diet, 4.08 +/- 0.17 Kg, versus high-fat diet, 4.37 +/- 0.24 Kg). Hypercholesterolemic rabbits presented a marked decrease in semen volume, sperm cell count, and percentage of sperm motility, associated with a significant increase in sperm cell abnormalities. Moreover, sperm capacitation measured by the characteristic phosphorylated protein pattern in and induced acrosomal reaction were also altered suggesting sperm dysfunction. However, the administration of OO (for 16 weeks) to rabbits that were fed with 50% of the high-fat diet normalized serum chol. Curiously, OO supply succeeded to attenuate the seminal and sperm alterations observed in HCR group. Administration of OO alone did not cause any significant changes in above mentioned parameters. These data suggest that OO administration to HCR male rabbits recovers the loss of semen quality and sperm functionality.	[Lancellotti, Tania E. Saez; Boarelli, Paola V.; Romero, Aida A.; Funes, Abi K.; Cabrillana, Maria E.; Monclus, Maria A.; Simon, Layla; Vicenti, Amanda E.; Fornes, Miguel W.] Univ Nacl Cuyo, Consejo Nacl Invest Cient & Tecn CONICET, Fac Ciencias Med, Inst Histol & Embriol IHEM,LIAM,CCT, RA-5500 Mendoza, Argentina; [Lancellotti, Tania E. Saez; Boarelli, Paola V.; Cid-Barria, Macarena; Cabrillana, Maria E.; Monclus, Maria A.; Fornes, Miguel W.] Univ Aconcagua, Fac Ciencias Med, Inst Invest, Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Fornes, MW (corresponding author), Univ Nacl Cuyo, Consejo Nacl Invest Cient & Tecn CONICET, Fac Ciencias Med, Inst Histol & Embriol IHEM,LIAM,CCT, RA-5500 Mendoza, Argentina.	mfornes@fcm.uncu.edu.ar	Lancellotti, T Estefania Saez/AAV-4007-2020	Lancellotti, T Estefania Saez/0000-0001-8830-6482; Funes, Abi/0000-0002-6540-3324; Cabrillana, Maria Eugenia/0000-0001-6794-8603	National University of Cuyo; Committee of Investigations of Aconcagua University (CIUDA), Aconcagua University	National University of Cuyo; Committee of Investigations of Aconcagua University (CIUDA), Aconcagua University	Funding: Funding provided by Program 2011-2014, Secretary of Science and Technology (SECyT), National University of Cuyo; and Projects 2011, 2012, 2013, Committee of Investigations of Aconcagua University (CIUDA), Aconcagua University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataineh HN, 2005, SAUDI MED J, V26, P398; Belmonte SA, 2005, DEV BIOL, V285, P393, DOI 10.1016/j.ydbio.2005.07.001; BIGGERS J. D., 1971, Methods in mammalian embryology, P86; Bolumar F, 2000, AM J EPIDEMIOL, V151, P1072, DOI 10.1093/oxfordjournals.aje.a010150; BREDDERMAN PJ, 1964, J REPROD FERTIL, V7, P401, DOI 10.1530/jrf.0.0070401; Buffone MG, 2009, J ANDROL, V30, P552, DOI 10.2164/jandrol.108.006551; Burgos MH, 1951, REV SOC ARG BIOL, P281; Charney DS, 2004, AM J PSYCHIAT, V161, P1, DOI 10.1176/appi.ajp.161.1.1; Chrysohoou C, 2010, QJM-INT J MED, V103, P413, DOI 10.1093/qjmed/hcq045; Comhaire FH, 2005, ASIAN J ANDROL, V7, P257, DOI 10.1111/j.1745-7262.2005.00047.x; Cross NL, 2004, BIOL REPROD, V71, P1367, DOI 10.1095/biolreprod.104.030502; DAVIS BK, 1974, P SOC EXP BIOL MED, V146, P11, DOI 10.3181/00379727-146-38033; DEBOER KF, 1991, LAB ANIM SCI, V41, P187; Diaz-Fontdevila M, 1998, ANDROLOGIA, V30, P15; DIAZFONTDEVILA M, 1993, MOL REPROD DEV, V35, P176, DOI 10.1002/mrd.1080350211; DIAZFONTDEVILA M, 1992, ANDROLOGIA, V24, P279; Fatma BA, 2009, ASIAN J ANDROL, V11, P393, DOI 10.1038/aja.2008.6; Gadella BM, 2008, INT J DEV BIOL, V52, P473, DOI 10.1387/ijdb.082583bg; Ghanayem BI, 2010, BIOL REPROD, V82, P96, DOI 10.1095/biolreprod.109.078915; GRIZARD G, 1995, INT J ANDROL, V18, P151, DOI 10.1111/j.1365-2605.1995.tb00404.x; GUPTA RS, 1988, Z ERNAHRUNGSWISS, V27, P236, DOI 10.1007/BF02019512; HALLIWELL B, 1993, HAEMOSTASIS, V23, P118; Hammoud AO, 2008, FERTIL STERIL, V90, P897, DOI 10.1016/j.fertnstert.2008.08.026; Hammoud AO, 2006, J ANDROL, V27, P619, DOI 10.2164/jandrol.106.000125; Hammoud AO, 2008, FERTIL STERIL, V90, P2222, DOI 10.1016/j.fertnstert.2007.10.011; Hoefel AL, 2011, CELL BIOCHEM FUNCT, V29, P569, DOI 10.1002/cbf.1789; Iqbal R, 2008, CIRCULATION, V118, P1929, DOI 10.1161/CIRCULATIONAHA.107.738716; JEYENDRAN RS, 1984, J REPROD FERTIL, V70, P219; Kamal R, 2003, PHYTOTHER RES, V17, P579, DOI 10.1002/ptr.1320; Katcher HI, 2009, ENDOCRIN METAB CLIN, V38, P45, DOI 10.1016/j.ecl.2008.11.010; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li XD, 2011, PROTEIN CELL, V2, P189, DOI 10.1007/s13238-011-1016-3; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Nguyen RHN, 2007, HUM REPROD, V22, P2488, DOI 10.1093/humrep/dem139; Orgebin-Crist M. C., 1969, Biology of Reproduction Suppl, VNo.1, P155, DOI 10.1095/biolreprod1.Supplement_1.155; Osheroff JE, 1999, MOL HUM REPROD, V5, P1017, DOI 10.1093/molehr/5.11.1017; Ouvrier A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026966; Palmer NO, 2012, AM J PHYSIOL-ENDOC M, V302, pE768, DOI 10.1152/ajpendo.00401.2011; Pasquali Renato, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P482, DOI 10.1097/MED.0b013e3282f1d6cb; Pasquali R, 2006, MATURITAS, V54, P363, DOI 10.1016/j.maturitas.2006.04.018; Pasquali R, 2006, REPROD BIOMED ONLINE, V12, P542, DOI 10.1016/S1472-6483(10)61179-0; Perez-Lopez FR, 2009, MATURITAS, V64, P67, DOI 10.1016/j.maturitas.2009.07.013; Perona JS, 2006, J NUTR BIOCHEM, V17, P429, DOI 10.1016/j.jnutbio.2005.11.007; Pietrobon EO, 2001, J ANDROL, V22, P96; Piomboni P, 2008, ASIAN J ANDROL, V10, P201, DOI 10.1111/j.1745-7262.2008.00356.x; Rich-Edwards JW, 2002, EPIDEMIOLOGY, V13, P184, DOI 10.1097/00001648-200203000-00013; Saez F, 2011, ASIAN J ANDROL, V13, P11, DOI 10.1038/aja.2010.64; Lancellotti TES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013457; Sallmen M, 2006, EPIDEMIOLOGY, V17, P520, DOI 10.1097/01.ede.0000229953.76862.e5; Selvaraj V, 2007, J ANDROL, V28, P588, DOI 10.2164/jandrol.106.002279; Singh RB, 2002, LANCET, V360, P1455, DOI 10.1016/S0140-6736(02)11472-3; TALBOT P, 1981, J EXP ZOOL, V215, P201, DOI 10.1002/jez.1402150210; Violante B, 2009, J ENDOCRINOL INVEST, V32, P794, DOI [10.1007/BF03345747, 10.3275/6103]; Visconti PE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3142pe35; Visconti PE, 1999, J BIOL CHEM, V274, P3235, DOI 10.1074/jbc.274.5.3235; Visconti PE, 1999, DEV BIOL, V214, P429, DOI 10.1006/dbio.1999.9428; Volle DH, 2007, MOL ENDOCRINOL, V21, P1014, DOI 10.1210/me.2006-0277; Yamamoto Y, 1999, HUM REPROD, V14, P1516, DOI 10.1093/humrep/14.6.1516; Yanagimachi R., 1994, P189; YEAGLE PL, 1991, BIOCHIMIE, V73, P1303, DOI 10.1016/0300-9084(91)90093-G	60	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52386	10.1371/journal.pone.0052386	http://dx.doi.org/10.1371/journal.pone.0052386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326331	Green Published, Green Submitted, gold			2022-12-25	WOS:000314705800016
J	Van Dam, NT; Sano, M; Mitsis, EM; Grossman, HT; Gu, XS; Park, Y; Hof, PR; Fan, J				Van Dam, Nicholas T.; Sano, Mary; Mitsis, Effie M.; Grossman, Hillel T.; Gu, Xiaosi; Park, Yunsoo; Hof, Patrick R.; Fan, Jin			Functional Neural Correlates of Attentional Deficits in Amnestic Mild Cognitive Impairment	PLOS ONE			English	Article							EXECUTIVE FUNCTION DEFICITS; ALZHEIMERS-DISEASE; SELECTIVE ATTENTION; DIVIDED ATTENTION; VISUOSPATIAL ATTENTION; METABOLIC-CHANGES; OLDER-ADULTS; EARLY-STAGE; DEMENTIA; NETWORKS	Although amnestic mild cognitive impairment (aMCI; often considered a prodromal phase of Alzheimer's disease, AD) is most recognized by its implications for decline in memory function, research suggests that deficits in attention are present early in aMCI and may be predictive of progression to AD. The present study used functional magnetic resonance imaging to examine differences in the brain during the attention network test between 8 individuals with aMCI and 8 neurologically healthy, demographically matched controls. While there were no significant behavioral differences between groups for the alerting and orienting functions, patients with aMCI showed more activity in neural regions typically associated with the networks subserving these functions (e.g., temporoparietal junction and posterior parietal regions, respectively). More importantly, there were both behavioral (i.e., greater conflict effect) and corresponding neural deficits in executive control (e.g., less activation in the prefrontal and anterior cingulate cortices). Although based on a small number of patients, our findings suggest that deficits of attention, especially the executive control of attention, may significantly contribute to the behavioral and cognitive deficits of aMCI.	[Van Dam, Nicholas T.; Fan, Jin] CUNY, Queens Coll, Dept Psychol, Flushing, NY 11367 USA; [Van Dam, Nicholas T.; Sano, Mary; Mitsis, Effie M.; Grossman, Hillel T.; Gu, Xiaosi; Park, Yunsoo; Fan, Jin] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Gu, Xiaosi; Hof, Patrick R.; Fan, Jin] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Grossman, Hillel T.] Mt Sinai Sch Med, Dept Neurol, New York, NY USA; [Sano, Mary; Mitsis, Effie M.; Grossman, Hillel T.; Hof, Patrick R.] Mt Sinai Sch Med, Alzheimers Dis Res Ctr, New York, NY USA; Mt Sinai Memory & Aging Ctr, Mt Sinai Sch Med, New York, NY USA; [Sano, Mary; Mitsis, Effie M.; Hof, Patrick R.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA	City University of New York (CUNY) System; Queens College NY (CUNY); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Fan, J (corresponding author), CUNY, Queens Coll, Dept Psychol, Flushing, NY 11367 USA.	jin.fan@qc.cuny.edu	Fan, Jin/L-2055-2019; Van Dam, Nicholas Thomas/G-2799-2010; Gu, Xiaosi/A-7724-2010; Fan, Jin/A-6716-2009	Fan, Jin/0000-0001-9630-8330; Van Dam, Nicholas Thomas/0000-0002-1131-0739; Gu, Xiaosi/0000-0002-9373-987X; Fan, Jin/0000-0001-9630-8330; Park, Yunsoo/0000-0002-2701-2306	National Institute on Aging (of the National Institutes of Health) [P50 AG005138]; NATIONAL INSTITUTE ON AGING [P50AG005138] Funding Source: NIH RePORTER	National Institute on Aging (of the National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The present study was funded as a pilot investigation to J.F. by National Institute on Aging (of the National Institutes of Health) grant P50 AG005138 (M.S., Sam Gandy, P.R.H.). Authors J.F., P.R.H., & M.S. conceived the research design. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; [Anonymous], [No title captured]; Backman L, 2005, NEUROPSYCHOLOGY, V19, P520, DOI 10.1037/0894-4105.19.4.520; Baddeley AD, 2001, BRAIN, V124, P1492, DOI 10.1093/brain/124.8.1492; Ballard C, 2001, ARCH NEUROL-CHICAGO, V58, P977, DOI 10.1001/archneur.58.6.977; Baudic S, 2006, ARCH CLIN NEUROPSYCH, V21, P15, DOI 10.1016/j.acn.2005.07.002; Berardi AM, 2005, DEV NEUROPSYCHOL, V28, P507, DOI 10.1207/s15326942dn2801_4; Binetti G, 1996, J NEUROL NEUROSUR PS, V60, P91, DOI 10.1136/jnnp.60.1.91; Bokde ALW, 2006, BRAIN, V129, P1113, DOI 10.1093/brain/awl051; Bozzali M, 2012, HUM BRAIN MAPP, V33, P1295, DOI 10.1002/hbm.21287; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Castel AD, 2007, NEUROPSYCHOLOGY, V21, P170, DOI 10.1037/0894-4105.21.2.170; Castel AD, 2009, NEUROPSYCHOLOGY, V23, P297, DOI 10.1037/a0014888; Celone KA, 2006, J NEUROSCI, V26, P10222, DOI 10.1523/JNEUROSCI.2250-06.2006; Collette F, 1999, CORTEX, V35, P57, DOI 10.1016/S0010-9452(08)70785-8; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; COWAN N, 1988, PSYCHOL BULL, V104, P163, DOI 10.1037/0033-2909.104.2.163; Dannhauser TM, 2005, BRAIN, V128, P1418, DOI 10.1093/brain/awh413; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; El Fakhri G, 2003, ARCH NEUROL-CHICAGO, V60, P1066, DOI 10.1001/archneur.60.8.1066; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fan J, 2004, PSYCHIAT PRAX, V31, pS210, DOI 10.1055/s-2004-828484; Fan JH, 2008, J HYDRO-ENVIRON RES, V2, P3, DOI 10.1016/j.jher.2008.04.001; Fan J, 2009, BRAIN COGNITION, V70, P209, DOI 10.1016/j.bandc.2009.02.002; Faust ME, 1997, NEUROPSYCHOLOGY, V11, P13, DOI 10.1037/0894-4105.11.1.13; Fernandez-Duque D, 2006, NEUROPSYCHOLOGY, V20, P133, DOI 10.1037/0894-4105.20.2.133; Festa EK, 2006, NEUROPSYCHOLOGY, V20, P757, DOI 10.1037/0894-4105.20.6.757; Festa-Martino E, 2004, NEUROPSYCHOLOGY, V18, P258, DOI 10.1037/0894-4105.18.2.258; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foster JK, 2001, FRONT BIOSCI-LANDMRK, V6, pD135, DOI 10.2741/Foster; Foster JK, 1999, NEUROPSYCHOLOGY, V13, P223, DOI 10.1037/0894-4105.13.2.223; Fouquet M, 2009, BRAIN, V132, P2058, DOI 10.1093/brain/awp132; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Geslani DM, 2005, DEMENT GERIATR COGN, V19, P383, DOI 10.1159/000084709; Gorus E, 2006, INT PSYCHOGERIATR, V18, P539, DOI 10.1017/S1041610205002723; GRADY CL, 1988, J CLIN EXP NEUROPSYC, V10, P576, DOI 10.1080/01688638808402796; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; Hao J, 2005, NEUROSCI LETT, V385, P18, DOI 10.1016/j.neulet.2005.05.028; HAXBY JV, 1990, ARCH NEUROL-CHICAGO, V47, P753, DOI 10.1001/archneur.1990.00530070043010; Jeyakumar SLE, 2004, EDUC PSYCHOL MEAS, V64, P71, DOI 10.1177/0013164403258407; Johannsen P, 1999, NEUROIMAGE, V10, P269, DOI 10.1006/nimg.1999.0475; Johnson KA, 1998, NEUROLOGY, V50, P1563, DOI 10.1212/WNL.50.6.1563; LAFLECHE G, 1995, NEUROPSYCHOLOGY, V9, P313, DOI 10.1037/0894-4105.9.3.313; Levinoff EJ, 2004, NEUROPSYCHOLOGY, V18, P580, DOI 10.1037/0894-4105.18.3.580; Marra C, 2000, DEMENT GERIATR COGN, V11, P212, DOI 10.1159/000017239; MILLER J, 1988, J EXP PSYCHOL HUMAN, V14, P539, DOI 10.1037/0096-1523.14.3.539; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mosconi L, 2004, NEUROLOGY, V63, P2332, DOI 10.1212/01.WNL.0000147469.18313.3B; NEBES RD, 1989, CORTEX, V25, P305, DOI 10.1016/S0010-9452(89)80045-0; OKEN BS, 1994, NEUROLOGY, V44, P657, DOI 10.1212/WNL.44.4.657; Parasuraman R, 2002, NEUROPSYCHOLOGY, V16, P254, DOI 10.1037//0894-4105.16.2.254; PARASURAMAN R, 1992, BRAIN, V115, P711, DOI 10.1093/brain/115.3.711; Parasuraman R., 1993, NEUROPSYCHOLOGY, V7, P242, DOI DOI 10.1037/0894-4105.7.3.242; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Perry RJ, 2000, NEUROPSYCHOLOGIA, V38, P252, DOI 10.1016/S0028-3932(99)00079-2; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Pignatti R, 2005, J CLIN EXP NEUROPSYC, V27, P436, DOI 10.1080/13803390490520427; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rafii MS, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-7; Rapp MA, 2005, AM J GERIAT PSYCHIAT, V13, P134, DOI 10.1176/appi.ajgp.13.2.134; Rizzo M, 2000, NEUROLOGY, V54, P1954, DOI 10.1212/WNL.54.10.1954; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Salmon E, 2007, NEUROBIOL AGING; Sano M, 2006, J GERIATR PSYCH NEUR, V19, P155, DOI 10.1177/0891988706291086; Sano M, 2011, ALZ DIS ASSOC DIS, V25, P122, DOI 10.1097/WAD.0b013e3181f883b7; Sebastian MV, 2006, CORTEX, V42, P1015, DOI 10.1016/S0010-9452(08)70207-7; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Simon SS, 2012, NEUROSCI BIOBEHAV R, V36, P1163, DOI 10.1016/j.neubiorev.2012.01.007; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Stern Y, 2000, NEUROLOGY, V55, P1291, DOI 10.1212/WNL.55.9.1291; Tales A, 2002, NEUROREPORT, V13, P2557, DOI 10.1097/00001756-200212200-00035; Tales A, 2006, NEUROPSYCHOLOGY, V20, P752, DOI 10.1037/0894-4105.20.6.752; Wang K, 2005, SCHIZOPHR RES, V78, P235, DOI 10.1016/j.schres.2005.01.019; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; WELSH KA, 1992, ARCH NEUROL-CHICAGO, V49, P448, DOI 10.1001/archneur.1992.00530290030008; Woo BKP, 2010, INT J GERIATR PSYCH, V25, P1150, DOI 10.1002/gps.2452; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075	88	40	41	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54035	10.1371/journal.pone.0054035	http://dx.doi.org/10.1371/journal.pone.0054035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086RY	23326568	Green Published, gold			2022-12-25	WOS:000314705800104
J	Dweep, H; Sticht, C; Kharkar, A; Pandey, P; Gretz, N				Dweep, Harsh; Sticht, Carsten; Kharkar, Asawari; Pandey, Priyanka; Gretz, Norbert			Parallel Analysis of mRNA and microRNA Microarray Profiles to Explore Functional Regulatory Patterns in Polycystic Kidney Disease: Using PKD/Mhm Rat Model	PLOS ONE			English	Article							EPITHELIAL-CELLS; SYSTEMS BIOLOGY; GENE-PRODUCT; APOPTOSIS; GROWTH; NEPHRONOPHTHISIS; PROLIFERATION; MICE; PATHOGENESIS; EXPRESSION	Autosomal polycystic kidney disease (ADPKD) is a frequent monogenic renal disease, characterised by fluid-filled cysts that are thought to result from multiple deregulated pathways such as cell proliferation and apoptosis. MicroRNAs (miRNAs) are small non-coding RNAs that regulate the expression of many genes associated with such biological processes and human pathologies. To explore the possible regulatory role of miRNAs in PKD, the PKD/Mhm (cy/+) rat, served as a model to study human ADPKD. A parallel microarray-based approach was conducted to profile the expression changes of mRNAs and miRNAs in PKD/Mhm rats. 1,573 up- and 1,760 down-regulated genes were differentially expressed in PKD/Mhm. These genes are associated with 17 pathways (such as focal adhesion, cell cycle, ECM-receptor interaction, DNA replication and metabolic pathways) and 47 (e.g., cell proliferation, Wnt and Tgf beta signaling) Gene Ontologies. Furthermore, we found the similar expression patterns of deregulated genes between PKD/Mhm (cy/+) rat and human ADPKD, PKD1(L3/L3), PKD1(-/-), Hnf1 alpha-deficient, and Glis2(lacZ/lacZ) models. Additionally, several differentially regulated genes were noted to be target hubs for miRNAs. We also obtained 8 significantly up-regulated miRNAs (rno-miR-199a-5p, -214, -146b, -21, -34a, -132, -31 and -503) in diseased kidneys of PKD/Mhm rats. Additionally, the binding site overrepresentation and pathway enrichment analyses were accomplished on the putative targets of these 8 miRNAs. 7 out of these 8 miRNAs and their possible interactions have not been previously described in ADPKD. We have shown a strong overlap of functional patterns (pathways) between deregulated miRNAs and mRNAs in the PKD/Mhm (cy/+) rat model. Our findings suggest that several miRNAs may be associated in regulating pathways in ADPKD. We further describe novel miRNAs and their possible targets in ADPKD, which will open new avenues to understand the pathogenesis of human ADPKD. Furthermore they could serve as a useful resource for anti-fibrotic therapeutics.	[Dweep, Harsh; Sticht, Carsten; Kharkar, Asawari; Gretz, Norbert] Heidelberg Univ, Med Fac Mannheim, Med Res Ctr, Mannheim, Germany	Ruprecht Karls University Heidelberg	Gretz, N (corresponding author), Heidelberg Univ, Med Fac Mannheim, Med Res Ctr, Mannheim, Germany.	norbert.gretz@medma.uni-heidelberg.de			Research Council through Graduiertenkolleg [886]; German Federal Ministry of Research and Education through the National Genome Research Network (NGFN-2) [01GR0450]	Research Council through Graduiertenkolleg(German Research Foundation (DFG)); German Federal Ministry of Research and Education through the National Genome Research Network (NGFN-2)	This work was funded by the Research Council through Graduiertenkolleg 886 and by the German Federal Ministry of Research and Education through the National Genome Research Network (NGFN-2, Grant no. 01GR0450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agre Peter, 2006, Proc Am Thorac Soc, V3, P5, DOI 10.1513/pats.200510-109JH; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Angerstein G, 2012, MOL NEUROBIOL; Attanasio M, 2007, NAT GENET, V39, P1018, DOI 10.1038/ng2072; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bastos AP, 2011, BRAZ J MED BIOL RES, V44, P606, DOI [10.1590/S0100-879X2011007500068, 10.1590/S0100-879X2011000700001]; Battini L, 2006, J AM SOC NEPHROL, V17, P3049, DOI 10.1681/ASN.2006030234; Chau BN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003205; Chen S, 2003, SEMIN NEPHROL, V23, P532, DOI 10.1053/S0270-9295(03)00132-3; Chen Wen-Cheng, 2008, BMC Res Notes, V1, P131, DOI 10.1186/1756-0500-1-131; Chung ACK, 2010, J AM SOC NEPHROL, V21, P1317, DOI 10.1681/ASN.2010020134; Couillard M, 2002, CANCER RES, V62, P2210; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; DWEEP H, 2011, J BIOMED INFORM; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Felekkis K, 2011, MOL BIOL EVOL, V28, P2421, DOI 10.1093/molbev/msr078; GABOW PA, 1990, AM J KIDNEY DIS, V16, P403, DOI 10.1016/S0272-6386(12)80051-5; Gresh L, 2004, EMBO J, V23, P1657, DOI 10.1038/sj.emboj.7600160; GRETZ N, 1995, KIDNEY INT, V48, P496, DOI 10.1038/ki.1995.319; Gretz N, 1996, NEPHROL DIAL TRANSPL, V11, P46; Ha E, 2010, MOL MED REP, V3, P275, DOI 10.3892/mmr_00000251; Hanaoka K, 2000, J AM SOC NEPHROL, V11, P1179, DOI 10.1681/ASN.V1171179; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ichii O, 2012, KIDNEY INT, V81, P280, DOI 10.1038/ki.2011.345; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Ju WJ, 2009, AM J PATHOL, V174, P2073, DOI 10.2353/ajpath.2009.080888; KASPAREITRITTINGHAUSEN J, 1990, TRANSPLANT P, V22, P2582; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lanoix J, 1996, ONCOGENE, V13, P1153; Le Roy H L, 1976, Experientia Suppl, V22, P191; Lee YB, 2009, NUCLEIC ACIDS RES, V37, P123, DOI 10.1093/nar/gkn920; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Morishita Y, 2005, MOL CELL BIOL, V25, P7770, DOI 10.1128/MCB.25.17.7770-7779.2005; O'Toole ET, 2003, MOL BIOL CELL, V14, P2999, DOI 10.1091/mbc.E02-11-0755; Obermuller N, 2001, AM J PHYSIOL-RENAL, V280, pF540, DOI 10.1152/ajprenal.2001.280.3.F540; Okada S, 2008, FASEB J, V22, P3672, DOI 10.1096/fj.08-111872; Pandey P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-56; Pandey P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-624; Papagregoriou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031021; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; SCHAFER K, 1994, KIDNEY INT, V46, P134, DOI 10.1038/ki.1994.253; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Song XW, 2009, HUM MOL GENET, V18, P2328, DOI 10.1093/hmg/ddp165; Susztak K, 2004, DIABETES, V53, P784, DOI 10.2337/diabetes.53.3.784; Tchekneva EE, 2008, J AM SOC NEPHROL, V19, P1955, DOI 10.1681/ASN.2008030296; Torres VE, 2007, J INTERN MED, V261, P17, DOI 10.1111/j.1365-2796.2006.01743.x; TRUDEL M, 1992, CONTRIB NEPHROL, V97, P47; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wilson PD, 1999, LAB INVEST, V79, P1311; Xu T, 2012, MOL BIOL REP, V39, P7743, DOI 10.1007/s11033-012-1611-2; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x; Yin G, 2010, ONCOGENE, V29, P3545, DOI 10.1038/onc.2010.111; Yoder BK, 2007, J AM SOC NEPHROL, V18, P1381, DOI 10.1681/ASN.2006111215; Zaman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031060; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zhang AM, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.03.030; Zhong H, 2010, INT J HEMATOL, V92, P129, DOI 10.1007/s12185-010-0626-5	62	51	54	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53780	10.1371/journal.pone.0053780	http://dx.doi.org/10.1371/journal.pone.0053780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326503	Green Published, gold			2022-12-25	WOS:000313552400044
J	Maita, C; Maita, H; Iguchi-Ariga, SMM; Ariga, H				Maita, Chinatsu; Maita, Hiroshi; Iguchi-Ariga, Sanae M. M.; Ariga, Hiroyoshi			Monomer DJ-1 and Its N-Terminal Sequence Are Necessary for Mitochondrial Localization of DJ-1 Mutants	PLOS ONE			English	Article							IDIOPATHIC PARKINSONS-DISEASE; CYSTEINE-SULFINIC ACID; PROTEIN DJ-1; ANDROGEN RECEPTOR; OXIDATIVE STRESS; ANTIOXIDATIVE STRESS; CELL INJURY; AUTOPHAGY; DYNAMICS; COMPLEX	DJ-1 is a novel oncogene and also a causative gene for familial Parkinson's disease (park7). DJ-1 has multiple functions that include transcriptional regulation, anti-oxidative reaction and chaperone and mitochondrial regulation. Mitochondrial dysfunction is observed in DJ-1-knockout mice and fry, and mitochondrial DJ-1 is more protective against oxidative stress-induced cell death. Although translocation of DJ-1 into mitochondria is enhanced by oxidative stress that leads to oxidation of cysteine 106 (C106) of DJ-1, the characteristics of mitochondrial DJ-1 and the mechanism by which DJ-1 is translocated into mitochondria are poorly understood. In this study, immunostaining, co-immunoprecipitation, cell fractionation and pull-down experiments showed that mutants of glutamine 18 (E18) DJ-1 are localized in mitochondria and do not make homodimers. Likewise, DJ-1 with mutations of two cysteines located in the dimer interface, C46S and C53A, and pathogenic mutants, M26I and L166P DJ-1, were found to be localized in mitochondria and not to make homodimers. Mutant DJ-1 harboring both E18A and C106S, in which C106 is not oxidized, was also localized in mitochondria, indicating that oxidation of C106 is important but not essential for mitochondrial localization of DJ-1. It should be noted that E18A DJ-1 was translocated from mitochondria to the cytoplasm when mitochondrial membrane potential was reduced by treatment of cells with CCCP, an uncoupler of the oxidative phosphorylation system in mitochondria. Furthermore, deletion or substitution of the N-terminal 12 amino acids in DJ-1 resulted in re-localization of E18A, M26I and L166P DJ-1 from mitochondria into the cytoplasm. These findings suggest that a monomer and the N-terminal 12 amino acids are necessary for mitochondrial localization of DJ-1 mutants and that conformation change induced by C106 oxidation or by E18 mutation leads to translocation of DJ-1 into mitochondria.	[Maita, Chinatsu; Maita, Hiroshi; Ariga, Hiroyoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan; [Iguchi-Ariga, Sanae M. M.] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Ariga, H (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan.	hiro@pharm.hokudai.ac.jp	Ariga, Sanae/H-9647-2013; Maita, Hiroshi/D-5495-2012		Ministry of Education, Science, Culture and Sports; National Institute of Biomedical Innovation (NIBIO) in Japan; Grants-in-Aid for Scientific Research [22300119, 24650191] Funding Source: KAKEN	Ministry of Education, Science, Culture and Sports(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO) in Japan(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Science, Culture and Sports and by the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation (NIBIO) in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandopadhyay R, 2004, BRAIN, V127, P420, DOI 10.1093/brain/awh054; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chen J, 2010, HUM MOL GENET, V19, P2395, DOI 10.1093/hmg/ddq113; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; Giaime E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040501; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; Hayashi T, 2009, BIOCHEM BIOPH RES CO, V390, P667, DOI 10.1016/j.bbrc.2009.10.025; Heo JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032629; Honbou K, 2003, J BIOL CHEM, V278, P31380, DOI 10.1074/jbc.M305878200; Hulleman JD, 2007, BIOCHEMISTRY-US, V46, P5776, DOI 10.1021/bi7001778; Inden M, 2006, NEUROBIOL DIS, V24, P144, DOI 10.1016/j.nbd.2006.06.004; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Ishikawa S, 2009, J BIOL CHEM, V284, P28832, DOI 10.1074/jbc.M109.019950; Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831; Kim YC, 2010, FEBS LETT, V584, P3891, DOI 10.1016/j.febslet.2010.08.010; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Koide-Yoshida S, 2007, INT J MOL MED, V19, P885; Krebiehl G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009367; Li HM, 2005, FREE RADICAL RES, V39, P1091, DOI 10.1080/10715760500260348; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Mccoy MK, 2011, AUTOPHAGY, V7, P531, DOI 10.4161/auto.7.5.14684; Mizuno Y, 1998, J NEUROCHEM, V71, P893; MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Niki T, 2003, MOL CANCER RES, V1, P247; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Ooe H, 2005, TOXICOL SCI, V88, P114, DOI 10.1093/toxsci/kfi278; Orth M, 2002, NEUROCHEM INT, V40, P533, DOI 10.1016/S0197-0186(01)00124-3; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Ren HG, 2011, J BIOL CHEM, V286, P35308, DOI 10.1074/jbc.M110.207134; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Shinbo Y, 2006, CELL DEATH DIFFER, V13, P96, DOI 10.1038/sj.cdd.4401704; Shinbo YM, 2005, INT J ONCOL, V26, P641; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; Tillman JE, 2007, CANCER RES, V67, P4630, DOI 10.1158/0008-5472.CAN-06-4556; Wang XL, 2012, J NEUROCHEM, V121, P830, DOI 10.1111/j.1471-4159.2012.07734.x; Witt AC, 2008, BIOCHEMISTRY-US, V47, P7430, DOI 10.1021/bi800282d; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Yanagida T, 2009, OXID MED CELL LONGEV, V2, P36, DOI 10.4161/oxim.2.1.7985; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030	50	42	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54087	10.1371/journal.pone.0054087	http://dx.doi.org/10.1371/journal.pone.0054087			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326576	Green Published, gold			2022-12-25	WOS:000313552400075
J	Mhlanga, P; Hassan, WAW; Hamerton, I; Howlin, BJ				Mhlanga, Phumzile; Hassan, Wan Aminah Wan; Hamerton, Ian; Howlin, Brendan J.			Using Combined Computational Techniques to Predict the Glass Transition Temperatures of Aromatic Polybenzoxazines	PLOS ONE			English	Article							MOLECULAR SIMULATION; NEURAL-NETWORK; FORCE-FIELD; POLYMERS; QSPR; POLYMERIZATION; BENZOXAZINES	The Molecular Operating Environment software (MOE) is used to construct a series of benzoxazine monomers for which a variety of parameters relating to the structures (e.g. water accessible surface area, negative van der Waals surface area, hydrophobic volume and the sum of atomic polarizabilities, etc.) are obtained and quantitative structure property relationships (QSPR) models are formulated. Three QSPR models (formulated using up to 5 descriptors) are first used to make predictions for the initiator data set (n = 9) and compared to published thermal data; in all of the QSPR models there is a high level of agreement between the actual data and the predicted data (within 0.63-1.86 K of the entire dataset). The water accessible surface area is found to be the most important descriptor in the prediction of T-g. Molecular modelling simulations of the benzoxazine polymer (minus initiator) carried out at the same time using the Materials Studio software suite provide an independent prediction of T-g. Predicted T-g values from molecular modelling fall in the middle of the range of the experimentally determined T-g values, indicating that the structure of the network is influenced by the nature of the initiator used. Hence both techniques can provide predictions of glass transition temperatures and provide complementary data for polymer design.	[Mhlanga, Phumzile; Hassan, Wan Aminah Wan; Hamerton, Ian; Howlin, Brendan J.] Univ Surrey, Dept Chem, Guildford GU2 5XH, Surrey, England	University of Surrey	Howlin, BJ (corresponding author), Univ Surrey, Dept Chem, Guildford GU2 5XH, Surrey, England.	b.howlin@surrey.ac.uk	Howlin, Brendan J/F-3343-2011; Hamerton, Ian/AAV-8918-2021	Howlin, Brendan J/0000-0002-9398-7152; Hamerton, Ian/0000-0003-3113-0345	Huntsman Corporation	Huntsman Corporation	PhD Studentship support for WAWH from Huntsman Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ACC MAT STUD VERS 5; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bertinetto C, 2007, POLYMER, V48, P7121, DOI 10.1016/j.polymer.2007.09.043; Bicerano J, 1996, J MACROMOL SCI R M C, VC36, P161; Bicerano J, 2004, J MACROMOL SCI-POL R, VC44, P53, DOI 10.1081/MC-120027934; Bicerano J, 1993, ANTEC 93 BE NUMBER, V1-3, P292; Brostow W, 2008, MATER LETT, V62, P3152, DOI 10.1016/j.matlet.2008.02.008; Camelio P, 1997, J POLYM SCI POL CHEM, V35, P2579, DOI 10.1002/(SICI)1099-0518(19970930)35:13<2579::AID-POLA5>3.0.CO;2-M; Chutayothin P, 2010, MACROMOLECULES, V43, P4562, DOI 10.1021/ma901743h; Conolly ML, 1983, J APPL CRYSTALLOGR, V16, P548; Hall SA, 2012, THESIS U SURREY; Hall SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042928; Hamerton I, 2006, POLYMER, V47, P690, DOI 10.1016/j.polymer.2005.11.082; HAMERTON I, 1995, J MOL GRAPHICS, V13, P14, DOI 10.1016/0263-7855(94)00009-H; Hamerton I, 1996, MODEL SIMUL MATER SC, V4, P151, DOI 10.1088/0965-0393/4/2/003; Hamerton I, 1996, MACROMOL THEOR SIMUL, V5, P305, DOI 10.1002/mats.1996.040050211; Hamerton I, 2011, USING MOL SIMULATION, P127; Hamerton I, 2012, POLYM DEGRA IN PRESS; Hamerton I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038424; Heap K, 2012, EXAMINING EFFE UNPUB; Holly FW, 1944, J AM CHEM SOC, V66, P1875, DOI 10.1021/ja01239a022; Howlin BJ, 2012, PLOS IN PRESS; Ishida H, 2005, POLYMER, V46, P5588, DOI 10.1016/j.polymer.2005.04.080; Ishida H, 2011, HANDBOOK OF BENZOXAZINE RESINS, P1; ISHIDA H, 1995, POLYMER, V36, P3151, DOI 10.1016/0032-3861(95)97878-J; Ishida H, 2011, HANDBOOK OF BENZOXAZINE RESINS, P3, DOI 10.1016/B978-0-444-53790-4.00046-1; JOYCE SJ, 1995, J CHEM SOC FARADAY T, V91, P2491, DOI 10.1039/ft9959102491; Karelson M, 1996, CHEM REV, V96, P1027, DOI 10.1021/cr950202r; KATRITZKY AR, 1995, CHEM SOC REV, V24, P279, DOI 10.1039/cs9952400279; Katritzky AR, 1998, J CHEM INF COMP SCI, V38, P300, DOI 10.1021/ci9700687; Kim HJ, 1999, POLYMER, V40, P1815; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Molecular Operating Environment (MOE), 2011, MOL OP ENV MOE 2011; Sudo A, 2008, MACROMOLECULES, V41, P9030, DOI 10.1021/ma8013178; SUN H, 1994, J AM CHEM SOC, V116, P2978, DOI 10.1021/ja00086a030; VanKrevelen DW, 2009, PROPERTIES OF POLYMERS: THEIR CORRELATION WITH CHEMICAL STRUCTURE; THEIR NUMERICAL ESTIMATION AND PREDICTION FROM ADDITIVE GROUP CONTRIBUTIONS, P1; VAZ RJ, 1993, MAKROMOL CHEM-M SYMP, V65, P261, DOI 10.1002/masy.19930650129; Wang YX, 1999, POLYMER, V40, P4563, DOI 10.1016/S0032-3861(99)00074-9	38	12	12	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53367	10.1371/journal.pone.0053367	http://dx.doi.org/10.1371/journal.pone.0053367			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326419	Green Submitted, Green Published, gold			2022-12-25	WOS:000313552400020
J	Tan, CO; Tamisier, R; Hamner, JW; Taylor, JA				Tan, Can Ozan; Tamisier, Renaud; Hamner, J. W.; Taylor, J. Andrew			Characterizing Sympathetic Neurovascular Transduction in Humans	PLOS ONE			English	Article							FREQUENCY-RESPONSE CHARACTERISTICS; LIMB BLOOD-FLOW; AGE-RELATED-CHANGES; NITRIC-OXIDE; NERVE ACTIVITY; VASCULAR-RESISTANCE; HEMODYNAMIC BALANCE; CONDUCTANCE; ACTIVATION; EXERCISE	Despite its critical role for cardiovascular homeostasis in humans, only a few studies have directly probed the transduction of sympathetic nerve activity to regional vascular responses - sympathetic neurovascular transduction. Those that have variably relied on either vascular resistance or vascular conductance to quantify the responses. However, it remains unclear which approach would better reflect the physiology. We assessed the utility of both of these as well as an alternative approach in 21 healthy men. We recorded arterial pressure (Finapres), peroneal sympathetic nerve activity (microneurography), and popliteal blood flow (Doppler) during isometric handgrip exercise to fatigue. We quantified and compared transduction via the relation of sympathetic activity to resistance and to conductance and via an adaptation of Poiseuille's relation including pressure, sympathetic activity, and flow. The average relationship between sympathetic activity and resistance (or conductance) was good when assessed over 30-second averages (mean R-2 = 0.49 +/- 0.07) but lesser when incorporating beat-by-beat time lags (R-2 = 0.37 +/- 0.06). However, in a third of the subjects, these relations provided relatively weak estimates (R-2<0.33). In contrast, the Poiseuille relation reflected vascular responses more accurately (R-2 = 0.77 +/- 0.03, >0.50 in 20 of 21 individuals), and provided reproducible estimates of transduction. The gain derived from the relation of resistance (but not conductance) was inversely related to transduction (R-2 = 0.37, p<0.05), but with a proportional bias. Thus, vascular resistance and conductance may not always be reliable surrogates for regional sympathetic neurovascular transduction, and assessment from a Poiseuille relation between pressure, sympathetic nerve activity, and flow may provide a better foundation to further explore differences in transduction in humans.	[Tan, Can Ozan; Hamner, J. W.; Taylor, J. Andrew] Spaulding Rehabil Hosp, Cardiovasc Res Lab, Boston, MA USA; [Tan, Can Ozan; Taylor, J. Andrew] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Tamisier, Renaud] Univ Hosp Grenoble, Sleep Lab, Grenoble, France; [Tamisier, Renaud] Univ Hosp Grenoble, EFCR, Dept Rehabil & Physiol, Grenoble, France; [Tamisier, Renaud] Univ Grenoble 1, INSERM, U1042, Lab Hypoxia Pathophysiol HP2, Grenoble, France	Harvard University; Spaulding Rehabilitation Hospital; Harvard University; Harvard Medical School; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Tan, CO (corresponding author), Spaulding Rehabil Hosp, Cardiovasc Res Lab, Boston, MA USA.	cotan@partners.org	Tamisier, Renaud/M-6858-2014; Hamner, J. W./B-4607-2017; Tan, Can Ozan/E-2598-2016	Tamisier, Renaud/0000-0003-1128-6529; Hamner, J. W./0000-0002-5819-2362; Tan, Can Ozan/0000-0001-9673-9907; Taylor, J Andrew/0000-0003-2802-4330				Agrawal A, 2008, INT J CLIN EXP MED, V1, P305; AKAIKE H, 1968, ANN I STAT MATH, V20, P425, DOI 10.1007/BF02911655; ANDO S, 1993, J AUTONOM NERV SYST, V45, P225, DOI 10.1016/0165-1838(93)90054-X; ARONNE LJ, 1995, AM J PHYSIOL-REG I, V269, pR222, DOI 10.1152/ajpregu.1995.269.1.R222; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Berne R., 2001, CARDIOVASCULAR PHYSL; BOUTOUYRIE P, 1994, AM J PHYSIOL-HEART C, V267, pH1368, DOI 10.1152/ajpheart.1994.267.4.H1368; Box GEP., 2008, TIME SERIES ANAL, DOI [10.1002/9781118619193, DOI 10.1002/9781118619193]; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; CELANDER O, 1954, Acta Physiol Scand Suppl, V32, P1; Charkoudian N, 2005, J PHYSIOL-LONDON, V568, P315, DOI 10.1113/jphysiol.2005.090076; COX RH, 1976, AM J PHYSIOL, V231, P420, DOI 10.1152/ajplegacy.1976.231.2.420; Crandall CG, 1995, J APPL PHYSIOL, V79, P1946, DOI 10.1152/jappl.1995.79.6.1946; Dinenno FA, 1999, CIRCULATION, V100, P164, DOI 10.1161/01.CIR.100.2.164; Dinenno FA, 2002, CIRCULATION, V106, P1349, DOI 10.1161/01.CIR.0000028819.64790.BE; Dinenno FA, 2001, J PHYSIOL-LONDON, V536, P977, DOI 10.1111/j.1469-7793.2001.00977.x; Dinenno FA, 2001, J PHYSIOL-LONDON, V531, P573, DOI 10.1111/j.1469-7793.2001.0573i.x; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; ESLER MD, 1995, AM J PHYSIOL-REG I, V268, pR278, DOI 10.1152/ajpregu.1995.268.1.R278; Ferrannini E, 1996, DIABETES, V45, P947, DOI 10.2337/diabetes.45.7.947; Fisher R.A., 1958, STAT METHODS RES WOR; Florian JP, 2010, EXP PHYSIOL, V95, P486, DOI 10.1113/expphysiol.2009.050997; FOLKOW B, 1993, PHYSIOL REV, V73, P725, DOI 10.1152/physrev.1993.73.4.725; GABRIEL A, 1992, CLIN PHYSIOL, V12, P229, DOI 10.1111/j.1475-097X.1992.tb00309.x; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Guild SJ, 2001, AM J PHYSIOL-REG I, V281, pR206, DOI 10.1152/ajpregu.2001.281.1.R206; Halliwill JR, 1996, J PHYSIOL-LONDON, V495, P279, DOI 10.1113/jphysiol.1996.sp021592; Hart EC, 2009, HYPERTENSION, V53, P571, DOI 10.1161/HYPERTENSIONAHA.108.126391; JOYNER MJ, 1992, AM J PHYSIOL, V263, pH1078, DOI 10.1152/ajpheart.1992.263.4.H1078; Kamiya A, 2004, AM J PHYSIOL-REG I, V286, pR151, DOI 10.1152/ajpregu.00685.2002; Kinlay S, 2001, HYPERTENSION, V38, P1049, DOI 10.1161/hy1101.095329; KIOWSKI W, 1983, CLIN PHARMACOL THER, V34, P565, DOI 10.1038/clpt.1983.216; LAL SKL, 1995, HYPERTENSION, V26, P307, DOI 10.1161/01.HYP.26.2.307; LANDSBERG L, 1993, INT J OBESITY, V17, pS29; LANDSBERG L, 1990, J NEUROSCI METH, V34, P179, DOI 10.1016/0165-0270(90)90056-L; LAUTT WW, 1989, MICROVASC RES, V37, P230, DOI 10.1016/0026-2862(89)90040-X; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lyons D, 1997, CLIN SCI, V93, P519, DOI 10.1042/cs0930519; MARIN J, 1995, MECH AGEING DEV, V79, P71, DOI 10.1016/0047-6374(94)01551-V; McCord GR, 2005, J APPL PHYSIOL, V98, P2011, DOI 10.1152/japplphysiol.00888.2004; Minson CT, 2000, CIRCULATION, V101, P862, DOI 10.1161/01.CIR.101.8.862; NIELSEN H, 1992, AM J PHYSIOL, V263, pH1190, DOI 10.1152/ajpheart.1992.263.4.H1190; NILSSON H, 1985, ACTA PHYSIOL SCAND, V123, P303, DOI 10.1111/j.1748-1716.1985.tb07592.x; OGAWA T, 1992, CIRCULATION, V86, P494, DOI 10.1161/01.CIR.86.2.494; OLEARY DS, 1991, AM J PHYSIOL, V260, pH632, DOI 10.1152/ajpheart.1991.260.2.H632; Oppenheim A.V., 1998, DISCRETE TIME SIGNAL, V2nd; Parker BA, 2007, AM J PHYSIOL-HEART C, V292, pH1148, DOI 10.1152/ajpheart.00729.2006; PRYOR WA, 1995, AM J PHYSIOL-LUNG C, V268, pL699, DOI 10.1152/ajplung.1995.268.5.L699; ROSENBAUM M, 1968, AM J PHYSIOL, V215, P1397, DOI 10.1152/ajplegacy.1968.215.6.1397; Rowell L., 1986, HUMAN CIRCULATION RE; SAITO M, 1990, EUR J APPL PHYSIOL O, V60, P277, DOI 10.1007/BF00379396; Schlager O, 2011, EUR J VASC ENDOVASC, V41, P821, DOI 10.1016/j.ejvs.2011.01.006; SEALS DR, 1989, J APPL PHYSIOL, V67, P1801, DOI 10.1152/jappl.1989.67.5.1801; Seals DR, 2004, AM J PHYSIOL-HEART C, V287, pH1895, DOI 10.1152/ajpheart.00486.2004; Seals DR, 2004, DIABETES, V53, P276, DOI 10.2337/diabetes.53.2.276; SEALS DR, 1989, J APPL PHYSIOL, V66, P2472, DOI 10.1152/jappl.1989.66.5.2472; Shoemaker JK, 2000, AM J PHYSIOL-HEART C, V279, pH1215, DOI 10.1152/ajpheart.2000.279.3.H1215; Smith AR, 2006, AGING CELL, V5, P391, DOI 10.1111/j.1474-9726.2006.00232.x; Smith EG, 2007, J PHYSIOL-LONDON, V582, P63, DOI 10.1113/jphysiol.2007.130591; Stauss HM, 1997, AM J PHYSIOL-HEART C, V273, pH786, DOI 10.1152/ajpheart.1997.273.2.H786; Stauss HM, 1998, AM J PHYSIOL-HEART C, V274, pH1277, DOI 10.1152/ajpheart.1998.274.4.H1277; Studinger P, 2009, J PHYSIOL-LONDON, V587, P2049, DOI 10.1113/jphysiol.2009.170134; SUNDLOF G, 1978, J PHYSIOL-LONDON, V278, P525, DOI 10.1113/jphysiol.1978.sp012322; Tan CO, 2009, IEEE T BIO-MED ENG, V56, P147, DOI 10.1109/TBME.2008.2002138; VALLBO AB, 1967, ELECTROEN CLIN NEURO, V23, P392; Vianna LC, 2012, AM J PHYSL HEART CIR; WALLIN BG, 1988, ANNU REV PHYSIOL, V50, P565, DOI 10.1146/annurev.ph.50.030188.003025; Wilkinson IB, 2002, CIRCULATION, V105, P213, DOI 10.1161/hc0202.101970; Wilson TE, 2006, J APPL PHYSIOL, V100, P1043, DOI 10.1152/japplphysiol.00579.2005	70	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53769	10.1371/journal.pone.0053769	http://dx.doi.org/10.1371/journal.pone.0053769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326501	Green Published, Green Submitted, gold			2022-12-25	WOS:000313552400043
J	Espina, J; Feijoo, CG; Solis, C; Glavic, A				Espina, Jaime; Feijoo, Carmen G.; Solis, Camila; Glavic, Alvaro			csrnp1a Is Necessary for the Development of Primitive Hematopoiesis Progenitors in Zebrafish	PLOS ONE			English	Article							CELL-DIFFERENTIATION; TRANSGENIC ZEBRAFISH; FATE; ERYTHROPOIESIS; SPECIFICATION; GENE; TIF1-GAMMA; EXPRESSION; SCL/TAL-1; LEUKEMIA	The CSRNP (cystein-serine-rich nuclear protein) transcription factors are conserved from Drosophila to human. Functional studies in mice, through knockout for each of their paralogs, have resulted insufficient to elucidate the function of this family of proteins in vertebrate development. Previously, we described the function of the zebrafish ortholog, Csnrp1/Axud1, showing its essential role in the survival and proliferation of cephalic progenitors. To extend our understanding of this family, we have studied the function of its paralog csrnp1a. Our results show that csrnp1a is expressed from 0 hpf, until larval stages, particularly in cephalic territories and in the intermediate cell mass (ICM). Using morpholinos in wild type and transgenic lines we observed that Csrnp1a knockdown generates a mild reduction in head size and a depletion of blood cells in circulation. This was combined with in situ hybridizations to analyze the expression of different mesodermal and primitive hematopoiesis markers. Morphant embryos have impaired blood formation without disruption of mesoderm specification, angiogenesis or heart development. The reduction of circulating blood cells occurs at the hematopoietic progenitor level, affecting both the erythroid and myeloid lineages. In addition, cell proliferation was also altered in hematopoietic anterior sites, specifically in spi1 expression domain. These and previous observations suggest an important role of Csnrps transcription factors in progenitor biology, both in the neural and hematopoietic linages.	[Espina, Jaime; Glavic, Alvaro] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile; [Espina, Jaime; Feijoo, Carmen G.; Solis, Camila] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Santiago, Chile	Universidad de Chile; Universidad Andres Bello	Glavic, A (corresponding author), Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile.	alglavic@uchile.cl	Feijoo, Carmen G/AAF-9003-2019; Glavic, Alvaro/F-5608-2013	Espina, Jaime/0000-0003-4357-7179; Feijoo, Carmen G/0000-0003-1128-403X	FONDAP grant [15090007]; Universidad Nacional Andres Bello grant [DI-07-09/R]; FONDECYT grant [11090102]	FONDAP grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Universidad Nacional Andres Bello grant; FONDECYT grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Funding was provided by FONDAP grant 15090007 (A.G.), Universidad Nacional Andres Bello grant DI-07-09/R (C.G.F. and A.G.) and FONDECYT grant 11090102 (C.G.F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALADHAMI MA, 1977, DEV GROWTH DIFFER, V19, P171; Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Berdougo E, 2003, DEVELOPMENT, V130, P6121, DOI 10.1242/dev.00838; BIELEK E, 1981, CELL TISSUE RES, V220, P163; Brownlie A, 2003, DEV BIOL, V255, P48, DOI 10.1016/S0012-1606(02)00041-6; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Feijoo CG, 2009, DEV DYNAM, V238, P2034, DOI 10.1002/dvdy.22006; Fu YF, 2009, BLOOD, V113, P1340, DOI 10.1182/blood-2008-08-174854; Gingras S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000808; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Glavic A, 2004, DEV BIOL, V272, P89, DOI 10.1016/j.ydbio.2004.04.020; Glavic A, 2009, MECH DEVELOP, V126, P184, DOI 10.1016/j.mod.2008.11.005; Feijoo CG, 2009, MOL CELL NEUROSCI, V40, P328, DOI 10.1016/j.mcn.2008.11.003; Hart DO, 2007, NATURE, V450, P1082, DOI 10.1038/nature06349; Heicklen-Klein A, 2004, DEV BIOL, V267, P490, DOI 10.1016/j.ydbio.2003.09.042; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Hogan BM, 2006, CURR BIOL, V16, P506, DOI 10.1016/j.cub.2006.01.047; Ishiguro H, 2001, ONCOGENE, V20, P5062, DOI 10.1038/sj.onc.1204603; IUCHI I, 1983, J EXP ZOOL, V226, P409, DOI 10.1002/jez.1402260311; Kawahara A, 2001, CURR BIOL, V11, P1353, DOI 10.1016/S0960-9822(01)00398-0; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Lieschke GJ, 2002, DEV BIOL, V246, P274, DOI 10.1006/dbio.2002.0657; Monteiro R, 2011, EMBO J, V30, P1093, DOI 10.1038/emboj.2011.34; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; O'BRIEN B.R.A., 1961, BIOTECH HISTOCHEM, V36, P57; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sarrazin AF, 2006, DEV BIOL, V295, P534, DOI 10.1016/j.ydbio.2006.03.037; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; Taneda T, 2011, GENES CELLS, V16, P231, DOI 10.1111/j.1365-2443.2010.01481.x; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE	40	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53858	10.1371/journal.pone.0053858	http://dx.doi.org/10.1371/journal.pone.0053858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326522	gold, Green Published, Green Submitted			2022-12-25	WOS:000313551500099
J	Singhapol, C; Pal, D; Czapiewski, R; Porika, M; Nelson, G; Saretzki, GC				Singhapol, Chatchawan; Pal, Deepali; Czapiewski, Rafal; Porika, Mahendar; Nelson, Glyn; Saretzki, Gabriele C.			Mitochondrial Telomerase Protects Cancer Cells from Nuclear DNA Damage and Apoptosis	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE; ASSOCIATION; EXPRESSION; GENES; RNA	Most cancer cells express high levels of telomerase and proliferate indefinitely. In addition to its telomere maintenance function, telomerase also has a pro-survival function resulting in an increased resistance against DNA damage and decreased apoptosis induction. However, the molecular mechanisms for this protective function remain elusive and it is unclear whether it is connected to telomere maintenance or is rather a non-telomeric function of the telomerase protein, TERT. It was shown recently that the protein subunit of telomerase can shuttle from the nucleus to the mitochondria upon oxidative stress where it protects mitochondrial function and decreases intracellular oxidative stress. Here we show that endogenous telomerase (TERT protein) shuttles from the nucleus into mitochondria upon oxidative stress in cancer cells and analyzed the nuclear exclusion patterns of endogenous telomerase after treatment with hydrogen peroxide in different cell lines. Cell populations excluded TERT from the nucleus upon oxidative stress in a heterogeneous fashion. We found a significant correlation between nuclear localization of telomerase and high DNA damage, while cells which excluded telomerase from the nucleus displayed no or very low DNA damage. We modeled nuclear and mitochondrial telomerase using organelle specific localization vectors and confirmed that mitochondrial localization of telomerase protects the nucleus from inflicted DNA damage and apoptosis while, in contrast, nuclear localization of telomerase correlated with higher amounts of DNA damage and apoptosis. It is known that nuclear DNA damage can be caused by mitochondrially generated reactive oxygen species (ROS). We demonstrate here that mitochondrial localization of telomerase specifically prevents nuclear DNA damage by decreasing levels of mitochondrial ROS. We suggest that this decrease of oxidative stress might be a possible cause for high stress resistance of cancer cells and could be especially important for cancer stem cells.	[Singhapol, Chatchawan; Pal, Deepali; Czapiewski, Rafal; Porika, Mahendar; Nelson, Glyn; Saretzki, Gabriele C.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Saretzki, GC (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Campus Ageing & Vital, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	gabriele.saretzki@ncl.ac.uk	nelson, glyn/A-6346-2009; Saretzki, Gabriele Christine/I-7175-2019	nelson, glyn/0000-0002-1895-4772; Saretzki, Gabriele Christine/0000-0003-2100-8223; Pal, Deepali/0000-0001-6326-5303; Czapiewski, Rafal/0000-0003-0211-8435	Thai government; BBSRC grant [BB/C008200/1(CISBAN)]; Biotechnology and Biological Sciences Research Council [BB/C008200/1] Funding Source: researchfish	Thai government; BBSRC grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Chatchawan Singhapol was funded by a scholarship from Thai government. Glyn Nelson was supported by the BBSRC grant nr. BB/C008200/1(CISBAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372; Bagheri S, 2006, P NATL ACAD SCI USA, V103, P11306, DOI 10.1073/pnas.0510085103; Buchner N, 2010, EXP GERONTOL, V45, P558, DOI 10.1016/j.exger.2010.03.003; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; FLINT J, 1994, AM J HUM GENET, V55, P505; Haendeler J, 2003, MOL CELL BIOL, V23, P4598, DOI 10.1128/MCB.23.13.4598-4610.2003; Haendeler J, 2009, ARTERIOSCL THROM VAS, V29, P929, DOI 10.1161/ATVBAHA.109.185546; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; Santos JH, 2006, HUM MOL GENET, V15, P1757, DOI 10.1093/hmg/ddl098; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Indran IR, 2011, CANCER RES, V71, P266, DOI 10.1158/0008-5472.CAN-10-1588; Joseph I, 2010, CANCER RES, V70, P9494, DOI 10.1158/0008-5472.CAN-10-0233; Kovalenko OA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010812; Kovalenko OA, 2010, AGING CELL, V9, P203, DOI 10.1111/j.1474-9726.2010.00551.x; Li S, 2005, J BIOL CHEM, V280, P23709, DOI 10.1074/jbc.M502782200; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Roth A, 2010, RECENT RESULTS CANC, V184, P221, DOI 10.1007/978-3-642-01222-8_16; Santos JH, 2004, AGING CELL, V3, P399, DOI 10.1111/j.1474-9728.2004.00124.x; Sharma NK, 2012, NUCLEIC ACIDS RES, V40, P712, DOI 10.1093/nar/gkr758; Smith LL, 2003, NAT CELL BIOL, V5, P474, DOI 10.1038/ncb985; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Temime-Smaali N, 2008, EMBO J, V27, P1513, DOI 10.1038/emboj.2008.74; Wong JMY, 2002, NAT CELL BIOL, V4, P731, DOI 10.1038/ncb846	25	109	112	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52989	10.1371/journal.pone.0052989	http://dx.doi.org/10.1371/journal.pone.0052989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326372	Green Published, gold, Green Accepted			2022-12-25	WOS:000313551500041
J	Thammanomai, A; Hamakawa, H; Bartolak-Suki, E; Suki, B				Thammanomai, Apiradee; Hamakawa, Hiroshi; Bartolak-Suki, Erzsebet; Suki, Bela			Combined Effects of Ventilation Mode and Positive End-Expiratory Pressure on Mechanics, Gas Exchange and the Epithelium in Mice with Acute Lung Injury	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; BIOLOGICALLY VARIABLE VENTILATION; TIDAL VOLUME VENTILATION; RECRUITMENT MANEUVERS; DEEP INFLATION; ARTERIAL OXYGENATION; ALVEOLAR COLLAPSE; PORCINE MODEL; MOUSE LUNG; E-CADHERIN	The accepted protocol to ventilate patients with acute lung injury is to use low tidal volume (V-T) in combination with recruitment maneuvers or positive end-expiratory pressure (PEEP). However, an important aspect of mechanical ventilation has not been considered: the combined effects of PEEP and ventilation modes on the integrity of the epithelium. Additionally, it is implicitly assumed that the best PEEP-V-T combination also protects the epithelium. We aimed to investigate the effects of ventilation mode and PEEP on respiratory mechanics, peak airway pressures and gas exchange as well as on lung surfactant and epithelial cell integrity in mice with acute lung injury. HCl-injured mice were ventilated at PEEPs of 3 and 6 cmH(2)O with conventional ventilation (CV), CV with intermittent large breaths (CVLB) to promote recruitment, and a new mode, variable ventilation, optimized for mice (VVN). Mechanics and gas exchange were measured during ventilation and surfactant protein (SP)-B, proSP-B and E-cadherin levels were determined from lavage and lung homogenate. PEEP had a significant effect on mechanics, gas exchange and the epithelium. The higher PEEP reduced lung collapse and improved mechanics and gas exchange but it also down regulated surfactant release and production and increased epithelial cell injury. While CVLB was better than CV, VVN outperformed CVLB in recruitment, reduced epithelial injury and, via a dynamic mechanotransduction, it also triggered increased release and production of surfactant. For long-term outcome, selection of optimal PEEP and ventilation mode may be based on balancing lung physiology with epithelial injury.	[Thammanomai, Apiradee; Hamakawa, Hiroshi; Bartolak-Suki, Erzsebet; Suki, Bela] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University	Suki, B (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	bsuki@bu.edu			National Institutes of Health (NIH) [HL-098976]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098976] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by National Institutes of Health (NIH) HL-098976. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 2004, J APPL PHYSIOL, V96, P293, DOI 10.1152/japplphysiol.00270.2003; Allen G, 2002, J APPL PHYSIOL, V93, P1709, DOI 10.1152/japplphysiol.00473.2002; Allen GB, 2007, AM J PHYSIOL-LUNG C, V292, pL1580, DOI 10.1152/ajplung.00483.2006; Allen GB, 2006, AM J PHYSIOL-LUNG C, V291, pL710, DOI 10.1152/ajplung.00532.2005; AMATO MBP, 1995, AM J RESP CRIT CARE, V152, P1835, DOI 10.1164/ajrccm.152.6.8520744; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Arold SP, 2003, AM J PHYSIOL-LUNG C, V285, pL370, DOI 10.1152/ajplung.00036.2003; Arold SP, 2002, AM J RESP CRIT CARE, V165, P366, DOI 10.1164/ajrccm.165.3.2010155; Azeloglu EU, 2008, J APPL PHYSIOL, V105, P652, DOI 10.1152/japplphysiol.00958.2007; Badet M, 2009, RESP CARE, V54, P847, DOI 10.4187/002013209793800448; Black CLB, 2007, CRIT CARE MED, V35, P870, DOI 10.1097/01.CCM.0000257331.42485.94; Bellardine CL, 2006, CRIT CARE MED, V34, P439, DOI 10.1097/01.CCM.0000196208.01682.87; Bilek AM, 2003, J APPL PHYSIOL, V94, P770, DOI 10.1152/japplphysiol.00764.2002; BO G, 1977, J APPL PHYSIOL, V42, P476, DOI 10.1152/jappl.1977.42.4.476; Briel M, 2010, JAMA-J AM MED ASSOC, V303, P865, DOI 10.1001/jama.2010.218; Brunner JX, 2009, INTENS CARE MED, V35, P1479, DOI 10.1007/s00134-009-1510-8; Carvalho AR, 2011, J APPL PHYSIOL, V110, P1083, DOI 10.1152/japplphysiol.00804.2010; Chiumello D, 1999, AM J RESP CRIT CARE, V160, P109, DOI 10.1164/ajrccm.160.1.9803046; Chiumello D, 2008, AM J RESP CRIT CARE, V178, P346, DOI 10.1164/rccm.200710-1589OC; Csendes T., 1988, Acta Cybernetica, V8, P361; Funk DJ, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-22; Gattinoni L, 2005, CURR OPIN CRIT CARE, V11, P69, DOI 10.1097/00075198-200502000-00011; Goto T, 2010, EUR J CARDIO-THORAC, V37, P426, DOI 10.1016/j.ejcts.2009.06.041; Goto Y, 2000, AM J RESP CELL MOL, V23, P712, DOI 10.1165/ajrcmb.23.6.4031; Halter JM, 2003, AM J RESP CRIT CARE, V167, P1620, DOI 10.1164/rccm.200205-435OC; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Hodgson Carol L, 2011, J Intensive Care Med, V26, P41, DOI 10.1177/0885066610383953; Ito S, 2004, J APPL PHYSIOL, V97, P204, DOI 10.1152/japplphysiol.01246.2003; JARDIN F, 1981, NEW ENGL J MED, V304, P387, DOI 10.1056/NEJM198102123040703; Kaczka DW, 2005, ANESTHESIOLOGY, V103, P306, DOI 10.1097/00000542-200508000-00014; Kostic P, 2011, CRIT CARE, V15, DOI 10.1186/cc10236; Krebs J, 2009, CRIT CARE, V13, DOI 10.1186/cc8118; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Lefevre GR, 1996, AM J RESP CRIT CARE, V154, P1567, DOI 10.1164/ajrccm.154.5.8912782; LUTCHEN KR, 1993, J APPL PHYSIOL, V75, P478, DOI 10.1152/jappl.1993.75.1.478; Martynowicz MA, 2001, J APPL PHYSIOL, V90, P1744, DOI 10.1152/jappl.2001.90.5.1744; Meade MO, 2008, RESP CARE, V53, P1441; Meade MO, 2008, JAMA-J AM MED ASSOC, V299, P637, DOI 10.1001/jama.299.6.637; Mergoni M, 2001, J APPL PHYSIOL, V91, P441, DOI 10.1152/jappl.2001.91.1.441; MUSCEDERE JG, 1994, AM J RESP CRIT CARE, V149, P1327, DOI 10.1164/ajrccm.149.5.8173774; Mutch WAC, 2000, AM J RESP CRIT CARE, V162, P319, DOI 10.1164/ajrccm.162.1.9903120; Mutch WAC, 2000, CRIT CARE MED, V28, P2457, DOI 10.1097/00003246-200007000-00045; Santiago VR, 2010, CRIT CARE MED, V38, P2207, DOI 10.1097/CCM.0b013e3181f3e076; Spieth PM, 2009, AM J RESP CRIT CARE, V179, P684, DOI 10.1164/rccm.200806-975OC; Suki B, 1998, NATURE, V393, P127, DOI 10.1038/30130; Thammanomai A, 2008, J APPL PHYSIOL, V104, P1329, DOI 10.1152/japplphysiol.01002.2007; Thammanomai A, 2007, J APPL PHYSIOL, V103, P1551, DOI 10.1152/japplphysiol.00006.2007; Tomashefski JF, 2000, CLIN CHEST MED, V21, P435, DOI 10.1016/S0272-5231(05)70158-1; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Tremblay LN, 1998, P ASSOC AM PHYSICIAN, V110, P482; Zhao ZQ, 2010, CRIT CARE, V14, DOI 10.1186/cc8860; 2000, N ENGL J MED, V342, P1301	52	40	45	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53934	10.1371/journal.pone.0053934	http://dx.doi.org/10.1371/journal.pone.0053934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326543	gold, Green Submitted, Green Published			2022-12-25	WOS:000313551500102
J	Wierzbicki, R; Kobler, C; Jensen, MRB; Lopacinska, J; Schmidt, MS; Skolimowski, M; Abeille, F; Qvortrup, K; Molhave, K				Wierzbicki, Rafal; Kobler, Carsten; Jensen, Mikkel R. B.; Lopacinska, Joanna; Schmidt, Michael S.; Skolimowski, Maciej; Abeille, Fabien; Qvortrup, Klaus; Molhave, Kristian			Mapping the Complex Morphology of Cell Interactions with Nanowire Substrates Using FIB-SEM	PLOS ONE			English	Article							SCANNING-ELECTRON-MICROSCOPY; SYNTHETIC NANOSTRUCTURES; FOCAL ADHESION; MOTILITY; SURFACE; ARRAYS; FORCE; PROLIFERATION; FABRICATION; BEHAVIOR	Using high resolution focused ion beam scanning electron microscopy (FIB-SEM) we study the details of cell-nanostructure interactions using serial block face imaging. 3T3 Fibroblast cellular monolayers are cultured on flat glass as a control surface and on two types of nanostructured scaffold substrates made from silicon black (Nanograss) with low- and high nanowire density. After culturing for 72 hours the cells were fixed, heavy metal stained, embedded in resin, and processed with FIB-SEM block face imaging without removing the substrate. The sample preparation procedure, image acquisition and image post-processing were specifically optimised for cellular monolayers cultured on nanostructured substrates. Cells display a wide range of interactions with the nanostructures depending on the surface morphology, but also greatly varying from one cell to another on the same substrate, illustrating a wide phenotypic variability. Depending on the substrate and cell, we observe that cells could for instance: break the nanowires and engulf them, flatten the nanowires or simply reside on top of them. Given the complexity of interactions, we have categorised our observations and created an overview map. The results demonstrate that detailed nanoscale resolution images are required to begin understanding the wide variety of individual cells' interactions with a structured substrate. The map will provide a framework for light microscopy studies of such interactions indicating what modes of interactions must be considered.	[Wierzbicki, Rafal; Kobler, Carsten; Jensen, Mikkel R. B.; Lopacinska, Joanna; Schmidt, Michael S.; Skolimowski, Maciej; Abeille, Fabien; Molhave, Kristian] Tech Univ Denmark, DTU Nanotech, DK-2800 Lyngby, Denmark; [Kobler, Carsten] Tech Univ Denmark, DTU CEN, DK-2800 Lyngby, Denmark; [Qvortrup, Klaus] Univ Copenhagen, CFIM, Dept Biomed Sci, Copenhagen, Denmark	Technical University of Denmark; Technical University of Denmark; University of Copenhagen	Molhave, K (corresponding author), Tech Univ Denmark, DTU Nanotech, DK-2800 Lyngby, Denmark.	kristian.molhave@nanotech.dtu.dk	Molhave, Kristian/B-9209-2008; Lopacinska-Jørgensen, Joanna/AGO-3187-2022; Schmidt, Michael S/F-1677-2010; Skolimowski, Maciej/G-6320-2011; Mølhave, Kristian/AAP-5837-2020	Molhave, Kristian/0000-0002-6493-2750; Lopacinska-Jørgensen, Joanna/0000-0001-7803-425X; Schmidt, Michael S/0000-0002-9673-3449; Mølhave, Kristian/0000-0002-6493-2750; Qvortrup, Klaus/0000-0001-8811-0260	FP7-Technotubes [CP-IP 228579-1]; FP7-Nanoscale [CP-FP 214566-2]; Technical University of Denmark; Institute: DTU CEN; Institute: DTU Nanotech	FP7-Technotubes; FP7-Nanoscale; Technical University of Denmark; Institute: DTU CEN; Institute: DTU Nanotech	This study was supported by FP7-Technotubes, CP-IP 228579-1; FP7-Nanoscale, CP-FP 214566-2 (http://www.nanoscale-fp7.eu/); Technical University of Denmark; Institutes: DTU CEN, DTU Nanotech (www.cen.dtu.dk and www.nanotech.dtu.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Berthing T, 2011, SMALL, V7, P640, DOI 10.1002/smll.201001642; Bittermann AG, 2009, ADV ENG MATER, V11, pB182, DOI 10.1002/adem.200900080; Canton I, 2012, CHEM SOC REV, V41, P2718, DOI 10.1039/c2cs15309b; Cellot G, 2009, NAT NANOTECHNOL, V4, P126, DOI [10.1038/NNANO.2008.374, 10.1038/nnano.2008.374]; Choi D, 2007, BIOMED MICRODEVICES, V9, P143, DOI 10.1007/s10544-006-9008-4; Cox G, 2004, MICROSC RES TECHNIQ, V63, P18, DOI 10.1002/jemt.10423; Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049; De Winter DAM, 2009, J MICROSC-OXFORD, V233, P372, DOI 10.1111/j.1365-2818.2009.03139.x; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Drobne D, 2008, ULTRAMICROSCOPY, V108, P663, DOI 10.1016/j.ultramic.2007.10.010; Edwards HK, 2009, J MICROSC-OXFORD, V234, P16, DOI 10.1111/j.1365-2818.2009.03152.x; Edwards RL, 2004, EXP MECH, V44, P49, DOI 10.1177/0014485104039749; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Friedmann A, 2011, ACTA BIOMATER, V7, P2499, DOI 10.1016/j.actbio.2011.02.024; Ghibaudo M, 2008, SOFT MATTER, V4, P1836, DOI 10.1039/b804103b; Gnauck P, 2005, MICROSC MICROANAL, V11, DOI [10.1017/S1431927605501843, DOI 10.1017/S1431927605501843]; Gradinaru C, 2012, COMPUT STRUCT BIOTEC, V1, DOI 10.5936/csbj.201207004; Greve F, 2007, BIOMATERIALS, V28, P5246, DOI 10.1016/j.biomaterials.2007.08.010; Hai A, 2009, J R SOC INTERFACE, V6, P1153, DOI 10.1098/rsif.2009.0087; Hallstrom W, 2007, NANO LETT, V7, P2960, DOI 10.1021/nl070728e; Hanson L, 2012, NANO LETT, V12, P5815, DOI 10.1021/nl303163y; Heymann JAW, 2006, J STRUCT BIOL, V155, P63, DOI 10.1016/j.jsb.2006.03.006; Hill JJ, 2010, ACS APPL MATER INTER, V2, P1992, DOI 10.1021/am100290z; Hoffmann S, 2006, NANO LETT, V6, P622, DOI 10.1021/nl052223z; JANSEN H, 1995, J MICROMECH MICROENG, V5, P115, DOI 10.1088/0960-1317/5/2/015; Jimenez N, 2010, J MICROSC-OXFORD, V237, P208, DOI 10.1111/j.1365-2818.2009.03329.x; Kim P, 2005, NANOTECHNOLOGY, V16, P2420, DOI 10.1088/0957-4484/16/10/072; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; KULKARNI GV, 1994, J CELL SCI, V107, P1169; Kwon NH, 2007, NANO LETT, V7, P2718, DOI 10.1021/nl071179f; Lamers E, 2011, TISSUE ENG PART C-ME, V17, P1, DOI [10.1089/ten.tec.2010.0251, 10.1089/ten.TEC.2010.0251]; Li Z, 2009, NANO LETT, V9, P3575, DOI 10.1021/nl901774m; Lopacinska JM, 2012, NANOSCALE, V4, P3739, DOI 10.1039/c2nr11455k; Marques MM, 2004, LASER SURG MED, V34, P260, DOI 10.1002/lsm.20008; Martinelli V, 2012, NANO LETT, V12, P1831, DOI 10.1021/nl204064s; Martinez E, 2008, MICRON, V39, P111, DOI 10.1016/j.micron.2006.12.003; McKnight TE, 2003, NANOTECHNOLOGY, V14, P551, DOI 10.1088/0957-4484/14/5/313; McNamara LE, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/120623; Munevar S, 2001, BIOPHYS J, V80, P1744, DOI 10.1016/S0006-3495(01)76145-0; Murphy GE, 2011, J STRUCT BIOL, V176, P268, DOI 10.1016/j.jsb.2011.08.013; Obataya I, 2005, NANO LETT, V5, P27, DOI 10.1021/nl0485399; OKAMOTO K, 1980, REV SCI INSTRUM, V51, P302, DOI 10.1063/1.1136205; Park J, 2009, SMALL, V5, P666, DOI 10.1002/smll.200801476; Persson H, 2012, NANO RES, V5, P190, DOI 10.1007/s12274-012-0199-0; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; Porter DW, 2010, TOXICOLOGY, V269, P136, DOI 10.1016/j.tox.2009.10.017; Robinson JT, 2012, NAT NANOTECHNOL, V7, P180, DOI [10.1038/nnano.2011.249, 10.1038/NNANO.2011.249]; Ryoo SR, 2010, ACS NANO, V4, P6587, DOI 10.1021/nn1018279; Safi M, 2011, ACS NANO, V5, P5354, DOI 10.1021/nn201121e; Schmidt MS, 2012, ADV MATER, V24, pOP11, DOI 10.1002/adma.201103496; Shalek AK, 2010, P NATL ACAD SCI USA, V107, P1870, DOI 10.1073/pnas.0909350107; Somosy Z, 2000, MICRON, V31, P165, DOI 10.1016/S0968-4328(99)00083-9; Stevenson PM, 2009, LANGMUIR, V25, P367, DOI 10.1021/la802859v; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Vitol EA, 2009, ACS NANO, V3, P3529, DOI 10.1021/nn9010768; Wrobel G, 2008, J R SOC INTERFACE, V5, P213, DOI 10.1098/rsif.2007.1094; Yang PD, 2010, NANO LETT, V10, P1529, DOI 10.1021/nl100665r; Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058; Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031; Yu Z, 2007, NANO LETT, V7, P2188, DOI 10.1021/nl070291a	61	50	50	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53307	10.1371/journal.pone.0053307	http://dx.doi.org/10.1371/journal.pone.0053307			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326412	Green Submitted, gold, Green Published			2022-12-25	WOS:000313551500064
J	Zilioli, S; Watson, NV				Zilioli, Samuele; Watson, Neil V.			Winning Isn't Everything: Mood and Testosterone Regulate the Cortisol Response in Competition	PLOS ONE			English	Article							SALIVARY TESTOSTERONE; SOCIAL STRESS; NEUROENDOCRINE; BEHAVIOR; DOMINANCE; PERSONALITY; STEROIDS; STYLES; JUDO	Dominance contests are recurrent and widespread causes of stress among mammals. Studies of activation of the stress axis in social defeat - as reflected in levels of adrenal glucocorticoid, cortisol - have generated scattered and sometimes contradictory results, suggesting that biopsychological individual differences might play an important mediating role, at least in humans. In the context of a larger study of the regulation of endocrine responses to competition, we evaluated the notion that mood states, such as self-assurance and hostility, may influence cortisol reactivity to dominance cues via an interplay with baseline testosterone, considered as a potential marker of individual differences in dominance. Seventy healthy male university students (mean age 20.02, range 18-26) provided saliva samples before and after competing for fifteen minutes on a rigged computer task. After a winner was determined, all participants were assessed on their mood states through a standardized psychometric instrument (PANAS-X). Among winners of a rigged videogame competition, we found a significant interaction between testosterone and self-assurance in relation to post-competition cortisol. Specifically, self-assurance was associated with lower post-competition cortisol in subjects with high baseline testosterone levels, but no such relationship was observed in subjects with lower baseline testosterone levels. In losers of the competition no interaction effect between basal testosterone and hostility was observed. However, in this subgroup a significant negative relationship between basal testosterone and post-competition cortisol was evident. Overall, these findings provide initial support for the novel hypothesis that biological motivational predispositions (i.e. basal testosterone) and state (i.e. mood changes) may interact in regulating the hypothalamic-pituitary-adrenal axis activation after a social contest.	[Zilioli, Samuele; Watson, Neil V.] Simon Fraser Univ, Dept Psychol, Behav Endocrinol Lab, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Watson, NV (corresponding author), Simon Fraser Univ, Dept Psychol, Behav Endocrinol Lab, Burnaby, BC V5A 1S6, Canada.	nwatson@sfu.ca		Watson, Neil/0000-0002-1709-4889	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant [00194522]	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant 00194522 to NVW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L.S., 1991, MULTIPLE REGRESSION; BERK LS, 1989, AM J MED SCI, V298, P390, DOI 10.1097/00000441-198912000-00006; Blanchard RJ, 2001, PHYSIOL BEHAV, V73, P261, DOI 10.1016/S0031-9384(01)00449-8; Bostock S, 2011, PSYCHONEUROENDOCRINO, V36, P1175, DOI 10.1016/j.psyneuen.2011.02.009; BREMNER WJ, 1983, J CLIN ENDOCR METAB, V56, P1278, DOI 10.1210/jcem-56-6-1278; CAMPBELL IT, 1982, CHRONOBIOLOGIA, V9, P389; Christensen AJ, 1996, PSYCHOSOM MED, V58, P150, DOI 10.1097/00006842-199603000-00009; Cohen J., 2003, APPL MULTIPLE REGRES; DABBS JM, 1990, PHYSIOL BEHAV, V48, P83, DOI 10.1016/0031-9384(90)90265-6; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; DIENER E, 1984, J PERS SOC PSYCHOL, V47, P1105, DOI 10.1037/0022-3514.47.5.1105; DIENSTBIER RA, 1989, PSYCHOL REV, V96, P84, DOI 10.1037/0033-295X.96.1.84; Flegr J, 2010, NEUROENDOCRINOL LETT, V31, P577; Geniole SN, 2011, BIOL PSYCHOL, V87, P137, DOI 10.1016/j.biopsycho.2011.02.020; Gonzalez-Bono E, 1999, HORM BEHAV, V35, P55, DOI 10.1006/hbeh.1998.1496; Gonzalez-Bono E, 2000, AGGRESSIVE BEHAV, V26, P235, DOI 10.1002/(SICI)1098-2337(2000)26:3<235::AID-AB3>3.0.CO;2-L; Hodge VJ, 2004, ARTIF INTELL REV, V22, P85, DOI 10.1023/B:AIRE.0000045502.10941.a9; HORROCKS PM, 1990, CLIN ENDOCRINOL, V32, P127, DOI 10.1111/j.1365-2265.1990.tb03758.x; Josephs RA, 2003, PSYCHOL SCI, V14, P158, DOI 10.1111/1467-9280.t01-1-01435; Keeney A, 2006, J NEUROENDOCRINOL, V18, P330, DOI 10.1111/j.1365-2826.2006.01422.x; KIRSCHBAUM C, 1992, PSYCHOSOM MED, V54, P648, DOI 10.1097/00006842-199211000-00004; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kramer M, 1999, NEUROSCI BIOBEHAV R, V23, P937, DOI 10.1016/S0149-7634(99)00027-5; Lazarus R.S., 1984, STRESS APPRAISAL COP; LOUCH CD, 1967, GEN COMP ENDOCR, V8, P441, DOI 10.1016/S0016-6480(67)80006-6; MANOGUE K R, 1975, Primates, V16, P457, DOI 10.1007/BF02382742; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; MCCAUL KD, 1992, HORM BEHAV, V26, P486, DOI 10.1016/0018-506X(92)90016-O; McNair D., 1971, MANUAL PROFILE MOOD; Mehta PH, 2008, J PERS SOC PSYCHOL, V94, P1078, DOI 10.1037/0022-3514.94.6.1078; Miller GE, 1999, BRAIN BEHAV IMMUN, V13, P109, DOI 10.1006/brbi.1998.0545; Mills PJ, 1996, J PSYCHOSOM RES, V40, P417, DOI 10.1016/0022-3999(95)00614-1; Newman ML, 2005, HORM BEHAV, V47, P205, DOI 10.1016/j.yhbeh.2004.09.008; Parmigiani S, 2006, AGGRESSIVE BEHAV, V32, P481, DOI 10.1002/ab.20148; Polk DE, 2005, PSYCHONEUROENDOCRINO, V30, P261, DOI 10.1016/j.psyneuen.2004.08.004; POPE MK, 1991, PSYCHOSOM MED, V53, P386, DOI 10.1097/00006842-199107000-00004; Popma A, 2007, BIOL PSYCHIAT, V61, P405, DOI 10.1016/j.biopsych.2006.06.006; RIADFAHMY D, 1987, J REPROD MED, V32, P254; RIADFAHMY D, 1982, ENDOCR REV, V3, P367, DOI 10.1210/edrv-3-4-367; Salvador A, 2005, NEUROSCI BIOBEHAV R, V29, P195, DOI 10.1016/j.neubiorev.2004.07.004; Salvador A, 2003, PSYCHONEUROENDOCRINO, V28, P364, DOI 10.1016/S0306-4530(02)00028-8; Salvador A, 2009, NEUROSCI BIOBEHAV R, V33, P160, DOI 10.1016/j.neubiorev.2008.09.005; Schultheiss OC, 2005, J PERS SOC PSYCHOL, V88, P174, DOI 10.1037/0022-3514.88.1.174; Sellers JG, 2007, J RES PERS, V41, P126, DOI 10.1016/j.jrp.2006.02.004; Steptoe A, 2005, P NATL ACAD SCI USA, V102, P6508, DOI 10.1073/pnas.0409174102; Suarez EC, 1998, PSYCHOSOM MED, V60, P78, DOI 10.1097/00006842-199801000-00017; SULS J, 1993, PSYCHOPHYSIOLOGY, V30, P615, DOI 10.1111/j.1469-8986.1993.tb02087.x; Takahashi T, 2005, BRAIN RES BULL, V67, P398, DOI 10.1016/j.brainresbull.2005.06.006; Van Anders SM, 2006, HUM NATURE-INT BIOS, V17, P212, DOI 10.1007/s12110-006-1018-7; Virgin CE, 1997, AM J PRIMATOL, V42, P25, DOI 10.1002/(SICI)1098-2345(1997)42:1<25::AID-AJP2>3.0.CO;2-0; Vogele C, 1998, INT J PSYCHOPHYSIOL, V28, P167, DOI 10.1016/S0167-8760(97)00094-9; Watson D., 1994, PANAS X MANUAL POSIT, DOI [10.17077/48vtm4t2, DOI 10.17077/48VTM4T2, DOI 10.13072/MIDSS.438]; Weiner H., 1992, PERTURBING ORGANISM; Wirth MM, 2006, HORM BEHAV, V49, P346, DOI 10.1016/j.yhbeh.2005.08.013; Zilioli S, 2012, PSYCHONEUROENDOCRINO, V37, P1855, DOI 10.1016/j.psyneuen.2012.03.022	56	30	31	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52582	10.1371/journal.pone.0052582	http://dx.doi.org/10.1371/journal.pone.0052582			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326343	Green Published, Green Submitted, gold			2022-12-25	WOS:000313551500021
J	Zong, J; Deng, W; Zhou, H; Bian, ZY; Dai, J; Yuan, Y; Zhang, JY; Zhang, R; Zhang, Y; Wu, QQ; Guo, HP; Li, HL; Tang, QZ				Zong, Jing; Deng, Wei; Zhou, Heng; Bian, Zhou-yan; Dai, Jia; Yuan, Yuan; Zhang, Jie-yu; Zhang, Rui; Zhang, Yan; Wu, Qing-qing; Guo, Hai-peng; Li, Hong-liang; Tang, Qi-zhu			3,3 '-Diindolylmethane Protects against Cardiac Hypertrophy via 5 '-Adenosine Monophosphate-Activated Protein Kinase-alpha 2	PLOS ONE			English	Article							GENE-EXPRESSION; CANCER CELLS; KINASE; AMPK; APOPTOSIS; MTOR; INDOLE-3-CARBINOL; DYSFUNCTION; INHIBITION; METABOLISM	Purpose: 3,3'-Diindolylmethane (DIM) is a natural component of cruciferous plants. It has strong antioxidant and anti-angiogenic effects and promotes the apoptosis of a variety of tumor cells. However, little is known about the critical role of DIM on cardiac hypertrophy. In the present study, we investigated the effects of DIM on cardiac hypertrophy. Methods: Multiple molecular techniques such as Western blot analysis, real-time PCR to determine RNA expression levels of hypertrophic, fibrotic and oxidative stress markers, and histological analysis including H&E for histopathology, PSR for collagen deposition, WGA for myocyte cross-sectional area, and immunohistochemical staining for protein expression were used. Results: In pre-treatment and reverse experiments, C57/BL6 mouse chow containing 0.05% DIM (dose 100 mg/kg/d DIM) was administered one week prior to surgery or one week after surgery, respectively, and continued for 8 weeks after surgery. In both experiments, DIM reduced to cardiac hypertrophy and fibrosis induced by aortic banding through the activation of 5'-adenosine monophosphate-activated protein kinase-alpha 2 (AMPK alpha 2) and inhibition of mammalian target of the rapamycin (mTOR) signaling pathway. Furthermore, DIM protected against cardiac oxidative stress by regulating expression of estrogen-related receptor-alpha (ERR alpha) and NRF2 etc. The cardioprotective effects of DIM were ablated in mice lacking functional AMPK alpha 2. Conclusion: DIM significantly improves left ventricular function via the activation of AMPK alpha 2 in a murine model of cardiac hypertrophy.	[Zong, Jing; Deng, Wei; Zhou, Heng; Bian, Zhou-yan; Dai, Jia; Yuan, Yuan; Zhang, Jie-yu; Zhang, Rui; Zhang, Yan; Wu, Qing-qing; Li, Hong-liang; Tang, Qi-zhu] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Peoples R China; [Zong, Jing; Deng, Wei; Zhou, Heng; Bian, Zhou-yan; Dai, Jia; Yuan, Yuan; Zhang, Jie-yu; Zhang, Rui; Zhang, Yan; Wu, Qing-qing; Li, Hong-liang; Tang, Qi-zhu] Wuhan Univ, Cardiovasc Res Inst, Wuhan 430072, Peoples R China; [Guo, Hai-peng] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Peoples R China; [Guo, Hai-peng] Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan 250100, Peoples R China	Wuhan University; Wuhan University; Shandong University; Shandong University	Tang, QZ (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Peoples R China.	qztang@whu.edu.cn			National Nature Science Foundation of China [30901628, 30972954, 81000036, 81000095]; Fundamental Research Funds for the Central Universities of China [20103020201000193]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Nature Science Foundation of China [30901628, 30972954, 81000036 and 81000095]; and the Fundamental Research Funds for the Central Universities of China [20103020201000193]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azmi AS, 2008, PHARM RES-DORDR, V25, P2117, DOI 10.1007/s11095-008-9581-8; Balakumar Pitchai, 2007, Journal of Pharmacological and Toxicological Methods, V56, P1, DOI 10.1016/j.vascn.2007.01.003; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Bian ZY, 2010, HYPERTENSION, V55, P257, DOI 10.1161/HYPERTENSIONAHA.109.135665; Chen DZ, 2001, J NUTR, V131, P3294, DOI 10.1093/jn/131.12.3294; Cho HJ, 2008, J NUTR, V138, P17, DOI 10.1093/jn/138.1.17; Ernst IMA, 2011, FREE RADICAL RES, V45, P941, DOI 10.3109/10715762.2011.571683; Finckenberg P, 2010, J HYPERTENS, V28, pS33, DOI 10.1097/01.hjh.0000388492.73954.0b; Gupta S, 2007, ANTIOXID REDOX SIGN, V9, P623, DOI 10.1089/ars.2007.1474; Heidrich F, 2010, CURR CARDIOL REV, V6, P337, DOI 10.2174/157340310793566073; Hu XL, 2011, HYPERTENSION, V58, P696, DOI 10.1161/HYPERTENSIONAHA.111.174128; Hwang JT, 2008, GENES NUTR, V2, P323, DOI 10.1007/s12263-007-0069-7; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Jensen TE, 2009, ACTA PHYSIOL, V196, P155, DOI 10.1111/j.1748-1716.2009.01979.x; Khwaja FS, 2009, CANCER PREV RES, V2, P566, DOI 10.1158/1940-6207.CAPR-08-0202; Kunimasa K, 2010, J NUTR, V140, P1, DOI 10.3945/jn.109.112359; Li HL, 2010, P NATL ACAD SCI USA, V107, P13818, DOI 10.1073/pnas.1008397107; Li JQ, 2009, ARTERIOSCL THROM VAS, V29, P1843, DOI 10.1161/ATVBAHA.109.189480; Li YW, 2007, J BIOL CHEM, V282, P21542, DOI 10.1074/jbc.M701978200; Maulik SK, 2012, TOXICOL MECH METHOD, V22, P359, DOI 10.3109/15376516.2012.666650; McKinsey TA, 2007, NAT REV DRUG DISCOV, V6, P617, DOI 10.1038/nrd2193; Ojamaa K, 2010, VASC PHARMACOL, V52, P113, DOI 10.1016/j.vph.2009.11.008; Proud CG, 2004, CARDIOVASC RES, V63, P403, DOI 10.1016/j.cardiores.2004.02.003; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Shirwany NA, 2010, ACTA PHARMACOL SIN, V31, P1075, DOI 10.1038/aps.2010.139; Soesanto W, 2009, HYPERTENSION, V54, P1321, DOI 10.1161/HYPERTENSIONAHA.109.138818; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Tian R, 2001, CIRCULATION, V104, P1664, DOI 10.1161/hc4001.097183; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Xue L, 2005, ONCOGENE, V24, P2343, DOI 10.1038/sj.onc.1208434; Zhang P, 2008, HYPERTENSION, V52, P918, DOI 10.1161/HYPERTENSIONAHA.108.114702; Zhou H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026744; Zhu H, 2008, CARDIOVASC TOXICOL, V8, P71, DOI 10.1007/s12012-008-9016-0	34	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53427	10.1371/journal.pone.0053427	http://dx.doi.org/10.1371/journal.pone.0053427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326427	Green Published, gold, Green Submitted			2022-12-25	WOS:000313551500071
J	Zhang, Z; Takeuchi, H; Gao, J; Wang, DG; James, DJ; Martin, TFJ; Hirata, M				Zhang, Zhao; Takeuchi, Hiroshi; Gao, Jing; Wang, DaGuang; James, Declan J.; Martin, Thomas F. J.; Hirata, Masato			PRIP (Phospholipase C-related but Catalytically Inactive Protein) Inhibits Exocytosis by Direct Interactions with Syntaxin 1 and SNAP-25 through Its C2 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; SNARE COMPLEX-FORMATION; MEMBRANE-FUSION; FUNCTIONAL DIVERSITY; PLASMA-MEMBRANE; VESICLE FUSION; BINDING; SYNAPTOTAGMIN; CA2+; SECRETION	Membrane fusion for exocytosis is mediated by SNAREs, forming trans-ternary complexes to bridge vesicle and target membranes. There is an array of accessory proteins that directly interact with and regulate SNARE proteins. PRIP (phospholipase C-related but catalytically inactive protein) is likely one of these proteins; PRIP, consisting of multiple functional modules including pleckstrin homology and C2 domains, inhibited exocytosis, probably via the binding to membrane phosphoinositides through the pleckstrin homology domain. However, the roles of the C2 domain have not yet been investigated. In this study, we found that the C2 domain of PRIP directly interacts with syntaxin 1 and SNAP-25 but not with VAMP2. The C2 domain promoted PRIP to co-localize with syntaxin 1 and SNAP-25 in PC12 cells. The binding profile of the C2 domain to SNAP-25 was comparable with that of synaptotagmin I, and PRIP inhibited synaptotagmin I in binding to SNAP-25 and syntaxin 1. It was also shown that the C2 domain was required for PRIP to suppress SDS-resistant ternary SNARE complex formation and inhibit high K+-induced noradrenalin release from PC12 cells. These results suggest that PRIP inhibits regulated exocytosis through the interaction of its C2 domain with syntaxin 1 and SNAP-25, potentially competing with other SNARE-binding, C2 domain-containing accessory proteins such as synaptotagmin I and by directly inhibiting trans-SNARE complex formation.	[Zhang, Zhao; Takeuchi, Hiroshi; Gao, Jing; Wang, DaGuang; Hirata, Masato] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 8128582, Japan; [Takeuchi, Hiroshi] Kyushu Dent Coll, Div Appl Pharmacol, Kitakyushu, Fukuoka 8038580, Japan; [Zhang, Zhao] Hebei Med Univ, Stomatol Hosp, Shijiazhuang 050017, Peoples R China; [James, Declan J.; Martin, Thomas F. J.] Univ Wisconsin Madison, Dept Biochem, Madison, WI 53706 USA	Kyushu University; Kyushu Dental University; Hebei Medical University; University of Wisconsin System; University of Wisconsin Madison	Takeuchi, H (corresponding author), Kyushu Dent Coll, Div Appl Pharmacol, Kitakyushu, Fukuoka 8038580, Japan.	r12takeuchi@fa.kyu-dent.ac.jp; hirata1@dent.kyushu-u.ac.jp	Takeuchi, Hiroshi/I-8849-2019	Takeuchi, Hiroshi/0000-0003-0033-2913	National Institutes of Health [DK025861]; Japan Society for the Promotion of Science KAKENHI [24592805, 23792127, 21249089, 23659782, 24229009]; Japanese Government; Hirose International Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025861, R01DK040428, R37DK025861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Government; Hirose International Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK025861 (to T. F. J. M). This work was also supported by Japan Society for the Promotion of Science KAKENHI Grants 24592805 (to H. T.), 23792127 (to J. G.), and 21249089, 23659782, and 24229009 (to M. H.).; Foreign graduate student supported by the Japanese Government.; Foreign graduate student supported by the Hirose International Scholarship.	Bai JH, 2004, NEURON, V41, P929, DOI 10.1016/S0896-6273(04)00117-5; Carr CM, 2010, CURR OPIN CELL BIOL, V22, P488, DOI 10.1016/j.ceb.2010.04.006; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Coudevylle N, 2008, J BIOL CHEM, V283, P35918, DOI 10.1074/jbc.M804094200; Czech MP, 2003, ANNU REV PHYSIOL, V65, P791, DOI 10.1146/annurev.physiol.65.092101.142522; Daily NJ, 2010, J BIOL CHEM, V285, P35320, DOI 10.1074/jbc.M110.145169; Deak F, 2006, EMBO J, V25, P2856, DOI 10.1038/sj.emboj.7601165; Doira N, 2001, BIOMED RES-TOKYO, V22, P157, DOI 10.2220/biomedres.22.157; Ellena JF, 2009, P NATL ACAD SCI USA, V106, P20306, DOI 10.1073/pnas.0908317106; Essen LO, 1997, BIOCHEMISTRY-US, V36, P2753, DOI 10.1021/bi962466t; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Friedrich R, 2008, J NEUROSCI, V28, P6794, DOI 10.1523/JNEUROSCI.0538-08.2008; Fujii M, 2010, J BIOL CHEM, V285, P4837, DOI 10.1074/jbc.M109.070045; Gao J, 2012, J BIOL CHEM, V287, P10565, DOI 10.1074/jbc.M111.294645; Gao J, 2010, ADV ENZYME REGUL, V50, P237, DOI 10.1016/j.advenzreg.2009.10.011; Gao J, 2009, CELL SIGNAL, V21, P1180, DOI 10.1016/j.cellsig.2009.03.008; HAY JC, 1993, NATURE, V366, P572, DOI 10.1038/366572a0; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; James DJ, 2009, P NATL ACAD SCI USA, V106, P17308, DOI 10.1073/pnas.0900755106; Kanematsu T, 1996, BIOCHEM J, V313, P319, DOI 10.1042/bj3130319; KANEMATSU T, 1992, J BIOL CHEM, V267, P6518; Kanematsu T, 2002, EMBO J, V21, P1004, DOI 10.1093/emboj/21.5.1004; Kanematsu T, 2007, J NEUROCHEM, V101, P898, DOI 10.1111/j.1471-4159.2006.04399.x; Kanematsu T, 2006, J BIOL CHEM, V281, P22180, DOI 10.1074/jbc.M603118200; Kubista H, 2004, J CELL SCI, V117, P955, DOI 10.1242/jcs.00941; Kwiatkowska K, 2010, CELL MOL LIFE SCI, V67, P3927, DOI 10.1007/s00018-010-0432-5; Lang T, 2002, J CELL BIOL, V158, P751, DOI 10.1083/jcb.200203088; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Masumoto T, 2012, MOL CELL NEUROSCI, V49, P1, DOI 10.1016/j.mcn.2011.09.007; Matsuda M, 2009, BIOL REPROD, V81, P681, DOI 10.1095/biolreprod.109.076760; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Ramakrishnan NA, 2009, J BIOL CHEM, V284, P1364, DOI 10.1074/jbc.M803605200; Rickman C, 2004, J BIOL CHEM, V279, P12574, DOI 10.1074/jbc.M310710200; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sugita S, 2008, ACTA PHYSIOL, V192, P185, DOI 10.1111/j.1748-1716.2007.01803.x; Sugiyama G, 2012, BIOCHEMISTRY-US, V51, P3394, DOI 10.1021/bi2018128; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takeuchi H, 2000, BIOCHEM J, V349, P357, DOI 10.1042/0264-6021:3490357; Takeuchi H, 1996, BIOCHEM J, V318, P561, DOI 10.1042/bj3180561; Takeuchi H, 2010, MOL CELL BIOL, V30, P1689, DOI 10.1128/MCB.01105-09; Tsuboi T, 2005, J BIOL CHEM, V280, P39253, DOI 10.1074/jbc.M507173200; Uji A, 2002, LIFE SCI, V72, P443, DOI 10.1016/S0024-3205(02)02275-0; Walter AM, 2011, TRENDS NEUROSCI, V34, P487, DOI 10.1016/j.tins.2011.07.003; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; YOSHIDA M, 1994, J BIOCHEM, V115, P973, DOI 10.1093/oxfordjournals.jbchem.a124447; Yoshimura K, 2001, J BIOL CHEM, V276, P17908, DOI 10.1074/jbc.M009677200	53	15	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7769	7780		10.1074/jbc.M112.419317	http://dx.doi.org/10.1074/jbc.M112.419317			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23341457	hybrid, Green Published			2022-12-25	WOS:000316455300032
J	Gillespie, JH				Gillespie, J. Hayley			Application of Stable Isotope Analysis to Study Temporal Changes in Foraging Ecology in a Highly Endangered Amphibian	PLOS ONE			English	Article							STREAM; TOO; SALAMANDERS; BACTERIA; CARBON; DIETS; CAVE	Background: Understanding dietary trends for endangered species may be essential to assessing the effects of ecological disturbances such as habitat modification, species introductions or global climate change. Documenting temporal variation in prey selection may also be crucial for understanding population dynamics. However, the rarity, secretive behaviours and obscure microhabitats of some endangered species can make direct foraging observations difficult or impossible. Furthermore, the lethality or invasiveness of some traditional methods of dietary analysis (e. g. gut contents analysis, gastric lavage) makes them inappropriate for such species. Stable isotope analysis facilitates non-lethal, indirect analysis of animal diet that has unrealized potential in the conservation of endangered organisms, particularly amphibians. Methodology/Findings: I determined proportional contributions of aquatic macroinvertebrate prey to the diet of an endangered aquatic salamander Eurycea sosorum over a two-year period using stable isotope analysis of C-13/12 and N-15/14 and the Bayesian stable isotope mixing model SIAR. I calculated Strauss' dietary electivity indices by comparing these proportions with changing relative abundance of potential prey species through time. Stable isotope analyses revealed that a previously unknown prey item (soft-bodied planarian flatworms in the genus Dugesia) made up the majority of E. sosorum diet. Results also demonstrate that E. sosorum is an opportunistic forager capable of diet switching to include a greater proportion of alternative prey when Dugesia populations decline. There is also evidence of intra-population dietary variation. Conclusions/Significance: Effective application of stable isotope analysis can help circumvent two key limitations commonly experienced by researchers of endangered species: the inability to directly observe these species in nature and the invasiveness or lethality of traditional methods of dietary analysis. This study illustrates the feasibility of stable isotope analysis in identifying preferred prey species that can be used to guide conservation management of both wild and captive food sources for endangered species.	Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Gillespie, JH (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	hayleygillespie@utexas.edu			Sigma Xi; Southwestern Association of Naturalists; Barton Springs Salamander Conservation Fund; Zoology Scholarship Endowment for Excellence; Dorothea Bennett Memorial Graduate Fellowship; Terrell H. Hamilton Endowed Graduate Fellowship at the University of Texas at Austin	Sigma Xi; Southwestern Association of Naturalists; Barton Springs Salamander Conservation Fund; Zoology Scholarship Endowment for Excellence; Dorothea Bennett Memorial Graduate Fellowship; Terrell H. Hamilton Endowed Graduate Fellowship at the University of Texas at Austin	This work was generously funded by a Sigma Xi Grant-In-Aid of Research (http://www.sigmaxi.org/programs/giar/index.shtml), a Howard McCarley Student Research Award from the Southwestern Association of Naturalists (http://biosurvey.ou.edu/swan/stuaeng.htm#_HOWARD_MCCARLEY), a grant from the Barton Springs Salamander Conservation Fund (administered by the City of Austin and Austin Community Foundation; http://www.austincommunityfoundation.org/?nd = news#Salamander) and grants from the Zoology Scholarship Endowment for Excellence, Dorothea Bennett Memorial Graduate Fellowship and Terrell H. Hamilton Endowed Graduate Fellowship at the University of Texas at Austin (http://www.biosci.utexas.edu/graduate/eeb/current.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altig R, 2007, FRESHWATER BIOL, V52, P386, DOI 10.1111/j.1365-2427.2006.01694.x; BOGART JP, 1967, THESIS U TEXAS AUSTI; Brey T, 2010, J SEA RES, V64, P334, DOI 10.1016/j.seares.2010.05.002; BRUNE G, 1981, SPRINGS TEXAS, V1; BURTON TM, 1975, COPEIA, P541; CHIPPINDALE PT, 1993, HERPETOLOGICA, V49, P248; Chippindale PT, 2000, HERPETOL MONOGR, V14, P1, DOI 10.2307/1467045; Church MR, 2009, CAN J FISH AQUAT SCI, V66, P1, DOI 10.1139/F08-206; COHN JP, 1994, BIOSCIENCE, V44, P219, DOI 10.2307/1312225; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Davic RD, 2004, ANNU REV ECOL EVOL S, V35, P405, DOI 10.1146/annurev.ecolsys.35.112202.130116; Deines P, 2007, ENVIRON MICROBIOL, V9, P1126, DOI 10.1111/j.1462-2920.2006.01235.x; Diaz Jr PH, 2010, THESIS TEXAS STATE U; EFFORD IE, 1973, T AM FISH SOC, V102, P33, DOI 10.1577/1548-8659(1973)102<33:ACOTFO>2.0.CO;2; ENGLISH WR, 1987, ENTOMOL NEWS, V98, P171; Fenolio DB, 2006, P ROY SOC B-BIOL SCI, V273, P439, DOI 10.1098/rspb.2005.3341; Fenolio DB, 2005, SOUTHWEST NAT, V50, P385, DOI 10.1894/0038-4909(2005)050[0385:SMPOPF]2.0.CO;2; Finlay JC, 2007, ECOLOGY, V88, P2187, DOI 10.1890/06-0344.1; FRASER DF, 1976, ECOLOGY, V57, P459, DOI 10.2307/1936431; Gerking SD., 2014, FEEDING ECOLOGY FISH; Hart DD, 1998, OECOLOGIA, V114, P263, DOI 10.1007/s004420050445; Hester F.E., 1962, T AM FISH SOC, V91, P420, DOI [10.1577/1548-8659(1962)91[420:AMSFAM]2.0.CO;2, DOI 10.1577/1548-8659(1962)91]; Hubbs C, 1995, COPEIA, P989, DOI 10.2307/1447053; Inger R, 2006, J ANIM ECOL, V75, P1190, DOI 10.1111/j.1365-2656.2006.01142.x; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; Jardine T D, 2003, CAN MANUSCR REP FISH, P39; Jones RI, 2008, ECOLOGY, V89, P857, DOI 10.1890/06-2010.1; Kamil A. C., 1981, FORAGING BEHAV ECOLO; Kohzu A, 2004, AQUAT MICROB ECOL, V36, P189, DOI 10.3354/ame036189; Kolasa J, 2010, AQUAT ECOL SER, P143, DOI 10.1016/B978-0-12-374855-3.00006-6; Limbacher & Godfrey Architects, 2008, BART SPRINGS POOL MA; Lowe WH, 2005, BIOSCIENCE, V55, P196, DOI 10.1641/0006-3568(2005)055[0196:MHSTTH]2.0.CO;2; MACAN TT, 1977, BIOL REV, V52, P45, DOI 10.1111/j.1469-185X.1977.tb01345.x; McCue MD, 2008, RAPID COMMUN MASS SP, V22, P2307, DOI 10.1002/rcm.3615; McKechnie AE, 2004, S AFR J SCI, V100, P131; Najera-Hillman E, 2009, NEW ZEAL J ZOOL, V36, P165, DOI 10.1080/03014220909510149; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Pilgrim M.A., 2005, THESIS U ARKANSAS US; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Ramos R, 2011, DIVERS DISTRIB, V17, P338, DOI 10.1111/j.1472-4642.2010.00736.x; Romero GQ, 2010, OECOLOGIA, V162, P941, DOI 10.1007/s00442-009-1533-4; Schmidt O, 1999, OECOLOGIA, V118, P9, DOI 10.1007/s004420050697; Singer MC, 2000, ECOL LETT, V3, P159; STRAUSS RE, 1979, T AM FISH SOC, V108, P344, DOI 10.1577/1548-8659(1979)108<344:REFIEI>2.0.CO;2; US Fish and Wildlife Service, 2005, BART SPRINGS SAL EUR; Verburg P, 2007, J TROP ECOL, V23, P643, DOI 10.1017/S0266467407004518; Whiles MR, 2006, FRONT ECOL ENVIRON, V4, P27, DOI 10.1890/1540-9295(2006)004[0027:TEOAPD]2.0.CO;2; Zambrano L, 2010, BIOL INVASIONS, V12, P3061, DOI 10.1007/s10530-010-9697-8	49	30	31	0	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53041	10.1371/journal.pone.0053041	http://dx.doi.org/10.1371/journal.pone.0053041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23341920	Green Published, Green Submitted, gold			2022-12-25	WOS:000314707700011
J	Basile, V; Belluti, S; Ferrari, E; Gozzoli, C; Ganassi, S; Quaglino, D; Saladini, M; Imbriano, C				Basile, Valentina; Belluti, Silvia; Ferrari, Erika; Gozzoli, Chiara; Ganassi, Sonia; Quaglino, Daniela; Saladini, Monica; Imbriano, Carol			bis-Dehydroxy-Curcumin Triggers Mitochondrial-Associated Cell Death in Human Colon Cancer Cells through ER-Stress Induced Autophagy	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; BCL-2 FAMILY-MEMBERS; INDUCED APOPTOSIS; SIGNALING PATHWAYS; COLORECTAL-CANCER; GENE-EXPRESSION; UP-REGULATION; IN-VITRO; NF-Y; ACTIVATION	Background: The activation of autophagy has been extensively described as a pro-survival strategy, which helps to keep cells alive following deprivation of nutrients/growth factors and other stressful cellular conditions. In addition to cytoprotective effects, autophagy can accompany cell death. Autophagic vacuoles can be observed before or during cell death, but the role of autophagy in the death process is still controversial. A complex interplay between autophagy and apoptosis has come to light, taking into account that numerous genes, such as p53 and Bcl-2 family members, are shared between these two pathways. Methodology/Principal Findings: In this study we showed a potent and irreversible cytotoxic activity of the stable Curcumin derivative bis-DeHydroxyCurcumin (bDHC) on human colon cancer cells, but not on human normal cells. Autophagy is elicited by bDHC before cell death as demonstrated by increased autophagosome formation -measured by electron microscopy, fluorescent LC3 puncta and LC3 lipidation- and autophagic flux -measured by interfering LC3-II turnover. The accumulation of poly-ubiquitinated proteins and ER-stress occurred upstream of autophagy induction and resulted in cell death. Cell cycle and Western blot analyses highlighted the activation of a mitochondrial-dependent apoptosis, which involves caspase 7, 8, 9 and Cytochrome C release. Using pharmacological inhibitions and RNAi experiments, we showed that ER-stress induced autophagy has a major role in triggering bDHC-cell death. Conclusion/Significance: Our findings describe the mechanism through which bDHC promotes tumor selective inhibition of proliferation, providing unequivocal evidence of the role of autophagy in contrasting the proliferation of colon cancer cells.	[Basile, Valentina; Belluti, Silvia; Gozzoli, Chiara; Ganassi, Sonia; Quaglino, Daniela; Imbriano, Carol] Univ Modena & Reggio Emilia, Dipartimento Sci Vita, Modena, Italy; [Ferrari, Erika; Saladini, Monica] Univ Modena & Reggio Emilia, Dipartimento Sci Chim & Geol, Modena, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia	Imbriano, C (corresponding author), Univ Modena & Reggio Emilia, Dipartimento Sci Vita, Via Campi 213-D, Modena, Italy.	cimbriano@unimo.it	Quaglino, Daniela/A-9381-2010; Saladini, Monica/N-8596-2015; Imbriano, Carol/ABD-8204-2021; BELLUTI, SILVIA/AAU-2625-2020; Ferrari, Erika/F-7742-2012; Basile, Valentina/S-3828-2016; Imbriano, Carol/C-9376-2015	Quaglino, Daniela/0000-0002-4302-5078; Saladini, Monica/0000-0003-2515-8317; Imbriano, Carol/0000-0003-2864-4820; BELLUTI, SILVIA/0000-0003-0846-9359; Ferrari, Erika/0000-0001-7627-2502; Basile, Valentina/0000-0003-3151-1228; Imbriano, Carol/0000-0003-2864-4820; Ganassi, Sonia/0000-0003-2518-7628	Associazione Italiana per la Ricerca sul Cancro-MFAG [6192]; Fondazione Cassa di Risparmio di Vignola	Associazione Italiana per la Ricerca sul Cancro-MFAG(Fondazione AIRC per la ricerca sul cancro); Fondazione Cassa di Risparmio di Vignola	This work was supported by Associazione Italiana per la Ricerca sul Cancro-MFAG (grant number 6192 to CI) and Fondazione Cassa di Risparmio di Vignola to CI and EF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Anand P, 2008, CANCER LETT, V267, P133, DOI 10.1016/j.canlet.2008.03.025; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Baliga B, 2003, CELL DEATH DIFFER, V10, P16, DOI 10.1038/sj.cdd.4401166; Baritaud M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.120; Basile V, 2006, J BIOL CHEM, V281, P2347, DOI 10.1074/jbc.M507712200; Basile V, 2009, BIOCHEM PHARMACOL, V78, P1305, DOI 10.1016/j.bcp.2009.06.105; Benatti P, 2008, NUCLEIC ACIDS RES, V36, P1415, DOI 10.1093/nar/gkm1046; Benatti P, 2011, NUCLEIC ACIDS RES, V39, P5356, DOI 10.1093/nar/gkr128; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; Bielak-Zmijewska A, 2004, CANCER CHEMOTH PHARM, V53, P179, DOI 10.1007/s00280-003-0705-x; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Bush JA, 2001, EXP CELL RES, V271, P305, DOI 10.1006/excr.2001.5381; Chen A, 2006, ONCOGENE, V25, P278, DOI [10.1038/sj.onc.1209019, 10.1038/sj.onc.1209573]; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; Cuervo AM, 2012, MOL ASPECTS MED, V33, P2, DOI 10.1016/j.mam.2011.09.001; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Donati G, 2006, NUCLEIC ACIDS RES, V34, P3116, DOI 10.1093/nar/gkl304; Donovan M, 2004, BBA-MOL CELL RES, V1644, P133, DOI 10.1016/j.bbamcr.2003.08.011; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Eskelinen EL, 2005, CELL DEATH DIFFER, V12, P1468, DOI 10.1038/sj.cdd.4401721; Faitova J, 2006, CELL MOL BIOL LETT, V11, P488, DOI 10.2478/s11658-006-0040-4; Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Ferrari E, 2011, J MED CHEM, V54, P8066, DOI 10.1021/jm200872q; Fuchs JR, 2009, BIOORG MED CHEM LETT, V19, P2065, DOI 10.1016/j.bmcl.2009.01.104; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; He ZY, 2011, CANCER INVEST, V29, P208, DOI 10.3109/07357907.2010.550592; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Ireson CR, 2002, CANCER EPIDEM BIOMAR, V11, P105; Jiang ZH, 2010, MOL CANCER THER, V9, P558, DOI 10.1158/1535-7163.MCT-09-0627; Jullig M, 2006, APOPTOSIS, V11, P627, DOI 10.1007/s10495-006-4990-9; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; Milacic V, 2008, CANCER RES, V68, P7283, DOI 10.1158/0008-5472.CAN-07-6246; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Moragoda L, 2001, ANTICANCER RES, V21, P873; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nardo L, 2012, J PHYS CHEM A, V116, P9321, DOI 10.1021/jp307928a; Ng APP, 2011, MOL CANCER RES, V9, P878, DOI 10.1158/1541-7786.MCR-10-0545; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Paglin S, 2001, CANCER RES, V61, P439; Pallauf K, 2012, AGEING RES REV; Priault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008755; Qin JZ, 2005, CANCER RES, V65, P6282, DOI 10.1158/0008-5472.CAN-05-0676; Ramachandran C, 2005, ANTICANCER RES, V25, P3293; Ravindran J, 2009, AAPS J, V11, P495, DOI 10.1208/s12248-009-9128-x; Reimertz C, 2003, J CELL BIOL, V162, P587, DOI 10.1083/jcb.200305149; Reuter S, 2008, BIOCHEM PHARMACOL, V76, P1340, DOI 10.1016/j.bcp.2008.07.031; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rosati E, 2010, BLOOD, V116, P2713, DOI 10.1182/blood-2010-03-275628; Singletary K, 2008, CANCER EPIDEM BIOMAR, V17, P1596, DOI 10.1158/1055-9965.EPI-07-2917; Speidel D, 2010, TRENDS CELL BIOL, V20, P14, DOI 10.1016/j.tcb.2009.10.002; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Verfaillie T, 2010, INT J CELL BIOL, V2010; Wang L, 2011, MOL CANCER THER, V10, P461, DOI 10.1158/1535-7163.MCT-10-0812; Wu JC, 2011, MOL NUTR FOOD RES, V55, P1646, DOI 10.1002/mnfr.201100454; Wu SH, 2010, ANTICANCER RES, V30, P2125; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yoon MJ, 2010, FREE RADICAL BIO MED, V48, P713, DOI 10.1016/j.freeradbiomed.2009.12.016; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zhang X, 2012, CELL PROLIFERAT, V45, P466, DOI 10.1111/j.1365-2184.2012.00833.x; Zhuang W, 2011, CANCER SCI, V103, P684	87	48	51	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53664	10.1371/journal.pone.0053664	http://dx.doi.org/10.1371/journal.pone.0053664			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326480	Green Published, Green Submitted, gold			2022-12-25	WOS:000314705800067
J	Iriemenam, NC; Pandey, JP; Williamson, J; Blackstock, AJ; Yesupriya, A; Namboodiri, AM; Rocca, KM; van Eijk, AM; Ayisi, J; Oteino, J; Lal, RB; ter Kuile, FO; Steketee, R; Nahlen, B; Slutsker, L; Shi, YP				Iriemenam, Nnaemeka C.; Pandey, Janardan P.; Williamson, John; Blackstock, Anna J.; Yesupriya, Ajay; Namboodiri, Aryan M.; Rocca, Keith M.; van Eijk, Anna Maria; Ayisi, John; Oteino, Juliana; Lal, Renu B.; ter Kuile, Feiko O.; Steketee, Richard; Nahlen, Bernard; Slutsker, Laurence; Shi, Ya Ping			Association between Immunoglobulin GM and KM Genotypes and Placental Malaria in HIV-1 Negative and Positive Women in Western Kenya	PLOS ONE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; CHONDROITIN SULFATE-A; PLASMODIUM-FALCIPARUM; ANTIBODY-RESPONSES; KM ALLOTYPES; HEAVY-CHAIN; PREGNANCY; BURDEN; SUSCEPTIBILITY; PHAGOCYTOSIS	Immunoglobulin (Ig) GM and KM allotypes, genetic markers of gamma and kappa chains, are associated with humoral immune responsiveness. Previous studies have shown the relationships between GM6-carrying haplotypes and susceptibility to malaria infection in children and adults; however, the role of the genetic markers in placental malaria (PM) infection and PM with HIV co-infection during pregnancy has not been investigated. We examined the relationship between the gene polymorphisms of Ig GM6 and KM allotypes and the risk of PM infection in pregnant women with known HIV status. DNA samples from 728 pregnant women were genotyped for GM6 and KM alleles using polymerase chain reaction-restriction fragment length polymorphism method. Individual GM6 and KM genotypes and the combined GM6 and KM genotypes were assessed in relation to PM in HIV-1 negative and positive women, respectively. There was no significant effect of individual GM6 and KM genotypes on the risk of PM infection in HIV-1 negative and positive women. However, the combination of homozygosity for GM6(+) and KM3 was associated with decreased risk of PM (adjusted OR, 0.25; 95% CI, 0.08-0.8; P = 0.019) in HIV-1 negative women while in HIV-1 positive women the combination of GM6(+/-) with either KM1-3 or KM1 was associated with increased risk of PM infection (adjusted OR, 2.10; 95% CI, 1.18-3.73; P = 0.011). Hardy-Weinberg Equilibrium (HWE) tests further showed an overall significant positive F(is) (indication of deficit in heterozygotes) for GM6 while there was no deviation for KM genotype frequency from HWE in the same population. These findings suggest that the combination of homozygous GM6(+) and KM3 may protect against PM in HIV-1 negative women while the HIV-1 positive women with heterozygous GM6(+/-) combined with KM1-3 or KM1 may be more susceptible to PM infection. The deficit in heterozygotes for GM6 further suggests that GM6 could be under selection likely by malaria infection.	[Iriemenam, Nnaemeka C.; Williamson, John; Blackstock, Anna J.; Steketee, Richard; Nahlen, Bernard; Slutsker, Laurence; Shi, Ya Ping] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA; [Pandey, Janardan P.; Namboodiri, Aryan M.; Rocca, Keith M.] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Blackstock, Anna J.] Vet Affairs Med Ctr, Atlanta Res & Educ Fdn, Decatur, GA 30033 USA; [Yesupriya, Ajay] Ctr Dis Control & Prevent, Natl Off Publ Hlth Genom, Coordinating Ctr Hlth Promot, Atlanta, GA USA; [van Eijk, Anna Maria; Ayisi, John] Kenya Govt Med Res Ctr, Ctr Vector Biol & Control Res, Kisumu, Kenya; [Oteino, Juliana] Minist Hlth, New Nyanza Prov Gen Hosp, Kisumu, Kenya; [Lal, Renu B.] Ctr Dis Control & Prevent, Div AIDS STD TB Lab Res, Natl Ctr HIV STD TB Prevent, Atlanta, GA USA; [ter Kuile, Feiko O.] Univ Liverpool, Liverpool Sch Trop Med, Child & Reprod Hlth Grp, Liverpool L3 5QA, Merseyside, England	Centers for Disease Control & Prevention - USA; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; Liverpool School of Tropical Medicine; University of Liverpool	Pandey, JP (corresponding author), Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA.	pandeyj@musc.edu; yps0@cdc.gov	Nahlen, Bernard/AAH-2051-2021; van Eijk, Anna Maria/AAQ-9894-2021; Kuile, Feiko ter/ABD-6681-2020	Kuile, Feiko ter/0000-0003-3663-5617; van Eijk, Anna Maria/0000-0003-1635-1289	National Office of Public Health Genomics, Centers for Disease Control and Prevention [92129RQ]; American Society for Microbiology (ASM); Centers for Disease Control and Prevention (CDC) (ASM/CDC)	National Office of Public Health Genomics, Centers for Disease Control and Prevention; American Society for Microbiology (ASM); Centers for Disease Control and Prevention (CDC) (ASM/CDC)	This study was supported by intramural funding from The National Office of Public Health Genomics, Centers for Disease Control and Prevention (Project ID# 92129RQ). NCI was supported by the American Society for Microbiology (ASM) and Centers for Disease Control and Prevention (CDC) Postdoctoral Fellowship (ASM/CDC Research Fellowship Program). The funders had no role in study design, data collection, and decision to publish, or preparation of the manuscript except for AY, a statistician, from the National Office of Public Health Genomics, CDC assisting in data analysis.	ALLISON AC, 1961, ANN NY ACAD SCI, V91, P710, DOI 10.1111/j.1749-6632.1961.tb31102.x; Alvarez G, 2008, GENET RES, V90, P209, DOI 10.1017/S0016672307009068; Ayisi JG, 2004, EMERG INFECT DIS, V10, P643, DOI 10.3201/eid1004.030303; Ayisi JG, 2003, J INFECTION, V46, P164, DOI 10.1053/jinf.2002.1088; BALLARD JL, 1979, J PEDIATR-US, V95, P769, DOI 10.1016/S0022-3476(79)80734-9; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Brouwer KC, 2004, J INFECT DIS, V190, P1192, DOI 10.1086/422850; BULMER JN, 1993, HISTOPATHOLOGY, V22, P211, DOI 10.1111/j.1365-2559.1993.tb00110.x; Czerwinski M, 1998, J IMMUNOL, V160, P4406; Dard P, 2001, EUR J HUM GENET, V9, P765, DOI 10.1038/sj.ejhg.5200700; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; DRUILHE P, 1987, INFECT IMMUN, V55, P888, DOI 10.1128/IAI.55.4.888-891.1987; Duffy PE, 2005, CURR TOP MICROBIOL, V295, P169; Giha HA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-306; GRUBB R, 1995, EXP CLIN IMMUNOGENET, V12, P191; Hedrick P. W., 2011, GENETICS POPULATIONS; Hviid L, 2010, HUM VACCINES, V6, P84, DOI 10.4161/hv.6.1.9602; Joos C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009871; Juompan L, 1998, APPL BIOCHEM BIOTECH, V75, P139, DOI 10.1007/BF02787714; Keen J, 2007, PLOS MED, V4, P912, DOI 10.1371/journal.pmed.0040181; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lachance J, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-15; Lee WC, 2003, AM J EPIDEMIOL, V158, P397, DOI 10.1093/aje/kwg150; Maubert B, 1999, INFECT IMMUN, V67, P5367, DOI 10.1128/IAI.67.10.5367-5371.1999; MENENDEZ C, 1995, PARASITOL TODAY, V11, P178, DOI 10.1016/0169-4758(95)80151-0; Menendez C, 2007, LANCET INFECT DIS, V7, P126, DOI 10.1016/S1473-3099(07)70024-5; Migot-Nabias F, 2008, J INFECT DIS, V198, P1892, DOI 10.1086/593210; Migot-Nabias F, 2011, MICROBES INFECT, V13, P771, DOI 10.1016/j.micinf.2011.04.001; Mount AM, 2004, LANCET, V363, P1860, DOI 10.1016/S0140-6736(04)16354-X; MOXLEY G, 1992, GENOMICS, V13, P104, DOI 10.1016/0888-7543(92)90208-A; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Pandey JP, 2007, PARASITE IMMUNOL, V29, P267, DOI 10.1111/j.1365-3024.2007.00938.x; Pandey JP, 2006, SCIENCE, V311, P1376; Pandey JP, 2004, J VIROL, V78, P4561, DOI 10.1128/JVI.78.9.4561-4565.2004; PANDEY JP, 1984, J IMMUNOGENET, V11, P159; Pandey JP, 2000, VACCINE, V19, P613, DOI 10.1016/S0264-410X(00)00255-3; Pozzoli U, 2010, TRENDS GENET, V26, P95, DOI 10.1016/j.tig.2009.12.010; STEINBERG AC, 1981, DISTRIBUTION HUMAN I; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Taylor DW, 2004, INFECT IMMUN, V72, P1603, DOI 10.1128/IAI.72.3.1603-1607.2004; Tebo AE, 2002, CLIN EXP IMMUNOL, V130, P300, DOI 10.1046/j.1365-2249.2002.01972.x; Ter Kuile FO, 2004, AM J TROP MED HYG, V71, P41, DOI 10.4269/ajtmh.2004.71.41; Torres M, 2007, J BIOL CHEM, V282, P13917, DOI 10.1074/jbc.M700661200; WACHSMUTH RR, 1987, EXP CLIN IMMUNOGENET, V4, P163; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Wittke-Thompson JK, 2005, AM J HUM GENET, V76, P967, DOI 10.1086/430507	47	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53948	10.1371/journal.pone.0053948	http://dx.doi.org/10.1371/journal.pone.0053948			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326546	Green Published, Green Accepted, gold			2022-12-25	WOS:000314705800092
J	Kanamaru, T; Fujii, H; Aihara, K				Kanamaru, Takashi; Fujii, Hiroshi; Aihara, Kazuyuki			Deformation of Attractor Landscape via Cholinergic Presynaptic Modulations: A Computational Study Using a Phase Neuron Model	PLOS ONE			English	Article							INHIBITORY CONNECTIONS; SYNAPTIC-TRANSMISSION; VISUAL-CORTEX; SENSORY RESPONSES; MEMORY RETRIEVAL; PARIETAL CORTEX; EPISODIC MEMORY; NETWORK MODEL; GABA RELEASE; ACETYLCHOLINE	Corticopetal acetylcholine (ACh) is released transiently from the nucleus basalis of Meynert (NBM) into the cortical layers and is associated with top-down attention. Recent experimental data suggest that this release of ACh disinhibits layer 2/3 pyramidal neurons (PYRs) via muscarinic presynaptic effects on inhibitory synapses. Together with other possible presynaptic cholinergic effects on excitatory synapses, this may result in dynamic and temporal modifications of synapses associated with top-down attention. However, the system-level consequences and cognitive relevance of such disinhibitions are poorly understood. Herein, we propose a theoretical possibility that such transient modifications of connectivity associated with ACh release, in addition to top-down glutamatergic input, may provide a neural mechanism for the temporal reactivation of attractors as neural correlates of memories. With baseline levels of ACh, the brain returns to quasi-attractor states, exhibiting transitive dynamics between several intrinsic internal states. This suggests that top-down attention may cause the attention-induced deformations between two types of attractor landscapes: the quasi-attractor landscape (Q-landscape, present under low-ACh, non-attentional conditions) and the attractor landscape (A-landscape, present under high-ACh, top-down attentional conditions). We present a conceptual computational model based on experimental knowledge of the structure of PYRs and interneurons (INs) in cortical layers 1 and 2/3 and discuss the possible physiological implications of our results.	[Kanamaru, Takashi] Kogakuin Univ, Dept Innovat Mech Engn, Tokyo, Japan; [Fujii, Hiroshi] Kyoto Sangyo Univ, Dept Intelligent Syst, Kyoto 603, Japan; [Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Tokyo, Japan	Kogakuin University; Kyoto Sangyo University; University of Tokyo	Kanamaru, T (corresponding author), Kogakuin Univ, Dept Innovat Mech Engn, Tokyo, Japan.	kanamaru@cc.kogakuin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [20700215, 4103, 21120002, 20246026]; Aihara Project; Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy (CSTP)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Aihara Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP))	The first author (TK) was supported by a Grant-in-Aid for Encouragement of Young Scientists (B) (No. 20700215) from The Ministry of Education, Culture, Sports, Science and Technology of Japan. The second author (HF) was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "The study on the neural dynamics for understanding communication in terms of complex hetero systems (No. 4103)" (21120002) from The Ministry of Education, Culture, Sports, Science and Technology of Japan. The third author (KA) was supported by a Grant-in-Aid for Scientific Research (A) (No. 20246026) from The Ministry of Education, Culture, Sports, Science and Technology of Japan. This research was also partially supported by the Aihara Project, the Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST) from the Japan Society for the Promotion of Science (JSPS), initiated by the Council for Science and Technology Policy (CSTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1997, NEURAL NETWORKS, V10, P83, DOI 10.1016/S0893-6080(96)00061-5; AIHARA K, 1990, PHYS LETT A, V144, P333, DOI 10.1016/0375-9601(90)90136-C; AIHARA K, 1984, J THEOR BIOL, V109, P249, DOI 10.1016/S0022-5193(84)80005-3; AIHARA K, 1986, PHYS LETT A, V116, P313, DOI 10.1016/0375-9601(86)90578-5; Aihara K, 1990, ADV SERIES DYNAMICAL, V8, P143; ARIELI A, 1995, J NEUROPHYSIOL, V73, P2072, DOI 10.1152/jn.1995.73.5.2072; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; BARBAS H, 1995, NEUROSCI BIOBEHAV R, V19, P499, DOI 10.1016/0149-7634(94)00053-4; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; Buno W, 2006, J MOL NEUROSCI, V30, P161, DOI 10.1385/JMN:30:1:161; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; CHEN LN, 1995, NEURAL NETWORKS, V8, P915, DOI 10.1016/0893-6080(95)00033-V; Christophe E, 2002, J NEUROPHYSIOL, V88, P1318, DOI 10.1152/jn.2002.88.3.1318; Ciaramelli E, 2008, NEUROPSYCHOLOGIA, V46, P1828, DOI 10.1016/j.neuropsychologia.2008.03.022; Daelli V, 2010, EXP BRAIN RES, V203, P241, DOI 10.1007/s00221-010-2243-1; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; Feudel U, 2000, CHAOS, V10, P231, DOI 10.1063/1.166488; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Fujii H, 2011, ADV COGNITIVE NEUROD, VII, P79; Fujii H, 2008, LECT NOTES COMPUT SC, V4984, P170; Fujii H, 2008, ADVANCES IN COGNITIVE NEURODYNAMICS, PROCEEDINGS, P249, DOI 10.1007/978-1-4020-8387-7_44; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Golmayo L, 2003, NEUROSCIENCE, V119, P597, DOI 10.1016/S0306-4522(03)00031-9; Gulledge AT, 2007, J NEUROPHYSIOL, V97, P2215, DOI 10.1152/jn.00493.2006; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; HAYASHI H, 1982, PHYS LETT A, V88, P435, DOI 10.1016/0375-9601(82)90674-0; Hess G, 1999, EXP BRAIN RES, V127, P279, DOI 10.1007/s002210050797; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Hsieh CY, 2000, BRAIN RES, V880, P51, DOI 10.1016/S0006-8993(00)02766-9; INOUE M, 1991, PHYS LETT A, V158, P373, DOI 10.1016/0375-9601(91)90677-Z; Ishai A, 2002, NEUROIMAGE, V17, P1729, DOI 10.1006/nimg.2002.1330; Izhikevich EM, 2000, INT J BIFURCAT CHAOS, V10, P1171, DOI 10.1142/S0218127400000840; Izhikevich EM, 1999, IEEE T NEURAL NETWOR, V10, P499, DOI 10.1109/72.761707; Kanamaru T, 2005, NEURAL COMPUT, V17, P1315, DOI 10.1162/0899766053630387; Kanamaru T, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031916; Kanamaru T, 2004, IEEE T NEURAL NETWOR, V15, P1009, DOI 10.1109/TNN.2004.832715; Kanamaru T, 2008, NEURAL COMPUT, V20, P1951, DOI 10.1162/neco.2008.05-07-516; Kanamaru T, 2007, NEURAL NETWORKS, V20, P781, DOI 10.1016/j.neunet.2007.06.002; Kanamaru T, 2006, INT J BIFURCAT CHAOS, V16, P3309, DOI 10.1142/S021812740601680X; Kanamaru T, 2006, NEURAL COMPUT, V18, P1111, DOI 10.1162/neco.2006.18.5.1111; Kastner S, 2001, NEUROPSYCHOLOGIA, V39, P1263, DOI 10.1016/S0028-3932(01)00116-6; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kimura F, 1999, EUR J NEUROSCI, V11, P3597, DOI 10.1046/j.1460-9568.1999.00779.x; Klein I, 2000, J COGNITIVE NEUROSCI, V12, P15, DOI 10.1162/089892900564037; Kosslyn SM, 2005, COGN NEUROPSYCHOL, V22, P333, DOI 10.1080/02643290442000130; Kruglikov I, 2008, NEURON, V58, P911, DOI 10.1016/j.neuron.2008.04.024; Kuczewski N, 2005, J PHYSIOL-LONDON, V566, P907, DOI 10.1113/jphysiol.2005.089987; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Kurashige H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024007; Kuroiwa J, 2004, INT J BIFURCAT CHAOS, V14, P1413, DOI 10.1142/S0218127404009867; Levy RB, 2006, J NEUROPHYSIOL, V95, P2155, DOI 10.1152/jn.00603.2005; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Matsumoto G., 1984, J THEOR NEUROBIOL, V3, P1; METHERATE R, 1992, J NEUROSCI, V12, P4701; MILNOR J, 1985, COMMUN MATH PHYS, V99, P177, DOI 10.1007/BF01212280; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; NARA S, 1995, INT J BIFURCAT CHAOS, V5, P1205, DOI 10.1142/S0218127495000867; NARA S, 1992, PROG THEOR PHYS, V88, P845, DOI 10.1143/PTP.88.845; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; PERRY EK, 1995, BRAIN COGNITION, V28, P240, DOI 10.1006/brcg.1995.1255; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Rempel-Clower NL, 2000, CEREB CORTEX, V10, P851, DOI 10.1093/cercor/10.9.851; Ringach DL, 2003, NATURE, V425, P912, DOI 10.1038/425912a; Rodriguez A, 2004, J COGNITIVE NEUROSCI, V16, P856, DOI 10.1162/089892904970690; Rumelhart D.E., 1986, PARALLEL DISTRIBUTED, V1; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Salgado H, 2007, J NEUROPHYSIOL, V98, P952, DOI 10.1152/jn.00060.2007; Thompson KA, 2005, ABA J, V91, P25; Tokuda I, 1997, NEURAL NETWORKS, V10, P1673, DOI 10.1016/S0893-6080(97)00023-3; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; TSUDA I, 1987, PROG THEOR PHYS, V78, P51, DOI 10.1143/PTP.78.51; TSUDA I, 1992, NEURAL NETWORKS, V5, P313, DOI 10.1016/S0893-6080(05)80029-2; Tsuda I, 1991, WORLD FUTURES, V32, P167, DOI [DOI 10.1080/02604027.1991.9972257, 10.1080/02604027.1991.9972257]; Tsuda Ichiro, 2004, Journal of Integrative Neuroscience, V3, P159, DOI 10.1142/S021963520400049X; Turrini P, 2001, NEUROSCIENCE, V105, P277, DOI 10.1016/S0306-4522(01)00172-5; Uchiyama S, 2004, CHAOS, V14, P699, DOI 10.1063/1.1785612; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Varona P, 2001, NEURAL NETWORKS, V14, P865, DOI 10.1016/S0893-6080(01)00046-6; Vecera S. P., 2000, BRAIN MIND, V1, P353, DOI [10.1023/A:1011565623996, DOI 10.1023/A:1011565623996, 10.1023/A]; VONDERMALSBURG C, 1981, CORRELATION THEORY B, P81; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Wang XJ, 2004, P NATL ACAD SCI USA, V101, P1368, DOI 10.1073/pnas.0305337101; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2; Yu AJ, 2002, NEURAL NETWORKS, V15, P719, DOI 10.1016/S0893-6080(02)00058-8	92	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53854	10.1371/journal.pone.0053854	http://dx.doi.org/10.1371/journal.pone.0053854			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326520	Green Submitted, Green Published, gold			2022-12-25	WOS:000314705800081
J	O'Neill, SC; DeFrank, JT; Vegella, P; Richman, AR; Henry, LR; Carey, LA; Brewer, NT				O'Neill, Suzanne C.; DeFrank, Jessica T.; Vegella, Patti; Richman, Alice R.; Henry, Leonard R.; Carey, Lisa A.; Brewer, Noel T.			Engaging in Health Behaviors to Lower Risk for Breast Cancer Recurrence	PLOS ONE			English	Article							QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; BLACK-WOMEN; WEIGHT-LOSS; SURVIVORS; ASSOCIATIONS; INTERVENTION; NUTRITION; ADHERENCE; OUTCOMES	Purpose: While post-treatment breast cancer survivors face up to twice the cancer risk of the general population, modifiable health behaviors may somewhat reduce this risk. We sought to better understand health behaviors that early stage breast cancer survivors engage in to reduce recurrence risk. Methods: Data came from a cross-sectional multi-site survey of 186 early-stage breast cancer survivors who received genomic testing for breast cancer recurrence risk (Oncotype DX) during their clinical care. Study outcomes were meeting health behavior recommendations (daily fruit and vegetable intake, regular physical activity, and having a healthy body mass index (BMI)). Results: Approximately three-quarters of survivors we surveyed believed the 3 behaviors might reduce their cancer risk but many did not engage in these behaviors for this purpose: 62% for BMI, 36% for fruit and vegetable consumption, and 37% for physical activity. Survivors with higher recurrence risk, as indicated by their genomic test results, were no more likely to meet any of the three health behavior recommendations. Adherence to health behavior recommendations was higher for women who were white, college-educated, and had higher incomes. Conclusions: Many nonadherent breast cancer survivors wish to use these behavioral strategies to reduce their risk for recurrence, suggesting an important opportunity for intervention. Improving BMI, which has the largest association with cancer risk, is an especially promising target.	[O'Neill, Suzanne C.; Vegella, Patti] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA; [DeFrank, Jessica T.; Brewer, Noel T.] Univ N Carolina, Dept Hlth Behav, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Richman, Alice R.] E Carolina Univ, Coll Hlth & Human Performance, Dept Hlth Educ & Promot, Greenville, NC USA; [Henry, Leonard R.] Indiana Univ Hlth, Goshen Ctr Canc Care, Goshen, IN USA; [Carey, Lisa A.; Brewer, Noel T.] UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA	Georgetown University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; East Carolina University; Indiana University System; University of North Carolina; University of North Carolina Chapel Hill	O'Neill, SC (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA.	sco4@georgetown.edu	Brewer, Noel T/C-4375-2008	Brewer, Noel T/0000-0003-2241-7002	American Cancer Society [MSRG-06-259-01-CPPB, MSRG-10-110-01-CPPB, 97-152-04]; National Cancer Institute [P30CA051008]; UNC Cancer Care and Quality Training Program (NCI R25 Grant) [CA116339]; NATIONAL CANCER INSTITUTE [P30CA016086, R25CA116339] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UNC Cancer Care and Quality Training Program (NCI R25 Grant); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial support was provided by grants MSRG-06-259-01-CPPB (NTB), MSRG-10-110-01-CPPB (SCO), and 97-152-04 (Georgetown University) from the American Cancer Society. The project was also supported, in part, by Award Number P30CA051008 from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. At the time of this research, Jessica T. DeFrank was funded by the UNC Cancer Care and Quality Training Program (NCI R25 Grant, CA116339). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; American Cancer Society, 2012, CANC FACTS FIG 2012; Ballard-Barbash R, 2012, JNCI-J NATL CANCER I, V104, P815, DOI 10.1093/jnci/djs207; Befort CA, 2012, BREAST CANCER RES TR, V132, P631, DOI 10.1007/s10549-011-1922-3; Blackburn GL, 2007, AM J CLIN NUTR, V86, p878S, DOI 10.1093/ajcn/86.3.878S; Blanchard CM, 2008, J CLIN ONCOL, V26, P2198, DOI 10.1200/JCO.2007.14.6217; Bloom Joan R, 2008, J Cancer Surviv, V2, P190, DOI 10.1007/s11764-008-0058-x; Brewster AM, 2008, JNCI-J NATL CANCER I, V100, P1179, DOI 10.1093/jnci/djn233; CHLEBOWSKI RT, 1992, BREAST CANCER RES TR, V20, P73; Christy SM, 2011, J AM DIET ASSOC, V111, P1844, DOI 10.1016/j.jada.2011.09.013; Chuang SC, 2012, AM J CLIN NUTR, V96, P164, DOI 10.3945/ajcn.111.028415; Costanza ME, 2005, PREV MED, V41, P707, DOI 10.1016/j.ypmed.2004.12.013; Darga LL, 2007, ONCOL NURS FORUM, V34, P86, DOI 10.1188/07.ONF.86-92; Davies NJ, 2011, BRIT J CANCER, V105, pS52, DOI 10.1038/bjc.2011.423; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Dillard AJ, 2012, HEALTH PSYCHOL, V31, P106, DOI 10.1037/a0024787; Ewertz M, 2011, J CLIN ONCOL, V29, P25, DOI 10.1200/JCO.2010.29.7614; Fairley TL, 2010, PREV CHRONIC DIS, V7; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Gao X, 2003, INT J RADIAT ONCOL, V56, P1038, DOI 10.1016/S0360-3016(03)00203-7; George SM, 2011, CANCER CAUSE CONTROL, V22, P589, DOI 10.1007/s10552-011-9732-9; Green L. W., 1999, HLTH PROMOTION PLANN; Greenlee HA, 2013, OBESITY, V21, P65, DOI 10.1002/oby.20245; Hansen-Krone IJ, 2012, THROMB HAEMOSTASIS, V108, P554, DOI 10.1160/TH11-11-0818; Irwin ML, 2008, J CLIN ONCOL, V26, P3958, DOI 10.1200/JCO.2007.15.9822; Key TJ, 2011, BRIT J CANCER, V104, P6, DOI 10.1038/sj.bjc.6606032; Kushi LH, 2012, CA-CANCER J CLIN, V62, P30, DOI 10.3322/caac.20140; Latka RN, 2009, J CANCER SURVIV, V3, P148, DOI 10.1007/s11764-009-0088-z; LERMAN C, 1991, HEALTH PSYCHOL, V10, P259, DOI 10.1037/0278-6133.10.4.259; Levy AG, 2006, CANCER EPIDEM BIOMAR, V15, P1893, DOI 10.1158/1055-9965.EPI-05-0482; Lu YN, 2011, J CLIN ONCOL, V29, P3358, DOI 10.1200/JCO.2010.34.2048; McQueen A, 2008, HEALTH PSYCHOL, V27, P68, DOI 10.1037/0278-6133.27.1.68; Meeske KA, 2009, BREAST CANCER RES TR, V113, P383, DOI 10.1007/s10549-008-9940-5; Morimoto LM, 2002, CANCER CAUSE CONTROL, V13, P741, DOI 10.1023/A:1020239211145; Mosher CE, 2008, J HEALTH PSYCHOL, V13, P1105, DOI 10.1177/1359105308095964; National Comprehensive Cancer Network, 2012, NCCN CLIN PRACT GUID; Nelson DE, 2004, J HEALTH COMMUN, V9, P443, DOI 10.1080/10810730490504233; Newman VA, 2005, J AM DIET ASSOC, V105, P382, DOI 10.1016/j.jada.2004.12.008; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Partridge AH, 2003, J CLIN ONCOL, V21, P602, DOI 10.1200/JCO.2003.07.071; Partridge AH, 2008, J CLIN ONCOL, V26, P556, DOI 10.1200/JCO.2007.11.5451; Patterson RE, 2010, MATURITAS, V66, P5, DOI 10.1016/j.maturitas.2010.01.004; Paxton RJ, 2012, CANCER-AM CANCER SOC, V118, P4024, DOI 10.1002/cncr.27389; Pekmezi DW, 2011, ACTA ONCOL, V50, P167, DOI 10.3109/0284186X.2010.529822; Pierce JP, 2007, JAMA-J AM MED ASSOC, V298, P289, DOI 10.1001/jama.298.3.289; Schmitz KH, 2010, MED SCI SPORT EXER, V42, P1409, DOI 10.1249/MSS.0b013e3181e0c112; Schootman M, 2010, CANCER CAUSE CONTROL, V21, P1387, DOI 10.1007/s10552-010-9566-x; Sparano JA, 2008, J CLIN ONCOL, V26, P721, DOI 10.1200/JCO.2008.16.7528; Stolley MR, 2009, CANCER-AM CANCER SOC, V115, P4385, DOI 10.1002/cncr.24585; Sulayman N, 2012, J CANCER EPIDEMIOL, V2012, DOI 10.1155/2012/728290; Tzeng JP, 2010, CANCER-AM CANCER SOC, V116, P1992, DOI 10.1002/cncr.24990; Winzer BM, 2011, CANCER CAUSE CONTROL, V22, P811, DOI 10.1007/s10552-011-9761-4	52	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53607	10.1371/journal.pone.0053607	http://dx.doi.org/10.1371/journal.pone.0053607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326466	Green Published, gold, Green Submitted			2022-12-25	WOS:000314705800060
J	Roach, JM; Racioppi, L; Jones, CD; Masci, AM				Roach, Jeffrey M.; Racioppi, Luigi; Jones, Corbin D.; Masci, Anna Maria			Phylogeny of Toll-Like Receptor Signaling: Adapting the Innate Response	PLOS ONE			English	Article							DOMAIN-CONTAINING ADAPTERS; DEPENDENT KINASE-IV; DENDRITIC CELLS; GENE FAMILY; INFLAMMATORY RESPONSES; PATHOGEN RECOGNITION; PROTEIN UNIVERSE; IMMUNE-RESPONSE; EVOLUTION; DATABASE	The Toll-like receptors represent a largely evolutionarily conserved pathogen recognition machinery responsible for recognition of bacterial, fungal, protozoan, and viral pathogen associated microbial patterns and initiation of inflammatory response. Structurally the Toll-like receptors are comprised of an extracellular leucine rich repeat domain and a cytoplasmic Toll/Interleukin 1 receptor domain. Recognition takes place in the extracellular domain where as the cytoplasmic domain triggers a complex signal network required to sustain appropriate immune response. Signal transduction is regulated by the recruitment of different intracellular adaptors. The Toll-like receptors can be grouped depending on the usage of the adaptor, MyD88, into MyD88-dependent and MyD88 independent subsets. Herein, we present a unique phylogenetic analysis of domain regions of these receptors and their cognate signaling adaptor molecules. Although previously unclear from the phylogeny of full length receptors, these analyses indicate a separate evolutionary origin for the MyD88-dependent and MyD88-independent signaling pathway and provide evidence of a common ancestor for the vertebrate and invertebrate orthologs of the adaptor molecule MyD88. Together these observations suggest a very ancient origin of the MyD88-dependent pathway Additionally we show that early duplications gave rise to several adaptor molecule families. In some cases there is also strong pattern of parallel duplication between adaptor molecules and their corresponding TLR. Our results further support the hypothesis that phylogeny of specific domains involved in signaling pathway can shed light on key processes that link innate to adaptive immune response.	[Roach, Jeffrey M.] Univ N Carolina, Ctr Res Comp, Chapel Hill, NC USA; [Racioppi, Luigi] Duke Univ, Dept Med, Durham, NC USA; [Racioppi, Luigi] Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol, Naples, Italy; [Jones, Corbin D.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Masci, Anna Maria] Duke Univ, Dept Immunol, Durham, NC 27710 USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University; University of Naples Federico II; University of North Carolina; University of North Carolina Chapel Hill; Duke University	Masci, AM (corresponding author), Duke Univ, Dept Immunol, Durham, NC 27710 USA.	annamaria.masci@duke.edu	racioppi, luigi/GNP-0349-2022; racioppi, luigi/AGB-8665-2022	racioppi, luigi/0000-0002-9207-6752; Masci, Anna Maria/0000-0003-1940-6740	Research Computing at the University of North Carolina, Chapel Hill	Research Computing at the University of North Carolina, Chapel Hill	We would like to acknowledge the support of Research Computing at the University of North Carolina, Chapel Hill in making use of the Kure computing environment.	ANDERSON KV, 1992, COLD SPRING HARB SYM, V57, P409, DOI 10.1101/SQB.1992.057.01.046; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; BRENNER SE, 1995, NATURE, V378, P140, DOI 10.1038/378140a0; Conow C, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-16; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P14132, DOI 10.1073/pnas.202497999; Dunne A, 2005, FEBS LETT, V579, P3330, DOI 10.1016/j.febslet.2005.04.024; FELSENSTEIN J, 1989, SCIENCE, V246, P941, DOI 10.1126/science.246.4932.941; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fornarino S, 2011, MOL BIOL EVOL, V28, P3087, DOI 10.1093/molbev/msr137; Friedman R, 2002, IMMUNOGENETICS, V53, P964, DOI 10.1007/s00251-001-0399-3; Galgani M, 2004, J BIOL CHEM, V279, P32507, DOI 10.1074/jbc.M403355200; Galgani M, 2004, INFECT IMMUN, V72, P4480, DOI 10.1128/IAI.72.8.4480-4485.2004; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Hughes AL, 2008, IMMUNOGENETICS, V60, P249, DOI 10.1007/s00251-008-0283-5; Illario M, 2008, BLOOD, V111, P723, DOI 10.1182/blood-2007-05-091173; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; Kanzok SM, 2004, J MOL EVOL, V58, P442, DOI 10.1007/s00239-003-2565-8; Kasamatsu J, 2010, DEV COMP IMMUNOL, V34, P855, DOI 10.1016/j.dci.2010.03.004; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Luo CH, 2000, IMMUNOGENETICS, V51, P92, DOI 10.1007/s002510050017; Masci AM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-70; Matsushima N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-124; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Muller A, 2002, GENOME RES, V12, P1625, DOI 10.1101/gr.221202; Napolitani G, 2003, EUR J IMMUNOL, V33, P2832, DOI 10.1002/eji.200324073; Nurnberger T, 2002, CURR OPIN PLANT BIOL, V5, P318, DOI 10.1016/S1369-5266(02)00265-0; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pham Y, 2007, MOL CELL, V25, P851, DOI 10.1016/j.molcel.2007.02.010; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Racioppi L, 2012, J BIOL CHEM, V287, P31658, DOI 10.1074/jbc.R112.356485; Racioppi L, 2012, J BIOL CHEM, V287, P11579, DOI 10.1074/jbc.M111.336032; Racioppi L, 2008, TRENDS IMMUNOL, V29, P600, DOI 10.1016/j.it.2008.08.005; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Satake H, 2010, ZOOL SCI, V27, P154, DOI 10.2108/zsj.27.154; SIPPL MJ, 1999, BIOL SEQUENCE ANAL P, V8, P695; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tanji T, 2005, TRENDS IMMUNOL, V26, P193, DOI 10.1016/j.it.2005.02.006; Teichmann SA, 1998, P NATL ACAD SCI USA, V95, P14658, DOI 10.1073/pnas.95.25.14658; Temperley ND, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-62; Towb P, 2009, J INNATE IMMUN, V1, P309, DOI 10.1159/000200773; Uematsu Satoshi, 2008, V183, P1; Wang LH, 2006, IMMUNOBIOLOGY, V211, P251, DOI 10.1016/j.imbio.2006.01.001; Werling D, 2009, TRENDS IMMUNOL, V30, P124, DOI 10.1016/j.it.2008.12.001; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Williams MJ, 1997, EMBO J, V16, P6120, DOI 10.1093/emboj/16.20.6120; Wu BJ, 2011, DEV COMP IMMUNOL, V35, P764, DOI 10.1016/j.dci.2011.02.009; Zhang Q, 2011, DEV COMP IMMUNOL, V35, P461, DOI 10.1016/j.dci.2010.11.013; Zhang Q, 2010, IMMUNOGENETICS, V62, P263, DOI 10.1007/s00251-010-0428-1; Zhou HJ, 2007, J MOL EVOL, V65, P119, DOI 10.1007/s00239-005-0008-4	56	21	24	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54156	10.1371/journal.pone.0054156	http://dx.doi.org/10.1371/journal.pone.0054156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326591	Green Published, gold, Green Submitted			2022-12-25	WOS:000314705800112
J	West, LC; Grotzke, JE; Cresswell, P				West, Laura Ciaccia; Grotzke, Jeff E.; Cresswell, Peter			MHC Class II-Restricted Presentation of the Major House Dust Mite Allergen Der p 1 Is GILT-Dependent: Implications for Allergic Asthma	PLOS ONE			English	Article							LYSOSOMAL THIOL REDUCTASE; ANTIGEN PRESENTATION; DISULFIDE BONDS; FREE MICE; RECOGNITION; CYTOKINES; DISEASE; CELLS	Gamma-interferon-inducible lysosomal thiol reductase (GILT) is known to reduce disulfide bonds present in proteins internalized by antigen presenting cells, facilitating optimal processing and presentation of peptides on Major Histocompatibility Complex class II molecules, as well as the subsequent activation of CD4-positive T lymphocytes. Here, we show that GILT is required for class II-restricted processing and presentation of immunodominant epitopes from the major house dust mite allergen Der p 1. In the absence of GILT, CD4-positive T cell responses to Der p 1 are significantly reduced, resulting in mitigated allergic airway inflammation in response to Der p 1 and house dust mite extracts in a murine model of asthma.	[West, Laura Ciaccia; Grotzke, Jeff E.; Cresswell, Peter] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06510 USA.	peter.cresswell@yale.edu			American Asthma Foundation; Howard Hughes Medical Institute; National Institutes of Health [T32AI07019]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007019] Funding Source: NIH RePORTER	American Asthma Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by the American Asthma Foundation, the Howard Hughes Medical Institute, and the National Institutes of Health Training Grant from T32AI07019, Yale Immunobiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda LK, 2001, J ALLERGY CLIN IMMUN, V107, P419, DOI 10.1067/mai.2001.112854; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; Bogunovic B, 2008, J BIOL CHEM, V283, P8855, DOI 10.1074/jbc.M708998200; Chruszcz M, 2009, J MOL BIOL, V386, P520, DOI 10.1016/j.jmb.2008.12.049; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Evans CM, 2009, CURR OPIN PULM MED, V15, P4, DOI 10.1097/MCP.0b013e32831da8d3; Finkelman FD, 2010, J IMMUNOL, V184, P1663, DOI 10.4049/jimmunol.0902185; Fitzpatrick AM, 2011, J ALLERGY CLIN IMMUN, V127, P1604, DOI 10.1016/j.jaci.2011.03.031; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Haque MA, 2002, J EXP MED, V195, P1267, DOI 10.1084/jem.20011853; Hastings KT, 2011, ANTIOXID REDOX SIGN, V15, P657, DOI 10.1089/ars.2010.3684; Honey K, 2003, NAT REV IMMUNOL, V3, P472, DOI 10.1038/nri1110; Kaiser L, 2007, J MOL BIOL, V370, P714, DOI 10.1016/j.jmb.2007.04.074; KAMPHUIS IG, 1984, J MOL BIOL, V179, P233, DOI 10.1016/0022-2836(84)90467-4; Lackman RL, 2007, TRAFFIC, V8, P1179, DOI 10.1111/j.1600-0854.2007.00600.x; Lackman RL, 2006, J IMMUNOL, V177, P4833, DOI 10.4049/jimmunol.177.7.4833; Li M, 2008, J BIOL CHEM, V283, P22806, DOI 10.1074/jbc.M800937200; Li P, 2002, J IMMUNOL, V169, P2444, DOI 10.4049/jimmunol.169.5.2444; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; NOVEY HS, 1979, J ALLERGY CLIN IMMUN, V63, P98, DOI 10.1016/0091-6749(79)90198-2; O'Donnell PW, 2004, J IMMUNOL, V173, P731, DOI 10.4049/jimmunol.173.2.731; Phan UT, 2000, J BIOL CHEM, V275, P25907, DOI 10.1074/jbc.M003459200; Rausch MP, 2010, J IMMUNOL, V185, P2828, DOI 10.4049/jimmunol.1000945; Riedl MA, 2008, CURR OPIN ALLERGY CL, V8, P49, DOI 10.1097/ACI.0b013e3282f3d913; Singh R, 2008, NATURE, V455, P1244, DOI 10.1038/nature07344; Singh R, 2010, SCIENCE, V328, P1394, DOI 10.1126/science.1189176; Tan YW, 2009, J BIOL CHEM, V284, P3148, DOI 10.1074/jbc.M807209200; TOPHAM CM, 1994, PROTEIN ENG, V7, P869, DOI 10.1093/protein/7.7.869; TOVEY ER, 1981, NATURE, V289, P592, DOI 10.1038/289592a0; ZIEGLER HK, 1982, P NATL ACAD SCI-BIOL, V79, P175, DOI 10.1073/pnas.79.1.175	30	20	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e51343	10.1371/journal.pone.0051343	http://dx.doi.org/10.1371/journal.pone.0051343			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326313	Green Submitted, Green Published, gold			2022-12-25	WOS:000314705800009
J	Fonovic, UP; Jevnikar, Z; Rojnik, M; Doljak, B; Fonovic, M; Jamnik, P; Kos, J				Fonovic, Ursa Pecar; Jevnikar, Zala; Rojnik, Matija; Doljak, Bojan; Fonovic, Marko; Jamnik, Polona; Kos, Janko			Profilin 1 as a Target for Cathepsin X Activity in Tumor Cells	PLOS ONE			English	Article							UP-REGULATION; CANCER; MOTILITY; PROLIFERATION; EXPRESSION; COMPLEXES; CARCINOMA; MIGRATION; PROTEASES; ENA/VASP	Cathepsin X has been reported to be a tumor promotion factor in various types of cancer; however, the molecular mechanisms linking its activity with malignant processes are not understood. Here we present profilin 1, a known tumor suppressor, as a target for cathepsin X carboxypeptidase activity in prostate cancer PC-3 cells. Profilin 1 co-localizes strongly with cathepsin X intracellularly in the perinuclear area as well as at the plasma membrane. Selective cleavage of C-terminal amino acids was demonstrated on a synthetic octapeptide representing the profilin C-terminal region, and on recombinant profilin 1. Further, intact profilin 1 binds its poly-L-proline ligand clathrin significantly better than it does the truncated one, as shown using cathepsin X specific inhibitor AMS-36 and immunoprecipitation of the profilin 1/clathrin complex. Moreover, the polymerization of actin, which depends also on the binding of poly-L-proline ligands to profilin 1, was promoted by AMS-36 treatment of cells and by siRNA cathepsin X silencing. Our results demonstrate that increased adhesion, migration and invasiveness of tumor cells depend on the inactivation of the tumor suppressive function of profilin 1 by cathepsin X. The latter is thus designated as a target for development of new antitumor strategies.	[Fonovic, Ursa Pecar; Jevnikar, Zala; Rojnik, Matija; Doljak, Bojan; Kos, Janko] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia; [Fonovic, Marko] Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, Ljubljana, Slovenia; [Fonovic, Marko] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia; [Jamnik, Polona] Biotech Fac, Ljubljana, Slovenia; [Kos, Janko] Jozef Stefan Inst, Dept Biotechnol, Ljubljana, Slovenia	University of Ljubljana; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Kos, J (corresponding author), Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia.	janko.kos@ffa.uni-lj.si	Fonović, Marko/X-9957-2019	Fonovic, Marko/0000-0002-8375-6713	Slovenia Research Agency [P4-0127, J4-0123]	Slovenia Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by Slovenia Research Agency grant P4-0127 and J4-0123 (to JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio-Fabre R, 2006, PLANT J, V47, P491, DOI 10.1111/j.1365-313X.2006.02787.x; Bae YH, 2010, P NATL ACAD SCI USA, V107, P21547, DOI 10.1073/pnas.1002309107; Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; BjorkegrenSjogren C, 1997, FEBS LETT, V418, P258, DOI 10.1016/S0014-5793(97)01376-8; CARLSSON L, 1977, J MOL BIOL, V115, P465, DOI 10.1016/0022-2836(77)90166-8; Das T, 2009, J CELL PHYSIOL, V218, P436, DOI 10.1002/jcp.21618; Ding ZJ, 2006, J CELL SCI, V119, P4127, DOI 10.1242/jcs.03178; Eisenberg MC, 2011, P NATL ACAD SCI USA, V108, P20078, DOI 10.1073/pnas.1116327108; Ferron F, 2007, EMBO J, V26, P4597, DOI 10.1038/sj.emboj.7601874; FINKEL T, 1994, P NATL ACAD SCI USA, V91, P1510, DOI 10.1073/pnas.91.4.1510; Fonovic UP, 2009, ACTA CHIM SLOV, V56, P985; Frohlich E, 2001, CANCER-AM CANCER SOC, V91, P972; Jevnikar Z, 2008, J CELL SCI, V121, P2652, DOI 10.1242/jcs.023721; Jevnikar Z, 2009, EUR J IMMUNOL, V39, P3217, DOI 10.1002/eji.200939562; Jockusch BM, 2007, REV PHYSIOL BIOCH P, V159, P131, DOI 10.1007/112_2007_704; Karlsson R, 2007, MOL BIOL INTELL UNIT, P29, DOI 10.1007/978-0-387-46407-7_3; Kos J, 2005, EXP CELL RES, V306, P103, DOI 10.1016/j.yexcr.2004.12.006; Kos J, 2009, CELL ADHES MIGR, V3, P164, DOI 10.4161/cam.3.2.7403; Krueger S, 2005, J PATHOL, V207, P32, DOI 10.1002/path.1820; Lechner AM, 2006, J BIOL CHEM, V281, P39588, DOI 10.1074/jbc.M513439200; Lwin ZM, 2010, MODERN PATHOL, V23, P1559, DOI 10.1038/modpathol.2010.173; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Nagler DK, 2004, PROSTATE, V60, P109, DOI 10.1002/pros.20046; Nascimento FD, 2005, ARCH BIOCHEM BIOPHYS, V436, P323, DOI 10.1016/j.abb.2005.01.013; Obermajer N, 2006, EXP CELL RES, V312, P2515, DOI 10.1016/j.yexcr.2006.04.019; Obermajer N, 2009, INT J BIOCHEM CELL B, V41, P1685, DOI 10.1016/j.biocel.2009.02.019; Puzer L, 2005, BIOL CHEM, V386, P1191, DOI 10.1515/BC.2005.136; Sadaghiani AM, 2007, CHEM BIOL, V14, P499, DOI 10.1016/j.chembiol.2007.03.010; Sevenich L, 2010, P NATL ACAD SCI USA, V107, P2497, DOI 10.1073/pnas.0907240107; Staudt ND, 2010, HAEMATOL-HEMATOL J, V95, P1452, DOI 10.3324/haematol.2009.018671; Turk V, 2004, CANCER CELL, V5, P409, DOI 10.1016/S1535-6108(04)00117-5; Vasiljeva O, 2008, ONCOGENE, V27, P4191, DOI 10.1038/onc.2008.59; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024967; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Zou L, 2007, BRIT J CANCER, V97, P1361, DOI 10.1038/sj.bjc.6604038	36	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53918	10.1371/journal.pone.0053918	http://dx.doi.org/10.1371/journal.pone.0053918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326535	Green Published, gold, Green Submitted			2022-12-25	WOS:000313552400058
J	Gruber, AV; Nisemblat, S; Zizelski, G; Parnas, A; Dzikowski, R; Azem, A; Weiss, C				Gruber, Anna Vitlin; Nisemblat, Shahar; Zizelski, Gal; Parnas, Avital; Dzikowski, Ron; Azem, Abdussalam; Weiss, Celeste			P. falciparum cpn20 Is a Bona Fide Co-Chaperonin That Can Replace GroES in E. coli	PLOS ONE			English	Article							ESCHERICHIA-COLI; PLASMODIUM-FALCIPARUM; ARABIDOPSIS-THALIANA; IN-VIVO; APICOPLAST; MITOCHONDRIAL; CHLOROPLASTS; CPN10; RING; COCHAPERONINS	Human malaria is among the most ubiquitous and destructive tropical, parasitic diseases in the world today. The causative agent, Plasmodium falciparum, contains an unusual, essential organelle known as the apicoplast. Inhibition of this degenerate chloroplast results in second generation death of the parasite and is the mechanism by which antibiotics function in treating malaria. In order to better understand the biochemistry of this organelle, we have cloned a putative, 20 kDa, co-chaperonin protein, Pf-cpn20, which localizes to the apicoplast. Although this protein is homologous to the cpn20 that is found in plant chloroplasts, its ability to function as a co-chaperonin was questioned in the past. In the present study, we carried out a structural analysis of Pf-cpn20 using circular dichroism and analytical ultracentrifugation and then used two different approaches to investigate the ability of this protein to function as a co-chaperonin. In the first approach, we purified recombinant Pf-cpn20 and tested its ability to act as a co-chaperonin for GroEL in vitro, while in the second, we examined the ability of Pf-cpn20 to complement an E. coli depletion of the essential bacterial co-chaperonin GroES. Our results demonstrate that Pf-cpn20 is fully functional as a co-chaperonin in vitro. Moreover, the parasitic co-chaperonin is able to replace GroES in E. coli at both normal and heat-shock temperatures. Thus, Pf-cpn20 functions as a co-chaperonin in chaperonin-mediated protein folding. The ability of the malarial protein to function in E. coli suggests that this simple system can be used as a tool for further analyses of Pf-cpn20 and perhaps other chaperone proteins from P. falciparum.	[Gruber, Anna Vitlin; Nisemblat, Shahar; Zizelski, Gal; Parnas, Avital; Azem, Abdussalam; Weiss, Celeste] Tel Aviv Univ, Dept Biochem & Mol Biol, George E Wise Fac Life Sci, Ramat Aviv, Israel; [Dzikowski, Ron] Hebrew Univ Jerusalem, Hadassah Med Sch, Kuvin Ctr Study Infect & Trop Dis, Inst Med Res Israel Canada,Dept Microbiol & Mol G, IL-91010 Jerusalem, Israel	Tel Aviv University; Hebrew University of Jerusalem	Azem, A (corresponding author), Tel Aviv Univ, Dept Biochem & Mol Biol, George E Wise Fac Life Sci, Ramat Aviv, Israel.	azema@tauex.tau.ac.il	Dzikowski, Ron/HHZ-2430-2022		BARD [US-4443-11]; United States-Israel Binational Research and Development Fund	BARD; United States-Israel Binational Research and Development Fund	This research was supported by Research Grant No. US-4443-11 from BARD, the United States-Israel Binational Research and Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behlke J, 1997, BIOCHEMISTRY-US, V36, P5149, DOI 10.1021/bi962755h; BERTSCH U, 1992, P NATL ACAD SCI USA, V89, P8696, DOI 10.1073/pnas.89.18.8696; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bonshtien AL, 2007, J BIOL CHEM, V282, P4463, DOI 10.1074/jbc.M606433200; Boudker O, 1997, J MOL BIOL, V272, P770, DOI 10.1006/jmbi.1997.1263; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; Dahl EL, 2008, TRENDS PARASITOL, V24, P279, DOI 10.1016/j.pt.2008.03.007; de Jongh HHJ, 1998, BIOCHEM BIOPH RES CO, V244, P884, DOI 10.1006/bbrc.1998.8360; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Fossati G, 2003, J BACTERIOL, V185, P4256, DOI 10.1128/JB.185.14.4256-4267.2003; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gur E, 2002, MOL MICROBIOL, V46, P1391, DOI 10.1046/j.1365-2958.2002.03257.x; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Higurashi T, 1999, J MOL BIOL, V291, P703, DOI 10.1006/jmbi.1999.2994; Hirohashi T, 1999, BBA-PROTEIN STRUCT M, V1429, P512, DOI 10.1016/S0167-4838(98)00268-4; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Hunt JF, 1997, CELL, V90, P361, DOI 10.1016/S0092-8674(00)80343-8; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kalanon M, 2010, BIOCHEM SOC T, V38, P775, DOI 10.1042/BST0380775; Koumoto Y, 2001, J BIOL CHEM, V276, P29688, DOI 10.1074/jbc.M102330200; Koumoto Y, 1999, PLANT J, V17, P467, DOI 10.1046/j.1365-313X.1999.00388.x; Kuo WY, 2013, NEW PHYTOL, V197, P99, DOI 10.1111/j.1469-8137.2012.04369.x; Luke K, 2006, ARCH BIOCHEM BIOPHYS, V456, P8, DOI 10.1016/j.abb.2006.10.003; Machaidze Gia, 2006, Journal of Biological Physics and Chemistry, V6, P91, DOI 10.4024/20608.jbpc.06.02; Mande SC, 1996, SCIENCE, V271, P203, DOI 10.1126/science.271.5246.203; McFadden GI, 2011, PROTOPLASMA, V248, P641, DOI 10.1007/s00709-010-0250-5; McLennan N, 1998, NATURE, V392, P139, DOI 10.1038/32317; Nielsen KL, 1999, J BACTERIOL, V181, P5871, DOI 10.1128/JB.181.18.5871-5875.1999; Parnas A, 2012, PLOS ONE IN PRESS; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Ralph SA, 2001, DRUG RESIST UPDATE, V4, P145, DOI 10.1054/drup.2001.0205; Roberts MM, 1999, ACTA CRYSTALLOGR D, V55, P910, DOI 10.1107/S0907444998018447; ROY H, 1989, PLANT CELL, V1, P1035, DOI 10.1105/tpc.1.11.1035; Sato S, 2005, MOL BIOCHEM PARASIT, V141, P133, DOI 10.1016/j.molbiopara.2005.01.010; Sato S, 2004, MOL BIOCHEM PARASIT, V134, P175, DOI 10.1016/j.molbiopara.2003.11.015; Sato S, 2011, CELL MOL LIFE SCI, V68, P1285, DOI 10.1007/s00018-011-0646-1; Seale JW, 1996, BIOCHEMISTRY-US, V35, P4079, DOI 10.1021/bi953087n; Seale JW, 1997, J PROTEIN CHEM, V16, P661, DOI 10.1023/A:1026350303043; Seeber F, 2010, INT REV CEL MOL BIO, V281, P161, DOI 10.1016/S1937-6448(10)81005-6; Sharkia R, 2003, BBA-PROTEINS PROTEOM, V1651, P76, DOI 10.1016/S1570-9639(03)00237-1; Sreerama N, 2003, PROTEIN SCI, V12, P384, DOI 10.1110/ps.0235003; Sun Z, 2003, J MOL BIOL, V332, P715, DOI 10.1016/S0022-2836(03)00830-1; Tsai YCC, 2012, J BIOL CHEM, V287, P20471, DOI 10.1074/jbc.M112.365411; VIITANEN PV, 1992, J BIOL CHEM, V267, P695; VIITANEN PV, 1995, J BIOL CHEM, V270, P18158, DOI 10.1074/jbc.270.30.18158; Vitlin A, 2011, PLANT MOL BIOL, V77, P105, DOI 10.1007/s11103-011-9797-6; Weiss C, 2009, PLANT MOL BIOL, V69, P227, DOI 10.1007/s11103-008-9432-3; Yeh E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001138	52	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53909	10.1371/journal.pone.0053909	http://dx.doi.org/10.1371/journal.pone.0053909			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326533	Green Published, gold, Green Submitted			2022-12-25	WOS:000313552400056
J	Jafari, P; Braissant, O; Zavadakova, P; Henry, H; Bonafe, L; Ballhausen, D				Jafari, Paris; Braissant, Olivier; Zavadakova, Petra; Henry, Hugues; Bonafe, Luisa; Ballhausen, Diana			Ammonium Accumulation and Cell Death in a Rat 3D Brain Cell Model of Glutaric Aciduria Type I	PLOS ONE			English	Article							COA DEHYDROGENASE-DEFICIENCY; MOUSE MODEL; NEURODEGENERATION; MANAGEMENT; DIAGNOSIS; TRANSPORT; SECONDARY; TOXICITY; CREATINE; ACIDS	Glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency) is an inborn error of metabolism that usually manifests in infancy by an acute encephalopathic crisis and often results in permanent motor handicap. Biochemical hallmarks of this disease are elevated levels of glutarate and 3-hydroxyglutarate in blood and urine. The neuropathology of this disease is still poorly understood, as low lysine diet and carnitine supplementation do not always prevent brain damage, even in early-treated patients. We used a 3D in vitro model of rat organotypic brain cell cultures in aggregates to mimic glutaric aciduria type I by repeated administration of 1 mM glutarate or 3-hydroxyglutarate at two time points representing different developmental stages. Both metabolites were deleterious for the developing brain cells, with 3-hydroxyglutarate being the most toxic metabolite in our model. Astrocytes were the cells most strongly affected by metabolite exposure. In culture medium, we observed an up to 11-fold increase of ammonium in the culture medium with a concomitant decrease of glutamine. We further observed an increase in lactate and a concomitant decrease in glucose. Exposure to 3-hydroxyglutarate led to a significantly increased cell death rate. Thus, we propose a three step model for brain damage in glutaric aciduria type I: (i) 3-OHGA causes the death of astrocytes, (ii) deficiency of the astrocytic enzyme glutamine synthetase leads to intracerebral ammonium accumulation, and (iii) high ammonium triggers secondary death of other brain cells. These unexpected findings need to be further investigated and verified in vivo. They suggest that intracerebral ammonium accumulation might be an important target for the development of more effective treatment strategies to prevent brain damage in patients with glutaric aciduria type I.	[Jafari, Paris; Braissant, Olivier; Zavadakova, Petra; Henry, Hugues; Bonafe, Luisa; Ballhausen, Diana] Univ Lausanne Hosp, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Ballhausen, D (corresponding author), Univ Lausanne Hosp, Lausanne, Switzerland.	diana.ballhausen@chuv.ch		Ballhausen, Diana/0000-0003-2940-3439	Swiss National Science Foundation [310030-127497]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was supported by the Swiss National Science Foundation (http://www.snf.ch) grant number 310030-127497. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral AU, 2012, MOL GENETICS METABOL; Beauchamp MH, 2009, J INHERITED METABOLI; Braissant O, 2002, J NEUROSCI, V22, P9810; Braissant O, 2008, EUR J NEUROSCI, V27, P1673, DOI 10.1111/j.1460-9568.2008.06126.x; Cagnon L, 2008, NEUROBIOL DIS, V32, P281, DOI 10.1016/j.nbd.2008.07.012; Cagnon L, 2007, BRAIN RES REV, V56, P183, DOI 10.1016/j.brainresrev.2007.06.026; Cagnon L, 2009, NEUROBIOL DIS, V33, P133, DOI 10.1016/j.nbd.2008.09.025; Ferreira da Costa G, 2005, NEUROCHEM RES, V30, P1123; Harting I, 2009, BRAIN, V132, P1764, DOI 10.1093/brain/awp112; Hedlund GL, 2006, AM J MED GENET C, V142C, P86, DOI 10.1002/ajmg.c.30088; Hoffmann GF, 1999, J INHERIT METAB DIS, V22, P381, DOI 10.1023/A:1005543904484; HOFFMANN GF, 1993, J INHERIT METAB DIS, V16, P648, DOI 10.1007/BF00711898; Honegger P, 2002, J NEUROCHEM, V81, P1141, DOI 10.1046/j.1471-4159.2002.00888.x; Jafari P, 2011, MOL GENET METAB, V104, P425, DOI 10.1016/j.ymgme.2011.08.027; Kolker S, 2007, J INHERIT METAB DIS, V30, P5, DOI 10.1007/s10545-006-0451-4; Kolker S, 2011, J INHERIT METAB DIS, V34, P677, DOI 10.1007/s10545-011-9289-5; Koeller DM, 2002, HUM MOL GENET, V11, P347, DOI 10.1093/hmg/11.4.347; Lamp J, 2011, J BIOL CHEM, V286, P17777, DOI 10.1074/jbc.M111.232744; Olivera-Bravo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020831; Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107; Sauer SW, 2006, J NEUROCHEM, V97, P899, DOI 10.1111/j.1471-4159.2006.03813.x; Strauss KA, 2003, AM J MED GENET C, V121C, P38, DOI 10.1002/ajmg.c.20007; Strauss KA, 2003, AM J MED GENET C, V121C, P53, DOI 10.1002/ajmg.c.20008; Ullrich K, 1999, J INHERIT METAB DIS, V22, P392, DOI 10.1023/A:1005595921323; Wick Regula, 2007, J Forensic Leg Med, V14, P42, DOI 10.1016/j.jcfm.2006.01.002; Zinnanti WJ, 2006, BRAIN, V129, P899, DOI 10.1093/brain/awl009	26	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53735	10.1371/journal.pone.0053735	http://dx.doi.org/10.1371/journal.pone.0053735			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326493	Green Published, gold			2022-12-25	WOS:000313552400038
J	Lu, Y; Li, YJ; Zhang, JC; Xiao, YT; Yue, YS; Duan, LS; Zhang, MC; Li, ZH				Lu, Yao; Li, Yajun; Zhang, Jiachang; Xiao, Yitao; Yue, Yuesen; Duan, Liusheng; Zhang, Mingcai; Li, Zhaohu			Overexpression of Arabidopsis Molybdenum Cofactor Sulfurase Gene Confers Drought Tolerance in Maize (Zea mays L.)	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; 9-CIS-EPOXYCAROTENOID DIOXYGENASE GENE; ALDEHYDE OXIDASE; HYDROGEN-PEROXIDE; GLYCINEBETAINE SYNTHESIS; HYDRAULIC CONDUCTIVITY; SALT TOLERANCE; LOCUS ENCODES; WATER-STRESS; EXPRESSION	Abscisic acid (ABA) is a key component of the signaling system that integrates plant adaptive responses to abiotic stress. Overexpression of Arabidopsis molybdenum cofactor sulfurase gene (LOS5) in maize markedly enhanced the expression of ZmAO and aldehyde oxidase (AO) activity, leading to ABA accumulation and increased drought tolerance. Transgenic maize (Zea mays L.) exhibited the expected reductions in stomatal aperture, which led to decreased water loss and maintenance of higher relative water content (RWC) and leaf water potential. Also, transgenic maize subjected to drought treatment exhibited lower leaf wilting, electrolyte leakage, malondialdehyde (MDA) and H2O2 content, and higher activities of antioxidative enzymes and proline content compared to wild-type (WT) maize. Moreover, overexpression of LOS5 enhanced the expression of stress-regulated genes such as Rad 17, NCED1, CAT1, and ZmP5CS1 under drought stress conditions, and increased root system development and biomass yield after re-watering. The increased drought tolerance in transgenic plants was associated with ABA accumulation via activated AO and expression of stress-related gene via ABA induction, which sequentially induced a set of favorable stress-related physiological and biochemical responses.	[Lu, Yao; Li, Yajun; Zhang, Jiachang; Xiao, Yitao; Yue, Yuesen; Duan, Liusheng; Zhang, Mingcai; Li, Zhaohu] China Agr Univ, Coll Agron & Biotechnol, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China	China Agricultural University	Zhang, MC (corresponding author), China Agr Univ, Coll Agron & Biotechnol, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China.	zmc1214@163.com	li, zh/HII-5698-2022; Duan, Liusheng/F-8954-2011	Duan, Liusheng/0000-0003-0323-9378; Lu, Yao/0000-0001-9258-8224	National Natural Science Foundation of China [30825028]; Ministry of Agricultural of China for transgenic research [2008ZX08004-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agricultural of China for transgenic research	This work was supported by National Natural Science Foundation of China (grant 30825028) and the Ministry of Agricultural of China for transgenic research (2008ZX08004-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Aswath CR, 2005, PLANT GROWTH REGUL, V47, P129, DOI 10.1007/s10725-005-3380-6; Baisakh N, 2012, PLANT BIOTECHNOL J, V10, P453, DOI 10.1111/j.1467-7652.2012.00678.x; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bittner F, 2001, J BIOL CHEM, V276, P40381, DOI 10.1074/jbc.C100472200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNAN T, 1977, PLANT PHYSIOL, V59, P411, DOI 10.1104/pp.59.3.411; Chen ZZ, 2006, MOL CELL BIOL, V26, P6902, DOI 10.1128/MCB.00433-06; Chernys JT, 2000, PLANT PHYSIOL, V124, P343, DOI 10.1104/pp.124.1.343; Cohen A, 1999, PLANT CELL ENVIRON, V22, P989, DOI 10.1046/j.1365-3040.1999.00474.x; Desikan R, 2001, PLANT PHYSIOL, V127, P159, DOI 10.1104/pp.127.1.159; Frame BR, 2002, PLANT PHYSIOL, V129, P13, DOI 10.1104/pp.000653; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Gong ZZ, 1997, PLANT MOL BIOL, V35, P915, DOI 10.1023/A:1005959203396; Gonzalez-Guzman M, 2002, PLANT CELL, V14, P1833, DOI 10.1105/tpc.002477; He CM, 2010, PLANT CELL TISS ORG, V101, P65, DOI 10.1007/s11240-009-9665-0; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Kizis D, 2002, PLANT J, V30, P679, DOI 10.1046/j.1365-313X.2002.01325.x; Laboski CAM, 1998, PLANT SOIL, V203, P239, DOI 10.1023/A:1004391104778; Lv S, 2007, MOL BREEDING, V20, P233, DOI 10.1007/s11032-007-9086-x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Parent B, 2009, PLANT PHYSIOL, V149, P2000, DOI 10.1104/pp.108.130682; Park EJ, 2004, PLANT J, V40, P474, DOI 10.1111/j.1365-313X.2004.02237.x; Park HY, 2008, BIOCHEM BIOPH RES CO, V375, P80, DOI 10.1016/j.bbrc.2008.07.128; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Porch TG, 2006, PLANT J, V45, P250, DOI 10.1111/j.1365-313X.2005.02621.x; Qin XQ, 2002, PLANT PHYSIOL, V128, P544, DOI 10.1104/pp.010663; Quan RD, 2004, PLANT SCI, V166, P141, DOI 10.1016/j.plantsci.2003.08.018; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Seo M, 2000, P NATL ACAD SCI USA, V97, P12908, DOI 10.1073/pnas.220426197; Seo M, 2002, TRENDS PLANT SCI, V7, P41, DOI 10.1016/S1360-1385(01)02187-2; Seo M, 2004, PLANT CELL PHYSIOL, V45, P1694, DOI 10.1093/pcp/pch198; Shi HZ, 2003, NAT BIOTECHNOL, V21, P81, DOI 10.1038/nbt766; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Shou HX, 2004, P NATL ACAD SCI USA, V101, P3298, DOI 10.1073/pnas.0308095100; Strizhov N, 1997, PLANT J, V12, P557, DOI 10.1046/j.1365-313X.1997.00557.x; Tan BC, 2003, PLANT J, V35, P44, DOI 10.1046/j.1365-313X.2003.01786.x; Tan BC, 1997, P NATL ACAD SCI USA, V94, P12235, DOI 10.1073/pnas.94.22.12235; Thompson AJ, 2000, PLANT J, V23, P363, DOI 10.1046/j.1365-313x.2000.00789.x; Thompson AJ, 2007, PLANT PHYSIOL, V143, P1905, DOI 10.1104/pp.106.093559; Tung SA, 2008, PLANT CELL ENVIRON, V31, P968, DOI 10.1111/j.1365-3040.2008.01812.x; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wei AY, 2011, PLANT BIOTECHNOL J, V9, P216, DOI 10.1111/j.1467-7652.2010.00548.x; Xiao BZ, 2009, MOL PLANT, V2, P73, DOI 10.1093/mp/ssn068; Xiong LM, 2003, PLANT PHYSIOL, V133, P29, DOI 10.1104/pp.103.025395; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang JC, 2001, PLANT PHYSIOL, V127, P315, DOI 10.1104/pp.127.1.315; Yang Q, 2009, MOL PLANT, V2, P22, DOI 10.1093/mp/ssn058; Yue YS, 2011, PLANT SCI, V181, P405, DOI 10.1016/j.plantsci.2011.06.010; Zdunek E, 2001, J EXP BOT, V52, P1269, DOI 10.1093/jexbot/52.359.1269; Zhang AY, 2007, NEW PHYTOL, V175, P36, DOI 10.1111/j.1469-8137.2007.02071.x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	59	110	120	6	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e52126	10.1371/journal.pone.0052126	http://dx.doi.org/10.1371/journal.pone.0052126			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326325	Green Published, gold, Green Submitted			2022-12-25	WOS:000313552400007
J	Yang, YC; Chang, LK				Yang, Ya-Chun; Chang, Li-Kwan			Role of TAF4 in Transcriptional Activation by Rta of Epstein-Barr Virus	PLOS ONE			English	Article							TATA-LESS PROMOTER; IMMEDIATE-EARLY PROTEIN; HUMAN EPITHELIAL-CELLS; TFIID COMPLEX; BRLF1 PROMOTER; FACTOR-R; LATENT MEMBRANE-PROTEIN-1; BMLF1 PROMOTER; LYTIC CYCLE; DNA-BINDING	Epstein-Barr virus (EBV) expresses an immediate-early protein, Rta, to activate the transcription of EBV lytic genes. This protein usually binds to Rta-response elements or interacts with Sp1 or Zta via a mediator protein, MCAF1, to activate transcription. Rta is also known to interact with TBP and TFIIB to activate transcription. This study finds that Rta interacts with TAF4, a component of TFIID complex, in vitro and in vivo, and on the TATA sequence in the BcLF1 promoter. Rta also interacts with TAF4 and Sp1 on Sp1-binding sequences on TATA-less promoters, including those of BNLF1, BALF5, and the human androgen receptor. These interactions are important to the transcriptional activation of these genes by Rta since introducing TAF4 shRNA substantially reduces the ability of Rta to activate these promoters. This investigation reveals how Rta interacts with TFIID to stimulate transcription.	[Yang, Ya-Chun; Chang, Li-Kwan] Natl Taiwan Univ, Coll Life Sci, Dept Biochem Sci & Technol, Taipei 10764, Taiwan	National Taiwan University	Chang, LK (corresponding author), Natl Taiwan Univ, Coll Life Sci, Dept Biochem Sci & Technol, Taipei 10764, Taiwan.	changlk@ntu.edu.tw	Hsiao, Wei-Hung/B-9931-2013		National Health Research Institute of the Republic of China, Taiwan [NHRI-EX101-10030BI]; National Science Council of the Republic of China, Taiwan [NSC-100-2311-B-002-011]	National Health Research Institute of the Republic of China, Taiwan(National Health Research Institutes - Taiwan); National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by the National Health Research Institute of the Republic of China, Taiwan (contract number NHRI-EX101-10030BI) and the National Science Council of the Republic of China, Taiwan (contract number NSC-100-2311-B-002-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AL, 2000, J VIROL, V74, P1224, DOI 10.1128/JVI.74.3.1224-1233.2000; Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Asahara H, 2001, MOL CELL BIOL, V21, P7892, DOI 10.1128/MCB.21.23.7892-7900.2001; Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229; Chang LK, 2008, J MOL BIOL, V379, P231, DOI 10.1016/j.jmb.2008.04.011; Chang LK, 2010, NUCLEIC ACIDS RES, V38, P4687, DOI 10.1093/nar/gkq243; Chang LK, 2005, NUCLEIC ACIDS RES, V33, P6528, DOI 10.1093/nar/gki956; Chang LK, 2000, NUCLEIC ACIDS RES, V28, P3918, DOI 10.1093/nar/28.20.3918; Chang LK, 2004, J BIOL CHEM, V279, P38803, DOI 10.1074/jbc.M405470200; Chang MH, 1997, DNA CELL BIOL, V16, P829, DOI 10.1089/dna.1997.16.829; Chang PJ, 1998, J VIROL, V72, P5128, DOI 10.1128/JVI.72.6.5128-5136.1998; Chang PJ, 1998, J GEN VIROL, V79, P2003, DOI 10.1099/0022-1317-79-8-2003; Chang Y, 2004, J VIROL, V78, P13028, DOI 10.1128/JVI.78.23.13028-13036.2004; CHEVALLIERGRECO A, 1989, J VIROL, V63, P615, DOI 10.1128/JVI.63.2.615-623.1989; CHEVALLIERGRECO A, 1986, EMBO J, V5, P3243, DOI 10.1002/j.1460-2075.1986.tb04635.x; Chiu YF, 2007, J GEN VIROL, V88, P2463, DOI 10.1099/vir.0.82881-0; Chua HH, 2007, J VIROL, V81, P2459, DOI 10.1128/JVI.02289-06; Cler E, 2009, CELL MOL LIFE SCI, V66, P2123, DOI 10.1007/s00018-009-0009-3; DAVIES AH, 1991, J VIROL, V65, P6838, DOI 10.1128/JVI.65.12.6838-6844.1991; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; DUSING MR, 1994, NUCLEIC ACIDS RES, V22, P669, DOI 10.1093/nar/22.4.669; FABER PW, 1993, J BIOL CHEM, V268, P9296; Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080; FERRERI K, 1994, P NATL ACAD SCI USA, V91, P1210, DOI 10.1073/pnas.91.4.1210; GILL G, 1994, P NATL ACAD SCI USA, V91, P192, DOI 10.1073/pnas.91.1.192; GIOT JF, 1991, NUCLEIC ACIDS RES, V19, P1251, DOI 10.1093/nar/19.6.1251; GRUFFAT H, 1990, NUCLEIC ACIDS RES, V18, P6835, DOI 10.1093/nar/18.23.6835; GRUFFAT H, 1992, J VIROL, V66, P46, DOI 10.1128/JVI.66.1.46-52.1992; Gruffat H, 2012, J VIROL, V86, P6023, DOI 10.1128/JVI.00159-12; Heilmann AMF, 2010, J VIROL, V84, P9920, DOI 10.1128/JVI.00573-10; Herbig E, 2010, MOL CELL BIOL, V30, P2376, DOI 10.1128/MCB.01046-09; Hinuma Y, 1967, J Virol, V1, P1045; HOLLEYGUTHRIE EA, 1990, J VIROL, V64, P3753, DOI 10.1128/JVI.64.8.3753-3759.1990; Hsu TY, 2005, J GEN VIROL, V86, P317, DOI 10.1099/vir.0.80556-0; Johannessen M, 2003, J GEN VIROL, V84, P1887, DOI 10.1099/vir.0.19057-0; KENNEY S, 1989, J VIROL, V63, P3878, DOI 10.1128/JVI.63.9.3878-3883.1989; KOBAYASHI N, 1995, MOL CELL BIOL, V15, P6465; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Lee YH, 2008, J GEN VIROL, V89, P2437, DOI 10.1099/vir.0.2008/003897-0; LIEBERMAN P, 1994, MOL CELL BIOL, V14, P8365, DOI 10.1128/MCB.14.12.8365; LIEBERMAN PM, 1991, GENE DEV, V5, P2441, DOI 10.1101/gad.5.12b.2441; Lieberman PM, 1997, MOL CELL BIOL, V17, P6624, DOI 10.1128/MCB.17.11.6624; Liu CN, 1996, J VIROL, V70, P2545, DOI 10.1128/JVI.70.4.2545-2555.1996; Liu PF, 2003, VIROLOGY, V310, P199, DOI 10.1016/S0042-6822(03)00145-4; Liu ST, 2006, VIRUS RES, V119, P163, DOI 10.1016/j.virusres.2006.01.004; LUKA J, 1979, VIROLOGY, V94, P228, DOI 10.1016/0042-6822(79)90455-0; Manet Evelyne, 1993, Gene Expression, V3, P49; Marr MT, 2009, P NATL ACAD SCI USA, V106, P1295, DOI 10.1073/pnas.0812990106; Mazzarelli JM, 1997, J VIROL, V71, P7978, DOI 10.1128/JVI.71.10.7978-7983.1997; Muller F, 2004, EMBO J, V23, P2, DOI 10.1038/sj.emboj.7600027; Paulson M, 2002, NAT CELL BIOL, V4, P140, DOI 10.1038/ncb747; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; QUINLIVAN EB, 1993, NUCLEIC ACIDS RES, V21, P1999, DOI 10.1093/nar/21.8.1999; Ragoczy T, 2001, J VIROL, V75, P5240, DOI 10.1128/JVI.75.11.5240-5251.2001; Robinson AR, 2011, J VIROL, V85, P8940, DOI 10.1128/JVI.00569-11; SADLER RH, 1995, J VIROL, V69, P4577, DOI 10.1128/JVI.69.7.4577-4581.1995; Saluja D, 1998, MOL CELL BIOL, V18, P5734, DOI 10.1128/MCB.18.10.5734; Serio TR, 1998, J VIROL, V72, P8338, DOI 10.1128/JVI.72.10.8338-8343.1998; Tanese N, 1996, P NATL ACAD SCI USA, V93, P13611, DOI 10.1073/pnas.93.24.13611; Tsai CN, 1999, VIROLOGY, V261, P288, DOI 10.1006/viro.1999.9851; Vorobyeva NE, 2009, P NATL ACAD SCI USA, V106, P11049, DOI 10.1073/pnas.0901801106; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103	62	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54075	10.1371/journal.pone.0054075	http://dx.doi.org/10.1371/journal.pone.0054075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326574	gold, Green Published, Green Submitted			2022-12-25	WOS:000313552400073
J	Bull-Otterson, L; Feng, WK; Kirpich, I; Wang, YH; Qin, X; Liu, YL; Gobejishvili, L; Joshi-Barve, S; Ayvaz, T; Petrosino, J; Kong, MY; Barker, D; McClain, C; Barve, S				Bull-Otterson, Lara; Feng, Wenke; Kirpich, Irina; Wang, Yuhua; Qin, Xiang; Liu, Yanlong; Gobejishvili, Leila; Joshi-Barve, Swati; Ayvaz, Tulin; Petrosino, Joseph; Kong, Maiying; Barker, David; McClain, Craig; Barve, Shirish			Metagenomic Analyses of Alcohol Induced Pathogenic Alterations in the Intestinal Microbiome and the Effect of Lactobacillus rhamnosus GG Treatment	PLOS ONE			English	Article							INDUCED LIVER-INJURY; GUT LEAKINESS; DISEASE; ENDOTOXEMIA; RATS; PERMEABILITY; PROBIOTICS; ETHANOL; STEATOHEPATITIS; MICROFLORA	Enteric dysbiosis plays an essential role in the pathogenesis of alcoholic liver disease (ALD). Detailed characterization of the alterations in the gut microbiome is needed for understanding their pathogenic role in ALD and developing effective therapeutic approaches using probiotic supplementation. Mice were fed liquid Lieber-DeCarli diet without or with alcohol (5% v/v) for 6 weeks. A subset of mice were administered the probiotic Lactobacillus rhamnosus GG (LGG) from 6 to 8 weeks. Indicators of intestinal permeability, hepatic steatosis, inflammation and injury were evaluated. Metagenomic analysis of the gut microbiome was performed by analyzing the fecal DNA by amplification of the V3-V5 regions of the 16S rRNA gene and large-scale parallel pyrosequencing on the 454 FLX Titanium platform. Chronic ethanol feeding caused a decline in the abundance of both Bacteriodetes and Firmicutes phyla, with a proportional increase in the gram negative Proteobacteria and gram positive Actinobacteria phyla; the bacterial genera that showed the biggest expansion were the gram negative alkaline tolerant Alcaligenes and gram positive Corynebacterium. Commensurate with the qualitative and quantitative alterations in the microbiome, ethanol caused an increase in plasma endotoxin, fecal pH, hepatic inflammation and injury. Notably, the ethanol-induced pathogenic changes in the microbiome and the liver were prevented by LGG supplementation. Overall, significant alterations in the gut microbiome over time occur in response to chronic alcohol exposure and correspond to increases in intestinal barrier dysfunction and development of ALD. Moreover, the altered bacterial communities of the gut may serve as significant therapeutic target for the prevention/treatment of chronic alcohol intake induced intestinal barrier dysfunction and liver disease.	[Bull-Otterson, Lara; Ayvaz, Tulin; Petrosino, Joseph] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Bull-Otterson, Lara; Ayvaz, Tulin; Petrosino, Joseph] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA; [Feng, Wenke; Kirpich, Irina; Wang, Yuhua; Liu, Yanlong; Gobejishvili, Leila; Joshi-Barve, Swati; Barker, David; McClain, Craig; Barve, Shirish] Univ Louisville, Sch Med, Dept Med, Alcohol Res Ctr, Louisville, KY 40292 USA; [Qin, Xiang] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Kong, Maiying] Univ Louisville, Sch Med, Dept Bioinformat & Biostat, Louisville, KY 40292 USA; [McClain, Craig; Barve, Shirish] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [McClain, Craig] Robley Rex VAMC, Louisville, KY USA	Baylor College of Medicine; Baylor College of Medicine; University of Louisville; Baylor College of Medicine; University of Louisville; University of Louisville	Barve, S (corresponding author), Univ Louisville, Sch Med, Dept Med, Alcohol Res Ctr, Louisville, KY 40292 USA.	shirishbarve@gmail.com	Petrosino, Joseph F./AAF-1621-2019; Barker, David/HHZ-0471-2022	Barker, David/0000-0002-1438-4100	National Institutes of Health (NIH) [AAO14371, P01 AA017103, R01 AA0015970, R01 AA018016, R01 DK071765, R37 AA010762, R01 AA018869, P30 AA019360, RC2AA019385]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018869, R01AA015970, P30AA019360, RC2AA019385, R21AA020849, P01AA017103, R37AA010762, R01AA018016, U01AA021901] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by National Institutes of Health (NIH) grants R01 AAO14371 (SB), P01 AA017103 (CM), R01 AA0015970 (CM), R01 AA018016 (CM, SB), R01 DK071765 (CM), R37 AA010762 (CM), R01 AA018869 (CM), P30 AA019360 (CM), RC2AA019385 (CM), and the Department of Veterans Affairs (CM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Donia MB, 2008, J TOXICOL ENV HEAL A, V71, P1415, DOI 10.1080/15287390802328630; ADACHI Y, 1995, GASTROENTEROLOGY, V108, P218, DOI 10.1016/0016-5085(95)90027-6; [Anonymous], 2012, PLOS ONE; [Anonymous], 2006, BROCK BIOL MICROORGA; Bezkorovainy A, 2001, AM J CLIN NUTR, V73, p399S, DOI 10.1093/ajcn/73.2.399s; BODE C, 1987, J HEPATOL, V4, P8, DOI 10.1016/S0168-8278(87)80003-X; Brandt K, 2003, INT J FOOD MICROBIOL, V84, P189, DOI 10.1016/S0168-1605(02)00419-1; Cericco M, 1996, GASTROEN CLIN BIOL, V20, P514; Dommels YEM, 2009, APPL ENVIRON MICROB, V75, P6198, DOI 10.1128/AEM.01054-09; Drisko Jeanne A, 2003, Altern Med Rev, V8, P143; Ferrier L, 2006, AM J PATHOL, V168, P1148, DOI 10.2353/ajpath.2006.050617; Fooks LJ, 2002, BRIT J NUTR, V88, pS39, DOI [10.1079/BJN2002628, 10.1079/BJNBJN2002591]; Forsyth CB, 2009, ALCOHOL, V43, P163, DOI 10.1016/j.alcohol.2008.12.009; Fouts DE, 2012, J HEPATOLOGY; FUKUI H, 1991, J HEPATOL, V12, P162, DOI 10.1016/0168-8278(91)90933-3; Gobejishvili L, 2008, AM J PHYSIOL-GASTR L, V295, pG718, DOI 10.1152/ajpgi.90232.2008; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; HARNISCH JP, 1989, ANN INTERN MED, V111, P71, DOI 10.7326/0003-4819-111-1-71; Horz HP, 2005, J CLIN MICROBIOL, V43, P5332, DOI 10.1128/JCM.43.10.5332-5337.2005; Keshavarzian A, 2001, J PHARMACOL EXP THER, V299, P442; Kirpich IA, 2008, ALCOHOL, V42, P675, DOI 10.1016/j.alcohol.2008.08.006; Kuczynski Justin, 2011, Curr Protoc Bioinformatics, VChapter 10, DOI [10.1002/9780471729259.mc01e05s27, 10.1002/0471250953.bi1007s36]; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4; Maidak BL, 1997, NUCLEIC ACIDS RES, V25, P109, DOI 10.1093/nar/25.1.109; McClain CJ, 1999, SEMIN LIVER DIS, V19, P205, DOI 10.1055/s-2007-1007110; Mutlu E, 2009, ALCOHOL CLIN EXP RES, V33, P1836, DOI 10.1111/j.1530-0277.2009.01022.x; Mutlu EA, 2012, AM J PHYSIOL-GASTR L, V302, pG966, DOI 10.1152/ajpgi.00380.2011; NANJI AA, 1994, P SOC EXP BIOL MED, V205, P243; Parlesak A, 2000, J HEPATOL, V32, P742, DOI 10.1016/S0168-8278(00)80242-1; Rao RK, 2004, AM J PHYSIOL-GASTR L, V286, pG881, DOI 10.1152/ajpgi.00006.2004; Saxelin M, 2002, LACTOBACILLUS GG ITS; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang YH, 2011, AM J PATHOL, V179, P2866, DOI 10.1016/j.ajpath.2011.08.039; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yan AW, 2011, HEPATOLOGY, V53, P96, DOI 10.1002/hep.24018; Zhao Hai Ying, 2004, Chin J Dig Dis, V5, P64, DOI 10.1111/j.1443-9573.2004.00157.x	41	335	355	6	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53028	10.1371/journal.pone.0053028	http://dx.doi.org/10.1371/journal.pone.0053028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326376	gold, Green Published, Green Submitted			2022-12-25	WOS:000313551500042
J	Woznica, A; Nowak, A; Ziemski, P; Kwasniewski, M; Bernas, T				Woznica, Andrzej; Nowak, Agnieszka; Ziemski, Przemyslaw; Kwasniewski, Miroslaw; Bernas, Tytus			Stimulatory Effect of Xenobiotics on Oxidative Electron Transport of Chemolithotrophic Nitrifying Bacteria Used as Biosensing Element	PLOS ONE			English	Article							AMMONIA-OXIDIZING BACTERIA; RIBOSOMAL-RNA GENE; NITROBACTER-HAMBURGENSIS; PSEUDOMONAS-AERUGINOSA; AEROMONAS-HYDROPHILA; GENOME SEQUENCE; ION CHANNELS; CYANIDE; HORMESIS; MITOCHONDRIAL	Electron transport chain (ETCh) of ammonium (AOB) and nitrite oxidizing bacteria (NOB) participates in oxidation of ammonium to nitrate (nitrification). Operation of ETCh may be perturbed by a range of water-soluble xenobiotics. Therefore, consortia of nitrifying bacteria may be used as a biosensor to detect water contamination. A surprising feature of this system is an increase of oxygen consumption, detected in the presence of certain inhibitors of ETCh. Thus, to shed light on the mechanism of this effect (and other differences between inhibitors) we monitored separately respiration of the bacteria of the first (AOB - Nitrosomonas) and second (NOB -Nitrobacter) stages of nitrification. Furthermore, we measured plasma membrane potential and the level of reduction of NAD(P)H. We propose a novel model of ETCh in NOB to explain the role of reverse electron transport in the stimulation of oxygen consumption (previously attributed to hormesis).	[Woznica, Andrzej; Nowak, Agnieszka; Ziemski, Przemyslaw] Univ Silesia, Fac Biol & Environm Protect, Dept Biochem, Katowice, Poland; [Kwasniewski, Miroslaw] Univ Silesia, Fac Biol & Environm Protect, Dept Genet, Katowice, Poland; [Bernas, Tytus] Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland	University of Silesia in Katowice; University of Silesia in Katowice; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Woznica, A (corresponding author), Univ Silesia, Fac Biol & Environm Protect, Dept Biochem, Katowice, Poland.	andrzej.woznica@us.edu.pl	Nowak, Agnieszka/AFN-1525-2022; Bernas, Tytus/P-2385-2016	Nowak, Agnieszka/0000-0002-5705-8938; Bernas, Tytus/0000-0003-0841-5940; Woznica, Andrzej/0000-0003-3051-1816	UE Innovate Economy Operational Programme, Priority 1 "Research and development of modern technologies" [POIG 01.01.02-24-078/09]; UE Innovate Economy Operational Programme, Subaction 1.1.2 "An integrated system supporting the management and protection of the water reservoir" [POIG 01.01.02-24-078/09]; Polish Ministry for Science and Higher Education (MNiSW) [N N301 463834]	UE Innovate Economy Operational Programme, Priority 1 "Research and development of modern technologies"; UE Innovate Economy Operational Programme, Subaction 1.1.2 "An integrated system supporting the management and protection of the water reservoir"; Polish Ministry for Science and Higher Education (MNiSW)(Ministry of Science and Higher Education, Poland)	This work was supported by the UE Innovate Economy Operational Programme, Priority 1 "Research and development of modern technologies", Subaction 1.1.2 "An integrated system supporting the management and protection of the water reservoir", Project number: POIG 01.01.02-24-078/09 (AW) and by the Polish Ministry for Science and Higher Education (MNiSW) grant Nr N N301 463834 (TB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames J.R., 1986, J FREE RADIC BIOL ME, V2, P371; APHA, 1995, STANDARD METHODS EXA; Arp DJ, 2003, CRIT REV BIOCHEM MOL, V38, P471, DOI 10.1080/10409230390267446; Bergmeyer HU, 1989, METHOD ENZYMATIC ANA; Bibby K, 2010, WATER RES, V44, P4252, DOI 10.1016/j.watres.2010.05.039; Blinova K, 2005, BIOCHEMISTRY-US, V44, P2585, DOI 10.1021/bi0485124; Bothe H, 2000, FEMS MICROBIOL REV, V24, P673, DOI 10.1111/j.1574-6976.2000.tb00566.x; Calabrese EJ, 2008, ENVIRON TOXICOL CHEM, V27, P1451, DOI [10.1897/07-541.1, 10.1897/07-541]; Calabrese EJ, 2009, ARCH TOXICOL, V83, P227, DOI 10.1007/s00204-009-0411-5; Calabrese EJ, 1999, RISK ANAL, V19, P261, DOI 10.1111/j.1539-6924.1999.tb00404.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cipollone R, 2007, APPL ENVIRON MICROB, V73, P390, DOI 10.1128/AEM.02143-06; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cooper M, 2003, MICROBIOL-SGM, V149, P1275, DOI 10.1099/mic.0.26017-0; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Do H, 2008, J IND MICROBIOL BIOT, V35, P1331, DOI 10.1007/s10295-008-0415-9; Elbehti A, 1999, J BIOL CHEM, V274, P16760, DOI 10.1074/jbc.274.24.16760; Ferguson SJ, 2002, BIOENERGETIC; Gieseke A, 2001, APPL ENVIRON MICROB, V67, P1351, DOI 10.1128/AEM.67.3.1351-1362.2001; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; HADDOCK BA, 1977, BACTERIOL REV, V41, P47, DOI 10.1128/MMBR.41.1.47-99.1977; Hovanec TA, 1998, APPL ENVIRON MICROB, V64, P258; ILZUMI T, 1998, APPL ENVIRON MICROB, V64, P3656; Inoue M, 1998, AM J PHYSIOL-CELL PH, V274, pC105, DOI 10.1152/ajpcell.1998.274.1.C105; Knight V, 1998, ARCH MICROBIOL, V169, P239, DOI 10.1007/s002030050567; Koops HP, 2001, FEMS MICROBIOL ECOL, V37, P1, DOI 10.1111/j.1574-6941.2001.tb00847.x; Koprowski P, 2001, BIOESSAYS, V23, P1148, DOI 10.1002/bies.10017; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lucker S, 2010, P NATL ACAD SCI USA, V107, P13479, DOI 10.1073/pnas.1003860107; MACDONALD RM, 1980, FEMS MICROBIOL LETT, V8, P143, DOI 10.1016/0378-1097(80)90018-X; Magnuson TS, 2000, FEMS MICROBIOL LETT, V185, P205, DOI 10.1016/S0378-1097(00)00081-1; Martinac B, 2008, PHYSIOL REV, V88, P1449, DOI 10.1152/physrev.00005.2008; MATSUNAGA T, 1993, APPL MICROBIOL BIOT, V39, P368; Mota C, 2005, APPL ENVIRON MICROB, V71, P8565, DOI 10.1128/AEM.71.12.8565-8572.2005; Sansom MSP, 2002, BBA-BIOMEMBRANES, V1565, P294, DOI 10.1016/S0005-2736(02)00576-X; Seligman L, 1971, J GEN MICROBIOL, V68, P135; Spieck E, 2006, ENVIRON MICROBIOL, V8, P405, DOI 10.1111/j.1462-2920.2005.00905.x; Spieck E, 1996, J STRUCT BIOL, V117, P117, DOI 10.1006/jsbi.1996.0076; Spieck E, 1998, ARCH MICROBIOL, V169, P225, DOI 10.1007/s002030050565; Spieck E, 2005, LITHOAUTOTROPHIC NIT, V2, P149; Starkenburg SR, 2008, APPL ENVIRON MICROB, V74, P2852, DOI 10.1128/AEM.02311-07; Starkenburg SR, 2006, APPL ENVIRON MICROB, V72, P2050, DOI 10.1128/AEM.72.3.2050-2063.2006; Subbarao GV, 2006, CRIT REV PLANT SCI, V25, P303, DOI 10.1080/07352680600794232; Thomas A. W., 2008, Proceedings of the Sendai International Symposium on Strangeness in Nuclear and Hadronic Systems - SENDAI08, P1, DOI 10.1017/S0033291708004042; Tolkatchev D, 1996, J BIOL CHEM, V271, P12356, DOI 10.1074/jbc.271.21.12356; Wang G, 2001, NEUROSCI LETT, V309, P125, DOI 10.1016/S0304-3940(01)02032-8; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Woznica A, 2003, ANAEROBE, V9, P125, DOI 10.1016/S1075-9964(03)00059-3; Woznica A, 2006, ECOPOLE 06 JAMR POL; Woznica A, 2010, CHEMOSPHERE, V81, P767, DOI 10.1016/j.chemosphere.2010.07.011; Woznica A, 2010, CHEMOSPHERE, V78, P1121, DOI 10.1016/j.chemosphere.2009.12.035; Xia H, 1997, PHYS REV B, V55, P15018, DOI 10.1103/PhysRevB.55.15018	53	4	4	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53484	10.1371/journal.pone.0053484	http://dx.doi.org/10.1371/journal.pone.0053484			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326438	gold, Green Submitted, Green Published			2022-12-25	WOS:000313551500077
J	Yuan, K; Cheng, P; Dong, T; Bi, YZ; Xing, LH; Yu, DH; Zhao, LM; Dong, MH; von Deneen, KM; Liu, YJ; Qin, W; Tian, J				Yuan, Kai; Cheng, Ping; Dong, Tao; Bi, Yanzhi; Xing, Lihong; Yu, Dahua; Zhao, Limei; Dong, Minghao; von Deneen, Karen M.; Liu, Yijun; Qin, Wei; Tian, Jie			Cortical Thickness Abnormalities in Late Adolescence with Online Gaming Addiction	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; PROBLEMATIC INTERNET USE; ORBITOFRONTAL CORTEX; CIGARETTE-SMOKING; FINGER MOVEMENT; DRUG-ADDICTION; TAXI DRIVERS; STROOP TASK; HUMAN BRAIN; SMOKERS	Online gaming addiction, as the most popular subtype of Internet addiction, had gained more and more attention from the whole world. However, the structural differences in cortical thickness of the brain between adolescents with online gaming addiction and healthy controls are not well unknown; neither was its association with the impaired cognitive control ability. High-resolution magnetic resonance imaging scans from late adolescence with online gaming addiction (n = 18) and age-, education- and gender-matched controls (n = 18) were acquired. The cortical thickness measurement method was employed to investigate alterations of cortical thickness in individuals with online gaming addiction. The color-word Stroop task was employed to investigate the functional implications of the cortical thickness abnormalities. Imaging data revealed increased cortical thickness in the left precentral cortex, precuneus, middle frontal cortex, inferior temporal and middle temporal cortices in late adolescence with online gaming addiction; meanwhile, the cortical thicknesses of the left lateral orbitofrontal cortex (OFC), insula, lingual gyrus, the right postcentral gyrus, entorhinal cortex and inferior parietal cortex were decreased. Correlation analysis demonstrated that the cortical thicknesses of the left precentral cortex, precuneus and lingual gyrus correlated with duration of online gaming addiction and the cortical thickness of the OFC correlated with the impaired task performance during the color-word Stroop task in adolescents with online gaming addiction. The findings in the current study suggested that the cortical thickness abnormalities of these regions may be implicated in the underlying pathophysiology of online gaming addiction.	[Yuan, Kai; Cheng, Ping; Dong, Tao; Bi, Yanzhi; Xing, Lihong; Yu, Dahua; Zhao, Limei; Dong, Minghao; von Deneen, Karen M.; Qin, Wei; Tian, Jie] Xidian Univ, Life Sci Res Ctr, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Yu, Dahua] Inner Mongolia Univ Sci & Technol, Sch Informat Engn, Informat Proc Lab, Baotou, Inner Mongolia, Peoples R China; [Liu, Yijun] Univ Florida, Dept Psychiat, McKnight Brain Inst, Gainesville, FL 32611 USA; [Liu, Yijun] Univ Florida, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Inner Mongolia University of Science & Technology; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Chinese Academy of Sciences; Institute of Automation, CAS	Qin, W (corresponding author), Xidian Univ, Life Sci Res Ctr, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China.	wqin@xidian.edu.cn; tian@ieee.org	tian, jie/M-6336-2013; Yuan, Kai/I-4150-2016; Yuan, Kai/M-9403-2013; Tian, Jie/H-1190-2011; Life, PAM/M-9552-2013; Dong, Minghao/A-6425-2014; Yu, Dahua/N-7242-2013; 秦, 伟/J-9770-2016	Yuan, Kai/0000-0002-3098-1124; Tian, Jie/0000-0003-0498-0432; Dong, Minghao/0000-0002-0190-6985; Yu, Dahua/0000-0001-7850-7512; 秦, 伟/0000-0003-4583-0406	Project for the National Key Basic Research and Development Program (973) [2011CB707702, 2012CB518501]; National Natural Science Foundation of China [30930112, 30970774, 60901064, 30873462, 81000640, 81000641, 81071217, 81101036, 81101108, 31150110171]; Fundamental Research Funds for the Central Universities; Knowledge Innovation Program of the Chinese Academy of Sciences [KGCX2-YW-129]	Project for the National Key Basic Research and Development Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This study was supported by the Project for the National Key Basic Research and Development Program (973) under Grant Nos. 2011CB707702 and 2012CB518501; the National Natural Science Foundation of China under Grant Nos. 30930112, 30970774, 60901064, 30873462, 81000640, 81000641, 81071217, 81101036, 81101108 and 31150110171; the Fundamental Research Funds for the Central Universities and the Knowledge Innovation Program of the Chinese Academy of Sciences under Grant No. KGCX2-YW-129. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboujaoude E, 2010, WORLD PSYCHIATRY, V9, P85; Beard KW, 2001, CYBERPSYCHOL BEHAV, V4, P377, DOI 10.1089/109493101300210286; Block JJ, 2008, AM J PSYCHIAT, V165, P306, DOI 10.1176/appi.ajp.2007.07101556; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Cao FL, 2007, EUR PSYCHIAT, V22, P466, DOI 10.1016/j.eurpsy.2007.05.004; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chou C, 2005, EDUC PSYCHOL REV, V17, P363, DOI 10.1007/s10648-005-8138-1; Christakis DA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-61; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; David SP, 2005, BIOL PSYCHIAT, V58, P488, DOI 10.1016/j.biopsych.2005.04.028; Dong GH, 2011, NEUROSCI LETT, V499, P114, DOI 10.1016/j.neulet.2011.05.047; Dong GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014703; Dong GH, 2010, NEUROSCI LETT, V485, P138, DOI 10.1016/j.neulet.2010.09.002; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Durkee T, 2012, ADDICTION, V107, P2210, DOI 10.1111/j.1360-0443.2012.03946.x; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Flisher C, 2010, J PAEDIATR CHILD H, V46, P557, DOI 10.1111/j.1440-1754.2010.01879.x; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Gilman JM, 2008, ADDICT BIOL, V13, P423, DOI 10.1111/j.1369-1600.2008.00111.x; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; JUN L, 2010, CHINESE MED J, V123, P1904; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kilts CD, 2001, ARCH GEN PSYCHIAT, V58, P334, DOI 10.1001/archpsyc.58.4.334; Kim SH, 2011, NEUROREPORT, V22, P407, DOI 10.1097/WNR.0b013e328346e16e; Ko CH, 2013, ADDICT BIOL, V18, P559, DOI 10.1111/j.1369-1600.2011.00405.x; Ko CH, 2010, PSYCHIAT RES, V175, P121, DOI 10.1016/j.psychres.2008.10.004; Ko CH, 2009, J PSYCHIATR RES, V43, P739, DOI 10.1016/j.jpsychires.2008.09.012; Kuhn S, 2010, BIOL PSYCHIAT, V68, P1061, DOI 10.1016/j.biopsych.2010.08.004; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maguire EA, 2006, HIPPOCAMPUS, V16, P1091, DOI 10.1002/hipo.20233; May A, 2011, TRENDS COGN SCI, V15, P475, DOI 10.1016/j.tics.2011.08.002; Morahan-Martin J, 2000, COMPUT HUM BEHAV, V16, P13, DOI 10.1016/S0747-5632(99)00049-7; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; Park HS, 2010, CNS SPECTRUMS, V15, P159, DOI 10.1017/S1092852900027437; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Pine D S, 2001, CNS Spectr, V6, P27; Primus RJ, 1997, J PHARMACOL EXP THER, V282, P1020; Rao SM, 1996, J CEREBR BLOOD F MET, V16, P1250, DOI 10.1097/00004647-199611000-00020; Recupero PR, 2008, J AM ACAD PSYCHIATRY, V36, P505; Schinka JA, 2002, AM J MED GENET, V114, P643, DOI 10.1002/ajmg.10649; Schnitzler A, 1997, NEUROIMAGE, V6, P201, DOI 10.1006/nimg.1997.0286; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; SHIBASAKI H, 1993, BRAIN, V116, P1387, DOI 10.1093/brain/116.6.1387; Silveri MM, 2004, ANN NY ACAD SCI, V1021, P363, DOI 10.1196/annals.1308.046; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Wilson SJ, 2004, NAT NEUROSCI, V7, P211, DOI 10.1038/nn1200; Xu J, 2007, NEUROPSYCHOPHARMACOL, V32, P1421, DOI 10.1038/sj.npp.1301272; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]; Young K S., 1999, INNOVATIONS CLIN PRA, P19; Young K, 2010, WORLD PSYCHIATRY, V9, P91; Yuan Kai, 2011, Commun Integr Biol, V4, P637; Yuan K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020708; Zhou Y, 2011, EUR J RADIOL, V79, P92, DOI 10.1016/j.ejrad.2009.10.025	57	90	94	5	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53055	10.1371/journal.pone.0053055	http://dx.doi.org/10.1371/journal.pone.0053055			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326379	Green Published, Green Submitted, gold			2022-12-25	WOS:000313551500045
J	Currie, MA; Cameron, K; Dias, FMV; Spencer, HL; Bayer, EA; Fontes, CMGA; Smith, SP; Jia, ZC				Currie, Mark A.; Cameron, Kate; Dias, Fernando M. V.; Spencer, Holly L.; Bayer, Edward A.; Fontes, Carlos M. G. A.; Smith, Steven P.; Jia, Zongchao			Small Angle X-ray Scattering Analysis of Clostridium thermocellum Cellulosome N-terminal Complexes Reveals a Highly Dynamic Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; COHESIN DOMAIN; BINDING; ENDOGLUCANASE; MECHANISM; PROTEINS; INSIGHTS; NANOMACHINES; PROVIDES; CIPA	Clostridium thermocellum produces the prototypical cellulosome, a large multienzyme complex that efficiently hydrolyzes plant cell wall polysaccharides into fermentable sugars. This ability has garnered great interest in its potential application in biofuel production. The core non-catalytic scaffoldin subunit, CipA, bears nine type I cohesin modules that interact with the type I dockerin modules of secreted hydrolytic enzymes and promotes catalytic synergy. Because the large size and flexibility of the cellulosome preclude structural determination by traditional means, the structural basis of this synergy remains unclear. Small angle x-ray scattering has been successfully applied to the study of flexible proteins. Here, we used small angle x-ray scattering to determine the solution structure and to analyze the conformational flexibility of two overlapping N-terminal cellulosomal scaffoldin fragments comprising two type I cohesin modules and the cellulose-specific carbohydrate-binding module from CipA in complex with Cel8A cellulases. The pair distribution functions, ab initio envelopes, and rigid body models generated for these two complexes reveal extended structures. These two N-terminal cellulosomal fragments are highly dynamic and display no preference for extended or compact conformations. Overall, our work reveals structural and dynamic features of the N terminus of the CipA scaffoldin that may aid in cellulosome substrate recognition and binding.	[Currie, Mark A.; Spencer, Holly L.; Smith, Steven P.; Jia, Zongchao] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Smith, Steven P.; Jia, Zongchao] Queens Univ, Prot Funct Discovery Grp, Kingston, ON K7L 3N6, Canada; [Cameron, Kate; Dias, Fernando M. V.; Fontes, Carlos M. G. A.] Univ Tecn Lisboa, Fac Med Vet, Ctr Interdisciplinar Invest Sanidade Anim, P-1300477 Lisbon, Portugal; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Queens University - Canada; Queens University - Canada; Universidade de Lisboa; Weizmann Institute of Science	Smith, SP (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Botterell Hall,18 Stuart St, Kingston, ON K7L 3N6, Canada.	steven.smith@queensu.ca; jia@queensu.ca	Dias, Fernando/I-4861-2012	Dias, Fernando/0000-0001-8109-2063; Smith, Steven/0000-0003-2710-4400; Fontes, Carlos/0000-0002-1219-9753	Natural Science and Engineering Research Council of Canada; Canadian Institutes of Health Research	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by research grants from the Natural Science and Engineering Research Council of Canada (to S. P. S.) and the Canadian Institutes of Health Research (to Z. J.).	Adams JJ, 2010, J MOL BIOL, V396, P833, DOI 10.1016/j.jmb.2010.01.015; Alzari PM, 1996, STRUCTURE, V4, P265, DOI 10.1016/S0969-2126(96)00031-7; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; BAYER EA, 1994, TRENDS BIOTECHNOL, V12, P379, DOI 10.1016/0167-7799(94)90039-6; Bayer EA, 1998, J STRUCT BIOL, V124, P221, DOI 10.1006/jsbi.1998.4065; BAYER EA, 1986, J BACTERIOL, V167, P828, DOI 10.1128/jb.167.3.828-836.1986; Beguin P, 1998, BIOCHEM SOC T, V26, P178, DOI 10.1042/bst0260178; Brett CT, 1996, PHYSL BIOCH PLANT CE; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104; Correia MAS, 2008, J MOL BIOL, V379, P64, DOI 10.1016/j.jmb.2008.03.037; Currie MA, 2012, J BIOL CHEM, V287, P26953, DOI 10.1074/jbc.M112.343897; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Garcia-Alvarez B, 2011, J MOL BIOL, V407, P571, DOI 10.1016/j.jmb.2011.01.060; GERNGROSS UT, 1993, MOL MICROBIOL, V8, P325, DOI 10.1111/j.1365-2958.1993.tb01576.x; Gilbert HJ, 2007, MOL MICROBIOL, V63, P1568, DOI 10.1111/j.1365-2958.2007.05640.x; Guimaraes BG, 2002, J MOL BIOL, V320, P587, DOI 10.1016/S0022-2836(02)00497-7; GUINIER A, 1955, SMALL ANGLE XRAYS; Hammel M, 2005, J BIOL CHEM, V280, P38562, DOI 10.1074/jbc.M503168200; Hammel M, 2004, J BIOL CHEM, V279, P55985, DOI 10.1074/jbc.M408979200; Himmel ME, 2009, CURR OPIN BIOTECH, V20, P316, DOI 10.1016/j.copbio.2009.05.005; Jordan DB, 2012, BIOCHEM J, V442, P241, DOI 10.1042/BJ20111922; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitago Y, 2007, J BIOL CHEM, V282, P35703, DOI 10.1074/jbc.M706835200; LAMED R, 1983, BIOTECHNOL BIOENG, P163; LAMED R, 1983, J BACTERIOL, V156, P828, DOI 10.1128/JB.156.2.828-836.1983; Lytle BL, 2001, J MOL BIOL, V307, P745, DOI 10.1006/jmbi.2001.4522; MAYER F, 1987, APPL ENVIRON MICROB, V53, P2785, DOI 10.1128/AEM.53.12.2785-2792.1987; Molinier AL, 2011, J MOL BIOL, V405, P143, DOI 10.1016/j.jmb.2010.10.013; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; POOLE DM, 1992, FEMS MICROBIOL LETT, V99, P181, DOI 10.1111/j.1574-6968.1992.tb05563.x; Schaeffer F, 2002, BIOCHEMISTRY-US, V41, P2106, DOI 10.1021/bi011853m; Shimon LJW, 1997, STRUCTURE, V5, P381, DOI 10.1016/S0969-2126(97)00195-0; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tavares GA, 1997, J MOL BIOL, V273, P701, DOI 10.1006/jmbi.1997.1326; Tormo J, 1996, J EUR MOL BIOL ORG E, V5, P5739; Warren RAJ, 1996, ANNU REV MICROBIOL, V50, P183, DOI 10.1146/annurev.micro.50.1.183	41	19	19	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7978	7985		10.1074/jbc.M112.408757	http://dx.doi.org/10.1074/jbc.M112.408757			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23341454	Green Published, hybrid			2022-12-25	WOS:000316455300050
J	Xu, L; Freitas, SMA; Yu, FH; Dong, M; Anten, NPR; Werger, MJA				Xu, Liang; Freitas, Sofia M. A.; Yu, Fei-Hai; Dong, Ming; Anten, Niels P. R.; Werger, Marinus J. A.			Effects of Trampling on Morphological and Mechanical Traits of Dryland Shrub Species Do Not Depend on Water Availability	PLOS ONE			English	Article							BEAN-PLANTS; GROWTH; VEGETATION; STRESS; RESISTANCE; THIGMOMORPHOGENESIS; HETEROGENEITY; AVOIDANCE; TOLERANCE; DIVERSITY	In semiarid drylands water shortage and trampling by large herbivores are two factors limiting plant growth and distribution. Trampling can strongly affect plant performance, but little is known about responses of morphological and mechanical traits of woody plants to trampling and their possible interaction with water availability. Seedlings of four shrubs (Caragana intermedia, Cynanchum komarovi, Hedysarum laeve and Hippophae rhamnoides) common in the semiarid Mu Us Sandland were grown at 4% and 10% soil water content and exposed to either simulated trampling or not. Growth, morphological and mechanical traits were measured. Trampling decreased vertical height and increased basal diameter and stem resistance to bending and rupture (as indicated by the increased minimum bend and break force) in all species. Increasing water availability increased biomass, stem length, basal diameter, leaf thickness and rigidity of stems in all species except C. komarovii. However, there were no interactive effects of trampling and water content on any of these traits among species except for minimum bend force and the ratio between stem resistance to rupture and bending. Overall shrub species have a high degree of trampling resistance by morphological and mechanical modifications, and the effects of trampling do not depend on water availability. However, the increasing water availability can also affect trade-off between stem strength and flexibility caused by trampling, which differs among species. Water plays an important role not only in growth but also in trampling adaptation in drylands.	[Xu, Liang; Dong, Ming] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Xu, Liang; Freitas, Sofia M. A.; Anten, Niels P. R.; Werger, Marinus J. A.] Univ Utrecht, Inst Environm Biol, Utrecht, Netherlands; [Yu, Fei-Hai] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China; [Anten, Niels P. R.] Wageningen Univ, Ctr Crop Syst Anal, NL-6700 AP Wageningen, Netherlands; [Xu, Liang; Dong, Ming] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China	Hangzhou Normal University; Utrecht University; Beijing Forestry University; Wageningen University & Research; Chinese Academy of Sciences; Institute of Botany, CAS	Dong, M (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	dongmingchina@126.com	Yu, Fei-Hai/O-9395-2016	Yu, Fei-Hai/0000-0001-5007-1745	NSFC [31070371, 31261120580]; Hangzhou Normal University; KNAW grant [02CDC015, 99CDC027]	NSFC(National Natural Science Foundation of China (NSFC)); Hangzhou Normal University; KNAW grant	This work was supported by NSFC grants (31070371, 31261120580), Innovative R&D Grant of Hangzhou Normal University and KNAW grants (02CDC015 and 99CDC027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres-Abellan M, 2006, ENVIRON MONIT ASSESS, V120, P93, DOI 10.1007/s10661-005-9051-2; Anten NPR, 2009, AM NAT, V173, P241, DOI 10.1086/595761; Anten NPR, 2005, AM NAT, V166, P650, DOI 10.1086/497442; BIRO RL, 1980, ANN BOT-LONDON, V45, P655, DOI 10.1093/oxfordjournals.aob.a085874; BOWLES JM, 1982, BIOL CONSERV, V24, P273, DOI 10.1016/0006-3207(82)90015-5; Cui H., 1998, FLORA CHINA, V42; Dong X.J., 1997, CHINESE J PLANT ECOL, V21, P208; Dunne T, 2011, J ARID ENVIRON, V75, P58, DOI 10.1016/j.jaridenv.2010.09.001; Fang W-P, 1983, FLORA CHINA, V52; Fu K-J, 1993, FLORA CHINA, V42; Gere JM, 1999, MECH MAT; Goodman AM, 1996, J EXP BOT, V47, P1499, DOI 10.1093/jxb/47.10.1499; Hamberg L, 2010, J ENVIRON MANAGE, V91, P1811, DOI 10.1016/j.jenvman.2010.04.003; Hanke W, 2011, J ARID ENVIRON, V75, P185, DOI 10.1016/j.jaridenv.2010.09.002; [贺斌 HE Bin], 2006, [西北林学院学报, Journal of Northwest Forestry College], V21, P54; Hill R, 2009, J ENVIRON MANAGE, V90, P1305, DOI 10.1016/j.jenvman.2008.07.015; Housman DC, 2007, SOIL BIOL BIOCHEM, V39, P2138, DOI 10.1016/j.soilbio.2007.03.015; Ibanez J, 2007, ECOL MODEL, V205, P277, DOI 10.1016/j.ecolmodel.2007.02.024; JAFFE MJ, 1984, PHYSIOL PLANTARUM, V62, P73, DOI 10.1111/j.1399-3054.1984.tb05925.x; Jiang Y, 1977, FLORA CHINA, V63; Kobayashi T, 1997, J VEG SCI, V8, P873, DOI 10.2307/3237032; Kobayashi T, 1999, PLANT BIOLOGY, V1, P445, DOI 10.1055/s-2007-978538; Kutiel P, 2000, J ARID ENVIRON, V44, P277, DOI 10.1006/jare.1999.0602; LIDDLE M J, 1975, Biological Conservation, V8, P251, DOI 10.1016/0006-3207(75)90002-6; Lin HuiLong, 2008, Acta Prataculturae Sinica, V17, P85; Littlemore James, 2001, Urban Ecosystems, V5, P257, DOI 10.1023/A:1025639828427; Malmivaara-Lamsa Minna, 2008, Urban Ecosystems, V11, P1, DOI 10.1007/s11252-007-0046-3; Meerts P, 1996, OECOLOGIA, V108, P438, DOI 10.1007/BF00333719; Niklas KJ, 1996, ANN BOT-LONDON, V78, P61, DOI 10.1006/anbo.1996.0096; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Puijalon S, 2011, NEW PHYTOL, V191, P1141, DOI 10.1111/j.1469-8137.2011.03763.x; Puijalon S, 2008, NEW PHYTOL, V177, P907, DOI 10.1111/j.1469-8137.2007.02314.x; Rodgers K, 2003, ENVIRON MANAGE, V31, P377, DOI 10.1007/s00267-002-2831-3; Rusterholz HP, 2009, PERSPECT PLANT ECOL, V11, P17, DOI 10.1016/j.ppees.2008.09.002; Sorensen LI, 2009, ECOSYSTEMS, V12, P830, DOI 10.1007/s10021-009-9260-6; Striker GG, 2011, APPL VEG SCI, V14, P95, DOI 10.1111/j.1654-109X.2010.01093.x; STRUIK GJ, 1965, ECOLOGY, V46, P401, DOI 10.2307/1934873; SUN D, 1993, BIOL CONSERV, V65, P35, DOI 10.1016/0006-3207(93)90194-6; Sun D, 1993, ENVIRON MANAGE, V17, P551; TELEWSKI FW, 1990, CAN J FOREST RES, V20, P1277, DOI 10.1139/x90-170; Wang YH, 2009, PLANT BIOLOGY, V11, P694, DOI 10.1111/j.1438-8677.2008.00168.x; Wang YH, 2008, INT J PLANT SCI, V169, P503, DOI 10.1086/528750; Xu L, 2012, ANN BOT-LONDON, V109, P1001, DOI 10.1093/aob/mcs006; Zhang C.Y., 2001, ACTA ECOL SIN, V21, P1986; Zhang X., 1994, ACTA ECOL SIN, V18, P1, DOI DOI 10.1111/1365-2745.12089	45	14	17	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53021	10.1371/journal.pone.0053021	http://dx.doi.org/10.1371/journal.pone.0053021			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341918	gold, Green Submitted, Green Published			2022-12-25	WOS:000313682700018
J	Moritoh, S; Komatsu, Y; Yamamori, T; Koizumi, A				Moritoh, Satoru; Komatsu, Yusuke; Yamamori, Tetsuo; Koizumi, Amane			Diversity of Retinal Ganglion Cells Identified by Transient GFP Transfection in Organotypic Tissue Culture of Adult Marmoset Monkey Retina	PLOS ONE			English	Article							NEW-WORLD MONKEY; MIDGET-PARVOCELLULAR PATHWAY; CALLITHRIX-JACCHUS; PRIMATE RETINA; SYNAPTIC CONNECTIVITY; SPATIAL DENSITY; BIPOLAR INPUT; IN-VITRO; MORPHOLOGY; MACAQUE	The mammalian retina has more diversity of neurons than scientists had once believed in order to establish complicated vision processing. In the monkey retina, morphological diversity of retinal ganglion cells (RGCs) besides dominant midget and parasol cells has been suggested. However, characteristic subtypes of RGCs in other species such as bistratified direction-selective ganglion cells (DSGC) have not yet been identified. Increasing interest has been shown in the common marmoset (Callithrix jacchus) monkey as a "super-model" of neuroscientific research. Here, we established organotypic tissue culture of the adult marmoset monkey retina with particle-mediated gene transfer of GFP to survey the morphological diversity of RGCs. We successfully incubated adult marmoset monkey retinas for 2 to 4 days ex vivo for transient expression of GFP. We morphologically examined 121 RGCs out of more than 3240 GFP-transfected cells in 5 retinas. Among them, we identified monostratified or broadly stratified ganglion cells (midget, parasol, sparse, recursive, thorny, and broad thorny ganglion cells), and bistratified ganglion cells (recursive, large, and small bistratified ganglion cells [blue-ON/yellow-OFF-like]). By this survey, we also found a candidate for bistratified DSGC whose dendrites were well cofasciculated with ChAT-positive starburst dendrites, costratified with ON and OFF ChAT bands, and had honeycomb-shaped dendritic arbors morphologically similar to those in rabbits. Our genetic engineering method provides a new approach to future investigation for morphological and functional diversity of RGCs in the monkey retina.	[Moritoh, Satoru; Koizumi, Amane] Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 444, Japan; [Komatsu, Yusuke; Yamamori, Tetsuo] Natl Inst Basic Biol, Div Brain Biol, Okazaki, Aichi 444, Japan; [Koizumi, Amane] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Physiol Sci, Okazaki, Aichi, Japan; [Yamamori, Tetsuo] Grad Univ Adv Studies SOKENDAI, Dept Mol Biomech, Okazaki, Aichi, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Graduate University for Advanced Studies - Japan	Koizumi, A (corresponding author), Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 444, Japan.	amane@nips.ac.jp	Yamamori, Tetsuo/N-6536-2015	Yamamori, Tetsuo/0000-0001-5016-0078; Koizumi, Amane/0000-0003-1177-0185	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was financially supported by a Grant-in-Aid for Scientific Research (C) (A.K.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. A part of this study is the result of the project, "Highly Creative Animal Model Development for Brain Sciences" carried out under the Strategic Research Program for Brain Sciences by the MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CJ, 2012, VISUAL NEUROSCI, V29, P157, DOI 10.1017/S095252381200017X; Badea TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007859; Dacey D, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P281; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; Dacey DM, 2003, NEURON, V37, P15, DOI 10.1016/S0896-6273(02)01143-1; Dong W, 2004, J PHYSIOL-LONDON, V556, P11, DOI 10.1113/jphysiol.2004.060715; Erikoz B, 2008, VISUAL NEUROSCI, V25, P67, DOI 10.1017/S0952523808080073; Ghosh KK, 1996, J COMP NEUROL, V366, P76, DOI 10.1002/(SICI)1096-9861(19960226)366:1<76::AID-CNE6>3.0.CO;2-H; Ghosh KK, 1997, J COMP NEUROL, V379, P211; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Goodchild AK, 1996, J COMP NEUROL, V366, P55, DOI 10.1002/(SICI)1096-9861(19960226)366:1<55::AID-CNE5>3.0.CO;2-J; Grunert U, 2011, VISUAL NEUROSCI, V28, P39, DOI 10.1017/S095252381000026X; Iioka H, 2004, J CELL BIOL, V164, P169, DOI 10.1083/jcb.200310027; Ivanova E, 2010, INVEST OPHTH VIS SCI, V51, P5288, DOI 10.1167/iovs.10-5389; Jakobs TC, 2008, J COMP NEUROL, V510, P221, DOI 10.1002/cne.21795; Jusuf PR, 2007, EUR J NEUROSCI, V26, P2906, DOI 10.1111/j.1460-9568.2007.05924.x; Jusuf PR, 2006, J COMP NEUROL, V494, P260, DOI 10.1002/cne.20804; Koizumi A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000221; Koizumi A, 2011, J COMP NEUROL, V519, P341, DOI 10.1002/cne.22522; KOLB H, 1992, J COMP NEUROL, V318, P147, DOI 10.1002/cne.903180204; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Moritoh S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012917; Percival KA, 2011, J COMP NEUROL, V519, P2135, DOI 10.1002/cne.22586; Percival KA, 2009, J COMP NEUROL, V517, P655, DOI 10.1002/cne.22183; RODIECK RW, 1992, J COMP NEUROL, V321, P46, DOI 10.1002/cne.903210106; RODIECK RW, 1993, J COMP NEUROL, V338, P289, DOI 10.1002/cne.903380211; Sanes JR, 2011, CEREBRAL PLASTICITY, P35; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; Szmajda BA, 2008, J COMP NEUROL, V510, P251, DOI 10.1002/cne.21783; Telkes I, 2008, J COMP NEUROL, V510, P539, DOI 10.1002/cne.21813; TROILO D, 1993, VISION RES, V33, P1301, DOI 10.1016/0042-6989(93)90038-X; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; Wilder HD, 1996, VISUAL NEUROSCI, V13, P335, DOI 10.1017/S0952523800007586; Yamada ES, 2005, VISUAL NEUROSCI, V22, P383, DOI 10.1017/S095252380522401X; YANG G, 1994, J NEUROSCI, V14, P5267	37	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54667	10.1371/journal.pone.0054667	http://dx.doi.org/10.1371/journal.pone.0054667			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23336011	Green Published, gold, Green Submitted			2022-12-25	WOS:000314707700069
J	Moon, CH; Lee, SJ; Lee, HY; Lee, JC; Cha, H; Cho, WJ; Park, JW; Park, HJ; Seo, J; Lee, YH; Song, HT; Min, YJ				Moon, Chang Hoon; Lee, Seung Ju; Lee, Ho Yong; Lee, Jong Cheol; Cha, HeeJeong; Cho, Wha Ja; Park, Jeong Woo; Park, Hyun Jin; Seo, Jin; Lee, Young Han; Song, Ho-Taek; Min, Young Joo			KML001 Displays Vascular Disrupting Properties and Irinotecan Combined Antitumor Activities in a Murine Tumor Model	PLOS ONE			English	Article							5,6-DIMETHYLXANTHENONE-4-ACETIC ACID; TARGETING AGENTS; CANCER; MECHANISMS; APOPTOSIS; NECROSIS; PROSTATE; BINDING	KML001 is sodium metaarsenite, and has shown cytotoxic activity in human tumor cell lines. The anti-cancer mechanism of KML001 involves cancer cell destruction due to DNA damage at the telomeres of cancer cell chromosomes. In this study, we assessed the vascular disrupting properties of KML001 and investigated whether KML001 as VDA is able to increase anti-tumor activity in irinotecan combined treatment. We used a murine model of the CT26 colon carcinoma cell line. CT26 isograft mice treated intraperitoneally with 10 mg/kg KML001 displayed extensive central necrosis of tumor by 24 h. The vascular disrupting effects of KML001 were assessed by dynamic contrast enhanced magnetic resonance imaging. Gadopentetic acid-diethylene triaminepentaacetic acid contrast enhancement was markedly decreased in KML001-treated mice one day after treatment, whereas persistently high signal enhancement was observed in mice injected with saline. Rate constant K-ep value representing capillary permeability was significantly decreased (p<0.05) in mice treated with KML001. Cytoskeletal changes of human umbilical vein endothelial cells (HUVECs) treated with 10 uM KML001 were assessed by immune blotting and confocal imaging. KML001 degraded tubulin protein in HUVECs, which may be related to vascular disrupting properties of KML001. Finally, in the mouse CT26 isograft model, KML001 combined with irinotecan significantly delayed tumor growth as compared to control and irinotecan alone. These results suggest that KML001 is a novel vascular disrupting agent, which exhibits significant vascular shut-down activity and enhances anti-tumor activity in combination with chemotherapy. These data further suggest an avenue for effective combination therapy in treating solid tumors.	[Moon, Chang Hoon; Lee, Seung Ju; Lee, Ho Yong; Cho, Wha Ja; Min, Young Joo] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Biomed Res Ctr, Ulsan 680749, South Korea; [Lee, Jong Cheol] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Otorhinolaryngol, Ulsan 680749, South Korea; [Cha, HeeJeong] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Pathol, Ulsan 680749, South Korea; [Park, Jeong Woo] Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea; [Park, Hyun Jin; Seo, Jin; Lee, Young Han; Song, Ho-Taek] Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Park, Hyun Jin; Seo, Jin; Lee, Young Han; Song, Ho-Taek] Yonsei Univ, Coll Med, Res Inst Radiol Sci, Seoul, South Korea; [Min, Young Joo] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Div Hematol Oncol,Dept Internal Med, Ulsan 680749, South Korea	University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital; University of Ulsan; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University of Ulsan; Ulsan University Hospital	Min, YJ (corresponding author), Univ Ulsan, Coll Med, Ulsan Univ Hosp, Biomed Res Ctr, Ulsan 680749, South Korea.	yjmin@uuh.ulsan.kr	Song, Ho-Taek/K-3807-2014; Lee, Jong Cheol/K-3603-2019	Song, Ho-Taek/0000-0002-6655-2575; Lee, Young Han/0000-0002-5602-391X	Priority Research Center Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0029621]; Komipharm International Co., LTD in Korea; Komipharm International Co., LTD.	Priority Research Center Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Komipharm International Co., LTD in Korea; Komipharm International Co., LTD.	This work was supported by Priority Research Center Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0029621) and by grants from the Komipharm International Co., LTD in Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received funding from a commercial source (Komipharm International Co., LTD). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bouzin C, 2007, DRUG RESIST UPDATE, V22, P97; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Chaplin DJ, 2006, CURR OPIN INVEST DR, V7, P522; Chen GQ, 1996, BLOOD, V88, P1052; Ching LM, 1999, CANCER RES, V59, P3304; Demsar F, 1997, MAGNET RESON MED, V37, P236, DOI 10.1002/mrm.1910370216; Esteve MA, 2007, CURR CANCER DRUG TAR, V7, P713; Hammers HJ, 2010, MOL CANCER THER, V9, P1525, DOI 10.1158/1535-7163.MCT-09-1106; Hinnen P, 2007, BRIT J CANCER, V96, P1159, DOI 10.1038/sj.bjc.6603694; Horsman MR, 2006, CANCER RES, V66, P11520, DOI 10.1158/0008-5472.CAN-06-2848; Jordan MA, 2007, CURR CANCER DRUG TAR, V7, P730, DOI 10.2174/156800907783220417; Joseph WR, 1999, CANCER RES, V59, P633; Kanthou C, 2009, INT J EXP PATHOL, V90, P284, DOI 10.1111/j.1365-2613.2009.00651.x; Kleespies A, 2005, NEOPLASIA, V7, P957, DOI 10.1593/neo.05304; Lew YS, 1999, CANCER RES, V59, P6033; Ma MK, 2003, CURR MED CHEM, V10, P41, DOI 10.2174/0929867033368619; McKeage MJ, 2008, BRIT J CANCER, V99, P2006, DOI 10.1038/sj.bjc.6604808; Miller WH, 2002, CANCER RES, V62, P3893; Patterson DA, 2007, CLIN ONCOL-UK, V19, P443, DOI 10.1016/j.clon.2007.03.014; Phatak P, 2008, CLIN CANCER RES, V14, P4593, DOI 10.1158/1078-0432.CCR-07-4572; Seshadri M, 2008, INT J RADIAT ONCOL, V72, P1198, DOI 10.1016/j.ijrobp.2008.07.043; Sun H. D., 1992, CHIN J INTEGRAT CHIN, V12, P170; Thorpe PE, 2004, CLIN CANCER RES, V10, P415, DOI 10.1158/1078-0432.CCR-0642-03; Uslu R, 2000, CLIN CANCER RES, V6, P4957; ZHANG P, 1996, CHIN J HEMATOL, V17, P58; Zweifel M, 2009, J CLIN ONCOL, V27; Zweifel M, 2010, EUR J NUCL MED MOL I, V37, pS164, DOI 10.1007/s00259-010-1451-z	27	122	124	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53900	10.1371/journal.pone.0053900	http://dx.doi.org/10.1371/journal.pone.0053900			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326531	Green Published, gold, Green Submitted			2022-12-25	WOS:000314705800085
J	Saponaro, C; Malfettone, A; Ranieri, G; Danza, K; Simone, G; Paradiso, A; Mangia, A				Saponaro, Concetta; Malfettone, Andrea; Ranieri, Girolamo; Danza, Katia; Simone, Giovanni; Paradiso, Angelo; Mangia, Anita			VEGF, HIF-1 alpha Expression and MVD as an Angiogenic Network in Familial Breast Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; MICROVESSEL DENSITY; PROGNOSTIC-SIGNIFICANCE; TUMOR ANGIOGENESIS; COLORECTAL-CANCER; BRCA1; CARCINOMA; ALPHA; HIF-1	Angiogenesis, which plays an important role in tumor growth and progression of breast cancer, is regulated by a balance between pro- and anti-angiogenic factors. Expression of vascular endothelial growth factor (VEGF) is up-regulated during hypoxia by hypoxia-inducible factor-1 alpha (HIF-1 alpha). It is known that there is an interaction between HIF-1 alpha and BRCA1 carrier cancers, but little has been reported about angiogenesis in BRCA1-2 carrier and BRCAX breast cancers. In this study, we investigated the expression of VEGF and HIF-1 alpha and microvessel density (MVD) in 26 BRCA1-2 carriers and 58 BRCAX compared to 77 sporadic breast cancers, by immunohistochemistry. VEGF expression in BRCA1-2 carriers was higher than in BRCAX cancer tissues (p = 0.0001). Furthermore, VEGF expression was higher in both BRCA1-2 carriers and BRCAX than the sporadic group (p<0.0001). VEGF immunoreactivity was correlated with poor tumor grade (p = 0.0074), hormone receptors negativity (p = 0.0206, p = 0.0002 respectively), and MIB-1-labeling index (p = 0.0044) in familial cancers (BRCA1-2 and BRCAX). The percentage of nuclear HIF-1 alpha expression was higher in the BRCA1-2 carriers than in BRCAX cancers (p<0.05), and in all familial than in sporadic tumor tissues (p = 0.0045). A higher MVD was observed in BRCA1-2 carrier than in BRCAX and sporadic cancer tissues (p = 0.002, p = 0.0001 respectively), and in all familial tumors than in sporadic tumors (p = 0.01). MVD was positively related to HIF-1 alpha expression in BRCA1-2 carriers (r = 0.521, p = 0.006), and, in particular, we observed a highly significant correlation in the familial group (r = 0.421, p<0.0001). Our findings suggest that angiogenesis plays a crucial role in BRCA1-2 carrier breast cancers. Prospective studies in larger BRCA1-2 carrier series are needed to improve the best therapeutic strategies for this subgroup of breast cancer patients.	[Saponaro, Concetta; Malfettone, Andrea; Mangia, Anita] Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Funct Biomorphol Lab, Bari, Italy; [Ranieri, Girolamo] Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Unit Intervent Radiol, Bari, Italy; [Danza, Katia] Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Mol Genet Lab, Bari, Italy; [Simone, Giovanni] Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Dept Pathol, Bari, Italy; [Paradiso, Angelo] Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Sci Direct, Bari, Italy	IRCCS Istituto Tumori Bari Giovanni Paolo II; IRCCS Istituto Tumori Bari Giovanni Paolo II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Istituto Tumori Bari Giovanni Paolo II; IRCCS Istituto Tumori Bari Giovanni Paolo II; IRCCS Istituto Tumori Bari Giovanni Paolo II	Mangia, A (corresponding author), Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Funct Biomorphol Lab, Bari, Italy.	a.mangia@oncologico.bari.it	paradiso, angelo V/J-9457-2018; Ranieri, Girolamo/AAJ-7929-2020; Danza, Katia/K-3182-2018; Malfettone, Andrea/AAK-9280-2021; Saponaro, Concetta/K-7886-2018; Mangia, Anita/K-3662-2018	Ranieri, Girolamo/0000-0002-7952-694X; Danza, Katia/0000-0001-6562-9094; Saponaro, Concetta/0000-0002-8196-3583; Mangia, Anita/0000-0003-4729-0888	Progetto Strategico Regionale Puglia- APQ "le biotecnologie applicate alla targeted therapy in oncologia (Biotecnoter)''	Progetto Strategico Regionale Puglia- APQ "le biotecnologie applicate alla targeted therapy in oncologia (Biotecnoter)''	This work was partially funded by Progetto Strategico Regionale Puglia- APQ "le biotecnologie applicate alla targeted therapy in oncologia (Biotecnoter)''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahlgren J, 2002, EUR J CANCER, V38, P64, DOI 10.1016/S0959-8049(01)00349-5; Ali SH, 2000, CANCER RES, V60, P7094; Bluff JE, 2009, BRIT J CANCER, V101, P666, DOI 10.1038/sj.bjc.6605196; Bos R, 2005, HISTOPATHOLOGY, V46, P31, DOI 10.1111/j.1365-2559.2005.02045.x; Cao D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-432; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carpini JD, 2010, ANGIOGENESIS, V13, P43, DOI 10.1007/s10456-010-9163-3; Chaudary Naz, 2006, Breast Dis, V26, P55; COSTELLO P, 1995, HUM PATHOL, V26, P1181, DOI 10.1016/0046-8177(95)90190-6; El-Gendi Saba, 2009, J Egypt Natl Canc Inst, V21, P139; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Fernandez-Ramires R, 2011, INT J CANCER, V128, P2635, DOI 10.1002/ijc.25603; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Ferrara N, 2009, EUR CYTOKINE NETW, V20, P158, DOI 10.1684/ecn.2009.0170; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; Garzetti GG, 1999, GYNECOL ONCOL, V73, P396, DOI 10.1006/gyno.1999.5377; Gronwald J, 2005, INT J CANCER, V114, P230, DOI 10.1002/ijc.20723; Guo SC, 2010, BBA-REV CANCER, V1806, P108, DOI 10.1016/j.bbcan.2010.04.004; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hansen S, 2000, BRIT J CANCER, V82, P339; Isobe T, 2013, INT J CLIN ONCOL, V18, P293, DOI 10.1007/s10147-012-0378-8; Kang HJ, 2006, J BIOL CHEM, V281, P13047, DOI 10.1074/jbc.M513033200; Kawai H, 2002, ONCOGENE, V21, P7730, DOI 10.1038/sj.onc.1205971; Kimbro KS, 2006, ENDOCR-RELAT CANCER, V13, P739, DOI 10.1677/erc.1.00728; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Kranz A, 1999, INT J CANCER, V84, P293, DOI 10.1002/(SICI)1097-0215(19990621)84:3<293::AID-IJC16>3.0.CO;2-T; Kuwai T, 2003, INT J CANCER, V105, P176, DOI 10.1002/ijc.11068; Liu LL, 2008, CANCER SCI, V99, P121, DOI 10.1111/j.1349-7006.2007.00643.x; Lynch BJ, 1998, HUM PATHOL, V29, P1140, DOI 10.1016/S0046-8177(98)90427-0; Mangia A, 2009, HISTOPATHOLOGY, V55, P600, DOI 10.1111/j.1365-2559.2009.03424.x; Mangia A, 2009, HISTOL HISTOPATHOL, V24, P69, DOI 10.14670/HH-24.69; Medri L, 2000, INT J CANCER, V89, P74, DOI 10.1002/(SICI)1097-0215(20000120)89:1<74::AID-IJC12>3.0.CO;2-L; Mohammed RAA, 2011, MODERN PATHOL, V24, P774, DOI 10.1038/modpathol.2011.4; Mori T, 2011, INT J GYNECOL CANCER, V21, P609, DOI 10.1097/IGC.0b013e3182017e9b; Oda Y, 2006, MODERN PATHOL, V19, P738, DOI 10.1038/modpathol.3800587; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Prager GW, 2012, HAMOSTASEOLOGIE, V32, P105, DOI 10.5482/ha-1163; Ranieri G, 2002, INT J ONCOL, V21, P1317; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Schindl M, 2002, CLIN CANCER RES, V8, P1831; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 2000, CRIT REV BIOCHEM MOL, V35, P71, DOI 10.1080/10409230091169186; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Tarnowski B, 2004, BREAST CANCER RES TR, V88, P287, DOI 10.1007/s10549-004-0779-0; Tayama M, 2011, WORLD J GASTROENTERO, V17, P4867, DOI 10.3748/wjg.v17.i44.4867; Tommasi S, 2005, MUTAT RES-FUND MOL M, V578, P395, DOI 10.1016/j.mrfmmm.2005.06.010; Trinh XB, 2011, CLIN TRANSL ONCOL, V13, P805, DOI 10.1007/s12094-011-0737-3; Tsutsui Shinichi, 2003, Breast Cancer, V10, P312, DOI 10.1007/BF02967651; Uzzan B, 2004, CANCER RES, V64, P2941, DOI 10.1158/0008-5472.CAN-03-1957; van der Groep P, 2008, BREAST CANCER RES TR, V111, P475, DOI 10.1007/s10549-007-9817-z; van der Groep P, 2011, CELL ONCOL, V34, P71, DOI 10.1007/s13402-011-0010-3; Vargas AC, 2011, J MAMMARY GLAND BIOL, V16, P27, DOI 10.1007/s10911-011-9204-6; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Yan M, 2009, BRIT J CANCER, V101, P1168, DOI 10.1038/sj.bjc.6605287; Yoshida K, 2004, CANCER SCI, V95, P866, DOI 10.1111/j.1349-7006.2004.tb02195.x	56	58	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53070	10.1371/journal.pone.0053070	http://dx.doi.org/10.1371/journal.pone.0053070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326384	Green Submitted, gold, Green Published			2022-12-25	WOS:000314705800030
J	Valencia, CA; Ankala, A; Rhodenizer, D; Bhide, S; Littlejohn, MR; Keong, LM; Rutkowski, A; Sparks, S; Bonnemann, C; Hegde, M				Valencia, C. Alexander; Ankala, Arunkanth; Rhodenizer, Devin; Bhide, Shruti; Littlejohn, Martin Robert; Keong, Lisa Mari; Rutkowski, Anne; Sparks, Susan; Bonnemann, Carsten; Hegde, Madhuri			Comprehensive Mutation Analysis for Congenital Muscular Dystrophy: A Clinical PCR-Based Enrichment and Next-Generation Sequencing Panel	PLOS ONE			English	Article							HYBRID SELECTION; CAPTURE; GENE; DIAGNOSTICS	The congenital muscular dystrophies (CMDs) comprise a heterogeneous group of heritable muscle disorders with often difficult to interpret muscle pathology, making them challenging to diagnose. Serial Sanger sequencing of suspected CMD genes, while the current molecular diagnostic method of choice, can be slow and expensive. A comprehensive panel test for simultaneous screening of mutations in all known CMD-associated genes would be a more effective diagnostic strategy. Thus, the CMDs are a model disorder group for development and validation of next-generation sequencing (NGS) strategies for diagnostic and clinical care applications. Using a highly multiplexed PCR-based target enrichment method (RainDance) in conjunction with NGS, we performed mutation detection in all CMD genes of 26 samples and compared the results with Sanger sequencing. The RainDance NGS panel showed great consistency in coverage depth, on-target efficiency, versatility of mutation detection, and genotype concordance with Sanger sequencing, demonstrating the test's appropriateness for clinical use. Compared to single tests, a higher diagnostic yield was observed by panel implementation. The panel's limitation is the amplification failure of select gene-specific exons which require Sanger sequencing for test completion. Successful validation and application of the CMD NGS panel to improve the diagnostic yield in a clinical laboratory was shown.	[Valencia, C. Alexander; Ankala, Arunkanth; Rhodenizer, Devin; Bhide, Shruti; Littlejohn, Martin Robert; Keong, Lisa Mari; Hegde, Madhuri] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Valencia, C. Alexander] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH USA; [Valencia, C. Alexander] Univ Cincinnati, Sch Med, Dept Pediat, Cincinnati, OH USA; [Rutkowski, Anne] Cure CMD, Los Angeles, CA USA; [Rutkowski, Anne] Kaiser SCPMG, Los Angeles, CA USA; [Sparks, Susan] Carolinas Med Ctr, Charlotte, NC 28203 USA; [Bonnemann, Carsten] NINDS, Neuromuscular & Neurogenet Disorders Childhood Se, Neurogenet Branch, NIH, Bethesda, MD 20892 USA	Emory University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Kaiser Permanente; Southern California Permanente Medical Group (SCPMG); Carolinas Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Hegde, M (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	mhegde@emory.edu	Ankala, Arunkanth/G-6330-2011	Ankala, Arunkanth/0000-0002-6373-9916	PHS from the Clinical and Translational Science Award Program, National Institutes of Health (NIH), National Center for Research Resources [UL1 RR025008, KL2 R0025009, TL1 RR025010]; intramural program of the National Institute of Neurological Disorders and Stroke, NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000456, UL1TR000454, KL2TR000455] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025010, UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003129] Funding Source: NIH RePORTER	PHS from the Clinical and Translational Science Award Program, National Institutes of Health (NIH), National Center for Research Resources; intramural program of the National Institute of Neurological Disorders and Stroke, NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported in part by PHS Grants (UL1 RR025008, KL2 R0025009, or TL1 RR025010) from the Clinical and Translational Science Award Program, National Institutes of Health (NIH), National Center for Research Resources. CB is supported by the intramural program of the National Institute of Neurological Disorders and Stroke, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Clement EM, 2012, NEUROMUSCULAR DISORD, V22, P522, DOI 10.1016/j.nmd.2012.01.010; Daiger SP, 2010, ADV EXP MED BIOL, V664, P325, DOI 10.1007/978-1-4419-1399-9_37; Gargis AS, 2012, NAT BIOTECHNOL, V30, P1033, DOI 10.1038/nbt.2403; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Goossens D, 2009, HUM MUTAT, V30, P472, DOI 10.1002/humu.20873; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hodges E, 2009, NAT PROTOC, V4, P960, DOI 10.1038/nprot.2009.68; Hoischen A, 2010, HUM MUTAT, V31, P492, DOI 10.1002/humu.21221; Hu Hao, 2009, Hugo J, V3, P41, DOI 10.1007/s11568-010-9137-y; Kirkness EF, 2009, NAT BIOTECHNOL, V27, P998, DOI 10.1038/nbt1109-998; Lisi MT, 2007, BBA-MOL BASIS DIS, V1772, P159, DOI 10.1016/j.bbadis.2006.09.006; Mendell JR, 2006, PEDIATR DEVEL PATHOL, V9, P427, DOI 10.2350/06-07-0127.1; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Muntoni F, 2004, NEUROMUSCULAR DISORD, V14, P635, DOI 10.1016/j.nmd.2004.06.009; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nikolaev SI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006659; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Reed UC, 2009, ARQ NEURO-PSIQUIAT, V67, P343, DOI 10.1590/S0004-282X2009000200035; Reed UC, 2009, ARQ NEURO-PSIQUIAT, V67, P144, DOI 10.1590/S0004-282X2009000100038; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Rios J, 2010, HUM MOL GENET, V19, P4313, DOI 10.1093/hmg/ddq352; Schessl Joachim, 2006, Semin Pediatr Neurol, V13, P80, DOI 10.1016/j.spen.2006.06.003; ten Bosch JR, 2008, J MOL DIAGN, V10, P484, DOI 10.2353/jmoldx.2008.080027; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Valencia CA, 2012, J MOL DIAGN, V14, P233, DOI 10.1016/j.jmoldx.2012.01.009; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789; Volpi L, 2010, AM J HUM GENET, V86, P72, DOI 10.1016/j.ajhg.2009.11.014	33	56	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53083	10.1371/journal.pone.0053083	http://dx.doi.org/10.1371/journal.pone.0053083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326386	Green Published, gold			2022-12-25	WOS:000314705800032
J	Xie, F; Zhang, YH; Li, G; Zhou, L; Liu, SG; Wang, CL				Xie, Fang; Zhang, Yanhe; Li, Gang; Zhou, Long; Liu, Siguo; Wang, Chunlai			The ClpP Protease Is Required for the Stress Tolerance and Biofilm Formation in Actinobacillus pleuropneumoniae	PLOS ONE			English	Article							ATP-DEPENDENT PROTEASE; VIRULENCE FACTORS; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; MULTIPLE; SYSTEM; PATHOGENESIS; DEGRADATION; EXPRESSION; DELETIONS	In the respiratory tract and lung tissue, a balanced physiological response is essential for Actinobacillus pleuropneumoniae to survive various types of challenges. ClpP, the catalytic core of the Clp proteolytic complex, is involved in various stresses response and regulation of biofilm formation in many pathogenic bacteria. To investigate the role of ClpP in the virulence of A. pleuropneumoniae, the clpP gene was deleted by homologous recombination, resulting in the mutant strain S8 Delta clpP. The reduced growth of S8 Delta clpP mutant at high temperatures and under several other stress conditions suggests that the ClpP protein is required for the stress tolerance of A. pleuropneumoniae. Interestingly, we observed that the S8 Delta clpP mutant exhibited an increased ability to take up iron in vitro compared to the wild-type strain. We also found that the cells without ClpP displayed rough and irregular surfaces and increased cell volume relative to the wild-type strain using scanning electron microscopy (SEM). Confocal laser scanning microscopy (CLSM) revealed that the S8 Delta clpP mutant showed decreased biofilm formation compared to the wild-type strain. We examined the transcriptional profiles of the wild type S8 and the S8 Delta clpP mutant strains of A. pleuropneumoniae using RNA sequencing. Our analysis revealed that the expression of 16 genes was changed by the deletion of the clpP gene. The data presented in this study illustrate the important role of ClpP protease in the stress response, iron acquisition, cell morphology and biofilm formation related to A. pleuropneumoniae and further suggest a putative role of ClpP protease in virulence regulation.	[Xie, Fang; Zhang, Yanhe; Li, Gang; Zhou, Long; Liu, Siguo; Wang, Chunlai] Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Bacterial Dis, State Key Lab Vet Biotechnol, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Wang, CL (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Bacterial Dis, State Key Lab Vet Biotechnol, Harbin, Peoples R China.	chunlai.w@hvri.ac.cn		Xie, Fang/0000-0003-2041-2208	National Natural Science Foundation of China [31100103]; National High Technology Research and Development Program of China [2011AA10A210]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China (No. 31100103, http://www.nsfc.gov.cn) and the National High Technology Research and Development Program of China (No. 2011AA10A210, http://www.863.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CE, 2009, J BACTERIOL, V191, P2638, DOI 10.1128/JB.01784-08; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Baltes N, 2003, FEMS MICROBIOL LETT, V220, P41, DOI 10.1016/S0378-1097(03)00064-8; Bottcher T, 2008, J AM CHEM SOC, V130, P14400, DOI 10.1021/ja8051365; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; Buettner FFR, 2008, VET MICROBIOL, V127, P106, DOI 10.1016/j.vetmic.2007.08.005; Capestany CA, 2008, J BACTERIOL, V190, P1436, DOI 10.1128/JB.01632-07; Chiers K, 1998, VET QUART, V20, P65, DOI 10.1080/01652176.1998.9694841; Chiers K, 2010, VET RES, V41, DOI 10.1051/vetres/2010037; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997; Deslandes V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-72; FENWICK B, 1994, J AM VET MED ASSOC, V204, P1334; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Frees D, 2003, MOL MICROBIOL, V48, P1565, DOI 10.1046/j.1365-2958.2003.03524.x; Gaillot O, 2000, MOL MICROBIOL, V35, P1286, DOI 10.1046/j.1365-2958.2000.01773.x; Haesebrouck F, 1997, VET MICROBIOL, V58, P239, DOI 10.1016/S0378-1135(97)00162-4; Hasona A, 2007, J BACTERIOL, V189, P1219, DOI 10.1128/JB.01146-06; HWANG BJ, 1987, P NATL ACAD SCI USA, V84, P5550, DOI 10.1073/pnas.84.16.5550; Izano EA, 2007, MICROB PATHOGENESIS, V43, P1, DOI 10.1016/j.micpath.2007.02.004; Jackson MW, 2004, MOL MICROBIOL, V54, P1364, DOI 10.1111/j.1365-2958.2004.04353.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaplan JB, 2005, VET MICROBIOL, V108, P89, DOI 10.1016/j.vetmic.2005.02.011; KATAYAMAFUJIMURA Y, 1987, J BIOL CHEM, V262, P4477; Lemos JAC, 2002, J BACTERIOL, V184, P6357, DOI 10.1128/JB.184.22.6357-6366.2002; Li L, 2008, MICROB PATHOGENESIS, V45, P192, DOI 10.1016/j.micpath.2008.05.008; Loughlin MF, 2009, MICROB PATHOGENESIS, V46, P53, DOI 10.1016/j.micpath.2008.10.004; Michel A, 2006, J BACTERIOL, V188, P5783, DOI 10.1128/JB.00074-06; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Oswald W, 1999, FEMS MICROBIOL LETT, V179, P153, DOI 10.1111/j.1574-6968.1999.tb08721.x; Pruteanu M, 2009, MOL MICROBIOL, V71, P912, DOI 10.1111/j.1365-2958.2008.06574.x; Raju RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002511; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Roy S, 2012, FEMS IMMUNOL MED MIC, V65, P116, DOI 10.1111/j.1574-695X.2012.00933.x; Rycroft AN, 2000, VET J, V159, P18, DOI 10.1053/tvjl.1999.0403; SENANAYAKE SD, 1995, MOL BIOTECHNOL, V4, P13, DOI 10.1007/BF02907467; Thomsen LE, 2002, MICROBIOL-SGM, V148, P2727, DOI 10.1099/00221287-148-9-2727; Wang CZ, 2007, MICROBES INFECT, V9, P1376, DOI 10.1016/j.micinf.2007.06.012; WILLSON PJ, 1989, ANTIMICROB AGENTS CH, V33, P1627, DOI 10.1128/AAC.33.9.1627	39	37	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53600	10.1371/journal.pone.0053600	http://dx.doi.org/10.1371/journal.pone.0053600			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326465	gold, Green Published, Green Submitted			2022-12-25	WOS:000314705800059
J	Fu, MQ; Lin, LJ; Kong, XX; Zhao, WD; Tang, L; Li, JY; Ouyang, J				Fu, Maoqing; Lin, Lijun; Kong, Xiangxue; Zhao, Weidong; Tang, Lei; Li, Jianyi; Ouyang, Jun			Construction and Accuracy Assessment of Patient-Specific Biocompatible Drill Template for Cervical Anterior Transpedicular Screw (ATPS) Insertion: An In Vitro Study	PLOS ONE			English	Article							GLASS-IONOMER CEMENTS; PEDICLE SCREW; BONE-CEMENT; PLACEMENT; SPINE; FIXATION; CORPECTOMY; RECONSTRUCTION; FEASIBILITY; STABILITY	Background: With the properties of three-column fixation and anterior-approach-only procedure, anterior transpedicular screw (ATPS) is ideal for severe multilevel traumatic cervical instabilities. However, the accurate insertion of ATPS remains challenging. Here we constructed a patient-specific biocompatible drill template and evaluated its accuracy in assisting ATPS insertion. Methods: After ethical approval, 24 formalin-preserved cervical vertebrae (C2-C7) were CT scanned. 3D reconstruction models of cervical vertebra were obtained with 2-mm-diameter virtual pin tracts at the central pedicles. The 3D models were used for rapid prototyping (RP) printing. A 2-mm-diameter Kirschner wire was then inserted into the pin tract of the RP model before polymethylmethacrylate was used to construct the patient-specific biocompatible drill template. After removal of the anterior soft tissue, a 2-mm-diameter Kirschner wire was inserted into the cervical pedicle with the assistance of drill template. Cadaveric cervical spines with pin tracts were subsequently scanned using the same CT scanner. A 3D reconstruction was performed of the scanned spines to get 3D models of the vertebrae containing the actual pin tracts. The deviations were calculated between 3D models with virtual and actual pin tracts at the middle point of the cervical pedicle. 3D models of 3.5 mm-diameter screws were used in simulated insertion to grade the screw positions. Findings: The patient-specific biocompatible drill template was constructed to assist ATPS insertion successfully. There were no significant differences between medial/lateral deviations (P=0.797) or between superior/inferior deviations (P=0.741). The absolute deviation values were 0.82 +/- 0.75 mm and 1.10 +/- 0.96 mm in axial and sagittal planes, respectively. In the simulated insertion, the screws in non-critical position were 44/48 (91.7%). Conclusions: The patient-specific drill template is biocompatible, easy-to-apply and accurate in assisting ATPS insertion. Its clinical applications should be further researched.	[Fu, Maoqing; Kong, Xiangxue; Zhao, Weidong; Tang, Lei; Li, Jianyi; Ouyang, Jun] So Med Univ, Sch Basic Med Sci, Dept Anat, Guangdong Prov Key Lab Med Biomech, Guangzhou, Guangdong, Peoples R China; [Lin, Lijun] So Med Univ, Zhujiang Hosp, Dept Orthoped, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Li, JY (corresponding author), So Med Univ, Sch Basic Med Sci, Dept Anat, Guangdong Prov Key Lab Med Biomech, Guangzhou, Guangdong, Peoples R China.	wuxili74@126.com			National Natural Science Foundation of China [6110920, 6110922, 6110923]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Projects 6110920, 6110922 and 6110923 were supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta FL, 2008, J SPINAL DISORD TECH, V21, P165, DOI 10.1097/BSD.0b013e3180654205; Aramomi M, 2008, ACTA NEUROCHIR, V150, P575, DOI 10.1007/s00701-008-1574-1; Berry E, 2005, P I MECH ENG H, V219, P111, DOI 10.1243/095441105X9273; Bozkus H, 2005, SPINE, V30, P915, DOI 10.1097/01.brs.0000158949.37281.d7; Brazenor GA, 2007, SPINE, V32, P63, DOI 10.1097/01.brs.0000250304.24001.24; Fallah A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043407; Fraser JF, 2002, SPINE, V27, P675, DOI 10.1097/00007632-200204010-00002; Gelalis ID, 2012, EUR SPINE J, V21, P247, DOI 10.1007/s00586-011-2011-3; GERHART TN, 1988, J ORTHOPAED RES, V6, P585, DOI 10.1002/jor.1100060417; Henriques T, 2004, J SPINAL DISORD TECH, V17, P1, DOI 10.1097/00024720-200402000-00002; Ishikawa Y, 2010, J NEUROSURG-SPINE, V13, P606, DOI 10.3171/2010.5.SPINE09993; Jones EL, 1997, SPINE, V22, P977, DOI 10.1097/00007632-199705010-00009; Kim SM, 2004, J NEUROSURG-SPINE, V1, P108, DOI 10.3171/spi.2004.1.1.0108; Koller H, 2008, EUR SPINE J, V17, P523, DOI 10.1007/s00586-007-0572-y; Koller H, 2008, EUR SPINE J, V17, P539, DOI 10.1007/s00586-007-0573-x; Koller H, 2007, EUR SPINE J, V16, P2055, DOI 10.1007/s00586-007-0398-7; Koller H, 2009, EUR SPINE J, V18, P1300, DOI 10.1007/s00586-009-1054-1; Lu GH, 2009, CHIN J TRAUMATOL, V12, P148, DOI 10.3760/cma.j.issn.1008-1275.2009.03.005; Lu S, 2012, MED BIOL ENG COMPUT, V50, P751, DOI 10.1007/s11517-012-0900-1; Lu S, 2011, COMPUT AIDED SURG, V16, P240, DOI 10.3109/10929088.2011.605173; Lu S, 2009, CHIN J TRAUMATOL, V12, P173, DOI 10.3760/cma.j.issn.1008-1275.2009.03.011; Lu S, 2009, SPINE, V34, pE959, DOI 10.1097/BRS.0b013e3181c09985; Lu S, 2009, EUR SPINE J, V18, P1379, DOI 10.1007/s00586-009-1051-4; Lu S, 2009, INT J MED ROBOT COMP, V5, P184, DOI 10.1002/rcs.249; Lye KW, 2011, CLIN ORAL IMPLANTS R; Mac-Thiong JM, 2003, EUR SPINE J, V12, P542, DOI 10.1007/s00586-003-0549-4; Nicholson JW, 2008, DENT MATER, V24, P1702, DOI 10.1016/j.dental.2008.04.005; Ohnari Hiroyuki, 2006, Spine J, V6, P221, DOI 10.1016/j.spinee.2005.10.014; Ormsby R, 2012, ACTA BIOMATER, V8, P1201, DOI 10.1016/j.actbio.2011.10.010; Owen BD, 2007, COMPUT AIDED SURG, V12, P303, DOI 10.1080/10929080701662826; Ponnusamy KE, 2011, SPINE J, V11, P54, DOI 10.1016/j.spinee.2010.09.024; Radermacher K, 1998, CLIN ORTHOP RELAT R, P28; Rao RD, 2006, J BONE JOINT SURG AM, V88A, P1619, DOI 10.2106/JBJS.F.00014; Richter M, 2005, SPINE, V30, P2280, DOI 10.1097/01.brs.0000182275.31425.cd; Schmidt R, 2005, EUR SPINE J, V14, P372, DOI 10.1007/s00586-004-0763-8; Souza PPC, 2006, DENT MATER, V22, P838, DOI 10.1016/j.dental.2005.10.002; Tomasino A, 2010, J NEUROSURG-SPINE, V13, P52, DOI 10.3171/2010.3.SPINE09231; Wang CS, 2011, CHIN J TRAUMATOL, V14, P137, DOI 10.3760/cma.j.issn.1008-1275.2011.03.002; Yang BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035032; Yu DK, 2008, J KOREAN NEUROSURG S, V44, P303, DOI 10.3340/jkns.2008.44.5.303; Yukawa Y, 2009, EUR SPINE J, V18, P911, DOI 10.1007/s00586-009-0949-1	41	37	62	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53580	10.1371/journal.pone.0053580	http://dx.doi.org/10.1371/journal.pone.0053580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326461	Green Published, Green Submitted, gold			2022-12-25	WOS:000313552400029
J	Koyama-Nasu, R; Takahashi, R; Yanagida, S; Nasu-Nishimura, Y; Oyama, M; Kozuka-Hata, H; Haruta, R; Manabe, E; Hoshino-Okubo, A; Omi, H; Yanaihara, N; Okamoto, A; Tanaka, T; Akiyama, T				Koyama-Nasu, Ryo; Takahashi, Rina; Yanagida, Satoshi; Nasu-Nishimura, Yukiko; Oyama, Masaaki; Kozuka-Hata, Hiroko; Haruta, Ryo; Manabe, Emi; Hoshino-Okubo, Akemi; Omi, Hiroko; Yanaihara, Nozomu; Okamoto, Aikou; Tanaka, Tadao; Akiyama, Tetsu			The Cancer Stem Cell Marker CD133 Interacts with Plakoglobin and Controls Desmoglein-2 Protein Levels	PLOS ONE			English	Article							LINES	The pentaspan membrane glycoprotein CD133 (also known as prominin-1) has been widely used as a marker for both cancer and normal stem cells. However, the function of CD133 has not been elucidated. Here we describe a cancer stem cell line established from clear cell carcinoma of the ovary (CCC) and show that CD133 interacts with plakoglobin (also known as c-catenin), a desmosomal linker protein. We further demonstrate that knockdown of CD133 by RNA interference (RNAi) results in the downregulation of desmoglein-2, a desmosomal cadherin, and abrogates cell-cell adhesion and tumorigenicity of CCC stem cells. We speculate that CD133 may be a promising target for cancer chemotherapy.	[Koyama-Nasu, Ryo; Takahashi, Rina; Yanagida, Satoshi; Nasu-Nishimura, Yukiko; Haruta, Ryo; Manabe, Emi; Hoshino-Okubo, Akemi; Akiyama, Tetsu] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, Tokyo, Japan; [Yanagida, Satoshi; Omi, Hiroko; Yanaihara, Nozomu; Okamoto, Aikou; Tanaka, Tadao] Jikei Univ, Sch Med, Dept Obstet & Gynecol, Minato Ku, Tokyo, Japan; [Oyama, Masaaki; Kozuka-Hata, Hiroko] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo, Japan	University of Tokyo; Jikei University; University of Tokyo	Akiyama, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, Tokyo, Japan.	akiyama@iam.u-tokyo.ac.jp		Kozuka-Hata, Hiroko/0000-0002-9286-6594; Oyama, Masaaki/0000-0001-6478-3735	Research Program of Innovative Cell Biology by Innovative Technology (Integrated Systems Analysis of Cellular Oncogenic Signaling Networks); Takeda Science Foundation; Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan	Research Program of Innovative Cell Biology by Innovative Technology (Integrated Systems Analysis of Cellular Oncogenic Signaling Networks); Takeda Science Foundation(Takeda Science Foundation (TSF)); Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Research Program of Innovative Cell Biology by Innovative Technology (Integrated Systems Analysis of Cellular Oncogenic Signaling Networks), Grants-in-Aid for Scientific Research on Innovative Areas (Integrative Research on Cancer Microenvironment Network) and for Scientific Research (C), Takeda Science Foundation and in part by Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alison MR, 2011, J PATHOL, V223, P147, DOI 10.1002/path.2793; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Chidgey M, 2007, BRIT J CANCER, V96, P1783, DOI 10.1038/sj.bjc.6603808; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Curley MD, 2009, STEM CELLS, V27, P2875, DOI 10.1002/stem.236; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; Gillette JM, 2009, NAT CELL BIOL, V11, P303, DOI 10.1038/ncb1838; Kozuka-Hata H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043398; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.3.CO;2-X	16	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53710	10.1371/journal.pone.0053710	http://dx.doi.org/10.1371/journal.pone.0053710			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326490	Green Published, Green Submitted, gold			2022-12-25	WOS:000313552400036
J	Meng, J; Cui, C; Liu, YC; Jin, ML; Wu, DD; Liu, C; Wang, EH; Yu, BZ				Meng, Jun; Cui, Cheng; Liu, Yanchun; Jin, Minglin; Wu, Didi; Liu, Chao; Wang, Enhua; Yu, Bingzhi			The Role of 14-3-3 epsilon Interaction with Phosphorylated Cdc25B at Its Ser321 in the Release of the Mouse Oocyte from Prophase I Arrest	PLOS ONE			English	Article							PROTEIN-KINASE-A; SUBCELLULAR-LOCALIZATION; MEIOTIC ARREST; MATURATION; RESUMPTION; PKA; 14-3-3-PROTEINS; PHOSPHATASE; MEIOSIS; WEE1B	The protein kinase A (PKA)/Cdc25B pathway plays a critical role in maintaining meiotic arrest in mouse oocytes. However, the molecular mechanism underlying this interchange is not known. In this study, we assessed the role of 14-3-3 epsilon interaction with phosphorylated Cdc25B at its Ser321 as the mouse oocyte is released from prophase I arrest. The 14-3-3 epsilon isoform is a highly conserved protein with various regulatory roles, including maintenance of meiotic arrest. Cdc25B phosphatase is also a key cell cycle regulator. 14-3-3 epsilon binds to Cdc25B-WT, which was abrogated when Ser321 of Cdc25B was mutated to Ala. In addition, we found that 14-3-3 epsilon and Cdc25B were co-localized. Cdc25B was translocated from the cytoplasm to the nucleus shortly before germinal vesicle breakdown (GVBD) during the primary oocyte stage of oogenesis. However, mutation of Ser321 to Ala completely abolished the cytoplasmic localization of Cdc25B. Furthermore, oocytes co-expressing of Cdc25B-WT or Cdc25B-Ser321D and 14-3-3 epsilon were unable to undergo GVBD. In contrast, co-expression of 14-33 epsilon and Cdc25B-Ser321A induced GVBD and allowed the process to continue. Down-regulation of 14-3-3 epsilon caused partial meiotic resumption. Taken together, these data indicate that Ser321 of Cdc25B is the specific binding site for 14-3-3 epsilon binding, and that 14-3-3 epsilon is the significant factor in Cdc25B regulation during meiotic resumption of GV stage.	[Meng, Jun; Cui, Cheng; Liu, Yanchun; Jin, Minglin; Wu, Didi; Liu, Chao; Yu, Bingzhi] China Med Univ, Dept Biochem & Mol Biol, Shenyang, Liaoning Provin, Peoples R China; [Meng, Jun] Inner Mongolia Med Univ, Affiliated Hosp, Ctr Clin Lab, Hohhot, Inner Mongolia, Peoples R China; [Wang, Enhua; Yu, Bingzhi] China Med Univ, Inst Pathol & Pathophysiol, Shenyang, Liaoning Provin, Peoples R China	China Medical University; Inner Mongolia Medical University; China Medical University	Yu, BZ (corresponding author), China Med Univ, Dept Biochem & Mol Biol, Shenyang, Liaoning Provin, Peoples R China.	ybzbiochem@yeah.net			National Nature Science Foundation of China [30900514, 81070489, 81270654]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China Grant #30900514, #81070489, and #81270654. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SQ, 2000, BIOL REPROD, V62, P616, DOI 10.1095/biolreprod62.3.616; BORNSLAEGER EA, 1986, DEV BIOL, V114, P453, DOI 10.1016/0012-1606(86)90209-5; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Chen MS, 2001, MOL CELL BIOL, V21, P3853, DOI 10.1128/MCB.21.12.3853-3861.2001; Cui C, 2008, BIOL REPROD, V79, P991, DOI 10.1095/biolreprod.108.068205; D'Angiolella V, 2001, CURR BIOL, V11, P1221, DOI 10.1016/S0960-9822(01)00352-9; Davezac N, 2000, ONCOGENE, V19, P2179, DOI 10.1038/sj.onc.1203545; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Duckworth BC, 2002, P NATL ACAD SCI USA, V99, P16794, DOI 10.1073/pnas.222661299; Duncan FE, 2006, DEV DYNAM, V235, P2961, DOI 10.1002/dvdy.20930; Forrest A, 2001, ONCOGENE, V20, P4393, DOI 10.1038/sj.onc.1204574; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gallicano GI, 1997, MOL REPROD DEV, V46, P587, DOI 10.1002/(SICI)1098-2795(199704)46:4&lt;587::AID-MRD16&gt;3.0.CO;2-T; Han SJ, 2005, CURR BIOL, V15, P1670, DOI 10.1016/j.cub.2005.07.056; Han SJ, 2006, CELL CYCLE, V5, P227, DOI 10.4161/cc.5.3.2395; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Kumagai A, 1998, MOL BIOL CELL, V9, P345, DOI 10.1091/mbc.9.2.345; Lincoln AJ, 2002, NAT GENET, V30, P446, DOI 10.1038/ng856; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; Margolis SS, 2004, CELL CYCLE, V3, P425; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Mils V, 2000, ONCOGENE, V19, P1257, DOI 10.1038/sj.onc.1203419; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Newhall KJ, 2006, CURR BIOL, V16, P321, DOI 10.1016/j.cub.2005.12.031; Oh JS, 2010, J CELL BIOL, V188, P199, DOI 10.1083/jcb.200907161; Pirino G, 2009, CELL CYCLE, V8, P665, DOI 10.4161/cc.8.4.7846; RoseHellekant TA, 1996, MOL REPROD DEV, V44, P241, DOI 10.1002/(SICI)1098-2795(199606)44:2&lt;241::AID-MRD14&gt;3.0.CO;2-5; Rubio MP, 2003, EMBO J, V22, P3514, DOI 10.1093/emboj/cdg363; Rudolph J, 2007, BIOCHEMISTRY-US, V46, P3595, DOI 10.1021/bi700026j; Schultz R, 2009, CELL CYCLE, V8, P516; SCHULTZ RM, 1983, DEV BIOL, V97, P264, DOI 10.1016/0012-1606(83)90085-4; Solc P, 2008, DEV BIOL, V317, P260, DOI 10.1016/j.ydbio.2008.02.028; Tzivion G, 2001, ONCOGENE, V20, P6331, DOI 10.1038/sj.onc.1204777; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Uchida S, 2004, J CELL SCI, V117, P3011, DOI 10.1242/jcs.01086; Uchida S, 2006, J BIOCHEM, V139, P761, DOI 10.1093/jb/mvj079; van Hemert MJ, 2004, J CELL SCI, V117, P1411, DOI 10.1242/jcs.00990; van Heusden GPH, 2005, IUBMB LIFE, V57, P623, DOI 10.1080/15216540500252666; Xiao JY, 2011, J BIOL CHEM, V286, P10356, DOI 10.1074/jbc.M110.150524; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yang J, 1999, EMBO J, V18, P2174, DOI 10.1093/emboj/18.8.2174; Yu BZ, 2005, DEV DYNAM, V232, P98, DOI 10.1002/dvdy.20205; Zhang Y, 2008, DEV DYNAM, V237, P3777, DOI 10.1002/dvdy.21799	46	19	23	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53633	10.1371/journal.pone.0053633	http://dx.doi.org/10.1371/journal.pone.0053633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326474	Green Published, Green Submitted, gold			2022-12-25	WOS:000313552400032
J	Daburon, S; Devaud, C; Costet, P; Morello, A; Garrigue-Antar, L; Maillasson, M; Hargous, N; Lapaillerie, D; Bonneu, M; Dechanet-Merville, J; Legembre, P; Capone, M; Moreau, JF; Taupin, JL				Daburon, Sophie; Devaud, Christel; Costet, Pierre; Morello, Aurore; Garrigue-Antar, Laure; Maillasson, Mike; Hargous, Nathalie; Lapaillerie, Delphine; Bonneu, Marc; Dechanet-Merville, Julie; Legembre, Patrick; Capone, Myriam; Moreau, Jean-Francois; Taupin, Jean-Luc			Functional Characterization of a Chimeric Soluble Fas Ligand Polymer with In Vivo Anti-Tumor Activity	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; LOW-AFFINITY RECEPTOR; MEDIATED APOPTOSIS; EXPRESSION; ANTIBODY; MICE; GP130; CYTOTOXICITY; ACTIVATION; HEPATITIS	Binding of ligand FasL to its receptor Fas triggers apoptosis via the caspase cascade. FasL itself is homotrimeric, and a productive apoptotic signal requires that FasL be oligomerized beyond the homotrimeric state. We generated a series of FasL chimeras by fusing FasL to domains of the Leukemia Inhibitory Factor receptor gp190 which confer homotypic oligomerization, and analyzed the capacity of these soluble chimeras to trigger cell death. We observed that the most efficient FasL chimera, called pFasL, was also the most polymeric, as it reached the size of a dodecamer. Using a cellular model, we investigated the structure-function relationships of the FasL/Fas interactions for our chimeras, and we demonstrated that the Fas-mediated apoptotic signal did not solely rely on ligand-mediated receptor aggregation, but also required a conformational adaptation of the Fas receptor. When injected into mice, pFasL did not trigger liver injury at a dose which displayed anti-tumor activity in a model of human tumor transplanted to immunodeficient animals, suggesting a potential therapeutic use. Therefore, the optimization of the FasL conformation has to be considered for the development of efficient FasL-derived anti-cancer drugs targeting Fas.	[Daburon, Sophie; Devaud, Christel; Morello, Aurore; Hargous, Nathalie; Dechanet-Merville, Julie; Capone, Myriam; Moreau, Jean-Francois; Taupin, Jean-Luc] Univ Bordeaux 2, CNRS 5164, Unite Mixte Rech, F-33076 Bordeaux, France; [Garrigue-Antar, Laure] Univ Paris Est Creteil, CNRS 7149, Unite Mixte Rech, Creteil, France; [Maillasson, Mike] Univ Nantes, INSERM 892, Unite Mixte Rech, Nantes, France; [Lapaillerie, Delphine; Bonneu, Marc] Univ Bordeaux 2, Ctr Genom Fonctionnelle, F-33076 Bordeaux, France; [Legembre, Patrick] Univ Rennes 1, Inst Rech Sante Environm Travail, Equipe Associe 4427, Rennes, France; [Moreau, Jean-Francois; Taupin, Jean-Luc] Ctr Hosp & Univ Bordeaux, Lab Immunol & Immunogenet, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; UDICE-French Research Universities; Universite de Bordeaux; Universite de Rennes; CHU Bordeaux	Taupin, JL (corresponding author), Univ Bordeaux 2, CNRS 5164, Unite Mixte Rech, F-33076 Bordeaux, France.	jean-luc.taupin@chu-bordeaux.fr	Devaud, Christel'/W-8141-2019; legembre, patrick/L-3475-2016; Legembre, Patrick/U-1882-2019; maillasson, mike/K-9627-2015	Devaud, Christel'/0000-0003-3511-3219; legembre, patrick/0000-0001-6649-8049; Legembre, Patrick/0000-0001-6649-8049; Garrigue-Antar, Laure/0000-0001-6331-8882	Association pour la Recherche sur le Cancer [3798]; Ligue Nationale Contre le Cancer (Comites des Landes, de la Dordogne, de la Gironde, des Charentes); MENRT; Conseil Regional d'Aquitaine; CNRS	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale Contre le Cancer (Comites des Landes, de la Dordogne, de la Gironde, des Charentes); MENRT; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); CNRS(Centre National de la Recherche Scientifique (CNRS))	Association pour la Recherche sur le Cancer (grant 3798), Ligue Nationale Contre le Cancer (Comites des Landes, de la Dordogne, de la Gironde, des Charentes). C. Devaud was supported by a grant from the MENRT. A. Morello was supported by a grant from the Conseil Regional d'Aquitaine and CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beneteau M, 2007, CANCER RES, V67, P108, DOI 10.1158/0008-5472.CAN-06-1415; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Boulanger MJ, 2004, ADV PROTEIN CHEM, V68, P107; CHEN TR, 1977, EXP CELL RES, V104, P255, DOI 10.1016/0014-4827(77)90089-1; Chida Y, 2005, GUT, V54, P994, DOI 10.1136/gut.2004.058818; Chodorge M, 2012, CELL DEATH DIFFER; DANDREA AD, 1991, MOL CELL BIOL, V11, P1980, DOI 10.1128/MCB.11.4.1980; Descamps D, 2006, HEPATOLOGY, V44, P399, DOI 10.1002/hep.21257; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; KAUFMAN RJ, 1991, NUCLEIC ACIDS RES, V19, P4485, DOI 10.1093/nar/19.16.4485; KAYAGAKI N, 1995, J EXP MED, V182, P1777, DOI 10.1084/jem.182.6.1777; Krautwald S, 2004, J BIOL CHEM, V279, P44005, DOI 10.1074/jbc.M401327200; Krueger A, 2003, IMMUNOL REV, V193, P58, DOI 10.1034/j.1600-065X.2003.00047.x; Legembre P, 2003, J IMMUNOL, V171, P5659, DOI 10.4049/jimmunol.171.11.5659; Legembre P, 2002, CELL DEATH DIFFER, V9, P329, DOI 10.1038/sj.cdd.4400960; MARIANI SM, 1995, EUR J IMMUNOL, V25, P2303, DOI 10.1002/eji.1830250828; Matsuda Y, 2006, INT J ONCOL, V29, P1119; MESSIER TL, 1991, GENE, V99, P291, DOI 10.1016/0378-1119(91)90141-W; Nagata S, 2002, CLIN CANCER RES, V8, P2345; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Schagger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Shiraishi T, 2004, BIOCHEM BIOPH RES CO, V322, P197, DOI 10.1016/j.bbrc.2004.07.098; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Suda T, 1997, J EXP MED, V186, P2045, DOI 10.1084/jem.186.12.2045; Taupin JL, 1999, J BIOL CHEM, V274, P14482, DOI 10.1074/jbc.274.20.14482; TAUPIN JL, 1993, SCAND J IMMUNOL, V38, P293, DOI 10.1111/j.1365-3083.1993.tb01728.x; Taupin JL, 1997, CYTOKINE, V9, P112, DOI 10.1006/cyto.1996.0144; Tenhumberg S, 2006, BIOCHEM BIOPH RES CO, V346, P649, DOI 10.1016/j.bbrc.2006.05.173; TIAN QS, 1995, J EXP MED, V182, P865, DOI 10.1084/jem.182.3.865; Uphoff Cord C, 2005, Methods Mol Biol, V290, P13; Voisin MB, 2002, J BIOL CHEM, V277, P13682, DOI 10.1074/jbc.M111624200; Xu YY, 2003, J IMMUNOL, V171, P562, DOI 10.4049/jimmunol.171.2.562	35	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e54000	10.1371/journal.pone.0054000	http://dx.doi.org/10.1371/journal.pone.0054000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326557	Green Published, gold			2022-12-25	WOS:000313551500107
J	Kajita, Y; Kato, T; Tamaki, S; Furu, M; Takahashi, R; Nagayama, S; Aoyama, T; Nishiyama, H; Nakamura, E; Katagiri, T; Nakamura, Y; Ogawa, O; Toguchida, J				Kajita, Yoichiro; Kato, Tomohisa, Jr.; Tamaki, Sakura; Furu, Moritoshi; Takahashi, Ryo; Nagayama, Satoshi; Aoyama, Tomoki; Nishiyama, Hiroyuki; Nakamura, Eijiro; Katagiri, Toyomasa; Nakamura, Yusuke; Ogawa, Osamu; Toguchida, Junya			The Transcription Factor Sp3 Regulates the Expression of a Metastasis-Related Marker of Sarcoma, Actin Filament-Associated Protein 1-Like 1 (AFAP1L1)	PLOS ONE			English	Article							GENE-EXPRESSION; CANCER; BINDING; PROMOTER; FAMILY; IDENTIFICATION; SURVIVAL	We previously identified actin filament-associated protein 1-like 1 (AFAP1L1) as a metastasis-predicting marker from the gene-expression profiles of 65 spindle cell sarcomas, and demonstrated the up-regulation of AFAP1L1 expression to be an independent risk factor for distant metastasis in multivariate analyses. Little is known, however, about how the expression of AFAP1L1 is regulated. Luciferase reporter assays showed tandem binding motives of a specificity protein (Sp) located at -85 to -75 relative to the transcriptional start site to be essential to the promoter activity. Overexpression of Sp1 and Sp3 proteins transactivated the proximal AFAP1L1 promoter construct, and electrophoretic mobility shift assays showed that both Sp1 and Sp3 were able to bind to this region in vitro. Chromatin immunoprecipitation experiments, however, revealed that Sp3 is the major factor binding to the proximal promoter region of the AFAP1L1 gene in AFAP1L1- positive cells. Treatment with mithramycin A, an inhibitor of proteins binding to GC-rich regions, prevented Sp3 from binding to the proximal promoter region of AFAP1L1 and decreased its expression in a dose-dependent manner. Finally, knocking down Sp3 using small inhibitory RNA duplex (siRNA) reduced AFAP1L1 expression significantly, which was partially restored by expressing siRNA-resistant Sp3. These findings indicate a novel role for Sp3 in sarcomas as a driver for expression of the metastasis-related gene AFAP1L1.	[Kajita, Yoichiro; Kato, Tomohisa, Jr.; Tamaki, Sakura; Furu, Moritoshi; Aoyama, Tomoki; Toguchida, Junya] Kyoto Univ, Inst Frontier Med Sci, Dept Tissue Regenerat, Kyoto, Japan; [Kajita, Yoichiro; Nishiyama, Hiroyuki; Nakamura, Eijiro; Ogawa, Osamu] Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto, Japan; [Furu, Moritoshi; Toguchida, Junya] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan; [Takahashi, Ryo; Nagayama, Satoshi] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan; [Katagiri, Toyomasa; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; [Toguchida, Junya] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; University of Tokyo; Kyoto University	Toguchida, J (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Tissue Regenerat, Kyoto, Japan.	togjun@frontier.kyoto-u.ac.jp		Kato, Tomohisa/0000-0002-3047-9847	Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [24659133, 23592330] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2004, CANCER RES, V64, P6740, DOI 10.1158/0008-5472.CAN-04-0713; Aoyama T, 2008, BIOCHEM BIOPH RES CO, V365, P124, DOI 10.1016/j.bbrc.2007.10.135; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Chiefari E, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-35; Detwiller KY, 2005, CANCER RES, V65, P5881, DOI 10.1158/0008-5472.CAN-04-4078; Essafi-Benkhadir K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004478; FLYNN DC, 1993, MOL CELL BIOL, V13, P7892, DOI 10.1128/MCB.13.12.7892; Furu M, 2011, ONCOGENE, V30, P4015, DOI 10.1038/onc.2011.108; Giatzakis C, 2007, BIOCHEMISTRY-US, V46, P4763, DOI 10.1021/bi062208o; Hosoi Y, 2004, INT J ONCOL, V25, P461; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Kato T, 2008, GENES CELLS, V13, P509, DOI 10.1111/j.1365-2443.2008.01182.x; Kawai A, 2004, CANCER LETT, V204, P105, DOI 10.1016/j.canlet.2003.09.031; Kohno Y, 2006, J BIOL CHEM, V281, P38941, DOI 10.1074/jbc.M608389200; Lodyga M, 2009, ONCOGENE, V28, P937, DOI 10.1038/onc.2008.447; RAY R, 1989, J CLIN INVEST, V83, P2003, DOI 10.1172/JCI114110; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Sapetschnig A, 2004, J BIOL CHEM, V279, P42095, DOI 10.1074/jbc.M404989200; Shirasaki F, 1999, ONCOGENE, V18, P7755, DOI 10.1038/sj.onc.1203360; Snyder BN, 2011, EUR J CELL BIOL, V90, P376, DOI 10.1016/j.ejcb.2010.11.016; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Wang LW, 2003, CLIN CANCER RES, V9, P6371; WRIGHT C, 1987, J PATHOL, V153, P325, DOI 10.1002/path.1711530406; Xu J, 2007, J BIOL CHEM, V282, P16401, DOI 10.1074/jbc.M701684200; Yu B, 2003, NUCLEIC ACIDS RES, V31, P5368, DOI 10.1093/nar/gkg706	27	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e49709	10.1371/journal.pone.0049709	http://dx.doi.org/10.1371/journal.pone.0049709			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326307	gold, Green Published, Green Submitted			2022-12-25	WOS:000313551500003
J	Sjoberg, V; Sandstrom, O; Hedberg, M; Hammarstrom, S; Hernell, O; Hammarstrom, ML				Sjoberg, Veronika; Sandstrom, Olof; Hedberg, Maria; Hammarstrom, Sten; Hernell, Olle; Hammarstrom, Marie-Louise			Intestinal T-cell Responses in Celiac Disease - Impact of Celiac Disease Associated Bacteria	PLOS ONE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; GENE REARRANGEMENT; MESSENGER-RNA; TC17 CELLS; TH17 CELLS; EXPRESSION; IDENTIFICATION; MUCOSA; IL-17; IMMUNITY	A hallmark of active celiac disease (CD), an inflammatory small-bowel enteropathy caused by permanent intolerance to gluten, is cytokine production by intestinal T lymphocytes. Prerequisites for contracting CD are that the individual carries the MHC class II alleles HLA-DQ2 and/or HLA-DQ8 and is exposed to gluten in the diet. Dysbiosis in the resident microbiota has been suggested to be another risk factor for CD. In fact, rod shaped bacteria adhering to the small intestinal mucosa were frequently seen in patients with CD during the "Swedish CD epidemic'' and bacterial candidates could later be isolated from patients born during the epidemic suggesting long-lasting changes in the gut microbiota. Interleukin-17A (IL-17A) plays a role in both inflammation and anti-bacterial responses. In active CD IL-17A was produced by both CD8(+) T cells (Tc17) and CD4(+) T cells (Th17), with intraepithelial Tc17 cells being the dominant producers. Gluten peptides as well as CD associated bacteria induced IL-17A responses in ex vivo challenged biopsies from patients with inactive CD. The IL-17A response was suppressed in patients born during the epidemic when a mixture of CD associated bacteria was added to gluten, while the reverse was the case in patients born after the epidemic. Under these conditions Th17 cells were the dominant producers. Thus Tc17 and Th17 responses to gluten and bacteria seem to pave the way for the chronic disease with interferon-gamma-production by intraepithelial Tc1 cells and lamina propria Th1 cells. The CD associated bacteria and the dysbiosis they might cause in the resident microbiota may be a risk factor for CD either by directly influencing the immune responses in the mucosa or by enhancing inflammatory responses to gluten.	[Sjoberg, Veronika; Hedberg, Maria; Hammarstrom, Sten; Hammarstrom, Marie-Louise] Umea Univ, Dept Clin Microbiol, Umea, Sweden; [Sandstrom, Olof; Hernell, Olle] Umea Univ, Dept Clin Sci, Umea, Sweden	Umea University; Umea University	Hammarstrom, ML (corresponding author), Umea Univ, Dept Clin Microbiol, Umea, Sweden.	Marie-Louise.Hammarstrom@climi.umu.se		Sandstrom, Olof/0000-0003-0899-0531; Hammarstrom, Marie-Louise/0000-0001-6182-4423	Swedish Research Council, Natural Sciences and Engineering Sciences [2010-5669]; TORNADO-project within the 7th framework program theme [222720-2]; Fund for Biotechnology-oriented Basic Science at Umea University; County of Vasterbotten; Oskar's Fund; Kempe Foundation; Swedish Celiac Society; "Insamlingsstiftelsen'' at the Medical faculty of Umea University; Medical Faculty of Umea University	Swedish Research Council, Natural Sciences and Engineering Sciences(Swedish Research Council); TORNADO-project within the 7th framework program theme; Fund for Biotechnology-oriented Basic Science at Umea University; County of Vasterbotten; Oskar's Fund; Kempe Foundation; Swedish Celiac Society; "Insamlingsstiftelsen'' at the Medical faculty of Umea University; Medical Faculty of Umea University	Funding was provided by the Swedish Research Council, Natural Sciences and Engineering Sciences (to M.L.H. and S.H.) No. 2010-5669 [URL: www.vr.se]; the TORNADO-project within the 7th framework program theme, grant agreement no. 222720-2 (to M.L.H. and O.H.) [URL: www.fp7tornado.eu]; the Fund for Biotechnology-oriented Basic Science at Umea University (to M.L.H.) [URL: www.medfak.umu.se]; the County of Vasterbotten (to M.L.H. and O.H.) [URL: www.vll.se/default.aspx?id = 1456&refid = 1405]; the Oskar's Fund (to V.S.) [URL: www.oskarfonden.se]; the Kempe Foundation (to V.S.) [URL: www.umeastudentkar.se/default.asp?ML = 195]; the Swedish Celiac Society (to M.L.H.) [URL://celiaki.se/]; "Insamlingsstiftelsen'' at the Medical faculty of Umea University (to M.L.H.) [URL: www.medfak.umu.se]; a PhD-study support to V.S. from the Medical Faculty of Umea University [URL: www.medfak.umu.se]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Bas A, 2009, GUT, V58, P189, DOI 10.1136/gut.2007.125526; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Bas A, 2003, J IMMUNOL, V171, P3359, DOI 10.4049/jimmunol.171.7.3359; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Bodd M, 2010, MUCOSAL IMMUNOL, V3, P594, DOI 10.1038/mi.2010.36; Castellanos-Rubio A, 2009, AUTOIMMUNITY, V42, P69, DOI 10.1080/08916930802350789; Ciric B, 2009, J IMMUNOL, V182, P5296, DOI 10.4049/jimmunol.0900036; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Costa VS, 2010, DIABETES RES CLIN PR, V88, P222, DOI 10.1016/j.diabres.2010.03.014; De Palma G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030791; Di Sabatino A, 2011, AM J GASTROENTEROL, V106, P519, DOI 10.1038/ajg.2010.450; Di Sabatino A, 2009, LANCET, V373, P1480, DOI 10.1016/S0140-6736(09)60254-3; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Fernandez S, 2011, AM J GASTROENTEROL, V106, P528, DOI 10.1038/ajg.2010.465; Forsberg G, 2004, AM J GASTROENTEROL, V99, P894, DOI 10.1111/j.1572-0241.2004.04157.x; Forsberg G, 2002, GASTROENTEROLOGY, V123, P667, DOI 10.1053/gast.2002.35355; Forsberg G, 2007, INT IMMUNOL, V19, P993, DOI 10.1093/intimm/dxm077; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Garrote JA, 2008, J PEDIAT GASTROENTER, V47, P27; Gianfrani C, 2003, J IMMUNOL, V170, P2719, DOI 10.4049/jimmunol.170.5.2719; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Hedberg ME, 2012, INT J SYST EVOL MICR, V62, P2685, DOI 10.1099/ijs.0.033613-0; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Huber M, 2009, EUR J IMMUNOL, V39, P1716, DOI 10.1002/eji.200939412; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Ivarsson A, 2000, ACTA PAEDIATR, V89, P165, DOI 10.1080/080352500750028771; Ivarsson A, 2002, AM J CLIN NUTR, V75, P914, DOI 10.1093/ajcn/75.5.914; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; La Scaleia R, 2012, MUCOSAL IMMUNOL, V5, P513, DOI 10.1038/mi.2012.26; Lahdenpera AI, 2012, CLIN EXP IMMUNOL, V167, P226, DOI 10.1111/j.1365-2249.2011.04510.x; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; LUNDIN KEA, 1993, J EXP MED, V178, P187, DOI 10.1084/jem.178.1.187; LUNDQVIST C, 1994, J IMMUNOL, V153, P2302; MARSH MN, 1990, GUT, V31, P111, DOI 10.1136/gut.31.1.111; Meresse B, 2006, J EXP MED, V203, P1343, DOI 10.1084/jem.20060028; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Monteleone I, 2010, J IMMUNOL, V184, P2211, DOI 10.4049/jimmunol.0901919; Morgan ME, 2005, HUM IMMUNOL, V66, P13, DOI 10.1016/j.humimm.2004.05.016; Myleus A, 2009, J PEDIATR GASTR NUTR, V49, P170, DOI 10.1097/MPG.0b013e31818c52cc; Ortega C, 2009, J LEUKOCYTE BIOL, V86, P435, DOI [10.1189/jlb.0109046, 10.1189/JLB.0109046]; Ou GW, 2009, AM J GASTROENTEROL, V104, P3058, DOI 10.1038/ajg.2009.524; Pamp SJ, 2012, GENOME RES, V22, P1107, DOI 10.1101/gr.131482.111; Rahman A, 2011, CLIN EXP IMMUNOL, V163, P123, DOI 10.1111/j.1365-2249.2010.04282.x; Sanz Y, 2011, INT REV IMMUNOL, V30, P207, DOI 10.3109/08830185.2011.599084; Sellitto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033387; Sjostrom H, 1998, SCAND J IMMUNOL, V48, P111; Sollid LM, 2011, J INTERN MED, V269, P604, DOI 10.1111/j.1365-2796.2011.02376.x; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Tack GJ, 2010, NAT REV GASTRO HEPAT, V7, P204, DOI 10.1038/nrgastro.2010.23; West CE, 2012, CLIN EXP ALLERGY, V42, P540, DOI 10.1111/j.1365-2222.2011.03941.x; Yeh N, 2010, J IMMUNOL, V185, P2089, DOI 10.4049/jimmunol.1000818; Yen HR, 2009, J IMMUNOL, V183, P7161, DOI 10.4049/jimmunol.0900368	55	51	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53414	10.1371/journal.pone.0053414	http://dx.doi.org/10.1371/journal.pone.0053414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326425	Green Published, gold, Green Submitted			2022-12-25	WOS:000313551500069
J	Watanabe, K; Fallahi, M; Dai, X				Watanabe, K.; Fallahi, M.; Dai, X.			Chromatin effector Pygo2 regulates mammary tumor initiation and heterogeneity in MMTV-Wnt1 mice	ONCOGENE			English	Article						MMTV-Wnt1; pygopus 2; Pygo2; mammary gland; tumor heterogeneity; cancer stem cells	CANCER STEM-CELLS; GENE-EXPRESSION; GLAND HYPERPLASIA; MYELOID-LEUKEMIA; BINDING-PROTEIN; TRANSGENIC MICE; BREAST-CANCER; INDUCE; POPULATIONS; CONTRIBUTE	Little is known about chromatin mechanisms that regulate tumor-initiating cells that are proposed to be responsible for tumor recurrence and relapse. We have previously shown that Pygopus 2 (Pygo2), a chromatin effector and context-dependent Wnt signaling coactivator, regulates mammary gland development by expanding epithelial stem/progenitor cells. However, the role of Pygo2 in mammary tumorigenesis in vivo remains to be addressed. In this study, we show that epithelia-specific ablation of Pygo2 in MMTV-Wnt1 transgenic mice results in delayed mammary ductal elongation, but the hyperbranching phenotype, aberrant accumulation of stem/progenitor-like cells, and canonical Wnt signaling output are largely unaffected. Chronic loss of Pygo2 significantly delays mammary tumor onset in MMTV-Wnt1 females, whereas acute deletion of Pygo2 in MMTV-Wnt1 tumor cells leads to a significant decrease in their tumor-initiating capability upon transplantation. Finally, we provide evidence supporting a role for Pygo2 in modulating the lineage potential of MMTV-Wnt1 tumor initiating cells. Collectively, our results suggest that Pygo2 acts at a step downstream of mammary stem cell accumulation to facilitate transformation, and that it regulates the tumor initiating capacity and lineage preference of the already transformed mammary cells, in MMTV-Wnt1 mice. These findings offer valuable insights into our understanding of the molecular basis of heterogeneity within breast tumors.	[Watanabe, K.; Fallahi, M.; Dai, X.] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Dai, X (corresponding author), Univ Calif Irvine, Sch Med, Dept Biol Chem, D250 Med Sci 1, Irvine, CA 92697 USA.	xdai@uci.edu	Watanabe, Kazuhide/C-9667-2017	Watanabe, Kazuhide/0000-0002-5331-0593; Dai, Xing/0000-0001-8134-1365	Susan G Komen grant [KG110897]; NIH [R01-GM083089]; U.S. Department of Defense Breast Cancer Research Program; (DOD BCRP) Postdoctoral Fellowship [W81XWH-10-1-0383]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083089] Funding Source: NIH RePORTER	Susan G Komen grant(Susan G. Komen Breast Cancer Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense Breast Cancer Research Program(United States Department of Defense); (DOD BCRP) Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the UCI Genomics High Throughput Facility and Sue and Bill Gross Stem Cell Research Center Core Facility (Vanessa Scarfone) for expert service, Yi Li and Julie Serge for the generous gifts of MMTV-Wnt1 mice and keratin antibodies, respectively, and Eva Lee for discussions. This work was supported by Susan G Komen grant KG110897 and NIH Grant R01-GM083089 (to XD). KW was supported by a U.S. Department of Defense Breast Cancer Research Program. (DOD BCRP) Postdoctoral Fellowship (W81XWH-10-1-0383).	Andrews PGP, 2007, INT J ONCOL, V30, P357; Andrews PGP, 2009, BIOCHEM J, V422, P493, DOI 10.1042/BJ20090134; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Baker R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008854; Belenkaya TY, 2002, DEVELOPMENT, V129, P4089; Bocchinfuso WP, 1999, CANCER RES, V59, P1869; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chen JK, 2010, MOL CELL BIOL, V30, P5621, DOI 10.1128/MCB.00465-10; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; EUSTICE DC, 1991, BIOTECHNIQUES, V11, P739; Fiedler M, 2008, MOL CELL, V30, P507, DOI 10.1016/j.molcel.2008.03.011; Gjorevski N, 2011, NAT REV MOL CELL BIO, V12, P581, DOI 10.1038/nrm3168; Gu BN, 2012, CELL CYCLE, V11, P79, DOI 10.4161/cc.11.1.18402; Gu BN, 2010, J CELL BIOCHEM, V110, P1279, DOI 10.1002/jcb.22650; Gu BN, 2009, J CELL BIOL, V185, P811, DOI 10.1083/jcb.200810133; Guo W, 2008, NATURE, V453, P529, DOI 10.1038/nature06933; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jagani Z, 2010, CELL CYCLE, V9, P3449, DOI 10.4161/cc.9.17.12945; Karantza-Wadsworth V, 2008, METHOD ENZYMOL, V446, P61, DOI 10.1016/S0076-6879(08)01604-2; Khalil S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033421; Kim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019310; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; LaMarca HL, 2010, STEM CELLS, V28, P535, DOI 10.1002/stem.297; Li B, 2007, GENESIS, V45, P318, DOI 10.1002/dvg.20299; Li Y, 2000, ONCOGENE, V19, P1002, DOI 10.1038/sj.onc.1203273; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Lindeman GJ, 2010, ASIA-PAC J CLIN ONCO, V6, P89, DOI 10.1111/j.1743-7563.2010.01279.x; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MUNN RJ, 1995, SEMIN CANCER BIOL, V6, P153, DOI 10.1006/scbi.1995.0020; Parker DS, 2002, DEVELOPMENT, V129, P2565; Raaphorst FM, 2003, TRENDS IMMUNOL, V24, P522, DOI 10.1016/S1471-4906(03)00241-2; Schwab KR, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-15; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; SMITH GH, 1990, CELL GROWTH DIFFER, V1, P161; Song N, 2007, DEVELOPMENT, V134, P1873, DOI 10.1242/dev.001495; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun P, 2010, HISTOCHEM CELL BIOL, V133, P213, DOI 10.1007/s00418-009-0662-5; Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537; Tepera SB, 2003, J CELL SCI, V116, P1137, DOI 10.1242/jcs.00334; Thompson B, 2002, NAT CELL BIOL, V4, P367, DOI 10.1038/ncb786; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786	54	20	21	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 30	2014	33	5					632	642		10.1038/onc.2012.620	http://dx.doi.org/10.1038/onc.2012.620			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA5GW	23334328	Green Accepted, Green Submitted			2022-12-25	WOS:000331125100011
J	Su, MY; Steiner, LA; Bogardus, H; Mishra, T; Schulz, VP; Hardison, RC; Gallagher, PG				Su, Mack Y.; Steiner, Laurie A.; Bogardus, Hannah; Mishra, Tejaswini; Schulz, Vincent P.; Hardison, Ross C.; Gallagher, Patrick G.			Identification of Biologically Relevant Enhancers in Human Erythroid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-SPECIFIC ENHANCERS; CIS-REGULATORY MODULES; LONG NONCODING RNAS; CHIP-SEQ REVEALS; ANEMIA TYPE-II; HISTONE MODIFICATIONS; PHYLOGENETIC ODYSSEY; STEM-CELLS; TRANSCRIPTIONAL PROGRAM; CHROMATIN SIGNATURES	Identification of cell type-specific enhancers is important for understanding the regulation of programs controlling cellular development and differentiation. Enhancers are typically marked by the co-transcriptional activator protein p300 or by groups of cell-expressed transcription factors. We hypothesized that a unique set of enhancers regulates gene expression in human erythroid cells, a highly specialized cell type evolved to provide adequate amounts of oxygen throughout the body. Using chromatin immunoprecipitation followed by massively parallel sequencing, genome-wide maps of candidate enhancers were constructed for p300 and four transcription factors, GATA1, NF-E2, KLF1, and SCL, using primary human erythroid cells. These data were combined with gene expression analyses, and candidate enhancers were identified. Consistent with their predicted function as candidate enhancers, there was statistically significant enrichment of p300 and combinations of co-localizing erythroid transcription factors within 1-50 kb of the transcriptional start site (TSS) of genes highly expressed in erythroid cells. Candidate enhancers were also enriched near genes with known erythroid cell function or phenotype. Candidate enhancers exhibited moderate conservation with mouse and minimal conservation with nonplacental vertebrates. Candidate enhancers were mapped to a set of erythroid-associated, biologically relevant, SNPs from the genome-wide association studies (GWAS) catalogue of NHGRI, National Institutes of Health. Fourteen candidate enhancers, representing 10 genetic loci, mapped to sites associated with biologically relevant erythroid traits. Fragments from these loci directed statistically significant expression in reporter gene assays. Identification of enhancers in human erythroid cells will allow a better understanding of erythroid cell development, differentiation, structure, and function and provide insights into inherited and acquired hematologic disease.	[Su, Mack Y.; Bogardus, Hannah; Schulz, Vincent P.; Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; [Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Steiner, Laurie A.] Univ Rochester, Dept Pediat, Rochester, NY 14642 USA; [Mishra, Tejaswini; Hardison, Ross C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Yale University; Yale University; Yale University; University of Rochester; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gallagher, PG (corresponding author), Yale Univ, Sch Med, 333 Cedar St,POB 208064, New Haven, CT 06520 USA.	patrick.gallagher@yale.edu	Hardison, Ross C/G-1142-2010; Mishra, Tejaswini/D-3528-2018; cheng, yong/I-4270-2012	Hardison, Ross C/0000-0003-4084-7516; Mishra, Tejaswini/0000-0001-9931-1260; Steiner, Laurie/0000-0002-2923-4105; Schulz, Vincent/0000-0001-6333-4284	National Institutes of Health [K12HD000850, HL65448, DK62039]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065448, R01HL106184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062039, R01DK065806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K12HD000850, HL65448, and DK62039.	AGRE P, 1985, NATURE, V314, P380, DOI 10.1038/314380a0; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barski A, 2009, J CELL BIOCHEM, V107, P11, DOI 10.1002/jcb.22077; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Borok MJ, 2010, DEVELOPMENT, V137, P5, DOI 10.1242/dev.036160; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chen CY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-152; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; Cheng Y, 2008, GENOME RES, V18, P1896, DOI 10.1101/gr.083089.108; Chlon TM, 2012, MOL CELL, V47, P608, DOI 10.1016/j.molcel.2012.05.051; Core LJ, 2009, GENE DEV, V23, P1606, DOI 10.1101/gad.1827709; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Delabesse E, 2005, MOL CELL BIOL, V25, P5215, DOI 10.1128/MCB.25.12.5215-5225.2005; Dhami P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009059; Dore LC, 2012, BLOOD, V119, P3724, DOI 10.1182/blood-2011-09-380634; Eber S, 2004, SEMIN HEMATOL, V41, P118, DOI 10.1053/j.seminhematol.2004.01.002; Elnitski L, 1997, J BIOL CHEM, V272, P369; England SJ, 2011, BLOOD, V117, P2708, DOI 10.1182/blood-2010-07-299743; Epstein Douglas J., 2009, Briefings in Functional Genomics & Proteomics, V8, P310, DOI 10.1093/bfgp/elp021; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Fromm G, 2009, BIOCHEM CELL BIOL, V87, P781, DOI 10.1139/O09-048; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Gallagher PG, 2005, J BIOL CHEM, V280, P39016, DOI 10.1074/jbc.M506062200; GALLAGHER PG, 1991, T ASSOC AM PHYSICIAN, V104, P32; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; GLOMSKI CA, 1992, HISTOL HISTOPATHOL, V7, P501; GLOMSKI CA, 1990, HISTOL HISTOPATHOL, V5, P513; Glomski CA, 1997, HISTOL HISTOPATHOL, V12, P147; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; Guerrero L, 2010, DEV BIOL, V337, P16, DOI 10.1016/j.ydbio.2009.10.006; Hardison RC, 2012, NAT REV GENET, V13, P469, DOI 10.1038/nrg3242; Harju S, 2002, EXP BIOL MED, V227, P683, DOI 10.1177/153537020222700902; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Higgs DR, 2009, CELL MOL LIFE SCI, V66, P1154, DOI 10.1007/s00018-008-8529-9; Higgs DR, 2008, ADV GENET, V61, P143, DOI 10.1016/S0065-2660(07)00005-3; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Hon G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000201; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Iolascon A, 2010, HAEMATOL-HEMATOL J, V95, P708, DOI 10.3324/haematol.2009.014985; JANE SM, 1992, EMBO J, V11, P2961, DOI 10.1002/j.1460-2075.1992.tb05366.x; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; Kadauke S, 2012, CELL, V150, P725, DOI 10.1016/j.cell.2012.06.038; Kadauke S, 2009, BBA-GENE REGUL MECH, V1789, P17, DOI 10.1016/j.bbagrm.2008.07.002; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Ko M, 2008, MUTAT RES-FUND MOL M, V647, P59, DOI 10.1016/j.mrfmmm.2008.08.004; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Li Q, 2010, DEV BIOL, V337, P484, DOI 10.1016/j.ydbio.2009.10.019; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Maksimenko O, 2008, MOL CELL BIOL, V28, P5469, DOI 10.1128/MCB.00461-08; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Mattick JS, 2010, DEV CELL, V19, P485, DOI 10.1016/j.devcel.2010.10.003; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; McDevitt MA, 1997, P NATL ACAD SCI USA, V94, P7976, DOI 10.1073/pnas.94.15.7976; McGrath KE, 2011, BLOOD, V117, P4600, DOI 10.1182/blood-2010-12-325357; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Migliaccio AR, 2002, BONE MARROW TRANSPL, V30, P75, DOI 10.1038/sj.bmt.1703599; Nikinmaa M, 1997, J EXP BIOL, V200, P369; Nishimura S, 2000, MOL CELL BIOL, V20, P713, DOI 10.1128/MCB.20.2.713-723.2000; Noonan JP, 2010, ANNU REV GENOM HUM G, V11, P1, DOI 10.1146/annurev-genom-082509-141651; Ogilvy S, 2007, MOL CELL BIOL, V27, P7206, DOI 10.1128/MCB.00931-07; Ong CT, 2012, EMBO REP, V13, P423, DOI 10.1038/embor.2012.52; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Onodera K, 1997, P NATL ACAD SCI USA, V94, P4487, DOI 10.1073/pnas.94.9.4487; Orom UA, 2011, TRENDS GENET, V27, P433, DOI 10.1016/j.tig.2011.06.009; Orom UA, 2011, CURR OPIN GENET DEV, V21, P194, DOI 10.1016/j.gde.2011.01.020; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Palii CG, 2011, EMBO J, V30, P494, DOI 10.1038/emboj.2010.342; Palis J, 2008, CURR OPIN HEMATOL, V15, P155, DOI 10.1097/MOH.0b013e3282f97ae1; Palis J, 2010, INT J DEV BIOL, V54, P1011, DOI 10.1387/ijdb.093056jp; Panzenbock B, 1998, BLOOD, V92, P3658, DOI 10.1182/blood.V92.10.3658.422k18_3658_3668; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pheasant M, 2007, GENOME RES, V17, P1245, DOI 10.1101/gr.6406307; Pilon AM, 2011, BLOOD, V118, pE139, DOI 10.1182/blood-2011-05-355107; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Russo R, 2010, AM J HEMATOL, V85, P915, DOI 10.1002/ajh.21866; Sankaran VG, 2010, BRIT J HAEMATOL, V149, P181, DOI 10.1111/j.1365-2141.2010.08105.x; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Siepel A, 2004, J COMPUT BIOL, V11, P413, DOI 10.1089/1066527041410472; Smith AM, 2008, GENOME RES, V18, P1422, DOI 10.1101/gr.077008.108; Steiner LA, 2011, J BIOL CHEM, V286, P39457, DOI 10.1074/jbc.M111.243006; Steiner LA, 2009, MOL CELL BIOL, V29, P5399, DOI 10.1128/MCB.00777-09; Suzuki M, 2009, MOL CELL BIOL, V29, P1163, DOI 10.1128/MCB.01572-08; Suzuki N, 2011, MOL CELL BIOL, V31, P3896, DOI 10.1128/MCB.05463-11; Szutorisz H, 2005, TRENDS BIOCHEM SCI, V30, P593, DOI 10.1016/j.tibs.2005.08.006; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; Valverde-Garduno V, 2004, BLOOD, V104, P3106, DOI 10.1182/blood-2004-04-1333; VanderMeer JE, 2011, DEV DYNAM, V240, P920, DOI 10.1002/dvdy.22535; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wilson NK, 2009, BLOOD, V113, P5456, DOI 10.1182/blood-2009-01-200048; Wozniak RJ, 2007, J BIOL CHEM, V282, P14665, DOI 10.1074/jbc.M700792200; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Yoo EJ, 2012, MOL CELL BIOL, V32, P2020, DOI 10.1128/MCB.06650-11; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	127	37	39	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8433	8444		10.1074/jbc.M112.413260	http://dx.doi.org/10.1074/jbc.M112.413260			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23341446	Green Published, hybrid			2022-12-25	WOS:000316564500041
J	Resmi, MS; Verma, P; Gokhale, RS; Soniya, EV				Resmi, Mohankumar Saraladevi; Verma, Priyanka; Gokhale, Rajesh S.; Soniya, Eppurathu Vasudevan			Identification and Characterization of a Type III Polyketide Synthase Involved in Quinolone Alkaloid Biosynthesis from Aegle marmelos Correa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHALCONE SYNTHASE; BENZALACETONE SYNTHASE; ENZYMATIC FORMATION; MOLECULAR-CLONING; ACRIDONE SYNTHASE; SKIMMIANINE; FAMILY; FUROQUINOLINES; SCAFFOLDS; STILBENE	Quinolone alkaloids, found abundantly in the roots of bael (Aegle marmelos), possess various biological activities and have recently gained attention as potential lead molecules for novel drug designing. Here, we report the characterization of a novel Type III polyketide synthase, quinolone synthase (QNS), from A. marmelos that is involved in the biosynthesis of quinolone alkaloid. Using homology-based structural modeling, we identify two crucial amino acid residues (Ser-132 and Ala-133) at the putative QNS active site. Substitution of Ser-132 to Thr and Ala-133 to Ser apparently constricted the active site cavity resulting in production of naringenin chalcone from p-coumaroyl-CoA. Measurement of steady-state kinetic parameters demonstrates that the catalytic efficiency of QNS was several-fold higher for larger acyl-coenzymeA substrates as compared with smaller precursors. Our mutagenic studies suggest that this protein might have evolved from an evolutionarily related member of chalcone synthase superfamily by mere substitution of two active site residues. The identification and characterization of QNS offers a promising target for gene manipulation studies toward the production of novel alkaloid scaffolds.	[Resmi, Mohankumar Saraladevi; Soniya, Eppurathu Vasudevan] Rajiv Gandhi Ctr Biotechnol, Plant Mol Biol Div, Thiruvananthapuram 695014, Kerala, India; [Verma, Priyanka] Natl Inst Immunol, New Delhi 110067, India; [Gokhale, Rajesh S.] CSIR, Inst Genom & Integrat Biol, Syst Biol Grp, Delhi 110007, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Soniya, EV (corresponding author), Rajiv Gandhi Ctr Biotechnol, Plant Mol Biol Div, Thycaud PO, Thiruvananthapuram 695014, Kerala, India.	evsoniya@rgcb.res.in			Department of Science and Technology, New Delhi, India; Council of Scientific and Industrial Research (New Delhi, India)	Department of Science and Technology, New Delhi, India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (New Delhi, India)(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Department of Science and Technology, New Delhi, India, and a senior research fellowship from Council of Scientific and Industrial Research (New Delhi, India).	Abe I, 2006, ORG LETT, V8, P499, DOI 10.1021/ol052912h; Abe I, 2001, EUR J BIOCHEM, V268, P3354, DOI 10.1046/j.1432-1327.2001.02255.x; Abe I, 2003, J BIOL CHEM, V278, P25218, DOI 10.1074/jbc.M303276200; Abe I, 2006, ORG LETT, V8, P6063, DOI 10.1021/ol0625233; Akiyama T, 1999, EUR J BIOCHEM, V263, P834, DOI 10.1046/j.1432-1327.1999.00562.x; ALHAIDER AA, 1985, J MED CHEM, V28, P1394, DOI 10.1021/jm00148a004; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Chen KS, 2000, PLANTA MED, V66, P80, DOI 10.1055/s-0029-1243116; CHENG JT, 1990, ARCH INT PHARMACOD T, V306, P65; CHENG JT, 1986, ARCH INT PHARMACOD T, V281, P35; CHENG JT, 1994, J AUTON PHARMACOL, V14, P365, DOI 10.1111/j.1474-8673.1994.tb00617.x; Dewick P. M., 1997, MED NATURAL PRODUCTS, P123; Durbin ML, 2000, PLANT MOL BIOL, V42, P79, DOI 10.1023/A:1006375904820; Eckermann S, 1998, NATURE, V396, P387, DOI 10.1038/24652; Ghosh R, 2008, J BIOL CHEM, V283, P11348, DOI 10.1074/jbc.M709588200; Heeb S, 2011, FEMS MICROBIOL REV, V35, P247, DOI 10.1111/j.1574-6976.2010.00247.x; Jansen O, 2006, J ETHNOPHARMACOL, V105, P241, DOI 10.1016/j.jep.2005.11.001; Jez JM, 2002, P NATL ACAD SCI USA, V99, P5319, DOI 10.1073/pnas.082590499; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; JUNGHANNS KT, 1995, PLANT MOL BIOL, V27, P681, DOI 10.1007/BF00020222; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Klundt T, 2009, J BIOL CHEM, V284, P30957, DOI 10.1074/jbc.M109.038927; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Lukacin R, 2001, FEBS LETT, V508, P413, DOI 10.1016/S0014-5793(01)03061-7; Michael JP, 2008, NAT PROD REP, V25, P166, DOI 10.1039/b612168n; Morita H, 2007, CHEM BIOL, V14, P359, DOI 10.1016/j.chembiol.2007.02.003; Morita H, 2011, P NATL ACAD SCI USA, V108, P13504, DOI 10.1073/pnas.1107782108; Nugroho A. E., 2010, Journal of Basic & Applied Sciences, V6, P141; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Resmi MS, 2012, GENE, V491, P278, DOI 10.1016/j.gene.2011.09.025; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Riyanto S., 2001, MALAYSIAN J ANAL SCI, V7, P463; Robert A, 1998, CHEM SOC REV, V27, P273, DOI 10.1039/a827273z; Samappito S, 2003, PHYTOCHEMISTRY, V62, P313, DOI 10.1016/S0031-9422(02)00545-9; Saxena P, 2003, J BIOL CHEM, V278, P44780, DOI 10.1074/jbc.M306714200; Schroder J, 1997, TRENDS PLANT SCI, V2, P373, DOI 10.1016/S1360-1385(97)01104-7; Shi SP, 2009, ORG LETT, V11, P551, DOI 10.1021/ol802606w; Tillequin Francois, 2007, Phytochemistry Reviews, V6, P65, DOI 10.1007/s11101-006-9010-8; Zheng DS, 2001, PLANT MOL BIOL, V46, P1, DOI 10.1023/A:1010642517738	40	24	26	0	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7271	7281		10.1074/jbc.M112.429886	http://dx.doi.org/10.1074/jbc.M112.429886			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23329842	hybrid, Green Published			2022-12-25	WOS:000316002400047
J	Thompson, MG; Foley, DA; Colley, KJ				Thompson, Matthew G.; Foley, Deirdre A.; Colley, Karen J.			The Polysialyltransferases Interact with Sequences in Two Domains of the Neural Cell Adhesion Molecule to Allow Its Polysialylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYSIALIC ACID SYNTHASE; ST8SIA II STX; IN-VIVO; GLYCAN POLYSIALYLATION; NERVOUS-SYSTEM; LUNG-CARCINOMA; WILMS TUMOR; NCAM; BRAIN; IDENTIFICATION	The neural cell adhesion molecule (NCAM) is the major substrate for the polysialyltransferases (polySTs), ST8SiaII/STX and ST8SiaIV/PST. The polysialylation of NCAM N-glycans decreases cell adhesion and alters signaling. Previous work demonstrated that the first fibronectin type III repeat (FN1) of NCAM is required for polyST recognition and the polysialylation of the N-glycans on the adjacent Ig5 domain. In this work, we highlight the importance of an FN1 acidic patch in polyST recognition and also reveal that the polySTs are required to interact with sequences in the Ig5 domain for polysialylation to occur. We find that features of the Ig5 domain of the olfactory cell adhesion molecule (OCAM) are responsible for its lack of polysialylation. Specifically, two basic OCAM Ig5 residues (Lys and Arg) found near asparagines equivalent to those carrying the polysialylated N-glycans in NCAM substantially decrease or eliminate polysialylation when used to replace the smaller and more neutral residues (Ser and Asn) in analogous positions in NCAM Ig5. This decrease in polysialylation does not reflect altered glycosylation but instead is correlated with a decrease in polyST-NCAM binding. In addition, inserting non-conserved OCAM sequences into NCAM Ig5, including an "extra" N-glycosylation site, decreases or completely blocks NCAM polysialylation. Taken together, these results indicate that the polySTs not only recognize an acidic patch in the FN1 domain of NCAM but also must contact sequences in the Ig5 domain for polysialylation of Ig5 N-glycans to occur.	[Thompson, Matthew G.; Foley, Deirdre A.; Colley, Karen J.] Univ Illinois, Dept Biochem & Mol Genet, Coll Med, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colley, KJ (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Coll Med, 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA.	karenc@uic.edu			National Institutes of Health [RO1 GM63843]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063843, R01GM101949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM63843 (to K. J. C.).	Alenius M, 1997, J BIOL CHEM, V272, P26083, DOI 10.1074/jbc.272.42.26083; Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Angata K, 2002, J BIOL CHEM, V277, P36808, DOI 10.1074/jbc.M204632200; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Foley DA, 2010, J BIOL CHEM, V285, P35056, DOI 10.1074/jbc.M110.170209; Foley DA, 2010, J BIOL CHEM, V285, P27360, DOI 10.1074/jbc.M110.140038; Foley DA, 2009, J BIOL CHEM, V284, P15505, DOI 10.1074/jbc.M809696200; Galuska SP, 2008, J BIOL CHEM, V283, P17, DOI 10.1074/jbc.M707024200; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hildebrandt H, 1998, CANCER RES, V58, P779; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Kanato Y, 2008, GLYCOBIOLOGY, V18, P1044, DOI 10.1093/glycob/cwn084; Kojima N, 1996, J BIOL CHEM, V271, P19457, DOI 10.1074/jbc.271.32.19457; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; KOMMINOTH P, 1991, AM J PATHOL, V139, P297; Kulahin N, 2011, STRUCTURE, V19, P203, DOI 10.1016/j.str.2010.12.014; Mendiratta SS, 2006, J BIOL CHEM, V281, P36052, DOI 10.1074/jbc.M608073200; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Nakayama J, 1998, PATHOL INT, V48, P665, DOI 10.1111/j.1440-1827.1998.tb03967.x; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; Ono S, 2012, J BIOL CHEM, V287, P3710, DOI 10.1074/jbc.M111.276618; PaoloniGiacobino A, 1997, GENOMICS, V43, P43, DOI 10.1006/geno.1997.4782; ROTH J, 1988, AM J PATHOL, V133, P227; ROTH J, 1988, VIRCHOWS ARCH B, V56, P95, DOI 10.1007/BF02890007; Rutishauser U, 1996, CURR OPIN CELL BIOL, V8, P679, DOI 10.1016/S0955-0674(96)80109-8; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; SCHEIDEGGER EP, 1995, J BIOL CHEM, V270, P22685, DOI 10.1074/jbc.270.39.22685; SCHEIDEGGER EP, 1994, LAB INVEST, V70, P95; Takahashi S, 2011, CANCER SCI, V102, P808, DOI 10.1111/j.1349-7006.2011.01855.x; Thompson MG, 2011, J BIOL CHEM, V286, P4525, DOI 10.1074/jbc.M110.200386; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Walz A, 2006, MOL CELL NEUROSCI, V32, P1, DOI 10.1016/j.mcn.2006.01.013; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; Zapater JL, 2012, J BIOL CHEM, V287, P6441, DOI 10.1074/jbc.M111.322024; ZUBER C, 1992, J BIOL CHEM, V267, P9965	48	15	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7282	7293		10.1074/jbc.M112.438374	http://dx.doi.org/10.1074/jbc.M112.438374			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23341449	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000316002400048
J	Becker, A; Allmann, L; Hofstatter, M; Casa, V; Weber, P; Lehmkuhl, A; Herce, HD; Cardoso, MC				Becker, Annette; Allmann, Lena; Hofstaetter, Maria; Casa, Valentina; Weber, Patrick; Lehmkuhl, Anne; Herce, Henry D.; Cardoso, M. Cristina			Direct Homo- and Hetero-Interactions of MeCP2 and MBD2	PLOS ONE			English	Article							CHROMATIN-REMODELING COMPLEX; CPG-BINDING PROTEIN-2; DNA METHYLATION; RETT-SYNDROME; TRANSCRIPTIONAL REPRESSION; HISTONE DEACETYLASE; MUTATIONS; DIFFERENTIATION; DOMAIN; SITES	Epigenetic marks like methylation of cytosines at CpG dinucleotides are essential for mammalian development and play a major role in the regulation of gene expression and chromatin architecture. The methyl-cytosine binding domain (MBD) protein family recognizes and translates this methylation mark. We have recently shown that the level of MeCP2 and MBD2, two members of the MBD family, increased during differentiation and their ectopic expression induced heterochromatin clustering in vivo. As oligomerization of these MBD proteins could constitute a factor contributing to the chromatin clustering effect, we addressed potential associations among the MBD family performing a series of different interaction assays in vitro as well as in vivo. Using recombinant purified MBDs we found that MeCP2 and MBD2 showed the stronger self and cross association as compared to the other family members. Besides demonstrating that these homo-and hetero-interactions occur in the absence of DNA, we could confirm them in mammalian cells using co-immunoprecipitation analysis. Employing a modified form of the fluorescent two-hybrid protein-protein interaction assay, we could clearly visualize these associations in single cells in vivo. Deletion analysis indicated that the region of MeCP2 comprising amino acids 163-309 as well the first 152 amino acids of MBD2 are the domains responsible for MeCP2 and MBD2 associations. Our results strengthen the possibility that MeCP2 and MBD2 direct interactions could crosslink chromatin fibers and therefore give novel insight into the molecular mechanism of MBD mediated global heterochromatin architecture.	[Becker, Annette; Allmann, Lena; Casa, Valentina; Weber, Patrick; Lehmkuhl, Anne; Herce, Henry D.; Cardoso, M. Cristina] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany; [Hofstaetter, Maria] Max Delbruck Ctr Mol Med, Berlin, Germany	Technical University of Darmstadt; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Cardoso, MC (corresponding author), Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany.	cardoso@bio.tu-darmstadt.de			Deutsche Forschungsgemeinschaft [DFG SPP 1356, 1129]; Bundesministerium fur Forschung und Technik BMBF [02S8355]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Forschung und Technik BMBF(Federal Ministry of Education & Research (BMBF))	This work was funded by grants of the Deutsche Forschungsgemeinschaft [DFG SPP 1356 and 1129] (URL: www.dfg.de) and the Bundesministerium fur Forschung und Technik BMBF 02S8355] (URL: www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VH, 2007, J BIOL CHEM, V282, P15057, DOI 10.1074/jbc.M700855200; Agarwal N, 2007, NUCLEIC ACIDS RES, V35, P5402, DOI 10.1093/nar/gkm599; Agarwal N, 2011, HUM MOL GENET, V20, P4187, DOI 10.1093/hmg/ddr346; Amir RE, 2000, AM J MED GENET, V97, P147, DOI 10.1002/1096-8628(200022)97:2<147::AID-AJMG6>3.0.CO;2-O; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Brero A, 2006, CURR TOP MICROBIOL, V301, P21; Brero A, 2005, J CELL BIOL, V169, P733, DOI 10.1083/jcb.200502062; Casas-Delucchi CS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks784; Chandler SP, 1999, BIOCHEMISTRY-US, V38, P7008, DOI 10.1021/bi990224y; Dantzer F, 2004, MOL CELL BIOL, V24, P1595, DOI 10.1128/MCB.24.4.1595-1607.2004; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Ghosh RP, 2010, MOL CELL BIOL, V30, P4656, DOI 10.1128/MCB.00379-10; Ghosh RP, 2010, BIOCHEMISTRY-US, V49, P4395, DOI 10.1021/bi9019753; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Jost KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026499; Klose RJ, 2004, J BIOL CHEM, V279, P46490, DOI 10.1074/jbc.M408284200; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Mortusewicz O, 2006, NUCLEIC ACIDS RES, V34, P3523, DOI 10.1093/nar/gkl492; Nan XS, 2007, P NATL ACAD SCI USA, V104, P2709, DOI 10.1073/pnas.0608056104; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nikitina T, 2007, J BIOL CHEM, V282, P28237, DOI 10.1074/jbc.M704304200; Pichler Garwin, 2012, Methods Mol Biol, V911, P475, DOI 10.1007/978-1-61779-968-6_29; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rottach A, 2009, J CELL BIOCHEM, V108, P43, DOI 10.1002/jcb.22253; Rottach A, 2008, HYBRIDOMA, V27, P337, DOI 10.1089/hyb.2008.0031; Saito M, 2002, J BIOL CHEM, V277, P35434, DOI 10.1074/jbc.M203455200; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zolghadr K, 2008, MOL CELL PROTEOMICS, V7, P2279, DOI 10.1074/mcp.M700548-MCP200	36	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53730	10.1371/journal.pone.0053730	http://dx.doi.org/10.1371/journal.pone.0053730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335972	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000314707700028
J	Bodvard, K; Jorhov, A; Blomberg, A; Molin, M; Kall, M				Bodvard, Kristofer; Jorhov, Anna; Blomberg, Anders; Molin, Mikael; Kall, Mikael			The Yeast Transcription Factor Crz1 Is Activated by Light in a Ca2+/Calcineurin-Dependent and PKA-Independent Manner	PLOS ONE			English	Article							AFFINITY CAMP-PHOSPHODIESTERASE; SACCHAROMYCES-CEREVISIAE; NUCLEAR-LOCALIZATION; GENE-EXPRESSION; H+/CA2+ EXCHANGE; OXIDATIVE STRESS; CALCIUM INFLUX; HEAT-SHOCK; CA2+; MSN2P	Light in the visible range can be stressful to non-photosynthetic organisms. The yeast Saccharomyces cerevisiae has earlier been reported to respond to blue light via activation of the stress-regulated transcription factor Msn2p. Environmental changes also induce activation of calcineurin, a Ca2+/calmodulin dependent phosphatase, which in turn controls gene transcription by dephosphorylating the transcription factor Crz1p. We investigated the connection between cellular stress caused by blue light and Ca2+ signalling in yeast by monitoring the nuclear localization dynamics of Crz1p, Msn2p and Msn4p. The three proteins exhibit distinctly different stress responses in relation to light exposure. Msn2p, and to a lesser degree Msn4p, oscillate rapidly between the nucleus and the cytoplasm in an apparently stochastic fashion. Crz1p, in contrast, displays a rapid and permanent nuclear localization induced by illumination, which triggers Crz1p-dependent transcription of its target gene CMK2. Moreover, increased extracellular Ca2+ levels stimulates the light-induced responses of all three transcription factors, e. g. Crz1p localizes much quicker to the nucleus and a larger fraction of cells exhibits permanent Msn2p nuclear localization at higher Ca2+ concentration. Studies in mutants lacking Ca2+ transporters indicate that influx of extracellular Ca2+ is crucial for the initial stages of light-induced Crz1p nuclear localization, while mobilization of intracellular Ca2+ stores appears necessary for a sustained response. Importantly, we found that Crz1p nuclear localization is dependent on calcineurin and the carrier protein Nmd5p, while not being affected by increased protein kinase A activity (PKA), which strongly inhibits light-induced nuclear localization of Msn2/4p. We conclude that the two central signalling pathways, cAMP-PKA-Msn2/4 and Ca2+-calcineurin-Crz1, are both activated by blue light illumination.	[Bodvard, Kristofer; Kall, Mikael] Chalmers Univ Technol, Dept Appl Phys, S-41296 Gothenburg, Sweden; [Bodvard, Kristofer; Jorhov, Anna; Blomberg, Anders; Molin, Mikael] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	Chalmers University of Technology; University of Gothenburg	Bodvard, K (corresponding author), Chalmers Univ Technol, Dept Appl Phys, S-41296 Gothenburg, Sweden.	kristofer.bodvard@chalmers.se	Käll, Mikael/A-6753-2012	Käll, Mikael/0000-0002-1163-0345; Blomberg, Anders/0000-0002-1260-3920; Molin, Mikael/0000-0002-3903-8503	Swedish Foundation for Strategic Research	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	The authors acknowledge financial support from the Swedish Foundation for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoros M, 2001, MOL MICROBIOL, V39, P1523, DOI 10.1046/j.1365-2958.2001.02339.x; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berry DB, 2008, MOL BIOL CELL, V19, P4580, DOI 10.1091/mbc.E07-07-0680; Bodvard K, 2011, BBA-MOL CELL RES, V1813, P358, DOI 10.1016/j.bbamcr.2010.12.004; Boustany LM, 2002, GENE DEV, V16, P608, DOI 10.1101/gad.967602; Boy-Marcotte E, 2006, MOL GENET GENOMICS, V275, P277, DOI 10.1007/s00438-005-0017-4; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Castermans D, 2012, CELL RES, V22, P1058, DOI 10.1038/cr.2012.20; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cui JJ, 2009, FEMS YEAST RES, V9, P1137, DOI 10.1111/j.1567-1364.2009.00552.x; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Cunningham KW, 2011, CELL CALCIUM, V50, P129, DOI 10.1016/j.ceca.2011.01.010; CYERT MS, 1992, MOL CELL BIOL, V12, P3460, DOI 10.1128/MCB.12.8.3460; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; DUNN T, 1994, J BIOL CHEM, V269, P7273; Durchschlag E, 2004, J BIOL CHEM, V279, P55425, DOI 10.1074/jbc.M407264200; Estruch F, 2000, FEMS MICROBIOL REV, V24, P469, DOI 10.1016/S0168-6445(00)00035-8; ESTRUCH F, 1993, MOL CELL BIOL, V13, P3872, DOI 10.1128/MCB.13.7.3872; Fischer M, 1997, FEBS LETT, V419, P259, DOI 10.1016/S0014-5793(97)01466-X; Fraunhofer-Chalmers Centre for Industrial Mathematics, CELLSTAT COMP SOFTW; Garmendia-Torres C, 2007, CURR BIOL, V17, P1044, DOI 10.1016/j.cub.2007.05.032; Garreau H, 2000, MICROBIOL-UK, V146, P2113, DOI 10.1099/00221287-146-9-2113; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Groppi S, 2011, CELL CALCIUM, V49, P376, DOI 10.1016/j.ceca.2011.03.006; Hao N, 2012, NAT STRUCT MOL BIOL, V19, P31, DOI 10.1038/nsmb.2192; Hockberger PE, 1999, P NATL ACAD SCI USA, V96, P6255, DOI 10.1073/pnas.96.11.6255; Jacquet M, 2003, J CELL BIOL, V161, P497, DOI 10.1083/jcb.200303030; Kafadar KA, 2004, EUKARYOT CELL, V3, P1147, DOI 10.1128/EC.3.5.1147-1153.2004; Kafadar KA, 2003, GENE DEV, V17, P2698, DOI 10.1101/gad.1140603; KUNO T, 1991, BIOCHEM BIOPH RES CO, V180, P1159, DOI 10.1016/S0006-291X(05)81188-X; Kvarnstrom M, 2008, OPT EXPRESS, V16, P12943, DOI 10.1364/OE.16.012943; Locke EG, 2000, MOL CELL BIOL, V20, P6686, DOI 10.1128/MCB.20.18.6686-6694.2000; Logg K, 2009, FEMS YEAST RES, V9, P875, DOI 10.1111/j.1567-1364.2009.00536.x; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Marchi V, 1999, FEBS LETT, V454, P181, DOI 10.1016/S0014-5793(99)00803-0; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Muend S, 2008, FEMS YEAST RES, V8, P425, DOI 10.1111/j.1567-1364.2008.00354.x; NIKAWA JI, 1987, MOL CELL BIOL, V7, P3629, DOI 10.1128/MCB.7.10.3629; Paidhungat M, 1997, MOL CELL BIOL, V17, P6339, DOI 10.1128/MCB.17.11.6339; Park JI, 2005, BIOCHEM BIOPH RES CO, V327, P311, DOI 10.1016/j.bbrc.2004.12.019; Polizotto RS, 2001, J CELL BIOL, V154, P951, DOI 10.1083/jcb.200104078; Popa CV, 2010, FEBS J, V277, P4027, DOI 10.1111/j.1742-4658.2010.07794.x; SASS P, 1986, P NATL ACAD SCI USA, V83, P9303, DOI 10.1073/pnas.83.24.9303; Schmitt AP, 1996, P NATL ACAD SCI USA, V93, P5777, DOI 10.1073/pnas.93.12.5777; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Strayle J, 1999, EMBO J, V18, P4733, DOI 10.1093/emboj/18.17.4733; Takatsume Y, 2010, BIOCHEM J, V427, P275, DOI 10.1042/BJ20091334; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; Treger JM, 1998, J BIOL CHEM, V273, P26875, DOI 10.1074/jbc.273.41.26875; Tsuzi D, 2004, FEBS LETT, V569, P301, DOI 10.1016/j.febslet.2004.05.077; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200	61	27	28	7	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53404	10.1371/journal.pone.0053404	http://dx.doi.org/10.1371/journal.pone.0053404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335962	Green Published, gold			2022-12-25	WOS:000314707700016
J	Imhof, P; Zahran, M				Imhof, Petra; Zahran, Mai			The Effect of a G:T Mispair on the Dynamics of DNA	PLOS ONE			English	Article							UNIQUE TETRANUCLEOTIDE SEQUENCES; IMINO PROTON-EXCHANGE; BASE-PAIR KINETICS; MOLECULAR-DYNAMICS; FREE-ENERGY; B-DNA; NUMERICAL-INTEGRATION; MISMATCH RECOGNITION; POLYMERASE-BETA; REPAIR ENZYMES	Distortions in the DNA sequence such as damages or mispairs are specifically recognized and processed by DNA repair enzymes. A particular challenge for the enzymatic specificity is the recognition of a wrongly-placed native nucleotide such as thymine in T: G mispairs. An important step of substrate binding which is observed in many repair proteins is the flipping of the target base out of the DNA helix into the enzyme's active site. In this work we investigate how much the intrinsic dynamics of mispaired DNA is changed compared to canonical DNA. Our molecular dynamics simulations of DNA with and without T: G mispairs show significant differences in the conformation of paired and mispaired DNA. The wobble pair T: G shows local distortions such as twist, shear and stretch which deviate from canonical B form values. Moreover, the T: G mispair is found to be kinetically less stable, exhibiting two states with respect to base opening: a closed state comparable to the canonical base pairs, and a more open state, indicating a proneness for base flip. In addition, we observe that the thymine base in a T: G mispair is significantly more probable to be flipped than thymine in a T: A pair or cytosine in a C: G pair. Such local deformations and in particular the existence of a second, more-open state can be speculated to help the target-site recognition by repair enzymes.	[Imhof, Petra; Zahran, Mai] Heidelberg Univ, Interdisciplinary Ctr Sci Comp, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Imhof, P (corresponding author), Free Univ Berlin, Berlin, Germany.	petra.imhof@fu-berlin.de	Imhof, Petra/G-5656-2013; Imhof, Petra/V-2392-2019	Imhof, Petra/0000-0001-9820-4578	German Science Foundation (DFG) [IM141/1-1]	German Science Foundation (DFG)(German Research Foundation (DFG))	This work has been supported by the German Science Foundation (DFG) [IM141/1-1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allawi HT, 1998, NUCLEIC ACIDS RES, V26, P4925, DOI 10.1093/nar/26.21.4925; Arora K, 2004, BIOPHYS J, V87, P3088, DOI 10.1529/biophysj.104.040915; Banavali NK, 2002, J MOL BIOL, V319, P141, DOI 10.1016/S0022-2836(02)00194-8; Beveridge DL, 2004, BIOPHYS J, V87, P3799, DOI 10.1529/biophysj.104.045252; Bouvier B, 2007, BIOPHYS J, V93, P770, DOI 10.1529/biophysj.106.091751; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cheatham TE, 2004, CURR OPIN STRUC BIOL, V14, P360, DOI 10.1016/j.sbi.2004.05.001; Chen J, 2008, NUCLEIC ACIDS RES, V36, P253, DOI 10.1093/nar/gkm622; Chipot C, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2138694; Curuksu J, 2008, NUCLEIC ACIDS RES, V36, P2268, DOI 10.1093/nar/gkm1135; Dalhus B, 2009, FEMS MICROBIOL REV, V33, P1044, DOI 10.1111/j.1574-6976.2009.00188.x; Daniels DS, 2004, NAT STRUCT MOL BIOL, V11, P714, DOI 10.1038/nsmb791; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978; Darve E, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2829861; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dixit SB, 2005, BIOPHYS J, V89, P3721, DOI 10.1529/biophysj.105.067397; EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303; EVANS DJ, 1985, J CHEM PHYS, V83, P4069, DOI 10.1063/1.449071; Fadda E, 2011, NUCLEIC ACIDS RES, V39, P767, DOI 10.1093/nar/gkq812; Friedman JI, 2010, BIOCHEMISTRY-US, V49, P4957, DOI 10.1021/bi100593a; Fujii S, 2007, NUCLEIC ACIDS RES, V35, P6063, DOI 10.1093/nar/gkm627; Giudice E, 2003, NUCLEIC ACIDS RES, V31, P1434, DOI 10.1093/nar/gkg239; Gueron M, 1995, METHOD ENZYMOL, V261, P383; GUERON M, 1987, NATURE, V328, P89, DOI 10.1038/328089a0; Hagan MF, 2003, P NATL ACAD SCI USA, V100, P13922, DOI 10.1073/pnas.2036378100; Hu J, 2008, P NATL ACAD SCI USA, V105, P4615, DOI 10.1073/pnas.0708058105; Huang N, 2004, PHILOS T R SOC A, V362, P1439, DOI 10.1098/rsta.2004.1383; Huang N, 2003, P NATL ACAD SCI USA, V100, P68, DOI 10.1073/pnas.0135427100; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isaacs RJ, 2004, J AM CHEM SOC, V126, P583, DOI 10.1021/ja037333r; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Lavery R, 2009, NUCL ACID RES; Lavery R, 2010, NUCLEIC ACIDS RES, V38, P299, DOI 10.1093/nar/gkp834; LEROY JL, 1988, J MOL BIOL, V200, P223, DOI 10.1016/0022-2836(88)90236-7; LINDAHL T, 1982, ANNU REV BIOCHEM, V51, P61, DOI 10.1146/annurev.bi.51.070182.000425; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Maiti A, 2008, P NATL ACAD SCI USA, V105, P8890, DOI 10.1073/pnas.0711061105; Maiti A, 2012, P NATL ACAD SCI USA, V109, P8091, DOI 10.1073/pnas.1201010109; Maiti A, 2011, DNA REPAIR, V10, P545, DOI 10.1016/j.dnarep.2011.03.004; Maiti A, 2009, J BIOL CHEM, V284, P36680, DOI 10.1074/jbc.M109.062356; MOE JG, 1992, BIOCHEMISTRY-US, V31, P8421, DOI 10.1021/bi00151a005; Nilsson L, 2006, COMPUTATIONAL STUDIE, P73; O'Neil LL, 2008, ORG BIOMOL CHEM, V6, P485, DOI 10.1039/b713318a; Orozco M, 2008, CURR OPIN STRUC BIOL, V18, P185, DOI 10.1016/j.sbi.2008.01.005; Perez A, 2007, J AM CHEM SOC, V129, P14739, DOI 10.1021/ja0753546; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Priyakumar UD, 2006, CHEM REV, V106, P489, DOI 10.1021/cr040475z; Priyakumar UD, 2006, J CHEM THEORY COMPUT, V2, P187, DOI 10.1021/ct0501957; RAVISHANKER G, 1989, J BIOMOL STRUCT DYN, V6, P669, DOI 10.1080/07391102.1989.10507729; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SANCAR A, 1988, ANNU REV BIOCHEM, V57, P29, DOI 10.1146/annurev.bi.57.070188.000333; Stivers JT, 2008, CHEM-EUR J, V14, P786, DOI 10.1002/chem.200701501; Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b; Szczepanowski RH, 2008, NUCLEIC ACIDS RES, V36, P6109, DOI 10.1093/nar/gkn622; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Varnai P, 2004, J AM CHEM SOC, V126, P14659, DOI 10.1021/ja0470721; Varnai P, 2002, J AM CHEM SOC, V124, P7272, DOI 10.1021/ja025980x; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Yang LJ, 2002, J MOL BIOL, V321, P459, DOI 10.1016/S0022-2836(02)00617-4; Zacharias M, 2006, BIOPHYS J, V91, P882, DOI 10.1529/biophysj.106.083816; Zahran M, 2010, J MOL BIOL, V401, P415, DOI 10.1016/j.jmb.2010.06.026	64	27	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53305	10.1371/journal.pone.0053305	http://dx.doi.org/10.1371/journal.pone.0053305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335959	Green Published, Green Submitted, gold			2022-12-25	WOS:000314707700013
J	Hopfe, M; Deenen, R; Degrandi, D; Kohrer, K; Henrich, B				Hopfe, Miriam; Deenen, Rene; Degrandi, Daniel; Koehrer, Karl; Henrich, Birgit			Host Cell Responses to Persistent Mycoplasmas - Different Stages in Infection of HeLa Cells with Mycoplasma hominis	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; INTRACELLULAR LOCATION; IN-VITRO; EXPRESSION; RECEPTOR; PROTEIN; OPPA; ADHERENCE; ADHESION; ATPASE	Mycoplasma hominis is a facultative human pathogen primarily associated with bacterial vaginosis and pelvic inflammatory disease, but it is also able to spread to other sites, leading to arthritis or, in neonates, meningitis. With a minimal set of 537 annotated genes, M. hominis is the second smallest self-replicating mycoplasma and thus an ideal model organism for studying the effects of an infectious agent on its host more closely. M. hominis adherence, colonisation and invasion of HeLa cells were characterised in a time-course study using scanning electron microscopy, confocal microscopy and microarray-based analysis of the HeLa cell transcriptome. At 4 h post infection, cytoadherence of M. hominis to the HeLa cell surface was accompanied by differential regulation of 723 host genes (>2 fold change in expression). Genes associated with immune responses and signal transduction pathways were mainly affected and components involved in cell-cycle regulation, growth and death were highly upregulated. At 48 h post infection, when mycoplasma invasion started, 1588 host genes were differentially expressed and expression of genes for lysosome-specific proteins associated with bacterial lysis was detected. In a chronically infected HeLa cell line (2 weeks), the proportion of intracellular mycoplasmas reached a maximum of 10% and M. hominis-filled protrusions of the host cell membrane were seen by confocal microscopy, suggesting exocytotic dissemination. Of the 1972 regulated host genes, components of the ECM-receptor interaction pathway and phagosome-related integrins were markedly increased. The immune response was quite different to that at the beginning of infection, with a prominent induction of IL1B gene expression, affecting pathways of MAPK signalling, and genes connected with cytokine-cytokine interactions and apoptosis. These data show for the first time the complex, time-dependent reaction of the host directed at mycoplasmal clearance and the counter measures of this pestering pathogen.	[Hopfe, Miriam; Degrandi, Daniel; Henrich, Birgit] Univ Dusseldorf, Inst Med Microbiol, D-40225 Dusseldorf, Germany; [Hopfe, Miriam; Degrandi, Daniel; Henrich, Birgit] Univ Dusseldorf, Hosp Hyg, D-40225 Dusseldorf, Germany; [Deenen, Rene; Koehrer, Karl] Univ Dusseldorf, Biol Med Res Ctr, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Henrich, B (corresponding author), Univ Dusseldorf, Inst Med Microbiol, D-40225 Dusseldorf, Germany.	birgit.henrich@uni-duesseldorf.de						Angus AA, 2008, INFECT IMMUN, V76, P1992, DOI 10.1128/IAI.01221-07; Axsen WS, 2009, MICROB PATHOGENESIS, V47, P231, DOI 10.1016/j.micpath.2009.08.002; Bengtson SH, 2006, BLOOD, V108, P2055, DOI 10.1182/blood-2006-04-016444; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brechter AB, 2008, BONE, V43, P72, DOI 10.1016/j.bone.2008.02.003; Brumell JH, 2002, CURR BIOL, V12, pR15, DOI 10.1016/S0960-9822(01)00640-6; Butler SE, 2010, PARASITOL RES, V107, P1023, DOI 10.1007/s00436-010-1975-y; Calixto JB, 2000, PAIN, V87, P1, DOI 10.1016/S0304-3959(00)00335-3; Canoz Ozlem, 2002, Pathology & Oncology Research, V8, P262; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Conus S, 2008, J EXP MED, V205, P685, DOI 10.1084/jem.20072152; Diaz-Garcia FJ, 2006, HUM REPROD, V21, P1591, DOI 10.1093/humrep/del032; Dorn BR, 2001, INFECT IMMUN, V69, P5698, DOI 10.1128/IAI.69.9.5698-5708.2001; Eckhardt ERM, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-133; Gdoura R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-129; Goh YY, 2010, J BIOL CHEM, V285, P32999, DOI 10.1074/jbc.M110.108175; Goyette J, 2011, AMINO ACIDS, V41, P821, DOI 10.1007/s00726-010-0528-0; Henrich B, 1999, J BACTERIOL, V181, P4873, DOI 10.1128/JB.181.16.4873-4878.1999; HENRICH B, 1993, INFECT IMMUN, V61, P2945, DOI 10.1128/IAI.61.7.2945-2951.1993; Higgins WJ, 2010, J BIOL CHEM, V285, P3722, DOI 10.1074/jbc.M109.037358; Hopfe M, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-46; Hopfe M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-185; Hopfe M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-55; Kaman WE, 2009, MED MICROBIOL IMMUN, V198, P39, DOI 10.1007/s00430-008-0103-4; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kang EH, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2797; Kehrer JP, 2010, CELL BIOL TOXICOL, V26, P83, DOI 10.1007/s10565-009-9119-9; Kim I, 2000, BIOCHEM J, V346, P603, DOI 10.1042/0264-6021:3460603; Kitzerow A, 1999, J MED MICROBIOL, V48, P485, DOI 10.1099/00222615-48-5-485; Lam GY, ADV IMMUNOL, V113, P7; Lazzell DR, 2004, J BIOL CHEM, V279, P52124, DOI 10.1074/jbc.M407502200; Lu B, 2010, BIOCHEM BIOPH RES CO, V391, P1737, DOI 10.1016/j.bbrc.2009.12.145; MacKenzie CR, 2010, INT J INFECT DIS, V14, pE307, DOI 10.1016/j.ijid.2010.02.2253; Mobius N, 2012, METHODS MOL BIOL, V903, P235, DOI 10.1007/978-1-61779-937-2_15; Mostowy S, 2009, CELL MOTIL CYTOSKEL, V66, P816, DOI 10.1002/cm.20353; OLSON LD, 1993, J BACTERIOL, V175, P3224, DOI 10.1128/JB.175.10.3224-3227.1993; PATTI JM, 1994, CURR OPIN CELL BIOL, V6, P752, DOI 10.1016/0955-0674(94)90104-X; Pereyre S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000677; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Poveda JB, 1998, METH MOL B, V104, P105; Rappelli P, 1998, LANCET, V352, P1286, DOI 10.1016/S0140-6736(98)00041-5; Rathman M, 1997, INFECT IMMUN, V65, P1475, DOI 10.1128/IAI.65.4.1475-1485.1997; Sato H, 2012, INTERNAL MED, V51, P425, DOI 10.2169/internalmedicine.51.6058; Scott K, 2005, IMMUNOLOGY, V116, P245, DOI 10.1111/j.1365-2567.2005.02218.x; Shin HS, 2011, FEMS IMMUNOL MED MIC, V63, P418, DOI 10.1111/j.1574-695X.2011.00868.x; Targosz A, 2006, J PHYSIOL PHARMACOL, V57, P265; TAYLORROBINSON D, 1991, INT J EXP PATHOL, V72, P705; Vancini RG, 2008, ARCH MICROBIOL, V189, P7, DOI 10.1007/s00203-007-0288-8; Viemann D, 2005, BLOOD, V105, P2955, DOI 10.1182/blood-2004-07-2520; Waites KB, 2005, CLIN MICROBIOL REV, V18, P757, DOI 10.1128/CMR.18.4.757-789.2005; Winner F, 2000, INFECT IMMUN, V68, P4238, DOI 10.1128/IAI.68.7.4238-4244.2000	52	41	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54219	10.1371/journal.pone.0054219	http://dx.doi.org/10.1371/journal.pone.0054219			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326599	Green Submitted, gold, Green Published			2022-12-25	WOS:000314705800116
J	Pardo, I; Pata, MP; Gomez, D; Garcia, MB				Pardo, Iker; Pata, Maria P.; Gomez, Daniel; Garcia, Maria B.			A Novel Method to Handle the Effect of Uneven Sampling Effort in Biodiversity Databases	PLOS ONE			English	Article							SPECIES RICHNESS ESTIMATORS; NONPARAMETRIC-ESTIMATION; ACCUMULATION FUNCTIONS; PLANT DIVERSITY; CONSERVATION; BIAS; INVENTORIES; COMPLETENESS; SENSITIVITY; SELECTION	How reliable are results on spatial distribution of biodiversity based on databases? Many studies have evidenced the uncertainty related to this kind of analysis due to sampling effort bias and the need for its quantification. Despite that a number of methods are available for that, little is known about their statistical limitations and discrimination capability, which could seriously constrain their use. We assess for the first time the discrimination capacity of two widely used methods and a proposed new one (FIDEGAM), all based on species accumulation curves, under different scenarios of sampling exhaustiveness using Receiver Operating Characteristic (ROC) analyses. Additionally, we examine to what extent the output of each method represents the sampling completeness in a simulated scenario where the true species richness is known. Finally, we apply FIDEGAM to a real situation and explore the spatial patterns of plant diversity in a National Park. FIDEGAM showed an excellent discrimination capability to distinguish between well and poorly sampled areas regardless of sampling exhaustiveness, whereas the other methods failed. Accordingly, FIDEGAM values were strongly correlated with the true percentage of species detected in a simulated scenario, whereas sampling completeness estimated with other methods showed no relationship due to null discrimination capability. Quantifying sampling effort is necessary to account for the uncertainty in biodiversity analyses, however, not all proposed methods are equally reliable. Our comparative analysis demonstrated that FIDEGAM was the most accurate discriminator method in all scenarios of sampling exhaustiveness, and therefore, it can be efficiently applied to most databases in order to enhance the reliability of biodiversity analyses.	[Pardo, Iker; Pata, Maria P.; Garcia, Maria B.] CSIC, Pyrenean Inst Ecol, Zaragoza, Spain; [Gomez, Daniel] CSIC, Pyrenean Inst Ecol, Jaca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE)	Pardo, I (corresponding author), CSIC, Pyrenean Inst Ecol, Zaragoza, Spain.	iker.pardo@ipe.csic.es	Garcia, Maria Begoña/B-6630-2015; Pardo, Iker/AAX-6123-2020	Garcia, Maria Begoña/0000-0003-4231-6006; Pardo, Iker/0000-0001-7005-6411	Spanish Ministry of Science and Technology [AP2008-01449]; National Parks [018/2008, 430/211]	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Parks	Funding: Funding was provided by the Spanish Ministry of Science and Technology through a doctoral grant(AP2008-01449), and two projects of National Parks (018/2008 and 430/211), (http://www.idi.mineco.gob.es/portal/site/MICINN/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrends A, 2011, DIVERS DISTRIB, V17, P191, DOI 10.1111/j.1472-4642.2010.00737.x; Aranda SC, 2010, BIODIVERS CONSERV, V19, P2469, DOI 10.1007/s10531-010-9854-5; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Brose U, 2003, ECOLOGY, V84, P2364, DOI 10.1890/02-0558; Brown CD, 2006, CHEMOMETR INTELL LAB, V80, P24, DOI 10.1016/j.chemolab.2005.05.004; BUNGE J, 1993, J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; CHAO A, 1984, SCAND J STAT, V11, P265; Chiarucci A, 2001, BIOL CONSERV, V101, P305, DOI 10.1016/S0006-3207(01)00073-8; Christen JA, 2003, J AGRIC BIOL ENVIR S, V8, P184, DOI 10.1198/1085711031553; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; De Ornellas P, 2011, BIOL CONSERV, V144, P1980, DOI 10.1016/j.biocon.2011.04.018; Dennis RLH, 2001, BIODIVERS CONSERV, V10, P483, DOI 10.1023/A:1016602309983; Dennis RLH, 1999, J INSECT CONSERV, V3, P33, DOI 10.1023/A:1009678422145; Diaz-Frances E, 2005, CONSERV BIOL, V19, P569, DOI 10.1111/j.1523-1739.2005.00453.x; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Fagan WF, 1997, BIOL CONSERV, V80, P249, DOI 10.1016/S0006-3207(96)00144-9; Feeley KJ, 2011, GLOBAL CHANGE BIOL, V17, P626, DOI 10.1111/j.1365-2486.2010.02239.x; Follner K, 2006, THESIS; Font X, 2010, WALDOKOLOGIE LANDSCH, V9, P15; Freitag S, 1998, P ROY SOC B-BIOL SCI, V265, P1475, DOI 10.1098/rspb.1998.0460; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gaston KJ, 2003, CONSERV BIOL, V17, P188, DOI 10.1046/j.1523-1739.2003.01268.x; Gonzalez JA, 2009, ENVIRON ENTOMOL, V38, P608, DOI 10.1603/022.038.0312; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Grand J, 2007, ECOL LETT, V10, P364, DOI 10.1111/j.1461-0248.2007.01025.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; HANLEY JA, 1989, CRIT REV DIAGN IMAG, V29, P307; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hastie T.J., 2017, STAT SCI; Hortal J, 2006, J ANIM ECOL, V75, P274, DOI 10.1111/j.1365-2656.2006.01048.x; Hortal J, 2005, BIODIVERS CONSERV, V14, P2913, DOI 10.1007/s10531-004-0224-z; Hortal J, 2004, ECOGRAPHY, V27, P68, DOI 10.1111/j.0906-7590.2004.03635.x; Hortal J, 2008, OIKOS, V117, P847, DOI 10.1111/j.0030-1299.2008.16434.x; Hortal J, 2007, CONSERV BIOL, V21, P853, DOI 10.1111/j.1523-1739.2007.00686.x; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Jansen F, 2010, J VEG SCI, V21, P1179, DOI 10.1111/j.1654-1103.2010.01209.x; Jennings MD, 2008, BIODIVERS CONSERV, V17, P833, DOI 10.1007/s10531-008-9322-7; Jimenez-Valverde A, 2006, BIODIVERS CONSERV, V15, P177, DOI 10.1007/s10531-004-5016-y; Kadmon R, 2004, ECOL APPL, V14, P401, DOI 10.1890/02-5364; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; Kleinbaum D. G., 2010, LOGISTIC REGRESSION; Knuppel L, 2010, ASTA-ADV STAT ANAL, V94, P53, DOI 10.1007/s10182-010-0122-5; Krishtalka L, 2000, BIOSCIENCE, V50, P611, DOI 10.1641/0006-3568(2000)050[0611:CNHMCT]2.0.CO;2; LEE SM, 1994, BIOMETRICS, V50, P88, DOI 10.2307/2533199; Lobo JM, 2002, CONSERV BIOL, V16, P158, DOI 10.1046/j.1523-1739.2002.00211.x; Lobo JM, 2008, BIODIVERS CONSERV, V17, P873, DOI 10.1007/s10531-008-9333-4; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Magurran A.E, 2004, MEASURING BIOL DIVER; Mao CX, 2005, BIOMETRICS, V61, P433, DOI 10.1111/j.1541-0420.2005.00316.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mazumdar M, 2000, STAT MED, V19, P113, DOI 10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O; Mora C, 2008, P ROY SOC B-BIOL SCI, V275, P149, DOI 10.1098/rspb.2007.1315; Moreno CE, 2000, J APPL ECOL, V37, P149, DOI 10.1046/j.1365-2664.2000.00483.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Oksanen J., 2017, R PACKAGE VERSION 26; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pepe M. S., 2003, STAT EVALUATION MED; Pepe MS, 2009, STATA J, V9, P1; Pepe MS, 2000, BIOMETRICS, V56, P352, DOI 10.1111/j.0006-341X.2000.00352.x; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Possingham HP, 2007, J BIOGEOGR, V34, P758, DOI 10.1111/j.1365-2699.2007.01717.x; Prendergast J.R., 1993, Biodiversity Letters, V1, P39, DOI 10.2307/2999649; R Development Core Team, 2011, R LANG ENV STAT; Reddy S, 2003, J BIOGEOGR, V30, P1719, DOI 10.1046/j.1365-2699.2003.00946.x; Robertson MP, 2010, DIVERS DISTRIB, V16, P363, DOI 10.1111/j.1472-4642.2010.00639.x; Rocchini D, 2011, PROG PHYS GEOG, V35, P211, DOI 10.1177/0309133311399491; Romo H, 2006, ECOGRAPHY, V29, P873, DOI 10.1111/j.2006.0906-7590.04680.x; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Sanchez-Fernandez D, 2008, DIVERS DISTRIB, V14, P754, DOI 10.1111/j.1472-4642.2008.00474.x; Santos AMC, 2010, INSECT CONSERV DIVER, V3, P72, DOI 10.1111/j.1752-4598.2010.00079.x; Sastre P, 2009, BIOL CONSERV, V142, P462, DOI 10.1016/j.biocon.2008.11.002; Seber G., 1989, NONLINEAR REGRESSION; SMITH EP, 1984, BIOMETRICS, V40, P119, DOI 10.2307/2530750; Soberon J, 2004, PHILOS T R SOC B, V359, P689, DOI 10.1098/rstb.2003.1439; SOBERON J, 1993, CONSERV BIOL, V7, P480, DOI 10.1046/j.1523-1739.1993.07030480.x; Soberon J, 2007, ECOGRAPHY, V30, P152, DOI 10.1111/j.2006.0906-7590.04627.x; Stockwell David, 2003, Ecological Indicators, V3, P213, DOI 10.1016/S1470-160X(03)00045-1; Swets J., 1982, EVALUATION DIAGNOSTI; Tibshirani R., 1993, INTRO BOOTSTRAP, DOI 10.1007/978-1-4899-4541-9; Tobler M, 2007, BIODIVERS CONSERV, V16, P659, DOI 10.1007/s10531-005-3373-9; Tucker CM, 2012, CONSERV BIOL, V26, P593, DOI 10.1111/j.1523-1739.2012.01845.x; Ulrich W, 2010, OIKOS, V119, P1149, DOI 10.1111/j.1600-0706.2009.18236.x; Wahba G., 1990, SPLINE MODELS OBSERV, VVolume 59, DOI [10.1137/1.9781611970128, DOI 10.1137/1.9781611970128]; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Williams VL, 2007, BIODIVERS CONSERV, V16, P2495, DOI 10.1007/s10531-006-9026-9; Wood SN, 2006, GEN ADDITIVE MODELS; Yesson C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001124; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zuur Alain F., 2009, P1	95	16	17	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52786	10.1371/journal.pone.0052786	http://dx.doi.org/10.1371/journal.pone.0052786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326357	Green Submitted, gold, Green Published			2022-12-25	WOS:000314705800025
J	Suzuki, M; Sugimura, Y; Yamada, S; Omori, Y; Miyamoto, M; Yamamoto, J				Suzuki, Makoto; Sugimura, Yuko; Yamada, Sumio; Omori, Yoshitsugu; Miyamoto, Masaaki; Yamamoto, Jun-ichi			Predicting Recovery of Cognitive Function Soon after Stroke: Differential Modeling of Logarithmic and Linear Regression	PLOS ONE			English	Article							MINI-MENTAL-STATE; WHITE-MATTER LESIONS; 2-YEAR FOLLOW-UP; IMPAIRMENT; POSTSTROKE; REHABILITATION; DEMENTIA; RISK; PROGRESSION; SURVIVORS	Cognitive disorders in the acute stage of stroke are common and are important independent predictors of adverse outcome in the long term. Despite the impact of cognitive disorders on both patients and their families, it is still difficult to predict the extent or duration of cognitive impairments. The objective of the present study was, therefore, to provide data on predicting the recovery of cognitive function soon after stroke by differential modeling with logarithmic and linear regression. This study included two rounds of data collection comprising 57 stroke patients enrolled in the first round for the purpose of identifying the time course of cognitive recovery in the early-phase group data, and 43 stroke patients in the second round for the purpose of ensuring that the correlation of the early-phase group data applied to the prediction of each individual's degree of cognitive recovery. In the first round, Mini-Mental State Examination (MMSE) scores were assessed 3 times during hospitalization, and the scores were regressed on the logarithm and linear of time. In the second round, calculations of MMSE scores were made for the first two scoring times after admission to tailor the structures of logarithmic and linear regression formulae to fit an individual's degree of functional recovery. The time course of early-phase recovery for cognitive functions resembled both logarithmic and linear functions. However, MMSE scores sampled at two baseline points based on logarithmic regression modeling could estimate prediction of cognitive recovery more accurately than could linear regression modeling (logarithmic modeling, R-2 = 0.676, P < 0.0001; linear regression modeling, R-2 = 0.598, P < 0.0001). Logarithmic modeling based on MMSE scores could accurately predict the recovery of cognitive function soon after the occurrence of stroke. This logarithmic modeling with mathematical procedures is simple enough to be adopted in daily clinical practice.	[Suzuki, Makoto] Niigata Univ Hlth & Welf, Fac Med Technol, Niigata, Japan; [Sugimura, Yuko] Kawasaki Municipal Tama Hosp, Dept Rehabil Med, Kawasaki, Kanagawa, Japan; [Yamada, Sumio] Nagoya Univ, Grad Sch Med, Dept Rehabil Sci, Nagoya, Aichi 4648601, Japan; [Omori, Yoshitsugu] St Marianna Univ, Yokohama City Seibu Hosp, Dept Rehabil Med, Yokohama, Kanagawa, Japan; [Miyamoto, Masaaki] Fuchinobe Gen Hosp, Dept Rehabil Med, Sagamihara, Kanagawa, Japan; [Yamamoto, Jun-ichi] Keio Univ, Grad Sch Human Relat, Minato Ku, Tokyo 108, Japan	Niigata University; Nagoya University; Saint Marianna University; Keio University	Suzuki, M (corresponding author), Niigata Univ Hlth & Welf, Fac Med Technol, Niigata, Japan.	mak-suzu@nuhw.ac.jp			Mitsubishi Foundation	Mitsubishi Foundation	This work was supported by Research Grants in the Humanities from the Mitsubishi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballard C, 2003, INT PSYCHOGERIATR, V15, P123, DOI 10.1017/S1041610203009074; Ballard C, 2003, STROKE, V34, P2440, DOI 10.1161/01.STR.0000089923.29724.CE; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; DAM M, 1993, STROKE, V24, P1186, DOI 10.1161/01.STR.24.8.1186; Desmond DW, 1996, STROKE, V27, P1798, DOI 10.1161/01.STR.27.10.1798; Donovan NJ, 2008, NEUROREHAB NEURAL RE, V22, P122, DOI 10.1177/1545968307306239; FERRUCCI L, 1993, STROKE, V24, P200, DOI 10.1161/01.STR.24.2.200; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fu JH, 2005, J NEUROL NEUROSUR PS, V76, P793, DOI 10.1136/jnnp.2003.032771; Goodwin N, 2003, CLIN REHABIL, V17, P69, DOI 10.1191/0269215503cr571oa; GRACE J, 1995, ARCH NEUROL-CHICAGO, V52, P477, DOI 10.1001/archneur.1995.00540290067019; Hajek VE, 1997, ARCH PHYS MED REHAB, V78, P1331, DOI 10.1016/S0003-9993(97)90306-3; Hochstenbach JB, 2003, ARCH PHYS MED REHAB, V84, P1499, DOI 10.1016/S0003-9993(03)00370-8; Hulley S. B., 1988, DESIGNING CLIN RES; Inzitari D, 1998, STROKE, V29, P2087, DOI 10.1161/01.STR.29.10.2087; JONGBLOED L, 1986, STROKE, V17, P765, DOI 10.1161/01.STR.17.4.765; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P406, DOI 10.1016/S0003-9993(95)80568-0; JUNQUE C, 1990, ARCH NEUROL-CHICAGO, V47, P151, DOI 10.1001/archneur.1990.00530020047013; KOTILA M, 1984, STROKE, V15, P1039, DOI 10.1161/01.STR.15.6.1039; Koyama T, 2005, CLIN REHABIL, V19, P779, DOI 10.1191/0269215505cr876oa; Mok VCT, 2004, J NEUROL NEUROSUR PS, V75, P560, DOI 10.1136/jnnp.2003.015107; MOLLOY DW, 1991, AM J PSYCHIAT, V148, P102; Moss A, 2006, STROKE, V37, P3043, DOI 10.1161/01.STR.0000249427.74970.15; Narushima K, 2003, AM J PSYCHIAT, V160, P1157, DOI 10.1176/appi.ajp.160.6.1157; Nys GMS, 2005, NEUROLOGY, V64, P821, DOI 10.1212/01.WNL.0000152984.28420.5A; Nys GMS, 2005, ARCH CLIN NEUROPSYCH, V20, P623, DOI 10.1016/j.acn.2005.04.001; PANTONI L, 1995, STROKE, V26, P1293, DOI 10.1161/01.STR.26.7.1293; Portney LG, 2000, FDN CLIN RES, V2nd; Rasquin SMC, 2005, J NEUROL SCI, V229, P21, DOI 10.1016/j.jns.2004.11.015; Roth EJ, 1998, ARCH PHYS MED REHAB, V79, P329, DOI 10.1016/S0003-9993(98)90015-6; Sachdev PS, 2004, NEUROLOGY, V63, P1618, DOI 10.1212/01.WNL.0000142964.83484.DE; Samuelsson M, 1996, STROKE, V27, P842, DOI 10.1161/01.STR.27.5.842; Sonohara K, 2008, GERIATR GERONTOL INT, V8, P93, DOI 10.1111/j.1447-0594.2008.00454.x; Subramanian SK, 2010, NEUROREHAB NEURAL RE, V24, P113, DOI 10.1177/1545968309349941; Suzuki M, 2008, AM J PHYS MED REHAB, V87, P740, DOI 10.1097/PHM.0b013e31818378b0; Suzuki M, 2006, ARCH PHYS MED REHAB, V87, P1496, DOI 10.1016/j.apmr.2006.07.267; Suzuki M, 2011, J REHABIL MED, V43, P935, DOI 10.2340/16501977-0877; TATEMICHI TK, 1990, STROKE, V21, P858, DOI 10.1161/01.STR.21.6.858; Taylor WD, 2003, AM J ROENTGENOL, V181, P571, DOI 10.2214/ajr.181.2.1810571; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Tham W, 2002, J NEUROL SCI, V203, P49, DOI 10.1016/S0022-510X(02)00260-5; Tilling K, 2001, STROKE, V32, P2867, DOI 10.1161/hs1201.099413; WADE DT, 1985, J NEUROL NEUROSUR PS, V48, P7, DOI 10.1136/jnnp.48.1.7; YLIKOSKI R, 1993, ARCH NEUROL-CHICAGO, V50, P818, DOI 10.1001/archneur.1993.00540080029009; Zinn S, 2004, ARCH PHYS MED REHAB, V85, P1084, DOI 10.1016/j.apmr.2003.10.022	46	11	13	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53488	10.1371/journal.pone.0053488	http://dx.doi.org/10.1371/journal.pone.0053488			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326439	Green Published, Green Submitted, gold			2022-12-25	WOS:000314705800048
J	Baronchelli, A; Chater, N; Christiansen, MH; Pastor-Satorras, R				Baronchelli, Andrea; Chater, Nick; Christiansen, Morten H.; Pastor-Satorras, Romualdo			Evolution in a Changing Environment	PLOS ONE			English	Article							CLIMATE-CHANGE; STATISTICAL PHYSICS; COEVOLUTION; ADAPTATION; EXTINCTION; SELECTION; LANGUAGE; GENES; TRAIT	We propose a simple model for genetic adaptation to a changing environment, describing a fitness landscape characterized by two maxima. One is associated with "specialist'' individuals that are adapted to the environment; this maximum moves over time as the environment changes. The other maximum is static, and represents "generalist'' individuals not affected by environmental changes. The rest of the landscape is occupied by "maladapted'' individuals. Our analysis considers the evolution of these three subpopulations. Our main result is that, in presence of a sufficiently stable environmental feature, as in the case of an unchanging aspect of a physical habitat, specialists can dominate the population. By contrast, rapidly changing environmental features, such as language or cultural habits, are a moving target for the genes; here, generalists dominate, because the best evolutionary strategy is to adopt neutral alleles not specialized for any specific environment. The model we propose is based on simple assumptions about evolutionary dynamics and describes all possible scenarios in a non-trivial phase diagram. The approach provides a general framework to address such fundamental issues as the Baldwin effect, the biological basis for language, or the ecological consequences of a rapid climate change.	[Baronchelli, Andrea] Northeastern Univ, Lab Modeling Biol & Sociotech Syst, Boston, MA 02115 USA; [Chater, Nick] Univ Warwick, Warwick Business Sch, Behav Sci Grp, Coventry CV4 7AL, W Midlands, England; [Christiansen, Morten H.] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA; [Christiansen, Morten H.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Pastor-Satorras, Romualdo] Univ Politecn Cataluna, Dept Fis & Engn Nucl, Barcelona, Spain	Northeastern University; University of Warwick; Cornell University; The Santa Fe Institute; Universitat Politecnica de Catalunya	Pastor-Satorras, R (corresponding author), Univ Politecn Cataluna, Dept Fis & Engn Nucl, Barcelona, Spain.	romualdo.pastor@upc.edu	Baronchelli, Andrea/F-9550-2016; Chater, Nick/GRX-6742-2022; Pastor-Satorras, Romualdo/L-8837-2013	Baronchelli, Andrea/0000-0002-0255-0829; Pastor-Satorras, Romualdo/0000-0002-4051-6007	Spanish MEC (FEDER) [FIS2010-21781-C02-01]; Junta de Andalucia [P09-FQM4682]; ICREA Academia; Generalitat de Catalunya	Spanish MEC (FEDER)(Spanish GovernmentEuropean Commission); Junta de Andalucia(Junta de Andalucia); ICREA Academia(ICREA); Generalitat de Catalunya(Generalitat de Catalunya)	AB and RP-S acknowledge financial support from the Spanish MEC (FEDER), under project FIS2010-21781-C02-01, and the Junta de Andalucia, under project No. P09-FQM4682. RP-S acknowledges additional support through ICREA Academia, funded by the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancel LW, 1999, J THEOR BIOL, V196, P197, DOI 10.1006/jtbi.1998.0833; Ancliff M, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021904; Ancliff M, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061910; Baldwin JM, 1896, AM NAT, V30, P441, DOI DOI 10.1086/276408; Baronchelli A, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/06/P06014; Beja-Pereira A, 2003, NAT GENET, V35, P311, DOI 10.1038/ng1263; BURGER R, 1995, EVOLUTION, V49, P151, DOI 10.1111/j.1558-5646.1995.tb05967.x; Chater N, 2009, P NATL ACAD SCI USA, V106, P1015, DOI 10.1073/pnas.0807191106; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Christiansen MH, 2008, BEHAV BRAIN SCI, V31, P489, DOI 10.1017/S0140525X08004998; Crill WD, 2000, GENETICS, V154, P27; de Vladar HP, 2011, TRENDS ECOL EVOL, V26, P424, DOI 10.1016/j.tree.2011.04.002; Drossel B, 2001, ADV PHYS, V50, P209, DOI 10.1080/00018730110041365; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; EIGEN M, 1989, ADV CHEM PHYS, V75, P149; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Gillespie J, 1994, OXFORD SERIES ECOLOG; Gilman RT, 2012, NATURE, V483, P328, DOI 10.1038/nature10853; Hancock AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040032; Kirkpatrick M, 2009, GENETICA, V136, P271, DOI 10.1007/s10709-008-9302-6; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.1111/j.1558-5646.1983.tb00236.x, 10.2307/2408842]; Legros M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-159; LYNCH M, 1991, LIMNOL OCEANOGR, V36, P1301, DOI 10.4319/lo.1991.36.7.1301; Moran P., 1962, STAT PROCESSES EVOLU; Nilsson M, 2002, B MATH BIOL, V64, P1033, DOI 10.1006/bulm.2002.0314; Nilsson M, 2000, PHYS REV LETT, V84, P191, DOI 10.1103/PhysRevLett.84.191; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Ohtsuki H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108106; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pinker S., 2003, LANGUAGE EVOLUTION, P16, DOI DOI 10.1093/ACPR0F:0S0/9780199244843.003.0002; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Saakian DB, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041913; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Saunders MA, 2002, GENETICS, V162, P1849; Sawyer SA, 2007, P NATL ACAD SCI USA, V104, P6504, DOI 10.1073/pnas.0701572104; Sella G, 2005, P NATL ACAD SCI USA, V102, P9541, DOI 10.1073/pnas.0501865102; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Traulsen A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.238701; Wagner N, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.188101; WIESENFELD SL, 1967, SCIENCE, V157, P1134, DOI 10.1126/science.157.3793.1134; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	43	10	10	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e52742	10.1371/journal.pone.0052742	http://dx.doi.org/10.1371/journal.pone.0052742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326355	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000313552400009
J	Vera-Ramirez, L; Sanchez-Rovira, P; Ramirez-Tortosa, CL; Quiles, JL; Ramirez-Tortosa, M; Lorente, JA				Vera-Ramirez, Laura; Sanchez-Rovira, Pedro; Ramirez-Tortosa, Cesar L.; Quiles, Jose L.; Ramirez-Tortosa, MCarmen; Lorente, Jose A.			Transcriptional Shift Identifies a Set of Genes Driving Breast Cancer Chemoresistance	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MAMMARY-GLAND DEVELOPMENT; KEY SIGNALING NODES; STEM-CELLS; HYPOXIA; EXPRESSION; RESISTANCE; THERAPY; CHEMOTHERAPY; PROGRESSION	Background: Distant recurrences after antineoplastic treatment remain a serious problem for breast cancer clinical management, which threats patients' life. Systemic therapy is administered to eradicate cancer cells from the organism, both at the site of the primary tumor and at any other potential location. Despite this intervention, a significant proportion of breast cancer patients relapse even many years after their primary tumor has been successfully treated according to current clinical standards, evidencing the existence of a chemoresistant cell subpopulation originating from the primary tumor. Methods/Findings: To identify key molecules and signaling pathways which drive breast cancer chemoresistance we performed gene expression analysis before and after anthracycline and taxane-based chemotherapy and compared the results between different histopathological response groups (good-, mid- and bad-response), established according to the Miller & Payne grading system. Two cohorts of 33 and 73 breast cancer patients receiving neoadjuvant chemotherapy were recruited for whole-genome expression analysis and validation assay, respectively. Identified genes were subjected to a bioinformatic analysis in order to ascertain the molecular function of the proteins they encode and the signaling in which they participate. High throughput technologies identified 65 gene sequences which were over-expressed in all groups (P <= 0.05 Bonferroni test). Notably we found that, after chemotherapy, a significant proportion of these genes were over-expressed in the good responders group, making their tumors indistinguishable from those of the bad responders in their expression profile (P <= 0.05 Benjamini-Hochgergs method). Conclusions: These data identify a set of key molecular pathways selectively up-regulated in post-chemotherapy cancer cells, which may become appropriate targets for the development of future directed therapies against breast cancer.	[Vera-Ramirez, Laura; Sanchez-Rovira, Pedro] Complejo Hosp Jaen, Dept Oncol, Jaen, Spain; [Vera-Ramirez, Laura; Sanchez-Rovira, Pedro; Lorente, Jose A.] Pfizer Univ Granada, GENyO Ctr, Granada, Spain; [Vera-Ramirez, Laura; Sanchez-Rovira, Pedro; Lorente, Jose A.] Andalusian Govt Ctr Genom & Oncol, Granada, Spain; [Ramirez-Tortosa, Cesar L.] Complejo Hosp Jaen, Dept Pathol, Jaen, Spain; [Quiles, Jose L.; Ramirez-Tortosa, MCarmen] Biomed Res Ctr CIBM, Inst Nutr & Food Technol Jose Mataix, Granada, Spain; [Quiles, Jose L.] Univ Granada, Dept Physiol, Granada, Spain; [Ramirez-Tortosa, MCarmen] Univ Granada, Dept Biochem & Mol Biol 2, Granada, Spain; [Lorente, Jose A.] Univ Granada, Dept Legal Med, Granada, Spain	Complejo Hospitalario de Jaen; Pfizer; University of Granada; Complejo Hospitalario de Jaen; University of Granada; University of Granada; University of Granada	Vera-Ramirez, L (corresponding author), Complejo Hosp Jaen, Dept Oncol, Jaen, Spain.	laura.vera@genyo.es	Quiles, José L./C-6911-2013; Ramirez, Laura Vera/S-3375-2018; Ramírez-Tortosa, César/F-2055-2016; LORENTE, JOSE A./B-8372-2008	Quiles, José L./0000-0002-9048-9086; Ramirez, Laura Vera/0000-0001-9184-9875; Ramírez-Tortosa, César/0000-0002-3302-707X; LORENTE, JOSE A./0000-0002-9892-7386	Consejeria de Economia, Innovacion y Ciencia (CEIC) from the Junta de Andalucia and Fondo Europeo de Desarrollo Regional (FEDER)/Fondo de Cohesion Europeo (FSE) [20072013, CTS-5350]; Ministerio de Sanidad [PN de I+D+i 20062009/ISCIII]; Servicios Sociales e Igualdad (Spain); Fondo Europeo de Desarrollo Regional (FEDER) from the European Union [PI06/90388]	Consejeria de Economia, Innovacion y Ciencia (CEIC) from the Junta de Andalucia and Fondo Europeo de Desarrollo Regional (FEDER)/Fondo de Cohesion Europeo (FSE); Ministerio de Sanidad(Instituto de Salud Carlos IIISpanish Government); Servicios Sociales e Igualdad (Spain); Fondo Europeo de Desarrollo Regional (FEDER) from the European Union	Thanks are due to the Consejeria de Economia, Innovacion y Ciencia (CEIC) from the Junta de Andalucia and Fondo Europeo de Desarrollo Regional (FEDER)/Fondo de Cohesion Europeo (FSE) to financial support through the Programa Operativo FEDER/FSE de Andalucia 20072013 and the research project CTS-5350. The authors also acknowledge financial support by the PN de I+D+i 20062009/ISCIII/Ministerio de Sanidad, Servicios Sociales e Igualdad (Spain) and Fondo Europeo de Desarrollo Regional (FEDER) from the European Union, through the research project PI06/90388. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bergamaschi A, 2008, J PATHOL, V214, P357, DOI 10.1002/path.2278; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; Cannito S, 2008, CARCINOGENESIS, V29, P2267, DOI 10.1093/carcin/bgn216; Cardoso F, 2008, J CLIN ONCOL, V26, P729, DOI 10.1200/JCO.2007.14.3222; Chang HR, 2010, CANCER-AM CANCER SOC, V116, P2856, DOI 10.1002/cncr.25120; Colombo PE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2890; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; Das B, 2008, STEM CELLS, V26, P1818, DOI 10.1634/stemcells.2007-0724; Derleth C, 2010, CLIN BREAST CANCER, V10, pE23, DOI 10.3816/CBC.2010.s.004; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Drury S, 2009, DIAGN MOL PATHOL, V18, P103, DOI 10.1097/PDM.0b013e31817c1ae2; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Foroni C, 2012, CANCER TREAT REV, V38, P689, DOI 10.1016/j.ctrv.2011.11.001; Foubert E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2585; Galanina N, 2011, CANCER J, V17, P96, DOI 10.1097/PPO.0b013e318212dee3; Gazzaniga P, 2010, INT J CANCER, V126, P2437, DOI 10.1002/ijc.24953; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Gradilone A, 2011, ANN ONCOL, V22, P86, DOI 10.1093/annonc/mdq323; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Han ML, 2012, CANCER SCI, V103, P1058, DOI 10.1111/j.1349-7006.2012.02281.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao J, 2008, CANCER GENE THER, V15, P449, DOI 10.1038/cgt.2008.4; Incassati A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2723; Kakarala M, 2008, J CLIN ONCOL, V26, P2813, DOI 10.1200/JCO.2008.16.3931; Kakarala M, 2007, CANCER J, V13, P271, DOI 10.1097/PPO.0b013e318156da4e; Ke X, 2012, CARCINOGENESIS, V33, P1598, DOI 10.1093/carcin/bgs196; Korkaya H, 2011, CLIN CANCER RES, V17, P6125, DOI 10.1158/1078-0432.CCR-10-2743; Lai SL, 2009, CELL RES, V19, P532, DOI 10.1038/cr.2009.41; Lonning PE, 2010, MOL ONCOL, V4, P284, DOI 10.1016/j.molonc.2010.04.005; Lopez-Knowles E, 2010, CANCER EPIDEM BIOMAR, V19, P301, DOI 10.1158/1055-9965.EPI-09-0741; Louie E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2773; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Ogston KN, 2003, BREAST, V12, P320, DOI 10.1016/S0960-9776(03)00106-1; Otto T, 2008, ENDOCRINOLOGY, V149, P2241, DOI 10.1210/en.2007-1238; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Rohwer N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012038; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sparano JA, 2008, J CLIN ONCOL, V26, P721, DOI 10.1200/JCO.2008.16.7528; Sparano JA, 2006, CLIN BREAST CANCER, V7, P347, DOI 10.3816/CBC.2006.n.051; Vera-Ramirez L, 2011, CRIT REV ONCOL HEMAT, V80, P347, DOI 10.1016/j.critrevonc.2011.01.004; Vera-Ramirez L, 2010, CANCER TREAT REV, V36, P477, DOI 10.1016/j.ctrv.2010.02.017; Vermeulen L, 2012, LANCET ONCOL, V13, pE83, DOI 10.1016/S1470-2045(11)70257-1; Walther Z, 2011, CANCER J, V17, P71, DOI 10.1097/PPO.0b013e318212dd6d; Weigelt B, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2734; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064	50	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53983	10.1371/journal.pone.0053983	http://dx.doi.org/10.1371/journal.pone.0053983			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326553	Green Submitted, gold, Green Published			2022-12-25	WOS:000313552400066
J	You, BJ; Lee, MH; Tien, N; Lee, MS; Hsieh, HC; Tseng, LH; Chung, YL; Lee, HZ				You, Bang-Jau; Lee, Miin-Huey; Tien, Ni; Lee, Meng-Shiou; Hsieh, Hui-Chuan; Tseng, Lin-Hsien; Chung, Yu-Lin; Lee, Hong-Zin			A Novel Approach to Enhancing Ganoderic Acid Production by Ganoderma lucidum Using Apoptosis Induction	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; NATURAL-PRODUCTS; CELL-DEATH; BIOSYNTHESIS; PATHWAYS; KINASE; GENE	Ganoderma lucidum is one of most widely used herbal medicine and functional food in Asia, and ganoderic acids (GAs) are its active ingredients. Regulation of GA biosynthesis and enhancing GA production are critical to using G. lucidum as a medicine. However, regulation of GA biosynthesis by various signaling remains poorly understood. This study investigated the role of apoptosis signaling on GA biosynthesis and presented a novel approach, namely apoptosis induction, to increasing GA production. Aspirin was able to induce cell apoptosis in G. lucidum, which was identified by terminal deoxynucleotidyl transferase mediated dUPT nick end labeling assay positive staining and a condensed nuclear morphology. The maximum induction of lanosta-7,9(11), 24-trien-3 alpha-01-26-oic acid (ganoderic acid 24, GA24) production and total GA production by aspirin were 2.7-fold and 2.8-fold, respectively, after 1 day. Significantly lower levels of GA 24 and total GAs were obtained after regular fungal culture for 1.5 months. ROS accumulation and phosphorylation of Hog-1 kinase, a putative homolog of MAPK p38 in mammals, occurred after aspirin treatment indicating that both factors may be involved in GA biosynthetic regulation. However, aspirin also reduced expression of the squalene synthase and lanosterol synthase coding genes, suggesting that these genes are not critical for GA induction. To the best of our knowledge, this is the first report showing that GA biosynthesis is linked to fungal apoptosis and provides a new approach to enhancing secondary metabolite production in fungi.	[You, Bang-Jau; Lee, Meng-Shiou; Hsieh, Hui-Chuan; Tseng, Lin-Hsien; Chung, Yu-Lin] China Med Univ, Dept Chinese Pharmaceut Sci & Chinese Med Resourc, Taichung, Taiwan; [Lee, Miin-Huey] Natl Chung Hsing Univ, Dept Plant Pathol, Taichung 40227, Taiwan; [Tien, Ni] China Med Univ Hosp, Dept Lab Med, Taichung, Taiwan; [Lee, Hong-Zin] China Med Univ, Sch Pharm, Taichung, Taiwan	China Medical University Taiwan; National Chung Hsing University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	You, BJ (corresponding author), China Med Univ, Dept Chinese Pharmaceut Sci & Chinese Med Resourc, Taichung, Taiwan.	bangjau@mail.cmu.edu.tw; hong@mail.cmu.edu.tw		Lee, Miin-Huey/0000-0001-8073-0916; Lee, Meng-Shiou/0000-0003-3470-4121	National Science Council of the Republic of China in Taiwan [NSC 97-2313-B-039-004-MY3, NSC 99-2321-B-039-001-MY3]; China Medical University in Taiwan [CMU98-N1-10]	National Science Council of the Republic of China in Taiwan(Ministry of Science and Technology, Taiwan); China Medical University in Taiwan(China Medical University)	This research was funded by National Science Council of the Republic of China in Taiwan (NSC 97-2313-B-039-004-MY3 and NSC 99-2321-B-039-001-MY3) and China Medical University in Taiwan (CMU98-N1-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzan R, 2004, MICROBIOL-SGM, V150, P109, DOI 10.1099/mic.0.26578-0; Bilsland E, 2004, MOL MICROBIOL, V53, P1743, DOI 10.1111/j.1365-2958.2004.04238.x; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P763, DOI 10.1038/cdd.2009.219; Chen NH, 2011, PHYTOMEDICINE, V18, P719, DOI 10.1016/j.phymed.2011.01.011; Delgado-Jarana J, 2006, MICROBIOL-SGM, V152, P1687, DOI 10.1099/mic.0.28729-0; Fox EM, 2008, CURR OPIN MICROBIOL, V11, P481, DOI 10.1016/j.mib.2008.10.007; Frohlich KU, 2007, SEMIN CANCER BIOL, V17, P112, DOI 10.1016/j.semcancer.2006.11.006; Georgianna DR, 2009, FUNGAL GENET BIOL, V46, P113, DOI 10.1016/j.fgb.2008.10.011; Hamann A, 2008, TRENDS MICROBIOL, V16, P276, DOI 10.1016/j.tim.2008.03.003; Handa N, 2010, PHYTOCHEMISTRY, V71, P1774, DOI 10.1016/j.phytochem.2010.07.005; HIROTANI M, 1990, J CHEM SOC PERK T 1, P2751, DOI 10.1039/p19900002751; Hofius D, 2007, SEMIN CANCER BIOL, V17, P166, DOI 10.1016/j.semcancer.2006.12.001; Jiang ZJ, 2011, PROCESS BIOCHEM, V46, P1307, DOI 10.1016/j.procbio.2011.02.023; Kawasaki L, 2002, MOL MICROBIOL, V45, P1153, DOI 10.1046/j.1365-2958.2002.03087.x; Li TH, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/128402; Liang CX, 2010, APPL MICROBIOL BIOT, V86, P1367, DOI 10.1007/s00253-009-2415-8; Liu RM, 2012, EUR J PHARMACOL, V681, P23, DOI 10.1016/j.ejphar.2012.02.007; Madeo F, 2004, CURR OPIN MICROBIOL, V7, P655, DOI 10.1016/j.mib.2004.10.012; Ramakrishna A, 2011, PLANT SIGNAL BEHAV, V6, P1720, DOI 10.4161/psb.6.11.17613; Raza H, 2011, EUR J PHARMACOL, V668, P15, DOI 10.1016/j.ejphar.2011.06.016; Ren A, 2010, BIORESOURCE TECHNOL, V101, P6785, DOI 10.1016/j.biortech.2010.03.118; Russell R, 2006, PHYTOCHEMISTRY, V67, P1985, DOI 10.1016/j.phytochem.2006.07.004; Sapienza K, 2008, CELL APOPTOSIS RES P, P49; Segmuller N, 2007, EUKARYOT CELL, V6, P211, DOI 10.1128/EC.00153-06; Shang CH, 2010, BIOSCI BIOTECH BIOCH, V74, P974, DOI 10.1271/bbb.90833; SHIAO MS, 1992, J CHIN CHEM SOC-TAIP, V39, P669, DOI 10.1002/jccs.199200102; Shiao MS, 2003, CHEM REC, V3, P172, DOI 10.1002/tcr.10058; Shwab EK, 2008, MYCOL RES, V112, P225, DOI 10.1016/j.mycres.2007.08.021; Thoms HC, 2007, CANCER RES, V67, P1660, DOI 10.1158/0008-5472.CAN-06-1038; Wang JW, 2002, ACTA BOT SIN, V44, P1233; Xu JW, 2012, APPL ENVIRON MICROB, V78, P7968, DOI 10.1128/AEM.01263-12; Xu JW, 2010, APPL MICROBIOL BIOT, V87, P457, DOI 10.1007/s00253-010-2576-5; Xu JW, 2010, APPL MICROBIOL BIOT, V85, P941, DOI 10.1007/s00253-009-2106-5; Xu K, 2010, PROCESS BIOCHEM, V45, P1261, DOI 10.1016/j.procbio.2010.04.013; Xu YN, 2018, BIOTECHNOL ADV; You BJ, 2012, BIOSCI BIOTECH BIOCH, V76, P1529, DOI 10.1271/bbb.120270; You BJ, 2012, FOOD RES INT, DOI [10.1016/j.foodres.2012.1009.1003, DOI 10.1016/J.FOODRES.2012.1009.1003]; Yu YL, 2009, EUR J IMMUNOL, V39, P2482, DOI 10.1002/eji.200839039; Yuan YJ, 2002, PROCESS BIOCHEM, V38, P193, DOI 10.1016/S0032-9592(02)00071-7; Zhang WX, 2010, J BIOSCI BIOENG, V109, P37, DOI 10.1016/j.jbiosc.2009.06.024; Zhao J, 2005, BIOTECHNOL ADV, V23, P283, DOI 10.1016/j.biotechadv.2005.01.003; Zhao J, 2007, NEW PHYTOL, V175, P215, DOI 10.1111/j.1469-8137.2007.02109.x; Zhao MW, 2007, J MICROBIOL BIOTECHN, V17, P1106; Zhao W, 2011, BIORESOURCE TECHNOL, V102, P8185, DOI 10.1016/j.biortech.2011.06.043; Zhou L, 2011, PROCESS BIOCHEM, V46, P219, DOI 10.1016/j.procbio.2010.08.014	45	64	71	5	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53616	10.1371/journal.pone.0053616	http://dx.doi.org/10.1371/journal.pone.0053616			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326470	Green Published, Green Submitted, gold			2022-12-25	WOS:000313552400031
J	Hinaux, H; Poulain, J; Da Silva, C; Noirot, C; Jeffery, WR; Casane, D; Retaux, S				Hinaux, Helene; Poulain, Julie; Da Silva, Corinne; Noirot, Celine; Jeffery, William R.; Casane, Didier; Retaux, Sylvie			De Novo Sequencing of Astyanax mexicanus Surface Fish and Pachon Cavefish Transcriptomes Reveals Enrichment of Mutations in Cavefish Putative Eye Genes	PLOS ONE			English	Article							BLIND CAVEFISH; PELVIC REDUCTION; FASCIATUS; LENS; DEGENERATION; CHARACIDAE; EVOLUTION; MODULES; PISCES; SYSTEM	Astyanax mexicanus, a teleost species with surface dwelling (surface fish) and cave adapted (cavefish) morphs, is an important model system in evolutionary developmental biology (evodevo). Astyanax cavefish differ from surface fish in numerous traits, including the enhancement of non-visual sensory systems, and the loss of eyes and pigmentation. The genetic bases for these differences are not fully understood as genomic and transcriptomic data are lacking. We here present de novo transcriptome sequencing of embryonic and larval stages of a surface fish population and a cavefish population originating from the Pachon cave using the Sanger method. This effort represents the first large scale sequence and clone resource for the Astyanax research community. The analysis of these sequences show low levels of polymorphism in cavefish compared to surface fish, confirming previous studies on a small number of genes. A high proportion of the genes mutated in cavefish are known to be expressed in the zebrafish visual system. Such a high number of mutations in cavefish putative eye genes may be explained by relaxed selection for vision during the evolution in the absence of light. Based on these sequence differences, we provide a list of 11 genes that are potential candidates for having a role in cavefish visual system degeneration.	[Hinaux, Helene; Retaux, Sylvie] CNRS, DECA Grp, N&D Lab, Gif Sur Yvette, France; [Poulain, Julie; Da Silva, Corinne] Genscope CEA Sequencing Ctr, Evry, France; [Noirot, Celine] INRA Bioinformat Platform, Toulouse, France; [Jeffery, William R.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Casane, Didier] CNRS Gif Sur Yvette, LEGS, Paris, France; [Casane, Didier] Univ Paris Diderot, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; University System of Maryland; University of Maryland College Park; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	Retaux, S (corresponding author), CNRS, DECA Grp, N&D Lab, Gif Sur Yvette, France.	retaux@inaf.cnrs-gif.fr		DA SILVA, Corinne/0000-0002-7618-7831; Hinaux, Helene/0000-0003-0032-1405; Poulain, Julie/0000-0002-8744-3116	Agence Nationale de la Recherche [ASTYCO] grant; National Institutes of Health grant [EY014619]; NATIONAL EYE INSTITUTE [R01EY014619] Funding Source: NIH RePORTER	Agence Nationale de la Recherche [ASTYCO] grant(French National Research Agency (ANR)); National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by an Agence Nationale de la Recherche [ASTYCO] grant to SR and by a National Institutes of Health grant (EY014619) to WRJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alunni A, 2007, J COMP NEUROL, V505, P221, DOI 10.1002/cne.21488; Behrens M, 1997, MOL BIOL EVOL, V14, P299, DOI 10.1093/oxfordjournals.molbev.a025765; Bradford Y, 2011, NUCLEIC ACIDS RES, V39, pD822, DOI 10.1093/nar/gkq1077; Bradic M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-9; Briggs JC, 2005, J BIOGEOGR, V32, P287, DOI 10.1111/j.1365-2699.2004.01170.x; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Gross JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000326; Hinaux H, 2011, ZEBRAFISH, V8, P155, DOI 10.1089/zeb.2011.0713; Hooven TA, 2004, INT J DEV BIOL, V48, P731, DOI 10.1387/ijdb.041874th; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; HUPPOP K, 1986, ENVIRON BIOL FISH, V17, P299, DOI 10.1007/BF00001496; Jeffery WR, 2010, HEREDITY, V105, P495, DOI 10.1038/hdy.2010.7; Jeffery WR, 2001, DEV BIOL, V231, P1, DOI 10.1006/dbio.2000.0121; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mitchell R.W., 1977, MEXICAN EYELESS CHAR; Mundry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031410; Nakatani M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-177; Peng ZG, 2006, GENE, V370, P113, DOI 10.1016/j.gene.2005.11.024; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pottin K, 2011, DEVELOPMENT, V138, P2467, DOI 10.1242/dev.054106; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Salin K, 2010, COMP BIOCHEM PHYS A, V156, P451, DOI 10.1016/j.cbpa.2010.03.030; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Soares D, 2004, DEV NEUROSCI-BASEL, V26, P308, DOI 10.1159/000082272; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Strecker U, 2003, MOL ECOL, V12, P699, DOI 10.1046/j.1365-294X.2003.01753.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tempel Sebastien, 2012, Methods Mol Biol, V859, P29, DOI 10.1007/978-1-61779-603-6_2; Thisse B, 2004, ZFIN DIRECT DATA SUB; Wilkens H, 2010, HEREDITY, V105, P413, DOI 10.1038/hdy.2009.184; Yamamoto Y, 2000, SCIENCE, V289, P631, DOI 10.1126/science.289.5479.631; YOKOYAMA S, 1995, MOL BIOL EVOL, V12, P527; Yoshizawa M, 2010, CURR BIOL, V20, P1631, DOI 10.1016/j.cub.2010.07.017; Zhang XB, 2004, FEBS LETT, V559, P57, DOI 10.1016/S0014-5793(04)00024-9	41	66	66	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53553	10.1371/journal.pone.0053553	http://dx.doi.org/10.1371/journal.pone.0053553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326453	Green Published, Green Submitted, gold			2022-12-25	WOS:000313551500081
J	Terman, DS; Viglianti, BL; Zennadi, R; Fels, D; Boruta, RJ; Yuan, H; Dreher, MR; Grant, G; Rabbani, ZN; Moon, E; Lan, L; Eble, J; Cao, YT; Sorg, B; Ashcraft, K; Palmer, G; Telen, MJ; Dewhirst, MW				Terman, David S.; Viglianti, Benjamin L.; Zennadi, Rahima; Fels, Diane; Boruta, Richard J.; Yuan, Hong; Dreher, Mathew R.; Grant, Gerald; Rabbani, Zahid N.; Moon, Ejung; Lan, Lan; Eble, Joseph; Cao, Yiting; Sorg, Brian; Ashcraft, Kathleen; Palmer, Greg; Telen, Marilyn J.; Dewhirst, Mark W.			Sickle Erythrocytes Target Cytotoxics to Hypoxic Tumor Microvessels and Potentiate a Tumoricidal Response	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; ENDOTHELIAL-CELLS; ZINC PROTOPORPHYRIN; HEME OXYGENASE-1; SOLID TUMORS; BLOOD-CELLS; ACTIVATION; MICE; CANCER; DISEASE	Resistance of hypoxic solid tumor niches to chemotherapy and radiotherapy remains a major scientific challenge that calls for conceptually new approaches. Here we exploit a hitherto unrecognized ability of sickled erythrocytes (SSRBCs) but not normal RBCs (NLRBCs) to selectively target hypoxic tumor vascular microenviroment and induce diffuse vaso-occlusion. Within minutes after injection SSRBCs, but not NLRBCs, home and adhere to hypoxic 4T1 tumor vasculature with hemoglobin saturation levels at or below 10% that are distributed over 70% of the tumor space. The bound SSRBCs thereupon form microaggregates that obstruct/occlude up to 88% of tumor microvessels. Importantly, SSRBCs, but not normal RBCs, combined with exogenous prooxidant zinc protoporphyrin (ZnPP) induce a potent tumoricidal response via a mutual potentiating mechanism. In a clonogenic tumor cell survival assay, SSRBC surrogate hemin, along with H2O2 and ZnPP demonstrate a similar mutual potentiation and tumoricidal effect. In contrast to existing treatments directed only to the hypoxic tumor cell, the present approach targets the hypoxic tumor vascular environment and induces injury to both tumor microvessels and tumor cells using intrinsic SSRBC-derived oxidants and locally generated ROS. Thus, the SSRBC appears to be a potent new tool for treatment of hypoxic solid tumors, which are notable for their resistance to existing cancer treatments.	[Terman, David S.] Jenomic, Mol Genet Program, Carmel, CA USA; [Viglianti, Benjamin L.] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA; [Zennadi, Rahima; Telen, Marilyn J.] Duke Univ, Med Ctr, Dept Med, Div Hematol, Durham, NC 27710 USA; [Fels, Diane; Rabbani, Zahid N.; Moon, Ejung; Ashcraft, Kathleen; Palmer, Greg; Dewhirst, Mark W.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA; [Boruta, Richard J.] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; [Yuan, Hong] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA; [Dreher, Mathew R.] NIH, Ctr Clin, Dept Diagnost Radiol, Bethesda, MD 20892 USA; [Grant, Gerald] Duke Univ, Med Ctr, Dept Surg, Div Neurosurg, Durham, NC 27710 USA; [Lan, Lan] Duke Univ, Med Ctr, Dept Biostat, Durham, NC USA; [Eble, Joseph] Mayo Clin Fdn, Dept Radiol, Rochester, MN USA; [Cao, Yiting] Duke Univ, Med Ctr, Dept Surg, Div Neurooncol, Durham, NC 27710 USA; [Sorg, Brian] NCI, Canc Diag Program, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Duke University; Duke University; Mayo Clinic; Duke University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Terman, DS (corresponding author), Jenomic, Mol Genet Program, Carmel, CA USA.	dst@sbcglobal.net; mark.dewhirst@duke.edu	Dewhirst, Mark/Q-1302-2019; Palmer, Gregory M/C-6910-2008; Moon, Eui Jung/AAM-3223-2021	Dewhirst, Mark/0000-0003-3459-6546; Palmer, Gregory M/0000-0003-2955-8297; Moon, Eui Jung/0000-0001-7916-7978; Telen, Marilyn/0000-0003-3809-1780; Yuan, Hong/0000-0002-0535-3214; Rabbani, zahid/0000-0002-4101-7947	National Institutes of Health (NIH) National Cancer Institute (NCI) [CA40355-23, CA40355-24, CA40355-25, CA40355-26, CA40355-27]; NATIONAL CANCER INSTITUTE [R01CA040355] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Institutes of Health (NIH) National Cancer Institute (NCI) CA40355-23, -24, -25, -26, 27 to M. W. Dewhirst. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MF, 1999, INT J RADIAT ONCOL, V45, P171, DOI 10.1016/S0360-3016(99)00157-1; Agrawal A, 2008, PEDIATR NEUROSURG, V44, P471, DOI 10.1159/000180301; ALGIRE GH, 1949, J NATL CANCER I, V10, P225; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; BALLA G, 1991, LAB INVEST, V64, P648; Ballas SK, 2006, TRANSFUSION, V46, P105, DOI 10.1111/j.1537-2995.2006.00679.x; Belcher JD, 2005, AM J PHYSIOL-HEART C, V288, pH2715, DOI 10.1152/ajpheart.00986.2004; Belcher JD, 2003, BLOOD, V101, P3953, DOI 10.1182/blood-2002-10-3313; Bennewith KL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-504; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Brown MD, 2001, PEDIATR PATHOL MOL M, V20, P47, DOI 10.1080/15513810109168817; Brown SL, 2003, MAGNET RESON MED, V50, P1209, DOI 10.1002/mrm.10646; Cao YT, 2005, CANCER RES, V65, P5498, DOI 10.1158/0008-5472.CAN-04-4553; Dewhirst MW, 2009, RADIAT RES, V172, P653, DOI 10.1667/RR1926.1; Dienst A, 2005, JNCI-J NATL CANCER I, V97, P733, DOI 10.1093/jnci/dji130; Du GJ, 2008, BIOCHEM BIOPH RES CO, V372, P497, DOI 10.1016/j.bbrc.2008.05.080; Embury SH, 2004, MICROCIRCULATION, V11, P101, DOI 10.1080/10739680490278277; Faller Douglas V., 1994, P235; Fang J, 2004, INT J CANCER, V109, P1, DOI 10.1002/ijc.11644; HEBBEL RP, 1988, P NATL ACAD SCI USA, V85, P237, DOI 10.1073/pnas.85.1.237; HEBBEL RP, 1982, J CLIN INVEST, V70, P1253, DOI 10.1172/JCI110724; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Jozkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2099, DOI 10.1089/ars.2007.1659; Kalambur VS, 2004, AM J HEMATOL, V77, P117, DOI 10.1002/ajh.20143; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Kaul DK, 2009, MICROCIRCULATION, V16, P97, DOI 10.1080/10739680802279394; Kaul DK, 2000, J CLIN INVEST, V106, P411, DOI 10.1172/JCI9225; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kikkawa Y, 2008, EXP CELL RES, V314, P2579, DOI 10.1016/j.yexcr.2008.05.021; Labbe RF, 1999, CLIN CHEM, V45, P2060; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; MACKAY F, 1993, J EXP MED, V177, P1277, DOI 10.1084/jem.177.5.1277; Milosevic M, 2001, GYNECOL ONCOL, V83, P428, DOI 10.1006/gyno.2001.6426; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Osarogiagbon UR, 2000, BLOOD, V96, P314, DOI 10.1182/blood.V96.1.314.013k39_314_320; Pasqualini R, 1997, NAT BIOTECHNOL, V15, P542, DOI 10.1038/nbt0697-542; Pries AR, 2010, NAT REV CANCER, V10, P587, DOI 10.1038/nrc2895; Reddy SB, 2009, EXPERT OPIN INV DRUG, V18, P77, DOI [10.1517/13543780802567250, 10.1517/13543780802567250 ]; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; REPKA T, 1991, BLOOD, V78, P2753; SIGGAARDANDERSEN O, 1984, CLIN CHEM, V30, P1646; Simizu S, 1998, J BIOL CHEM, V273, P26900, DOI 10.1074/jbc.273.41.26900; SMOLINSKI PA, 1995, BLOOD, V85, P2945, DOI 10.1182/blood.V85.10.2945.bloodjournal85102945; Solovey A, 1997, NEW ENGL J MED, V337, P1584, DOI 10.1056/NEJM199711273372203; Sorg BS, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2003369; Stuart MJ, 2004, LANCET, V364, P1343, DOI 10.1016/S0140-6736(04)17192-4; Sultana C, 1998, BLOOD, V92, P3924, DOI 10.1182/blood.V92.10.3924.422k07_3924_3935; Telen MJ, 2005, TRANSFUS MED REV, V19, P32, DOI 10.1016/j.tmrv.2004.09.006; Terada LS, 2002, CRIT CARE MED, V30, pS186, DOI 10.1097/00003246-200205001-00003; Terman DS, 1999, US patent Serial Number, Patent No. [7,803,637, 7803637]; UNTHANK JL, 1993, MICROVASC RES, V45, P193, DOI 10.1006/mvre.1993.1018; Vishwanath K, 2009, NEOPLASIA, V11, P889, DOI 10.1593/neo.09580; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wood KC, 2007, CLIN EXP PHARMACOL P, V34, P926, DOI 10.1111/j.1440-1681.2007.04639.x; Zennadi R, 2004, BLOOD, V104, P3774, DOI 10.1182/blood-2004-01-0042; Zennadi R, 2007, BLOOD, V110, P2708, DOI 10.1182/blood-2006-11-056101	57	17	20	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52543	10.1371/journal.pone.0052543	http://dx.doi.org/10.1371/journal.pone.0052543			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326340	Green Published, gold, Green Submitted			2022-12-25	WOS:000313551500017
J	Cuesta-Marban, A; Botet, J; Czyz, O; Cacharro, LM; Gajate, C; Hornillos, V; Delgado, J; Zhang, H; Amat-Guerri, F; Acuna, AU; McMaster, CR; Revuelta, JL; Zaremberg, V; Mollinedo, F				Cuesta-Marban, Alvaro; Botet, Javier; Czyz, Ola; Cacharro, Luis M.; Gajate, Consuelo; Hornillos, Valentin; Delgado, Javier; Zhang, Hui; Amat-Guerri, Francisco; Ulises Acuna, A.; McMaster, Christopher R.; Luis Revuelta, Jose; Zaremberg, Vanina; Mollinedo, Faustino			Drug Uptake, Lipid Rafts, and Vesicle Trafficking Modulate Resistance to an Anticancer Lysophosphatidylcholine Analogue in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASES; PLASMA-MEMBRANE; ET-18-OCH3 EDELFOSINE; SUBCELLULAR-LOCALIZATION; SACCHAROMYCES-CEREVISIAE; APOPTOSIS; COMPLEX; PROTEIN; RECRUITMENT; TRANSPORT	The ether-phospholipid edelfosine, a prototype antitumor lipid (ATL), kills yeast cells and selectively kills several cancer cell types. To gain insight into its mechanism of action, we performed chemogenomic screens in the Saccharomyces cerevisiae gene-deletion strain collection, identifying edelfosine-resistant mutants. LEM3, AGP2, and DOC1 genes were required for drug uptake. Edelfosine displaced the essential proton pump Pma1p from rafts, inducing its internalization into the vacuole. Additional ATLs, including miltefosine and perifosine, also displaced Pma1p from rafts to the vacuole, suggesting that this process is a major hallmark of ATL cytotoxicity in yeast. Radioactive and synthetic fluorescent edelfosine analogues accumulated in yeast plasma membrane rafts and subsequently the endoplasmic reticulum. Although both edelfosine and Pma1p were initially located at membrane rafts, internalization of the drug toward endoplasmic reticulum and Pma1p to the vacuole followed different routes. Drug internalization was not dependent on endocytosis and was not critical for yeast cytotoxicity. However, mutants affecting endocytosis, vesicle sorting, or trafficking to the vacuole, including the retromer and ESCRT complexes, prevented Pma1p internalization and were edelfosine-resistant. Our data suggest that edelfosine-induced cytotoxicity involves raft reorganization and retromer- and ESCRT-mediated vesicular transport and degradation of essential raft proteins leading to cell death. Cytotoxicity of ATLs is mainly dependent on the changes they induce in plasma membrane raft-located proteins that lead to their internalization and subsequent degradation. Edelfosine toxicity can be circumvented by inactivating genes that then result in the recycling of internalized cell-surface proteins back to the plasma membrane.	[Cuesta-Marban, Alvaro; Cacharro, Luis M.; Gajate, Consuelo; Zhang, Hui; Mollinedo, Faustino] Univ Salamanca, Consejo Super Invest Cient, Ctr Invest Canc, Inst Biol Mol & Celular Canc, E-37007 Salamanca, Spain; [Botet, Javier; Luis Revuelta, Jose] Univ Salamanca, Dept Microbiol & Genet, E-37007 Salamanca, Spain; [Czyz, Ola; Zaremberg, Vanina] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Hornillos, Valentin; Delgado, Javier; Amat-Guerri, Francisco] CSIC, Inst Quim Organ Gen, E-28006 Madrid, Spain; [Ulises Acuna, A.] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain; [McMaster, Christopher R.] Dalhousie Univ, Atlantic Res Ctr, Dept Pharmacol, Halifax, NS B3H 4R2, Canada	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; University of Calgary; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Organica General (IQOG); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Dalhousie University	Zaremberg, V (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vzarembe@ucalgary.ca; fmollin@usal.es	Revuelta, Jose L/C-2324-2012; Revuelta, Jose Luis/ABG-1502-2020; Delgado, Javier F/S-1688-2018; Hornillos, Valentin/L-9357-2014	Revuelta, Jose L/0000-0001-7838-5308; Revuelta, Jose Luis/0000-0001-7838-5308; Hornillos, Valentin/0000-0002-6181-9146; Gajate, Consuelo/0000-0003-0604-6459; McMaster, Christopher/0000-0003-0822-5776; Cuesta Marban, Alvaro/0000-0002-7144-0500; Delgado, Javier/0000-0003-1302-5445	Spanish Ministerio de Economia y Competitividad [SAF2005-04293, SAF2008-02251, SAF2011-30518, CTQ2010-16457]; Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III; Fondo Europeo de Desarrollo Regional of the European Union [RD06/0020/1037, RD12/0036/0065]; European Community's Seventh Framework Programme [HEALTH-F2-2011-256986]; Fundacion "la Caixa" [BM05-30-0]; Junta de Castilla y Leon [CSI052A11-2, CSI221A12-2]; Fondo de Investigacion Sanitaria and European Commission (FIS-FEDER) [06/0813, PS09/01915]; Junta de Castilla y Leon Biomedicine Project; Canadian Institutes of Health Research [14124]; Natural Sciences and Engineering Research Council of Canada; University of Calgary; Natural Sciences and Engineering Research Council of Canada University; Spanish Ministerio de Ciencia e Innovacion	Spanish Ministerio de Economia y Competitividad(Spanish Government); Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional of the European Union; European Community's Seventh Framework Programme(European Commission); Fundacion "la Caixa"(La Caixa Foundation); Junta de Castilla y Leon(Junta de Castilla y Leon); Fondo de Investigacion Sanitaria and European Commission (FIS-FEDER); Junta de Castilla y Leon Biomedicine Project(Junta de Castilla y Leon); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Calgary; Natural Sciences and Engineering Research Council of Canada University(Natural Sciences and Engineering Research Council of Canada (NSERC)); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported in part by Spanish Ministerio de Economia y Competitividad Grants SAF2005-04293, SAF2008-02251, and SAF2011-30518, Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III, co-funded by the Fondo Europeo de Desarrollo Regional of the European Union Grants RD06/0020/1037 and RD12/0036/0065, European Community's Seventh Framework Programme FP7-2007-2013 Grant HEALTH-F2-2011-256986 (PANACREAS), Fundacion "la Caixa" Grant BM05-30-0, Junta de Castilla y Leon Grants CSI052A11-2 and CSI221A12-2 (to F.M.), Spanish Ministerio de Economia y Competitividad Grants BIO2008-00194 and BIO2011-23901, Junta de Castilla y Leon Grant GR147 (to J.L.R.), Fondo de Investigacion Sanitaria and European Commission (FIS-FEDER) Grants 06/0813 and PS09/01915, Junta de Castilla y Leon Biomedicine Project 2010-2011 (to C.G.), Spanish Ministerio de Economia y Competitividad Grant CTQ2010-16457 (to A.U.A.), Canadian Institutes of Health Research Grant 14124 (to C.R.M.), a Natural Sciences and Engineering Research Council of Canada discovery grant, a seed grant from the University of Calgary, and an Natural Sciences and Engineering Research Council of Canada University faculty award (to V.Z.).; Supported by the Ramon y Cajal Program from the Spanish Ministerio de Ciencia e Innovacion.	Aouida M, 2004, CANCER RES, V64, P1102, DOI 10.1158/0008-5472.CAN-03-2729; Aouida M, 2010, J BIOL CHEM, V285, P6275, DOI 10.1074/jbc.M109.046151; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ausili A, 2008, J PHYS CHEM B, V112, P11643, DOI 10.1021/jp802165n; Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; Balguerie A, 2002, EUKARYOT CELL, V1, P1021, DOI 10.1128/EC.1.6.1021-1031.2002; Bjornsti MA, 2002, CANCER CELL, V2, P267, DOI 10.1016/S1535-6108(02)00160-5; Busto Jon V, 2008, J Chem Biol, V1, P89, DOI 10.1007/s12154-008-0009-z; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Conibear E, 2000, MOL BIOL CELL, V11, P305, DOI 10.1091/mbc.11.1.305; Czyz O, 2013, J BIOL CHEM, V288, P8419, DOI 10.1074/jbc.M112.425744; Foury F, 1997, GENE, V195, P1, DOI 10.1016/S0378-1119(97)00140-6; Gajate C, 2000, INT J CANCER, V85, P674, DOI 10.1002/(SICI)1097-0215(20000301)85:5<674::AID-IJC13>3.0.CO;2-Z; Gajate C, 2004, J EXP MED, V200, P353, DOI 10.1084/jem.20040213; Gajate C, 2012, ONCOGENE, V31, P2627, DOI 10.1038/onc.2011.446; Gajate C, 2002, CURR DRUG METAB, V3, P491, DOI 10.2174/1389200023337225; Gajate C, 2001, BLOOD, V98, P3860, DOI 10.1182/blood.V98.13.3860; Gajate C, 2007, BLOOD, V109, P711, DOI 10.1182/blood-2006-04-016824; Gajate C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005044; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Hanson PJ, 2003, ECOL STUD-ANAL SYNTH, V166, P3; Hettema EH, 2003, EMBO J, V22, P548, DOI 10.1093/emboj/cdg062; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jendrossek V., 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P343, DOI 10.2174/1568011033482341; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Luo WJ, 1997, J CELL BIOL, V138, P731, DOI 10.1083/jcb.138.4.731; Mager WH, 2005, TRENDS PHARMACOL SCI, V26, P265, DOI 10.1016/j.tips.2005.03.004; Mollinedo F, 1997, CANCER RES, V57, P1320; Mollinedo F, 2004, CURR MED CHEM, V11, P3163, DOI 10.2174/0929867043363703; Mollinedo F, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.41; Mollinedo F, 2010, ONCOGENE, V29, P3748, DOI 10.1038/onc.2010.131; Mollinedo F, 2007, EXPERT OPIN THER PAT, V17, P385, DOI 10.1517/13543776.17.4.385; Mollinedo F, 2010, CLIN CANCER RES, V16, P2046, DOI 10.1158/1078-0432.CCR-09-2456; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Nieto-Miguel T, 2007, CANCER RES, V67, P10368, DOI 10.1158/0008-5472.CAN-07-0278; Nieto-Miguel T, 2006, J BIOL CHEM, V281, P14833, DOI 10.1074/jbc.M511251200; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Riekhof WR, 2007, J BIOL CHEM, V282, P36853, DOI 10.1074/jbc.M706718200; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Shi YF, 2011, MOL BIOL CELL, V22, P4093, DOI 10.1091/mbc.E11-05-0440; van der Luit AH, 2002, J BIOL CHEM, V277, P39541, DOI 10.1074/jbc.M203176200; Zaremberg V, 2005, J BIOL CHEM, V280, P38047, DOI 10.1074/jbc.M502849200	45	36	36	1	32	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8405	8418		10.1074/jbc.M112.425769	http://dx.doi.org/10.1074/jbc.M112.425769			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23335509	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000316564500039
J	Lenarduzzi, M; Hui, ABY; Alajez, NM; Shi, W; Williams, J; Yue, SJ; O'Sullivan, B; Liu, FF				Lenarduzzi, Michelle; Hui, Angela B. Y.; Alajez, Nehad M.; Shi, Wei; Williams, Justin; Yue, Shijun; O'Sullivan, Brian; Liu, Fei-Fei			MicroRNA-193b Enhances Tumor Progression via Down Regulation of Neurofibromin 1	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; SOMATIC MUTATIONS; EXPRESSION; HEAD; CANCER; GENE; IDENTIFICATION; DOMAIN; RAS; ACTIVATION	Despite improvements in therapeutic approaches for head and neck squamous cell carcinomas (HNSCC), clinical outcome has remained disappointing, with 5-year overall survival rates hovering around 40-50%, underscoring an urgent need to better understand the biological bases of this disease. We chose to address this challenge by studying the role of microRNAs (miRNAs) in HNSCC. MiR-193b was identified as an over-expressed miRNA from global miRNA profiling studies previously conducted in our lab, and confirmed in HNSCC cell lines. In vitro knockdown of miR-193b in FaDu cancer cells substantially reduced cell proliferation, migration and invasion, along with suppressed tumour formation in vivo. By integrating in silico prediction algorithms with in vitro experimental mRNA profilings, plus mRNA expression data of clinical specimens, neurofibromin 1 (NF1) was identified to be a target of miR-193b. Concordantly, miR-193b knockdown decreased NF1 transcript and protein levels significantly. Luciferase reporter assays confirmed the direct interaction of miR-193b with NF1. Moreover, p-ERK, a downstream target of NF1 was also suppressed after miR-193b knockdown. FaDu cells treated with a p-ERK inhibitor (U0126) phenocopied the reduced cell proliferation, migration and invasion observed with miR-193b knockdown. Finally, HNSCC patients whose tumours expressed high levels of miR-193b experienced a lower disease-free survival compared to patients with low miR-193b expression. Our findings identified miR-193b as a potentially novel prognostic marker in HNSCC that drives tumour progression via down-regulating NF1, in turn leading to activation of ERK, resulting in proliferation, migration, invasion, and tumour formation.	[Lenarduzzi, Michelle; Hui, Angela B. Y.; Shi, Wei; Williams, Justin; Yue, Shijun; Liu, Fei-Fei] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada; [Lenarduzzi, Michelle; Liu, Fei-Fei] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Alajez, Nehad M.] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11461, Saudi Arabia; [O'Sullivan, Brian; Liu, Fei-Fei] Univ Hlth Network, Radiat Med Program, Toronto, ON, Canada; [O'Sullivan, Brian; Liu, Fei-Fei] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; King Saud University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Liu, FF (corresponding author), Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada.	Fei-Fei.Liu@rmp.uhn.on.ca		Alajez, Nehad/0000-0002-1546-1091; Spence, Tara/0000-0001-7098-4103; O'Sullivan, Brian/0000-0001-8887-843X; Liu, Fei-Fei/0000-0003-4344-6486	Terry Fox Foundation Strategic Training Initiative for Excellence in Radiation Research of the 21st Century (EIRR21) at the Canadian Institutes of Health Research (CIHR)	Terry Fox Foundation Strategic Training Initiative for Excellence in Radiation Research of the 21st Century (EIRR21) at the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Michelle Lenarduzzi is a recipient of a scholarship from the Terry Fox Foundation Strategic Training Initiative for Excellence in Radiation Research of the 21st Century (EIRR21) at the Canadian Institutes of Health Research (CIHR). This scholarship has provided funding to this project. The authors also gratefully acknowledge the philanthropic support from the Wharton Family, Joe's Team, and Gordon Tozer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alajez NM, 2011, CANCER RES, V71, P2381, DOI 10.1158/0008-5472.CAN-10-2754; Avissar M, 2009, CLIN CANCER RES, V15, P2850, DOI 10.1158/1078-0432.CCR-08-3131; Bancroft CC, 2002, INT J CANCER, V99, P538, DOI 10.1002/ijc.10398; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; Boston SR, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-7; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cassell A, 2010, EXPERT OPIN INV DRUG, V19, P709, DOI 10.1517/13543781003769844; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Cummings B, 2007, RADIOTHER ONCOL, V85, P7, DOI 10.1016/j.radonc.2007.09.010; Ferlay J, 2008, IARC CANCERBASE; Fletcher AM, 2008, TRANSL ONCOL, V1, P202, DOI 10.1593/tlo.08163; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gao XN, 2011, LEUKEMIA RES, V35, P1226, DOI 10.1016/j.leukres.2011.06.010; Gery S, 2005, BLOOD, V106, P2827, DOI 10.1182/blood-2005-01-0358; Hancock CN, 2005, J MED CHEM, V48, P4586, DOI 10.1021/jm0501174; Hsu CM, 2012, TUMOR BIOL, V33, P149, DOI 10.1007/s13277-011-0258-2; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Hui ABY, 2009, CLIN CANCER RES, V15, P3716, DOI 10.1158/1078-0432.CCR-08-2790; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; JOHNSON MR, 1994, MOL CELL BIOL, V14, P641, DOI 10.1128/MCB.14.1.641; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Le LQ, 2007, ONCOGENE, V26, P4609, DOI 10.1038/sj.onc.1210261; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li XF, 2009, ONCOGENE, V28, P3937, DOI 10.1038/onc.2009.245; LI Y, 1992, CELL, V69, P275, DOI 10.1016/0092-8674(92)90408-5; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Lin CJ, 2007, HEAD NECK-J SCI SPEC, V29, P163, DOI 10.1002/hed.20478; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Markou A, 2008, CLIN CHEM, V54, P1696, DOI 10.1373/clinchem.2007.101741; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Moniz LS, 2011, MOL CELL BIOL, V31, P30, DOI 10.1128/MCB.00648-10; Nakamura T, 2009, P NATL ACAD SCI USA, V106, P15436, DOI 10.1073/pnas.0903302106; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; PEKKOLAHEINO K, 1992, HEAD NECK-J SCI SPEC, V14, P196, DOI 10.1002/hed.2880140306; Rauhala HE, 2010, INT J CANCER, V127, P1363, DOI 10.1002/ijc.25162; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Steelman LS, 2011, AGING-US, V3, P192, DOI 10.18632/aging.100296; THE I, 1993, NAT GENET, V3, P62, DOI 10.1038/ng0193-62; Thiel G, 1995, ANTICANCER RES, V15, P2495; Tran N, 2007, BIOCHEM BIOPH RES CO, V358, P12, DOI 10.1016/j.bbrc.2007.03.201; Unno K, 2009, LEUKEMIA LYMPHOMA, V50, P1865, DOI 10.3109/10428190903221010; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wolfer A, 2011, CANCER RES, V71, P2034, DOI 10.1158/0008-5472.CAN-10-3776; Wood PA, 2009, INTEGR CANCER THER, V8, P303, DOI 10.1177/1534735409355292; Worley LA, 2008, MELANOMA RES, V18, P184, DOI 10.1097/CMR.0b013e3282feeac6; Wu WG, 2009, EUR J CANCER PREV, V18, P50, DOI 10.1097/CEJ.0b013e328305a07a; Zhang XY, 2009, INT J CANCER, V124, P2855, DOI 10.1002/ijc.24298	54	52	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53765	10.1371/journal.pone.0053765	http://dx.doi.org/10.1371/journal.pone.0053765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335975	gold, Green Published, Green Submitted			2022-12-25	WOS:000314707700031
J	Dai, BZ; Mao, ZF; Mei, J; Levkoff, S; Wang, HL; Pacheco, M; Wu, B				Dai, Baozhen; Mao, Zongfu; Mei, John; Levkoff, Sue; Wang, Huali; Pacheco, Misty; Wu, Bei			Caregivers in China: Knowledge of Mild Cognitive Impairment	PLOS ONE			English	Article							ALZHEIMER-DISEASE; HIGH-RISK; CARE; DEMENTIA; ONSET; PREVALENCE; DIAGNOSIS; BURDEN	This study aimed to examine the experience and knowledge of mild cognitive impairment (MCI) among Chinese family caregivers of individuals with MCI. The sample was recruited from memory clinics in Zhongnan Hospital in Wuhan, China. In-depth semi-structured interviews were used. Thirteen family members of individuals diagnosed with MCI participated in the study. Data analysis revealed three themes: 1) initial recognition of cognitive decline; 2) experience of the diagnosis of MCI; 3) perception of cognitive decline as a normal part of aging. While family members recognized the serious consequences of memory loss (e. g. getting lost), they would typically not take their family members to see a doctor until something specific triggered their access to the medical care system. The Chinese traditional perception of dementia as part of normal aging may serve to lessen the stigma of individuals with MCI, while the term "laonian chidai" which literally translates to "stupid, demented elderly" may exacerbate the stigma associated with individuals with MCI. It is suggested that family members' worries may be relieved by improving their access to accurate knowledge of the disease, community-based and institutional care services, and culturally appropriately words are needed for MCI.	[Dai, Baozhen] Jiangsu Univ, Sch Management, Zhenjiang, Peoples R China; [Dai, Baozhen] Jiangsu Univ, Res Inst New Rural Dev, Zhenjiang, Peoples R China; [Mao, Zongfu] Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Peoples R China; [Mei, John] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; [Levkoff, Sue] Univ S Carolina, Coll Social Work, DeSaussure Coll, Columbia, SC 29208 USA; [Wang, Huali] Peking Univ, Inst Mental Hlth, Dementia Care & Res Ctr, Beijing 100871, Peoples R China; [Pacheco, Misty] Univ Hawaii Manoa, Honolulu, HI 96822 USA; [Wu, Bei] Duke Univ, Sch Nursing, Durham, NC 27706 USA; [Wu, Bei] Duke Univ, Global Hlth Inst, Durham, NC USA	Jiangsu University; Jiangsu University; Wuhan University; Harvard University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Peking University; University of Hawaii System; University of Hawaii Manoa; Duke University; Duke University	Wu, B (corresponding author), Duke Univ, Sch Nursing, Durham, NC 27706 USA.	bei.wu@duke.edu	dai, bz/HGC-0467-2022; Wang, Huali/S-9848-2018; Wu, Bei/X-2404-2019	Wu, Bei/0000-0002-6891-244X	National Institutes of Health Fogarty International Center/National Institute on Aging [1R21AG028180]; Natural Science Foundation of China [71203080, 30500178, 30971044]; Senior Professionals Scientific Research Foundation of Jiangsu University; Ministry of Science and Technology [2007AA02Z421]; NATIONAL INSTITUTE ON AGING [R21AG028180] Funding Source: NIH RePORTER	National Institutes of Health Fogarty International Center/National Institute on Aging; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Senior Professionals Scientific Research Foundation of Jiangsu University; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was funded by the National Institutes of Health Fogarty International Center/National Institute on Aging (1R21AG028180), the Natural Science Foundation of China (71203080) and Senior Professionals Scientific Research Foundation of Jiangsu University. The case registry of cognitive impairment at Dementia Care & Research Center of Peking University Institute of Mental Health was supported by research funding from the Natural Science Foundation of China (30500178, 30971044) and the Ministry of Science and Technology (2007AA02Z421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's Association, 2010, Alzheimers Dement, V6, P158, DOI 10.1016/j.jalz.2010.01.009; Austrom MG, 2009, CURR ALZHEIMER RES, V6, P392, DOI 10.2174/156720509788929291; Bartlett H, 1997, HEALTH PLACE, V3, P149, DOI 10.1016/S1353-8292(97)00008-7; Bi M, 2010, MED SOC, V23, P79; Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]; Blieszner R, 2010, GERONTOLOGIST, V50, P11, DOI 10.1093/geront/gnp068; Bruce JM, 2008, DEMENT GERIATR COGN, V25, P385, DOI 10.1159/000122587; Carpenter BD, 2011, AM J ALZHEIMERS DIS, V26, P121, DOI 10.1177/1533317510394157; Chu LW, 2008, J AM MED DIR ASSOC, V9, P239, DOI 10.1016/j.jamda.2008.01.008; Dai B, 2012, KNOWLEDGE ATTITUDE B; Feldman HH, 2007, LANCET NEUROL, V6, P501, DOI 10.1016/S1474-4422(07)70109-6; Garand L, 2005, INT J GERIATR PSYCH, V20, P512, DOI 10.1002/gps.1318; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Glaser B, 1978, DISCOV GROUNDED THEO; Gray HL, 2009, AM J GERIAT PSYCHIAT, V17, P925, DOI 10.1097/JGP.0b013e3181ad4f3c; Grundman M, 2004, ARCH NEUROL-CHICAGO, V61, P59, DOI 10.1001/archneur.61.1.59; Guo ZB, 2000, RECRUITMENT AND RETENTION IN MINORITY POPULATIONS, P103; Hesketh T, 2005, NEW ENGL J MED, V353, P1171, DOI 10.1056/NEJMhpr051833; Hinton L, 2000, J Cross Cult Gerontol, V15, P119, DOI 10.1023/A:1006798316654; Hinton WL, 1999, CULT MED PSYCHIAT, V23, P453, DOI 10.1023/A:1005516002792; Huang Juebin, 2005, Current Alzheimer Research, V2, P571, DOI 10.2174/156720505774932223; Jiang RuiHui, 2009, Chinese Journal of Clinical Healthcare, V12, P194; Kleinman A, 1986, SOCIAL ORIGINS DISTR; Kleinman A., 1980, PATIENTS HEALERS CON; Levey A, 2006, CLIN THER, V28, P991, DOI 10.1016/j.clinthera.2006.07.006; Lu YFY, 2009, CURR ALZHEIMER RES, V6, P384, DOI 10.2174/156720509788929309; Mahoney DF, 2005, GERONTOLOGIST, V45, P783, DOI 10.1093/geront/45.6.783; Marcheco B, 2003, GENET TEST, V7, P45, DOI 10.1089/109065703321560930; McIlvane JM, 2008, ALZ DIS ASSOC DIS, V22, P284, DOI 10.1097/WAD.0b013e318169d714; Mebane-Sims I, 2009, ALZHEIMERS DEMENT, V5, P234, DOI 10.1016/j.jalz.2009.03.001; Nie HW, 2011, INT J GERIATR PSYCH, V26, P558, DOI 10.1002/gps.2579; Peng P, 1998, China Popul Today, V15, P5; Peng P, 1998, CHINA POPUL TODAY, V15, P10; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Qiu Chang-jian, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P1104; Schulz R, 2004, AM J GERIAT PSYCHIAT, V12, P240, DOI 10.1176/appi.ajgp.12.3.240; SPSS, 2006, SPSS 15 0 WIND REL 1; Strauss A., 1997, GROUNDED THEORY PRAC; Tabert MH, 2006, ARCH GEN PSYCHIAT, V63, P916, DOI 10.1001/archpsyc.63.8.916; Tuokko H, 2005, NEUROCASE, V11, P40, DOI 10.1080/13554790490896802; Werner P, 2001, INT J GERIATR PSYCH, V16, P32, DOI 10.1002/1099-1166(200101)16:1<32::AID-GPS268>3.0.CO;2-2; Wu Bei, 2005, J Aging Soc Policy, V17, P37, DOI 10.1300/J031v17n04_03; Wu B, 2010, AGEING INT, V35, P128, DOI 10.1007/s12126-010-9055-2; Wu B, 2009, J AM MED DIR ASSOC, V10, P472, DOI 10.1016/j.jamda.2009.07.008; Wu B, 2008, J AGING SOC POLICY, V20, P218, DOI 10.1080/08959420801977632; Wu J, 2010, CHINESE J SOCIAL MED, V27, P215; Zhan L, 2004, J GERONTOLOGICAL NUR, V30, P20; Zhang X, 2001, HLTH CHINA, V6, P36; [张振馨 Zhang Zhenxin], 2004, [中国医学科学院学报, Acta Academiae Medicinae Sinicae], V26, P116	49	20	21	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53928	10.1371/journal.pone.0053928	http://dx.doi.org/10.1371/journal.pone.0053928			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086RY	23326541	Green Published, gold, Green Submitted			2022-12-25	WOS:000314705800090
J	Davidson, D; Zaytseva, A; Miskolci, V; Castro-Alcaraz, S; Vancurova, I; Patel, H				Davidson, Dennis; Zaytseva, Alla; Miskolci, Veronika; Castro-Alcaraz, Susana; Vancurova, Ivana; Patel, Hardik			Gene Expression Profile of Endotoxin-stimulated Leukocytes of the Term New Born: Control of Cytokine Gene Expression by Interleukin-10	PLOS ONE			English	Article							HYALINE-MEMBRANE DISEASE; INFLAMMATORY RESPONSE SYNDROME; RESPIRATORY-DISTRESS SYNDROME; CHRONIC LUNG-DISEASE; BRONCHOPULMONARY DYSPLASIA; PRETERM INFANTS; ANTIINFLAMMATORY RESPONSE; NEWBORN-INFANTS; IL-10; POLYMORPHONUCLEAR	Introduction: Increasing evidence now supports the association between the fetal inflammatory response syndrome (FIRS) with the pathogenesis of preterm labor, intraventricular hemorrhage and bronchopulmonary dysplasia. Polymorphonuclear leukocyte (PMNs) and mononuclear cell (MONOs) infiltration of the placenta is associated with these disorders. The aim of this study was to reveal cell-specific differences in gene expression and cytokine release in response to endotoxin that would elucidate inflammatory control mechanisms in the newly born. Methods: PMNs and MONOs were separately isolated from the same cord blood sample. A genome-wide microarray screened for gene expression and related pathways at 4 h of LPS stimulation (n = 5). RT-qPCR and ELISA were performed for selected cytokines at 4 h and 18 h of LPS stimulation. Results: Compared to PMNs, MONOs had a greater diversity and more robust gene expression that included pro-inflammatory (PI) cytokines, chemokines and growth factors at 4 h. Only MONOs had genes changing expression (all up regulated including interleukin-10) that were clustered in the JAK/STAT pathway. Pre-incubation with IL-10 antibody, for LPS-stimulated MONOs, led to up regulated PI and IL-10 gene expression and release of PI cytokines after 4 h. Discussion: The present study suggests a dominant role of MONO gene expression in control of the fetal inflammatory response syndrome at 4 hrs of LPS stimulation. LPS-stimulated MONOs but not PMNs of the newborn have the ability to inhibit PI cytokine gene expression by latent IL-10 release.	[Davidson, Dennis] Stony Brook Long Isl Childrens Hosp, Div Neonatal Perinatal Med, Stony Brook, NY USA; [Zaytseva, Alla; Miskolci, Veronika; Castro-Alcaraz, Susana; Patel, Hardik] Feinstein Inst Med Res, Manhasset, NY USA; [Vancurova, Ivana] St Johns Univ, Dept Biol, New York, NY USA	Northwell Health; Saint John's University	Davidson, D (corresponding author), Stony Brook Long Isl Childrens Hosp, Div Neonatal Perinatal Med, Stony Brook, NY USA.	dennis.davidson@stonybrookmedicine.edu	Patel, Hardik/L-9000-2013	Patel, Hardik/0000-0003-3819-4691	NICHD [R03-HD048508]; Lilling Family of the Neonatal Research Laboratory at The Feinstein Institute for Medical Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD048508] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Lilling Family of the Neonatal Research Laboratory at The Feinstein Institute for Medical Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was funded in part by R03-HD048508 (NICHD), http://www.nichd.nih.gov, and by the Lilling Family support of the Neonatal Research Laboratory at The Feinstein Institute for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambalavanan N, 2009, PEDIATRICS, V123, P1132, DOI 10.1542/peds.2008-0526; Andrews WW, 2006, AM J OBSTET GYNECOL, V195, P803, DOI 10.1016/j.ajog.2006.06.083; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Bayraktar M, 2009, AM J REPROD IMMUNOL, V62, P390, DOI 10.1111/j.1600-0897.2009.00756.x; Beresford MW, 2002, PEDIATR RES, V52, P973, DOI 10.1203/01.PDR.0000036626.67304.65; Bose CL, 2008, ARCH DIS CHILD-FETAL, V93, P1455, DOI 10.1136/adc.2007.121327; Chusid LA, 2010, NEONATOLOGY, V97, P108, DOI 10.1159/000235807; Citarella BV, 2009, PEDIATR RES, V65, P425, DOI 10.1203/PDR.0b013e318199384d; Davidson D, 2007, NEONATOLOGY, V92, P127, DOI 10.1159/000101432; Dessardo NS, 2012, AM J PERINAT, V29, P133, DOI 10.1055/s-0031-1295654; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; JACKSON JC, 1987, AM REV RESPIR DIS, V135, P937, DOI 10.1164/arrd.1987.135.4.937; Jones CA, 1996, PEDIATR RES, V39, P966, DOI 10.1203/00006450-199606000-00007; Kuypers E, 2012, AM J PHYSIOL-LUNG C, V302, pL380, DOI 10.1152/ajplung.00338.2011; Kwong KYC, 1998, CLIN IMMUNOL IMMUNOP, V88, P105, DOI 10.1006/clin.1997.4510; Leviton A, 2010, PEDIATR RES, V67, P95, DOI 10.1203/PDR.0b013e3181bf5fab; Madsen-Bouterse SA, 2010, AM J REPROD IMMUNOL, V63, P73, DOI 10.1111/j.1600-0897.2009.00791.x; McCall CE, 2011, J LEUKOCYTE BIOL, V90, P439, DOI 10.1189/jlb.0211075; McGowan EC, 2009, PEDIATR RES, V66, P455, DOI 10.1203/PDR.0b013e3181b3b0fa; Medzhitov R, 2011, NAT REV IMMUNOL, V11, P693, DOI 10.1038/nri3063; MERRITT TA, 1983, J CLIN INVEST, V72, P656, DOI 10.1172/JCI111015; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Munshi UK, 1997, PEDIATR PULM, V24, P331; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Oei J, 2002, ACTA PAEDIATR, V91, P1194; Roberts PC, 2008, BIOTECHNOL ANN REV, V14, P29, DOI 10.1016/S1387-2656(08)00002-1; ROMERO R, 1988, AM J OBSTET GYNECOL, V158, P1044, DOI 10.1016/0002-9378(88)90216-5; Schultz C, 2004, CLIN EXP IMMUNOL, V135, P130, DOI 10.1111/j.1365-2249.2004.02313.x; Sorokin Y, 2010, AM J PERINAT, V27, P631, DOI 10.1055/s-0030-1249366; Thornton NL, 2012, NEONATOLOGY, V101, P140, DOI 10.1159/000330567; Viscardi RM, 2012, SEMIN FETAL NEONAT M, V17, P30, DOI 10.1016/j.siny.2011.08.002	31	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53641	10.1371/journal.pone.0053641	http://dx.doi.org/10.1371/journal.pone.0053641			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326478	Green Submitted, Green Published, gold			2022-12-25	WOS:000314705800065
J	Hao, Z; Zhao, ZY; Berthoud, HR; Ye, JP				Hao, Zheng; Zhao, Zhiyun; Berthoud, Hans-Rudolf; Ye, Jianping			Development and Verification of a Mouse Model for Roux-en-Y Gastric Bypass Surgery with a Small Gastric Pouch	PLOS ONE			English	Article							HISTONE DEACETYLASE 3; BARIATRIC SURGERY; ENERGY-EXPENDITURE; INSULIN-RESISTANCE; TRANSGENIC MICE; MEDICAL THERAPY; OBESITY; RAT	Existing mouse models of Roux-en-Y gastric bypass (RYGB) surgery are not comparable to human RYGB in gastric pouch volume for a large or absent gastric volume. The aim of this study was to develop and characterize a mouse RYGB model that closely replicates gastric pouch size of human RYGB surgery of about 5% of total gastric volume. We established this model in diet-induced obese (DIO) mice of C57BL/6J. This surgery resulted in a sustained 30% weight loss, entirely accounted for by decreased fat mass but not lean mass, compared to sham-operated mice on the high fat diet. Compared to sham-operated mice, energy expenditure corrected for total body weight was significantly increased by about 25%, and substrate utilization was shifted toward higher carbohydrate utilization at 8 weeks after RYGB when body weight had stabilized at the lower level. The energy expenditure persisted and carbohydrate utilization was even more pronounced when the mice were fed chow diet. Although significantly increased during daytime, overall locomotor activity was not significantly different. In response to cold exposure, RYGB mice exhibited an improved capacity to maintain the body temperature. In insulin tolerance test, exogenous insulin-induced suppression of plasma glucose levels was significantly greater in RYGB mice at 4 weeks after surgery. Paradoxically, food intake measured at 5 weeks after surgery was significantly increased, possibly in compensation for increased fecal energy loss and energy expenditure. In conclusion, this new model is a viable alternative to existing murine RYGB models and the model matches human RYGB surgery in anatomy. This model will be useful for studying molecular mechanisms involved in the beneficial effects of RYGB on body weight and glucose homeostasis.	[Hao, Zheng; Zhao, Zhiyun; Ye, Jianping] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Antioxidant & Gene Regulat Lab, Baton Rouge, LA USA; [Berthoud, Hans-Rudolf] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Neurobiol Nutr Lab, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Ye, JP (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Antioxidant & Gene Regulat Lab, Baton Rouge, LA USA.	yej@pbrc.edu	Berthoud, Hans-Rudolf/N-1950-2017; Ye, Jianping/N-1998-2017	Ye, Jianping/0000-0003-3875-365X	National Institute of Health (NIH) [DK085495, DK068036, DK047348]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047348, R01DK068036, R01DK085495, P30DK072476, R56DK068036] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is supported by the National Institute of Health (NIH) through three projects (DK085495; DK068036; DK047348). Those projects are listed under each the project number at NIH website: http://projectreporter.nih.gov/reporter.cfm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bueter M, 2010, GASTROENTEROLOGY, V138, P1845, DOI 10.1053/j.gastro.2009.11.012; Chandarana K, 2011, DIABETES, V60, P810, DOI 10.2337/db10-0566; Collins BJ, 2007, ARCH SURG-CHICAGO, V142, P1000, DOI 10.1001/archsurg.142.10.1000; Elder KA, 2007, GASTROENTEROLOGY, V132, P2253, DOI 10.1053/j.gastro.2007.03.057; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Hatoum IJ, 2012, J CLIN ENDOCRINOLOGY; Huang WD, 2011, NATURE, V470, P414, DOI 10.1038/nature09703; Linner JH, 2007, SURG OBES RELAT DIS, V3, P569, DOI 10.1016/j.soard.2007.06.007; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Nestoridi E, 2012, ENDOCRINOLOGY, V153, P2234, DOI 10.1210/en.2011-2041; Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Stylopoulos N, 2009, OBESITY, V17, P1839, DOI 10.1038/oby.2009.207; Tang T, 2010, J BIOL CHEM, V285, P4637, DOI 10.1074/jbc.M109.068007; Troy S, 2008, CELL METAB, V8, P201, DOI 10.1016/j.cmet.2008.08.008; Xu Y, 2002, J SURG RES, V107, P56, DOI [10.1006/jsre.2002.6508, 10.1016/S0022-4804(02)96508-X]; Yin DP, 2011, ANN SURG, V254, P73, DOI 10.1097/SLA.0b013e3182197035; Zheng HY, 2009, AM J PHYSIOL-REG I, V297, pR1273, DOI 10.1152/ajpregu.00343.2009	20	43	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52922	10.1371/journal.pone.0052922	http://dx.doi.org/10.1371/journal.pone.0052922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326365	Green Submitted, Green Published, gold			2022-12-25	WOS:000314705800027
J	Krupovic, M; Gonnet, M; Ben Hania, W; Forterre, P; Erauso, G				Krupovic, Mart; Gonnet, Mathieu; Ben Hania, Wajdi; Forterre, Patrick; Erauso, Gael			Insights into Dynamics of Mobile Genetic Elements in Hyperthermophilic Environments from Five New Thermococcus Plasmids	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; ROLLING-CIRCLE REPLICATION; VIRUS-LIKE PARTICLE; ESCHERICHIA-COLI; ARCHAEAL VIRUSES; SP. NOV.; PROTEIN; EVOLUTION; GENOME; SULFOLOBUS	Mobilome of hyperthermophilic archaea dwelling in deep-sea hydrothermal vents is poorly characterized. To gain insight into genetic diversity and dynamics of mobile genetic elements in these environments we have sequenced five new plasmids from different Thermococcus strains that have been isolated from geographically remote hydrothermal vents. The plasmids were ascribed to two subfamilies, pTN2-like and pEXT9a-like. Gene content and phylogenetic analyses illuminated a robust connection between pTN2-like plasmids and Pyrococcus abyssi virus 1 (PAV1), with roughly half of the viral genome being composed of genes that have homologues in plasmids. Unexpectedly, pEXT9a-like plasmids were found to be closely related to the previously sequenced plasmid pMETVU01 from Methanocaldococcus vulcanius M7. Our data suggests that the latter observation is most compatible with an unprecedented horizontal transfer of a pEXT9a-like plasmid from Thermococcales to Methanococcales. Gene content analysis revealed that thermococcal plasmids encode Hfq-like proteins and toxin-antitoxin (TA) systems of two different families, VapBC and RelBE. Notably, although abundant in archaeal genomes, to our knowledge, TA and hfq-like genes have not been previously found in archaeal plasmids or viruses. Finally, the plasmids described here might prove to be useful in developing new genetic tools for hyperthermophiles.	[Krupovic, Mart; Forterre, Patrick] Inst Pasteur, Dept Microbiol, Unite Biol Mol Gene Extremophiles, Paris, France; [Gonnet, Mathieu; Erauso, Gael] Univ Bretagne Occidentale, CNRS, IFREMER, Lab Microbiol Environm Extremes,UMR6197, Plouzane, France; [Ben Hania, Wajdi; Erauso, Gael] UMR CNRS IRD 7294 235, Mediterranean Inst Oceanog, Equipe Microbiol Environm & Biotechnol, Marseille, France; [Forterre, Patrick] Univ Paris 11, CNRS, UMR 8621, Lab Biol Mol Gene & Extremophiles,Inst Genet & Mi, F-91405 Orsay, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Erauso, G (corresponding author), Univ Bretagne Occidentale, CNRS, IFREMER, Lab Microbiol Environm Extremes,UMR6197, Plouzane, France.	gael.erauso@univ-amu.fr	Krupovic, Mart/ABD-6255-2021; Krupovic, Mart/I-4209-2012	Krupovic, Mart/0000-0001-5486-0098; Krupovic, Mart/0000-0001-5486-0098	CNRS; MESR; IFREMER; EU [PYRED QLK36CT-2001-01676]; Marine Genomic Europe MGE [GOCE-CT-2004-5054003]; ANR Genoarchaea [M2TFP]; Souchotheque de Bretagne; Region Bretagne	CNRS(Centre National de la Recherche Scientifique (CNRS)); MESR(Ministry of Research, France); IFREMER; EU(European Commission); Marine Genomic Europe MGE; ANR Genoarchaea(French National Research Agency (ANR)); Souchotheque de Bretagne; Region Bretagne(Region Bretagne)	Funding: This work was supported by the CNRS, the MESR, the IFREMER and grants from the EU projects PYRED QLK36CT-2001-01676 to GE and Marine Genomic Europe MGE GOCE-CT-2004-5054003, ANR Genoarchaea M2TFP and the Souchotheque de Bretagne (Brittany Microbe Culture Collection). MG has received a PhD Fellowship from the Region Bretagne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold HP, 1999, MOL MICROBIOL, V34, P217, DOI 10.1046/j.1365-2958.1999.01573.x; Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; Benbouzid-Rollet N, 1997, RES MICROBIOL, V148, P767, DOI 10.1016/S0923-2508(97)82452-7; Berkner S, 2007, J BACTERIOL, V189, P1711, DOI 10.1128/JB.01586-06; BERTANI G, 1987, J BACTERIOL, V169, P2730, DOI 10.1128/jb.169.6.2730-2738.1987; Bruand C, 2000, MOL MICROBIOL, V35, P204, DOI 10.1046/j.1365-2958.2000.01700.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Duffaud GD, 1998, SYST APPL MICROBIOL, V21, P40, DOI 10.1016/S0723-2020(98)80007-6; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erauso G, 1996, J BACTERIOL, V178, P3232, DOI 10.1128/jb.178.11.3232-3237.1996; Erauso G, 1995, THERMOPHILES ARCHAEA, P25; Erauso G, 2006, MICROBIOL-SGM, V152, P1951, DOI 10.1099/mic.0.28861-0; Friedberg I, 2006, PROTEIN SCI, V15, P1527, DOI 10.1110/ps.062158406; Gaudin M, 2012, ENV MICROBI IN PRESS; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Geslin C, 2007, J BACTERIOL, V189, P4510, DOI 10.1128/JB.01896-06; Geslin C, 2003, J BACTERIOL, V185, P3888, DOI 10.1128/JB.185.13.3888-3894.2003; Gonnet M, 2011, RES MICROBIOL, V162, P132, DOI 10.1016/j.resmic.2010.11.003; Gorlas A, 2012, ENVIRON MICROBIOL, V14, P503, DOI 10.1111/j.1462-2920.2011.02662.x; Greve Bo, 2005, Archaea, V1, P319, DOI 10.1155/2005/159218; Greve Bo, 2004, Archaea, V1, P231, DOI 10.1155/2004/151926; Gu X, 2005, BIOINFORMATICS, V21, P1713, DOI 10.1093/bioinformatics/bti208; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; Iyer LM, 2005, NUCLEIC ACIDS RES, V33, P3875, DOI 10.1093/nar/gki702; Jeanthon C, 1999, INT J SYST BACTERIOL, V49, P583, DOI 10.1099/00207713-49-2-583; Krupovic M, 2008, VIROLOGY, V375, P292, DOI 10.1016/j.virol.2008.01.043; Krupovic M, 2012, ADV VIRUS RES, V82, P33, DOI 10.1016/B978-0-12-394621-8.00012-1; Krupovic M, 2011, MICROBIOL MOL BIOL R, V75, P610, DOI 10.1128/MMBR.00011-11; Krupovic M, 2010, MOL BIOL EVOL, V27, P2716, DOI 10.1093/molbev/msq161; Krupovic M, 2010, J MOL BIOL, V397, P144, DOI 10.1016/j.jmb.2010.01.037; Krupovic M, 2009, NAT REV MICROBIOL, V7, P250, DOI 10.1038/nrmicro2030-c1; Le Derout J, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-17; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lepage E, 2004, APPL ENVIRON MICROB, V70, P1277, DOI 10.1128/AEM.70.3.1277-1286.2004; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Marsin S, 1998, MOL MICROBIOL, V27, P1183, DOI 10.1046/j.1365-2958.1998.00759.x; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Prieur D, 2001, THERMOPHILES: BIODIVERSITY, ECOLOGY, AND EVOLUTION, P11; Prieur D, 2004, BIOCHEM SOC T, V32, P184, DOI 10.1042/BST0320184; Ravin NV, 2011, PLASMID, V65, P102, DOI 10.1016/j.plasmid.2010.12.004; Sato T, 2003, J BACTERIOL, V185, P210, DOI 10.1128/JB.185.1.210-220.2003; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soler N, 2008, RES MICROBIOL, V159, P390, DOI 10.1016/j.resmic.2008.04.015; Soler N, 2007, MOL MICROBIOL, V66, P357, DOI 10.1111/j.1365-2958.2007.05912.x; Soler N, 2011, BIOCHEM SOC T, V39, P36, DOI 10.1042/BST0390036; Soler N, 2010, NUCLEIC ACIDS RES, V38, P5088, DOI 10.1093/nar/gkq236; TAKAHASHI S, 1979, CAN J BIOCHEM CELL B, V57, P855, DOI 10.1139/o79-105; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vannier P, 2011, J BACTERIOL, V193, P1481, DOI 10.1128/JB.01490-10; Wang Y, 2007, VIROLOGY, V363, P124, DOI 10.1016/j.virol.2007.01.035; Ward DE, 2002, J BACTERIOL, V184, P2561, DOI 10.1128/JB.184.9.2561-2566.2002; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weigel C, 2006, FEMS MICROBIOL REV, V30, P321, DOI 10.1111/j.1574-6976.2006.00015.x; Wilusz CJ, 2005, NAT STRUCT MOL BIOL, V12, P1031, DOI 10.1038/nsmb1037; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; Zivanovic Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r70	57	48	51	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e49044	10.1371/journal.pone.0049044	http://dx.doi.org/10.1371/journal.pone.0049044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326305	Green Published, gold			2022-12-25	WOS:000314705800006
J	Mairiang, D; Zhang, HM; Sodja, A; Murali, T; Suriyaphol, P; Malasit, P; Limjindaporn, T; Finley, RL				Mairiang, Dumrong; Zhang, Huamei; Sodja, Ann; Murali, Thilakam; Suriyaphol, Prapat; Malasit, Prida; Limjindaporn, Thawornchai; Finley, Russell L., Jr.			Identification of New Protein Interactions between Dengue Fever Virus and Its Hosts, Human and Mosquito	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; INNATE IMMUNE-RESPONSE; OPEN READING FRAMES; NF-KAPPA-B; ENDOPLASMIC-RETICULUM; WEST-NILE; CAPSID PROTEIN; NUCLEAR-LOCALIZATION; INTERACTION NETWORK; GENE-EXPRESSION	The four divergent serotypes of dengue virus are the causative agents of dengue fever, dengue hemorrhagic fever and dengue shock syndrome. About two-fifths of the world's population live in areas where dengue is prevalent, and thousands of deaths are caused by the viruses every year. Dengue virus is transmitted from one person to another primarily by the yellow fever mosquito, Aedes aegypti. Recent studies have begun to define how the dengue viral proteins interact with host proteins to mediate viral replication and pathogenesis. A combined analysis of these studies, however, suggests that many virus-host protein interactions remain to be identified, especially for the mosquito host. In this study, we used high-throughput yeast two-hybrid screening to identify mosquito and human proteins that physically interact with dengue proteins. We tested each identified host protein against the proteins from all four serotypes of dengue to identify interactions that are conserved across serotypes. We further confirmed many of the interactions using co-affinity purification assays. As in other large-scale screens, we identified some previously detected interactions and many new ones, moving us closer to a complete host - dengue protein interactome. To help summarize and prioritize the data for further study, we combined our interactions with other published data and identified a subset of the host-dengue interactions that are now supported by multiple forms of evidence. These data should be useful for understanding the interplay between dengue and its hosts and may provide candidates for drug targets and vector control strategies.	[Mairiang, Dumrong; Zhang, Huamei; Murali, Thilakam; Finley, Russell L., Jr.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48202 USA; [Sodja, Ann] Wayne State Univ, Dept Biol, Detroit, MI USA; [Suriyaphol, Prapat] Mahidol Univ, Siriraj Hosp, Fac Med, Bioinformat & Data Management Res Unit, Bangkok 10700, Thailand; [Suriyaphol, Prapat] Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Bangkok 10700, Thailand; [Malasit, Prida] Mahidol Univ, Dengue Hemorrhag Fever Res Unit, Off Res & Dev, Fac Med,Siriraj Hosp, Bangkok 10700, Thailand; [Malasit, Prida] Natl Sci & Technol Dev Agcy, Med Biotechnol Res Unit, Natl Ctr Genet Engn & Biotechnol, Bangkok, Thailand; [Limjindaporn, Thawornchai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Anat, Bangkok 10700, Thailand; [Finley, Russell L., Jr.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI USA	Wayne State University; Wayne State University; Mahidol University; Mahidol University; Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University; Wayne State University	Finley, RL (corresponding author), Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48202 USA.	rfinley@wayne.edu		Finley, Russ/0000-0003-1144-6887	Mahidol University; Commission of Higher Education (CHE); Mahidol University under the National Research Universities Initiative; National Institutes of Health [HG001536]; Thailand Research Fund (TRF)-CHE; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG001536, R01HG001536] Funding Source: NIH RePORTER	Mahidol University; Commission of Higher Education (CHE)(Office of Higher Education Commission (OHEC)); Mahidol University under the National Research Universities Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thailand Research Fund (TRF)-CHE; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Dr. Thawornchai Limjindaporn is supported by Mahidol University and currently a Thailand Research Fund (TRF)-CHE research Scholar; Dr. Prapat Suriyaphol is supported by the Commission of Higher Education (CHE) and Mahidol University under the National Research Universities Initiative; This project was supported in part by the National Institutes of Health grant HG001536 to RLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Alcock F, 2009, J MOL BIOL, V385, P1032, DOI 10.1016/j.jmb.2008.11.045; Arakawa R, 2010, BIOCHEM CELL BIOL, V88, P899, DOI 10.1139/O10-014; Aranda B, 2009, NUCLEIC ACIDS RES, V38, P22; Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P342, DOI 10.1016/S0968-0004(99)01437-1; ARIAS CF, 1993, VIROLOGY, V193, P888, DOI 10.1006/viro.1993.1198; Arita M, 2012, J VIROL, V86, P5541, DOI 10.1128/JVI.00114-12; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08; Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750; Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545; Babu M, 2012, NATURE, V489, P585, DOI 10.1038/nature11354; Balmaseda A, 2006, AM J TROP MED HYG, V74, P449, DOI 10.4269/ajtmh.2006.74.449; Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Bhattacharya D, 2009, J VIROL, V83, P9195, DOI 10.1128/JVI.00271-09; Bhuvanakantham R, 2009, BIOCHEM BIOPH RES CO, V389, P63, DOI 10.1016/j.bbrc.2009.08.108; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9; Brault JB, 2011, VIROLOGY, V417, P369, DOI 10.1016/j.virol.2011.06.022; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Ceol A, 2009, NUCLEIC ACIDS RES, V38, P6; Chang CJ, 2001, DNA CELL BIOL, V20, P569, DOI 10.1089/104454901317094981; Chatr-aryamontri A, 2009, NUCLEIC ACIDS RES, V37, pD669, DOI 10.1093/nar/gkn739; Chen YC, 2010, NAT METHODS, V7, P667, DOI 10.1038/nmeth0910-667; Chiu MW, 2007, J BIOMED SCI, V14, P429, DOI 10.1007/s11373-007-9151-9; Chua JJE, 2005, VIRUS RES, V112, P85, DOI 10.1016/j.virusres.2005.03.025; Chua JJE, 2004, VIRUS RES, V102, P151, DOI 10.1016/j.virusres.2004.01.025; Clum S, 1997, J BIOL CHEM, V272, P30715, DOI 10.1074/jbc.272.49.30715; Colpitts TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024365; Colpitts TM, 2011, VIROLOGY, V417, P179, DOI 10.1016/j.virol.2011.06.002; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/NMETH.1284, 10.1038/nmeth.1284]; Dame DA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S2; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108; Deane CM, 2002, MOL CELL PROTEOMICS, V1, P349, DOI 10.1074/mcp.M100037-MCP200; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Doolittle JM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000954; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Ellencrona K, 2009, BIOL CHEM, V390, P319, DOI 10.1515/BC.2009.041; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; FINLEY RL, 1994, P NATL ACAD SCI USA, V91, P12980, DOI 10.1073/pnas.91.26.12980; Fischl W, 2011, CURR OPIN MICROBIOL, V14, P470, DOI 10.1016/j.mib.2011.07.012; Folly BB, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-34; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Garcia-Montalvo BM, 2004, VIRUS RES, V102, P141, DOI 10.1016/j.virusres.2004.01.024; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gifford R, 2005, J VIROL, V79, P6478, DOI 10.1128/JVI.79.10.6478-6486.2005; Gilmore TD, 2012, IMMUNOL REV, V246, P14, DOI 10.1111/j.1600-065X.2012.01096.x; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goel R, 2011, MOL BIOTECHNOL, V48, P87, DOI 10.1007/s12033-010-9336-8; Golemis EA, 2001, CURR PROTOC MOL BIOL; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guo XA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-380; Guzman A, 2010, INT J ANTIMICROB AG, V36, pS40, DOI 10.1016/j.ijantimicag.2010.06.018; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hart GT, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-120; Haw R, 2011, PROTEOMICS, V1002; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; Hershkovitz O, 2009, J IMMUNOL, V183, P2610, DOI 10.4049/jimmunol.0802806; Hiscox JA, 2007, NAT REV MICROBIOL, V5, P119, DOI 10.1038/nrmicro1597; Hiscox JA, 2010, PROTEOMICS, V10, P4077, DOI 10.1002/pmic.201000251; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Huang H, 2007, PLOS COMPUT BIOL, V3, P2155, DOI 10.1371/journal.pcbi.0030214; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jensen LJ, 2008, SCIENCE, V322, P56, DOI 10.1126/science.1164801; Jiang LB, 2009, BIOCHEM BIOPH RES CO, V385, P187, DOI 10.1016/j.bbrc.2009.05.036; Jiao BY, 2011, ARCH VIROL, V156, P2015, DOI 10.1007/s00705-011-1099-4; Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Khadka S, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.012187-1, 10.1074/mcp.M111.012187]; Klueg KM, 2002, GENESIS, V34, P119, DOI 10.1002/gene.10148; Kolonin MG, 2000, METHOD ENZYMOL, V328, P26, DOI 10.1016/S0076-6879(00)28388-2; Kou Z, 2008, J MED VIROL, V80, P134, DOI 10.1002/jmv.21051; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Kurosu T, 2007, BIOCHEM BIOPH RES CO, V362, P1051, DOI 10.1016/j.bbrc.2007.08.137; Kwofie SK, 2011, INFECT GENET EVOL, V11, P1971, DOI 10.1016/j.meegid.2011.09.001; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Le Breton M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-234; Le Negrate G, 2012, CELL MICROBIOL, V14, P168, DOI 10.1111/j.1462-5822.2011.01720.x; Lilley BN, 2006, J VIROL, V80, P8739, DOI 10.1128/JVI.00791-06; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Limjindaporn T, 2009, BIOCHEM BIOPH RES CO, V379, P196, DOI 10.1016/j.bbrc.2008.12.070; Limjindaporn T, 2007, BIOCHEM BIOPH RES CO, V362, P334, DOI 10.1016/j.bbrc.2007.07.194; Lindenbach B. D., 2006, FIELDS VIROLOGY, P1153; Liu DM, 2010, GENETICS, V184, P1025, DOI 10.1534/genetics.110.114017; LOBIGS M, 1993, P NATL ACAD SCI USA, V90, P6218, DOI 10.1073/pnas.90.13.6218; Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200; Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Morales C, 2009, J IMMUNOL, V183, P5121, DOI 10.4049/jimmunol.0900811; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Munstermann L. E., 1997, The molecular biology of insect disease vectors: a methods manual., P13; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; Nagila A, 2011, BIOCHEM BIOPH RES CO, V410, P428, DOI 10.1016/j.bbrc.2011.05.151; Najera JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000412; Netsawang J, 2010, VIRUS RES, V147, P275, DOI 10.1016/j.virusres.2009.11.012; Noisakran S, 2008, BIOCHEM BIOPH RES CO, V372, P67, DOI 10.1016/j.bbrc.2008.04.165; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; ORRWEAVER TL, 1983, P NATL ACAD SCI-BIOL, V80, P4417, DOI 10.1073/pnas.80.14.4417; Parrish JR, 2004, J PROTEOME RES, V3, P582, DOI 10.1021/pr0341134; Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703; Pham AM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002465; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Pinney JW, 2009, AIDS, V23, P549, DOI 10.1097/QAD.0b013e328325a495; Ptak RG, 2008, AIDS RES HUM RETROV, V24, P1497, DOI 10.1089/aid.2008.0113; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Rawlinson SM, 2009, J BIOL CHEM, V284, P15589, DOI 10.1074/jbc.M808271200; RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; Sangiambut S, 2008, J GEN VIROL, V89, P1254, DOI 10.1099/vir.0.83264-0; Schmitz J, 2011, VACCINE, V29, P7276, DOI 10.1016/j.vaccine.2011.07.017; Schwartz AS, 2009, NAT METHODS, V6, P55, DOI [10.1038/nmeth.1283, 10.1038/NMETH.1283]; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631; Sim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010678; SMITH GW, 1985, J GEN VIROL, V66, P559, DOI 10.1099/0022-1317-66-3-559; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sodja A, 2007, J INSECT PHYSIOL, V53, P833, DOI 10.1016/j.jinsphys.2007.03.017; Stanyon CA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r96; Stanyon CA, 2003, BIOTECHNIQUES, V35, P520, DOI 10.2144/03353st05; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; TADANO M, 1989, J GEN VIROL, V70, P1409, DOI 10.1099/0022-1317-70-6-1409; Tanigawa K, 2009, CLIN EXP IMMUNOL, V156, P495, DOI 10.1111/j.1365-2249.2009.03930.x; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577; Tsuda Y, 2006, MICROBIOL IMMUNOL, V50, P225, DOI 10.1111/j.1348-0421.2006.tb03789.x; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; Vasudevan SG, 2001, FARMACO, V56, P33, DOI 10.1016/S0014-827X(01)01014-X; Veraksa A, 2005, DEV DYNAM, V232, P827, DOI 10.1002/dvdy.20272; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wang M, 2010, CELL DEATH DIFFER, V17, P488, DOI 10.1038/cdd.2009.144; Wang SH, 2002, J GEN VIROL, V83, P3093, DOI 10.1099/0022-1317-83-12-3093; Wang SL, 1999, J VIROL, V73, P2547, DOI 10.1128/JVI.73.3.2547-2551.1999; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Westaway E. G., 1997, P147; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098; Xu XF, 2009, INTERVIROLOGY, V52, P258, DOI 10.1159/000230669; Xu ZK, 2011, J VIROL, V85, P5571, DOI 10.1128/JVI.01933-10; Yang MR, 2008, CELL MICROBIOL, V10, P165, DOI 10.1111/j.1462-5822.2007.01027.x; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636; Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904; Yu JK, 2012, METHODS MOL BIOL, V812, P161, DOI 10.1007/978-1-61779-455-1_9; Yu JK, 2009, BIOINFORMATICS, V25, P105, DOI 10.1093/bioinformatics/btn597; Zhong JH, 2003, GENOME RES, V13, P2691, DOI 10.1101/gr.1134603	167	82	84	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53535	10.1371/journal.pone.0053535	http://dx.doi.org/10.1371/journal.pone.0053535			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326450	gold, Green Published, Green Submitted			2022-12-25	WOS:000314705800053
J	Yuan, QJ; Su, HX; Chau, WH; Ng, CT; Huang, JD; Wu, WT; Lin, ZX				Yuan, Qiuju; Su, Huanxing; Chau, Wing Hin; Cheung Toa Ng; Huang, Jian-Dong; Wu, Wutian; Lin, Zhi-Xiu			Behavioral Stress Fails to Accelerate the Onset and Progression of Plaque Pathology in the Brain of a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							REPEATED RESTRAINT STRESS; APOLIPOPROTEIN-E; PARAVENTRICULAR NUCLEUS; AMYLOID DEPOSITION; TRANSGENIC MICE; TG2576 MICE; COGNITIVE DEFICITS; GENE-EXPRESSION; TYPE-4 ALLELE; FEMALE RATS	Conflicting findings exist regarding the link between environmental factors and development of Alzheimer's disease (AD) in a variety of transgenic mouse models of AD. In the present study, we investigated the effect of behavioral stress on the onset and progression of A beta pathology in the brains of TgCRND8 mice, a transgenic mouse model of AD. One group of TgCRND8 mice was subjected to restraint stress starting at 1 month of age until they were 3 months old, while restraint stress in the second group started at 4 months of age until they were 6 months old. After 2 months of treatment, no differences in the soluble, formic acid extracted, or histologically detected A beta deposition in the cortical and hippocampal levels were found between non-stressed and stressed mice. These results showed that restraint stress alone failed to aggravate amyloid pathology when initiated either before or after the age of amyloid plaque deposition in TgCRND8 mice, suggesting that if stress aggravated AD phenotype, it may not be via an amyloid-related mechanism in the TgCRND8 mice. These findings are indicative that plaque load per se may not be used as a significant criterion for evaluating the effect of stress on AD patients.	[Yuan, Qiuju; Lin, Zhi-Xiu] Chinese Univ Hong Kong, Fac Sci, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Su, Huanxing] Univ Macau, State Key Lab Qual Res Chinese Med, Macao, Peoples R China; [Su, Huanxing] Univ Macau, Inst Chinese Med Sci, Macao, Peoples R China; [Chau, Wing Hin; Cheung Toa Ng; Huang, Jian-Dong] Univ Hong Kong, Li Ka Shing Fac Med, Dept Biochem, Pokfulam, Hong Kong, Peoples R China; [Wu, Wutian] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China; [Wu, Wutian] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Brain & Cognit Sci, Pokfulam, Hong Kong, Peoples R China; [Wu, Wutian] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Reprod Dev & Growth, Pokfulam, Hong Kong, Peoples R China; [Wu, Wutian] Jinan Univ, Inst Cent Nervous Syst Regenerat, Guangzhou, Guangdong, Peoples R China	Chinese University of Hong Kong; University of Macau; University of Macau; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Jinan University	Wu, WT (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China.	wtwu@hkucc.hku.hk; linzx@cuhk.edu.hk	Su, Huanxing/X-3954-2019; Lin, Zhi-Xiu/H-2807-2016; Su, Huanxing/X-3980-2019; Yuan, Qiuju/AAJ-3101-2020; /C-4277-2009	Su, Huanxing/0000-0003-3254-825X; Su, Huanxing/0000-0002-0513-4943; /0000-0001-7531-2816	Chinese University of Hong Kong; University of Hong Kong	Chinese University of Hong Kong(Chinese University of Hong Kong); University of Hong Kong(University of Hong Kong)	This study was supported by a Direct Grant of The Chinese University of Hong Kong and the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Ambree O, 2006, AM J PATHOL, V169, P544, DOI 10.2353/ajpath.2006.051107; Arendash GW, 2004, BRAIN RES, V1012, P29, DOI 10.1016/j.brainres.2004.02.081; Bao AM, 2008, BRAIN RES REV, V57, P531, DOI 10.1016/j.brainresrev.2007.04.005; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; Chadda R, 2005, PHARMACOL BIOCHEM BE, V81, P854, DOI 10.1016/j.pbb.2005.06.009; Chagra SL, 2011, REGUL PEPTIDES, V167, P70, DOI 10.1016/j.regpep.2010.11.006; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Costa DA, 2007, NEUROBIOL AGING, V28, P831, DOI 10.1016/j.neurobiolaging.2006.04.009; Cotel MC, 2012, NEUROBIOL AGING, V33, P96, DOI 10.1016/j.neurobiolaging.2010.02.012; Cuadrado-Tejedor M, 2012, J ALZHEIMERS DIS, V28, P567, DOI 10.3233/JAD-2011-110572; D'Alton S, 2011, J ALZHEIMERS DIS, V25, P571, DOI 10.3233/JAD-2011-110089; Devi L, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-34; Durairajan SS, 2012, NEUROBIOL AGING; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Harvey SC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-15; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Hyman BT, 1996, ANN NY ACAD SCI, V802, P1, DOI 10.1111/j.1749-6632.1996.tb32592.x; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; Jeong YH, 2006, FASEB J, V20, P729, DOI 10.1096/fj.05-4265fje; Jeong YH, 2011, J NEUROCHEM, V119, P1282, DOI 10.1111/j.1471-4159.2011.07514.x; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lee KW, 2009, J NEUROCHEM, V108, P165, DOI 10.1111/j.1471-4159.2008.05769.x; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Masuda J, 2004, NEUROSCI LETT, V358, P169, DOI 10.1016/j.neulet.2004.01.021; Mayeux R, 2003, ANNU REV NEUROSCI, V26, P81, DOI 10.1146/annurev.neuro.26.043002.094919; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Nomura M, 2003, J NEUROENDOCRINOL, V15, P1054, DOI 10.1046/j.1365-2826.2003.01095.x; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Spires Tara L, 2005, NeuroRx, V2, P423, DOI 10.1602/neurorx.2.3.423; Sterrenburg L, 2012, J NEUROSCI RES, V90, P179, DOI 10.1002/jnr.22737; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; Umriukhin PE, 2012, NEUROSCI LETT, V506, P184, DOI 10.1016/j.neulet.2011.11.001; Wilson RS, 2005, NEUROEPIDEMIOLOGY, V25, P8, DOI 10.1159/000085307; Wilson RS, 2003, NEUROLOGY, V61, P1102, DOI 10.1212/01.WNL.0000092914.04345.97; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004; Yuan QJ, 2003, DEV NEUROSCI-BASEL, V25, P72, DOI 10.1159/000071470; Zavala JK, 2011, PHYSIOL BEHAV, V104, P215, DOI 10.1016/j.physbeh.2011.03.022	43	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53480	10.1371/journal.pone.0053480	http://dx.doi.org/10.1371/journal.pone.0053480			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326437	gold, Green Published			2022-12-25	WOS:000314705800047
J	Fujiwara, K; Nomura, SM				Fujiwara, Kei; Nomura, Shin-ichiro M.			Condensation of an Additive-Free Cell Extract to Mimic the Conditions of Live Cells	PLOS ONE			English	Article							SIZED LIPID VESICLES; ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; ARTIFICIAL CELL; GENE-EXPRESSION; DYNAMICS; DNA	The cellular environment differs from that of reconstituted materials mainly because of the presence of highly condensed biomacromolecules. To mimic the environment and conditions in living cells, we developed a method to prepare additive-free, highly concentrated cell extracts. First, we verified the requirement for specific salts and buffers for functional cell-free translation extracts. The S30 fraction of Escherichia coli cell extracts without additives exhibited sufficient cell-free protein production. Next, we established a method to accumulate biological components by gradual evaporation by using a vacuum desiccator. Bovine serum albumin, green fluorescent protein, alkaline phosphatase, and a diluted reconstituted protein expression system were successfully condensed in their active forms using this method. The protein concentration of the prepared cell extract was elevated to 180 mg/mL, which was expected to contain approximately 260 mg/mL macromolecules, without the loss of cell-free protein expression activity. Such a condensed cell extract may be useful for investigating the differences between cells and reconstituted materials and may contribute to the development of methods to synthesize cells from cell extracts in the future.	[Fujiwara, Kei; Nomura, Shin-ichiro M.] Tohoku Univ, Dept Bioengn & Robot, Sendai, Miyagi 980, Japan	Tohoku University	Fujiwara, K (corresponding author), Tohoku Univ, Dept Bioengn & Robot, Sendai, Miyagi 980, Japan.	fujiwara@molbot.mech.tohoku.ac.jp; nomura@molbot.mech.tohoku.ac.jp	FUJIWARA, KEI/U-8308-2019; FUJIWARA, KEI/G-5467-2010; nomura, Shinichiro/AAD-9593-2019	FUJIWARA, KEI/0000-0001-7308-774X; FUJIWARA, KEI/0000-0001-7308-774X; NOMURA, Shin-ichiro/0000-0002-0346-130X	JST; PRESTO; JSPS KAKENHI [22220001, 23.3718]; Grants-in-Aid for Scientific Research [22220001, 11J03718] Funding Source: KAKEN	JST(Japan Science & Technology Agency (JST)); PRESTO; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JST, PRESTO, and JSPS KAKENHI (grant numbers 22220001 and 23.3718). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Elcock AH, 2010, CURR OPIN STRUC BIOL, V20, P196, DOI 10.1016/j.sbi.2010.01.008; Fujiwara K, 2010, EMBO J, V29, P1552, DOI 10.1038/emboj.2010.52; Ge XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028707; Hamada T, 2005, BIOPHYS J, V88, p238A; KAGUNI JM, 1984, CELL, V38, P183, DOI 10.1016/0092-8674(84)90539-7; Kaneda M, 2009, BIOMATERIALS, V30, P3971, DOI 10.1016/j.biomaterials.2009.04.006; Kato A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00283; Kigawa T, 1999, FEBS LETT, V442, P15, DOI 10.1016/S0014-5793(98)01620-2; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; Mukherjee S, 2009, J MOL BIOL, V393, P227, DOI 10.1016/j.jmb.2009.08.016; NAKANO H, 1994, BIOSCI BIOTECH BIOCH, V58, P631, DOI 10.1271/bbb.58.631; Niwa T, 2012, P NATL ACAD SCI USA, V109, P8937, DOI 10.1073/pnas.1201380109; Noireaux V, 2004, P NATL ACAD SCI USA, V101, P17669, DOI 10.1073/pnas.0408236101; Noireaux V, 2011, P NATL ACAD SCI USA, V108, P3473, DOI 10.1073/pnas.1017075108; Nomura S, 2003, CHEMBIOCHEM, V4, P1172, DOI 10.1002/cbic.200300630; Nomura SIM, 2008, J BIOTECHNOL, V133, P190, DOI 10.1016/j.jbiotec.2007.08.023; Nomura SM, 2001, CHEMBIOCHEM, V2, P457, DOI 10.1002/1439-7633(20010601)2:6<457::AID-CBIC457>3.0.CO;2-F; Oikawa K, 2005, J BIOL CHEM, V280, P5527, DOI 10.1074/jbc.M412392200; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pedersen A, 2011, NEW BIOTECHNOL, V28, P218, DOI 10.1016/j.nbt.2010.06.015; Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984; SETHI VS, 1970, FEBS LETT, V8, P236, DOI 10.1016/0014-5793(70)80274-5; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Shin Jonghyeon, 2010, J Biol Eng, V4, P8, DOI 10.1186/1754-1611-4-8; Shirokov Vladimir A., 2007, V375, P19; Tsumoto K, 2001, LANGMUIR, V17, P7225, DOI 10.1021/la010887s; Walde P, 2010, BIOESSAYS, V32, P296, DOI 10.1002/bies.200900141; Yu W, 2001, J BIOSCI BIOENG, V92, P590, DOI 10.1263/jbb.92.590; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V	30	28	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54155	10.1371/journal.pone.0054155	http://dx.doi.org/10.1371/journal.pone.0054155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326590	Green Submitted, Green Published, gold			2022-12-25	WOS:000313552400080
J	Sundrani, D; Khot, V; Pisal, H; Mehendale, S; Wagh, G; Joshi, A; Joshi, S				Sundrani, Deepali; Khot, Vinita; Pisal, Hemlata; Mehendale, Savita; Wagh, Girija; Joshi, Asmita; Joshi, Sadhana			Gestation Dependant Changes in Angiogenic Factors and Their Associations with Fetal Growth Measures in Normotensive Pregnancy	PLOS ONE			English	Article							HUMAN FETOPLACENTAL VASCULOGENESIS; PHYSIOLOGICAL TRANSFORMATION; FACTOR RECEPTOR-1; TYROSINE KINASE; SPIRAL ARTERIES; PLASMA-LEVELS; HYPOXIA; PREECLAMPSIA; RISK; VEGF	Background: Earlier studies indicate that altered angiogenesis at birth is associated with poor birth outcome in women with preeclampsia. Now, we hypothesize that the progressive gestation dependant changes in markers of angiogenesis will be more useful to predict birth weight early even in a normotensive pregnancy. This study for the first time examines the association of gestation dependant changes in the levels of maternal angiogenic factors in addition to their levels in cord with birth weight. Method: Ninety two pregnant women were followed at three different time points: 16-20 weeks, 26-30 weeks and at delivery during pregnancy. Plasma levels of angiogenic and anti angiogenic factors were determined by commercial enzyme-linked immunosorbent assay (ELISA) kits. Results: Maternal plasma VEGF levels increased (p<0.01) till the second time point and decreased (p<0.05) up to delivery while plasma sFlt-1 levels increased (p<0.01) at delivery. PlGF levels peaked (p<0.01) at second time point and decreased (p<0.01) at delivery. Cord plasma VEGF levels were higher (p<0.01) and sFlt-1 levels were lower (p<0.01) as compared to maternal values at all time points. Maternal plasma VEGF levels at first time point and PlGF levels at delivery were positively (p<0.05 and p<0.01 respectively), while sFlt-1/PlGF ratio at delivery was negatively associated (p<0.05) with birth weight. Conclusion: Levels of pro- and anti-angiogenic factors may be differentially regulated across gestation. Maternal VEGF levels at early gestation (16-20 weeks) may be predictive of birth weight in healthy term pregnancies.	[Sundrani, Deepali; Khot, Vinita; Pisal, Hemlata; Joshi, Asmita; Joshi, Sadhana] Bharati Vidyapeeth Univ, Interact Res Sch Hlth Affairs, Dept Med Nutr, Pune, Maharashtra, India; [Mehendale, Savita; Wagh, Girija] Bharati Vidyapeeth Univ, Bharati Med Coll & Hosp, Dept Obstet & Gynecol, Pune, Maharashtra, India	Bharati Vidyapeeth Deemed University; Bharati Vidyapeeth Deemed University	Joshi, S (corresponding author), Bharati Vidyapeeth Univ, Interact Res Sch Hlth Affairs, Dept Med Nutr, Pune, Maharashtra, India.	srjoshi62@gmail.com	Joshi, Sudhanshu/L-2284-2019	Joshi, Sudhanshu/0000-0003-4748-5001; Sundrani, Deepali/0000-0002-2403-5115	Department of Biotechnology Government of India	Department of Biotechnology Government of India(Department of Biotechnology (DBT) India)	The Department of Biotechnology Government of India partly funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ADAIR TH, 1990, AM J PHYSIOL, V259, pR393, DOI 10.1152/ajpregu.1990.259.3.R393; Ali KZ, 2010, J MATERN-FETAL NEO M, V23, P1244, DOI 10.3109/14767050903511560; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Andraweera PH, 2012, HUM REPROD UPDATE, V18, P436, DOI 10.1093/humupd/dms011; Autiero M, 2003, J THROMB HAEMOST, V1, P1356, DOI 10.1046/j.1538-7836.2003.00263.x; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Bdolah Y, 2004, SEMIN NEPHROL, V24, P548, DOI 10.1016/S0270-9295(04)00125-1; Boksa P, 2003, NEUROSCI BIOBEHAV R, V27, P91, DOI 10.1016/S0149-7634(03)00012-5; Bukhari SA, 2011, MOL BIOL REP, V38, P2703, DOI 10.1007/s11033-010-0413-7; BULTERYS MG, 1990, PEDIATRICS, V86, P535; Burton GJ, 2009, J ANAT, V215, P27, DOI 10.1111/j.1469-7580.2008.00978.x; Chappell LC, 2002, AM J OBSTET GYNECOL, V187, P127, DOI 10.1067/mob.2002.122969; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Kalish RB, 2004, AM J OBSTET GYNECOL, V191, P975, DOI 10.1016/j.ajog.2004.06.053; Kaufmann P, 2004, PLACENTA, V25, P114, DOI 10.1016/j.placenta.2003.10.009; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kim YM, 2002, AM J OBSTET GYNECOL, V187, P1137, DOI 10.1067/mob.2002.127720; Kim YM, 2003, AM J OBSTET GYNECOL, V189, P1063, DOI 10.1067/S0002-9378(03)00838-X; Kulkarni A, 2011, CLIN NUTR, V30, P60, DOI 10.1016/j.clnu.2010.07.007; Kulkarni AV, 2010, HYPERTENS RES, V33, P561, DOI 10.1038/hr.2010.31; Kumar Neeta, 2012, Indian J Public Health, V56, P103, DOI 10.4103/0019-557X.96988; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lygnos MC, 2006, IN VIVO, V20, P157; Mayhew TM, 2004, PLACENTA, V25, P127, DOI 10.1016/j.placenta.2003.10.010; Mihailovic M, 2000, BIOL TRACE ELEM RES, V73, P47, DOI 10.1385/BTER:73:1:47; Mijal RS, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.10.001; Noori M, 2010, CIRCULATION, V122, P478, DOI 10.1161/CIRCULATIONAHA.109.895458; Ozkan Y, 2012, ARCH GYNECOL OBSTET, V285, P1319, DOI 10.1007/s00404-011-2150-0; Palm M, 2011, ACTA OBSTET GYN SCAN, V90, P1244, DOI 10.1111/j.1600-0412.2011.01186.x; Patel J, 2010, PLACENTA, V31, P951, DOI 10.1016/j.placenta.2010.08.008; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rana S, 2007, HYPERTENSION, V50, P137, DOI 10.1161/HYPERTENSIONAHA.107.087700; Rao S, 2001, J NUTR, V131, P1217, DOI 10.1093/jn/131.4.1217; Ream M, 2008, AM J PHYSIOL-REG I, V295, pR583, DOI 10.1152/ajpregu.00771.2007; Redman CWG, 2009, PLACENTA, V30, pS38, DOI 10.1016/j.placenta.2008.11.021; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Ross B, 2010, AM J HYPERTENS, V23, P1228, DOI 10.1038/ajh.2010.160; Simas TAM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.030; Tal R, 2010, AM J PATHOL, V177, P2950, DOI 10.2353/ajpath.2010.090800; Taylor RN, 2003, AM J OBSTET GYNECOL, V188, P177, DOI 10.1067/mob.2003.111; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; Thadhani R, 2004, J CLIN ENDOCR METAB, V89, P770, DOI 10.1210/jc.2003-031244; Tidwell SC, 2001, AM J OBSTET GYNECOL, V184, P1267, DOI 10.1067/mob.2001.113129; Wills AK, 2010, EARLY HUM DEV, V86, P535, DOI 10.1016/j.earlhumdev.2010.07.002; Yajnik CS, 2008, DIABETOLOGIA, V51, P29, DOI 10.1007/s00125-007-0793-y	47	38	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54153	10.1371/journal.pone.0054153	http://dx.doi.org/10.1371/journal.pone.0054153			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326589	Green Published, Green Submitted, gold			2022-12-25	WOS:000313552400079
J	Wang, GH; Li, CQ; Wang, Y; Chen, GJ				Wang, Guihong; Li, Chaoqun; Wang, Yan; Chen, Guangju			Cooperative Assembly of Co-Smad4 MH1 with R-Smad1/3 MH1 on DNA: A Molecular Dynamics Simulation Study	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNAL; AMBER FORCE-FIELD; CONTINUUM SOLVENT; TUMOR-SUPPRESSOR; STRUCTURAL BASIS; CELL-MEMBRANE; FREE-ENERGIES; BETA; BINDING; SMAD4	Background: Smads, the homologs of Sma and MAD proteins, play a key role in gene expression regulation in the transforming growth factor-beta (TGF-beta) signaling pathway. Recent experimental studies have revealed that Smad4/R-Smad heterodimers bound on DNA are energetically more favorable than homodimeric R-Smad/R-Smad complexes bound on DNA, which indicates that Smad4 might act as binding vehicle to cooperatively assemble with activated R-Smads on DNA in the nucleus. However, the details of interaction mechanism for cooperative recruitment of Smad4 protein to R-Smad proteins on DNA, and allosteric communication between the Smad4-DNA and R-Smad-DNA interfaces via DNA mediating are not yet clear so far. Methodology: In the present work, we have constructed a series of Smadn+DNA+Smadn (n = 1, 3, 4) models and carried out molecular dynamics simulations, free energy calculations and DNA dynamics analysis for them to study the interaction properties of Smadn (n = 1, 3, 4) with DNA molecule. Results: The results revealed that the binding of Smad4 protein to DNA molecule facilitates energetically the formation of the heteromeric Smad4+DNA+Smad1/3 complex by increasing the affinity of Smad1/3 with DNA molecule. Further investigations through the residue/base motion correlation and DNA dynamics analyses predicted that the binding of Smad4 protein to DNA molecule in the heteromeric Smad4+DNA+Smad1/3 model induces an allosteric communication from the Smad4-DNA interface to Smad1/Smad3-DNA interface via DNA base-pair helical motions, surface conformation changes and new hydrogen bond formations. The present work theoretically explains the mechanism of cooperative recruitment of Smad4 protein to Smad1/3 protein via DNA-mediated indirect readout mode in the nucleus.	[Wang, Guihong; Li, Chaoqun; Wang, Yan; Chen, Guangju] Beijing Normal Univ, Coll Chem, Beijing 100875, Peoples R China	Beijing Normal University	Wang, Y (corresponding author), Beijing Normal Univ, Coll Chem, Beijing 100875, Peoples R China.	wangy@bnu.edu.cn; gjchen@bnu.edu.cn	Li, Chao/GSM-8117-2022	Li, Chao/0000-0001-6110-6210	National Science Foundation of China [20973024, 21073015, 21131003, 21271029]; Major State Basic Research Development Programs [2011CB808500]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Programs(National Basic Research Program of China)	The authors acknowledge research support from the National Science Foundation of China (No. 20973024, 21073015, 21131003 and 21271029), the Major State Basic Research Development Programs (grant No. 2011CB808500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdulHameed MDM, 2006, J PHYS CHEM B, V110, P26365, DOI 10.1021/jp065207e; Alexandrow MG, 1997, J CELL BIOCHEM, V66, P427, DOI 10.1002/(SICI)1097-4644(19970915)66:4<427::AID-JCB1>3.3.CO;2-Y; [Anonymous], 1999, INTRO COMPUTATIONAL; Baburajendran N, 2011, NUCLEIC ACIDS RES, V39, P8213, DOI 10.1093/nar/gkr500; BabuRajendran N, 2010, NUCLEIC ACIDS RES, V38, P3477, DOI 10.1093/nar/gkq046; Baburajendran N, 2009, ACTA CRYSTALLOGR F, V65, P1105, DOI 10.1107/S1744309109037476; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Chai JJ, 2003, J BIOL CHEM, V278, P20327, DOI 10.1074/jbc.C300134200; Cheatham TE, 1998, J BIOMOL STRUCT DYN, V16, P265, DOI 10.1080/07391102.1998.10508245; Clarke DC, 2006, IEE P SYST BIOL, V153, P412, DOI 10.1049/ip-syb:20050055; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Hao GF, 2010, J PHYS CHEM B, V114, P9663, DOI 10.1021/jp102546s; Hariharan R, 2008, PROTEINS, V71, P1853, DOI 10.1002/prot.21869; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Jayaram B, 1998, J AM CHEM SOC, V120, P10629, DOI 10.1021/ja981307p; Sadiq SK, 2010, PROTEINS, V78, P2873, DOI 10.1002/prot.22806; Kennedy BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022606; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; KOTTALAM J, 1990, BIOPOLYMERS, V29, P1409, DOI 10.1002/bip.360291008; Koyama M, 1999, MUTAT RES-GENOMICS, V406, P71, DOI 10.1016/S1383-5726(99)00003-5; Kusanagi K, 2001, J BIOL CHEM, V276, P28155, DOI 10.1074/jbc.M103371200; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Lee MC, 2004, PROTEINS, V55, P620, DOI 10.1002/prot.10470; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Lu Q, 2007, J PHYS CHEM B, V111, P11538, DOI 10.1021/jp0742261; Makkar P, 2009, J MOL GRAPH MODEL, V27, P803, DOI 10.1016/j.jmgm.2008.12.003; Markowitz Sanford D., 1996, Cytokine and Growth Factor Reviews, V7, P93, DOI 10.1016/1359-6101(96)00001-9; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McQuarrie D. A, 2000, STAT MECH; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Onwuegbusi BA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000177; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Schmierer B, 2008, P NATL ACAD SCI USA, V105, P6608, DOI 10.1073/pnas.0710134105; Schwarte-Waldhoff I, 2000, P NATL ACAD SCI USA, V97, P9624, DOI 10.1073/pnas.97.17.9624; Shankaran H, 2008, PERSPECT, V1, P1; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Strahs D, 2000, J MOL BIOL, V301, P643, DOI 10.1006/jmbi.2000.3863; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Ten Dijke PT, 2002, J CELL PHYSIOL, V191, P1, DOI 10.1002/jcp.10066; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; Xiao Z, 2000, P NATL ACAD SCI USA, V97, P7853, DOI 10.1073/pnas.97.14.7853; Xiao Z, 2003, ONCOGENE, V22, P1057, DOI 10.1038/sj.onc.1206212; Xiao Z, 2001, J BIOL CHEM, V276, P39404, DOI 10.1074/jbc.M103117200; Yang B, 2011, J COMPUT CHEM, V32, P416, DOI 10.1002/jcc.21630; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Yap KL, 2001, METHOD MOL BIOL, V173, P1; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang Y, 1997, CURR BIOL, V7, P270, DOI 10.1016/S0960-9822(06)00123-0; Zhu XL, 2009, J CHEM INF MODEL, V49, P1936, DOI 10.1021/ci900174d; Zi Z, 2007, PLOS ONE, V2, P1	59	38	39	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53841	10.1371/journal.pone.0053841	http://dx.doi.org/10.1371/journal.pone.0053841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326519	gold, Green Published, Green Submitted			2022-12-25	WOS:000313552400052
J	Cizek, O; Vrba, P; Benes, J; Hrazsky, Z; Koptik, J; Kucera, T; Marhoul, P; Zamecnik, J; Konvicka, M				Cizek, Oldrich; Vrba, Pavel; Benes, Jiri; Hrazsky, Zaboj; Koptik, Jiri; Kucera, Tomas; Marhoul, Pavel; Zamecnik, Jaroslav; Konvicka, Martin			Conservation Potential of Abandoned Military Areas Matches That of Established Reserves: Plants and Butterflies in the Czech Republic	PLOS ONE			English	Article							RECONCILIATION ECOLOGY; TRAINING AREAS; DISTURBANCE; DYNAMICS; HABITAT; MANAGEMENT; EUROPE; BIODIVERSITY; RESTORATION; PERSISTENCE	Military training generates frequent and irregular disturbance followed by succession, resulting in fine-scaled mosaics of ecological conditions in military training areas (MTAs). The awareness that MTAs may represent important biodiversity sanctuaries is increasing recently. Concurrently, changes in military doctrine are leading to abandonment of many MTAs, which are being brought under civilian administration and opened for development. We surveyed vascular plants in 43 and butterflies in 41 MTAs in the Czech Republic and compared the records with plants and butterfly records from 301 and 125 nature reserves, respectively. After controlling for effects of area, geography, and climate, we found that plant species richness was equal in the two land use categories; butterfly richness was higher in MTAs; reserves hosted more endangered plants and more endangered butterflies. Ordination analyses, again controlled for potential nuisance effects, showed that MTAs and reserves differed also in species composition. While specialist species of nationally rarest habitat types inclined towards the reserves, MTAs hosted a high representation of endangered species depending on either disturbed ground, or successionaly transient conditions. These patterns reflect the history of the national nature reserves network, and the disturbance-succession dynamics within MTAs. The conservation value of formerly army-used lands is increasingly threatened by abandonment, and conservationists should support either alternative uses mimicking army activities, or sustainable management regimes.	[Cizek, Oldrich; Vrba, Pavel; Hrazsky, Zaboj; Kucera, Tomas; Konvicka, Martin] Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Vrba, Pavel; Benes, Jiri; Konvicka, Martin] Acad Sci Czech Republic, Inst Entomol, Biol Ctr CAS, CR-37005 Ceske Budejovice, Czech Republic; [Cizek, Oldrich] Hutur NGO, Hradec Kralove, Czech Republic; [Hrazsky, Zaboj; Koptik, Jiri; Marhoul, Pavel] Daphne CR Inst Aplikovane Ekol, Ceske Budejovice, Czech Republic; [Zamecnik, Jaroslav] Museum Eastern Bohemia, Hradec Kralove, Czech Republic	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Konvicka, M (corresponding author), Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.	konva333@gmail.com	Vrba, Pavel/AAC-6024-2021; Konvicka, Martin/H-1446-2014	Vrba, Pavel/0000-0002-3537-5596; Kucera, Tomas/0000-0001-7587-7032; Benes, Jiri/0000-0003-2809-0389	Ministry of Environment of the Czech Republic [SP/2D3/153/08, VaV 620/2/03]; Grant Agency of the Czech Republic [P505/10/2167]; University of South Bohemia [144/2010/100]	Ministry of Environment of the Czech Republic; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); University of South Bohemia	The study was supported by the Ministry of Environment of the Czech Republic (SP/2D3/153/08 and VaV 620/2/03), the Grant Agency of the Czech Republic (P505/10/2167), and University of South Bohemia (144/2010/100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, PRIRODA; Benes J., 2006, OCHRANA PRIRODY, V61, P145; Benton N., 2008, CONSERVING BIODIVERS; Cabeza M, 2001, TRENDS ECOL EVOL, V16, P242, DOI 10.1016/S0169-5347(01)02125-5; Caforio G, 2006, HDB SOCIOLOGY MILITA, P323; Cizek O, 2012, J INSECT CONSERV, V16, P215, DOI 10.1007/s10841-011-9407-6; Danihelka J, 2009, SEZNAM JMEN CEVNATYC; Davies H, 2007, BIODIVERS CONSERV, V16, P3719, DOI 10.1007/s10531-007-9176-4; Dennis RLH, 2003, OIKOS, V102, P417, DOI 10.1034/j.1600-0706.2003.12387.x; Dover JW, 2010, J INSECT CONSERV, V14, P413, DOI 10.1007/s10841-010-9267-5; Farka J., 2005, CERVENY SEZNAM OHROZ; Gaertner M, 2010, J NAT CONSERV, V18, P63, DOI 10.1016/j.jnc.2009.03.001; Gazenbeek A., 2005, LIFE NATURA 2000 MIL; Haight RG, 2008, ENVIRON MODEL ASSESS, V13, P243, DOI 10.1007/s10666-007-9088-4; Hirst R. A., 2000, Aspects of Applied Biology, P293; Hirst RA, 2000, J ENVIRON MANAGE, V60, P181, DOI 10.1006/jema.2000.0356; Humbert JY, 2009, AGR ECOSYST ENVIRON, V130, P1, DOI 10.1016/j.agee.2008.11.014; Jarosik V, 2011, BIOL CONSERV, V144, P490, DOI 10.1016/j.biocon.2010.10.002; Jentsch A, 2009, RESTOR ECOL, V17, P107, DOI 10.1111/j.1526-100X.2007.00339.x; Kadlec T, 2008, LANDSCAPE URBAN PLAN, V85, P1, DOI 10.1016/j.landurbplan.2007.07.007; Konvicka M, 2008, J INSECT CONSERV, V12, P519, DOI 10.1007/s10841-007-9092-7; Kuras T, 2003, POPUL ECOL, V45, P115, DOI 10.1007/s10144-003-0144-x; Lundholm JT, 2010, J APPL ECOL, V47, P966, DOI 10.1111/j.1365-2664.2010.01857.x; Maes D, 2001, BIOL CONSERV, V99, P263, DOI 10.1016/S0006-3207(00)00182-8; Milchunas DG, 2000, ENVIRON MANAGE, V25, P525, DOI 10.1007/s002679910041; Morris MG, 2000, BIOL CONSERV, V95, P129, DOI 10.1016/S0006-3207(00)00028-8; Oliver T, 2010, ECOL LETT, V13, P473, DOI 10.1111/j.1461-0248.2010.01441.x; PETRICEK V., 1999, PECE CHRANENA UZEMI; Pysek P, 2002, GLOBAL ECOL BIOGEOGR, V11, P279, DOI 10.1046/j.1466-822X.2002.00288.x; Pysek P, 2012, PRESLIA, V84, P575; R Core Development Team, 2009, R LANG ENV STAT COMP; Reif J, 2011, BIODIVERS CONSERV, V20, P3645, DOI 10.1007/s10531-011-0155-4; Rivers JW, 2010, ENVIRON MANAGE, V45, P203, DOI 10.1007/s00267-009-9421-6; Rosenzweig ML, 2003, ORYX, V37, P194, DOI 10.1017/S0030605303000371; Sadlo J, 2007, PRESLIA, V79, P303; Samways MJ, 2007, ANNU REV ENTOMOL, V52, P465, DOI 10.1146/annurev.ento.52.110405.091317; Stursa J, 1998, AMBIO, V27, P358; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; THOMAS JA, 1994, PHILOS T ROY SOC B, V344, P47, DOI 10.1098/rstb.1994.0050; Tropek R, 2010, J APPL ECOL, V47, P139, DOI 10.1111/j.1365-2664.2009.01746.x; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; Vera FWM, 2000, GRAZING ECOLOGY FORE; Vesely J, 1954, OCHRANA CESKOSLOVENS; Vesely J, 1954, OCHRANA CESKOSLOVENS; WallisDeVries MF, 2002, BIOL CONSERV, V104, P265, DOI 10.1016/S0006-3207(01)00191-4; Warren SD, 2008, J INSECT CONSERV, V12, P671, DOI 10.1007/s10841-007-9109-2; Warren SD, 2007, RESTOR ECOL, V15, P606, DOI 10.1111/j.1526-100X.2007.00272.x; Wu JG, 1995, Q REV BIOL, V70, P439, DOI 10.1086/419172; Young TP, 2005, ECOL LETT, V8, P662, DOI 10.1111/j.1461-0248.2005.00764.x	49	46	48	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53124	10.1371/journal.pone.0053124	http://dx.doi.org/10.1371/journal.pone.0053124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326388	Green Published, Green Submitted, gold			2022-12-25	WOS:000313551500050
J	Gao, Y; Zhu, J; Zhang, XH; Wu, QQ; Jiang, SN; Liu, YQ; Hu, ZB; Liu, BR; Chen, XF				Gao, Yong; Zhu, Jing; Zhang, Xiaohui; Wu, Qingquan; Jiang, Shaoning; Liu, Yangqing; Hu, Zhibin; Liu, Baorui; Chen, Xiaofei			BRCA1 mRNA Expression as a Predictive and Prognostic Marker in Advanced Esophageal Squamous Cell Carcinoma Treated with Cisplatin- or Docetaxel-Based Chemotherapy/Chemoradiotherapy	PLOS ONE			English	Article							DNA-REPAIR; TRIMODALITY THERAPY; LUNG-CANCER; PHASE-II; CHEMOTHERAPY; ERCC1; SURVIVAL; CHEMOSENSITIVITY; CHEMORESISTANCE; INACTIVATION	Background: The molecular backgrounds that determine therapeutic effectiveness in esophageal cancer remain largely unknown. Breast cancer susceptibility gene 1 (BRCA1) expression has been found to switch the response to cisplatin- or paclitaxel-based chemotherapy. It remains unclear how variations in BRCA1 expression influence clinical outcomes in esophageal cancer. Patients and Methods: Quantitative real-time polymerase chain reaction (qPCR) was performed to examine BRCA1 mRNA expressions in paraffin-embedded specimens from 144 patients with advanced or metastatic esophageal squamous cell carcinoma who received cisplatin- or docetaxel-based first-line treatments. Results: Low BRCA1 mRNA expression correlated with increased response rate (RR; P = 0.025 and 0.017, respectively) and median overall survival (mOS; P = 0.002 and P<0.001, respectively) in cisplatin-based chemotherapy or chemoradiotherapy group and also correlated with decreased RR (P = 0.017 and 0.024, respectively) and mOS (both P<0.001) in docetaxel-based chemotherapy or chemoradiotherapy group. Multivariate analysis revealed that low BRCA1 expression was an independent prognostic factor in cisplatin-based chemotherapy (HR 0.29; 95%CI 0.12-0.71; P = 0.007) or chemoradiotherapy (HR 0.12; 95%CI 0.04-0.37; P<0.001) group and higher risk for mortality in docetaxel-based chemotherapy (HR 5.02; 95%CI 2.05-12.28; P<0.001) or chemoradiotherapy (HR 7.02; 95%CI 2.37-27.77; P<0.001) group. Conclusions: BRCA1 mRNA expression could be used as a predictive and prognostic marker in esophageal cancer who underwent first-line cisplatin- or docetaxel-based treatments.	[Gao, Yong; Zhu, Jing; Zhang, Xiaohui; Liu, Yangqing; Chen, Xiaofei] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Med Oncol, Huaian, Peoples R China; [Wu, Qingquan] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Thorac Surg, Huaian, Peoples R China; [Jiang, Shaoning] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Hu, Zhibin] Nanjing Med Univ, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Liu, Baorui] Nanjing Med Univ, Gulou Sch Clin Med, Ctr Comprehens Canc, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; University of Alabama System; University of Alabama Birmingham; Nanjing Medical University; Nanjing Medical University	Liu, BR (corresponding author), Nanjing Med Univ, Gulou Sch Clin Med, Ctr Comprehens Canc, Nanjing, Jiangsu, Peoples R China.	baoruiliu@hotmail.com; hayycxf@163.com			Science Developing Foundation of Nanjing Medical University [09NJMUM063]; Science Developing Foundation of Huaian Government [HAS2011028]	Science Developing Foundation of Nanjing Medical University; Science Developing Foundation of Huaian Government	This work was supported in part by Science Developing Foundation of Nanjing Medical University (09NJMUM063 to Y.G.) and Science Developing Foundation of Huaian Government (HAS2011028 to X.F.C.). The funders had no role in study design, data collection and analysis.	AJANI JA, 1994, J NATL CANCER I, V86, P1086, DOI 10.1093/jnci/86.14.1086; Alexander BM, 2012, INT J RADIAT ONCOL, V83, P164, DOI 10.1016/j.ijrobp.2011.05.033; Byrski T, 2009, BREAST CANCER RES TR, V115, P359, DOI 10.1007/s10549-008-0128-9; Byrski T, 2010, J CLIN ONCOL, V28, P375, DOI 10.1200/JCO.2008.20.7019; Carser JE, 2011, GYNECOL ONCOL, V123, P492, DOI 10.1016/j.ygyno.2011.08.017; Chabalier C, 2006, CELL CYCLE, V5, P1001, DOI 10.4161/cc.5.9.2726; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; EZDINLI EZ, 1980, CANCER, V46, P2149, DOI 10.1002/1097-0142(19801115)46:10<2149::AID-CNCR2820461006>3.0.CO;2-W; Furuta T, 2002, CANCER RES, V62, P4899; Harpole DH, 2001, CLIN CANCER RES, V7, P562; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Husain A, 1998, CANCER RES, V58, P1120; Ilson DH, 1998, J CLIN ONCOL, V16, P1826, DOI 10.1200/JCO.1998.16.5.1826; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Joshi MBM, 2005, CLIN CANCER RES, V11, P2215; Kennedy RD, 2002, LANCET, V360, P1007, DOI 10.1016/S0140-6736(02)11087-7; Lafarge S, 2001, ONCOGENE, V20, P6597, DOI 10.1038/sj.onc.1204812; LEICHMAN L, 1991, SEMIN ONCOL, V18, P64; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mullan PB, 2001, ONCOGENE, V20, P6123, DOI 10.1038/sj.onc.1204712; Muro K, 2004, ANN ONCOL, V15, P955, DOI 10.1093/annonc/mdh231; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; PANETTIERE FJ, 1984, CANCER TREAT REP, V68, P1023; Papadaki C, 2011, BRIT J CANCER, V104, P316, DOI 10.1038/sj.bjc.6606027; Quinn JE, 2003, CANCER RES, V63, P6221; Rosell R, 2003, ONCOGENE, V22, P3548, DOI 10.1038/sj.onc.1206419; Rosell R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005133; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Santarosa M, 2009, MOL CANCER THER, V8, P844, DOI 10.1158/1535-7163.MCT-08-0951; Shen SX, 1998, ONCOGENE, V17, P3115, DOI 10.1038/sj.onc.1202243; Shibata T, 2011, NEOPLASIA, V13, P864, DOI 10.1593/neo.11750; Shim HJ, 2010, CANCER SCI, V101, P1247, DOI 10.1111/j.1349-7006.2010.01514.x; Taron M, 2004, HUM MOL GENET, V13, P2443, DOI 10.1093/hmg/ddh260; Tassone P, 2003, BRIT J CANCER, V88, P1285, DOI 10.1038/sj.bjc.6600859; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Wang LF, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-97; Weberpals JI, 2011, ANN ONCOL, V22, P2403, DOI 10.1093/annonc/mdq770; Weberpals J, 2009, INT J CANCER, V124, P806, DOI 10.1002/ijc.23987; Wei J, 2011, J NATL CANCER I, V103, P1552, DOI 10.1093/jnci/djr326; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955	40	40	42	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52589	10.1371/journal.pone.0052589	http://dx.doi.org/10.1371/journal.pone.0052589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326344	Green Published, Green Submitted, gold			2022-12-25	WOS:000313551500022
J	Guilliere, F; Danioux, C; Jaubert, C; Desnoues, N; Delepierre, M; Prangishvili, D; Sezonov, G; Guijarro, JI				Guilliere, Florence; Danioux, Chloe; Jaubert, Carole; Desnoues, Nicole; Delepierre, Muriel; Prangishvili, David; Sezonov, Guennadi; Guijarro, J. Inaki			Solution Structure of an Archaeal DNA Binding Protein with an Eukaryotic Zinc Finger Fold	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; REGULATORY PROTEIN; BACKBONE DYNAMICS; GENOMIC ANALYSIS; CHEMICAL-SHIFTS; NMR EXPERIMENTS; RNA-POLYMERASE; DOMAIN; TRANSCRIPTION; RECOGNITION	While the basal transcription machinery in archaea is eukaryal-like, transcription factors in archaea and their viruses are usually related to bacterial transcription factors. Nevertheless, some of these organisms show predicted classical zinc fingers motifs of the C2H2 type, which are almost exclusively found in proteins of eukaryotes and most often associated with transcription regulators. In this work, we focused on the protein AFV1p06 from the hyperthermophilic archaeal virus AFV1. The sequence of the protein consists of the classical eukaryotic C2H2 motif with the fourth histidine coordinating zinc missing, as well as of N-and C-terminal extensions. We showed that the protein AFV1p06 binds zinc and solved its solution structure by NMR. AFV1p06 displays a zinc finger fold with a novel structure extension and disordered N- and C-termini. Structure calculations show that a glutamic acid residue that coordinates zinc replaces the fourth histidine of the C2H2 motif. Electromobility gel shift assays indicate that the protein binds to DNA with different affinities depending on the DNA sequence. AFV1p06 is the first experimentally characterised archaeal zinc finger protein with a DNA binding activity. The AFV1p06 protein family has homologues in diverse viruses of hyperthermophilic archaea. A phylogenetic analysis points out a common origin of archaeal and eukaryotic C2H2 zinc fingers.	[Guilliere, Florence; Delepierre, Muriel; Guijarro, J. Inaki] Inst Pasteur, Unite RMN Biomol, Dept Biol Struct & Chim, Paris, France; [Guilliere, Florence; Guijarro, J. Inaki] CNRS, UMR 3528, Paris, France; [Guilliere, Florence] Univ Paris 07, Paris, France; [Danioux, Chloe; Jaubert, Carole; Desnoues, Nicole; Prangishvili, David; Sezonov, Guennadi] Inst Pasteur, Unite Biol Mol Gene Extremophiles, Dept Microbiol, Paris, France; [Danioux, Chloe; Jaubert, Carole; Sezonov, Guennadi] Univ Paris 06, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite	Sezonov, G (corresponding author), Inst Pasteur, Unite Biol Mol Gene Extremophiles, Dept Microbiol, Paris, France.	guennadi.sezonov@pasteur.fr; inaki.guijarro@pasteur.fr	Sezonov, Guennadi/ABB-5734-2020; Guijarro, J. Inaki/E-6438-2019	Sezonov, Guennadi/0000-0002-2016-6126; Guijarro, J. Inaki/0000-0002-3826-5245; GUILLIERE, Florence/0000-0002-4025-2988	Institut Pasteur; Centre National de la Recherche Scientifique [CNRS UMR 3528]; French Ministere de l'Enseignement Superieur et de la Recherche; Region Ile de France	Institut Pasteur(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); French Ministere de l'Enseignement Superieur et de la Recherche; Region Ile de France(Region Ile-de-France)	This work was supported by the Institut Pasteur and the Centre National de la Recherche Scientifique (CNRS UMR 3528). FG, CD and CJ were supported by the French "Ministere de l'Enseignement Superieur et de la Recherche". The 600 MHz spectrometer was funded by the Region Ile de France and the Institut Pasteur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella M, 2007, NUCLEIC ACIDS RES, V35, P6788, DOI 10.1093/nar/gkm782; Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P4658, DOI 10.1093/nar/27.23.4658; Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Barraud P, 2012, J BIOMOL NMR, V53, P93, DOI 10.1007/s10858-012-9625-6; Bell SD, 2005, TRENDS MICROBIOL, V13, P262, DOI 10.1016/j.tim.2005.03.015; Bell SD, 2001, CURR OPIN MICROBIOL, V4, P208, DOI 10.1016/S1369-5274(00)00190-9; Bettstetter M, 2003, VIROLOGY, V315, P68, DOI 10.1016/S0042-6822(03)00481-1; Bowers PW, 1999, NAT STRUCT BIOL, V6, P478; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cordier F, 2008, J MOL BIOL, V377, P1419, DOI 10.1016/j.jmb.2008.01.048; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dutnall RN, 1996, STRUCTURE, V4, P599, DOI 10.1016/S0969-2126(96)00064-0; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Feng B, 1998, MOL CELL BIOL, V18, P3983, DOI 10.1128/MCB.18.7.3983; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; GRZESIEK S, 1995, J AM CHEM SOC, V117, P5312, DOI 10.1021/ja00124a014; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Guilliere F, 2009, J BIOL CHEM, V284, P22222, DOI 10.1074/jbc.M109.029850; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Isalan M, 1998, BIOCHEMISTRY-US, V37, P12026, DOI 10.1021/bi981358z; Isalan M, 1997, P NATL ACAD SCI USA, V94, P5617, DOI 10.1073/pnas.94.11.5617; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kessler A, 2006, NUCLEIC ACIDS RES, V34, P4837, DOI 10.1093/nar/gkl502; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liew CK, 2005, P NATL ACAD SCI USA, V102, P583, DOI 10.1073/pnas.0407511102; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; LOGAN TM, 1993, J BIOMOL NMR, V3, P225; Mackay JP, 1998, J BIOL CHEM, V273, P30560, DOI 10.1074/jbc.273.46.30560; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Newton A, 2001, J BIOL CHEM, V276, P35794, DOI 10.1074/jbc.M106256200; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Omichinski JG, 1997, NAT STRUCT BIOL, V4, P122, DOI 10.1038/nsb0297-122; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PALM P, 1991, VIROLOGY, V185, P242, DOI 10.1016/0042-6822(91)90771-3; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Peng X, 2008, MICROBIOL-SGM, V154, P383, DOI 10.1099/mic.0.2007/012963-0; Perez-Rueda E, 2010, MOL BIOL EVOL, V27, P1449, DOI 10.1093/molbev/msq033; Prangishvili D, 2004, BIOCHEM SOC T, V32, P204, DOI 10.1042/BST0320204; Prangishvill D, 2006, VIRUS RES, V117, P52, DOI 10.1016/j.virusres.2006.01.007; Redder P, 2009, ENVIRON MICROBIOL, V11, P2849, DOI 10.1111/j.1462-2920.2009.02009.x; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Schanda P, 2006, MAGN RESON CHEM, V44, pS177, DOI 10.1002/mrc.1825; Schlenker C, 2012, BIOCHEMISTRY-US, V51, P2899, DOI 10.1021/bi201791s; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Simpson RJY, 2003, J BIOL CHEM, V278, P28011, DOI 10.1074/jbc.M211146200; Stedman KM, 2003, RES MICROBIOL, V154, P295, DOI 10.1016/S0923-2508(03)00074-3; Stoll R, 2007, J MOL BIOL, V372, P1227, DOI 10.1016/j.jmb.2007.07.017; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Wiedenheft B, 2004, J VIROL, V78, P1954, DOI 10.1128/JVI.78.4.1954-1961.2004; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	63	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52908	10.1371/journal.pone.0052908	http://dx.doi.org/10.1371/journal.pone.0052908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326363	gold, Green Published, Green Submitted			2022-12-25	WOS:000313551500034
J	Rogers, TL; Ciaglia, MB; Klinck, H; Southwell, C				Rogers, Tracey L.; Ciaglia, Michaela B.; Klinck, Holger; Southwell, Colin			Density Can Be Misleading for Low-Density Species: Benefits of Passive Acoustic Monitoring	PLOS ONE			English	Article							SPERM-WHALE ABUNDANCE; PACK-ICE SEALS; LEOPARD SEALS; HYDRURGA-LEPTONYX; PRYDZ BAY; RESPONSES; VOCALIZATIONS; PROBABILITY; DIVERSITY; BEHAVIOR	Climate-induced changes may be more substantial within the marine environment, where following ecological change is logistically difficult, and typically expensive. As marine animals tend to produce stereotyped, long-range signals, they are ideal for repeatable surveying. In this study we illustrate the potential for calling rates to be used as a tool for determining habitat quality by using an Antarctic pack-ice seal, the leopard seal, as a model. With an understanding of the vocal behavior of a species, their seasonal and diurnal patterns, sex and age-related differences, an underwater passive-acoustic survey conducted alongside a visual survey in an arc of 4,225 km across the Davis Sea, Eastern Antarctica, showed that while acoustic and visual surveys identified similar regions as having high densities, the acoustic surveys surprisingly identified the opposite regions as being 'critical' habitats. Density surveys of species that cannot be differentiated into population classes may be misleading because overall density can be a negative indicator of habitat quality. Under special circumstances acoustics can offer enormous advantage over traditional techniques and open up monitoring to regions that are remote, difficult and expensive to work within, no longer restricting long-term community assessment to resource-wealthy communities. As climatic change affects a broad range of organisms across geographic boundaries we propose that capitalizing on the significant advances in passive acoustic technology, alongside physical acoustics and population modeling, can help in addressing ecological questions more broadly.	[Rogers, Tracey L.; Ciaglia, Michaela B.] Univ New S Wales, Sch BEES, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Klinck, Holger] Oregon State Univ, Cooperat Inst Marine Resources Studies, Newport, OR USA; [Klinck, Holger] Oregon State Univ, Hatfield Marine Sci Ctr, Natl Ocean & Atmospher Adm, Pacific Marine Environm Lab, Newport, OR 97365 USA; [Southwell, Colin] Australian Antarctic Div, Dept Sustainabil Environm Water Populat & Communi, Kingston, Tas, Australia	University of New South Wales Sydney; Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University; Australian Antarctic Division	Rogers, TL (corresponding author), Univ New S Wales, Sch BEES, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	tracey.rogers@unsw.edu.au	Rogers, Tracey L/C-3419-2008; Klinck, Holger/X-5214-2019	Klinck, Holger/0000-0003-1078-7268; Rogers, Tracey/0000-0002-7141-4177	Antarctic Scientific Advisory Committee [ASAC 552, 1140]; Sea World Research and Rescue Foundation Inc.; Scott Foundation; U.S. Office of Naval Research [N00014-11-1-0606]	Antarctic Scientific Advisory Committee; Sea World Research and Rescue Foundation Inc.; Scott Foundation; U.S. Office of Naval Research(Office of Naval Research)	This study was supported financially by the Antarctic Scientific Advisory Committee (ASAC 552 and 1140), the Sea World Research and Rescue Foundation Inc., the Scott Foundation and the U.S. Office of Naval Research grant # N00014-11-1-0606 this is NOAA PMEL contribution # 3836. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 2008, J ACOUST SOC AM, V123, P4403, DOI 10.1121/1.2912449; Barlow J, 2005, MAR MAMMAL SCI, V21, P429, DOI 10.1111/j.1748-7692.2005.tb01242.x; BESTER MN, 1995, ANTARCT SCI, V7, P357, DOI 10.1017/S0954102095000502; Bock CE, 2004, FRONT ECOL ENVIRON, V2, P403, DOI 10.2307/3868428; Buckland S.T., 2001, pi; Cardillo M, 2006, P NATL ACAD SCI USA, V103, P4157, DOI 10.1073/pnas.0510541103; Carwardine J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002586; de Solla SR, 2005, BIOL CONSERV, V121, P585, DOI 10.1016/j.biocon.2004.06.018; Eklund C. R., 1962, Journal of Mammalogy, V43, P229, DOI 10.2307/1377094; Erickson A.W., 1990, P253; ERICKSON AW, 1974, ANTARCT J US, V9, P292; ERICKSON AW, 1973, ANTARCT J US, V8, P191; Erickson AW, 1983, POLAR STAR ANTARCTIC, V18, P163; Erickson JR, 1972, ANTARCT J US, V6, P98; Forcada J, 2012, BIOL CONSERV, V149, P40, DOI 10.1016/j.biocon.2012.02.002; Frankel AS, 2000, J ACOUST SOC AM, V108, P1930, DOI 10.1121/1.1289668; Gedamke J, 2001, J ACOUST SOC AM, V109, P3038, DOI 10.1121/1.1371763; Gilbert J, 1977, ADAPTATIONS ANTARCTI, P703; Gondy RR, 1976, STH AFRICAN J ANTARC, V6, P2; Gondy RR, 1977, STH AFRICAN J ANTARC, V7, P10; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Hall-Martin AJ, 1974, STH AFRICAN J ANTARC, V4, P34; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; HAUSER MD, 1993, AM NAT, V142, P528, DOI 10.1086/285553; Heimlich SL, 2005, J ACOUST SOC AM, V118, P1830, DOI 10.1121/1.1992674; Johnson M, 2006, J EXP BIOL, V209, P5038, DOI 10.1242/jeb.02596; Kusel ET, 2011, J ACOUST SOC AM, V129, P3610, DOI 10.1121/1.3583504; Laiolo P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001822; Lewis T, 2007, J MAR BIOL ASSOC UK, V87, P353, DOI 10.1017/S0025315407054896; LIEBERMAN PH, 1969, SCIENCE, V164, P1185, DOI 10.1126/science.164.3884.1185; MacKenzie DI, 2006, J WILDLIFE MANAGE, V70, P367, DOI 10.2193/0022-541X(2006)70[367:MTPORU]2.0.CO;2; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; MARQUES T. A., 2010, J ORNITHOL, V152, pS445, DOI [10.1007/s10336-010-0535-7, DOI 10.1007/S10336-010-0535-7]; Marques TA, 2009, J ACOUST SOC AM, V125, P1982, DOI 10.1121/1.3089590; Mayer F, 2001, P ROY SOC B-BIOL SCI, V268, P1825, DOI 10.1098/rspb.2001.1744; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Oleson EM, 2007, ANIM BEHAV, V74, P881, DOI 10.1016/j.anbehav.2007.01.022; Oritsland T., 1970, P361; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Poole KG, 2007, ANIM BEHAV, V73, P513, DOI 10.1016/j.anbehav.2006.09.008; Ray G. C., 1970, ANTARCT ECOL, V1, P398; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Reby D, 2010, P ROY SOC B-BIOL SCI, V277, P2747, DOI 10.1098/rspb.2010.0467; Rogers TL, 2002, BEHAVIOUR, V139, P1267, DOI 10.1163/156853902321104154; Rogers TL, 1997, MAR MAMMAL SCI, V13, P293, DOI 10.1111/j.1748-7692.1997.tb00632.x; Rogers TL, 1996, MAR MAMMAL SCI, V12, P414, DOI 10.1111/j.1748-7692.1996.tb00593.x; Rogers TL, PLOSONE UNPUB; Rogers TL, PLOS ONE UNPUB; Rogers Tracey, 1995, P223; Rogers TL, 2007, J ACOUST SOC AM, V122, P596, DOI 10.1121/1.2736976; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Siniff DB, 1970, ANTARCT ECOL, V1, P37; SMITH NR, 1984, DEEP-SEA RES, V31, P1121, DOI 10.1016/0198-0149(84)90016-5; Soto NA, 2008, J ANIM ECOL, V77, P936, DOI 10.1111/j.1365-2656.2008.01393.x; Sousa-Lima RS, 2002, ANIM BEHAV, V63, P301, DOI 10.1006/anbe.2001.1873; Southwell C, 2004, MAR MAMMAL SCI, V20, P602, DOI 10.1111/j.1748-7692.2004.tb01182.x; Southwell C, 2003, POLAR BIOL, V26, P648, DOI 10.1007/s00300-003-0534-8; Southwell C, 2008, DEEP-SEA RES PT I, V55, P519, DOI 10.1016/j.dsr.2008.01.005; Stafford Kathleen M., 2001, Journal of Cetacean Research and Management, V3, P65; Stimpert AK, 2007, BIOL LETTERS, V3, P467, DOI 10.1098/rsbl.2007.0281; THOMAS JA, 1982, CAN J ZOOL, V60, P2028, DOI 10.1139/z82-260; Thompson AA, 1997, MAR ECOL PROG SER, V154, P53, DOI 10.3354/meps154053; Titze IR, 1994, PRINCIPLES VOICE PRO; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; van Oort BEH, 2005, NATURE, V438, P1095, DOI 10.1038/4381095a; Van Parijs SM, 2002, J APPL ECOL, V39, P853, DOI 10.1046/j.1365-2664.2002.00756.x; Van Parijs SM, 2009, MAR ECOL PROG SER, V395, P21, DOI 10.3354/meps08123; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Whitehead H, 2009, J WILDLIFE MANAGE, V73, P1000, DOI 10.2193/2008-303; Zimmer WMX, 2008, J ACOUST SOC AM, V124, P2823, DOI 10.1121/1.2988277	73	31	31	3	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52542	10.1371/journal.pone.0052542	http://dx.doi.org/10.1371/journal.pone.0052542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326339	Green Submitted, Green Published, gold			2022-12-25	WOS:000313551500016
J	Sciacqua, A; Marini, MA; Hribal, ML; Perticone, F; Sesti, G				Sciacqua, Angela; Marini, Maria Adelaide; Hribal, Marta Letizia; Perticone, Francesco; Sesti, Giorgio			Association of Insulin Resistance Indexes to Carotid Intima-Media Thickness	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; GLUCOSE DISPOSAL; ARTERY INTIMA; RISK-FACTOR; SENSITIVITY; PREDICTOR; NONOBESE	Objectives: Accumulating evidence suggests an association between insulin resistance (IR) and cardiovascular diseases The aim of this study was to examine the relationship between indexes of IR and common carotid intima-media thickness (IMT), an indicator of vascular damage. Methods: In 847 non-diabetic Caucasians a 75 g oral glucose tolerance test was performed and surrogate indexes of IR were computed according to published formulas. IMT was measured by ultrasound method. Results: The Stumvoll ISIOGTT index was correlated with IMT more strongly than the other indexes of IR. The IR indexes correlated significantly (P<0.0001) with all cardiovascular risk factors examined. The Stumvoll ISIOGTT index was correlated with waist circumference and high sensitivity C-reactive protein more strongly than the other indexes of IR. The area under the ROC curve (AUC), used to evaluate the accuracy of the IR indexes in identifying individuals with vascular damage defined as IMT >0.9 mm, for the Stumvoll ISIOGTT index was significantly higher (0.710) as compared with the AUCs of Matsuda (0.642) (P = 0.0009), OGIS (0.666) (P = 0.04), HOMA (0.611) (P<0.0001) and Liver IR (0.648) (P = 0.0008) indexes. In a logistic regression model adjusted for age and gender, subjects in the lowest tertile of the Stumvoll ISIOGTT index had the highest risk of having vascular damage (OR 4.95, 95% CI 2.99-8.192) as compared to the corresponding tertiles of the other surrogate indexes. Conclusion: The Stumvoll ISIOGTT index correlated more strongly than other validated surrogates indexes of IR with carotid IMT, and, therefore, it might be a significant indicator of vascular damage.	[Sciacqua, Angela; Hribal, Marta Letizia; Perticone, Francesco; Sesti, Giorgio] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy; [Marini, Maria Adelaide] Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy	Magna Graecia University of Catanzaro; University of Rome Tor Vergata	Sesti, G (corresponding author), Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy.	sesti@unicz.it	Sesti, Giorgio/B-1509-2012; Perticone, Francesco/I-4260-2017	Sesti, Giorgio/0000-0002-1618-7688				Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519; Cardellini M, 2007, AM J PHYSIOL-ENDOC M, V292, pE347, DOI 10.1152/ajpendo.00291.2006; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Haffner SM, 1996, DIABETES, V45, P742, DOI 10.2337/diabetes.45.6.742; HAFFNER SM, 1990, METABOLISM, V39, P842, DOI 10.1016/0026-0495(90)90130-5; Hanley AJG, 2002, DIABETES CARE, V25, P1177, DOI 10.2337/diacare.25.7.1177; Howard G, 1996, CIRCULATION, V93, P1809, DOI 10.1161/01.CIR.93.10.1809; Hu G., 2004, DIABETOLOGIA, V47, P1245; Lorenzo C, 2003, DIABETES CARE, V26, P3153, DOI 10.2337/diacare.26.11.3153; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Mari A, 2001, DIABETES CARE, V24, P539, DOI 10.2337/diacare.24.3.539; Marini MA, 2007, DIABETES CARE, V30, P2145, DOI 10.2337/dc07-0419; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rutter MK, 2005, DIABETES, V54, P3252, DOI 10.2337/diabetes.54.11.3252; Sesti G, 2006, BEST PRACT RES CL EN, V20, P665, DOI 10.1016/j.beem.2006.09.007; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Succurro E, 2009, ATHEROSCLEROSIS, V207, P245, DOI 10.1016/j.atherosclerosis.2009.04.006; Vangipurapu J, 2011, DIABETOLOGIA, V54, P540, DOI 10.1007/s00125-010-1966-7; Verma S, 2002, CIRCULATION, V106, P913, DOI 10.1161/01.CIR.0000029802.88087.5E; Yip J, 1998, J CLIN ENDOCR METAB, V83, P2773, DOI 10.1210/jc.83.8.2773	27	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53968	10.1371/journal.pone.0053968	http://dx.doi.org/10.1371/journal.pone.0053968			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326550	Green Published, Green Submitted, gold			2022-12-25	WOS:000313551500104
J	Boiani, M; Daniel, C; Liu, XY; Hogarty, MD; Marnett, LJ				Boiani, Mariana; Daniel, Cristina; Liu, Xueyuan; Hogarty, Michael D.; Marnett, Lawrence J.			The Stress Protein BAG3 Stabilizes Mcl-1 Protein and Promotes Survival of Cancer Cells and Resistance to Antagonist ABT-737	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING LIGAND; BCL-2 FAMILY PROTEINS; BH3 MIMETIC ABT-737; DOWN-REGULATION; HEAT-SHOCK; BCL-2-BINDING PROTEIN; MYELOID-LEUKEMIA; IN-VIVO; NEUROBLASTOMA; DEATH	Members of the Bcl-2 family of proteins are important inhibitors of apoptosis in human cancer and are targets for novel anticancer agents such as the Bcl-2 antagonists, ABT-263 (Navitoclax), and its analog ABT-737. Unlike Bcl-2, Mcl-1 is not antagonized by ABT-263 or ABT-737 and is considered to be a major factor in resistance. Also, Mcl-1 exhibits differential regulation when compared with other Bcl-2 family members and is a target for anticancer drug discovery. Here, we demonstrate that BAG3, an Hsp70 co-chaperone, protects Mcl-1 from proteasomal degradation, thereby promoting its antiapoptotic activity. Using neuroblastoma cell lines, with a defined Bcl-2 family dependence, we found that BAG3 expression correlated with Mcl-1 dependence and ABT-737 resistance. RNA silencing of BAG3 led to a marked reduction in Mcl-1 protein levels and overcame ABT-737 resistance in Mcl-1-dependent cells. In ABT-737-resistant cells, Mcl-1 co-immunoprecipitated with BAG3, and loss of Mcl-1 after BAG3 silencing was prevented by proteasome inhibition. BAG3 and Mcl-1 were co-expressed in a panel of diverse cancer cell lines resistant to ABT-737. Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells. These studies identify BAG3-mediated Mcl-1 stabilization as a potential target for cancer drug discovery.	[Boiani, Mariana; Daniel, Cristina; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Dept Biochem,Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Boiani, Mariana; Daniel, Cristina; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Dept Chem,Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Boiani, Mariana; Daniel, Cristina; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Dept Pharmacol,Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Boiani, Mariana; Daniel, Cristina; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Liu, Xueyuan; Hogarty, Michael D.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Liu, Xueyuan; Hogarty, Michael D.] Univ Penn, Sch Med, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Dept Biochem,Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu			National Institutes of Health from the NIEHS [ES013125, CA97323]; Alex's Lemonade Stand Foundation; NATIONAL CANCER INSTITUTE [P01CA097323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, P01ES013125] Funding Source: NIH RePORTER	National Institutes of Health from the NIEHS; Alex's Lemonade Stand Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES013125 (to L. J. M.) and CA97323 (to M. D. H.) from the NIEHS and an Innovator Award from Alex's Lemonade Stand Foundation (to M. D. H.).	Aichberger KJ, 2005, BLOOD, V105, P3303, DOI 10.1182/blood-2004-02-0749; Akgul C, 2000, FEBS LETT, V478, P72, DOI 10.1016/S0014-5793(00)01809-3; Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Baou M, 2010, HAEMATOL-HEMATOL J, V95, P1510, DOI 10.3324/haematol.2010.022368; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen Hao-Yue, 2010, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V18, P838; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Chiappetta G, 2007, J CLIN ENDOCR METAB, V92, P1159, DOI 10.1210/jc.2006-1712; Cho-Vega JH, 2004, HUM PATHOL, V35, P1095, DOI 10.1016/j.humpath.2004.04.018; Clohessy JG, 2004, BRIT J HAEMATOL, V125, P655, DOI 10.1111/j.1365-2141.2004.04949.x; Craig RW, 2002, LEUKEMIA, V16, P444, DOI 10.1038/sj.leu.2402416; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Derenne S, 2002, BLOOD, V100, P194, DOI 10.1182/blood.V100.1.194; Ding QQ, 2008, CANCER RES, V68, P6109, DOI 10.1158/0008-5472.CAN-08-0579; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Gentilella A, 2011, J BIOL CHEM, V286, P9205, DOI 10.1074/jbc.M110.175836; Goldsmith KC, 2010, CELL DEATH DIFFER, V17, P872, DOI 10.1038/cdd.2009.171; Goldsmith KC, 2005, CANCER LETT, V228, P133, DOI 10.1016/j.canlet.2005.01.048; Goldsmith KC, 2012, CANCER RES, V72, P2565, DOI 10.1158/0008-5472.CAN-11-3603; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Hackett CS, 2003, CANCER RES, V63, P5266; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoang AT, 2000, AM J PATHOL, V156, P857, DOI 10.1016/S0002-9440(10)64954-1; Homma S, 2006, AM J PATHOL, V169, P761, DOI 10.2353/ajpath.2006.060250; Inoshita S, 2002, J BIOL CHEM, V277, P43730, DOI 10.1074/jbc.M207951200; Iwasaki M, 2007, CANCER RES, V67, P10252, DOI 10.1158/0008-5472.CAN-07-0618; Jacobs AT, 2009, J BIOL CHEM, V284, P9176, DOI 10.1074/jbc.M808656200; Janoueix-Lerosey I, 2009, J CLIN ONCOL, V27, P1026, DOI 10.1200/JCO.2008.16.0630; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; KRAJEWSKI S, 1995, AM J PATHOL, V146, P1309; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Lee JH, 1999, ONCOGENE, V18, P6183, DOI 10.1038/sj.onc.1203043; Lestini BJ, 2009, CANCER BIOL THER, V8, P1587, DOI 10.4161/cbt.8.16.8964; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Liao Q, 2001, FEBS LETT, V503, P151, DOI 10.1016/S0014-5793(01)02728-4; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Mosse YP, 2005, GENE CHROMOSOME CANC, V43, P390, DOI 10.1002/gcc.20198; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Quinn BA, 2011, EXPERT OPIN INV DRUG, V20, P1397, DOI 10.1517/13543784.2011.609167; REED JC, 1990, CANCER RES, V50, P6565; REED JC, 1988, NATURE, V336, P259, DOI 10.1038/336259a0; Rosati A, 2007, INT J BIOCHEM CELL B, V39, P1337, DOI 10.1016/j.biocel.2007.03.007; Schwab M, 2003, LANCET ONCOL, V4, P472, DOI 10.1016/S1470-2045(03)01166-5; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Selcen D, 2009, ANN NEUROL, V65, P83, DOI 10.1002/ana.21553; Sieghart W, 2006, J HEPATOL, V44, P151, DOI 10.1016/j.jhep.2005.09.010; Stewart DP, 2010, MOL CELL BIOL, V30, P3099, DOI 10.1128/MCB.01266-09; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; YANG T, 1995, J CELL BIOL, V128, P1173, DOI 10.1083/jcb.128.6.1173; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	69	63	65	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6980	6990		10.1074/jbc.M112.414177	http://dx.doi.org/10.1074/jbc.M112.414177			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23341456	Green Published, hybrid			2022-12-25	WOS:000316002400020
J	Kaminski, PA; Labesse, G				Kaminski, Pierre Alexandre; Labesse, Gilles			Phosphodeoxyribosyltransferases, Designed Enzymes for Deoxyribonucleotides Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-N-DEOXYRIBOSYLASE; HERPES-SIMPLEX VIRUS; LACTOBACILLUS-HELVETICUS; NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASE; DROSOPHILA-MELANOGASTER; MULTIFUNCTIONAL ENZYME; SUBSTRATE-SPECIFICITY; THYMIDYLATE KINASE; ACTIVE-SITE; BASES	A large number of nucleoside analogues and 2'-deoxynucleoside triphosphates (dNTP) have been synthesized to interfere with DNA metabolism. However, in vivo the concentration and phosphorylation of these analogues are key limiting factors. In this context, we designed enzymes to switch nucleobases attached to a deoxyribose monophosphate. Active chimeras were made from two distantly related enzymes: a nucleoside deoxyribosyltransferase from lactobacilli and a 5'-monophosphate-2'-deoxyribonucleoside hydrolase from rat. Then their unprecedented activity was further extended to deoxyribose triphosphate, and in vitro biosyntheses could be successfully performed with several base analogues. These new enzymes provide new tools to synthesize dNTP analogues and to deliver them into cells.	[Kaminski, Pierre Alexandre] Inst Pasteur, Unite Chim & Biocatalyse, F-75724 Paris 15, France; [Kaminski, Pierre Alexandre] CNRS, UMR 3523, F-75724 Paris 15, France; [Labesse, Gilles] CNRS, UMR 5048, Ctr Biochim Struct, F-34090 Montpellier, France; [Labesse, Gilles] INSERM, U1054, F-34090 Montpellier, France; [Labesse, Gilles] Univ Montpellier 1 & 2, IFR3, F-34090 Montpellier, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Kaminski, PA (corresponding author), Inst Pasteur, Unite Chim & Biocatalyse, 28 Rue Dr Roux, F-75724 Paris 15, France.	pierre-alexandre.kaminski@pasteur.fr		Kaminski, Pierre Alexandre/0000-0001-9841-6837; Labesse, Gilles/0000-0002-6861-3300				Armstrong SR, 1996, STRUCTURE, V4, P97, DOI 10.1016/S0969-2126(96)00013-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bao J, 2007, BIOTECHNOL BIOENG, V98, P1, DOI 10.1002/bit.21498; Benner SA, 2004, ACCOUNTS CHEM RES, V37, P784, DOI 10.1021/ar040004z; Burgess K, 2000, CHEM REV, V100, P2047, DOI 10.1021/cr990045m; CARDINAUD R, 1979, BIOCHIM BIOPHYS ACTA, V568, P339, DOI 10.1016/0005-2744(79)90301-2; Caton-Williams J, 2011, ORG LETT, V13, P4156, DOI 10.1021/ol201073e; CHEN MS, 1979, J VIROL, V30, P942, DOI 10.1128/JVI.30.3.942-945.1979; CHEN MS, 1979, J BIOL CHEM, V254, P747; Doddapaneni K, 2011, BIOCHEMISTRY-US, V50, P4712, DOI 10.1021/bi101742z; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x; FREEMAN GA, 1995, BIOORGAN MED CHEM, V3, P447, DOI 10.1016/0968-0896(95)00030-K; Gerlt JA, 2009, CURR OPIN CHEM BIOL, V13, P10, DOI 10.1016/j.cbpa.2009.01.014; Ghiorghi YK, 2007, J BIOL CHEM, V282, P8150, DOI 10.1074/jbc.M610648200; Gibson DG, 2010, NAT METHODS, V7, P901, DOI 10.1038/nmeth.1515; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Hebrard C, 2009, CANCER GENE THER, V16, P541, DOI 10.1038/cgt.2009.25; Hohne M, 2010, NAT CHEM BIOL, V6, P807, DOI [10.1038/nchembio.447, 10.1038/NCHEMBIO.447]; HOLGUIN J, 1975, EUR J BIOCHEM, V54, P515, DOI 10.1111/j.1432-1033.1975.tb04164.x; HUANG MC, 1983, ARCH BIOCHEM BIOPHYS, V222, P133, DOI 10.1016/0003-9861(83)90510-6; HUANG MC, 1981, BIOCHEM PHARMACOL, V30, P2663, DOI 10.1016/0006-2952(81)90535-9; Jochens H, 2010, CHEMBIOCHEM, V11, P1861, DOI 10.1002/cbic.201000284; Johansson M, 1999, J BIOL CHEM, V274, P23814, DOI 10.1074/jbc.274.34.23814; Johnson D. C., 2004, CURRENT PROTOCOLS NU; Kaminski PA, 2002, J BIOL CHEM, V277, P14400, DOI 10.1074/jbc.M111995200; Kaminski PA, 2008, J BIOL CHEM, V283, P20053, DOI 10.1074/jbc.M802706200; Khakshoor O, 2011, CHEM COMMUN, V47, P7018, DOI 10.1039/c1cc11021g; KIRNOS MD, 1977, NATURE, V270, P369, DOI 10.1038/270369a0; Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z; LADNER WE, 1985, J ORG CHEM, V50, P1076, DOI 10.1021/jo00207a032; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Marliere P, 2011, ANGEW CHEM INT EDIT, V50, P7109, DOI 10.1002/anie.201100535; Mikhailopulo IA, 2011, MENDELEEV COMMUN, V21, P57, DOI 10.1016/j.mencom.2011.03.001; Muller M, 1996, CHEM RES TOXICOL, V9, P1140, DOI 10.1021/tx9600661; Munch-Petersen B, 1998, J BIOL CHEM, V273, P3926, DOI 10.1074/jbc.273.7.3926; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Padilla A, 2013, ACTA CRYSTALLOGR D, V69, P247, DOI 10.1107/S0907444912045039; Pons JL, 2009, NUCLEIC ACIDS RES, V37, pW485, DOI 10.1093/nar/gkp368; PORTER DJT, 1995, J BIOL CHEM, V270, P15551, DOI 10.1074/jbc.270.26.15551; Schnetz-Boutaud NC, 2000, CHEM RES TOXICOL, V13, P90, DOI 10.1021/tx990141i; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; WARREN RAJ, 1980, ANNU REV MICROBIOL, V34, P137, DOI 10.1146/annurev.mi.34.100180.001033; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yang YS, 2009, J MOL BIOL, V394, P435, DOI 10.1016/j.jmb.2009.10.004	47	13	13	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6534	6541		10.1074/jbc.M112.446492	http://dx.doi.org/10.1074/jbc.M112.446492			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23325804	Green Published, hybrid			2022-12-25	WOS:000315820700046
J	Mullally, SL; O'Mara, SM				Mullally, Sinead L.; O'Mara, Shane M.			Suppressing the Encoding of New Information in Memory: A Behavioral Study Derived from Principles of Hippocampal Function	PLOS ONE			English	Article							UNWANTED MEMORIES; WORKING-MEMORY; ASSOCIATIVE RECOGNITION; ITEM RECOGNITION; TASK-SET; SWITCH; DISSOCIATION; RETRIEVAL; DEACTIVATION; CONNECTIVITY	Cognitive processes do not occur in isolation. Interactions between cognitive processes can be observed as a cost in performance following a switch between tasks, a cost that is greatest when the cognitive requirements of the sequential tasks compete. Interestingly, the long-term mnemonic goals associated with specific cognitive tasks can also directly compete. For example, encoding the sequential order in which stimuli are presented in the commonly-utilised 2-Back working memory (WM) tasks is counter-productive to task performance, as this task requires the continual updating of the contents of one's current mental set. Performance of this task consistently results in reduced activity within the medial temporal lobe (MTL), and this response is believed to reflect the inhibitory mnemonic component of the task. Conversely, there are numerous cognitive paradigms in which participants are explicitly instructed to encode incoming information and performance of these tasks reliably increases MTL activity. Here, we explore the behavioural cost of sequentially performing two tasks with conflicting long-term mnemonic goals and contrasting neural profiles within the MTL. We hypothesised that performing the 2-Back WM prior to a hippocampal-dependent memory task would impair performance on the latter task. We found that participants who performed the 2-Back WM task, prior to the encoding of novel verbal/face-name stimuli, recollected significantly fewer of these stimuli, compared to those who had performed a 0-Back control task. Memory processes believed to be independent of the MTL were unaffected. Our results suggest that the inhibition of MTL-dependent mnemonic function persists beyond the cessation of the 2-Back WM task and can alter performance on entirely separate and subsequently performed memory tasks. Furthermore, they indicate that performance of such tasks may induce a temporarily-sustained, virtual lesion of the hippocampus, which could be used as a probe to explore cognitive processes in the absence of hippocampal involvement.	[Mullally, Sinead L.] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; Trinity Coll Dublin, Sch Psychol, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin	Mullally, SL (corresponding author), Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland.	s.mullally@ucl.ac.uk; smomara@tcd.ie		Mullally, Sinead/0000-0002-4234-3445; O'Mara, Shane/0000-0001-8087-8531	Programme for Research in Third-Level Institutions - Cycle 3 from the Higher Education Authority	Programme for Research in Third-Level Institutions - Cycle 3 from the Higher Education Authority	This work was funded under a Programme for Research in Third-Level Institutions - Cycle 3 from the Higher Education Authority (O'Mara/Robertson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison JD, 2000, NEUROLOGY, V54, P135, DOI 10.1212/WNL.54.1.135; ALLPORT A, 1994, ATTENTION PERFORM, V15, P421; Allport A, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P35; Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Anderson MC, 2001, NATURE, V410, P366, DOI 10.1038/35066572; Anderson MC, 2011, PSYCHOL AGING, V26, P397, DOI 10.1037/a0022505; Arbuthnott K, 2000, CAN J EXP PSYCHOL, V54, P33, DOI 10.1037/h0087328; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buchner A, 2000, COGNITIVE PSYCHOL, V40, P227, DOI 10.1006/cogp.1999.0731; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Cameron KA, 2001, NEURON, V30, P289, DOI 10.1016/S0896-6273(01)00280-X; Chua EF, 2007, HIPPOCAMPUS, V17, P1071, DOI 10.1002/hipo.20340; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Dahm T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026351; De Jong R, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P357; Depue BE, 2007, SCIENCE, V317, P215, DOI 10.1126/science.1139560; Duncan K, 2012, SCIENCE, V337, P485, DOI 10.1126/science.1221936; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Eldridge LL, 2005, J NEUROSCI, V25, P3280, DOI 10.1523/JNEUROSCI.3420-04.2005; Fassbender C, 2004, COGNITIVE BRAIN RES, V20, P132, DOI 10.1016/j.cogbrainres.2004.02.007; FRITH CD, 1991, P ROY SOC B-BIOL SCI, V244, P241, DOI 10.1098/rspb.1991.0077; Gilbert SJ, 2002, COGNITIVE PSYCHOL, V44, P297, DOI 10.1006/cogp.2001.0770; Giovanello KS, 2003, COGN AFFECT BEHAV NE, V3, P186, DOI 10.3758/CABN.3.3.186; Glabus MF, 2003, CEREB CORTEX, V13, P1352, DOI 10.1093/cercor/bhg082; GRAF P, 1984, J EXP PSYCHOL LEARN, V10, P164, DOI 10.1037/0278-7393.10.1.164; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Henke K, 1997, HIPPOCAMPUS, V7, P249, DOI 10.1002/(SICI)1098-1063(1997)7:3<249::AID-HIPO1>3.0.CO;2-G; Holdstock JS, 2005, HIPPOCAMPUS, V15, P203, DOI 10.1002/hipo.20046; Jonides J, 1997, J COGNITIVE NEUROSCI, V9, P462, DOI 10.1162/jocn.1997.9.4.462; Kastrup A, 2008, NEUROIMAGE, V41, P1364, DOI 10.1016/j.neuroimage.2008.03.049; KEANE MM, 1995, BRAIN, V118, P1129, DOI 10.1093/brain/118.5.1129; Koch I, 2010, PSYCHON B REV, V17, P1, DOI 10.3758/PBR.17.1.1; Levy BJ, 2008, ACTA PSYCHOL, V127, P623, DOI 10.1016/j.actpsy.2007.12.004; Mayes AR, 1998, BEHAV NEUROL, V11, P163; Meyer-Lindenberg A, 2001, AM J PSYCHIAT, V158, P1809, DOI 10.1176/appi.ajp.158.11.1809; Meyer-Lindenberg AS, 2005, ARCH GEN PSYCHIAT, V62, P379, DOI 10.1001/archpsyc.62.4.379; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Monsell S, 2000, PSYCHOL RES-PSYCH FO, V63, P250, DOI 10.1007/s004269900005; Mullally SL, 2005, J COGNITIVE NEUROSCI, P103; Nelson HE., 1982, NATL ADULT READING T; Nieuwenhuis S, 2002, PSYCHON B REV, V9, P86, DOI 10.3758/BF03196259; Nyberg L, 1996, J NEUROSCI, V16, P3753; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; Paz-Alonso PM, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.024.2009; Raichle ME, 1998, P NATL ACAD SCI USA, V95, P765, DOI 10.1073/pnas.95.3.765; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Roediger H. L., 1993, HANDB NEUR, P63; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Schacter DL, 1998, NEUROBIOL LEARN MEM, V70, P284, DOI 10.1006/nlme.1998.3854; Schumacher EH, 1996, NEUROIMAGE, V3, P79, DOI 10.1006/nimg.1996.0009; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stark CEL, 2002, LEARN MEMORY, V9, P238, DOI 10.1101/lm.51802; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Suzuki WA, 2008, PROG BRAIN RES, V169, P305, DOI 10.1016/S0079-6123(07)00019-2; Thorndike E.L., 1944, TEACHERS WORD BOOK 3; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wais PE, 2008, NEUROPSYCHOLOGIA, V46, P3185, DOI 10.1016/j.neuropsychologia.2008.08.025; WARRINGTON EK, 1974, NEUROPSYCHOLOGIA, V12, P419, DOI 10.1016/0028-3932(74)90072-4; Wu X, 2008, NEUROREPORT, V19, P483, DOI 10.1097/WNR.0b013e3282f6030b; Wylie G, 2000, PSYCHOL RES-PSYCH FO, V63, P212, DOI 10.1007/s004269900003; Zeineh MM, 2003, SCIENCE, V299, P577, DOI 10.1126/science.1077775	67	6	7	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e50814	10.1371/journal.pone.0050814	http://dx.doi.org/10.1371/journal.pone.0050814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23341876	Green Published, gold			2022-12-25	WOS:000313682700006
J	Shiryaev, SA; Chernov, AV; Golubkov, VS; Thomsen, ER; Chudin, E; Chee, MS; Kozlov, IA; Strongin, AY; Cieplak, P				Shiryaev, Sergey A.; Chernov, Andrei V.; Golubkov, Vladislav S.; Thomsen, Elliot R.; Chudin, Eugene; Chee, Mark S.; Kozlov, Igor A.; Strongin, Alex Y.; Cieplak, Piotr			High-Resolution Analysis and Functional Mapping of Cleavage Sites and Substrate Proteins of Furin in the Human Proteome	PLOS ONE			English	Article							INTEGRIN ALPHA(V) SUBUNIT; PROPROTEIN CONVERTASES; ACTIVATION; EXPRESSION; INHIBITORS; RECEPTOR; DATABASE; MT1-MMP; ENZYMES; VIRUSES	Background: There is a growing appreciation of the role of proteolytic processes in human health and disease, but tools for analysis of such processes on a proteome-wide scale are limited. Furin is a ubiquitous proprotein convertase that cleaves after basic residues and transforms secretory proproteins into biologically active proteins. Despite this important role, many furin substrates remain unknown in the human proteome. Methodology/Principal Findings: We devised an approach for proteinase target identification that combines an in silico discovery pipeline with highly multiplexed proteinase activity assays. We performed in silico analysis of the human proteome and identified over 1,050 secretory proteins as potential furin substrates. We then used a multiplexed protease assay to validate these tentative targets. The assay was carried out on over 3,260 overlapping peptides designed to represent P7-P1' and P4-P4' positions of furin cleavage sites in the candidate proteins. The obtained results greatly increased our knowledge of the unique cleavage preferences of furin, revealed the importance of both short-range (P4-P1) and long-range (P7-P6) interactions in defining furin cleavage specificity, demonstrated that the R-X-R/K/X-R down arrow motif alone is insufficient for predicting furin proteolysis of the substrate, and identified similar to 490 potential protein substrates of furin in the human proteome. Conclusions/Significance: The assignment of these substrates to cellular pathways suggests an important role of furin in development, including axonal guidance, cardiogenesis, and maintenance of stem cell pluripotency. The novel approach proposed in this study can be readily applied to other proteinases.	[Shiryaev, Sergey A.; Chernov, Andrei V.; Golubkov, Vladislav S.; Strongin, Alex Y.; Cieplak, Piotr] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA USA; [Thomsen, Elliot R.; Chudin, Eugene; Chee, Mark S.; Kozlov, Igor A.] Prognosys Biosci Inc, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Cieplak, P (corresponding author), Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA USA.	strongin@sanfordburnham.org; pcieplak@sanfordburnham.org	Strongin, Alex/R-6609-2019; Golubkov, Vladislav/L-6828-2017; Chernov, Andrei/I-1623-2019	Strongin, Alex/0000-0003-3765-3016; Chernov, Andrei/0000-0002-3294-5418	National Institutes of Health (NIH) [R43GM085884, R01CA83017, R01CA157328, R01GM98835]; NATIONAL CANCER INSTITUTE [R01CA157328, R01CA083017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098835, R43GM085884] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) grants R43GM085884 (IAK), R01CA83017 and R01CA157328 (AYS), and R01GM98835 (PC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; [Anonymous], ING PATHW AN IPA SYS; Baciu PC, 2003, EXP CELL RES, V291, P167, DOI 10.1016/S0014-4827(03)00387-2; Basak A, 2001, BIOCHEM J, V353, P537, DOI 10.1042/0264-6021:3530537; Becker GL, 2012, J BIOL CHEM, V287, P21992, DOI 10.1074/jbc.M111.332643; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bidart M, 2012, CELL MOL LIFE SCI, V69, P313, DOI 10.1007/s00018-011-0751-1; Case D.A., 2022, AMBER 2020; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Coppola J, 2008, NEOPLASIA, V10, P363, DOI 10.1593/neo.08166; Creemers JWM, 2008, FRONT BIOSCI-LANDMRK, V13, P4960, DOI 10.2741/3055; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Deryugina EI, 2004, TRAFFIC, V5, P627, DOI 10.1111/j.1600-0854.2004.00206.x; Deryugina EI, 1997, J CELL SCI, V110, P2473; Deryugina EI, 2002, J BIOL CHEM, V277, P9749, DOI 10.1074/jbc.M110269200; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Forneris F, 2012, CURR OPIN STRUCT BIO; Fortugno P, 2012, HUM MOL GENET, V21, P4187, DOI 10.1093/hmg/dds243; Gawlik K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011305; Gawlik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005031; Gordon WR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006613; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Igarashi Y, 2007, NUCLEIC ACIDS RES, V35, pD546, DOI 10.1093/nar/gkl813; Jaroszewski L, 2011, NUCLEIC ACIDS RES, V39, pW38, DOI 10.1093/nar/gkr441; Kazanov MD, 2011, J PROTEOME RES, V10, P3642, DOI 10.1021/pr200271w; Kim W, 2012, MOL CELL BI IN PRESS; Kozlov IA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037441; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lei X, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217638; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; MOEHRING JM, 1993, J BIOL CHEM, V268, P2590; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ratnikov BI, 2002, J BIOL CHEM, V277, P7377, DOI 10.1074/jbc.M109580200; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; ROBERTSON BJ, 1993, J BIOL CHEM, V268, P24274; Rother K, 1998, COMPLEMENT SYSTEM; Seidah NG, 2011, METHODS MOL BIOL, V768, P23, DOI 10.1007/978-1-61779-204-5_3; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; Shiryaev SA, 2006, BIOCHEM J, V393, P503, DOI 10.1042/BJ20051374; Shiryaev SA, 2007, J BIOL CHEM, V282, P20847, DOI 10.1074/jbc.M703847200; Shiryaev SA, 2007, J VIROL, V81, P4501, DOI 10.1128/JVI.02719-06; Shiryaev SA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040029, 10.1371/journal.pone.0035759]; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Sun XW, 2011, J BIOL CHEM, V286, P29063, DOI 10.1074/jbc.M111.242479; TAKAHASHI S, 1995, J BIOL CHEM, V270, P26565, DOI 10.1074/jbc.270.44.26565; Taneja-Bageshwar S, 2012, DEV BIOL, V371, P66, DOI 10.1016/j.ydbio.2012.08.006; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tian S, 2011, INT J MOL SCI, V12, P1060, DOI 10.3390/ijms12021060; Turpeinen H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-618	55	40	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54290	10.1371/journal.pone.0054290	http://dx.doi.org/10.1371/journal.pone.0054290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335997	Green Submitted, Green Published, gold			2022-12-25	WOS:000314707700055
J	Psomopoulos, FE; Mitkas, PA; Ouzounis, CA				Psomopoulos, Fotis E.; Mitkas, Pericles A.; Ouzounis, Christos A.			Detection of Genomic Idiosyncrasies Using Fuzzy Phylogenetic Profiles	PLOS ONE			English	Article							COMPUTATIONAL GENOMICS; FUNCTIONAL LINKAGES; DATA ENVIRONMENT; EVOLUTION; SEQUENCE; GENES; PREDICTION; BACTERIAL; PATHWAYS; IDENTIFICATION	Phylogenetic profiles express the presence or absence of genes and their homologs across a number of reference genomes. They have emerged as an elegant representation framework for comparative genomics and have been used for the genome-wide inference and discovery of functionally linked genes or metabolic pathways. As the number of reference genomes grows, there is an acute need for faster and more accurate methods for phylogenetic profile analysis with increased performance in speed and quality. We propose a novel, efficient method for the detection of genomic idiosyncrasies, i.e. sets of genes found in a specific genome with peculiar phylogenetic properties, such as intra-genome correlations or inter-genome relationships. Our algorithm is a four-step process where genome profiles are first defined as fuzzy vectors, then discretized to binary vectors, followed by a de-noising step, and finally a comparison step to generate intra-and inter-genome distances for each gene profile. The method is validated with a carefully selected benchmark set of five reference genomes, using a range of approaches regarding similarity metrics and pre-processing stages for noise reduction. We demonstrate that the fuzzy profile method consistently identifies the actual phylogenetic relationship and origin of the genes under consideration for the majority of the cases, while the detected outliers are found to be particular genes with peculiar phylogenetic patterns. The proposed method provides a time-efficient and highly scalable approach for phylogenetic stratification, with the detected groups of genes being either similar to their own genome profile or different from it, thus revealing atypical evolutionary histories.	[Psomopoulos, Fotis E.; Mitkas, Pericles A.] Aristotle Univ Thessaloniki, Dept Elect & Comp Engn, GR-54006 Thessaloniki, Greece; [Ouzounis, Christos A.] Kings Coll London, Sch Nat & Math Sci, Dept Informat, Ctr Bioinformat, London WC2R 2LS, England	Aristotle University of Thessaloniki; University of London; King's College London	Ouzounis, CA (corresponding author), Ctr Res & Technol Hellas CERTH, Inst Appl Biosci, Computat Genom Unit, Thessaloniki, Greece.	ouzounis@certh.gr	Psomopoulos, Fotis/E-9995-2013; Ouzounis, Christos A/G-2302-2010	Psomopoulos, Fotis/0000-0002-0222-4273; Ouzounis, Christos A/0000-0002-0086-8657	FP6 Network of Excellence ENFIN [LSHG-CT-2005-518254]; FP7 Collaborative Project MICROME [222886-2]; European Commission	FP6 Network of Excellence ENFIN; FP7 Collaborative Project MICROME; European Commission(European CommissionEuropean Commission Joint Research Centre)	Parts of this work have been supported by the FP6 Network of Excellence ENFIN (contract # LSHG-CT-2005-518254) and the FP7 Collaborative Project MICROME (grant agreement # 222886-2), both funded by the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen LF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r17; Cokus S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S7; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Ferrer L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-493; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Freilich S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-355; Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Glass JI, 2000, NATURE, V407, P757, DOI 10.1038/35037619; Goldovsky L, 2005, BIOINFORMATICS, V21, P3806, DOI 10.1093/bioinformatics/bti579; Gonzalez O, 2008, BIOINFORMATICS, V24, P1257, DOI 10.1093/bioinformatics/btn106; HENDLER RW, 1994, J BIOCHEM BIOPH METH, V28, P1, DOI 10.1016/0165-022X(94)90061-2; Huynen MA, 1998, P NATL ACAD SCI USA, V95, P5849, DOI 10.1073/pnas.95.11.5849; Janssen P, 2003, BIOINFORMATICS, V19, P1451, DOI 10.1093/bioinformatics/btg161; Jothi R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-173; Karimpour-Fard A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-393; Kastenmuller G, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r28; Kunin V, 2005, NUCLEIC ACIDS RES, V33, P616, DOI 10.1093/nar/gki181; Kunin V, 2003, GENOME RES, V13, P1589, DOI 10.1101/gr.1092603; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Mikkelsen TS, 2005, BIOINFORMATICS, V21, P464, DOI 10.1093/bioinformatics/bti027; Moreno-Hagelsieb G, 2008, PROTEINS, V70, P344, DOI 10.1002/prot.21564; Ouzounis C, 1996, FEBS LETT, V390, P119, DOI 10.1016/0014-5793(96)00631-X; Ouzounis CA, 2006, RES MICROBIOL, V157, P57, DOI 10.1016/j.resmic.2005.06.015; Ouzounis CA, 2003, NAT REV GENET, V4, P508, DOI 10.1038/nrg1113; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Peregrin-Alvarez JM, 2003, GENOME RES, V13, P422, DOI 10.1101/gr.246903; Pereyre S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000677; Saikolappan S, 2009, J BACTERIOL, V191, P6675, DOI 10.1128/JB.01066-08; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Smith M, 2005, BIOINFORMATICS, V21, P3429, DOI 10.1093/bioinformatics/bti548; Snitkin ES, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-420; Steimann F, 1997, ARTIF INTELL MED, V11, P1; Sun JC, 2007, BIOCHEM BIOPH RES CO, V353, P985, DOI 10.1016/j.bbrc.2006.12.146; Tamames J, 1997, J MOL EVOL, V44, P66, DOI 10.1007/PL00006122; Tamura M, 2008, BIOINFORMATICS, V24, P1523, DOI 10.1093/bioinformatics/btn210; Tekaia F, 2005, PLOS COMPUT BIOL, V1, P604, DOI 10.1371/journal.pcbi.0010075; von Mering C, 2003, P NATL ACAD SCI USA, V100, P15428, DOI 10.1073/pnas.2136809100; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Wu J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-80; Wu J, 2003, BIOINFORMATICS, V19, P1524, DOI 10.1093/bioinformatics/btg187	43	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52854	10.1371/journal.pone.0052854	http://dx.doi.org/10.1371/journal.pone.0052854			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341912	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400023
J	Hart, AW; Mella, S; Mendrychowski, J; van Heyningen, V; Kleinjan, DA				Hart, Alan W.; Mella, Sebastien; Mendrychowski, Jacek; van Heyningen, Veronica; Kleinjan, Dirk A.			The Developmental Regulator Pax6 Is Essential for Maintenance of Islet Cell Function in the Adult Mouse Pancreas	PLOS ONE			English	Article							BETA-CELLS; EARLY-ONSET; GLUCOSE; GENES; MICE; EXPRESSION; GHRELIN; TRANSCRIPTION; PDX1; DIFFERENTIATION	The transcription factor Pax6 is a developmental regulator with a crucial role in development of the eye, brain, and olfactory system. Pax6 is also required for correct development of the endocrine pancreas and specification of hormone producing endocrine cell types. Glucagon-producing cells are almost completely lost in Pax6-null embryos, and insulin-expressing beta and somatostatin-expressing delta cells are reduced. While the developmental role of Pax6 is well-established, investigation of a further role for Pax6 in the maintenance of adult pancreatic function is normally precluded due to neonatal lethality of Pax6-null mice. Here a tamoxifen-inducible ubiquitous Cre transgene was used to inactivate Pax6 at 6 months of age in a conditional mouse model to assess the effect of losing Pax6 function in adulthood. The effect on glucose homeostasis and the expression of key islet cell markers was measured. Homozygous Pax6 deletion mice, but not controls, presented with all the symptoms of classical diabetes leading to severe weight loss requiring termination of the experiment five weeks after first tamoxifen administration. Immunohistochemical analysis of the pancreata revealed almost complete loss of Pax6 and much reduced expression of insulin, glucagon, and somatostatin. Several other markers of islet cell function were also affected. Notably, strong upregulation in the number of ghrelin-expressing endocrine cells was observed. These findings demonstrate that Pax6 is essential for adult maintenance of glucose homeostasis and function of the endocrine pancreas.	[Hart, Alan W.; Mella, Sebastien; Mendrychowski, Jacek; van Heyningen, Veronica; Kleinjan, Dirk A.] Univ Edinburgh, Human Genet Unit, Med Res Council, Inst Genet & Mol Med, Edinburgh EH8 9YL, Midlothian, Scotland	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh	Kleinjan, DA (corresponding author), Univ Edinburgh, Human Genet Unit, Med Res Council, Inst Genet & Mol Med, Edinburgh EH8 9YL, Midlothian, Scotland.	Dirk-Jan.Kleinjan@igmm.ed.ac.uk	VAN HEYNINGEN, Veronica/GYE-0531-2022; van Heyningen, Veronica/B-8039-2008	van Heyningen, Veronica/0000-0003-0359-0141; Hart, Alan/0000-0001-7463-2535	Medical Research Council UK; EU FP6 [LSHG-CT-2005-512036]; Medical Research Council [MC_PC_U127527199, MC_U127527199] Funding Source: researchfish; MRC [MC_PC_U127527199, MC_U127527199] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU FP6(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Work at the IGMM Human Genetics Unit is supported by core funding from the Medical Research Council UK (http://www.mrc.ac.uk/). SM was supported by an EU FP6 collaborative grant LSHG-CT-2005-512036. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Ahlqvist E, 2012, DIABETOLOGIA, V55, P94, DOI 10.1007/s00125-011-2300-8; Andersen FG, 1999, FEBS LETT, V445, P315, DOI 10.1016/S0014-5793(99)00144-1; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Ashery-Padan R, 2004, DEV BIOL, V269, P479, DOI 10.1016/j.ydbio.2004.01.040; Bewick GA, 2009, DIABETES, V58, P840, DOI 10.2337/db08-1428; Bhatia B, 2011, INVEST OPHTH VIS SCI, V52, P136, DOI 10.1167/iovs.10-5208; Bonal C, 2008, INT J DEV BIOL, V52, P823, DOI 10.1387/ijdb.072444cb; Briggs DI, 2011, CURR DIABETES REV, V7, P201, DOI 10.2174/157339911795843140; Brill MS, 2008, J NEUROSCI, V28, P6439, DOI 10.1523/JNEUROSCI.0700-08.2008; Coutinho P, 2011, GENOME RES, V21, P1349, DOI 10.1101/gr.124115.111; Dames P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-39; Davidson EH, 2006, REG GEN GEN REG; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Delporte FM, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-53; Ding J, 2009, ENDOCRINOLOGY, V150, P2136, DOI 10.1210/en.2008-1006; Ellard S, 2006, HUM MUTAT, V27, P854, DOI 10.1002/humu.20357; Gosmain Y, 2012, MOL ENDOCRINOL, V26, P696, DOI 10.1210/me.2011-1256; Gosmain Y, 2010, J BIOL CHEM, V285, P33381, DOI 10.1074/jbc.M110.147215; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Guillam MT, 1997, NAT GENET, V17, P327, DOI 10.1038/ng1197-327; Hamasaki A, 2007, BIOCHEM BIOPH RES CO, V353, P40, DOI 10.1016/j.bbrc.2006.11.105; Hart AW, 2000, NATURE, V408, P864, DOI 10.1038/35048589; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Heller RS, 2004, DEV BIOL, V268, P123, DOI 10.1016/j.ydbio.2003.12.008; Heller RS, 2005, DEV BIOL, V286, P217, DOI 10.1016/j.ydbio.2005.06.041; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Holland AM, 2005, DIABETES, V54, P2586, DOI 10.2337/diabetes.54.9.2586; Inui A, 2001, NAT REV NEUROSCI, V2, P551, DOI 10.1038/35086018; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Kammandel B, 1999, DEV BIOL, V205, P79, DOI 10.1006/dbio.1998.9128; Katz LS, 2009, MOL CELL BIOL, V29, P2322, DOI 10.1128/MCB.01543-08; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Nishi M, 2005, DIABETIC MED, V22, P641, DOI 10.1111/j.1464-5491.2005.01469.x; Nitta Y, 2009, EXP ANIM TOKYO, V58, P105, DOI 10.1538/expanim.58.105; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Prado CL, 2004, P NATL ACAD SCI USA, V101, P2924, DOI 10.1073/pnas.0308604100; Ramaesh K, 2005, INT J BIOCHEM CELL B, V37, P547, DOI 10.1016/j.biocel.2004.09.002; Ruige JB, 1999, DIABETOLOGIA, V42, P177, DOI 10.1007/s001250051136; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; Simpson TI, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-19; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Sisodiya SM, 2001, NAT GENET, V28, P214, DOI 10.1038/90042; Steiner DF, 2011, METHODS MOL BIOL, V768, P3, DOI 10.1007/978-1-61779-204-5_1; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Sun YX, 2008, ENDOCRINOLOGY, V149, P843, DOI 10.1210/en.2007-0271; Veldhuis Johannes D, 2010, Int J Pept, V2010, DOI 10.1155/2010/879503; Wen JH, 2009, DIABETOLOGIA, V52, P504, DOI 10.1007/s00125-008-1210-x; Williams SC, 1998, MECH DEVELOP, V73, P225, DOI 10.1016/S0925-4773(98)00057-4; Xu PX, 1999, DEVELOPMENT, V126, P383; Yasuda T, 2002, DIABETES, V51, P224, DOI 10.2337/diabetes.51.1.224; Zhang X, 2003, GENESIS, V35, P22, DOI 10.1002/gene.10160; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	55	56	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54173	10.1371/journal.pone.0054173	http://dx.doi.org/10.1371/journal.pone.0054173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326594	gold, Green Submitted, Green Published			2022-12-25	WOS:000314705800114
J	D'Addio, F; Boenisch, O; Magee, CN; Yeung, MY; Yuan, XL; Mfarrej, B; Vergani, A; Ansari, MJ; Fiorina, P; Najafian, N				D'Addio, Francesca; Boenisch, Olaf; Magee, Ciara N.; Yeung, Melissa Y.; Yuan, Xueli; Mfarrej, Bechara; Vergani, Andrea; Ansari, Mohammed Javeed; Fiorina, Paolo; Najafian, Nader			Prolonged, Low-Dose Anti-Thymocyte Globulin, Combined with CTLA4-Ig, Promotes Engraftment in a Stringent Transplant Model	PLOS ONE			English	Article							REGULATORY T-CELLS; IMMUNOSUPPRESSIVE DRUGS; RABBIT ATG; PHASE-III; IN-VITRO; TOLERANCE; DEPLETION; PROGRESS; BALANCE; VIVO	Background: Despite significant nephrotoxicity, calcineurin inhibitors (CNIs) remain the cornerstone of immunosuppression in solid organ transplantation. We, along with others, have reported tolerogenic properties of anti-thymocyte globulin (ATG, Thymoglobulin (R)), evinced by its ability both to spare Tregs from depletion in vivo and, when administered at low, non-depleting doses, to expand Tregs ex vivo. Clinical trials investigating B7/CD28 blockade (LEA29Y, Belatacept) in kidney transplant recipients have proven that the replacement of toxic CNI use is feasible in selected populations. Methods: Rabbit polyclonal anti-murine thymocyte globulin (mATG) was administered as induction and/or prolonged, low-dose therapy, in combination with CTLA4-Ig, in a stringent, fully MHC-mismatched murine skin transplant model to assess graft survival and mechanisms of action. Results: Prolonged, low-dose mATG, combined with CTLA4-Ig, effectively promotes engraftment in a stringent transplant model. Our data demonstrate that mATG achieves graft acceptance primarily by promoting Tregs, while CTLA4-Ig enhances mATG function by limiting activation of the effector T cell pool in the early stages of treatment, and by inhibiting production of anti-rabbit antibodies in the maintenance phase, thereby promoting regulation of alloreactivity. Conclusion: These data provide the rationale for development of novel, CNI-free clinical protocols in human transplant recipients.	[D'Addio, Francesca; Boenisch, Olaf; Magee, Ciara N.; Yeung, Melissa Y.; Yuan, Xueli; Mfarrej, Bechara; Vergani, Andrea; Ansari, Mohammed Javeed; Fiorina, Paolo; Najafian, Nader] Brigham & Womens Hosp, Div Renal, Transplantat Res Ctr, Boston, MA 02115 USA; [D'Addio, Francesca; Boenisch, Olaf; Magee, Ciara N.; Yeung, Melissa Y.; Yuan, Xueli; Mfarrej, Bechara; Vergani, Andrea; Ansari, Mohammed Javeed; Fiorina, Paolo; Najafian, Nader] Harvard Univ, Childrens Hosp Boston, Sch Med, Boston, MA USA; [D'Addio, Francesca; Vergani, Andrea; Fiorina, Paolo] Hosp San Raffaele, Transplantat Med Div, I-20132 Milan, Italy; [Ansari, Mohammed Javeed] Northwestern Univ, Feinberg Sch Med, Div Nephrol & Organ Transplantat, Chicago, IL 60611 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Northwestern University; Feinberg School of Medicine	Najafian, N (corresponding author), Brigham & Womens Hosp, Div Renal, Transplantat Res Ctr, 75 Francis St, Boston, MA 02115 USA.	nnajafian@rics.bwh.harvard.edu	Mfarrej, Bechara/AAE-9616-2021; D'Addio, Francesca/F-3417-2017; Fiorina, Paolo/B-4532-2019	Mfarrej, Bechara/0000-0002-8361-5240; D'Addio, Francesca/0000-0002-0345-0694; Fiorina, Paolo/0000-0002-1093-7724	National Institutes of Health [1KO8AI064335-01A2]; Genzyme; ERA-EDTA Fellowship Grant; SISQT-Biotest Fellowship Grant; NIH Grant [K08 AI080836-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI064335, K08AI080836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genzyme(Sanofi-AventisGenzyme Corporation); ERA-EDTA Fellowship Grant; SISQT-Biotest Fellowship Grant; NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health 1KO8AI064335-01A2 and a grant from Genzyme. FD was supported by the ERA-EDTA Fellowship Grant and the SISQT-Biotest Fellowship Grant. MJA was supported by a NIH Grant K08 AI080836-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bestard O, 2007, J IMMUNOL, V179, P4901, DOI 10.4049/jimmunol.179.7.4901; Bloom DD, 2008, AM J TRANSPLANT, V8, P793, DOI 10.1111/j.1600-6143.2007.02134.x; Boenisch O, 2012, AM J TRANSPLANT, V12, P856, DOI 10.1111/j.1600-6143.2011.03978.x; Broady R, 2009, BLOOD, V114, P5003, DOI 10.1182/blood-2009-04-214437; Chapman JR, 2011, AM J TRANSPLANT, V11, P693, DOI 10.1111/j.1600-6143.2011.03504.x; D'Addio F, 2010, TRANSPLANTATION, V90, P260, DOI 10.1097/TP.0b013e3181e64217; De Serres SA, 2009, CLIN J AM SOC NEPHRO, V4, P1661, DOI 10.2215/CJN.03180509; Durrbach A, 2010, AM J TRANSPLANT, V10, P547, DOI 10.1111/j.1600-6143.2010.03016.x; Feng XM, 2008, BLOOD, V111, P3675, DOI 10.1182/blood-2008-01-130146; Golshayan D, 2008, DRUGS, V68, P2113, DOI 10.2165/00003495-200868150-00004; Kang SM, 2007, AM J TRANSPLANT, V7, P1457; LaCorcia G, 2009, TRANSPLANTATION, V87, P966, DOI 10.1097/TP.0b013e31819c84b8; Lechler RI, 2003, NAT REV IMMUNOL, V3, P147, DOI 10.1038/nri1002; Li XC, 2009, IMMUNOL REV, V229, P271, DOI 10.1111/j.1600-065X.2009.00781.x; Lopez M, 2006, J AM SOC NEPHROL, V17, P2844, DOI 10.1681/ASN.2006050422; Matthews JB, 2003, AM J TRANSPLANT, V3, P794, DOI 10.1046/j.1600-6135.2003.0154.x; Nador RG, 2010, AM J TRANSPLANT, V10, P262, DOI 10.1111/j.1600-6143.2009.02942.x; Ndejembi MP, 2006, J IMMUNOL, V177, P7698, DOI 10.4049/jimmunol.177.11.7698; Neujahr DC, 2006, J IMMUNOL, V176, P4632, DOI 10.4049/jimmunol.176.8.4632; Noris M, 2007, J AM SOC NEPHROL, V18, P1007, DOI 10.1681/ASN.2006101143; Pascual M, 2002, NEW ENGL J MED, V346, P580, DOI 10.1056/NEJMra011295; Ruzek MC, 2008, BLOOD, V111, P1726, DOI 10.1182/blood-2007-08-106526; Ruzek MC, 2009, TRANSPLANTATION, V88, P170, DOI 10.1097/TP.0b013e3181abc061; Salama AD, 2003, J AM SOC NEPHROL, V14, P1643, DOI 10.1097/01.ASN.0000057540.98231.C1; Shen SQ, 2005, J CLIN INVEST, V115, P3517, DOI 10.1172/JCI25463; Torrealba JR, 2003, TRANSPLANTATION, V76, P524, DOI 10.1097/01.TP.0000075788.72614.D4; Turka LA, 2009, NAT REV IMMUNOL, V9, P521, DOI 10.1038/nri2568; Vergani A, 2010, DIABETES, V59, P2253, DOI 10.2337/db09-1264; Vincenti F, 2012, AM J TRANSPLANT, V12, P210, DOI 10.1111/j.1600-6143.2011.03785.x; Vincenti F, 2002, AM J TRANSPLANT, V2, P898, DOI 10.1034/j.1600-6143.2002.21005.x; Vincenti F, 2010, AM J TRANSPLANT, V10, P535, DOI 10.1111/j.1600-6143.2009.03005.x; Waldmann H, 2001, IMMUNITY, V14, P399, DOI 10.1016/S1074-7613(01)00120-0; Wells AD, 1999, NAT MED, V5, P1303, DOI 10.1038/15260; Zheng XX, 2003, IMMUNITY, V19, P503, DOI 10.1016/S1074-7613(03)00259-0; Zheng XX, 2003, IMMUNOL REV, V196, P75, DOI 10.1046/j.1600-065X.2003.00089.x	35	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53797	10.1371/journal.pone.0053797	http://dx.doi.org/10.1371/journal.pone.0053797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326509	Green Submitted, Green Published, gold			2022-12-25	WOS:000313552400047
J	Dzierma, Y; Nuesken, FG; Fleckenstein, J; Kremp, S; Licht, NP; Ruebe, C				Dzierma, Yvonne; Nuesken, Frank G.; Fleckenstein, Jochen; Kremp, Stephanie; Licht, Norbert P.; Ruebe, Christian			Visualisation of Respiratory Tumour Motion and Co-Moving Isodose Lines in the Context of Respiratory Gating, IMRT and Flattening-Filter-Free Beams	PLOS ONE			English	Article							BREATHING ADAPTED RADIOTHERAPY; STEREOTACTIC BODY RADIOTHERAPY; MODULATED RADIATION-THERAPY; INTERNAL TARGET VOLUME; 4-DIMENSIONAL CT SCANS; I LUNG-CANCER; ORGAN MOTION; MULTILEAF COLLIMATOR; DOSIMETRIC IMPACT; MONTE-CARLO	Respiratory motion during percutaneous radiotherapy can be considered based on respiration-correlated computed tomography (4DCT). However, most treatment planning systems perform the dose calculation based on a single primary CT data set, even though cine mode displays may allow for a visualisation of the complete breathing cycle. This might create the mistaken impression that the dose distribution were independent of tumour motion. We present a movie visualisation technique with the aim to direct attention to the fact that the dose distribution migrates to some degree with the tumour and discuss consequences for gated treatment, IMRT plans and flattening-filter-free beams. This is a feasibility test for a visualisation of tumour and isodose motion. Ten respiratory phases are distinguished on the CT, and the dose distribution from a stationary IMRT plan is calculated on each phase, to be integrated into a movie of tumour and dose motion during breathing. For one example patient out of the sample of five lesions, the plan is compared with a gated treatment plan with respect to tumour coverage and lung sparing. The interplay-effect for small segments in the IMRT plan is estimated. While the high dose rate, together with the cone-shaped beam profile, makes the use of flattening-filter-free beams more problematic for conformal and IMRT treatment, it can be the option of choice if gated treatment is preferred. The different effects of respiratory motion, dose build-up and beam properties (segments and flatness) for gated vs. un-gated treatment can best be considered if planning is performed on the full 4DCT data set, which may be an incentive for future developments of treatment planning systems.	[Dzierma, Yvonne; Nuesken, Frank G.; Fleckenstein, Jochen; Kremp, Stephanie; Licht, Norbert P.; Ruebe, Christian] Univ Saarland, Med Ctr, Dept Radiat Oncol, Homburg, Germany	Saarland University	Dzierma, Y (corresponding author), Univ Saarland, Med Ctr, Dept Radiat Oncol, Homburg, Germany.	yvonne.dzierma@uks.eu						Alasti H, 2006, PHYS MED BIOL, V51, P3251, DOI 10.1088/0031-9155/51/12/017; Allen AM, 2004, INT J RADIAT ONCOL, V58, P1251, DOI 10.1016/j.ijrobp.2003.09.081; Balter JM, 1996, INT J RADIAT ONCOL, V36, P167, DOI 10.1016/S0360-3016(96)00275-1; Boda-Heggemann J, 2011, STRAHLENTHERAPIE UND, V5, P284; Bortfeld T, 2002, PHYS MED BIOL, V47, P2203, DOI 10.1088/0031-9155/47/13/302; Brock J, 2011, INT J RADIAT ONCOL, V81, P369, DOI 10.1016/j.ijrobp.2010.05.038; Chen HC, 2009, MED PHYS, V36, P893, DOI 10.1118/1.3070542; Chui CS, 2003, MED PHYS, V30, P1736, DOI 10.1118/1.1578771; Court L, 2011, J APPL CLIN MED PHYS, V12, P28, DOI 10.1120/jacmp.v12i1.3276; Ding CX, 2007, MED PHYS, V34, P3500, DOI 10.1118/1.2760308; Dzierma Y, 2012, MED PHYS, V39, P2595, DOI 10.1118/1.3703835; Flampouri S, 2006, PHYS MED BIOL, V51, P2763, DOI 10.1088/0031-9155/51/11/006; Frazier RC, 2004, INT J RADIAT ONCOL, V58, P1041, DOI 10.1016/j.ijrobp.2003.07.005; Gabrys D, 2011, RADIOTHER ONCOL, V100, P360, DOI 10.1016/j.radonc.2011.09.006; Guckenberger M, 2007, INT J RADIAT ONCOL, V69, P276, DOI 10.1016/j.ijrobp.2007.04.074; Jiang SB, 2003, PHYS MED BIOL, V48, P1773, DOI 10.1088/0031-9155/48/12/307; Keall PJ, 2005, MED PHYS, V32, P942, DOI 10.1118/1.1879152; Korreman SS, 2005, RADIOTHER ONCOL, V76, P311, DOI 10.1016/j.radonc.2005.07.009; Langen KM, 2001, INT J RADIAT ONCOL, V50, P265, DOI 10.1016/S0360-3016(01)01453-5; Liu HH, 2007, INT J RADIAT ONCOL, V68, P531, DOI 10.1016/j.ijrobp.2006.12.066; Liu J, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-11; Mancosu P, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-16; McQuaid D, 2011, PHYS MED BIOL, V56, P6935, DOI 10.1088/0031-9155/56/21/011; Muirhead R, 2010, RADIOTHER ONCOL, V95, P172, DOI 10.1016/j.radonc.2010.02.002; Nohadani O, 2010, PHYS MED BIOL, V55, P5189, DOI 10.1088/0031-9155/55/17/019; Peguret N, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-78; Rietzel E, 2005, INT J RADIAT ONCOL, V61, P1535, DOI 10.1016/j.ijrobp.2004.11.037; Rietzel E, 2006, INT J RADIAT ONCOL, V66, P287, DOI 10.1016/j.ijrobp.2006.05.024; Roland T, 2009, PHYS MED BIOL, V54, P5509, DOI 10.1088/0031-9155/54/18/011; ROSS CS, 1990, INT J RADIAT ONCOL, V18, P671, DOI 10.1016/0360-3016(90)90076-V; Saw C B, 2007, Biomed Imaging Interv J, V3, pe40, DOI 10.2349/biij.3.1.e40; Seco J, 2008, MED PHYS, V35, P356, DOI 10.1118/1.2821704; Sonke JJ, 2005, MED PHYS, V32, P1176, DOI 10.1118/1.1869074; Stromberg JS, 2000, INT J RADIAT ONCOL, V48, P797, DOI 10.1016/S0360-3016(00)00681-7; Underberg RWM, 2005, INT J RADIAT ONCOL, V62, P554, DOI 10.1016/j.ijrobp.2005.01.032; Underberg RWM, 2004, INT J RADIAT ONCOL, V60, P1283, DOI 10.1016/j.ijrobp.2004.07.665; Vedam S, 2005, MED PHYS, V32, P1607, DOI 10.1118/1.1915017; Webb S, 2008, PHYS MED BIOL, V53, P5177, DOI 10.1088/0031-9155/53/18/022; Webb S, 2006, PHYS MED BIOL, V51, pR403, DOI 10.1088/0031-9155/51/13/R23; Wu JZ, 2008, RADIOTHER ONCOL, V87, P35, DOI 10.1016/j.radonc.2008.02.010; Zhao B, 2009, MED PHYS, V36, P2248, DOI 10.1118/1.3129161	41	8	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53799	10.1371/journal.pone.0053799	http://dx.doi.org/10.1371/journal.pone.0053799			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326510	Green Published, gold, Green Submitted			2022-12-25	WOS:000313552400048
J	Sohn, I; Sung, CO				Sohn, Insuk; Sung, Chang Ohk			Predictive Modeling Using a Somatic Mutational Profile in Ovarian High Grade Serous Carcinoma	PLOS ONE			English	Article							CROSS-VALIDATION; BRCA2; SURVIVAL; CHEMOTHERAPY; ACCURACY; OUTCOMES	Purpose: Recent high-throughput sequencing technology has identified numerous somatic mutations across the whole exome in a variety of cancers. In this study, we generate a predictive model employing the whole exome somatic mutational profile of ovarian high-grade serous carcinomas (Ov-HGSCs) obtained from The Cancer Genome Atlas data portal. Methods: A total of 311 patients were included for modeling overall survival (OS) and 259 patients were included for modeling progression free survival (PFS) in an analysis of 509 genes. The model was validated with complete leave-one-out cross-validation involving re-selecting genes for each iteration of the cross-validation procedure. Cross-validated Kaplan-Meier curves were generated. Cross-validated time dependent receiver operating characteristic (ROC) curves were computed and the area under the curve (AUC) values were calculated from the ROC curves to estimate the predictive accuracy of the survival risk models. Results: There was a significant difference in OS between the high-risk group (median, 28.1 months) and the low-risk group (median, 61.5 months) (permutated p-value <0.001). For PFS, there was also a significant difference in PFS between the high-risk group (10.9 months) and the low-risk group (22.3 months) (permutated p-value <0.001). Cross-validated AUC values were 0.807 for the OS and 0.747 for the PFS based on a defined landmark time t = 36 months. In comparisons between a predictive model containing only gene variables and a combined model containing both gene variables and clinical covariates, the predictive model containing gene variables without clinical covariates were effective and high AUC values for both OS and PFS were observed. Conclusions: We designed a predictive model using a somatic mutation profile obtained from high-throughput genomic sequencing data in Ov-HGSC samples that may represent a new strategy for applying high-throughput sequencing data to clinical practice.	[Sohn, Insuk] Samsung Canc Res Inst, Seoul, South Korea; [Sung, Chang Ohk] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea	University of Ulsan; Asan Medical Center	Sung, CO (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea.	co.sung@amc.seoul.kr		Sung, Chang Ohk/0000-0002-8567-456X				Azuaje F, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-5; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bookman MA, 2003, J CLIN ONCOL, V21, P283, DOI 10.1200/JCO.2003.10.104; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Braga-Neto UM, 2004, BIOINFORMATICS, V20, P374, DOI 10.1093/bioinformatics/btg419; Foulkes WD, 2006, FAM CANCER, V5, P135, DOI 10.1007/s10689-005-2832-5; Gallagher DJ, 2011, ANN ONCOL, V22, P1127, DOI 10.1093/annonc/mdq577; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; Hickey JM, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-23; Lacour RA, 2011, GYNECOL ONCOL, V121, P358, DOI 10.1016/j.ygyno.2010.12.354; McConville CM, 1996, AM J HUM GENET, V59, P320; Miller DS, 2009, J CLIN ONCOL, V27, P2686, DOI 10.1200/JCO.2008.19.2963; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Norquist B, 2011, J CLIN ONCOL, V29, P3008, DOI 10.1200/JCO.2010.34.2980; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Sabatier R, 2009, CRIT REV ONCOL HEMAT, V72, P98, DOI 10.1016/j.critrevonc.2009.01.007; Simon RM, 2011, BRIEF BIOINFORM, V12, P203, DOI 10.1093/bib/bbr001; Sohn I, 2012, GYNECOL ONCOL, V126, P103, DOI 10.1016/j.ygyno.2012.03.050; Waldron L, 2011, BIOINFORMATICS, V27, P3399, DOI 10.1093/bioinformatics/btr591; Xia F, 2001, P NATL ACAD SCI USA, V98, P8644, DOI 10.1073/pnas.151253498; Yang D, 2011, JAMA-J AM MED ASSOC, V306, P1557, DOI 10.1001/jama.2011.1456; Yuan SSF, 1999, CANCER RES, V59, P3547	25	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54089	10.1371/journal.pone.0054089	http://dx.doi.org/10.1371/journal.pone.0054089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326577	Green Published, Green Submitted, gold			2022-12-25	WOS:000313552400076
J	Tayade, AB; Dhar, P; Kumar, J; Sharma, M; Chauhan, RS; Chaurasia, OP; Srivastava, RB				Tayade, Amol B.; Dhar, Priyanka; Kumar, Jatinder; Sharma, Manu; Chauhan, Rajinder S.; Chaurasia, Om P.; Srivastava, Ravi B.			Chemometric Profile of Root Extracts of Rhodiola imbricata Edgew. with Hyphenated Gas Chromatography Mass Spectrometric Technique	PLOS ONE			English	Article							AQUEOUS EXTRACT; RHIZOME; NUCLEAR	Rhodiola imbricata Edgew. (Rose root or Arctic root or Golden root or Shrolo), belonging to the family Crassulaceae, is an important food crop and medicinal plant in the Indian trans-Himalayan cold desert. Chemometric profile of the n-hexane, chloroform, dichloroethane, ethyl acetate, methanol, and 60% ethanol root extracts of R. imbricata were performed by hyphenated gas chromatography mass spectrometry (GC/MS) technique. GC/MS analysis was carried out using Thermo Finnigan PolarisQ Ion Trap GC/MS MS system comprising of an AS2000 liquid autosampler. Interpretation on mass spectrum of GC/MS was done using the NIST/EPA/NIH Mass Spectral Database, with NIST MS search program v.2.0g. Chemometric profile of root extracts revealed the presence of 63 phyto-chemotypes, among them, 1-pentacosanol; stigmast-5-en-3-ol, (3 beta,24S); 1-teracosanol; 1-henteracontanol; 17-pentatriacontene; 13-tetradecen-1-ol acetate; methyl tri-butyl ammonium chloride; bis(2-ethylhexyl) phthalate; 7,8-dimethylbenzocyclooctene; ethyl linoleate; 3-methoxy-5-methylphenol; hexadecanoic acid; camphor; 1,3-dimethoxybenzene; thujone; 1,3-benzenediol, 5-pentadecyl; benzenemethanol, 3-hydroxy, 5-methoxy; cholest-4-ene-3,6-dione; dodecanoic acid, 3-hydroxy; octadecane, 1-chloro; ethanone, 1-(4-hydroxyphenyl); alpha-tocopherol; ascaridole; campesterol; 1-dotriacontane; heptadecane, 9-hexyl were found to be present in major amount. Eventually, in the present study we have found phytosterols, terpenoids, fatty acids, fatty acid esters, alkyl halides, phenols, alcohols, ethers, alkanes, and alkenes as the major group of phyto-chemotypes in the different root extracts of R. imbricata. All these compounds identified by GC/MS analysis were further investigated for their biological activities and it was found that they possess a diverse range of positive pharmacological actions. In future, isolation of individual phyto-chemotypes and subjecting them to biological activity will definitely prove fruitful results in designing a novel drug.	[Tayade, Amol B.; Dhar, Priyanka; Kumar, Jatinder; Chaurasia, Om P.; Srivastava, Ravi B.] Def Res & Dev Org, Def Inst High Altitude Res, Leh Ladakh, Jammu & Kashmir, India; [Sharma, Manu] Jaypee Univ Informat Technol, Dept Pharm, Waknaghat, Solan, India; [Chauhan, Rajinder S.] Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Waknaghat, Solan, India	Defence Research & Development Organisation (DRDO); Defence Institute of High Altitude Research (DIHAR); Jaypee University of Information Technology; Jaypee University of Information Technology	Chaurasia, OP (corresponding author), Def Res & Dev Org, Def Inst High Altitude Res, Leh Ladakh, Jammu & Kashmir, India.	dropchaurasiadihardrdo@gmail.com	CHAURASIA, OM/AAW-6347-2021; CHAURASIA, OM PRAKASH/AAP-3358-2021; Sharma, Manu/GOJ-9290-2022; Chauhan, Rajinder Singh/HGB-5642-2022	CHAURASIA, OM PRAKASH/0000-0003-2921-2755; Sharma, Prof (Dr) Manu/0000-0003-3903-1683	Defence Research & Development Organization, Ministry of Defence, Government of India	Defence Research & Development Organization, Ministry of Defence, Government of India	Funding provided by Defence Research & Development Organization, Ministry of Defence, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora R, 2005, MOL CELL BIOCHEM, V273, P209, DOI 10.1007/s11010-005-0822-4; Arora Rajesh, 2008, Journal of Dietary Supplements, V5, P147, DOI 10.1080/19390210802332695; Carro N, 1997, ANALYST, V122, P325, DOI 10.1039/a605856f; Chawla R, 2010, J PHARM BIOALLIED SC, V2, P213, DOI 10.4103/0975-7406.68503; Gherman C, 2000, TALANTA, V53, P253, DOI 10.1016/S0039-9140(00)00458-6; Goel HC, 2006, J MED FOOD, V9, P154, DOI 10.1089/jmf.2006.9.154; Gullberg J, 2004, ANAL BIOCHEM, V331, P283, DOI 10.1016/j.ab.2004.04.037; Gupta A, 2007, PLANTA MED, V73, P774, DOI 10.1055/s-2007-981546; Gupta V, 2008, FOOD CHEM TOXICOL, V46, P1645, DOI 10.1016/j.fct.2007.12.027; Gupta V, 2010, FOOD CHEM TOXICOL, V48, P1019, DOI 10.1016/j.fct.2010.01.012; Gupta V, 2009, FOOD CHEM TOXICOL, V47, P1239, DOI 10.1016/j.fct.2009.02.017; Iordache A, 2009, NUCL INSTRUM METH B, V267, P338, DOI 10.1016/j.nimb.2008.10.021; Kanupriya D, 2005, MOL CELL BIOCHEM, V275, P1, DOI 10.1007/s11010-005-7637-1; Khanum F, 2005, COMPR REV FOOD SCI F, V4, P55, DOI 10.1111/j.1541-4337.2005.tb00073.x; Kumar R, 2007, IND J CLIN BIOCH S, V22, P171; Mishra KP, 2008, IMMUNOBIOLOGY, V213, P125, DOI 10.1016/j.imbio.2007.07.003; Mishra KP, 2006, IMMUNOPHARM IMMUNOT, V28, P201, DOI 10.1080/08923970600815139; Mishra KP, 2012, IMMUNOPHARM IMMUNOT, V34, P513, DOI 10.3109/08923973.2011.638307; Mishra KP, 2010, IMMUNOPHARM IMMUNOT, V32, P141, DOI [10.3109/08923970903218874, 10.3109/08923970903503668]; Mishra KP, 2009, IMMUNOBIOLOGY, V214, P27, DOI 10.1016/j.imbio.2008.04.001; Pallado P, 1997, RAPID COMMUN MASS SP, V11, P1335; Raj K., 2010, Pharmacognosy Journal, V2, P431; Raj K., 2010, Pharmacognosy Journal, V2, P157; Robards K, 1997, ANALYST, V122, pR11, DOI 10.1039/a606499j; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; Shellie RA, 2009, J SEP SCI, V32, P3720, DOI 10.1002/jssc.200900422; Tulsawani R, 2013, J APPL TOXICOL, V33, P350, DOI 10.1002/jat.1739	27	36	39	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e52797	10.1371/journal.pone.0052797	http://dx.doi.org/10.1371/journal.pone.0052797			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326358	Green Published, Green Submitted, gold			2022-12-25	WOS:000313552400010
J	Altincicek, B; Elashry, A; Guz, N; Grundler, FMW; Vilcinskas, A; Dehne, HW				Altincicek, Boran; Elashry, Abdelnaser; Guz, Nurper; Grundler, Florian M. W.; Vilcinskas, Andreas; Dehne, Heinz-Wilhelm			Next Generation Sequencing Based Transcriptome Analysis of Septic-Injury Responsive Genes in the Beetle Tribolium castaneum	PLOS ONE			English	Article							IMMUNE-INDUCIBLE GENES; GENOME-WIDE ANALYSIS; RED FLOUR BEETLE; MOLECULAR-CLONING; BINDING PROTEIN; DEFENSE; IDENTIFICATION; INSECT; RECOGNITION; COAGULATION	Beetles (Coleoptera) are the most diverse animal group on earth and interact with numerous symbiotic or pathogenic microbes in their environments. The red flour beetle Tribolium castaneum is a genetically tractable model beetle species and its whole genome sequence has recently been determined. To advance our understanding of the molecular basis of beetle immunity here we analyzed the whole transcriptome of T. castaneum by high-throughput next generation sequencing technology. Here, we demonstrate that the Illumina/Solexa sequencing approach of cDNA samples from T. castaneum including over 9.7 million reads with 72 base pairs (bp) length (approximately 700 million bp sequence information with about 30 x transcriptome coverage) confirms the expression of most predicted genes and enabled subsequent qualitative and quantitative transcriptome analysis. This approach recapitulates our recent quantitative real-time PCR studies of immune-challenged and naive T. castaneum beetles, validating our approach. Furthermore, this sequencing analysis resulted in the identification of 73 differentially expressed genes upon immune-challenge with statistical significance by comparing expression data to calculated values derived by fitting to generalized linear models. We identified up regulation of diverse immune-related genes (e.g. Toll receptor, serine proteinases, DOPA decarboxylase and thaumatin) and of numerous genes encoding proteins with yet unknown functions. Of note, septic-injury resulted also in the elevated expression of genes encoding heat-shock proteins or cytochrome P450s supporting the view that there is crosstalk between immune and stress responses in T. castaneum. The present study provides a first comprehensive overview of septic-injury responsive genes in T. castaneum beetles. Identified genes advance our understanding of T. castaneum specific gene expression alteration upon immune-challenge in particular and may help to understand beetle immunity in general.	[Altincicek, Boran; Elashry, Abdelnaser; Grundler, Florian M. W.; Dehne, Heinz-Wilhelm] Univ Bonn, INRES Phytomed, Bonn, Germany; [Guz, Nurper] Ankara Univ, Fac Agr, Dept Plant Protect, TR-06100 Ankara, Turkey; [Vilcinskas, Andreas] Univ Giessen, Inst Phytopathol & Appl Zool, D-35390 Giessen, Germany	University of Bonn; Ankara University; Justus Liebig University Giessen	Altincicek, B (corresponding author), Univ Bonn, INRES Phytomed, Nussallee 9, Bonn, Germany.	boran.altincicek@uni-bonn.de	Elashry, Abdelnaser/ABA-3330-2021; Guz, Nurper/AAD-8374-2022	Grundler, Florian M.W./0000-0001-8101-0558; Altincicek, Boran/0000-0003-2019-452X	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [AL902/4-1, AL902/2-1]; University of Bonn (Landwirtschaftliche Fakultat); excellence initiative of the Hessian Ministry of Science and Art, which encompasses a generous grant for the LOEWE research focus "Insect Biotechnology"	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); University of Bonn (Landwirtschaftliche Fakultat); excellence initiative of the Hessian Ministry of Science and Art, which encompasses a generous grant for the LOEWE research focus "Insect Biotechnology"	The authors acknowledge support by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) with a Heisenberg-fellowship to BA (AL902/4-1), a research grant to BA and AV (AL902/2-1), by the University of Bonn (Landwirtschaftliche Fakultat) with a start-up fund to BA and by the excellence initiative of the Hessian Ministry of Science and Art, which encompasses a generous grant for the LOEWE research focus "Insect Biotechnology" to AV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Altincicek B, 2009, INSECT MOL BIOL, V18, P119, DOI 10.1111/j.1365-2583.2008.00856.x; Altincicek B, 2008, INSECT MOL BIOL, V17, P711, DOI 10.1111/j.1365-2583.2008.00835.x; Altincicek B, 2008, DEV COMP IMMUNOL, V32, P1416, DOI 10.1016/j.dci.2008.06.004; Altincicek B, 2008, J IMMUNOL, V181, P2705, DOI 10.4049/jimmunol.181.4.2705; Altincicek B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-326; Altincicek B, 2008, DEV COMP IMMUNOL, V32, P585, DOI 10.1016/j.dci.2007.09.005; Altincicek B, 2007, INSECT BIOCHEM MOLEC, V37, P726, DOI 10.1016/j.ibmb.2007.03.012; Altincicek B, 2009, BIOL CHEM, V390, P1303, DOI 10.1515/BC.2009.128; Anders S., 2010, ANAL RNA SEQ DATA DE; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Freitak D, 2012, BIOL LETTERS, V8, P860, DOI 10.1098/rsbl.2012.0273; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Han BW, 2008, SCIENCE, V321, P1834, DOI 10.1126/science.1162484; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Johansson KC, 2005, EXP CELL RES, V305, P145, DOI 10.1016/j.yexcr.2004.12.018; JOMORI T, 1991, J BIOL CHEM, V266, P13318; Koizumi N, 1997, EUR J BIOCHEM, V248, P217, DOI 10.1111/j.1432-1033.1997.t01-1-00217.x; Lee WJ, 1996, P NATL ACAD SCI USA, V93, P7888, DOI 10.1073/pnas.93.15.7888; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; MUTA T, 1991, J BIOL CHEM, V266, P6554; Parker BJ, 2011, TRENDS ECOL EVOL, V26, P242, DOI 10.1016/j.tree.2011.02.005; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Pursall ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019972; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; Roth O, 2008, J EVOLUTION BIOL, V21, P1703, DOI 10.1111/j.1420-9101.2008.01584.x; Roth O, 2009, P ROY SOC B-BIOL SCI, V276, P145, DOI 10.1098/rspb.2008.1157; Roxstrom-Lindquist K, 2004, EMBO REP, V5, P207, DOI 10.1038/sj.embor.7400073; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Short SM, 2010, P ROY SOC B-BIOL SCI, V277, P3649, DOI 10.1098/rspb.2010.0937; Vogel H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-308; Wang Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S5; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	40	39	41	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52004	10.1371/journal.pone.0052004	http://dx.doi.org/10.1371/journal.pone.0052004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326321	Green Published, gold, Green Submitted			2022-12-25	WOS:000313551500009
J	Fury, CA; Ruckstuhl, KE; Harrison, PL				Fury, Christine Ann; Ruckstuhl, Kathreen E.; Harrison, Peter L.			Spatial and Social Sexual Segregation Patterns in Indo-Pacific Bottlenose Dolphins (Tursiops aduncus)	PLOS ONE			English	Article							HABITAT USE; HOME-RANGE; MOVEMENT PATTERNS; PREDATION RISK; CARCHARHINUS-LEUCAS; ALLIANCE FORMATION; SITE FIDELITY; BULL SHARKS; GROUP-SIZE; FEMALE	Sexual segregation seems to be common in bottlenose dolphins, whereby males and females live in different pods that mix mainly for mating. Male dolphins often use aggressive behaviour to mate with females, while females with calves may have different activity and dietary requirements to males and different susceptibility to predation. We investigated the degree of spatial and social sexual segregation in Indo-Pacific bottlenose dolphins (Tursiops aduncus) in a subtropical estuary in Australia. Based on surveys completed over three years, dolphin groups were mostly mixed-sex or female. Mixed-sex groups were found in larger groups in mostly deeper water, whereas, female groups were foraging across all water depths in smaller groups. Aggressive coercive behaviour by males towards females was high, occurring mainly in deeper water, at higher tides, and outside the breeding season. Habitat use by female dolphin groups suggests that shallow tributaries may provide a sanctuary from aggressive males, access to suitable prey items and density for mothers and their calves, or a combination of these factors.	[Fury, Christine Ann; Harrison, Peter L.] So Cross Univ, Marine Ecol Res Ctr, Lismore, NSW 2480, Australia; [Ruckstuhl, Kathreen E.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	Southern Cross University; University of Calgary	Fury, CA (corresponding author), So Cross Univ, Marine Ecol Res Ctr, Lismore, NSW 2480, Australia.	cfury10@gmail.com	Ruckstuhl, Kathreen Eva/B-4469-2013; Harrison, Peter L/B-4763-2011	Harrison, Peter L/0000-0002-4048-2409; Ruckstuhl, Kathreen/0000-0002-2949-242X; Fury, Christine/0000-0002-0563-3136	Australian Geographic, Angourie Rainforest Resort, Project Aware; Southern Cross University Whale Research Centre	Australian Geographic, Angourie Rainforest Resort, Project Aware; Southern Cross University Whale Research Centre	This study was funded by Australian Geographic, Angourie Rainforest Resort, Project Aware and Southern Cross University Whale Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MC, 2001, MAR ECOL PROG SER, V222, P253, DOI 10.3354/meps222253; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2008, SPSS VERS 17; Barnett A, 2011, ANIM BEHAV, V81, P1039, DOI 10.1016/j.anbehav.2011.02.011; Bon R, 1996, BEHAV PROCESS, V38, P131, DOI 10.1016/S0376-6357(96)00029-0; Breed GA, 2006, P R SOC B, V273, P2319, DOI 10.1098/rspb.2006.3581; Carlson JK, 2010, J FISH BIOL, V77, P661, DOI 10.1111/j.1095-8649.2010.02707.x; Cartwright R, 2009, BEHAVIOUR, V146, P1573, DOI 10.1163/156853909X458377; Clark DA, 1998, URSUS-SERIES, V10, P243; Connor RC, 2000, CETACEAN SOCIETIES, P91; Connor RC, 1999, NATURE, V397, P571, DOI 10.1038/17501; CONNOR RC, 1992, P NATL ACAD SCI USA, V89, P987, DOI 10.1073/pnas.89.3.987; Connor RG, 2010, BIOL LETT; Connor Richard C., 1992, P415; Conradt Larissa, 2005, P11; Cransac N, 1998, J ZOOL, V244, P371, DOI 10.1111/j.1469-7998.1998.tb00042.x; Croft DP, 2006, AM NAT, V167, P867, DOI 10.1086/504853; Danilewicz D, 2009, J MAR BIOL ASSOC UK, V89, P943, DOI 10.1017/S002531540900054X; Darden SK, 2008, BIOL LETTERS, V4, P449, DOI 10.1098/rsbl.2008.0308; Dyall A, 2005, NEW S WALES COASTAL; Eyre BD, 2000, MAR ECOL PROG SER, V205, P61, DOI 10.3354/meps205061; Fury CA, 2009, THESIS SO CROSS U LI; Fury CA, 2011, ESTUAR COAST SHELF S, V93, P389, DOI 10.1016/j.ecss.2011.05.003; Fury CA, 2011, MAR MAMMAL SCI, V27, pE185, DOI 10.1111/j.1748-7692.2010.00447.x; Fury CA, 2008, MAR FRESHWATER RES, V59, P1015, DOI 10.1071/MF08109; Gubbins C, 2002, J MAMMAL, V83, P178, DOI 10.1644/1545-1542(2002)083<0178:UOHRBR>2.0.CO;2; Hancox D, 2010, ANIM BEHAV, V80, P845, DOI 10.1016/j.anbehav.2010.08.004; Heithaus MR, 2006, OIKOS, V114, P257; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; Heupel MR, 2011, MAR ECOL PROG SER, V433, P237, DOI 10.3354/meps09191; Heupel MR, 2010, MAR FRESHWATER RES, V61, P1, DOI 10.1071/MF09019; Hildebrand B, 1997, WAYPOINT VERSION 1 8; Hooge P. M., 2000, ANIMAL MOVEMENT EXTE, P2; Hooge PN, 2001, LOW WAKE FI, V17, P37; IRVINE AB, 1981, FISH B-NOAA, V79, P671; KOVACS KM, 1990, MAR MAMMAL SCI, V6, P204, DOI 10.1111/j.1748-7692.1990.tb00244.x; Laidre KL, 2009, ICES J MAR SCI, V66, P2253, DOI 10.1093/icesjms/fsp191; Last PR, 1994, SHARKS RAYS AUSTR, DOI 10.2307/1446735; Le Boeuf BJ, 2000, ECOL MONOGR, V70, P353, DOI 10.1890/0012-9615(2000)070[0353:FEONES]2.0.CO;2; Loseto LL, 2006, CAN J ZOOL, V84, P1743, DOI 10.1139/Z06-160; MacFarlane AM, 2009, J ZOOL, V277, P37, DOI 10.1111/j.1469-7998.2008.00508.x; Main MB, 2008, ECOLOGY, V89, P693, DOI 10.1890/07-0645.1; Mann J, 2000, BEHAV ECOL, V11, P210, DOI 10.1093/beheco/11.2.210; Mann J, 1999, BEHAVIOUR, V136, P529, DOI 10.1163/156853999501469; Mann Janet, 2003, P236, DOI 10.1017/CBO9780511584022.010; Martin AR, 2004, J ZOOL, V263, P295, DOI 10.1017/S095283690400528X; Matich P, 2011, J ANIM ECOL, V80, P294, DOI 10.1111/j.1365-2656.2010.01753.x; Michaud Robert, 2005, P303; Milner RNC, 2010, ANIM BEHAV, V79, P735, DOI 10.1016/j.anbehav.2009.12.030; Moller LM, 2001, P ROY SOC B-BIOL SCI, V268, P1941, DOI 10.1098/rspb.2001.1756; Moller LM, 2006, BEHAV ECOL SOCIOBIOL, V61, P109, DOI 10.1007/s00265-006-0241-x; Moller Luciana M., 2008, Research Letters in Ecology, V2008, P1, DOI 10.1155/2008/498390; Moquin P, 2010, ANIM BEHAV, V79, P1047, DOI 10.1016/j.anbehav.2010.01.020; Muller MN, 2007, P ROY SOC B-BIOL SCI, V274, P1009, DOI 10.1098/rspb.2006.0206; Parsons KM, 2003, ANIM BEHAV, V66, P185, DOI 10.1006/anbe.2003.2186; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; Ruckstuhl KE, 1998, ANIM BEHAV, V56, P99, DOI 10.1006/anbe.1998.0745; Ruckstuhl KE, 2002, BIOL REV, V77, P77, DOI 10.1017/S1464793101005814; Ruckstuhl KE, 2002, ANIM BEHAV, V64, P909, DOI 10.1006/anbe.2002.2015; SAS Institute Inc, 2009, JMP VERS 8; Scott M.D., 1990, P235; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Seminoff JA, 2002, MAR ECOL PROG SER, V242, P253, DOI 10.3354/meps242253; Silverman B.W., 1986, DENSITY ESTIMATION S; SMUTS BB, 1993, ADV STUD BEHAV, V22, P1, DOI 10.1016/S0065-3454(08)60404-0; Stewart BS, 1997, J MAMMAL, V78, P1101, DOI 10.2307/1383053; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; WALSH S, 2004, MAJOR FISH KILLS NO; Webster Trudi A., 2009, Aquatic Mammals, V35, P212, DOI 10.1578/AM.35.2.2009.212; Weckerly FW, 2001, J MAMMAL, V82, P825, DOI 10.1644/1545-1542(2001)082<0825:SSIREC>2.0.CO;2; Weir JS, 2008, CAN J ZOOL, V86, P1225, DOI 10.1139/Z08-101; Wells RS, 2003, ANIMAL SOCIAL COMPLEXITY, P32; West RJ, 2002, FISH RES, V54, P409, DOI 10.1016/S0165-7836(01)00277-6; West RJ, 1996, ESTUARIES, V19, P31, DOI 10.2307/1352649; White G.C., 1990, ANAL WILDLIFE RADIO; Whitehead H, 2000, CETACEAN SOCIETIES, P154; WIELGUS RB, 1995, J WILDLIFE MANAGE, V59, P552, DOI 10.2307/3802462; WIELGUS RB, 1994, J WILDLIFE MANAGE, V58, P405, DOI 10.2307/3809310; Wilson B, 1997, J APPL ECOL, V34, P1365, DOI 10.2307/2405254; Wilson Ben, 1993, European Research on Cetaceans, V7, P54; Wilson Ben, 1992, European Research on Cetaceans, V6, P114; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; WORTON BJ, 1995, J WILDLIFE MANAGE, V59, P794, DOI 10.2307/3801959; WORTON BJ, 1987, ECOL MODEL, V38, P277, DOI 10.1016/0304-3800(87)90101-3	84	35	35	1	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52987	10.1371/journal.pone.0052987	http://dx.doi.org/10.1371/journal.pone.0052987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326370	gold, Green Published, Green Submitted			2022-12-25	WOS:000313551500039
J	Gray, SM; McGeown, JG; McMurray, G; McCloskey, KD				Gray, Susannah M.; McGeown, J. Graham; McMurray, Gordon; McCloskey, Karen D.			Functional Innervation of Guinea-Pig Bladder Interstitial Cells of Cajal Subtypes: Neurogenic Stimulation Evokes In Situ Calcium Transients	PLOS ONE			English	Article							DETRUSOR SMOOTH MUSCLES; HUMAN URINARY-BLADDER; ALTERED DISTRIBUTION; MUSCULARIS MUCOSAE; GAP-JUNCTIONS; MYOFIBROBLAST; EXPRESSION	Several populations of interstitial cells of Cajal (ICC) exist in the bladder, associated with intramural nerves. Although ICC respond to exogenous agonists, there is currently no evidence of their functional innervation. The objective was to determine whether bladder ICC are functionally innervated. Guinea-pig bladder tissues, loaded with fluo-4AM were imaged with fluorescent microscopy and challenged with neurogenic electrical field stimulation (EFS). All subtypes of ICC and smooth muscle cells (SMC) displayed spontaneous Ca2+-oscillations. EFS (0.5 Hz, 2 Hz, 10 Hz) evoked tetrodotoxin (1 mu M)-sensitive Ca2+-transients in lamina propria ICC (ICC-LP), detrusor ICC and perivascular ICC (PICC) associated with mucosal microvessels. EFS responses in ICC-LP were significantly reduced by atropine or suramin. SMC and vascular SMC (VSM) also responded to EFS. Spontaneous Ca2+-oscillations in individual ICC-LP within networks occurred asynchronously whereas EFS evoked coordinated Ca2+-transients in all ICC-LP within a field of view. Non-correlated Ca2+-oscillations in detrusor ICC and adjacent SMC pre-EFS, contrasted with simultaneous neurogenic Ca2+ transients evoked by EFS. Spontaneous Ca2+-oscillations in PICC were little affected by EFS, whereas large Ca2+-transients were evoked in pre-EFS quiescent PICC. EFS also increased the frequency of VSM Ca2+-oscillations. In conclusion, ICC-LP, detrusor ICC and PICC are functionally innervated. Interestingly, Ca2+-activity within ICC-LP networks and between detrusor ICC and their adjacent SMC were synchronous under neural control. VSM and PICC Ca2+-activity was regulated by bladder nerves. These novel findings demonstrate functional neural control of bladder ICC. Similar studies should now be carried out on neurogenic bladder to elucidate the contribution of impaired nerve-ICC communication to bladder pathophysiology.	[Gray, Susannah M.; McGeown, J. Graham; McCloskey, Karen D.] Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [McMurray, Gordon] Pfizer Ltd, Neusentis, Cambridge, England	Pfizer	McCloskey, KD (corresponding author), Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland.	k.mccloskey@qub.ac.uk		McCloskey, Karen/0000-0002-9135-9013	European Union Framework 7, INComb grant [223234]; Pfizer-BBSRC CASE Studentship	European Union Framework 7, INComb grant; Pfizer-BBSRC CASE Studentship	Financial assistance from the European Union Framework 7, INComb grant (223234) is acknowledged. SM Gray is supported by a Pfizer-BBSRC CASE Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; BURNSTOCK G, 1986, J ANAT, V146, P1; BURNSTOCK G, 1977, J INVEST DERMATOL, V69, P47, DOI 10.1111/1523-1747.ep12497872; Cunningham RMJ, 2011, J UROLOGY, V185, P1123, DOI 10.1016/j.juro.2010.10.037; Davidson RA, 2005, J UROLOGY, V173, P1385, DOI 10.1097/01.ju.0000146272.80848.37; DIXON JS, 1983, J ANAT, V136, P265; Ferguson DR, 1997, J PHYSIOL-LONDON, V505, P503, DOI 10.1111/j.1469-7793.1997.503bb.x; Fry GH, 2012, AM J PHYSL RENAL PHY; Hashitani H, 2004, J PHYSIOL-LONDON, V559, P567, DOI 10.1113/jphysiol.2004.065136; Hashitani H, 2004, BRIT J PHARMACOL, V141, P183, DOI 10.1038/sj.bjp.0705602; Hashitani H, 2003, BRIT J PHARMACOL, V140, P146, DOI 10.1038/sj.bjp.0705319; Hashitani H, 2011, J UROLOGY, V185, P2382, DOI 10.1016/j.juro.2011.02.046; Heppner TJ, 2011, AM J PHYSIOL-REG I, V301, pR351, DOI 10.1152/ajpregu.00656.2010; Johnston L, 2008, AM J PHYSIOL-RENAL, V294, pF645, DOI 10.1152/ajprenal.00526.2007; Johnston L, 2012, J CELL MOL MED, V16, P1533, DOI 10.1111/j.1582-4934.2011.01410.x; Johnston L, 2010, J UROLOGY, V184, P370, DOI 10.1016/j.juro.2010.03.005; Kubota Y, 2008, NEUROUROL URODYNAM, V27, P330, DOI 10.1002/nau.20502; McCloskey KD, 2002, J UROLOGY, V168, P832, DOI 10.1016/S0022-5347(05)64752-0; Sui GP, 2002, BJU INT, V90, P118, DOI 10.1046/j.1464-410X.2002.02834.x; Sui GP, 2008, AM J PHYSIOL-RENAL, V295, pF688, DOI 10.1152/ajprenal.00133.2008; Ward SM, 2004, NEUROGASTROENT MOTIL, V16, P112, DOI 10.1111/j.1743-3150.2004.00485.x; Wiseman OJ, 2003, BJU INT, V91, P89, DOI 10.1046/j.1464-410X.2003.03802.x; Wu C, 2004, J PHYSIOL-LONDON, V559, P231, DOI 10.1113/jphysiol.2004.067934; Young JS, 2008, J PHYSIOL-LONDON, V586, P5743, DOI 10.1113/jphysiol.2008.162040; Zagorodnyuk VP, 2009, BRIT J PHARMACOL, V157, P607, DOI 10.1111/j.1476-5381.2009.00166.x	25	26	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53423	10.1371/journal.pone.0053423	http://dx.doi.org/10.1371/journal.pone.0053423			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326426	Green Published, gold, Green Submitted			2022-12-25	WOS:000313551500070
J	Rolland-Turner, M; Goretti, E; Bousquenaud, M; Leonard, F; Nicolas, C; Zhang, L; Maskali, F; Marie, PY; Devaux, Y; Wagner, D				Rolland-Turner, Magali; Goretti, Emeline; Bousquenaud, Melanie; Leonard, Frederique; Nicolas, Christelle; Zhang, Lu; Maskali, Fatiha; Marie, Pierre-Yves; Devaux, Yvan; Wagner, Daniel			Adenosine Stimulates the Migration of Human Endothelial Progenitor Cells. Role ofCXCR4 and MicroRNA-150	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE-ACTIVITY; CORONARY-ARTERY-DISEASE; NECROSIS-FACTOR-ALPHA; MATRIX-METALLOPROTEINASE-9 SECRETION; DIFFERENTIAL REGULATION; MYOCARDIAL-INFARCTION; INTERNATIONAL UNION; CARDIAC EXPRESSION; HUMAN MACROPHAGES; VASCULAR INJURY	Background: Administration of endothelial progenitor cells (EPC) represents a promising option to regenerate the heart after myocardial infarction, but is limited because of low recruitment and engraftment in the myocardium. Mobilization and migration of EPC are mainly controlled by stromal cell-derived factor 1 alpha (SDF-1 alpha) and its receptor CXCR4. We hypothesized that adenosine, a cardioprotective molecule, may improve the recruitment of EPC to the heart. Methods: EPC were obtained from peripheral blood mononuclear cells of healthy volunteers. Expression of chemokines and their receptors was evaluated using microarrays, quantitative PCR, and flow cytometry. A Boyden chamber assay was used to assess chemotaxis. Recruitment of EPC to the infarcted heart was evaluated in rats after permanent occlusion of the left anterior descending coronary artery. Results: Microarray analysis revealed that adenosine modulates the expression of several members of the chemokine family in EPC. Among these, CXCR4 was up-regulated by adenosine, and this result was confirmed by quantitative PCR (3-fold increase, P<0.001). CXCR4 expression at the cell surface was also increased. This effect involved the A(2B) receptor. Pretreatment of EPC with adenosine amplified their migration towards recombinant SDF-1 alpha or conditioned medium from cardiac fibroblasts. Both effects were abolished by CXCR4 blocking antibodies. Adenosine also increased CXCR4 under ischemic conditions, and decreased miR-150 expression. Binding of miR-150 to the 3' untranslated region of CXCR4 was verified by luciferase assay. Addition of pre-miR-150 blunted the effect of adenosine on CXCR4. Administration of adenosine to rats after induction of myocardial infarction stimulated EPC recruitment to the heart and enhanced angiogenesis. Conclusion: Adenosine increases the migration of EPC. The mechanism involves A(2B) receptor activation, decreased expression of miR-150 and increased expression of CXCR4. These results suggest that adenosine may be used to enhance the capacity of EPC to revascularize the ischemic heart.	[Rolland-Turner, Magali; Goretti, Emeline; Bousquenaud, Melanie; Leonard, Frederique; Nicolas, Christelle; Zhang, Lu; Devaux, Yvan; Wagner, Daniel] Publ Res Ctr Hlth CRP Sante, Cardiovasc Res Lab, Luxembourg, Luxembourg; [Maskali, Fatiha; Marie, Pierre-Yves] Nancyclotep Expt Imaging Platform, Vandoeuvre Les Nancy, France; [Wagner, Daniel] Ctr Hosp, Div Cardiol, Luxembourg, Luxembourg	Luxembourg Institute of Health; Luxembourg Hospital Center	Devaux, Y (corresponding author), Publ Res Ctr Hlth CRP Sante, Cardiovasc Res Lab, Luxembourg, Luxembourg.	yvan.devaux@crp-sante.lu	DEVAUX, Yvan/AAK-3463-2020; Marie, pierre-yves/AAY-6971-2020	Devaux, Yvan/0000-0002-5321-8543; Bousquenaud, Melanie/0000-0003-0556-0798; Zhang, Lu/0000-0001-7141-6730	Society for Research on Cardiovascular Diseases; Ministry of Culture, Higher Education and Research of Luxembourg; National Fund for Research of Luxembourg [TR-PHF BFR07-132]	Society for Research on Cardiovascular Diseases; Ministry of Culture, Higher Education and Research of Luxembourg; National Fund for Research of Luxembourg	This study was supported by the Society for Research on Cardiovascular Diseases and the Ministry of Culture, Higher Education and Research of Luxembourg. FL is the recipient of a fellowship from the National Fund for Research of Luxembourg (grant # TR-PHF BFR07-132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Azuaje F, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-7; Azuaje FJ, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-46; Bousquenaud M, 2012, CARDIOVASC RES, V94, P519, DOI 10.1093/cvr/cvs140; Capoccia BJ, 2009, BLOOD, V113, P5340, DOI 10.1182/blood-2008-04-154567; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chavakis E, 2008, CIRC RES, V102, P942, DOI 10.1161/CIRCRESAHA.107.164376; Devaux Y, 2010, FUNCT INTEGR GENOMIC, V10, P329, DOI 10.1007/s10142-010-0169-0; Ernens I, 2006, CIRC RES, V99, P590, DOI 10.1161/01.RES.0000241428.82502.d4; Ernens I, 2010, BIOCHEM BIOPH RES CO, V392, P351, DOI 10.1016/j.bbrc.2010.01.023; Fleissner F, 2010, CIRC RES, V107, P138, DOI 10.1161/CIRCRESAHA.110.216770; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Goldman S, 1995, J Card Fail, V1, P169, DOI 10.1016/1071-9164(95)90019-5; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Klaasse EC, 2008, PURINERG SIGNAL, V4, P21, DOI 10.1007/s11302-007-9086-7; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Le Brigand K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl485; Leonard F, 2011, J LEUKOCYTE BIOL, V90, P199, DOI 10.1189/jlb.0910505; Mause SF, 2010, CIRCULATION, V122, P495, DOI 10.1161/CIRCULATIONAHA.109.909473; Montesinos MC, 2004, AM J PATHOL, V164, P1887, DOI 10.1016/S0002-9440(10)63749-2; Murphree LJ, 2005, BIOCHEM J, V391, P575, DOI 10.1042/BJ20050888; Oh BJ, 2010, BIOCHEM BIOPH RES CO, V398, P627, DOI 10.1016/j.bbrc.2010.06.108; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Povsic TJ, 2007, J AM COLL CARDIOL, V50, P2243, DOI 10.1016/j.jacc.2007.08.033; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Ramanathan M, 2009, J LEUKOCYTE BIOL, V86, P681, DOI 10.1189/jlb.0109021; Richard CL, 2006, INT J CANCER, V119, P2044, DOI 10.1002/ijc.22084; Ryzhov S, 2008, CIRC RES, V102, P356, DOI 10.1161/CIRCRESAHA.107.158147; Siddique A, 2010, J ANGIOGENES RES, V22, P2; Sondergaard CS, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-24; Tano N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023114; Tongers J, 2011, EUR HEART J, V32, P1197, DOI 10.1093/eurheartj/ehr018; VANBELLE H, 1987, AM J PHYSIOL, V252, pH886, DOI 10.1152/ajpheart.1987.252.5.H886; Velot E, 2008, CARDIOVASC RES, V80, P246, DOI 10.1093/cvr/cvn201; Wagner DR, 1998, CIRCULATION, V97, P521; Wagner DR, 1999, AM J PHYSIOL-HEART C, V276, pH2141, DOI 10.1152/ajpheart.1999.276.6.H2141; Wagner DR, 1998, CIRC RES, V82, P47; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; Yang D, 2008, P NATL ACAD SCI USA, V105, P792, DOI 10.1073/pnas.0705563105; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	42	37	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e54135	10.1371/journal.pone.0054135	http://dx.doi.org/10.1371/journal.pone.0054135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326587	Green Published, gold, Green Submitted			2022-12-25	WOS:000313551500110
J	Rasheed, SAK; Teo, CR; Beillard, EJ; Voorhoeve, PM; Casey, PJ				Rasheed, Suhail Ahmed Kabeer; Teo, Cui Rong; Beillard, Emmanuel Jean; Voorhoeve, P. Mathijs; Casey, Patrick J.			MicroRNA-182 and MicroRNA-200a Control G-protein Subunit alpha-13 (GNA13) Expression and Cell Invasion Synergistically in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; LYSOPHOSPHATIDIC ACID; TUMOR-SUPPRESSOR; MIR-200 FAMILY; G12 FAMILY; METASTASIS; MIGRATION; RECEPTORS; G-ALPHA(13); ACTIVATION	G protein-coupled receptors (GPCRs) and their ligands have been implicated in progression and metastasis of several cancers. GPCRs signal through heterotrimeric G proteins, and among the different types of G proteins, GNA12/13 have been most closely linked to tumor progression. In this study, we explored the role of GNA13 in prostate cancer cell invasion and the mechanism of up-regulation of GNA13 in these cells. An initial screen for GNA13 protein expression showed that GNA13 is highly expressed in the most aggressive cancer cell lines. Knockdown of GNA13 in highly invasive PC3 cells revealed that these cells depend on GNA13 expression for their invasion, migration, and Rho activation. As mRNA levels in these cells did not correlate with protein levels, we assessed the potential involvement of micro-RNAs (miRNAs) in post-transcriptional control of GNA13 expression. Expression analysis of miRNAs predicted to bind the 3'-UTR of GNA13 revealed that miR-182 and miR-141/200a showed an inverse correlation to the protein expression in LnCAP and PC3 cells. Ectopic expression of miR-182 and miR-141/200a in PC3 cells significantly reduced protein levels, GNA13-3'-UTR reporter activity and in vitro invasion of these cells. This effect was blocked by restoration of GNA13 expression in these cells. Importantly, inhibition of miR-182 and miR-141/200a in LnCAP cells using specific miRNA inhibitors elevated the expression of GNA13 and enhanced invasion of these cells. These data provide strong evidence that GNA13 is an important mediator of prostate cancer cell invasion, and that miR-182 and miR-200 family members regulate its expression post-transcriptionally.	[Rasheed, Suhail Ahmed Kabeer; Teo, Cui Rong; Beillard, Emmanuel Jean; Voorhoeve, P. Mathijs; Casey, Patrick J.] Duke NUS Grad Med Sch, Dept Canc & Stem Cell Biol, Singapore 169857, Singapore; [Voorhoeve, P. Mathijs] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore	National University of Singapore; National University of Singapore	Casey, PJ (corresponding author), Duke NUS Grad Med Sch, Dept Canc & Stem Cell Biol, 8 Coll Rd, Singapore 169857, Singapore.	patrick.casey@duke-nus.edu.sg	Rasheed, Suhail Ahmed Kabeer/P-1257-2019	Rasheed, Suhail Ahmed Kabeer/0000-0002-7674-7560; Casey, Patrick/0000-0002-7366-9309				Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Barshack I, 2010, PATHOL RES PRACT, V206, P578, DOI 10.1016/j.prp.2010.03.005; Beillard E, 2012, RNA, V18, P1091, DOI 10.1261/rna.031831.111; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chen Z, 2012, J BIOL CHEM, V287, P25490, DOI 10.1074/jbc.M111.333716; Cheong SC, 2009, ORAL ONCOL, V45, P712, DOI 10.1016/j.oraloncology.2008.11.002; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hains MD, 2006, MOL PHARMACOL, V69, P2068, DOI 10.1124/mol.105.017921; Hu MH, 2010, DIGEST DIS SCI, V55, P2365, DOI 10.1007/s10620-009-1008-9; Huang Y, 2011, J PHYSIOL BIOCHEM, V67, P129, DOI 10.1007/s13105-010-0050-6; Juneja J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026085; Kasina S, 2012, MOL CELL ENDOCRINOL, V351, P249, DOI 10.1016/j.mce.2011.12.015; Kelly P, 2007, BIOCHEMISTRY-US, V46, P6677, DOI 10.1021/bi700235f; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Kim ES, 2011, ONCOL RES, V19, P297, DOI 10.3727/096504011X13021877989919; Kozasa T, 2011, J BIOCHEM, V150, P357, DOI 10.1093/jb/mvr105; Lappano R, 2012, ACTA PHARMACOL SIN, V33, P351, DOI 10.1038/aps.2011.183; Li SY, 2005, INT J ONCOL, V27, P1329; Malchnkhuu E, 2008, BIOCHEM BIOPH RES CO, V366, P963, DOI 10.1016/j.bbrc.2007.12.054; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pi M, 2012, PROSTATE, V72, P399, DOI 10.1002/pros.21442; Rasheed SAK, 2010, INT J CANCER, V127, P1475, DOI 10.1002/ijc.25315; Rutnam ZJ, 2012, HISTOL HISTOPATHOL, V27, P1263, DOI 10.14670/HH-27.1263; Sayas CL, 2002, J NEUROSCI, V22, P6863; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Shan DD, 2006, DEV CELL, V10, P707, DOI 10.1016/j.devcel.2006.03.014; Shumay E, 2007, J BIOL CHEM, V282, P21529, DOI 10.1074/jbc.M701998200; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Spiegelberg BD, 2007, CURR OPIN GENET DEV, V17, P40, DOI 10.1016/j.gde.2006.12.002; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; Weeraratne SD, 2012, ACTA NEUROPATHOL, V123, P539, DOI 10.1007/s00401-012-0969-5; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Xie LK, 2012, BLOOD, V119, P3503, DOI 10.1182/blood-2011-09-381905; Yagi H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002221; Zeng Y, 2009, PROSTATE, V69, P283, DOI 10.1002/pros.20879; Zhang ZJ, 2012, ONCOL REP, V27, P903, DOI 10.3892/or.2011.1611	39	65	70	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7986	7995		10.1074/jbc.M112.437749	http://dx.doi.org/10.1074/jbc.M112.437749			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23329838	Green Published, hybrid			2022-12-25	WOS:000316455300051
J	Burch, ML; Getachew, R; Osman, N; Febbraio, MA; Little, PJ				Burch, Micah L.; Getachew, Robel; Osman, Narin; Febbraio, Mark A.; Little, Peter J.			Thrombin-mediated Proteoglycan Synthesis Utilizes Both Protein-tyrosine Kinase and Serine/Threonine Kinase Receptor Transactivation in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; TO-RETENTION HYPOTHESIS; DELTA-OPIOID RECEPTORS; TRANSFORMING GROWTH-FACTOR-BETA-1; INCREASED BINDING; MAP KINASE; ACTIVATION; STIMULATION; ELONGATION; EXPRESSION	G protein-coupled receptor signaling is mediated by three main mechanisms of action; these are the classical pathway, beta-arrestin scaffold signaling, and the transactivation of protein-tyrosine kinase receptors such as those for EGF and PDGF. Recently, it has been demonstrated that G protein-coupled receptors can also mediate signals via transactivation of serine/threonine kinase receptors, most notably the transforming growth factor-beta receptor family. Atherosclerosis is characterized by the development of lipid-laden plaques in blood vessel walls. Initiation of plaque development occurs via low density lipoprotein retention in the neointima of vessels due to binding with modified proteoglycans secreted by vascular smooth muscle cells. Here we show that transactivation of protein-tyrosine kinase receptors is mediated by matrix metalloproteinase triple membrane bypass signaling. In contrast, serine/threonine kinase receptor transactivation is mediated by a cytoskeletal rearrangement-Rho kinase-integrin system, and both protein-tyrosine kinase and serine/threonine kinase receptor transactivation concomitantly account for the total proteoglycan synthesis stimulated by thrombin in vascular smooth muscle. This work provides evidence of thrombin-mediated proteoglycan synthesis and paves the way for a potential therapeutic target for plaque development and atherosclerosis.	[Burch, Micah L.; Getachew, Robel; Osman, Narin; Little, Peter J.] RMIT Univ, Hlth Innovat Inst, Diabet Complicat Lab, Bundoora, Vic 3004, Australia; [Burch, Micah L.; Febbraio, Mark A.] BakerIDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Melbourne, Vic 3004, Australia; [Burch, Micah L.; Osman, Narin; Little, Peter J.] Monash Univ, Alfred Hosp, Dept Med, Cent & Eastern Clin Sch, Melbourne, Vic 3004, Australia	Royal Melbourne Institute of Technology (RMIT); Florey Institute of Neuroscience & Mental Health; Monash University	Little, PJ (corresponding author), RMIT Univ, Hlth Innovat Inst, Diabet Complicat Lab, Bundoora, Vic 3004, Australia.	peter.little@rmit.edu.au	Little, Peter J./F-9865-2015; Febbraio, Mark/AAE-9632-2019	Little, Peter J./0000-0002-0335-3835; Febbraio, Mark/0000-0002-9296-4418	National Health and Medical Research Council; National Heart Foundation of Australia [PB09M4769]; Diabetes Australia Research Trust; GlaxoSmithKline Australia	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); Diabetes Australia Research Trust; GlaxoSmithKline Australia(GlaxoSmithKline)	This work was supported by a National Health and Medical Research Council Fellowship (to P. J. L.) and a National Heart Foundation of Australia grant-in-aid (to P. J. L.) and Diabetes Australia Research Trust grants (to P. J. L. and N. O.). The Ph. D. Program of M. L. B. generously received support through a National Heart Foundation of Australia postgraduate scholarship (PB09M4769) and a postgraduate support award to the laboratory head from GlaxoSmithKline Australia.	Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; Anggraeni VY, 2011, BIOCHEM BIOPH RES CO, V406, P36, DOI 10.1016/j.bbrc.2011.01.096; Asano Y, 2005, J IMMUNOL, V175, P7708, DOI 10.4049/jimmunol.175.11.7708; Asano Y, 2005, ARTHRITIS RHEUM-US, V52, P2897, DOI 10.1002/art.21246; Ballinger ML, 2009, ATHEROSCLEROSIS, V205, P451, DOI 10.1016/j.atherosclerosis.2009.01.024; Ballinger ML, 2004, CELL MOL LIFE SCI, V61, P1296, DOI 10.1007/s00018-004-3389-4; Belmadani S, 2008, AM J PHYSIOL-HEART C, V295, pH69, DOI 10.1152/ajpheart.00341.2008; Burch ML, 2010, J BIOL CHEM, V285, P26798, DOI 10.1074/jbc.M109.092767; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Eisinger DA, 2008, FEBS LETT, V582, P3325, DOI 10.1016/j.febslet.2008.08.021; Eisinger DA, 2008, CELL SIGNAL, V20, P2324, DOI 10.1016/j.cellsig.2008.09.002; Getachew R, 2010, ENDOCRINOLOGY, V151, P4356, DOI 10.1210/en.2010-0027; Ivey ME, 2008, THROMB RES, V123, P288, DOI 10.1016/j.thromres.2008.04.019; Jenkins RG, 2006, J CLIN INVEST, V116, P1606, DOI 10.1172/JCI27183; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Lefkowitz RJ, 2007, BBA-BIOMEMBRANES, V1768, P748, DOI 10.1016/j.bbamem.2006.11.001; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liebmann C, 2011, MOL CELL ENDOCRINOL, V331, P222, DOI 10.1016/j.mce.2010.04.008; Little PJ, 2010, J CARDIOVASC PHARM, V56, P360, DOI 10.1097/FJC.0b013e3181ee6811; Little PJ, 2002, ARTERIOSCL THROM VAS, V22, P55, DOI 10.1161/hq0102.101100; Liu YL, 2009, FASEB J, V23, P2299, DOI 10.1096/fj.08-127910; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Nakashima Y, 2007, ARTERIOSCL THROM VAS, V27, P1159, DOI 10.1161/ATVBAHA.106.134080; Neurohr C, 2006, AM J RESP CELL MOL, V35, P252, DOI 10.1165/rcmb.2006-0013OC; NEYLON CB, 1990, CIRC RES, V67, P814, DOI 10.1161/01.RES.67.4.814; Otani H, 2011, J PHARMACOL SCI, V115, P135, DOI 10.1254/jphs.10197FP; SCHONHERR E, 1993, ARTERIOSCLER THROMB, V13, P1026, DOI 10.1161/01.ATV.13.7.1026; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; WASTESON A, 1973, BIOCHEM J, V136, P1069, DOI 10.1042/bj1361069; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Williams KJ, 1998, CURR OPIN LIPIDOL, V9, P471, DOI 10.1097/00041433-199810000-00012; Wu LY, 2009, DEV CELL, V17, P35, DOI 10.1016/j.devcel.2009.05.010; Xu MY, 2009, AM J PATHOL, V174, P1264, DOI 10.2353/ajpath.2009.080160	37	37	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7410	7419		10.1074/jbc.M112.400259	http://dx.doi.org/10.1074/jbc.M112.400259			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23335513	Green Published, hybrid			2022-12-25	WOS:000316002400059
J	Selvakumar, D; Drescher, MJ; Drescher, DG				Selvakumar, Dakshnamurthy; Drescher, Marian J.; Drescher, Dennis G.			Cyclic Nucleotide-gated Channel alpha-3 (CNGA3) Interacts with Stereocilia Tip-Link Cadherin 23 plus Exon 68 or Alternatively with Myosin VIIa, Two Proteins Required for Hair Cell Mechanotransduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							USHER-SYNDROME PROTEINS; BINDING PROTEINS; DEAFNESS DFNB12; MOLECULAR-BASIS; MUTATIONS; HARMONIN; CDH23; TRANSDUCTION; EXPRESSION; HEARING	Previously, we obtained evidence for a photoreceptor/olfactory type of CNGA3 transcript in a purified teleost vestibular hair cell preparation with immunolocalization of CNGA3 protein to stereocilia of teleost vestibular and mammalian cochlear hair cells. The carboxyl terminus of highly Ca2+-permeable CNGA3 expressed in the mammalian organ of Corti and saccular hair cells was found to interact with an intracellular domain of microfibril interface-located protein 1 (EMILIN 1), a member of the elastin superfamily, also immunolocalizd to hair cell stereocilia (Selvakumar, D., Drescher, M. J., Dowdall, J. R., Khan, K. M., Hatfield, J. S., Ramakrishnan, N. A., and Drescher, D. G. (2012) Biochem. J. 443, 463-476). Here, we provide evidence for organ of Corti proteins, of Ca2+-dependent binding of the amino terminus of CNGA3 specifically to the carboxyl terminus of stereocilia tip-link protein CDH23 +68 (cadherin 23 with expressed exon 68) by yeast two-hybrid mating and co-transformation protocols, pulldown assays, and surface plasmon resonance analysis. Myosin VIIa, required for adaptation of hair cell mechanotransduction (MET) channel(s), competed with CDH23 +68, with direct Ca2+-dependent binding to the amino terminus of CNGA3. Based upon the premise that hair cell stereocilia tip-link proteins are closely coupled with MET, these results are consistent with the possibility that CNGA3 participates in hair-cell MET. Together with the demonstration of protein-protein interaction between HCN1 and tip-link protein protocadherin 15 CD3 (Ramakrishnan, N. A., Drescher, M. J., Barretto, R. L., Beisel, K. W., Hatfield, J. S., and Drescher, D. G. (2009) J. Biol. Chem. 284, 3227-3238; Ramakrishnan, N. A., Drescher, M. J., Khan, K. M., Hatfield, J. S., and Drescher, D. G. (2012) J. Biol. Chem. 287, 37628-37646), a protein-protein interaction for CNGA3 and a second tip-link protein, CDH23 +68, further suggests possible association of two different channels with a single stereocilia tip link.	[Selvakumar, Dakshnamurthy; Drescher, Marian J.; Drescher, Dennis G.] Wayne State Univ, Sch Med, Dept Otolaryngol, Lab Biootol, Detroit, MI 48201 USA; [Drescher, Dennis G.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Drescher, MJ (corresponding author), Wayne State Univ, Sch Med, Dept Otolaryngol, Lab Biootol, 261 Lande Med Res Bldg,540 East Canfield Ave, Detroit, MI 48201 USA.	mdresche@med.wayne.edu			National Institutes of Health [R01 DC004076, R01 DC000156]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004076, R01DC000156, P30DC005188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DC004076 (to M. J. D.) and R01 DC000156 (to D. G. D.).	Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Akhmanova A, 2010, CURR OPIN CELL BIOL, V22, P479, DOI 10.1016/j.ceb.2010.04.008; Alagramam KN, 2001, HUM MOL GENET, V10, P1709, DOI 10.1093/hmg/10.16.1709; Alagramam KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019183; Bahloul A, 2010, HUM MOL GENET, V19, P3557, DOI 10.1093/hmg/ddq271; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Biel M, 2009, J BIOL CHEM, V284, P9017, DOI 10.1074/jbc.R800075200; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Bright SR, 2007, MOL PHARMACOL, V71, P176, DOI 10.1124/mol.106.026401; Corey D, 2003, J CELL SCI, V116, P1, DOI 10.1242/jcs.00101; de Brouwer APM, 2003, HUM GENET, V112, P156, DOI 10.1007/s00439-002-0833-0; Di Palma F, 2001, GENE, V281, P31, DOI 10.1016/S0378-1119(01)00761-2; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Drescher Dennis G., 2009, V493, P323, DOI 10.1007/978-1-59745-523-7_20; Drescher M. J., 2001, ASS RES OT ABSTR, V24, P40; Drescher MJ, 2002, MOL BRAIN RES, V98, P1, DOI 10.1016/S0169-328X(01)00289-3; Ehrlicher AJ, 2011, NATURE, V478, P260, DOI 10.1038/nature10430; Fettiplace R, 2009, PFLUG ARCH EUR J PHY, V458, P1115, DOI 10.1007/s00424-009-0683-x; Frolenkov G., 2012, ASS RES OT ABSTR, V35, P204; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108; Hudspeth AJ, 1997, NEURON, V19, P947, DOI 10.1016/S0896-6273(00)80385-2; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kohl S, 1998, NAT GENET, V19, P257, DOI 10.1038/935; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; LeMasurier M, 2005, NEURON, V48, P403, DOI 10.1016/j.neuron.2005.10.017; Meyer MR, 2000, P NATL ACAD SCI USA, V97, P10595, DOI 10.1073/pnas.97.19.10595; Nishiguchi KM, 2005, HUM MUTAT, V25, P248, DOI 10.1002/humu.20142; Oh CK, 1999, MOL BRAIN RES, V70, P135, DOI 10.1016/S0169-328X(99)00110-2; Patrie KM, 2002, J BIOL CHEM, V277, P30183, DOI 10.1074/jbc.M203072200; Peng CH, 2003, J BIOL CHEM, V278, P24617, DOI 10.1074/jbc.M301699200; Ramakrishnan NA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375832; Ramakrishnan NA, 2009, J BIOL CHEM, V284, P3227, DOI 10.1074/jbc.M806177200; Reuter P, 2008, HUM MUTAT, V29, P1228, DOI 10.1002/humu.20790; Ricci AJ, 2006, J MEMBRANE BIOL, V209, P71, DOI 10.1007/s00232-005-0834-8; Schultz JM, 2011, J MED GENET, V48, P767, DOI 10.1136/jmedgenet-2011-100262; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Selvakumar D, 2012, BIOCHEM J, V443, P463, DOI 10.1042/BJ20111255; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Sengupta S, 2009, J BIOL CHEM, V284, P20121, DOI 10.1074/jbc.M109.025668; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; Sotomayor M, 2010, NEURON, V66, P85, DOI 10.1016/j.neuron.2010.03.028; Spessotto P, 2003, J BIOL CHEM, V278, P6160, DOI 10.1074/jbc.M208322200; Sul B, 2010, BIOPHYS J, V99, P1027, DOI 10.1016/j.bpj.2010.05.029; Thapa A, 2012, J BIOL CHEM, V287, P18018, DOI 10.1074/jbc.M112.342220; van Netten SM, 2009, PFLUG ARCH EUR J PHY, V458, P273, DOI 10.1007/s00424-008-0617-z; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; Wang X, 2011, HUM MUTAT, V32, P1450, DOI 10.1002/humu.21587; Xu ZG, 2008, J NEUROSCI, V28, P11269, DOI 10.1523/JNEUROSCI.3833-08.2008; Xu ZG, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-80; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zhao YD, 1996, P NATL ACAD SCI USA, V93, P15469, DOI 10.1073/pnas.93.26.15469; Zheng LL, 2010, J NEUROSCI, V30, P7187, DOI 10.1523/JNEUROSCI.0852-10.2010; Zhou Y, 2006, PROTEINS, V65, P643, DOI 10.1002/prot.21139	57	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7215	7229		10.1074/jbc.M112.443226	http://dx.doi.org/10.1074/jbc.M112.443226			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23329832	Green Published, hybrid			2022-12-25	WOS:000316002400042
J	Huang, L; Wang, ZB; Jiang, ZZ; Hu, MW; Lin, F; Zhang, QH; Luo, YB; Hou, Y; Zhao, Y; Fan, HY; Schatten, H; Sun, QY				Huang, Lin; Wang, Zhen-Bo; Jiang, Zong-Zhe; Hu, Meng-Wen; Lin, Fei; Zhang, Qing-Hua; Luo, Yi-Bo; Hou, Yi; Zhao, Yong; Fan, Heng-Yu; Schatten, Heide; Sun, Qing-Yuan			Specific Disruption of Tsc1 in Ovarian Granulosa Cells Promotes Ovulation and Causes Progressive Accumulation of Corpora Lutea	PLOS ONE			English	Article							TUBEROUS SCLEROSIS COMPLEX; PRIMORDIAL FOLLICLES; MOUSE MODEL; LIFE-SPAN; ACTIVATION; RAPAMYCIN; GROWTH; MTOR; DIFFERENTIATION; EXPRESSION	Tuberous sclerosis complex 1 (Tsc1) is a tumor suppressor negatively regulating mammalian target of rapamycin complex 1 (mTORC1). It is reported that mice lacking Tsc1 gene in oocytes show depletion of primordial follicles, resulting in premature ovarian failure and subsequent infertility. A recent study indicated that deletion of Tsc1 in somatic cells of the reproductive tract caused infertility of female mice. However, it is not known whether specific disruption of Tsc1 in granulosa cells influences the reproductive activity of female mice. To clarify this problem, we mated Tsc1(flox/flox) mice with transgenic mice strain expressing cyp19-cre which exclusively expresses in granulosa cells of the ovary. Our results demonstrated that Tsc1(flox/flox); cyp19-cre mutant mice were fertile, ovulating more oocytes and giving birth to more pups than control Tsc1(flox/flox) mice. Progressive accumulation of corpora lutea occurred in the Tsc1(flox/flox); cyp19-cre mutant mice with advanced age. These phenotypes could be explained by the elevated activity of mTORC1, as indicated by increased phosphorylation of rpS6, a substrate of S6 in the Tsc1(flox/flox); cyp19-cre mutant granulosa cells. In addition, rapamycin, a specific mTORC1 inhibitor, effectively rescued the phenotype caused by increased mTORC1 activity in the Tsc1(cko) ovaries. Our data suggest that conditional knockout of Tsc1 in granulosa cells promotes reproductive activity in mice.	[Huang, Lin; Wang, Zhen-Bo; Jiang, Zong-Zhe; Hu, Meng-Wen; Lin, Fei; Zhang, Qing-Hua; Luo, Yi-Bo; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Huang, Lin; Jiang, Zong-Zhe; Hu, Meng-Wen] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Zhao, Yong] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing, Peoples R China; [Fan, Heng-Yu] Zhejiang Univ, Inst Life Sci, Hangzhou, Zhejiang, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Zhejiang University; University of Missouri System; University of Missouri Columbia	Sun, QY (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	sunqy@ioz.ac.cn		Hu, Mengwen/0000-0002-7480-6432	National Basic Research Program of China [2012CB944404, 2011CB944501]; National Natural Science Foundation of China [30930065]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China (2012CB944404, 2011CB944501, www.973.gov.cn/English/ReadItem.aspxitemid=487) and National Natural Science Foundation of China (No. 30930065, www.nsfc.gov.cn/Portal0/default166.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari D, 2010, HUM MOL GENET, V19, P397, DOI 10.1093/hmg/ddp483; Adhikari D, 2009, MOL HUM REPROD, V15, P765, DOI 10.1093/molehr/gap092; Alam H, 2004, J BIOL CHEM, V279, P19431, DOI 10.1074/jbc.M401235200; Arango NA, 2008, MOL REPROD DEV, V75, P1154, DOI 10.1002/mrd.20858; Carson RP, 2012, NEUROBIOL DIS, V45, P369, DOI 10.1016/j.nbd.2011.08.024; Chong-Kopera H, 2006, J BIOL CHEM, V281, P8313, DOI 10.1074/jbc.C500451200; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Fan HY, 2008, MOL ENDOCRINOL, V22, P2128, DOI 10.1210/me.2008-0095; Fan HY, 2008, DEVELOPMENT, V135, P2127, DOI 10.1242/dev.020560; Gonzalez-Robayna IJ, 2000, MOL ENDOCRINOL, V14, P1283, DOI 10.1210/me.14.8.1283; Hu MW, 2012, J GENET GENOMICS, V39, P61, DOI 10.1016/j.jgg.2012.01.004; Hunzicker-Dunn M, 2006, CELL SIGNAL, V18, P1351, DOI 10.1016/j.cellsig.2006.02.011; John GB, 2007, REPRODUCTION, V133, P855, DOI 10.1530/REP-06-0051; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Liu K, 2006, DEV BIOL, V299, P1, DOI 10.1016/j.ydbio.2006.07.038; Malhowski AJ, 2011, HUM MOL GENET, V20, P1290, DOI 10.1093/hmg/ddq570; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Park Y, 2005, J BIOL CHEM, V280, P9135, DOI 10.1074/jbc.M409486200; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Reddy P, 2009, HUM MOL GENET, V18, P2813, DOI 10.1093/hmg/ddp217; Richards JS, 2002, MOL ENDOCRINOL, V16, P580, DOI 10.1210/me.16.3.580; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Tanaka Y, 2012, ENDOCRINOLOGY, V153, P404, DOI 10.1210/en.2011-1191; Tomasoni R, 2011, BIOCHEM SOC T, V39, P466, DOI 10.1042/BST0390466; Wayne CM, 2007, MOL ENDOCRINOL, V21, P1940, DOI 10.1210/me.2007-0020; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zeng LH, 2011, HUM MOL GENET, V20, P445, DOI 10.1093/hmg/ddq491; Zhou J, 2009, HUM MOL GENET, V18, P4428, DOI 10.1093/hmg/ddp398	31	17	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54052	10.1371/journal.pone.0054052	http://dx.doi.org/10.1371/journal.pone.0054052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335988	gold, Green Published, Green Submitted			2022-12-25	WOS:000314707700046
J	Milagro, FI; Miranda, J; Portillo, MP; Fernandez-Quintela, A; Campion, J; Martinez, JA				Milagro, Fermin I.; Miranda, Jonatan; Portillo, Maria P.; Fernandez-Quintela, Alfredo; Campion, Javier; Alfredo Martinez, J.			High-Throughput Sequencing of microRNAs in Peripheral Blood Mononuclear Cells: Identification of Potential Weight Loss Biomarkers	PLOS ONE			English	Article							HIGH-FAT DIET; DIFFERENTIAL EXPRESSION; SUBCUTANEOUS ADIPOSE; GENE-EXPRESSION; CANDIDATE GENES; OBESITY; METHYLATION; MIRNAS; TRANSCRIPTOME; ADIPOGENESIS	Introduction: MicroRNAs (miRNAs) are being increasingly studied in relation to energy metabolism and body composition homeostasis. Indeed, the quantitative analysis of miRNAs expression in different adiposity conditions may contribute to understand the intimate mechanisms participating in body weight control and to find new biomarkers with diagnostic or prognostic value in obesity management. Objective: The aim of this study was the search for miRNAs in blood cells whose expression could be used as prognostic biomarkers of weight loss. Methods: Ten Caucasian obese women were selected among the participants in a weight-loss trial that consisted in following an energy-restricted treatment. Weight loss was considered unsuccessful when <5% of initial body weight (non-responders) and successful when >5% (responders). At baseline, total miRNA isolated from peripheral blood mononuclear cells (PBMC) was sequenced with SOLiD v4. The miRNA sequencing data were validated by RT-PCR. Results: Differential baseline expression of several miRNAs was found between responders and non-responders. Two miRNAs were up-regulated in the non-responder group (mir-935 and mir-4772) and three others were down-regulated (mir-223, mir-224 and mir-376b). Both mir-935 and mir-4772 showed relevant associations with the magnitude of weight loss, although the expression of other transcripts (mir-874, mir-199b, mir-766, mir-589 and mir-148b) also correlated with weight loss. Conclusions: This research addresses the use of high-throughput sequencing technologies in the search for miRNA expression biomarkers in obesity, by determining the miRNA transcriptome of PBMC. Basal expression of different miRNAs, particularly mir-935 and mir-4772, could be prognostic biomarkers and may forecast the response to a hypocaloric diet.	[Milagro, Fermin I.; Campion, Javier; Alfredo Martinez, J.] Univ Navarra, Dept Nutr Food Sci & Physiol, E-31080 Pamplona, Spain; [Miranda, Jonatan; Portillo, Maria P.; Fernandez-Quintela, Alfredo] Univ Basque Country, Dept Nutr & Food Sci, UPV EHU, Vitoria, Spain	University of Navarra; University of Basque Country	Martinez, JA (corresponding author), Univ Navarra, Dept Nutr Food Sci & Physiol, E-31080 Pamplona, Spain.	jalfmtz@unav.es	Martinez-Gonzalez, Miguel A./AAE-7669-2019; Milagro, Fermin/F-2315-2015; Fernández-Quintela, Alfredo/U-1272-2019; Miranda, Jonatan/L-4511-2014; Portillo, Maria Puy/ABH-2374-2020; Miranda, Jonatan/F-3289-2011; Martinez Hernandez, J Alfredo/K-8709-2014	Milagro, Fermin/0000-0002-3228-9916; Fernández-Quintela, Alfredo/0000-0003-2709-4118; Miranda, Jonatan/0000-0002-5484-2671; Portillo, Maria Puy/0000-0003-0210-6549; Campion, Javier/0000-0002-6522-8271; PORTILLO BAQUEDANO, MARIA PUY/0000-0003-2290-592X; Martinez Hernandez, J Alfredo/0000-0001-5218-6941	Linea Especial LE/97 of the University of Navarra; RETICS; CIBERobn Schemes; Instituto de Salud Carlos III; Government of the Basque Country [IT-386-10, IT-572-13]; University of the Basque Country UPV/EHU (ELDUNANOTEK) [UFI11/32]	Linea Especial LE/97 of the University of Navarra; RETICS; CIBERobn Schemes; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Government of the Basque Country; University of the Basque Country UPV/EHU (ELDUNANOTEK)	This work has been supported by the Linea Especial LE/97 of the University of Navarra, the RETICS and CIBERobn Schemes funded by Instituto de Salud Carlos III, the Government of the Basque Country (IT-386-10 and IT-572-13) and the University of the Basque Country UPV/EHU (ELDUNANOTEK UFI11/32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HW, 2010, MOL HUM REPROD, V16, P463, DOI 10.1093/molehr/gaq017; Alegra-Torres JA, 2011, EPIGENOMICS-UK, V3, P267, DOI [10.2217/EPI.11.22, 10.2217/epi.11.22]; Ali AS, 2011, OBES REV, V12, P1050, DOI 10.1111/j.1467-789X.2011.00906.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bengestrate L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021305; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bouchard L, 2010, AM J CLIN NUTR, V91, P309, DOI 10.3945/ajcn.2009.28085; Campion J, 2010, PROG MOL BIOL TRANSL, V94, P291, DOI 10.1016/S1877-1173(10)94011-8; Campion J, 2009, OBESITY, V17, P1293, DOI 10.1038/oby.2008.679; Cao P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-108; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chang CL, 2011, ENDOCRINOLOGY, V152, P384, DOI 10.1210/en.2010-0493; Cordero P, 2011, J PHYSIOL BIOCHEM, V67, P463, DOI 10.1007/s13105-011-0084-4; Crujeiras AB, 2008, OMICS, V12, P251, DOI 10.1089/omi.2008.0001; Estep M, 2010, ALIMENT PHARM THER, V32, P487, DOI 10.1111/j.1365-2036.2010.04366.x; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Heneghan HM, 2011, J CLIN ENDOCR METAB, V96, pE846, DOI 10.1210/jc.2010-2701; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kloting N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004699; Lee EK, 2011, MOL CELL BIOL, V31, P626, DOI 10.1128/MCB.00894-10; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomba A, 2010, MOL GENET METAB, V101, P273, DOI 10.1016/j.ymgme.2010.07.017; Lu H, 2010, CARDIOVASC RES, V86, P410, DOI 10.1093/cvr/cvq010; Martinez-Gonzalez MA, 2005, PUBLIC HEALTH NUTR, V8, P920, DOI 10.1079/PHN2005745; McGregor RA, 2011, CURR MOL MED, V11, P304; Milagro FI, 2009, J PHYSIOL BIOCHEM, V65, P1, DOI 10.1007/BF03165964; Milagro FI, 2011, FASEB J, V25, P1378, DOI 10.1096/fj.10-170365; Mutch DM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001344; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Nakada C, 2011, J PATHOL, V224, P280, DOI 10.1002/path.2860; Nakanishi N, 2009, BIOCHEM BIOPH RES CO, V385, P492, DOI 10.1016/j.bbrc.2009.05.058; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Park JH, 2011, MOL CELLS, V31, P33, DOI 10.1007/s10059-011-0009-7; Parra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013005; Plagemann A, 2009, J PHYSIOL-LONDON, V587, P4963, DOI 10.1113/jphysiol.2009.176156; Pogribny IP, 2010, LAB INVEST, V90, P1437, DOI 10.1038/labinvest.2010.113; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rampersaud E, 2007, DIABETES, V56, P3053, DOI 10.2337/db07-0457; Sarzynski MA, 2011, INT J OBESITY, V35, P676, DOI 10.1038/ijo.2010.166; Stepanow S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017711; Thulasingam S, 2011, MOL CELL BIOCHEM, V352, P181, DOI 10.1007/s11010-011-0752-2; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Vaz C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-288; Vreugdenhil E, 2009, ENDOCRINOLOGY, V150, P2220, DOI 10.1210/en.2008-1335; Wang XL, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-87; Widiker S, 2010, J APPL GENET, V51, P193, DOI 10.1007/BF03195727; Xie HM, 2009, EXPERT OPIN THER TAR, V13, P1227, DOI 10.1517/14728220903190707; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhang YX, 2011, FEBS LETT, V585, P1269, DOI 10.1016/j.febslet.2011.03.059; Zhao EP, 2009, MAMM GENOME, V20, P476, DOI 10.1007/s00335-009-9217-2	55	63	65	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54319	10.1371/journal.pone.0054319	http://dx.doi.org/10.1371/journal.pone.0054319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335998	Green Published, gold, Green Submitted			2022-12-25	WOS:000314707700056
J	Rozhon, W; Husar, S; Kalaivanan, F; Khan, M; Idlhammer, M; Shumilina, D; Lange, T; Hoffmann, T; Schwab, W; Fujioka, S; Poppenberger, B				Rozhon, Wilfried; Husar, Sigrid; Kalaivanan, Florian; Khan, Mamoona; Idlhammer, Markus; Shumilina, Daria; Lange, Theo; Hoffmann, Thomas; Schwab, Wilfried; Fujioka, Shozo; Poppenberger, Brigitte			Genetic Variation in Plant CYP51s Confers Resistance against Voriconazole, a Novel Inhibitor of Brassinosteroid-Dependent Sterol Biosynthesis	PLOS ONE			English	Article							GIBBERELLIN BIOSYNTHESIS; CYTOCHROME-P450 MONOOXYGENASE; SIGNAL-TRANSDUCTION; CELL ELONGATION; DE-ETIOLATION; ARABIDOPSIS; GROWTH; EXPRESSION; TRIAZOLE; 14-ALPHA-DEMETHYLASE	Brassinosteroids (BRs) are plant steroid hormones with structural similarity to mammalian sex steroids and ecdysteroids from insects. The BRs are synthesized from sterols and are essential regulators of cell division, cell elongation and cell differentiation. In this work we show that voriconazole, an antifungal therapeutic drug used in human and veterinary medicine, severely impairs plant growth by inhibiting sterol-14 alpha-demethylation and thereby interfering with BR production. The plant growth regulatory properties of voriconazole and related triazoles were identified in a screen for compounds with the ability to alter BR homeostasis. Voriconazole suppressed growth of the model plant Arabidopsis thaliana and of a wide range of both monocotyledonous and dicotyledonous plants. We uncover that voriconazole toxicity in plants is a result of a deficiency in BRs that stems from an inhibition of the cytochrome P450 CYP51, which catalyzes a step of BR-dependent sterol biosynthesis. Interestingly, we found that the woodland strawberry Fragaria vesca, a member of the Rosaceae, is naturally voriconazole resistant and that this resistance is conferred by the specific CYP51 variant of F. vesca. The potential of voriconazole as a novel tool for plant research is discussed.	[Rozhon, Wilfried; Khan, Mamoona; Hoffmann, Thomas; Schwab, Wilfried; Poppenberger, Brigitte] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Freising Weihenstephan, Germany; [Rozhon, Wilfried; Husar, Sigrid; Kalaivanan, Florian; Khan, Mamoona; Idlhammer, Markus; Shumilina, Daria; Poppenberger, Brigitte] Univ Vienna, Max F Perutz Labs, Vienna, Austria; [Lange, Theo] Tech Univ Carolo Wilhelmina Braunschweig, Inst Plant Biol, D-38106 Braunschweig, Germany; [Fujioka, Shozo] RIKEN Adv Sci Inst, Wako, Saitama, Japan	Technical University of Munich; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Braunschweig University of Technology; RIKEN	Poppenberger, B (corresponding author), Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Freising Weihenstephan, Germany.	brigitte.poppenberger@wzw.tum.de	Lange, Theo/H-6148-2018; Rozhon, Wilfried/AFK-4445-2022; Rozhon, Wilfried/AAG-3162-2022	Lange, Theo/0000-0003-1294-2647; Rozhon, Wilfried/0000-0003-0659-0593; Rozhon, Wilfried/0000-0003-0659-0593; Khan, Mamoona/0000-0003-3301-9536	Austrian Science Fund FWF [P19948, P22734]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [19380069, 23380066]; Higher Education Commission of Pakistan; FWF; Austrian Science Fund (FWF) [P 22734] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund FWF (projects P19948 and P22734), by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Grant-in-Aid for Scientific Research (B) 19380069 and 23380066 (to S.F.) and by research fellowships to MK (Ph.D. fellowship of the Higher Education Commission of Pakistan) and BP (Hertha-Firnberg fellowship of the FWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOYAMA Y, 1994, BIOCHEM BIOPH RES CO, V201, P1320, DOI 10.1006/bbrc.1994.1848; Asami T, 2003, BIOCHEM J, V369, P71, DOI 10.1042/BJ20020835; Asami T, 1999, TRENDS PLANT SCI, V4, P348, DOI 10.1016/S1360-1385(99)01456-9; Asami T, 2001, J BIOL CHEM, V276, P25687, DOI 10.1074/jbc.M103524200; Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; Benveniste P, 2004, ANNU REV PLANT BIOL, V55, P429, DOI 10.1146/annurev.arplant.55.031903.141616; Bishop GJ, 2007, TRENDS PLANT SCI, V12, P377, DOI 10.1016/j.tplants.2007.07.001; Boutte Y, 2009, CURR OPIN PLANT BIOL, V12, P705, DOI 10.1016/j.pbi.2009.09.013; BURDEN RS, 1989, PHYTOCHEMISTRY, V28, P1791, DOI 10.1016/S0031-9422(00)97862-2; Choe S, 2007, J PLANT BIOL, V50, P225, DOI 10.1007/BF03030649; Choe SW, 1999, PLANT CELL, V11, P207, DOI 10.1105/tpc.11.2.207; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Clouse SD, 2000, CURR BIOL, V10, pR601, DOI 10.1016/S0960-9822(00)00639-4; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Cohen P, 2010, BIOCHEM J, V425, P53, DOI 10.1042/BJ20091428; Debeljak N, 2003, ARCH BIOCHEM BIOPHYS, V409, P159, DOI 10.1016/S0003-9861(02)00418-6; Delye C, 1998, CURR GENET, V34, P399, DOI 10.1007/s002940050413; Diener AC, 2000, PLANT CELL, V12, P853, DOI 10.1105/tpc.12.6.853; FELDMANN KA, 1989, SCIENCE, V243, P1351, DOI 10.1126/science.243.4896.1351; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; Fujioka S, 2002, PLANT PHYSIOL, V130, P930, DOI 10.1104/pp.008722; Fung-Tomc J C, 1997, Expert Opin Investig Drugs, V6, P129, DOI 10.1517/13543784.6.2.129; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; GRAUSEM B, 1995, PLANT J, V7, P761, DOI 10.1046/j.1365-313X.1995.07050761.x; GROVE MD, 1979, NATURE, V281, P216, DOI 10.1038/281216a0; Hartwig T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036625; Hayashi K, 2000, PHYTOCHEMISTRY, V55, P1, DOI 10.1016/S0031-9422(00)00204-1; He JX, 2003, PLANT PHYSIOL, V131, P1258, DOI 10.1104/pp.014605; Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191; Hicks GR, 2009, NAT CHEM BIOL, V5, P268, DOI 10.1038/nchembio0509-268; Kim HB, 2005, PLANT PHYSIOL, V138, P2033, DOI 10.1104/pp.105.061598; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; Lange T, 2005, PLANT PHYSIOL, V139, P213, DOI 10.1104/pp.105.064162; LENTON JR, 1994, PLANT GROWTH REGUL, V15, P281, DOI 10.1007/BF00029901; Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Lupetti A, 2003, TRENDS MOL MED, V9, P269, DOI 10.1016/S1471-4914(03)00091-1; McCourt P, 2010, NEW PHYTOL, V185, P15, DOI 10.1111/j.1469-8137.2009.03045.x; Min YK, 1999, BIOORG MED CHEM LETT, V9, P425, DOI 10.1016/S0960-894X(99)00008-6; NAMBARA E, 1991, PLANT PHYSIOL, V97, P736, DOI 10.1104/pp.97.2.736; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Oh K, 2012, BIOORG MED CHEM LETT, V22, P1625, DOI 10.1016/j.bmcl.2011.12.120; Ohnishi T, 2009, PHYTOCHEMISTRY, V70, P1918, DOI 10.1016/j.phytochem.2009.09.015; Poppenberger B, 2005, P NATL ACAD SCI USA, V102, P15253, DOI 10.1073/pnas.0504279102; Poppenberger B, 2011, EMBO J, V30, P1149, DOI 10.1038/emboj.2011.35; Rozhon W, 2010, PLANT J, V62, P215, DOI 10.1111/j.1365-313X.2010.04145.x; Sanati H, 1997, ANTIMICROB AGENTS CH, V41, P2492, DOI 10.1128/AAC.41.11.2492; Schrick K, 2000, GENE DEV, V14, P1471; Sekimata K, 2002, J AGR FOOD CHEM, V50, P3486, DOI 10.1021/jf011716w; Sekimata K, 2001, PLANTA, V213, P716, DOI 10.1007/s004250100546; Sekimata K, 2008, BIOSCI BIOTECH BIOCH, V72, P7, DOI 10.1271/bbb.70141; Souter M, 2002, PLANT CELL, V14, P1017, DOI 10.1105/tpc.001248; Steber CM, 2001, PLANT PHYSIOL, V125, P763, DOI 10.1104/pp.125.2.763; Swain SM, 2005, PLANT CELL PHYSIOL, V46, P284, DOI 10.1093/pcp/pci027; Symons GM, 2008, PLANT SIGNAL BEHAV, V3, P868, DOI 10.4161/psb.3.10.6063; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; TATON M, 1988, PESTIC BIOCHEM PHYS, V30, P178, DOI 10.1016/0048-3575(88)90051-X; Turk EM, 2005, PLANT J, V42, P23, DOI 10.1111/j.1365-313X.2005.02358.x; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang H, 2009, PLANT CELL, V21, P3781, DOI 10.1105/tpc.109.072504; Wang JM, 2001, BIOSCI BIOTECH BIOCH, V65, P817, DOI 10.1271/bbb.65.817; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Yin YH, 2005, CELL, V120, P249, DOI 10.1016/j.cell.2004.11.044; Zhang LY, 2009, PLANT CELL, V21, P3767, DOI 10.1105/tpc.109.070441	65	14	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53650	10.1371/journal.pone.0053650	http://dx.doi.org/10.1371/journal.pone.0053650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335967	gold, Green Submitted, Green Published			2022-12-25	WOS:000314707700023
J	Lundberg, K; Albrekt, AS; Nelissen, I; Santegoets, S; de Gruijl, TD; Gibbs, S; Lindstedt, M				Lundberg, Kristina; Albrekt, Ann-Sofie; Nelissen, Inge; Santegoets, Saskia; de Gruijl, Tanja D.; Gibbs, Sue; Lindstedt, Malin			Transcriptional Profiling of Human Dendritic Cell Populations and Models - Unique Profiles of In Vitro Dendritic Cells and Implications on Functionality and Applicability	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; TUMOR-NECROSIS-FACTOR; LANGERHANS CELLS; SKIN SENSITIZERS; BONE-MARROW; TNF-ALPHA; GM-CSF; ANTIGEN; BLOOD; DIFFERENTIATION	Background: Dendritic cells (DCs) comprise heterogeneous populations of cells, which act as central orchestrators of the immune response. Applicability of primary DCs is restricted due to their scarcity and therefore DC models are commonly employed in DC-based immunotherapy strategies and in vitro tests assessing DC function. However, the interrelationship between the individual in vitro DC models and their relative resemblance to specific primary DC populations remain elusive. Objective: To describe and assess functionality and applicability of the available in vitro DC models by using a genome-wide transcriptional approach. Methods: Transcriptional profiling was performed with four commonly used in vitro DC models (MUTZ-3-DCs, monocyte-derived DCs, CD34-derived DCs and Langerhans cells (LCs)) and nine primary DC populations (dermal DCs, LCs, blood and tonsillar CD123(+), CD1c(+) and CD141(+) DCs, and blood CD16(+) DCs). Results: Principal Component Analysis showed that transcriptional profiles of each in vitro DC model most closely resembled CD1c(+) and CD141(+) tonsillar myeloid DCs (mDCs) among primary DC populations. Thus, additional differentiation factors may be required to generate model DCs that more closely resemble other primary DC populations. Also, no model DC stood out in terms of primary DC resemblance. Nevertheless, hierarchical clustering showed clusters of differentially expressed genes among individual DC models as well as primary DC populations. Furthermore, model DCs were shown to differentially express immunologically relevant transcripts and transcriptional signatures identified for each model DC included several immune-associated transcripts. Conclusion: The unique transcriptional profiles of in vitro DC models suggest distinct functionality in immune applications. The presented results will aid in the selection of an appropriate DC model for in vitro assays and assist development of DC-based immunotherapy.	[Lundberg, Kristina; Albrekt, Ann-Sofie; Lindstedt, Malin] Lund Univ, Dept Immunotechnol, Lund, Sweden; [Nelissen, Inge] Flemish Inst Technol Res VITO, Environm Risk & Hlth Unit, Mol, Belgium; [Santegoets, Saskia; de Gruijl, Tanja D.] Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Amsterdam, Netherlands; [Gibbs, Sue] Vrije Univ Amsterdam Med Ctr, Dept Dermatol, Amsterdam, Netherlands	Lund University; VITO; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Lundberg, K (corresponding author), Lund Univ, Dept Immunotechnol, Lund, Sweden.	kristina.lundberg@immun.lth.se	Lindstedt, Malin/A-3855-2009	Lindstedt, Malin/0000-0001-9136-1087; Santegoets, Saskia/0000-0002-2874-4402	Swedish Research Council [2008-743-57748-66]; European Commission as part of the Integrated project 'Novel Testing Strategies for in vitro Assessment of Allergens; Sens-it-iv' [LSHB-CT-2005-018681]	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Commission as part of the Integrated project 'Novel Testing Strategies for in vitro Assessment of Allergens; Sens-it-iv'	This work was supported by grants from the Swedish Research Council (2008-743-57748-66, http://www.vr.se) and the European Commission as part of the Integrated project 'Novel Testing Strategies for in vitro Assessment of Allergens; Sens-it-iv' (LSHB-CT-2005-018681, http://www.sens-it-iv.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby P, 2007, ALTEX-ALTERN TIEREXP, V24, P3; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Azam P, 2006, TOXICOL APPL PHARM, V212, P14, DOI 10.1016/j.taap.2005.06.018; Boullart ACI, 2008, CANCER IMMUNOL IMMUN, V57, P1589, DOI 10.1007/s00262-008-0489-2; Bratke K, 2007, THORAX, V62, P168, DOI 10.1136/thx.2006.067793; Cao WP, 2005, BIOCHEM J, V385, P85, DOI 10.1042/BJ20040741; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; Chieppa M, 2003, J IMMUNOL, V171, P4552, DOI 10.4049/jimmunol.171.9.4552; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; de Jong MAWP, 2010, MOL IMMUNOL, V47, P1216, DOI 10.1016/j.molimm.2009.12.016; Demeure CE, 2000, J IMMUNOL, V164, P2193, DOI 10.4049/jimmunol.164.4.2193; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Dominguez-Soto A, 2007, BLOOD, V109, P5337, DOI 10.1182/blood-2006-09-048058; Garcia F, 2011, VACCINE, V29, P6454, DOI 10.1016/j.vaccine.2011.07.043; Genser B, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-27; Guimond M, 2009, NAT IMMUNOL, V10, P149, DOI 10.1038/ni.1695; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; HEUFLER C, 1993, J EXP MED, V178, P1109, DOI 10.1084/jem.178.3.1109; Hooyberghs J, 2008, TOXICOL APPL PHARM, V231, P103, DOI 10.1016/j.taap.2008.03.014; Hu ZB, 1996, LEUKEMIA, V10, P1025; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jahnsen FL, 2000, J IMMUNOL, V165, P4062, DOI 10.4049/jimmunol.165.7.4062; Jahnsen FL, 2001, THORAX, V56, P823, DOI 10.1136/thorax.56.11.823; Johansson H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-399; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Kalinski P, 1997, ADV EXP MED BIOL, V417, P363; KleinJan A, 2006, J ALLERGY CLIN IMMUN, V118, P1117, DOI 10.1016/j.jaci.2006.05.030; Kunikata T, 2005, NAT IMMUNOL, V6, P524, DOI 10.1038/ni1188; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lardon F, 1997, IMMUNOLOGY, V91, P553, DOI 10.1046/j.1365-2567.1997.00295.x; Larsson K, 2006, IMMUNOLOGY, V117, P156, DOI 10.1111/j.1365-2567.2005.02274.x; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Li DP, 2012, J EXP MED, V209, P109, DOI 10.1084/jem.20110399; Lindstedt M, 2005, J IMMUNOL, V175, P4839, DOI 10.4049/jimmunol.175.8.4839; Lindstedt M, 2002, INT IMMUNOL, V14, P1203, DOI 10.1093/intimm/dxf082; Lundberg K, 2008, CLIN IMMUNOL, V128, P358, DOI 10.1016/j.clim.2008.04.011; Lundberg K, 2010, HUM IMMUNOL, V71, P931, DOI 10.1016/j.humimm.2010.07.008; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Masterson AJ, 2002, BLOOD, V100, P701, DOI 10.1182/blood.V100.2.701; Meyer-Wentrup F, 2008, BLOOD, V111, P4245, DOI 10.1182/blood-2007-03-081398; Meyer-Wentrup F, 2009, J LEUKOCYTE BIOL, V85, P518, DOI 10.1189/jlb.0608352; Nencioni A, 2008, CRIT REV ONCOL HEMAT, V65, P191, DOI 10.1016/j.critrevonc.2007.10.002; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Novak N, 2004, J ALLERGY CLIN IMMUN, V113, P949, DOI 10.1016/j.jaci.2004.02.005; Palucka K, 2011, CURR TOP MICROBIOL, V344, P173, DOI 10.1007/82_2010_48; Prechtel AT, 2007, J IMMUNOL, V178, P5454, DOI 10.4049/jimmunol.178.9.5454; Python F, 2009, TOXICOL APPL PHARM, V239, P273, DOI 10.1016/j.taap.2009.06.003; Quast T, 2011, BLOOD, V118, P1818, DOI 10.1182/blood-2010-12-326595; REID CDL, 1990, BLOOD, V76, P1139; REID CDL, 1992, J IMMUNOL, V149, P2681; Reuter H, 2011, TOXICOL IN VITRO, V25, P315, DOI 10.1016/j.tiv.2010.09.016; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Rosenzwajg M, 1996, BLOOD, V87, P535, DOI 10.1182/blood.V87.2.535.bloodjournal872535; Saini M, 2009, BLOOD, V113, P5793, DOI 10.1182/blood-2008-12-192252; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Santegoets SJAM, 2008, J LEUKOCYTE BIOL, V84, P1364, DOI 10.1189/jlb.0208092; Santegoets SJAM, 2008, J LEUKOCYTE BIOL, V84, P143, DOI 10.1189/jlb.1107750; Schoeters E, 2007, MOL IMMUNOL, V44, P3222, DOI 10.1016/j.molimm.2007.01.031; Schuurhuis DH, 2006, J IMMUNOL, V176, P4573, DOI 10.4049/jimmunol.176.8.4573; Skrzypek F, 2009, MICROBES INFECT, V11, P661, DOI 10.1016/j.micinf.2009.03.010; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; SUDO T, 1989, J EXP MED, V170, P333, DOI 10.1084/jem.170.1.333; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Toebak MJ, 2009, CONTACT DERMATITIS, V60, P2, DOI 10.1111/j.1600-0536.2008.01443.x; Torres-Aguilar H, 2010, AUTOIMMUN REV, V10, P8, DOI 10.1016/j.autrev.2010.07.015; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; van der Vlist M, 2011, EUR J IMMUNOL, V41, P2619, DOI 10.1002/eji.201041305; Van Gulck E, 2010, CURR HIV RES, V8, P310, DOI 10.2174/157016210791208631; Wang S, 2007, J IMMUNOL, V179, P6421, DOI 10.4049/jimmunol.179.10.6421; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Yerkovich ST, 2009, J ALLERGY CLIN IMMUN, V123, P209, DOI 10.1016/j.jaci.2008.09.009	74	77	78	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52875	10.1371/journal.pone.0052875	http://dx.doi.org/10.1371/journal.pone.0052875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341914	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400026
J	Sato, Y; Inoue, N; Ishikawa, T; Ishibashi, R; Obata, M; Aoki, H; Atsumi, T; Komaru, A				Sato, Yu; Inoue, Nariaki; Ishikawa, Takashi; Ishibashi, Ryo; Obata, Mayu; Aoki, Hideo; Atsumi, Takashi; Komaru, Akira			Pearl Microstructure and Expression of Shell Matrix Protein Genes MSI31 and MSI60 in the Pearl Sac Epithelium of Pinctada fucata by In Situ Hybridization	PLOS ONE			English	Article							PRISMATIC LAYER; NACREOUS LAYER; OYSTER; CLONING; FAMILY	Expression patterns of the shell matrix protein genes MSI31 and MSI60 in the pearl sac epithelium were examined by in situ hybridization 38 days after implantation, and related to pearl quality. A pearl sac that produced a nacreous pearl showed very weak expression of MSI31 and strong expression of MSI60. A pearl sac, which yielded a prismatic pearl, strongly expressed MSI31 and very weakly expressed MSI60. In a complex pearl, whose surface consisted of a mosaic of both nacreous and prismatic layers, the expression pattern of MSI31 and MSI60 similarly corresponded to the underlying surface structures of the pearl. A nacreous pearl whose pearl sac showed strong MSI31 expression had an entirely nacreous surface composed of a laminar structure with unusual tablet growth at the corresponding site. MSI31 and MSI60 are the major components of the shell matrix proteins of the nacreous and prismatic layers. Clearly, high expression of MSI31 does not always result in prismatic secretion. These observations cannot be explained solely on the basis of the expression patterns of MSI31 and MSI60. We propose that, in addition to the MSI genes that form the prismatic and nacreous layers, upstream from these genes there are regulatory master genes that determine whether a nacreous layer (aragonite) or a prismatic layer (calcite) is formed.	[Sato, Yu; Inoue, Nariaki; Ishikawa, Takashi; Ishibashi, Ryo; Obata, Mayu; Komaru, Akira] Mie Univ, Grad Sch Bioresources, Tsu, Mie 514, Japan; [Aoki, Hideo; Atsumi, Takashi] Mie Prefecture Fisheries Res Lab, Shima, Mie, Japan	Mie University	Komaru, A (corresponding author), Mie Univ, Grad Sch Bioresources, Tsu, Mie 514, Japan.	komaru@bio.mie-u.ac.jp			Japanese Government, Ministry of Agriculture, Forestry and Fisheries [22065]	Japanese Government, Ministry of Agriculture, Forestry and Fisheries	This study have been supported by the fund of Japanese Government, Ministry of Agriculture, Forestry and Fisheries during 2012-2015. The title of the fund is "A research program aimed at utilizing advanced technologies in agriculture, forestry and fisheries: MAFF, Japan." The No. of the funding is #22065. The funders had no role in our experiment and study design, data collection and analysis, decision to publish, and preparation of manuscript.	Aoki S, 1957, B NATL PEARL RES LAB, V2, P113; Aoki S, 1966, NIPPON SUISAN GAKK, V32, P1; Dauphin Y, 2008, ANAL BIOANAL CHEM, V390, P1659, DOI 10.1007/s00216-008-1860-z; Hayashi M, 2007, ZENSHINREN GIJUTU KE, V21, P7; Inoue N, 2011, MAR BIOTECHNOL, V13, P474, DOI 10.1007/s10126-010-9318-7; Inoue N, 2011, MAR BIOTECHNOL, V13, P48, DOI 10.1007/s10126-010-9267-1; Inoue N, 2010, AQUACULTURE, V308, pS68, DOI 10.1016/j.aquaculture.2010.06.036; Kawakami IK, 1952, MEM FS KYUSHU U, V1, P86; Kinoshita S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021238; Kong YW, 2009, J BIOL CHEM, V284, P10841, DOI 10.1074/jbc.M808357200; Miyashita T, 2000, MAR BIOTECHNOL, V2, P409; Nakahara H, 1956, B NATL PEARL RES LAB, V1, P10; Obata M, 2010, DEV GENES EVOL, V220, P139, DOI 10.1007/s00427-010-0335-3; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Samata Tetsuro, 2004, Thalassas, V20, P25; Saruwatari K, 2009, BIOMATERIALS, V30, P3028, DOI 10.1016/j.biomaterials.2009.03.011; Simkiss K., 1989, BIOMINERALIZATION CE, P230; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2004, BIOCHEM J, V382, P205, DOI 10.1042/BJ20040319; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Takagi R, 2010, ZOOL SCI, V27, P416, DOI 10.2108/zsj.27.416; Takeuchi T, 2006, MAR BIOTECHNOL, V8, P52, DOI 10.1007/s10126-005-5037-x; Taylor J, 2008, PEARL OYSTER, P273, DOI 10.1016/B978-0-444-52976-3.00008-5; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; WADA K, 1966, NATURE, V211, P1427, DOI 10.1038/2111427a0; WADA K., 1957, BULL JAPANESE SOC SCI FISH, V23, P302; Wada K., 1962, B NATL PEARL RES LAB, V8, P948; Wada K., 1957, B NATL PEARL RES LAB, V3, P167; Wada K, 1999, J GEMMOL SOC JPN, V20, P47; Watabe N, 1954, REP FAC FISH PREF U, V1, P449; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cbpb.2006.03.004; Zhang C, 2006, MAR BIOTECHNOL, V8, P572, DOI 10.1007/s10126-005-6029-6; Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P565, DOI 10.1016/S1096-4959(03)00138-6	34	23	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52372	10.1371/journal.pone.0052372	http://dx.doi.org/10.1371/journal.pone.0052372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341897	Green Submitted, gold, Green Published			2022-12-25	WOS:000314759400014
J	Almeida, C; Nagarajan, D; Tian, J; Leal, SW; Wheeler, K; Munley, M; Blackstock, W; Zhao, WL				Almeida, Celine; Nagarajan, Devipriya; Tian, Jian; Leal, Sofia Walder; Wheeler, Kenneth; Munley, Michael; Blackstock, William; Zhao, Weiling			The Role of Alveolar Epithelium in Radiation-Induced Lung Injury	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; HISTONE DEACETYLASE INHIBITORS; INDUCED PULMONARY-FIBROSIS; HEPATIC STELLATE CELLS; THORACIC IRRADIATION; GROWTH-FACTOR; MOUSE LUNG; RAT LUNG; DECREASED EXPRESSION; TGF-BETA	Pneumonitis and fibrosis are major lung complications of irradiating thoracic malignancies. In the current study, we determined the effect of thoracic irradiation on the lungs of FVB/N mice. Survival data showed a dose-dependent increase in morbidity following thoracic irradiation with single (11-13 Gy) and fractionated doses (24-36 Gy) of Cs-137 gamma-rays. Histological examination showed a thickening of vessel walls, accumulation of inflammatory cells, collagen deposition, and regional fibrosis in the lungs 14 weeks after a single 12 Gy dose and a fractionated 30 Gy dose; this damage was also seen 5 months after a fractionated 24 Gy dose. After both single and fractionated doses, i] aquaporin-5 was markedly decreased, ii] E-cadherin was reduced and iii] prosurfactant Protein C (pro-SP-c), the number of pro-SP-c(+) cells and vimentin expression were increased in the lungs. Immunofluorescence analysis revealed co-localization of pro-SP-c and alpha-smooth muscle actin in the alveoli after a single dose of 12 Gy. These data suggest that, i] the FVB/N mouse strain is sensitive to thoracic radiation ii] aquaporin-5, E-cadherin, and pro-SP-c may serve as sensitive indicators of radiation-induced lung injury; and iii] the epithelial-to-mesenchymal transition may play an important role in the development of radiation-induced lung fibrosis.	[Almeida, Celine; Nagarajan, Devipriya; Leal, Sofia Walder; Munley, Michael; Blackstock, William; Zhao, Weiling] Wake Forest Sch Med, Dept Radiat Oncol, Winston Salem, NC USA; [Wheeler, Kenneth] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC USA; [Almeida, Celine; Nagarajan, Devipriya; Leal, Sofia Walder; Wheeler, Kenneth; Zhao, Weiling] Wake Forest Univ, Wake Forest Sch Med, Brain Tumor Ctr, Winston Salem, NC 27109 USA; [Tian, Jian] Loma Linda Univ, Dept Radiat Med, Radiat Res Labs, Loma Linda, CA 92350 USA; [Tian, Jian] Loma Linda Univ, Med Ctr, Loma Linda, CA USA	Wake Forest University; Wake Forest University; Wake Forest University; Loma Linda University; Loma Linda University	Zhao, WL (corresponding author), Wake Forest Sch Med, Dept Radiat Oncol, Winston Salem, NC USA.	wzhao@wfubmc.edu	Nagarajan, Devipriya/GNO-9425-2022	Nagarajan, Devipriya/0000-0002-4569-2624				Adamson IY, 1988, AM J PATHOL, V41, P377; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Calveley VL, 2010, RADIAT RES, V173, P602, DOI 10.1667/RR1896.1; Chung YL, 2004, MOL CANCER THER, V3, P317; COGGLE JE, 1987, INT J RADIAT BIOL, V51, P393, DOI 10.1080/09553008714550891; Cole TJ, 2004, AM J RESP CELL MOL, V30, P613, DOI 10.1165/rcmb.2003-0236OC; Epperly MW, 2003, AM J RESP CELL MOL, V29, P213, DOI 10.1165/rcmb.2002-0069OC; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Fleckenstein K, 2007, INT J RADIAT ONCOL, V68, P196, DOI 10.1016/j.ijrobp.2006.12.056; Folkerts G, 1998, TRENDS PHARMACOL SCI, V19, P334, DOI 10.1016/S0165-6147(98)01232-2; Franko AJ, 1996, RADIAT RES, V146, P68, DOI 10.2307/3579397; Franko AJ, 1996, RADIAT RES, V146, P586, DOI 10.2307/3579561; FRANKO AJ, 1994, RADIAT RES, V140, P347, DOI 10.2307/3579112; Gabazza EC, 2004, PATHOL INT, V54, P774, DOI 10.1111/j.1440-1827.2004.01754.x; Ghafoori P, 2008, ONCOLOGY-NY, V22, P37; GIRI PGS, 1986, BRIT J CANCER, V53, P324; GIRI PGS, 1985, INT J RADIAT ONCOL, V11, P527, DOI 10.1016/0360-3016(85)90184-1; Grundmann O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-417; Han P, 2011, CIRC RES, V108, P378, DOI 10.1161/CIRCRESAHA.110.224287; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Hodge S, 2009, AM J TRANSPLANT, V9, P727, DOI 10.1111/j.1600-6143.2009.02558.x; Houchen CW, 2000, AM J PHYSIOL-GASTR L, V279, pG858, DOI 10.1152/ajpgi.2000.279.5.G858; Jackson IL, 2011, RADIAT RES, V175, P510, DOI 10.1667/RR2421.1; Jackson IL, 2010, RADIAT RES, V173, P10, DOI 10.1667/RR1911.1; JOHNSTON CJ, 1995, RADIAT RES, V142, P197, DOI 10.2307/3579029; Jung JW, 2007, EUR J CANCER, V43, P1214, DOI 10.1016/j.ejca.2007.01.034; Kaimori A, 2010, HEPATOLOGY, V52, P1033, DOI 10.1002/hep.23765; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; King LS, 2000, MOL MED TODAY, V6, P60, DOI 10.1016/S1357-4310(99)01636-6; Kong Feng-Ming, 2008, Cancer Control, V15, P140; Liu DG, 2008, CHINESE MED J-PEKING, V121, P1925, DOI 10.1097/00029330-200810010-00014; Mannaerts I, 2010, HEPATOLOGY, V51, P603, DOI 10.1002/hep.23334; Marks L B, 1994, Oncology (Williston Park), V8, P89; Marks LB, 2003, SEMIN RADIAT ONCOL, V13, P333, DOI 10.1016/S1053-4296(03)00034-1; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; MCCORMAC FX, 1995, AM J RESP CRIT CARE, V152, P751, DOI 10.1164/ajrccm.152.2.7633738; Molla M, 2003, INT J RADIAT ONCOL, V57, P264, DOI 10.1016/S0360-3016(03)00523-6; Movsas B, 1997, CHEST, V111, P1061, DOI 10.1378/chest.111.4.1061; Nagarajan D, 2012, FREE RADICAL BIO MED, V52, P983, DOI 10.1016/j.freeradbiomed.2011.11.024; Niki T, 1999, HEPATOLOGY, V29, P858, DOI 10.1002/hep.510290328; O'Brien TJ, 2005, CAN J PHYSIOL PHARM, V83, P117, DOI 10.1139/Y05-005; Pang MY, 2010, J PHARMACOL EXP THER, V335, P266, DOI 10.1124/jpet.110.168385; Park JH, 2004, CLIN CANCER RES, V10, P5271, DOI 10.1158/1078-0432.CCR-03-0709; Radisky DC, 2005, J CELL SCI, V118, P4325, DOI 10.1242/jcs.02552; Reed JAH, 1997, AM J PHYSIOL-LUNG C, V273, pL715, DOI 10.1152/ajplung.1997.273.4.L715; Remiszewski SW, 2002, CURR OPIN DRUG DISC, V5, P487; Rube CE, 2000, INT J RADIAT ONCOL, V47, P1033, DOI 10.1016/S0360-3016(00)00482-X; RUBIN P, 1995, INT J RADIAT ONCOL, V33, P99, DOI 10.1016/0360-3016(95)00095-G; SHARPLIN J, 1989, RADIAT RES, V119, P1, DOI 10.2307/3577363; Sisson TH, 2010, AM J RESP CRIT CARE, V181, P254, DOI 10.1164/rccm.200810-1615OC; STEEL GG, 1979, BRIT J RADIOL, V52, P741, DOI 10.1259/0007-1285-52-621-741; Takayasu H, 2007, J PEDIATR SURG, V42, P415, DOI 10.1016/j.jpedsurg.2006.10.029; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Thore CR, 2007, J NEUROPATH EXP NEUR, V66, P337, DOI 10.1097/nen.0b013e3180537147; Towne JE, 2000, AM J RESP CELL MOL, V22, P34, DOI 10.1165/ajrcmb.22.1.3818; TRAVIS EL, 1980, INT J RADIAT ONCOL, V6, P345, DOI 10.1016/0360-3016(80)90145-5; Tsoutsou PG, 2006, INT J RADIAT ONCOL, V66, P1281, DOI 10.1016/j.ijrobp.2006.08.058; VERKMAN AS, 2000, EXP PHYSL, V85; Williams JP, 2012, RADIAT RES, V177; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; Yang XB, 2011, AM J RESP CELL MOL, V45, P127, DOI 10.1165/rcmb.2010-0265OC; Yoshikawa M, 2007, J AM SOC NEPHROL, V18, P58, DOI 10.1681/ASN.2005111187	64	67	73	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53628	10.1371/journal.pone.0053628	http://dx.doi.org/10.1371/journal.pone.0053628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326473	Green Published, Green Submitted, gold			2022-12-25	WOS:000314705800064
J	Behere, GT; Tay, WT; Russell, DA; Kranthi, KR; Batterham, P				Behere, Gajanan Tryambak; Tay, Wee Tek; Russell, Derek Alan; Kranthi, Keshav Raj; Batterham, Philip			Population Genetic Structure of the Cotton Bollworm Helicoverpa armigera (Hubner) (Lepidoptera: Noctuidae) in India as Inferred from EPIC-PCR DNA Markers	PLOS ONE			English	Article							MICROSATELLITE NULL ALLELES; PYRETHROID-RESISTANCE; INSECTICIDE RESISTANCE; BEMISIA-TABACI; HELIOTHIS; MIGRATION; DYNAMICS; MOTH; FLOW; CROPS	Helicoverpa armigera is an important pest of cotton and other agricultural crops in the Old World. Its wide host range, high mobility and fecundity, and the ability to adapt and develop resistance against all common groups of insecticides used for its management have exacerbated its pest status. An understanding of the population genetic structure in H. armigera under Indian agricultural conditions will help ascertain gene flow patterns across different agricultural zones. This study inferred the population genetic structure of Indian H. armigera using five Exon-Primed Intron-Crossing (EPIC)-PCR markers. Nested alternative EPIC markers detected moderate null allele frequencies (4.3% to 9.4%) in loci used to infer population genetic structure but the apparently genome-wide heterozygote deficit suggests in-breeding or a Wahlund effect rather than a null allele effect. Population genetic analysis of the 26 populations suggested significant genetic differentiation within India but especially in cotton-feeding populations in the 2006-07 cropping season. In contrast, overall pair-wise F-ST estimates from populations feeding on food crops indicated no significant population substructure irrespective of cropping seasons. A Baysian cluster analysis was used to assign the genetic make-up of individuals to likely membership of population clusters. Some evidence was found for four major clusters with individuals in two populations from cotton in one year (from two populations in northern India) showing especially high homogeneity. Taken as a whole, this study found evidence of population substructure at host crop, temporal and spatial levels in Indian H. armigera, without, however, a clear biological rationale for these structures being evident.	[Behere, Gajanan Tryambak; Batterham, Philip] Univ Melbourne, Dept Genet, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic, Australia; [Tay, Wee Tek] CSIRO Ecosyst Sci, Canberra, ACT, Australia; [Russell, Derek Alan] Univ Melbourne, Dept Agr & Food Syst, Melbourne, Vic, Australia; [Behere, Gajanan Tryambak] Indian Council Agr Res, Div Entomol, Shilong, Meghalaya, India; [Kranthi, Keshav Raj] Cent Inst Cotton Res, Nagpur, Maharashtra, India	University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Melbourne; Indian Council of Agricultural Research (ICAR); Indian Council of Agricultural Research (ICAR); ICAR - Central Institute of Cotton Research	Tay, WT (corresponding author), CSIRO Ecosyst Sci, Canberra, ACT, Australia.	weetek.tay@csiro.au	Behere, Gajanan Tryambak/AAP-5289-2020; Tay, Wee Tek/C-1818-2008; Tay, Wee Tek/GPF-6142-2022; Batterham, Philip/G-5914-2012	Behere, Gajanan Tryambak/0000-0003-0222-7367; Tay, Wee Tek/0000-0002-8451-0811; Tay, Wee Tek/0000-0002-8451-0811; Batterham, Philip/0000-0001-9840-9119	Melbourne International Research Scholarship (MIRS); Melbourne International Fee Remission Scholarship (MIFRS); Albert Shimmins Post Graduate Writing-up Award (Faculty of Science, University of Melbourne); Australian Research Council (ARC)	Melbourne International Research Scholarship (MIRS); Melbourne International Fee Remission Scholarship (MIFRS); Albert Shimmins Post Graduate Writing-up Award (Faculty of Science, University of Melbourne); Australian Research Council (ARC)(Australian Research Council)	GTB was supported by grants from the Melbourne International Research Scholarship (MIRS), the Melbourne International Fee Remission Scholarship (MIFRS), and the Albert Shimmins Post Graduate Writing-up Award (Faculty of Science, University of Melbourne). The Australian Research Council (ARC) provided funding to the Special Research Centre for Environmental Stress and Adaptation Research (CESAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMES NJ, 1992, PESTIC SCI, V34, P355, DOI 10.1002/ps.2780340409; Armes NJ, 1996, B ENTOMOL RES, V86, P499, DOI 10.1017/S0007485300039298; Behere GT, 2008, B ENTOMOL RES, V98, P599, DOI 10.1017/S0007485308005956; Behere GT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-117; Bhatnagar VS, 1980, REPORT RES HELIOTHIS; Bhattacherjee NS, 1972, ENTOMOL NEWSLETT, V2, P3; Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chowda-Reddy RV, 2012, J INTEGR AGR, V11, P235, DOI 10.1016/S2095-3119(12)60008-2; DALY JC, 1985, B ENTOMOL RES, V75, P169, DOI 10.1017/S0007485300014243; De Barro PJ, 2005, MOL ECOL, V14, P3695, DOI 10.1111/j.1365-294X.2005.02700.x; DeSouza K, 1995, ECOL ENTOMOL, V20, P333, DOI 10.1111/j.1365-2311.1995.tb00465.x; Durairaj C., 2005, Heliothis/Helicoverpa management: emerging trends and strategies for future research, P91; Endersby NM, 2007, ENTOMOL EXP APPL, V122, P253, DOI 10.1111/j.1570-7458.2006.00515.x; Endersby NM, 2006, MOL ECOL, V15, P107, DOI 10.1111/j.1365-294X.2005.02789.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Fakrudin B, 2004, CURR SCI INDIA, V87, P1654; FIREMPONG S, 1990, AUST J ZOOL, V37, P665, DOI 10.1071/ZO9890665; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Gordon K, 2009, MOL BIOL GENETICS LE, P219; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Jallow MFA, 2004, CROP PROT, V23, P955, DOI 10.1016/j.cropro.2004.02.008; Jallow MFA, 1996, AUST J ZOOL, V44, P503, DOI 10.1071/ZO9960503; Jayaraj S, 1982, BIOLOGICAL AND ECOLO, P17; Ji YJ, 2003, MOL ECOL NOTES, V3, P102, DOI 10.1046/j.1471-8286.2003.00366.x; JOHNSON MS, 1984, MAR BIOL, V79, P295, DOI 10.1007/BF00393261; Khadi BM, 2003, STRENGTHS WEAKNESSES, P393; Kranthi KR, 2004, CURR SCI INDIA, V87, P1096; Kranthi KR, 2002, CROP PROT, V21, P449, DOI 10.1016/S0261-2194(01)00131-4; Kranthi KR, 2001, B ENTOMOL RES, V91, P37; Kranthi KR, 1997, PESTIC SCI, V50, P91, DOI 10.1002/(SICI)1096-9063(199706)50:2&lt;91::AID-PS570&gt;3.0.CO;2-X; Kranthi S, 2009, CROP PROT, V28, P371, DOI 10.1016/j.cropro.2008.12.001; LESSA EP, 1992, MOL BIOL EVOL, V9, P323; MADDEN AD, 1995, ECOL MODEL, V82, P61, DOI 10.1016/0304-3800(94)00071-O; Manjunath TH, 1970, CIBC TECH B, V13, P111; Manjunath TM, 1989, INDIA ASSESSMENT THE, P197; McKechnie SW, 1993, P BELTW COTT C NEW O, P838; Nibouche S, 1998, HEREDITY, V80, P438, DOI 10.1046/j.1365-2540.1998.00273.x; Nielsen EE, 2003, MOL ECOL, V12, P1497, DOI 10.1046/j.1365-294X.2003.01819.x; PALUMBI SR, 1994, MOL BIOL EVOL, V11, P426; PEDGLEY DE, 1987, INSECT SCI APPL, V8, P599, DOI 10.1017/S1742758400022669; Pritchard JK, 2000, GENETICS, V155, P945; Ravi KC, 2005, ENVIRON ENTOMOL, V34, P59, DOI 10.1603/0046-225X-34.1.59; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed W, 1982, HELIOTHIS A GLOBAL P, P9; Reyes PFM, 2007, MOL ECOL, V16, P3554, DOI 10.1111/j.1365-294X.2007.03410.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Sachan J.N., 1987, P91; Schneider S, 2000, ARLEQUIN A SOFTWARE; Scott KD, 2005, B ENTOMOL RES, V95, P381, DOI 10.1079/BER2005369; Scott KD, 2005, J ECON ENTOMOL, V98, P2210, DOI 10.1603/0022-0493-98.6.2210; Scott KD, 2004, MOL ECOL NOTES, V4, P204, DOI 10.1111/j.1471-8286.2004.00617.x; Scott KD, 2003, AUST J AGR RES, V54, P739, DOI 10.1071/AR02164; Scott LJ, 2006, J ECON ENTOMOL, V99, P155, DOI 10.1603/0022-0493(2006)099[0155:PDAGFO]2.0.CO;2; Singh J., 1990, Journal of Insect Science, V3, P47; SINGH J, 1986, Indian Journal of Ecology, V13, P113; Singh J, 1992, P 1 NAT WORKSH, P92; Stipanovic RD, 2006, J CHEM ECOL, V32, P959, DOI 10.1007/s10886-006-9052-9; Stokes NH, 1997, AUST J ENTOMOL, V36, P191, DOI 10.1111/j.1440-6055.1997.tb01454.x; Tamhankar AJ, 2003, CURR SCI INDIA, V84, P448; Tay WT, 2008, B ENTOMOL RES, V98, P509, DOI 10.1017/S000748530800583X; Tay WT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-144; Vassal Jean-Michel, 2008, Commun Agric Appl Biol Sci, V73, P433; Verma A.K., 1993, Pest Management and Economic Zoology, V1, P43; Weeks AR, 2010, B ENTOMOL RES, V100, P445, DOI 10.1017/S0007485309990460; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Zalucki MP, 2012, B ENTOMOL RES, V102, P468, DOI 10.1017/S0007485311000848; Zalucki Myron P., 2005, Insect Science, V12, P45, DOI 10.1111/j.1672-9609.2005.00007.x; Zhou XF, 2000, HEREDITY, V85, P251, DOI 10.1046/j.1365-2540.2000.00738.x; Zraket CA, 1989, GENETIC LINKAGE MAPP, P13	72	38	41	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53448	10.1371/journal.pone.0053448	http://dx.doi.org/10.1371/journal.pone.0053448			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326431	Green Published, gold			2022-12-25	WOS:000314705800045
J	Wolf, A; Akrap, N; Marg, B; Galliardt, H; Heiligentag, M; Humpert, F; Sauer, M; Kaltschmidt, B; Kaltschmidt, C; Seidel, T				Wolf, Annette; Akrap, Nina; Marg, Berenice; Galliardt, Helena; Heiligentag, Martyna; Humpert, Fabian; Sauer, Markus; Kaltschmidt, Barbara; Kaltschmidt, Christian; Seidel, Thorsten			Elements of Transcriptional Machinery Are Compatible among Plants and Mammals	PLOS ONE			English	Article							NF-KAPPA-B; RNA-BINDING PROTEIN; GENE-EXPRESSION; NUCLEAR-PORE; DNA-BINDING; ALPHA; DYNAMICS; RECEPTOR; ATPASE; SIGNAL	In the present work, the objective has been to analyse the compatibility of plant and human transcriptional machinery. The experiments revealed that nuclear import and export are conserved among plants and mammals. Further it has been shown that transactivation of a human promoter occurs by human transcription factor NF-kappa B in plant cells, demonstrating that the transcriptional machinery is highly conserved in both kingdoms. Functionality was also seen for regulatory elements of NF-kappa B such as its inhibitor I kappa B isoform alpha that negatively regulated the transactivation activity of the p50/RelA heterodimer by interaction with NF-kappa B in plant cells. Nuclear export of RelA could be demonstrated by FRAP-measurements so that RelA shows nucleo-cytoplasmic shuttling as reported for RelA in mammalian cells. The data reveals the high level of compatibility of human transcriptional elements with the plant transcriptional machinery. Thus, Arabidopsis thaliana mesophyll protoplasts might provide a new heterologous expression system for the investigation of the human NF-kappa B signaling pathways. The system successfully enabled the controlled manipulation of NF-kappa B activity. We suggest the plant protoplast system as a tool for reconstitution and analyses of mammalian pathways and for direct observation of responses to e. g. pharmaceuticals. The major advantage of the system is the absence of interference with endogenous factors that affect and crosstalk with the pathway.	[Wolf, Annette; Akrap, Nina; Marg, Berenice; Galliardt, Helena; Heiligentag, Martyna; Humpert, Fabian; Kaltschmidt, Barbara; Seidel, Thorsten] Univ Bielefeld, D-33615 Bielefeld, Germany; [Sauer, Markus] Univ Wurzburg, Biozentrum, D-97070 Wurzburg, Germany; [Kaltschmidt, Christian] Univ Bielefeld, Dept Cell Biol, D-33615 Bielefeld, Germany	University of Bielefeld; University of Wurzburg; University of Bielefeld	Seidel, T (corresponding author), Univ Bielefeld, D-33615 Bielefeld, Germany.	thorsten.seidel@uni-bielefeld.de	Sauer, Markus/C-4378-2017	Sauer, Markus/0000-0002-1692-3219	Deutsche Forschungsgemeinschaft [SFB613/A5]; Bielefeld University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bielefeld University	This work was supported by Deutsche Forschungsgemeinschaft (SFB613/A5) and Bielefeld University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Beemiller P, 2006, PLOS BIOL, V4, P987, DOI 10.1371/journal.pbio.0040162; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; De Lorenzi R, 2009, GENESIS, V47, P323, DOI 10.1002/dvg.20468; ERNST MK, 1995, MOL CELL BIOL, V15, P872; GERACE L, 1995, CELL, V82, P341, DOI 10.1016/0092-8674(95)90420-4; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gilmore TD, 2009, E L S, DOI [1 0 . 1 0 0 2 /9780470015902. a0002332.pub3, DOI 10.1002/9780470015902.A0002332.PUB3]; Gitzinger M, 2009, PLANT BIOTECHNOL J, V7, P73, DOI 10.1111/j.1467-7652.2008.00376.x; Goedhart J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001011; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Harhaj EW, 1999, MOL CELL BIOL, V19, P7088; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; ITO CY, 1994, NUCLEIC ACIDS RES, V22, P3787, DOI 10.1093/nar/22.18.3787; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; Lopez-Molina L, 2002, PLANT J, V32, P317, DOI 10.1046/j.1365-313X.2002.01430.x; Lummer M, 2011, TRAFFIC, V12, P693, DOI 10.1111/j.1600-0854.2011.01180.x; Meier I, 2009, CURR OPIN PLANT BIOL, V12, P87, DOI 10.1016/j.pbi.2008.09.001; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rao P, 2010, NATURE, V466, P1115, DOI 10.1038/nature09283; Schooley K, 2003, BIOCHEM J, V369, P331, DOI 10.1042/BJ20020253; Seidel T, 2005, FEBS LETT, V579, P4374, DOI 10.1016/j.febslet.2005.06.077; Seidel T, 2004, J BIOTECHNOL, V112, P165, DOI 10.1016/j.jbiotec.2004.04.027; Weil R, 1997, IMMUNOBIOLOGY, V198, P14, DOI 10.1016/S0171-2985(97)80023-X; Whiteside ST, 1997, SEMIN CANCER BIOL, V8, P75, DOI 10.1006/scbi.1997.0058; Widera D, 2009, ENCY NEUROSCIENCE, P2862; Ziemienowicz A, 2003, PLANT MOL BIOL, V53, P201, DOI 10.1023/B:PLAN.0000009288.46713.1f	31	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53737	10.1371/journal.pone.0053737	http://dx.doi.org/10.1371/journal.pone.0053737			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326494	gold, Green Published, Green Submitted			2022-12-25	WOS:000314705800072
J	Ai, JH; Jin, Y; Wang, ZZ; Yang, L; Luo, D				Ai Junhua; Jin Yun; Wang Zhenzhou; Yang Ling; Luo Ding			Treatment of Malignant Liver Tumors by Radiofrequency Ablation Combined with Low-Frequency Ultrasound Radiation with Microbubbles	PLOS ONE			English	Article								Objective: To explore the therapeutic efficacy and safety of malignant liver tumor treatment by radiofrequency ablation (RA) combined with low frequency ultrasound radiation with microbubbles (LFURM). Methods: Retrospective analysis of 25 patients with malignant hepatic tumors treated by RA/LFURM in the Department of Hepatobiliary Surgery of Kunming General Hospital affiliated to Chengdu Military District, PLA from January 2010 to June 2011. Ultrasound guided RA was performed, which was followed one week later by LFURM. Basal contrast ultrasound, liver function tests, and serum alpha fetoprotein (AFP) were obtained, and repeated 3 and 6 months after treatment. T-test and chi-square were used to compare parametric and non-parametric variables respectively. Results: In 17 cases, gross tumor volume was significantly reduced 6 months after treatment while mean tumor showed a reduction of 50% compared to pre-treatment values. In 7 cases gross tumor volumes reduction was partial, but surrounding tumor tissue showed blood flow signals. One patient had no reduction in gross tumor volume. Levels of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBIL), alpha fetoprotein (AFP) decreased significantly 6 months after treatment (all p<0.05). No tumor recurrence was seen during the 6 month follow-up. Quality of life scores (QOL) were good in 21 patients (84%), improved in 2 patients (8%), unchanged in 1 patient (4%) and got worst in 1 patient (4%). Karnofsky scores (KPS) improved in 19 patients (76%), remained unchanged in 5 patients (2%) and got worst in 1 patient (4%). Both QOL and KPS changes were statistically significant (P<0.05). Conclusion: RA/LFURM treatment of liver tumors is efficient and safe, and can reduce the gross tumor volumes and protect liver function.	[Ai Junhua] Chinese Peoples Armed Police Force 8710 Hosp, Dept Gen Surg, Putian, Fujian Province, Peoples R China; [Jin Yun; Luo Ding] Chengdu Mil Dist Chinese Peoples Liberat Army, Kunming Gen Hosp Affiliated, Dept Hepatobiliary Surg, Kunming, Yunnan Province, Peoples R China; [Wang Zhenzhou] Chengdu Mil Dist Chinese Peoples Liberat Army, Kunming Gen Hosp Affiliated, Dept Med Engn, Kunming, Yunnan Province, Peoples R China; [Yang Ling] Chengdu Mil Dist Chinese Peoples Liberat Army, Kunming Gen Hosp Affiliated, Dept Special Diag, Kunming, Yunnan Province, Peoples R China		Luo, D (corresponding author), Chengdu Mil Dist Chinese Peoples Liberat Army, Kunming Gen Hosp Affiliated, Dept Hepatobiliary Surg, Kunming, Yunnan Province, Peoples R China.	digluo@sohu.com						Chen MH, 2004, RADIOLOGY, V232, P260, DOI 10.1148/radiol.2321030821; Chen MH, 2008, JOURNAL OF CHINESE A, V30, P15; Chen XiaoPing, 2009, Chinese Journal of Digestive Surgery, V8, P88; Chiou Yi-You, 2005, Kaohsiung Journal of Medical Sciences, V21, P304; Fang LH, 2011, J CLIN ONCOL, V16, P510; Jiang Z, 2005, MODERN MEDICINE, V33, P171; Kamphues C, 2011, J HEPATOBILIARY PANC, V17, P509; Kang JA, 2010, J ULTRAS MED, V29, P61, DOI 10.7863/jum.2010.29.1.61; Kim JH, 2011, EUR J RADIOL, V80, pE221, DOI 10.1016/j.ejrad.2010.09.019; Kim JH, 2011, AM J ROENTGENOL, V196, pW205, DOI 10.2214/AJR.10.4937; Kudo M, 2010, ONCOLOGY-BASEL, V78, P113, DOI 10.1159/000315239; Liang TingBo, 2010, Chinese Journal of Digestive Surgery, V9, P15; Mason T, 2007, J GASTROINTEST SURG, V11, P1333, DOI 10.1007/s11605-007-0214-z; Massarweh NN, 2012, ANN SURG ONCOL, V19, P1058, DOI 10.1245/s10434-011-2067-7; Park Donghee, 2010, Open Biomed Eng J, V4, P56, DOI 10.2174/1874120701004010056; Poon RT, 2004, ANN SURG, V239, P441, DOI 10.1097/01.sla.0000118565.21298.0a; Rai R, 2005, WORLD J GASTROENTERO, V11, P612; Roberts WW, 2006, J UROLOGY, V175, P447; Saiura A, 2011, AM J SURG, V201, P203, DOI 10.1016/j.amjsurg.2008.12.035; Slakey DP, 2002, AM SURGEON, V68, P395; Wang L, 2011, INTERNATIONAL JOURNA, V34, P364; Wang Y, 2011, MODERN ONCOLOGICAL M, V19, P1063; Yu MA, 2011, EUR J RADIOL, V80, P548, DOI 10.1016/j.ejrad.2011.01.014; Zgodzinski W, 2005, WORLD J GASTROENTERO, V11, P5239	24	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53351	10.1371/journal.pone.0053351	http://dx.doi.org/10.1371/journal.pone.0053351			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326418	Green Published, gold, Green Submitted			2022-12-25	WOS:000313552400019
J	Shi, FY; Fan, YN; Zhang, LG; Meng, L; Zhi, HF; Hu, HY; Lin, AX				Shi, Fangyu; Fan, Yannan; Zhang, Laiguang; Meng, Lu; Zhi, Huifang; Hu, Hongyu; Lin, Aixin			The Expression of Pax6 Variants Is Subject to Posttranscriptional Regulation in the Developing Mouse Eyelid	PLOS ONE			English	Article							CORNEAL EPITHELIAL-CELLS; PAIRED DOMAIN; PROLIFERATION; GENE; OVEREXPRESSION; DOSAGE; MIGRATION; PROMOTES; MICE; DIFFERENTIATION	Pax6 is a pivotal transcription factor that plays a role during early eye morphogenesis, but its expression and function in eyelid development remain unknown. In this study, the expression patterns of Pax6 mRNA and protein were examined in the developing mouse eyelid at embryonic days 14.5, 15.5, and 16.5. The function of Pax6 in eyelid development was determined by comparing it to that in the eyes-open-at-birth mutant mouse. In the normally developing eyelid, Pax6 and Pax6(5a) mRNA levels were low at E14.5, increased at E15.5, and then declined at E16.5, accompanied by a change in the Pax6/Pax6(5a) ratio. Pax6 protein was mainly located in the mesenchyme and conjunctiva. It was expressed at low levels in the epidermis at E14.5, severely reduced at E15.5, but re-expressed in the keratinocyte cells of the periderm at E16.5. In contrast, Pax6 and the Pax6/Pax6(5a) ratio were considerably higher with strong nuclear expression in the mutant at E15.5. Next, we examined the relationship of Pax6 to epidermal cell proliferation, migration, and the associated signalling pathways. The Pax6 protein in the developing eyelid was negatively correlated with epidermal cell proliferation but not migration, and it is in contrast to the activation of the EGFR-ERK pathway. Our in vivo data suggest that Pax6 expression and the Pax6/Pax6(5a) ratio are at relatively low levels in the eyelid, and acting as a transcription factor, Pax6 is required for the initiation of eyelid formation and for differential development of the keratinised cells in the closed eyelid. The Pax6 protein is likely to be controlled by the EGFR-ERK pathways. An abnormal increase in Pax6 expression and the Pax6/Pax6(5a) ratio due to alteration of the pathway activity could suppress epidermal cell proliferation leading to the eyes-open-at-birth defect. This study offers insight into the function of the Pax6 protein in eyelid development.	[Shi, Fangyu; Fan, Yannan; Zhang, Laiguang; Meng, Lu; Zhi, Huifang; Hu, Hongyu; Lin, Aixin] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University	Hu, HY (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	huhy2008@cau.edu.cn; linaix@cau.edu.cn			National Natural Science Foundation of China [31071990]; State Key Laboratory of Agrobiotechnology; National Transgenic Major Program [2009ZX08009-152B]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Agrobiotechnology; National Transgenic Major Program	This work is supported by the National Natural Science Foundation of China (No. 31071990), partly supported by the Project for Extramural Scientists of State Key Laboratory of Agrobiotechnology and by the National Transgenic Major Program (No. 2009ZX08009-152B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashery-Padan R, 2001, CURR OPIN CELL BIOL, V13, P706, DOI 10.1016/S0955-0674(00)00274-X; Azuma N, 1999, AM J HUM GENET, V65, P656, DOI 10.1086/302529; Azuma N, 2005, HUM MOL GENET, V14, P735, DOI 10.1093/hmg/ddi069; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; Chauhan BK, 2004, NUCLEIC ACIDS RES, V32, P1696, DOI 10.1093/nar/gkh334; Collinson JM, 2003, DEV BIOL, V255, P303, DOI 10.1016/S0012-1606(02)00095-7; Davis N, 2009, DEV BIOL, V333, P132, DOI 10.1016/j.ydbio.2009.06.023; de Chevigny A, 2012, NAT NEUROSCI, V15, P1120, DOI 10.1038/nn.3142; Dora N, 2008, DEV DYNAM, V237, P1295, DOI 10.1002/dvdy.21528; Duncan MK, 2000, J CELL SCI, V113, P3173; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; FINDLATER GS, 1993, J ANAT, V183, P121; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Grocott T, 2007, NUCLEIC ACIDS RES, V35, P890, DOI 10.1093/nar/gkl1105; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hislop NR, 2008, DEV BIOL, V321, P263, DOI 10.1016/j.ydbio.2008.06.026; Kao WWY, 2008, OCUL SURF, V6, P9; Kiselev Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031915; Kleinjan DA, 2006, DEV BIOL, V299, P563, DOI 10.1016/j.ydbio.2006.08.060; Koroma BM, 1997, INVEST OPHTH VIS SCI, V38, P108; Kozmik Z, 2008, BRAIN RES BULL, V75, P335, DOI 10.1016/j.brainresbull.2007.10.046; KUBBEN FJGM, 1994, GUT, V35, P530, DOI 10.1136/gut.35.4.530; Li T, 2005, J BIOL CHEM, V280, P12988, DOI 10.1074/jbc.M412458200; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; Manuel M, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-59; Mine N, 2005, DEVELOPMENT, V132, P4317, DOI 10.1242/dev.02030; Ouyang J, 2006, INVEST OPHTH VIS SCI, V47, P2397, DOI 10.1167/iovs.05-1083; PEI YF, 1970, ANAT REC, V168, P105, DOI 10.1002/ar.1091680109; Pinson J, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-13; Sakurai K, 2008, J NEUROSCI, V28, P4604, DOI 10.1523/JNEUROSCI.5074-07.2008; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Singh S, 2002, P NATL ACAD SCI USA, V99, P6812, DOI 10.1073/pnas.102691299; Symonds D, 2003, ANAT REC PART A, V273A, P681, DOI 10.1002/ar.a.10090; Tao H, 2005, DEVELOPMENT, V132, P3217, DOI 10.1242/dev.01892; Tyas DA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-21; van Raamsdonk CD, 2000, DEVELOPMENT, V127, P5439; WEISS LW, 1975, ACTA DERM-VENEREOL, V55, P321; Wu D, 2006, INVEST OPHTH VIS SCI, V47, P2422, DOI 10.1167/iovs.05-0536; Zhang L, 2003, EMBO J, V22, P4443, DOI 10.1093/emboj/cdg440	41	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53919	10.1371/journal.pone.0053919	http://dx.doi.org/10.1371/journal.pone.0053919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326536	Green Submitted, Green Published, gold			2022-12-25	WOS:000313552400059
J	Teixido, N; Casas, E; Cebrian, E; Linares, C; Garrabou, J				Teixido, Nuria; Casas, Edgar; Cebrian, Emma; Linares, Cristina; Garrabou, Joaquim			Impacts on Coralligenous Outcrop Biodiversity of a Dramatic Coastal Storm	PLOS ONE			English	Article							CORAL-REEFS; CLIMATE-CHANGE; MARINE INVERTEBRATE; COMMUNITY STABILITY; MEDITERRANEAN SEA; LIFE-HISTORY; DISTURBANCE; MORTALITY; PATTERNS; ASSEMBLAGES	Extreme events are rare, stochastic perturbations that can cause abrupt and dramatic ecological change within a short period of time relative to the lifespan of organisms. Studies over time provide exceptional opportunities to detect the effects of extreme climatic events and to measure their impacts by quantifying rates of change at population and community levels. In this study, we show how an extreme storm event affected the dynamics of benthic coralligenous outcrops in the NW Mediterranean Sea using data acquired before (2006-2008) and after the impact (2009-2010) at four different sites. Storms of comparable severity have been documented to occur occasionally within periods of 50 years in the Mediterranean Sea. We assessed the effects derived from the storm comparing changes in benthic community composition at sites exposed to and sheltered from this extreme event. The sites analyzed showed different damage from severe to negligible. The most exposed and impacted site experienced a major shift immediately after the storm, represented by changes in the species richness and beta diversity of benthic species. This site also showed higher compositional variability immediately after the storm and over the following year. The loss of cover of benthic species resulted between 22% and 58%. The damage across these species (e.g. calcareous algae, sponges, anthozoans, bryozoans, tunicates) was uneven, and those with fragile forms were the most impacted, showing cover losses up to 50 to 100%. Interestingly, small patches survived after the storm and began to grow slightly during the following year. In contrast, sheltered sites showed no significant changes in all the studied parameters, indicating no variations due to the storm. This study provides new insights into the responses to large and rare extreme events of Mediterranean communities with low dynamics and long-lived species, which are among the most threatened by the effects of global change.	[Teixido, Nuria; Linares, Cristina] Univ Barcelona, Dept Ecol, Fac Biol, E-08028 Barcelona, Spain; [Teixido, Nuria; Casas, Edgar; Garrabou, Joaquim] Inst Marine Sci ICM CSIC, Barcelona, Spain; [Cebrian, Emma] Ctr Adv Studies Blanes CEAB CSIC, Blanes, Spain	University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Teixido, N (corresponding author), Univ Barcelona, Dept Ecol, Fac Biol, E-08028 Barcelona, Spain.	nteixido@icm.csic.es	Linares, Cristina/A-5244-2018; Cebrian, Emma/J-9640-2012	Linares, Cristina/0000-0003-3855-2743; Cebrian, Emma/0000-0001-7588-0135; Teixido, Nuria/0000-0001-9286-2852	Agence National de la Recherche (Medchange project); Total Foundation (medDIVERSA project); CSIC project [PIEC 200430E599]; Agency for Management of University and Research Grants [2009-BP-263]; Spanish Ministry of Science and Innovation [CTM2009-08045]; Spanish National Research Council	Agence National de la Recherche (Medchange project)(French National Research Agency (ANR)); Total Foundation (medDIVERSA project); CSIC project; Agency for Management of University and Research Grants; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish National Research Council	This study has been funded by the Agence National de la Recherche (Medchange project) and Total Foundation (medDIVERSA project, http://meddiversa.medrecover.org), as well as the CSIC project (PIEC 200430E599). Support of this work was also provided by the Agency for Management of University and Research Grants (to NT, research contract Beatriu de Pinos 2009-BP-263), the Spanish Ministry of Science and Innovation (to E. Casas, doctoral fellowship linked to Biorock project CTM2009-08045; to CL, research contract Ramon y Cajal), and the Spanish National Research Council (to E. Cebrian, research contract JAE doc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 1998, ECOLOGY, V79, P2759, DOI 10.1890/0012-9658(1998)079[2759:RODSSA]2.0.CO;2; Alvarez-Filip L, 2009, B MAR SCI, V84, P295; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2008, PERMANOVA PRIMER GUI, P214; Ansell TJ, 2006, J CLIMATE, V19, P2717, DOI 10.1175/JCLI3775.1; Balata D, 2005, MAR ENVIRON RES, V60, P403, DOI 10.1016/j.marenvres.2004.12.005; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Bolanos R, 2009, J MARINE SYST, V77, P237, DOI 10.1016/j.jmarsys.2007.12.018; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Cebrian E, 2012, BIOL INVASIONS, V14, P2647, DOI 10.1007/s10530-012-0261-6; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Clarke KR, 1994, CHANGE MARINE COMMUN; Cocito S, 1998, MAR BIOL, V131, P73, DOI 10.1007/s002270050298; Coll M, 2010, PLOS ONE, V5; Collins SL, 2000, AM NAT, V155, P311, DOI 10.1086/303326; Coma R, 2004, ECOL APPL, V14, P1466, DOI 10.1890/03-5176; Coma R, 1998, ESTUAR COAST SHELF S, V47, P459, DOI 10.1006/ecss.1998.0375; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; Deque M, 2007, GLOBAL PLANET CHANGE, V57, P16, DOI 10.1016/j.gloplacha.2006.11.030; Diffenbaugh NS, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030000; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; EDMUNDS PJ, 1991, MAR ECOL PROG SER, V78, P201, DOI 10.3354/meps078201; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Foster DR, 1998, ECOSYSTEMS, V1, P497, DOI 10.1007/s100219900046; Fraterrigo JM, 2008, ECOL LETT, V11, P756, DOI 10.1111/j.1461-0248.2008.01191.x; Gardner TA, 2005, ECOLOGY, V86, P174, DOI 10.1890/04-0141; Garrabou J, 2000, EUR J PHYCOL, V35, P1; Garrabou J, 2002, J ANIM ECOL, V71, P966, DOI 10.1046/j.1365-2656.2002.00661.x; Garrabou J, 2002, ESTUAR COAST SHELF S, V55, P493, DOI 10.1006/ecss.2001.0920; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Garrabou J, 1998, CONSERV BIOL, V12, P302, DOI 10.1046/j.1523-1739.1998.96417.x; GILI JM, 1985, PSZNI MAR ECOL, V6, P219, DOI 10.1111/j.1439-0485.1985.tb00323.x; Gili JM, 1998, TRENDS ECOL EVOL, V13, P316, DOI 10.1016/S0169-5347(98)01365-2; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harmelin-Vivien M.L., 1994, J COASTAL RES, P211, DOI DOI 10.1111/NYAS.13322; Hereu B, 2012, 200430E599 CEABCSIC, P123; Hereu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036901; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; IPCC, 2007, PHYS SCI BAS CONTR W, V996, P2007; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Jimenez J, 2012, ASSESSMENT ECOLOGICA, P31; Kipson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027103; KNOWLTON N, 1981, NATURE, V294, P251, DOI 10.1038/294251a0; Linares C, 2005, MAR ECOL PROG SER, V305, P127, DOI 10.3354/meps305127; Linares C, 2007, ECOLOGY, V88, P918, DOI 10.1890/05-1931; Linares C, 2012, MAR ECOL PROG SER, V452, P81, DOI 10.3354/meps09586; Marcos M, 2011, GLOBAL PLANET CHANGE, V77, P116, DOI 10.1016/j.gloplacha.2011.04.002; Mateo MA, 2012, 200430E599 PIEC CTR; Mendoza ET, 2009, P I CIVIL ENG-MAR EN, V162, P127, DOI 10.1680/maen.2009.162.3.127; Miriti MN, 2007, ECOLOGY, V88, P32, DOI 10.1890/0012-9658(2007)88[32:EDASOD]2.0.CO;2; Navarro L, 2011, ESTUAR COAST SHELF S, V95, P52, DOI 10.1016/j.ecss.2011.08.002; PETRAITIS PS, 1989, Q REV BIOL, V64, P393, DOI 10.1086/416457; Piazzi L, 2001, MAR ECOL PROG SER, V210, P149, DOI 10.3354/meps210149; Pickett S. T. A., 1985, ECOLOGY NATURAL DIST; Rosenzweig C, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P79; Sala E, 1997, MAR ECOL PROG SER, V152, P273, DOI 10.3354/meps152273; Sanchez-Vidal A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030395, 10.1371/journal.pone.0043943]; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Somot S, 2008, GLOBAL PLANET CHANGE, V63, P112, DOI 10.1016/j.gloplacha.2007.10.003; Sousa WP, 2001, MARINE COMMUNITY ECOLOGY, P85; Stoddart D.R., 1974, P 2 INT COR REEF S, V2, P473; Teixido N, 2007, ECOSYSTEMS, V10, P142, DOI 10.1007/s10021-006-9012-9; Teixido N, 2009, MAR ECOL PROG SER, V375, P113, DOI 10.3354/meps07757; Teixido N, 2011, PLOS ONE, V6; Teixido N, 2011, WORLD C MAR BIOD AB; Turner MG, 1998, ECOSYSTEMS, V1, P511, DOI 10.1007/s100219900047; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; Ulbrich U, 2009, THEOR APPL CLIMATOL, V96, P117, DOI 10.1007/s00704-008-0083-8; Underwood AJ, 1999, J EXP MAR BIOL ECOL, V232, P125, DOI 10.1016/S0022-0981(98)00105-1; Walker SJ, 2008, GLOBAL CHANGE BIOL, V14, P2755, DOI 10.1111/j.1365-2486.2008.01644.x; WHITE PS, 1979, BOT REV, V45, P229, DOI 10.1007/BF02860857; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; WOODLEY JD, 1981, SCIENCE, V214, P749, DOI 10.1126/science.214.4522.749; Young IR, 2011, SCIENCE, V332, P451, DOI 10.1126/science.1197219	87	67	67	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53742	10.1371/journal.pone.0053742	http://dx.doi.org/10.1371/journal.pone.0053742			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326496	Green Published, Green Submitted, gold			2022-12-25	WOS:000313552400039
J	Zhang, XM; Lepelley, A; Azria, E; Lebon, P; Roguet, G; Schwartz, O; Launay, O; Leclerc, C; Lo-Man, R				Zhang, Xiaoming; Lepelley, Alice; Azria, Elie; Lebon, Pierre; Roguet, Gwenaelle; Schwartz, Olivier; Launay, Odile; Leclerc, Claude; Lo-Man, Richard			Neonatal Plasmacytoid Dendritic Cells (pDCs) Display Subset Variation but Can Elicit Potent Anti-Viral Innate Responses	PLOS ONE			English	Article							RECOGNITION; CAPACITY; IMMUNITY; DISTINCT; DEFECT	Neonates are highly susceptible to infectious diseases and defective antiviral pDC immune responses have been proposed to contribute to this phenomenon. Isolated cord blood pDCs innately responded to a variety of TLR7 and TLR9 dependent viruses, including influenza A virus (IAV), human immunodeficiency virus (HIV) or herpes-simplex virus (HSV) by efficiently producing IFN-alpha, TNF-alpha as well as chemokines. Interestingly, following activation by CpGA, but not viruses, cord pDCs tend to survive less efficiently. We found that a hallmark of pDCs in neonates is an extended CD2+pDCs compartment compared to adult pDCs without affecting the antiviral IFN-alpha response. Within CD2+pDCs, we identified a subpopulation expressing CD5 and responsible for IL-12p40 production, however this population is significantly decreased in cord blood compared to adult blood. Therefore, neonatal pDCs clearly display variation in phenotype and subset composition, but without major consequences for their antiviral responses.	[Zhang, Xiaoming; Lepelley, Alice; Schwartz, Olivier; Leclerc, Claude; Lo-Man, Richard] Inst Pasteur, Paris, France; [Zhang, Xiaoming; Leclerc, Claude; Lo-Man, Richard] INSERM, U1041, Paris, France; [Zhang, Xiaoming; Schwartz, Olivier] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Unit Innate Def & Immune Modulat, Shanghai, Peoples R China; [Lepelley, Alice] URA CNRS 3015, Paris, France; [Azria, Elie] Grp Hosp Bichat Claude Bernard, Dept Obstet & Gynecol, Paris, France; [Azria, Elie] Univ Paris 07, Paris, France; [Lebon, Pierre] Hop Cochin St Vincent de Paul, Assistance Publ Hop Paris, Virol & EA1833, Paris, France; [Roguet, Gwenaelle; Launay, Odile] Hop Cochin, Assistance Publ Hop Paris, CIC BT505, F-75674 Paris, France; [Launay, Odile] Univ Paris 05, Fac Med, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Lo-Man, R (corresponding author), Inst Pasteur, Paris, France.	richard.lo-man@pasteur.fr	Schwartz, Olivier/AAZ-3765-2021; Lepelley, Alice/P-1197-2018	Schwartz, Olivier/0000-0002-0729-1475; Lepelley, Alice/0000-0001-8656-7291; Azria, Elie/0000-0002-6159-6253	Agence Nationale pour la Recherche [ANR 09-MIEN-017]; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]; ANRS; Sidaction; Areva Foundation; Center for Human Immunology at Institut Pasteur	Agence Nationale pour la Recherche(French National Research Agency (ANR)); French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR)); ANRS(ANRSFrench National Research Agency (ANR)); Sidaction; Areva Foundation; Center for Human Immunology at Institut Pasteur	This work was supported by grants from Agence Nationale pour la Recherche (ANR 09-MIEN-017) and has received funding from the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant noANR-10-LABX-62-IBEID)). Work in the O.S. lab is also supported by ANRS, Sidaction and Areva Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful to F. Goffinet (CIC Mere-Enfant) for the cord blood sample collections. This work was supported by grants from Agence Nationale pour la Recherche (ANR 09-MIEN-017) and has received funding from the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant noANR-10-LABX-62-IBEID)). Work in the O.S. lab is also supported by ANRS, Sidaction and Areva Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials. We acknowledge the Center for Human Immunology at Institut Pasteur for support in conducting these studies.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Blom B, 2000, J EXP MED, V192, P1785, DOI 10.1084/jem.192.12.1785; Corbett NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015041; Cruz A, 2006, J IMMUNOL, V177, P1416, DOI 10.4049/jimmunol.177.3.1416; Danis B, 2008, EUR J IMMUNOL, V38, P507, DOI 10.1002/eji.200737760; De Wit D, 2004, BLOOD, V103, P1030, DOI 10.1182/blood-2003-04-1216; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Duramad O, 2003, BLOOD, V102, P4487, DOI 10.1182/blood-2003-07-2465; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Ghirelli C, 2010, BLOOD, V115, P5037, DOI 10.1182/blood-2010-01-266932; Gold MC, 2006, PEDIATR RES, V60, P34, DOI 10.1203/01.pdr.0000220352.13547.f4; Goriely S, 2004, J EXP MED, V199, P1011, DOI 10.1084/jem.20031272; Ito T, 2006, BLOOD, V107, P2423, DOI 10.1182/blood-2005-07-2709; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Matsui T, 2009, J IMMUNOL, V182, P6815, DOI 10.4049/jimmunol.0802008; Nguyen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010407; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Renneson J, 2009, EUR J IMMUNOL, V39, P2789, DOI 10.1002/eji.200939414; Sun CM, 2005, IMMUNITY, V22, P467, DOI 10.1016/j.immuni.2005.02.008; Sun CM, 2003, BLOOD, V102, P585, DOI 10.1182/blood-2002-09-2966; Upham JW, 2002, INFECT IMMUN, V70, P6583, DOI 10.1128/IAI.70.12.6583-6588.2002; Wang YM, 2011, IMMUNOL REV, V243, P74, DOI 10.1111/j.1600-065X.2011.01049.x; Zhang XM, 2007, J EXP MED, V204, P1107, DOI 10.1084/jem.20062013	28	24	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e52003	10.1371/journal.pone.0052003	http://dx.doi.org/10.1371/journal.pone.0052003			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326320	Green Published, gold, Green Submitted			2022-12-25	WOS:000313552400005
J	Phalan, B; Bertzky, M; Butchart, SHM; Donald, PF; Scharlemann, JPW; Stattersfield, AJ; Balmford, A				Phalan, Ben; Bertzky, Monika; Butchart, Stuart H. M.; Donald, Paul F.; Scharlemann, Joern P. W.; Stattersfield, Alison J.; Balmford, Andrew			Crop Expansion and Conservation Priorities in Tropical Countries	PLOS ONE			English	Article							GLOBAL LAND-COVER; BIODIVERSITY CONSERVATION; DEFORESTATION; FOREST; AGRICULTURE; HABITAT; INTENSIFICATION; QUANTIFICATION; ECOREGIONS; POPULATION	Expansion of cropland in tropical countries is one of the principal causes of biodiversity loss, and threatens to undermine progress towards meeting the Aichi Biodiversity Targets. To understand this threat better, we analysed data on crop distribution and expansion in 128 tropical countries, assessed changes in area of the main crops and mapped overlaps between conservation priorities and cultivation potential. Rice was the single crop grown over the largest area, especially in tropical forest biomes. Cropland in tropical countries expanded by c. 48,000 km(2) per year from 1999-2008. The countries which added the greatest area of new cropland were Nigeria, Indonesia, Ethiopia, Sudan and Brazil. Soybeans and maize are the crops which expanded most in absolute area. Other crops with large increases included rice, sorghum, oil palm, beans, sugar cane, cow peas, wheat and cassava. Areas of high cultivation potential-while bearing in mind that political and socio-economic conditions can be as influential as biophysical ones-may be vulnerable to conversion in the future. These include some priority areas for biodiversity conservation in tropical countries (e. g., Frontier Forests and High Biodiversity Wilderness Areas), which have previously been identified as having 'low vulnerability', in particular in central Africa and northern Australia. There are also many other smaller areas which are important for biodiversity and which have high cultivation potential (e. g., in the fringes of the Amazon basin, in the Paraguayan Chaco, and in the savanna woodlands of the Sahel and East Africa). We highlight the urgent need for more effective sustainability standards and policies addressing both production and consumption of tropical commodities, including robust land-use planning in agricultural frontiers, establishment of new protected areas or REDD+ projects in places agriculture has not yet reached, and reduction or elimination of incentives for land-demanding bioenergy feedstocks.	[Phalan, Ben; Balmford, Andrew] Univ Cambridge, Dept Zool, Cambridge, England; [Bertzky, Monika; Scharlemann, Joern P. W.] United Nations Environm Programme, World Conservat Monitoring Ctr, Cambridge, England; [Butchart, Stuart H. M.; Stattersfield, Alison J.] BirdLife Int, Cambridge, England; [Donald, Paul F.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Scharlemann, Joern P. W.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Cambridge; BirdLife International; Royal Society for Protection of Birds; University of Sussex	Phalan, B (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	btp22@cam.ac.uk	Scharlemann, Jorn/A-4737-2008; Phalan, Ben/A-5783-2009; Butchart, Stuart HM/Y-2711-2018; Butchart, Stuart/AAJ-1852-2021	Scharlemann, Jorn/0000-0002-2834-6367; Phalan, Ben/0000-0001-7876-7226; Butchart, Stuart/0000-0002-1140-4049; Donald, Paul F./0000-0003-0023-6200; Balmford, Andrew/0000-0002-0144-3589	Isaac Newton Trust; Royal Society for the Protection of Birds; United Nations Environment Programme World Conservation Monitoring Centre	Isaac Newton Trust; Royal Society for the Protection of Birds; United Nations Environment Programme World Conservation Monitoring Centre	BP was funded by the Isaac Newton Trust, the Royal Society for the Protection of Birds and the United Nations Environment Programme World Conservation Monitoring Centre. Other than the direct involvement of authors from the named institutions in this research, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldhous P, 2004, NATURE, V432, P144, DOI 10.1038/432144a; [Anonymous], 2010, ECONOMIST; [Anonymous], FAOSTAT STAT DAT; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Balmford Andrew, 2012, P R SOC B; Barona E, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/024002; Baudron F, 2011, BIOL CONSERV, V144, P1481, DOI 10.1016/j.biocon.2011.01.017; BirdLife International, 2011, BIRDLIFE SPEC FACTSH; Boakes EH, 2010, P ROY SOC B-BIOL SCI, V277, P1081, DOI 10.1098/rspb.2009.1771; Bongaarts J, 2011, SCIENCE, V333, P574, DOI 10.1126/science.1207558; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brown HCP, 2011, J ENVIRON DEV, V20, P381, DOI 10.1177/1070496511426480; Bryant D., 1997, LAST FRONTIER FOREST; Butler RA, 2008, TRENDS ECOL EVOL, V23, P469, DOI 10.1016/j.tree.2008.05.006; Carrere R., 1996, PULPING S IND TREE P; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; CHOMITZ K, 2006, LOGGERHEADS AGR EXPA; Chowdhury J. A., 2006, BETTER FOREST MANAGE; Clay J., 2004, WORLD AGR ENV COMMOD; Cohen JE, 2003, SCIENCE, V302, P1172, DOI 10.1126/science.1088665; Cook G, 2009, NO AUSTR LAND WATER; Davalos LM, 2011, ENVIRON SCI TECHNOL, V45, P1219, DOI 10.1021/es102373d; de Araujo LM, 2011, NATURE, V469, P299, DOI 10.1038/469299d; Deininger K, 2011, RISING GLOBAL INTERE; Dobrovolski R, 2011, BIODIVERS CONSERV, V20, P2445, DOI 10.1007/s10531-011-9997-z; Donald PF, 2004, CONSERV BIOL, V18, P17, DOI 10.1111/j.1523-1739.2004.01803.x; Duveiller G, 2008, REMOTE SENS ENVIRON, V112, P1969, DOI 10.1016/j.rse.2007.07.026; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; ESRI, 2009, ARCGIS DESKT REL 9 3; Ewers RM, 2009, GLOBAL CHANGE BIOL, V15, P1716, DOI 10.1111/j.1365-2486.2009.01849.x; FAO, 2010, WORLD PROGR CENS A 2; FAO, 2011, TREE CROPS GUID EST; FAO, 2011, CROPS STAT CONC DEF; FAO, 2002, WORLD AGR 2015 2030; FAO,, 2010, WORLD PROGR CENS AGR; Fearnside PM, 2001, ENVIRON CONSERV, V28, P23, DOI 10.1017/S0376892901000030; Fischer G, 2002, GLOBAL AGROECOLOGICA; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fritz S, 2008, GLOBAL CHANGE BIOL, V14, P1057, DOI 10.1111/j.1365-2486.2007.01519.x; Galford GL, 2010, EARTH INTERACT, V14, DOI 10.1175/2010EI327.1; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Glaser B, 2001, NATURWISSENSCHAFTEN, V88, P37, DOI 10.1007/s001140000193; Gomez MI, 2011, SCIENCE, V332, P1154, DOI 10.1126/science.1202543; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Havlik P, 2011, ENERG POLICY, V39, P5690, DOI 10.1016/j.enpol.2010.03.030; Hellmann F, 2010, J ENVIRON MANAGE, V91, P1389, DOI 10.1016/j.jenvman.2010.02.022; Herold M, 2008, REMOTE SENS ENVIRON, V112, P2538, DOI 10.1016/j.rse.2007.11.013; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; IMAGE Team, 2001, NETH ENV ASS AG MNP; Kaptue Tchuente AT, 2011, INT J APPL EARTH OBS, V13, P207, DOI 10.1016/j.jag.2010.11.005; Karsenty A., 2010, LARGE SCALE ACQUISIT; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Koh LP, 2007, CONSERV BIOL, V21, P1373, DOI 10.1111/j.1523-1739.2007.00771.x; Lapola DM, 2010, P NATL ACAD SCI USA, V107, P3388, DOI 10.1073/pnas.0907318107; Laporte NT, 2007, SCIENCE, V316, P1451, DOI 10.1126/science.1141057; Laurance WF, 2007, TRENDS ECOL EVOL, V22, P65, DOI 10.1016/j.tree.2006.09.014; Lee JSH, 2011, BIOL CONSERV, V144, P2512, DOI 10.1016/j.biocon.2011.07.006; Li HM, 2007, BIODIVERS CONSERV, V16, P1731, DOI 10.1007/s10531-006-9052-7; Martinelli LA, 2011, NATURE, V474, P579, DOI 10.1038/474579a; McCallum I, 2006, INT J APPL EARTH OBS, V8, P246, DOI 10.1016/j.jag.2005.12.002; McIntyre B.D., 2009, AGR CROSSROADS INT A; Melillo JM, 2009, SCIENCE, V326, P1397, DOI 10.1126/science.1180251; Mertens B, 2000, ANN ASSOC AM GEOGR, V90, P467, DOI 10.1111/0004-5608.00205; Miles L, 2008, SCIENCE, V320, P1454, DOI 10.1126/science.1155358; Mittermeier R. A., 1997, MEGADIVERSITY; Mittermeier R.A., 2004, HOTSPOTS REVISITED; Mittermeier RA, 2003, P NATL ACAD SCI USA, V100, P10309, DOI 10.1073/pnas.1732458100; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Muller R, 2013, LAND USE POLICY, V30, P895, DOI 10.1016/j.landusepol.2012.06.019; Muok B. O., 2010, ENV SUITABILITY AGRO; NEMA, 2010, POT BIOF UG ASS LAND; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Organisation for Economic Cooperation and Development (OECD), 2017, OECD EC SURV UK; Parfitt J, 2010, PHILOS T R SOC B, V365, P3065, DOI 10.1098/rstb.2010.0126; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Phalan B, 2011, FOOD POLICY, V36, pS62, DOI 10.1016/j.foodpol.2010.11.008; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Ramankutty N, 2004, EARTH INTERACT, V8; Rappole JH, 2003, CONSERV BIOL, V17, P334, DOI 10.1046/j.1523-1739.2003.01548.x; Rudel T., 2005, TROPICAL FORESTS REG; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanchez PA, 2002, SCIENCE, V295, P2019, DOI 10.1126/science.1065256; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Scales IR, 2011, ENVIRON HIST-UK, V17, P499, DOI 10.3197/096734011X13150366551481; Scarlat N, 2011, ENERG POLICY, V39, P1630, DOI 10.1016/j.enpol.2010.12.039; Scharlemann JPW, 2004, GLOBAL CHANGE BIOL, V10, P2046, DOI 10.1111/j.1365-2486.2004.00860.x; Schroth G, 2007, BIODIVERS CONSERV, V16, P2237, DOI 10.1007/s10531-007-9195-1; Seddon N, 2000, ORYX, V34, P287, DOI 10.1017/S0030605300031355; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; SPEHAR CR, 1995, FIELD CROP RES, V41, P141, DOI 10.1016/0378-4290(95)00007-D; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V7; Tabor K, 2010, ECOL APPL, V20, P554, DOI 10.1890/09-0173.1; Thoenes P, 2011, FAO PRICE POLICY B; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Toth G, 2011, GLOBAL AGROECOLOGICA; UNEP, 2011, UNEPCBDCOP1027; United Nations Population Division, 2011, WORLD POP PROSP 2010; Wilcove DS, 2010, BIODIVERS CONSERV, V19, P999, DOI 10.1007/s10531-009-9760-x; Wilkie D, 2000, CONSERV BIOL, V14, P1614, DOI 10.1046/j.1523-1739.2000.99102.x; Wirsenius S, 2010, AGR SYST, V103, P621, DOI 10.1016/j.agsy.2010.07.005; Wolfire D., 1998, FORESTS DEMOCRATIC R; Wright HL, 2012, CONSERV LETT, V5, P11, DOI 10.1111/j.1755-263X.2011.00208.x; Wunder S., 2004, LAND USE NATURE CONS, P3; WWF IUCN, 1997, CTR PLANT DIV; Yang L., 1985, ZOOL RES, V6, P353; You L., 2010, SPATIAL PRODUCTION A; Zhang QF, 2005, ENVIRON MONIT ASSESS, V101, P69	116	155	162	1	345	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e51759	10.1371/journal.pone.0051759	http://dx.doi.org/10.1371/journal.pone.0051759			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326316	gold, Green Published, Green Accepted			2022-12-25	WOS:000313551500007
J	Kirchner, P; Bug, M; Meyer, H				Kirchner, Philipp; Bug, Monika; Meyer, Hemmo			Ubiquitination of the N-terminal Region of Caveolin-1 Regulates Endosomal Sorting by the VCP/p97 AAA-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; PROTEIN; DEGRADATION; AUTOPHAGY; SYSTEM; P97; TRAFFICKING; BIOGENESIS; MUTATIONS; COMPLEXES	Caveolin-1 (CAV1) is the defining constituent of caveolae at the plasma membrane of many mammalian cells. For turnover, CAV1 is ubiquitinated and sorted to late endosomes and lysosomes. Sorting of CAV1 requires the AAA+-type ATPase VCP and its cofactor UBXD1. However, it is unclear in which region CAV1 is ubiquitinated and how ubiquitination is linked to sorting of CAV1 by VCP-UBXD1. Here, we show through site-directed mutagenesis that ubiquitination of CAV1 occurs at any of the six lysine residues, 5, 26, 30, 39, 47, and 57, that are clustered in the N-terminal region but not at lysines in the oligomerization, intramembrane, or C-terminal domains. Mutation of Lys-5-57 to arginines prevented binding of the VCP-UBXD1 complex and, importantly, strongly reduced recruitment of VCP-UBXD1 to endocytic compartments. Moreover, the Lys-5-57Arg mutation specifically interfered with trafficking of CAV1 from early to late endosomes. Conversely and consistently, depletion of VCP or UBXD1 led to accumulation of ubiquitinated CAV1, suggesting that VCP acts downstream of ubiquitination and is required for transport of the ubiquitinated form of CAV1 to late endosomes. These results define the N-terminal region of CAV1 as the critical ubiquitin conjugation site and, together with previous data, demonstrate the significance of this ubiquitination for binding to the VCP-UBXD1 complex and for sorting into lysosomes.	[Kirchner, Philipp; Bug, Monika; Meyer, Hemmo] Univ Duisburg Essen, Ctr Med Biotechnol, Fac Biol, D-45117 Essen, Germany; [Kirchner, Philipp] BIOME, Grad Sch Biomed Sci, D-45147 Essen, Germany	University of Duisburg Essen	Meyer, H (corresponding author), Univ Duisburg Essen, Ctr Med Biotechnol, Fac Biol, Univ Str 5, D-45117 Essen, Germany.	hemmo.meyer@uni-due.de	Meyer, Hemmo/GNH-5784-2022	Meyer, Hemmo/0000-0003-1883-1796; Kirchner, Philipp/0000-0002-7972-2318	Deutsche Forschungsgemeinschaft (DFG) [SPP1365/2, Me1626/2-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft (DFG) Priority Program SPP1365/2 Grant Me1626/2-1.	Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bug M, 2012, J STRUCT BIOL, V179, P78, DOI 10.1016/j.jsb.2012.03.003; Chapman E, 2011, MOL BIOSYST, V7, P700, DOI 10.1039/c0mb00176g; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Fernandez I, 2002, P NATL ACAD SCI USA, V99, P11193, DOI 10.1073/pnas.172196599; Galbiati F, 2000, J BIOL CHEM, V275, P37702, DOI 10.1074/jbc.M006657200; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Hayer A, 2010, TRAFFIC, V11, P361, DOI 10.1111/j.1600-0854.2009.01023.x; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Ju JS, 2010, AUTOPHAGY, V6, P283, DOI 10.4161/auto.6.2.11063; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; Parat MO, 2009, INT REV CEL MOL BIO, V273, P117, DOI 10.1016/S1937-6448(08)01804-2; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; PLEASURE IT, 1993, NATURE, V365, P459, DOI 10.1038/365459a0; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ramanathan HN, 2012, CELL RES, V22, P346, DOI 10.1038/cr.2011.80; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Ritz D, 2011, NAT CELL BIOL, V13, P1116, DOI 10.1038/ncb2301; Rusten TE, 2009, J CELL SCI, V122, P2179, DOI 10.1242/jcs.050021; Scheiffele P, 1998, J CELL BIOL, V140, P795, DOI 10.1083/jcb.140.4.795; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062	39	36	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7363	7372		10.1074/jbc.M112.429076	http://dx.doi.org/10.1074/jbc.M112.429076			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23335559	hybrid, Green Published			2022-12-25	WOS:000316002400055
J	Martins, MA; Bonaldo, MC; Rudersdorf, RA; Piaskowski, SM; Rakasz, EG; Weisgrau, KL; Furlott, JR; Eernisse, CM; de Santana, MGV; Hidalgo, B; Friedrich, TC; Chiuchiolo, MJ; Parks, CL; Wilson, NA; Allison, DB; Galler, R; Watkins, DI				Martins, Mauricio A.; Bonaldo, Myrna C.; Rudersdorf, Richard A.; Piaskowski, Shari M.; Rakasz, Eva G.; Weisgrau, Kim L.; Furlott, Jessica R.; Eernisse, Christopher M.; Veloso de Santana, Marlon G.; Hidalgo, Bertha; Friedrich, Thomas C.; Chiuchiolo, Maria J.; Parks, Christopher L.; Wilson, Nancy A.; Allison, David B.; Galler, Ricardo; Watkins, David I.			Immunogenicity of Seven New Recombinant Yellow Fever Viruses 17D Expressing Fragments of SIVmac239 Gag, Nef, and Vif in Indian Rhesus Macaques	PLOS ONE			English	Article							T-CELL RESPONSES; CLASS-I MOLECULE; IMMUNODEFICIENCY-VIRUS; HIV-1 VACCINE; ATTENUATED VACCINE; INNATE IMMUNITY; VIRAL LOAD; EPITOPES; VECTOR; LIVE	An effective vaccine remains the best solution to stop the spread of human immunodeficiency virus (HIV). Cellular immune responses have been repeatedly associated with control of viral replication and thus may be an important element of the immune response that must be evoked by an efficacious vaccine. Recombinant viral vectors can induce potent T-cell responses. Although several viral vectors have been developed to deliver HIV genes, only a few have been advanced for clinical trials. The live-attenuated yellow fever vaccine virus 17D (YF17D) has many properties that make it an attractive vector for AIDS vaccine regimens. YF17D is well tolerated in humans and vaccination induces robust T-cell responses that persist for years. Additionally, methods to manipulate the YF17D genome have been established, enabling the generation of recombinant (r)YF17D vectors carrying genes from unrelated pathogens. Here, we report the generation of seven new rYF17D viruses expressing fragments of simian immunodeficiency virus (SIV)mac239 Gag, Nef, and Vif. Studies in Indian rhesus macaques demonstrated that these live-attenuated vectors replicated in vivo, but only elicited low levels of SIV-specific cellular responses. Boosting with recombinant Adenovirus type-5 (rAd5) vectors resulted in robust expansion of SIV-specific CD8(+) T-cell responses, particularly those targeting Vif. Priming with rYF17D also increased the frequency of CD4(+) cellular responses in rYF17D/ rAd5-immunized macaques compared to animals that received rAd5 only. The effect of the rYF17D prime on the breadth of SIV-specific T-cell responses was limited and we also found evidence that some rYF17D vectors were more effective than others at priming SIV-specific T-cell responses. Together, our data suggest that YF17D - a clinically relevant vaccine vector - can be used to prime AIDS virus-specific T-cell responses in heterologous prime boost regimens. However, it will be important to optimize rYF17D-based vaccine regimens to ensure maximum delivery of all immunogens in a multivalent vaccine.	[Martins, Mauricio A.; Watkins, David I.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Bonaldo, Myrna C.; Veloso de Santana, Marlon G.; Galler, Ricardo] Inst Oswaldo Cruz, FIOCRUZ, Lab Biol Mol Flavivirus, BR-20001 Rio De Janeiro, Brazil; [Rudersdorf, Richard A.; Piaskowski, Shari M.; Rakasz, Eva G.; Weisgrau, Kim L.; Furlott, Jessica R.; Eernisse, Christopher M.; Friedrich, Thomas C.; Wilson, Nancy A.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Friedrich, Thomas C.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Chiuchiolo, Maria J.; Parks, Christopher L.] Brooklyn Army Terminal, Int AIDS Vaccine Initiat, AIDS Vaccine Design & Dev Lab, Brooklyn, NY USA; [Wilson, Nancy A.] Univ Wisconsin, Dept Med, Madison, WI USA; [Hidalgo, Bertha; Allison, David B.] Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA	University of Miami; Fundacao Oswaldo Cruz; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; International AIDS Vaccine Initiative; University of Wisconsin System; University of Wisconsin Madison; University of Alabama System; University of Alabama Birmingham	Watkins, DI (corresponding author), Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.	dwatkins@med.miami.edu	Galler, Ricardo/B-3280-2014; Bonaldo, Myrna C/D-9494-2013; Bonaldo, Myrna/AAE-2799-2021; Rakasz, Eva G/H-9197-2019; Martins, Mauricio/AAU-9226-2020; Veloso de Santana, Marlon Gilsepp/H-8146-2017	Martins, Mauricio/0000-0001-8336-216X; Wilson, Nancy/0000-0002-9472-6026; Friedrich, Thomas/0000-0001-9831-6895; Allison, David/0000-0003-3566-9399; Veloso de Santana, Marlon Gilsepp/0000-0002-3427-841X	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Disease (NIAID) [R01 AI076114, R01 AI049120]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); FIOCRUZ in Brazil; National Institute for Vaccine Technology (INCTV/CNPq); NCRR [P51 RR000167]; Research Facilities Improvement Program [RR15459, RR020141]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR020141, C06RR015459, P51RR000167] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049120, R01AI076114] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FIOCRUZ in Brazil; National Institute for Vaccine Technology (INCTV/CNPq); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by National Institutes of Health (NIH)/National Institute of Allergy and Infectious Disease (NIAID) grants R01 AI076114 and R01 AI049120 awarded to DIW. Funding also came from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and FIOCRUZ in Brazil. Part of the work done in FIOCRUZ was supported by the National Institute for Vaccine Technology (INCTV/CNPq). In addition, this work was supported by NCRR grant P51 RR000167 to the Wisconsin National Primate Research Center, University of Wisconsin-Madison. This research was conducted in part at a facility constructed with support from Research Facilities Improvement Program grant numbers RR15459 and RR020141. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; [Anonymous], 2009, WHO VACC PREV DIS MO; Appaiahgari MB, 2010, EXPERT REV VACCINES, V9, P1371, DOI [10.1586/erv.10.139, 10.1586/ERV.10.139]; Arroyo J, 2004, J VIROL, V78, P12497, DOI 10.1128/JVI.78.22.12497-12507.2004; Barnett ED, 2007, CLIN INFECT DIS, V44, P850, DOI 10.1086/511869; Barouch DH, 2010, CURR OPIN HIV AIDS, V5, P386, DOI 10.1097/COH.0b013e32833cfe4c; Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376; Bonaldo MC, 2006, CELL BIOCHEM BIOPHYS, V44, P313, DOI 10.1385/CBB:44:3:313; Bonaldo MC, 2002, J MOL BIOL, V315, P873, DOI 10.1006/jmbi.2001.5258; Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09; Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Caufour PS, 2001, VIRUS RES, V79, P1, DOI 10.1016/S0168-1702(01)00273-8; Centers for Disease Control (CDC), 1981, MMWR Morb Mortal Wkly Rep, V30, P250; Cline AN, 2005, J MED PRIMATOL, V34, P303; dos Santos AP, 2005, MEM I OSWALDO CRUZ, V100, P331, DOI 10.1590/S0074-02762005000300021; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Franco D, 2010, VACCINE, V28, P5676, DOI 10.1016/j.vaccine.2010.06.052; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Giraldo-Vela JP, 2008, J VIROL, V82, P859, DOI 10.1128/JVI.01816-07; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004; Guy B, 2008, VACCINE, V26, P5712, DOI 10.1016/j.vaccine.2008.08.019; Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094; Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098; Hanke T, 2007, J GEN VIROL, V88, P1, DOI 10.1099/vir.0.82493-0; HIV/ AIDS JUNPo, 2010, GLOB REP UNAIDS REP; Im EJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002041; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kaizu M, 2007, IMMUNOGENETICS, V59, P693, DOI 10.1007/s00251-007-0233-7; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Liu JY, 2006, J VIROL, V80, P11991, DOI 10.1128/JVI.01348-06; Liu MA, 2010, IMMUNITY, V33, P504, DOI 10.1016/j.immuni.2010.10.004; Liu Y, 2011, VACCINE, V29, P2582, DOI 10.1016/j.vaccine.2011.01.049; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Loffredo JT, 2004, J IMMUNOL, V173, P5064, DOI 10.4049/jimmunol.173.8.5064; Martins MA, 2010, J VIROL, V84, P4352, DOI 10.1128/JVI.02365-09; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; McAllister A, 2000, J VIROL, V74, P9197, DOI 10.1128/JVI.74.19.9197-9205.2000; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996; Monath TP, 2006, P NATL ACAD SCI USA, V103, P6694, DOI 10.1073/pnas.0601932103; Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553; Monath TP, 2003, J INFECT DIS, V188, P1213, DOI 10.1086/378356; Mothe BR, 2002, J VIROL, V76, P875, DOI 10.1128/JVI.76.2.875-884.2002; Neves PCC, 2010, VACCINE, V28, P8183, DOI 10.1016/j.vaccine.2010.09.090; Nitayaphan S, 2004, J INFECT DIS, V190, P702, DOI 10.1086/422258; Pantaleo G, 2010, CURR OPIN HIV AIDS, V5, P391, DOI 10.1097/COH.0b013e32833d1e87; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Peters B, 2005, VACCINE, V23, P5212, DOI 10.1016/j.vaccine.2005.07.086; Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2007, ADV EXP MED BIOL, V590, P43; Robert-Guroff M, 2007, CURR OPIN BIOTECH, V18, P546, DOI 10.1016/j.copbio.2007.10.010; Rodriguez F, 2002, J VIROL, V76, P4251, DOI 10.1128/JVI.76.9.4251-4259.2002; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Rolland M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001424; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Russell ND, 2007, JAIDS-J ACQ IMM DEF, V44, P203, DOI 10.1097/01.qai.0000248356.48501.ff; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Smith HL, 2011, J INFECT DIS, V203, P513, DOI 10.1093/infdis/jiq074; Tao D, 2005, J EXP MED, V201, P201, DOI 10.1084/jem.20041526; Thorner AR, 2006, J CLIN MICROBIOL, V44, P3781, DOI 10.1128/JCM.01249-06; Vogel TU, 2002, J VIROL, V76, P11623, DOI 10.1128/JVI.76.22.11623-11636.2002; Weatherall D., 2006, USE NONHUMAN PRIMATE; Winstone N, 2011, J VIROL, V85, P9578, DOI 10.1128/JVI.05060-11	72	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54434	10.1371/journal.pone.0054434	http://dx.doi.org/10.1371/journal.pone.0054434			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23336000	Green Published, Green Submitted, gold			2022-12-25	WOS:000314707700058
J	Kauppila, E; Vanninen, E; Kaurijoki, S; Karhunen, L; Pietilainen, KH; Rissanen, A; Tiihonen, J; Pesonen, U; Kaprio, J				Kauppila, Esa; Vanninen, Esko; Kaurijoki, Salla; Karhunen, Leila; Pietilainen, Kirsi H.; Rissanen, Aila; Tiihonen, Jari; Pesonen, Ullamari; Kaprio, Jaakko			Influence of Serotonin Transporter Gene Polymorphism (5-HTTLPR Polymorphism) on the Relation between Brain 5-HT Transporter Binding and Heart Rate Corrected Cardiac Repolarization Interval	PLOS ONE			English	Article							PHOTON-EMISSION-TOMOGRAPHY; NOR-BETA-CIT; IN-VIVO; QT INTERVAL; EXPRESSION; SPECT; NEUROTOXICITY; AVAILABILITY; GENOTYPE; REST	Objective: Serotonin transporter gene polymorphism (5-HTTLPR polymorphism) predicts the degree of structural and functional connectivity in the brain, and less consistently the degree of vulnerability for anxiety and depressive disorders. It is less known how 5-HTTLPR polymorphism influences on the coupling between brain and neuronal cardiovascular control. The present study demonstrates the impact of 5-HTTLPR polymorphism on the relations between heart rate (HR) corrected cardiac repolarization interval (QTc interval) and the brain 5-HTT binding. Material and Methods: Thirty healthy young adults (fifteen monozygotic twin pairs) (mean age 26 +/- 1.3 years, 16 females) were imagined with single-photon emission computed tomography (SPECT) using iodine-123 labeled 2 beta-carbomethoxy-3 beta-(4-iodophenyl) nortropane (nor-beta-CIT). Continuous ECG recording was obtained from each participant at supine rest. Signal averaged QTc interval on continuous ECG was calculated and compared with the brain imaging results. Results: In the two groups [l homozygotes (n = 16, 10 females), s carriers (n = 14, 8 female)] HR and the length of QTc interval were not influenced by 5-HTTLPR polymorphism. There were no significant relations between HR and 5-HTT binding in the brain. There were significant associations between QTc interval and nor-beta-CIT binding in the brain in l homozygotes, but not in s carriers (correlations for QTc interval and nor-beta-CIT binding of striatum, thalamus and right temporal region were -0.8--0.9, (p < 0.0005), respectively). Conclusion: The finding of longer QTc interval with less 5-HTT binding availability in major serotonergic binding sites in l homozygotes, but not in s carriers, implicate to differentiated control of QTc interval by 5-HTTLPR polymorphism.	[Kauppila, Esa; Vanninen, Esko] Kuopio Univ Hosp, Dept Clin Physiol & Nucl Med, SF-70210 Kuopio, Finland; [Kauppila, Esa; Vanninen, Esko] Univ Eastern Finland, Kuopio, Finland; [Kauppila, Esa] N Karelia Cent Hosp, Dept Clin Physiol, Joensuu, Finland; [Kaurijoki, Salla; Karhunen, Leila] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Dept Clin Nutr, Kuopio, Finland; [Pietilainen, Kirsi H.] Univ Helsinki, Cent Hosp, Dept Med, Obes Res Unit,Div Endocrinol, Helsinki, Finland; [Pietilainen, Kirsi H.] Univ Helsinki, Helsinki, Finland; [Pietilainen, Kirsi H.] Univ Helsinki, FIMM, Inst Mol Med Finland, Helsinki, Finland; [Rissanen, Aila] Helsinki Univ Hosp, Dept Psychiat, Obes Res Unit, Helsinki, Finland; [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Tiihonen, Jari] Univ Eastern Finland, Niuvanniemi Hosp, Dept Forens Psychiat, Kuopio, Finland; [Tiihonen, Jari] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Tiihonen, Jari; Kaprio, Jaakko] Natl Inst Hlth & Welf, Dept Mental Hlth & Subst Abuse Serv, Helsinki, Finland; [Pesonen, Ullamari] Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland; [Kaprio, Jaakko] Univ Helsinki, Inst Mol Med, Helsinki, Finland	Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Eastern Finland; Karolinska Institutet; Finland National Institute for Health & Welfare; University of Turku; University of Helsinki	Kauppila, E (corresponding author), Kuopio Univ Hosp, Dept Clin Physiol & Nucl Med, SF-70210 Kuopio, Finland.	ekauppil@gmail.com	Tiihonen, Jari/G-3078-2012; Kaprio, Jaakko/A-1820-2008	Tiihonen, Jari/0000-0002-0400-6798; Kaprio, Jaakko/0000-0002-3716-2455; Pesonen, Ullamari/0000-0002-9962-212X; Pietilainen, Kirsi/0000-0002-8522-1288	Saastamoinen Foundation, Kuopio, Finland; University of Eastern Finland	Saastamoinen Foundation, Kuopio, Finland; University of Eastern Finland	This work was supported by the Saastamoinen Foundation, Kuopio, Finland; and University of Eastern Finland (previously University of Kuopio) for research periods (6 months). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud H, 2006, ANN NEUROL, V59, P691, DOI 10.1002/ana.20806; Acton PD, 1999, EUR J NUCL MED, V26, P518, DOI 10.1007/s002590050420; Bazett HC, 1920, HEART; de Win MML, 2005, NEUROPSYCHOPHARMACOL, V30, P996, DOI 10.1038/sj.npp.1300683; Egawa H, 2001, REGION ANESTH PAIN M, V26, P539, DOI 10.1053/rapm.2001.25935; Greenberg BD, 1999, AM J MED GENET, V88, P83, DOI 10.1002/(SICI)1096-8628(19990205)88:1<83::AID-AJMG15>3.3.CO;2-S; Halldin C, 2003, EUR J NUCL MED MOL I, V30, P1220, DOI 10.1007/s00259-003-1212-3; Hariri AR, 2006, BIOL PSYCHIAT, V59, P888, DOI 10.1016/j.biopsych.2005.11.005; Heils A, 1996, J NEUROCHEM, V66, P2621; Heinz A, 2000, BIOL PSYCHIAT, V47, P643, DOI 10.1016/S0006-3223(99)00171-7; Hiltunen J, 1998, EUR J NUCL MED, V25, P19; Hojgaard MV, 2005, BLOOD PRESS MONIT, V10, P19; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; KARJALAINEN J, 1994, J AM COLL CARDIOL, V23, P1547, DOI 10.1016/0735-1097(94)90654-8; Kauppila E, 2009, NUCL MED COMMUNICATI; Koskela AK, 2008, PHYSIOL BEHAV, V93, P724, DOI 10.1016/j.physbeh.2007.11.043; Lundberg J, 2005, J NUCL MED, V46, P1505; Magnano AR, 2006, AM J CARDIOL, V97, P1244, DOI 10.1016/j.amjcard.2005.11.046; Meyer-Lindenberg A, 2009, HUM BRAIN MAPP, V30, P1938, DOI 10.1002/hbm.20639; Murthy NV, 2010, NEUROIMAGE, V52, P50, DOI 10.1016/j.neuroimage.2010.04.032; Nolan ER, 2008, AUTON NEUROSCI-BASIC, V140, P66, DOI 10.1016/j.autneu.2008.04.004; Parsey RV, 2006, AM J PSYCHIAT, V163, P52, DOI 10.1176/appi.ajp.163.1.52; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Praschak-Rieder N, 2007, BIOL PSYCHIAT, V62, P327, DOI 10.1016/j.biopsych.2006.09.022; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; Reneman L, 1999, SYNAPSE, V34, P77, DOI 10.1002/(SICI)1098-2396(199910)34:1<77::AID-SYN9>3.0.CO;2-Y; Reneman L, 2002, SYNAPSE, V46, P199, DOI 10.1002/syn.10130; Van Dyck CH, 2004, AM J PSYCHIAT, V161, P525, DOI 10.1176/appi.ajp.161.3.525; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Zamotrinsky AV, 2001, AUTON NEUROSCI-BASIC, V88, P109, DOI 10.1016/S1566-0702(01)00227-2	30	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e50303	10.1371/journal.pone.0050303	http://dx.doi.org/10.1371/journal.pone.0050303			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341873	gold, Green Submitted, Green Published			2022-12-25	WOS:000314759400001
J	Le, MT; Lobmeyer, MT; Campbell, M; Cheng, J; Wang, ZY; Turner, ST; Chapman, AB; Boerwinkle, E; Gums, JG; Gong, Y; Johnson, RJ; Johnson, JA				Le, MyPhuong T.; Lobmeyer, Maximilian T.; Campbell, Marcus; Cheng, Jing; Wang, Zhiying; Turner, Stephen T.; Chapman, Arlene B.; Boerwinkle, Eric; Gums, John G.; Gong, Yan; Johnson, Richard J.; Johnson, Julie A.			Impact of Genetic Polymorphisms of SLC2A2, SLC2A5, and KHK on Metabolic Phenotypes in Hypertensive Individuals	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; SINGLE-NUCLEOTIDE POLYMORPHISMS; FRUCTOSE-SWEETENED BEVERAGES; SOFT DRINK CONSUMPTION; CORONARY-HEART-DISEASE; SERUM URIC-ACID; CARDIOVASCULAR-DISEASE; KIDNEY-DISEASE; ANTIHYPERTENSIVE RESPONSE; HDL METABOLISM	Objective: In the past few decades, consumption of added sugars has increased dramatically. Studies have linked high sugar intake with increased risk for a number of diseases. Importantly, fructose, a component of sugar, has been linked with the development of features of metabolic syndrome. This study determined if single nucleotide polymorphisms in genes involved in fructose transport (solute carrier family 2 facilitated glucose transporter, member 2 (SLC2A2) and solute carrier family 2 facilitated glucose/fructose transporter, member 5 (SLC2A5)) and metabolism (ketohexokinase (KHK)) affect inter-individual variability in metabolic phenotypes, such as increased serum uric acid levels. Materials/Methods: The influence of SLC2A2, SLC2A5, and KHK SNPs on metabolic phenotypes was tested in 237 European Americans and 167 African Americans from the Pharmacogenomic Evaluation and Antihypertensive Responses (PEAR) study. Using baseline untreated fasting data, associations were considered significant if p <= 0.005. These SNPs were then evaluated for potential replication (p <= 0.05) using data from the Genetic Epidemiology of Responses to Antihypertensives (GERA) studies. Results: SLC2A5 rs5438 was associated with an increase in serum uric acid in European American males. However, we were unable to replicate the association in GERA. The minor allele of SLC2A2 rs8192675 showed an association with lower high-density lipoproteins in European Americans (A/A: 51.0 mg/dL, A/G: 47.0 mg/dL, G/G: 41.5 mg/dL, p = 0.0034) in PEAR. The association between rs8192675 and lower high-density lipoproteins was replicated in the combined European American GERA study samples (A/A: 47.6 mg/dL, A/G: 48.6 mg/dL, G/G: 41.9 mg/dL, p = 0.0315). Conclusions: The association between SLC2A2 rs8192675 and high-density lipoproteins suggests the polymorphism may play a role in influencing high-density lipoproteins and thus metabolic risk of cardiovascular disease.	[Le, MyPhuong T.; Lobmeyer, Maximilian T.; Campbell, Marcus; Gums, John G.; Gong, Yan; Johnson, Julie A.] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32611 USA; [Le, MyPhuong T.; Lobmeyer, Maximilian T.; Campbell, Marcus; Gums, John G.; Gong, Yan; Johnson, Julie A.] Univ Florida, Coll Pharm, Ctr Pharmacogen, Gainesville, FL USA; [Cheng, Jing] Univ Florida, Coll Med, Dept Epidemiol & Hlth Policy Res, Gainesville, FL USA; [Wang, Zhiying; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; [Wang, Zhiying; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Inst Mol Med, Houston, TX USA; [Turner, Stephen T.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA; [Chapman, Arlene B.] Emory Univ, Dept Med, Div Renal, Atlanta, GA 30322 USA; [Johnson, Richard J.] Univ Colorado Denver, Dept Med, Div Renal Dis & Hypertens, Aurora, CO USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Mayo Clinic; Emory University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Johnson, JA (corresponding author), Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32611 USA.	johnson@cop.ufl.edu	Turner, Stephen/GXM-4654-2022		National Institutes of Health (Bethesda, MD), Pharmacogenetics Research Network (PEAR) [U01 GM074492]; Pharmacogenetics Research Network (PEAR); CTSA [UL1-RR029890, UL1-RR025008, UL1-RR024150]; Mayo Foundation; institutional National Institutes of Health training grant in the Division of Nephrology, University of Florida [T32-DK007518-23]; National Institutes of Health (Bethesda, MD) [R01HL53330]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150, UL1RR029890, UL1RR025008] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074492] Funding Source: NIH RePORTER	National Institutes of Health (Bethesda, MD), Pharmacogenetics Research Network (PEAR); Pharmacogenetics Research Network (PEAR); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Mayo Foundation; institutional National Institutes of Health training grant in the Division of Nephrology, University of Florida; National Institutes of Health (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by a grants from the National Institutes of Health (Bethesda, MD), grant #U01 GM074492, funded as part of the Pharmacogenetics Research Network (PEAR) and R01HL53330 (GERA I and II). Additional support for this work includes: CTSA grants UL1-RR029890 (University of Florida), UL1-RR025008 (Emory University), and UL1-RR024150 (Mayo Clinic); and funds from the Mayo Foundation. M. Le was supported by institutional National Institutes of Health training grant (T32-DK007518-23) in the Division of Nephrology, University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeli K, 2001, TRENDS CARDIOVAS MED, V11, P170, DOI 10.1016/S1050-1738(01)00084-6; Barbalic M, 2009, PHYSIOL GENOMICS, V39, P56, DOI 10.1152/physiolgenomics.00061.2009; Barone S, 2009, J BIOL CHEM, V284, P5056, DOI 10.1074/jbc.M808128200; Barroso I, 2003, PLOS BIOL, V1, P41, DOI 10.1371/journal.pbio.0000020; BOOKSTEIN L, 1990, ARCH INTERN MED, V150, P1653, DOI 10.1001/archinte.150.8.1653; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Bray GA, 2010, CURR OPIN LIPIDOL, V21, P51, DOI 10.1097/MOL.0b013e3283346ca2; Brown CM, 2008, INT J OBESITY, V32, pS28, DOI 10.1038/ijo.2008.204; Brown IJ, 2011, HYPERTENSION, V57, P695, DOI 10.1161/HYPERTENSIONAHA.110.165456; Canzanello VJ, 2008, AM J HYPERTENS, V21, P61, DOI 10.1038/ajh.2007.24; Chapman AB, 2002, KIDNEY INT, V61, P1047, DOI 10.1046/j.1523-1755.2002.00200.x; Choi JWJ, 2008, ARTHRIT RHEUM-ARTHR, V59, P109, DOI 10.1002/art.23245; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; Conen D, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-9; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; EMMERSON BT, 1974, ANN RHEUM DIS, V33, P276, DOI 10.1136/ard.33.3.276; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fung TT, 2009, AM J CLIN NUTR, V89, P1037, DOI 10.3945/ajcn.2008.27140; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Howie BN, 2006, HUM GENET, V120, P58, DOI 10.1007/s00439-006-0182-5; Jalal DI, 2010, J AM SOC NEPHROL, V21, P1543, DOI 10.1681/ASN.2009111111; Johnson JA, 2009, AM HEART J, V157, P442, DOI 10.1016/j.ahj.2008.11.018; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Jurgens H, 2005, OBES RES, V13, P1146, DOI 10.1038/oby.2005.136; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; Kellett GL, 2005, DIABETES, V54, P3056, DOI 10.2337/diabetes.54.10.3056; Laukkanen O, 2005, DIABETES, V54, P2256, DOI 10.2337/diabetes.54.7.2256; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Madero M, 2011, CURR HYPERTENS REP, V13, P29, DOI 10.1007/s11906-010-0163-x; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Nakagawa T, 2006, KIDNEY INT, V69, P1722, DOI 10.1038/sj.ki.5000391; Palmer JR, 2008, ARCH INTERN MED, V168, P1487, DOI 10.1001/archinte.168.14.1487; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Santer R, 1997, NAT GENET, V17, P324, DOI 10.1038/ng1197-324; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Short RA, 2005, SEMIN NEPHROL, V25, P25, DOI 10.1016/j.semnephrol.2004.09.005; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Steemers Frank J., 2007, Biotechnology Journal, V2, P41, DOI 10.1002/biot.200600213; Steinmann B, 2001, METABOLIC MOL BASES, P1489; Swarbrick MM, 2008, BRIT J NUTR, V100, P947, DOI 10.1017/S0007114508968252; Taha D, 2008, J PEDIATR ENDOCR MET, V21, P581; Teff KL, 2009, J CLIN ENDOCR METAB, V94, P1562, DOI 10.1210/jc.2008-2192; Turner ST, 2008, HYPERTENSION, V52, P359, DOI 10.1161/HYPERTENSIONAHA.107.104273; United States Department of Agriculture/Economic Research Service, 2000, US PER CAP FOOD CONS; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Weiner DE, 2008, J AM SOC NEPHROL, V19, P1204, DOI 10.1681/ASN.2007101075; Yamamoto T, 1997, METABOLISM, V46, P544, DOI 10.1016/S0026-0495(97)90192-X; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236	55	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52062	10.1371/journal.pone.0052062	http://dx.doi.org/10.1371/journal.pone.0052062			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341889	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400008
J	Matsunami, N; Hadley, D; Hensel, CH; Christensen, GB; Kim, C; Frackelton, E; Thomas, K; da Silva, RP; Stevens, J; Baird, L; Otterud, B; Ho, K; Varvil, T; Leppert, T; Lambert, CG; Leppert, M; Hakonarson, H				Matsunami, Nori; Hadley, Dexter; Hensel, Charles H.; Christensen, G. Bryce; Kim, Cecilia; Frackelton, Edward; Thomas, Kelly; da Silva, Renata Pellegrino; Stevens, Jeff; Baird, Lisa; Otterud, Brith; Ho, Karen; Varvil, Tena; Leppert, Tami; Lambert, Christophe G.; Leppert, Mark; Hakonarson, Hakon			Identification of Rare Recurrent Copy Number Variants in High-Risk Autism Families and Their Prevalence in a Large ASD Population	PLOS ONE			English	Article							DE-NOVO; STRUCTURAL VARIATION; SPECTRUM DISORDERS; HIGH-FREQUENCY; GENES; LOCI; NEUREXIN-1-BETA; SCHIZOPHRENIA; DELETIONS; CHILDREN	Structural variation is thought to play a major etiological role in the development of autism spectrum disorders (ASDs), and numerous studies documenting the relevance of copy number variants (CNVs) in ASD have been published since 2006. To determine if large ASD families harbor high-impact CNVs that may have broader impact in the general ASD population, we used the Affymetrix genome-wide human SNP array 6.0 to identify 153 putative autism-specific CNVs present in 55 individuals with ASD from 9 multiplex ASD pedigrees. To evaluate the actual prevalence of these CNVs as well as 185 CNVs reportedly associated with ASD from published studies many of which are insufficiently powered, we designed a custom Illumina array and used it to interrogate these CNVs in 3,000 ASD cases and 6,000 controls. Additional single nucleotide variants (SNVs) on the array identified 25 CNVs that we did not detect in our family studies at the standard SNP array resolution. After molecular validation, our results demonstrated that 15 CNVs identified in high-risk ASD families also were found in two or more ASD cases with odds ratios greater than 2.0, strengthening their support as ASD risk variants. In addition, of the 25 CNVs identified using SNV probes on our custom array, 9 also had odds ratios greater than 2.0, suggesting that these CNVs also are ASD risk variants. Eighteen of the validated CNVs have not been reported previously in individuals with ASD and three have only been observed once. Finally, we confirmed the association of 31 of 185 published ASD-associated CNVs in our dataset with odds ratios greater than 2.0, suggesting they may be of clinical relevance in the evaluation of children with ASDs. Taken together, these data provide strong support for the existence and application of high-impact CNVs in the clinical genetic evaluation of children with ASD.	[Matsunami, Nori; Stevens, Jeff; Baird, Lisa; Otterud, Brith; Varvil, Tena; Leppert, Tami; Leppert, Mark] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Hadley, Dexter; Kim, Cecilia; Frackelton, Edward; Thomas, Kelly; da Silva, Renata Pellegrino; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Hensel, Charles H.; Ho, Karen] Lineagen Inc, Salt Lake City, UT USA; [Christensen, G. Bryce; Lambert, Christophe G.] Golden Helix Inc, Bozeman, MT USA; [Hakonarson, Hakon] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	Utah System of Higher Education; University of Utah; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	hakonarson@email.chop.edu	Romanova, Raisa/O-5724-2018; Lambert, Christophe/AAH-4448-2021; Hadley, Dexter/ABB-7568-2021	Lambert, Christophe/0000-0003-1994-2893; Hadley, Dexter/0000-0003-0990-4674; Leppert, Tami/0000-0002-7893-8619	National Institute of Mental Health [1U24MH081810]; Margaret Q. Landenberger Foundation; Lineagen, Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U19HD035476] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH081810] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Margaret Q. Landenberger Foundation; Lineagen, Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	All Utah subjects were ascertained and DNA collected with support from R01 MH 06359 from the National Institute of Mental Health and U19HD035476 from the National Institute of Child Health and Human Development. DNA was processed with support from GCRC M01-RR025764 from the National Center for Research Resources. The Autism Genetic Resource Exchange is a program of Autism Speaks and is supported, in part, by grant 1U24MH081810 from the National Institute of Mental Health to Clara M. Lajonchere (PI). Dr. Hakonaron is additionally supported by the Margaret Q. Landenberger Foundation. Additional funding for this study was provided by Lineagen, Inc. Scientific input into study design, data analysis, and preparation of the manuscript were provided by two authors who are Lineagen employees (CHH, KH). The remaining funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey A, 1998, HUM MOL GENET, V7, P571; Bergboer JGM, 2012, J INVEST DERMATOL; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Biswas AK, 2012, CANCER RES, V72, P13, DOI 10.1158/0008-5472.CAN-11-2196; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Buxbaum JD, 2004, MOL PSYCHIATR, V9, P144, DOI 10.1038/sj.mp.4001465; Camacho-Garcia RJ, 2012, NEUROBIOL DIS, V47, P135, DOI 10.1016/j.nbd.2012.03.031; Carrie A, 1999, NAT GENET, V23, P25, DOI 10.1038/12623; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Christian SL, 2008, BIOL PSYCHIAT, V63, P1111, DOI 10.1016/j.biopsych.2008.01.009; Cook EH, 1997, AM J HUM GENET, V60, P928; Davis LK, 2009, J NEURODEV DISORD, V1, P292, DOI 10.1007/s11689-009-9013-z; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Fernandez BA, 2010, J MED GENET, V47, P195, DOI 10.1136/jmg.2009.069369; Gambino F, 2007, P NATL ACAD SCI USA, V104, P9063, DOI 10.1073/pnas.0701133104; Girirajan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002334; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Grant SGN, 2012, CURR OPIN NEUROBIOL, V22, P522, DOI 10.1016/j.conb.2012.02.002; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Harrison V, 2011, AM J MED GENET A, V155A, P2826, DOI 10.1002/ajmg.a.34255; Havik B, 2011, BIOL PSYCHIAT, V70, P35, DOI 10.1016/j.biopsych.2011.01.030; Hedges DJ, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-2; Hogart A, 2007, HUM MOL GENET, V16, P691, DOI 10.1093/hmg/ddm014; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Kalia LV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014695; Kang JQ, 2013, J AUTISM DEV DISORD, V43, P68, DOI 10.1007/s10803-012-1543-7; Kao WT, 2010, P NATL ACAD SCI USA, V107, P15619, DOI 10.1073/pnas.1005410107; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kirov G, 2009, SCHIZOPHRENIA BULL, V35, P851, DOI 10.1093/schbul/sbp079; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Lionel AC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002464; Manning M, 2010, GENET MED, V12, P742, DOI 10.1097/GIM.0b013e3181f8baad; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Martin Christa Lese, 2007, Curr Psychiatry Rep, V9, P141; Michel M, 2012, DEV NEUROBIOL; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nunn C, 2006, SEMIN CELL DEV BIOL, V17, P390, DOI 10.1016/j.semcdb.2006.04.001; Palferman S, 2001, AM J HUM GENET, V69, P570; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Prescott SM, 2008, ANNU REV GENOM HUM G, V9, P347, DOI 10.1146/annurev.genom.9.081307.164441; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Punia S, 2010, PHARMACOGENET GENOM, V20, P435, DOI 10.1097/FPC.0b013e32833ad3bb; Qiao Y, 2009, J MED GENET, V46, P680, DOI 10.1136/jmg.2009.066795; Ronald A, 2011, AM J MED GENET B, V156B, P255, DOI 10.1002/ajmg.b.31159; Rosenberg RE, 2009, ARCH PEDIAT ADOL MED, V163, P907, DOI 10.1001/archpediatrics.2009.98; Sahoo T, 2011, GENET MED, V13, P868, DOI 10.1097/GIM.0b013e3182217a06; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Schaaf CP, 2012, EUR J HUM GENET; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shema E, 2011, MOL CELL, V42, P477, DOI 10.1016/j.molcel.2011.03.011; Shen YP, 2010, PEDIATRICS, V125, pE727, DOI 10.1542/peds.2009-1684; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Stone TW, 2012, FEBS J, V279, P1386, DOI 10.1111/j.1742-4658.2012.08487.x; Sumioka A, 2003, BIOCHEM J, V374, P261, DOI 10.1042/BJ20030489; Sun J, 2012, PSYCHIAT RES; Swaminathan Shanker, 2011, Int J Alzheimers Dis, V2011, P729478, DOI 10.4061/2011/729478; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Vilarino-Guell C, 2010, NEUROGENETICS, V11, P401, DOI 10.1007/s10048-010-0241-x; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Williams AL, 2011, J BIOL CHEM, V286, P14542, DOI 10.1074/jbc.M110.215624; Wu YW, 2011, HUM GENET, V129, P611, DOI 10.1007/s00439-011-0955-3; Xu L, 2011, BRIT J DERMATOL, V165, P882, DOI 10.1111/j.1365-2133.2011.10485.x; Yalcin O, 2012, SEIZURE-EUR J EPILEP, V21, P79, DOI 10.1016/j.seizure.2011.12.002; Yamamoto Y, 2010, J BIOL CHEM, V285, P40943, DOI 10.1074/jbc.M110.156893	72	45	47	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52239	10.1371/journal.pone.0052239	http://dx.doi.org/10.1371/journal.pone.0052239			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341896	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400013
J	Gassei, K; Orwig, KE				Gassei, Kathrin; Orwig, Kyle E.			SALL4 Expression in Gonocytes and Spermatogonial Clones of Postnatal Mouse Testes	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HOMEOTIC GENE SPALT; UNDIFFERENTIATED SPERMATOGONIA; OKIHIRO-SYNDROME; STEM/PROGENITOR CELLS; DROSOPHILA EMBRYO; KIT EXPRESSION; MURINE HOMOLOG; FATE DECISION; PROTEIN	The spermatogenic lineage is established after birth when gonocytes migrate to the basement membrane of seminiferous tubules and give rise to spermatogonial stem cells (SSC). In adults, SSCs reside within the population of undifferentiated spermatogonia (A(undiff)) that expands clonally from single cells (A(single)) to form pairs (A(paired)) and chains of 4, 8 and 16 A(aligned) spermatogonia. Although stem cell activity is thought to reside in the population of Asingle spermatogonia, new research suggests that clone size alone does not define the stem cell pool. The mechanisms that regulate self-renewal and differentiation fate decisions are poorly understood due to limited availability of experimental tools that distinguish the products of those fate decisions. The pluripotency factor SALL4 (sal-like protein 4) is implicated in stem cell maintenance and patterning in many organs during embryonic development, but expression becomes restricted to the gonads after birth. We analyzed the expression of SALL4 in the mouse testis during the first weeks after birth and in adult seminiferous tubules. In newborn mice, the isoform SALL4B is expressed in quiescent gonocytes at postnatal day 0 (PND0) and SALL4A is upregulated at PND7 when gonocytes have colonized the basement membrane and given rise to spermatogonia. During steady-state spermatogenesis in adult testes, SALL4 expression overlapped substantially with PLZF and LIN28 in Asingle, A(paired) and A(aligned) spermatogonia and therefore appears to be a marker of undifferentiated spermatogonia in mice. In contrast, co-expression of SALL4 with GFR alpha 1 and cKIT identified distinct subpopulations of A(undiff) in all clone sizes that might provide clues about SSC regulation. Collectively, these results indicate that 1) SALL4 isoforms are differentially expressed at the initiation of spermatogenesis, 2) SALL4 is expressed in undifferentiated spermatogonia in adult testes and 3) SALL4 co-staining with GFRa1 and cKIT reveals distinct subpopulations of A(undiff) spermatogonia that merit further investigation.	[Gassei, Kathrin; Orwig, Kyle E.] Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Orwig, KE (corresponding author), Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA.	orwigke@upmc.edu	Gassei, Kathrin/E-3791-2013	Orwig, Kyle/0000-0002-7952-8419	United States National Institutes of Health [HD055475, HD061289, HD008610]; Lalor Foundation; Magee-Womens Research Institute and Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055475] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD008610, R21HD061289] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lalor Foundation; Magee-Womens Research Institute and Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Financial support was provided by United States National Institutes of Health grants HD055475, HD061289 and HD008610 (KEO), a Lalor Foundation Postdoctoral Fellowship (KG) and Magee-Womens Research Institute and Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buageaw A, 2005, BIOL REPROD, V73, P1011, DOI 10.1095/biolreprod.105.043810; Camp E, 2003, DEV GENES EVOL, V213, P35, DOI 10.1007/s00427-002-0284-6; Culty M, 2009, BIRTH DEFECTS RES C, V87, P1, DOI 10.1002/bdrc.20142; De Rooij DG, 2000, J ANDROL, V21, P776; Eildermann K, 2012, CELLS TISSUES ORGANS, V196, P206, DOI 10.1159/000335031; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Filipponi D, 2007, MOL CELL BIOL, V27, P6770, DOI 10.1128/MCB.00479-07; Grisanti L, 2009, STEM CELLS, V27, P3043, DOI 10.1002/stem.206; Hobbs RM, 2012, CELL STEM CELL, V10, P284, DOI 10.1016/j.stem.2012.02.004; Hofmann MC, 2008, MOL CELL ENDOCRINOL, V288, P95, DOI 10.1016/j.mce.2008.04.012; Hollemann T, 1996, MECH DEVELOP, V55, P19, DOI 10.1016/0925-4773(95)00485-8; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; JURGENS G, 1988, EMBO J, V7, P189, DOI 10.1002/j.1460-2075.1988.tb02799.x; KLUIN PM, 1981, INT J ANDROL, V4, P475, DOI 10.1111/j.1365-2605.1981.tb00732.x; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Kohlhase J, 2002, CYTOGENET GENOME RES, V98, P274, DOI 10.1159/000071048; Kohlhase J, 1996, GENOMICS, V38, P291, DOI 10.1006/geno.1996.0631; Koshiba-Takeuchi K, 2006, NAT GENET, V38, P175, DOI 10.1038/ng1707; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; LOK D, 1982, ANAT REC, V203, P83, DOI 10.1002/ar.1092030109; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Oatley MJ, 2011, BIOL REPROD, V84, P639, DOI 10.1095/biolreprod.110.087320; Oikawa T, 2009, GASTROENTEROLOGY, V136, P1000, DOI 10.1053/j.gastro.2008.11.018; Ott T, 1996, MECH DEVELOP, V56, P117, DOI 10.1016/0925-4773(96)00516-3; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Rao S, 2010, MOL CELL BIOL, V30, P5364, DOI 10.1128/MCB.00419-10; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Suzuki H, 2009, DEV BIOL, V336, P222, DOI 10.1016/j.ydbio.2009.10.002; Sweetman D, 2006, DEV BIOL, V293, P285, DOI 10.1016/j.ydbio.2006.02.009; Sweetman D, 2003, J BIOL CHEM, V278, P6560, DOI 10.1074/jbc.M209066200; TEGELENBOSCH RAJ, 1993, MUTAT RES, V290, P193; Tokuda M, 2007, BIOL REPROD, V76, P130, DOI 10.1095/biolreprod.106.053181; Uez N, 2008, GENESIS, V46, P463, DOI 10.1002/dvg.20421; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Warren M, 2007, GENESIS, V45, P51, DOI 10.1002/dvg.20264; Yamatani H, 2004, J COMP NEUROL, V475, P247, DOI 10.1002/cne.20155; Yang JC, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-38; Yang JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010766; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316; Yoshida S, 2007, ANN NY ACAD SCI, V1120, P47, DOI 10.1196/annals.1411.003; YOSHINAGA K, 1991, DEVELOPMENT, V113, P689; Yuri S, 2009, STEM CELLS, V27, P796, DOI 10.1002/stem.14; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38	47	74	75	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53976	10.1371/journal.pone.0053976	http://dx.doi.org/10.1371/journal.pone.0053976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326552	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000314705800095
J	Yasuo, M; Mizuno, S; Allegood, J; Kraskauskas, D; Bogaard, HJ; Spiegel, S; Voelkel, NF				Yasuo, Masanori; Mizuno, Shiro; Allegood, Jeremy; Kraskauskas, Donatas; Bogaard, Harm J.; Spiegel, Sarah; Voelkel, Norbert F.			Fenretinide Causes Emphysema, Which Is Prevented by Sphingosine 1-Phoshate	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OBSTRUCTIVE PULMONARY-DISEASE; INDUCED APOPTOSIS; CELL APOPTOSIS; CERAMIDE SYNTHASE; UP-REGULATION; LUNG; SPHINGOSINE-1-PHOSPHATE; NEUROBLASTOMA; DIHYDROCERAMIDE	Sphingolipids play a role in the development of emphysema and ceramide levels are increased in experimental models of emphysema; however, the mechanisms of ceramide-related pulmonary emphysema are not fully understood. Here we examine mechanisms of ceramide-induced pulmonary emphysema. Male Sprague-Dawley rats were treated with fenretinide (20 mg/kg BW), a synthetic derivative of retinoic acid that causes the formation of ceramide, and we postulated that the effects of fenretinide could be offset by administering sphingosine 1-phosphate (S1P) (100 mg/kg BW). Lung tissues were analyzed and mean alveolar airspace area, total length of the alveolar perimeter and the number of caspase-3 positive cells were measured. Hypoxia-inducible factor alpha (HIF-1 alpha), vascular endothelial growth factor (VEGF) and other related proteins were analyzed by Western blot analysis. Immunohistochemical analysis of HIF-1 alpha was also performed. Ceramide, dihydroceramide, S1P, and dihydro-S1P were measured by mass spectrometer. Chronic intraperitoneal injection of fenretinide increased the alveolar airspace surface area and increased the number of caspase-3 positive cells in rat lungs. Fenretinide also suppressed HIF-1 alpha and VEGF protein expression in rat lungs. Concomitant injection of S1P prevented the decrease in the expression of HIF-1 alpha, VEGF, histone deacetylase 2 (HDAC2), and nuclear factor (erythroid-derived 2)-like 2 (Nrf2) protein expression in the lungs. S1P injection also increased phosphorylated sphingosine kinase 1. Dihydroceramide was significantly increased by fenretinide injection and S1P treatment prevented the increase in dihydroceramide levels in rat lungs. These data support the concept that increased de novo ceramide production causes alveolar septal cell apoptosis and causes emphysema via suppressing HIF-1 alpha. Concomitant treatment with S1P normalizes the ceramide-S1P balance in the rat lungs and increases HIF-1 alpha protein expression via activation of sphingosine kinase 1; as a consequence, S1P salvages fenretinide induced emphysema in rat lungs.	[Yasuo, Masanori; Mizuno, Shiro; Kraskauskas, Donatas; Bogaard, Harm J.; Voelkel, Norbert F.] Virginia Commonwealth Univ, Pulm & Crit Care Med Div, Richmond, VA 23284 USA; [Yasuo, Masanori; Mizuno, Shiro; Kraskauskas, Donatas; Bogaard, Harm J.; Voelkel, Norbert F.] Virginia Commonwealth Univ, Victoria Johnson Ctr Obstruct Lung Dis, Richmond, VA USA; [Yasuo, Masanori] Shinshu Univ, Sch Med, Dept Internal Med 1, Matsumoto, Nagano 390, Japan; [Allegood, Jeremy; Spiegel, Sarah] Virginia Commonwealth Univ, Dept Biochem, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Shinshu University; Virginia Commonwealth University	Voelkel, NF (corresponding author), Virginia Commonwealth Univ, Pulm & Crit Care Med Div, Richmond, VA 23284 USA.	nvoelkel@mcvh-vcu.edu		Bogaard, Harm Jan/0000-0001-5371-0346	National Institutes of Health (NIH) Lung Division LTRC [N01-HR-46160-3]; Victoria Johnson Center for obstructive Lung Disease Research	National Institutes of Health (NIH) Lung Division LTRC; Victoria Johnson Center for obstructive Lung Disease Research	This work was supported by the National Institutes of Health (NIH) Lung Division LTRC grant support mechanism (Grant number; N01-HR-46160-3, contact name; Norbert F. Voelkel) and by the Victoria Johnson Center for obstructive Lung Disease Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ader I, 2008, CANCER RES, V68, P8635, DOI 10.1158/0008-5472.CAN-08-0917; Baldi S, 2001, AM J RESP CRIT CARE, V164, P585, DOI 10.1164/ajrccm.164.4.2010066; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen SD, 2005, ANN NY ACAD SCI, V1042, P357, DOI 10.1196/annals.1338.033; Claus RA, 2009, CURR MED CHEM, V16, P1978, DOI 10.2174/092986709788682182; Diab KJ, 2010, AM J RESP CRIT CARE, V181, P344, DOI 10.1164/rccm.200906-0826OC; Erdreich-Epstein A, 2002, J BIOL CHEM, V277, P49531, DOI 10.1074/jbc.M209962200; FINKELSTEIN R, 1995, AM J RESP CRIT CARE, V152, P1666, DOI 10.1164/ajrccm.152.5.7582312; Golubkov V, 2005, ANTICANCER RES, V25, P249; Goven D, 2008, THORAX, V63, P916, DOI 10.1136/thx.2007.091181; Hail N, 2006, APOPTOSIS, V11, P1677, DOI 10.1007/s10495-006-9289-3; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Huwiler A, 2006, CURR PHARM DESIGN, V12, P4625, DOI 10.2174/138161206779010422; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; KIM WD, 1991, AM REV RESPIR DIS, V144, P1385, DOI 10.1164/ajrccm/144.6.1385; Kim WD, 2007, CHEST, V131, P1372, DOI 10.1378/chest.06-2194; Kraveka JM, 2007, J BIOL CHEM, V282, P16718, DOI 10.1074/jbc.M700647200; Liu HB, 2008, PANCREAS, V36, pE10, DOI 10.1097/MPA.0b013e31815f3905; Lovat PE, 2003, CANCER LETT, V197, P157, DOI 10.1016/S0304-3835(03)00098-3; Lovat PE, 2002, CANCER RES, V62, P5158; Medler TR, 2008, AM J RESP CELL MOL, V38, P639, DOI 10.1165/rcmb.2007-0274OC; Michaud MD, 2009, ARTERIOSCL THROM VAS, V29, P902, DOI 10.1161/ATVBAHA.109.185280; Mizuno S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030678; Mizuno S, 2011, AM J PHYSIOL-LUNG C, V300, pL402, DOI 10.1152/ajplung.00207.2010; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Ruvolo VR, 2010, J SIGNAL TRANSDUCT, V2010, DOI DOI 10.1155/2010/584657; Senkal CE, 2011, J BIOL CHEM, V286, P42446, DOI 10.1074/jbc.M111.287383; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Spiegel S, 2012, ONCOGENE, V31, P537, DOI 10.1038/onc.2011.267; Sreekumar PG, 2008, INVEST OPHTH VIS SCI, V49, P1210, DOI 10.1167/iovs.07-0667; Sullivan AK, 2005, AM J RESP CRIT CARE, V172, P590, DOI 10.1164/rccm.200410-1332OC; Suzuki M, 2008, INHAL TOXICOL, V20, P349, DOI 10.1080/08958370701866412 ; Suzuki M, 2008, AM J RESP CELL MOL, V39, P673, DOI 10.1165/rcmb.2007-0424OC; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Taraseviciene-Stewart L, 2008, J CLIN INVEST, V118, P394, DOI 10.1172/JCI31811; Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002-0228OC; Tuder RM, 2008, CURR OPIN PHARMACOL, V8, P255, DOI 10.1016/j.coph.2008.03.003; Villorbina G, 2007, BIOORGAN MED CHEM, V15, P50, DOI 10.1016/j.bmc.2006.10.024; Voelkel NF, 2006, AM J PHYSIOL-LUNG C, V290, pL209, DOI 10.1152/ajplung.00185.2005; Voelkel Norbert F, 2011, Pulm Circ, V1, P320, DOI 10.4103/2045-8932.87295; Voelkel NF, 2009, IMMUNOL CELL BIOL, V87, P601, DOI 10.1038/icb.2009.45; Wang H, 2008, MOL CANCER THER, V7, P2967, DOI 10.1158/1535-7163.MCT-08-0549; Wang HT, 2001, CANCER RES, V61, P5102; Yang Yang, 2011, Ther Adv Respir Dis, V5, P325, DOI 10.1177/1753465811406772; Yasuo M, 2011, EUR RESPIR J, V37, P775, DOI 10.1183/09031936.00022910; Yoshida T, 2007, PHYSIOL REV, V87, P1047, DOI 10.1152/physrev.00048.2006; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	49	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53927	10.1371/journal.pone.0053927	http://dx.doi.org/10.1371/journal.pone.0053927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326540	Green Published, Green Submitted, gold			2022-12-25	WOS:000314705800089
J	Foti, F; Menghini, D; Mandolesi, L; Federico, F; Vicari, S; Petrosini, L				Foti, Francesca; Menghini, Deny; Mandolesi, Laura; Federico, Francesca; Vicari, Stefano; Petrosini, Laura			Learning by Observation: Insights from Williams Syndrome	PLOS ONE			English	Article							NEURAL MECHANISMS; HUMAN IMITATION; MOTOR CONTROL; DOWN-SYNDROME; HAND ACTIONS; CHILDREN; MEMORY; PATTERN; CORTEX; FMRI	Observing another person performing a complex action accelerates the observer's acquisition of the same action and limits the time-consuming process of learning by trial and error. Observational learning makes an interesting and potentially important topic in the developmental domain, especially when disorders are considered. The implications of studies aimed at clarifying whether and how this form of learning is spared by pathology are manifold. We focused on a specific population with learning and intellectual disabilities, the individuals with Williams syndrome. The performance of twenty-eight individuals with Williams syndrome was compared with that of mental age- and gender-matched thirty-two typically developing children on tasks of learning of a visuo-motor sequence by observation or by trial and error. Regardless of the learning modality, acquiring the correct sequence involved three main phases: a detection phase, in which participants discovered the correct sequence and learned how to perform the task; an exercise phase, in which they reproduced the sequence until performance was error-free; an automatization phase, in which by repeating the error-free sequence they became accurate and speedy. Participants with Williams syndrome beneficiated of observational training (in which they observed an actor detecting the visuo-motor sequence) in the detection phase, while they performed worse than typically developing children in the exercise and automatization phases. Thus, by exploiting competencies learned by observation, individuals with Williams syndrome detected the visuo-motor sequence, putting into action the appropriate procedural strategies. Conversely, their impaired performances in the exercise phases appeared linked to impaired spatial working memory, while their deficits in automatization phases to deficits in processes increasing efficiency and speed of the response. Overall, observational experience was advantageous for acquiring competencies, since it primed subjects' interest in the actions to be performed and functioned as a catalyst for executed action.	[Foti, Francesca; Federico, Francesca] Univ Roma La Sapienza, Dept Dev & Social Psychol, Rome, Italy; [Foti, Francesca; Mandolesi, Laura; Petrosini, Laura] IRCCS Santa Lucia Fdn, Rome, Italy; [Menghini, Deny; Vicari, Stefano] Childrens Hosp Bambino Gesu, Dept Neurosci, Child Neuropsychiat Unit, Rome, Italy; [Mandolesi, Laura] Univ Naples Parthenope, Sch Movement Sci DiSIST, Naples, Italy; [Petrosini, Laura] Univ Roma La Sapienza, Dept Psychol, Rome, Italy	Sapienza University Rome; IRCCS Santa Lucia; IRCCS Bambino Gesu; Parthenope University Naples; Sapienza University Rome	Foti, F (corresponding author), Univ Roma La Sapienza, Dept Dev & Social Psychol, Rome, Italy.	francesca.foti@uniroma1.it	Menghini, Deny/AAB-4343-2020; Foti, Francesca/AAB-9878-2019; Vicari, Stefano/J-3008-2012; Meijer, Anna/K-5118-2016	Menghini, Deny/0000-0002-3459-2601; MANDOLESI, Laura/0000-0002-3685-7554; Federico, Francesca/0000-0002-3589-4783; FOTI, FRANCESCA IRENE/0000-0002-7094-7078; Vicari, Stefano/0000-0002-5395-2262	Fondation Jerome Lejeune	Fondation Jerome Lejeune	This work was supported by the Fondation Jerome Lejeune to L.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson J, 2003, DEV NEUROPSYCHOL, V23, P139, DOI 10.1207/S15326942DN231&2_7; Atkinson J, 2001, DEV MED CHILD NEUROL, V43, P330, DOI 10.1017/S0012162201000615; Atkinson J, 2011, PROG BRAIN RES, V189, P261, DOI 10.1016/B978-0-444-53884-0.00029-4; Avanzino L, 2011, J NEUROSCI, V31, P3423, DOI 10.1523/JNEUROSCI.4893-10.2011; Barr R, 1996, INFANT BEHAV DEV, V19, P159, DOI 10.1016/S0163-6383(96)90015-6; Beery KE, 2000, ITALIAN ADAPTATION; Bellugi U, 2000, J COGNITIVE NEUROSCI, V12, P7, DOI 10.1162/089892900561959; Berthoz A, 1996, COGNITIVE BRAIN RES, V3, P101, DOI 10.1016/0926-6410(95)00035-6; Bird G, 2005, J EXP PSYCHOL HUMAN, V31, P262, DOI 10.1037/0096-1523.31.2.262; Brass M, 2008, NEUROSCIENTIST, V14, P319, DOI 10.1177/1073858408317417; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Burke CJ, 2010, P NATL ACAD SCI USA, V107, P14431, DOI 10.1073/pnas.1003111107; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Chambers CD, 2007, J NEUROPHYSIOL, V98, P3638, DOI 10.1152/jn.00685.2007; Chaminade T, 2002, NEUROIMAGE, V15, P318, DOI 10.1006/nimg.2001.0981; Chiang MC, 2007, NEUROIMAGE, V36, P1096, DOI 10.1016/j.neuroimage.2007.04.024; Clarke HF, 2008, J NEUROSCI, V28, P10972, DOI 10.1523/JNEUROSCI.1521-08.2008; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Ersche KD, 2011, BIOL PSYCHIAT, V70, P754, DOI 10.1016/j.biopsych.2011.06.033; Farran EK, 2001, J CHILD PSYCHOL PSYC, V42, P719, DOI 10.1111/1469-7610.00768; Fenstermacher SK, 2007, BEHAV GENET, V37, P639, DOI 10.1007/s10519-007-9160-5; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Foti F, 2011, RES DEV DISABIL, V32, P972, DOI 10.1016/j.ridd.2011.02.001; Foti F, 2011, BEHAV GENET, V41, P445, DOI 10.1007/s10519-011-9471-4; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; GRAFMAN J, 1992, NEUROLOGY, V42, P1493, DOI 10.1212/WNL.42.8.1493; HAMMILL D, 1994, TPV TEST PERCEZIONE; Hoffstaedter F, 2012, CEREB CORTE IN PRESS; Hubert V, 2007, HUM BRAIN MAPP, V28, P1415, DOI 10.1002/hbm.20354; Hughes G, 2011, NEUROIMAGE, V56, P1632, DOI 10.1016/j.neuroimage.2011.02.057; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2005, CURR OPIN NEUROBIOL, V15, P632, DOI 10.1016/j.conb.2005.10.010; Jarrold C, 2004, J AUTISM DEV DISORD, V34, P81, DOI 10.1023/B:JADD.0000018078.82542.ab; JERNIGAN TL, 1990, ARCH NEUROL-CHICAGO, V47, P529, DOI 10.1001/archneur.1990.00530050049011; Jones W, 2002, DEV MED CHILD NEUROL, V44, P688; Klein BP, 1999, DEV NEUROPSYCHOL, V16, P177, DOI 10.1207/S15326942DN1602_3; Kokkinaki T, 2000, J REPROD INFANT PSYC, V18, P173, DOI 10.1080/713683042; Leggio MG, 2000, P NATL ACAD SCI USA, V97, P2320, DOI 10.1073/pnas.040554297; Mandolesi L, 2009, INT J DEV NEUROSCI, V27, P205, DOI 10.1016/j.ijdevneu.2009.01.004; MELTZOFF AN, 1995, DEV PSYCHOL, V31, P838, DOI 10.1037/0012-1649.31.5.838; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; Meltzoff AN, 2003, PHILOS T R SOC B, V358, P491, DOI 10.1098/rstb.2002.1261; Meltzoff AN, 2009, SCIENCE, V325, P284, DOI 10.1126/science.1175626; Menghini D, 2010, J INTELL DISABIL RES, V54, P418, DOI 10.1111/j.1365-2788.2010.01287.x; Menghini D, 2011, NEUROPSYCHOLOGIA, V49, P1996, DOI 10.1016/j.neuropsychologia.2011.03.029; Menghini D, 2011, BEHAV GENET, V41, P394, DOI 10.1007/s10519-010-9419-0; Mervis CB, 2000, BRAIN COGNITION, V44, P604, DOI 10.1006/brcg.2000.1232; Metzinger T, 2003, CONSCIOUS COGN, V12, P549, DOI 10.1016/S1053-8100(03)00072-2; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Mobbs D, 2007, BIOL PSYCHIAT, V62, P256, DOI 10.1016/j.biopsych.2006.05.041; Nadel J, 1998, IMITATION INFANCY; Nadel J., 2002, CAMBRIDGE STUDIES CO, P42, DOI [10.1017/CBO9780511489969.003, DOI 10.1017/CBO9780511489969.003]; Petrosini L, 2007, NEUROSCIENTIST, V13, P335, DOI 10.1177/10738584070130040701; Reiss AL, 2000, J COGNITIVE NEUROSCI, V12, P65, DOI 10.1162/089892900561986; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 1997, CURR OPIN NEUROBIOL, V7, P562, DOI 10.1016/S0959-4388(97)80037-2; Rizzolatti G, 2003, EXP BRAIN RES, V153, P146, DOI 10.1007/s00221-003-1588-0; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Roid G. H., 2002, LEITER R LEITER INT; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Schmitt JE, 2001, DEV MED CHILD NEUROL, V43, P155, DOI 10.1017/S0012162201000305; Schutz-Bosbach S, 2007, TRENDS COGN SCI, V11, P349, DOI 10.1016/j.tics.2007.06.005; Seidler RD, 2005, EXP BRAIN RES, V165, P114, DOI 10.1007/s00221-005-2284-z; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Sokolov AA, 2010, CEREB CORTEX, V20, P486, DOI 10.1093/cercor/bhp117; Sparaci L, 2012, NEUROPSYCHOLOGIA, V50, P1639, DOI 10.1016/j.neuropsychologia.2012.03.019; Swick D, 2011, NEUROIMAGE, V56, P1655, DOI 10.1016/j.neuroimage.2011.02.070; Torriero S, 2007, J COGNITIVE NEUROSCI, V19, P1656, DOI 10.1162/jocn.2007.19.10.1656; Torriero S, 2011, J COGNITIVE NEUROSCI, V23, P338, DOI 10.1162/jocn.2010.21471; Van der Werf YD, 2009, P NATL ACAD SCI USA, V106, P18926, DOI 10.1073/pnas.0901320106; Vicari S, 2007, J INTELL DISABIL RES, V51, P932, DOI 10.1111/j.1365-2788.2007.01003.x; Vicari S, 2006, DEV MED CHILD NEUROL, V48, P126, DOI 10.1017/S0012162206000272; Vicari S, 2005, DEV MED CHILD NEUROL, V47, P305, DOI 10.1017/S0012162205000599; Vicari S, 2001, NEUROPSYCHOLOGIA, V39, P665, DOI 10.1016/S0028-3932(01)00012-4; Vicari S., 2007, PROMEA PROVE MEMORIA; Vogt S, 2007, NEUROIMAGE, V37, P1371, DOI 10.1016/j.neuroimage.2007.07.005; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5	80	12	12	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53782	10.1371/journal.pone.0053782	http://dx.doi.org/10.1371/journal.pone.0053782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YV	23326504	Green Published, Green Submitted, gold			2022-12-25	WOS:000313552400045
J	Kleisner, K; Priplatova, L; Frost, P; Flegr, J				Kleisner, Karel; Priplatova, Lenka; Frost, Peter; Flegr, Jaroslav			Trustworthy-Looking Face Meets Brown Eyes	PLOS ONE			English	Article							IRIS PIGMENTATION; UNIQUE MORPHOLOGY; COLOR; BLUE; HAIR; PERCEPTION; DOMINANCE; GENDER; BEAUTY	We tested whether eye color influences perception of trustworthiness. Facial photographs of 40 female and 40 male students were rated for perceived trustworthiness. Eye color had a significant effect, the brown-eyed faces being perceived as more trustworthy than the blue-eyed ones. Geometric morphometrics, however, revealed significant correlations between eye color and face shape. Thus, face shape likewise had a significant effect on perceived trustworthiness but only for male faces, the effect for female faces not being significant. To determine whether perception of trustworthiness was being influenced primarily by eye color or by face shape, we recolored the eyes on the same male facial photos and repeated the test procedure. Eye color now had no effect on perceived trustworthiness. We concluded that although the brown-eyed faces were perceived as more trustworthy than the blue-eyed ones, it was not brown eye color per se that caused the stronger perception of trustworthiness but rather the facial features associated with brown eyes.	[Kleisner, Karel; Priplatova, Lenka; Flegr, Jaroslav] Charles Univ Prague, Dept Philosophy & Hist Sci, Prague, Czech Republic; [Frost, Peter] Univ Laval, Dept Anthropol, Quebec City, PQ, Canada	Charles University Prague; Laval University	Kleisner, K (corresponding author), Charles Univ Prague, Dept Philosophy & Hist Sci, Prague, Czech Republic.	kleisner@seznam.cz	Flegr, Jaroslav/AAG-7568-2021; Frost, Peter/AAQ-4107-2020; Kleisner, Karel/M-2718-2017; Flegr, Jaroslav/A-1564-2008	Flegr, Jaroslav/0000-0002-0822-0126; Frost, Peter/0000-0002-5498-1866; Kleisner, Karel/0000-0002-3277-8365; Flegr, Jaroslav/0000-0002-0822-0126; Priplatova, Lenka/0000-0002-2860-3853	Czech Grant Agency [P407/11/1464]; Charles University in Prague project of University Center [204004]	Czech Grant Agency(Grant Agency of the Czech Republic); Charles University in Prague project of University Center	This research was supported by Czech Grant Agency project P407/11/1464 and by Charles University in Prague project of University Center 204004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Buckingham G, 2006, EVOL HUM BEHAV, V27, P381, DOI 10.1016/j.evolhumbehav.2006.03.001; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; Coplan RJ, 1998, DEV PSYCHOBIOL, V32, P37, DOI 10.1002/(SICI)1098-2302(199801)32:1<37::AID-DEV4>3.0.CO;2-U; Eiberg H, 2008, HUM GENET, V123, P177, DOI 10.1007/s00439-007-0460-x; Engell AD, 2007, J COGNITIVE NEUROSCI, V19, P1508, DOI 10.1162/jocn.2007.19.9.1508; Fink B, 2005, P ROY SOC B-BIOL SCI, V272, P1995, DOI 10.1098/rspb.2005.3179; FOOTE M, 1993, PALEOBIOLOGY, V19, P403, DOI 10.1017/S0094837300014056; Freiwald WA, 2010, SCIENCE, V330, P845, DOI 10.1126/science.1194908; Frost P, 2006, EVOL HUM BEHAV, V27, P85, DOI 10.1016/j.evolhumbehav.2005.07.002; HAMERMESH DS, 1994, AM ECON REV, V84, P1174; Kagan J., 2004, LONG SHADOW TEMPERAM; Keating CF, 2002, J EXP SOC PSYCHOL, V38, P414, DOI 10.1016/S0022-1031(02)00007-0; Kleisner K, 2010, PERS INDIV DIFFER, V49, P59, DOI 10.1016/j.paid.2010.03.011; Kobayashi H, 1997, NATURE, V387, P767, DOI 10.1038/42842; Kobayashi H, 2001, J HUM EVOL, V40, P419, DOI 10.1006/jhev.2001.0468; Laeng B, 2007, BEHAV ECOL SOCIOBIOL, V61, P371, DOI 10.1007/s00265-006-0266-1; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Lehre AC, 2009, DEV PSYCHOBIOL, V51, P198, DOI 10.1002/dev.20358; Liu F, 2009, CURR BIOL, V19, pR192, DOI 10.1016/j.cub.2009.01.027; Oksanen J., 2016, R PACKAG; Oosterhof NN, 2009, EMOTION, V9, P128, DOI 10.1037/a0014520; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Rezlescu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034293; Rohlf J., 2008, TPSRELW VERSION 1 46; Rohlf J. F., 2009, TPSDIG2 VERSION 2 14; Rohlf J. F., 2009, TPSREGR VERSION 1 36; ROSENBERG A, 1987, DEV PSYCHOBIOL, V20, P377, DOI 10.1002/dev.420200403; ROSENBERG AA, 1989, DEV PSYCHOBIOL, V22, P753, DOI 10.1002/dev.420220802; Schaefer K, 2006, AM J PHYS ANTHROPOL, V129, P132, DOI 10.1002/ajpa.20224; Shekar SN, 2008, PHOTOCHEM PHOTOBIOL, V84, P719, DOI 10.1111/j.1751-1097.2007.00237.x; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Todorov A, 2008, ANN NY ACAD SCI, V1124, P208, DOI 10.1196/annals.1440.012; Tomasello M, 2007, J HUM EVOL, V52, P314, DOI 10.1016/j.jhevol.2006.10.001; van't Wout M, 2008, COGNITION, V108, P796, DOI 10.1016/j.cognition.2008.07.002; WAGATSUMA H, 1967, DAEDALUS, V96, P407; Weston EM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000710; Windhager S, 2011, AM J HUM BIOL, V23, P805, DOI 10.1002/ajhb.21219; Zebrowitz LA, 2008, SOC PERSONAL PSYCHOL, V2, P1497, DOI 10.1111/j.1751-9004.2008.00109.x; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5; Zhu Q, 2010, CURR BIOL, V20, P137, DOI 10.1016/j.cub.2009.11.067	45	45	47	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53285	10.1371/journal.pone.0053285	http://dx.doi.org/10.1371/journal.pone.0053285			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326406	gold, Green Published, Green Submitted			2022-12-25	WOS:000313551500057
J	Wang, X; Chen, N; Zuo, ZT; Xue, R; Jing, L; Yan, Z; Shen, DG; Li, KC				Wang Xing; Chen Nan; Zuo ZhenTao; Xue Rong; Jing Luo; Yan Zhuo; Shen DingGang; Li KunCheng			Probabilistic MRI Brain Anatomical Atlases Based on 1,000 Chinese Subjects	PLOS ONE			English	Article							MNI; DECLINE; HAMMER	Brain atlases are designed to provide a standard reference coordinate system of the brain for neuroscience research. Existing human brain atlases are widely used to provide anatomical references and information regarding structural characteristics of the brain. The majority of them, however, are derived from one paticipant or small samples of the Western population. This poses a limitation for scientific studies on Eastern subjects. In this study, 10 new Chinese brain atlases for different ages and genders were constructed using MR anatomical images based on HAMMER (Hierarchical Attribute Matching Mechanism for Elastic Registration). A total of 1,000 Chinese volunteers ranging from 18 to 70 years old participated in this study. These population-specific brain atlases represent the basic structural characteristics of the Chinese population. They may be utilized for basic neuroscience studies and clinical diagnosis, including evaluation of neurological and neuropsychiatric disorders, in Chinese patients and those from other Eastern countries.	[Wang Xing; Chen Nan; Li KunCheng] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China; [Zuo ZhenTao; Xue Rong; Jing Luo; Yan Zhuo] Chinese Acad Sci, Inst Biophys, Beijing MRI Ctr Brain Res, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Shen DingGang] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA; [Shen DingGang] Univ N Carolina, Biomed Res Imaging Ctr, Chapel Hill, NC USA	Capital Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Xue, R (corresponding author), Chinese Acad Sci, Inst Biophys, Beijing MRI Ctr Brain Res, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	rxue@bcslab.ibp.ac.cn; likuncheng19551@yahoo.com.cn	CHEN, NAN/L-1223-2019; Shen, Dinggang/ABF-6812-2020	Shen, Dinggang/0000-0002-7934-5698	Ministry of Science and Technology of China [2006AA02z391, 2005CB522800, 2004CB318101]; National Natural Science Foundation of China [30621004]; Knowledge Innovation Program of the Chinese Academy of Sciences; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009634] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Ministry of Science and Technology of China grants (2006AA02z391, 2005CB522800, 2004CB318101), National Natural Science Foundation of China grant (30621004), and the Knowledge Innovation Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhondi-Asl A, 2011, NEUROIMAGE, V54, pS218, DOI 10.1016/j.neuroimage.2010.03.066; Bang OY, 2010, CEREBROVASC DIS, V29, P87, DOI 10.1159/000256653; Bendlin BB, 2010, DEV NEUROPSYCHOL, V35, P257, DOI 10.1080/87565641003696775; Brodmann K, 2006, BRODMANNS LOCALIZATI; Cardoso MJ, 2011, NEUROIMAGE, V56, P1386, DOI 10.1016/j.neuroimage.2011.02.013; Chau W, 2005, NEUROIMAGE, V25, P408, DOI 10.1016/j.neuroimage.2004.12.007; Driscoll I, 2009, NEUROLOGY, V72, P1906, DOI 10.1212/WNL.0b013e3181a82634; Fotenos AF, 2008, ARCH NEUROL-CHICAGO, V65, P113, DOI 10.1001/archneurol.2007.27; Giorgio A, 2010, NEUROIMAGE, V51, P943, DOI 10.1016/j.neuroimage.2010.03.004; Haegelen C, 2012, INT J COMPUT ASSIST, V18; Jao T, 2009, IEEE ENG MED BIO, P4779, DOI 10.1109/IEMBS.2009.5334211; Kannurpatti SS, 2010, MAGN RESON IMAGING, V28, P466, DOI 10.1016/j.mri.2009.12.007; Kruggel F, 2006, NEUROIMAGE, V30, P1, DOI 10.1016/j.neuroimage.2005.09.063; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lee JS, 2005, J KOREAN MED SCI, V20, P483, DOI 10.3346/jkms.2005.20.3.483; Liu QM, 2005, THESIS SHANDONG U; Mazoyer B, 2008, HUM BRAIN MAPP, V29, P250, DOI 10.1002/hbm.20473; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Morgan KD, 2010, PSYCHOL MED, V40, P1137, DOI 10.1017/S0033291709991565; Moriguchi Y, 2005, NEUROREPORT, V16, P133, DOI 10.1097/00001756-200502080-00012; Raz N, 2010, NEUROIMAGE, V51, P501, DOI 10.1016/j.neuroimage.2010.03.020; Sadikot AF, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00071; Shen D, 2008, HAMMER USERS MANUAL; Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111; Shen DG, 2003, NEUROIMAGE, V18, P28, DOI 10.1006/nimg.2002.1301; Sluimer JD, 2008, RADIOLOGY, V248, P590, DOI 10.1148/radiol.2482070938; Taki Y, 2011, NEUROBIOL AGING, V32, P907, DOI 10.1016/j.neurobiolaging.2009.05.003; Tang YC, 2010, NEUROIMAGE, V51, P33, DOI 10.1016/j.neuroimage.2010.01.111; Toga AW, 2006, NAT REV NEUROSCI, V7, P952, DOI 10.1038/nrn2012; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776	30	6	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e50939	10.1371/journal.pone.0050939	http://dx.doi.org/10.1371/journal.pone.0050939			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23341878	Green Published, gold			2022-12-25	WOS:000313320900005
J	Lu, BX; Palacino, J				Lu, Boxun; Palacino, James			A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration	FASEB JOURNAL			English	Article						aggregation; high-throughput imaging	INACTIVATION; INHIBITION; LETHALITY	Most neurodegenerative diseases are linked to aberrant accumulation of aggregation-prone proteins. Among them, Huntington's disease (HD) is caused by an expanded polyglutamine repeat stretch in the N terminus of the mutant huntingtin protein (mHTT), which gets cleaved and aggregates in the brain. Recently established human induced pluripotent stem cell-derived HD neurons exhibit some disease-relevant phenotypes and provide tools for HD research. However, they have limitations such as genetic heterogeneity and an absence of mHTT aggregates and lack a robust neurodegeneration phenotype. In addition, the relationship between the phenotype and mHTT levels has not been elucidated. Herein, we present a human embryonic stem cell (hESC)-derived HD neuronal model expressing HT-Texon1 fragments, which addresses the deficiencies enumerated above. The wild-type and HD lines are derived from an isogenic background and exhibit insoluble mHTT aggregates and neurodegeneration. We also demonstrate a quantitative relationship between neurodegeneration and soluble monomeric (but not oligomeric or aggregated) mHTT levels. Reduction of similar to 10% of mHTT is sufficient to prevent toxicity, whereas similar to 90% reduction of wild-type HTT is safe and well-tolerated in these cells. A known HD toxicity modifier (Rhes) showed expected rescue of neurodegeneration. Therefore, the hESC-derived neuronal models complement existing induced pluripotent stem cell-derived neuronal models and provide valuable tools for HD research.-Lu, B., Palacino, J. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration. FASEB J. 27, 1820-1829 (2013). www.fasebj.org	[Lu, Boxun] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Lu, Boxun; Palacino, James] Novartis Inst BioMed Res Inc, Dev & Mol Pathways, Cambridge, MA USA	Fudan University; Novartis	Palacino, J (corresponding author), Novartis Inst BioMed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	luboxun@fudan.edu.cn; james.palacino@novartis.com			Novartis Institutes for Biomedical Research	Novartis Institutes for Biomedical Research	The authors thank Dr. Andreas Weiss for providing technical help on TR-FRET assays, Drs. Gul Erdemli and Chiawei Lin for providing assistance with electrophysiology recordings, Drs. Marian Difiglia and Sarah Luchansky for critical readings of earlier versions of the manuscript, and Dr. Arnaud Lacoste, Frada Berenshteyn, Philip Manos, and Christopher Littlefield for work on human stem cell culture and neuron differentiation, including some of the quality control experiments. The study was funded by Novartis Institutes for Biomedical Research. The authors declare no conflicts of interest.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Baldo B, 2012, CHEM BIOL, V19, P264, DOI 10.1016/j.chembiol.2011.12.020; Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Grondin R, 2012, BRAIN, V135, P1197, DOI 10.1093/brain/awr333; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; KIDD M, 1985, LANCET, V1, P278; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ratovitski T, 2007, CELL CYCLE, V6, P2970, DOI 10.4161/cc.6.23.4992; Rodriguez-Lebron E, 2005, MOL THER, V12, P618, DOI 10.1016/j.ymthe.2005.05.006; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thon JN, 2012, BLOOD, V120, P1975, DOI 10.1182/blood-2012-04-420968; Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001; Weiss A, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-11; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155	23	60	65	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2013	27	5					1820	1829		10.1096/fj.12-219220	http://dx.doi.org/10.1096/fj.12-219220			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23325320				2022-12-25	WOS:000318226100003
J	Fredrickson, EK; Gallagher, PS; Candadai, SVC; Gardner, RG				Fredrickson, Eric K.; Gallagher, Pamela S.; Candadai, Sarah V. Clowes; Gardner, Richard G.			Substrate Recognition in Nuclear Protein Quality Control Degradation Is Governed by Exposed Hydrophobicity That Correlates with Aggregation and Insolubility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ER-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; UBIQUITIN-LIGASE; POLYGLUTAMINE PROTEINS; SACCHAROMYCES-CEREVISIAE; CYTOSOLIC PROTEINS; MEMBRANE-PROTEIN; YEAST; PROTEASOME	Misfolded proteins present an escalating deleterious challenge to cells over the course of their lifetime. One mechanism the cell possesses to prevent misfolded protein accumulation is their destruction by protein quality control (PQC) degradation systems. In eukaryotes, PQC degradation typically proceeds via multiple ubiquitin-protein ligases that act throughout the cell to ubiquitinate misfolded proteins for proteasome degradation. What the exact feature of misfolding that each PQC ubiquitin-protein ligase recognizes in their substrates remains an open question. Our previous studies of the budding yeast nuclear ubiquitin-protein ligase San1 indicated that it recognizes exposed hydrophobicity within its substrates, with the threshold of hydrophobicity equivalent to that of 5 contiguous hydrophobic residues. Here, we uncover an additional parameter: the nature of the exposed hydrophobicity that confers San1-mediated degradation correlates with significant protein insolubility. San1 particularly targets exposed hydrophobicity that leads to insolubility and aggregation above a certain threshold. Our studies presented here provide additional insight into the details of misfolded nuclear protein recognition and demonstrate that there is selectivity for the type of exposed hydrophobicity.	[Fredrickson, Eric K.; Gallagher, Pamela S.; Candadai, Sarah V. Clowes; Gardner, Richard G.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Gardner, RG (corresponding author), Univ Washington, Dept Pharmacol, Box 357280,1959 NE Pacific St, Seattle, WA 98195 USA.	gardnerr@uw.edu		Gardner, Richard/0000-0003-2162-6275	National Institutes of Health through the NIGMS [5T32GM007750]; National Institutes of Health through the NIA [R01AG031136]; Ellison Medical Foundation New Scholar Award in Aging; Marian E. Smith Junior Faculty Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031136] Funding Source: NIH RePORTER	National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health through the NIA; Ellison Medical Foundation New Scholar Award in Aging; Marian E. Smith Junior Faculty Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This worked was supported, in whole or in part, by National Institutes of Health Training Grant 5T32GM007750 through the NIGMS (to E. K. F.) and Grant R01AG031136 through the NIA (to R. G. G.). This work was also supported by an Ellison Medical Foundation New Scholar Award in Aging (to R. G. G.) and a Marian E. Smith Junior Faculty Award (to R. G. G.).	Angeli S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009053; [Anonymous], 1991, Methods Enzymol, V194, P1; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Beerten J, 2012, PROTEIN ENG DES SEL, V25, P357, DOI 10.1093/protein/gzs031; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Brachmann CB, 1998, YEAST, V14, P115; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Fredrickson EK, 2012, SEMIN CELL DEV BIOL, V23, P530, DOI 10.1016/j.semcdb.2011.12.006; Fredrickson EK, 2011, MOL BIOL CELL, V22, P2384, DOI 10.1091/mbc.E11-03-0256; Fu LW, 2005, MOL BIOL CELL, V16, P4905, DOI 10.1091/mbc.E05-01-0019; Furth N, 2011, MOL BIOL CELL, V22, P4726, DOI 10.1091/mbc.E11-05-0463; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hill K, 2000, EMBO J, V19, P550, DOI 10.1093/emboj/19.4.550; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Ignatova Z, 2007, J BIOL CHEM, V282, P36736, DOI 10.1074/jbc.M703682200; Iwata A, 2009, J BIOL CHEM, V284, P9796, DOI 10.1074/jbc.M809739200; Janer A, 2006, J CELL BIOL, V174, P65, DOI 10.1083/jcb.200511045; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jung CH, 2004, PROTEIN SCI, V13, P694, DOI 10.1110/ps.03356604; Kanehara K, 2010, J CELL BIOL, V188, P707, DOI 10.1083/jcb.200907055; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lakhani VV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000772; Lefebvre BG, 2004, PROTEIN SCI, V13, P1538, DOI 10.1110/ps.03579304; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Nadav E, 2003, BIOCHEM BIOPH RES CO, V303, P91, DOI 10.1016/S0006-291X(03)00279-1; Nillegoda NB, 2010, MOL BIOL CELL, V21, P2102, DOI 10.1091/mbc.E10-02-0098; Prasad R, 2012, BIOCHEM BIOPH RES CO, V425, P689, DOI 10.1016/j.bbrc.2012.07.080; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Robertson AL, 2008, BIOPHYS J, V95, P5922, DOI 10.1529/biophysj.108.138487; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Shulga N, 2000, J CELL BIOL, V149, P1027, DOI 10.1083/jcb.149.5.1027; Shulga N, 2003, MOL CELL BIOL, V23, P534, DOI 10.1128/MCB.23.2.534-542.2003; Siwach P, 2011, NEUROSCI RES, V70, P435, DOI 10.1016/j.neures.2011.05.001; Snyder H, 2003, J BIOL CHEM, V278, P11753, DOI 10.1074/jbc.M208641200; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Theodoraki MA, 2012, J BIOL CHEM, V287, P23911, DOI 10.1074/jbc.M112.341164; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Wang Steven S-S, 2008, Biotechnol J, V3, P165, DOI 10.1002/biot.200700065; Wang Z, 2009, MOL CELL BIOL, V29, P1694, DOI 10.1128/MCB.01470-08; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wilhovsky S, 2000, MOL BIOL CELL, V11, P1697, DOI 10.1091/mbc.11.5.1697; Woulfe JM, 2007, NEUROPATH APPL NEURO, V33, P2, DOI 10.1111/j.1365-2990.2006.00819.x	54	35	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6130	6139		10.1074/jbc.M112.406710	http://dx.doi.org/10.1074/jbc.M112.406710			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23335508	Green Published, hybrid			2022-12-25	WOS:000315820700010
J	Bhutia, YD; Hung, SW; Krentz, M; Patel, D; Lovin, D; Manoharan, R; Thomson, JM; Govindarajan, R				Bhutia, Yangzom Doma; Hung, Sau Wai; Krentz, Madeline; Patel, Dimal; Lovin, Dylan; Manoharan, Radhika; Thomson, J. Michael; Govindarajan, Rajgopal			Differential Processing of let-7a Precursors Influences RRM2 Expression and Chemosensitivity in Pancreatic Cancer: Role of LIN-28 and SET Oncoprotein	PLOS ONE			English	Article							RIBONUCLEOTIDE REDUCTASE R2; GEMCITABINE CHEMORESISTANCE; MESENCHYMAL TRANSITION; CELL-PROLIFERATION; UP-REGULATION; DNA-DAMAGE; M2 SUBUNIT; RESISTANCE; MICRORNAS; GENE	Overexpression of ribonucleotide reductase subunit M2 (RRM2), involved in deoxyribonucleotide synthesis, drives the chemoresistance of pancreatic cancer to nucleoside analogs (e. g., gemcitabine). While silencing RRM2 by synthetic means has shown promise in reducing chemoresistance, targeting endogenous molecules, especially microRNAs (miRNAs), to advance chemotherapeutic outcomes has been poorly explored. Based on computational predictions, we hypothesized that the let-7 tumor suppressor miRNAs will inhibit RRM2-mediated gemcitabine chemoresistance in pancreatic cancer. Reduced expression of the majority of let-7 miRNAs with an inverse relationship to RRM2 expression was identified in innately gemcitabine-resistant pancreatic cancer cell lines. Direct binding of let-7 miRNAs to the 39 UTR of RRM2 transcripts identified post-transcriptional regulation of RRM2 influencing gemcitabine chemosensitivity. Intriguingly, overexpression of human precursor-let-7 miRNAs led to differential RRM2 expression and chemosensitivity responses in a poorly differentiated pancreatic cancer cell line, MIA PaCa-2. Defective processing of let-7a precursors to mature forms, in part, explained the discrepancies observed with let-7a expressional outcomes. Consistently, the ratios of mature to precursor let-7a were progressively reduced in gemcitabine-sensitive L3.6pl and Capan-1 cell lines induced to acquire gemcitabine resistance. Besides known regulators of let-7 biogenesis (e.g., LIN-28), short hairpin RNA library screening identified several novel RNA binding proteins, including the SET oncoprotein, to differentially impact let-7 biogenesis and chemosensitivity in gemcitabine-sensitive versus - resistant pancreatic cancer cells. Further, LIN-28 and SET knockdown in the cells led to profound reductions in cellular proliferation and colony-formation capacities. Finally, defective processing of let-7a precursors with a positive correlation to RRM2 overexpression was identified in patient-derived pancreatic ductal adenocarcinoma (PDAC) tissues. These data demonstrate an intricate post-transcriptional regulation of RRM2 and chemosensitivity by let-7a and that the manipulation of regulatory proteins involved in let-7a transcription/processing may provide a mechanism for improving chemotherapeutic and/or tumor growth control responses in pancreatic cancer.	[Bhutia, Yangzom Doma; Hung, Sau Wai; Krentz, Madeline; Patel, Dimal; Lovin, Dylan; Manoharan, Radhika; Govindarajan, Rajgopal] Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Thomson, J. Michael] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA	University System of Georgia; University of Georgia; Vanderbilt University	Govindarajan, R (corresponding author), Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	rgovinda@rx.uga.edu			Georgia Cancer Coalition-Georgia Research Alliance; Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA;  [NCI-5-P50-CA128613-SPORE];  [NCI-1R03CA161832-01]; NATIONAL CANCER INSTITUTE [P50CA128613, R03CA161832] Funding Source: NIH RePORTER	Georgia Cancer Coalition-Georgia Research Alliance; Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NCI-5-P50-CA128613-SPORE (RG), NCI-1R03CA161832-01 (RG), Georgia Cancer Coalition-Georgia Research Alliance (RG), and by the Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barh D, 2010, CURR ONCOL, V17, P70; Bayraktar S, 2010, WORLD J GASTROENTERO, V16, P673, DOI 10.3748/wjg.v16.i6.673; Bergman AM, 2002, DRUG RESIST UPDATE, V5, P19, DOI 10.1016/S1368-7646(02)00002-X; Bhutia YD, 2011, CANCER RES, V71, P1825, DOI 10.1158/0008-5472.CAN-10-2736; Boyerinas B, 2012, INT J CANCER, V130, P1787, DOI 10.1002/ijc.26190; Brueckner B, 2007, CANCER RES, V67, P1419, DOI 10.1158/0008-5472.CAN-06-4074; Chabes A, 2000, J BIOL CHEM, V275, P17747, DOI 10.1074/jbc.M000799200; Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Chang CJ, 2011, ONCOL REP, V26, P1003, DOI 10.3892/or.2011.1360; Duxbury MS, 2004, ONCOGENE, V23, P1539, DOI 10.1038/sj.onc.1207272; Duxbury MS, 2005, CLIN CANCER RES, V11, P3433, DOI 10.1158/1078-0432.CCR-04-1510; Garrido-Laguna I, 2011, CLIN CANCER RES, V17, P5793, DOI 10.1158/1078-0432.CCR-11-0341; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Giovannetti E, 2011, CRIT REV ONCOL HEMAT, V81; Goan YG, 1999, CANCER RES, V59, P4204; Govindarajan R, 2008, AM J PHYSIOL-GASTR L, V295, pG570, DOI 10.1152/ajpgi.00542.2007; Hung SW, 2012, CANCER LETT, V320, P138, DOI 10.1016/j.canlet.2012.03.007; Itoi T, 2007, J GASTROENTEROL, V42, P389, DOI 10.1007/s00535-007-2017-0; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Juhasz A, 2006, ONCOL REP, V15, P1299; Kuo ML, 2003, CANCER J, V9, P277, DOI 10.1097/00130404-200307000-00010; Kuschak TI, 2002, ONCOGENE, V21, P909, DOI 10.1038/sj.onc.1205145; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Liu XY, 2004, BIOCHEM PHARMACOL, V67, P1499, DOI 10.1016/j.bcp.2003.12.026; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu L, 2007, CANCER RES, V67, P10117, DOI 10.1158/0008-5472.CAN-07-2544; Meng FY, 2012, J CELL MOL MED, V16, P160, DOI 10.1111/j.1582-4934.2011.01282.x; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Nakano Y, 2007, BRIT J CANCER, V96, P457, DOI 10.1038/sj.bjc.6603559; Noma B, 2008, INT J ONCOL, V33, P1187, DOI 10.3892/ijo_00000108; Oh JS, 2010, INT J RADIAT ONCOL, V76, P5, DOI 10.1016/j.ijrobp.2009.08.028; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Saletta F, 2010, BBA-REV CANCER, V1806, P275, DOI 10.1016/j.bbcan.2010.07.005; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Schniewind B, 2004, INT J CANCER, V109, P182, DOI 10.1002/ijc.11679; Switzer CH, 2011, ONCOGENE, V30, P2504, DOI 10.1038/onc.2010.622; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Torrisani J, 2009, HUM GENE THER, V20, P831, DOI 10.1089/hum.2008.134; Trujillo RD, 2010, EMBO J, V29, P3272, DOI 10.1038/emboj.2010.208; Van Wynsberghe PM, 2011, NAT STRUCT MOL BIOL, V18, P302, DOI 10.1038/nsmb.1986; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Wang ZW, 2011, NAT REV GASTRO HEPAT, V8, P27, DOI 10.1038/nrgastro.2010.188; Wey JS, 2005, BRIT J CANCER, V93, P233, DOI 10.1038/sj.bjc.6602663; Wong A, 2009, DRUG METAB REV, V41, P77, DOI 10.1080/03602530902741828; Zhang YW, 2009, J BIOL CHEM, V284, P18085, DOI 10.1074/jbc.M109.003020; Zhou B, 2001, CYTOGENET CELL GENET, V95, P34, DOI 10.1159/000057014; Zhou BS, 2003, CANCER RES, V63, P6583	50	62	66	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53436	10.1371/journal.pone.0053436	http://dx.doi.org/10.1371/journal.pone.0053436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335963	Green Published, gold, Green Submitted			2022-12-25	WOS:000314707700017
J	Penton, CM; Thomas-Ahner, JM; Johnson, EK; McAllister, C; Montanaro, F				Penton, Christopher M.; Thomas-Ahner, Jennifer M.; Johnson, Eric K.; McAllister, Cynthia; Montanaro, Federica			Muscle Side Population Cells from Dystrophic or Injured Muscle Adopt a Fibro-Adipogenic Fate	PLOS ONE			English	Article							SKELETAL-MUSCLE; SATELLITE CELLS; PROGENITOR CELLS; STEM-CELLS; MDX MICE; DIFFERENTIATION; EXPRESSION; PROLIFERATION; REGENERATION; PURIFICATION	Muscle side population (SP) cells are rare multipotent stem cells that can participate in myogenesis and muscle regeneration upon transplantation. While they have been primarily studied for the development of cell-based therapies for Duchenne muscular dystrophy, little is known regarding their non-muscle lineage choices or whether the dystrophic muscle environment affects their ability to repair muscle. Unfortunately, the study of muscle SP cells has been challenged by their low abundance and the absence of specific SP cell markers. To address these issues, we developed culture conditions for the propagation and spontaneous multi-lineage differentiation of muscle SP cells. Using this approach, we show that SP cells from wild type muscle robustly differentiate into satellite cells and form myotubes without requiring co-culture with myogenic cells. Furthermore, this myogenic activity is associated with SP cells negative for immune (CD45) and vascular (CD31) markers but positive for Pax7, Sca1, and the mesenchymal progenitor marker PDGFR alpha. Additionally, our studies revealed that SP cells isolated from dystrophic or cardiotoxin-injured muscle fail to undergo myogenesis. Instead, these SP cells rapidly expand giving rise to fibroblast and adipocyte progenitors (FAPs) and to their differentiated progeny, fibroblasts and adipocytes. Our findings indicate that muscle damage affects the lineage choices of muscle SP cells, promoting their differentiation along fibro-adipogenic lineages while inhibiting myogenesis. These results have implications for a possible role of muscle SP cells in fibrosis and fat deposition in muscular dystrophy. In addition, our studies provide a useful in vitro system to analyze SP cell biology in both normal and pathological conditions.	[Penton, Christopher M.; Thomas-Ahner, Jennifer M.; Johnson, Eric K.; Montanaro, Federica] Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH USA; [Penton, Christopher M.; Montanaro, Federica] Ohio State Univ, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Thomas-Ahner, Jennifer M.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Johnson, Eric K.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [McAllister, Cynthia] Nationwide Childrens Hosp, Res Inst, Morphol Core, Columbus, OH USA; [Montanaro, Federica] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Montanaro, F (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH USA.	montanaf@pediatrics.ohio-state.edu	Montanaro, Federica/GRJ-5139-2022; Thomas-Ahner, Jennifer/I-7598-2013; Thomas-Ahner, Jennifer/M-3955-2015	Montanaro, Federica/0000-0002-3338-0498; Thomas-Ahner, Jennifer/0000-0001-5264-7592	Muscle Group; American Heart Association; Nationwide Children's Hospital; Parent Project Muscular Dystrophy	Muscle Group; American Heart Association(American Heart Association); Nationwide Children's Hospital(Ohio State University); Parent Project Muscular Dystrophy	This work was supported by funds from Nationwide Children's Hospital and Parent Project Muscular Dystrophy to FM, an award from the Muscle Group to CMP, and a fellowship from the American Heart Association and from Nationwide Children's Hospital to EKJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DC, 2011, CYTOMETRY A; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Bachrach E, 2004, P NATL ACAD SCI USA, V101, P3581, DOI 10.1073/pnas.0400373101; Bachrach E, 2006, MUSCLE NERVE, V34, P44, DOI 10.1002/mus.20560; Beastrom N, 2011, AM J PATHOL; Beastrom N, 2011, AM J PATHOL, V179, P2464, DOI 10.1016/j.ajpath.2011.07.009; BLAU HM, 1983, P NATL ACAD SCI-BIOL, V80, P4856, DOI 10.1073/pnas.80.15.4856; BLAU HM, 1981, P NATL ACAD SCI-BIOL, V78, P5623, DOI 10.1073/pnas.78.9.5623; Bosnakovski D, 2008, STEM CELLS, V26, P3194, DOI 10.1634/stemcells.2007-1017; DANKO I, 1992, PEDIATR RES, V32, P128, DOI 10.1203/00006450-199207000-00025; Decary S, 2000, NEUROMUSCULAR DISORD, V10, P113, DOI 10.1016/S0960-8966(99)00093-0; Doyle MJ, 2011, J CELL BIOL; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; GUNNING P, 1987, MOL CELL BIOL, V7, P4100, DOI 10.1128/MCB.7.11.4100; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Im WB, 1996, HUM MOL GENET, V5, P1149, DOI 10.1093/hmg/5.8.1149; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Lapan AD, 2012, HUM MOL GENET; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McKinney-Freeman SL, 2003, EXP HEMATOL, V31, P806, DOI 10.1016/S0301-472X(03)00186-3; Meeson AP, 2004, STEM CELLS, V22, P1305, DOI 10.1634/stemcells.2004-0077; Mitchell PO, 2005, DEV BIOL, V283, P240, DOI 10.1016/j.ydbio.2005.04.016; Montanaro F, 2004, EXP CELL RES, V298, P144, DOI 10.1016/j.yexcr.2004.04.010; Montanaro F, 1998, J NEUROSCI, V18, P1250; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Motohashi N, 2008, AM J PATHOL, V173, P781, DOI 10.2353/ajpath.2008.070902; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Muskiewicz KR, 2005, J HISTOCHEM CYTOCHEM, V53, P861, DOI 10.1369/jhc.4A6573.2005; Ojima K, 2004, BIOCHEM BIOPH RES CO, V321, P1050, DOI 10.1016/j.bbrc.2004.07.069; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; Pasut A, 2012, METHODS MOL BIOL, V798, P53, DOI 10.1007/978-1-61779-343-1_3; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Rivier F, 2004, J CELL SCI, V117, P1979, DOI 10.1242/jcs.01051; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Schienda J, 2006, P NATL ACAD SCI USA, V103, P945, DOI 10.1073/pnas.0510164103; Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Uezumi A, 2006, BIOCHEM BIOPH RES CO, V341, P864, DOI 10.1016/j.bbrc.2006.01.037; Uezumi A, 2011, J CELL SCI, V124, P3654, DOI 10.1242/jcs.086629; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Wang YX, 2011, NAT REV MOL CELL BIO; WEBSTER C, 1990, SOMAT CELL MOLEC GEN, V16, P557, DOI 10.1007/BF01233096; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	46	28	28	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54553	10.1371/journal.pone.0054553	http://dx.doi.org/10.1371/journal.pone.0054553			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23336007	gold, Green Published, Green Submitted			2022-12-25	WOS:000314707700065
J	Weitensteiner, SB; Liebl, J; Krystof, V; Havlicek, L; Gucky, T; Strnad, M; Furst, R; Vollmar, AM; Zahler, S				Weitensteiner, Sabine B.; Liebl, Johanna; Krystof, Vladimir; Havlicek, Libor; Gucky, Tomas; Strnad, Miroslav; Fuerst, Robert; Vollmar, Angelika M.; Zahler, Stefan			Trisubstituted Pyrazolopyrimidines as Novel Angiogenesis Inhibitors	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; ENDOTHELIAL-CELL MIGRATION; IN-VITRO; ROSCOVITINE; CANCER; CDK5	Current inhibitors of angiogenesis comprise either therapeutic antibodies (e.g. bevacicumab binding to VEGF-A) or small molecular inhibitors of receptor tyrosin kinases like e.g. sunitinib, which inhibits PDGFR and VEGFR. We have recently identified cyclin-dependent kinase 5 (Cdk5) as novel alternative and pharmacologically accessible target in the context of angiogenesis. In the present work we demonstrate that trisubstituted pyrazolo[4,3-d]pyrimidines constitute a novel class of compounds which potently inhibit angiogenesis. All seven tested compounds inhibited endothelial cell proliferation with IC50 values between 1 and 18 mu M. Interestingly, this seems not to be due to cytotoxicity, since none of them showed acute cytotoxic effects on endothelial cells at a concentration of 10 mu M,. The three most potent compounds (LGR1404, LGR1406 and LGR1407) also inhibited cell migration (by 27, 51 and 31%, resp.), chemotaxis (by 50, 70 and 60% in accumulative distance, resp.), and tube formation (by 25, 60 and 30% of total tube length, resp.) at the non-toxic concentration of 10 mu M. Furthermore, angiogenesis was reduced in vivo in the CAM assay by these three compounds. A kinase selectivity profiling revealed that the compounds prevalently inhibit Cdk2, Cdk5 and Cdk9. The phenotype of the migrating cells (reduced formation of lamellipodia, loss of Rac-1 translocation to the membrane) resembles the previously described effects of silencing of Cdk5 in endothelial cells. We conclude that especially LGR1406 and LGR1407 are highly attractive anti-angiogenic compounds, whose effects seem to largely depend on their Cdk5 inhibiting properties.	[Weitensteiner, Sabine B.; Liebl, Johanna; Fuerst, Robert; Vollmar, Angelika M.; Zahler, Stefan] Univ Munich, Dept Pharm, Munich, Germany; [Krystof, Vladimir; Gucky, Tomas; Strnad, Miroslav] Palacky Univ, Fac Sci, Lab Growth Regulators, CR-77147 Olomouc, Czech Republic; [Krystof, Vladimir; Gucky, Tomas; Strnad, Miroslav] Inst Expt Bot AS CR, Olomouc, Czech Republic; [Havlicek, Libor] Inst Expt Bot AS CR, Isotope Lab, Prague, Czech Republic; [Gucky, Tomas; Strnad, Miroslav] Palacky Univ, Fac Sci, Dept Growth Regulators, Ctr Reg Hana Biotechnol & Agr Res, CR-77147 Olomouc, Czech Republic	University of Munich; Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Palacky University Olomouc	Zahler, S (corresponding author), Univ Munich, Dept Pharm, Munich, Germany.	stefan.zahler@cup.uni-muenchen.de	Krystof, Vladimir/B-9499-2009; Havlicek, Libor/H-2171-2014; Strnad, Miroslav/H-1858-2014	Krystof, Vladimir/0000-0001-5838-2118; Strnad, Miroslav/0000-0002-2806-794X; Zahler, Stefan/0000-0002-5140-7287; Furst, Robert/0000-0002-9926-7578	Czech Science Foundation [P305/12/0783]; Centre of the Region Hana for Biotechnological and Agricultural Research (Ministry of Education, Youth and Sports, Czech Republic) [ED0007/01/01]; German Research Foundation (DFG); German Federal Ministry of Education and Research;  [ZA 186/4-1]	Czech Science Foundation(Grant Agency of the Czech Republic); Centre of the Region Hana for Biotechnological and Agricultural Research (Ministry of Education, Youth and Sports, Czech Republic); German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); 	This work was supported by grants P305/12/0783 (Czech Science Foundation), ED0007/01/01 of Centre of the Region Hana for Biotechnological and Agricultural Research (Ministry of Education, Youth and Sports, Czech Republic), by the German Research Foundation (DFG), grant ZA 186/4-1, and the German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Aldoss IT, 2009, EXPERT OPIN INV DRUG, V18, P1957, DOI 10.1517/13543780903418445; Berberich N, 2011, BRIT J PHARMACOL, V163, P1086, DOI 10.1111/j.1476-5381.2011.01309.x; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; Jorda R, 2011, J MED CHEM, V54, P2980, DOI 10.1021/jm200064p; Kerr JS, 1999, ANTICANCER RES, V19, P959; Krystof V, 2011, EUR J MED CHEM, V46, P4289, DOI 10.1016/j.ejmech.2011.06.035; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Liebl J, 2011, CELL SIGNAL, V23, P1698, DOI 10.1016/j.cellsig.2011.06.020; Liebl J, 2011, ANGIOGENESIS, V14, P281, DOI 10.1007/s10456-011-9212-6; Liebl J, 2010, J BIOL CHEM, V285, P35932, DOI 10.1074/jbc.M110.126177; Lilja L, 2001, J BIOL CHEM, V276, P34199, DOI 10.1074/jbc.M103776200; McClue SJ, 2002, INT J CANCER, V102, P463, DOI 10.1002/ijc.10738; Meijer L, 2003, ACCOUNTS CHEM RES, V36, P417, DOI 10.1021/ar0201198; MEIJER L, 2006, INHIBITORS CYCLIN DE; Rosales JL, 2006, BIOESSAYS, V28, P1023, DOI 10.1002/bies.20473; Rothmeier AS, 2008, FASEB J; Smith DS, 2002, TRENDS CELL BIOL, V12, P28, DOI 10.1016/S0962-8924(01)02181-X; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Strock CJ, 2006, CANCER RES, V66, P7509, DOI 10.1158/0008-5472.CAN-05-3048; Su SC, 2010, ANN REV CELL DEV BIO; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Tonini T, 2003, ONCOGENE, V22, P6549, DOI 10.1038/sj.onc.1206816; Zahler S, 2010, ANGIOGENESIS, V13, P239, DOI 10.1007/s10456-010-9181-1	28	22	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54607	10.1371/journal.pone.0054607	http://dx.doi.org/10.1371/journal.pone.0054607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23336010	Green Published, gold, Green Submitted			2022-12-25	WOS:000314707700068
J	Buckle, T; Kuil, J; van den Berg, NS; Bunschoten, A; Lamb, HJ; Yuan, HH; Josephson, L; Jonkers, J; Borowsky, AD; van Leeuwen, FWB				Buckle, Tessa; Kuil, Joeri; van den Berg, Nynke S.; Bunschoten, Anton; Lamb, Hildo J.; Yuan, Hushan; Josephson, Lee; Jonkers, Jos; Borowsky, Alexander D.; van Leeuwen, Fijs W. B.			Use of a Single Hybrid Imaging Agent for Integration of Target Validation with In Vivo and Ex Vivo Imaging of Mouse Tumor Lesions Resembling Human DCIS	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; BREAST-CANCER; PROSTATE-CANCER; FLOW-CYTOMETRY; PROGRESSION; EXPRESSION; CARCINOMA; GROWTH; MODEL; OVEREXPRESSION	Screening of biomarker expression levels in tumor biopsy samples not only provides an assessment of prognostic and predictive factors, but may also be used for selection of biomarker-specific imaging strategies. To assess the feasibility of using a biopsy specimen for a personalized selection of an imaging agent, the chemokine receptor 4 (CXCR4) was used as a reference biomarker. Methods: A hybrid CXCR4 targeting peptide (MSAP-Ac-TZ14011) containing a fluorescent dye and a chelate for radioactive labeling was used to directly compare initial flow cytometry-based target validation in fresh tumor tissue to in vivo single photon emission computed tomography (SPECT) imaging and in vivo and ex vivo fluorescence imaging. Results: Flow cytometric analysis of mouse tumor derived cell suspensions enabled discrimination between 4T1 control tumor lesions (with low levels of CXCR4 expression) and CXCR4 positive early, intermediate and late stage MIN-O lesions based on their CXCR4 expression levels; CXCR4(basal), CXCR4(+) and CXCR4(++) cell populations could be accurately discriminated. Mean fluorescent intensity ratios between expression in MIN-O and 4T1 tissue found with flow cytometry were comparable to ratios obtained with in vivo SPECT/CT and fluorescence imaging, ex vivo fluorescence evaluation and standard immunohistochemistry. Conclusion: The hybrid nature of a targeting imaging agent like MSAP-Ac-TZ14011 enables integration of target selection, in vivo imaging and ex vivo validation using a single agent. The use of biopsy tissue for biomarker screening can readily be expanded to other targeting hybrid imaging agents and can possibly help increase the clinical applicability of tumor-specific imaging approaches.	[Buckle, Tessa; Kuil, Joeri; van den Berg, Nynke S.; Bunschoten, Anton; van Leeuwen, Fijs W. B.] Leiden Univ, Med Ctr, Dept Radiol, Intervent Mol Imaging Lab, Leiden, Netherlands; [Buckle, Tessa; Kuil, Joeri; van den Berg, Nynke S.; Bunschoten, Anton; van Leeuwen, Fijs W. B.] Netherlands Canc Inst Antoni van Leeuwenhoekhuis, Dept Radiol, Amsterdam, Netherlands; [Buckle, Tessa; Kuil, Joeri; van den Berg, Nynke S.; Bunschoten, Anton; van Leeuwen, Fijs W. B.] Netherlands Canc Inst Antoni van Leeuwenhoekhuis, Dept Nucl Med, Amsterdam, Netherlands; [Lamb, Hildo J.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Yuan, Hushan; Josephson, Lee] Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA USA; [Yuan, Hushan; Josephson, Lee] Harvard Univ, Sch Med, Charlestown, MA USA; [Jonkers, Jos] Netherlands Canc Inst Antoni van Leeuwenhoek Hosp, Div Cell Biol, Amsterdam, Netherlands; [Borowsky, Alexander D.] Univ Calif Davis, Sch Med, Ctr Comparat Med, Dept Pathol & Lab Med, Sacramento, CA 95817 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute; Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Massachusetts General Hospital; Harvard University; Netherlands Cancer Institute; University of California System; University of California Davis	van Leeuwen, FWB (corresponding author), Leiden Univ, Med Ctr, Dept Radiol, Intervent Mol Imaging Lab, Leiden, Netherlands.	F.W.B.van_Leeuwen@lumc.nl	Borowsky, Alexander D/S-5404-2017; Jonkers, Jos/AAG-3246-2019; Lamb, Hildo/ABE-1171-2021; van leeuwen, Fijs/AAX-2098-2021	Jonkers, Jos/0000-0002-9264-9792; Lamb, Hildo/0000-0002-6969-2418; van leeuwen, Fijs/0000-0002-6844-4025; Bunschoten, Anton/0000-0002-4167-5077; Buckle, Tessa/0000-0003-2980-6895	Dutch Cancer Society [PGF 2009-4344]; VIDI grant [STW11272]; FP7-HYPERImage [201651]; Centre for Translational Molecular Medicine grant, project Breast CARE [030-104]; National Center for Research resources grant [K26 RR0243037]; National Institutes of Health [R01 EB-009691, EB011996]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009691, R01EB011996] Funding Source: NIH RePORTER	Dutch Cancer Society(KWF Kankerbestrijding); VIDI grant; FP7-HYPERImage; Centre for Translational Molecular Medicine grant, project Breast CARE; National Center for Research resources grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding: This research is supported by a Dutch Cancer Society translational research award (Grant No. PGF 2009-4344; FvL), a VIDI grant (Grant No. STW11272, FvL) and via FP7-HYPERImage (Grant No. 201651; TB), a Centre for Translational Molecular Medicine grant, project Breast CARE (Grant No. 030-104; JK) a National Center for Research resources grant (K26 RR0243037; ADB), and by National Institutes of Health grants R01 EB-009691 and EB011996 (LJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey CK, 2004, P NATL ACAD SCI USA, V101, P11438, DOI 10.1073/pnas.0404396101; Allred DC, 2010, MODERN PATHOL, V23, pS52, DOI 10.1038/modpathol.2010.55; Azhdarinia A, 2012, MOL IMAGING BIOL, V14, P261, DOI 10.1007/s11307-011-0528-9; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Banerjee SR, 2011, ANGEW CHEM INT EDIT, V50, P9167, DOI 10.1002/anie.201102872; Brouwer OR, 2012, J NUCL MED, V53, P1; Brouwer OR, 2012, ANN SURG ONCOL, V19, P1988, DOI 10.1245/s10434-011-2180-7; Buckle T, 2012, AM J NUCL MED MOLEC, V2, P99; Buckle T, 2012, J NUCL MED, V53, P1026, DOI 10.2967/jnumed.111.098517; Bunschoten A, 2012, CHEMBIOCHEM, V13, P1039, DOI 10.1002/cbic.201200034; Bunschoten A, 2012, BIOMATERIALS, V33, P867, DOI 10.1016/j.biomaterials.2011.10.005; Carlisle AJ, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-126; Chu QD, 2011, SURGERY, V149, P193, DOI 10.1016/j.surg.2010.05.016; Dijkers EC, 2010, CLIN PHARMACOL THER, V87, P586, DOI 10.1038/clpt.2010.12; Estey EH, 2012, AM J HEMATOL, V87, P90, DOI 10.1002/ajh.22246; Goldhirsch A, 2002, JNCI-J NATL CANCER I, V94, P1054; Hanaoka H, 2006, NUCL MED BIOL, V33, P489, DOI 10.1016/j.nucmedbio.2006.01.006; Hassan S, 2009, AM J PATHOL, V175, P66, DOI 10.2353/ajpath.2009.080948; Holm NT, 2007, J SURG RES, V141, P53, DOI 10.1016/j.jss.2007.03.015; Kang H, 2005, BREAST, V14, P360, DOI 10.1016/j.breast.2004.12.007; Kuil J, 2012, CHEM SOC REV, V41, P5239, DOI 10.1039/c2cs35085h; Kuil J, 2011, MOL PHARMACEUT, V8, P2444, DOI 10.1021/mp200401p; Kuil J, 2011, BIOCONJUGATE CHEM, V22, P859, DOI 10.1021/bc2000947; Kuil J, 2010, BIOCONJUGATE CHEM, V21, P1709, DOI 10.1021/bc100276j; Leong ASY, 2011, PATHOBIOLOGY, V78, P99, DOI 10.1159/000292644; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Namba R, 2006, CLIN CANCER RES, V12, P2613, DOI 10.1158/1078-0432.CCR-05-2170; Namba R, 2005, BREAST CANCER RES, V7, pR881, DOI 10.1186/bcr1317; Nolan GR, 2011, BEST PRACT RES CL HA, V24, P505, DOI 10.1016/j.beha.2011.09.005; Penault-Llorca F, 2003, INT J ONCOL, V22, P1319; Pritchard KI, 2006, NEW ENGL J MED, V354, P2103, DOI 10.1056/NEJMoa054504; Salvucci O, 2006, BREAST CANCER RES TR, V97, P275, DOI 10.1007/s10549-005-9121-8; Sampath L, 2007, J NUCL MED, V48, P1501, DOI 10.2967/jnumed.107.042234; Taly V, 2012, TRENDS MOL MED, V18, P405, DOI 10.1016/j.molmed.2012.05.001; van den Berg NS, 2012, EUR J NUCL MED MOL I, V39, P1128, DOI 10.1007/s00259-012-2129-5; van den Berg NS, 2011, TRANSL ONCOL, V4, P224, DOI 10.1593/tlo.11115; van der Poel HG, 2011, EUR UROL, V60, P826, DOI 10.1016/j.eururo.2011.03.024; van Leeuwen AC, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3528027; Yura H, 2006, J BIOCHEM, V139, P637, DOI 10.1093/jb/mvj077; Zare H, 2012, AM J CLIN PATHOL, V137, P75, DOI 10.1309/AJCPMMLQ67YOMGEW	40	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e48324	10.1371/journal.pone.0048324	http://dx.doi.org/10.1371/journal.pone.0048324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326303	Green Published, Green Submitted, gold			2022-12-25	WOS:000314705800005
J	Hagarman, JA; Motley, MP; Kristjansdottir, K; Soloway, PD				Hagarman, James A.; Motley, Michael P.; Kristjansdottir, Katla; Soloway, Paul D.			Coordinate Regulation of DNA Methylation and H3K27me3 in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							EPIGENETIC INHERITANCE; CHROMATIN STATE; PROTEIN EED; HISTONE; GENES; PLURIPOTENT; IMMUNOPRECIPITATION; HYPERMETHYLATION; LYSINE-27; SEQUENCES	Chromatin is separated into functional domains distinguished by combinatorial patterns of post-translational histone modifications and DNA methylation. Recent studies examining multiple histone modifications have found numerous chromatin states with distinct profiles of chromatin marks and functional enrichments. There are data showing coordinate regulation between DNAme and H3K27me3, which are both involved in the establishment and maintenance of epigenetic gene silencing, but the data are conflicting. Multiple studies have presented evidence to support the theory that PRC2 and DNAme cooperate to achieve silencing, or alternatively that H3K27me3 and DNAme act antagonistically. Here we examine the effect loss of either PRC2 or DNA methyltransferase activity has on the placement of the reciprocal mark in mouse ES cells. We find that DNAme is acting globally to antagonize the placement of H3K27me3, in accordance with recently published results. At least 471,011 domains in the mouse genome acquire H3K27me3 when DNAme is diminished. Of these 466,563 have been shown to be fully methylated in wildtype ES cells, indicating the effects of DNAme on H3K27me3 are direct. In a reciprocal experiment, we examine the effect loss of PRC2 has on the placement of DNAme. In contrast to the global antagonism DNAme has on the placement of H3K27me3, loss of H3K27me3 has a modest effect on DNAme, with only 4% of genes undergoing changes in DNAme, including 861 showing increases and 552 showing losses of overall DNAme. We anticipate that integrating genomic datasets where the effect of loss of a particular epigenetic mark has on the placement of other marks will help elucidate the rules governing epigenetic regulation and what role coordinate regulation of epigenetic marks plays in development and disease.	[Hagarman, James A.; Motley, Michael P.; Kristjansdottir, Katla; Soloway, Paul D.] Cornell Univ, Coll Agr & Life Sci, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University	Soloway, PD (corresponding author), Cornell Univ, Coll Agr & Life Sci, Div Nutr Sci, Ithaca, NY 14853 USA.	soloway@cornell.edu	Soloway, Paul/T-8243-2019	Motley, Michael/0000-0002-4271-1375; Soloway, Paul/0000-0003-1967-0437	National Institutes of Health (NIH) [CA120870]; Cornell Center for Vertebrate Genomics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052471] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA120870, R01CA098597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105243] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornell Center for Vertebrate Genomics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a grant from the National Institutes of Health (NIH), CA120870, and the Cornell Center for Vertebrate Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brinkman AB, 2012, GENOME RES; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lindroth AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000145; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Mager J, 2003, NAT GENET, V33, P502, DOI 10.1038/ng1125; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Mathieu O, 2005, EMBO J, V24, P2783, DOI 10.1038/sj.emboj.7600743; McGarvey KM, 2007, CANCER RES, V67, P5097, DOI 10.1158/0008-5472.CAN-06-2029; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Minard ME, 2009, GENESIS, V47, P559, DOI 10.1002/dvg.20534; Mohn Fabio, 2009, V507, P55, DOI 10.1007/978-1-59745-522-0_5; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Morin-Kensicki Elizabeth M., 2001, Genesis The Journal of Genetics and Development, V31, P142, DOI 10.1002/gene.10017; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rideout WM, 2000, NAT GENET, V24, P109, DOI 10.1038/72753; RINCHIK EM, 1993, MAMM GENOME, V4, P349, DOI 10.1007/BF00360583; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Sorensen AL, 2009, METHODS MOL BIOL, V567, P249, DOI 10.1007/978-1-60327-414-2_16; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Sugimura K, 2010, EXP CELL RES, V316, P2731, DOI 10.1016/j.yexcr.2010.06.016; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	55	71	72	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53880	10.1371/journal.pone.0053880	http://dx.doi.org/10.1371/journal.pone.0053880			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326524	Green Published, gold, Green Submitted			2022-12-25	WOS:000314705800082
J	Ji, SY; Hao, JX; Li, L; Zhang, J; Zheng, QS; Li, XX; Wang, XN; Han, CS; Gao, F; Liu, YX				Ji, Shao-Yang; Hao, Jian-Xiu; Li, Lei; Zhang, Jun; Zheng, Qiao-Song; Li, Xi-Xia; Wang, Xiao-Na; Han, Chun-Sheng; Gao, Fei; Liu, Yi-Xun			Expression of Inhibin-Alpha Is Regulated Synergistically by Wilms' Tumor Gene 1 (Wt1) and Steroidogenic Factor-1 (Sf1) in Sertoli Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; SUPPRESSOR GENE; PROTEIN WT1; RAT INHIBIN; REPRESSION; PROMOTER; RECEPTOR; ACTIVATION; SUBUNITS; LOCALIZATION	Wt1 encodes a zinc finger nuclear transcriptional factor, which is specifically expressed in testicular Sertoli cells and knockdown of Wt1 in Sertoli cells causes male mice subfertility. However, the underlying mechanism is still unclear. In this study, we found that expression of inhibin-alpha is significantly reduced in Wt1-deficient Sertoli cells. Luciferase assays using the inhibin-alpha promoter indicated that the inhibin-alpha promoter is transactivated by the Wt1 A, and B isoforms (-KTS), but not the C, and D isoforms (+KTS). Analysis of the Wt1 responsive element of the inhibin-alpha promoter region using site-directed mutagenesis showed that the nucleotides between -58 and -49 are essential for Wt1-dependent transactivation of the inhibin-alpha promoter. ChIP assays indicated that Wt1 directly interacts with the inhibin-alpha promoter. In addition, the inhibin-alpha promoter is activated synergistically by Wt1 and Sf1. Mutation of the ligand binding domain (LBD) of Sf1 (residues 235-238) completely abolished the synergistic action between Wt1 and Sf1, but did not affect the physical interaction between these two proteins, suggesting that other factor(s) may also be involved in the regulation of inhibin-alpha in Sertoli cells. Further studies demonstrated that beta-catenin enhances the synergistic activation of Wt1 and Sf1 on the inhibin-alpha promoter. Given the fact that inhibin-alpha, a subunit of inhibin, is known to be involved in the regulation of spermatogenesis and testicular steroidogenesis, this study reveals a new regulatory mechanism of inhibin-alpha in Sertoli cells and also sheds light on the physiological functions of Wt1 in gonad development and spermatogenesis.	[Ji, Shao-Yang; Hao, Jian-Xiu; Li, Lei; Zhang, Jun; Zheng, Qiao-Song; Li, Xi-Xia; Wang, Xiao-Na; Han, Chun-Sheng; Gao, Fei; Liu, Yi-Xun] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Ji, Shao-Yang; Hao, Jian-Xiu; Li, Lei; Zhang, Jun; Zheng, Qiao-Song; Li, Xi-Xia; Wang, Xiao-Na] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gao, F (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	gaof@ioz.ac.cn; Liuyx@ioz.ac.cn			Major Research Plan [2011CB944300, 2013CB945001]; CAS Innovation Project [KSCX2-YW-R-081]; National Natural Science Foundation of China [31071271, 31071018, 31171373, 31171380]	Major Research Plan; CAS Innovation Project(Knowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Major Research Plan (2011CB944300 and 2013CB945001), the CAS Innovation Project (KSCX2-YW-R-081), and the National Natural Science Foundation of China (31071271, 31071018, 31171373, and 31171380). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blount MA, 2010, AM J PHYSIOL-RENAL, V298, pF857, DOI 10.1152/ajprenal.00725.2009; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Cho BN, 2001, ENDOCRINOLOGY, V142, P4994, DOI 10.1210/en.142.11.4994; Cook DM, 1996, ONCOGENE, V13, P1789; DRUMMOND IA, 1992, SCIENCE, V257, P674, DOI 10.1126/science.1323141; Englert C, 1997, CANCER RES, V57, P1429; ENGLERT C, 1995, EMBO J, V14, P4662, DOI 10.1002/j.1460-2075.1995.tb00148.x; Englert C, 1998, TRENDS BIOCHEM SCI, V23, P389, DOI 10.1016/S0968-0004(98)01277-8; FORAGE RG, 1986, P NATL ACAD SCI USA, V83, P3091, DOI 10.1073/pnas.83.10.3091; Gao F, 2006, P NATL ACAD SCI USA, V103, P11987, DOI 10.1073/pnas.0600994103; GASHLER AL, 1993, MOL CELL BIOL, V13, P4556, DOI 10.1128/MCB.13.8.4556; Gummow BM, 2003, J BIOL CHEM, V278, P26572, DOI 10.1074/jbc.M212677200; HSU SY, 1995, MOL ENDOCRINOL, V9, P1356, DOI 10.1210/me.9.10.1356; Ito M, 2000, MOL ENDOCRINOL, V14, P66, DOI 10.1210/me.14.1.66; Iversen PO, 2010, AM J PHYSIOL-REG I, V298, pR808, DOI 10.1152/ajpregu.00250.2009; KUDOH T, 1995, P NATL ACAD SCI USA, V92, P4517, DOI 10.1073/pnas.92.10.4517; LALA DS, 1992, MOL ENDOCRINOL, V6, P1249, DOI 10.1210/me.6.8.1249; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Lee SB, 1999, CELL, V98, P663, DOI 10.1016/S0092-8674(00)80053-7; LING N, 1986, NATURE, V321, P779, DOI 10.1038/321779a0; Lu CL, 2009, MOL CELL ENDOCRINOL, V298, P48, DOI 10.1016/j.mce.2008.09.039; Lue YH, 1999, ENDOCRINOLOGY, V140, P1709, DOI 10.1210/en.140.4.1709; MATHER JP, 1980, BIOL REPROD, V23, P243, DOI 10.1095/biolreprod23.1.243; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; MAYO KE, 1986, P NATL ACAD SCI USA, V83, P5849, DOI 10.1073/pnas.83.16.5849; MEUNIER H, 1988, MOL ENDOCRINOL, V2, P1352, DOI 10.1210/mend-2-12-1352; Mizusaki H, 2003, MOL ENDOCRINOL, V17, P507, DOI 10.1210/me.2002-0362; MOROHASHI K, 1992, J BIOL CHEM, V267, P17913; MORRIS JF, 1991, ONCOGENE, V6, P2339; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; NICHOLS KE, 1995, CANCER RES, V55, P4540; Parakh TN, 2006, P NATL ACAD SCI USA, V103, P12435, DOI 10.1073/pnas.0603006103; PELLETIER J, 1991, GENE DEV, V5, P1345, DOI 10.1101/gad.5.8.1345; Rao MK, 2006, GENE DEV, V20, P147, DOI 10.1101/gad1367806; Reddy JC, 1996, BBA-REV CANCER, V1287, P1, DOI 10.1016/0304-419X(95)00014-7; RIVIER C, 1986, SCIENCE, V234, P205, DOI 10.1126/science.3092356; RYAN G, 1995, DEVELOPMENT, V121, P867; WANG ZY, 1992, J BIOL CHEM, V267, P21999; WERNER H, 1993, P NATL ACAD SCI USA, V90, P5828, DOI 10.1073/pnas.90.12.5828; WOODRUFF TK, 1987, MOL ENDOCRINOL, V1, P561, DOI 10.1210/mend-1-8-561; WOODRUFF TK, 1988, SCIENCE, V239, P1296, DOI 10.1126/science.3125611	41	6	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53140	10.1371/journal.pone.0053140	http://dx.doi.org/10.1371/journal.pone.0053140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326390	gold, Green Published, Green Submitted			2022-12-25	WOS:000314705800033
J	Takiguchi, M; Dow, LE; Prier, JE; Carmichael, CL; Kile, BT; Turner, SJ; Lowe, SW; Huang, DCS; Dickins, RA				Takiguchi, Megumi; Dow, Lukas E.; Prier, Julia E.; Carmichael, Catherine L.; Kile, Benjamin T.; Turner, Stephen J.; Lowe, Scott W.; Huang, David C. S.; Dickins, Ross A.			Variability of Inducible Expression across the Hematopoietic System of Tetracycline Transactivator Transgenic Mice	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; RNA INTERFERENCE; IN-VIVO; PROMOTER; GENOME; ENHANCER; VECTOR; TUMORIGENESIS; ELEMENT	The tetracycline (tet)-regulated expression system allows for the inducible overexpression of protein-coding genes, or inducible gene knockdown based on expression of short hairpin RNAs (shRNAs). The system is widely used in mice, however it requires robust expression of a tet transactivator protein (tTA or rtTA) in the cell type of interest. Here we used an in vivo tet-regulated fluorescent reporter approach to characterise inducible gene/shRNA expression across a range of hematopoietic cell types of several commonly used transgenic tet transactivator mouse strains. We find that even in strains where the tet transactivator is expressed from a nominally ubiquitous promoter, the efficiency of tet-regulated expression can be highly variable between hematopoietic lineages and between differentiation stages within a lineage. In some cases tet-regulated reporter expression differs markedly between cells within a discrete, immunophenotypically defined population, suggesting mosaic transactivator expression. A recently developed CAG-rtTA3 transgenic mouse displays intense and efficient reporter expression in most blood cell types, establishing this strain as a highly effective tool for probing hematopoietic development and disease. These findings have important implications for interpreting tet-regulated hematopoietic phenotypes in mice, and identify mouse strains that provide optimal tet-regulated expression in particular hematopoietic progenitor cell types and mature blood lineages.	[Takiguchi, Megumi; Dickins, Ross A.] Walter & Eliza Hall Inst Med Res, Div Mol Med, Parkville, Vic, Australia; [Takiguchi, Megumi; Huang, David C. S.] Walter & Eliza Hall Inst Med Res, Chem Biol Div, Parkville, Vic, Australia; [Carmichael, Catherine L.; Kile, Benjamin T.] Walter & Eliza Hall Inst Med Res, Canc & Haematol Div, Parkville, Vic, Australia; [Takiguchi, Megumi; Carmichael, Catherine L.; Kile, Benjamin T.; Huang, David C. S.; Dickins, Ross A.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Prier, Julia E.; Turner, Stephen J.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Dow, Lukas E.; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Lowe, Scott W.] Howard Hughes Med Inst, New York, NY USA	Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Dickins, RA (corresponding author), Walter & Eliza Hall Inst Med Res, Div Mol Med, Parkville, Vic, Australia.	rdickins@wehi.edu.au	Turner, Stephen/GXM-4654-2022; Kile, Benjamin/GNP-3246-2022; Dickins, Ross A/K-2852-2012; Huang, David C. S./C-7586-2013; Kile, Benjamin T/F-6593-2011	Kile, Benjamin/0000-0002-8836-8947; Dickins, Ross A/0000-0003-4112-5304; Huang, David C. S./0000-0002-3101-4873; Kile, Benjamin T/0000-0002-8836-8947; Turner, Stephen/0000-0002-1002-0000; Prier, Julia/0000-0002-2653-6300; Carmichael, Catherine/0000-0002-6751-153X; Dow, Lukas/0000-0001-7048-1418	National Health and Medical Research Council of Australia [575535, 1024599, 509693]; Australian Government National Health and Medical Research Council; Sylvia and Charles Viertel Charitable Foundation; Victorian State Government OIS; Australian Research Council; Victorian Endowment for Science, Knowledge and Innovation (VESKI); NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Government National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Charitable Foundation; Victorian State Government OIS; Australian Research Council(Australian Research Council); Victorian Endowment for Science, Knowledge and Innovation (VESKI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Health and Medical Research Council of Australia (Project grants 575535 and 1024599 and Fellowship 509693 to RAD), Australian Government National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme, the Sylvia and Charles Viertel Charitable Foundation (Fellowships to BTK and RAD), Victorian State Government OIS grants, Australian Research Council Future Fellowship (awarded to SJT) and the Victorian Endowment for Science, Knowledge and Innovation (VESKI Fellowship to RAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; An DS, 2000, J VIROL, V74, P1286, DOI 10.1128/JVI.74.3.1286-1295.2000; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Das AT, 2004, J BIOL CHEM, V279, P18776, DOI 10.1074/jbc.M313895200; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Dupuy FP, 2005, J GENE MED, V7, P1158, DOI 10.1002/jgm.769; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; FOECKING MK, 1986, GENE, V45, P101, DOI 10.1016/0378-1119(86)90137-X; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4; Glaser S, 2005, NAT GENET, V37, P1187, DOI 10.1038/ng1668; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Heaney JD, 2006, MAMM GENOME, V17, P791, DOI 10.1007/s00335-006-0023-9; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Kim WI, 2007, EXP HEMATOL, V35, P1231, DOI 10.1016/j.exphem.2007.04.012; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ogilvy S, 1999, BLOOD, V94, P1855; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Rawlings JS, 2011, EMBO J, V30, P263, DOI 10.1038/emboj.2010.314; SCHMIDT EV, 1990, MOL CELL BIOL, V10, P4406, DOI 10.1128/MCB.10.8.4406; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takiguchi M, 2010, J THROMB HAEMOST, V8, P2751, DOI 10.1111/j.1538-7836.2010.04077.x; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	34	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54009	10.1371/journal.pone.0054009	http://dx.doi.org/10.1371/journal.pone.0054009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326559	Green Published, gold			2022-12-25	WOS:000314705800098
J	Tombari, W; Paul, M; Bettaieb, J; Larbi, I; Nsiri, J; Elbehi, I; Gribaa, L; Ghram, A				Tombari, Wafa; Paul, Mathilde; Bettaieb, Jihene; Larbi, Imen; Nsiri, Jihene; Elbehi, Imen; Gribaa, Latifa; Ghram, Abdeljelil			Risk Factors and Characteristics of Low Pathogenic Avian Influenza Virus Isolated from Commercial Poultry in Tunisia	PLOS ONE			English	Article							COMPETITIVE ELISA; A VIRUSES; HUMAN INFECTION; H9 SUBTYPE; PCR ASSAY; HONG-KONG; SURVEILLANCE; NUCLEOPROTEIN; ANTIBODIES; FLOCKS	Objective: Estimate the seroprevalence of influenza A virus in various commercial poultry farms and evaluate specific risk factors as well as analyze their genetic nature using molecular assays. Materials and Methods: This report summarizes the findings of a national survey realized from October 2010 to May 2011 on 800 flocks in 20 governorates. Serum samples were screened for the presence of specific influenza virus antibodies using cELISA test. Additionally, swab samples were tested by real time and conventional RT-PCR and compared with results obtained by others assays. Phylogenetic and genetic analyses of the glycoproteins were established for some strains. Results: Out of the 800 chicken and turkey flocks tested by cELISA, 223 showed positive anti-NP antibodies (28.7%, 95% CI: 25.6-32.1). Significantly higher seroprevalence was found among the coastal areas compared to inland and during the autumn and winter. Broiler flocks showed significantly lower seroprevalence than layers and broiler breeders. The influenza virus infection prevalence increased after the laying phase among layer flocks. In addition, AIV seropositivity was significantly associated with low biosecurity measures. The Ag EIA and rRT-PCR tests revealed significantly higher numbers of AI positive samples as compared to cell cultures or egg inoculation. All new strains were subtyped as H9N2 by real time and conventional RT-PCR. Drift mutations, addition or deletion of glycosylation sites were likely to have occurred in the HA and NA glycoproteins of Tunisian strains resulting in multiple new amino acid substitutions. This fact may reflect different evolutionary pressures affecting these glycoproteins. The role of these newly detected substitutions should be tested. Conclusion: Our findings highlight the potential risk of AIV to avian health. Strict enforcement of biosecurity measures and possible vaccination of all poultry flocks with continuous monitoring of poultry stations may ensure reduction of AIV prevalence and avoid emergence of more pathogenic strains.	[Tombari, Wafa; Larbi, Imen; Nsiri, Jihene; Elbehi, Imen; Gribaa, Latifa; Ghram, Abdeljelil] Univ Tunis El Manar, Inst Pasteur Tunis, Vet Microbiol Lab, Tunis, Tunisia; [Paul, Mathilde] INRA, UMR IHAP 1225, F-31931 Toulouse, France; [Paul, Mathilde] Univ Toulouse INP, Ecole Natl Vet Toulouse, Toulouse, France; [Bettaieb, Jihene] Pasteur Inst Tunis, Med Epidemiol Unit, Tunis, Tunisia	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis	Ghram, A (corresponding author), Univ Tunis El Manar, Inst Pasteur Tunis, Vet Microbiol Lab, Tunis, Tunisia.	abdeljelil.ghram@pasteur.rns.tn		PAUL, Mathilde C./0000-0003-2940-8547	Tunisian Ministry of Research and Technology;  [MEV09]	Tunisian Ministry of Research and Technology; 	This work has been developed under the MEV09 project and the research platform Vet Microbiol and benefited from funds from the Tunisian Ministry of Research and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir UB, 2007, VIROLOGY, V361, P45, DOI 10.1016/j.virol.2006.10.037; Afifi MAA, 2013, TROP ANIM HEALTH PRO, V45, P687, DOI 10.1007/s11250-012-0243-9; Al-Natour MQ, 2005, PREV VET MED, V70, P45, DOI 10.1016/j.prevetmed.2005.02.009; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Alexander DJ, 2000, REV SCI TECH OIE, V19, P197, DOI 10.20506/rst.19.1.1220; Cameron KR, 2000, VIROLOGY, V278, P36, DOI 10.1006/viro.2000.0585; Capua I, 2004, AVIAN PATHOL, V33, P393, DOI 10.1080/03079450410001724085; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Couacy-Hymann E, 2012, EMERG INFECT DIS, V18, P1446, DOI 10.3201/eid1809.111296; FAO, 2008, TUN REV SECT AV; Feare CJ, 2010, AVIAN DIS, V54, P201, DOI 10.1637/8766-033109-ResNote.1; Gilbert M, 2012, SPAT SPATIO-TEMPORAL, V3, P173, DOI 10.1016/j.sste.2012.01.002; Goffard A, 2008, PATHOL BIOL, V56, P482, DOI 10.1016/j.patbio.2008.07.030; HOMME P J, 1970, Avian Diseases, V14, P66, DOI 10.2307/1588557; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Ji K, 2010, J VIROL METHODS, V163, P186, DOI 10.1016/j.jviromet.2009.09.013; Kwon HJ, 2006, AVIAN PATHOL, V35, P309, DOI 10.1080/03079450600821166; Lee CW, 2008, J VIROL METHODS, V153, P22, DOI 10.1016/j.jviromet.2008.06.019; Li KS, 2003, J VIROL, V77, P6988, DOI 10.1128/JVI.77.12.6988-6994.2003; Molia S, AVIAN DIS, V55, P650; Monne I, 2008, J CLIN MICROBIOL, V46, P1769, DOI 10.1128/JCM.02204-07; Naeem K, 2003, AVIAN PATHOL, V32, P285, DOI [10.1080/1030794503100009788, 10.1080/0307945031000097886]; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Roussan DA, 2009, PREV VET MED, V88, P77, DOI 10.1016/j.prevetmed.2008.06.021; Sergeant ESG, 2012, EPITOOLS EPIDEMIOLOG; Shortridge K F, 1992, Semin Respir Infect, V7, P11; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; Soliman A, 2012, J WILDLIFE DIS, V48, P669, DOI 10.7589/0090-3558-48.3.669; Song DS, 2009, J VET SCI, V10, P323, DOI 10.4142/jvs.2009.10.4.323; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Starick E, 2006, J VET MED B, V53, P370, DOI 10.1111/j.1439-0450.2006.01007.x; Swayne D. E, 2003, AVIAN INFLUENZA DIS, P135; Toennessen R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-21; Tombari W, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-467; Velarde R, 2010, AVIAN DIS, V54, P411, DOI 10.1637/8808-040109-Reg.1; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO Global Influenza Surveillance Network, 2011, MAN LAB DIAGN VIR SU; Zhou EM, 1998, AVIAN DIS, V42, P517, DOI 10.2307/1592678	38	28	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53524	10.1371/journal.pone.0053524	http://dx.doi.org/10.1371/journal.pone.0053524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326449	Green Published, gold			2022-12-25	WOS:000314705800052
J	Castegren, M; Skorup, P; Lipcsey, M; Larsson, A; Sjolin, J				Castegren, Markus; Skorup, Paul; Lipcsey, Miklos; Larsson, Anders; Sjolin, Jan			Endotoxin Tolerance Variation over 24 h during Porcine Endotoxemia: Association with Changes in Circulation and Organ Dysfunction	PLOS ONE			English	Article							SHWARTZMAN REACTION; CLINICAL-RELEVANCE; ANESTHETIZED PIG; INJURY; INTERLEUKIN-10; RESPONSES; SHOCK; LIPOPOLYSACCHARIDE; PRETREATMENT; ISCHEMIA	Endotoxin tolerance (ET), defined as reduced inflammatory responsiveness to endotoxin challenge following a first encounter with endotoxin, is an extensively studied phenomenon. Although reduced mortality and morbidity in the presence of ET has been demonstrated in animal studies, little is known about the temporal development of ET. Further, in acute respiratory distress syndrome ET correlates to the severity of the disease, suggesting a complicated relation between ET and organ dysfunction. Eighteen pigs were subjected to intensive care and a continuous endotoxin infusion for 24 h with the aim to study the time course of early ET and to relate ET to outcome in organ dysfunction. Three animals served as non-endotoxemic controls. Blood samples for cytokine analyses were taken and physiological variables registered every third hour. Production of TNF-alpha, IL-6, and IL-10 before and after endotoxin stimulation ex vivo was measured. The difference between cytokine values after and before ex vivo LPS stimulation (Delta-values) was calculated for all time points. Delta TNF-alpha was employed as the principal marker of ET and lower Delta TNF-alpha values were interpreted as higher levels of ET. During endotoxin infusion, there was suppression of ex vivo productions of TNF-alpha and IL-6 but not of IL-10 in comparison with that at 0 h. The ex vivo TNF-alpha values followed another time concentration curve than those in vivo. Delta TNF-alpha was at the lowest already at 6 h, followed by an increase during the ensuing hours. Delta TNF-alpha at 6 h correlated positively to blood pressure and systemic vascular resistance and negatively to cardiac index at 24 h. In this study a temporal variation of ET was demonstrated that did not follow changes in plasma TNF-alpha concentrations. Maximal ET occurred early in the course and the higher the ET, the more hyperdynamic the circulation 18 h later.	[Castegren, Markus] Uppsala Univ, Ctr Clin Res Sormland, Uppsala, Sweden; [Castegren, Markus; Skorup, Paul; Sjolin, Jan] Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden; [Lipcsey, Miklos] Uppsala Univ, Dept Surg Sci, Sect Anesthesiol & Intens Care, Uppsala, Sweden; [Larsson, Anders] Uppsala Univ, Dept Med Sci, Sect Clin Chem, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University	Castegren, M (corresponding author), Uppsala Univ, Ctr Clin Res Sormland, Uppsala, Sweden.	markus.castegren@dll.se	Castegren, Markus/AAF-2620-2019; Lipcsey, Miklos/K-4308-2012	Lipcsey, Miklos/0000-0002-1976-4129; skorup, paul/0000-0002-5407-6612; Castegren, Markus/0000-0002-9292-0298	Sormland County Council; Uppsala University Hospital; Olinder-Nielsen Family fund	Sormland County Council; Uppsala University Hospital; Olinder-Nielsen Family fund	The R&D funds of the Sormland County Council and Uppsala University Hospital as well as the Olinder-Nielsen Family fund contributed with financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2001, J ENDOTOXIN RES, V7, P105, DOI 10.1177/09680519010070020401; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Allen ML, 2006, CRIT CARE MED, V34, P2658, DOI 10.1097/01.CCM.0000240243.28129.36; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; BROWN JM, 1989, P NATL ACAD SCI USA, V86, P2516, DOI 10.1073/pnas.86.7.2516; BROZNA JP, 1990, SEMIN THROMB HEMOST, V16, P326, DOI 10.1055/s-2007-1002685; Buttenschoen K, 2008, LANGENBECK ARCH SURG, V393, P473, DOI 10.1007/s00423-008-0317-3; Carlsson M, 2009, CRIT CARE MED, V37, P1031, DOI 10.1097/CCM.0b013e31819b5683; Castegren M, 2012, SHOCK, V37, P501, DOI 10.1097/SHK.0b013e318249bb0d; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Cavaillon JM, 2003, J ENDOTOXIN RES, V9, P101, DOI 10.1179/096805103125001487; Chang Y, 2005, TOXICOL APPL PHARM, V204, P27, DOI 10.1016/j.taap.2004.08.011; Dias MB, 2005, J APPL PHYSIOL, V98, P1322, DOI 10.1152/japplphysiol.01243.2004; Draisma A, 2009, CRIT CARE MED, V37, P1261, DOI 10.1097/CCM.0b013e31819c3c67; Friedrich I, 2003, AM J PHYSIOL-LUNG C, V284, pL224, DOI 10.1152/ajplung.00138.2002; Fu Y, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002526; Fujii E, 2000, BRIT J PHARMACOL, V130, P90, DOI 10.1038/sj.bjp.0703277; Gao J, 2010, INFLAMM RES, V59, P491, DOI 10.1007/s00011-009-0110-y; Godet C, 2006, SHOCK, V25, P384, DOI 10.1097/01.shk.0000209528.35743.54; Greisman S E, 1975, Trans Am Clin Climatol Assoc, V86, P43; HE W, 1992, J INFECT DIS, V165, P859, DOI 10.1093/infdis/165.5.859; Heemann U, 2000, AM J PATHOL, V156, P287, DOI 10.1016/S0002-9440(10)64729-3; Hollenberg SM, 2009, CRIT CARE, V13, DOI 10.1186/cc7706; KOFF WC, 1986, LYMPHOKINE RES, V5, P239; Lipcsey M, 2006, J ENDOTOXIN RES, V12, P99, DOI 10.1179/096805106X89053; Lipcsey M, 2008, SHOCK, V29, P173, DOI 10.1097/SHK.0b013e318067dfbc; LOVETT EJ, 1980, J SURG ONCOL, V15, P327, DOI 10.1002/jso.2930150405; Madera-Salcedo IK, 2011, J NEUROIMMUNOL, V232, P101, DOI 10.1016/j.jneuroim.2010.10.017; Poli-De-Figueiredo LF, 2008, SHOCK, V30, P53, DOI 10.1097/SHK.0b013e318181a343; Protti A, 2006, CRIT CARE, V10, DOI 10.1186/cc5014; RANDOW F, 1995, J EXP MED, V181, P1887, DOI 10.1084/jem.181.5.1887; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Riviere J.E., 2018, VET PHARM THERAPEUTI; Rocksen D, 2004, SHOCK, V22, P482, DOI 10.1097/01.shk.0000142183.42353.58; Schmidhammer R, 2006, SHOCK, V25, P389, DOI 10.1097/01.shk.0000209529.43367.00; Wang WM, 2011, INFLAMMATION, V34, P509, DOI 10.1007/s10753-010-9258-4; WATSON DW, 1963, J EXP MED, V118, P425, DOI 10.1084/jem.118.3.425; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009; West MA, 2008, J TRAUMA, V65, P893, DOI 10.1097/TA.0b013e3181877fde	40	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53221	10.1371/journal.pone.0053221	http://dx.doi.org/10.1371/journal.pone.0053221			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326400	gold, Green Submitted, Green Published			2022-12-25	WOS:000313552400016
J	Lo Sardo, A; Altamura, S; Pegoraro, S; Maurizio, E; Sgarra, R; Manfioletti, G				Lo Sardo, Alessandra; Altamura, Sandro; Pegoraro, Silvia; Maurizio, Elisa; Sgarra, Riccardo; Manfioletti, Guidalberto			Identification and Characterization of New Molecular Partners for the Protein Arginine Methyltransferase 6 (PRMT6)	PLOS ONE			English	Article							INHIBITORY FACTOR MIF; SUBSTRATE-SPECIFICITY; SUBCELLULAR-LOCALIZATION; N-METHYLTRANSFERASE; CRYSTAL-STRUCTURE; GENE-EXPRESSION; P53 ACTIVITY; METHYLATION; BINDING; OLIGOMERIZATION	PRMT6 is a protein arginine methyltransferase that has been implicated in transcriptional regulation, DNA repair, and human immunodeficiency virus pathogenesis. Only few substrates of this enzyme are known and therefore its cellular role is not well understood. To identify in an unbiased manner substrates and potential regulators of PRMT6 we have used a yeast two-hybrid approach. We identified 36 new putative partners for PRMT6 and we validated the interaction in vivo for 7 of them. In addition, using in vitro methylation assay we identified 4 new substrates for PRMT6, extending the involvement of this enzyme to other cellular processes beyond its well-established role in gene expression regulation. Holistic approaches create molecular connections that allow to test functional hypotheses. The assembly of PRMT6 protein network allowed us to formulate functional hypotheses which led to the discovery of new molecular partners for the architectural transcription factor HMGA1a, a known substrate for PRMT6, and to provide evidences for a modulatory role of HMGA1a on the methyltransferase activity of PRMT6.	[Lo Sardo, Alessandra; Altamura, Sandro; Pegoraro, Silvia; Maurizio, Elisa; Sgarra, Riccardo; Manfioletti, Guidalberto] Univ Trieste, Dept Life Sci, Trieste, Italy	University of Trieste	Manfioletti, G (corresponding author), Univ Trieste, Dept Life Sci, Trieste, Italy.	manfiole@units.it	Altamura, Sandro/R-1195-2016; Pegoraro, Silvia/G-9217-2018	Pegoraro, Silvia/0000-0002-1819-7417; MANFIOLETTI, GUIDALBERTO/0000-0001-7913-2601; Altamura, Sandro/0000-0002-6781-1073; Sgarra, Riccardo/0000-0002-4496-2856	AIRC (Associazione Italiana per la Ricerca sul Cancro); Universita degli Studi di Trieste; project "Rete Nazionale Proteomica'' [FIRB 2008-RBRN07BMCT]; FIRC (Fondazione Italiana per la Ricerca sul Cancro)	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Universita degli Studi di Trieste; project "Rete Nazionale Proteomica''; FIRC (Fondazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by AIRC (Associazione Italiana per la Ricerca sul Cancro), Universita degli Studi di Trieste, and project "Rete Nazionale Proteomica'' FIRB 2008-RBRN07BMCT to G.M. E.M. is supported by a FIRC (Fondazione Italiana per la Ricerca sul Cancro) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Boulanger MC, 2005, J VIROL, V79, P124, DOI 10.1128/JVI.79.1.124-131.2005; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; El-Andaloussi N, 2006, MOL CELL, V22, P51, DOI 10.1016/j.molcel.2006.02.013; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Frasca F, 2006, CANCER RES, V66, P2980, DOI 10.1158/0008-5472.CAN-05-2637; Goulet I, 2007, J BIOL CHEM, V282, P33009, DOI 10.1074/jbc.M704349200; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Harrison MJ, 2010, NUCLEIC ACIDS RES, V38, P2201, DOI 10.1093/nar/gkp1203; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Iberg AN, 2008, J BIOL CHEM, V283, P3006, DOI 10.1074/jbc.C700192200; Invernizzi CF, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-93; Iwasaki H, 2008, BIOCHEM BIOPH RES CO, V372, P314, DOI 10.1016/j.bbrc.2008.05.051; Jung H, 2008, J BIOL CHEM, V283, P32669, DOI 10.1074/jbc.M806225200; Jung HY, 2008, J BIOL CHEM, V283, P20383, DOI 10.1074/jbc.M800050200; Kleinschmidt MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041446; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Lee DY, 2007, MOL ENDOCRINOL, V21, P1381, DOI 10.1210/me.2006-0389; Malini E, 2011, BIOCHEMISTRY-US, V50, P3462, DOI 10.1021/bi200101f; Michaud-Levesque J, 2009, J BIOL CHEM, V284, P21338, DOI 10.1074/jbc.M109.005322; Miranda TB, 2005, BIOCHEM BIOPH RES CO, V336, P831, DOI 10.1016/j.bbrc.2005.08.179; Neault M, 2012, NUCL ACIDS RES; Obianyo O, 2012, J BIOL CHEM, V287, P6062, DOI 10.1074/jbc.M111.333609; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Passos DO, 2006, BIOCHEM BIOPH RES CO, V346, P517, DOI 10.1016/j.bbrc.2006.05.152; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Sgarra R, 2006, J BIOL CHEM, V281, P3764, DOI 10.1074/jbc.M510231200; Sgarra R, 2005, PROTEOMICS, V5, P1494, DOI 10.1002/pmic.200401028; Sgarra R, 2010, BBA-GENE REGUL MECH, V1799, P37, DOI 10.1016/j.bbagrm.2009.08.009; Sivakumaran H, 2009, J VIROL, V83, P11694, DOI 10.1128/JVI.00499-09; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Vallance P, 2001, LANCET, V358, P2096, DOI 10.1016/S0140-6736(01)07229-4; Waldmann T, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-11; Xie B, 2007, J VIROL, V81, P4226, DOI 10.1128/JVI.01888-06; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509; Zhang XT, 2005, MOL CELL, V19, P89, DOI 10.1016/j.molcel.2005.05.015	42	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53750	10.1371/journal.pone.0053750	http://dx.doi.org/10.1371/journal.pone.0053750			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326497	gold, Green Published, Green Submitted			2022-12-25	WOS:000313552400040
J	Maguire, CT; Demarest, BL; Hill, JT; Palmer, JD; Brothman, AR; Yost, HJ; Condic, ML				Maguire, Colin T.; Demarest, Bradley L.; Hill, Jonathon T.; Palmer, James D.; Brothman, Arthur R.; Yost, H. Joseph; Condic, Maureen L.			Genome-Wide Analysis Reveals the Unique Stem Cell Identity of Human Amniocytes	PLOS ONE			English	Article							HUMAN AMNIOTIC-FLUID; DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; HETEROGENEITY; PLURIPOTENCY; ORIGIN; EFFICIENCY; ENDODERM; CAPACITY; NANOG	Human amniotic fluid contains cells that potentially have important stem cell characteristics, yet the programs controlling their developmental potency are unclear. Here, we provide evidence that amniocytes derived from multiple patients are marked by heterogeneity and variability in expression levels of pluripotency markers. Clonal analysis from multiple patients indicates that amniocytes have large pools of self-renewing cells that have an inherent property to give rise to a distinct amniocyte phenotype with a heterogeneity of pluripotent markers. Significant to their therapeutic potential, genome-wide profiles are distinct at different gestational ages and times in culture, but do not differ between genders. Based on hierarchical clustering and differential expression analyses of the entire transcriptome, amniocytes express canonical regulators associated with pluripotency and stem cell repression. Their profiles are distinct from human embryonic stem cells (ESCs), induced-pluripotent stem cells (iPSCs), and newborn foreskin fibroblasts. Amniocytes have a complex molecular signature, coexpressing trophoblastic, ectodermal, mesodermal, and endodermal cell-type-specific regulators. In contrast to the current view of the ground state of stem cells, ESCs and iPSCs also express high levels of a wide range of cell-typespecific regulators. The coexpression of multilineage differentiation markers combined with the strong expression of a subset of ES cell repressors in amniocytes suggests that these cells have a distinct phenotype that is unlike any other known cell-type or lineage.	[Maguire, Colin T.; Demarest, Bradley L.; Hill, Jonathon T.; Palmer, James D.; Yost, H. Joseph; Condic, Maureen L.] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA; [Brothman, Arthur R.] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Brothman, Arthur R.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA; [Brothman, Arthur R.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA; [Maguire, Colin T.; Demarest, Bradley L.; Hill, Jonathon T.; Palmer, James D.; Yost, H. Joseph] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT USA; [Brothman, Arthur R.] Univ Utah, Sch Med, ARUP Labs, ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories	Maguire, CT (corresponding author), Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA.	cmaguire@genetics.utah.edu		Hill, Jonathon/0000-0003-1190-6302	National Institutes of Health [T32HL007576]; National Institute of Neurological Disorders and Stroke [5R01NS048382]; National Heart, Lung, and Blood Institute Bench-to-Bassinet Consortium [5U01HL098160]; Bench-to-Bassinet core facilities support grant [U01HL098188]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098188, T32HL007576, U01HL098160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute Bench-to-Bassinet Consortium; Bench-to-Bassinet core facilities support grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by postdoctoral training fellowship T32HL007576 (National Institutes of Health) to CTM, 5R01NS048382 (National Institute of Neurological Disorders and Stroke) to MLC, 5U01HL098160 (National Heart, Lung, and Blood Institute Bench-to-Bassinet Consortium: URL http://www.benchtobassinet.com) to HJY and U01HL098188 (a Bench-to-Bassinet core facilities support grant) to New England Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Anchan RM, 2011, HUM MOL GENET, V20, P962, DOI 10.1093/hmg/ddq542; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Antonucci I, 2012, CURR PHARM DESIGN, V18, P1846, DOI 10.2174/138161212799859602; AULA P, 1980, BRIT MED J, V281, P1456, DOI 10.1136/bmj.281.6253.1456; Bilic J, 2012, STEM CELLS, V30, P33, DOI 10.1002/stem.700; Bossolasco P, 2006, CELL RES, V16, P329, DOI 10.1038/sj.cr.7310043; Bottai D, 2012, RESTOR NEUROL NEUROS, V30, P55, DOI 10.3233/RNN-2011-0620; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; CHEN WW, 1982, J MED GENET, V19, P433, DOI 10.1136/jmg.19.6.433; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; De Santis M, 2011, Minerva Ginecol, V63, P387; Decembrini S, 2011, STEM CELLS DEV, V20, P851, DOI 10.1089/scd.2010.0291; Ditadi A, 2009, BLOOD, V113, P3953, DOI 10.1182/blood-2008-10-182105; Dobreva MP, 2010, INT J DEV BIOL, V54, P761, DOI 10.1387/ijdb.092935md; Easley CA, 2012, CELL REPROGRAM, V14, P193, DOI 10.1089/cell.2011.0106; Eckmann-Scholz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039014; Fauza D, 2004, BEST PRACT RES CL OB, V18, P877, DOI 10.1016/j.bpobgyn.2004.07.001; Frankenberg S, 2011, DEV CELL, V21, P1005, DOI 10.1016/j.devcel.2011.10.019; Galende E, 2010, CELL REPROGRAM, V12, P117, DOI 10.1089/cell.2009.0077; Ge X, 2012, STEM CELLS DEV, V21, P2798, DOI 10.1089/scd.2011.0435; Ginsberg M, 2012, CELL, V151, P559, DOI 10.1016/j.cell.2012.09.032; GOOI HC, 1981, NATURE, V292, P156, DOI 10.1038/292156a0; GOSDEN CM, 1983, BRIT MED BULL, V39, P348, DOI 10.1093/oxfordjournals.bmb.a071847; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Grisafi D, 2008, STEM CELLS DEV, V17, P953, DOI 10.1089/scd.2007.0188; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; HEIKINHEIMO M, 1980, J CLIN ENDOCR METAB, V51, P1432, DOI 10.1210/jcem-51-6-1432; HOEHN H, 1982, METHOD CELL BIOL, V26, P11; Jezierski A, 2010, STEM CELL REV REP, V6, P199, DOI 10.1007/s12015-010-9116-7; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kolambkar YM, 2007, J MOL HISTOL, V38, P405, DOI 10.1007/s10735-007-9118-1; Kunisaki SM, 2012, ORGANOGENESIS, V1, P8; Li CL, 2009, HUM MOL GENET, V18, P4340, DOI 10.1093/hmg/ddp386; Liu T, 2012, STEM CELLS DEV, V21, P2322, DOI 10.1089/scd.2011.0715; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Mimeault M, 2007, CLIN PHARMACOL THER, V82, P252, DOI 10.1038/sj.clpt.6100301; Moschidou D, 2012, MOL THER, V20, P1953, DOI 10.1038/mt.2012.117; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Parolini O, 2009, REGEN MED, V4, P275, DOI 10.2217/17460751.4.2.275; Perin L, 2007, CELL PROLIFERAT, V40, P936, DOI 10.1111/j.1365-2184.2007.00478.x; Perin L, 2008, PEDIATR RES, V63, P467, DOI 10.1203/PDR.0b013e3181660653; Phanstiel DH, 2011, NAT METHODS, V8, P821, DOI [10.1038/NMETH.1699, 10.1038/nmeth.1699]; PLOUZEK CA, 1993, PLACENTA, V14, P277, DOI 10.1016/S0143-4004(05)80427-8; Pozzobon M, 2010, PEDIATR SURG INT, V26, P3, DOI 10.1007/s00383-009-2478-8; Prusa AR, 2004, AM J OBSTET GYNECOL, V191, P309, DOI 10.1016/j.ajog.2003.12.014; Prusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramirez JM, 2011, STEM CELLS, V29, P1469, DOI 10.1002/stem.681; Roubelakis MG, 2007, STEM CELLS DEV, V16, P931, DOI 10.1089/scd.2007.0036; Shaw SWS, 2011, CURR OPIN OBSTET GYN, V23, P109, DOI 10.1097/GCO.0b013e32834457b1; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Sun CH, 2009, MOL CELL BIOL, V29, P4574, DOI 10.1128/MCB.01863-08; Suzuki R, 2012, PVCLUST HIERARCHICAL; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Tsai MS, 2006, BIOL REPROD, V74, P545, DOI 10.1095/biolreprod.105.046029; Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290; VONKOSKULL H, 1981, PRENATAL DIAG, V1, P259, DOI 10.1002/pd.1970010405; Walther G, 2009, CATHETER CARDIO INTE, V73, P917, DOI 10.1002/ccd.22016; Warburton David, 2008, Proc Am Thorac Soc, V5, P703, DOI 10.1513/pats.200801-012AW; Williams SA, 2009, GLYCOCONJUGATE J, V26, P335, DOI 10.1007/s10719-008-9181-1; Wolfrum K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013703; Woodbury D, 2006, MOL REPROD DEV, V73, P1463, DOI 10.1002/mrd.20587; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	72	40	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53372	10.1371/journal.pone.0053372	http://dx.doi.org/10.1371/journal.pone.0053372			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326421	Green Submitted, Green Published, gold			2022-12-25	WOS:000313552400021
J	Wafa, K; MacLean, J; Zhang, FX; Pasumarthi, KBS				Wafa, Karim; MacLean, Jessica; Zhang, Feixiong; Pasumarthi, Kishore B. S.			Characterization of Growth Suppressive Functions of a Splice Variant of Cyclin D2	PLOS ONE			English	Article							CELL-CYCLE; KINASE-ACTIVITY; SUBCELLULAR-LOCALIZATION; PROTEIN AGGREGATION; HEMATOPOIETIC-CELLS; HUMAN FIBROBLASTS; I-TASSER; HA-RAS; D1; AUTOPHAGY	We have recently cloned a novel splice variant of cyclin D2 termed as cycD2SV. CycD2SV overexpression in several immortalized cell lines led to formation of ubiquitinated protein aggregates accompanied by a significant decrease in cell proliferation. Based on immuno co-localization and ultrastructural analysis experiments, cycD2SV protein aggregates were frequently found in various subcellular compartments such as endosomes, autophagosomes, lysosomes and the microtubule organizing centre. Secondary structure analysis revealed that the amino terminal alpha-helix in cycD2SV is not tightly packed with the cyclin box suggesting a misfolded conformation compared to other cyclins. Deletion analysis suggests that 1-53 amino acid region of cycD2SV may be required for protein aggregation and 54-136 amino acid region may mediate cell cycle inhibition. Based on co-immunoprecipitation experiments, we have shown that cycD2SV binds to cycD2 as well as CDK4. In addition, gene expression analysis demonstrated an upregulation in GADD45 alpha and dynamin 2 mRNA levels in cycD2SV overexpressing cells. These two proteins are known to play critical roles in the DNA damage response and apoptosis pathways. TUNEL experiments were negative for apoptosis, however, cycD2SV expressing cells were more sensitive to cell death induced by external stressors such as trypsinization. Collectively our results suggest that cycD2SV mediates cell cycle inhibition by sequestering endogenous cell cycle proteins, such as cycD2 and CDK4, and possibly targeting them for ubiquitin mediated protein degradation.	[Wafa, Karim; MacLean, Jessica; Zhang, Feixiong; Pasumarthi, Kishore B. S.] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4H7, Canada	Dalhousie University	Pasumarthi, KBS (corresponding author), Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4H7, Canada.	kpasumar@dal.ca		Pasumarthi, Kishore/0000-0001-9317-076X	Heart and Stroke Foundation of Nova Scotia; Canada Foundation for Innovation	Heart and Stroke Foundation of Nova Scotia; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was supported by grants from the Heart and Stroke Foundation of Nova Scotia and Canada Foundation for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao JP, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-7; ATADJA P, 1995, EXP CELL RES, V217, P205, DOI 10.1006/excr.1995.1080; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; BROWN NR, 1995, STRUCTURE, V3, P1235, DOI 10.1016/S0969-2126(01)00259-3; Ciemerych MA, 2005, ONCOGENE, V24, P2877, DOI 10.1038/sj.onc.1208608; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Denicourt C, 2008, ONCOGENE, V27, P1253, DOI 10.1038/sj.onc.1210750; Denicourt C, 2003, J VIROL, V77, P37, DOI 10.1128/JVI.77.1.37-44.2003; Diehl JA, 1997, MOL CELL BIOL, V17, P7362, DOI 10.1128/MCB.17.12.7362; EVANS DL, 1990, DEV COMP IMMUNOL, V14, P223, DOI 10.1016/0145-305X(90)90093-T; Fish KN, 2000, J CELL BIOL, V150, P145, DOI 10.1083/jcb.150.1.145; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Garkavtsev I, 1998, EXP GERONTOL, V33, P81, DOI 10.1016/S0531-5565(97)00086-7; Han EKH, 1999, APOPTOSIS, V4, P213, DOI 10.1023/A:1009618824145; Hollander MC, 2002, ONCOGENE, V21, P6228, DOI 10.1038/sj.onc.1205774; Huang HL, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-36; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Kajitani K, 2010, NEUROSCI LETT, V477, P100, DOI 10.1016/j.neulet.2010.04.042; Kida A, 2007, ONCOGENE, V26, P6630, DOI 10.1038/sj.onc.1210490; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klionsky DJ, 2010, DEV CELL, V19, P11, DOI 10.1016/j.devcel.2010.07.005; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Liebermann DA, 2007, BLOOD CELL MOL DIS, V39, P329, DOI 10.1016/j.bcmd.2007.06.006; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATSUOKA S, 1994, J BIOL CHEM, V269, P11030; McMullen NM, 2009, DEV DYNAM, V238, P2787, DOI 10.1002/dvdy.22112; Meyyappan M, 1998, MOL CELL BIOL, V18, P3163, DOI 10.1128/MCB.18.6.3163; Mohney RP, 2003, J BIOL CHEM, V278, P47038, DOI 10.1074/jbc.M303895200; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; NEWBOLD RF, 1983, NATURE, V304, P648, DOI 10.1038/304648a0; Okabe H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000128; PAGANO M, 1994, GENE DEV, V8, P1627, DOI 10.1101/gad.8.14.1627; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Reynaud EG, 2000, ONCOGENE, V19, P1147, DOI 10.1038/sj.onc.1203403; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sumrejkanchanakij P, 2003, ONCOGENE, V22, P8723, DOI 10.1038/sj.onc.1206870; Sun Q, 2009, J CELL SCI, V122, P1563, DOI 10.1242/jcs.047738; Takaki T, 2009, P NATL ACAD SCI USA, V106, P4171, DOI 10.1073/pnas.0809674106; von Bergwelt-Baildon MS, 2011, EXPERT REV VACCINES, V10, P389, DOI [10.1586/ERV.10.170, 10.1586/erv.10.170]; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; Wedegaertner PB, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-12; Wei S, 1999, CANCER RES, V59, P1539; Williams O, 2004, APOPTOSIS METHODS PR, P31; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zhang FX, 2007, J CELL MOL MED, V11, P552, DOI 10.1111/j.1582-4934.2007.00044.x; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zwicker J, 1999, ONCOGENE, V18, P19, DOI 10.1038/sj.onc.1202286	54	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53503	10.1371/journal.pone.0053503	http://dx.doi.org/10.1371/journal.pone.0053503			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326442	Green Published, gold, Green Submitted			2022-12-25	WOS:000313552400024
J	Yang, CM; Lee, H; Jove, V; Deng, JH; Zhang, W; Liu, XL; Forman, S; Dellinger, TH; Wakabayashi, M; Yu, H; Pal, S				Yang, Chunmei; Lee, Heehyoung; Jove, Veronica; Deng, Jiehui; Zhang, Wang; Liu, Xueli; Forman, Stephen; Dellinger, Thanh H.; Wakabayashi, Mark; Yu, Hua; Pal, Sumanta			Prognostic Significance of B-Cells and pSTAT3 in Patients with Ovarian Cancer	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; INTRAEPITHELIAL T-CELLS; ADOPTIVE TRANSFER; IMMUNE-RESPONSES; CARCINOMA; STAGE; EXPRESSION; CISPLATIN; MICE; CTL	Background: Several previous studies have identified a strong association between T-cell infiltration and clinical outcome in ovarian cancer. The role of B-cells remains controversial, however. Methods: Forty-nine paraffin-embedded omental specimens derived from patients with high grade epithelial ovarian cancer were assessed. Immunohistochemical analyses were performed to characterize expression of CD19+B-cells and pSTAT3 as high (>50% positively staining cells [PSCs]) or low (>50% PSCs). The Kaplan-Meier method with log-rank test was used to determine the association between clinicopathologic parameters and overall survival (OS). A multi-variate Cox proportional hazards regression analysis including nature of debulking (primary vs secondary), histology, tumor grade, receipt of prior chemotherapy, B-cell infiltration and pSTAT3 expression was performed. Results: Median OS was 160.6 months in those patients with low B-cell expression vs 47.3 months in those with high B-cell expression (P = 0.0015). Similarly, median OS was improved in those patients with low pSTAT3 expression (160.6 vs 47.9 months, P = 0.02). In a multivariate model to predict survival, only the degree of B-cell infiltration and clinical stage were retained. pSTAT3 expression did not enter the final model, possibly be due to a high positive correlation with B-cell infiltration (r = 0.82, P<0.0001). Conclusions: Increased B-cell infiltration and pSTAT3 expression in omental tissue are associated with poorer survival.	[Yang, Chunmei; Lee, Heehyoung; Jove, Veronica; Deng, Jiehui; Zhang, Wang; Yu, Hua] City Hope Comprehens Canc Ctr, Beckman Res Inst, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA USA; [Liu, Xueli] City Hope Comprehens Canc Ctr, Dept Biostat, Duarte, CA USA; [Forman, Stephen] City Hope Comprehens Canc Ctr, Dept Hematol, Duarte, CA USA; [Dellinger, Thanh H.; Wakabayashi, Mark] City Hope Comprehens Canc Ctr, Dept Surg, Duarte, CA USA; [Pal, Sumanta] City Hope Comprehens Canc Ctr, Dept Med Oncol, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; City of Hope; City of Hope; City of Hope	Yu, H (corresponding author), City Hope Comprehens Canc Ctr, Beckman Res Inst, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA USA.	hyu@coh.org; spal@coh.org		YU, Hua/0000-0003-0931-1000; DELLINGER, THANH/0000-0003-1855-1989; Deng, Jiehui/0000-0001-7986-8643	National Institutes of Health [K12 2K12CA001727-16A1, NIH U54 CA163117, NIH R01 CA122976-01, NIH P50 CA107399]; Markel Fund; NATIONAL CANCER INSTITUTE [P50CA107399, K12CA001727, R01CA140692, U54CA163117, R01CA122976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Markel Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Pal's efforts are supported by National Institutes of Health K12 2K12CA001727-16A1. Dr. Yu's efforts are supported by NIH U54 CA163117, NIH R01 CA122976-01, NIH P50 CA107399 and the Markel Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SF, 2009, CANCER-AM CANCER SOC, V115, P2891, DOI 10.1002/cncr.24317; AOKI Y, 1991, CANCER RES, V51, P1934; Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Barbera-Guillem E, 2000, CANCER IMMUNOL IMMUN, V48, P541, DOI 10.1007/PL00006672; Barnett JC, 2010, GYNECOL ONCOL, V116, P556, DOI 10.1016/j.ygyno.2009.11.020; Callahan MJ, 2008, CLIN CANCER RES, V14, P7667, DOI 10.1158/1078-0432.CCR-08-0479; Clarke B, 2009, MODERN PATHOL, V22, P393, DOI 10.1038/modpathol.2008.191; Fialova A, 2012, INT J CANC; Fujita K, 1995, CLIN CANCER RES, V1, P501; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Han LY, 2008, CLIN CANCER RES, V14, P3372, DOI 10.1158/1078-0432.CCR-07-4433; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Hwang WT, 2012, GYNECOL ONCOL, V124, P192, DOI 10.1016/j.ygyno.2011.09.039; IKARASHI H, 1994, CANCER RES, V54, P190; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kortylewski M, 2009, NAT BIOTECHNOL, V27, P925, DOI 10.1038/nbt.1564; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Leffers N, 2009, CANCER IMMUNOL IMMUN, V58, P449, DOI 10.1007/s00262-008-0583-5; Milne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006412; Nelson BH, 2010, J IMMUNOL, V185, P4977, DOI 10.4049/jimmunol.1001323; Pardanani A, 2011, J CLIN ONCOL, V29, P789, DOI 10.1200/JCO.2010.32.8021; Qin ZH, 1998, NAT MED, V4, P627, DOI 10.1038/nm0598-627; Rustin GJS, 2010, LANCET, V376, P1155, DOI 10.1016/S0140-6736(10)61268-8; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shah S, 2005, INT J CANCER, V117, P574, DOI 10.1002/ijc.21177; Stumpf M, 2009, BRIT J CANCER, V101, P1513, DOI 10.1038/sj.bjc.6605274; Tang LD, 2010, EUR J CANCER, V46, P170, DOI 10.1016/j.ejca.2009.10.003; Tomsova M, 2008, GYNECOL ONCOL, V108, P415, DOI 10.1016/j.ygyno.2007.10.016; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	30	44	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54029	10.1371/journal.pone.0054029	http://dx.doi.org/10.1371/journal.pone.0054029			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326565	gold, Green Published, Green Submitted			2022-12-25	WOS:000313552400067
J	Hellmich, HL; Rojo, DR; Micci, MA; Sell, SL; Boone, DR; Crookshanks, JM; DeWitt, DS; Masel, BE; Prough, DS				Hellmich, Helen L.; Rojo, Daniel R.; Micci, Maria-Adelaide; Sell, Stacy L.; Boone, Deborah R.; Crookshanks, Jeanna M.; DeWitt, Douglas S.; Masel, Brent E.; Prough, Donald S.			Pathway Analysis Reveals Common Pro-Survival Mechanisms of Metyrapone and Carbenoxolone after Traumatic Brain Injury	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; GENE-EXPRESSION; OXIDATIVE-PHOSPHORYLATION; COGNITIVE FUNCTION; MESSENGER-RNA; ALZHEIMERS; NEUROPROTECTION; GLUCOCORTICOIDS; IMPAIRMENT; INHIBITOR	Developing new pharmacotherapies for traumatic brain injury (TBI) requires elucidation of the neuroprotective mechanisms of many structurally and functionally diverse compounds. To test our hypothesis that diverse neuroprotective drugs similarly affect common gene targets after TBI, we compared the effects of two drugs, metyrapone (MT) and carbenoxolone (CB), which, though used clinically for noncognitive conditions, improved learning and memory in rats and humans. Although structurally different, both MT and CB inhibit a common molecular target, 11 beta hydroxysteroid dehydrogenase type 1, which converts inactive cortisone to cortisol, thereby effectively reducing glucocorticoid levels. We examined injury-induced signaling pathways to determine how the effects of these two compounds correlate with pro-survival effects in surviving neurons of the injured rat hippocampus. We found that treatment of TBI rats with MT or CB acutely induced in hippocampal neurons transcriptional profiles that were remarkably similar (i.e., a coordinated attenuation of gene expression across multiple injury-induced cell signaling networks). We also found, to a lesser extent, a coordinated increase in cell survival signals. Analysis of injury-induced gene expression altered by MT and CB provided additional insight into the protective effects of each. Both drugs attenuated expression of genes in the apoptosis, death receptor and stress signaling pathways, as well as multiple genes in the oxidative phosphorylation pathway such as subunits of NADH dehydrogenase (Complex1), cytochrome c oxidase (Complex IV) and ATP synthase (Complex V). This suggests an overall inhibition of mitochondrial function. Complex 1 is the primary source of reactive oxygen species in the mitochondrial oxidative phosphorylation pathway, thus linking the protective effects of these drugs to a reduction in oxidative stress. The net effect of the drug-induced transcriptional changes observed here indicates that suppressing expression of potentially harmful genes, and also, surprisingly, reduced expression of pro-survival genes may be a hallmark of neuroprotective therapeutic effects.	[Hellmich, Helen L.; Rojo, Daniel R.; Micci, Maria-Adelaide; Sell, Stacy L.; Boone, Deborah R.; Crookshanks, Jeanna M.; DeWitt, Douglas S.; Masel, Brent E.; Prough, Donald S.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Hellmich, HL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	hhellmic@utmb.edu	Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X	Department of Anesthesiology; Moody Foundation; Moody Center for Traumatic Brain Injury and Spinal Cord Injury Research	Department of Anesthesiology; Moody Foundation; Moody Center for Traumatic Brain Injury and Spinal Cord Injury Research	This study was supported by the Department of Anesthesiology, the Moody Foundation and the Moody Center for Traumatic Brain Injury and Spinal Cord Injury Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Aubrecht J, 1996, RES COMMUN MOL PATH, V94, P47; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; BRODY TM, 1955, PHARMACOL REV, V7, P335; CAMPISI D, 1985, PHARMATHERAPEUTICA, V4, P166; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Cole GM, 2010, CNS NEUROL DISORD-DR, V9, P140, DOI 10.2174/187152710791011991; Cote S, 2012, ALZHEIMERS DEMENT, V8, P219, DOI 10.1016/j.jalz.2011.03.012; DAVIES GJ, 1974, BRIT MED J, V3, P400, DOI 10.1136/bmj.3.5927.400; De Felice FG, 2006, IUBMB LIFE, V58, P185, DOI 10.1080/15216540600702198; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Du J, 2009, P NATL ACAD SCI USA, V106, P3543, DOI 10.1073/pnas.0812671106; Finkbeiner S, 2006, J NEUROSCI, V26, P10349, DOI 10.1523/JNEUROSCI.3829-06.2006; Frantseva MV, 2002, J CEREBR BLOOD F MET, V22, P453, DOI 10.1097/00004647-200204000-00009; Gareri P, 2004, NEUROPHARMACOLOGY, V47, P1205, DOI 10.1016/j.neuropharm.2004.08.021; Gohil M, 2010, NAT BIOTECHNOL, V28, P249; Gomes E, 2007, MOL CELL BIOCHEM, V305, P179, DOI 10.1007/s11010-007-9542-2; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Haines BA, 2010, J CEREBR BLOOD F MET, V30, P1825, DOI 10.1038/jcbfm.2010.52; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; Jahn H, 2004, ARCH GEN PSYCHIAT, V61, P1235, DOI 10.1001/archpsyc.61.12.1235; Jahn H, 2003, SLEEP, V26, P823, DOI 10.1093/sleep/26.7.823; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kadenbach B, 2003, BBA-BIOENERGETICS, V1604, P77, DOI 10.1016/S0005-2728(03)00027-6; Kasarskis A, 2011, PHARMACOGENOMICS, V12, P1695, DOI [10.2217/pgs.11.115, 10.2217/PGS.11.115]; KENNEDY JA, 1990, BRIT J ADDICT, V85, P1133; Khorasani MZ, 2009, PAK J PHARM SCI, V22, P349; Krugers HJ, 2000, STROKE, V31, P1162, DOI 10.1161/01.STR.31.5.1162; Laborie C, 2003, J NEUROENDOCRINOL, V15, P15, DOI 10.1046/j.1365-2826.2003.00859.x; Laborie C, 1995, NEUROENDOCRINOLOGY, V62, P601, DOI 10.1159/000127056; Lui JC, 2010, FASEB J, V24, P3083, DOI 10.1096/fj.09-152835; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; Mahmud T, 1996, ARTHRITIS RHEUM, V39, P1998, DOI 10.1002/art.1780391208; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nagayama S, 2001, LIFE SCI, V69, P2867, DOI 10.1016/S0024-3205(01)01362-5; Nguyen T, 2008, INT J DEV NEUROSCI, V26, P141, DOI 10.1016/j.ijdevneu.2007.10.004; Pilipovic K, 2011, NEUROCHEM RES, V36, P913, DOI 10.1007/s11064-011-0424-3; Pivato LS, 2006, J BIOCHEM MOL TOXIC, V20, P230, DOI 10.1002/jbt.20139; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Riepe MW, 1997, J CEREBR BLOOD F MET, V17, P257, DOI 10.1097/00004647-199703000-00002; Rogoz Z, 2007, PHARMACOL REP, V59, P588; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Roozendaal B, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn766; Rotllant D, 2002, EUR J NEUROSCI, V16, P693, DOI 10.1046/j.1460-9568.2002.02120.x; Sandeep TC, 2004, P NATL ACAD SCI USA, V101, P6734, DOI 10.1073/pnas.0306996101; SAS Institute, 2004, SAS STAT 9 1 US GUID; Sato H, 2010, J CLIN BIOCHEM NUTR, V47, P224, DOI 10.3164/jcbn.10-58; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shimamura M, 2005, NEUROSCIENCE, V131, P87, DOI 10.1016/j.neuroscience.2004.10.041; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; SmithSwintosky VL, 1996, J CEREBR BLOOD F MET, V16, P585, DOI 10.1097/00004647-199607000-00008; Srivastava S, 2011, CURR PHARM DESIGN, V17, P3418, DOI 10.2174/138161211798072526; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Tovar KR, 2009, J NEUROPHYSIOL, V102, P974, DOI 10.1152/jn.00060.2009; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Whitehead D, 1997, J MOL ENDOCRINOL, V19, P291, DOI 10.1677/jme.0.0190291; YOUNG EA, 1994, ARCH GEN PSYCHIAT, V51, P701; Zhang ZQ, 2010, METHODS MOL BIOL, V662, P317, DOI 10.1007/978-1-60761-800-3_16	72	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53230	10.1371/journal.pone.0053230	http://dx.doi.org/10.1371/journal.pone.0053230			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326402	Green Published, Green Submitted, gold			2022-12-25	WOS:000313551500054
J	Pan, W; Zhong, Y; Cheng, CF; Liu, BR; Wang, L; Li, AQ; Xiong, LG; Liu, SM				Pan, Wei; Zhong, Yun; Cheng, Chuanfang; Liu, Benrong; Wang, Li; Li, Aiqun; Xiong, Longgen; Liu, Shiming			MiR-30-Regulated Autophagy Mediates Angiotensin II-Induced Myocardial Hypertrophy	PLOS ONE			English	Article							CIRCULATING MICRORNAS; MIR-30; EXPRESSION; BIOMARKER; REVEALS; INHIBITORS; TARGETS; MIRNAS; BLOOD	Dysregulated autophagy may lead to the development of disease. Role of autophagy and the diagnostic potential of microRNAs that regulate the autophagy in cardiac hypertrophy have not been evaluated. A rat model of cardiac hypertrophy was established using transverse abdominal aortic constriction (operation group). Cardiomyocyte autophagy was enhanced in rats from the operation group, compared with those in the sham operation group. Moreover, the operation group showed up-regulation of beclin-1 (an autophagy-related gene), and down-regulation of miR-30 in cardiac tissue. The effects of inhibition and over-expression of the beclin-1 gene on the expression of hypertrophy-related genes and on autophagy were assessed. Angiotensin II-induced myocardial hypertrophy was found to be mediated by over-expression of the beclin-1 gene. A dual luciferase reporter assay confirmed that beclin-1 was a target gene of miR-30a. miR-30a induced alterations in beclin-1 gene expression and autophagy in cardiomyocytes. Treatment of cardiomyocytes with miR-30a mimic attenuated the Angiotensin II-induced up-regulation of hypertrophy-related genes and decreased in the cardiomyocyte surface area. Conversely, treatment with miR-30a inhibitor enhanced the up-regulation of hypertrophy-related genes and increased the surface area of cardiomyocytes induced by Angiotensin II. In addition, circulating miR-30 was elevated in patients with left ventricular hypertrophy, and circulating miR-30 was positively associated with left ventricular wall thickness. Collectively, these above-mentioned results suggest that Angiotensin II induces down-regulation of miR-30 in cardiomyocytes, which in turn promotes myocardial hypertrophy through excessive autophagy. Circulating miR-30 may be an important marker for the diagnosis of left ventricular hypertrophy.	[Pan, Wei; Zhong, Yun; Cheng, Chuanfang; Liu, Benrong; Wang, Li; Li, Aiqun; Xiong, Longgen; Liu, Shiming] Guangzhou Med Univ, Hosp Affiliated 2, Guangzhou Inst Cardiovasc Dis, Cardiovasc Dept, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Liu, SM (corresponding author), Guangzhou Med Univ, Hosp Affiliated 2, Guangzhou Inst Cardiovasc Dis, Cardiovasc Dept, Guangzhou, Guangdong, Peoples R China.	gzliushiming@126.com	Zhong, Yun/HCH-6868-2022		Guangzhou Science and Technology Project [11A72020279]	Guangzhou Science and Technology Project	Funding was supported by Guangzhou Science and Technology Project grants 11A72020279. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2010, CLIN CHEM, V56, P1183, DOI 10.1373/clinchem.2010.144121; Agrawal R, 2009, DEVELOPMENT, V136, P3927, DOI 10.1242/dev.037432; Cao DJ, 2011, P NATL ACAD SCI USA, V108, P4123, DOI 10.1073/pnas.1015081108; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872; Cheng YH, 2010, CLIN SCI, V119, P87, DOI 10.1042/CS20090645; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Dai DF, 2011, CIRC RES, V108, P837, DOI 10.1161/CIRCRESAHA.110.232306; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gradus B, 2011, DEV BIOL, V360, P58, DOI 10.1016/j.ydbio.2011.09.002; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Guo R, 2012, AUTOPHAGY, V8, P593, DOI 10.4161/auto.18997; Hand NJ, 2009, GASTROENTEROLOGY, V136, P1081, DOI 10.1053/j.gastro.2008.12.006; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kuokkanen S, 2010, BIOL REPROD, V82, P791, DOI 10.1095/biolreprod.109.081059; Lin J, 2011, LEUKEMIA, V25, P145, DOI 10.1038/leu.2010.230; Lu LH, 2009, INT J CARDIOL, V134, P82, DOI 10.1016/j.ijcard.2008.01.043; Martineza I, 2011, P NATL ACAD SCI USA, V108, P522, DOI 10.1073/pnas.1017346108; Meder B, 2011, BASIC RES CARDIOL, V106, P13, DOI 10.1007/s00395-010-0123-2; Mellios N, 2008, HUM MOL GENET, V17, P3030, DOI 10.1093/hmg/ddn201; Mellios N, 2012, SCHIZOPHRENIA BULL, V38, P433, DOI 10.1093/schbul/sbq091; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Scagnolari C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-311; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wu TT, 2012, J BIOL CHEM, V287, P7503, DOI 10.1074/jbc.M111.292722; Xu Y, 2010, SCHIZOPHR RES, V119, P219, DOI 10.1016/j.schres.2010.02.1070; Yu Y, 2012, LEUKEMIA, V26, P1752, DOI 10.1038/leu.2012.65; Zaragosi LE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r64; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523; Zhu H, 2009, AUTOPHAGY, V5, P816, DOI 10.4161/auto.9064	39	146	161	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53950	10.1371/journal.pone.0053950	http://dx.doi.org/10.1371/journal.pone.0053950			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326547	Green Submitted, gold, Green Published			2022-12-25	WOS:000313551500103
J	Wu, DWL; DiGiacomo, A; Kingstone, A				Wu, David W. -L.; DiGiacomo, Alessandra; Kingstone, Alan			A Sustainable Building Promotes Pro-Environmental Behavior: An Observational Study on Food Disposal	PLOS ONE			English	Article							ADAPTIVE-BEHAVIOR; GREEN; PSYCHOLOGY; CULTURE; HEALTH; IMPACT; USER	In order to develop a more sustainable society, the wider public will need to increase engagement in pro-environmental behaviors. Psychological research on pro-environmental behaviors has thus far focused on identifying individual factors that promote such behavior, designing interventions based on these factors, and evaluating these interventions. Contextual factors that may also influence behavior at an aggregate level have been largely ignored. In the current study, we test a novel hypothesis - whether simply being in a sustainable building can elicit environmentally sustainable behavior. We find support for our hypothesis: people are significantly more likely to correctly choose the proper disposal bin (garbage, compost, recycling) in a building designed with sustainability in mind compared to a building that was not. Questionnaires reveal that these results are not due to self-selection biases. Our study provides empirical support that one's surroundings can have a profound and positive impact on behavior. It also suggests the opportunity for a new line of research that bridges psychology, design, and policy-making in an attempt to understand how the human environment can be designed and used as a subtle yet powerful tool to encourage and achieve aggregate pro-environmental behavior.	[Wu, David W. -L.; DiGiacomo, Alessandra; Kingstone, Alan] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of British Columbia	Wu, DWL (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	David.wl.wu@gmail.com		Wu, David/0000-0002-6924-6047	National Sciences and Engineering Research Council of Canada (NSERC)	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Work for this paper was supported by a Discovery Grant (to A.K.) from the National Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse W, 2005, J ENVIRON PSYCHOL, V25, P273, DOI 10.1016/j.jenvp.2005.08.002; BITNER MJ, 1992, J MARKETING, V56, P57, DOI 10.2307/1252042; Boyd R, 2011, P NATL ACAD SCI USA, V108, P10918, DOI 10.1073/pnas.1100290108; Brown Z, 2010, FACILITIES, V28, P225, DOI 10.1108/02632771011023168; Brown ZB, 2009, INTELL BUILD INT, V1, P296, DOI 10.3763/inbi.2009.0034; Chiel HJ, 1997, TRENDS NEUROSCI, V20, P553, DOI 10.1016/S0166-2236(97)01149-1; Chudek M, 2011, TRENDS COGN SCI, V15, P218, DOI 10.1016/j.tics.2011.03.003; Cole RJ, 2012, BUILD RES INF, V40, P39, DOI 10.1080/09613218.2011.610608; Duffy S, 2009, ENVIRON BEHAV, V41, P741, DOI 10.1177/0013916508323737; GUAGNANO GA, 1995, ENVIRON BEHAV, V27, P699, DOI 10.1177/0013916595275005; Henrich J, 2001, AM ANTHROPOL, V103, P992, DOI 10.1525/aa.2001.103.4.992; Hunecke M, 2001, ENVIRON BEHAV, V33, P830, DOI 10.1177/00139160121973269; Jackson RJ, 2003, AM J PUBLIC HEALTH, V93, P1382, DOI 10.2105/AJPH.93.9.1382; Jamieson P., 2003, INT J ACAD DEV, V8, P119, DOI DOI 10.1080/1360144042000277991; Lockton D, 2010, APPL ERGON, V41, P382, DOI 10.1016/j.apergo.2009.09.001; Lockton D, 2008, INT J SUSTAIN ENG, V1, P3, DOI 10.1080/19397030802131068; Mehta R, 2009, SCIENCE, V323, P1226, DOI 10.1126/science.1169144; Meyers-Levy J, 2010, J CONSUM RES, V37, P1, DOI 10.1086/649028; Osbaldiston R, 2012, ENVIRON BEHAV, V44, P257, DOI 10.1177/0013916511402673; Oskamp S, 2000, AM PSYCHOL, V55, P496, DOI 10.1037/0003-066X.55.5.496; Schmuck P, 2003, EUR PSYCHOL, V8, P66, DOI 10.1027//1016-9040.8.2.66; SCHULTZ PW, 1995, J ENVIRON PSYCHOL, V15, P105, DOI 10.1016/0272-4944(95)90019-5; Shalev I, 2011, PERSPECT PSYCHOL SCI, V6, P488, DOI 10.1177/1745691611416993; Spence A, 2009, ENVIRONMENT, V51, P8, DOI 10.1080/00139150903337217; Steg L, 2009, J ENVIRON PSYCHOL, V29, P309, DOI 10.1016/j.jenvp.2008.10.004; Williams LE, 2008, SCIENCE, V322, P606, DOI 10.1126/science.1162548; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322	27	30	30	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53856	10.1371/journal.pone.0053856	http://dx.doi.org/10.1371/journal.pone.0053856			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326521	Green Published, gold, Green Submitted			2022-12-25	WOS:000313551500098
J	Gordon, LK; Kiyohara, M; Fu, M; Braun, J; Dhawan, P; Chan, A; Goodglick, L; Wadehra, M				Gordon, L. K.; Kiyohara, M.; Fu, M.; Braun, J.; Dhawan, P.; Chan, A.; Goodglick, L.; Wadehra, M.			EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF	ONCOGENE			English	Article						EMP2; VEGF; neoangiogenesis	EPITHELIAL MEMBRANE PROTEIN-2; ENDOTHELIAL GROWTH-FACTOR; COLLAGEN GEL CONTRACTION; TUMOR ANGIOGENESIS; SPLICE VARIANTS; EXPRESSION; TARGET; GLIOBLASTOMA; INHIBITION; RECEPTOR	Understanding tumor-induced angiogenesis is a challenging problem with important consequences for the diagnosis and treatment of cancer. In this study, we define a novel function for epithelial membrane protein-2 (EMP2) in the control of angiogenesis. EMP2 functions as an oncogene in endometrial cancer, and its expression has been linked to decreased survival. Using endometrial cancer xenografts, modulation of EMP2 expression resulted in profound changes to the tumor microvasculature. Under hypoxic conditions, upregulation of EMP2 promoted vascular endothelial growth factors (VEGF) expression through a HIF-1 alpha-dependent pathway and resulted in successful capillary-like tube formation. In contrast, reduction of EMP2 correlated with reduced HIF-1 alpha and VEGF expression with the net consequence of poorly vascularized tumors in vivo. We have previously shown that targeting of EMP2 using diabodies in endometrial cancer resulted in a reduction of tumor load, and since then we have constructed a fully human EMP2 IgG1. Treatment of endometrial cancer cells with EMP2-IgG1 reduced tumor load with a significant improvement in survival. These results support the role of EMP2 in the control of the tumor microenvironment and confirm the cytotoxic effects observed by EMP2 treatment in vivo.	[Gordon, L. K.; Chan, A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Kiyohara, M.; Fu, M.; Braun, J.; Chan, A.; Goodglick, L.; Wadehra, M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Braun, J.; Goodglick, L.; Wadehra, M.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Dhawan, P.] Harbor UCLA Med Ctr, Dept Surg, Torrance, CA 90509 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Wadehra, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	mwadehra@mednet.ucla.edu		Braun, Jonathan/0000-0003-1646-2974	Early Detection Research Network NCI [CA-86366]; NIH [CA16042, CA131756, CA163971]; Stein Oppenheimer Award; Richard and Barbara Braun fund; NATIONAL CANCER INSTITUTE [R01CA163971, U24CA086366, R21CA131756, P30CA016042] Funding Source: NIH RePORTER	Early Detection Research Network NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stein Oppenheimer Award; Richard and Barbara Braun fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Dr Heather Christofk and her laboratory for use of the hypoxic chamber, and thankful to Dr Judith Berliner and Dr Sangderk Lee for providing HAEC cells. This work was generously supported by the Early Detection Research Network NCI CA-86366 (LG), NIH grants CA16042 (JB), CA131756 (MW), CA163971 (MW), the Stein Oppenheimer Award (MW) and Richard and Barbara Braun fund.	Aplin AE, 1999, J BIOL CHEM, V274, P31223, DOI 10.1074/jbc.274.44.31223; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Arsham AM, 2002, J BIOL CHEM, V277, P15162, DOI 10.1074/jbc.M111162200; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bates DO, 2006, CLIN SCI, V110, P575, DOI 10.1042/CS20050292; Cebe-Suarez S, 2006, CELL MOL LIFE SCI, V63, P601, DOI 10.1007/s00018-005-5426-3; de Oliveira RL, 2011, MOL ASPECTS MED, V32, P71, DOI 10.1016/j.mam.2011.04.001; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Fu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019945; Fu MY, 2010, CLIN CANCER RES, V16, P3954, DOI 10.1158/1078-0432.CCR-10-0368; Habeeb O, 2010, CANCER-AM CANCER SOC, V116, P4718, DOI 10.1002/cncr.25259; Inoue M, 2002, CANCER CELL, V1, P193, DOI 10.1016/S1535-6108(02)00031-4; Kadenhe-Chiweshe A, 2008, MOL CANCER RES, V6, P1, DOI 10.1158/1541-7786.MCR-07-0101; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kilarski WW, 2009, NAT MED, V15, P657, DOI 10.1038/nm.1985; Lu KV, 2009, CANCER RES, V69, P6889, DOI 10.1158/0008-5472.CAN-09-0347; Mahimainathan L, 2005, AM J PHYSIOL-RENAL, V289, pF72, DOI 10.1152/ajprenal.00277.2004; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Merdzhanova G, 2010, ONCOGENE, V29, P5392, DOI 10.1038/onc.2010.281; Morales SA, 2007, EXP EYE RES, V85, P790, DOI 10.1016/j.exer.2007.08.014; Morales SA, 2009, INVEST OPHTH VIS SCI, V50, P4949, DOI 10.1167/iovs.08-3315; Morales SA, 2009, INVEST OPHTH VIS SCI, V50, P462, DOI 10.1167/iovs.07-1598; Ogawa K, 2000, ONCOGENE, V19, P6043, DOI 10.1038/sj.onc.1204004; Okada F, 1998, P NATL ACAD SCI USA, V95, P3609, DOI 10.1073/pnas.95.7.3609; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Robinson CJ, 2001, J CELL SCI, V114, P853; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Seton-Rogers S, 2011, NAT REV CANCER, V11, P391, DOI 10.1038/nrc3074; Shimazaki K, 2008, CLIN CANCER RES, V14, P7367, DOI 10.1158/1078-0432.CCR-08-1016; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Travasso RDM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019989; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wadehra M, 2006, DEV BIOL, V292, P430, DOI 10.1016/j.ydbio.2006.01.015; Wadehra M, 2005, DEV BIOL, V287, P336, DOI 10.1016/j.ydbio.2005.09.003; Wadehra M, 2002, BIOTECHNIQUES, V32, P242, DOI 10.2144/02322bm02; Wadehra M, 2002, J BIOL CHEM, V277, P41094, DOI 10.1074/jbc.M206868200; Wadehra M, 2006, CANCER-AM CANCER SOC, V107, P90, DOI 10.1002/cncr.21957; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wang MY, 2006, CANCER RES, V66, P7864, DOI 10.1158/0008-5472.CAN-04-4392; Zagzag D, 2006, LAB INVEST, V86, P1221, DOI 10.1038/labinvest.3700482	43	36	42	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 14	2013	32	46					5369	5376		10.1038/onc.2012.622	http://dx.doi.org/10.1038/onc.2012.622			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	251IU	23334331	Green Published, hybrid			2022-12-25	WOS:000326922400007
J	Chen, Y; Sawada, O; Kohno, H; Le, YZ; Subauste, C; Maeda, T; Maeda, A				Chen, Yu; Sawada, Osamu; Kohno, Hideo; Le, Yun-Zheng; Subauste, Carlos; Maeda, Tadao; Maeda, Akiko			Autophagy Protects the Retina from Light-induced Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACULAR DEGENERATION; OXIDATIVE STRESS; TUMOR-SUPPRESSOR; MOUSE RETINA; IN-VIVO; MICE; BECLIN-1; PARKIN; CELLS; GENE	Autophagy is a conserved feature of lysosome-mediated intracellular degradation. Dysregulated autophagy is implicated as a contributor in neurodegenerative diseases; however, the role of autophagy in retinal degeneration remains largely unknown. Here, we report that the photo-activated visual chromophore, all-trans-retinal, modulated autophagosome formation in ARPE19 retinal cells. Increased formation of autophagosomes in these cells was observed when incubated with 2.5 mu M all-trans-retinal, a condition that did not cause cell death after 24 h in culture. However, autophagosome formation was decreased at concentrations, which caused cell death. Increased expression of activating transcription factor 4 (Atf4), which indicates the activation of oxidative stress, was recorded in response to light illumination in retinas of Abca4(-/-) Rdh8(-/-) mice, which showed delayed clearance of all-trans-retinal after light exposure. Expression of autophagosome marker LC3B-II and mitochondria-specific autophagy, mitophagy, regulator Park2, were significantly increased in the retinas of Abca4(-/-) Rdh8(-/-) mice after light exposure, suggesting involvement of autophagy and mitophagy in the pathogenesis of light-induced retinal degeneration. Deletion of essential genes required for autophagy, including Beclin1 systemically or Atg7 in only rod photoreceptors resulted in increased susceptibility to light-induced retinal damage. Increased photoreceptor cell death was observed when retinas lacking the rod photoreceptor-specific Atg7 gene were coincubated with 20 mu M all-trans-retinal. Park2(-/-) mice also displayed light-induced retinal degeneration. Ultra-structural analyses showed mitochondrial and endoplasmic reticulum impairment in retinas of these model animals after light exposure. Taken together, these observations provide novel evidence implicating an important role of autophagy and mitophagy in protecting the retina from all-trans-retinal- and light-induced degeneration.	[Chen, Yu; Kohno, Hideo; Maeda, Tadao; Maeda, Akiko] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Sawada, Osamu; Maeda, Tadao; Maeda, Akiko] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Subauste, Carlos] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Chen, Yu] Shanghai Univ Tradit Chinese Med, Yueyang Hosp, Shanghai 200437, Peoples R China; [Chen, Yu] Shanghai Univ Tradit Chinese Med, Clin Res Inst Integrat Med, Shanghai 200437, Peoples R China; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; University of Oklahoma System; University of Oklahoma Health Sciences Center	Maeda, A (corresponding author), Case Western Reserve Univ, 10900 Euclid Ave, Cleveland, OH 44106 USA.	aam19@case.edu		Subauste, Carlos/0000-0002-5602-1439	National Institutes of Health [K08EY019031, K08EY019880, R01EY022658, R01EY018341, R24EY021126, P30EY011373]; Research to Prevent Blindness Foundation; Foundation Fighting Blindness; Fight for Sight; Ohio Lions Eye Research Foundation; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; NATIONAL EYE INSTITUTE [R01EY018341, K08EY019880, K08EY019031, P30EY011373, R24EY021126, R01EY022658] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Foundation Fighting Blindness(European Commission); Fight for Sight; Ohio Lions Eye Research Foundation; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants K08EY019031, K08EY019880, R01EY022658, R01EY018341, R24EY021126, and P30EY011373. This work was also supported by the Research to Prevent Blindness Foundation, Foundation Fighting Blindness, Fight for Sight, Ohio Lions Eye Research Foundation, and the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning.	Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Esteve-Rudd J, 2010, BRAIN RES, V1352, P70, DOI 10.1016/j.brainres.2010.07.019; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Holz F G, 1995, Ger J Ophthalmol, V4, P336; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Le YZ, 2006, MOL VIS, V12, P389; Lee IH, 2012, SCIENCE, V336, P225, DOI 10.1126/science.1218395; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Maeda A, 2009, INVEST OPHTH VIS SCI, V50, P5435, DOI 10.1167/iovs.09-3944; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Okano K, 2012, J NEUROCHEM, V121, P146, DOI 10.1111/j.1471-4159.2012.07647.x; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Portillo JAC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014472; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Reme CE, 1999, INVEST OPHTH VIS SCI, V40, P2398; REME CE, 1977, INVEST OPHTH VIS SCI, V16, P815; Shelley EJ, 2009, ARCH OPHTHALMOL-CHIC, V127, P483, DOI 10.1001/archophthalmol.2008.622; Sparrow JR, 2010, ADV EXP MED BIOL, V703, P63, DOI 10.1007/978-1-4419-5635-4_5; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	41	106	110	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7506	7518		10.1074/jbc.M112.439935	http://dx.doi.org/10.1074/jbc.M112.439935			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23341467	Green Published, hybrid			2022-12-25	WOS:000316455300007
J	Agarwal, V; Kuchipudi, A; Fulde, M; Riesbeck, K; Bergmann, S; Blom, AM				Agarwal, Vaibhav; Kuchipudi, Arunakar; Fulde, Marcus; Riesbeck, Kristian; Bergmann, Simone; Blom, Anna M.			Streptococcus pneumoniae Endopeptidase O (PepO) Is a Multifunctional Plasminogen- and Fibronectin-binding Protein, Facilitating Evasion of Innate Immunity and Invasion of Host Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; FACTOR-H; EXTRACELLULAR-MATRIX; SURFACE PROTEIN; MEDIATED INTERNALIZATION; SECRETORY COMPONENT; VIRULENCE FACTORS; ADHERENCE; ADHESIN; DISEASE	Streptococcus pneumoniae infections remain a major cause of morbidity and mortality worldwide. Therefore a detailed understanding and characterization of the mechanism of host cell colonization and dissemination is critical to gain control over this versatile pathogen. Here we identified a novel 72-kDa pneumococcal protein endopeptidase O (PepO), as a plasminogen-and fibronectin-binding protein. Using a collection of clinical isolates, representing different serotypes, we found PepO to be ubiquitously present both at the gene and protein level. In addition, PepO protein was secreted in a growth phase-dependent manner to the culture supernatants of the pneumococcal isolates. Recombinant PepO bound human plasminogen and fibronectin in a dose-dependent manner and plasminogen did not compete with fibronectin for binding PepO. PepO bound plasminogen via lysine residues and the interaction was influenced by ionic strength. Moreover, upon activation of PepO-bound plasminogen by urokinase-type plasminogen activator, generated plasmin cleaved complement protein C3b thus assisting in complement control. Furthermore, direct binding assays demonstrated the interaction of PepO with epithelial and endothelial cells that in turn blocked pneumococcal adherence. Moreover, a pepO-mutant strain showed impaired adherence to and invasion of host cells compared with their isogenic wildtype strains. Taken together, the results demonstrated that PepO is a ubiquitously expressed plasminogen-and fibronectin-binding protein, which plays role in pneumococcal invasion of host cells and aids in immune evasion.	[Agarwal, Vaibhav; Kuchipudi, Arunakar; Riesbeck, Kristian; Blom, Anna M.] Lund Univ, Dept Lab Med, S-20502 Malmo, Sweden; [Fulde, Marcus] Hannover Med Sch, Inst Med Microbiol & Hosp Epidemiol, D-30625 Hannover, Germany; [Bergmann, Simone] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany	Lund University; Hannover Medical School; Braunschweig University of Technology	Blom, AM (corresponding author), Wallenberg Inst & Labs, Dept Lab Med, Floor 4, S-20502 Malmo, Sweden.	anna.blom@med.lu.se	Blom, Anna/B-9607-2009; Blom, Anna/AFS-7369-2022	Blom, Anna/0000-0002-1348-1734; Riesbeck, Kristian/0000-0001-6274-6965	Swedish Research Council [K2012-66X-14928-09-5]; National Board of Health and Welfare; Foundations of Osterlund; Greta and Johan Kock; King Gustav V's 80th Anniversary; Inga-Britt and Arne Lundberg; Torsten and Ragnar Soderbergs; Royal Physiographic Society in Lund; Skane University Hospital; Swedish Society for Medical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); National Board of Health and Welfare; Foundations of Osterlund; Greta and Johan Kock; King Gustav V's 80th Anniversary; Inga-Britt and Arne Lundberg; Torsten and Ragnar Soderbergs; Royal Physiographic Society in Lund; Skane University Hospital; Swedish Society for Medical Research	This work was supported in part by Swedish Research Council Grant K2012-66X-14928-09-5 and grants from the National Board of Health and Welfare, Foundations of Osterlund, Greta and Johan Kock, King Gustav V's 80th Anniversary, Knut and Alice Wallenberg, Inga-Britt and Arne Lundberg, Torsten and Ragnar Soderbergs, Royal Physiographic Society in Lund, and the Skane University Hospital. Recipient of a postdoctoral stipend from the Swedish Society for Medical Research.	Agarwal V, 2010, J BIOL CHEM, V285, P23484, DOI 10.1074/jbc.M110.142703; Agarwal V, 2009, J BIOL CHEM, V284, P19427, DOI 10.1074/jbc.M109.003442; Anderton JM, 2007, MICROB PATHOGENESIS, V42, P225, DOI 10.1016/j.micpath.2007.02.003; Ansai T, 2003, ORAL MICROBIOL IMMUN, V18, P398, DOI 10.1046/j.0902-0055.2003.00080.x; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Barthel D, 2012, J BIOL CHEM, V287, P18831, DOI 10.1074/jbc.M111.323287; Barthel D, 2012, J IMMUNOL, V188, P379, DOI 10.4049/jimmunol.1101927; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Bergmann S, 2005, THROMB HAEMOSTASIS, V94, P304, DOI 10.1160/TH05-05-0369; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Bernardo-Garcia N, 2011, ACTA CRYSTALLOGR F, V67, P1285, DOI 10.1107/S1744309111030922; Bland ND, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-16; Cartwright K, 2002, EUR J PEDIATR, V161, P188, DOI 10.1007/s00431-001-0907-3; COLLEN D, 1975, THROMB DIATH HAEMOST, V34, P403, DOI 10.1055/s-0038-1651399; Elm C, 2004, J BIOL CHEM, V279, P6296, DOI 10.1074/jbc.M310528200; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Frolet C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-190; Hallstrom T, 2010, J INFECT DIS, V202, P490, DOI 10.1086/653825; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; Hammerschmidt S, 1997, MOL MICROBIOL, V25, P1113, DOI 10.1046/j.1365-2958.1997.5391899.x; Hammerschmidt S, 2000, MOL MICROBIOL, V36, P726, DOI 10.1046/j.1365-2958.2000.01897.x; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Jensch I, 2010, MOL MICROBIOL, V77, P22, DOI 10.1111/j.1365-2958.2010.07189.x; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Lofling J, 2011, CELL MICROBIOL, V13, P186, DOI 10.1111/j.1462-5822.2010.01560.x; Luo SS, 2009, MOL IMMUNOL, V47, P541, DOI 10.1016/j.molimm.2009.07.017; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Papasergi S, 2010, J BIOL CHEM, V285, P7517, DOI 10.1074/jbc.M109.062075; Poltermann S, 2007, J BIOL CHEM, V282, P37537, DOI 10.1074/jbc.M707280200; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; Rose L, 2008, J INFECT DIS, V198, P375, DOI 10.1086/589775; Rosenow C, 1997, MOL MICROBIOL, V25, P819, DOI 10.1111/j.1365-2958.1997.mmi494.x; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Talay Susanne R., 2005, V12, P90, DOI 10.1159/000081691; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Turner AJ, 2000, ADV EXP MED BIOL, V477, P229; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Wiles KG, 2010, J BIOL CHEM, V285, P21153, DOI 10.1074/jbc.M110.107730; Yamaguchi M, 2008, J BIOL CHEM, V283, P36272, DOI 10.1074/jbc.M807087200; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	52	72	77	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6849	6863		10.1074/jbc.M112.405530	http://dx.doi.org/10.1074/jbc.M112.405530			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23341464	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000316002400007
J	Schamber-Reis, BLF; Petritus, PM; Caetano, BC; Martinez, ER; Okuda, K; Golenbock, D; Scott, P; Gazzinelli, RT				Schamber-Reis, Bruno Luiz Fonseca; Petritus, Patricia M.; Caetano, Braulia C.; Martinez, Espiridion R.; Okuda, Kendi; Golenbock, Douglas; Scott, Phillip; Gazzinelli, Ricardo T.			UNC93B1 and Nucleic Acid-sensing Toll-like Receptors Mediate Host Resistance to Infection with Leishmania major	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CUTANEOUS LEISHMANIASIS; INTERFERON-GAMMA; CELL-DEVELOPMENT; DENDRITIC CELLS; MICE; SUSCEPTIBILITY; IL-12; RESOLUTION; RESPONSES; MYD88	The mammalian homolog B1 of Unc-93 Caenorhabditis elegans known as UNC93B1 is a chaperone protein that mediates translocation of the nucleic acid-sensing Toll-like receptors (TLRs) from the endoplasmic reticulum to the endolysosomes. The triple deficient (UNC93B1 mutant) mice have a functional single point mutation in the UNC93B1 that results in non-functional TLR3, TLR7, and TLR9. Herein, we demonstrate that UNC93B1 mutant mice, in the C57BL/6 (resistant) genetic background, are highly susceptible to Leishmania major infection. Enhanced swelling of the footpad was associated with high levels of interleukin 10, decreased levels of interferon gamma, and increased parasitism. None of the single TLR3, TLR7, and TLR9 knock-out (KO) mice resemble the UNC93B1 mutant phenotype upon infection with L. major. Whereas the double TLR7/TLR9 KO showed a partial phenotype, the triple TLR3/TLR7/TLR9 KO mice were as susceptible as the UNC93B1 mutant mice, when infected with Leishmania parasites. Finally, we demonstrate that treatment with either anti-interleukin 10 receptor monoclonal antibody or recombinant interleukin 12 restored a robust anti-parasite T(H)1 response and reverted the susceptible phenotype of UNC93B1 mutant mice. Altogether, our results indicate the redundant and essential role of nucleic acid-sensing TLR3, TLR7 and TLR9 in inducing interleukin 12, development of a T(H)1 response, and resistance to L. major infection in resistant C57BL/6 mice.	[Schamber-Reis, Bruno Luiz Fonseca; Caetano, Braulia C.; Martinez, Espiridion R.; Okuda, Kendi; Golenbock, Douglas; Gazzinelli, Ricardo T.] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA; [Petritus, Patricia M.; Scott, Phillip] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Golenbock, Douglas; Gazzinelli, Ricardo T.] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil; [Gazzinelli, Ricardo T.] Univ Fed Minas Gerais, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil	University of Massachusetts System; University of Massachusetts Worcester; University of Pennsylvania; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Gazzinelli, RT (corresponding author), Univ Massachusetts, Sch Med, Dept Med, LRB Rm 302, Worcester, MA 01605 USA.	ricardo.gazzinelli@umassmed.edu	Okuda, Kendi/D-4562-2013	Gazzinelli, Ricardo/0000-0003-2427-7699	National Institutes of Health [R01 AI071319-01, R01 AI76257, T32 AI55400-8]; National Institute of Science and Technology for Vaccines; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); CAPES/Brazil; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076257, R01AI071319, T32AI055400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Science and Technology for Vaccines; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES/Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health Grants R01 AI071319-01 and R01 AI76257 and T32 AI55400-8 and the National Institute of Science and Technology for Vaccines, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG).; A recipient of a postdoctoral fellowship from CAPES/Brazil.	Abou Fakher FH, 2009, J IMMUNOL, V182, P1386, DOI 10.4049/jimmunol.182.3.1386; AFONSO LCC, 1993, INFECT IMMUN, V61, P2952, DOI 10.1128/IAI.61.7.2952-2959.1993; Becker I, 2003, MOL BIOCHEM PARASIT, V130, P65, DOI 10.1016/S0166-6851(03)00160-9; Berberich C, 2003, J IMMUNOL, V170, P3171, DOI 10.4049/jimmunol.170.6.3171; Caetano BC, 2011, J IMMUNOL, V187, P1903, DOI 10.4049/jimmunol.1003911; Carvalho LP, 2012, J IMMUNOL, V188, P1394, DOI 10.4049/jimmunol.1101018; Cockburn IA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001318; de Veer MJ, 2003, EUR J IMMUNOL, V33, P2822, DOI 10.1002/eji.200324128; Flandin JF, 2006, EUR J IMMUNOL, V36, P411, DOI 10.1002/eji.200535079; Gazzinelli RT, 2006, NAT REV IMMUNOL, V6, P895, DOI 10.1038/nri1978; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; HEINZEL FP, 1993, J EXP MED, V177, P1505, DOI 10.1084/jem.177.5.1505; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Hemmi Hiroaki, 2005, V86, P120, DOI 10.1159/000086657; Ives A, 2011, SCIENCE, V331, P775, DOI 10.1126/science.1199326; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kaisho T, 2001, TRENDS IMMUNOL, V22, P78, DOI 10.1016/S1471-4906(00)01811-1; Kane MM, 2001, J IMMUNOL, V166, P1141, DOI 10.4049/jimmunol.166.2.1141; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kropf P, 2004, INFECT IMMUN, V72, P1920, DOI 10.1128/IAI.72.4.1920-1928.2004; Melo MB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001071; Muraille E, 2003, J IMMUNOL, V170, P4237, DOI 10.4049/jimmunol.170.8.4237; Noben-Trauth N, 2003, J IMMUNOL, V170, P5152, DOI 10.4049/jimmunol.170.10.5152; Pifer R, 2011, J BIOL CHEM, V286, P3307, DOI 10.1074/jbc.M110.171025; Radwanska M, 2007, PLOS PATHOG, V3, P619, DOI 10.1371/journal.ppat.0030068; Revaz-Breton M, 2010, EUR J IMMUNOL, V40, P1697, DOI 10.1002/eji.200939821; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; SCHARTONKERSTEN T, 1995, J IMMUNOL, V154, P5320; SCOTT P, 1988, J EXP MED, V168, P1675, DOI 10.1084/jem.168.5.1675; Siednienko J, 2010, EUR J IMMUNOL, V40, P3150, DOI 10.1002/eji.201040547; Stobie L, 2000, P NATL ACAD SCI USA, V97, P8427, DOI 10.1073/pnas.160197797; SYPEK JP, 1993, J EXP MED, V177, P1797, DOI 10.1084/jem.177.6.1797; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; von Stebut E, 2000, EUR J IMMUNOL, V30, P3498, DOI 10.1002/1521-4141(2000012)30:12&lt;3498::AID-IMMU3498&gt;3.0.CO;2-6; Zimmermann S, 1998, J IMMUNOL, V160, P3627	35	31	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7127	7136		10.1074/jbc.M112.407684	http://dx.doi.org/10.1074/jbc.M112.407684			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23325805	Green Published, hybrid			2022-12-25	WOS:000316002400034
J	Beiroa, D; Romero-Pico, A; Langa, C; Bernabeu, C; Lopez, M; Lopez-Novoa, JM; Nogueiras, R; Dieguez, C				Beiroa, Daniel; Romero-Pico, Amparo; Langa, Carmen; Bernabeu, Carmelo; Lopez, Miguel; Lopez-Novoa, Jose M.; Nogueiras, Ruben; Dieguez, Carlos			Heterozygous Deficiency of Endoglin Decreases Insulin and Hepatic Triglyceride Levels during High Fat Diet	PLOS ONE			English	Article							BETA RECEPTOR; ANGIOGENESIS; OBESITY; INFLAMMATION; EXPRESSION; HYPERTENSION; DIAGNOSIS; PROTEIN; SYSTEM; CD105	Endoglin is a transmembrane auxiliary receptor for transforming growth factor-beta (TGF-beta) that is predominantly expressed on proliferating endothelial cells. It plays a wide range of physiological roles but its importance on energy balance or insulin sensitivity has been unexplored. Endoglin deficient mice die during midgestation due to cardiovascular defects. Here we report for first time that heterozygous endoglin deficiency in mice decreases high fat diet-induced hepatic triglyceride content and insulin levels. Importantly, these effects are independent of changes in body weight or adiposity. At molecular level, we failed to detect relevant changes in the insulin signalling pathway at basal levels in liver, muscle or adipose tissues that could explain the insulin-dependent effect. However, we found decreased triglyceride content in the liver of endoglin heterozygous mice fed a high fat diet in comparison to their wild type littermates. Overall, our findings indicate that endoglin is a potentially important physiological mediator of insulin levels and hepatic lipid metabolism.	[Beiroa, Daniel; Romero-Pico, Amparo; Lopez, Miguel; Nogueiras, Ruben; Dieguez, Carlos] Univ Santiago de Compostela, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Inst Invest Sanitarias IDIS, Dept Physiol,Sch Med,CIMUS, Santiago De Compostela, A Coruna, Spain; [Langa, Carmen; Bernabeu, Carmelo] CSIC, Ctr Invest Biol, Madrid, Spain; [Langa, Carmen; Bernabeu, Carmelo] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain; [Lopez-Novoa, Jose M.] Univ Salamanca, Dept Physiol & Pharmacol, Renal & Cardiovasc Physiopathol Unit, E-37008 Salamanca, Spain; [Lopez-Novoa, Jose M.] Inst Invest Biomed Salamanca IBSAL, Salamanca, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universidade de Santiago de Compostela; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC)	Nogueiras, R (corresponding author), Univ Santiago de Compostela, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Inst Invest Sanitarias IDIS, Dept Physiol,Sch Med,CIMUS, Santiago De Compostela, A Coruna, Spain.	ruben.nogueiras@usc.es; carlos.dieguez@usc.es	Bernabeu, Carmelo/P-4662-2019; Nogueiras, Ruben/AAS-9427-2021; Beiroa, Daniel/AAB-8662-2020; Lopez-Novoa, Jose M/A-3672-2008; López, Miguel/ABF-4844-2021; Bernabeu, Carmelo/L-3226-2014	Bernabeu, Carmelo/0000-0002-1563-6162; Nogueiras, Ruben/0000-0002-9976-9930; Beiroa, Daniel/0000-0003-1862-1668; López, Miguel/0000-0002-7823-1648; Bernabeu, Carmelo/0000-0002-1563-6162; Romero-Pico, Amparo/0000-0001-5104-6998; Lopez-Novoa, Jose M./0000-0002-6211-7269; dieguez, carlos/0000-0002-0919-4337	Ministerio de Educacion y Ciencia [BFU2011, RyC-2007-00211, RYC- 2008-02219, SAF2009-07049, RYC-2009-04972, SAF2010-15881, SAF2010-19347, SAF2010-61827]; Xunta de Galicia [10PXIB208164PR, 2010/14]; Junta de Castilla y Leon (Excellence Group) [GR100]; Fondo Investigationes Sanitarias [PS09/01880]; Centro de Investigacion Biomedica en Red (CIBER) de Fisiopatologia de la Obesidad y Nutricion (CIBERobn); CIBER de Enfermedades Raras (CIBERER); Red de Investigacion Cooperativa en Enfermedades Renales (REDinREN); FEDER; European Community [245009, ERC-2011-StG-OBESITY53-281408]	Ministerio de Educacion y Ciencia(Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Junta de Castilla y Leon (Excellence Group)(Junta de Castilla y Leon); Fondo Investigationes Sanitarias(Instituto de Salud Carlos III); Centro de Investigacion Biomedica en Red (CIBER) de Fisiopatologia de la Obesidad y Nutricion (CIBERobn); CIBER de Enfermedades Raras (CIBERER); Red de Investigacion Cooperativa en Enfermedades Renales (REDinREN); FEDER(European Commission); European Community(European Commission)	This work has been supported by grants from Ministerio de Educacion y Ciencia (CD: BFU2011; ML: RyC-2007-00211; RN: RYC- 2008-02219 and SAF2009-07049; GS: RYC-2009-04972, SAF2010-15881 and SAF2010-19347; JML-N: SAF2010-15881; CB: SAF2010-61827), Xunta de Galicia (ML: 10PXIB208164PR and RN: 2010/14), Junta de Castilla y Leon (Excellence Group GR100) Fondo Investigationes Sanitarias (ML: PS09/01880), Centro de Investigacion Biomedica en Red (CIBER) de Fisiopatologia de la Obesidad y Nutricion (CIBERobn), CIBER de Enfermedades Raras (CIBERER) and Red de Investigacion Cooperativa en Enfermedades Renales (REDinREN). CIBERobn, CIBERER and RETIC REDinREN are initiatives of the Instituto de Salud Carlos III (ISCIII) of Spain supported by FEDER funds. The research leading to these results has also received funding from the European Community's Seventh Framework Programme under grant agreements (CD, ML and RN: FP7/2007-2013: no 245009: NeuroFAST, and RN: ERC-2011-StG-OBESITY53-281408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; Blazquez-Medela AM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-86; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Carobbio S, 2011, CURR OPIN CLIN NUTR, V14, P520, DOI 10.1097/MCO.0b013e32834ad966; Casimir M, 2009, J BIOL CHEM, V284, P25004, DOI 10.1074/jbc.M109.015495; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Cudmore MJ, 2012, EUR HEART J, V33, P1150, DOI 10.1093/eurheartj/ehr065; Czyzyk TA, 2010, FASEB J, V24, P1151, DOI 10.1096/fj.09-143610; Fernandez-L A, 2007, THROMB HAEMOSTASIS, V97, P254, DOI 10.1160/TH06-07-0373; Fornoni A, 2005, CURR HYPERTENS REP, V7, P88, DOI 10.1007/s11906-005-0080-6; Gilbert JS, 2009, HYPERTENSION, V53, P399, DOI 10.1161/HYPERTENSIONAHA.108.123513; Gonzalez CR, 2009, J PHYSIOL-LONDON, V587, P3741, DOI 10.1113/jphysiol.2009.172510; GOUGOS A, 1990, J BIOL CHEM, V265, P8361; Graham TE, 2007, HORM METAB RES, V39, P717, DOI 10.1055/s-2007-985879; Hsueh WA, 2004, AM J MED, V117, P109, DOI 10.1016/j.amjmed.2004.02.042; Jerkic M, 2004, FASEB J, V18, P609, DOI 10.1096/fj.03-0197fje; Jerkic M, 2006, CARDIOVASC RES, V69, P845, DOI 10.1016/j.cardiores.2005.11.020; Jerkic M, 2006, CIRC RES, V99, P248, DOI 10.1161/01.RES.0000236755.98627.69; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Lee SJ, 2010, CELL METAB, V12, P65, DOI 10.1016/j.cmet.2010.05.003; Li CG, 2003, J CELL SCI, V116, P2677, DOI 10.1242/jcs.00470; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; Mahmoud M, 2011, BIOCHEM SOC T, V39, P1659, DOI 10.1042/BST20110664; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Nassiri F, 2011, ANTICANCER RES, V31, P2283; Nishi Y, 2011, BIOCHEM J, V435, P421, DOI 10.1042/BJ20101708; Nogueiras R, 2009, J NEUROSCI, V29, P5916, DOI 10.1523/JNEUROSCI.5977-08.2009; Parrish MR, 2010, AM J HYPERTENS, V23, P911, DOI 10.1038/ajh.2010.70; Perez-Gomez E, 2010, THESCIENTIFICWORLDJO, V10, P2367, DOI 10.1100/tsw.2010.230; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Rodriguez-Pena A, 2002, HYPERTENSION, V40, P713, DOI 10.1161/01.HYP.0000037429.73954.27; Santibanez JF, 2007, J CELL PHYSIOL, V210, P456, DOI 10.1002/jcp.20878; Shovlin CL, 2010, BLOOD REV, V24, P203, DOI 10.1016/j.blre.2010.07.001; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; Toporsian M, 2005, CIRC RES, V96, P684, DOI 10.1161/01.res.0000159936.38601.22; Torsney E, 2002, INFLAMM RES, V51, P464, DOI 10.1007/PL00012413; van Laake LW, 2006, CIRCULATION, V114, P2288, DOI 10.1161/CIRCULATIONAHA.106.639161; Vazquez MJ, 2008, ENDOCRINOLOGY, V149, P4534, DOI 10.1210/en.2007-1708; Velasquez DA, 2011, DIABETES, V60, P1177, DOI 10.2337/db10-0802; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006	43	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54591	10.1371/journal.pone.0054591	http://dx.doi.org/10.1371/journal.pone.0054591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23336009	Green Submitted, Green Published, gold			2022-12-25	WOS:000314707700067
J	Zeng, Y; Wang, HX; Guo, SB; Yang, H; Zeng, XJ; Fang, Q; Tang, CS; Du, J; Li, HH				Zeng, Yong; Wang, Hong-Xia; Guo, Shu-Bin; Yang, Hui; Zeng, Xiang-Jun; Fang, Quan; Tang, Chao-Shu; Du, Jie; Li, Hui-Hua			Transcriptional Effects of E3 Ligase Atrogin-1/MAFbx on Apoptosis, Hypertrophy and Inflammation in Neonatal Rat Cardiomyocytes	PLOS ONE			English	Article							SKELETAL-MUSCLE ATROPHY; DEPENDENT CARDIAC-HYPERTROPHY; ACETYL-COA TRANSPORTER; UBIQUITIN LIGASE; HEART-FAILURE; GENE-EXPRESSION; CARDIOVASCULAR-DISEASE; MYOCARDIAL EXPRESSION; SIGNALING PATHWAYS; EP3 RECEPTORS	Atrogin-1/MAFbx is an ubiquitin E3 ligase that regulates myocardial structure and function through the ubiquitin-dependent protein modification. However, little is known about the effect of atrogin-1 activation on the gene expression changes in cardiomyocytes. Neonatal rat cardiomyocytes were infected with adenovirus atrogin-1 (Ad-atrogin-1) or GFP control (Ad-GFP) for 24 hours. The gene expression profiles were compared with microarray analysis. 314 genes were identified as differentially expressed by overexpression of atrogin-1, of which 222 were up-regulated and 92 were down-regulated. Atrogin-1 overexpression significantly modulated the expression of genes in 30 main functional categories, most genes clustered around the regulation of cell death, proliferation, inflammation, metabolism and cardiomyoctye structure and function. Moreover, overexpression of atrogin-1 significantly inhibited cardiomyocyte survival, hypertrophy and inflammation under basal condition or in response to lipopolysaccharide (LPS). In contrast, knockdown of atrogin-1 by siRNA had opposite effects. The mechanisms underlying these effects were associated with inhibition of MAPK (ERK1/2, JNK1/2 and p38) and NF-kappa B signaling pathways. In conclusion, the present microarray analysis reveals previously unappreciated atrogin-1 regulation of genes that could contribute to the effects of atrogin-1 on cardiomyocyte survival, hypertrophy and inflammation in response to endotoxin, and may provide novel insight into how atrogin-1 modulates the programming of cardiac muscle gene expression.	[Zeng, Yong; Fang, Quan] Peking Union Med Hosp, Dept Cardiol, Beijing, Peoples R China; [Wang, Hong-Xia; Yang, Hui; Zeng, Xiang-Jun; Tang, Chao-Shu; Li, Hui-Hua] Capital Med Univ, Sch Basic Med Sci, Dept Pathol & Pathophysiol, Key Lab Remodeling Related Cardiovasc Dis, Beijing, Peoples R China; [Guo, Shu-Bin] Peking Union Med Hosp, Dept Emergency Med, Beijing, Peoples R China; [Du, Jie] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Key Lab Remodeling Related Cardiovasc Dis,Lab Vas, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Capital Medical University	Zeng, Y (corresponding author), Peking Union Med Hosp, Dept Cardiol, Beijing, Peoples R China.	zengyong1999@yahoo.com; hhli1935@yahoo.cn			China Natural Science Foundation [81025001, 30971097, 30888004]; Beijing High-Level Talents Program [PHR20110507]	China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing High-Level Talents Program	This study was supported by grants from the China Natural Science Foundation (81025001, 30971097 and 30888004), the Beijing High-Level Talents Program (PHR20110507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2007, CARDIOVASC RES, V73, P120, DOI 10.1016/j.cardiores.2006.10.026; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Ancey C, 2002, CYTOKINE, V18, P199, DOI 10.1006/cyto.2002.1033; Andersson KB, 2009, J MOL CELL CARDIOL, V47, P180, DOI 10.1016/j.yjmcc.2009.03.013; Arya R, 2004, J CELL BIOL, V167, P1147, DOI 10.1083/jcb.200402033; Baba Y, 2010, CANCER EPIDEM BIOMAR, V19, P822, DOI 10.1158/1055-9965.EPI-09-1154; Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Carniel E, 2005, CIRCULATION, V112, P54, DOI 10.1161/CIRCULATIONAHA.104.507699; Chen W, 2010, HEART FAIL REV, V15, P415, DOI 10.1007/s10741-010-9161-y; Choi JK, 2011, APOPTOSIS, V16, P127, DOI 10.1007/s10495-010-0552-2; Csibi A, 2009, J BIOL CHEM, V284, P4413, DOI 10.1074/jbc.M807641200; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feng LL, 2000, IMMUNOL RES, V21, P203, DOI 10.1385/IR:21:2-3:203; Frantz S, 1999, J CLIN INVEST, V104, P271, DOI 10.1172/JCI6709; Fredj S, 2005, J CELL PHYSIOL, V204, P428, DOI 10.1002/jcp.20307; Galasso G, 2010, EUR J HEART FAIL, V12, P1290, DOI 10.1093/eurjhf/hfq102; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gonzalez-Navajas JM, 2010, J EXP MED, V207, P2799, DOI 10.1084/jem.20101326; Gross S, 2007, J EXP MED, V204, P311, DOI 10.1084/jem.20061617; Heinzelmann M, 2005, J IMMUNOL, V174, P2280, DOI 10.4049/jimmunol.174.4.2280; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jin BW, 2007, J CELL BIOCHEM, V100, P960, DOI 10.1002/jcb.21060; Kanamori A, 1997, P NATL ACAD SCI USA, V94, P2897, DOI 10.1073/pnas.94.7.2897; Kovacic JC, 2007, J MOL CELL CARDIOL, V42, P19, DOI 10.1016/j.yjmcc.2006.10.001; Kwon S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-23; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Lantz KA, 2004, J CLIN INVEST, V114, P512, DOI 10.1172/JCI200421149; Lee SJ, 2010, CELL METAB, V12, P65, DOI 10.1016/j.cmet.2010.05.003; Lee S, 2008, ENDOCRINOLOGY, V149, P2451, DOI 10.1210/en.2007-1595; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Li JJ, 2011, CELL PHYSIOL BIOCHEM, V27, P463, DOI 10.1159/000329967; Li MX, 2005, CIRCULATION, V111, P2494, DOI 10.1161/01.CIR.0000165117.71483.0C; Li YP, 2005, FASEB J, V19, P362, DOI 10.1096/fj.04-2364com; Li YP, 2003, FASEB J, V17, P1048, DOI 10.1096/fj.02-0759com; Lin PF, 2008, AM J HUM GENET, V83, P752, DOI 10.1016/j.ajhg.2008.11.003; Liu CJ, 2008, MOL CELL BIOCHEM, V313, P167, DOI 10.1007/s11010-008-9754-0; Liu Y, 2010, J BIOL CHEM, V285, P27429, DOI 10.1074/jbc.M110.142752; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loureiro B, 2011, AM J REPROD IMMUNOL; Luo X, 2005, J BIOL CHEM, V280, P12668, DOI 10.1074/jbc.M411973200; Lusis AJ, 2008, NAT REV GENET, V9, P819, DOI 10.1038/nrg2468; Martin P, 2002, EMBO J, V21, P4049, DOI 10.1093/emboj/cdf407; Michel MC, 2001, N-S ARCH PHARMACOL, V363, P245, DOI 10.1007/s002100000363; Moreb JS, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-87; Moser B, 2004, ANN RHEUM DIS, V63, P84, DOI 10.1136/ard.2004.028316; Nakayama T, 2010, INT ANGIOL, V29, P33; Niwano K, 2008, MOL THER, V16, P1026, DOI 10.1038/mt.2008.61; Reversade B, 2009, NAT GENET, V41, P1016, DOI 10.1038/ng.413; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Seelan RS, 2009, J BIOL CHEM, V284, P9443, DOI 10.1074/jbc.M900206200; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Sun HP, 2008, CELL SIGNAL, V20, P1952, DOI 10.1016/j.cellsig.2008.07.003; Suzuki J, 2007, J AM COLL CARDIOL, V49, P491, DOI 10.1016/j.jacc.2006.10.043; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Tsuchiya H, 2008, J BIOL CHEM, V283, P11064, DOI 10.1074/jbc.M801359200; Usui S, 2011, CIRC RES, V109, P161, DOI 10.1161/CIRCRESAHA.110.238717; Willis MS, 2010, CIRC RES, V106, P463, DOI 10.1161/CIRCRESAHA.109.208801; Wu LY, 2003, INVEST OPHTH VIS SCI, V44, P2404, DOI 10.1167/iovs.02-0317; Xie P, 2009, J BIOL CHEM, V284, P5488, DOI 10.1074/jbc.M806487200; Yamamoto Y, 2008, CARDIOVASC RES, V79, P89, DOI 10.1093/cvr/cvn076; Yang D, 2010, CELL PHYSIOL BIOCHEM, V25, P605, DOI 10.1159/000315079; Yoshida T, 2010, AM J PHYSIOL-HEART C, V298, pH1565, DOI 10.1152/ajpheart.00146.2010; Yu HMI, 2007, MECH DEVELOP, V124, P146, DOI 10.1016/j.mod.2006.10.002; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021104	68	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53831	10.1371/journal.pone.0053831	http://dx.doi.org/10.1371/journal.pone.0053831			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335977	gold, Green Published, Green Submitted			2022-12-25	WOS:000314707700035
J	Zhivov, A; Winter, K; Hovakimyan, M; Peschel, S; Harder, V; Schober, HC; Kundt, G; Baltrusch, S; Guthoff, RF; Stachs, O				Zhivov, Andrey; Winter, Karsten; Hovakimyan, Marine; Peschel, Sabine; Harder, Volker; Schober, Hans-Christof; Kundt, Guenther; Baltrusch, Simone; Guthoff, Rudolf F.; Stachs, Oliver			Imaging and Quantification of Subbasal Nerve Plexus in Healthy Volunteers and Diabetic Patients with or without Retinopathy	PLOS ONE			English	Article							VIVO CONFOCAL MICROSCOPY; CORNEAL NERVES; PERIPHERAL NEUROPATHY; FIBER DAMAGE; SENSITIVITY; POPULATION; PREVALENCE; PERCEPTION; MORPHOLOGY; SEVERITY	Background: The alterations of subbasal nerve plexus (SBP) innervation and corneal sensation were estimated non-invasively and compared with the values in healthy volunteers. Additionally, this study addressed the relation of SBP changes to the retinal status, glycemic control and diabetes duration. Methodology/Principal Findings: Eighteen eyes of diabetic patients with peripheral diabetic neuropathy aged 68.8 +/- 8.8 years and twenty eyes of healthy volunteers aged 66.3 +/- 13.3 yrs. were investigated with in vivo confocal laser-scanning microscopy (CLSM). An adapted algorithm for image analysis was used to quantify the morphological and topological properties of SBP. These properties were correlated to incidence of diabetic retinopathy (DR) and corneal sensation (Cochet-Bonnet esthesiometer). The developed algorithm allows a fully automated analysis of pre-segmented SBP structures. Altogether, 10 parameters were analysed, and all of them revealed significant differences between diabetic patients and healthy volunteers. The nerve fibre density, total fibre length and nerve branches were found to be significantly lower in patients with diabetes than those of control subjects (nerve fibre density 0.006 +/- 0.002 vs. 0.020 +/- 0.007 mm/mm(2); total fibre length 6223 +/- 2419 vs. 19961 +/- 6553 mu m; nerve branches 25.3 +/- 28.6 vs. 141.9 +/- 85.7 in healthy volunteers). Also the corneal sensation was significantly lower in diabetic group when compared to controls (43 +/- 11 vs. 59 +/- 18 mm). There was found no difference in SBP morphology or corneal sensation in the subgroups with (DR) or without (NDR) diabetic retinopathy. Conclusions/Significance: SBP parameters were significantly reduced in diabetic patients, compared to control group. Interestingly, the SBP impairment could be shown even in the diabetic patients without DR. Although automatic adapted image analysis simplifies the evaluation of in vivo CLSM data, image acquisition and quantitative analysis should be optimised for the everyday clinical practice.	[Zhivov, Andrey; Hovakimyan, Marine; Peschel, Sabine; Guthoff, Rudolf F.; Stachs, Oliver] Univ Rostock, Dept Ophthalmol, D-18055 Rostock, Germany; [Winter, Karsten] Univ Leipzig, Translat Ctr Regenerat Med TRM, D-04109 Leipzig, Germany; [Harder, Volker; Schober, Hans-Christof] Klinikum Sudstadt, Clin Internal Med 1, Rostock, Germany; [Kundt, Guenther] Univ Rostock, Inst Biostat & Informat Med & Ageing Res, D-18055 Rostock, Germany; [Baltrusch, Simone] Univ Rostock, Inst Med Biochem & Mol Biol, D-18055 Rostock, Germany	University of Rostock; Leipzig University; University of Rostock; University of Rostock	Zhivov, A (corresponding author), Univ Rostock, Dept Ophthalmol, D-18055 Rostock, Germany.	andyzhyvov@yahoo.com			DFG (Deutsche Forschungsgemeinschaft) [Transregio 37]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The study was generously supported by the DFG (Deutsche Forschungsgemeinschaft) (Transregio 37, Micro- and Nanosystems in Medicine - Reconstruction of Biological Functions). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aqaba MA, 2010, BRIT J OPHTHALMOL, V94, P1251, DOI 10.1136/bjo.2009.178244; Allgeier S, 2011, INVEST OPHTH VIS SCI, V52, P5022, DOI 10.1167/iovs.10-6065; Argoff CE, 2006, MAYO CLIN PROC, V81, pS3, DOI 10.1016/S0025-6196(11)61474-2; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Barr ELM, 2006, DIABETES CARE, V29, P1114, DOI 10.2337/dc05-2464; BRESNICK GH, 1986, ARCH OPHTHALMOL-CHIC, V104, P989; Chang PY, 2006, AM J OPHTHALMOL, V142, P488, DOI 10.1016/j.ajo.2006.04.033; Cruzat A, 2010, SEMIN OPHTHALMOL, V25, P171, DOI 10.3109/08820538.2010.518133; Dabbah M. A., 2011, MED IMAGE ANAL; De Cilla S, 2009, INVEST OPHTH VIS SCI, V50, P5155, DOI 10.1167/iovs.09-3384; Erie JC, 2005, AM J OPHTHALMOL, V140, P1059, DOI 10.1016/j.ajo.2005.07.027; Heintz E, 2010, DIABETOLOGIA, V53, P2147, DOI 10.1007/s00125-010-1836-3; Holmes TJ, 2010, INVEST OPHTH VIS SCI, V51, P4480, DOI 10.1167/iovs.09-4108; Hossain P, 2005, LANCET, V366, P1340, DOI 10.1016/S0140-6736(05)67546-0; Kallinikos P, 2004, INVEST OPHTH VIS SCI, V45, P418, DOI 10.1167/iovs.03-0637; KLEIN BEK, 1984, OPHTHALMOLOGY, V91, P10; Labbe A, 2012, INVEST OPHTH VIS SCI, V53, P4926, DOI 10.1167/iovs.11-8708; Lauria G, 2010, EUR J NEUROL, V17, P903, DOI 10.1111/j.1468-1331.2010.03023.x; Li J Y, 1995, J Tongji Med Univ, V15, P38; MacDonald BK, 2000, BRAIN, V123, P665, DOI 10.1093/brain/123.4.665; Malik RA, 2003, DIABETOLOGIA, V46, P683, DOI 10.1007/s00125-003-1086-8; Marfurt CF, 2010, EXP EYE RES, V90, P478, DOI 10.1016/j.exer.2009.12.010; MARFURT CF, 1995, INVEST OPHTH VIS SCI, V36, P1100; Mehra S, 2007, DIABETES CARE, V30, P2608, DOI 10.2337/dc07-0870; Messmer EM, 2010, GRAEF ARCH CLIN EXP, V248, P1307, DOI 10.1007/s00417-010-1396-8; Midena E, 2006, J REFRACT SURG, V22, pS1047, DOI 10.3928/1081-597X-20061102-08; Mimura T, 2004, DIABETIC MED, V21, P559, DOI 10.1111/j.1464-5491.2004.01204.x; Mocan MC, 2006, CORNEA, V25, P769, DOI 10.1097/01.ico.0000224640.58848.54; NIELSEN NV, 1979, ACTA NEUROL SCAND, V59, P15; Oliveira-Soto L, 2001, CORNEA, V20, P374, DOI 10.1097/00003226-200105000-00008; Patel DV, 2009, BRIT J OPHTHALMOL, V93, P853, DOI 10.1136/bjo.2008.150615; Patel DV, 2009, CORNEA, V28, P735, DOI 10.1097/ICO.0b013e318193e0e3; Patel DV, 2005, INVEST OPHTH VIS SCI, V46, P4485, DOI 10.1167/iovs.05-0794; PIRART J, 1978, NOUV PRESSE MED, V7, P4031; Rosenberg ME, 2000, INVEST OPHTH VIS SCI, V41, P2915; Scarpa F, 2008, INVEST OPHTH VIS SCI, V49, P4801, DOI 10.1167/iovs.08-2061; Shahidi AM, 2010, CLIN EXP OPTOM, V93, P309, DOI 10.1111/j.1444-0938.2010.00491.x; Stachs O, 2010, J REFRACT SURG, V26, P159, DOI 10.3928/1081597X-20100224-01; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Tavakoli M, 2011, JOVE-J VIS EXP, DOI 10.3791/2194; Tavakoli M, 2010, DIABETES CARE, V33, P1792, DOI 10.2337/dc10-0253; Tavee J, 2009, CLEV CLIN J MED, V76, P297, DOI 10.3949/ccjm.76a.08070; Vinik AI, 2004, MED CLIN N AM, V88, P947, DOI [10.1016/j.mcna.2004.04.009, 10.1212/01.CON.0000455884.29545.d2]; VINIK AI, 1995, MUSCLE NERVE, V18, P574, DOI 10.1002/mus.880180603; Vlckova-Moravcova E, 2008, MUSCLE NERVE, V37, P50, DOI 10.1002/mus.20889; Winter Karsten, 2010, Biomedizinische Technik, V55, P252, DOI 10.1515/BMT.2010.562; Zhang Wenbo, 2011, J Cardiovasc Dis Res, V2, P96, DOI 10.4103/0975-3583.83035; Zhivov A, 2009, BRIT J OPHTHALMOL, V93, P667, DOI 10.1136/bjo.2008.137430; Zhivov A, 2010, BRIT J OPHTHALMOL, V94, P1133, DOI 10.1136/bjo.2009.175489; Ziegler D, 2008, DIABETES CARE, V31, P556, DOI 10.2337/dc07-1615	50	76	80	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e52157	10.1371/journal.pone.0052157	http://dx.doi.org/10.1371/journal.pone.0052157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23341892	Green Published, Green Submitted, gold			2022-12-25	WOS:000314707700007
J	Deng, FY; Lei, SF; Zhang, YH; Zhang, ZL; Guo, YF				Deng, Fei-Yan; Lei, Shu-Feng; Zhang, Yong-Hong; Zhang, Zeng-Li; Guo, Yu-Fan			Functional Relevance for Associations between Genetic Variants and Systemic Lupus Erythematosus	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INCREASED RISK; IRF5 GENE; POPULATION; EXPRESSION; SUSCEPTIBILITY; AGGREGATION; HAPLOTYPE; CHINESE; ITGAM	Systemic lupus erythematosus (SLE) is a serious prototype autoimmune disease characterized by chronic inflammation, auto-antibody production and multi-organ damage. Recent association studies have identified a long list of loci that were associated with SLE with relatively high statistical power. However, most of them only established the statistical associations of genetic markers and SLE at the DNA level without supporting evidence of functional relevance. Here, using publically available datasets, we performed integrative analyses (gene relationship across implicated loci analysis, differential gene expression analysis and functional annotation clustering analysis) and combined with expression quantitative trait loci (eQTLs) results to dissect functional mechanisms underlying the associations for SLE. We found that 14 SNPs, which were significantly associated with SLE in previous studies, have cis-regulation effects on four eQTL genes (HLA-DQA1, HLA-DQB1, HLA-DQB2, and IRF5) that were also differentially expressed in SLE-related cell groups. The functional evidence, taken together, suggested the functional mechanisms underlying the associations of 14 SNPs and SLE. The study may serve as an example of mining publically available datasets and results in validation of significant disease-association results. Utilization of public data resources for integrative analyses may provide novel insights into the molecular genetic mechanisms underlying human diseases.	[Deng, Fei-Yan; Lei, Shu-Feng; Zhang, Yong-Hong; Zhang, Zeng-Li] Soochow Univ, Ctr Genet Epidemiol & Genom, Suzhou, Jiangsu, Peoples R China; [Lei, Shu-Feng; Zhang, Yong-Hong] Soochow Univ, Sch Publ Hlth, Dept Epidemiol, Suzhou, Jiangsu, Peoples R China; [Guo, Yu-Fan] Soochow Univ, Dept Rheumatol, Affiliated Hosp 1, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Lei, SF (corresponding author), Soochow Univ, Ctr Genet Epidemiol & Genom, Suzhou, Jiangsu, Peoples R China.	leisf@suda.edu.cn			Natural Science Foundation of China (NSFC) [31271336, 31071097]; NSFC-Canadian Institutes of Health Research (CIHR) Joint Health Research Initiative Proposal [30811120436]; Soochow University [Q41390112]; Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC-Canadian Institutes of Health Research (CIHR) Joint Health Research Initiative Proposal(Canadian Institutes of Health Research (CIHR)); Soochow University; Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions	The study was supported by Natural Science Foundation of China (NSFC) (31271336, 31071097), NSFC-Canadian Institutes of Health Research (CIHR) Joint Health Research Initiative Proposal (30811120436), Startup Fund from Soochow University (Q41390112), and a Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1976, MEDICINE, V55, P313, DOI 10.1097/00005792-197607000-00003; Chung SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001323; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; Demirci FYK, 2007, ANN HUM GENET, V71, P308, DOI 10.1111/j.1469-1809.2006.00336.x; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jimenez S, 2003, CLIN REV ALLERG IMMU, V25, P3, DOI 10.1385/CRIAI:25:1:3; Kawasaki A, 2008, ARTHRITIS RHEUM-US, V58, P826, DOI 10.1002/art.23216; Kelly JA, 2008, GENES IMMUN, V9, P187, DOI 10.1038/gene.2008.4; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Lee HM, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3317; Lofgren SE, 2010, J RHEUMATOL, V37, P574, DOI 10.3899/jrheum.090440; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; RAMOSNIEMBRO F, 1978, J RHEUMATOL, V5, P433; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Sestak AL, 1999, J RHEUMATOL, V26, P1495; Shin HD, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2152; Sigurdsson S, 2008, HUM MOL GENET, V17, P872, DOI 10.1093/hmg/ddm359; Siu HO, 2008, J RHEUMATOL, V35, P360; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Yang J, 2011, HUM MOL GENET, V20, P601, DOI 10.1093/hmg/ddq474; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841; Yu W, 2011, EUR J HUM GENET, V19, P1095, DOI 10.1038/ejhg.2011.91; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	34	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53037	10.1371/journal.pone.0053037	http://dx.doi.org/10.1371/journal.pone.0053037			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341919	Green Submitted, gold, Green Published			2022-12-25	WOS:000314759400029
J	Franceschini, A; Vilotti, S; Ferrari, MD; van den Maagdenberg, AMJM; Nistri, A; Fabbretti, E				Franceschini, Alessia; Vilotti, Sandra; Ferrari, Michel D.; van den Maagdenberg, Arn M. J. M.; Nistri, Andrea; Fabbretti, Elsa			TNF alpha Levels and Macrophages Expression Reflect an Inflammatory Potential of Trigeminal Ganglia in a Mouse Model of Familial Hemiplegic Migraine	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; DORSAL-ROOT GANGLION; MOLECULAR-MECHANISMS; SPREADING DEPRESSION; SODIUM-CHANNELS; NEURONS; MICROGLIA; RESPONSES; RECEPTOR; PAIN	Latent changes in trigeminal ganglion structure and function resembling inflammatory conditions may predispose to acute attacks of migraine pain. Here, we investigated whether, in trigeminal sensory ganglia, cytokines such as TNF alpha might contribute to a local inflammatory phenotype of a transgenic knock-in (KI) mouse model of familial hemiplegic migraine type-1 (FHM-1). To this end, macrophage occurrence and cytokine expression in trigeminal ganglia were compared between wild type (WT) and R192Q mutant CaV2.1 Ca2+ channel (R192Q KI) mice, a genetic model of FHM-1. Cellular and molecular characterization was performed using a combination of confocal immunohistochemistry and cytokine assays. With respect to WT, R192Q KI trigeminal ganglia were enriched in activated macrophages as suggested by their morphology and immunoreactivity to the markers Iba1, CD11b, and ED1. R192Q KI trigeminal ganglia constitutively expressed higher mRNA levels of IL1 beta, IL6, IL10 and TNF alpha cytokines and the MCP-1 chemokine. Consistent with the report that TNF alpha is a major factor to sensitize trigeminal ganglia, we observed that, following an inflammatory reaction evoked by LPS injection, TNF alpha expression and macrophage occurrence were significantly higher in R192Q KI ganglia with respect to WT ganglia. Our data suggest that, in KI trigeminal ganglia, the complex cellular and molecular environment could support a new tissue phenotype compatible with a neuroinflammatory profile. We propose that, in FHM patients, this condition might contribute to trigeminal pain pathophysiology through release of soluble mediators, including TNF alpha, that may modulate the crosstalk between sensory neurons and resident glia, underlying the process of neuronal sensitisation.	[Franceschini, Alessia; Vilotti, Sandra; Nistri, Andrea; Fabbretti, Elsa] Scuola Int Super Studi Avanzati, Dept Neurosci, Trieste, Italy; [Ferrari, Michel D.; van den Maagdenberg, Arn M. J. M.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [van den Maagdenberg, Arn M. J. M.] Leiden Genet Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Fabbretti, Elsa] Univ Nova Gorica, Ctr Biomed Sci & Engn, Nova Gorica, Slovenia	International School for Advanced Studies (SISSA); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Nova Gorica	Fabbretti, E (corresponding author), Scuola Int Super Studi Avanzati, Dept Neurosci, Trieste, Italy.	fabbre@sissa.it	Ferrari, Michel D./ABE-3758-2021; Franceschini, Alessia/H-4992-2017; van den Maagdenberg, Arn M.J.M./AAE-9052-2019; Franceschini, Alessia/K-3426-2018	Ferrari, Michel D./0000-0001-9691-9449; Franceschini, Alessia/0000-0001-7122-6232; Franceschini, Alessia/0000-0001-7122-6232	Telethon - Italy [GGP10082]; Italian Institute of Technology; Cariplo Foundation [2011-0505]; Research Agency of the Republic of Slovenia [J3-2376-1540]; Centre for Medical Systems Biology	Telethon - Italy(Fondazione Telethon); Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); Cariplo Foundation(Fondazione Cariplo); Research Agency of the Republic of Slovenia(Slovenian Research Agency - Slovenia); Centre for Medical Systems Biology	Funding: The financial support of Telethon - Italy (Grant no. GGP10082 to AN) is gratefully acknowledged. This work was also supported by the Italian Institute of Technology and Cariplo Foundation Grant no. 2011-0505 (to AN), and by the Research Agency of the Republic of Slovenia grant J3-2376-1540 (to EF), and by a grant from the Centre for Medical Systems Biology within the framework of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (to AMJMVDM and MDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aita M, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-8; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Balkowiec-Iskra E, 2011, NEUROSCIENCE, V180, P322, DOI 10.1016/j.neuroscience.2011.02.028; Beutler B, 2001, DRUG METAB DISPOS, V29, P474; Bo SH, 2009, CEPHALALGIA, V29, P365, DOI 10.1111/j.1468-2982.2008.01727.x; Bolay H, 2002, NAT MED, V8, P136, DOI 10.1038/nm0202-136; Bolay Hayrunnisa, 2010, Handb Clin Neurol, V97, P47, DOI 10.1016/S0072-9752(10)97004-8; Bowen EJ, 2006, J NEUROCHEM, V96, P65, DOI 10.1111/j.1471-4159.2005.03524.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carson MJ, 1998, GLIA, V22, P72, DOI 10.1002/(SICI)1098-1136(199801)22:1<72::AID-GLIA7>3.0.CO;2-A; Ceruti S, 2011, J NEUROSCI, V31, P3638, DOI 10.1523/JNEUROSCI.6440-10.2011; Chen X, 2011, EXP NEUROL, V227, P279, DOI 10.1016/j.expneurol.2010.11.017; Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Fioretti B, 2011, J PHYSIOL-LONDON, V589, P5879, DOI 10.1113/jphysiol.2011.220533; Franceschini A, 2012, PURINERGIC SIGNAL; Friedman MH, 2004, HEADACHE, V44, P767, DOI 10.1111/j.1526-4610.2004.04143.x; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Giniatullin R, 2008, MOL NEUROBIOL, V37, P83, DOI 10.1007/s12035-008-8020-5; GLENN JA, 1993, J ANAT, V183, P475; Goadsby PJ, 2005, HEADACHE, V45, pS14, DOI 10.1111/j.1526-4610.2005.4501003.x; Gordon R, 2011, J NEUROSCI METH, V194, P287, DOI 10.1016/j.jneumeth.2010.11.001; Hanani M, 2010, BRAIN RES REV, V64, P304, DOI 10.1016/j.brainresrev.2010.04.009; Hansen JM, 2008, CEPHALALGIA, V28, P496, DOI 10.1111/j.1468-2982.2008.01559.x; Hansen JM, 2008, NEUROLOGY, V71, P841, DOI 10.1212/01.wnl.0000325482.64106.3f; Heinsbroek SEM, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001069; HOLNESS CL, 1993, BLOOD, V81, P1607; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Ji RC, 2012, CELL MOL LIFE SCI, V69, P897, DOI 10.1007/s00018-011-0848-6; Jin XC, 2006, J NEUROSCI, V26, P246, DOI 10.1523/JNEUROSCI.3858-05.2006; Jurkat-Rott K, 2010, ADV EXP MED BIOL, V686, P305, DOI 10.1007/978-90-481-9485-8_18; Kalita J, 2009, CLIN J PAIN, V25, P696, DOI 10.1097/AJP.0b013e3181b12dd3; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim D, 2007, J BIOL CHEM, V282, P14975, DOI 10.1074/jbc.M607277200; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Leung L, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-27; Li YZ, 2004, J NEUROSCI, V24, P9623, DOI 10.1523/JNEUROSCI.2392-04.2004; Lin HH, 2005, J EXP MED, V201, P1615, DOI 10.1084/jem.20042307; Lynch MA, 2009, MOL NEUROBIOL, V40, P139, DOI 10.1007/s12035-009-8077-9; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; MartinezPomares L, 1996, IMMUNOBIOLOGY, V195, P407, DOI 10.1016/S0171-2985(96)80012-X; Mathew R, 2011, CEPHALALGIA, V31, P1368, DOI 10.1177/0333102411418847; McMahon SB, 2009, NEURON, V64, P46, DOI 10.1016/j.neuron.2009.09.033; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; MOSKOWITZ MA, 1993, NEUROLOGY, V43, P16; Nair A, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-48; Olesen J, 2011, TRENDS PHARMACOL SCI, V32, P352, DOI 10.1016/j.tips.2011.02.016; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Pietrobon D, 2007, NEUROTHERAPEUTICS, V4, P274, DOI 10.1016/j.nurt.2007.01.008; Pietrobon D, 2010, J PHYSIOL-LONDON, V588, P1871, DOI 10.1113/jphysiol.2010.188003; PUIL E, 1988, NEUROSCIENCE, V24, P635, DOI 10.1016/0306-4522(88)90357-0; PUIL E, 1988, J NEUROPHYSIOL, V59, P77, DOI 10.1152/jn.1988.59.1.77; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Rajakulendran S, 2012, NAT REV NEUROL, V8, P86, DOI 10.1038/nrneurol.2011.228; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Reuter U, 2001, BRAIN, V124, P2490, DOI 10.1093/brain/124.12.2490; Reuter U, 2002, ANN NEUROL, V51, P507, DOI 10.1002/ana.10159; Rowe BH, 2008, HEADACHE, V48, P333, DOI 10.1111/j.1526-4610.2007.00959.x; Russell MB, 2011, LANCET NEUROL, V10, P457, DOI 10.1016/S1474-4422(11)70048-5; Salegio EAA, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-11; Santos AM, 2008, J COMP NEUROL, V506, P224, DOI 10.1002/cne.21538; Sarchielli P, 2006, HEADACHE, V46, P200, DOI 10.1111/j.1526-4610.2006.00337.x; Sarchielli P, 2004, HEADACHE, V44, P961, DOI 10.1111/j.1526-4610.2004.04189.x; Sasaki Y, 2001, BIOCHEM BIOPH RES CO, V286, P292, DOI 10.1006/bbrc.2001.5388; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Simonetti M, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-11; Sorge RE, 2011, J NEUROSCI, V31, P15450, DOI 10.1523/JNEUROSCI.3859-11.2011; Sun JH, 2006, J NEUROPHYSIOL, V96, P2189, DOI 10.1152/jn.00222.2006; Tfelt-Hansen PC, 2011, HEADACHE, V51, P752, DOI 10.1111/j.1526-4610.2011.01892.x; Thalakoti S, 2007, HEADACHE, V47, P1008, DOI 10.1111/j.1526-4610.2007.00854.x; Thompson WL, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-35; Tietjen GE, 2009, HEADACHE, V49, P1333, DOI 10.1111/j.1526-4610.2009.01521.x; Tottene A, 2009, NEURON, V61, P762, DOI 10.1016/j.neuron.2009.01.027; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Tsuda M, 2012, CURR OPIN PHARMACOL, V12, P74, DOI 10.1016/j.coph.2011.10.014; Tvedskov JF, 2010, CEPHALALGIA, V30, P928, DOI 10.1111/j.1468-2982.2009.02014.x; Uceyler N, 2009, EXP BRAIN RES, V196, P67, DOI 10.1007/s00221-009-1755-z; van den Berg TK, 2005, TRENDS IMMUNOL, V26, P506, DOI 10.1016/j.it.2005.07.008; van den Maagdenberg AMJM, 2004, NEURON, V41, P701, DOI 10.1016/S0896-6273(04)00085-6; van den Maagdenberg AMJM, 2007, CURR OPIN NEUROL, V20, P299, DOI 10.1097/WCO.0b013e3281338d1f; van Velzen M, 2009, J IMMUNOL, V183, P2456, DOI 10.4049/jimmunol.0900890; Vecchia D, 2012, TRENDS NEUROSCI, V35, P507, DOI 10.1016/j.tins.2012.04.007; Vega-Avelaira D, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-70; Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001; Villa G, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-89; Waeber C, 2005, NEUROLOGY, V64, pS9, DOI 10.1212/WNL.64.10_suppl_2.S9; Yang GA, 2011, BRAIN PATHOL, V21, P279, DOI 10.1111/j.1750-3639.2010.00445.x; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang XC, 2011, PAIN, V152, P140, DOI 10.1016/j.pain.2010.10.002	90	62	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52394	10.1371/journal.pone.0052394	http://dx.doi.org/10.1371/journal.pone.0052394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326332	Green Published, Green Submitted, gold			2022-12-25	WOS:000314705800017
J	Liman, R; Facey, PD; van Keulen, G; Dyson, PJ; Del Sol, R				Liman, Recep; Facey, Paul D.; van Keulen, Geertje; Dyson, Paul J.; Del Sol, Ricardo			A Laterally Acquired Galactose Oxidase-Like Gene Is Required for Aerial Development during Osmotic Stress in Streptomyces coelicolor	PLOS ONE			English	Article							KELCH-REPEAT SUPERFAMILY; MYCELIUM FORMATION; ESCHERICHIA-COLI; GLYOXAL OXIDASE; TRANSFER-RNA; PROTEINS; PRODUCT; GROWTH	Phylogenetic reconstruction revealed that most Actinobacterial orthologs of S. coelicolor SCO2837, encoding a metal-dependent galactose oxidase-like protein, are found within Streptomyces and were probably acquired by horizontal gene transfer from fungi. Disruption of SCO2837 (glxA) caused a conditional bld phenotype that could not be reversed by extracellular complementation. Studies aimed at characterising the regulation of expression of glxA showed that it is not a target for other bld genes. We provide evidence that glxA is required for osmotic adaptation, although independently from the known osmotic stress response element SigB. glxA has been predicted to be part of an operon with the transcription unit comprising the upstream cslA gene and glxA. However, both phenotypic and expression studies indicate that it is also expressed from an independent promoter region internal to cslA. GlxA displays an in situ localisation pattern similar to that one observed for CslA at hyphal tips, but localisation of the former is independent of the latter. The functional role of GlxA in relation to CslA is discussed.	[Liman, Recep] Usak Univ, Dept Genet, Fac Sci, Usak, Turkey; [Facey, Paul D.; van Keulen, Geertje; Dyson, Paul J.; Del Sol, Ricardo] Swansea Univ, Inst Life Sci, Coll Med, Swansea, W Glam, Wales	Usak University; Swansea University	Del Sol, R (corresponding author), Swansea Univ, Inst Life Sci, Coll Med, Singleton Pk, Swansea, W Glam, Wales.	e.r.abascal@swansea.ac.uk	Facey, Paul/AAK-3265-2021; Dyson, Paul/S-7312-2019; liman, recep/J-3338-2012; Del Sol, Ricardo/L-3171-2015; Liman, Recep/AAO-9652-2020	Del Sol, Ricardo/0000-0003-0015-3843; Liman, Recep/0000-0002-7944-4952; Dyson, Paul/0000-0002-0558-2666; Facey, Paul/0000-0002-3229-0255	Biotechnology and Biological Sciences Research Council [BB/E019242/1] Funding Source: Medline; BBSRC [BB/E019242/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARON AJ, 1994, J BIOL CHEM, V269, P25095; Bishop A, 2004, GENOME RES, V14, P893, DOI 10.1101/gr.1710304; BORK P, 1994, J MOL BIOL, V236, P1277, DOI 10.1016/0022-2836(94)90056-6; CHAMPNESS WC, 1988, J BACTERIOL, V170, P1168, DOI 10.1128/jb.170.3.1168-1174.1988; Claessen D, 2006, TRENDS MICROBIOL, V14, P313, DOI 10.1016/j.tim.2006.05.008; de Jong W, 2009, MOL MICROBIOL, V73, P1128, DOI 10.1111/j.1365-2958.2009.06838.x; Del Sol R, 2006, J BACTERIOL, V188, P1540, DOI 10.1128/JB.188.4.1540-1550.2006; Facey PD, 2009, MOL MICROBIOL, V73, P1186, DOI 10.1111/j.1365-2958.2009.06848.x; Fernandez-Martinez LT, 2011, ANTON LEEUW INT J G, V99, P515, DOI 10.1007/s10482-010-9518-1; Fernandez-Martinez L, 2009, MOL MICROBIOL, V71, P1250, DOI 10.1111/j.1365-2958.2009.06599.x; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1111/j.1574-6968.1997.tb13882.x; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; JANSSEN GR, 1993, GENE, V124, P133, DOI 10.1016/0378-1119(93)90774-W; Kanhere A, 2005, NUCLEIC ACIDS RES, V33, P3165, DOI 10.1093/nar/gki627; Kelemen GH, 1998, CURR OPIN MICROBIOL, V1, P656, DOI 10.1016/S1369-5274(98)80111-2; KERSTEN PJ, 1990, P NATL ACAD SCI USA, V87, P2936, DOI 10.1073/pnas.87.8.2936; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim DW, 2005, J BACTERIOL, V187, P2957, DOI 10.1128/JB.187.9.2957-2966.2005; Laloi C, 2004, CURR OPIN PLANT BIOL, V7, P323, DOI 10.1016/j.pbi.2004.03.005; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAWLOR EJ, 1987, GENE DEV, V1, P1305, DOI 10.1101/gad.1.10.1305; Leuthner B, 2005, MOL GENET GENOMICS, V272, P639, DOI 10.1007/s00438-004-1085-6; Lyons E., 2008, Tropical Plant Biology, V1, P181, DOI 10.1007/s12042-008-9017-y; MERRICK MJ, 1976, J GEN MICROBIOL, V96, P299, DOI 10.1099/00221287-96-2-299; Mistry BV, 2008, J BACTERIOL, V190, P5555, DOI 10.1128/JB.00398-08; Nodwell JR, 1996, MOL MICROBIOL, V22, P881, DOI 10.1046/j.1365-2958.1996.01540.x; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Rangannan V, 2010, BIOINFORMATICS, V26, P3043, DOI 10.1093/bioinformatics/btq577; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Silakowski B, 1998, J BACTERIOL, V180, P1241, DOI 10.1128/JB.180.5.1241-1247.1998; Spadiut O, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-68; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vanden Wymelenberg A, 2006, APPL ENVIRON MICROB, V72, P4871, DOI 10.1128/AEM.00375-06; Whittaker JW, 2005, ARCH BIOCHEM BIOPHYS, V433, P227, DOI 10.1016/j.abb.2004.08.034; Whittaker JW, 2003, CHEM REV, V103, P2347, DOI 10.1021/cr020425z; Whittaker MM, 2006, ARCH BIOCHEM BIOPHYS, V452, P108, DOI 10.1016/j.abb.2006.06.020; WILLEY J, 1993, GENE DEV, V7, P895, DOI 10.1101/gad.7.5.895; Xu HB, 2008, J BACTERIOL, V190, P4971, DOI 10.1128/JB.01849-07; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	42	24	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54112	10.1371/journal.pone.0054112	http://dx.doi.org/10.1371/journal.pone.0054112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326581	Green Published, gold, Green Submitted			2022-12-25	WOS:000314705800108
J	Du, WL; Wang, J; Pang, YH; Li, YL; Chen, XH; Zhao, JX; Yang, QH; Wu, J				Du, Wanli; Wang, Jing; Pang, Yuhui; Li, Yanli; Chen, Xinhong; Zhao, Jixin; Yang, Qunhui; Wu, Jun			Isolation and Characterization of a Psathyrostachys huashanica Keng 6Ns Chromosome Addition in Common Wheat	PLOS ONE			English	Article							MARKERS; GENE; IDENTIFICATION; INTROGRESSION; RESISTANCE; LOCATION	The development of alien addition lines is important for transferring useful genes from exotic species into common wheat. A hybrid of common wheat cv. 7182 (2n = 6x = 42, AABBDD) and Psathyrostachys huashanica Keng (2n = 2x = 14, NsNs) via embryo culture produced the novel intergeneric disomic addition line 59-11. The seed morphology of 59-11 resembled the parent 7182 and it exhibited extreme agronomic characteristics, i.e., twin stable spikelets, fertile florets, and multi-kernel clusters. Furthermore, 59-11 produced plump kernels with a high seed-setting percentage during the advanced maturation stage. The line was screened based on genomic in situ hybridization, EST-SSR, EST-STS, and gliadin to identify P. huashanica chromatin in the wheat background. The chromosome number and configuration of 59-11 was 2n = 44 = 22 II and we confirmed the 6Ns disomic chromosome additions based on A-PAGE analysis and molecular markers. The results suggested that the production of twin spikelets and multiple kernels per spike in the wheat-P. huashanica addition line was related to homologous group 6 in the wheat chromosome. This is the first report of the introduction of improved spike traits into common wheat from the alien species P. huashanica and it opens up the possibility of increasing the wheat yield based on this enlarged gene pool.	[Du, Wanli; Wang, Jing; Pang, Yuhui; Li, Yanli; Chen, Xinhong; Zhao, Jixin; Yang, Qunhui; Wu, Jun] NW A& F Univ, Coll Agron, Shaanxi Key Lab Genet Engn Plant Breeding, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Wu, J (corresponding author), NW A& F Univ, Coll Agron, Shaanxi Key Lab Genet Engn Plant Breeding, Yangling, Shaanxi, Peoples R China.	wjnwsu@yahoo.com.cn			Ministry of Science and Technology of the People's Repubilc of China [2011AA10010203]; Northwest AF University [Z109021002, A212020716]	Ministry of Science and Technology of the People's Repubilc of China; Northwest AF University	The funds of the Ministry of Science and Technology of the People's Repubilc of China (No. 2011AA10010203) and Northwest A&F University (No. Z109021002, A212020716), which only provide funds for purchases equipments and reagents. The funders had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADEN C, 1991, NORD J BOT, V11, P3, DOI 10.1111/j.1756-1051.1991.tb01790.x; Chen GL, 2012, J BIOSCIENCES, V37, P149, DOI 10.1007/s12038-011-9175-1; Chen HM, 2005, CHINESE SCI BULL, V50, P2328, DOI 10.1360/982005-379; CHEN S, 1991, Acta Genetica Sinica, V18, P508; Chen SY., 1996, ACTA GENET SIN, V23, P447; Cherif-Mouaki S, 2011, EUPHYTICA, V178, P63, DOI 10.1007/s10681-010-0268-y; Cota-Sanchez JH, 2006, PLANT MOL BIOL REP, V24, P161, DOI 10.1007/BF02914055; Dobrovolskaya O, 2009, THEOR APPL GENET, V119, P867, DOI 10.1007/s00122-009-1095-1; Guo ZF, 2010, GENES GENOM, V32, P259, DOI 10.1007/s13258-010-0005-x; Hu LJ, 2011, EUPHYTICA, V177, P169, DOI 10.1007/s10681-010-0216-x; Hu LJ, 2012, GENES GENOMICS, DOI 101007/s13258-011-0153-7; Ishikawa G, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-135; Kang HY, 2009, PLANT BREEDING, V128, P36, DOI 10.1111/j.1439-0523.2008.01542.x; Kang HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021802; Kishii M, 2010, GENES GENET SYST, V85, P281, DOI 10.1266/ggs.85.281; Kuo P. C., 1987, FLORA REIPUBLICAE PO, P51; Lin ZS, 2007, EUPHYTICA, V158, P109, DOI 10.1007/s10681-007-9435-1; Lu BR, 1995, CHINESE BIODIVERSITY, V3, P63; Nakazawa D, 2011, EUPHYTICA, V181, P197, DOI 10.1007/s10681-011-0393-2; PENNELL AL, 1983, EUPHYTICA, V32, P767, DOI 10.1007/BF00042157; Qi LL, 2008, THEOR APPL GENET, V117, P1155, DOI 10.1007/s00122-008-0853-9; Qi LL, 2007, CHROMOSOME RES, V15, P3, DOI 10.1007/s10577-006-1108-8; Rossini L, 2006, THEOR APPL GENET, V112, P1073, DOI 10.1007/s00122-006-0209-2; Vaccino P, 2010, CROP SCI, V50, P528, DOI 10.2135/cropsci2009.04.0179; Walling JG, 2005, METHOD ENZYMOL, V395, P443, DOI 10.1016/S0076-6879(05)95024-6; Wang RRC, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: CEREALS, P77, DOI 10.1007/978-3-642-14228-4_2; Wang Y, 2011, AFR J BIOTECHNOL, V10, P2201; Wang Y, 2011, BIOTECHNOL LETT, V33, P1233, DOI 10.1007/s10529-011-0537-4; Wu J, 2006, THEOR APPL GENET, V114, P13, DOI 10.1007/s00122-006-0405-0; Yang ZJ, 2006, EUPHYTICA, V149, P11, DOI 10.1007/s10681-005-9010-6; Zhao JX, 2010, GENET RESOUR CROP EV, V57, P387, DOI 10.1007/s10722-009-9477-4; Zheng Y. L., 1993, Wheat Information Service, P25; Zhuang LF, 2011, MOL BREEDING, V27, P455, DOI 10.1007/s11032-010-9443-z; 魏育明, 1999, [四川农业大学学报, Journal of Sichuan Agricultural University], V17, P136	34	34	46	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53921	10.1371/journal.pone.0053921	http://dx.doi.org/10.1371/journal.pone.0053921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326537	Green Published, gold, Green Submitted			2022-12-25	WOS:000313552400060
J	Dvorsky, M; Dolezal, J; Kopecky, M; Chlumska, Z; Janatkova, K; Altman, J; de Bello, F; Rehakova, K				Dvorsky, Miroslav; Dolezal, Jiri; Kopecky, Martin; Chlumska, Zuzana; Janatkova, Katerina; Altman, Jan; de Bello, Francesco; Rehakova, Klara			Testing the Stress-Gradient Hypothesis at the Roof of the World: Effects of the Cushion Plant Thylacospermum caespitosum on Species Assemblages	PLOS ONE			English	Article							CHILEAN PATAGONIAN ANDES; POSITIVE ASSOCIATIONS; ECOSYSTEM ENGINEERS; ALPINE ENVIRONMENT; ARID ENVIRONMENTS; AZORELLA-MONANTHA; ABIOTIC STRESS; NURSE PLANTS; VEGETATION; COMMUNITIES	Many cushion plants ameliorate the harsh environment they inhabit in alpine ecosystems and act as nurse plants, with significantly more species growing within their canopy than outside. These facilitative interactions seem to increase with the abiotic stress, thus supporting the stress-gradient hypothesis. We tested this prediction by exploring the association pattern of vascular plants with the dominant cushion plant Thylacospermum caespitosum (Caryophyllaceae) in the arid Trans-Himalaya, where vascular plants occur at one of the highest worldwide elevational limits. We compared plant composition between 1112 pair-plots placed both inside cushions and in surrounding open areas, in communities from cold steppes to subnival zones along two elevational gradients (East Karakoram: 4850-5250 m and Little Tibet: 5350-5850 m). We used PERMANOVA to assess differences in species composition, Friedman-based permutation tests to determine individual species habitat preferences, species-area curves to assess whether interactions are size-dependent and competitive intensity and importance indices to evaluate plant-plant interactions. No indications for net facilitation were found along the elevation gradients. The open areas were not only richer in species, but not a single species preferred to grow exclusively inside cushions, while 39-60% of 56 species detected had a significant preference for the habitat outside cushions. Across the entire elevation range of T. caespitosum, the number and abundance of species were greater outside cushions, suggesting that competitive rather than facilitative interactions prevail. This was supported by lower soil nutrient contents inside cushions, indicating a resource preemption, and little thermal amelioration at the extreme end of the elevational gradient. We attribute the negative associations to competition for limited resources, a strong environmental filter in arid high-mountain environment selecting the stress-tolerant species that do not rely on help from other plants during their life cycle and to the fact the cushions do not provide a better microhabitat to grow in.	[Dvorsky, Miroslav; Dolezal, Jiri; Chlumska, Zuzana; Janatkova, Katerina; Altman, Jan; de Bello, Francesco; Rehakova, Klara] Acad Sci Czech Republic, Inst Bot, Sect Plant Ecol, Trebon, Czech Republic; [Dvorsky, Miroslav; Dolezal, Jiri; Chlumska, Zuzana; Janatkova, Katerina; Altman, Jan] Univ S Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic; [Kopecky, Martin] Acad Sci Czech Republic, Inst Bot, Dept Vegetat Ecol, Brno, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Dolezal, J (corresponding author), Acad Sci Czech Republic, Inst Bot, Sect Plant Ecol, Trebon, Czech Republic.	jiriddolezal@gmail.com	de Bello, Francesco/H-1582-2014; Kopecký, Martin/A-1466-2009; Altman, Jan/B-4305-2015; Doležal, Jiří/H-1583-2014; Rehakova, Klara/B-2143-2012; de Bello, Francesco/AFQ-8650-2022; de Bello, Francesco/HCI-1196-2022; Čapková, Kateřina/M-1430-2014	de Bello, Francesco/0000-0001-9202-8198; Kopecký, Martin/0000-0002-1018-9316; de Bello, Francesco/0000-0001-9202-8198; Čapková, Kateřina/0000-0002-8928-5983; Rehakova, Klara/0000-0002-8871-9989; Dolezal, Jiri/0000-0002-5829-4051	Institute of Botany, Academy of Sciences of the Czech Republic [AV0Z60050516, GD206/08/H044]; Grant Agency of the Academy of Sciences of the Czech Republic [GAAV-IAA600050802]; French National Center for Scientific Research [CNRS-PICs4876]; Grant Agency of the Czech Republic [GD206/08/H044]; Grant Agency of the University of South Bohemia [GAJU-138/2010/P]	Institute of Botany, Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); French National Center for Scientific Research(Centre National de la Recherche Scientifique (CNRS)); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency of the University of South Bohemia	This study was funded by the Institute of Botany, Academy of Sciences of the Czech Republic (AV0Z60050516, GD206/08/H044) and by the projects funded by the Grant Agency of the Academy of Sciences of the Czech Republic (GAAV-IAA600050802), French National Center for Scientific Research (CNRS-PICs4876), Grant Agency of the Czech Republic (GD206/08/H044) and Grant Agency of the University of South Bohemia (GAJU-138/2010/P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Rodriguez IS, 2006, REV CHIL HIST NAT, V79, P329; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2003, ALPINE PLANT LIFE, DOI DOI 10.1007/978-3-642-18970-8; Anthelme F, 2012, J VEG SCI, V23, P62, DOI 10.1111/j.1654-1103.2011.01333.x; Antonsson H, 2009, PLANT ECOL DIVERS, V2, P17, DOI 10.1080/17550870902926504; Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; Arredondo-Nunez A, 2009, COMMUNITY ECOL, V10, P1, DOI 10.1556/ComEc.10.2009.1.1; Arroyo MTK, 2003, PLANT ECOL, V169, P121, DOI 10.1023/A:1026281405115; Badano EI, 2006, J BIOGEOGR, V33, P304, DOI 10.1111/j.1365-2699.2005.01384.x; Badano EI, 2002, REV CHIL HIST NAT, V75, P757; Badano EI, 2008, OECOLOGIA, V155, P821, DOI 10.1007/s00442-007-0953-2; Badano EI, 2006, OIKOS, V115, P369, DOI 10.1111/j.2006.0030-1299.15132.x; Badano EI, 2006, DIVERS DISTRIB, V12, P388, DOI 10.1111/j.1366-9516.2006.00248.x; Bates D., 2010, LME4 LINEAR MIXED EF; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Brooker RW, 2006, NEW PHYTOL, V171, P271, DOI 10.1111/j.1469-8137.2006.01752.x; Cavieres L, 2002, J VEG SCI, V13, P547, DOI 10.1111/j.1654-1103.2002.tb02081.x; Cavieres LA, 2005, PERSPECT PLANT ECOL, V7, P217, DOI 10.1016/j.ppees.2005.09.002; Cavieres LA, 2006, NEW PHYTOL, V169, P59, DOI 10.1111/j.1469-8137.2005.01573.x; Cavieres LA, 2007, ARCT ANTARCT ALP RES, V39, P229, DOI 10.1657/1523-0430(2007)39[229:MMOCPA]2.0.CO;2; Cavieres LA, 2009, J ECOL, V97, P1181, DOI 10.1111/j.1365-2745.2009.01579.x; de Bello F, 2011, ANN BOT-LONDON, V108, P567, DOI 10.1093/aob/mcr183; Dvorsky M, 2011, APPL VEG SCI, V14, P132, DOI 10.1111/j.1654-109X.2010.01103.x; Erschbamer B, 2011, PRESLIA, V83, P387; Fajardo A, 2008, J VEG SCI, V19, P87, DOI 10.3170/2007-8-18332; GOLD WG, 1995, ECOLOGY, V76, P1558, DOI 10.2307/1938157; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/NCLIMATE1329, 10.1038/nclimate1329]; Guo YR, 2008, ENVIRON GEOL, V54, P653, DOI 10.1007/s00254-007-1130-y; Hager J., 1990, PARODIANA, V6, P109; Hartmann H., 1983, JB VER SCHUTZ BERGWE, V48, P131; Haussmann NS, 2010, ACTA OECOL, V36, P299, DOI 10.1016/j.actao.2010.02.001; Hollander M, 1973, NONPARAMETRIC STAT M; Holmgren M, 2010, J ECOL, V98, P1269, DOI 10.1111/j.1365-2745.2010.01709.x; Hothorn T, 2008, J STAT SOFTW, V28, P1; Kleier C, 2004, AUSTRAL ECOL, V29, P461, DOI 10.1111/j.1442-9993.2004.01386.x; Klimes L, 2006, FLORA LADAKH JAMMU K; Klimes L, 2010, ECOGRAPHY, V33, P590, DOI 10.1111/j.1600-0587.2009.05967.x; Klimesova J, 2011, FOLIA GEOBOT, V46, P191, DOI 10.1007/s12224-010-9076-3; le Roux PC, 2004, ARCT ANTARCT ALP RES, V36, P509, DOI 10.1657/1523-0430(2004)36[509:TUOSAA]2.0.CO;2; Leps J, 2005, VEGETATION ECOLOGY, P199; Lortie CJ, 2006, J ECOL, V94, P7, DOI 10.1111/j.1365-2745.2005.01066.x; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Maestre FT, 2005, J ECOL, V93, P748, DOI 10.1111/j.1365-2745.2005.01017.x; Maestre FT, 2006, J ECOL, V94, P17, DOI 10.1111/j.1365-2745.2005.01089.x; Michalet R, 2007, NEW PHYTOL, V173, P3, DOI 10.1111/j.1469-8137.2006.01949.x; Miehe G., 1991, OKOLOGIE ERDE, P181; Miehe G., 2001, ERDKUNDE, V55, P94, DOI [10.3112/erdkunde.2001.01.06, DOI 10.3112/ERDKUNDE.2001.01.06]; Nunez CI, 1999, J VEG SCI, V10, P357, DOI 10.2307/3237064; Oksanen J., 2016, R PACKAG; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Phillips RJ, 2008, J MAPS, V4, P21, DOI 10.4113/jom.2008.98; PYSEK P, 1991, ARCTIC ALPINE RES, V23, P263, DOI 10.2307/1551603; Quiroz CL, 2009, REV CHIL HIST NAT, V82, P171; R Development Core Team, 2010, R LANG ENV STAT COMP; Rehakova K, 2011, MICROB ECOL, V62, P337, DOI 10.1007/s00248-011-9878-8; Romdal TS, 2007, ECOGRAPHY, V30, P440, DOI [10.1111/j.2007.0906-7590.04954.x, 10.1111/j.0906-7590.2007.04954.x]; Seifan M, 2010, J ECOL, V98, P356, DOI 10.1111/j.1365-2745.2009.01621.x; Sklenar P, 2009, FLORA, V204, P270, DOI 10.1016/j.flora.2008.04.001; Tichy L, 2002, J VEG SCI, V13, P451, DOI 10.1111/j.1654-1103.2002.tb02069.x; WANG JT, 1988, VEGETATIO, V75, P135; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Xu JC, 2009, CONSERV BIOL, V23, P520, DOI 10.1111/j.1523-1739.2009.01237.x; Yang Y, 2010, J VEG SCI, V21, P1048, DOI 10.1111/j.1654-1103.2010.01215.x; Zingg T, 1954, BESTIMMUNG KLIMATISC; Zoller H, 2006, BOT HELV, V116, P31, DOI 10.1007/s00035-006-0734-2	67	52	54	3	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53514	10.1371/journal.pone.0053514	http://dx.doi.org/10.1371/journal.pone.0053514			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326446	gold, Green Published, Green Submitted			2022-12-25	WOS:000313552400026
J	Ta, LE; Schmelzer, JD; Bieber, AJ; Loprinzi, CL; Sieck, GC; Brederson, JD; Low, PA; Windebank, AJ				Ta, Lauren E.; Schmelzer, James D.; Bieber, Allan J.; Loprinzi, Charles L.; Sieck, Gary C.; Brederson, Jill D.; Low, Philip A.; Windebank, Anthony J.			A Novel and Selective Poly (ADP-Ribose) Polymerase Inhibitor Ameliorates Chemotherapy-Induced Painful Neuropathy	PLOS ONE			English	Article							ROOT GANGLION NEURONS; INDUCED PERIPHERAL NEUROPATHY; ADVANCED COLORECTAL-CANCER; OXIDATIVE STRESS; NERVOUS-SYSTEM; DNA-DAMAGE; PHASE-I; OXALIPLATIN; CISPLATIN; POLY(ADP-RIBOSE)	Background: Chemotherapy-induced neuropathy is the principle dose limiting factor requiring discontinuation of many chemotherapeutic agents, including cisplatin and oxaliplatin. About 30 to 40% of patients receiving chemotherapy develop pain and sensory changes. Given that poly (ADP-ribose) polymerase (PARP) inhibition has been shown to provide neuroprotection, the current study was developed to test whether the novel PARP inhibitor compound 4a (analog of ABT-888) would attenuate pain in cisplatin and oxaliplatin-induced neuropathy in mice. Results: An established chemotherapy-induced painful neuropathy model of two weekly cycles of 10 intraperitoneal (i.p.) injections separated by 5 days rest was used to examine the therapeutic potential of the PARP inhibitor compound 4a. Behavioral testing using von Frey, paw radiant heat, cold plate, and exploratory behaviors were taken at baseline, and followed by testing at 3, 6, and 8 weeks from the beginning of drug treatment. Conclusion: Cisplatin-treated mice developed heat hyperalgesia and mechanical allodynia while oxaliplatin-treated mice exhibited cold hyperalgesia and mechanical allodynia. Co-administration of 50 mg/kg or 25 mg/kg compound 4a with platinum regimen, attenuated cisplatin-induced heat hyperalgesia and mechanical allodynia in a dose dependent manner. Similarly, co-administration of 50 mg/kg compound 4a attenuated oxaliplatin-induced cold hyperalgesia and mechanical allodynia. These data indicate that administration of a novel PARP inhibitor may have important applications as a therapeutic agent for human chemotherapy-induced painful neuropathy.	[Ta, Lauren E.; Schmelzer, James D.; Bieber, Allan J.; Low, Philip A.; Windebank, Anthony J.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA; [Ta, Lauren E.; Bieber, Allan J.; Windebank, Anthony J.] Mayo Clin, Coll Med, Dept Neurosci, Rochester, MN USA; [Ta, Lauren E.; Bieber, Allan J.; Windebank, Anthony J.] Mayo Clin, Coll Med, Program Mol Neurosci, Rochester, MN USA; [Loprinzi, Charles L.] Mayo Clin, Coll Med, Div Med Oncol, Rochester, MN USA; [Sieck, Gary C.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN USA; [Brederson, Jill D.] Abbott Labs, Abbott Pk, IL 60064 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Abbott Laboratories	Ta, LE (corresponding author), Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA.	ta.lauren@mayo.edu		sieck, gary/0000-0003-3040-9424	National Institutes of Health [NIDCR-DE020868, NCI- CA37404]; American Cancer Society-Institutional Research; Abbott Laboratories; NATIONAL CANCER INSTITUTE [U10CA037404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE020868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society-Institutional Research(American Cancer Society); Abbott Laboratories(Abbott Laboratories); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health grants: NIDCR-DE020868 (L.E.T.), NCI- CA37404 (C.L.L. and L.E.T.), American Cancer Society-Institutional Research Grant New Investigator Award (L.E.T.); an unrestricted research grant from Abbott Laboratories (L.E.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; L.E.T. receives research funding support from Abbott Laboratories. J.D.B. is an employee of Abbott Laboratories. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; APFEL SC, 1992, ANN NEUROL, V31, P76, DOI 10.1002/ana.410310114; Authier N, 2003, EXP NEUROL, V182, P12, DOI 10.1016/S0014-4886(03)00003-7; Barajon I, 1996, EXP NEUROL, V138, P93, DOI 10.1006/exnr.1996.0050; Binder A, 2007, EUR J CANCER, V43, P2658, DOI 10.1016/j.ejca.2007.07.030; Cata JP, 2008, BRAIN RES, V1230, P91, DOI 10.1016/j.brainres.2008.07.022; Cavaletti G, 2001, EUR J CANCER, V37, P2457, DOI 10.1016/S0959-8049(01)00300-8; Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; Donawho CK, 2007, CLIN CANCER RES, V13, P2728, DOI 10.1158/1078-0432.CCR-06-3039; Drel VR, 2009, INVEST OPHTH VIS SCI, V50, P1778, DOI 10.1167/iovs.08-2191; Dzagnidze A, 2007, J NEUROSCI, V27, P9451, DOI 10.1523/JNEUROSCI.0523-07.2007; Farez MF, 2009, NAT IMMUNOL, V10, P958, DOI 10.1038/ni.1775; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Furuta T, 2002, CANCER RES, V62, P4899; Gamelin E, 2002, SEMIN ONCOL, V29, P21, DOI 10.1053/sonc.2002.35525; Gill JS, 1998, J CLIN INVEST, V101, P2842, DOI 10.1172/JCI1130; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; HIGBY DJ, 1974, CANCER, V33, P1219, DOI 10.1002/1097-0142(197405)33:5<1219::AID-CNCR2820330505>3.0.CO;2-U; Ilnytska O, 2006, DIABETES, V55, P1686, DOI 10.2337/db06-0067; Jamieson SMF, 2005, CANCER CHEMOTH PHARM, V56, P391, DOI 10.1007/s00280-004-0953-4; Jiang YL, 2008, CANCER RES, V68, P6425, DOI 10.1158/0008-5472.CAN-08-1173; Joseph EK, 2008, J PAIN, V9, P463, DOI 10.1016/j.jpain.2008.01.335; Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j; Krishnan AV, 2005, MUSCLE NERVE, V32, P51, DOI 10.1002/mus.20340; Ling B, 2007, TOXICOLOGY, V234, P176, DOI 10.1016/j.tox.2007.02.013; Loprinzi Charles L, 2007, J Support Oncol, V5, P119; LOPRINZI CL, 2007, J SUPPORT ONCOL, V5, P128; McDonald ES, 2005, NEUROBIOL DIS, V18, P305, DOI 10.1016/j.nbd.2004.09.013; Meyer L, 2011, PAIN, V152, P170, DOI 10.1016/j.pain.2010.10.015; Miyamoto T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007596; Nassini R, 2011, PAIN, V152, P1621, DOI 10.1016/j.pain.2011.02.051; Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176; OZOLS RF, 1985, J CLIN ONCOL, V3, P1445, DOI 10.1200/JCO.1985.3.11.1445; Pachman DR, 2011, CLIN PHARMACOL THER, V90, P377, DOI 10.1038/clpt.2011.115; Penning TD, 2009, J MED CHEM, V52, P514, DOI 10.1021/jm801171j; Plummer R, 2010, CLIN CANCER RES, V16, P4527, DOI 10.1158/1078-0432.CCR-10-0984; Renn CL, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-29; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Szabo C, 2006, DIABETES, V55, P3004, DOI 10.2337/db06-0147; Ta LE, 2006, NEUROTOXICOLOGY, V27, P992, DOI 10.1016/j.neuro.2006.04.010; Ta LE, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-15; Ta LE, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-9; Tortora G, 2002, ANN ONCOL, V13, P392, DOI 10.1093/annonc/mdf030; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Verdu E, 1999, MUSCLE NERVE, V22, P329, DOI 10.1002/(SICI)1097-4598(199903)22:3<329::AID-MUS5>3.0.CO;2-8; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Windebank AJ, 2008, J PERIPHER NERV SYST, V13, P27, DOI 10.1111/j.1529-8027.2008.00156.x; Xiao WH, 2012, NEUROSCIENCE, V203, P194, DOI 10.1016/j.neuroscience.2011.12.023; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	54	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54161	10.1371/journal.pone.0054161	http://dx.doi.org/10.1371/journal.pone.0054161			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326593	gold, Green Submitted, Green Published			2022-12-25	WOS:000313552400081
J	Zhang, W; Johnston, JA; Ross, MA; Sanniec, K; Gleason, EA; Dueck, AC; Santello, M				Zhang, Wei; Johnston, Jamie A.; Ross, Mark A.; Sanniec, Kyle; Gleason, Elizabeth A.; Dueck, Amylou C.; Santello, Marco			Effects of Carpal Tunnel Syndrome on Dexterous Manipulation Are Grip Type-Dependent	PLOS ONE			English	Article							PRECISION GRIP; MEDIAN NERVE; SENSORIMOTOR MEMORY; COMPRESSION; OBJECTS; FORCE; POSITIONS	Carpal tunnel syndrome (CTS) impairs sensation of a subset of digits. Although the effects of CTS on manipulation performed with CTS-affected digits have been studied using precision grip tasks, the extent to which CTS affects multi-digit force coordination has only recently been studied. Whole-hand manipulation studies have shown that CTS patients retain the ability to modulate multi-digit forces to object mass, mass distribution, and texture. However, CTS results in sensorimotor deficits relative to healthy controls, including significantly larger grip force and lower ability to balance the torques generated by the digits. Here we investigated the effects of CTS on multi-digit force modulation to object weight when manipulating an object with a variable number of fingers. We hypothesized that CTS patients would be able to modulate digit forces to object weight. However, as different grip types involve the exclusive use of CTS-affected digits ('uniform' grips) or a combination of CTS-affected and non-affected digits ('mixed' grips), we addressed the question of whether 'mixed' grips would reduce or worsen CTS-induced force coordination deficits. The former scenario would be due to adding digits with intact tactile feedback, whereas the latter scenario might occur due to a potentially greater challenge for the central nervous system of integrating 'noisy' and intact tactile feedback. CTS patients learned multi-digit force modulation to object weight regardless of grip type. Although controls exerted the same total grip force across all grip types, patients exerted significantly larger grip force than controls but only for manipulations with four and five digits. Importantly, this effect was due to CTS patients' inability to change the finger force distribution when adding the ring and little fingers. These findings suggest that CTS primarily challenges sensorimotor integration processes for dexterous manipulation underlying the coordination of CTS-affected and non-affected digits.	[Zhang, Wei; Santello, Marco] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA; [Zhang, Wei] CUNY Coll Staten Isl, Dept Phys Therapy, Staten Isl, NY USA; [Johnston, Jamie A.] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Johnston, Jamie A.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Ross, Mark A.; Sanniec, Kyle; Gleason, Elizabeth A.; Dueck, Amylou C.] Mayo Clin Hosp, Phoenix, AZ USA	Arizona State University; Arizona State University-Tempe; City University of New York (CUNY) System; College of Staten Island (CUNY); University of Calgary; University of Calgary; Mayo Clinic; Mayo Clinic Phoenix	Santello, M (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA.	marco.santello@asu.edu	zhang, wei/AAV-9554-2021	zhang, wei/0000-0002-2341-0876	National Institute of Child and Health Development (NICHD) at the National Institutes of Health (NIH) [1R01 HD057152]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057152] Funding Source: NIH RePORTER	National Institute of Child and Health Development (NICHD) at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This publication was made possible by grant number 1R01 HD057152 from the National Institute of Child and Health Development (NICHD) at the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afifi M, 2012, CLIN NEUROPHYSIOL, V123, P2281, DOI 10.1016/j.clinph.2012.04.013; Augurelle AS, 2003, J NEUROPHYSIOL, V89, P665, DOI 10.1152/jn.00249.2002; Cole KJ, 2003, EXP BRAIN RES, V148, P150, DOI 10.1007/s00221-002-1283-6; Dun S, 2007, J ELECTROMYOGR KINES, V17, P348, DOI 10.1016/j.jelekin.2006.02.002; Fu QS, 2010, J NEUROSCI, V30, P9117, DOI 10.1523/JNEUROSCI.4159-09.2010; Jaberzadeh S, 2006, MANUAL THER, V11, P22, DOI 10.1016/j.math.2005.02.007; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P59; Lowe BD, 1999, ERGONOMICS, V42, P550, DOI 10.1080/001401399185469; Lukos J, 2007, J NEUROSCI, V27, P3894, DOI 10.1523/JNEUROSCI.4693-06.2007; Lukos JR, 2008, J NEUROSCI, V28, P12765, DOI 10.1523/JNEUROSCI.4335-08.2008; Napadow V, 2006, NEUROIMAGE, V31, P520, DOI 10.1016/j.neuroimage.2005.12.017; Nowak DA, 2003, CLIN NEUROPHYSIOL, V114, P472, DOI 10.1016/S1388-2457(02)00386-3; Papanicolaou GD, 2001, J HAND SURG-AM, V26A, P460, DOI 10.1053/jhsu.2001.24972; Tecchio F, 2002, HUM BRAIN MAPP, V17, P28, DOI 10.1002/hbm.10049; Thonnard JL, 1999, EXP BRAIN RES, V128, P61, DOI 10.1007/s002210050817; Tinazzi M, 1998, BRAIN, V121, P1785, DOI 10.1093/brain/121.9.1785; Zhang W, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-83; Zhang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027715; Zhang W, 2010, J NEUROPHYSIOL, V103, P2953, DOI 10.1152/jn.00140.2010	20	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53751	10.1371/journal.pone.0053751	http://dx.doi.org/10.1371/journal.pone.0053751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326498	Green Published, gold			2022-12-25	WOS:000313552400041
J	Embleton, L; Atwoli, L; Ayuku, D; Braitstein, P				Embleton, Lonnie; Atwoli, Lukoye; Ayuku, David; Braitstein, Paula			The Journey of Addiction: Barriers to and Facilitators of Drug Use Cessation among Street Children and Youths in Western Kenya	PLOS ONE			English	Article							VOLATILE SUBSTANCE MISUSE; RISK BEHAVIORS; BRAZIL; ABUSE; INDIA; LIFE; HIV; INTERVENTIONS; PAKISTAN; KHARTOUM	This mixed-methods study examined barriers to and facilitators of street children's drug use cessation in Eldoret, Kenya utilizing a cross-sectional survey and focus group discussions with a community-based sample of street-involved children and youth. The primary objective of this study was to describe factors that may assist or impede cessation of drug use that can be utilized in developing substance use interventions for this marginalized population. In 2011, 146 children and youth ages 10-19 years, classified as either children on the street or children of the street were recruited to participate in the cross-sectional survey. Of the 146 children that participated in the survey 40 were invited to participate in focus group discussion; 30 returned voluntarily to participate in the discussions. Several themes were derived from children's narratives that described the barriers to and facilitators of drug cessation. Specifically, our findings reveal the strength of the addiction to inhalants, the dual role that peers and family play in substance use, and how the social, cultural, and economic context influence or impede cessation. Our findings demonstrate the need to integrate community, family and peers into any intervention in addition to traditional medical and psychological models for treatment of substance use dependence.	[Embleton, Lonnie; Braitstein, Paula] Moi Univ, Sch Med, Coll Hlth Sci, Dept Med, Eldoret, Kenya; [Atwoli, Lukoye] Moi Univ, Sch Med, Coll Hlth Sci, Dept Mental Hlth, Eldoret, Kenya; [Ayuku, David] Moi Univ, Sch Med, Coll Hlth Sci, Dept Behav Sci, Eldoret, Kenya; [Braitstein, Paula] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA; [Braitstein, Paula] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Braitstein, Paula] Regenstrief Inst Inc, Indianapolis, IN USA	Moi University; Moi University; Moi University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Toronto; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Braitstein, P (corresponding author), Moi Univ, Sch Med, Coll Hlth Sci, Dept Med, Eldoret, Kenya.	pbraitst@iupui.edu	Ayuku, David/AAB-8485-2019	Atwoli, Lukoye/0000-0001-7710-9723	Eunice Kennedy Shriver National Institute Of Child Health & Human Development [R01HD060478]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060478] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute Of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The project described was supported in part by Award Number R01HD060478 from the Eunice Kennedy Shriver National Institute Of Child Health & Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development or the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], 2008, STAT AFR CIT FRAM AD; Atwoli L, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-34; Ayaya S O, 2001, East Afr Med J, V78, P624; Ayuku D, 2003, HEALTH POLICY PLANN, V18, P109, DOI 10.1093/heapol/18.1.109; Ayuku D, 2004, AFRICAN J FOOD AGR N, V4, P1; Ayuku DO, 2004, INT SOC WORK, V47, P293, DOI 10.1177/0020872804041428; Bal B, 2010, SUBST USE MISUSE, V45, P1668, DOI 10.3109/10826081003674856; Baldivieso L E, 1995, NIDA Res Monogr, V148, P50; Cairney S, 2010, J PAEDIATR CHILD H, V46, P510, DOI 10.1111/j.1440-1754.2010.01850.x; Carlini-Cotrim B, 1995, NIDA Res Monogr, V148, P64; Coleman H, 2001, J CHILD ADOLESCENT S, V10; Cottrell-Boyce J, 2010, AFR J DRUG ALCOHOL S, V9, P93; de Carvalho FT, 2006, AIDS BEHAV, V10, pS57, DOI 10.1007/s10461-006-9124-4; Dell C. A., 2006, YOUTH VOLATILE SOLVE; Dybicz P, 2005, INT SOC WORK, V48, P763, DOI 10.1177/0020872805057083; Einterz RM, 2007, ACAD MED, V82, P812, DOI 10.1097/ACM.0b013e3180cc29f1; Elkoussi A, 2011, SUBST USE MISUSE, V46, P35, DOI 10.3109/10826084.2011.580202; Embleton L, 2012, SUBST USE MISUSE, V47, P1234, DOI 10.3109/10826084.2012.700678; Fernandes GT, 2008, INT SOC WORK, V51, P669, DOI 10.1177/0020872808093344; Forster LMK, 1996, DRUG ALCOHOL DEPEN, V43, P57, DOI 10.1016/S0376-8716(96)01288-4; HUSELID RF, 1991, AM J DRUG ALCOHOL AB, V17, P89, DOI 10.3109/00952999108992812; Inciardi JA, 1998, SUBST USE MISUSE, V33, P1461, DOI 10.3109/10826089809069809; Jumper-Thurman P, 1995, NIDA Res Monogr, V148, P250; Kaime-Atterhog W, 2008, CHILD YOUTH SERV REV, V30, P1345, DOI 10.1016/j.childyouth.2008.04.003; Kudrati M, 2008, CHILD ABUSE NEGLECT, V32, P439, DOI 10.1016/j.chiabu.2007.07.009; Lerner R, 1995, NIDA Res Monogr, V148, P191; Ling Minhua, 2019, INCONVENIENT GENERAT; Moos RH, 1997, J SUBST ABUSE TREAT, V14, P71, DOI 10.1016/S0740-5472(96)00189-4; Morakinyo J, 2003, DRUG ALCOHOL DEPEN, V71, P109, DOI 10.1016/S0376-8716(03)00093-0; Nada KH, 2010, AIDS, V24, pS39, DOI 10.1097/01.aids.0000386732.02425.d1; Njord L, 2010, ASIA-PAC J PUBLIC HE, V22, P203, DOI 10.1177/1010539510361515; Olley BO, 2006, CHILD ABUSE NEGLECT, V30, P271, DOI 10.1016/j.chiabu.2005.10.011; Pagare Deepti, 2004, Indian Pediatr, V41, P221; Papas RK, 2010, AIDS BEHAV, V14, P836, DOI 10.1007/s10461-008-9492-z; PARTANEN J, 1993, ADDICTION, V88, pS129, DOI 10.1111/j.1360-0443.1993.tb02171.x; Plummer ML, 2007, CHILD YOUTH SERV REV, V29, P1520, DOI 10.1016/j.childyouth.2007.06.008; Project. KOD, 2011, KEN OP DAT PROJ; Seth R, 2005, SUBST USE MISUSE, V40, P1659, DOI 10.1080/10826080500222792; Sharma S, 2011, SUBST USE MISUSE, V46, P46, DOI 10.3109/10826084.2011.580206; Sherman SS, 2005, J URBAN HEALTH, V82, pIV113, DOI 10.1093/jurban/jti113; Souza R, 2010, INT J SOC PSYCHIAT; Towe VL, 2009, J ADOLESCENT HEALTH, V44, P222, DOI 10.1016/j.jadohealth.2008.09.003; UNICEF, 2006, STAT WORLDS CHILDR 2; Vederhus JK, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-35; Wittig MCW, 1997, SUBST USE MISUSE, V32, P805, DOI 10.3109/10826089709055860	45	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53435	10.1371/journal.pone.0053435	http://dx.doi.org/10.1371/journal.pone.0053435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326428	Green Published, Green Submitted, gold			2022-12-25	WOS:000313551500072
J	Fang, XL; Shu, G; Yu, JJ; Wang, LN; Yang, J; Zeng, QJ; Cheng, X; Zhang, ZQ; Wang, SB; Gao, P; Zhu, XT; Xi, QY; Zhang, YL; Jiang, QY				Fang, Xin-Ling; Shu, Gang; Yu, Jian-Jian; Wang, Li-Na; Yang, Jing; Zeng, Qing-Jie; Cheng, Xiao; Zhang, Zhi-Qi; Wang, Song-Bo; Gao, Ping; Zhu, Xiao-Tong; Xi, Qian-Yun; Zhang, Yong-Liang; Jiang, Qing-Yan			The Anorexigenic Effect of Serotonin Is Mediated by the Generation of NADPH Oxidase-Dependent ROS	PLOS ONE			English	Article							UNCOUPLING PROTEIN-2; PARAVENTRICULAR NUCLEUS; NEUROPEPTIDE-Y; FOOD-INTAKE; PROOPIOMELANOCORTIN NEURONS; OXIDATIVE STRESS; GENE-EXPRESSION; D-FENFLURAMINE; RAT; ACTIVATION	Serotonin (5-HT) is a central inhibitor of food intake in mammals. Thus far, the intracellular mechanisms for the effect of serotonin on appetite regulation remain unclear. It has been recently demonstrated that reactive oxygen species (ROS) in the hypothalamus are a crucial integrative target for the regulation of food intake. To investigate the role of ROS in the serotonin-induced anorexigenic effects, conscious mice were treated with 5-HT alone or combination with Trolox (a ROS scavenger) or Apocynin (an NADPH oxidase inhibitor) by acute intracerebroventricular injection. Both Trolox and Apocynin reversed the anorexigenic action of 5-HT and the 5-HT-induced hypothalamic ROS elevation. The mRNA and protein expression levels of pro-opiomelanocortin (POMC) were dramatically increased after ICV injection with 5-HT. The anorexigenic action of 5-HT was accompanied by markedly elevated hypothalamic MDA levels and GSH-Px activity, while the SOD activity was decreased. Moreover, 5-HT significantly increased the mRNA expression of UCP-2 but reduced the levels of UCP-3. Both Trolox and Apocynin could block the 5-HT-induced changes in UCP-2 and UCP-3 gene expression. Our study demonstrates for the first time that the anorexigenic effect of 5-HT is mediated by the generation of ROS in the hypothalamus through an NADPH oxidase-dependent pathway.	[Fang, Xin-Ling; Shu, Gang; Yu, Jian-Jian; Wang, Li-Na; Yang, Jing; Zeng, Qing-Jie; Cheng, Xiao; Zhang, Zhi-Qi; Wang, Song-Bo; Gao, Ping; Zhu, Xiao-Tong; Xi, Qian-Yun; Zhang, Yong-Liang; Jiang, Qing-Yan] S China Agr Univ, Coll Anim Sci, Guangzhou 510642, Guangdong, Peoples R China	South China Agricultural University	Jiang, QY (corresponding author), S China Agr Univ, Coll Anim Sci, Guangzhou 510642, Guangdong, Peoples R China.	380197470@qq.com			National Basic Research Program of China- the 973 Program [2012CB124701, 2009CB941601]; National Natural Science Foundation of China [30871845]	National Basic Research Program of China- the 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China- the 973 Program (2012CB124701; 2009CB941601) and the National Natural Science Foundation of China (30871845). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Asaba K, 2004, ENDOCRINOLOGY, V145, P39, DOI 10.1210/en.2003-0375; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Benani A, 2007, DIABETES, V56, P152, DOI 10.2337/db06-0440; Choi SJ, 2002, BRAIN RES, V928, P30, DOI 10.1016/S0006-8993(01)03330-3; COON MJ, 1992, FASEB J, V6, P669, DOI 10.1096/fasebj.6.2.1537454; Coppola A, 2007, CELL METAB, V5, P21, DOI 10.1016/j.cmet.2006.12.002; Currie PJ, 2002, PHARMACOL BIOCHEM BE, V71, P709, DOI 10.1016/S0091-3057(01)00671-2; DUBE MG, 1992, BRAIN RES BULL, V29, P865, DOI 10.1016/0361-9230(92)90157-S; Fetissov SO, 2000, NEUROSCIENCE, V101, P657, DOI 10.1016/S0306-4522(00)00374-2; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Freitas JJS, 2001, J NEUROCHEM, V77, P655, DOI 10.1046/j.1471-4159.2001.00280.x; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Heisler LK, 2006, NEURON, V51, P239, DOI 10.1016/j.neuron.2006.06.004; Horvath TL, 1999, J NEUROSCI, V19, P10417; HUTSON PH, 1988, PSYCHOPHARMACOLOGY, V95, P550; Ibrahim N, 2003, ENDOCRINOLOGY, V144, P1331, DOI 10.1210/en.2002-221033; Jaillard T, 2009, DIABETES, V58, P1544, DOI 10.2337/db08-1039; Kageyama K, 1998, NEUROSCI LETT, V243, P17, DOI 10.1016/S0304-3940(98)00097-4; KENNETT GA, 1988, PSYCHOPHARMACOLOGY, V96, P93, DOI 10.1007/BF02431539; Kim MJ, 2005, BRAIN RES, V1040, P178, DOI 10.1016/j.brainres.2005.01.066; Kullisaar T, 2002, INT J FOOD MICROBIOL, V72, P215, DOI 10.1016/S0168-1605(01)00674-2; Kuo DY, 2011, ANTIOXID REDOX SIGN, V15, P2147, DOI 10.1089/ars.2010.3738; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Lee SL, 1998, FREE RADICAL BIO MED, V24, P855, DOI 10.1016/S0891-5849(97)00359-6; Lee SL, 1997, AM J PHYSIOL-CELL PH, V272, pC223, DOI 10.1152/ajpcell.1997.272.1.C223; Leibowitz SF, 1998, BIOL PSYCHIAT, V44, P851, DOI 10.1016/S0006-3223(98)00186-3; Leloup C, 2006, DIABETES, V55, P2084, DOI 10.2337/db06-0086; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Mailloux RJ, 2011, J BIOL CHEM, V286, P21865, DOI 10.1074/jbc.M111.240242; Mukhin YV, 2000, BIOCHEM J, V347, P61, DOI 10.1042/0264-6021:3470061; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Nonogaki K, 2007, INT J NEUROPSYCHOPH, V10, P675, DOI 10.1017/S1461145706007206; Pecqueur C, 2001, J MOL MED, V79, P48, DOI 10.1007/s001090000150; Pietri M, 2005, FASEB J, V19, P1078, DOI 10.1096/fj.04-3631com; Richard D, 1998, J COMP NEUROL, V397, P549; Serrano F, 2003, BRAIN RES, V988, P193, DOI 10.1016/S0006-8993(03)03364-X; Simansky KJ, 1996, BEHAV BRAIN RES, V73, P37, DOI 10.1016/0166-4328(96)00066-6; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Steffens SM, 1997, BRAIN RES BULL, V44, P681, DOI 10.1016/S0361-9230(97)00199-8; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Usuki F, 2001, NEUROSCI LETT, V304, P199, DOI 10.1016/S0304-3940(01)01764-5; Vallet P, 2005, NEUROSCIENCE, V132, P233, DOI 10.1016/j.neuroscience.2004.12.038; Vickers SP, 2001, NEUROPHARMACOLOGY, V41, P200, DOI 10.1016/S0028-3908(01)00063-6; Vickers SP, 1999, PSYCHOPHARMACOLOGY, V143, P309, DOI 10.1007/s002130050952; Voight JP, 2002, PHARMACOL BIOCHEM BE, V72, P403, DOI 10.1016/S0091-3057(01)00763-8; Wang HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019790; Wang JH, 2008, NEUROSCIENCE, V156, P89, DOI 10.1016/j.neuroscience.2008.04.079; Wolfgang MJ, 2007, P NATL ACAD SCI USA, V104, P19285, DOI 10.1073/pnas.0709778104; YOKOYAMA Y, 1990, AM J PHYSIOL, V258, pG564, DOI 10.1152/ajpgi.1990.258.4.G564	52	25	31	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53142	10.1371/journal.pone.0053142	http://dx.doi.org/10.1371/journal.pone.0053142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326391	gold, Green Published, Green Submitted			2022-12-25	WOS:000313551500052
J	Mailloux, RJ; Xuan, JY; Beauchamp, B; Jui, LD; Lou, M; Harper, ME				Mailloux, Ryan J.; Xuan, Jian Ying; Beauchamp, Brittany; Jui, Linda; Lou, Marjorie; Harper, Mary-Ellen			Glutaredoxin-2 Is Required to Control Proton Leak through Uncoupling Protein-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN SPECIES PRODUCTION; SKELETAL-MUSCLE; S-GLUTATHIONYLATION; REDOX STATE; COMPLEX-I; THIOLTRANSFERASE GLUTAREDOXIN; REVERSIBLE GLUTATHIONYLATION; MITOCHONDRIAL CA2+; DEPENDENT CONTROL; OXIDATIVE STRESS	Glutathionylation has emerged as a key modification required for controlling protein function in response to changes in cell redox status. Recently, we showed that the glutathionylation state of uncoupling protein-3 (UCP3) modulates the leak of protons back into the mitochondrial matrix, thus controlling reactive oxygen species production. However, whether or not UCP3 glutathionylation is mediated enzymatically has remained unknown because previous work relied on the use of pharmacological agents, such as diamide, to alter the UCP3 glutathionylation state. Here, we demonstrate that glutaredoxin-2 (Grx2), a matrix oxidoreductase, is required to glutathionylate and inhibit UCP3. Analysis of bioenergetics in skeletal muscle mitochondria revealed that knock-out of Grx2 (Grx2(-/-)) increased proton leak in a UCP3-dependent manner. These effects were reversed using diamide, a glutathionylation catalyst. Importantly, the increased leak did not compromise coupled respiration. Knockdown of Grx2 augmented proton leak-dependent respiration in primary myotubes from wild type mice, an effect that was absent in UCP3(-/-) cells. These results confirm that Grx2 deactivates UCP3 by glutathionylation. To our knowledge, this is the first enzyme identified to regulate UCP3 by glutathionylation and is the first study on the role of Grx2 in the regulation of energy metabolism.	[Mailloux, Ryan J.; Xuan, Jian Ying; Beauchamp, Brittany; Jui, Linda; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Immunol & Microbiol, Ottawa, ON K1H 8M5, Canada; [Lou, Marjorie] Univ Nebraska, Ctr Redox Biol, Lincoln, NE 68583 USA; [Lou, Marjorie] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA	University of Ottawa; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Harper, ME (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Immunol & Microbiol, Ottawa, ON K1H 8M5, Canada.	mharper@uottawa.ca		Harper, Mary-Ellen/0000-0003-3864-5886; Mailloux, Ryan/0000-0003-3986-9830	Canadian Institutes of Health Research, Institute of Nutrition, Metabolism, and Diabetes; Canadian Institutes of Health Research	Canadian Institutes of Health Research, Institute of Nutrition, Metabolism, and Diabetes(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research, Institute of Nutrition, Metabolism, and Diabetes (to M.E.H.), and a postdoctoral fellowship from Canadian Institutes of Health Research (to R.J.M.).	Adams SH, 2000, J NUTR, V130, P711, DOI 10.1093/jn/130.4.711; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Applegate MAB, 2008, BIOCHEMISTRY-US, V47, P473, DOI 10.1021/bi7017464; Azzu V, 2008, BIOCHEM J, V413, P323, DOI 10.1042/BJ20080321; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; Bevilacqua L, 2005, AM J PHYSIOL-ENDOC M, V289, pE429, DOI 10.1152/ajpendo.00435.2004; Bevilacqua L, 2010, BBA-BIOENERGETICS, V1797, P1389, DOI 10.1016/j.bbabio.2010.02.018; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Chen YR, 2007, J BIOL CHEM, V282, P32640, DOI 10.1074/jbc.M702294200; Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Costford SR, 2008, AM J PHYSIOL-ENDOC M, V295, pE1018, DOI 10.1152/ajpendo.00779.2007; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Diao J, 2008, P NATL ACAD SCI USA, V105, P12057, DOI 10.1073/pnas.0710434105; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Gallogly MM, 2008, BIOCHEMISTRY-US, V47, P11144, DOI 10.1021/bi800966v; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gladyshev VN, 2001, J BIOL CHEM, V276, P30374, DOI 10.1074/jbc.M100020200; Graier WF, 2008, CELL CALCIUM, V44, P36, DOI 10.1016/j.ceca.2008.01.001; Harper ME, 2002, DIABETES, V51, P2459, DOI 10.2337/diabetes.51.8.2459; Himms-Hagen J, 1999, INT J OBESITY, V23, pS30, DOI 10.1038/sj.ijo.0800940; Hirasaka K, 2011, ANTIOXID REDOX SIGN, V15, P2645, DOI 10.1089/ars.2011.3888; Huppertz C, 2001, J BIOL CHEM, V276, P12520, DOI 10.1074/jbc.M011708200; Hurd TR, 2008, J BIOL CHEM, V283, P24801, DOI 10.1074/jbc.M803432200; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; ISAACS J, 1977, BIOCHIM BIOPHYS ACTA, V497, P192, DOI 10.1016/0304-4165(77)90152-0; ISAACS JT, 1977, BIOCHIM BIOPHYS ACTA, V498, P29, DOI 10.1016/0304-4165(77)90084-8; Kemp M, 2008, FREE RADICAL BIO MED, V44, P921, DOI 10.1016/j.freeradbiomed.2007.11.008; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Liedhegner EAS, 2012, ANTIOXID REDOX SIGN, V16, P543, DOI 10.1089/ars.2011.4119; Lombardi A, 2010, J BIOL CHEM, V285, P16599, DOI 10.1074/jbc.M110.102699; Mailloux RJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.393538; Mailloux RJ, 2012, TRENDS ENDOCRIN MET, V23, P451, DOI 10.1016/j.tem.2012.04.004; Mailloux RJ, 2012, FASEB J, V26, P363, DOI 10.1096/fj.11-189639; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Mailloux RJ, 2011, BIOCHEM J, V437, P301, DOI 10.1042/BJ20110571; Mailloux RJ, 2011, J BIOL CHEM, V286, P21865, DOI 10.1074/jbc.M111.240242; Mailloux RJ, 2010, FASEB J, V24, P2495, DOI 10.1096/fj.09-151803; MANNERVIK B, 1980, BIOCHEM J, V190, P125, DOI 10.1042/bj1900125; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Mieyal JJ, 2012, ANTIOXID REDOX SIGN, V16, P471, DOI 10.1089/ars.2011.4454; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Mookerjee SA, 2011, BBA-BIOENERGETICS, V1807, P1474, DOI 10.1016/j.bbabio.2011.07.011; Murphy MP, 2012, ANTIOXID REDOX SIGN, V16, P476, DOI 10.1089/ars.2011.4289; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; PAPOV VV, 1994, PROTEIN SCI, V3, P428; Pastore A, 2012, EUR J PHARM SCI, V46, P279, DOI 10.1016/j.ejps.2012.03.010; Pfefferle A, 2013, BBA-MOL CELL RES, V1833, P80, DOI 10.1016/j.bbamcr.2012.10.006; Queiroga CSF, 2010, J BIOL CHEM, V285, P17077, DOI 10.1074/jbc.M109.065052; Robson-Doucette CA, 2011, DIABETES, V60, P2710, DOI 10.2337/db11-0132; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Seifert EL, 2008, J BIOL CHEM, V283, P25124, DOI 10.1074/jbc.M803871200; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Shutt T, 2012, EMBO REP, V13, P909, DOI 10.1038/embor.2012.128; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Wu HL, 2011, FREE RADICAL BIO MED, V51, P2108, DOI 10.1016/j.freeradbiomed.2011.09.011; Wu HL, 2010, BBA-BIOENERGETICS, V1797, P1705, DOI 10.1016/j.bbabio.2010.06.003; Zaffagnini M, 2012, PLANT SCI, V185, P86, DOI 10.1016/j.plantsci.2012.01.005; Zhang HL, 2012, FASEB J, V26, P1442, DOI 10.1096/fj.11-199869; ZIEGLER DM, 1985, ANNU REV BIOCHEM, V54, P305, DOI 10.1146/annurev.bi.54.070185.001513	65	54	54	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8365	8379		10.1074/jbc.M112.442905	http://dx.doi.org/10.1074/jbc.M112.442905			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23335511	hybrid, Green Published			2022-12-25	WOS:000316564500036
J	Cohen-Katsenelson, K; Wasserman, T; Darlyuk-Saadon, I; Rabner, A; Glaser, F; Aronheim, A				Cohen-Katsenelson, Ksenya; Wasserman, Tanya; Darlyuk-Saadon, Ilona; Rabner, Alona; Glaser, Fabian; Aronheim, Ami			Identification and Analysis of a Novel Dimerization Domain Shared by Various Members of c-Jun N-terminal Kinase (JNK) Scaffold Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOCKING INTERACTIONS; SPINDLE POLE; WDR62; MUTATIONS; ACTIVATION; SEQUENCE; JIP; FAMILIES; MODULE	Mitogen-activated protein kinases (MAPKs) form a kinase tier module in which MAPK, MAP2K, and MAP3K are held by scaffold proteins. The scaffold proteins serve as a protein platform for selective and spatial kinase activation. The precise mechanism by which the scaffold proteins function has not yet been fully explained. WDR62 is a novel scaffold protein of the c-Jun N-terminal kinase (JNK) pathway. Recessive mutations within WDR62 result in severe cerebral cortical malformations. One of the WDR62 mutant proteins found in a patient with microcephaly encodes a C-terminal truncated protein that fails to associate efficiently with JNK and MKK7 beta 1. The present article shows that the WDR62 C-terminal region harbors a novel dimerization domain composed of a putative loop-helix domain that is necessary and sufficient for WDR62 dimerization and is critical for its scaffolding function. The loop-helix domain is highly conserved between orthologues and is also shared by the JNK scaffold protein, JNKBP1/MAPKBP1. Based on the high sequence conservation of the loop-helix domain, our article shows that MAPKBP1 homodimerizes and heterodimerizes with WDR62. Endogenous WDR62 and MAPKBP1 co-localize to stress granules following arsenite treatment, but not during mitosis. This study proposes another layer of complexity, in which coordinated activation of signaling pathways is mediated by the association between the different JNK scaffold proteins depending on their biological function.	[Cohen-Katsenelson, Ksenya; Wasserman, Tanya; Darlyuk-Saadon, Ilona; Aronheim, Ami] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Dept Mol Genet, IL-31096 Haifa, Israel; [Rabner, Alona; Glaser, Fabian] Technion Israel Inst Technol, Lorry I Lokey Interdisciplinary Ctr Life Sci & En, Bioinformat Knowledge Unit, IL-32000 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Aronheim, A (corresponding author), Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Dept Mol Genet, 1 Efron St, IL-31096 Haifa, Israel.	aronheim@tx.technion.ac.il		Aronheim, Ami/0000-0002-8575-4092	Israeli Science Foundation [573/11]	Israeli Science Foundation(Israel Science Foundation)	This work was supported by the Israeli Science Foundation Grant 573/11 (to A. A.).	Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Bhat V, 2011, CLIN GENET, V80, P532, DOI 10.1111/j.1399-0004.2011.01686.x; Biesecker LG, 2011, AM J MED GENET A, V155A, P2069, DOI 10.1002/ajmg.a.34183; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Bogoyevitch MA, 2012, J CELL SCI, V125, P5096, DOI 10.1242/jcs.107326; Borsello T, 2007, J NEUROSCI RES, V85, P3632, DOI 10.1002/jnr.21435; Cohen-Katsenelson K, 2011, BIOCHEM J, V439, P381, DOI 10.1042/BJ20110284; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dard N, 2006, BIOESSAYS, V28, P146, DOI 10.1002/bies.20351; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Dhanasekaran DN, 2007, ONCOGENE, V26, P3097, DOI 10.1038/sj.onc.1210395; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; ECK MJ, 1994, NATURE, V368, P764, DOI 10.1038/368764a0; Enslen H, 2001, BIOL CELL, V93, P5, DOI 10.1016/S0248-4900(01)01156-X; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Haeusgen W, 2011, EUR J CELL BIOL, V90, P536, DOI 10.1016/j.ejcb.2010.11.008; Holmberg C, 2002, J BIOL CHEM, V277, P31918, DOI 10.1074/jbc.M200719200; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Kousar R, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-119; Koyano S, 1999, FEBS LETT, V457, P385, DOI 10.1016/S0014-5793(99)01084-4; Kristensen O, 2006, EMBO J, V25, P785, DOI 10.1038/sj.emboj.7600982; Kukekov NV, 2006, J BIOL CHEM, V281, P15517, DOI 10.1074/jbc.M601056200; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Mooney LM, 2004, J BIOL CHEM, V279, P11843, DOI 10.1074/jbc.M311841200; Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682; Nihalani D, 2001, EMBO J, V20, P3447, DOI 10.1093/emboj/20.13.3447; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Wasserman T, 2010, MOL BIOL CELL, V21, P117, DOI 10.1091/mbc.E09-06-0512; Weidenfeld-Baranboim K, 2008, NUCLEIC ACIDS RES, V36, P3608, DOI 10.1093/nar/gkn268; Weston CR, 2002, SCIENCE, V296, P2345, DOI 10.1126/science.1073344; Whitmarsh AJ, 2006, BIOCHEM SOC T, V34, P828, DOI 10.1042/BST0340828; Yablonski D, 1996, P NATL ACAD SCI USA, V93, P13864, DOI 10.1073/pnas.93.24.13864; Yamaguchi T, 2009, CELL BIOL INT, V33, P364, DOI 10.1016/j.cellbi.2009.01.003; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683; Zaki MS, 2011, AM J MED GENET A, V155A, P3035, DOI 10.1002/ajmg.a.34078	43	14	14	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7294	7304		10.1074/jbc.M112.422055	http://dx.doi.org/10.1074/jbc.M112.422055			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23341463	Green Published, hybrid			2022-12-25	WOS:000316002400049
J	Mochida, K; Hasegawa, A; Li, MW; Fray, MD; Kito, S; Vallelunga, JM; Lloyd, KCK; Yoshiki, A; Obata, Y; Ogura, A				Mochida, Keiji; Hasegawa, Ayumi; Li, Ming-Wen; Fray, Martin D.; Kito, Seiji; Vallelunga, Jadine M.; Lloyd, K. C. Kent; Yoshiki, Atsushi; Obata, Yuichi; Ogura, Atsuo			High Osmolality Vitrification: A New Method for the Simple and Temperature-Permissive Cryopreservation of Mouse Embryos	PLOS ONE			English	Article							FERTILIZATION; INVITRO; BLASTOCYSTS; SURVIVAL; BIRTH	Procedures for cryopreserving embryos vary considerably, each having its specific advantages and disadvantages in terms of technical feasibility, embryo survival yield, temperature permissibility and species-or strain-dependent applicability. Here we report a high osmolality vitrification (HOV) method that is advantageous in these respects. Cryopreservation by vitrification is generally very simple, but, unlike slow freezing, embryos should be kept at a supercooling temperature (below -130 degrees C) to avoid cryodamage. We overcame this problem by using an HOV solution containing 42.5% (v/v) ethylene glycol, 17.3% (w/v) Ficoll and 1.0 M sucrose. This solution is more viscous than other cryopreservation solutions, but easy handling of embryos was assured by employing a less viscous equilibration solution before vitrification. Most (>80%) embryos cryopreserved in this solution survived at -80 degrees C for at least 30 days. Normal mice were recovered even after intercontinental transportation in a conventional dry-ice package for 2-3 days, indicating that special containers such as dry shippers with liquid nitrogen vapor are unnecessary. The HOV solution could also be employed for long-term storage in liquid nitrogen, as with other conventional cryoprotectants. Finally, we confirmed that this new vitrification method could be applied successfully to embryos of all six strains of mice we have tested so far. Thus, our HOV method provides an efficient and reliable strategy for the routine cryopreservation of mouse embryos in animal facilities and biomedical laboratories, and for easy and cheap transportation.	[Mochida, Keiji; Hasegawa, Ayumi; Yoshiki, Atsushi; Obata, Yuichi; Ogura, Atsuo] RIKEN, BioResource Ctr, Tsukuba, Ibaraki, Japan; [Li, Ming-Wen; Vallelunga, Jadine M.; Lloyd, K. C. Kent] Univ Calif Davis, Sch Vet Med, Mouse Biol Program, Davis, CA 95616 USA; [Fray, Martin D.] Harwell Sci & Innovat Ctr, Med Res Council, Mary Lyon Ctr, Oxford, England; [Kito, Seiji] Natl Inst Radiol Sci, Chiba 260, Japan; [Ogura, Atsuo] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki, Japan; [Ogura, Atsuo] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Tokyo 113, Japan	RIKEN; University of California System; University of California Davis; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); National Institutes for Quantum Science & Technology; University of Tsukuba; University of Tokyo	Ogura, A (corresponding author), RIKEN, BioResource Ctr, Tsukuba, Ibaraki, Japan.	ogura@rtc.riken.go.jp	Obata, Yuichi/A-5300-2016; Yoshiki, Atsushi/O-6162-2019; Ogura, Atsuo/J-3916-2014	Obata, Yuichi/0000-0003-1839-4709; Yoshiki, Atsushi/0000-0002-9450-5151; Ogura, Atsuo/0000-0003-0447-1988	Fundamental Technologies Upgrading Program; National BioResource Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan; MEXT Japan; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006364] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD012210, U42OD011175] Funding Source: NIH RePORTER	Fundamental Technologies Upgrading Program; National BioResource Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan; MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by Fundamental Technologies Upgrading Program, the National BioResource Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan and a Grant-in-Aid from the MEXT Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Han MS, 2003, THERIOGENOLOGY, V59, P1851, DOI 10.1016/S0093-691X(02)01227-X; Hasegawa A, 2012, J REPROD DEVELOP, V58, P156, DOI 10.1262/jrd.11-097N; HOCHI S, 1994, THERIOGENOLOGY, V42, P483, DOI 10.1016/0093-691X(94)90686-D; Jin B, 2010, BIOL REPROD, V82, P444, DOI 10.1095/biolreprod.109.077685; KASAI M, 1992, BIOL REPROD, V46, P1042, DOI 10.1095/biolreprod46.6.1042; KASAI M, 1990, J REPROD FERTIL, V89, P91, DOI 10.1530/jrf.0.0890091; Martinez AG, 1998, THERIOGENOLOGY, V49, P1039, DOI 10.1016/S0093-691X(98)00052-1; Mochida K, 2005, THERIOGENOLOGY, V64, P135, DOI 10.1016/j.theriogenology.2004.11.013; Mochida K, 2005, MOL REPROD DEV, V70, P464, DOI 10.1002/mrd.20226; Mochida K., 2010, J MAMMALIAN OVA RES, V27, P87, DOI [10.1274/jmor.27.87, DOI 10.1274/JMOR.27.87]; Mochida K, 2001, REPROD BIOTECHNOLOGY, P279; Mochida K, 2011, J VIS EXP, V57; Nakao K, 1997, EXP ANIM TOKYO, V46, P231, DOI 10.1538/expanim.46.231; QUINN P, 1985, FERTIL STERIL, V44, P493; TACHIKAWA S, 1993, MOL REPROD DEV, V34, P266, DOI 10.1002/mrd.1080340306; VALDEZ CA, 1992, J REPROD FERTIL, V96, P793, DOI 10.1530/jrf.0.0960793; WHITTINGHAM DG, 1974, GENETICS, V78, P395; WHITTINGHAM DG, 1972, SCIENCE, V178, P411, DOI 10.1126/science.178.4059.411; Yavin S, 2007, THERIOGENOLOGY, V67, P81, DOI 10.1016/j.theriogenology.2006.09.029; Zhou GB, 2005, ANIM BIOTECHNOL, V16, P153, DOI 10.1080/10495390500263831	21	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e49316	10.1371/journal.pone.0049316	http://dx.doi.org/10.1371/journal.pone.0049316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341870	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700003
J	Moore, JE; Barlow, JP				Moore, Jeffrey E.; Barlow, Jay P.			Declining Abundance of Beaked Whales ( Family Ziphiidae) in the California Current Large Marine Ecosystem	PLOS ONE			English	Article							LINE-TRANSECT SURVEYS; POPULATION-DENSITY; BERARDIUS-BAIRDII; NORTH PACIFIC; CETACEANS; TRENDS; BYCATCH; OXYGEN; NOISE; SEA	Beaked whales are among the most diverse yet least understood groups of marine mammals. A diverse set of mostly anthropogenic threats necessitates improvement in our ability to assess population status for this cryptic group. The Southwest Fisheries Science Center (NOAA) conducted six ship line-transect cetacean abundance surveys in the California Current off the contiguous western United States between 1991 and 2008. We used a Bayesian hidden-process modeling approach to estimate abundance and population trends of beaked whales using sightings data from these surveys. We also compiled records of beaked whale stranding events (3 genera, at least 8 species) on adjacent beaches from 1900 to 2012, to help assess population status of beaked whales in the northern part of the California Current. Bayesian posterior summaries for trend parameters provide strong evidence of declining beaked whale abundance in the study area. The probability of negative trend for Cuvier's beaked whale (Ziphius cavirostris) during 1991-2008 was 0.84, with 1991 and 2008 estimates of 10771 (CV = 0.51) and approximate to 7550 (CV = 0.55), respectively. The probability of decline for Mesoplodon spp. (pooled across species) was 0.96, with 1991 and 2008 estimates of 2206 (CV = 0.46) and 811 (CV = 0.65). The mean posterior estimates for average rate of decline were 2.9% and 7.0% per year. There was no evidence of abundance trend for Baird's beaked whale (Berardius bairdii), for which annual abundance estimates in the survey area ranged from approximate to 900 to 1300 (CV approximate to 1.3). Stranding data were consistent with the survey results. Causes of apparent declines are unknown. Direct impacts of fisheries (bycatch) can be ruled out, but impacts of anthropogenic sound (e.g., naval active sonar) and ecosystem change are plausible hypotheses that merit investigation.	[Moore, Jeffrey E.; Barlow, Jay P.] NOAA, Protected Resources Div, SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA	National Oceanic Atmospheric Admin (NOAA) - USA	Moore, JE (corresponding author), NOAA, Protected Resources Div, SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA.	jeff.e.moore@noaa.gov	Barlow, Jay/D-3565-2019	Barlow, Jay/0000-0001-7862-855X	National Oceanic and Atmospheric Administration	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	Research was supported by the National Oceanic and Atmospheric Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew R. K., 2002, Acoustics Research Letters Online, V3, P65, DOI 10.1121/1.1461915; Antonelis George A., 1994, P211; Baird RW, 2008, MAR MAMMAL SCI, V24, P630, DOI 10.1111/j.1748-7692.2008.00211.x; Baker CS, 2006, ANIM CONSERV, V9, P474, DOI 10.1111/j.1469-1795.2006.00062.x; Barlow J, 1999, MARINE MAMMAL SURVEY AND ASSESSMENT METHODS, P209; Barlow J, 2010, NOAATMNMFSSWFSC456; Barlow J, 2007, FISH B-NOAA, V105, P509; Bograd SJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034185; Buckland S.T., 2001, pi; Carretta J V, 2003, MAR FISH REV, V66, P21; Carretta JV, 2008, MAR MAMMAL SCI, V24, P956, DOI 10.1111/j.1748-7692.2008.00218.x; Carretta James V., 2011, Bulletin Southern California Academy of Sciences, V110, P152; Carretta JV, 2011, NMFSSWFSC488 NOAA US; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Claridge DE, 2012, 2012 MARINE MAMMALS; Committee on Taxonomy, 2012, LIST MAR MAMM SPEC S; Condit R, 2012, MARINE MAMM IN PRESS; Cox T. M., 2005, Journal of Cetacean Research and Management, V7, P177; Dalebout ML, 2002, MAR MAMMAL SCI, V18, P577, DOI 10.1111/j.1748-7692.2002.tb01061.x; Danil Kerri, 2010, Journal of Cetacean Research and Management, V11, P163; Davidson AD, 2012, P NATL ACAD SCI USA, V109, P3395, DOI 10.1073/pnas.1121469109; Faerber MM, 2010, MAR MAMMAL SCI, V26, P602, DOI 10.1111/j.1748-7692.2010.00370.x; Falcone EA, 2009, MAR BIOL, V156, P2631, DOI 10.1007/s00227-009-1289-8; Fernandez A, 2004, NATURE, V428, DOI 10.1038/nature02528; Field JC, 2007, CAL COOP OCEAN FISH, V48, P131; Fiscus CH, 1989, 83 NOAA NMFS US DEP; Gerrodette T, 2011, MAR ECOL-EVOL PERSP, V32, P404, DOI 10.1111/j.1439-0485.2011.00466.x; Hildebrand J, 2005, MARINE MAMMAL RESEARCH: CONSERVATION BEYOND CRISIS, P101; Hooker SK, 2012, P ROY SOC B-BIOL SCI, V279, P1041, DOI 10.1098/rspb.2011.2088; *IWC, 2012, REP SCI COMM; IWC (International Whaling Commisssion), 2012, J CETACEAN RES MANAG, V13, P263; Jepson PD, 2003, NATURE, V425, P575, DOI 10.1038/425575a; Jewell R, 2012, MAR ECOL PROG SER, V453, P227, DOI 10.3354/meps09636; Julian F, 1998, FISH B-NOAA, V96, P271; Keller AA, 2012, FISH B-NOAA, V110, P205; Kery M, 2010, J ANIM ECOL, V79, P453, DOI 10.1111/j.1365-2656.2009.01632.x; Kery M, 2009, J APPL ECOL, V46, P1163, DOI 10.1111/j.1365-2664.2009.01724.x; Kinzey D., 2000, LJ0008 NOAA SWFSC; Koslow JA, 2011, MAR ECOL PROG SER, V436, P207, DOI 10.3354/meps09270; Levin PS, 2006, CONSERV BIOL, V20, P1181, DOI 10.1111/j.1523-1739.2006.00400.x; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MacLeod CD, 2003, J MAR BIOL ASSOC UK, V83, P651, DOI 10.1017/S0025315403007616h; MacLeod Colin D., 2005, Journal of Cetacean Research and Management, V7, P211; MacLeod Colin D., 2005, Journal of Cetacean Research and Management, V7, P271; Marques FFC, 2004, ADV DISTANCE SAMPLIN; Marques TA, 2009, J ACOUST SOC AM, V125, P1982, DOI 10.1121/1.3089590; McCarthy E, 2011, MAR MAMMAL SCI, V27, pE206, DOI 10.1111/j.1748-7692.2010.00457.x; McDonald MA, 2006, J ACOUST SOC AM, V120, P711, DOI 10.1121/1.2216565; MEAD JG, 1981, J MAMMAL, V62, P430, DOI 10.2307/1380733; Moore JE, 2011, J APPL ECOL, V48, P1195, DOI 10.1111/j.1365-2664.2011.02018.x; Moore JE, 2009, MAR POLICY, V33, P435, DOI 10.1016/j.marpol.2008.09.003; Moretti D, 2006, P OC 2006 MTS IEEE C; Norman S. A., 2004, Journal of Cetacean Research and Management, V6, P87; Northridge S, 1996, ESTIMATION CET UNPUB; Ohizumi H, 2003, FISHERIES SCI, V69, P11, DOI 10.1046/j.1444-2906.2003.00582.x; Parsons ECM, 2008, MAR POLLUT BULL, V56, P1248, DOI 10.1016/j.marpolbul.2008.04.025; Perrin WF, 2011, MAR MAMMAL SCI, V27, P769, DOI 10.1111/j.1748-7692.2010.00442.x; Peterson WT, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017528; Pierce SD, 2012, J PHYS OCEANOGR, V42, P495, DOI 10.1175/JPO-D-11-0170.1; Pitman R, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P721; Seibel BA, 2011, J EXP BIOL, V214, P326, DOI 10.1242/jeb.049171; Soto NA, 2006, MAR MAMMAL SCI, V22, P690, DOI 10.1111/j.1748-7692.2006.00044.x; Spiegelhalter D., 2007, WINBUGS USER MANUAL; Stewart Brent S., 1994, P29; Taylor BL, 2007, MAR MAMMAL SCI, V23, P157, DOI 10.1111/j.1748-7692.2006.00092.x; TAYLOR BL, 1993, CONSERV BIOL, V7, P489, DOI 10.1046/j.1523-1739.1993.07030489.x; Thompson WL, 2004, SAMPLING RARE ELUSIV; Tyack PL, 2008, J MAMMAL, V89, P549, DOI 10.1644/07-MAMM-S-307R.1; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; Walker WA, 2002, MAR MAMMAL SCI, V18, P902, DOI 10.1111/j.1748-7692.2002.tb01081.x; Weilgart LS, 2007, CAN J ZOOL, V85, P1091, DOI 10.1139/Z07-101; Williams R, 2011, CONSERV LETT, V4, P228, DOI 10.1111/j.1755-263X.2011.00168.x; Wright A.J., 2007, INTERJ COMP PSYCHO, V20, P274, DOI DOI 10.5070/P4202009994; Wright AJ, 2011, MAR POLLUT BULL, V63, P5, DOI 10.1016/j.marpolbul.2009.11.024; Zeidberg LD, 2007, P NATL ACAD SCI USA, V104, P12946, DOI 10.1073/pnas.0702043104	75	43	45	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e52770	10.1371/journal.pone.0052770	http://dx.doi.org/10.1371/journal.pone.0052770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341907	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700014
J	Wang, B; Zhang, Q; Zhu, BL; Cui, ZL; Zhou, J				Wang, Biao; Zhang, Qi; Zhu, Bili; Cui, Zhonglin; Zhou, Jie			Protective Effect of Gadolinium Chloride on Early Warm Ischemia/Reperfusion Injury in Rat Bile Duct during Liver Transplantation	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; RISK-FACTORS; HEPATIC ISCHEMIA; KUPFFER CELLS; FAS RECEPTOR; TNF-ALPHA; BILIARY; APOPTOSIS; GDCL3; COMPLICATIONS	Background: Activation of Kupffer cell (KC) is acknowledged as a key event in the initiation and perpetuation of bile duct warm ischemia/reperfusion injury. The inhibitory effect of gadolinium chloride (GdCl3) on KC activation shows potential as a protective intervention in liver injury, but there is less research with regard to bile duct injury. Methods: Sixty-five male Sprague-Dawley rats (200-250 g) were randomly divided into three experimental groups: a sham group (n = 15), a control group (n = 25), and a GdCl3 group (n = 25). Specimen was collected at 0.5, 2, 6, 12 and 24 h after operation. Alanine aminotransferase (ALT), alkaline phosphatase (ALP) and total bilirubin (TBIL) of serum were measured. Tumor necrosis factor-alpha (TNF-alpha), Capase-3 activity and soluble Fas (sFas) were detected. The pathologic changes of bile duct were observed. Immunochemistry for bile duct Fas was performed. Apoptosis of bile duct cells was evaluated by the terminal UDP nick end labeling assay. Results: GdCl3 significantly decreased the levels of ALT, ALP and TBIL at 2, 6, 12, and 24 h, and increased serum sFas at 2, 6 and 12 h (P < 0.05). TNF-alpha was lower in the GdCl3 group than in the control group at 2, 6, 12 and 24 h (P < 0.05). Preadministration of GdCl3 significantly reduced the Caspase-3 activity and bile duct cell apoptosis at 2, 6, 12 and 24 h. After operation for 2, 6 and 12 h, the expression of Fas protein was lower in the GdCl3 group than in the control group (P < 0.05). Conclusions: GdCl3 plays an important role in suppressing bile duct cell apoptosis, including decreasing ALT, ALP, TBIL and TNF-alpha; suppressing Fas-FasL-Caspase signal transduction during transplantation.	[Wang, Biao; Cui, Zhonglin; Zhou, Jie] So Med Univ, Nanfang Hosp, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China; [Zhang, Qi] Sun Yat Sen Univ, Affiliated Hosp 3, Liver Transplantat Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Bili] So Med Univ, Nanfang Hosp, Huiqiao Dept, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Sun Yat Sen University; Southern Medical University - China	Zhou, J (corresponding author), So Med Univ, Nanfang Hosp, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China.	zhoujiejacky@126.com						Ban D, 2009, J SURG RES, V153, P310, DOI 10.1016/j.jss.2008.02.064; Cag M, 2010, TRANSPL P, V42, P3630, DOI 10.1016/j.transproceed.2010.08.061; Cardinal H, 2010, AM J CARDIOL, V105, P797, DOI 10.1016/j.amjcard.2009.10.061; Crescenzi E, 2011, ONCOGENE, V30, P2707, DOI 10.1038/onc.2011.1; de Vera ME, 2009, AM J TRANSPLANT, V9, P773, DOI 10.1111/j.1600-6143.2009.02560.x; Esposito E, 2009, CURR MED CHEM, V16, P3152, DOI 10.2174/092986709788803024; Giakoustidis D, 2006, SURG TODAY, V36, P450, DOI 10.1007/s00595-005-3162-9; Guichelaar MMJ, 2003, AM J TRANSPLANT, V3, P885, DOI 10.1034/j.1600-6143.2003.00165.x; Heidenhain C, 2010, TRANSPL INT, V23, P14, DOI 10.1111/j.1432-2277.2009.00947.x; Henrich D, 2008, MICROCIRCULATION, V15, P427, DOI 10.1080/10739680701675213; Iwata M, 2003, HEPATOL RES, V25, P329, DOI 10.1016/S1386-6346(02)00273-5; Lee CM, 2004, INT J BIOCHEM CELL B, V36, P481, DOI 10.1016/j.biocel.2003.08.004; Li JY, 2009, HEPATOB PANCREAT DIS, V8, P518; LIU P, 1995, SHOCK, V3, P56, DOI 10.1097/00024382-199503010-00010; Monbaliu D, 2009, ANN SURG, V250, P808, DOI 10.1097/SLA.0b013e3181bdd787; Montalvo-Jave EE, 2008, J SURG RES, V147, P153, DOI 10.1016/j.jss.2007.06.015; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Ohkohchi N, 2001, TRANSPLANT P, V33, P3728, DOI 10.1016/S0041-1345(01)02522-2; Paulsen M, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-7; Rentsch M, 2005, TRANSPLANT INT, V18, P1079, DOI 10.1111/j.1432-2277.2005.00185.x; Schneider L, 2010, PANCREAS, V39, P502, DOI 10.1097/MPA.0b013e3181bd6470; Singhal A, 2010, TRANSPL INT, V23, P245, DOI 10.1111/j.1432-2277.2009.01037.x; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Tian YH, 2006, P NATL ACAD SCI USA, V103, P4598, DOI 10.1073/pnas.0600499103; Wang MF, 2011, HEPATOB PANCREAT DIS, V10, P374, DOI 10.1016/S1499-3872(11)60063-5; Wang XD, 2007, FREE RADICAL BIO MED, V42, P971, DOI 10.1016/j.freeradbiomed.2006.12.023; Zhao HF, 2009, HEPATOB PANCREAT DIS, V8, P247	27	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52743	10.1371/journal.pone.0052743	http://dx.doi.org/10.1371/journal.pone.0052743			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341905	Green Submitted, gold, Green Published			2022-12-25	WOS:000314759400020
J	Balint, M; Tiffin, P; Hallstrom, B; O'Hara, RB; Olson, MS; Fankhauser, JD; Piepenbring, M; Schmitt, I				Balint, Miklos; Tiffin, Peter; Hallstroem, Bjoern; O'Hara, Robert B.; Olson, Matthew S.; Fankhauser, Johnathon D.; Piepenbring, Meike; Schmitt, Imke			Host Genotype Shapes the Foliar Fungal Microbiome of Balsam Poplar (Populus balsamifera)	PLOS ONE			English	Article							ENDOPHYTIC FUNGI; DIVERSITY; COMMUNITIES; ENVIRONMENT; GENERATION; SEQUENCES; DISTANCE; LEAVES; GROWTH; RANGE	Foliar fungal communities of plants are diverse and ubiquitous. In grasses endophytes may increase host fitness; in trees, their ecological roles are poorly understood. We investigated whether the genotype of the host tree influences community structure of foliar fungi. We sampled leaves from genotyped balsam poplars from across the species' range, and applied 454 amplicon sequencing to characterize foliar fungal communities. At the time of the sampling the poplars had been growing in a common garden for two years. We found diverse fungal communities associated with the poplar leaves. Linear discriminant analysis and generalized linear models showed that host genotypes had a structuring effect on the composition of foliar fungal communities. The observed patterns may be explained by a filtering mechanism which allows the trees to selectively recruit fungal strains from the environment. Alternatively, host genotype-specific fungal communities may be present in the tree systemically, and persist in the host even after two clonal reproductions. Both scenarios are consistent with host tree adaptation to specific foliar fungal communities and suggest that there is a functional basis for the strong biotic interaction.	[Balint, Miklos; Hallstroem, Bjoern; O'Hara, Robert B.; Schmitt, Imke] Senckenberg Gesell Nat Forsch, Biodivers & Climate Res Ctr, Frankfurt, Germany; [Balint, Miklos] Univ Babes Bolyai, Ctr Mol Biol, R-3400 Cluj Napoca, Romania; [Tiffin, Peter] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; [Olson, Matthew S.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Olson, Matthew S.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [Fankhauser, Johnathon D.] Univ Minnesota, St Paul, MN 55108 USA; [Piepenbring, Meike; Schmitt, Imke] Goethe Univ Frankfurt, Inst Okol Evolut & Diversitat, D-60054 Frankfurt, Germany	Senckenberg Gesellschaft fur Naturforschung (SGN); Babes Bolyai University from Cluj; University of Minnesota System; University of Minnesota Twin Cities; Texas Tech University System; Texas Tech University; University of Alaska System; University of Alaska Fairbanks; University of Minnesota System; University of Minnesota Twin Cities; Goethe University Frankfurt	Balint, M (corresponding author), Senckenberg Gesell Nat Forsch, Biodivers & Climate Res Ctr, Frankfurt, Germany.	mbalint@senckenberg.de; ischmitt@senckenberg.de	rolshausen, philippe/F-7999-2011; O'Hara, Bob/A-7499-2008; Olson, Matthew S./ABI-7695-2020	O'Hara, Bob/0000-0001-9737-3724; Tiffin, Peter/0000-0003-1975-610X	Hesse's Ministry of Higher Education, Research, and the Arts; US National Science Foundation [DBI-0701911, 1137001]; Alaska EPSCoR (NSF) [EPS-0701898]; Alaska EPSCoR (state of Alaska)	Hesse's Ministry of Higher Education, Research, and the Arts; US National Science Foundation(National Science Foundation (NSF)); Alaska EPSCoR (NSF); Alaska EPSCoR (state of Alaska)	This study was funded by the research funding program Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) of Hesse's Ministry of Higher Education, Research, and the Arts, a US National Science Foundation Plant Genome Research Program grant (DBI-0701911 and 1137001) and a grant from Alaska EPSCoR (NSF award #EPS-0701898 and the state of Alaska). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aly AH, 2008, PHYTOCHEMISTRY, V69, P1716, DOI 10.1016/j.phytochem.2008.02.013; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Arnold A. Elizabeth, 2007, Fungal Biology Reviews, V21, P51, DOI 10.1016/j.fbr.2007.05.003; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; Bakker MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044357; Bazzicalupo AL, 2013, FUNGAL ECOL, V6, P102, DOI 10.1016/j.funeco.2012.09.003; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; BULMER MG, 1974, BIOMETRICS, V30, P101, DOI 10.2307/2529621; Cannon PF, 2007, FUNGAL FAMILIES WORL; Cordier T, 2012, FUNGAL ECOL, V5, P509, DOI 10.1016/j.funeco.2011.12.004; Crawford KM, 2010, OECOLOGIA, V164, P431, DOI 10.1007/s00442-010-1685-2; Dickie IA, 2010, NEW PHYTOL, V188, P916, DOI 10.1111/j.1469-8137.2010.03473.x; Elamo P, 1999, OECOLOGIA, V118, P151, DOI 10.1007/s004420050713; FONSECA A, 1992, SYST APPL MICROBIOL, V15, P47, DOI 10.1016/S0723-2020(11)80137-2; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Grotan V, 2008, POILOG POISSON LOGNO; Helander M, 2007, NEW PHYTOL, V175, P547, DOI 10.1111/j.1469-8137.2007.02110.x; Hoffman MT, 2008, MYCOL RES, V112, P331, DOI 10.1016/j.mycres.2007.10.014; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; IQBAL SH, 1995, CAN J BOT, V73, P538, DOI 10.1139/b95-055; Jumpponen A, 2010, NEW PHYTOL, V186, P496, DOI 10.1111/j.1469-8137.2010.03197.x; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Keller SR, 2010, MOL ECOL, V19, P1212, DOI 10.1111/j.1365-294X.2010.04546.x; Khan AL, 2011, PHYSIOL PLANTARUM, V143, P329, DOI 10.1111/j.1399-3054.2011.01508.x; Leuchtmann Adrian, 1992, Natural Toxins, V1, P150, DOI 10.1002/nt.2620010303; Linderman RG, 2004, SCI HORTIC-AMSTERDAM, V99, P67, DOI 10.1016/S0304-4238(03)00081-5; Little E. L. Jr., 1971, MISCELLANEOUS PUBLIC, V1146; Marquez SS, 2007, FUNGAL DIVERS, V27, P171; Newcombe G, 2003, MYCOL RES, V107, P108, DOI 10.1017/S0953756202007086; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Nilsson RH, 2011, NEW PHYTOL, V191, P314, DOI 10.1111/j.1469-8137.2011.03755.x; Nilsson RH, 2010, FUNGAL ECOL, V3, P284, DOI 10.1016/j.funeco.2010.05.002; Oksanen J., 2016, R PACKAG; Olson MS, 2010, NEW PHYTOL, V186, P526, DOI 10.1111/j.1469-8137.2009.03174.x; Pan JJ, 2008, NEW PHYTOL, V178, P147, DOI 10.1111/j.1469-8137.2007.02350.x; Pan JJ, 2009, MICROB ECOL, V58, P668, DOI 10.1007/s00248-009-9543-7; Photita W, 2004, FUNGAL DIVERS, V16, P131; Piepenbring M, 2011, ECOTROPICA, V17, P27; Pompanon F, 2011, BIOFUTUR, P30; Porras-Alfaro A, 2011, ANNU REV PHYTOPATHOL, V49, P291, DOI 10.1146/annurev-phyto-080508-081831; Prillinger H, MOL CHARACTERISATION; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Redman RS, 2002, SCIENCE, V298, P1581, DOI 10.1126/science.1072191; Reiher A, 2011, THESIS LEIPZIG U; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rodriguez R.J., 2012, BIOCOMPLEXITY PLANT, V6, P155, DOI [10.1002/9781118314364.ch7, DOI 10.1002/9781118314364.CH7]; Russell DJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-601; Sampaio Jose Paulo, 2003, Mycological Progress, V2, P53, DOI 10.1007/s11557-006-0044-5; Saunders M, 2008, APPL ENVIRON MICROB, V74, P136, DOI 10.1128/AEM.01538-07; Saunders M, 2009, NEW PHYTOL, V182, P229, DOI 10.1111/j.1469-8137.2008.02746.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schubert K., 2003, SCHLECHTENDALIA, V9, P1; Shepherd R.W., 2012, BIOCOMPLEXITY PLANT, P131; Soolanayakanahally RY, 2009, PLANT CELL ENVIRON, V32, P1821, DOI 10.1111/j.1365-3040.2009.02042.x; Suryanarayanan TS, 2006, J BASIC MICROB, V46, P305, DOI 10.1002/jobm.200510126; SUTTON BC, 1969, CAN J BOTANY, V47, P2095, DOI 10.1139/b69-303; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Tedersoo L, 2010, ISME J, V4, P465, DOI 10.1038/ismej.2009.131; TODD D, 1988, CAN J FOREST RES, V18, P601, DOI 10.1139/x88-087; Upson R, 2009, MYCORRHIZA, V20, P1, DOI 10.1007/s00572-009-0260-3; Vaz ABM, 2009, CAN J MICROBIOL, V55, P1381, DOI 10.1139/W09-101; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Webster J., 2007, INTRO FUNGI, V3rd; White IR, 2007, AUST J BOT, V55, P178, DOI 10.1071/BT06125; White TJ, 1990, GENETICS EVOLUT 3, P315, DOI [DOI 10.1016/B978-0-12-372180-8.50042-1, 10.1016/B978-0-12-372180-8.50042-1]; WILSON D, 1995, OIKOS, V73, P274, DOI 10.2307/3545919	70	135	136	2	159	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53987	10.1371/journal.pone.0053987	http://dx.doi.org/10.1371/journal.pone.0053987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326555	Green Submitted, Green Published, gold			2022-12-25	WOS:000314705800096
J	Barton, PS; Cunningham, SA; Macdonald, BCT; McIntyre, S; Lindenmayer, DB; Manning, AD				Barton, Philip S.; Cunningham, Saul A.; Macdonald, Ben C. T.; McIntyre, Sue; Lindenmayer, David B.; Manning, Adrian D.			Species Traits Predict Assemblage Dynamics at Ephemeral Resource Patches Created by Carrion	PLOS ONE			English	Article							ARTHROPOD ASSEMBLAGES; CARCASSES; VEGETATION; DIVERSITY; NITROGEN; SOIL; DECOMPOSITION; SUCCESSION; DISPERSION; BIOMASS	Carrion is an ephemeral and spatially patchy resource that supports a diverse subset of species linked to nutrient cycling and the decomposition process. A number of studies have separately documented changes in the diversity of plants, arthropods and vertebrates at individual carcasses, but there are few studies that have examined how functional traits of different groups of organisms underpin their responses to carrion patches. We used a carrion addition experiment to compare changes in composition and functional traits of insect and plant assemblages at carcasses compared with control sites. We found that significant changes in insect assemblage evenness and heterogeneity was associated with species' dispersal traits, and that plant assemblage responses to subsequent soil nitrogen changes was most apparent among graminoids and exotic species. Beetles at carcasses were twice as large as their counterparts at control sites during the first week of carrion decomposition, and also had higher wing loadings. Plants with high specific leaf area responded faster to the carcass addition, and twice as many species recolonised the centre of carcasses in exotic-dominated grassland compared with carcasses in native-dominated grassland. These results provide an example of how traits of opportunist species enable them to exploit patchy and dynamic resources. This increases our understanding of how carcasses can drive biodiversity dynamics, and has implications for the way carrion might be managed in ecosystems, such as appropriate consideration of spatial and temporal continuity in carrion resources to promote heterogeneity in nutrient cycling and species diversity within landscapes.	[Barton, Philip S.; Lindenmayer, David B.; Manning, Adrian D.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Barton, Philip S.; Lindenmayer, David B.] Australian Natl Univ, Australian Res Council, Ctr Excellence Environm Decis, Canberra, ACT, Australia; [Barton, Philip S.; Lindenmayer, David B.] Australian Natl Univ, Natl Environm Res Program, Canberra, ACT, Australia; [Cunningham, Saul A.; McIntyre, Sue] CSIRO, Ecosyst Sci, Canberra, ACT, Australia; [Macdonald, Ben C. T.] CSIRO, Land & Water, Canberra, ACT, Australia	Australian National University; Australian National University; Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Barton, PS (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia.	philip.barton@anu.edu.au	Macdonald, Ben/G-1078-2012; Cunningham, Saul A/B-9947-2009; Lindenmayer, David B/P-7183-2017; Barton, Philip S/A-6400-2010; McIntyre, Sue/F-1885-2010; Manning, Adrian/AAG-2949-2019; Manning, Adrian/AAX-7288-2021	Macdonald, Ben/0000-0001-8105-0779; Cunningham, Saul A/0000-0003-0703-6893; Lindenmayer, David B/0000-0002-4766-4088; Barton, Philip S/0000-0002-8377-2211; McIntyre, Sue/0000-0002-0399-750X; Manning, Adrian/0000-0003-0989-9203	Mulligans Flat - Goorooyarroo Woodland Experiment (Australian Research Council) [LP0561817, LP110100126]	Mulligans Flat - Goorooyarroo Woodland Experiment (Australian Research Council)(Australian Research Council)	This research was supported by the Mulligans Flat - Goorooyarroo Woodland Experiment (Australian Research Council Linkage Grants LP0561817 and LP110100126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen A. N, 1991, ANTS SO AUSTR GUIDE; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; [Anonymous], 2004, PERMDISP FORTRAN COM; Archer MS, 2003, AUST J ZOOL, V51, P569, DOI 10.1071/ZO03053; Barton PS, 2011, J APPL ECOL, V48, P943, DOI 10.1111/j.1365-2664.2011.01994.x; Barton PS, 2011, BIOL J LINN SOC, V102, P301, DOI 10.1111/j.1095-8312.2010.01580.x; Barton PS, 2012, OECOLOGIA, DOI [10.1007/s00442-00012-02460-00443., DOI 10.1007/S00442-00012-02460-00443]; Beasley JC, 2012, OIKOS, V121, P1021, DOI 10.1111/j.1600-0706.2012.20353.x; Bornemissza G. F., 1957, Australian Journal of Zoology, V5, P1; BRAACK L E O, 1981, Koedoe, P33; BRAACK LEO, 1987, OECOLOGIA, V72, P402, DOI 10.1007/BF00377571; Bump JK, 2009, ECOLOGY, V90, P3159, DOI 10.1890/09-0292.1; Bump JK, 2009, ECOSYSTEMS, V12, P996, DOI 10.1007/s10021-009-9274-0; Carter DO, 2007, NATURWISSENSCHAFTEN, V94, P12, DOI 10.1007/s00114-006-0159-1; Danell K, 2002, ARCTIC, V55, P389; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Dudley R., 2000, BIOMECHANICS INSECT; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Finn JA, 2001, OIKOS, V92, P363, DOI 10.1034/j.1600-0706.2001.920219.x; Freilich JE, 2003, BIOSCIENCE, V53, P759, DOI 10.1641/0006-3568(2003)053[0759:EEORAS]2.0.CO;2; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Gibb H, 2010, OECOLOGIA, V164, P1061, DOI 10.1007/s00442-010-1703-4; Giller P.S., 1987, ORG COMMUNITIES PRES, P253; Gordon IJ, 2004, J APPL ECOL, V41, P1021, DOI 10.1111/j.0021-8901.2004.00985.x; Hocking MD, 2011, SCIENCE, V331, P1609, DOI 10.1126/science.1201079; Hodar JA, 1996, ACTA OECOL, V17, P421; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Kavazos CRJ, 2012, LANDSCAPE URBAN PLAN, V106, P183, DOI 10.1016/j.landurbplan.2012.03.002; Khan SA, 2001, SOIL SCI SOC AM J, V65, P1751, DOI 10.2136/sssaj2001.1751; Lawrence J.F., 1991, P543; Loomis RS, 1997, P NATL ACAD SCI USA, V94, P13378, DOI 10.1073/pnas.94.25.13378; Manning A.D., 2011, Australian Zoologist, V35, P633; Marini L, 2012, INSECT CONSERV DIVER, V5, P37, DOI 10.1111/j.1752-4598.2011.00152.x; McIntyre S, 2008, AGR ECOSYST ENVIRON, V128, P251, DOI 10.1016/j.agee.2008.06.015; McIntyre S., 2010, Cunninghamia, V11, P319; McIntyre S, 2011, BIOL CONSERV, V144, P1781, DOI 10.1016/j.biocon.2011.03.023; Melis C, 2007, ECOL RES, V22, P807, DOI 10.1007/s11284-006-0321-4; Mokany K, 2008, J VEG SCI, V19, P119, DOI 10.3170/2007-8-18340; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; Parmenter RR, 2009, ECOL MONOGR, V79, P637, DOI 10.1890/08-0972.1; PIELOU E C, 1969, P286; PUTMAN RJ, 1977, J ANIM ECOL, V46, P853, DOI 10.2307/3645; Rayment G.E., 2011, SOIL CHEM METHODS AU; Sarty M, 2006, OECOLOGIA, V149, P465, DOI 10.1007/s00442-006-0453-9; SCHOENLY K, 1991, J AGR ENTOMOL, V8, P227; SCHOENLY K, 1987, OECOLOGIA, V73, P192, DOI 10.1007/BF00377507; SCHOENLY K, 1983, J ARID ENVIRON, V6, P253, DOI 10.1016/S0140-1963(18)31510-6; Selva N, 2007, P ROY SOC B-BIOL SCI, V274, P1101, DOI 10.1098/rspb.2006.0232; Sikes DS, 1998, YELLOWSTONE SCI, V6, P10; Smith KE, 1997, ECOL ENTOMOL, V22, P468, DOI 10.1046/j.1365-2311.1997.00093.x; Smith RJ, 2001, ECOL ENTOMOL, V26, P173, DOI 10.1046/j.1365-2311.2001.00307.x; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Towne EG, 2000, OECOLOGIA, V122, P232, DOI 10.1007/PL00008851; VSNI, 2020, GENSTAT WINDOWS, V21; Wilmers CC, 2003, ECOL LETT, V6, P996, DOI 10.1046/j.1461-0248.2003.00522.x; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Yang LH, 2004, SCIENCE, V306, P1565, DOI 10.1126/science.1103114	59	31	33	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53961	10.1371/journal.pone.0053961	http://dx.doi.org/10.1371/journal.pone.0053961			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326549	Green Published, gold			2022-12-25	WOS:000314705800093
J	Henn, D; Bandner-Risch, D; Perttunen, H; Schmied, W; Porras, C; Ceballos, F; Rodriguez-Losada, N; Schafers, HJ				Henn, Dominic; Bandner-Risch, Doris; Perttunen, Hilja; Schmied, Wolfram; Porras, Carlos; Ceballos, Francisco; Rodriguez-Losada, Noela; Schaefers, Hans-Joachim			Identification of Reference Genes for Quantitative RT-PCR in Ascending Aortic Aneurysms	PLOS ONE			English	Article							MARFAN-SYNDROME; BETA-ACTIN; HOUSEKEEPING GENES; ROOT DILATATION; RIBOSOMAL-RNA; EXPRESSION; VALVES; GAPDH; SELECTION; DISEASE	Hypertension and congenital aortic valve malformations are frequent causes of ascending aortic aneurysms. The molecular mechanisms of aneurysm formation under these circumstances are not well understood. Reference genes for gene activity studies in aortic tissue that are not influenced by aortic valve morphology and its hemodynamic consequences, aortic dilatation, hypertension, or antihypertensive medication are not available so far. This study determines genes in ascending aortic tissue that are independent of these parameters. Tissue specimens from dilated and undilated ascending aortas were obtained from 60 patients (age <= 70 years) with different morphologies of the aortic valve (tricuspid undilated n = 24, dilated n = 11; bicuspid undilated n = 6, dilated n = 15; unicuspid dilated n = 4). Of the studied individuals, 36 had hypertension, and 31 received ACE inhibitors or AT1 receptor antagonists. The specimens were obtained intraoperatively from the wall of the ascending aorta. We analyzed the expression levels of 32 candidate reference genes by quantitative RTPCR (RT-qPCR). Differential expression levels were assessed by parametric statistics. The expression analysis of these 32 genes by RT-qPCR showed that EIF2B1, ELF1, and PPIA remained constant in their expression levels in the different specimen groups, thus being insensitive to aortic valve morphology, aortic dilatation, hypertension, and medication with ACE inhibitors or AT1 receptor antagonists. Unlike many other commonly used reference genes, the genes EIF2B1, ELF1, and PPIA are neither confounded by aortic comorbidities nor by antihypertensive medication and therefore are most suitable for gene expression analysis of ascending aortic tissue.	[Henn, Dominic; Bandner-Risch, Doris; Perttunen, Hilja; Schmied, Wolfram; Schaefers, Hans-Joachim] Saarland Univ Hosp, Dept Thorac & Cardiovasc Surg, Homburg, Germany; [Porras, Carlos] Hosp Virgen de la Victoria Malaga, Dept Cardiac Surg, Malaga, Spain; [Ceballos, Francisco] Univ Santiago de Compostela, Fac Biol, Dept Genet, Santiago De Compostela, Spain; [Rodriguez-Losada, Noela] Carlos Haya Univ Hosp, Fdn IMABIS, Malaga, Spain	Universitatsklinikum des Saarlandes; Universidade de Santiago de Compostela; FIMABIS	Henn, D (corresponding author), Saarland Univ Hosp, Dept Thorac & Cardiovasc Surg, Homburg, Germany.	s9dohenn@stud.uni-saarland.de	Ceballos, Francisco C./C-6116-2011; Ceballos, Francisco/ABG-3183-2020; Henn, Dominic/U-3564-2019; losada, noela rodriguez/O-4739-2015	Ceballos, Francisco C./0000-0001-7113-7387; losada, noela rodriguez/0000-0003-3629-4883; Henn, Dominic/0000-0003-4775-0151; Porras, Carlos/0000-0002-8975-716X				Ahimastos AA, 2007, JAMA-J AM MED ASSOC, V298, P1539, DOI 10.1001/jama.298.13.1539; Aicher D, 2007, ANN THORAC SURG, V83, P1290, DOI 10.1016/j.athoracsur.2006.11.086; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Bruce KD, 2012, LIVER INT, V32, P1315, DOI 10.1111/j.1478-3231.2012.02813.x; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Deindl E, 2002, MOL CELL BIOCHEM, V236, P139, DOI 10.1023/A:1016166127465; DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799; Fealey ME, 2012, CARDIOVASC PATHOL, V21, P324, DOI 10.1016/j.carpath.2011.11.004; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Hashemi A, 2012, BIOCHEM BIOPH RES CO, V426, P649, DOI 10.1016/j.bbrc.2012.09.009; Ikonomidis JS, 2007, J THORAC CARDIOV SUR, V133, P1028, DOI 10.1016/j.jtcvs.2006.10.083; Ince H, 2007, NAT CLIN PRACT CARD, V4, P418, DOI 10.1038/ncpcardio0937; Karakaya O, 2006, AM J HYPERTENS, V19, P361, DOI 10.1016/j.amjhyper.2005.08.013; Mane PV, 2008, J BIOMOL TECH, V19, P342; Nataatmadja M, 2003, CIRCULATION, V108, P329, DOI 10.1161/01.cir.0000087660.82721.15; Nistri S, 1999, HEART, V82, P19, DOI 10.1136/hrt.82.1.19; Sokal R. R., 1994, BIOMETRY PRINCIPLES, P272; Tadros TM, 2009, CIRCULATION, V119, P880, DOI 10.1161/CIRCULATIONAHA.108.795401; Thanassoulis G, 2008, NAT CLIN PRACT CARD, V5, P821, DOI 10.1038/ncpcardio1369; Tichopad A, 2009, CLIN CHEM, V55, P1816, DOI 10.1373/clinchem.2009.126201; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vergara C, 2012, ARTIF ORGANS, V36, P368, DOI 10.1111/j.1525-1594.2011.01356.x; Zhong H, 1999, BIOCHEM BIOPH RES CO, V259, P523, DOI 10.1006/bbrc.1999.0815	24	11	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54132	10.1371/journal.pone.0054132	http://dx.doi.org/10.1371/journal.pone.0054132			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326585	Green Published, gold, Green Submitted			2022-12-25	WOS:000314705800110
J	Paulsen, VS; Blencke, HM; Benincasa, M; Haug, T; Eksteen, JJ; Styrvold, OB; Scocchi, M; Stensvag, K				Paulsen, Victoria S.; Blencke, Hans-Matti; Benincasa, Monica; Haug, Tor; Eksteen, Jacobus J.; Styrvold, Olaf B.; Scocchi, Marco; Stensvag, Klara			Structure-Activity Relationships of the Antimicrobial Peptide Arasin 1-And Mode of Action Studies of the N-Terminal, Proline-Rich Region	PLOS ONE			English	Article							CHITIN-BINDING ACTIVITY; ANTIBACTERIAL PEPTIDE; HYAS-ARANEUS; SPIDER CRAB; SECONDARY STRUCTURE; PIG INTESTINE; CECROPIN P1; MEMBRANE; PR-39; SEQUENCE	Arasin 1 is a 37 amino acid long proline-rich antimicrobial peptide isolated from the spider crab, Hyas araneus. In this work the active region of arasin 1 was identified through structure-activity studies using different peptide fragments derived from the arasin 1 sequence. The pharmacophore was found to be located in the proline/arginine-rich NH2 terminus of the peptide and the fragment arasin 1(1-23) was almost equally active to the full length peptide. Arasin 1 and its active fragment arasin 1(1-23) were shown to be non-toxic to human red blood cells and arasin 1(1-23) was able to bind chitin, a component of fungal cell walls and the crustacean shell. The mode of action of the fully active N-terminal arasin 1(1-23) was explored through killing kinetic and membrane permeabilization studies. At the minimal inhibitory concentration (MIC), arasin 1(1-23) was not bactericidal and had no membrane disruptive effect. In contrast, at concentrations of 5xMIC and above it was bactericidal and interfered with membrane integrity. We conclude that arasin 1(1-23) has a different mode of action than lytic peptides, like cecropin P1. Thus, we suggest a dual mode of action for arasin 1(1-23) involving membrane disruption at peptide concentrations above MIC, and an alternative mechanism of action, possibly involving intracellular targets, at MIC.	[Paulsen, Victoria S.; Blencke, Hans-Matti; Haug, Tor; Styrvold, Olaf B.; Stensvag, Klara] Univ Tromso, Norwegian Coll Fishery Sci, Tromso, Norway; [Benincasa, Monica; Scocchi, Marco] Univ Trieste, Dept Life Sci, Trieste, Italy; [Eksteen, Jacobus J.] Univ Tromso, Dept Med Biol, Tromso, Norway	UiT The Arctic University of Tromso; University of Trieste; UiT The Arctic University of Tromso	Stensvag, K (corresponding author), Univ Tromso, Norwegian Coll Fishery Sci, Tromso, Norway.	klara.stensvag@uit.no	Benincasa, Monica/R-6457-2016; Haug, Tor/J-2498-2017; Haug, Tor/I-8163-2019	Benincasa, Monica/0000-0001-6087-4461; Haug, Tor/0000-0003-1104-5813; Haug, Tor/0000-0003-1104-5813; Stensvag, Klara/0000-0002-4717-6711; Eksteen, Jacobus Johannes/0000-0002-5735-3582; Blencke, Hans-Matti/0000-0002-6759-4566	Norwegian Research Council [184688/S40]; University of Tromso; regional FUGE-N (Functional genomics in Norway, the Norwegian Research Council)	Norwegian Research Council(Research Council of NorwayEuropean Commission); University of Tromso; regional FUGE-N (Functional genomics in Norway, the Norwegian Research Council)	The present work was supported by the Norwegian Research Council (project number 184688/S40) (http://www.forskningsradet.no/servlet/Satellite?c = Page&cid = 1177315753906&p = 1177315753906&pagename = ForskningsradetEngelsk%2FHovedsidemal), grants from the University of Tromso (http://uit.no/startsida) and the regional FUGE-N (Functional genomics in Norway, the Norwegian Research Council). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGERBERTH B, 1991, EUR J BIOCHEM, V202, P849, DOI 10.1111/j.1432-1033.1991.tb16442.x; Andersson M, 2003, CELL MOL LIFE SCI, V60, P599, DOI 10.1007/s000180300051; Benincasa M, 2004, PEPTIDES, V25, P2055, DOI 10.1016/j.peptides.2004.08.004; BOMAN HG, 1993, INFECT IMMUN, V61, P2978, DOI 10.1128/IAI.61.7.2978-2984.1993; Bormann C, 1999, J BACTERIOL, V181, P7421, DOI 10.1128/JB.181.24.7421-7429.1999; Bradshaw JP, 2003, BIODRUGS, V17, P233, DOI 10.2165/00063030-200317040-00002; BROEKAERT WF, 1992, BIOCHEMISTRY-US, V31, P4308, DOI 10.1021/bi00132a023; Bulet P, 1996, EUR J BIOCHEM, V238, P64, DOI 10.1111/j.1432-1033.1996.0064q.x; BULET P, 1993, J BIOL CHEM, V268, P14893; CABIAUX V, 1994, EUR J BIOCHEM, V224, P1019, DOI 10.1111/j.1432-1033.1994.01019.x; CASTEELS P, 1989, EMBO J, V8, P2387, DOI 10.1002/j.1460-2075.1989.tb08368.x; Chan YR, 2001, J INVEST DERMATOL, V116, P230, DOI 10.1046/j.1523-1747.2001.01231.x; COCIANCICH S, 1994, BIOCHEM J, V300, P567, DOI 10.1042/bj3000567; Cuthbertson BJ, 2004, BIOCHEM J, V381, P79, DOI 10.1042/BJ20040330; Destoumieux D, 2000, J CELL SCI, V113, P461; Destoumieux D, 1997, J BIOL CHEM, V272, P28398, DOI 10.1074/jbc.272.45.28398; Destoumieux D, 1999, EUR J BIOCHEM, V266, P335, DOI 10.1046/j.1432-1327.1999.00855.x; Dutta RC, 2008, INT J BIOCHEM CELL B, V40, P1005, DOI 10.1016/j.biocel.2007.11.005; Galluzzi L, 2007, J BIOTECHNOL, V127, P188, DOI 10.1016/j.jbiotec.2006.06.019; GAZIT E, 1995, BIOCHEMISTRY-US, V34, P11479, DOI 10.1021/bi00036a021; GENNARO R, 1989, INFECT IMMUN, V57, P3142, DOI 10.1128/IAI.57.10.3142-3146.1989; Gennaro R, 1994, P 13 AM PEPT S PEPT; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Kawabata S, 1996, J BIOCHEM-TOKYO, V120, P1253; Kjuul AK, 1999, J FISH DIS, V22, P387, DOI 10.1046/j.1365-2761.1999.00191.x; Kolbe S, 1998, MICROBIOL-SGM, V144, P1291, DOI 10.1099/00221287-144-5-1291; Kragol G, 2002, EUR J BIOCHEM, V269, P4226, DOI 10.1046/j.1432-1033.2002.03119.x; Kragol G, 2001, BIOCHEMISTRY-US, V40, P3016, DOI 10.1021/bi002656a; LEAH R, 1991, J BIOL CHEM, V266, P1564; Li WF, 2006, PEPTIDES, V27, P2350, DOI 10.1016/j.peptides.2006.03.016; Ludtke SJ, 1996, BIOCHEMISTRY-US, V35, P13723, DOI 10.1021/bi9620621; Osaki T, 1999, J BIOL CHEM, V274, P26172, DOI 10.1074/jbc.274.37.26172; Otvos L, 2000, BIOCHEMISTRY-US, V39, P14150, DOI 10.1021/bi0012843; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Peters BM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001067; Podda E, 2006, BBA-GEN SUBJECTS, V1760, P1732, DOI 10.1016/j.bbagen.2006.09.006; Sadler K, 2002, BIOCHEMISTRY-US, V41, P14150, DOI 10.1021/bi026661l; Scocchi M, 2011, CELL MOL LIFE SCI, V68, P2317, DOI 10.1007/s00018-011-0721-7; Scocchi M, 2009, INT J PEPT RES THER, V15, P147, DOI 10.1007/s10989-009-9182-3; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Shi JH, 1996, ANTIMICROB AGENTS CH, V40, P115, DOI 10.1128/AAC.40.1.115; Shi JS, 1996, P NATL ACAD SCI USA, V93, P6014, DOI 10.1073/pnas.93.12.6014; Sperstad SV, 2009, MOL IMMUNOL, V46, P2604, DOI 10.1016/j.molimm.2009.05.002; Sperstad SV, 2009, DEV COMP IMMUNOL, V33, P583, DOI 10.1016/j.dci.2008.10.010; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Steinstraesser L, 2011, IMMUNOBIOLOGY, V216, P322, DOI 10.1016/j.imbio.2010.07.003; Stensvag K, 2008, DEV COMP IMMUNOL, V32, P275, DOI 10.1016/j.dci.2007.06.002; Strom MB, 2000, J PEPT RES, V56, P265, DOI 10.1034/j.1399-3011.2000.00770.x; TANI A, 1995, J BIOCHEM-TOKYO, V117, P560, DOI 10.1093/oxfordjournals.jbchem.a124744; Tokunaga Y, 2001, J PEPT SCI, V7, P297, DOI 10.1002/psc.317; VIRTA M, 1995, J ANTIMICROB CHEMOTH, V36, P303, DOI 10.1093/jac/36.2.303; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; WESTERHOFF HV, 1989, P NATL ACAD SCI USA, V86, P6597, DOI 10.1073/pnas.86.17.6597; Wimley WC, 2011, J MEMBRANE BIOL, V239, P27, DOI 10.1007/s00232-011-9343-0	56	55	58	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53326	10.1371/journal.pone.0053326	http://dx.doi.org/10.1371/journal.pone.0053326			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326415	Green Published, gold, Green Submitted			2022-12-25	WOS:000314705800041
J	Jauch-Chara, K; Schmid, SM; Hallschmid, M; Oltmanns, KM; Schultes, B				Jauch-Chara, Kamila; Schmid, Sebastian M.; Hallschmid, Manfred; Oltmanns, Kerstin M.; Schultes, Bernd			Pituitary-Gonadal and Pituitary-Thyroid Axis Hormone Concentrations before and during a Hypoglycemic Clamp after Sleep Deprivation in Healthy Men	PLOS ONE			English	Article							BRAIN ENERGY-METABOLISM; TESTOSTERONE; SECRETION; GLYCOGEN; PROLACTIN; INSULIN; HUMANS; PHASE; LH	Total sleep deprivation (TSD) exerts strong modulatory effects on the secretory activity of endocrine systems that might be related to TSD-induced challenges of cerebral glucose metabolism. Here, we investigate whether TSD affects the course of male pituitary-gonadal and pituitary-thyroid axis related hormones during a subsequent 240-min hypoglycemic clamp. Ten healthy men were tested on 2 different conditions, TSD and 7-hour regular sleep. Circulating concentrations of total testosterone, prolactin (PRL), thyroid stimulating hormone (TSH), free triiodothyronine (fT3), and free thyroxin (fT4) were measured during baseline and a subsequent hypoglycemic clamp taking place in the morning. Basal, i.e. at 07:00 am measured, concentrations of total testosterone (P = 0.05) and PRL (P<0.01) were lower while the values of TSH (P = 0.02), fT3 (P = 0.08), and fT4 (P = 0.04) were higher after TSD as compared to regular sleep. During the subsequent hypoglycemic clamp (all measurements from baseline to the end of the clamp analyzed) total testosterone concentrations in the regular sleep (P<0.01) but not in the TSD condition (P = 0.61) decreased, while PRL levels increased (P = 0.05) irrespectively of the experimental condition (P = 0.31). TSH concentrations decreased during hypoglycemia (P<0.01), with this decrease being more pronounced after TSD (P = 0.04). However, at the end of the hypoglycemic clamp concentrations all of the above mentioned hormones did not differ between the two sleep conditions. Our data indicate a profound influence of TSD on male pituitary-gonadal and pituitary-thyroid axis hormones characterized by reduced basal testosterone and PRL levels and increased TSH levels. However, since concentrations of these hormones measured at the end of the 240-min hypoglycemic clamp were not affected by TSD it can be speculated that the influence of TSD on the two endocrine axes is rather short lived or does not interact in an additive manner with their responses to hypoglycemia.	[Jauch-Chara, Kamila; Oltmanns, Kerstin M.] Univ Lubeck, Dept Psychiat & Psychotherapy, Lubeck, Germany; [Schmid, Sebastian M.; Schultes, Bernd] Univ Lubeck, Dept Internal Med 1, Lubeck, Germany; [Hallschmid, Manfred] Univ Lubeck, Dept Neuroendocrinol, Lubeck, Germany; [Schultes, Bernd] eSwiss Med & Surg Ctr, Interdisciplinary Obes Ctr, St Gallen, Switzerland	University of Lubeck; University of Lubeck; University of Lubeck	Jauch-Chara, K (corresponding author), Univ Lubeck, Dept Psychiat & Psychotherapy, Lubeck, Germany.	kamila.jauchchara@psychiatrie.uk-sh.de	Schmid, Sebastian M/E-5354-2015	Meyhofer, Sebastian/0000-0003-2034-5922	German Research Foundation (DFG) [SFB 654]	German Research Foundation (DFG)(German Research Foundation (DFG))	The study was supported by the German Research Foundation (DFG; SFB 654). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTEDT T, 1980, SLEEP, V3, P23, DOI 10.1093/sleep/3.1.23; ALLAN JS, 1994, J CLIN ENDOCR METAB, V79, P508, DOI 10.1210/jc.79.2.508; AMIEL S, 1993, NEW ENGL J MED, V329, P876, DOI 10.1056/NEJM199309163291211; Axelsson J, 2005, J CLIN ENDOCR METAB, V90, P4530, DOI 10.1210/jc.2005-0520; BENINGTON JH, 1995, PROG NEUROBIOL, V45, P347, DOI 10.1016/0301-0082(94)00057-O; Bischof MG, 2004, DIABETOLOGIA, V47, P648, DOI 10.1007/s00125-004-1362-2; Boelaert K, 2005, J ENDOCRINOL, V187, P1, DOI 10.1677/joe.1.06131; BRABANT G, 1992, TRENDS ENDOCRIN MET, V3, P183, DOI 10.1016/1043-2760(92)90169-2; Bremner WJ, 2010, NEW ENGL J MED, V363, P189, DOI 10.1056/NEJMe1006197; Brown AM, 2004, J NEUROCHEM, V89, P537, DOI 10.1111/j.1471-4159.2004.02421.x; Carnegie Christina, 2004, Rev Urol, V6 Suppl 6, pS3; CATALDO AM, 1986, J NEUROCYTOL, V15, P511, DOI 10.1007/BF01611733; Chiamolera MI, 2009, ENDOCRINOLOGY, V150, P1091, DOI 10.1210/en.2008-1795; Diver MJ, 2003, CLIN ENDOCRINOL, V58, P710, DOI 10.1046/j.1365-2265.2003.01772.x; Gruetter R, 2003, J NEUROSCI RES, V74, P179, DOI 10.1002/jnr.10785; Klieverik LP, 2009, ENDOCRINOLOGY, V150, P5639, DOI 10.1210/en.2009-0297; Krassas GE, 2010, ENDOCR REV, V31, P702, DOI 10.1210/er.2009-0041; Leproult R, 2011, JAMA-J AM MED ASSOC, V305, P2173, DOI 10.1001/jama.2011.710; Martins RCS, 2010, SLEEP, V33, P243, DOI 10.1093/sleep/33.2.243; MITRAKOU A, 1991, AM J PHYSIOL, V260, pE67, DOI 10.1152/ajpendo.1991.260.1.E67; Oltmanns KM, 2005, CLIN ENDOCRINOL, V62, P217, DOI 10.1111/j.1365-2265.2005.02203.x; Oltmanns KM, 2001, J CLIN ENDOCR METAB, V86, P4913, DOI 10.1210/jc.86.10.4913; Sanford LM, 2010, REPRODUCTION, V139, P197, DOI 10.1530/REP-09-0180; Schmid SM, 2007, J CLIN ENDOCR METAB, V92, P3044, DOI 10.1210/jc.2006-2788; Schmid SM, 2012, CLIN ENDOCRINOL, V77, P749, DOI 10.1111/j.1365-2265.2012.04419.x; Schoeller EL, 2012, CELL TISSUE RES; Schultes B, 2002, METABOLISM, V51, P1370, DOI 10.1053/meta.2002.35193; STRASSMAN RJ, 1991, ACTA ENDOCRINOL-COP, V124, P646, DOI 10.1530/acta.0.1240646; Tanriverdi F, 2003, J ENDOCRINOL, V176, P293, DOI 10.1677/joe.0.1760293; TRESGUERRES JAF, 1985, J ENDOCRINOL, V105, P423, DOI 10.1677/joe.0.1050423; VANCAUTER E, 1994, AM J PHYSIOL, V266, pE953, DOI 10.1152/ajpendo.1994.266.6.E953; WEEKE J, 1978, ACTA ENDOCRINOL-COP, V89, P659, DOI 10.1530/acta.0.0890659; WEINSTEIN D, 1981, FEBS LETT, V126, P29, DOI 10.1016/0014-5793(81)81025-3	33	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54209	10.1371/journal.pone.0054209	http://dx.doi.org/10.1371/journal.pone.0054209			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326598	Green Published, Green Submitted, gold			2022-12-25	WOS:000313552400084
J	Brandlova, K; Bartos, L; Haberova, T				Brandlova, Karolina; Bartos, Ludek; Haberova, Tamara			Camel Calves as Opportunistic Milk Thefts? The First Description of Allosuckling in Domestic Bactrian Camel (Camelus bactrianus)	PLOS ONE			English	Article							GUANACOS LAMA-GUANICOE; DEER CERVUS-ELAPHUS; RED DEER; BUBALUS-BUBALIS; RIVER BUFFALO; FALLOW DEER; BEHAVIOR; ADOPTION; DROMEDARIUS; GROWTH	Allosuckling is a situation when a female nurses a non-filial offspring. It was described in various ungulate species; however for camels this is the first description of this behaviour. The aim of the study was to assess the occurrence of allosuckling in captive camels (Camelus bactrianus) and to test whether it can be explained as a 'milk-theft' (opportunistic behaviour of calves) or alternatively as an altruistic behaviour of females. During 2005 and 2007, nine camel females and ten calves in four zoological gardens in the Czech Republic were observed. In total, 373 sucking bouts were recorded, from which 32 were non-filial (the calf sucked from the non-maternal female). Allosuckling regularly appeared in captive camel herds. As predicted for the milk-theft explanation, the non-filial calves sucked more often in the lateral position and even did not suck in the antiparallel position at all. The non-filial calves preferably joined the filial calf when sucking but in five cases (15.6% of non-filial sucking bouts) the calves sucked from non-maternal dam without the presence of filial calf. We then expected the differences in terminations of sucking bouts by females but did not find any difference in sucking terminations for filial and non-filial calves. As the calves were getting older, the incidence of allosucking increased. This was probably because skills of the calf to outwit the non-maternal dam increased and/or the older calves might be more motivated for allosucking due to the weaning process. Finally, duration of a sucking bout was shorter with non-filial than filial calves. The results of the study support the hypothesis of 'milk theft', being mostly performed by calves behaving as opportunistic parasites, but we cannot reject certain level of altruism from the allonursing females or their increased degree of tolerance to non-filial calves.	[Brandlova, Karolina; Haberova, Tamara] Czech Univ Life Sci Prague, Inst Trop & Subtrop, Dept Anim Sci & Food Proc Trop & Subtrop, Prague, Czech Republic; [Bartos, Ludek] Inst Anim Sci, Dept Ethol, Prague, Czech Republic; [Bartos, Ludek] Czech Univ Life Sci Prague, Dept Anim Sci & Ethol, Fac Agrobiol Food & Nat Resources, Prague, Czech Republic	Czech University of Life Sciences Prague; Czech Research Institute of Animal Science; Czech University of Life Sciences Prague	Brandlova, K (corresponding author), Czech Univ Life Sci Prague, Inst Trop & Subtrop, Dept Anim Sci & Food Proc Trop & Subtrop, Prague, Czech Republic.	brandlova@its.czu.cz	Brandlova, Karolina/B-7839-2013; Brandlova, Karolina/E-3802-2016	Brandlova, Karolina/0000-0002-2014-7275; Fedorova, Tamara/0000-0003-3209-6572	grants IGA [51120/1312/513103]; Ministry of Agriculture of the Czech Republic [MZe 0002701404]	grants IGA; Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	The project was a part of the work in the Czech University of Life Sciences Prague, Institute of Tropics and Subtropics, and was supported by grants IGA 51120/1312/513103 and the Ministry of Agriculture of the Czech Republic (MZe 0002701404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Eknah MM, 2000, ANIM REPROD SCI, V60, P583, DOI 10.1016/S0378-4320(00)00134-2; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Bartos L, 2001, ANIM SCI, V72, P483, DOI 10.1017/S1357729800052000; Bartos L, 2001, ANIM SCI, V72, P493, DOI 10.1017/S1357729800052012; BIRGERSSON B, 1991, ANIM BEHAV, V42, P326, DOI 10.1016/S0003-3472(05)80567-6; Boness DJ, 1998, J MAMMAL, V79, P1060, DOI 10.2307/1383115; Cameron EZ, 2003, BEHAV ECOL SOCIOBIOL, V53, P92, DOI 10.1007/s00265-002-0556-1; Cassinello J, 1999, Z SAUGETIERKD, V64, P363; da Costa MJRP, 2000, APPL ANIM BEHAV SCI, V66, P1, DOI 10.1016/S0168-1591(99)00083-0; DEGEN AA, 1987, ANIM PROD, V45, P301, DOI 10.1017/S0003356100018870; Dorges B, 1992, 1992 P 1 INT CAM C D, P317; Drabkova J, 2008, APPL ANIM BEHAV SCI, V113, P215, DOI 10.1016/j.applanim.2007.10.009; Ekvall K, 1998, ANIM BEHAV, V56, P695, DOI 10.1006/anbe.1998.0825; ELIAS E, 1986, COMP BIOCHEM PHYS A, V84, P413, DOI 10.1016/0300-9629(86)90339-7; Gentry A, 2004, J ARCHAEOL SCI, V31, P645, DOI 10.1016/j.jas.2003.10.006; Hare J, 2008, CAMELUS FERUS IUCN R; Hayes LD, 2000, ANIM BEHAV, V59, P677, DOI 10.1006/anbe.1999.1390; Landete-Castillejos T, 2000, ANIM BEHAV, V60, P679, DOI 10.1006/anbe.2000.1515; MURPHEY RM, 1991, APPL ANIM BEHAV SCI, V28, P341, DOI 10.1016/0168-1591(91)90166-U; MURPHEY RM, 1995, ANIM BEHAV, V49, P1611, DOI 10.1016/0003-3472(95)90083-7; Olleova M, 2012, J ZOOL, V288, P127, DOI 10.1111/j.1469-7998.2012.00930.x; PACKER C, 1992, ANIM BEHAV, V43, P265, DOI 10.1016/S0003-3472(05)80222-2; Pluhacek J, 2011, MAMM BIOL, V76, P380, DOI 10.1016/j.mambio.2010.06.007; Pluhacek J, 2011, BEHAV PROCESS, V86, P174, DOI 10.1016/j.beproc.2010.11.003; PUSEY AE, 1994, BEHAV ECOL, V5, P362, DOI 10.1093/beheco/5.4.362; REITER J, 1978, BEHAV ECOL SOCIOBIOL, V3, P337, DOI 10.1007/BF00303199; RIEDMAN ML, 1982, Q REV BIOL, V57, P405, DOI 10.1086/412936; Roulin A, 2002, ANIM BEHAV, V63, P201, DOI 10.1006/anbe.2001.1895; Sambraus HH, 1995, J ANIM BREED GENET, V112, P469; Schaller GB., 1998, WILDLIFE TIBETAN STE; SPINKA M, 1992, APPL ANIM BEHAV SCI, V33, P165, DOI 10.1016/S0168-1591(05)80005-X; TIBARY A, 2001, RECENT ADV CAMELID R; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Vichova J, 2005, APPL ANIM BEHAV SCI, V94, P223, DOI 10.1016/j.applanim.2005.02.015; WILKINSON GS, 1992, BEHAV ECOL SOCIOBIOL, V31, P225; Zapata B, 2006, ACT 4 C MUND CAM CAT, P45; Zapata B, 2010, APPL ANIM BEHAV SCI, V122, P119, DOI 10.1016/j.applanim.2009.12.004; Zapata B, 2009, J ETHOL, V27, P295, DOI 10.1007/s10164-008-0127-7; Zapata B, 2009, ETHOLOGY, V115, P731, DOI 10.1111/j.1439-0310.2009.01660.x	39	18	18	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53052	10.1371/journal.pone.0053052	http://dx.doi.org/10.1371/journal.pone.0053052			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326378	Green Published, gold, Green Submitted			2022-12-25	WOS:000313551500044
J	McFarland, KP; Rimmer, CC; Goetz, JE; Aubry, Y; Wunderle, JM; Sutton, A; Townsend, JM; Sosa, AL; Kirkconnell, A				McFarland, Kent P.; Rimmer, Christopher C.; Goetz, James E.; Aubry, Yves; Wunderle, Joseph M., Jr.; Sutton, Anne; Townsend, Jason M.; Llanes Sosa, Alejandro; Kirkconnell, Arturo			A Winter Distribution Model for Bicknell's Thrush (Catharus bicknelli), a Conservation Tool for a Threatened Migratory Songbird	PLOS ONE			English	Article							MAXIMUM-ENTROPY; CLIMATE-CHANGE; NORTH-AMERICA; PASSERINES; BEHAVIOR; REGION; AREAS	Conservation planning and implementation require identifying pertinent habitats and locations where protection and management may improve viability of targeted species. The winter range of Bicknell's Thrush (Catharus bicknelli), a threatened Nearctic-Neotropical migratory songbird, is restricted to the Greater Antilles. We analyzed winter records from the mid-1970s to 2009 to quantitatively evaluate winter distribution and habitat selection. Additionally, we conducted targeted surveys in Jamaica (n = 433), Cuba (n = 363), Dominican Republic (n = 1,000), Haiti (n = 131) and Puerto Rico (n = 242) yielding 179 sites with thrush presence. We modeled Bicknell's Thrush winter habitat selection and distribution in the Greater Antilles in Maxent version 3.3.1. using environmental predictors represented in 30 arc second study area rasters. These included nine landform, land cover and climatic variables that were thought a priori to have potentially high predictive power. We used the average training gain from ten model runs to select the best subset of predictors. Total winter precipitation, aspect and land cover, particularly broadleaf forests, emerged as important variables. A five-variable model that contained land cover, winter precipitation, aspect, slope, and elevation was the most parsimonious and not significantly different than the models with more variables. We used the best fitting model to depict potential winter habitat. Using the 10 percentile threshold (>0.25), we estimated winter habitat to cover 33,170 km 2, nearly 10% of the study area. The Dominican Republic contained half of all potential habitat (51%), followed by Cuba (15.1%), Jamaica (13.5%), Haiti (10.6%), and Puerto Rico (9.9%). Nearly one-third of the range was found to be in protected areas. By providing the first detailed predictive map of Bicknell's Thrush winter distribution, our study provides a useful tool to prioritize and direct conservation planning for this and other wet, broadleaf forest specialists in the Greater Antilles.	[McFarland, Kent P.; Rimmer, Christopher C.] Vermont Ctr Ecostudies, Norwich, VT USA; [Goetz, James E.] Cornell Univ, Dept Nat Resources, Ithaca, NY 14853 USA; [Aubry, Yves] Environm Canada, Canadian Wildlife Serv, Ste Foy, PQ, Canada; [Wunderle, Joseph M., Jr.] USDA Forest Serv, Int Inst Trop Forestry, Sabana Field Res Stn, Luquillo, PR USA; [Townsend, Jason M.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Llanes Sosa, Alejandro] Inst Ecol & Sistemat, Havana, Cuba; [Kirkconnell, Arturo] Museo Nacl Hist Nat Cuba, Havana, Cuba	Cornell University; Environment & Climate Change Canada; Canadian Wildlife Service; United States Department of Agriculture (USDA); United States Forest Service; University of California System; University of California Davis	McFarland, KP (corresponding author), Vermont Ctr Ecostudies, Norwich, VT USA.	kmcfarland@vtecostudies.org		McFarland, Kent/0000-0001-7809-5503; Goetz, James/0000-0003-2741-6869	Carolyn Foundation; Charles Blake Fund of the Nuttall Ornithological Club; Conservation and Research Foundation; National Fish and Wildlife Foundation; National Geographic Society Committee for Research and Exploration; Nature Conservancy; Stewart Foundation; Thomas Marshall Foundation; United States Fish and Wildlife Service; United States Department of Agriculture Forest Service Office of International Programs; Wildlife Conservation Society; Vermont Center for Ecostudies; Vermont Institute of Natural Science; Environment Canada; Latin-America Program	Carolyn Foundation; Charles Blake Fund of the Nuttall Ornithological Club; Conservation and Research Foundation; National Fish and Wildlife Foundation; National Geographic Society Committee for Research and Exploration(National Geographic Society); Nature Conservancy; Stewart Foundation; Thomas Marshall Foundation; United States Fish and Wildlife Service(US Fish & Wildlife Service); United States Department of Agriculture Forest Service Office of International Programs; Wildlife Conservation Society; Vermont Center for Ecostudies; Vermont Institute of Natural Science; Environment Canada(CGIAR); Latin-America Program	The authors gratefully acknowledge funding support over the many years of this study from the Carolyn Foundation, the Charles Blake Fund of the Nuttall Ornithological Club, the Conservation and Research Foundation, the National Fish and Wildlife Foundation, the National Geographic Society Committee for Research and Exploration, The Nature Conservancy, the Stewart Foundation, the Thomas Marshall Foundation, the United States Fish and Wildlife Service, the United States Department of Agriculture Forest Service Office of International Programs, and the Wildlife Conservation Society. Additional funding was provided by friends of the Vermont Center for Ecostudies and the Vermont Institute of Natural Science. Field work in Cuba was financially supported by Environment Canada and its Latin-America Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeles ME, 2007, INT J CLIMATOL, V27, P555, DOI 10.1002/joc.1416; Atwood JL, 1996, WILSON BULL, V108, P650; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Bicheron P., 2008, GLOBCOVER PRODUCTS D; BirdLife International, 2000, THREAT BIRDS WORLD; Chisholm SE, 2008, CAN J ZOOL, V86, P217, DOI 10.1139/Z07-131; Connolly V, 2002, WILSON BULL, V114, P333, DOI 10.1676/0043-5643(2002)114[0333:HUBTBT]2.0.CO;2; COSEWIC, 2009, UNSOLICITED UP UNPUB; *FAO, 1991, FOR RES ASS 1990; Frey S., 2011, ECOGRAPHY, V34, P1; Gardiner R, 2006, THESIS MOUNT ALLISON; Garrido O.H., 1975, CATALOGO AVES CUBA; Graveland J, 1996, OECOLOGIA, V105, P351, DOI 10.1007/BF00328738; Hames RS, 2002, P NATL ACAD SCI USA, V99, P11235, DOI 10.1073/pnas.172700199; Hart JA, 2010, CONSERVATION ACTION; Helmer EH, 2002, CARIBB J SCI, V38, P165; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Johnson AH, 1992, ECOLOGY DECLINE RED, P387; Lambert JD, 2005, WILSON BULL, V117, P1, DOI 10.1676/04-013; Lambert JD, 2008, NORTHEAST NAT, V15; LATTA S., 2006, BIRDS DOMINICAN REPU; Latta SC, 2005, ANIM CONSERV, V8, P69, DOI 10.1017/S136794300400188X; Martin PH, 2007, J BIOGEOGR, V34, P1792, DOI 10.1111/j.1365-2699.2007.01726.x; Ottenwalder JA, 2000, MEDIO AMBIENTE SOSTE, P65; Pashley D.N., 2000, PARTNERS FLIGHT CONS; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; RICH TD, 2004, PARTNERS FLIGHT N AM; Rimmer C. C., 2005, J CARIBBEAN ORNITHOL, V18, P86; Rimmer C. C., 2004, EVALUATING USE VERMO; Rimmer CC, 2005, ECOTOXICOLOGY, V14, P223, DOI 10.1007/s10646-004-6270-1; RIMMER CC, 2001, BIRDS N AM, V592; Rodenhouse NL, 2008, MITIG ADAPT STRAT GL, V13, P517, DOI 10.1007/s11027-007-9126-1; Rompre Ghislain, 2000, Cotinga, V13, P66; Sherman RE, 2005, J TORREY BOT SOC, V132, P293, DOI 10.3159/1095-5674(2005)132[293:VRIFEO]2.0.CO;2; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Strong A. M., 2009, MOUNTAIN RESORTS ECO, P99; Townsend JM, 2010, AUK, V127, P514, DOI 10.1525/auk.2010.09160; Townsend JM, 2009, CONDOR, V111, P565, DOI 10.1525/cond.2009.090062; WALLACE GEORGE J., 1939, PROC BOSTON SOC NAT HIST, V41, P211; Wells J. V., 2007, BIRDERS CONSERVATION; WETMORE A, 1931, US NATL MUSEUM B, V155; Whittam B, 2010, HIGH ELEVATION LANDB; Yost AC, 2008, ECOL INFORM, V3, P375, DOI 10.1016/j.ecoinf.2008.08.004	44	23	25	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53986	10.1371/journal.pone.0053986	http://dx.doi.org/10.1371/journal.pone.0053986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326554	Green Published, gold			2022-12-25	WOS:000313551500105
J	Pradhan, S; Mallick, SK; Chowdhury, R				Pradhan, Subhra; Mallick, Sanjaya K.; Chowdhury, Rukhsana			Vibrio cholerae Classical Biotype Is Converted to the Viable Non-Culturable State when Cultured with the El Tor Biotype	PLOS ONE			English	Article							CONTACT-DEPENDENT INHIBITION; ESCHERICHIA-COLI; STATIONARY-PHASE; GENE-EXPRESSION; NONCULTURABLE STATE; GROWTH ADVANTAGE; SECRETION SYSTEM; BACTERIA; BANGLADESH; ENVIRONMENT	A unique event in bacterial epidemiology was the emergence of the El Tor biotype of Vibrio cholerae O1 and the subsequent rapid displacement of the existing classical biotype as the predominant cause of epidemic cholera. We demonstrate that when the El Tor and classical biotypes were cocultured in standard laboratory medium a precipitous decline in colony forming units (CFU) of the classical biotype occurred in a contact dependent manner. Several lines of evidence including DNA release, microscopy and flow cytometric analysis indicated that the drastic reduction in CFU of the classical biotype in cocultures was not accompanied by lysis, although when the classical biotype was grown individually in monocultures, lysis of the cells occurred concomitant with decrease in CFU starting from late stationary phase. Furthermore, uptake of a membrane potential sensitive dye and protection of genomic DNA from extracellular DNase strongly suggested that the classical biotype cells in cocultures retained viability in spite of loss of culturability. These results suggest that coculturing the classical biotype with the El Tor biotype protects the former from lysis allowing the cells to remain viable in spite of the loss of culturability. The stationary phase sigma factor RpoS may have a role in the loss of culturability of the classical biotype in cocultures. Although competitive exclusion of closely related strains has been reported for several bacterial species, conversion of the target bacterial population to the viable non-culturable state has not been demonstrated previously and may have important implications in the evolution of bacterial strains.	[Pradhan, Subhra; Chowdhury, Rukhsana] CSIR, Indian Inst Chem Biol, Div Infect Dis & Immunol, Kolkata, India; [Mallick, Sanjaya K.] Univ Calcutta, Ctr Res Nanosci & Nanotechnol, CU BD Ctr Excellence Nanobiotechnol, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); University of Calcutta	Chowdhury, R (corresponding author), CSIR, Indian Inst Chem Biol, Div Infect Dis & Immunol, Kolkata, India.	rukhsana@iicb.res.in		Pradhan, Subhra/0000-0002-5751-4016	Indian Council for Medical Research [5/8-1(196)/D/2004-ECD-II]; Council of Scientific and Industrial Research (CSIR), India; CSIR	Indian Council for Medical Research(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	The work was supported by a research grant [5/8-1(196)/D/2004-ECD-II] from the Indian Council for Medical Research, and a grant from Council of Scientific and Industrial Research (CSIR), India. Subhra Pradhan received a research fellowship from CSIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuaita BH, 2009, INFECT IMMUN, V77, P4111, DOI 10.1128/IAI.00409-09; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Basu A, 2000, EMERG INFECT DIS, V6, P139, DOI 10.3201/eid0602.000206; Beyhan S, 2006, INFECT IMMUN, V74, P3633, DOI 10.1128/IAI.01750-05; BISWAS SK, 1992, J BACTERIOL, V174, P6221, DOI 10.1128/JB.174.19.6221-6229.1992; Blokesch M, 2008, J BACTERIOL, V190, P7232, DOI 10.1128/JB.00959-08; CHOWDHURY R, 1989, J VIROL, V63, P392, DOI 10.1128/JVI.63.1.392-397.1989; COLWELL RR, 1985, BIO-TECHNOL, V3, P817, DOI 10.1038/nbt0985-817; Colwell RR, 1996, WORLD J MICROB BIOT, V12, P28, DOI 10.1007/BF00327795; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; DiRita VJ, 1996, P NATL ACAD SCI USA, V93, P7991, DOI 10.1073/pnas.93.15.7991; Dziejman M, 2002, P NATL ACAD SCI USA, V99, P1556, DOI 10.1073/pnas.042667999; Farrell MJ, 2003, J BACTERIOL, V185, P7044, DOI 10.1128/JB.185.24.7044-7052.2003; Faruque SM, 2003, P NATL ACAD SCI USA, V100, P1304, DOI 10.1073/pnas.0337468100; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; FARUQUE SM, 1993, J CLIN MICROBIOL, V31, P2513, DOI 10.1128/JCM.31.9.2513-2516.1993; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Gunasekera TS, 2002, APPL ENVIRON MICROB, V68, P1988, DOI 10.1128/AEM.68.4.1988-1993.2002; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; KEASLER SP, 1993, LANCET, V341, P1661, DOI 10.1016/0140-6736(93)90792-F; Kimsey HH, 1998, P NATL ACAD SCI USA, V95, P7035, DOI 10.1073/pnas.95.12.7035; Lemonnier M, 2008, P R SOC B, V275, P3, DOI 10.1098/rspb.2007.1234; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; MCFALL E, 1996, ESCHERICHIA COLI SAL, P358; Murley YM, 2000, INFECT IMMUN, V68, P3010, DOI 10.1128/IAI.68.5.3010-3014.2000; Nair GB, 2002, J CLIN MICROBIOL, V40, P3296, DOI 10.1128/JCM.40.9.3296-3299.2002; Oliver James D., 2005, Journal of Water and Health, V3, P249; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Oliver JD, 2005, J MICROBIOL, V43, P93; Pawlowski DR, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018169, 10.1371/journal.pone.0017585]; Pradhan S, 2010, J BACTERIOL, V192, P955, DOI 10.1128/JB.01180-09; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Rubin EJ, 1999, P NATL ACAD SCI USA, V96, P1645, DOI 10.1073/pnas.96.4.1645; Ryan ET, 2011, EMERG INFECT DIS, V17, P2175, DOI 10.3201/eid1711.110849; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; SAMADI AR, 1983, LANCET, V1, P805; Senoh M, 2010, MICROBIOL IMMUNOL, V54, P502, DOI 10.1111/j.1348-0421.2010.00245.x; SIDDIQUE AK, 1991, LANCET, V337, P1125, DOI 10.1016/0140-6736(91)92789-5; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Steinmoen H, 2002, P NATL ACAD SCI USA, V99, P7681, DOI 10.1073/pnas.112464599; TAKEYA K, 1981, J CLIN MICROBIOL, V14, P222, DOI 10.1128/JCM.14.2.222-224.1981; Udden SMN, 2008, P NATL ACAD SCI USA, V105, P11951, DOI 10.1073/pnas.0805560105; XU HS, 1982, MICROBIAL ECOL, V8, P313, DOI 10.1007/BF02010671; Yoon SS, 2006, INFECT IMMUN, V74, P6547, DOI 10.1128/IAI.00695-06; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219	46	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53504	10.1371/journal.pone.0053504	http://dx.doi.org/10.1371/journal.pone.0053504			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326443	Green Published, Green Submitted, gold			2022-12-25	WOS:000313551500078
J	Keskin, F; Suhre, A; Kose, K; Ersahin, T; Cetin, AE; Cetin-Atalay, R				Keskin, Furkan; Suhre, Alexander; Kose, Kivanc; Ersahin, Tulin; Cetin, A. Enis; Cetin-Atalay, Rengul			Image Classification of Human Carcinoma Cells Using Complex Wavelet-Based Covariance Descriptors	PLOS ONE			English	Article							SEGMENTATION	Cancer cell lines are widely used for research purposes in laboratories all over the world. Computer-assisted classification of cancer cells can alleviate the burden of manual labeling and help cancer research. In this paper, we present a novel computerized method for cancer cell line image classification. The aim is to automatically classify 14 different classes of cell lines including 7 classes of breast and 7 classes of liver cancer cells. Microscopic images containing irregular carcinoma cell patterns are represented by subwindows which correspond to foreground pixels. For each subwindow, a covariance descriptor utilizing the dual-tree complex wavelet transform (DT-CWT) coefficients and several morphological attributes are computed. Directionally selective DT-CWT feature parameters are preferred primarily because of their ability to characterize edges at multiple orientations which is the characteristic feature of carcinoma cell line images. A Support Vector Machine (SVM) classifier with radial basis function (RBF) kernel is employed for final classification. Over a dataset of 840 images, we achieve an accuracy above 98%, which outperforms the classical covariance-based methods. The proposed system can be used as a reliable decision maker for laboratory studies. Our tool provides an automated, time-and cost-efficient analysis of cancer cell morphology to classify different cancer cell lines using image-processing techniques, which can be used as an alternative to the costly short tandem repeat (STR) analysis. The data set used in this manuscript is available as supplementary material through http://signal.ee.bilkent.edu.tr/cancerCellLineClassificationSampleImages.html.	[Keskin, Furkan; Suhre, Alexander; Kose, Kivanc; Cetin, A. Enis] Bilkent Univ, Dept Elect & Elect Engn, TR-06533 Ankara, Turkey; [Ersahin, Tulin; Cetin-Atalay, Rengul] Bilkent Univ, Dept Mol Biol & Genet, Ankara, Turkey	Ihsan Dogramaci Bilkent University; Ihsan Dogramaci Bilkent University	Cetin-Atalay, R (corresponding author), Bilkent Univ, Dept Mol Biol & Genet, Ankara, Turkey.	rengul@bilkent.edu.tr	Cetin-Atalay, Rengul/F-5780-2013; Cetin-Atalay, Rengul/O-9826-2014; Ersahin, Tulin/M-5721-2013; Kose, Kivanc/AAG-8130-2019	Cetin-Atalay, Rengul/0000-0003-2408-6606; Cetin-Atalay, Rengul/0000-0003-2408-6606; Ersahin, Tulin/0000-0002-7474-7890; Kose, Kivanc/0000-0003-3185-2639; Keskin, Musa Furkan/0000-0002-7718-8377	European Union [PIRSES-GA-2009-247091]	European Union(European Commission)	This study was funded by the Seventh Framework program of the European Union under grant agreement number PIRSES-GA-2009-247091 "MIRACLE-Microscopic Image Processing, Analysis, Classification and Modelling Environment''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydogan DB, 2008, COMP MED SY, P614, DOI 10.1109/CBMS.2008.46; Bouzahzah B, 1984, IN VITRO, V20, P493; Buontempo F, 2011, INVEST NEW DRUG, V29, P1303, DOI 10.1007/s10637-010-9486-3; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chabrier S, 2006, EURASIP J APPL SIG P, DOI 10.1155/ASP/2006/96306; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen GY, 2006, IEEE IMAGE PROC, P2645, DOI 10.1109/ICIP.2006.313053; Conrad C, 2004, GENOME RES, V14, P1130, DOI 10.1101/gr.2383804; Doyle S, 2007, I S BIOMED IMAGING, P1284, DOI 10.1109/ISBI.2007.357094; Dundar M. M., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P2732, DOI 10.1109/ICPR.2010.669; Habiboglu YH, 2011, EUR SIGNAL PR CONF, P894; Habiboglu YH, 2011, INT CONF ACOUST SPEE, P1817; He L, 1985, J CELL PHYSL, V165, P459; Kilic N, 2010, J MED SYST, V34, P101, DOI 10.1007/s10916-008-9221-1; Kingsbury N, 1999, PHILOS T R SOC A, V357, P2543, DOI 10.1098/rsta.1999.0447; Kwitt Roland, 2007, 2007 11th IEEE International Conference on Computer Vision, P1, DOI 10.1109/ICCV.2007.4409170; Kwitt R, 2010, P IEEE COMP SOC C CO, P103, DOI [10.1109/CVPRW.2010.5543146, DOI 10.1109/CVPRW.2010.5543146]; Lebrun G, 2007, CELL MOL BIOL, V53, P51, DOI 10.1170/T787; Loo P, 2000, 2000 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL III, PROCEEDINGS, P29, DOI 10.1109/ICIP.2000.899275; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Maree R, 2005, PROC CVPR IEEE, P34; NAZIF AM, 1984, IEEE T PATTERN ANAL, V6, P555, DOI 10.1109/TPAMI.1984.4767570; Oefinger P, 1981, J GEN VIROL, V53; Raza SH, 2010, IEEE ENG MED BIO, P6749, DOI 10.1109/IEMBS.2010.5626009; Sayan B, 2009, HYBRIDOMA, V28, P1, DOI 10.1089/hyb.2008.0058; Selesnick IW, 2005, IEEE SIGNAL PROC MAG, V22, P123, DOI 10.1109/MSP.2005.1550194; Selesnick IW, 2003, PROC SPIE, V5207, P607, DOI 10.1117/12.504896; Selesnick IW, 2001, IEEE SIGNAL PROC LET, V8, P170, DOI 10.1109/97.923042; Steuer R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002218; Suhre A, 2011, EUR SIGNAL PR CONF, P1005; Thamarai M., 2010, Proceedings of the 2nd International Conference on Machine Learning and Computing (ICMLC 2010), P174, DOI 10.1109/ICMLC.2010.39; Tuna H, 2009, IEEE SIGNAL PROC LET, V16, P751, DOI 10.1109/LSP.2009.2024589; Tuzel O, 2008, IEEE T PATTERN ANAL, V30, P1713, DOI 10.1109/TPAMI.2008.75; Tuzel O, 2006, LECT NOTES COMPUT SC, V3952, P589; Vilela M, 2010, PLOS COMPUT BIOL, V6	35	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e52807	10.1371/journal.pone.0052807	http://dx.doi.org/10.1371/journal.pone.0052807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341908	Green Submitted, Green Published, gold			2022-12-25	WOS:000313682700015
J	Yoshimoto, M; Yoder, MC; Guevara, P; Adkins, B				Yoshimoto, Momoko; Yoder, Mervin C.; Guevara, Patricia; Adkins, Becky			The Murine Th2 Locus Undergoes Epigenetic Modification in the Thymus during Fetal and Postnatal Ontogeny	PLOS ONE			English	Article							LYMPHOCYTE PRECURSOR CELLS; DISTAL REGULATORY ELEMENTS; HEMATOPOIETIC STEM-CELLS; PRIMORDIAL GERM-CELLS; T-CELLS; DNA METHYLATION; IL-4 GENE; LINEAGE COMMITMENT; CYCLIC RENEWAL; IMMUNE-SYSTEM	Epigenetic modifications play a central role in the differentiation and function of immune cells in adult animals. Developmentally regulated epigenetic patterns also appear to contribute to the ontogeny of the immune system. We show here that the epigenetic profile of the T-helper (Th) 2 locus undergoes changes in T lineage cells beginning in mid-gestation and extending throughout the first week of life. In particular, regulatory regions of the Th2 locus are largely methylated at CpG residues among fetal liver common lymphoid progenitor cells. The locus subsequently becomes highly hypomethylated among the downstream progeny of these cells within the fetal thymus. This hypomethylated state is preserved until birth when the locus becomes rapidly re-methylated, achieving adult-like status by 3-6 days post birth. Notably, the capacity for rapid, high level Th2 cytokine production is lost in parallel with this re-methylation. In vitro organ culture and in vivo transplantation experiments indicate that signals from the adult environment are required to achieve the postnatal methylated state. Together, these findings indicate that the Th2 bias of neonates may be conferred, in part, by an epigenetic profile inherited from fetal life. However, the fetal program is rapidly terminated post birth by the development of signals leading to the acquisition of adult-like epigenetic patterns.	[Yoshimoto, Momoko; Yoder, Mervin C.] Indiana Univ Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN USA; [Guevara, Patricia; Adkins, Becky] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA	Indiana University System; Indiana University Bloomington; University of Miami	Adkins, B (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA.	radkins@med.miami.edu	Yoshimoto, Momoko/N-4238-2014; Yoshimoto, Momoko/AFP-3523-2022	Yoshimoto, Momoko/0000-0002-7272-6682; Yoshimoto, Momoko/0000-0002-7272-6682; Yoder, Mervin/0000-0003-4354-7631	National Institute of Allergy and Infectious Diseases [AI044923, AI080759]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044923, R01AI080759, R56AI044923] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institute of Allergy and Infectious Diseases AI044923 (B.A) and AI080759 (M.C.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKINS B, 1994, J IMMUNOL, V153, P5359; Adkins B, 2003, J IMMUNOL, V171, P5157, DOI 10.4049/jimmunol.171.10.5157; Adkins B, 2006, Haematol Rep, V2, P9; Adkins B, 2000, Int Rev Immunol, V19, P157, DOI 10.3109/08830180009088503; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Aoki K, 2009, J IMMUNOL, V182, P7698, DOI 10.4049/jimmunol.0801643; BENDELAC A, 1995, CURR OPIN IMMUNOL, V7, P367, DOI 10.1016/0952-7915(95)80112-X; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; CALVERT JE, 1983, J IMMUNOL, V131, P1693; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; COLTEY M, 1989, J EXP MED, V170, P543, DOI 10.1084/jem.170.2.543; COLTEY M, 1987, CELL DIFFER DEV, V22, P71, DOI 10.1016/0045-6039(87)90414-3; Fadel S, 2000, Int Rev Immunol, V19, P173, DOI 10.3109/08830180009088504; Fields PE, 2004, IMMUNITY, V21, P865, DOI 10.1016/j.immuni.2004.10.015; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Grogan JL, 2003, J IMMUNOL, V171, P6672, DOI 10.4049/jimmunol.171.12.6672; Guo LY, 2002, P NATL ACAD SCI USA, V99, P10623, DOI 10.1073/pnas.162360199; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hammond K, 1998, INT IMMUNOL, V10, P1491, DOI 10.1093/intimm/10.10.1491; Ikawa T, 2004, BLOOD, V103, P530, DOI 10.1182/blood-2003-06-1797; JOTEREAU F, 1987, J IMMUNOL, V138, P1026; JOTEREAU FV, 1982, J IMMUNOL, V129, P1869; Kawamoto H, 2000, IMMUNITY, V12, P441, DOI 10.1016/S1074-7613(00)80196-X; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; MACDONALD HR, 1995, J EXP MED, V182, P633, DOI 10.1084/jem.182.3.633; Makar KW, 2003, NAT IMMUNOL, V4, P1183, DOI 10.1038/ni1004; Martino D., 2012, GENES IMMUN; Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Prescott SL, 1998, J IMMUNOL, V160, P4730; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; Ribeiro-do-Couto LM, 2001, EUR J IMMUNOL, V31, P3394, DOI 10.1002/1521-4141(200111)31:11<3394::AID-IMMU3394>3.0.CO;2-B; Rose S, 2007, J IMMUNOL, V178, P2667, DOI 10.4049/jimmunol.178.5.2667; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Siegrist C A, 2000, Int Rev Immunol, V19, P195, DOI 10.3109/08830180009088505; Tykocinski LO, 2005, J BIOL CHEM, V280, P28177, DOI 10.1074/jbc.M502038200; Upham JW, 2006, INFECT IMMUN, V74, P1106, DOI 10.1128/IAI.74.2.1106-1112.2006; Webster RB, 2007, J BIOL CHEM, V282, P700, DOI 10.1074/jbc.M609501200; Wilson CB, 2005, SEMIN IMMUNOL, V17, P105, DOI 10.1016/j.smim.2005.01.005; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Yoshimoto M, 2012, BLOOD, V119, P5706, DOI 10.1182/blood-2011-12-397489	48	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e51587	10.1371/journal.pone.0051587	http://dx.doi.org/10.1371/journal.pone.0051587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335954	Green Published, gold, Green Submitted			2022-12-25	WOS:000314707700005
J	Wang, QP; Cao, XZ; Wang, XD; Gu, J; Wen, LM; Mao, LM; Shan, PN; Tang, AG				Wang, Qing-ping; Cao, Xiao-zhi; Wang, Xue-dong; Gu, Juan; Wen, Li-min; Mao, Li-ming; Shan, Ping-nan; Tang, Ai-guo			Utility of NT-proBNP for Identifying LV Failure in Patients with Acute Exacerbation of Chronic Bronchitis	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; ACUTE HEART-FAILURE; OBSTRUCTIVE PULMONARY-DISEASE; DIAGNOSTIC-ACCURACY; GENERAL-POPULATION; DYSPNEIC SUBJECTS; ELDERLY-PATIENTS; DYSFUNCTION; BNP; ASSOCIATION	Background: NT-proBNP has been widely regarded as a useful tool for diagnosis or exclusion of heart failure (HF) in many settings. However, in patients with acute exacerbation of chronic bronchitis (AECB), its roles have not been well described. The objective of this study was to evaluate the diagnostic performance of NT-proBNP for identifying left ventricular (LV) failure in such patients. Methods and Results: 311 AECB patients and 102 stable chronic bronchitis patients with no history of HF were enrolled. Plasma NT-proBNP concentrations were measured using Roche Elecsys. The European Society of Cardiology (ESC) diagnostic principles were adopted to identify HF and the diagnostic performance of NT-proBNP was evaluated by ROC. Our results showed, the median NT-proBNP level in patients with LV failure [4828.4 (2044.4-9203.6) ng/L] was significantly higher than that in those without LV failure [519.2 (179.1-1409.8) ng/L, p < 0.001] and stable controls [207.5 (186.5-318.2) ng/L, p < 0.001]. LV failure, renal function, atrial fibrillation and systolic pulmonary artery pressure were independent predictors of NT-proBNP levels (all p < 0.05). The area under ROC curve (AUC) of NT-proBNP for identifying LV failure was 0.884, significantly superior to clinical judgment alone (AUC 0.835, p = 0.0294). At the optimal cutoff value of 935.0 ng/L, NT-proBNP yielded sensitivity 94.4%, specificity 68.2%, accuracy 74.3% and negative predictive value 97.6%. Adding the results of NT-proBNP to those of clinical judgment improved the diagnostic accuracy for LV failure. Conclusion: As a tool for diagnosis or exclusion of HF, NT-proBNP can help physicians identify LV failure in patients with AECB.	[Wang, Qing-ping; Wang, Xue-dong; Gu, Juan] Nanjing Med Univ, Affiliated Hosp, Peoples Hosp Wuxi 5, Dept Clin Lab, Wuxi, Jiangsu, Peoples R China; [Wang, Qing-ping; Wen, Li-min; Mao, Li-ming; Shan, Ping-nan] China Med Univ, Shaoxing Hosp, Dept Clin Lab, Shaoxing Cty, Zhejiang, Peoples R China; [Wang, Qing-ping; Wen, Li-min; Mao, Li-ming; Shan, Ping-nan] Cent Hosp Shaoxing Cty, Shaoxing Cty, Zhejiang, Peoples R China; [Cao, Xiao-zhi] PLA, Nanjing Command, Fuzhou Gen Hosp, Dept Caroliol, Fuzhou, Fujian, Peoples R China; [Tang, Ai-guo] Cent South Univ, XiangYa Hosp 2, Dept Clin Lab, Changsha, Hunan, Peoples R China	Nanjing Medical University; Central South University	Wang, XD (corresponding author), Nanjing Med Univ, Affiliated Hosp, Peoples Hosp Wuxi 5, Dept Clin Lab, Wuxi, Jiangsu, Peoples R China.	wxd729@126.com	Qingping, Wang/K-2645-2019	Wang, Qing-ping/0000-0002-7239-9693	Medical Research Foundation of the Wuxi Municipal Health Bureau [ML201203]; Scientific Technology Development Foundation of Nanjing Medical University [2012NJMU071]	Medical Research Foundation of the Wuxi Municipal Health Bureau; Scientific Technology Development Foundation of Nanjing Medical University	This research was supported by the Medical Research Foundation of the Wuxi Municipal Health Bureau (Grant No. ML201203) and supported by the Scientific Technology Development Foundation of Nanjing Medical University (Grant No. 2012NJMU071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abroug F, 2008, CURR OPIN CRIT CARE, V14, P340, DOI 10.1097/MCC.0b013e3282faa304; Abroug F, 2006, AM J RESP CRIT CARE, V174, P990, DOI 10.1164/rccm.200603-380OC; Albertson TE, 2010, J AM GERIATR SOC, V58, P570, DOI 10.1111/j.1532-5415.2010.02741.x; Balter M, 1997, INT J ANTIMICROB AG, V9, P83, DOI 10.1016/S0924-8579(97)00034-4; Balter Meyer S, 2003, Can Respir J, V10, P248; Bayes-Genis A, 2004, EUR J HEART FAIL, V6, P301, DOI 10.1016/j.ejheart.2003.12.013; Clerico A, 2004, CLIN CHEM, V50, P33, DOI 10.1373/clinchem.2003.024760; Clerico A, 2007, CLIN CHEM, V53, P813, DOI 10.1373/clinchem.2006.075713; Clerico A, 2011, AM J PHYSIOL-HEART C, V301, pH12, DOI 10.1152/ajpheart.00226.2011; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Donner CF, 2006, PULM PHARMACOL THER, V19, P4, DOI 10.1016/j.pupt.2005.10.011; Epshteyn V, 2003, DIABETES CARE, V26, P2081, DOI 10.2337/diacare.26.7.2081; Fabbri LM, 2008, EUR RESPIR J, V31, P204, DOI 10.1183/09031936.00114307; Gariani K, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13298; Goetze JP, 2006, EUR HEART J, V27, P3004, DOI 10.1093/eurheartj/ehl406; Hayes D, 2007, DRUG AGING, V24, P555, DOI 10.2165/00002512-200724070-00004; HUNT PJ, 1995, BIOCHEM BIOPH RES CO, V214, P1175, DOI 10.1006/bbrc.1995.2410; Inoue Y, 2009, INTERNAL MED, V48, P503, DOI 10.2169/internalmedicine.48.1701; Januzzi JL, 2005, AM J CARDIOL, V95, P948, DOI 10.1016/j.amjcard.2004.12.032; Krauser DG, 2006, J CARD FAIL, V12, P452, DOI 10.1016/j.cardfail.2006.04.005; Lainchbury JG, 2003, J AM COLL CARDIOL, V42, P728, DOI 10.1016/S0735-1097(03)00787-3; Luchner A, 2005, HYPERTENSION, V46, P118, DOI 10.1161/01.HYP.0000170140.36633.8f; McCullough PA, 2003, ACAD EMERG MED, V10, P198, DOI 10.1197/aemj.10.3.198; Mogelvang R, 2007, J AM COLL CARDIOL, V50, P1694, DOI 10.1016/j.jacc.2007.07.073; Morello A, 2007, AM HEART J, V153, P90, DOI 10.1016/j.ahj.2006.10.005; Nagaya N, 2000, CIRCULATION, V102, P865; Redfield MM, 2004, CIRCULATION, V109, P3176, DOI 10.1161/01.CIR.0000130845.38133.8F; Seemungal TAR, 2000, AM J RESP CRIT CARE, V161, P1608, DOI 10.1164/ajrccm.161.5.9908022; Sethi S, 2000, CHEST, V118, P1557, DOI 10.1378/chest.118.6.1557; Sethi S, 2000, CHEST, V117, p380S, DOI 10.1378/chest.117.5_suppl_2.380S; Shelton RJ, 2006, EUR HEART J, V27, P2353, DOI 10.1093/eurheartj/ehl233; Sirithunyanont Chirasak, 2003, J Med Assoc Thai, V86 Suppl 1, pS87; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Sykes Annemarie, 2007, Proc Am Thorac Soc, V4, P642, DOI 10.1513/pats.200707-101TH; Tsang KWT, 2001, CHEMOTHERAPY, V47, P28, DOI 10.1159/000049178; Tung RH, 2006, ANN EMERG MED, V48, P66, DOI 10.1016/j.annemergmed.2005.12.022; Vassaux C, 2008, EUR RESPIR J, V32, P1275, DOI 10.1183/09031936.00151707; Villacorta H, 2002, ARQ BRAS CARDIOL, V79, P564; Villacorta Humberto, 2002, Arq. Bras. Cardiol., V79, P569, DOI 10.1590/S0066-782X2002001500002; Wang QP, 2009, ANN CLIN BIOCHEM, V46, P495, DOI 10.1258/acb.2009.009065; Zaninotto M, 2005, CLIN BIOCHEM, V38, P1041, DOI 10.1016/j.clinbiochem.2005.07.010	41	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52553	10.1371/journal.pone.0052553	http://dx.doi.org/10.1371/journal.pone.0052553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341901	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400018
J	Liu, L; Cao, YY; Cui, GL; Li, ZZ; Sun, J; Zhang, LN; Chen, C; Wang, Y; Wang, PH; Ding, H; Wang, DW				Liu, Lei; Cao, Yanyan; Cui, Guanglin; Li, Zongzhe; Sun, Jing; Zhang, Lina; Chen, Chen; Wang, Yan; Wang, Peihua; Ding, Hu; Wang, Dao Wen			Association Analysis of Polymorphisms in ROCK2 with Cardiovascular Disease in a Chinese Population	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; VASCULAR SMOOTH-MUSCLE; ESSENTIAL-HYPERTENSION SUSCEPTIBILITY; RHO-KINASE INHIBITOR; NITRIC-OXIDE; HAN CHINESE; CELL; PATHOPHYSIOLOGY; INVOLVEMENT; ACTIVATION	Background: Rho-kinase (ROCK) has been shown to play an important role in cardiovascular disease such as coronary artery disease (CAD) and hypertension. Recently, common variants of ROCK2 have been reported to influence blood pressure, but the relationship between common ROCK2 variants and cardiovascular disease has not been extensively studied in the Chinese population. Methods: To derive a more precise estimation of their relationship, we screened for the common variants by direct sequencing of all exons of ROCK2, and then we performed genetic association analyses in a CAD case-control study, including a total of 1344 cases and 1267 ethnically and geographically matched controls. Results: Unconditional logistic regression showed that no significant association between common variants in the coding region of ROCK2 and CAD was observed in our study (for rs978906, OR = 0.92, 95% CI 0.72-1.20 and P = 0.63; for rs2230774, OR = 0.90, 95% CI 0.70-1.16 and P = 0.47; for rs56304104, OR = 0.97, 95% CI 0.70-1.31 and P = 0.83; respectively). Conclusions: The relationship between the ROCK2 polymorphisms and cardiovascular disease risk cannot be entirely discounted and warrants further evaluation in a large population.	[Liu, Lei; Cao, Yanyan; Cui, Guanglin; Li, Zongzhe; Sun, Jing; Zhang, Lina; Chen, Chen; Wang, Yan; Wang, Peihua; Ding, Hu; Wang, Dao Wen] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Internal Med, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Ding, H (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Internal Med, Wuhan 430074, Peoples R China.	huding@tjh.tjmu.edu.cn; dwwang@tjh.tjmu.edu.cn	Wei, Qin/AAF-3325-2019; Zhang, Li/GWM-7501-2022; Chen, Chen/B-2080-2014	Wang, Dao Wen/0000-0002-9774-3980; ding, hu/0000-0002-1814-1552	National '973' Project [2012CB518004, 2012CB517801]; National Nature Science Foundation of China [30930039, 81100066]	National '973' Project(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National '973' Project (2012CB518004, 2012CB517801), and National Nature Science Foundation of China (30930039, 81100066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angius A, 2002, AM J HUM GENET, V71, P893, DOI 10.1086/342929; Ding H, 2011, ATHEROSCLEROSIS, V216, P381, DOI 10.1016/j.atherosclerosis.2011.02.005; Ding H, 2010, PHARMACOGENET GENOM, V20, P187, DOI 10.1097/FPC.0b013e328336eefe; Dong Ming, 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P322; Guerin P, 2005, J VASC RES, V42, P21, DOI 10.1159/000082873; Inokuchi K, 2004, J CARDIOVASC PHARM, V44, P275, DOI 10.1097/01.fjc.0000134775.76636.3f; Kandabashi T, 2002, ARTERIOSCL THROM VAS, V22, P243, DOI 10.1161/hq0202.104274; Kuo TY, 2012, AM J HYPERTENS, V25, P804, DOI 10.1038/ajh.2012.44; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Lunetta KL, 2008, CIRCULATION, V118, P96, DOI 10.1161/CIRCULATIONAHA.107.700401; Mallat Z, 2003, CIRC RES, V93, P884, DOI 10.1161/01.RES.0000099062.55042.9A; Masumoto A, 2002, CIRCULATION, V105, P1545, DOI 10.1161/hc1002.105938; Masumoto A, 2001, HYPERTENSION, V38, P1307, DOI 10.1161/hy1201.096541; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Ming XF, 2004, CIRCULATION, V110, P3708, DOI 10.1161/01.CIR.0000142867.26182.32; Montorsi P, 2006, EUR HEART J, V27, P2632, DOI 10.1093/eurheartj/ehl142; Moriki N, 2004, HYPERTENS RES, V27, P263, DOI 10.1291/hypres.27.263; Mukai Yasushi, 2001, FASEB Journal, V15, P1062; Nohria A, 2006, CIRC RES, V99, P1426, DOI 10.1161/01.RES.0000251668.39526.c7; Noma K, 2006, AM J PHYSIOL-CELL PH, V290, pC661, DOI 10.1152/ajpcell.00459.2005; Nunes KP, 2010, CELL MOL LIFE SCI, V67, P3823, DOI 10.1007/s00018-010-0460-1; Rankinen T, 2008, HYPERTENS RES, V31, P1651, DOI 10.1291/hypres.31.1651; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23; Sauzeau V, 2001, CIRC RES, V88, P1102, DOI 10.1161/hh1101.092034; Schmandke A, 2007, NEUROSCIENTIST, V13, P454, DOI 10.1177/1073858407303611; Seasholtz TM, 2006, HYPERTENSION, V47, P937, DOI 10.1161/01.HYP.0000217364.45622.f0; Seko T, 2003, CIRC RES, V92, P411, DOI 10.1161/01.RES.0000059987.90200.44; Shi JJ, 2007, ARCH IMMUNOL THER EX, V55, P61, DOI 10.1007/s00005-007-0009-7; Stamatovic SM, 2003, J CELL SCI, V116, P4615, DOI 10.1242/jcs.00755; Surma M, 2011, FUTUR CARDIOL, V7, P657, DOI [10.2217/fca.11.51, 10.2217/FCA.11.51]; Takeuchi F, 2012, EUR J HUM GENET, V20, P333, DOI 10.1038/ejhg.2011.184; Thumkeo D, 2003, MOL CELL BIOL, V23, P5043, DOI 10.1128/MCB.23.14.5043-5055.2003; Topol EJ, 2006, HUM MOL GENET, V15, pR117, DOI 10.1093/hmg/ddl183; Wang Q, 2005, CURR OPIN CARDIOL, V20, P182, DOI 10.1097/01.hco.0000160373.77190.f1; Xu YJ, 2011, PHARMACOGENET GENOM, V21, P489, DOI 10.1097/FPC.0b013e3283485eb2; Zeller T, 2012, CLIN CHEM, V58, P92, DOI 10.1373/clinchem.2011.170431; Zhao Q, 2008, PHARMACOGENET GENOM, V18, P459, DOI 10.1097/FPC.0b013e3282f97fb2; Zhou QA, 2011, TRENDS PHARMACOL SCI, V32, P167, DOI 10.1016/j.tips.2010.12.006	42	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53905	10.1371/journal.pone.0053905	http://dx.doi.org/10.1371/journal.pone.0053905			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326532	Green Published, gold, Green Submitted			2022-12-25	WOS:000314705800086
J	Tulinski, P; Fluit, AC; van Putten, JPM; de Bruin, A; Glorieux, S; Wagenaar, JA; Duim, B				Tulinski, Pawel; Fluit, Ad C.; van Putten, Jos P. M.; de Bruin, Alain; Glorieux, Sarah; Wagenaar, Jaap A.; Duim, Birgitta			An Ex Vivo Porcine Nasal Mucosa Explants Model to Study MRSA Colonization	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; ADHERENCE; BACTERIAL; CARRIAGE; CULTURE	Staphylococcus aureus is an opportunistic pathogen able to colonize the upper respiratory tract and skin surfaces in mammals. Methicillin-resistant S. aureus ST398 is prevalent in pigs in Europe and North America. However, the mechanism of successful pig colonization by MRSA ST398 is poorly understood. To study MRSA colonization in pigs, an ex vivo model consisting of porcine nasal mucosa explants cultured at an air-liquid interface was evaluated. In cultured mucosa explants from the surfaces of the ventral turbinates and septum of the pig nose no changes in cell morphology and viability were observed up to 72 h. MRSA colonization on the explants was evaluated followed for three MRSA ST398 isolates for 180 minutes. The explants were incubated with 3x10(8) CFU/ml in PBS for 2 h to allow bacteria to adhere to the explants surface. Next the explants were washed and in the first 30 minutes post adhering time, a decline in the number of CFU was observed for all MRSA. Subsequently, the isolates showed either: bacterial growth, no growth, or a further reduction in bacterial numbers. The MRSA were either localized as clusters between the cilia or as single bacteria on the cilia surface. No morphological changes in the epithelium layer were observed during the incubation with MRSA. We conclude that porcine nasal mucosa explants are a valuable ex vivo model to unravel the interaction of MRSA with nasal tissue.	[Tulinski, Pawel; van Putten, Jos P. M.; Wagenaar, Jaap A.; Duim, Birgitta] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Fluit, Ad C.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [de Bruin, Alain] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [Glorieux, Sarah] Univ Ghent, Fac Vet Med, Virol Lab, Merelbeke, Belgium; [Wagenaar, Jaap A.] Wageningen UR, Cent Vet Inst, Lelystad, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Ghent University; Wageningen University & Research	Duim, B (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands.	b.duim@uu.nl	de Bruin, Alain/AAL-9195-2020; Tulinski, Pawel/P-8365-2014	Tulinski, Pawel/0000-0002-5033-5859; de Bruin, Alain/0000-0001-8579-2649; van Putten, Jos/0000-0002-4126-8172	European Union [222718]	European Union(European Commission)	The work was supported by European Union Framework 7 Programme HEALTH project CONCORD (CONtrol of COmmunity-acquired MRSA: Rationale and Development of counteractions), grant number 222718. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes MB, 2007, BIOTECHNIQUES, V43, P195, DOI 10.2144/000112531; Broens EM, 2012, VET MICROBIOL, V155, P381, DOI 10.1016/j.vetmic.2011.09.010; Burian M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010040; Crombe F, 2012, APPL ENVIRON MICROB, V78, P1631, DOI 10.1128/AEM.07356-11; Ekkelenkamp M B, 2006, Ned Tijdschr Geneeskd, V150, P2442; Glorieux S, 2007, J VIROL METHODS, V142, P105, DOI 10.1016/j.jviromet.2007.01.018; Golding GR, 2010, EMERG INFECT DIS, V16, P587, DOI 10.3201/eid1604.091435; Gonzalez-Zorn B, 2005, INFECT IMMUN, V73, P1847, DOI 10.1128/IAI.73.3.1847-1851.2005; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Jackson AD, 1996, AM J RESP CRIT CARE, V153, P1130, DOI 10.1164/ajrccm.153.3.8630556; Kiser KB, 1999, INFECT IMMUN, V67, P5001, DOI 10.1128/IAI.67.10.5001-5006.1999; Kokai-Kun John F., 2008, V431, P241; MartineauDoize B, 1996, ANAT REC, V246, P169, DOI 10.1002/(SICI)1097-0185(199610)246:2<169::AID-AR3>3.0.CO;2-X; Moodley A, 2011, EPIDEMIOL INFECT, V139, P1594, DOI 10.1017/S0950268810002888; Roche FM, 2003, MICROBIOL-SGM, V149, P2759, DOI 10.1099/mic.0.26412-0; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; WYATT JE, 1990, J APPL BACTERIOL, V69, P834	22	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53783	10.1371/journal.pone.0053783	http://dx.doi.org/10.1371/journal.pone.0053783			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326505	Green Published, Green Submitted, gold			2022-12-25	WOS:000314705800074
J	Kovach, RP; Joyce, JE; Echave, JD; Lindberg, MS; Tallmon, DA				Kovach, Ryan P.; Joyce, John E.; Echave, Jesse D.; Lindberg, Mark S.; Tallmon, David A.			Earlier Migration Timing, Decreasing Phenotypic Variation, and Biocomplexity in Multiple Salmonid Species	PLOS ONE			English	Article							ECO-EVOLUTIONARY DYNAMICS; CLIMATE-CHANGE; SOCKEYE-SALMON; PACIFIC SALMON; LIFE-HISTORY; PINK SALMON; ECOLOGICAL CONSEQUENCES; ONCORHYNCHUS-NERKA; MARINE SURVIVAL; FRASER-RIVER	Climate-induced phenological shifts can influence population, evolutionary, and ecological dynamics, but our understanding of these phenomena is hampered by a lack of long-term demographic data. We use a multi-decade census of 5 salmonid species representing 14 life histories in a warming Alaskan stream to address the following key questions about climate change and phenology: How consistent are temporal patterns and drivers of phenology for similar species and alternative life histories? Are shifts in phenology associated with changes in phenotypic variation? How do phenological changes influence the availability of resource subsidies? For most salmonid species, life stages, and life histories, freshwater temperature influences migration timing-migration events are occurring earlier in time (mean = 1.7 days earlier per decade over the 3-5 decades), and the number of days over which migration events occur is decreasing (mean = 1.5 days per decade). Temporal trends in migration timing were not correlated with changes in intra-annual phenotypic variation, suggesting that these components of the phenotypic distribution have responded to environmental change independently. Despite commonalities across species and life histories, there was important biocomplexity in the form of disparate shifts in migration timing and variation in the environmental factors influencing migration timing for alternative life history strategies in the same population. Overall, adult populations have been stable during these phenotypic and environmental changes (lambda approximate to 1.0), but the temporal availability of salmon as a resource in freshwater has decreased by nearly 30 days since 1971 due to changes in the median date of migration timing and decreases in intra-annual variation in migration timing. These novel observations advance our understanding of phenological change in response to climate warming, and indicate that climate change has influenced the ecology of salmon populations, which will have important consequences for the numerous species that depend on this resource.	[Kovach, Ryan P.; Lindberg, Mark S.; Tallmon, David A.] Univ Alaska Fairbanks, Dept Biol & Wildlife, Inst Arctic Biol, Fairbanks, AK USA; [Joyce, John E.; Echave, Jesse D.] Natl Ocean & Atmospher Adm, Alaska Fisheries Sci Ctr, Auke Bay Labs, Juneau, AK USA; [Tallmon, David A.] Univ Alaska SE, Biol & Marine Biol Program, Juneau, AK USA	University of Alaska System; University of Alaska Fairbanks; National Oceanic Atmospheric Admin (NOAA) - USA; University of Alaska System; University of Alaska Southeastern	Kovach, RP (corresponding author), Univ Alaska Fairbanks, Dept Biol & Wildlife, Inst Arctic Biol, Fairbanks, AK USA.	rpkovach@alaska.edu			Alaska EPSCoR; Institute of Arctic Biology; Direct For Biological Sciences [0960285] Funding Source: National Science Foundation	Alaska EPSCoR; Institute of Arctic Biology; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	An Alaska EPSCoR Graduate Research Fellowship and Institute of Arctic Biology Summer Research Fellowship supported R.P.K. This research was prepared by R.P.K. and D.A.T. under North Pacific Research Board (http://www.nprb.org/) project 1110 and award 45965 from the National Oceanic and Atmospheric Administration, U.S. Department of Commerce, administered by the Alaska Department of Fish and Game (http://www.akssf.org/akssf_org/home.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F., 2007, CONSERVATION GENETIC; Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; BEACHAM TD, 1990, T AM FISH SOC, V119, P927, DOI 10.1577/1548-8659(1990)119&lt;0927:TESADO&gt;2.3.CO;2; BenDavid M, 1997, CAN J ZOOL, V75, P376, DOI 10.1139/z97-047; Brodeur Richard D., 2003, North Pacific Anadromous Fish Commission Bulletin, V3, P89; BRODIE ED, 1995, TRENDS ECOL EVOL, V10, P313, DOI 10.1016/S0169-5347(00)89117-X; Bryant MD, 2009, CLIMATIC CHANGE, V95, P169, DOI 10.1007/s10584-008-9530-x; Carlson SM, 2011, HEREDITY, V106, P438, DOI 10.1038/hdy.2010.163; Carlson SM, 2008, EVOL APPL, V1, P222, DOI 10.1111/j.1752-4571.2008.00025.x; Carlson SM, 2007, ECOLOGY, V88, P2620, DOI 10.1890/06-1171.1; Carlson SM, 2011, CAN J FISH AQUAT SCI, V68, P1579, DOI 10.1139/F2011-084; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Cooke SJ, 2004, FISHERIES, V29, P22, DOI 10.1577/1548-8446(2004)29[22:AMTAHE]2.0.CO;2; Crozier LG, 2008, EVOL APPL, V1, P252, DOI 10.1111/j.1752-4571.2008.00033.x; Crozier LG, 2011, AM NAT, V178, P755, DOI 10.1086/662669; Dickerson BR, 2005, ECOLOGY, V86, P347, DOI 10.1890/03-625; Diez JM, 2012, ECOL LETT, V15, P545, DOI 10.1111/j.1461-0248.2012.01765.x; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Duffy EJ, 2008, T AM FISH SOC, V137, P165, DOI 10.1577/T07-049.1; Dunham J, 2008, FISHERIES, V33, P537, DOI 10.1577/1548-8446-33.11.537; Ezard THG, 2009, PHILOS T R SOC B, V364, P1491, DOI 10.1098/rstb.2009.0006; Fukushima M, 1998, T AM FISH SOC, V127, P253, DOI 10.1577/1548-8659(1998)127<0253:SHSOSS>2.0.CO;2; Gende SM, 2002, BIOSCIENCE, V52, P917, DOI 10.1641/0006-3568(2002)052[0917:PSIAAT]2.0.CO;2; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Greene CM, 2010, BIOL LETTERS, V6, P382, DOI 10.1098/rsbl.2009.0780; Hansen MM, 2012, MOL ECOL, V21, P1311, DOI 10.1111/j.1365-294X.2011.05463.x; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Hocking MD, 2011, SCIENCE, V331, P1609, DOI 10.1126/science.1201079; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Humbert JY, 2009, OIKOS, V118, P1940, DOI 10.1111/j.1600-0706.2009.17839.x; Hutchings JA, 2011, HEREDITY, V106, P421, DOI 10.1038/hdy.2010.166; Jones JD, 1997, SEA-RUN CUTTHROAT TROUT, P27; Juanes F, 2004, CAN J FISH AQUAT SCI, V61, P2392, DOI 10.1139/f04-207; Kennedy RJ, 2010, J FISH BIOL, V76, P1786, DOI 10.1111/j.1095-8649.2010.02617.x; Kinnison MT, 2007, FUNCT ECOL, V21, P444, DOI 10.1111/j.1365-2435.2007.01278.x; Kovach RP, 2012, P ROY SOC B-BIOL SCI, V279, P3870, DOI 10.1098/rspb.2012.1158; Lisi PJ, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00173.1; Malick MJ, 2009, T AM FISH SOC, V138, P846, DOI 10.1577/T08-177.1; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Martins EG, 2012, REV FISH BIOL FISHER, V22, P887, DOI 10.1007/s11160-012-9271-9; Mcphee MV, 2012, CURR ZOOL, V58, P21, DOI 10.1093/czoolo/58.1.21; Moore JW, 2010, CONSERV LETT, V3, P340, DOI 10.1111/j.1755-263X.2010.00119.x; Moore JW, 2010, P ROY SOC B-BIOL SCI, V277, P1695, DOI 10.1098/rspb.2009.2342; Mundy PR, 2011, ICES J MAR SCI, V68, P1155, DOI 10.1093/icesjms/fsr080; Olsen EM, 2009, ECOL LETT, V12, P622, DOI 10.1111/j.1461-0248.2009.01311.x; Pachauri RK, 2007, CLIM CHANG 2007 SYNT; Palkovacs EP, 2012, EVOL APPL, V5, P183, DOI 10.1111/j.1752-4571.2011.00212.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Quinn TP, 2007, ECOL APPL, V17, P731, DOI 10.1890/06-0771; Quinn Thomas P., 2005, P1; Quinn TP, 1996, ECOLOGY, V77, P1151, DOI 10.2307/2265584; Quinn TP, 2002, T AM FISH SOC, V131, P591, DOI 10.1577/1548-8659(2002)131&lt;0591:ASAECC&gt;2.0.CO;2; Reed TE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020380; Rich HB, 2009, CAN J FISH AQUAT SCI, V66, P238, DOI 10.1139/F08-210; Robards MD, 2002, T AM FISH SOC, V131, P523, DOI 10.1577/1548-8659(2002)131<0523:TMTOAS>2.0.CO;2; Roper BB, 1999, CAN J FISH AQUAT SCI, V56, P939, DOI 10.1139/cjfas-56-6-939; Scheuerell MD, 2009, J APPL ECOL, V46, P983, DOI 10.1111/j.1365-2664.2009.01693.x; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Schindler DE, 2005, ECOLOGY, V86, P198, DOI 10.1890/03-0408; Schindler DE, 2003, FRONT ECOL ENVIRON, V1, P31, DOI 10.1890/1540-9295(2003)001[0031:PSATEO]2.0.CO;2; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Shaul L, 2011, SPECIAL PUBLICATION, V11-23; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; TAYLOR EB, 1991, AQUACULTURE, V98, P185, DOI 10.1016/0044-8486(91)90383-I; TAYLOR SG, 1980, T AM FISH SOC, V109, P79, DOI 10.1577/1548-8659(1980)109<79:MSOPSF>2.0.CO;2; Taylor SG, 2008, GLOBAL CHANGE BIOL, V14, P229, DOI 10.1111/j.1365-2486.2007.01494.x; Thomson RE, 2011, FISH OCEANOGR, V20, P47, DOI 10.1111/j.1365-2419.2010.00565.x; Todd BD, 2011, P ROY SOC B-BIOL SCI, V278, P2191, DOI 10.1098/rspb.2010.1768; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren DR, 2012, GLOBAL CHANGE BIOL, V18, P1804, DOI 10.1111/j.1365-2486.2012.02670.x; Williams JG, 2008, EVOL APPL, V1, P271, DOI 10.1111/j.1752-4571.2008.00027.x; WILLSON MF, 1995, CONSERV BIOL, V9, P489, DOI 10.1046/j.1523-1739.1995.09030489.x; Zabel RW, 2004, ECOLOGY, V85, P795, DOI 10.1890/02-0719	76	77	81	2	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53807	10.1371/journal.pone.0053807	http://dx.doi.org/10.1371/journal.pone.0053807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326513	Green Published, Green Submitted, gold			2022-12-25	WOS:000313552400051
J	Volberg, G; Wutz, A; Greenlee, MW				Volberg, Gregor; Wutz, Andreas; Greenlee, Mark W.			Top-Down Control in Contour Grouping	PLOS ONE			English	Article							EEG ALPHA OSCILLATIONS; PRIMARY VISUAL-CORTEX; SPATIAL ATTENTION; ELECTROPHYSIOLOGICAL CORRELATE; THETA OSCILLATIONS; GLOBAL SHAPES; INTEGRATION; MECHANISMS; SYNCHRONIZATION; ORGANIZATION	Human observers tend to group oriented line segments into full contours if they follow the Gestalt rule of 'good continuation'. It is commonly assumed that contour grouping emerges automatically in early visual cortex. In contrast, recent work in animal models suggests that contour grouping requires learning and thus involves top-down control from higher brain structures. Here we explore mechanisms of top-down control in perceptual grouping by investigating synchronicity within EEG oscillations. Human participants saw two micro-Gabor arrays in a random order, with the task to indicate whether the first (S1) or the second stimulus (S2) contained a contour of collinearly aligned elements. Contour compared to non-contour S1 produced a larger posterior post-stimulus beta power (15-21 Hz). Contour S2 was associated with a pre-stimulus decrease in posterior alpha power (11-12 Hz) and in fronto-posterior theta (4-5 Hz) phase couplings, but not with a post-stimulus increase in beta power. The results indicate that subjects used prior knowledge from S1 processing for S2 contour grouping. Expanding previous work on theta oscillations, we propose that long-range theta synchrony shapes neural responses to perceptual groupings regulating lateral inhibition in early visual cortex.	[Volberg, Gregor; Wutz, Andreas; Greenlee, Mark W.] Univ Regensburg, Inst Psychol, D-93053 Regensburg, Germany; [Wutz, Andreas] Univ Trento, Ctr Cognit & Brain Sci, Rovereto, Italy	University of Regensburg; University of Trento	Volberg, G (corresponding author), Univ Regensburg, Inst Psychol, D-93053 Regensburg, Germany.	gregor.volberg@psychologie.uni-regensburg.de	Wutz, Andreas/AAH-6931-2020; Greenlee, Mark/M-6414-2018; Wutz, Andreas/E-9125-2019	Wutz, Andreas/0000-0003-2807-0863; Greenlee, Mark/0000-0003-2305-9286; Volberg, Gregor/0000-0002-4427-2409				Achtman RL, 2003, J VISION, V3, P616, DOI 10.1167/3.10.4; Altmann CF, 2003, CURR BIOL, V13, P342, DOI 10.1016/S0960-9822(03)00052-6; Baker DH, 2007, VISION RES, V47, P3096, DOI 10.1016/j.visres.2007.08.013; Banerjee S, 2011, J NEUROSCI, V31, P9923, DOI 10.1523/JNEUROSCI.4660-10.2011; Beaudot WHA, 2003, VISUAL NEUROSCI, V20, P51, DOI 10.1017/S0952523803201061; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Craft E, 2007, J NEUROPHYSIOL, V97, P4310, DOI 10.1152/jn.00203.2007; DeCoteau WE, 2007, P NATL ACAD SCI USA, V104, P5644, DOI 10.1073/pnas.0700818104; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DILOLLO V, 1980, J EXP PSYCHOL GEN, V109, P75, DOI 10.1037/0096-3445.109.1.75; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Donderi DC, 2006, PSYCHOL BULL, V132, P73, DOI 10.1037/0033-2909.132.1.73; Donkers Franc C L, 2011, Front Psychiatry, V2, P51, DOI 10.3389/fpsyt.2011.00051; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Flevaris AV, 2011, J VISION, V11, DOI 10.1167/11.7.11; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Haegens S, 2011, J NEUROSCI, V31, P5197, DOI 10.1523/JNEUROSCI.5199-10.2011; Hanslmayr S, 2011, J NEUROSCI, V31, P15674, DOI 10.1523/JNEUROSCI.3140-11.2011; Hess R, 1999, TRENDS COGN SCI, V3, P480, DOI 10.1016/S1364-6613(99)01410-2; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Jirmann KU, 2009, EXP BRAIN RES, V192, P369, DOI 10.1007/s00221-008-1583-6; Kamarajan C, 2012, HUM BRAIN MAPP, V33, P1019, DOI 10.1002/hbm.21267; Kayser J., 2009, CURRENT SOURCE DENSI; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Li W, 2002, J NEUROPHYSIOL, V88, P2846, DOI 10.1152/jn.00289.2002; Li W, 2008, NEURON, V57, P442, DOI 10.1016/j.neuron.2007.12.011; Li W, 2006, NEURON, V50, P951, DOI 10.1016/j.neuron.2006.04.035; Mao R, 2012, CEREB CORTEX, V22, P493, DOI 10.1093/cercor/bhr057; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mathes B, 2007, PSYCHOPHYSIOLOGY, V44, P305, DOI 10.1111/j.1469-8986.2007.00501.x; Mathes B, 2006, BRAIN RES, V1114, P98, DOI 10.1016/j.brainres.2006.07.068; May ES, 2012, NEUROIMAGE, V62, P1965, DOI 10.1016/j.neuroimage.2012.05.071; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Norman KA, 2006, NEURAL COMPUT, V18, P1577, DOI 10.1162/neco.2006.18.7.1577; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Rohenkohl G, 2011, J NEUROSCI, V31, P14076, DOI 10.1523/JNEUROSCI.3387-11.2011; Romei V, 2011, CURR BIOL, V21, P334, DOI 10.1016/j.cub.2011.01.035; Sander MC, 2012, NEUROIMAGE, V59, P646, DOI 10.1016/j.neuroimage.2011.06.092; Sato H, 1996, J PHYSIOL-LONDON, V494, P757, DOI 10.1113/jphysiol.1996.sp021530; Tanskanen T, 2008, J VISION, V8, DOI 10.1167/8.7.15; Tarokh L, 2009, BEHAV BRAIN RES, V196, P55, DOI 10.1016/j.bbr.2008.07.026; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; Volberg G, 2009, HUM BRAIN MAPP, V30, P2173, DOI 10.1002/hbm.20659; Wagemans J, 2012, PSYCHOL BULL, V138, P1172, DOI 10.1037/a0029333; Watt R, 2008, J VISION, V8, DOI 10.1167/8.7.23; Womelsdorf T, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00210; Worden MS, 2000, J NEUROSCI, V20; Yeshurun Y, 2008, VISION RES, V48, P1837, DOI 10.1016/j.visres.2008.05.008; Zhang NR, 2010, J NEUROSCI, V30, P6482, DOI 10.1523/JNEUROSCI.5168-09.2010	58	18	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54085	10.1371/journal.pone.0054085	http://dx.doi.org/10.1371/journal.pone.0054085			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326575	Green Published, gold, Green Submitted			2022-12-25	WOS:000313552400074
J	Yang, FY; Chiu, WH				Yang, Feng-Yi; Chiu, Wei-Hsiu			Focused Ultrasound-Modulated Glomerular Ultrafiltration Assessed by Functional Changes in Renal Arteries	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; PERMEABILITY; TUMOR	This study demonstrates the feasibility of using focused ultrasound (FUS) to modulate glomerular ultrafiltration by renal artery sonication and determine if protein-creatinine ratios are estimated through vascular parameters. All animal experiments were approved by our Animal Care and Use Committee. The renal arteries of Sprague-Dawley rats were surgically exposed and sonicated at various acoustic power levels using a FUS transducer with a resonant frequency of 1 MHz. The mean peak systolic velocity (PSV) of the blood flow was measured by Doppler ultrasound imaging. Urinary protein-creatinine ratios were calculated during the experiments. Histological examination of renal arteries and whole kidneys was performed. The PSV, pulsatility index, and resistance index of blood flow significantly increased in the arteries after FUS sonication without microbubbles (p<0.05). The change in normalized protein-creatinine ratios significantly increased with increasing acoustic power, but such was not observed when microbubbles were administered. Furthermore, no histological changes were observed in the hematoxylin-and eosin-stained sections. Glomerular ultrafiltration is regulated temporarily by renal artery sonication without microbubbles. Monitoring vascular parameters are useful in estimating the normalized change in protein-creatinine ratios.	[Yang, Feng-Yi; Chiu, Wei-Hsiu] Natl Yang Ming Univ, Sch Biomed Sci & Engn, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan	National Yang Ming Chiao Tung University	Yang, FY (corresponding author), Natl Yang Ming Univ, Sch Biomed Sci & Engn, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan.	fyyang@ym.edu.tw			National Science Council of Taiwan [NSC 101-2320-B-010-036-MY3, NSC 100-2321-B-010-010, NSC 99-2321-B-010-017]; Cheng Hsin General Hospital Foundation [100F117CY25, 101F195CY18]; Veterans General Hospitals University [VGHUST100-G1-3-3]; Yen Tjing Ling Medical Foundation [CI-100-17]; Department of Health of Taiwan [DOH101-TD-PB-111-TM012]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Cheng Hsin General Hospital Foundation; Veterans General Hospitals University; Yen Tjing Ling Medical Foundation; Department of Health of Taiwan	This study was supported by grants from the National Science Council of Taiwan (no. NSC 101-2320-B-010-036-MY3, NSC 100-2321-B-010-010 and NSC 99-2321-B-010-017), Cheng Hsin General Hospital Foundation (no. 100F117CY25 and 101F195CY18), Veterans General Hospitals University System of Taiwan Joint Research Program (#VGHUST100-G1-3-3), Yen Tjing Ling Medical Foundation (grant CI-100-17), Department of Health of Taiwan (DOH101-TD-PB-111-TM012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekeredjian R, 2007, ULTRASOUND MED BIOL, V33, P1592, DOI 10.1016/j.ultrasmedbio.2007.05.003; Fischer K, 2009, RADIOLOGY, V253, P697, DOI 10.1148/radiol.2532082100; GOSLING RG, 1974, P ROY SOC MED, V67, P447, DOI 10.1177/00359157740676P113; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Ishikawa T, 2003, ULTRASOUND MED BIOL, V29, P1471, DOI 10.1016/S0301-5629(03)00951-7; Khaibullina A, 2008, J NUCL MED, V49, P295, DOI 10.2967/jnumed.107.046888; LEGARTH J, 1990, J ULTRAS MED, V9, P449; Mcdannold N, 2008, ULTRASOUND MED BIOL, V34, P930, DOI 10.1016/j.ultrasmedbio.2007.11.009; Meairs S, 2009, MED BIOL ENG COMPUT, V47, P839, DOI 10.1007/s11517-009-0468-6; Miner JH, 2012, EXP CELL RES, V318, P973, DOI 10.1016/j.yexcr.2012.02.031; Raymond SB, 2007, J CEREBR BLOOD F MET, V27, P393, DOI 10.1038/sj.jcbfm.9600336; Tachibana K, 1999, LANCET, V353, P1409, DOI 10.1016/S0140-6736(99)01244-1; Unger EC, 2004, ADV DRUG DELIVER REV, V56, P1291, DOI 10.1016/j.addr.2003.12.006; Yang FY, 2008, ULTRASON SONOCHEM, V15, P636, DOI 10.1016/j.ultsonch.2007.08.003; Yang FY, 2012, MED ENG PHYS, V34, P313, DOI 10.1016/j.medengphy.2011.07.021; Yang FY, 2012, INT J NANOMED, V7, P965, DOI 10.2147/IJN.S29229; Yang FY, 2012, INT J NANOMED, V7, P723, DOI 10.2147/IJN.S28503; Yang FY, 2011, J NUCL MED, V52, P478, DOI 10.2967/jnumed.110.083071; Yang FY, 2011, J CONTROL RELEASE, V150, P111, DOI 10.1016/j.jconrel.2010.10.038; Yang FY, 2010, IEEE T ULTRASON FERR, V57, P1594, DOI 10.1109/TUFFC.2010.1589; Yang FY, 2009, J ACOUST SOC AM, V126, P3344, DOI 10.1121/1.3242376; Yang FY, 2009, IEEE T ULTRASON FERR, V56, P2643, DOI 10.1109/TUFFC.2009.1355; Yang FY, 2012, J CONTROL RELEASE; Zderic V, 2006, ULTRASONICS, V45, P113, DOI 10.1016/j.ultras.2006.07.018	24	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54034	10.1371/journal.pone.0054034	http://dx.doi.org/10.1371/journal.pone.0054034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326567	Green Submitted, gold, Green Published			2022-12-25	WOS:000313552400068
J	Goodbody-Gringley, G; Wetzel, DL; Gillon, D; Pulster, E; Miller, A; Ritchie, KB				Goodbody-Gringley, Gretchen; Wetzel, Dana L.; Gillon, Daniel; Pulster, Erin; Miller, Allison; Ritchie, Kim B.			Toxicity of Deepwater Horizon Source Oil and the Chemical Dispersant, Corexit (R) 9500, to Coral Larvae	PLOS ONE			English	Article							CRUDE-OIL; REEF; METAMORPHOSIS; SPILLS; IMPACT	Acute catastrophic events can cause significant damage to marine environments in a short time period and may have devastating long-term impacts. In April 2010 the BP-operated Deepwater Horizon (DWH) offshore oil rig exploded, releasing an estimated 760 million liters of crude oil into the Gulf of Mexico. This study examines the potential effects of oil spill exposure on coral larvae of the Florida Keys. Larvae of the brooding coral, Porites astreoides, and the broadcast spawning coral, Montastraea faveolata, were exposed to multiple concentrations of BP Horizon source oil (crude, weathered and WAF), oil in combination with the dispersant Corexit (R) 9500 (CEWAF), and dispersant alone, and analyzed for behavior, settlement, and survival. Settlement and survival of P. astreoides and M. faveolata larvae decreased with increasing concentrations of WAF, CEWAF and Corexit (R) 9500, however the degree of the response varied by species and solution. P. astreoides larvae experienced decreased settlement and survival following exposure to 0.62 ppm source oil, while M. faveolata larvae were negatively impacted by 0.65, 1.34 and 1.5 ppm, suggesting that P. astreoides larvae may be more tolerant to WAF exposure than M. faveolata larvae. Exposure to medium and high concentrations of CEWAF (4.28/18.56 and 30.99/35.76 ppm) and dispersant Corexit (R) 9500 (50 and 100 ppm), significantly decreased larval settlement and survival for both species. Furthermore, exposure to Corexit (R) 9500 resulted in settlement failure and complete larval mortality after exposure to 50 and 100 ppm for M. faveolata and 100 ppm for P. astreoides. These results indicate that exposure of coral larvae to oil spill related contaminants, particularly the dispersant Corexit (R) 9500, has the potential to negatively impact coral settlement and survival, thereby affecting the resilience and recovery of coral reefs following exposure to oil and dispersants.	[Goodbody-Gringley, Gretchen; Wetzel, Dana L.; Gillon, Daniel; Pulster, Erin; Miller, Allison; Ritchie, Kim B.] Mote Marine Lab, Sarasota, FL 34236 USA	Mote Marine Laboratory & Aquarium	Ritchie, KB (corresponding author), Mote Marine Lab, Sarasota, FL 34236 USA.	ritchie@mote.org			Protect Our Reefs Emergency; NSF (National Science Foundation) [REU-1004181]; NSF [OCE-0926822]; Dart Foundation	Protect Our Reefs Emergency; NSF (National Science Foundation)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Dart Foundation	Funding for this project was provided via Protect Our Reefs 2010 Emergency funding to KB Ritchie, NSF (National Science Foundation) REU-1004181 funding to DG, NSF OCE-0926822 funding to Mary Alice Coffroth, and the Dart Foundation to KBR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, OIL SEA; Aurand D, 2006, 0703 EC MAN ASS INC, P105; Birkeland G, 1976, SURVEY MARINE COMMUN, P76; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Chandrasekar S, 2006, ICES J MAR SCI, V63, P1418, DOI 10.1016/j.icesjms.2006.04.019; CHIA F-S, 1973, Marine Pollution Bulletin, V4, P29, DOI 10.1016/0025-326X(73)90208-7; Edmunds PJ, 2001, MAR BIOL, V139, P981; Epstein N, 2000, MAR POLLUT BULL, V40, P497, DOI 10.1016/S0025-326X(99)00232-5; Fiocco RJ, 1999, PURE APPL CHEM, V71, P27, DOI 10.1351/pac199971010027; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GRIFFIN LF, 1977, APPL ENVIRON MICROB, V33, P1092, DOI 10.1128/AEM.33.5.1092-1096.1977; Harrison P., 1999, OIL POLLUTANTS INHIB, P8; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Heubeck M, 2003, MAR POLLUT BULL, V46, P900, DOI 10.1016/S0025-326X(03)00098-5; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kemp DW, 2011, GLOBAL CHANGE BIOL, V17, P3468, DOI 10.1111/j.1365-2486.2011.02487.x; Klemas V, 2010, J COASTAL RES, V26, P789, DOI 10.2112/10A-00012.1; LOYA Y, 1980, MAR ECOL PROG SER, V3, P167, DOI 10.3354/meps003167; LOYA Y, 1979, MAR ECOL PROG SER, V1, P77, DOI 10.3354/meps001077; MANAHAN DT, 1990, AM ZOOL, V30, P147; Mearns A., 2003, P INT OIL SPILL C, P523; Minerals Management Service, 2009, 2009012 OCS MMS; Munn C, 2004, MARINE MICROBIOLOGY; Negri AP, 2000, MAR POLLUT BULL, V41, P420, DOI 10.1016/S0025-326X(00)00139-9; NRC, 2005, OIL SPILL DISP EFF E, P193, DOI 10.17226/11283; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Payne J. R., 1985, PETROLEUM SPILLS MAR; PORTER JW, 1992, AM ZOOL, V32, P625; Ramseur J.L., 2011, FATE OIL DEEP HORIZ, P1; RICHMOND RH, 1987, MAR BIOL, V93, P527, DOI 10.1007/BF00392790; Ritson-Williams R, 2010, CORAL REEFS, V29, P71, DOI 10.1007/s00338-009-0555-z; Shafir S, 2007, ENVIRON SCI TECHNOL, V41, P5571, DOI 10.1021/es0704582; Sharp KH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010898; Shinegaka G, 2001, 8 NOAA NOS OR R; SINGER MM, 1990, WATER RES, V24, P899, DOI 10.1016/0043-1354(90)90140-2; Szmant AM, 1997, MAR BIOL, V129, P561, DOI 10.1007/s002270050197; SZMANT AM, 1986, CORAL REEFS, V5, P43, DOI 10.1007/BF00302170; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; Wetzel D.L., 2001, P 2001 INT OIL SPILL, P1237, DOI DOI 10.7901/2169-3358-2001-2-1237	40	117	117	2	367	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e45574	10.1371/journal.pone.0045574	http://dx.doi.org/10.1371/journal.pone.0045574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326298	Green Published, gold, Green Submitted			2022-12-25	WOS:000313551500001
J	Vander Wal, E; van Beest, FM; Brook, RK				Vander Wal, Eric; van Beest, Floris M.; Brook, Ryan K.			Density-Dependent Effects on Group Size Are Sex-Specific in a Gregarious Ungulate	PLOS ONE			English	Article							MOUNTAIN-NATIONAL-PARK; TEMPORAL VARIATION; PREDATION RISK; HERD SIZE; ELK; POPULATION; SEGREGATION; BEHAVIOR; DEER; RED	Density dependence can have marked effects on social behaviors such as group size. We tested whether changes in population density of a large herbivore (elk, Cervus canadensis) affected sex-specific group size and whether the response was density- or frequency-dependent. We quantified the probability and strength of changes in group sizes and dispersion as population density changed for each sex. We used group size data from a population of elk in Manitoba, Canada, that was experimentally reduced from 1.20 to 0.67 elk/km(2) between 2002 and 2009. Our results indicated that functional responses of group size to population density are sex-specific. Females showed a positive density-dependent response in group size at population densities >= 0.70 elk/km(2) and we found evidence for a minimum group size at population density <= 0.70 elk/km(2). Changes in male group size were also density-dependent; however, the strength of the relationship was lower than for females. Density dependence in male group size was predominantly a result of fusion of solitary males into larger groups, rather than fusion among existing groups. Our study revealed that density affects group size of a large herbivore differently between males and females, which has important implications for the benefits e.g., alleviating predation risk, and costs of social behaviors e. g., competition for resources and mates, and intra-specific pathogen transmission.	[Vander Wal, Eric; van Beest, Floris M.; Brook, Ryan K.] Univ Saskatchewan, Dept Anim & Poultry Sci, Coll Agr & Bioresources, Saskatoon, SK S7N 0W0, Canada; [Vander Wal, Eric] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada	University of Saskatchewan; University of Sherbrooke	Vander Wal, E (corresponding author), Univ Saskatchewan, Dept Anim & Poultry Sci, Coll Agr & Bioresources, Saskatoon, SK S7N 0W0, Canada.	eric.vander.wal@usherbrooke.ca	van Beest, Floris M./C-6745-2019	van Beest, Floris M./0000-0002-5701-4927	Parks Canada Agency; PrioNet Canada; National Science and Engineering Research Council of Canada; Manitoba Conservation; Manitoba Agriculture, Food and Rural Initiatives; Canadian Food Inspection Agency; University of Manitoba; University of Saskatchewan; Riding Mountain Biosphere Reserve; Louisiana Pacific; Nature Conservancy of Canada; Rocky Mountain Elk Foundation; Manitoba Wildlife Federation; Eastlands Wildlife Association; Westlake Wildlife Association; Earth Rhythms Inc.; Seven Oaks Game and Fish; Global Precision Inc.	Parks Canada Agency; PrioNet Canada; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Manitoba Conservation; Manitoba Agriculture, Food and Rural Initiatives; Canadian Food Inspection Agency; University of Manitoba; University of Saskatchewan; Riding Mountain Biosphere Reserve; Louisiana Pacific; Nature Conservancy of Canada; Rocky Mountain Elk Foundation; Manitoba Wildlife Federation; Eastlands Wildlife Association; Westlake Wildlife Association; Earth Rhythms Inc.; Seven Oaks Game and Fish; Global Precision Inc.	Funding was provided primarily by Parks Canada Agency and PrioNet Canada. Additional financial support was obtained from the National Science and Engineering Research Council of Canada grants to S. McLauchlin and F. Messier, Manitoba Conservation, Manitoba Agriculture, Food and Rural Initiatives, the Canadian Food Inspection Agency, University of Manitoba, University of Saskatchewan, Riding Mountain Biosphere Reserve, Louisiana Pacific, Nature Conservancy of Canada, Rocky Mountain Elk Foundation, Manitoba Wildlife Federation, Eastlands Wildlife Association, Westlake Wildlife Association, Earth Rhythms Inc., Seven Oaks Game and Fish, and Global Precision Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received funding from the following commercial sources: Louisiana Pacific, Earth Rhythms Inc., Seven Oaks Game and Fish, and Global Precision Inc.. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	ALBON SD, 1992, J ANIM ECOL, V61, P131, DOI 10.2307/5516; BARRETTE C, 1991, MAMMALIA, V55, P207, DOI 10.1515/mamm.1991.55.2.207; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; Bateman AW, 2011, J ANIMAL ECOLOGY; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Blank D, 2012, EUROPEAN J WILDLIFE; Bonenfant C, 2009, ADV ECOL RES, V41, P313, DOI 10.1016/S0065-2504(09)00405-X; Borkowski J, 2000, CAN J ZOOL, V78, P1369, DOI 10.1139/cjz-78-8-1369; Bowyer RT, 2004, J MAMMAL, V85, P1039, DOI 10.1644/BBL-002.1; Brook R. K., 2008, ELK AGR CONFLICTS GR; Brook RK, 2009, PREV VET MED, V91, P197, DOI 10.1016/j.prevetmed.2009.05.021; Brook Ryan K., 2009, Human-Wildlife Conflicts, V3, P72; Caners RT, 2003, COMMUNITY ECOL, V4, P185, DOI 10.1556/ComEc.4.2003.2.6; CARBYN LN, 1983, J WILDLIFE MANAGE, V47, P963, DOI 10.2307/3808155; Childress MJ, 2003, ANIM BEHAV, V66, P389, DOI 10.1006/anbe.2003.2217; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Coulson T, 1997, ECOLOGY, V78, P852, DOI 10.1890/0012-9658(1997)078[0852:PSLDAC]2.0.CO;2; Creel S, 2005, ANIM BEHAV, V69, P1181, DOI 10.1016/j.anbehav.2004.07.022; Cross PC, 2010, ECOL APPL, V20, P278, DOI 10.1890/08-2062.1; Fortin D, 2009, ANIM BEHAV, V78, P887, DOI 10.1016/j.anbehav.2009.06.026; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; GEIST V, 1986, CAN J ZOOL, V64, P380, DOI 10.1139/z86-059; Gerard JF, 2002, BIOL BULL, V202, P275, DOI 10.2307/1543479; Giraldeau LA, 1999, TRENDS ECOL EVOL, V14, P102, DOI 10.1016/S0169-5347(98)01542-0; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hebblewhite M, 2002, CAN J ZOOL, V80, P800, DOI 10.1139/Z02-059; Jackson AL, 2006, P R SOC B, V273, P1055, DOI 10.1098/rspb.2005.3421; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; JOHNSON CN, 1983, AUST WILDLIFE RES, V10, P25; Krause J, 2002, LIVING GROUPS; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; Main MB, 1996, J MAMMAL, V77, P449, DOI 10.2307/1382821; Mathews F, 2009, ADV PARASIT, V68, P185, DOI 10.1016/S0065-308X(08)00608-8; Millspaugh JJ, 2004, WILDLIFE SOC B, V32, P506, DOI 10.2193/0091-7648(2004)32[506:HOOCEI]2.0.CO;2; Minderman J, 2006, J ANIM ECOL, V75, P713, DOI 10.1111/j.1365-2656.2006.01092.x; Monteith KL, 2007, J WILDLIFE MANAGE, V71, P1712, DOI 10.2193/2005-763; MORI H, 1965, PROG THEOR PHYS, V33, P423, DOI 10.1143/PTP.33.423; Morrell LJ, 2008, BEHAV ECOL, V19, P193, DOI 10.1093/beheco/arm122; Mysterud A, 2000, OECOLOGIA, V124, P40, DOI 10.1007/s004420050023; Nishi JS, 2006, VET MICROBIOL, V112, P325, DOI 10.1016/j.vetmic.2005.11.013; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pepin D, 2008, ANIM BEHAV, V75, P361, DOI 10.1016/j.anbehav.2006.09.030; Proffitt KM, 2012, J WILDLIFE MANAGE, V76, P847, DOI 10.1002/jwmg.310; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Richardson KE, 2007, CAN J ZOOL, V85, P759, DOI 10.1139/Z07-057; Roberts G, 1996, ANIM BEHAV, V51, P1077, DOI 10.1006/anbe.1996.0109; ROUNDS RC, 1981, J WILDLIFE MANAGE, V45, P187, DOI 10.2307/3807886; Rowcliffe JM, 2004, J ANIM ECOL, V73, P97, DOI 10.1111/j.1365-2656.2004.00783.x; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; Seno H, 2006, J MATH BIOL, V52, P70, DOI 10.1007/s00285-005-0341-7; SIBLY RM, 1983, ANIM BEHAV, V31, P947, DOI 10.1016/S0003-3472(83)80250-4; Stillman RA, 1997, J ANIM ECOL, V66, P692, DOI 10.2307/5922; Tompkins DM, 2011, J ANIM ECOL, V80, P19, DOI 10.1111/j.1365-2656.2010.01742.x; TURNER GF, 1986, AM NAT, V128, P228, DOI 10.1086/284556; Vander Wal E, 2012, ECOLOGY, V93, P206, DOI 10.1890/11-0020.1; Vander Wal E, 2011, SEX FRIENDS DIS SOCI; Vander Wal E, SOCIAL INTERAC UNPUB; Vander Wal E, 2011, J WILDLIFE MANAGE, V75, P1521, DOI 10.1002/jwmg.208; Walker D, 2001, THESIS U MANITOBA WI; Weckerly F, 2004, AM MIDL NAT, V152, P386, DOI 10.1674/0003-0031(2004)152[0386:REDASS]2.0.CO;2; Weckerly FW, 2001, J MAMMAL, V82, P414, DOI 10.1644/1545-1542(2001)082&lt;0414:ALMREL&gt;2.0.CO;2; White G.C., 1990, ANAL WILDLIFE RADIO; White PJ, 2012, AM MIDL NAT, V167, P174, DOI 10.1674/0003-0031-167.1.174; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; WRONA FJ, 1991, AM NAT, V137, P186, DOI 10.1086/285153; Zuur Alain F., 2009, P1	68	29	29	4	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53777	10.1371/journal.pone.0053777	http://dx.doi.org/10.1371/journal.pone.0053777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326502	gold, Green Published, Green Submitted			2022-12-25	WOS:000313551500096
J	Adhikari, D; Risal, S; Liu, K; Shen, Y				Adhikari, Deepak; Risal, Sanjiv; Liu, Kui; Shen, Yan			Pharmacological Inhibition of mTORC1 Prevents Over-Activation of the Primordial Follicle Pool in Response to Elevated PI3K Signaling	PLOS ONE			English	Article							OVARIAN TOXICITY; MOUSE OVARY; OOCYTES; CHEMOTHERAPY; OVOTOXICITY; SURVIVAL; PATHWAY; GROWTH	The majority of ovarian primordial follicles must be preserved in a quiescent state to allow for the regular production of gametes over the female reproductive lifespan. However, the molecular mechanism that maintains the long quiescence of primordial follicles is poorly understood. Under certain pathological conditions, the entire pool of primordial follicles matures simultaneously leading to an accelerated loss of primordial follicles and to premature ovarian failure (POF). We have previously shown that loss of Pten (phosphatase and tensin homolog deleted on chromosome ten) in mouse oocytes leads to premature activation of the entire pool of primordial follicles, subsequent follicular depletion in early adulthood, and the onset of POF. Lack of PTEN leads to increased phosphatidylinositol 3-kinase (PI3K)-Akt and mammalian target of rapamycin complex 1 (mTORC1) signaling in the oocytes. To study the functional and pathological roles of elevated mTORC1 signaling in the oocytes, we treated the Pten-mutant mice with the specific mTORC1 inhibitor rapamycin. When administered to Pten-deficient mice prior to the activation of the primordial follicles, rapamycin effectively prevented global follicular activation and preserved the ovarian reserve. These results provide a rationale for exploring the possible use of rapamycin as a drug for the preservation of the primordial follicle pool, and the possible prevention of POF.	[Adhikari, Deepak; Risal, Sanjiv; Liu, Kui; Shen, Yan] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	University of Gothenburg	Adhikari, D (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden.	deepak.adhikari@medchem.umu.se; yan.shen@vgregion.se	Risal, Sanjiv/P-5758-2019; Hamilton, John P/G-1379-2016; zerillo, marcelo/M-4159-2016; Risal, Sanjiv/K-9883-2017; Adhikari, Deepak/H-6176-2013; zerillo, marcelo M/AAE-1735-2022	Risal, Sanjiv/0000-0003-1723-5431; Hamilton, John P/0000-0002-8682-5526; zerillo, marcelo/0000-0001-9671-2894; Risal, Sanjiv/0000-0003-1723-5431; Adhikari, Deepak/0000-0003-0656-9858; Buell, C Robin/0000-0002-6727-4677; Adhikari, Deepak/0000-0002-3404-8753; Adhikari, Bishwo/0000-0003-4840-9609				Adhikari D, 2010, CELL CYCLE, V9, P1673, DOI 10.4161/cc.9.9.11626; Adhikari D, 2010, HUM MOL GENET, V19, P397, DOI 10.1093/hmg/ddp483; Adhikari D, 2009, MOL HUM REPROD, V15, P765, DOI 10.1093/molehr/gap092; Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; Beck-Peccoz P, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-9; Ben-Aharon I, 2012, REPRODUCTION, V144, P153, DOI 10.1530/REP-12-0121; Braun M, 2012, NEW ENGL J MED, V366, P1062, DOI 10.1056/NEJMc1113145; Broekmans FJ, 2007, TRENDS ENDOCRIN MET, V18, P58, DOI 10.1016/j.tem.2007.01.004; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408; Jagarlamudi K, 2010, MOL CELL ENDOCRINOL, V315, P1, DOI 10.1016/j.mce.2009.07.016; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Lan ZJ, 2004, BIOL REPROD, V71, P1469, DOI 10.1095/biolreprod.104.031757; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Meirow D, 2010, CLIN OBSTET GYNECOL, V53, P727, DOI 10.1097/GRF.0b013e3181f96b54; Morgan S, 2012, HUM REPROD UPDATE, V18, P525, DOI 10.1093/humupd/dms022; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Reddy P, 2010, TRENDS ENDOCRIN MET, V21, P96, DOI 10.1016/j.tem.2009.10.001; Reddy P, 2009, HUM MOL GENET, V18, P2813, DOI 10.1093/hmg/ddp217; Sobinoff AP, 2012, TOXICOL SCI, V128, P258, DOI 10.1093/toxsci/kfs137; Sobinoff AP, 2011, TOXICOL SCI, V123, P563, DOI 10.1093/toxsci/kfr195; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021415; Zhang H, 2012, P NATL ACAD SCI USA, V109, P12580, DOI 10.1073/pnas.1206600109	28	155	159	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53810	10.1371/journal.pone.0053810	http://dx.doi.org/10.1371/journal.pone.0053810			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	24124466	Green Submitted, Green Published, gold			2022-12-25	WOS:000314705800077
J	Seo, EH; Lee, DY; Lee, JM; Park, JS; Sohn, BK; Lee, DS; Choe, YM; Woo, JI				Seo, Eun Hyun; Lee, Dong Young; Lee, Jong-Min; Park, Jun-Sung; Sohn, Bo Kyung; Lee, Dong Soo; Choe, Young Min; Woo, Jong Inn			Whole-brain Functional Networks in Cognitively Normal, Mild Cognitive Impairment, and Alzheimer's Disease	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; RESTING-STATE NETWORKS; DEFAULT-MODE NETWORK; NEUROPSYCHOLOGICAL ASSESSMENT; TOPOLOGICAL PATTERNS; CORTICAL NETWORKS; CEREBRAL-CORTEX; BLOOD-FLOW; CONNECTIVITY; DEMENTIA	The conceptual significance of understanding functional brain alterations and cognitive deficits associated with Alzheimer's disease (AD) process has been widely established. However, the whole-brain functional networks of AD and its prodromal stage, mild cognitive impairment (MCI), are not well clarified yet. In this study, we compared the characteristics of the whole-brain functional networks among cognitively normal (CN), MCI, and AD individuals by applying graph theoretical analyses to [F-18] fluorodeoxyglucose positron emission tomography (FDG-PET) data. Ninety-four CN elderly, 183 with MCI, and 216 with AD underwent clinical evaluation and FDG-PET scan. The overall small-world property as seen in the CN whole-brain network was preserved in MCI and AD. In contrast, individual parameters of the network were altered with the following patterns of changes: local clustering of networks was lower in both MCI and AD compared to CN, while path length was not different among the three groups. Then, MCI had a lower level of local clustering than AD. Subgroup analyses for AD also revealed that very mild AD had lower local clustering and shorter path length compared to mild AD. Regarding the local properties of the whole-brain networks, MCI and AD had significantly decreased normalized betweenness centrality in several hubs regionally associated with the default mode network compared to CN. Our results suggest that the functional integration in whole-brain network progressively declines due to the AD process. On the other hand, functional relatedness between neighboring brain regions may not gradually decrease, but be the most severely altered in MCI stage and gradually re-increase in clinical AD stages.	[Seo, Eun Hyun; Lee, Dong Young; Sohn, Bo Kyung; Choe, Young Min; Woo, Jong Inn] Seoul Natl Univ Hosp, Dept Neuropsychiat, Seoul 110744, South Korea; [Seo, Eun Hyun; Lee, Dong Young; Sohn, Bo Kyung; Choe, Young Min; Woo, Jong Inn] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul 110744, South Korea; [Seo, Eun Hyun; Lee, Dong Young; Woo, Jong Inn] Seoul Natl Univ, Interdisciplinary Program Cognit Sci, Seoul, South Korea; [Lee, Jong-Min; Park, Jun-Sung] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea; [Lee, Dong Soo] Seoul Natl Univ Hosp, Dept Nucl Med, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Hanyang University; Seoul National University (SNU); Seoul National University Hospital	Lee, DS (corresponding author), Seoul Natl Univ Hosp, Dept Nucl Med, Seoul 110744, South Korea.	selfpsy@snu.ac.kr	Lee, Jeong Min/V-3429-2019	Lee, Jeong Min/0000-0003-0561-8777; Kim, Jae Ho/0000-0003-4323-4790; Jang, Il Ho/0000-0002-0820-3035	Seoul National University Hospital [2011-0564]; Korea Healthcare Technology R & D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea [A092145]; Korea government (MEST) [2011-0028333]	Seoul National University Hospital; Korea Healthcare Technology R & D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea; Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by a grant from the Seoul National University Hospital (Grant No. 2011-0564), a grant from the Korea Healthcare Technology R & D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea (Grant No. A092145), and a grant from the Korea government (MEST) (Grant No. 2011-0028333). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Braak E, 1999, EUR ARCH PSY CLIN N, V249, P14; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brown JA, 2011, P NATL ACAD SCI USA, V108, P20760, DOI 10.1073/pnas.1109038108; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Buldu JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019584; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Chetelat G, 2003, NEUROLOGY, V60, P1374, DOI 10.1212/01.WNL.0000055847.17752.E6; Choo IH, 2007, ALZ DIS ASSOC DIS, V21, P77, DOI 10.1097/WAD.0b013e3180687418; Del Sole A, 2008, EUR J NUCL MED MOL I, V35, P1357, DOI 10.1007/s00259-008-0773-6; DELACOSTE MC, 1993, NEUROBIOL AGING, V14, P1, DOI 10.1016/0197-4580(93)90015-4; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; Dickerson BC, 2005, NEUROLOGY, V65, P404, DOI 10.1212/01.wnl.0000171450.97464.49; Dukart J, 2010, NEUROIMAGE, V49, P1490, DOI 10.1016/j.neuroimage.2009.09.017; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Golob EJ, 2001, NEUROBIOL AGING, V22, P755, DOI 10.1016/S0197-4580(01)00244-5; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Grady CL, 2008, ANN NY ACAD SCI, V1124, P127, DOI 10.1196/annals.1440.009; GRADY CL, 1989, ARCH NEUROL-CHICAGO, V46, P317, DOI 10.1001/archneur.1989.00520390083021; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Ishii K, 2003, J NEUROL SCI, V215, P71, DOI 10.1016/S0022-510X(03)00206-5; Jhoo JH, 2010, PSYCHIAT RES-NEUROIM, V183, P237, DOI 10.1016/j.pscychresns.2010.03.006; JUEPTNER M, 1995, NEUROIMAGE, V2, P148, DOI 10.1006/nimg.1995.1017; Lee DY, 2009, NEUROLOGY, V73, P1722, DOI 10.1212/WNL.0b013e3181c33afb; Lee DY, 2010, STROKE, V41, P1791, DOI 10.1161/STROKEAHA.110.582163; Lee DY, 2004, J INT NEUROPSYCH SOC, V10, P72, DOI 10.1017/s1355617704101094; Lee JH, 2002, J GERONTOL B-PSYCHOL, V57, pP47, DOI 10.1093/geronb/57.1.P47; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MOHR E, 1990, J CLIN EXP NEUROPSYC, V12, P235, DOI 10.1080/01688639008400970; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Mosconi L, 2005, NEUROLOGY, V64, P1860, DOI 10.1212/01.WNL.0000163856.13524.08; Nestor PJ, 2003, ANN NEUROL, V54, P343, DOI 10.1002/ana.10669; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Pihlajamaki M, 2009, BEHAV NEUROL, V21, P77, DOI 10.3233/BEN-2009-0231; Pihlajamaki M, 2009, CURR ALZHEIMER RES, V6, P179, DOI 10.2174/156720509787602898; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SOKOLOFF L, 1981, FED PROC, V40, P2311; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Sydykova D, 2007, CEREB CORTEX, V17, P2276, DOI 10.1093/cercor/bhl136; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vecchio Fabrizio, 2011, Int J Alzheimers Dis, V2011, P214580, DOI 10.4061/2011/214580; Wada Y, 1998, ALZ DIS ASSOC DIS, V12, P175, DOI 10.1097/00002093-199809000-00009; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Westlye ET, 2011, J NEUROSCI, V31, P7775, DOI 10.1523/JNEUROSCI.1230-11.2011; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Yun JY, 2011, DEMENT GER COGN D EX, V1, P190, DOI 10.1159/000329517; Zhu WL, 2012, NEUROBIOL AGING, V33, P899, DOI 10.1016/j.neurobiolaging.2010.06.022	73	109	111	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53922	10.1371/journal.pone.0053922	http://dx.doi.org/10.1371/journal.pone.0053922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086SQ	24098810	gold, Green Published, Green Submitted			2022-12-25	WOS:000314707700038
J	Zeng, JG; Liu, YS; Liu, W; Liu, XB; Liu, FQ; Huang, P; Zhu, PC; Chen, JJ; Shi, MM; Guo, F; Cheng, P; Zeng, J; Liao, YF; Gong, J; Zhang, HM; Wang, DP; Guo, AY; Xiong, XY				Zeng, Jianguo; Liu, Yisong; Liu, Wei; Liu, Xiubing; Liu, Fuqing; Huang, Peng; Zhu, Pengcheng; Chen, Jinjun; Shi, Mingming; Guo, Fang; Cheng, Pi; Zeng, Jing; Liao, Yifang; Gong, Jing; Zhang, Hong-Mei; Wang, Depeng; Guo, An-Yuan; Xiong, Xingyao			Integration of Transcriptome, Proteome and Metabolism Data Reveals the Alkaloids Biosynthesis in Macleaya cordata and Macleaya microcarpa	PLOS ONE			English	Article							CANADENSIS CELL-CULTURES; RNA-SEQ DATA; OPIUM POPPY; DIHYDROBENZOPHENANTHRIDINE OXIDASE; SANGUINARINE REDUCTASE; MASS-SPECTROMETRY; MOLECULAR-CLONING; SAFETY ASSESSMENT; REFERENCE GENOME; SIEVE ELEMENTS	Background: The Macleaya spp., including Macleaya cordata and Macleaya microcarpa, are traditional anti-virus, inflammation eliminating, and insecticide herb medicines for their isoquinoline alkaloids. They are also known as the basis of the popular natural animal food addictive in Europe. However, few studies especially at genomics level were conducted on them. Hence, we performed the Macleaya spp. transcriptome and integrated it with iTRAQ proteome analysis in order to identify potential genes involved in alkaloids biosynthesis. Methodology and Principal Findings: We elaborately designed the transcriptome, proteome and metabolism profiling for 10 samples of both species to explore their alkaloids biosynthesis. From the transcriptome data, we obtained 69367 and 78255 unigenes for M. cordata and M. microcarpa, in which about two thirds of them were similar to sequences in public databases. By metabolism profiling, reverse patterns for alkaloids sanguinarine, chelerythrine, protopine, and allocryptopine were observed in different organs of two species. We characterized the expressions of enzymes in alkaloid biosynthesis pathways. We also identified more than 1000 proteins from iTRAQ proteome data. Our results strongly suggest that the root maybe the organ for major alkaloids biosynthesis of Macleaya spp. Except for biosynthesis, the alkaloids storage and transport were also important for their accumulation. The ultrastructure of laticifers by SEM helps us to prove the alkaloids maybe accumulated in the mature roots. Conclusions/Significance: To our knowledge this is the first study to elucidate the genetic makeup of Macleaya spp. This work provides clues to the identification of the potential modulate genes involved in alkaloids biosynthesis in Macleaya spp., and sheds light on researches for non-model medicinal plants by integrating different high-throughput technologies.	[Zeng, Jianguo; Liu, Yisong; Liu, Xiubing; Zhu, Pengcheng; Chen, Jinjun; Xiong, Xingyao] Hunan Agr Univ, Hunan Prov Key Lab Crop Germplasm Innovat & Utili, Changsha, Hunan, Peoples R China; [Zeng, Jianguo; Liu, Yisong; Liu, Xiubing; Zhu, Pengcheng; Chen, Jinjun; Xiong, Xingyao] Hunan Agr Univ, Natl Chinese Med Herbs Hunan Technol Ctr, Changsha, Hunan, Peoples R China; [Liu, Wei; Liao, Yifang; Gong, Jing; Zhang, Hong-Mei; Guo, An-Yuan] Huazhong Univ Sci & Technol, Dept Biomed Engn, Coll Life Sci & Technol, Wuhan 430074, Peoples R China; [Liu, Wei; Liao, Yifang; Gong, Jing; Zhang, Hong-Mei; Wang, Depeng] Next Biosci Co Ltd, Wuhan, Peoples R China; [Shi, Mingming; Guo, Fang] BGI Shenzhen, Shenzhen, Peoples R China	Hunan Agricultural University; Hunan Agricultural University; Huazhong University of Science & Technology; Beijing Genomics Institute (BGI)	Guo, AY (corresponding author), Huazhong Univ Sci & Technol, Dept Biomed Engn, Coll Life Sci & Technol, Wuhan 430074, Peoples R China.	zengjianguo@hunau.net; guoay@mail.hust.edu.cn; xiongxy@hunau.net	Huang, Peng/AAJ-9432-2021; Guo, An-Yuan/K-3656-2012; Feng, Yuan/F-7295-2012	Huang, Peng/0000-0002-8367-8196; Chen, Wei/0000-0003-2275-4527; , Jinjun/0000-0001-5495-051X; Feng, Yuan/0000-0002-6369-0737	China-Belgium Cooperation Research on Plants Medicine Utilization & Crop Pests Forecasting and Control Technology [2010DFA32810]; National Key technology R&D Program for demonstration of neotype Chinese herbal veterinary drugs [2011BAD34B02]; National Natural Science Foundation of China [31171271]; Young Teachers' Fund for Doctor Stations; Ministry of Education of China [20110142120042]	China-Belgium Cooperation Research on Plants Medicine Utilization & Crop Pests Forecasting and Control Technology; National Key technology R&D Program for demonstration of neotype Chinese herbal veterinary drugs(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Teachers' Fund for Doctor Stations; Ministry of Education of China(Ministry of Education, China)	This work was supported by China-Belgium Cooperation Research on Plants Medicine Utilization & Crop Pests Forecasting and Control Technology (2010DFA32810), the National Key technology R&D Program (2011BAD34B02) for demonstration of neotype Chinese herbal veterinary drugs, National Natural Science Foundation of China (31171271), Young Teachers' Fund for Doctor Stations, Ministry of Education of China (20110142120042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKAWA H, 1992, ARCH BIOCHEM BIOPHYS, V299, P1, DOI 10.1016/0003-9861(92)90236-P; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barkan A, 2009, METHODS MOL BIOL, V553, P13, DOI 10.1007/978-1-60327-563-7_2; Bird DA, 2003, PLANT CELL, V15, P2626, DOI 10.1105/tpc.015396; Chen YZ, 2009, J CHROMATOGR A, V1216, P2104, DOI 10.1016/j.chroma.2008.08.066; Chow KS, 2011, J EXP BOT; Desgagne-Penix I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-252; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Facchini Peter J., 2007, Phytochemistry Reviews, V6, P97, DOI 10.1007/s11101-006-9042-0; Franz C, 2005, CFTEFSAFEEDAP200501; Fuchino H, 2010, CHEM PHARM BULL, V58, P1047, DOI 10.1248/cpb.58.1047; Glen A, 2008, J PROTEOME RES, V7, P897, DOI 10.1021/pr070378x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Ignatov A, 1996, PHYTOCHEMISTRY, V43, P1141, DOI 10.1016/S0031-9422(96)00540-7; Ikezawa N, 2009, PLANT CELL REP, V28, P123, DOI 10.1007/s00299-008-0624-8; Ikezawa N, 2007, FEBS J, V274, P1019, DOI 10.1111/j.1742-4658.2007.05652.x; Jensen K, 2010, PHYTOCHEMISTRY, V71, P132, DOI 10.1016/j.phytochem.2009.10.017; Juskiewicz J, 2011, J ANIM PHYSIOL AN N, V95, P171, DOI 10.1111/j.1439-0396.2010.01037.x; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kosina P, 2010, FITOTERAPIA, V81, P1006, DOI 10.1016/j.fitote.2010.06.020; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Liu H, 2009, NAT PROD COMMUN, V4, P1557; NESSLER CL, 1992, PLANT MOL BIOL, V20, P749, DOI 10.1007/BF00046460; Park SU, 2002, PLANT PHYSIOL, V128, P696, DOI 10.1104/pp.010741; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Psotova J, 2006, VET MED-CZECH, V51, P145, DOI 10.17221/5534-VETMED; RUEFFER M, 1987, TETRAHEDRON LETT, V28, P5307, DOI 10.1016/S0040-4039(00)96715-7; Samanani N, 2006, PLANT J, V47, P547, DOI 10.1111/j.1365-313X.2006.02801.x; Shitan N, 2007, CURR PHARM BIOTECHNO, V8, P244; Stiborova M, 2008, BIOMED PAP, V152, P35, DOI 10.5507/bp.2008.005; Torres TT, 2008, GENOME RES, V18, P172, DOI 10.1101/gr.6984908; Urbanczyk-Wochniak E, 2003, EMBO REP, V4, P989, DOI 10.1038/sj.embor.embor944; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Vichkanova S.A., 1982, PHARM CHEM J+, V16, P925, DOI [10.1007/BF00767855, DOI 10.1007/BF00767855]; Vogel M, 2010, J BIOL CHEM, V285, P18397, DOI 10.1074/jbc.M109.088989; Vrba J, 2011, TOXICOL LETT, V203, P135, DOI 10.1016/j.toxlet.2011.03.015; Weiss D, 2006, PLANT CELL ENVIRON, V29, P291, DOI 10.1111/j.1365-3040.2005.01421.x; Yang J, 1999, Zhong Yao Cai, V22, P82; Yao JY, 2010, PARASITOL RES, V107, P1035, DOI 10.1007/s00436-010-1966-z; Yazaki K, 2006, FEBS LETT, V580, P1183, DOI 10.1016/j.febslet.2005.12.009; Ye Fengzhi, 2009, Zhongguo Zhong Yao Za Zhi, V34, P1683; Ye HG, 2010, MOL CELL BIOCHEM, V343, P91, DOI 10.1007/s11010-010-0502-x; Zdarilova A, 2008, FOOD CHEM TOXICOL, V46, P3721, DOI 10.1016/j.fct.2008.09.054; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730; Zulak KG, 2007, PLANTA, V225, P1085, DOI 10.1007/s00425-006-0419-5	47	86	103	3	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53409	10.1371/journal.pone.0053409	http://dx.doi.org/10.1371/journal.pone.0053409			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326424	Green Submitted, Green Published, gold			2022-12-25	WOS:000313551500068
J	Cao, Y; Zhou, XX; Huang, XY; Li, QL; Gao, LL; Jiang, LJ; Huang, M; Zhou, JF				Cao, Yang; Zhou, Xiaoxi; Huang, Xiaoyuan; Li, Qinlu; Gao, Lili; Jiang, Lijun; Huang, Mei; Zhou, Jianfeng			Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis	PLOS ONE			English	Article							CELLS; TARGETS; ESCAPE	Background: T cell immunoglobulin mucin-3 (Tim-3) has been identified as a negative regulator of anti-tumor immunity. Recent studies highlight the important role of Tim-3 in the CD8(+) T cell exhaustion that takes place in both human and animal cancer models. However, the nature of Tim-3 expression in the tumor cell and the mechanism by which it inhibits anti-tumor immunity are unclear. This present study aims to determine Tim-3 is expressed in cervical cancer cells and to evaluate the role of Tim-3 in cervical cancer progression. Methodology: A total of 85 cervical tissue specimens including 43 human cervical cancer, 22 cervical intraepithelial neoplasia (CIN) and 20 chronic cervicitis were involved. Tim-3 expression in tumor cells was detected and was found to correlate with clinicopathological parameters. Meanwhile, expression of Tim-3 was assessed by RT-PCR, Western Blot and confocal microscopy in cervical cancer cell lines, HeLa and SiHa. The migration and invasion potential of Hela cells was evaluated after inhibiting Tim-3 expression by ADV-antisense Tim-3. Conclusions: We found that Tim-3 was expressed at a higher level in the clinical cervical cancer cells compared to the CIN and chronic cervicitis controls. We supported this finding by confirming the presence of Tim-3 mRNA and protein in the cervical cell lines. Tim-3 expression in tumor cells correlated with clinicopathological parameters. Patients with high expression of Tim-3 had a significant metastatic potential, advanced cancer grades and shorter overall survival than those with lower expression. Multivariate analysis showed that Tim-3 expression was an independent factor for predicting the prognosis of cervical cancer. Significantly, down-regulating the expression of Tim-3 protein inhibited migration and invasion of Hela cells. Our study suggests that the expression of Tim-3 in tumor cells may be an independent prognostic factor for patients with cervical cancer. Moreover, Tim-3 expression may promote metastatic potential in cervical cancers.	[Cao, Yang; Zhou, Xiaoxi; Huang, Xiaoyuan; Li, Qinlu; Gao, Lili; Jiang, Lijun; Huang, Mei; Zhou, Jianfeng] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Huang, M (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan, Hubei, Peoples R China.	huangmei@medmail.com.cn	Cao, Yang/HGD-6463-2022	Yu, Shiqiang/0000-0003-3519-0943	National Science Foundation of China [81001049]; National Science Fund for Distinguished Young Scholars of China [81025011]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This article was supported by National Science Foundation of China (No. 81001049) and National Science Fund for Distinguished Young Scholars of China (No. 81025011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton GK, 2012, NAT REV CANCER, V12, P453; Anderson AC, 2012, CURR OPIN IMMUNOL, V24, P213, DOI 10.1016/j.coi.2011.12.005; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Geng H, 2006, J IMMUNOL, V176, P1411, DOI 10.4049/jimmunol.176.3.1411; Huang XY, 2010, J EXP MED, V207, P505, DOI 10.1084/jem.20090397; Ibrahim R, 2006, CANCER-AM CANCER SOC, V106, P1065, DOI 10.1002/cncr.21697; Jan M, 2011, P NATL ACAD SCI USA, V108, P5009, DOI 10.1073/pnas.1100551108; Kikushige Y, 2010, CELL STEM CELL, V7, P708, DOI 10.1016/j.stem.2010.11.014; Kloth JN, 2008, J PATHOL, V215, P222, DOI 10.1002/path.2347; Kong LY, 2010, CLIN CANCER RES, V16, P2550, DOI 10.1158/1078-0432.CCR-10-0279; Li S, 2012, CANCER RES, V72, P865, DOI 10.1158/0008-5472.CAN-11-1357; No JH, 2011, MOL CARCINOGEN, V50, P244, DOI 10.1002/mc.20657; Norde WJ, 2012, BLOOD, V120, P728, DOI 10.1182/blood-2012-02-412510; Sakuishi K, 2011, TRENDS IMMUNOL, V32, P345, DOI 10.1016/j.it.2011.05.003; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Tu B, 2012, CANCER LETT, V325, P80, DOI 10.1016/j.canlet.2012.06.006; Wiener Z, 2007, J INVEST DERMATOL, V127, P906, DOI 10.1038/sj.jid.5700616; Zhou JF, 2005, CLIN CANCER RES, V11, P8431, DOI 10.1158/1078-0432.CCR-05-1085; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425	19	106	126	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53834	10.1371/journal.pone.0053834	http://dx.doi.org/10.1371/journal.pone.0053834			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335978	Green Published, Green Submitted, gold			2022-12-25	WOS:000314707700036
J	Zhang, WW; Li, ZZ				Zhang, Weiwei; Li, Zhenzhong			The Effects of Target Skeletal Muscle Cells on Dorsal Root Ganglion Neuronal Outgrowth and Migration In Vitro	PLOS ONE			English	Article							GROWTH-ASSOCIATED PROTEIN; PRIMARY SENSORY NEURONS; GAP-43 MESSENGER-RNA; SPINAL-CORD; NEUROMUSCULAR-JUNCTION; NMDA RECEPTOR; EXPRESSION; RAT; INJURY; PHOSPHORYLATION	Targets of neuronal innervations play a vital role in regulating the survival and differentiation of innervating neurotrophin-responsive neurons. During development, neurons extend axons to their targets, and then their survival become dependent on the trophic substances secreted by their target cells. Sensory endings were present on myoblasts, myotubes, and myofibers in all intrafusal bundles regardless of age. The interdependence of sensory neurons and skeletal muscle (SKM) cells during both embryonic development and the maintenance of the mature functional state has not been fully understood. In the present study, neuromuscular cocultures of organotypic dorsal root ganglion (DRG) explants and dissociate SKM cells were established. Using this culture system, the morphological relationship between DRG neurons and SKM cells, neurites growth and neuronal migration were investigated. The migrating neurons were determined by fluorescent labeling of microtubule-associated protein-2 (MAP-2) and neurofilament 200 (NF-200) or growth-associated protein 43 (GAP-43). The expression of NF-200 and GAP-43 and their mRNAs was evaluated by Western blot assay and real time-PCR analysis. The results reveal that DRG explants showed more dense neurites outgrowth in neuromuscular cocultures as compared with that in the culture of DRG explants alone. The number of total migrating neurons (the MAP-2-expressing neurons) and the percentage NF-200-immunoreactive (IR) and GAP-43-IR neurons increased significantly in the presence of SKM cells. The levels of NF-200 and GAP-43 and their mRNAs increased significantly in neuromuscular cocultures as compared with that in the culture of DRG explants alone. These results suggested that target SKM cells play an important role in regulating neuronal protein synthesis, promoting neuritis outgrowth and neuronal migration of DRG explants in vitro. These results not only provide new clues for a better understanding of the association of SKM cells with DRG sensory neurons during development, they may also have implications for axonal regeneration after nerve injury.	[Zhang, Weiwei; Li, Zhenzhong] Shandong Univ, Sch Med, Dept Anat, Jinan 250100, Peoples R China	Shandong University	Li, ZZ (corresponding author), Shandong Univ, Sch Med, Dept Anat, Jinan 250100, Peoples R China.	zli@sdu.edu.cn			National Natural Science Foundation of China [30973051]; Natural Science Foundation of Shandong Province of China [ZR2010HM027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province of China(Natural Science Foundation of Shandong Province)	This work was supported by the National Natural Science Foundation of China (No. 30973051) and the Natural Science Foundation of Shandong Province of China (ZR2010HM027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIGNER L, 1993, J CELL BIOL, V123, P417, DOI 10.1083/jcb.123.2.417; Albright MJ, 2007, J NEUROPHYSIOL, V98, P1610, DOI 10.1152/jn.00219.2007; Anand U, 2008, J NEURO-ONCOL, V89, P1, DOI 10.1007/s11060-008-9585-6; Anderson KD, 2003, EXP NEUROL, V183, P100, DOI 10.1016/S0014-4886(03)00103-1; Baird DH, 1996, J NEUROSCI, V16, P2642; Bergman E, 1999, BRAIN RES, V832, P63, DOI 10.1016/S0006-8993(99)01469-9; Buddle M, 2003, BRAIN RES, V978, P38, DOI 10.1016/S0006-8993(03)02758-6; Cafferty WBJ, 2004, J NEUROSCI, V24, P4432, DOI 10.1523/JNEUROSCI.2245-02.2004; Daniels MP, 2000, MICROSC RES TECHNIQ, V49, P26, DOI 10.1002/(SICI)1097-0029(20000401)49:1<26::AID-JEMT4>3.0.CO;2-8; Dehmelt L, 2003, J NEUROSCI, V23, P9479; Denny JB, 2006, CURR NEUROPHARMACOL, V4, P293, DOI 10.2174/157015906778520782; Di Stefano G, 2001, J HISTOCHEM CYTOCHEM, V49, P1065, DOI 10.1177/002215540104900818; El-Nour H, 2006, IMMUNOPHARM IMMUNOT, V28, P621, DOI 10.1080/08923970601067136; Ettorre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031451; Gotow Takahiro, 2000, Medical Electron Microscopy, V33, P173, DOI 10.1007/s007950000019; Gupta SK, 2009, CELL DEATH DIFFER, V16, P624, DOI 10.1038/cdd.2008.188; Hall AK, 1997, J NEUROSCI, V17, P2775; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Kaech S, 2001, P NATL ACAD SCI USA, V98, P7086, DOI 10.1073/pnas.111146798; Kato N, 2003, NEUROSCI RES, V45, P297, DOI 10.1016/S0168-0102(02)00234-1; Kato N, 2001, J Orthop Sci, V6, P419, DOI 10.1007/s007760170008; Kesavapany S, 2003, NEUROSIGNALS, V12, P252, DOI 10.1159/000074627; Keswani SC, 2004, J NEUROSCI METH, V136, P193, DOI 10.1016/j.jneumeth.2004.01.004; Liu YL, 2003, ADV ANAT PATHOL, V10, P101, DOI 10.1097/00125480-200303000-00005; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Lu JJ, 2001, NEUROSCI RES, V41, P355, DOI 10.1016/S0168-0102(01)00293-0; Manzini MC, 2006, J NEUROSCI, V26, P6040, DOI 10.1523/JNEUROSCI.4815-05.2006; Mars T, 2001, PFLUG ARCH EUR J PHY, V442, pR177, DOI 10.1007/s004240100015; Mason CA, 1997, PERSPECT DEV NEUROBI, V5, P69; Mechsner S, 2007, FERTIL STERIL, V88, P581, DOI 10.1016/j.fertnstert.2006.12.087; Murata R, 2006, AUTON NEUROSCI-BASIC, V128, P96, DOI 10.1016/j.autneu.2006.04.003; Nagamoto-Combs K, 2010, J NEUROTRAUM, V27, P565, DOI 10.1089/neu.2009.0966; Oppenheim RW, 1996, NEURON, V17, P195, DOI 10.1016/S0896-6273(00)80151-8; Ozer RS, 2000, MOL BIOL CELL, V11, P3573, DOI 10.1091/mbc.11.10.3573; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Rowan SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029082; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Silver L, 2005, DNA CELL BIOL, V24, P438, DOI 10.1089/dna.2005.24.438; Tabernero A, 2002, J NEUROCHEM, V81, P881, DOI 10.1046/j.1471-4159.2002.00843.x; Tanaka H, 2000, J MUSCLE RES CELL M, V21, P507, DOI 10.1023/A:1026561120566; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Torres-Benito L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026164; Tsai SY, 2007, J NEUROSCI RES, V85, P321, DOI 10.1002/jnr.21119; Tsai SY, 2002, NEUROSCIENCE, V114, P55, DOI 10.1016/S0306-4522(02)00261-0; Uhm CS, 2001, J NEUROSCI, V21, P9678, DOI 10.1523/JNEUROSCI.21-24-09678.2001; Umbach JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036049; VALMIER J, 1993, MUSCLE NERVE, V16, P397, DOI 10.1002/mus.880160409; Wang H, 1999, NATURE, V401, P765, DOI 10.1038/44521; Wang LH, 2009, ANAT REC, V292, P107, DOI 10.1002/ar.20777; Wang XH, 1997, NEURON, V19, P825, DOI 10.1016/S0896-6273(00)80964-2; Yabe JT, 2001, CELL MOTIL CYTOSKEL, V50, P1, DOI 10.1002/cm.1037; Zhao CN, 2004, J NEUROTRAUM, V21, P1468, DOI 10.1089/neu.2004.21.1468	52	92	105	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52849	10.1371/journal.pone.0052849	http://dx.doi.org/10.1371/journal.pone.0052849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23405095	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400022
J	Tan, TC; Spadiut, O; Wongnate, T; Sucharitakul, J; Krondorfer, I; Sygmund, C; Haltrich, D; Chaiyen, P; Peterbauer, CK; Divne, C				Tan, Tien Chye; Spadiut, Oliver; Wongnate, Thanyaporn; Sucharitakul, Jeerus; Krondorfer, Iris; Sygmund, Christoph; Haltrich, Dietmar; Chaiyen, Pimchai; Peterbauer, Clemens K.; Divne, Christina			The 1.6 angstrom Crystal Structure of Pyranose Dehydrogenase from Agaricus meleagris Rationalizes Substrate Specificity and Reveals a Flavin Intermediate	PLOS ONE			English	Article							FLAVOPROTEIN OXIDASES; OXYGEN ACTIVATION; PROTEIN-STRUCTURE; HYDRIDE TRANSFER; ALCOHOL OXIDASE; C-3 OXIDATION; ACTIVE-SITE; MECHANISM; 2-OXIDASE; SUGAR	Pyranose dehydrogenases (PDHs) are extracellular flavin-dependent oxidoreductases secreted by litter-decomposing fungi with a role in natural recycling of plant matter. All major monosaccharides in lignocellulose are oxidized by PDH at comparable yields and efficiencies. Oxidation takes place as single-oxidation or sequential double-oxidation reactions of the carbohydrates, resulting in sugar derivatives oxidized primarily at C2, C3 or C2/3 with the concomitant reduction of the flavin. A suitable electron acceptor then reoxidizes the reduced flavin. Whereas oxygen is a poor electron acceptor for PDH, several alternative acceptors, e. g., quinone compounds, naturally present during lignocellulose degradation, can be used. We have determined the 1.6-angstrom crystal structure of PDH from Agaricus meleagris. Interestingly, the flavin ring in PDH is modified by a covalent mono- or di-atomic species at the C(4a) position. Under normal conditions, PDH is not oxidized by oxygen; however, the related enzyme pyranose 2-oxidase (P2O) activates oxygen by a mechanism that proceeds via a covalent flavin C(4a)-hydroperoxide intermediate. Although the flavin C(4a) adduct is common in monooxygenases, it is unusual for flavoprotein oxidases, and it has been proposed that formation of the intermediate would be unfavorable in these oxidases. Thus, the flavin adduct in PDH not only shows that the adduct can be favorably accommodated in the active site, but also provides important details regarding the structural, spatial and physicochemical requirements for formation of this flavin intermediate in related oxidases. Extensive in silico modeling of carbohydrates in the PDH active site allowed us to rationalize the previously reported patterns of substrate specificity and regioselectivity. To evaluate the regioselectivity of D-glucose oxidation, reduction experiments were performed using fluorinated glucose. PDH was rapidly reduced by 3-fluorinated glucose, which has the C2 position accessible for oxidation, whereas 2-fluorinated glucose performed poorly (C3 accessible), indicating that the glucose C2 position is the primary site of attack.	[Tan, Tien Chye; Spadiut, Oliver; Divne, Christina] KTH Royal Inst Technol, Sch Biotechnol, Stockholm, Sweden; [Tan, Tien Chye; Divne, Christina] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Wongnate, Thanyaporn; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Wongnate, Thanyaporn; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Ctr Excellence Prot Struct & Funct, Bangkok 10400, Thailand; [Sucharitakul, Jeerus] Chulalongkorn Univ, Fac Dent, Dept Biochem, Bangkok, Thailand; [Krondorfer, Iris; Sygmund, Christoph; Haltrich, Dietmar; Peterbauer, Clemens K.] BOKU Univ Nat Resources & Life Sci, Food Biotechnol Lab, Vienna, Austria	Royal Institute of Technology; Karolinska Institutet; Mahidol University; Mahidol University; Chulalongkorn University; University of Natural Resources & Life Sciences, Vienna	Divne, C (corresponding author), KTH Royal Inst Technol, Sch Biotechnol, Stockholm, Sweden.	divne@biotech.kth.se	Divne, Christina/E-8646-2010; Chaiyen, Pimchai/R-5052-2019; Haltrich, Dietmar/N-2624-2019	Divne, Christina/0000-0002-5805-2693; Chaiyen, Pimchai/0000-0002-8533-1604; Haltrich, Dietmar/0000-0002-8722-8176; Peterbauer, Clemens/0000-0002-8033-198X	Swedish Research Council Formas; Swedish Research Council VR; Carl Tryggers Foundation; Thailand Research Fund [BRG5480001]; Faculty of Science, Mahidol University; Austrian Science Fund (FWF) [P22094]; BioTop (Biomolecular Technology of Proteins; Austrian Science Fund) [FWF W1224]; Austrian Science Fund (FWF) [P 22094] Funding Source: researchfish	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council VR(Swedish Research Council); Carl Tryggers Foundation; Thailand Research Fund(Thailand Research Fund (TRF)); Faculty of Science, Mahidol University; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); BioTop (Biomolecular Technology of Proteins; Austrian Science Fund); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors acknowledge support to CD and TCT from the Swedish Research Council Formas, the Swedish Research Council VR, and the Carl Tryggers Foundation. PC acknowledges research support by the Thailand Research Fund (BRG5480001) and the Faculty of Science, Mahidol University. CKP thanks the Austrian Science Fund (FWF) for financial support (grant P22094). IK is part of the doctoral program BioTop (Biomolecular Technology of Proteins; Austrian Science Fund FWF W1224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ander P, 1997, J BIOTECHNOL, V53, P115, DOI 10.1016/S0168-1656(97)01680-5; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Chaiyen P, 2010, ARCH BIOCHEM BIOPHYS, V493, P62, DOI 10.1016/j.abb.2009.08.021; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coulombe R, 2001, J BIOL CHEM, V276, P30435, DOI 10.1074/jbc.M104103200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dix NJ, 1995, FUNGAL ECOL, P549; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez IS, 2009, ACTA CRYSTALLOGR D, V65, P1196, DOI 10.1107/S0907444909035860; Finnegan S, 2010, ARCH BIOCHEM BIOPHYS, V501, P207, DOI 10.1016/j.abb.2010.06.014; Finnegan S, 2010, BIOCHEMISTRY-US, V49, P2952, DOI 10.1021/bi902048c; Forneris F, 2008, BIOCHEMISTRY-US, V47, P978, DOI 10.1021/bi701886t; Fraaije MW, 1998, TRENDS BIOCHEM SCI, V23, P206, DOI 10.1016/S0968-0004(98)01210-9; Gadda G, 2012, BIOCHEMISTRY-US, V51, P2662, DOI 10.1021/bi300227d; Gadda G, 2008, BIOCHEMISTRY-US, V47, P13745, DOI 10.1021/bi801994c; Giffhorn F, 2000, APPL MICROBIOL BIOT, V54, P727, DOI 10.1007/s002530000446; Hallberg BM, 2004, J MOL BIOL, V341, P781, DOI 10.1016/j.jmb.2004.06.033; Hallberg BM, 2003, J BIOL CHEM, V278, P7160, DOI 10.1074/jbc.M210961200; Hallberg BM, 2002, J MOL BIOL, V315, P421, DOI 10.1006/jmbi.2001.5246; Hernandez-Ortega A, 2011, J BIOL CHEM, V286, P41105, DOI 10.1074/jbc.M111.282467; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kittl R, 2008, CURR GENET, V53, P117, DOI 10.1007/s00294-007-0171-9; Klinman JP, 2007, ACCOUNTS CHEM RES, V40, P325, DOI 10.1021/ar6000507; Kommoju PR, 2011, BIOCHEMISTRY-US, V50, P5521, DOI 10.1021/bi200388g; Kujawa M, 2007, FEBS J, V274, P879, DOI 10.1111/j.1742-4658.2007.05634.x; Kujawa M, 2006, J BIOL CHEM, V281, P35104, DOI 10.1074/jbc.M604718200; Leferink NGH, 2009, J BIOL CHEM, V284, P4392, DOI 10.1074/jbc.M808202200; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; MASSEY V, 1994, J BIOL CHEM, V269, P22459; McDonald CA, 2011, J AM CHEM SOC, V133, P16809, DOI 10.1021/ja2081873; Menova P, 2011, J MOL STRUCT, V1004, P178, DOI 10.1016/j.molstruc.2011.08.002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Orville AM, 2009, BIOCHEMISTRY-US, V48, P720, DOI 10.1021/bi801918u; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Peterbauer CK, 2010, APPL MICROBIOL BIOT, V85, P837, DOI 10.1007/s00253-009-2226-y; Pisanelli I, 2012, APPL MICROBIOL BIOT, V93, P1157, DOI 10.1007/s00253-011-3568-9; Pitsawong W, 2010, J BIOL CHEM, V285, P9697, DOI 10.1074/jbc.M109.073247; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Prongjit M, 2009, BIOCHEMISTRY-US, V48, P4170, DOI 10.1021/bi802331r; Quaye O, 2008, BIOCHEMISTRY-US, V47, P243, DOI 10.1021/bi7017943; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; Ruangchan N, 2011, J BIOL CHEM, V286, P223, DOI 10.1074/jbc.M110.163881; Sedmera P, 2004, TETRAHEDRON LETT, V45, P8677, DOI 10.1016/j.tetlet.2004.09.149; Sedmera P, 2006, J MOL CATAL B-ENZYM, V41, P32, DOI 10.1016/j.molcatb.2006.04.004; Sucharitakul J, 2008, BIOCHEMISTRY-US, V47, P8485, DOI 10.1021/bi801039d; Sucharitakul J, 2011, J BIOL CHEM, V286, P16900, DOI 10.1074/jbc.M111.222976; Sucharitakul J, 2010, BIOCHEMISTRY-US, V49, P3753, DOI 10.1021/bi100187b; Sygmund C, 2008, J BIOTECHNOL, V133, P334, DOI 10.1016/j.jbiotec.2007.10.013; Sygmund C, 2012, APPL MICROBIOL BIOT, V94, P695, DOI 10.1007/s00253-011-3667-7; Tan TC, 2011, J MOL BIOL, V409, P588, DOI 10.1016/j.jmb.2011.04.019; Tan TC, 2010, J MOL BIOL, V402, P578, DOI 10.1016/j.jmb.2010.08.011; Thotsaporn K, 2011, J BIOL CHEM, V286, P28170, DOI 10.1074/jbc.M111.241836; UENO K, 1984, ACTA CRYSTALLOGR C, V40, P1726, DOI 10.1107/S0108270184009306; Volc J, 2004, J MOL CATAL B-ENZYM, V30, P177, DOI 10.1016/j.molcatb.2004.05.006; Volc J, 2002, J MOL CATAL B-ENZYM, V17, P91, DOI 10.1016/S1381-1177(02)00014-0; VOLC J, 1985, FOLIA MICROBIOL, V30, P141, DOI 10.1007/BF02922207; Volc J, 1998, CARBOHYD RES, V310, P151, DOI 10.1016/S0008-6215(98)00151-7; Volc J, 2000, CARBOHYD RES, V329, P219, DOI 10.1016/S0008-6215(00)00167-1; Volc J, 2001, ARCH MICROBIOL, V176, P178, DOI 10.1007/s002030100308; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wohlfahrt G, 1999, ACTA CRYSTALLOGR D, V55, P969, DOI 10.1107/S0907444999003431; Wong CM, 2008, APPL MICROBIOL BIOT, V78, P927, DOI 10.1007/s00253-008-1407-4; Wongnate T, 2011, CHEMBIOCHEM, V12, P2577, DOI 10.1002/cbic.201100564	68	38	39	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53567	10.1371/journal.pone.0053567	http://dx.doi.org/10.1371/journal.pone.0053567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	24039879	Green Published, gold, Green Submitted			2022-12-25	WOS:000313551500085
J	Adhikari, BN; Hamilton, JP; Zerillo, MM; Tisserat, N; Levesque, CA; Buell, CR				Adhikari, Bishwo N.; Hamilton, John P.; Zerillo, Marcelo M.; Tisserat, Ned; Levesque, C. Andre; Buell, C. Robin			Comparative Genomics Reveals Insight into Virulence Strategies of Plant Pathogenic Oomycetes	PLOS ONE			English	Article							PYTHIUM-OLIGANDRUM; BIOLOGICAL-CONTROL; EFFECTOR PROTEINS; PHYLOGENETIC-RELATIONSHIPS; PHYTOPHTHORA-INFESTANS; MOLECULAR PHYLOGENY; EVOLUTION; SEQUENCE; DISEASE; WHEAT	The kingdom Stramenopile includes diatoms, brown algae, and oomycetes. Plant pathogenic oomycetes, including Phytophthora, Pythium and downy mildew species, cause devastating diseases on a wide range of host species and have a significant impact on agriculture. Here, we report comparative analyses on the genomes of thirteen straminipilous species, including eleven plant pathogenic oomycetes, to explore common features linked to their pathogenic lifestyle. We report the sequencing, assembly, and annotation of six Pythium genomes and comparison with other stramenopiles including photosynthetic diatoms, and other plant pathogenic oomycetes such as Phytophthora species, Hyaloperonospora arabidopsidis, and Pythium ultimum var. ultimum. Novel features of the oomycete genomes include an expansion of genes encoding secreted effectors and plant cell wall degrading enzymes in Phytophthora species and an over-representation of genes involved in proteolytic degradation and signal transduction in Pythium species. A complete lack of classical RxLR effectors was observed in the seven surveyed Pythium genomes along with an overall reduction of pathogenesis-related gene families in H. arabidopsidis. Comparative analyses revealed fewer genes encoding enzymes involved in carbohydrate metabolism in Pythium species and H. arabidopsidis as compared to Phytophthora species, suggesting variation in virulence mechanisms within plant pathogenic oomycete species. Shared features between the oomycetes and diatoms revealed common mechanisms of intracellular signaling and transportation. Our analyses demonstrate the value of comparative genome analyses for exploring the evolution of pathogenesis and survival mechanisms in the oomycetes. The comparative analyses of seven Pythium species with the closely related oomycetes, Phytophthora species and H. arabidopsidis, and distantly related diatoms provide insight into genes that underlie virulence.	[Adhikari, Bishwo N.; Hamilton, John P.; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Zerillo, Marcelo M.; Tisserat, Ned] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Levesque, C. Andre] Agr & Agri Food Canada, Ottawa, ON, Canada; [Levesque, C. Andre] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	Michigan State University; Colorado State University; Agriculture & Agri Food Canada; Carleton University	Buell, CR (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	buell@msu.edu	Risal, Sanjiv/P-5758-2019; Hamilton, John P/G-1379-2016; zerillo, marcelo/M-4159-2016; Risal, Sanjiv/K-9883-2017; Adhikari, Deepak/H-6176-2013; zerillo, marcelo M/AAE-1735-2022	Risal, Sanjiv/0000-0003-1723-5431; Hamilton, John P/0000-0002-8682-5526; zerillo, marcelo/0000-0001-9671-2894; Risal, Sanjiv/0000-0003-1723-5431; Adhikari, Deepak/0000-0003-0656-9858; Buell, C Robin/0000-0002-6727-4677; Adhikari, Deepak/0000-0002-3404-8753; Adhikari, Bishwo/0000-0003-4840-9609	United States Department of Agriculture National Institute of Food and Agriculture Microbial Genome Sequencing Program [2007-35600-17774, 2007-35600-18886]	United States Department of Agriculture National Institute of Food and Agriculture Microbial Genome Sequencing Program	Funding for the work was provided by the United States Department of Agriculture National Institute of Food and Agriculture Microbial Genome Sequencing Program to CRB and NT (2007-35600-17774 and 2007-35600-18886). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, V3, P103; ADAMS PB, 1990, ANNU REV PHYTOPATHOL, V28, P59, DOI 10.1146/annurev.py.28.090190.000423; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bala K, 2010, PERSOONIA, V25, P22, DOI 10.3767/003158510X524754; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Baurain D, 2010, MOL BIOL EVOL, V27, P1698, DOI 10.1093/molbev/msq059; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Beakes GW, 2012, PROTOPLASMA, V249, P3, DOI 10.1007/s00709-011-0269-2; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Bouwmeester K, 2009, ANNU PLANT REV, V34, P102, DOI 10.1111/b.9781405175326.2009.00005.x; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bradley A, 2007, REF USER SERV Q, V47, P133; BRASIER CM, 1992, ANNU REV PHYTOPATHOL, V30, P173, DOI 10.1146/annurev.py.30.090192.001133; Bridge PD, 2008, PLANT PATHOL, V57, P1066, DOI 10.1111/j.1365-3059.2008.01868.x; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Capra John A, 2010, Genome Biol, V11, P306, DOI 10.1186/gb-2010-11-6-306; Cavalier-Smith T, 2006, J MOL EVOL, V62, P388, DOI 10.1007/s00239-004-0353-8; Cheung F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-542; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COOK RJ, 1987, PHYTOPATHOLOGY, V77, P1192, DOI 10.1094/Phyto-77-1192; COOK RJ, 1980, PLANT DIS, V64, P102, DOI 10.1094/PD-64-1061; Cooke DEL, 2000, FUNGAL GENET BIOL, V30, P17, DOI 10.1006/fgbi.2000.1202; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dick MW, 2001, STRAMINIPILOUS FUNGI; Dieguez-Uribeondo J, 2009, FUNGAL GENET BIOL, V46, P365, DOI 10.1016/j.fgb.2009.02.004; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Gaulin E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001723; Gijzen M, 2006, PHYTOCHEMISTRY, V67, P1800, DOI 10.1016/j.phytochem.2005.12.008; Goker M, 2007, FUNGAL GENET BIOL, V44, P105, DOI 10.1016/j.fgb.2006.07.005; GOLD SE, 1985, PHYTOPATHOLOGY, V75, P333, DOI 10.1094/Phyto-75-333; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Harvey P., 2008, Outlooks on Pest Management, V19, P127, DOI 10.1564/19jun09; Harvey PR, 2000, PLANT PATHOL, V49, P619, DOI 10.1046/j.1365-3059.2000.00493.x; Harvey PR, 2001, MYCOL RES, V105, P85, DOI 10.1017/S0953756200002902; Horner NR, 2012, FUNGAL BIOL-UK, V116, P24, DOI 10.1016/j.funbio.2011.09.004; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iwayama S, 1933, NEW SNOW ROT DIS CER; Kale SD, 2012, NEW PHYTOL, V193, P874, DOI 10.1111/j.1469-8137.2011.03968.x; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Kemen E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001094; Koike S.T., 2006, VEGETABLE DIS COLOR; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LARKIN RP, 1995, PHYTOPATHOLOGY, V85, P430, DOI 10.1094/Phyto-85-430; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Levesque CA, 2004, MYCOL RES, V108, P1363, DOI 10.1017/S0953756204001431; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martens C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-353; Martin F.N., 2009, OOMYCETE GENETICS GE, P574; Martin FN, 2000, MYCOLOGIA, V92, P711, DOI 10.2307/3761428; Martin FN, 1999, CRIT REV PLANT SCI, V18, P111, DOI 10.1016/S0735-2689(99)00389-5; MARTIN FN, 1987, PHYTOPATHOLOGY, V77, P1013, DOI 10.1094/Phyto-77-1013; McLeod A, 2009, MYCOL RES, V113, P933, DOI 10.1016/j.mycres.2009.04.009; Mendoza L, 1996, J MYCOL MED, V6, P151; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; Mulder Nicola, 2007, V396, P59; Ospina-Giraldo MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-525; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Paulitz TC, 2003, PHYTOPATHOLOGY, V93, P867, DOI 10.1094/PHYTO.2003.93.7.867; Quinn E, 2012, RESOLVING PYTHIUM UL; Raffaele S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-637; Robideau GP, 2011, MOL ECOL RESOUR, V11, P1002, DOI 10.1111/j.1755-0998.2011.03041.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Runge F, 2011, EUR J PLANT PATHOL, V129, P135, DOI 10.1007/s10658-010-9714-x; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SAUNDERS GA, 1988, J INVERTEBR PATHOL, V52, P360, DOI 10.1016/0022-2011(88)90148-6; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Seidl MF, 2012, GENOME BIOL EVOL, V4, P199, DOI 10.1093/gbe/evs003; Seidl MF, 2011, PLANT PHYSIOL, V155, P628, DOI 10.1104/pp.110.167841; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Snowdon A. L., 1990, COLOUR ATLAS POSTHAR, V1; Soanes DM, 2007, PLANT CELL, V19, P3318, DOI 10.1105/tpc.107.056663; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; Spies CFJ, 2011, FUNGAL BIOL-UK, V115, P1210, DOI 10.1016/j.funbio.2011.08.006; Spies CFJ, 2011, FUNGAL BIOL-UK, V115, P157, DOI 10.1016/j.funbio.2010.11.005; Stassen JHM, 2011, CURR OPIN PLANT BIOL, V14, P407, DOI 10.1016/j.pbi.2011.05.002; Stefanato FL, 2009, PLANT J, V58, P499, DOI 10.1111/j.1365-313X.2009.03794.x; SUMNER DR, 1990, PLANT DIS, V74, P704, DOI 10.1094/PD-74-0704; TAKAHASHI M, 1977, T MYCOL SOC JPN, V18, P279; Takenaka S, 2008, PHYTOPATHOLOGY, V98, P187, DOI 10.1094/PHYTO-98-2-0187; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van Damme M, 2011, EFFECTORS PLANT MICR, P101; VANDERPLAATSNITERINK AJ, 1981, STUD MYCOL, P1; Vawdrey LL, 2005, AUSTRALAS PLANT PATH, V34, P127, DOI 10.1071/AP04093; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P15507, DOI 10.1073/pnas.242379899; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zeng HC, 2005, MYCOPATHOLOGIA, V159, P601, DOI 10.1007/s11046-005-5258-6; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	107	155	159	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75072	10.1371/journal.pone.0075072	http://dx.doi.org/10.1371/journal.pone.0075072			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124466	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100023
J	Zhang, L; Xiao, RJ; Xiong, J; Leng, J; Ehtisham, A; Hu, Y; Ding, QS; Xu, H; Liu, SW; Wang, J; Tang, DG; Zhang, QP				Zhang, Li; Xiao, Ruijing; Xiong, Jie; Leng, Jun; Ehtisham, Altaf; Hu, Yi; Ding, Qianshan; Xu, Hui; Liu, Shengwu; Wang, Jin; Tang, Dean G.; Zhang, Qiuping			Activated ERM Protein Plays a Critical Role in Drug Resistance of MOLT4 Cells Induced by CCL25	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; ACTIN CYTOSKELETON; MYELOID-LEUKEMIA; IN-VITRO; EXPRESSION; TRANSPORTERS; MECHANISM; APOPTOSIS; EZRIN	We have previously demonstrated that the CCR9/CCL25 signaling pathway plays an important role in drug resistance in human acute T-lymphocytic leukemia (T-ALL) by inducing activation of ERM protein with polarized distribution in T-ALL cell line MOLT4. However, the mechanism of action of the activated ERM protein in the drug resistance of MOLT4 cells induced by CCL25 remains uncharacterized. Here we investigated the mechanism of CCR9/CCL25-initiated drug resistance in CCR9-high-expressing T-ALL cells. Our results showed that 1) the function of P-gp was increased after treatment with CCL25; 2) P-gp colocalized and co-immunoprecipitated with p-ERM and F-actin in CCL25 treated cells; and 3) ERM-shRNA conferred drug sensitivity coincident with release of ERM interactions with P-gp and F-actin after treatment with CCL25. These data suggest it is pivotal that P-gp associate with the F-actin cytoskeleton through p-ERM in CCR9/CCL25 induced multidrug resistance of T-ALL cells. Strategies aimed at inhibiting P-gp-F-actin cytoskeleton association may be helpful in increasing the efficiency of therapies in T-ALL.	[Zhang, Li; Xiao, Ruijing; Xiong, Jie; Leng, Jun; Ehtisham, Altaf; Hu, Yi; Ding, Qianshan; Xu, Hui; Liu, Shengwu; Wang, Jin; Zhang, Qiuping] Wuhan Univ, Sch Basic Med Sci, Dept Immunol, Wuhan 430072, Peoples R China; [Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA	Wuhan University; University of Texas System; UTMD Anderson Cancer Center	Zhang, QP (corresponding author), Wuhan Univ, Sch Basic Med Sci, Dept Immunol, Wuhan 430072, Peoples R China.	qpzhang@whu.edu.cn	zhang, qiu/GXG-5600-2022; Tang, Dean/AAI-3457-2020	Tang, Dean/0000-0001-5029-1174	National Science Foundation of China [30570780, 30971280, 30801336]; National Ministry of Doctoral Fund [200804860039]; Fundamental Research Funds for the Central Universities [301274622]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Ministry of Doctoral Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Science Foundation of China (No.30570780, 30971280, 30801336), National Ministry of Doctoral Fund (No.200804860039) and the Fundamental Research Funds for the Central Universities (No.301274622). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2004, CARCINOGENESIS, V25, P941, DOI 10.1093/carcin/bgh060; Asakura K, 2004, MOL CANCER RES, V2, P339; Brambilla D, 2012, INT J CANCER, V130, P2824, DOI 10.1002/ijc.26285; Bretscher A, 1999, CURR OPIN CELL BIOL, V11, P109, DOI 10.1016/S0955-0674(99)80013-1; Brown KL, 2005, EXP CELL RES, V303, P400, DOI 10.1016/j.yexcr.2004.10.002; Cohen JD, 2011, TOXICOL SCI, V122, P361, DOI 10.1093/toxsci/kfr118; Ding KF, 2009, CARCINOGENESIS, V30, P35, DOI 10.1093/carcin/bgn251; Fu D, 2007, AM J PHYSIOL-CELL PH, V292, pC1543, DOI 10.1152/ajpcell.00068.2006; Galski H, 2006, LEUKEMIA RES, V30, P1151, DOI 10.1016/j.leukres.2006.02.016; Goler-Baron V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016007; Gottesman MM, 2006, FEBS LETT, V580, P998, DOI 10.1016/j.febslet.2005.12.060; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hayashi K, 1999, J CELL SCI, V112, P1149; Hebert M, 2008, J IMMUNOL, V181, P5963, DOI 10.4049/jimmunol.181.9.5963; Villar VH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037735; Kater L, 2012, TOXICOL IN VITRO, V26, P119, DOI 10.1016/j.tiv.2011.09.010; Lallemand D, 2009, J CELL SCI, V122, P4141, DOI 10.1242/jcs.045914; Liu ZL, 2002, CANCER CHEMOTH PHARM, V49, P391, DOI 10.1007/s00280-001-0411-5; Luciani F, 2002, BLOOD, V99, P641, DOI 10.1182/blood.V99.2.641; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; Meschini S, 2000, INT J CANCER, V87, P615, DOI 10.1002/1097-0215(20000901)87:5<615::AID-IJC1>3.3.CO;2-W; Molinari A, 2002, CURR PROTEIN PEPT SC, V3, P653, DOI 10.2174/1389203023380413; Padanyi R, 2010, J BIOL CHEM, V285, P31704, DOI 10.1074/jbc.M110.164137; PUI CH, 1993, BLOOD, V82, P343; Raaijmakers MHGP, 2007, LEUKEMIA, V21, P2094, DOI 10.1038/sj.leu.2404859; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Rudd LP, 2011, CHEM-BIOL INTERACT, V194, P113, DOI 10.1016/j.cbi.2011.08.012; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Stege A, 2004, CANCER GENE THER, V11, P699, DOI 10.1038/sj.cgt.7700751; Tong XL, 2009, CELL MOL IMMUNOL, V6, P181, DOI 10.1038/cmi.2009.25; TSURUO T, 1981, CANCER RES, V41, P1967; Walter RB, 2007, BLOOD, V109, P4168, DOI 10.1182/blood-2006-09-047399; Willemse MJ, 2002, BLOOD, V99, P4386, DOI 10.1182/blood.V99.12.4386; Wisser RJ, 2011, P NATL ACAD SCI USA, V108, P7339, DOI 10.1073/pnas.1011739108; Zhang QP, 2004, CANCER RES, V64, P7579, DOI 10.1158/0008-5472.CAN-04-0641; Zhou BB, 2010, LEUKEMIA RES, V34, P769, DOI 10.1016/j.leukres.2009.11.025	37	104	111	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52384	10.1371/journal.pone.0052384	http://dx.doi.org/10.1371/journal.pone.0052384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326330	Green Published, Green Submitted, gold			2022-12-25	WOS:000313551500013
J	Cheng, HR; Liu, CJ; Tseng, TC; Su, TH; Yang, HI; Chen, CJ; Kao, JH				Cheng, Huei-Ru; Liu, Chun-Jen; Tseng, Tai-Chung; Su, Tung-Hung; Yang, Hwai-I; Chen, Chien-Jen; Kao, Jia-Horng			Host Genetic Factors Affecting Spontaneous HBsAg Seroclearance in Chronic Hepatitis B Patients	PLOS ONE			English	Article							SURFACE-ANTIGEN SEROCLEARANCE; VIRUS-INFECTION; HEPATOCELLULAR-CARCINOMA; FOLLOW-UP; DNA LEVEL; DETERMINANTS; ASSOCIATION; CLEARANCE; PROGNOSIS; TAIWAN	Spontaneous clearance of hepatitis B surface antigen (HBsAg) in chronic hepatitis B (CHB) patients usually indicates a remission of hepatitis activity and a favorable outcome. Two single nucleotide polymorphisms (SNP), rs3077 near HLA-DPA1 region and rs9277535 near HLA-DPB1 region, have been shown to be associated with HBV persistence after acute HBV infection. However, little is known about the impact of these 2 SNPs on spontaneous HBsAg clearance in CHB patients. In this case-control study, a total of 100 male HBeAg-negative chronic HBV carriers who cleared HBsAg spontaneously (case group) and 100 age-matched HBeAg-negative male patients with persistent HBsAg positivity (control group) were enrolled. We investigated the relationship between these 2 SNPs and HBsAg clearance. There was a higher frequency of rs9277535 non-GG genotype in the case group (57% vs. 42%). Patients with rs9277535 non-GG genotype had a higher chance to clear HBsAg [Odds ratio (OR): 1.83, 95% confidence interval (CI): 1.04 similar to 3.21, P = 0.034]. Compared to GG haplotype of rs3077 and rs9277535, GA haplotype had a higher chance of achieving spontaneous HBsAg loss (OR: 2.17, 95% CI: 1.14 similar to 4.16, P = 0.030). In conclusion, rs9277535 non-GG genotype is associated with a higher likelihood of spontaneous HBsAg seroclearance in CHB patients.	[Cheng, Huei-Ru; Liu, Chun-Jen; Kao, Jia-Horng] Natl Taiwan Univ, Grad Inst Clin Med, Taipei 10764, Taiwan; [Liu, Chun-Jen; Su, Tung-Hung; Kao, Jia-Horng] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei 10764, Taiwan; [Liu, Chun-Jen; Su, Tung-Hung; Kao, Jia-Horng] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Liu, Chun-Jen; Su, Tung-Hung; Kao, Jia-Horng] Natl Taiwan Univ, Coll Med, Hepatitis Res Ctr, Taipei 10764, Taiwan; [Kao, Jia-Horng] Natl Taiwan Univ, Dept Med Res, Coll Med, Taipei 10764, Taiwan; [Tseng, Tai-Chung] Buddhist Tzu Chi Gen Hosp, Taipei Branch, Dept Internal Med, Taipei, Taiwan; [Yang, Hwai-I] China Med Univ Hosp, Mol & Genom Epidemiol Ctr, Taichung, Taiwan; [Yang, Hwai-I] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Yang, Hwai-I; Chen, Chien-Jen] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Buddhist Tzu Chi General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Academia Sinica - Taiwan	Kao, JH (corresponding author), Natl Taiwan Univ, Grad Inst Clin Med, Taipei 10764, Taiwan.	kaojh@ntu.edu.tw	Kao, Jia-Horng/AAB-8947-2019; Ekanayake, Kanchana/P-8817-2016; Rooney, Kieron/I-6252-2018; Cheng, Hoi Lun/AAK-8937-2021; O'Connor, Helen/C-1289-2014; Research Institute, ANZAC/CAE-9030-2022; Steinbeck, Kate/AAX-6197-2020; Chen, Chien-Jen/C-6976-2008; Yang, Hwai-I/A-9470-2008; Chen, Chien-Jen/N-4723-2019	Kao, Jia-Horng/0000-0002-2442-7952; Rooney, Kieron/0000-0001-6563-7617; Cheng, Hoi Lun/0000-0002-2144-9195; O'Connor, Helen/0000-0002-6198-4141; Yang, Hwai-I/0000-0002-3433-942X; LIU, CHUN-JEN/0000-0002-6202-0993; SU, TUNG-HUNG/0000-0002-6747-7941	National Taiwan University; National Science Council, and Department of Health, Executive Yuan, Taiwan; National Taiwan University Hospital, Taiwan	National Taiwan University(National Taiwan University); National Science Council, and Department of Health, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital, Taiwan	The work was supported by grants from the National Taiwan University; the National Science Council, and Department of Health, Executive Yuan, Taiwan; National Taiwan University Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; CHEN DS, 1993, SCIENCE, V262, P369, DOI 10.1126/science.8211155; Chen YC, 2002, GASTROENTEROLOGY, V123, P1084, DOI 10.1053/gast.2002.36026; Chu CM, 2007, HEPATOLOGY, V45, P1187, DOI 10.1002/hep.21612; Chu CM, 2010, ANTIVIR THER, V15, P133, DOI 10.3851/IMP1497; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Guo XC, 2011, HEPATOLOGY, V53, P422, DOI 10.1002/hep.24048; Handunnetthi L, 2010, GENES IMMUN, V11, P99, DOI 10.1038/gene.2009.83; HSU HY, 1986, J MED VIROL, V18, P301, DOI 10.1002/jmv.1890180402; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kao JH, 2003, INTERVIROLOGY, V46, P400, DOI 10.1159/000074999; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Kim JH, 2008, HEPATO-GASTROENTEROL, V55, P578; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024221; LIAW YF, 1991, HEPATOLOGY, V13, P627, DOI 10.1002/hep.1840130403; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu J, 2010, GASTROENTEROLOGY, V139, P474, DOI 10.1053/j.gastro.2010.04.048; McMahon BJ, 2001, ANN INTERN MED, V135, P759, DOI 10.7326/0003-4819-135-9-200111060-00006; Nishida N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039175; Simonetti J, 2010, HEPATOLOGY, V51, P1531, DOI 10.1002/hep.23464; Su TH, 2010, ANTIVIR THER, V15, P1133, DOI 10.3851/IMP1696; Tseng TC, 2012, HEPATOLOGY, V55, P68, DOI 10.1002/hep.24615; Tseng TC, 2011, GASTROENTEROLOGY, V141, P517, DOI 10.1053/j.gastro.2011.04.046; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017608; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Yeh SH, 2004, J HEPATOL, V41, P659, DOI 10.1016/j.jhep.2004.06.031	27	91	93	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53008	10.1371/journal.pone.0053008	http://dx.doi.org/10.1371/journal.pone.0053008			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23861932	Green Submitted, gold, Green Published			2022-12-25	WOS:000314705800028
J	Cheng, HL; Bryant, CE; Rooney, KB; Steinbeck, KS; Griffin, HJ; Petocz, P; O'Connor, HT				Cheng, Hoi Lun; Bryant, Christian E.; Rooney, Kieron B.; Steinbeck, Katharine S.; Griffin, Hayley J.; Petocz, Peter; O'Connor, Helen T.			Iron, Hepcidin and Inflammatory Status of Young Healthy Overweight and Obese Women in Australia	PLOS ONE			English	Article							TRANSFERRIN RECEPTOR; SERUM HEPCIDIN; DEFICIENCY; HYPOFERREMIA; ADULTS; LEVEL; RISK; DIET	Background and Aims: Evidence suggests obesity-related inflammation alters iron metabolism potentially increasing the risk of iron deficiency. This cross-sectional study aimed to investigate iron, hepcidin and inflammatory status in young, healthy overweight and obese women. Methods: 114 young (18-25 years), healthy comorbidity-free women with a body mass index (BMI) >= 27.5 kg/m(2) were recruited. Biochemical data were analysed using mean +/- standard deviation or median (interquartile range) and multivariate modelling. Biochemical markers were also stratified according to varying degrees of overweight and obesity. Results: Anaemia (haemoglobin <120 g/l) and iron deficiency (serum ferritin <15.0 mu g/l) were prevalent in 10% and 17% of participants respectively. Mean/median soluble transferrin receptor was 1.61 +/- 0.44 mg/l; hepcidin 6.40 (7.85) ng/ml and C-reactive protein (CRP) 3.58 (5.81) mg/l. Multivariate modelling showed that BMI was a significant predictor of serum iron (coefficient = -0.379; standard error = 0.139; p = 0.008), transferrin saturation (coefficient = -0.588; standard error = 0.222; p = 0.009) and CRP (coefficient = 0.127; standard error = 0.024; p<0.001). Stratification of participants according to BMI showed those with >= 35.0 kg/m(2) had significantly higher CRP (p<0.001) than those in lower BMI categories. Conclusions: Increasing obesity was associated with minor disturbances in iron metabolism. However, overall outcomes indicated simple iron deficiency (hypoferritinaemia) was the primary iron-related abnormality with no apparent contribution of inflammation or hepcidin, even in those with BMI >35.0 kg/m(2). This indicates that obesity alone may not be sufficient to induce clinically significant disturbances to iron metabolism as previously described. This may be attributed to the lack of comorbidity in this cohort.	[Cheng, Hoi Lun; Rooney, Kieron B.; Griffin, Hayley J.; O'Connor, Helen T.] Univ Sydney, Fac Hlth Sci, Discipline Exercise & Sport Sci, Sydney, NSW 2006, Australia; [Bryant, Christian E.] Univ Sydney, Anzac Res Inst, Sydney, NSW 2006, Australia; [Steinbeck, Katharine S.] Univ Sydney, Acad Dept Adolescent Med, Sydney, NSW 2006, Australia; [Petocz, Peter] Macquarie Univ, Dept Stat, Sydney, NSW 2109, Australia	University of Sydney; University of Sydney; ANZAC Research Institute; University of Sydney; Macquarie University	Cheng, HL (corresponding author), Univ Sydney, Fac Hlth Sci, Discipline Exercise & Sport Sci, Sydney, NSW 2006, Australia.	hche3056@uni.sydney.edu.au	Kao, Jia-Horng/AAB-8947-2019; Ekanayake, Kanchana/P-8817-2016; Rooney, Kieron/I-6252-2018; Cheng, Hoi Lun/AAK-8937-2021; O'Connor, Helen/C-1289-2014; Research Institute, ANZAC/CAE-9030-2022; Steinbeck, Kate/AAX-6197-2020; Chen, Chien-Jen/C-6976-2008; Yang, Hwai-I/A-9470-2008; Chen, Chien-Jen/N-4723-2019	Kao, Jia-Horng/0000-0002-2442-7952; Rooney, Kieron/0000-0001-6563-7617; Cheng, Hoi Lun/0000-0002-2144-9195; O'Connor, Helen/0000-0002-6198-4141; Yang, Hwai-I/0000-0002-3433-942X; LIU, CHUN-JEN/0000-0002-6202-0993; SU, TUNG-HUNG/0000-0002-6747-7941	Meat and Livestock Australia	Meat and Livestock Australia(Meat and Livestock Australia)	This work was supported by a grant from Meat and Livestock Australia. The authors declare that Meat and Livestock Australia had no influence on any part of the analysis or interpretation of data, including the conclusions drawn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeberli I, 2009, INT J OBESITY, V33, P1111, DOI 10.1038/ijo.2009.146; Ahmed F, 2008, ASIA PAC J CLIN NUTR, V17, P40; [Anonymous], 2000, WHO TECH REP SER, P894; ARBER N, 1994, DIGEST DIS SCI, V39, P2656, DOI 10.1007/BF02087705; Ausk KJ, 2008, OBESITY, V16, P2356, DOI 10.1038/oby.2008.353; Ball K, 2009, OBESITY, V17, P66, DOI 10.1038/oby.2008.497; Bansal SS, 2010, RAPID COMMUN MASS SP, V24, P1251, DOI 10.1002/rcm.4512; Cheng HL, 2012, OBES REV, V13, P150, DOI 10.1111/j.1467-789X.2011.00938.x; Corwin EJ, 2003, J NUTR, V133, P4139, DOI 10.1093/jn/133.12.4139; Franklin M, 2010, CLIN CHEM, V57, pA171; Ganz Tomas, 2012, Biochim Biophys Acta, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Griffin HJ, 2013, DIABETES OBES METAB, V15, P572, DOI 10.1111/dom.12056; HALLBERG L, 1966, ACTA OBSTET GYN SCAN, V45, P320, DOI 10.3109/00016346609158455; Karl JP, 2009, J AM COLL NUTR, V28, P37, DOI 10.1080/07315724.2009.10719759; Koulaouzidis A, 2009, SCAND J GASTROENTERO, V44, P126, DOI 10.1080/00365520802555983; Lagergren J, 2011, NAT REV GASTRO HEPAT, V8, P340, DOI 10.1038/nrgastro.2011.73; Macdougall IC, 2010, CLIN J AM SOC NEPHRO, V5, P1681, DOI 10.2215/CJN.05990809; Murray-Kolb LE, 2007, AM J CLIN NUTR, V85, P778, DOI 10.1093/ajcn/85.3.778; O'Connor H, 2011, ASIA PAC J CLIN NUTR, V20, P206; Pasricha SR, 2011, HAEMATOL-HEMATOL J, V96, P1099, DOI 10.3324/haematol.2010.037960; Pynaert I, 2007, ANN NUTR METAB, V51, P172, DOI 10.1159/000103278; Skikne BS, 2008, AM J HEMATOL, V83, P872, DOI 10.1002/ajh.21279; Suominen P, 1998, BLOOD, V92, P2934, DOI 10.1182/blood.V92.8.2934.420k07_2934_2939; Tussing-Humphreys LM, 2010, OBESITY, V18, P2010, DOI 10.1038/oby.2009.490; Tussing-Humphreys LM, 2009, J AM DIET ASSOC, V109, P297, DOI 10.1016/j.jada.2008.10.044; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; WHO, 2001, AN DEF; World Health Organization, 2011, WAIST CIRC WAIST HIP, Vi-vi; Yanoff LB, 2007, INT J OBESITY, V31, P1412, DOI 10.1038/sj.ijo.0803625	29	91	93	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68675	10.1371/journal.pone.0068675	http://dx.doi.org/10.1371/journal.pone.0068675			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861932	Green Published, gold, Green Submitted			2022-12-25	WOS:000323350700097
J	Wang, XL; Falkner, B; Zhu, HD; Shi, HD; Su, SY; Xu, XJ; Sharma, AK; Dong, YB; Treiber, F; Gutin, B; Harshfield, G; Snieder, H				Wang, Xiaoling; Falkner, Bonita; Zhu, Haidong; Shi, Huidong; Su, Shaoyong; Xu, Xiaojing; Sharma, Ashok Kumar; Dong, Yanbin; Treiber, Frank; Gutin, Bernard; Harshfield, Gregory; Snieder, Harold			A Genome-Wide Methylation Study on Essential Hypertension in Young African American Males	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; BLOOD-PRESSURE; DNA METHYLATION; MALE TWINS; HSULF-1; CANCER; GENE; VARIANTS; HEMODYNAMICS; INFLAMMATION	Objective: There is emerging evidence from animal studies suggesting a key role for methylation in the pathogenesis of essential hypertension. However, to date, very few studies have investigated the role of methylation in the development of human hypertension, and none has taken a genome-wide approach. Based on the recent studies that highlight the involvement of inflammation in the development of hypertension, we hypothesize that changes in DNA methylation of leukocytes are involved in the pathogenesis of hypertension. Method & Results: We conducted a genome-wide methylation analysis on 8 hypertensive cases and 8 normotensive age-matched controls aged 14-23 years and performed validation of the most significant CpG sites in 2 genes in an independent sample of 36 hypertensive cases and 60 normotensive controls aged 14-30 years. Validation of the CpG sites in the SULF1 gene was further conducted in a second replication sample of 36 hypertensive cases and 34 controls aged 15.8-40 years. A CpG site in the SULF1 gene showed higher methylation levels in cases than in healthy controls in the genome-wide step (p = 6.2 x 10(-5)), which was confirmed in the validation step (p = 0.011) for subjects <= 30 years old but was not significant for subjects of all ages combined (p = 0.095). Conclusion: The identification of a difference in a blood leukocyte DNA methylation site between hypertensive cases and normotensive controls suggests that changes in DNA methylation may play an important role in the pathogenesis of hypertension. The age dependency of the effect further suggests complexity of epigenetic regulation in this age-related disease.	[Wang, Xiaoling; Zhu, Haidong; Su, Shaoyong; Xu, Xiaojing; Dong, Yanbin; Gutin, Bernard; Harshfield, Gregory] Georgia Hlth Sci Univ, Dept Pediat, Georgia Prevent Inst, Augusta, GA USA; [Falkner, Bonita] Thomas Jefferson Univ, Dept Med, Philadelphia, PA 19107 USA; [Shi, Huidong] Georgia Hlth Sci Univ, Sch Med, Canc Res Ctr, Augusta, GA USA; [Sharma, Ashok Kumar] Georgia Hlth Sci Univ, Sch Med, Ctr Biotechnol & Genom Med, Augusta, GA USA; [Treiber, Frank] Med Univ S Carolina, Coll Nursing, Technol Applicat Ctr Healthful Lifestyles, Charleston, SC 29425 USA; [Treiber, Frank] Med Univ S Carolina, Coll Med, Technol Applicat Ctr Healthful Lifestyles, Charleston, SC 29425 USA; [Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Unit Genet Epidemiol & Bioinformat, Groningen, Netherlands	University System of Georgia; Augusta University; Jefferson University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Medical University of South Carolina; Medical University of South Carolina; University of Groningen	Wang, XL (corresponding author), Georgia Hlth Sci Univ, Dept Pediat, Georgia Prevent Inst, Augusta, GA USA.	xwang@georgiahealth.edu	xu, xiaojing/C-2759-2014; Falkner, Bonita/Y-8451-2019	Shi, Huidong/0000-0003-1137-3390; Sanfacon, Helene/0000-0003-3807-3590; Sharma, Ashok/0000-0001-9597-4374	National Institutes of Health [HL69999, HL56622, HL077230, HL64157, DK046107, HL092030]; NLHBI [HL105689]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104125, R01HL092030, P01HL069999, R01HL056622, R01HL105689, R01HL064157, R01HL077230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NLHBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The participants in this study were recruited by several National Institutes of Health funded projects including HL69999, HL56622, HL077230, HL64157, DK046107 & HL092030. The current study is funded by the NLHBI HL105689. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Alikhani-Koopaei R, 2004, J CLIN INVEST, V114, P1146, DOI 10.1172/JCI200421647; Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Baty F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-422; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogdarina I, 2007, CIRC RES, V100, P520, DOI 10.1161/01.RES.0000258855.60637.58; Cantarin MPM, 2010, CTS-CLIN TRANSL SCI, V3, P279, DOI 10.1111/j.1752-8062.2010.00242.x; CARMELLI D, 1994, J HYPERTENS, V12, P323; CARMELLI D, 1994, AM J HUM GENET, V55, P566; Chen Z, 2009, INT J CANCER, V124, P739, DOI 10.1002/ijc.23960; COLLETTO GMDD, 1993, GENET EPIDEMIOL, V10, P533, DOI 10.1002/gepi.1370100634; Dai YM, 2005, J BIOL CHEM, V280, P40066, DOI 10.1074/jbc.M508136200; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Falkner B, 2012, J PEADIAT IN PRESS; Frey FJ, 2005, NEPHROL DIAL TRANSPL, V20, P868, DOI 10.1093/ndt/gfh746; Friso S, 2008, ATHEROSCLEROSIS, V199, P323, DOI 10.1016/j.atherosclerosis.2007.11.029; Ge DL, 2006, TWIN RES HUM GENET, V9, P965, DOI 10.1375/twin.9.6.965; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Groom A, 2011, ARCH DIS CHILD, V96, P863, DOI 10.1136/adc.2009.165712; Gutin B, 2007, OBESITY, V15, P1029, DOI 10.1038/oby.2007.602; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Kapur G, 2010, CLIN HYPERTENSION VA, P241; Koestler DC, 2012, CANCER EPIDEM BIOMAR, V21, P1293, DOI 10.1158/1055-9965.EPI-12-0361; Kupper N, 2006, HYPERTENSION, V47, P948, DOI 10.1161/01.HYP.0000217521.79447.9a; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Li JS, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-14; Pauletto P, 2006, NEPHROL DIAL TRANSPL, V21, P850, DOI 10.1093/ndt/gfl019; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Savoia C, 2006, CURR OPIN NEPHROL HY, V15, P152, DOI 10.1097/01.mnh.0000203189.57513.76; Smolarek I, 2010, MED SCI MONITOR, V16, pCR149; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Snieder H, 2002, AM J HYPERTENS, V15, P973, DOI 10.1016/S0895-7061(02)02991-6; Staub J, 2007, ONCOGENE, V26, P4969, DOI 10.1038/sj.onc.1210300; Wang X, 2010, CLIN HYPERTENSION VA, P241; Wang XL, 2006, CIRCULATION, V114, P2780, DOI 10.1161/CIRCULATIONAHA.106.643940; Zhang DY, 2009, KIDNEY INT, V75, P260, DOI 10.1038/ki.2008.475; Zhu HD, 2009, PEDIATR RES, V65, P443, DOI 10.1203/PDR.0b013e3181994b85	41	163	175	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53938	10.1371/journal.pone.0053938	http://dx.doi.org/10.1371/journal.pone.0053938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23325143	gold, Green Published, Green Submitted			2022-12-25	WOS:000313552400062
J	Meng, Q; Kang, J				Meng, Qi; Kang, Jian			Influence of Social and Behavioural Characteristics of Users on Their Evaluation of Subjective Loudness and Acoustic Comfort in Shopping Malls	PLOS ONE			English	Article							RECTANGULAR LONG ENCLOSURES; SPEECH-INTELLIGIBILITY; MULTIPLE LOUDSPEAKERS; REVERBERATION; SOUNDSCAPES; ENVIRONMENT	A large-scale subjective survey was conducted in six shopping malls in Harbin City, China, to determine the influence of social and behavioural characteristics of users on their evaluation of subjective loudness and acoustic comfort. The analysis of social characteristics shows that evaluation of subjective loudness is influenced by income and occupation, with correlation coefficients or contingency coefficients of 0.10 to 0.40 (p<0.05 or p<0.01). Meanwhile, evaluation of acoustic comfort evaluation is influenced by income, education level, and occupation, with correlation coefficients or contingency coefficients of 0.10 to 0.60 (p<0.05 or p<0.01). The effect of gender and age on evaluation of subjective loudness and acoustic comfort is statistically insignificant. The effects of occupation are mainly caused by the differences in income and education level, in which the effects of income are greater than that of education level. In terms of behavioural characteristics, evaluation of subjective loudness is influenced by the reason for visit, frequency of visit, and length of stay, with correlation coefficients or contingency coefficients of 0.10 to 0.40 (p<0.05 or p<0.01). Evaluation of acoustic comfort is influenced by the reason for visit to the site, the frequency of visit, length of stay, and also season of visit, with correlation coefficients of 0.10 to 0.30 (p<0.05 or p<0.01). In particular, users who are waiting for someone show lower evaluation of acoustic comfort, whereas users who go to shopping malls more than once a month show higher evaluation of acoustic comfort. On the contrary, the influence of the period of visit and the accompanying persons are found insignificant.	[Meng, Qi; Kang, Jian] Harbin Inst Technol, Sch Architecture, Harbin 150006, Peoples R China; [Kang, Jian] Univ Sheffield, Sch Architecture, Sheffield, S Yorkshire, England	Harbin Institute of Technology; University of Sheffield	Meng, Q (corresponding author), Harbin Inst Technol, Sch Architecture, Harbin 150006, Peoples R China.	mengq@hit.edu.cn; j.kang@sheffield.ac.uk	Yue, Shanchao/D-1846-2009	Yue, Shanchao/0000-0001-8724-2974; Meng, Qingfeng/0000-0003-0047-3089; Kang, Jian/0000-0001-8995-5636	China Natural Science Foundation [50928801]; PR China Ministry of Education Foundation for PhD Bases [20112302110045]; Harbin Technological Innovation Fund [2012RFXXS046]	China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); PR China Ministry of Education Foundation for PhD Bases; Harbin Technological Innovation Fund	The work was supported by the China Natural Science Foundation (No. 50928801), the PR China Ministry of Education Foundation for PhD Bases (20112302110045) and the Harbin Technological Innovation Fund (2012RFXXS046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertoni D, 1993, P 6 C NOIS PUBL HLTH; Brown AL, 2010, NOISE CONTROL ENG J, V58, P493, DOI 10.3397/1.3484178; Bull Michael, 2000, SOUNDING OUT CITY PE; Chen B., 2004, ARCHIT SCI REV, V47, P107, DOI [10.1080/00038628.2004.9697033, DOI 10.1080/00038628.2004.9697033]; COSMAS SC, 1982, J CONSUM RES, V8, P453, DOI 10.1086/208886; Croome D. J., 1977, NOISE BUILDING PEOPL; Della Crociata S, 2013, BUILD ENVIRON, V59, P369, DOI 10.1016/j.buildenv.2012.09.002; Della Crociata S, 2012, BUILD ENVIRON, V47, P288, DOI 10.1016/j.buildenv.2011.07.011; Deng SC, 1994, CHINESE PUBLIC HLTH, V2, P93; Ellermeier W, 2001, J ACOUST SOC AM, V109, P1464, DOI 10.1121/1.1350402; FIELDS JM, 1993, J ACOUST SOC AM, V93, P2753, DOI 10.1121/1.405851; General Administration of Quality Supervision Inspection and Quarantine of the People's Republic of China, 2008, GB30962008 GEN ADM Q; Harbin Statistical Bureau, 2011, STAT YB HARB 2011; Harbin Statistical Bureau, 2012, STAT YB HARB 2012; Huang L, 2012, BUILD ENVIRON, V49, P304, DOI 10.1016/j.buildenv.2011.07.022; Jin H, 2009, P INT OTT CAN; Job RFS, 1999, P INT FORT LAUD US; Kang J, 1997, APPL ACOUST, V51, P169, DOI 10.1016/S0003-682X(96)00062-X; Kang J, 1996, ACUSTICA, V82, P509; Kang J, 1998, ACUSTICA, V84, P689; Kang J, 2002, ACTA ACUST UNITED AC, V88, P77; Kang J, 1998, J ACOUST SOC AM, V103, P1213, DOI 10.1121/1.421253; Kang J, 1996, APPL ACOUST, V47, P129, DOI 10.1016/0003-682X(95)00037-A; Kang J, 2010, BUILD ENVIRON, V45, P150, DOI 10.1016/j.buildenv.2009.05.014; Kang J, 1996, J ACOUST SOC AM, V99, P985, DOI 10.1121/1.414627; Kang J, 1996, BUILD ENVIRON, V31, P245, DOI 10.1016/0360-1323(95)00046-1; Kang J., 2006, URBAN SOUND ENV; Kang J, 2012, SCI TOTAL ENVIRON, V435, P80, DOI 10.1016/j.scitotenv.2012.06.105; Karlsson Henrik, 2000, J ACOUSTIC ECOLOGY, V1, P10; Li LS, 2006, DESIGN INVESTIGATION; Lin N., 2002, SOCIAL CAPITAL THEOR, V19; Liu SZ, 2011, INT J VENT, V10, P251; Mao Dong-xing, 2009, Technical Acoustics, V28, P693, DOI 10.3969/j.issn1000-3630.2009.06.002; Mehrabian A., 1976, PUBLIC PLACES PRIVAT; Meng Q., 2010, THESIS HARBIN I TECH; Meng Q., 2011, J HARBIN I TECHNO S2, V18, P231; Meng Q., 2010, HUAZHONG ARCHITECTUR, V28, P90; Miedema HME, 1998, J ACOUST SOC AM, V104, P3432, DOI 10.1121/1.423927; Ministry of Environmental Protection of the People's Republic of China, 2008, GB223372008 MIN ENV; Nilsson ME, 2006, ACTA ACUST UNITED AC, V92, P857; Pallant J., 2005, SPSS SURVIVAL GUIDE; Reingold DA, 1999, ECON DEV Q, V13, P23; Schulte-Fortkamp B, 1999, P INT FORT LAUD FL U; Song F, 2011, THESIS HARBIN I TECH; SOUTHWORTH M, 1969, ENVIRON BEHAV, V1, P49; Szeremeta B, 2009, SCI TOTAL ENVIRON, V407, P6143, DOI 10.1016/j.scitotenv.2009.08.039; Tang ZZ, 2009, P EUR 2009 ED SCOTL; Tang ZZ, 2011, J HARBIN I TECHNO S2, V18, P354; Wayne WD, 1979, BUSINESS STAT BASIC; Woolley Helen., 2003, URBAN OPEN SPACES; Yang W, 2005, APPL ACOUST, V66, P211, DOI 10.1016/j.apacoust.2004.07.011; Yang W, 2000, THESIS U SHEFFIELD S; Yang W, 2005, J URBAN DES, V10, P61, DOI 10.1080/13574800500062395; Yu L, 2008, J ACOUST SOC AM, V123, P772, DOI 10.1121/1.2821955; Yu L, 2010, APPL ACOUST, V71, P622, DOI 10.1016/j.apacoust.2010.02.005; Yu L, 2009, J ACOUST SOC AM, V126, P1163, DOI 10.1121/1.3183377; Zhang M, 2007, ENVIRON PLANN B, V34, P68, DOI 10.1068/b31162; Zhang M, 2009, INT J ENVIRON POLLUT, V39, P187, DOI 10.1504/IJEP.2009.027151; Zhao MD, 2009, E MOSCOW HARBIN CITY; Zimmer K, 1999, J ENVIRON PSYCHOL, V19, P295, DOI 10.1006/jevp.1999.0133	60	56	58	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54497	10.1371/journal.pone.0054497	http://dx.doi.org/10.1371/journal.pone.0054497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086SQ	23336003	Green Accepted, Green Published, gold			2022-12-25	WOS:000314707700061
J	Yang, JK; Liu, LY; Dai, JH; Li, Q				Yang, Jiang-Ke; Liu, Li-Ying; Dai, Jiang-Hong; Li, Qin			de novo Design and Synthesis of Candida antarctica Lipase B Gene and alpha-Factor Leads to High-Level Expression in Pichia pastoris	PLOS ONE			English	Article							WHOLE-CELL BIOCATALYST; CODON OPTIMIZATION; ESCHERICHIA-COLI; PROTEIN	Candida antarctica lipase B (CALB) is one of the most widely used and studied enzymes in the world. In order to achieve the high-level expression of CALB in Pichia, we optimized the codons of CALB gene and alpha-factor by using a de novo design and synthesis strategy. Through comparative analysis of a series of recombinants with different expression components, we found that the methanol-inducible expression recombinant carrying the codon-optimized alpha-factor and mature CALB gene (pPIC9K alpha M-CalBM) has the highest lipase production capacity. After fermentation parameters optimization, the lipase activity and protein content of the recombinant pPIC9K alpha M-CalBM reached 6,100 U/mL and 3.0 g/L, respectively, in a 5-L fermentor. We believe this strategy could be of special interest due to its capacity to improve the expression level of target gene, and the Pichia transformants carrying the codon-optimized gene had great potential for the industrial-scale production of CALB lipase.	[Yang, Jiang-Ke; Dai, Jiang-Hong; Li, Qin] Wuhan Polytech Univ, Coll Biol & Pharmaceut Engn, Wuhan, Hubei, Peoples R China; [Liu, Li-Ying] Huazhong Univ Sci & Technol, Sch Life Sci, Wuhan 430074, Hubei, Peoples R China	Wuhan Polytechnic University; Huazhong University of Science & Technology	Yang, JK (corresponding author), Wuhan Polytech Univ, Coll Biol & Pharmaceut Engn, Wuhan, Hubei, Peoples R China.	jiangke.yang@gmail.com	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X; Li, Hong Tao/0000-0002-1290-0917	Human Recourse Foundation of Wuhan Polytechnic University; Chinese Ministry of Education [212118]	Human Recourse Foundation of Wuhan Polytechnic University; Chinese Ministry of Education(Ministry of Education, China)	This work was financially supported by Human Recourse Foundation of Wuhan Polytechnic University and the Key Project of Chinese Ministry of Education (No. 212118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcapinar GB, 2011, BIOTECHNOL PROGR, V27, P1257, DOI 10.1002/btpr.663; Anderson EM, 1998, BIOCATAL BIOTRANSFOR, V16, P181, DOI 10.3109/10242429809003198; Andrade LH, 2009, ORG LETT, V11, P3052, DOI 10.1021/ol901091f; Blank K, 2006, J BIOTECHNOL, V125, P474, DOI 10.1016/j.jbiotec.2006.04.004; Budisa N, 2010, MOL BIOSYST, V6, P1630, DOI 10.1039/c002256j; Chang SW, 2011, J AGR FOOD CHEM, V59, P6710, DOI 10.1021/jf200537w; Benaiges MD, 2010, BIOTECHNOL PROGR, V26, P1252, DOI 10.1002/btpr.444; Fernandez L, 2006, PROTEIN EXPRES PURIF, V49, P256, DOI 10.1016/j.pep.2006.06.015; HOEGH I, 1995, CAN J BOT, V73, pS869; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Jahic M, 2003, J BIOTECHNOL, V102, P45, DOI 10.1016/S0168-1656(03)00003-8; Jahic M, 2002, BIOPROC BIOSYST ENG, V24, P385, DOI 10.1007/s00449-001-0274-5; Jung SY, 2008, BIOTECHNOL LETT, V30, P717, DOI 10.1007/s10529-007-9591-3; Kittl R, 2012, BIOENGINEERED, V3, P232, DOI 10.4161/bioe.20037; Ko MJ, 2012, BIOPROC BIOSYST ENG, V35, P69, DOI 10.1007/s00449-011-0604-1; Koganesawa N, 2001, PROTEIN ENG, V14, P705, DOI 10.1093/protein/14.9.705; Kruger N J, 1994, Methods Mol Biol, V32, P9; Larsen MW, 2008, PROTEIN EXPRES PURIF, V62, P90, DOI 10.1016/j.pep.2008.07.012; Oberg F, 2011, MOL MEMBR BIOL, V28, P398, DOI 10.3109/09687688.2011.602219; PATKAR SA, 1993, INDIAN J CHEM B, V32, P76; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; Rotticci-Mulder JC, 2001, PROTEIN EXPRES PURIF, V21, P386, DOI 10.1006/prep.2000.1387; Rouillard JM, 2004, NUCLEIC ACIDS RES, V32, pW176, DOI 10.1093/nar/gkh401; Shu ZY, 2009, BIOTECHNOL PROGR, V25, P409, DOI 10.1002/btpr.147; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Surribas A, 2007, J BIOTECHNOL, V130, P291, DOI 10.1016/j.jbiotec.2007.04.009; Tamalampudi S, 2007, APPL MICROBIOL BIOT, V75, P387, DOI 10.1007/s00253-006-0814-7; Tanino T, 2009, APPL MICROBIOL BIOT, V82, P59, DOI 10.1007/s00253-008-1764-z; Ward NJ, 2011, BLOOD, V117, P798, DOI 10.1182/blood-2010-05-282707; Xiong AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh094; Yang JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036607; Yang JK, 2007, J MOL CATAL B-ENZYM, V45, P91, DOI 10.1016/j.molcatb.2006.12.007; Yang JK, 2010, J MOL CATAL B-ENZYM, V63, P164, DOI 10.1016/j.molcatb.2010.01.011; Yang JK, 2009, APPL BIOCHEM BIOTECH, V159, P355, DOI 10.1007/s12010-008-8419-5; Young L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh058; Yu Y, 2010, BIOTECHNOL BIOENG, V105, P44, DOI 10.1002/bit.22471	36	76	82	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53939	10.1371/journal.pone.0053939	http://dx.doi.org/10.1371/journal.pone.0053939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326544	Green Published, gold, Green Submitted			2022-12-25	WOS:000313552400063
J	Wu, DM; Kraut, JA; Abraham, WM				Wu, Dongmei; Kraut, Jeffrey A.; Abraham, William M.			Sabiporide Improves Cardiovascular Function, Decreases the Inflammatory Response and Reduces Mortality in Acute Metabolic Acidosis in Pigs	PLOS ONE			English	Article							EXTRACELLULAR ACIDOSIS; EXCHANGE INHIBITION; SODIUM-BICARBONATE; LACTIC-ACIDOSIS; MECHANISMS; CONTRACTILITY; MYOCARDIUM; ACTIVATION; MANAGEMENT; DIAGNOSIS	Introduction: Acute metabolic acidosis impairs cardiovascular function and increases the mortality of critically ill patients. However, the precise mechanism(s) underlying these effects remain unclear. We hypothesized that targeting pH-regulatory protein, Na+/H+ exchanger (NHE1) could be a novel approach for the treatment of acute metabolic acidosis. The aim of the present study was to examine the impact of a novel NHE1 inhibitor, sabiporide, on cardiovascular function, blood oxygen transportation, and inflammatory response in an experimental model of metabolic acidosis produced by hemorrhage-induced hypovolemia followed by an infusion of lactic acid. Methods and Results: Anesthetized pigs were subjected to hypovolemia for 30 minutes. The animals then received a bolus infusion of sabiporide (3 mg/kg) or vehicle, followed by an infusion of lactic acid for 2 hours. The animals were continuously monitored for additional 3 hours. Hypovolemia followed by a lactic acid infusion resulted in a severe metabolic acidosis with blood pH falling to 6.8. In association with production of the acidemia, there was an excessive increase in pulmonary artery pressure (PAP) and pulmonary vascular resistance (PVR). Treatment with sabiporide significantly attenuated the increase in PAP by 38% and PVR by 67%, as well as significantly improved cardiac output by 51%. Sabiporide treatment also improved mixed venous blood oxygen saturation (55% in sabiporide group vs. 28% in control group), and improved systemic blood oxygen delivery by 36%. In addition, sabiporide treatment reduced plasma levels of TNF-alpha (by 33%), IL-6 (by 63%), troponin-I (by 54%), ALT (by 34%), AST (by 35%), and urea (by 40%). Conclusion: These findings support the possible beneficial effects of sabiporide in the treatment of acute metabolic acidosis and could have implications for the treatment of metabolic acidosis in man.	[Wu, Dongmei] Mt Sinai Med Ctr, Dept Res, Div Neonatol, Miami Beach, FL 33140 USA; [Abraham, William M.] Mt Sinai Med Ctr, Div Pulm & Crit Care Med, Miami Beach, FL 33140 USA; [Wu, Dongmei] Chonbuk Natl Univ, Dept BIN Fus Technol, Jeonju, South Korea; [Kraut, Jeffrey A.] Vet Adm Greater Angeles Healthcare Syst, Div Nephrol Med & Res Serv, Los Angeles, CA USA; [Kraut, Jeffrey A.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Mount Sinai Medical Center; Mount Sinai Medical Center; Jeonbuk National University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wu, DM (corresponding author), Mt Sinai Med Ctr, Dept Res, Div Neonatol, Miami Beach, FL 33140 USA.	dongmeiwu@bellsouth.net	Wu, Dongmei/I-3213-2016; Chen, Zhong-Hua/B-8927-2008; Dai, Fei/F-6512-2010; Wu, Dezhi/AAO-9316-2020; Wu, Dongrui/E-1956-2011; Schaefer, Dirk/I-9806-2018	Chen, Zhong-Hua/0000-0002-7531-320X; Wu, Dongrui/0000-0002-7153-9703; Schaefer, Dirk/0000-0002-5695-9312; Wu, Dezhi/0000-0002-7900-0542; Parsons, Thomas/0000-0003-0331-5019; Wu, Feibo/0000-0001-8797-3398	USAMRMC [W81XWH-06-1-0719]; Ministry of Education, Science and Technology [R31-20029, 2012007331]; National Research Foundation of Korea (NRF); honbuk National University, Korea	USAMRMC(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); honbuk National University, Korea	This work was supported by a USAMRMC grant W81XWH-06-1-0719 (to DW); and in part by the World Class University Program (R31-20029) funded by the Ministry of Education, Science and Technology; by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012007331); and by New Faculty funding from Chonbuk National University, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrogue HJ, 1998, NEW ENGL J MED, V338, P107, DOI 10.1056/NEJM199801083380207; ANDERSON SE, 1990, AM J PHYSIOL, V259, pC940, DOI 10.1152/ajpcell.1990.259.6.C940; BRIMIOULLE S, 1990, AM J PHYSIOL, V258, pH347, DOI 10.1152/ajpheart.1990.258.2.H347; CINGOLANI HE, 1975, SURGERY, V77, P427; COOPER DJ, 1993, AM REV RESPIR DIS, V148, P317, DOI 10.1164/ajrccm/148.2.317; Doods H, 2013, J BIOMEDICI IN PRESS; Forsythe SM, 2000, CHEST, V117, P260, DOI 10.1378/chest.117.1.260; Gunnerson KJ, 2006, CRIT CARE, V10, DOI 10.1186/cc3987; HUSEBY JS, 1981, CHEST, V79, P552, DOI 10.1378/chest.79.5.552; Karmazyn M, 1999, J THROMB THROMBOLYS, V8, P33, DOI 10.1023/A:1008990530176; Kellum JA, 2004, CRIT CARE, V8, P331, DOI 10.1186/cc2900; Kellum JA, 2004, AM J PHYSIOL-REG I, V286, pR686, DOI 10.1152/ajpregu.00564.2003; Kellum JA, 2004, CHEST, V125, P243, DOI 10.1378/chest.125.1.243; Kraut JA, 2005, AM J KIDNEY DIS, V45, P978, DOI 10.1053/j.ajkd.2005.03.003; Kraut JA, 2010, NAT REV NEPHROL, V6, P274, DOI 10.1038/nrneph.2010.33; Lin X, 2012, RESUSCITATION; MARSIGLIA JC, 1973, CARDIOVASC RES, V7, P336, DOI 10.1093/cvr/7.3.336; Martinez D, 2006, J IMMUNOL, V176, P1163, DOI 10.4049/jimmunol.176.2.1163; MATHIEU D, 1991, CRIT CARE MED, V19, P1352, DOI 10.1097/00003246-199111000-00008; Nemeth ZH, 2002, AM J PHYSIOL-CELL PH, V283, pC396, DOI 10.1152/ajpcell.00491.2001; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Serrano CV, 1996, AM J PHYSIOL-CELL PH, V271, pC962, DOI 10.1152/ajpcell.1996.271.3.C962; Siesjo BK, 1996, ACT NEUR S, V66, P8; Sikes PJ, 2005, CRIT CARE MED, V33, P605, DOI 10.1097/01.ccm.0000155910.89252.FE; Vaughan-Jones Richard D, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS134, DOI 10.1111/j.1540-8167.2006.00394.x; Webster KA, 1999, J CLIN INVEST, V104, P239; WIKLUND L, 1985, CRIT CARE MED, V13, P109, DOI 10.1097/00003246-198502000-00012; Wu DM, 2000, BASIC RES CARDIOL, V95, P449, DOI 10.1007/s003950070020; Wu DM, 2008, SHOCK, V29, P519, DOI 10.1097/SHK.0b013e318150757a; Wu DM, 2012, RESUSCITATION, V83, P774, DOI 10.1016/j.resuscitation.2011.11.025; Wu DM, 2009, CRIT CARE MED, V37, P1994, DOI 10.1097/CCM.0b013e3181a0052e	32	207	219	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53932	10.1371/journal.pone.0053932	http://dx.doi.org/10.1371/journal.pone.0053932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23437188	Green Submitted, Green Published, gold			2022-12-25	WOS:000313552400061
J	Wu, DZ; Cai, SG; Chen, MX; Ye, LZ; Chen, ZH; Zhang, HT; Dai, F; Wu, FB; Zhang, GP				Wu, Dezhi; Cai, Shengguan; Chen, Mingxian; Ye, Lingzhen; Chen, Zhonghua; Zhang, Haitao; Dai, Fei; Wu, Feibo; Zhang, Guoping			Tissue Metabolic Responses to Salt Stress in Wild and Cultivated Barley	PLOS ONE			English	Article							PROLINE ACCUMULATION; GAS-CHROMATOGRAPHY; SODIUM-TRANSPORT; ABIOTIC STRESS; DROUGHT STRESS; TOLERANCE; PLANTS; ARABIDOPSIS; HOMEOSTASIS; MANNITOL	A thorough understanding of the mechanisms underlying barley salt tolerance and exploitation of elite genetic resource are essential for utilizing wild barley germplasm in developing barley varieties with salt tolerance. In order to reveal the physiological and molecular difference in salt tolerance between Tibetan wild barley (Hordeum spontaneum) and cultivated barley (Hordeum vulgare), profiles of 82 key metabolites were studies in wild and cultivated barley in response to salinity. According to shoot dry biomass under salt stress, XZ16 is a fast growing and salt tolerant wild barley. The results of metabolite profiling analysis suggested osmotic adjustment was a basic mechanism, and polyols played important roles in developing salt tolerance only in roots, and high level of sugars and energy in roots and active photosynthesis in leaves were important for barley to develop salt tolerance. The metabolites involved in tolerance enhancement differed between roots and shoots, and also between genotypes. Tibetan wild barley, XZ16 had higher chlorophyll content and higher contents of compatible solutes than CM72, while the cultivated barley, CM72 probably enhanced its salt tolerance mainly through increasing glycolysis and energy consumption, when the plants were exposed to high salinity. The current research extends our understanding of the mechanisms involved in barley salt tolerance and provides possible utilization of Tibetan wild barley in developing barley cultivars with salt tolerance.	[Wu, Dezhi; Cai, Shengguan; Chen, Mingxian; Ye, Lingzhen; Zhang, Haitao; Dai, Fei; Wu, Feibo; Zhang, Guoping] Zhejiang Univ, Dept Agron, Key Lab Crop Germplasm Resource Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Zhonghua] Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 1797, Australia	Zhejiang University; Western Sydney University	Zhang, GP (corresponding author), Zhejiang Univ, Dept Agron, Key Lab Crop Germplasm Resource Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China.	zhanggp@zju.edu.cn	Wu, Dongmei/I-3213-2016; Chen, Zhong-Hua/B-8927-2008; Dai, Fei/F-6512-2010; Wu, Dezhi/AAO-9316-2020; Wu, Dongrui/E-1956-2011; Schaefer, Dirk/I-9806-2018	Chen, Zhong-Hua/0000-0002-7531-320X; Wu, Dongrui/0000-0002-7153-9703; Schaefer, Dirk/0000-0002-5695-9312; Wu, Dezhi/0000-0002-7900-0542; Parsons, Thomas/0000-0003-0331-5019; Wu, Feibo/0000-0001-8797-3398	Natural Science Foundation of China [31129005, 31171544]; Natural Science Foundation of Zhejiang Province, China [Z3110054]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province)	This research was supported by Natural Science Foundation of China (31129005 and 31171544), Natural Science Foundation of Zhejiang Province, China (Z3110054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe T, 2003, PLANT PHYSIOL, V131, P1748, DOI 10.1104/pp.102.003616; Alvarez S, 2008, PLANT CELL ENVIRON, V31, P325, DOI 10.1111/j.1365-3040.2007.01770.x; Armengaud P, 2009, PLANT PHYSIOL, V150, P772, DOI 10.1104/pp.108.133629; Blumwald E, 2000, CURR OPIN CELL BIOL, V12, P431, DOI 10.1016/S0955-0674(00)00112-5; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Chen THH, 2002, CURR OPIN PLANT BIOL, V5, P250, DOI 10.1016/S1369-5266(02)00255-8; Chen Z, 2005, PLANT CELL ENVIRON, V28, P1230, DOI 10.1111/j.1365-3040.2005.01364.x; Chen Z, 2007, J EXP BOT, V58, P4245, DOI 10.1093/jxb/erm284; Chen ZH, 2007, PLANT PHYSIOL, V145, P1714, DOI 10.1104/pp.107.110262; Cuin TA, 2007, PLANTA, V225, P753, DOI 10.1007/s00425-006-0386-x; Dai F, 2012, P NATL ACAD SCI USA, V109, P16969, DOI 10.1073/pnas.1215265109; Dai HX, 2011, J PLANT NUTR SOIL SC, V174, P952, DOI 10.1002/jpln.201100148; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Du J, 2008, PLANT J, V56, P653, DOI 10.1111/j.1365-313X.2008.03602.x; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Gong QQ, 2005, PLANT J, V44, P826, DOI 10.1111/j.1365-313X.2005.02587.x; Hare PD, 1998, PLANT CELL ENVIRON, V21, P535, DOI 10.1046/j.1365-3040.1998.00309.x; Hong ZL, 2000, PLANT PHYSIOL, V122, P1129, DOI 10.1104/pp.122.4.1129; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kim HK, 2010, PHYTOCHEM ANALYSIS, V21, P4, DOI 10.1002/pca.1188; Kim JK, 2007, J EXP BOT, V58, P415, DOI 10.1093/jxb/erl216; Kronzucker HJ, 2011, NEW PHYTOL, V189, P54, DOI 10.1111/j.1469-8137.2010.03540.x; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Liu JP, 1997, PLANT PHYSIOL, V114, P591, DOI 10.1104/pp.114.2.591; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nevo E, 2010, PLANT CELL ENVIRON, V33, P670, DOI 10.1111/j.1365-3040.2009.02107.x; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Oliver MJ, 2011, PLANT CELL, V23, P1231, DOI 10.1105/tpc.110.082800; PHARR DM, 1995, HORTSCIENCE, V30, P1182, DOI 10.21273/HORTSCI.30.6.1182; Qiu L, 2011, THEOR APPL GENET, V122, P695, DOI 10.1007/s00122-010-1479-2; Renberg L, 2010, PLANT PHYSIOL, V154, P187, DOI 10.1104/pp.110.157651; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Roessner U, 2006, PLANT PHYSIOL, V142, P1087, DOI 10.1104/pp.106.084053; Sakamoto A, 1998, PLANT MOL BIOL, V38, P1011, DOI 10.1023/A:1006095015717; Sanchez DH, 2008, PHYSIOL PLANTARUM, V132, P209, DOI 10.1111/j.1399-3054.2007.00993.x; Shabala S, 2005, J EXP BOT, V56, P1369, DOI 10.1093/jxb/eri138; Shulaev V, 2008, PHYSIOL PLANTARUM, V132, P199, DOI 10.1111/j.1399-3054.2007.01025.x; Stoop JMH, 1996, TRENDS PLANT SCI, V1, P139, DOI 10.1016/S1360-1385(96)80048-3; Ueda A, 2004, J EXP BOT, V55, P2213, DOI 10.1093/jxb/erh242; Urano K, 2010, CURR OPIN PLANT BIOL, V13, P132, DOI 10.1016/j.pbi.2009.12.006; Wang X, 2008, PLANTA, V227, P611, DOI 10.1007/s00425-007-0643-7; Widodo, 2009, J EXP BOT, V60, P4089, DOI 10.1093/jxb/erp243; Wu DZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022938; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; XU T, 1982, Acta Genetica Sinica, V9, P440; Yamaguchi T, 2005, TRENDS PLANT SCI, V10, P615, DOI 10.1016/j.tplants.2005.10.002; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Zhao J, 2010, EUPHYTICA, V172, P395, DOI 10.1007/s10681-009-0064-8; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	54	207	219	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55431	10.1371/journal.pone.0055431	http://dx.doi.org/10.1371/journal.pone.0055431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23437188	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600104
J	Liu, L; Boffa, MB; Koschinsky, ML				Liu, Lei; Boffa, Michael B.; Koschinsky, Marlys L.			Apolipoprotein(a) Inhibits In Vitro Tube Formation in Endothelial Cells: Identification of Roles for Kringle V and the Plasminogen Activation System	PLOS ONE			English	Article							LYSINE-BINDING SITE; FIBRIN FRAGMENT-E; TUMOR-GROWTH; MATRIX METALLOPROTEINASES; MAMMALIAN-CELLS; NITRIC-OXIDE; RISK-FACTOR; ANGIOGENESIS; LIPOPROTEIN(A); ATHEROSCLEROSIS	Elevated plasma concentrations of lipoprotein(a) are associated with increased risk for atherothrombotic diseases. Apolipoprotein(a), the unique glycoprotein component of lipoprotein(a), is characterized by the presence of multiple kringle domains, and shares a high degree of sequence homology with the serine protease zymogen plasminogen. It has been shown that angiostatin, a proteolytic fragment of plasminogen containing kringles 1-4, can effectively inhibit angiogenesis. Moreover, proteolytic fragments of plasminogen containing kringle 5 are even more potent inhibitors of angiogenesis than angiostatin. Despite its strong similarity with plasminogen, the role of apolipoprotein(a) in angiogenesis remains controversial, with both pro-and anti-angiogenic effects reported. In the current study, we evaluated the ability of apolipoprotein(a) to inhibit VEGF-and angiopoietin-induced tube formation in human umbilical cord endothelial cells. A 17 kringle-containing form of recombinant apo(a) (17K), corresponding to a well-characterized, physiologically-relevant form of the molecule, effectively inhibited tube formation induced by either VEGF or angiopoietin-1. Using additional recombinant apolipoprotein(a) (r-apo(a)) variants, we demonstrated that this effect was dependent on the presence of an intact lysine-binding site in kringle V domain of apo(a), but not on the presence of the functional lysine-binding site in apo(a) kringle IV type 10; sequences within in the amino-terminal half of the molecule were also not required for the inhibitory effects of apo(a). We also showed that the apo(a)-mediated inhibition tube formation could be reversed, in part by the addition of plasmin or urokinase plasminogen activator, or by removal of plasminogen from the system. Further, we demonstrated that apo(a) treated with glycosidases to remove sialic acid was significantly less effective in inhibiting tube formation. This is the first report of a functional role for the glycosylation of apo(a) although the mechanisms underlying this observation remain to be determined in the context of angiogenesis.	[Liu, Lei] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Boffa, Michael B.; Koschinsky, Marlys L.] Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada	Queens University - Canada; University of Windsor	Boffa, MB (corresponding author), Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada.	mboffa@uwindsor.ca	Boffa, Michael/N-6539-2019; Liu, Lei/J-7929-2017; Gundersen, Per/B-2192-2008	Boffa, Michael/0000-0003-1211-3064; Koschinsky, Marlys/0000-0002-2643-2288; Liu, Lei/0000-0002-8063-610X; Gundersen, Per/0000-0002-9199-4033; Qu, Cunmin/0000-0003-2413-2350	Heart and Stroke Foundation of Ontario [T5916]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	Funding: This work was funded by a grant (T5916) from the Heart and Stroke Foundation of Ontario to Dr. Koschinsky. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaei S, 2003, AM J PATHOL, V162, P1927, DOI 10.1016/S0002-9440(10)64326-X; Babaei S, 1998, CIRC RES, V82, P1007, DOI 10.1161/01.RES.82.9.1007; Becker L, 2004, BIOCHEMISTRY-US, V43, P9978, DOI 10.1021/bi049536d; Belczewski AR, 2005, BIOCHEMISTRY-US, V44, P555, DOI 10.1021/bi048156p; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669; Boffa MB, 2004, CLIN BIOCHEM, V37, P333, DOI 10.1016/j.clinbiochem.2003.12.007; Cao YH, 1997, J BIOL CHEM, V272, P22924, DOI 10.1074/jbc.272.36.22924; Cho T, 2008, J BIOL CHEM, V283, P30503, DOI 10.1074/jbc.M802648200; Edelstein C, 2003, J BIOL CHEM, V278, P52841, DOI 10.1074/jbc.M310425200; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; FLESS GM, 1986, J BIOL CHEM, V261, P8712; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; GRAINGER DJ, 1993, SCIENCE, V260, P1655, DOI 10.1126/science.8503012; Hancock MA, 2003, J BIOL CHEM, V278, P23260, DOI 10.1074/jbc.M302780200; HARPEL PC, 1989, P NATL ACAD SCI USA, V86, P3847, DOI 10.1073/pnas.86.10.3847; Ji WR, 1998, BIOCHEM BIOPH RES CO, V247, P414, DOI 10.1006/bbrc.1998.8825; Kim JS, 2004, BIOCHEM BIOPH RES CO, V313, P534, DOI 10.1016/j.bbrc.2003.11.148; Kim JS, 2003, J BIOL CHEM, V278, P29000, DOI 10.1074/jbc.M301042200; Koolwijk P, 1996, J CELL BIOL, V132, P1177, DOI 10.1083/jcb.132.6.1177; KOSCHINSKY ML, 1991, BIOCHEMISTRY-US, V30, P5044, DOI 10.1021/bi00234a029; KOSCHINSKY ML, 1993, J BIOL CHEM, V268, P19819; Koschinsky ML, 2009, CLIN LIPIDOLOGY COMP, P130; Kostner KM, 1996, ARTERIOSCL THROM VAS, V16, P905, DOI 10.1161/01.ATV.16.8.905; KRATZIN H, 1987, BIOL CHEM H-S, V368, P1533, DOI 10.1515/bchm3.1987.368.2.1533; Kroon Marielle E., 2002, Angiogenesis, V5, P257, DOI 10.1023/A:1024540701634; Kroon ME, 1999, AM J PATHOL, V154, P1731, DOI 10.1016/S0002-9440(10)65429-6; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; Lee K, 2006, HEPATOLOGY, V43, P1063, DOI 10.1002/hep.21149; Lim YM, 2012, DIABETES, V61, P1599, DOI 10.2337/db11-1541; Liu L, 2009, BIOCHEM J, V418, P325, DOI 10.1042/BJ20080744; Lou XJ, 1998, EXP MOL PATHOL, V65, P53, DOI 10.1006/exmp.1998.2230; Marcovina SM, 2003, CURR OPIN LIPIDOL, V14, P361, DOI 10.1097/00041433-200308000-00004; MCCANCE SG, 1994, J BIOL CHEM, V269, P32405; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Mignatti P, 1996, ENZYME PROTEIN, V49, P117, DOI 10.1159/000468621; Moreno PR, 2006, CIRCULATION, V113, P2245, DOI 10.1161/CIRCULATIONAHA.105.578955; Morishita R, 2002, CIRCULATION, V105, P1491, DOI 10.1161/01.CIR.0000012146.07240.FD; O'Neil CH, 2004, J BIOL CHEM, V279, P55187, DOI 10.1074/jbc.M409860200; O'Reilly M S, 1997, EXS, V79, P273; Pepper M S, 1996, Vasc Med, V1, P259; Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685; Perri SR, 2007, MOL CANCER THER, V6, P441, DOI 10.1158/1535-7163.MCT-06-0434; Ribatti D, 1998, EUR J CLIN INVEST, V28, P533; SANGRAR W, 1994, PROTEIN ENG, V7, P723, DOI 10.1093/protein/7.5.723; Sangrar W, 1997, BIOCHEMISTRY-US, V36, P10353, DOI 10.1021/bi962433d; Schulter V, 2001, ARTERIOSCL THROM VAS, V21, P433, DOI 10.1161/01.ATV.21.3.433; Shen L, 2008, BIOL CHEM, V389, P135, DOI 10.1515/BC.2008.016; Stirk CM, 2000, GEN PHARMACOL-VASC S, V35, P261, DOI 10.1016/S0306-3623(01)00114-8; THOMPSON WD, 1992, J PATHOL, V168, P47, DOI 10.1002/path.1711680109; Trieu VN, 1999, BIOCHEM BIOPH RES CO, V257, P714, DOI 10.1006/bbrc.1999.0519; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P716, DOI 10.1016/j.jacc.2012.04.038; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; VANDERHOEK YY, 1993, HUM MOL GENET, V2, P361, DOI 10.1093/hmg/2.4.361; Yang BH, 2004, J CELL PHYSIOL, V200, P360, DOI 10.1002/jcp.20025; Yi ZF, 2009, INT J CANCER, V124, P843, DOI 10.1002/ijc.24027	57	242	254	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52287	10.1371/journal.pone.0052287	http://dx.doi.org/10.1371/journal.pone.0052287			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23593427	Green Submitted, gold, Green Published			2022-12-25	WOS:000314705800014
J	Li, YY; Xie, J; Wu, SY; Xia, J; Zhang, PF; Liu, C; Zhang, P; Huang, X				Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi			Protein Kinase Regulated by dsRNA Downregulates the Interferon Production in Dengue Virus- and dsRNA-Stimulated Human Lung Epithelial Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; PKR-DEPENDENT ACTIVATION; CELLULAR ACTIVATOR; RIG-I; BINDING PROTEIN; ADAPTER IPS-1; INDUCTION; INFECTION; TRANSLATION	Background: Dengue virus (DENV) is found in the tropical and subtropical regions and affects millions of people annually. Currently, no specific vaccine or antiviral treatment against dengue virus is available. Innate immunity has been shown to be important for host resistance to DENV infection. Although protein kinase regulated by double-stranded RNA (PKR) has been found to promote the innate signaling in response to infection by several viruses, its role in the innate response to DENV infection is still unclear. Our study aimed to investigate the role of PKR in DENV-induced innate immune responses. Methodology/Principal Findings: By RNAi, silencing of PKR significantly enhanced the expression of interferon (IFN)-beta in DENV infected human lung epithelial A549 cells. Western blot and immunofluorescence microscopy data showed that PKR knockdown upregulated the activation of innate signaling cascades including p38 and JNK mitogen-activated protein kinases (MAPKs), interferon regulatory factor-3 and NF-kappa B, following DENV2 infection. Likewise, a negative regulatory effect of PKR on the IFN production was also observed in poly(IC) challenged cells. Moreover, the PKR knockdown-mediated IFN induction was attenuated by RIG-I or IPS-1 silencing. Finally, overexpression of a catalytically inactive PKR mutant (K296R), but not of a mutant lacking dsRNA binding activity (K64E) or the double mutant (K64EK296R), reversed the IFN induction mediated by PKR knockdown, suggesting that the dsRNA binding activity is required for PKR to downregulate IFN production. Conclusions/Significance: PKR acts as a negative regulator of IFN induction triggered by DENVs and poly(IC), and this regulation relies on its dsRNA binding activity. These findings reveal a novel regulatory role for PKR in innate immunity, suggesting that PKR might be a promising target for anti-DENV treatments.	[Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, P (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China.	zhangp36@mail.sysu.edu.cn; huangxi6@mail.sysu.edu.cn	Liu, Hongliang/P-3444-2014; Scott, Colin/A-4682-2009; Oakeshott, John/B-5365-2009; Teese, Mark George/B-4307-2008; Chen, Huaping/O-3096-2014	Liu, Hongliang/0000-0001-7639-0904; Scott, Colin/0000-0001-6110-6982; Oakeshott, John/0000-0001-8324-7874; Tollefsbol, Trygve/0000-0002-0284-1511; Li, Yong/0000-0002-3595-6673; Li, Yongwen/0000-0001-6102-2949; Teese, Mark George/0000-0002-8003-4918; HUANG, XI/0000-0002-4829-8390; Song, Yajun/0000-0002-6628-2747; Chen, Huaping/0000-0002-9835-5138; Yang, Xianwei/0000-0003-4388-9674	National Natural Science Foundation of China [30972763, 81261160323, 81171576, 30901345, U0832006]; Guangdong innovative research team program [2009010058]; Guangdong Province Universities and Colleges Pearl River School Funded Scheme [2009]; Guangdong Natural Science Foundation [10251008901000013]; National Basic Research Program of China [2010CB530004]; Doctoral Fund of Ministry of Education of China [20100171110047]; Fundamental Research Funds for the Central Universities of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong innovative research team program; Guangdong Province Universities and Colleges Pearl River School Funded Scheme; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National Basic Research Program of China(National Basic Research Program of China); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (30972763, 81261160323, 81171576, 30901345, U0832006), Guangdong innovative research team program (NO. 2009010058), Guangdong Province Universities and Colleges Pearl River School Funded Scheme (NO. 2009), Guangdong Natural Science Foundation (10251008901000013), National Basic Research Program of China (2010CB530004), Doctoral Fund of Ministry of Education of China (20100171110047), Fundamental Research Funds for the Central Universities of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Arnaud N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002289; Arnaud N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010575; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Barry G, 2009, J GEN VIROL, V90, P1382, DOI 10.1099/vir.0.007336-0; Bonnet MC, 2006, CELL SIGNAL, V18, P1865, DOI 10.1016/j.cellsig.2006.02.010; Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000; Boonyaratanakornkit J, 2011, J VIROL, V85, P1495, DOI 10.1128/JVI.01297-10; Brown MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034055; Cheung BKW, 2005, J IMMUNOL, V175, P7218, DOI 10.4049/jimmunol.175.11.7218; COLTHURST DR, 1987, EUR J BIOCHEM, V166, P357, DOI 10.1111/j.1432-1033.1987.tb13523.x; Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000; Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Katze Michael G., 1995, Trends in Microbiology, V3, P75, DOI 10.1016/S0966-842X(00)88880-0; Kok KH, 2011, CELL HOST MICROBE, V9, P299, DOI 10.1016/j.chom.2011.03.007; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Langland JO, 1999, BIOCHEMISTRY-US, V38, P6361, DOI 10.1021/bi982410u; Lee YR, 2007, VIRUS RES, V126, P216, DOI 10.1016/j.virusres.2007.03.003; McAllister CS, 2012, J BIOL CHEM, V287, P36384, DOI 10.1074/jbc.M112.390039; McAllister CS, 2010, J VIROL, V84, P380, DOI 10.1128/JVI.02630-08; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Nakayama Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000966; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Pereira RMS, 2010, FASEB J, V24, P617, DOI 10.1096/fj.09-140053; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099; Porterfield J S, 1980, Med Trop (Mars), V40, P493; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; RUSSELL PK, 1967, J IMMUNOL, V99, P291; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Sadler AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000311; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; Sen A, 2011, J VIROL, V85, P3717, DOI 10.1128/JVI.02634-10; Silva AM, 2004, J BIOL CHEM, V279, P37670, DOI 10.1074/jbc.M406554200; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Thomas Stephen J, 2003, Adv Virus Res, V61, P235, DOI 10.1016/S0065-3527(03)61006-7; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0; Weber F, 2006, J INTERF CYTOK RES, V26, P1, DOI 10.1089/jir.2006.26.1; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zhang P, 2009, J VIROL, V83, P5718, DOI 10.1128/JVI.00224-09; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	63	321	342	10	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55108	10.1371/journal.pone.0055108	http://dx.doi.org/10.1371/journal.pone.0055108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23342141	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400065
